PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Mathew, P; Bullock, R; Graham, DI; Maxwell, WL; Teasdale, GM; McCulloch, J				Mathew, P; Bullock, R; Graham, DI; Maxwell, WL; Teasdale, GM; McCulloch, J			A new experimental model of contusion in the rat - Histopathological analysis and temporal patterns of cerebral blood flow disturbances	JOURNAL OF NEUROSURGERY			English	Article						focal injury; inflammation; ischemia; rat	TRAUMATIC BRAIN INJURY; PHORBOL-MYRISTATE ACETATE; FLUID-PERCUSSION MODEL; DIFFUSE AXONAL INJURY; ACUTE HEAD-INJURY; GLUTAMATE NEUROTOXICITY; VASCULAR DISRUPTION; ISCHEMIC DAMAGE; CORTICAL INJURY; OXYGEN RADICALS	The authors have derived a simple reproducible rodent of focal injury that uses a mechanical suction force applied through intact dura. The time course and pattern of changes in neurons, glia, and microvasculature were investigated using this model. Early traumatic disruption of the blood-brain barrier and hemorrhage do not occur in this model; however, many of the features of human contusion seen with light and electron microscopy are closely reproduced. At the site of injury, early swelling adn lucency of neural dendritic processes have been shown to precede an astrocyte response. In the absence of perivascular hemorrhage, delayed perivascular protein leakage and polymorphonuclear infiltration of the damaged cortex occurs, which is suggestive of an acute inflammatory response. Cerebral blood flow (CBF) has been measured using C-14-iodoantipyrine autoradiography at 30 minutes, 4 hours, and 24 hours after induction of negative-pressure injury in rats anesthetized with halothane and in time-matched sham-operated controls. A significant reduction in blood flow in the sensorimotor cortex at the site of the injury was present at 30 minutes, 4 hours, and 24 hours after induction of the lesion, compared to the contralateral cortex (superficial lamina, ipsilateral 50 +/- 7 ml/100 g/minute, contralateral 112 +/- 26 ml/100 g/minute). The CBF was significantly reduced at the ipsilateral entorhinal cortex at 30 minutes postinjury but no significant reduction was demonstrated at later time points. Although marked alternations in CBF occurred in this cortical injury model, the magnitude and duration of the reduction in CBF are not consistent with those necessary for production of ischemic cell damage. These data indicate that this model of cortical injury can be used to examine biomechanical aspects of confusion without domination by ischemic pathophysiology.	SO GEN HOSP, INST NEUROL SCI, DEPT NEUROSURG, GLASGOW G51 4TF, LANARK, SCOTLAND; SO GEN HOSP, INST NEUROL SCI, DEPT NEUROPATHOL, GLASGOW G51 4TF, LANARK, SCOTLAND; WELLCOME SURG INST, GLASGOW, LANARK, SCOTLAND; UNIV GLASGOW, DEPT ANAT, GLASGOW G12 8QQ, LANARK, SCOTLAND					Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1982, RECENT ADV NEUROPATH, V2, P165; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; CHEUNG JY, 1986, NEW ENGL J MED, V314, P1670; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P407, DOI 10.1111/j.1365-2990.1991.tb00740.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FINEMAN I, 1990, Society for Neuroscience Abstracts, V16, P778; FUJISAWA H, 1994, ACT NEUR S, V60, P193; FUMEYA H, 1990, ACT NEUR S, V51, P283; GENNARELLI TA, P 15 STAPP CAR CRASH, P296; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GRAHAM DI, 1971, LANCET, V1, P265; HANSEN AJ, 1985, PHYSIOL REV, V65, P101; HEISS WD, 1992, STROKE, V23, P1668, DOI 10.1161/01.STR.23.11.1668; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1989, INTRACRANIAL PRESSUR, V7, P584; KAWAI K, 1989, ACTA NEUROPATHOL, V77, P449, DOI 10.1007/BF00687245; KIMELBERG HK, 1989, J NEUROSCI, V9, P1141; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KOCHANEK PM, 1990, LIPID MEDIATORS ISCH, P220; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; LITTLE JR, 1976, STROKE, V7, P25, DOI 10.1161/01.STR.7.1.25; MATHEW P, 1994, ACTA NEUROCHIR, P428; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MAXWELL WL, 1981, J ANAT, V164, P249; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; MENDELOW AD, 1991, J CEREB BLOOD FLOW M, V11, pS867; MIES G, 1991, J CEREB BLOOD FLOW M, V11, P735; NICHOLLS D, TRENDS; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ORRENIUS S, 1988, ISI ATLAS-PHARMACOL, V2, P319; RIPPERGER EA, 1975, HDB CLIN NEUROLOGY, V23, P91; ROPER SN, 1991, J NUCL MED, V32, P1684; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHURER L, 1990, ACT NEUR S, V51, P49; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHASBY DM, 1982, AM REV RESPIR DIS, V125, P443; SHASBY DM, 1983, AM REV RESPIR DIS, V127, P72, DOI 10.1164/arrd.1983.127.1.72; SHIMADA N, 1989, J CEREBR BLOOD F MET, V9, P603, DOI 10.1038/jcbfm.1989.86; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SIESJO BK, 1992, NEURODEGENER DIS, P35; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TEASDALE E, 1990, HDB CLIN NEUROLOGY, V13, P143; THOMAS MJ, 1990, SOC NEUR ABSTR, V16, P77; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; TYSON GW, 1984, ANN NEUROL, V15, P559, DOI 10.1002/ana.410150608; UHL M W, 1990, Critical Care Medicine, V18, pS274; UNTERHARNSCHEID.FJ, 1970, DYNAMIC RESPONSE BIO; VANEZIS P, 1987, FORENSIC SCI INT, V35, P1, DOI 10.1016/0379-0738(87)90018-1; VORNOV JJ, 1991, J NEUROCHEM, V56, P996, DOI 10.1111/j.1471-4159.1991.tb02020.x; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WEISSMANN G, 1980, NEW ENGL J MED, V303, P27; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	73	17	19	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	1996	85	5					860	870		10.3171/jns.1996.85.5.0860			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	VP489	WOS:A1996VP48900017	8893725				2021-06-18	
J	Jordan, FM; CremonaMeteyard, S; King, A				Jordan, FM; CremonaMeteyard, S; King, A			High-level linguistic disturbances subsequent to childhood closed head injury	BRAIN INJURY			English	Article							INTELLECTUAL ABILITY; ADOLESCENTS; CHILDREN; RECOVERY	High-level language functioning was assessed in a group of 11 children with severe closed head injury (CHI). Performance was examined on measures of figurative language, oral expression, inferencing, and interpretation of ambiguous sentences, and was compared with that of a control group matched for age, gender, and handedness. The children with CHI demonstrated inferior performance on the oral expression, ambiguous sentences, and figurative language tests; however, performance on the inferencing task appeared intact. These findings are discussed with respect to the underlying nature of the observed impairments. Both linguistic and cognitive factors are considered. It is concluded that a complex interaction of cognitive and linguistic impairments experienced by children with CHI may underlie the performance deficits identified in the current study.		Jordan, FM (corresponding author), UNIV QUEENSLAND,DEPT SPEECH PATHOL & AUDIOL,ST LUCIA,QLD 4072,AUSTRALIA.						BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Bloom L., 1978, LANGUAGE DEV LANGUAG; BOCK JK, 1982, PSYCHOL REV, V89, P1, DOI 10.1037/0033-295X.89.1.1; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Ewing-Cobbs L., 1985, SPEECH LANGUAGE EVAL, P97; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FISHER JP, 1992, 100 PICTURES NAMING; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; Guilford J. P., 1967, NATURE HUMAN INTELLI; HELIMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265; IMES C, 1983, COGNITIVE REHABILITA, V1, P11; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; JORDAN FM, 1995, J INT NEUROPSYCHOLOG, V1, P328; JORDAN FM, 1996, IN PRESS APHASIOLOGY; Kaplan E., 1983, BOSTON NAMING TEST; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kolb B., 1990, FUNDAMENTALS HUMAN N; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MALKMUS D, 1982, MOD TECHN COGN REH I, V2; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; SCHULTZ TR, 1973, CHILD DEV, V44, P728; Secord, 1989, TEST LANGUAGE COMPET; Spreen O, 1969, NEUROSENSORY CTR COM; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; TEASDALE G, 1974, LANCET, V2, P81; TOWNE RL, 1993, LANG SPEECH HEAR SER, V24, P100; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; WARD K, 1995, THESIS U QUEENSLAND; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186	34	17	17	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1996	10	10					729	738		10.1080/026990596123990			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	VH730	WOS:A1996VH73000003	8879663				2021-06-18	
J	Fattori, B; Borsari, C; Vannucci, G; Casani, A; Cristofani, R; Bonuccelli, L; Ghilardi, PL				Fattori, B; Borsari, C; Vannucci, G; Casani, A; Cristofani, R; Bonuccelli, L; Ghilardi, PL			Acupuncture treatment for balance disorders following whiplash injury	ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH			English	Article						acupuncture; whiplash injury; posturography; cervical vertigo	MACULAR VESTIBULAR INPUTS; NECK; NEURONS; RESPONSES	In this study, by means of computerized static posturography, we evaluated the postural changes after acupuncture treatment in a group of 15 patients with balance disorders caused by cervical torsion due to Whiplash Injury (WI). The acupuncture treatment consisted of 3 sessions (one weekly session for 3 weeks) during which the acupuncture points Bladder 10 (B1.10) and Gall Bladder 20 (G.B.20). VB were stimulated by means of piercing with needles, and manipulating the needles for 20 seconds. Each patient underwent posturographic evaluations before and just after each session of acupuncture. The posturographic tests were performed with open eyes (OE), closed eyes (CE) and closed eyes with retroflexed head (CER). As a control group, we used 17 patients complaining of the same symptoms as the study group due to WT, but treated with drugs (FANS and myorelaxing) and physiotherapy only. The patients of the control group also underwent posturographic tests once a week for three weeks. We observed a significant difference between the two groups regarding the reduction of the CER Length of the statokinesigram just before each session of acupuncture and reduction of the frequency oscillations (FFT) of the patients on the sagittal plane in the study group, in CER, whereas in the control group we observed a progressive increase in these values. The high percentage of positive results in our WI patients leads us to advocate the therapeutic efficacy of acupuncture for balance disorders due to cervical pathology, where it can be associated with or be a valid alternative to pharmacological treatment.		Fattori, B (corresponding author), UNIV PISA, ENT CLIN, 10 VIA SAVI, I-56100 PISA, ITALY.		salimi, mehdi/D-1192-2009				ABRAHAMS VC, 1988, PROG BRAIN RES, V76, P125; BAOHIAN P, 1993, WORLD J ACUPUNTURE M, V3, P43; BONUCCELLI L, 1991, GIORNALE ITALIANO RI, V3, P2; BOYLE R, 1981, J NEUROPHYSIOL, V45, P852; CHAN SHH, 1975, EXP NEUROL, V48, P336, DOI 10.1016/0014-4886(75)90161-2; COAN RM, 1982, AM J CLIN MED, V9, P327; CORVAJA N, 1979, NEUROSCIENCE, V4, P507, DOI 10.1016/0306-4522(79)90127-1; COULTER JD, 1976, J NEUROPHYSIOL, V39, P45; DENOTH F, 1980, J NEUROPHYSIOL, V43, P46; GURFINKEL E V, 1973, Agressologie, V14, P9; HAN J, 1988, SCI BASES ACUPUNCTUR, P7; HINOKI M, 1975, ACTA OTO-LARYNGOL, P185; Ito, 1984, CEREBELLUM NEURAL CO; Karlberg M, 1996, J VESTIBUL RES-EQUIL, V6, P37; KUBIN L, 1981, J NEUROPHYSIOL, V46, P48; MARCHAND AR, 1987, PFLUG ARCH EUR J PHY, V409, P13, DOI 10.1007/BF00584745; NORRE M E, 1987, Acta Oto-Rhino-Laryngologica Belgica, V41, P574; Norre M E, 1985, Ann Otolaryngol Chir Cervicofac, V102, P503; NORRE ME, 1988, CAHIERS ORL, V23, P11; NORRE ME, 1985, CAHIERS ORL, V20, P255; OMURA Y, 1982, ACUPUNCTURE ELECTRO, V7, P209, DOI 10.3727/036012982816952026; OMURA Y, 1983, ACUPUNCTURE ELECTRO, V8, P177; Omura Y., 1985, ACUPUNCTURE ELECTRO, V10, P1; Omura Y., 1975, ACUPUNCTURE ELECTRO, V1, P51; OMURA Y, 1996, ACUPUNCTURE MED ITS; Omura Y., 1976, ACUPUNCTURE ELECTRO, V2, P1; POMERANZ B, 1988, SCI BASES ACUPUNCTUR; POMPEIANO O, 1995, ACTA OTO-LARYNGOL, P82; POMPEIANO O, 1957, ARCH ITAL BIOL, V95, P166; QIU CZ, 1993, WORD J ACUPUNCTURE M, V3, P46; SENELAR R, 1979, NOUVEAU TRAITE ACUPU, P249; Zhang S, 1991, J Tradit Chin Med, V11, P26; ZIZZO A, 1990, 4 C AG NEUR, P29	33	17	17	1	9	COGNIZANT COMMUNICATION CORP	PUTNAM VALLEY	18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA	0360-1293	2167-9010		ACUPUNCTURE ELECTRO	Acupunct. Electro-Ther. Res.	JUL-DEC	1996	21	3-4					207	217		10.3727/036012996816356861			11	Integrative & Complementary Medicine; Neurosciences	Integrative & Complementary Medicine; Neurosciences & Neurology	WJ613	WOS:A1996WJ61300004	9051168				2021-06-18	
J	Gutman, SA; NapierKlemic, J				Gutman, SA; NapierKlemic, J			The experience of head injury on the impairment of gender identity and gender role	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activity configuration analysis; personality development		Objectives. This study explored the disruption of gender identity and gender role as a result a traumatic brain injury (TBI). Method. Four adults (two men, two women) who sustained a TBI between the ages of 18 and 30 years and were at least I year postinjury participated in six I-hr interviews concerning changes in (a) perceived masculinity or femininity, (b) involvement in intimate relationships, (c) enactment of gender roles, and (d) organization of activities that support gender roles. Results. The men expressed greater feelings, of gender inadequacy postinjury than did the women and appeared to have greater difficulty resolving rites of passage (e.g., achievement of the adult work role, marriage, parenting) and developmental issues characteristic of the life which they experienced their injury The men appeared to depend more heavily on traditional gender-specific activities before and after injury to define and support gender vole; the women relied more on cross-gender activities. The women appeared to be able to maintain more preinjury activities postinjury than did the men. Conclusion. Postinjury possession of a personally satisfying sense of gender appears to be related to the ability to maintain much of the preinjury activities that defined and supported the participants' sense of masculinity or femininity The ability to satisfactorily resolve rites of passage or developmental issues characteristic of the life stage at which the brain injury occurred appears to be related to the ability to participate in activities that define and express gender role during that particular life stage.	BEECHWOOD HEAD TRAUMA CTR,LANGHORNE,PA	Gutman, SA (corresponding author), NYU,DEPT OCCUPAT THERAPY,35 W 4TH ST,11TH FLOOR,NEW YORK,NY 10012, USA.						ALONI R, 1993, SEX DISABIL, V11, P121; ANDAMO EM, 1980, SEX DISABIL, V3, P26, DOI 10.1007/BF01102600; BAILEY MP, 1985, QUALITATIVE RES METH, P317; Bogdan R., 1992, QUALITATIVE RES ED I; BOLDRINI P, 1991, ARCH PHYS MED REHAB, V72, P202; CHAMPAGNE MP, 1982, SEX DISABIL, V5, P172, DOI 10.1007/BF01116416; Chandani A., 1989, BRIT J OCCUP THER, V52, P233, DOI [10.1177/030802268905200609, DOI 10.1177/030802268905200609]; CLARK RV, 1993, SEX DISABIL, V11, P235; Cole S. S, 1993, SEX DISABIL, V11, P189, DOI DOI 10.1007/BF01102578; COLE SS, 1991, SEX DISABIL, V9, P3; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; DEMTRAL GD, 1982, SEXUALITY DISBILITY, V6, P38; DIASIOSERRETT K, 1994, CAN AM OCC THER C BO; DUCHARME S, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI DOI 10.1097/00001199-199005020-00007; DUCHARME S, 1992, SEX DISABIL, V10, P193; EVANS J, 1985, AM J OCCUP THER, V39, P664, DOI 10.5014/ajot.39.10.664; FINGER WW, 1993, SEX DISABIL, V11, P39; FINGER WW, 1993, SEX DISABIL, V11, P3; FLINN S, 1982, SEX DISABIL, V5, P230, DOI 10.1007/BF01119864; FRENCH ME, 1992, SEX DISABIL, V10, P3; Goffman E., 1963, STIGMA NOTES MANAGEM; GRAVES WH, 1993, SEX DISABIL, V11, P243; GREEN DT, 1982, SEX DISABIL, V6, P20; HAHN H, 1981, SEX DISABIL, V4, P220, DOI 10.1007/BF01103307; HEPNER PJ, 1978, SEX DISABIL, V2, P38; HOWARD R, 1992, HEADLINES        JAN, P9; JOE BE, 1992, OT WEEK         0709, V6, P12; KAHN L, 1992, HEADLINES        JAN, P12; Kempton W., 1991, SEX DISABIL, V9, P93, DOI DOI 10.1007/BF01101735; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; LEFEBVRE KA, 1990, J HEAD TRAUMA REHABI, V5, P25; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; MONEY J, 1988, GAY STRAIGHT IN BETW; Money J, 1984, INT J FAM PSYCHIAT, V5, P317; Neistadt M. E., 1987, CHOICES GUIDE SEX CO; NEISTADT ME, 1986, AM J OCCUP THER, V40, P542, DOI 10.5014/ajot.40.8.542; NEISTADT ME, 1988, OT WEEK         0512, V2, P6; NEISTADT ME, 1988, OT WEEK         0512, V2, P30; PAYNE MJ, 1988, AM J OCCUP THER, V42, P227, DOI 10.5014/ajot.42.4.227; RHODES R, 1993, SEXUALITY DISABILITI, P2; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; Strauss A., 1987, QUALITATIVE ANAL SOC; Strauss D, 1991, SEX DISABIL, V9, P49; STRAVOS MK, 1991, SEX DISABIL, V1, P69; Tepper MS, 1992, SEX DISABIL, V10, P15, DOI DOI 10.1007/BF01102245; TRUDEL G, 1992, SEX DISABIL, V10, P173; Valentich M, 1984, SEX DISABIL, V7; WALTER E, 1982, SEX DISABIL, V5, P9, DOI 10.1007/BF01243807; WEINSTEIN BD, 1992, OCCUPATIONAL THERAPY, V4, P32; Zasler ND, 1991, SEX DISABIL, V9, P11	51	17	17	0	5	AMER OCCUPATION THERAPY ASSN	ROCKVILLE	1383 PICCARD DRIVE PO BOX ROCKVILLE, MD 20850-4375	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	1996	50	7					535	544		10.5014/ajot.50.7.535			10	Rehabilitation	Rehabilitation	UY446	WOS:A1996UY44600007	8819605				2021-06-18	
J	Little, AJ; Templer, DI; Persel, CS; Ashley, MJ				Little, AJ; Templer, DI; Persel, CS; Ashley, MJ			Feasibility of the neuropsychological spectrum in prediction of outcome following head injury	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article								This study provided further substantiation of the neuropsychological spectrum conceptualization (Templer, Campodonico, Trent, Spencer, & Hartlage, to appear; Templer, Spencer, & Hartlage, 1993; Templer, Campodonico, Trent, & Spencer, 1991). Two hundred and two traumatic brain injury patients were administered the Wechsler Adult Intelligence Scale-Revised, the Luria-Nebraska Neuropsychological Battery, the Wisconsin Card Sorting Test, the Booklet Category Test, and Trails A and B. The correlations between neuropsychological and intellectual tests were significantly lower than the correlations within intelligence tests and within neuropsychological tests. Neuropsychological tests predicted outcome better than intelligence tests. This was interpreted in terms of outcome for severely brain-damaged patients being more dependent upon basic neuropsychological functioning than on abstract thinking ability. (C) 1996 John Wiley & Sons, Inc.	CTR NEURO SKILLS,BAKERSFIELD,CA	Little, AJ (corresponding author), CALIF SCH PROFESS PSYCHOL,FRESNO,CA 93721, USA.						Ashley M. J., 1993, J HEAD TRAUMA REHAB, V8, P30; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Golden C. J., 1980, LURIA NEBRASKA NEURO; Heaton R. K, 1981, WISCONSIN CARD SORTI; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1955, J GEN PSYCHOL, V53, P97, DOI 10.1080/00221309.1955.9710140; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; TEMPLER D, IN PRESS INT J CLIN; TEMPLER D, 1991, NEUROPSYCHOLOGICAL S; Templer D. I., 1993, BIOSOCIAL PSYCHOPATH; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th	14	17	17	0	1	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	JUL	1996	52	4					455	460		10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F			6	Psychology, Clinical	Psychology	UZ761	WOS:A1996UZ76100011	8842883				2021-06-18	
J	Meyer, MA				Meyer, MA			Evaluating brain death with positron emission tomography: Case report on dynamic imaging of F-18-fluorodeoxyglucose activity after intravenous bolus injection	JOURNAL OF NEUROIMAGING			English	Article							CEREBRAL BLOOD-FLOW; GLUCOSE-UTILIZATION	A dynamic positron emission tomography (PET) study of the head was performed over 1 hour after the intravenous bolus administration of F-18-fluorodeoxyglucose (F-18-FDG) to a 18-year-old patient with the clinical diagnosis of brain death. This dynamic PET study was performed on the seventh day after a severe posttraumatic closed-head injury. No intracerebral uptake or retention of tracer was noted, consistent with a diffuse absence of brain metabolism. A small amount of tracer was noted to slowly rise over time within the sagittal sinus, indicating that visualization of sagittal sinuses on technetium 99m-diethylenetriaminepentaacetic acid planar images could provide a falsely negative scintigraphic evaluation for the presence of brain death. It is concluded that PET FDG imaging may be a useful technique in evaluating patients for brain death.	UNIV TENNESSEE,MED CTR,BIOMED IMAGING CTR,KNOXVILLE,TN							ALTMAN DI, 1987, PEDIATR RES, V21, pA487; BLACKLOCK JB, 1987, J NEUROSURG, V67, P71, DOI 10.3171/jns.1987.67.1.0071; GOODMAN JM, 1985, NEUROSURGERY, V16, P492, DOI 10.1227/00006123-198504000-00010; LAURIN NR, 1989, J NUCL MED, V30, P1627; LEE VW, 1987, J NUCL MED, V28, P1279; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; MEDLOCK MD, 1993, J NEUROSURG, V79, P752, DOI 10.3171/jns.1993.79.5.0752; MEYER MA, 1994, J NEUROSURG, V81, P644; Momose T, 1992, Kaku Igaku, V29, P1139; Sandler M. P., 1995, Journal of Nuclear Medicine, V36, p35P; Tsuchida T, 1993, Kaku Igaku, V30, P663	11	17	17	0	0	LITTLE BROWN CO	BOSTON	34 BEACON STREET, BOSTON, MA 02108-1493	1051-2284			J NEUROIMAGING	J. Neuroimaging	APR	1996	6	2					117	119		10.1111/jon199662117			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UG268	WOS:A1996UG26800011	8634485				2021-06-18	
J	Tsur, A; Sazbon, L; Lotem, M				Tsur, A; Sazbon, L; Lotem, M			Relationship between muscular tone, movement and periarticular new bone formation in postcoma-unaware (PC-U) patients	BRAIN INJURY			English	Article								Forty-eight post-traumatic brain-injured patients in postcoma-unawareness (PC-U) state, are included in this study. All recovered consciousness at least 1 month after the accident. The muscular tone and movement of all limbs was examined. At least two X-rays of the big joints were taken. Periarticular new bone formation appeared in 26 patients. This heterotopic ossification occurs in severely injured patients, primarily in proximal joints of the upper and lower extremities. Their aetiology in brain injury is unknown. Risk factors include prolonged coma, tone and movements in the involved extremity, and associated fractures. We found that the appearance of periarticular new bone formation had a close correlation with pathological movement (paresis or plegia), a borderline correlation with hypertonus, and no correlation with hypotonus or with associated fractures.	TEL AVIV UNIV,SACKLER SCH MED,IL-69978 TEL AVIV,ISRAEL; LOEWENSTEIN HOSP & REHABIL CTR,COMA INTENS CARE UNIT,RAANANA,ISRAEL; MEIR HOSP,DEPT ORTHOPAED SURG,KEFAR SAVA,ISRAEL	Tsur, A (corresponding author), WESTERN GALILEE HOSP NAHARIYA,DEPT GERIATR,REHABIL UNIT,POB 21,IL-22100 NAHARIYYA,ISRAEL.						BAGLEY SL, 1979, ORTHOPEDIC REV, V8, P113; BARRY DT, 1990, KRUSENS HDB PHYSICAL, P61; CHANTRAINE A, 1989, J TRAUMATOLOGY SPORT, V3, P128; DEJERINE, 1919, REV NEUROL, V26, P399; DEJERINE MME, 1918, ANN MED, V5, P497; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V245, P303; GROSSWASSER Z, 1986, HAREFUAH, V7, P323; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Sazbon L, 1989, Brain Inj, V3, P57, DOI 10.3109/02699058909008074; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120; SAZBON L, 1980, HAREFUAH, V10, P317; TSUR A, 1992, HAREFUAH, V3, P86	14	17	17	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1996	10	4					259	262		10.1080/026990596124430			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UJ541	WOS:A1996UJ54100003	9044691				2021-06-18	
J	Shohami, E; Bass, R; Trembovler, V; Weidenfeld, J				Shohami, E; Bass, R; Trembovler, V; Weidenfeld, J			The effect of the adrenocortical axis upon recovery from closed head injury	JOURNAL OF NEUROTRAUMA			English	Article						ACTH; adrenalectomy; closed-head injury; edema; hypophysectomy	TRAUMATIC BRAIN INJURY; FUNCTIONAL RECOVERY; NUCLEUS ACCUMBENS; DOPAMINE SYSTEMS; II RECEPTORS; RAT; DESTRUCTION; GLUCOCORTICOIDS	Fragments and analogs of the hormone ACTH were previously shown to have beneficial effect on the outcome of head injury, while elevated levels of corticosterone (CS) exacerbate it, In the present study we investigated the role of the hypothalamo-pituitary-adrenal (HPA) axis in the pathophysiology of closed head injury (CHI), CHI was produced in ether-anesthetized rats by a calibrated weight-drop device, After evaluating the functional status according to a set of criteria, at 1 and 24 h, the rats were sacrificed and cortical tissue was removed to determine its water content, CHI was also produced in rats that underwent surgical procedures to remove their adrenal gland (ADEX) or the pituitary (HypoX), thus altering the levels of their circulating HPA hormones, Given after CHI, to rats with intact HPA axis, ACTH reduced edema and improved recovery, ADEX rats (6 days postsurgery) had 10-fold higher levels of plasma ACTH, ADEX rats subjected to CHI showed improved functional outcome (p = 0.008) and reduced edema (p = 0.02), We then produced CHI in three groups of rats: HypoX (15 days postsurgery), HypoX treated with ACTH, and controls, In HypoX rats, CHI resulted in increased mortality (35% vs 0) and edema in the surviving rats, and a slower recovery, as compared with the control, Mortality was prevented, edema slightly reduced, and recovery significantly improved after administration of 1-24-ACTH to HypoX rats with CHI, Our results suggest that ACTH has a cerebroprotective effect on the outcome of CHI.	HADASSAH MED CTR,SCH PHARM,DEPT PHARMACOL,IL-91120 JERUSALEM,ISRAEL; HADASSAH MED CTR,DEPT NEUROL,IL-91120 JERUSALEM,ISRAEL							ATTELLA MJ, 1992, BEHAV NEURAL BIOL, V53, P157; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; DEKOSKY ST, 1984, NEUROENDOCRINOLOGY, V38, P33, DOI 10.1159/000123862; DUNN AJ, 1994, BRAIN RES, V645, P103, DOI 10.1016/0006-8993(94)91643-8; FERTIG A, 1971, EXP NEUROL, V33, P372, DOI 10.1016/0014-4886(71)90029-X; GOLDMAN H, 1993, J NEUROTRAUM, V10, P386; MCDANIEL WF, 1993, BEHAV BRAIN RES, V56, P11, DOI 10.1016/0166-4328(93)90018-L; MCMASTERS RE, 1962, J COMP NEUROL, V119, P251; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MORSE JK, 1990, EXP NEUROL, V110, P86, DOI 10.1016/0014-4886(90)90053-U; NAVARRA P, 1991, ENDOCRINOLOGY, V128, P37, DOI 10.1210/endo-128-1-37; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; RATKA A, 1989, NEUROENDOCRINOLOGY, V50, P117, DOI 10.1159/000125210; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1228; SCHEFF SW, 1980, EXP NEUROL, V68, P195, DOI 10.1016/0014-4886(80)90077-1; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SHARP BM, 1993, ENDOCRINOLOGY, V132, P269, DOI 10.1210/en.132.1.269; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SPRUIJT BM, 1992, PSYCHONEUROENDOCRINO, V17, P315, DOI 10.1016/0306-4530(92)90037-8; WEIDENFELD J, 1993, NEUROENDOCRINOLOGY, V58, P49, DOI 10.1159/000126511; WEIDENFELD J, 1993, ENDOCRINOLOGY, V132, P941, DOI 10.1210/en.132.3.941; WEIDENFELD J, 1989, NEUROENDOCRINOLOGY, V50, P132, DOI 10.1159/000125212; WEXLER BC, 1957, ENDOCRINOLOGY, V61, P488, DOI 10.1210/endo-61-5-488; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; WOLTERINK G, 1990, BRAIN RES, V507, P101, DOI 10.1016/0006-8993(90)90527-I; WOLTERINK G, 1990, BRAIN RES, V507, P109, DOI 10.1016/0006-8993(90)90528-J; WOLTERINK G, 1990, BRAIN RES, V507, P92, DOI 10.1016/0006-8993(90)90526-H	35	17	18	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1995	12	6					1069	1077		10.1089/neu.1995.12.1069			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	TU518	WOS:A1995TU51800007	8742135				2021-06-18	
J	CONSTANTINIDOU, F; NEILS, J				CONSTANTINIDOU, F; NEILS, J			STIMULUS MODALITY AND VERBAL-LEARNING AFTER MODERATE TO SEVERE CLOSED-HEAD INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	American-Speech-Language-Hearing-Association Annual Convention	NOV, 1993	ANAHEIM, CA	Amer Speech Language Hearing Assoc			MEMORY	Objective: To determine the effects of stimulus modality on the verbal learning of patients with closed head injury (CHI) and to compare the performance of the patients with CHI to matched normal subjects. Patients: Twenty-four randomly selected subjects with moderate to severe CHI were matched In age, sex, education, and handedness to 16 normal volunteers. Main outcome measure: A multitrial free recall paradigm incorporating three modalities (auditory, visual, and auditory plus visual) was used to measure the number of words learned per trial. Results: Subjects with CHI learned new information at a significantly slower rate compared with normal subjects. Patients with CHI learned more words presented visually (with or without auditory presentation of names) during free recall and recognition. Conclusions: Visual therapy methods that incorporate pictures may enhance verbal learning in patients with moderate to severe CHI.	UNIV CINCINNATI,DEPT COMMUN SCI & DISORDERS,CINCINNATI,OH	CONSTANTINIDOU, F (corresponding author), MIAMI UNIV,DEPT COMMUN,OXFORD,OH 45056, USA.			Constantinidou, Fofi/0000-0002-7928-8363			AGRESTI AA, 1987, DISS ABSTR INT, V47, P3097; ARNETT JA, 1986, PSYCHOL REP, V59, P315, DOI 10.2466/pr0.1986.59.1.315; BROOKS D N, 1975, Cortex, V11, P329; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CONSTANTINIDOU F, 1989, THESIS SO ILLINOIS U; DARLEY F, 1972, CLIN APHASIOLOGY C P; DELIS D, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; ELBERT M, 1980, CONTRASTS PICTURE FI; Gentilini M., 1989, MILD HEAD INJURY; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Hagen C., 1972, REHABILITATION HEAD; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1992, SCANDINAVIAN J REHAB, V26, P14; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCAFFREY RJ, 1987, INT J CLIN NEUROPSYC, V9, P171; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; ODONNELL JP, 1988, J GEN PSYCHOL, V115, P355, DOI 10.1080/00221309.1988.9710572; Paivio A., 1971, IMAGERY VERBAL PROCE; Paivio A., 1976, RECALL RECOGNITION; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SPSS, 1988, SPSS X US GUID; STEVENS J, 1992, APPLIED MULTIVARIATE; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Thorndike EL, 1944, TEACHERS BOOK 30000; VENTRY IM, 1986, EVALUATING RES SPEEC; VINYARD A, 1988, COMP PERFORMANCE NOR; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Zechmeister E. B., 1982, HUMAN MEMORY INTRO R	30	17	17	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1995	10	4					90	100		10.1097/00001199-199508000-00009			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	RN010	WOS:A1995RN01000009					2021-06-18	
J	DELATORRE, JC				DELATORRE, JC			TREATMENT OF HEAD-INJURY IN MICE, USING A FRUCTOSE 1,6-DIPHOSPHATE AND DIMETHYL-SULFOXIDE COMBINATION	NEUROSURGERY			English	Article						ATP HEAD INJURY; CA1 HIPPOCAMPUS; DIMETHYL SULFOXIDE; FREE RADICALS; FRUCTOSE 1,6-DIPHOSPHATE; NEURONAL DAMAGE	BRAIN INJURY; DIMETHYLSULFOXIDE THERAPY; LIPID-PEROXIDATION; 1-6 DIPHOSPHATE; ISCHEMIA; TRAUMA; EDEMA; FRUCTOSE-1,6-DIPHOSPHATE; DAMAGE; SHOCK	MICE WERE SUBJECTED to moderate (800 g/cm force) or severe (900 g/cm force) head injury and treated 5 minutes later with various compounds. Treatments consisted of intravenous administration of the following compounds: 1) fructose 1,6-diphosphate (FDP), 2) dimethyl sulfoxide (DMSO), 3) FDP + DMSO, and 4) vehicle nontreated, Sensory-motor evaluations 1 and 2 hours after 800 g/cm-force head injury showed that significant protection of motor function (grip test) was achieved with FDP + DMSO but not with treatment by either drug alone. Evaluation of mice following a severe 900-g/cm force injury demonstrated significant survival after treatment with FDP + DMSO but not with the vehicle or treatment by either of these agents alone. Histopathological morphometry indicated that cortical and hippocampal CA1 neurons were markedly protected from damage when mice were treated with combined FDP + DMSO. More modest protection of CA1 but not of cortical neurons was observed after treatment with DMSO alone but not after treatment with FDP alone or administration of the vehicle. These findings indicate that combining FDP with DMSO results in considerable synergy in protecting animals from sensory-motor loss and neuronal brain damage and in ultimate survival stemming from a moderate or severe closed head injury.	UNIV NEW MEXICO,DEPT PHYSIOL,ALBUQUERQUE,NM 87131	DELATORRE, JC (corresponding author), UNIV NEW MEXICO,DIV NEUROSURG,915 STANFORD DR NE,ALBUQUERQUE,NM 87131, USA.						ASHWOODS.MJ, 1967, ANN NY ACAD SCI, V141, P45, DOI 10.1111/j.1749-6632.1967.tb34865.x; BEHARRY S, 1992, J BIOENERG BIOMEMBR, V24, P507, DOI 10.1007/BF00762369; BENESCH R, 1967, BIOCHEM BIOPH RES CO, V26, P162, DOI 10.1016/0006-291X(67)90228-8; BENESCH R, 1969, NATURE, V221, P618, DOI 10.1038/221618a0; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BROWN AW, 1968, BRIT J EXP PATHOL, V49, P87; BROWN FD, 1983, ANN NY ACAD SCI, V411, P245, DOI 10.1111/j.1749-6632.1983.tb47305.x; Bures J., 1976, TECHNIQUES BASIC EXP; CAMP PE, 1981, NEUROSURGERY, V9, P28, DOI 10.1227/00006123-198107000-00005; De La Torre J. C., 1994, Society for Neuroscience Abstracts, V20, P194; DELATORRE JC, 1973, J NEUROSURG, V38, P345, DOI 10.3171/jns.1973.38.3.0345; DELATORRE JC, 1976, DYNAMICS BRAIN EDEMA, P306; DELATORRE JC, 1990, CAN J PHYSL PHARM, V69, P191; DELATORRE JC, 1983, ANN NY ACAD SCI, V1, P402; FARIAS LA, 1990, STROKE, V21, P606, DOI 10.1161/01.STR.21.4.606; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HARRIS RJ, 1981, J CEREBR BLOOD F MET, V1, P203, DOI 10.1038/jcbfm.1981.21; HECKLER FR, 1983, J HAND SURG, V8, P622; IAPICHINO G, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P157; IKEDA Y, 1990, NEUROSURGERY, V27, P1; KARACA M, 1991, EUR J CLIN PHARMACOL, V40, P113, DOI 10.1007/BF00315149; KUBLER W, 1970, Journal of Molecular and Cellular Cardiology, V1, P351, DOI 10.1016/0022-2828(70)90034-9; KULUZ JW, 1993, STROKE, V24, P1576, DOI 10.1161/01.STR.24.10.1576; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; MARCEL GA, 1979, J MED, V10, P409; MARKOV A, 1983, CLIN RES, V31, pA503; MARKOV AK, 1986, ANN EMERG MED, V15, P1470, DOI 10.1016/S0196-0644(86)80946-5; MARKOV AK, 1981, SURGERY, V90, P482; MARKOV AK, 1987, MICROCIRCULATION UPD, V1, P709; MARKOV AK, 1994, EUR HEART J S, V15, P277; MARSHALL LF, 1984, NEUROSURGERY, V14, P659, DOI 10.1227/00006123-198406000-00002; MULLAN S, 1988, CEREBRAL ARTERIAL SP, P646; REPINE JE, 1979, J CLIN INVEST, V64, P1642, DOI 10.1172/JCI109626; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; SUTTON R L, 1990, Society for Neuroscience Abstracts, V16, P777; WALLER FT, 1979, NEUROSURGERY, V5, P583; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WEISSMAN.G, 1967, ANN NY ACAD SCI, V141, P326, DOI 10.1111/j.1749-6632.1967.tb34897.x; WIESER PB, 1977, BIOCHEM PHARMACOL, V26, P775, DOI 10.1016/0006-2952(77)90223-4; WILLMORE LJ, 1984, BRAIN RES, V296, P389, DOI 10.1016/0006-8993(84)90080-5	44	17	17	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	AUG	1995	37	2					273	279		10.1227/00006123-199508000-00012			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	RK745	WOS:A1995RK74500038	7477779				2021-06-18	
J	NILSSON, F; AKESON, J; MESSETER, K; RYDING, E; ROSEN, I; NORDSTROM, CH				NILSSON, F; AKESON, J; MESSETER, K; RYDING, E; ROSEN, I; NORDSTROM, CH			A PORCINE MODEL FOR EVALUATION OF CEREBRAL HEMODYNAMICS AND METABOLISM DURING INCREASED INTRACRANIAL-PRESSURE	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						INTRACRANIAL HYPERTENSION; CEREBRAL BLOOD FLOW; EXTRADURAL MASS; EEG; PIG	TRAUMATIC BRAIN-LESIONS; BLOOD-FLOW; HEAD-INJURY; VASOREACTIVITY	In patients with severe head injuries raised intracranial pressure (ICP) constitutes the most important cause of mortality. Several new therapies for increased ICP have recently been suggested and it is of importance to study the physiological effects of these treatments in animal experiments during steady state conditions. A porcine model for evaluation of cerebral haemodynamics and metabolism during increased ICP is presented. Intracranial hypertension was induced by inflation of two tonometric gastric balloons placed extradurally covering a major part of the parietooccipital region bilaterally The distribution of the blood flow supplied by the carotid artery used for the cerebral blood flow (CBF) measurements was studied by intraarterial (i.a.) injection of Tc-99np-HMPAO. The measurements showed that following ligation of the external carotid and the occipital artery no accumulation of tracer substance occurred in extracranial tissues during normal or increased ICP. Cerebral physiological variabies (CBF, Cavo(2), and ICP) were measured 5, 20 and 60 min after induction of intracranial hypertension. The results confirm that the experimental situation gives a reproducible increase in ICP (25-28 mm Hg) and that the physiologial variables remain stable during the period of intracranial hypertension. We conclude chat the model simulates the effects of an acute intracranial focal mass and is well suited for the evaluation of different pharmacological therapies of increased ICP.		NILSSON, F (corresponding author), LUND UNIV,MALMO GEN HOSP 04266,DEPT ANAESTHESIA & INTENS CARE,S-21401 MALMO,SWEDEN.						AKESON J, 1993, ACTA ANAESTH SCAND, V37, P525, DOI 10.1111/j.1399-6576.1993.tb03759.x; AKESON J, 1992, ACTA ANAESTH SCAND, V36, P419, DOI 10.1111/j.1399-6576.1992.tb03491.x; AKESON J, 1992, ACTA ANAESTH SCAND, V37, P85; AKESON J, 1992, ACTA ANAESTH SCAND, V37, P211; BJORKMAN S, 1993, J PHARM BIOPHARM Q, V2, P637; CARLSSON C, 1977, BRAIN RES, V119, P223, DOI 10.1016/0006-8993(77)90102-0; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; CUMMINGS MF, 1983, BRIT J ANAESTH, V55, P619, DOI 10.1093/bja/55.7.619; DOMENECH J S, 1976, British Journal of Anaesthesia, V48, P1143, DOI 10.1093/bja/48.12.1143; HAGGENDAL E, 1970, ACTA PHYSIOL SCAND, V79, P262, DOI 10.1111/j.1748-1716.1970.tb04725.x; IVANKOVICH AD, 1975, J PHARM PHARMACOL, V27, P837, DOI 10.1111/j.2042-7158.1975.tb10226.x; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NEIRINCKX RD, 1987, J NUCL MED, V18, P191; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; SCARBOUGH FW, 1973, STROKE, V4, P674; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841	22	17	17	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	AUG	1995	39	6					827	834		10.1111/j.1399-6576.1995.tb04179.x			8	Anesthesiology	Anesthesiology	RL987	WOS:A1995RL98700022	7484043				2021-06-18	
J	KIHARA, T; SAKATA, S; IKEDA, M				KIHARA, T; SAKATA, S; IKEDA, M			DIRECT-DETECTION OF ASCORBYL RADICAL IN EXPERIMENTAL BRAIN INJURY - MICRODIALYSIS AND AN ELECTRON-SPIN-RESONANCE SPECTROSCOPIC STUDY	JOURNAL OF NEUROCHEMISTRY			English	Article						ASCORBYL RADICAL; ELECTRON SPIN RESONANCE; COLD INJURY; MICRODIALYSIS	ENTRAPPED SUPEROXIDE-DISMUTASE; EDEMA; REPERFUSION; ISCHEMIA; GENERATION; OXIDATION; SYSTEM	To examine the role played by free radicals in brain injury, we performed experiments to detect radicals in the frontal cortex of rats, using electron spin resonance (ESR) and microdialysis. A dialysis probe was inserted into the frontal cortex, and spin adducts in perfusates were immediately detected by ESR. We obtained a relatively stable doublet signal, with parameters of g = 2.0057 and aH = 0.17 mT. This signal corresponded with that of the ascorbyl radical. Ascorbyl radical in the perfusate collected from the frontal cortex was augmented by microinjection of H2O2 and FeCl2 adjacent to the dialysis probe. When the rats were challenged with cold-induced brain injury, ascorbyl radical and lactate dehydrogenase (LDH) level in the perfusate increased significantly. Pretreatment with superoxide dismutase and catalase attenuated the increase in ascorbyl radical and LDH level induced by the cold injury. Infusion of FeCl2 dissolved in perfusate caused a pronounced increase in ascorbyl radical and LDH level after the cold injury. We conclude that the direct detection of free radical formation further supports the hypothesis that free radicals play an important role in traumatic brain injury. Our findings also indicate that combined microdialysis with ESR spectroscopy is a useful in vivo method for monitoring free radical production in the brain.		KIHARA, T (corresponding author), SHIONOGI & CO LTD,SHIONOGI RES LABS,KANZAKIGAWA LAB,3-1-1 FUTABA CHO,TOYONAKA,OSAKA 561,JAPAN.						ANDO Y, 1989, BRAIN RES, V477, P286, DOI 10.1016/0006-8993(89)91416-9; ASANO T, 1989, MOL CHEM NEUROPATHOL, V10, P101, DOI 10.1007/BF03159717; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; IKEDA Y, 1990, NEUROSURGERY, V27, P1; IKEDA Y, 1989, NEUROSURGERY, V24, P820, DOI 10.1227/00006123-198906000-00006; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; LIU TH, 1989, AM J PHYSIOL, V259, pH589; MINETTI M, 1992, BIOCHEM J, V282, P459, DOI 10.1042/bj2820459; NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X; Pellegrino L.J., 1979, STEREOTAXIC ATLAS RA; PIETRI S, 1990, EUR J BIOCHEM, V193, P845, DOI 10.1111/j.1432-1033.1990.tb19408.x; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; SAKAMOTO A, 1991, BRAIN RES, V554, P186, DOI 10.1016/0006-8993(91)90187-Z; Ungerstedt U, 1991, MICRODIALYSIS NEUROS, P3; WANG XY, 1992, FREE RADICAL BIO MED, V12, P121, DOI 10.1016/0891-5849(92)90005-2; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; ZETTERSTROM T, 1983, J NEUROCHEM, V41, P1769, DOI 10.1111/j.1471-4159.1983.tb00893.x; ZINI I, 1992, NEUROSCI LETT, V138, P279, DOI 10.1016/0304-3940(92)90933-X; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	21	17	17	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	JUL	1995	65	1					282	286					5	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	RX166	WOS:A1995RX16600035	7790872				2021-06-18	
J	MUIR, JK; LYETH, BG; HAMM, RJ; ELLIS, EF				MUIR, JK; LYETH, BG; HAMM, RJ; ELLIS, EF			THE EFFECT OF ACUTE COCAINE OR LIDOCAINE ON BEHAVIORAL FUNCTION FOLLOWING FLUID PERCUSSION BRAIN INJURY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article							CEREBRAL BLOOD-FLOW; RADICAL SCAVENGER; RECOVERY; NOREPINEPHRINE; DEFICITS; ISCHEMIA; RELEASE; MOTOR; MODEL	One of the goals of our laboratory is to examine how the presence of drugs of abuse will influence traumatic brain injury. Previous studies in our laboratory have shown that cocaine or lidocaine treatment before experimental fluid percussion brain injury in rats seduces the cortical hypoperfusion normally found in the early posttraumatic period. The purpose of the current study was to determine if pretreatment with cocaine or lidocaine is also associated with changes in trauma-induced suppression of reflexes and motor and cognitive dysfunction that occurs following traumatic brain injury (TBI). Twenty-four hours after surgical preparation, rats were randomly assigned to a saline or drug pretreatment group, cocaine (0.5, 2, or 5 mg/kg) car lidocaine (2 mg/kg), which was injected via the tail vein. None of the drug pretreatments worsened injury. Lidocaine and cocaine decreased the duration of suppression of some neurological reflexes and reduced posttraumatic body weight losses. Lidocaine and cocaine both decreased postinjury motor deficits. Lidocaine and cocaine did not affect cognitive function on days 11-15 postinjury. The mechanism by which lidocaine improves acute neurological and motor function following brain injury is unknown, but may involve improved posttraumatic cortical blood now, as seen in our previous study. Our results, along with other studies showing lidocaine to be neuroprotective in animal models of ischemia, suggest that studies of the effect of posttraumatic administration of lidocaine are warranted.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,DIV NEUROSURG,RICHMOND,VA 23298				Lyeth, Bruce/0000-0003-4811-1474	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [27214, 05274, 29995] Funding Source: Medline		BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; DAS KC, 1992, MOL CELL BIOCHEM, V115, P179; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUTKA AJ, 1992, STROKE, V23, P1515, DOI 10.1161/01.STR.23.10.1515; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hamm RJ, 1993, BRAIN RES COGN BRAIN, V1, P223, DOI [10.1016/0926-6410(93)90006-Q, DOI 10.1016/0926-6410(93)90006-Q]; HAMM RJ, 1994, BEHAV BRAIN RES, V59, P169; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; IMPERATO A, 1993, EUR J PHARMACOL, V238, P377, DOI 10.1016/0014-2999(93)90869-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; MUIR JK, 1992, J NEUROTRAUM, V9, P394; MUIR JK, 1995, AM J PHYSIOL, V268, P468; MUIR JK, 1993, 11TH ANN NEUR S; NAGAO S, 1988, J TRAUMA, V28, P1650, DOI 10.1097/00005373-198812000-00006; PORRINO LJ, 1988, NEUROPSYCHOPHARMACOL, V1, P109, DOI 10.1016/0893-133X(88)90002-4; RASOOL N, 1990, STROKE, V21, P929, DOI 10.1161/01.STR.21.6.929; SHOKUNBI MT, 1990, STROKE, V21, P107, DOI 10.1161/01.STR.21.1.107; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	32	17	17	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	1995	12	1					87	97		10.1089/neu.1995.12.87			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	QN638	WOS:A1995QN63800007	7783235				2021-06-18	
J	FARMER, JE; PETERSON, L				FARMER, JE; PETERSON, L			PEDIATRIC TRAUMATIC BRAIN INJURY - PROMOTING SUCCESSFUL SCHOOL REENTRY	SCHOOL PSYCHOLOGY REVIEW			English	Article							CLOSED-HEAD-INJURY; CHILDREN; ADOLESCENTS; SEVERITY; COHORT; SEQUELAE; MILD	This article reviews physical, cognitive, and behavioral characteristics, of traumatic brain injury (TBI) that can place a child at risk for poor school adjustment. It proposes an ecological approach to school-based assessment and intervention that considers not only the nature of the child's brain injury, but also developmental factors and the quality of the school environment. Key issues for school success are discussed, including early identification of the child with TBI, neuropsychological assessment, multidisciplinary collaboration, individualized programming, and interventions aimed at modifying the environment to provide needed supports.	UNIV MISSOURI,SCH MED,COLUMBIA,MO 65211							ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BEGALI V, 1992, HEAD INJURY CHILDREN; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; COIE JD, 1993, AM PSYCHOL, V48, P1013, DOI 10.1037/0003-066X.48.10.1013; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DELIS DC, 1993, CALIFORNIA VERBAL LE; DEPOMPEI R, 1991, J HEAD TRAUMA REHABI, V6, P1; DORONZO JF, 1990, PSYCHOL MANAGEMENT T, P207; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FEAGENS LD, 1992, EMOTION COGNITION HL, P165; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GOLDSTEIN FC, 1990, TRAUMATIC BRAIN INJU, P51; HAGEN C, 1981, RANCHO AMIGOS LEVELS; HANSON SL, 1992, PHYSICAL MED REHABIL, V6, P483; HARRINGTON DE, 1990, REHABILITATION ADULT, P476; HOPEWELL CA, 1990, COGNITIVE REHABILITA, P229; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jorgensen C., 1992, NATURAL SUPPORTS SCH, P179; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Lehr E., 1990, COMMUNITY INTEGRATIO, P301; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MCKEE WT, 1990, HDB SCH PSYCHOL, P821; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MIDGLEY C, 1989, J EDUC PSYCHOL, V81, P247, DOI 10.1037/0022-0663.81.2.247; *NAT HEAD INJ F, 1980, SIL EP; Nisbet J., 1992, NATURAL SUPPORTS SCH; POLLOCK E, 1993, TEACHERS GUIDE MANAG; Reitan R.M., 1992, NEUROPSYCHOLOGICAL E; Reynolds C.R., 1994, TEST MEMORY LEARNING; Rifkinson-Mann Stephanie, 1993, Contemporary Neurosurgery, V15, P1; Ringle-Bartels J, 1993, NeuroRehabilitation, V3, P26, DOI 10.3233/NRE-1993-3305; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; ROSENTHAL M, 1990, REHABILITATION ADULT; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SAVAGE RC, 1994, ED DIMENSIONS ACQUIR; Sheslow D., 1990, WIDE RANGE ASSESSMEN; SLOMKA GT, 1993, HDB CHILD ADOLESCENT, P208; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; Spreen O., 1991, COMPENDIUM NEUROPSYC; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1991, J HEAD TRAUMA REHAB, V6, P23; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; *VIRG DEP ED, 1992, GUID ED SERV STUD TR; WAALAND PK, 1993, RETURNING SCH FOLLOW; Weber A. M., 1990, J HEAD TRAUMA REHABI, V5, P73, DOI [10.1097/00001199-199003000-00012, DOI 10.1097/00001199-199003000-00012]; Wechsler D., 1974, MANUAL WECHSLER INTE; WEST M, 1992, LIFE CLASSROOM TRANS, P395; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Ylvisaker Mark, 1993, Seminars in Speech and Language, V14, P74, DOI 10.1055/s-2008-1064160; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	64	17	17	0	3	NATL ASSN SCHOOL PSYCHOL	HARRISONBURG	JAMES MADISON UNIV DEPT PSYCHOL, HARRISONBURG, VA 22807	0279-6015			SCHOOL PSYCHOL REV	Sch. Psychol. Rev.		1995	24	2					230	243					14	Psychology, Educational	Psychology	RP664	WOS:A1995RP66400010					2021-06-18	
J	Talamonti, G; Fontana, RA; Versari, PP; Villa, F; DAliberti, GA; Car, P; Collice, M				Talamonti, G; Fontana, RA; Versari, PP; Villa, F; DAliberti, GA; Car, P; Collice, M			Delayed complications of ethmoid fractures: A ''growing fracture'' phenomenon	ACTA NEUROCHIRURGICA			English	Article						head injury; meningitis; rhinorrhea; skull fracture	CEREBROSPINAL-FLUID RHINORRHEA; LEPTOMENINGEAL CYST; HEAD-INJURY; MANAGEMENT; MENINGITIS; TRAUMA; FOSSA	Delayed complications of ethmoid fractures are considered relatively rare. However, meningitis, recurrence of previously ceased cerebrospinal fluid rhinorrhea and delayed onset of cerebrospinal fluid rhinorrhea are possible even years after trauma. We report 10 consecutive patients with delayed complications of ethmoid fractures, whom we treated over the past 11 years. All patients had previously sustained a closed head injury and had remained anosmic. Variously after trauma (ranging from 2 months to 31 years), these patients were re-admitted because of meningitis (6 cases), recurrence of previously ceased cerebrospinal fluid rhinorrhea (3 cases), and delayed onset of cerebrospinal fluid rhinorrhea (1 case). In all cases the delayed complications were associated with relatively large defects of the ethmoid bone. These bone lesions were now evident even in those patients whose radiological assessments had been normal after trauma. All patients underwent a successful surgical repair and remained well during the follow-up. We discuss the possibility that delayed complications of ethmoid fractures are due to a mechanism like that of ''growing fractures'' in children.		Talamonti, G (corresponding author), OSPED NIGUARDA CA GRANDA,DEPT NEUROSURG,PIAZZA OSPED MAGGIORE 3,I-20162 MILAN,ITALY.		Talamonti, Giuseppe/AAC-2760-2019; D'Aliberti, Giuseppe Antonio/AAS-3059-2020	Talamonti, Giuseppe/0000-0002-9164-3292; 			ABERNETHY LJ, 1989, CLIN RADIOL, V40, P531, DOI 10.1016/S0009-9260(89)80278-8; BRAWLEY BW, 1967, J NEUROSURG, V26, P57, DOI 10.3171/jns.1967.26.1part1.0057; BYRNE JV, 1992, NEURORADIOLOGY, V34, P528, DOI 10.1007/BF00598968; Cairns H., 1937, J LARYNG, V52, P589, DOI 10.1017/S0022215100043991; COMOY J, 1986, J NEURORADIOLOGY, V13, P248; COOK PG, 1988, CLIN RADIOL, V39, P214; COSTA H, 1993, BRIT J PLAST SURG, V46, P503, DOI 10.1016/0007-1226(93)90225-Z; DAGI TF, 1983, AM J EMERG MED, V3, P295; DAGI TF, 1988, OPERATIVE NEUROSURGI, P57; Dandy WE, 1944, ARCH SURG-CHICAGO, V49, P75, DOI 10.1001/archsurg.1944.01230020080001; DYKE CG, 1937, NELSONS LOOSE LEAF M, P185; FARRELL VJ, 1993, SURG NEUROL, V37, P378; HALLIDAY AL, 1990, NEUROSURGERY, V26, P150, DOI 10.1227/00006123-199001000-00025; JEFFERSON A, 1972, BRIT J SURG, V59, P585, DOI 10.1002/bjs.1800590802; KOONSMAN M, 1992, AM J SURG, V164, P487, DOI 10.1016/S0002-9610(05)81186-9; KRAUS H, 1962, J Int Coll Surg, V38, P372; LEECH PJ, 1973, LANCET, V1, P1013; Lewin W, 1964, Clin Neurosurg, V12, P237; LEWIN W, 1954, BRIT J SURG, V42, P1, DOI 10.1002/bjs.18004217102; MACGEE EE, 1970, J NEUROSURG, V33, P312, DOI 10.3171/jns.1970.33.3.0312; MINCY JE, 1966, J TRAUM, V6, P618, DOI 10.1097/00005373-196609000-00007; PAPPAS DG, 1993, CLIN INFECT DIS, V17, P364, DOI 10.1093/clinids/17.3.364; PARK JI, 1983, LARYNGOSCOPE, V93, P1294; PRERE J, 1986, J NEURORADIOLOGY, V13, P278; RAHIMIZADEH A, 1986, NEUROSURGERY, V18, P386; RUSSELL T, 1984, NEUROSURGERY, V15, P705, DOI 10.1227/00006123-198411000-00013; SOULE AB, 1946, ARCH NEURO PSYCHIATR, V55, P382, DOI 10.1001/archneurpsyc.1946.02300150086006; SPETZLER RF, 1990, CLIN NEUROSURG, P2269; STEWART BT, 1992, AUST NZ J SURG, V62, P818, DOI 10.1111/j.1445-2197.1992.tb06927.x; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; WESTMORE GA, 1982, BRIT J SURG, V69, P489, DOI 10.1002/bjs.1800690821	31	17	19	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1995	137	3-4					164	173		10.1007/BF02187189			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	TL370	WOS:A1995TL37000014	8789657				2021-06-18	
J	CASSIDY, JW				CASSIDY, JW			NEUROPHARMACOLOGICAL MANAGEMENT OF DESTRUCTIVE BEHAVIOR AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						AGGRESSION; AGITATION; DESTRUCTIVE BEHAVIOR; PHARMACOLOGY		Destructive behavior following traumatic brain injury can occur during every phase of recovery. It is a symptom of many neuropsychiatric syndromes. To date, there have been few adequately controlled studies to guide clinicians in the neuropharmacologic management of this problem. However, there are emerging strategies that have been helpful for some patients. This article develops a syndromic approach to understanding these behavioral disorders and summarizes the available data and clinical experience in their management.		CASSIDY, JW (corresponding author), DEL ORO INST REHABIL, NEUROBEHAV PROGRAMS, HOUSTON, TX USA.						ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; ADAMS F, 1984, CANCER B, V36, P156; ANDEN N, 1973, J PHARM PHARMACOL, V25, P346, DOI 10.1111/j.2042-7158.1973.tb10025.x; BALLENGER JC, 1980, AM J PSYCHIAT, V137, P782; BLUMER D, 1975, J NERV MENT DIS, V160, P127, DOI 10.1097/00005053-197502000-00007; BOND WS, 1986, J CLIN PSYCHOPHARM, V6, P81; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; CASSIDY JW, 1994, NEUROPSYCHIATRY TRAU; CASSIDY JW, 1990, J HEAD TRAUMA REHAB, V5, P83; Chandler M C, 1988, Brain Inj, V2, P309; COLENDA CC, 1988, LANCET, V1, P1169; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; DEBERDT R, 1978, ACTA PSYCHIAT SCAND, P104; DONALDSON SR, 1983, SCHIZOPHR B, P504; EAMES P, 1989, MODELS BRAIN INJURY; EAMES P, 1990, REHABILITATION ADULT; Eichelman B, 1990, J Neuropsychiatry Clin Neurosci, V2, P288; EISON AS, 1986, AM J MED, V80, P1, DOI 10.1016/0002-9343(86)90325-6; ELLIOTT FA, 1977, ANN NEUROL, V1, P489, DOI 10.1002/ana.410010516; ERWIN CW, 1973, ARCH GEN PSYCHIAT, V28, P646; EVANS RW, 1985, CLIN NEUROPHARMACOL, V8, P221, DOI 10.1097/00002826-198509000-00003; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FERNANDEZ F, 1988, J CLIN PSYCHIAT, V49, P239; Flor-Henry P., 1983, CEREBRAL BASIS PSYCH; FOLKS DG, 1982, AM J PSYCHIAT, V139, P115; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREEMAN TW, 1992, AM J PSYCHIAT, V149, P108; GARBUTT JC, 1983, AM J PSYCHIAT, V140, P1363; GARDOS G, 1977, AM J PSYCHIAT, V134, P302; GILMAN A, 1985, PHARM BASIS THERAPEU; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; GRANT I, 1987, NEUROBEHAVIORAL RECO; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; HUMPHRIES SR, 1988, BRIT J PSYCHIAT, V152, P571; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; JACOBS HE, 1993, BEHAVIOR ANAL GUIDEL; Janicak P, 1993, PRINCIPLES PRACTICE; Levine A M, 1988, Brain Inj, V2, P165, DOI 10.3109/02699058809150940; LIPOWSKI ZJ, 1980, COMPR PSYCHIAT, V21, P190, DOI 10.1016/0010-440X(80)90002-4; Lipowski ZJ., 1990, DELIRIUM ACUTE CONFU; LIPPER S, 1976, J NERV MENT DIS, V162, P366, DOI 10.1097/00005053-197605000-00008; LUCHINS DJ, 1984, PSYCHOPHARMACOL BULL, V20, P569; MATTES JA, 1984, PSYCHOPHARMACOL BULL, V20, P98; MCALLISTER TW, 1985, J CLIN PSYCHIAT, V46, P393; MCELROY SL, 1989, J CLIN PSYCHIAT, V50, P23; MCELROY SL, 1987, J CLIN PSYCHOPHARM, V7, P16; MCELROY SL, 1988, USE ANTICONVULSANTS; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MENZA MA, 1987, J CLIN PSYCHIAT, V48, P278; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; MORRISON SD, 1973, DIS NERV SYST, V34, P186; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; NEPPE VM, 1983, J CLIN PSYCHIAT, V44, P326; ONEIL M, 1986, LANCET, V2, P859; PATTERSON JF, 1988, J CLIN PSYCHOPHARM, V8, P296, DOI 10.1097/00004714-198808000-00026; POLAKOFF SA, 1986, J CLIN PSYCHOPHARM, V6, P125; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; RALL TW, 1985, PHARM BASIS THERAPEU; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RATEY JJ, 1992, J CLIN PSYCHOPHARM, V12, P362; RIBLET LA, 1982, J CLIN PSYCHIAT, V43, P11; ROSENTHAL M, 1990, REHABILITATION ADULT; RUDD P, 1985, PHARM BASIS THERAPEU; SALZMAN C, 1987, PSYCHOPHARMACOLOGY 3; SCHATZBERG AF, 1986, MANUAL CLIN PSYCHOPH; SCHOU M, 1988, JAMA-J AM MED ASSOC, V259, P1834, DOI 10.1001/jama.259.12.1834; SHAPIRO LB, 1939, IMJ, V10, P150; SHEARD MH, 1975, J NERV MENT DIS, V160, P108, DOI 10.1097/00005053-197502000-00005; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SILVER JM, 1987, TXB NEUROPSYCHIATRY; SOS J, 1980, DRUG THER, V10, P103; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; SPIKER DG, 1985, AM J PSYCHIAT, V142, P430; STERN JM, 1978, SCAND J REHABIL MED, V10, P7; STRUB RL, 1988, NEUROBEHAVIORAL DISO; Taylor M. A., 1981, NEUROPSYCHIATRIC MEN; TESAR GE, 1985, J CLIN PSYCHOPHARM, V5, P344, DOI 10.1097/00004714-198505060-00009; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; VOLAVKA J, 1988, POSTGRAD MED, P163; WATSON AJS, 1986, LANCET, V2, P1462; WEINSTEIN GS, 1981, J CLIN PSYCHIAT, V42, P120; WILCOCK GK, 1987, LANCET, V1, P929; WILLIAMS KH, 1979, AM J PSYCHIAT, V136, P800; WISE MG, 1987, TXB NEUROPSYCHIATRY; Wood R. L., 1987, BRAIN INJURY REHABIL; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218; YUDOFSKY SC, 1990, J CLIN PSYCHIAT, V51, P22	96	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP	1994	9	3					43	60		10.1097/00001199-199409000-00005			18	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QD376	WOS:A1994QD37600005					2021-06-18	
J	COPE, DN				COPE, DN			AN INTEGRATION OF PSYCHOPHARMACOLOGICAL AND REHABILITATION APPROACHES TO TRAUMATIC BRAIN INJURY REHABILITATION	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						BRAIN INJURY; INTEGRATION; METHODOLOGY; PSYCHOPHARMACOLOGY	MANAGEMENT	Although significant advances have been made in the application of psychopharmacological treatment methodologies to the survivors of traumatic brain injury, to date little has been published regarding the integration of these new therapeutic options within the context of traditional rehabilitation approaches. This article describes a conceptual approach to such an integration and discusses aspects of current clinical, fiscal, and legal environments that affect implementation of such an integration.		COPE, DN (corresponding author), PARADIGM HLTH CORP,MED AFFAIRS,CONCORD,CA, USA.						ABELOFF MD, 1992, JAMA-J AM MED ASSOC, V267, P2473, DOI 10.1001/jama.267.18.2473; AYD FJ, 1991, NEUROPSYCHOPHARMACOL, V5, P71; BLEIBERG J, 1989, PHYSICAL MED REHABIL, V3; Block S H, 1987, Brain Inj, V1, P203, DOI 10.3109/02699058709034459; CASSIDY JW, 1990, NEUROBEHAVIORAL SEQU; COPE DN, 1990, NEUROBEHAVIORAL SEQU; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA; Hayes R L, 1987, Brain Inj, V1, P1, DOI 10.3109/02699058709034437; JOHNSTON A, 1991, J CLIN PSYCHIAT, V52, P450; LAETZ T, 1991, JAMA-J AM MED ASSOC, V266, P2996, DOI 10.1001/jama.266.21.2996; LEININGER BE, 1992, PHYS MED REHABIL STA, V6, P180; ODDEY M, 1985, J NEUROL NEUROSUR PS, V48, P564; *PHARM MAN ASS, 1991, DRUGS DEV DEB DIS AL; Prigatano G. P., 1990, CLIN NEUROPSYCHOL, V4, P163, DOI [10.1080/13854049008401509, DOI 10.1080/13854049008401509]; SABEL BA, 1986, NATURE, V323, P493, DOI 10.1038/323493a0; SHARFSTEIN SS, 1989, AM J PSYCHIAT, V146, P345; Silver J M, 1991, J Neuropsychiatry Clin Neurosci, V3, pS22; SILVER JM, 1992, AM PSYCHIATRIC PRESS; SILVER JM, 1992, J NEUROPSYCHIAT, V4, P103; SKERRETT PJ, 1990, SCIENCE, V250, P1504; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TISCHLER GL, 1990, AM J PSYCHIAT, V147, P967; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; WOOD RL, 1989, PHYSICAL MED REHABIL, V3; YARNELL PR, 1990, J NEUROREHABIL, V4, P9; ZASLER N D, 1992, Brain Injury, V6, P1, DOI 10.3109/02699059209008117	28	17	17	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP	1994	9	3					1	18		10.1097/00001199-199409000-00003			18	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QD376	WOS:A1994QD37600003					2021-06-18	
J	SHUM, DHK; MCFARLAND, K; BAIN, JD				SHUM, DHK; MCFARLAND, K; BAIN, JD			EFFECTS OF CLOSED-HEAD INJURY ON ATTENTIONAL PROCESSES - GENERALITY OF STERNBERG ADDITIVE FACTOR METHOD	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article								The present study examined the generality of Shum, McFarland, Bain, and Humphreys' (1990) findings that closed-head injury (CHI) selectively impairs different processes of attention (operationalized in terms of stages of information processing) depending on the severity of, and the time since, injury. The procedure of Shum et al. was based on Sternberg's additive factor method (AFM), with the mode of information processing involved being a physical-directional matching of visual stimuli. The present study followed a similar procedure except that a name-matching task was used. This task was administered to 16 first-year psychology students and two groups of CHI patients (viz., severe short-term (SS) and severe long-term (SL)) with matched control groups. The results obtained replicated the study by Shum in that the SS group was found to be impaired on the identification and response-selection stages of information processing whereas the SL group was found to be impaired only on the response-selection stage. The present study confirms that the AFM is not limited to one specific mode of information process and strengthens the validity of the conclusions made by Shum et al. regarding the effects of CHI on attention.	UNIV QUEENSLAND,DEPT PSYCHOL,ST LUCIA,QLD 4072,AUSTRALIA; GRIFFITH UNIV,NEUROPSYCHOL UNIT,NATHAN,QLD 4111,AUSTRALIA; GRIFFITH UNIV,FAC EDUC,NATHAN,QLD 4111,AUSTRALIA			Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262			BLOUGH DS, 1985, J EXP PSYCHOL ANIM B, V11, P261, DOI 10.1037/0097-7403.11.2.261; BOND MR, 1983, REHABILITATION HEAD, P97; DODD DH, 1973, PSYCHOL BULL, V79, P391, DOI 10.1037/h0034347; FROWEIN HW, 1981, BIOL PSYCHOL, V13, P239, DOI 10.1016/0301-0511(81)90039-9; FROWEIN HW, 1981, ACTA PSYCHOL, V47, P105, DOI 10.1016/0001-6918(81)90002-0; GILMORE GC, 1979, PERCEPT PSYCHOPHYS, V25, P425, DOI 10.3758/BF03199852; Gronwall D, 1989, MILD HEAD INJURY, P153; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; HUNT EB, 1982, ADV PSYCHOL HUMAN IN, P201; KEEPEL G, 1982, DESIGN ANAL RES HDB; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MANNING SK, 1977, BEHAV RES METH INSTR, V9, P495, DOI 10.3758/BF03213982; Meier M. J., 1987, NEUROPSYCHOLOGICAL R; Mirsky A. F., 1989, INTEGRATING THEORY P, P75; PARSONS OA, 1978, J CONSULT CLIN PSYCH, V46, P608, DOI 10.1037/0022-006X.46.4.608; POSNER MI, 1969, J EXP PSYCHOL, V79, P1, DOI 10.1037/h0026947; SANDERS AF, 1982, ACTA PSYCHOL, V51, P41, DOI 10.1016/0001-6918(82)90018-X; SANDERS AF, 1990, ACTA PSYCHOL, V51, P41; SANDERS AF, 1980, TUTORIALS MOTOR BEHA, P331, DOI DOI 10.1016/S0166-4115(08)61955-X; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SHWARTZ SP, 1977, J EXP PSYCHOL HUMAN, V3, P402, DOI 10.1037/0096-1523.3.3.402; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Tabachnick BG, 1983, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VANDERMEERE J, 1989, J ABNORM CHILD PSYCH, V17, P409, DOI 10.1007/BF00915035	30	17	17	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1994	16	4					547	555		10.1080/01688639408402666			9	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	NW682	WOS:A1994NW68200007	7818694				2021-06-18	
J	GOLDSTEIN, P; ZIEGLER, W; VOGEL, M; HOOLE, P				GOLDSTEIN, P; ZIEGLER, W; VOGEL, M; HOOLE, P			COMBINED PALATAL-LIFT AND EPG-FEEDBACK THERAPY IN DYSARTHRIA - A CASE-STUDY	CLINICAL LINGUISTICS & PHONETICS			English	Article						DYSARTHRIA; THERAPY; PALATAL LIFT; EPG INTELLIGIBILITY	CLEFT-PALATE; SPEECH; ELECTROPALATOGRAPHY; BIOFEEDBACK; PROSTHESES; DYSPHONIA; DISORDERS; PATIENT; VOICE	A therapeutic intervention in a case of severe dysarthria after closed-head injury is described. The patient, whose articulation was characterized by a severe velopharyngeal incompetence, was supplied with a palatal lift prosthesis. In order to help the patient improve his remaining deficit of lingual motor control he was further treated with an EPG feedback device. The clinically relevant details of this intervention are described and the treatment effects are documented on the basis of EPG, acoustic, and perceptual data.	CITY HOSP BOGENHAUSEN,ENTWICKLUNGSGRP KLIN NEUROPSYCHOL,MUNICH,GERMANY	GOLDSTEIN, P (corresponding author), UNIV MUNICH,INST PHOENET & SPRACHLICHE KOMMUN,W-8000 MUNICH 2,GERMANY.						ANDREWS S, 1986, BRIT J DISORD COMMUN, V21, P353; BARLOW SM, 1990, J SPEECH HEAR RES, V33, P660, DOI 10.1044/jshr.3304.660; BARRY RM, 1989, CLIN LINGUIST PHONET, V3, P81, DOI 10.3109/02699208908985273; BASTIAN RW, 1987, J VOICE, V1, P279; BEDWINEK AP, 1985, J COMMUN DISORD, V18, P169, DOI 10.1016/0021-9924(85)90019-X; BRIN MF, 1989, MOVEMENT DISORD, V4, P287, DOI 10.1002/mds.870040401; DANIEL B, 1982, J PROSTHET DENT, V48, P565, DOI 10.1016/0022-3913(82)90364-X; DAVIS SM, 1980, BIOFEEDBACK SELF-REG, V5, P159, DOI 10.1007/BF00998593; DEDO HH, 1991, ANN OTOLOGY RHINOLOG, V3100, P274; EDWARDS S, 1989, CLIN LINGUIST PHONET, V3, P111, DOI 10.3109/02699208908985275; FINSTERWALD M, 1990, THESIS U BUNDESWEHR; FURUSAWA K, 1992, BRAIN RES BULL, V29, P69, DOI 10.1016/0361-9230(92)90010-U; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; Gonzalez JB, 1970, CLEFT PALATE J, V7, P91; HARDCASTLE W, 1989, CLIN LINGUIST PHONET, V3, P1, DOI 10.3109/02699208908985268; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HIRSCHBERG J, 1986, FOLIA PHONIATR, V38, P221, DOI 10.1159/000265828; Huber W., 1983, AACHENER APHASIE TES; KUNZEL HJ, 1982, FOLIA PHONIATR, V34, P92; LAVELLE WE, 1979, J PROSTHET DENT, V42, P308, DOI 10.1016/0022-3913(79)90222-1; MCLEAN MD, 1987, J SPEECH HEAR RES, V30, P276; MICHI K, 1986, J SPEECH HEAR DISORD, V51, P226, DOI 10.1044/jshd.5103.226; MORR KE, 1988, FOLIA PHONIATR, V40, P284, DOI 10.1159/000265921; NETSELL R, 1973, J SPEECH HEAR RES, V38, P131, DOI 10.1044/jshd.3801.131; NETSELL R, 1985, SPEECH LANGUAGE EVAL; PHILIPS BJ, 1984, SPEECH LANGUAGE ADV, V11; ROSENBEK JC, 1984, SEMINARS SPEECH LANG, V5, P359; RUBOW R, 1984, DYSARTHRIAS PHYSL AC; SIMPSON MB, 1988, J SPEECH HEAR DISORD, V53, P433, DOI 10.1044/jshd.5304.433; SUZUKI N, 1989, CLIN LINGUIST PHONET, V3, P127, DOI 10.3109/02699208908985276; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; TILL JA, 1988, J SPEECH HEAR DISORD, V53, P449, DOI 10.1044/jshd.5304.449; TOMODA H, 1987, NEUROLOGY, V37, P117, DOI 10.1212/WNL.37.1.117; VOGEL M, 1992, 11TH C INT ASS DENT; VOLIN RA, 1991, TOP LANG DISORD, V11, P65, DOI 10.1097/00011363-199111020-00007; Weismer Gary, 1992, INTELLIGIBILITY SPEE; WOLF SL, 1987, BIOFEEDBACK STUDIES; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215; ZIEGLER W, 1993, J SPEECH HEAR RES, V36, P683, DOI 10.1044/jshr.3604.683; ZIEGLER W, 1992, NERVENARZT, V63, P602; ZIEGLER W, 1988, CLIN LINGUIST PHONET, V2, P291, DOI 10.3109/02699208808985261; ZIEGLER W, 1993, NERVENARZT, V654, P653; ZIEGLER W, 1994, IN PRESS 1ST P C ICP	44	17	17	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9206			CLIN LINGUIST PHONET	Clin. Linguist. Phon.	JUL-SEP	1994	8	3					201	218		10.3109/02699209408985307			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	NP452	WOS:A1994NP45200002					2021-06-18	
J	PARKER, RS				PARKER, RS			NEUROBEHAVIORAL OUTCOME OF CHILDRENS MILD TRAUMATIC BRAIN INJURY	SEMINARS IN NEUROLOGY			English	Article							HEAD-INJURY; CHILDHOOD; SEQUELAE; INFANT; ADOLESCENCE; ATTENTION; EPILEPSY; LANGUAGE; LESIONS; APHASIA	This article offers an overview of children's and adolescents' neuropsychologic dysfunctions after mild brain injury, organized according to a taxonomy of neurobehavioral systems. Neurobehavioral outcome of children's brain injury differs from adults' because of developmental implications and substantial anatomic differences between the neonate and adult, but not in range of dysfunctions. It is a disturbance of adaptation-that is, integrated coping with one's environment.1 Mild head injury (MHI) implies minimal loss of consciousness (LOC) and lack of focal neurologic findings (although soft signs may exist) after an acceleration or impact injury, or both. MHI may be established by neuropsychologic study of higher processes,2 deviation from baseline functioning, and impaired development. Without wide range and precise study of neuropsychologic outcome, cases may be described as ''asymptomatic.''3 Traumatic brain injury (TBI) is a process that is primary: Mechanical forces causing injury; secondary: Mass effects that may be initiated by the initial injury; tertiary: Late-developing neurobehavioral symptoms; quaternary: Late developing symptoms due to a damaged hypothalamic-pituitary-endocrine axis. Relatively, MHI is the most common injury sustained by children.4 Occult brain damage is common: parents may be unaware of an accident; physicians may not recognize it in their office or the emergency room; children may conceal or be unable to report it; there may be no LOC; deficits appear years later. Therefore it is difficult to attribute symptoms to a particular incident. Even ''trivial'' head trauma alerts the physician to the need for monitoring later development.5-7 Undocumented injuries as high as 89% have been reported.8		PARKER, RS (corresponding author), NYU MED CTR,DEPT NEUROL,550 1ST AVE,NEW YORK,NY 10016, USA.						AICARDI J, 1992, DIS NERV SYST, P736; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; ASARNOW RB, 1991, J PEDIATR NEUROL, V5, P543; Bailey B. N., 1989, TXB HEAD INJURY, P308; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BEERS S, 1993, NEUROPSYCHOL REV, V3, P281; Begali V., 1987, HEAD INJURY CHILDREN; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; Berg R., 1986, CHILD NEUROPSYCHOL, V2, P113; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; Bigler E. D., 1988, ASSESSMENT ISSUES CH, P67; BIJUR PE, 1990, PEDIATRICS, V86, P337; BOYCE WT, 1992, PEDIATRICS, V90, P483; BROWN ER, 1991, SEMIN NEUROL, V11, P167, DOI 10.1055/s-2008-1041218; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bruce D., 1990, REHABILITATION ADULT, P521; CAFFEY J, 1974, PEDIATRICS, V54, P396; CHELUNE GJ, 1981, J CONSULT CLIN PSYCH, P777; CHRISTOFFEL KK, 1991, JAMA-J AM MED ASSOC, V266, P1146; CRANBERG LD, 1987, NEUROLOGY, V37, P1165, DOI 10.1212/WNL.37.7.1165; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; DEAN RS, 1986, CHILD NEUROPSYCHOL, V2, P83; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; Deuel R. K., 1987, SOFT NEUROLOGICAL SI, P95; DIAMOND A, 1991, BRAIN MATURATION COG; DIEKEMA DS, 1993, PEDIATRICS, V91, P612; DREIFUSS JE, 1989, PEDIATR NEUROL, V1, P393; EPSTEIN FM, 1987, MED COMPLICATIONS HE, P390; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FENICHEL G, 1993, CLIN PEDIATRIC NEURO, P260; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; FUTAGI Y, 1992, BRAIN DEV-JPN, V14, P294, DOI 10.1016/S0387-7604(12)80146-X; GODANO U, 1992, CHILD NERV SYST, V8, P136, DOI 10.1007/BF00298269; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Grumbach MM, 1992, WILLIAMS TXB ENDOCRI, P1139; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Jaffe K. M., 1990, REHABILITATION ADULT, P539; JORDAN FM, 1990, ACQUIRED NEUROLOGICA, P124; Kaiser G., 1986, HEAD INJURIES NEWBOR, P263; KLONOFF H, 1984, ADV CLIN NEUROPSYCHO, V2, P139; KUYPERS HGM, 1989, ENCY NEUROSCIENCE S, V1, P107; Lantz J. A., 1990, PSYCHOL MANAGEMENT T, P133; LEHR E, 1990, PSYCHOL MANAGEMENT T, P6; LESCOHIER I, 1993, PEDIATRICS, V91, P721; Levin H. S., 1991, ACQUIRED APHASIA, P455; LIEDERMAN J, 1989, BRAIN LATERALIZATION, P375; MCLAURIN RL, 1989, NEUROLOGICAL SURGERY, V1, P2148; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MILLER WL, 1980, NEW ENGL J MED, V302, P724, DOI 10.1056/NEJM198003273021305; NASS R, 1985, NEUROLOGY, V35, P1059, DOI 10.1212/WNL.35.7.1059; Ozanne AE, 1990, ACQUIRED NEUROLOGICA, P1; PARKER RS, 1990, TRAUMATIC BRAIN INJU, P76; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; Peacock W. J., 1986, HEAD INJURIES NEWBOR, P53; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; PESCOVITZ O H, 1992, P473; Raimondi J. R., 1986, HEAD INJURIES NEWBOR, P141; REYNOLDS CR, 1985, HDB INTELLIGENCE, P60; ROSMAN NP, 1989, PEDIATRIC NEUROLOGY, V2; ROSS ED, 1993, NEUROL CLIN, V11, P9; RUDEL R, 1979, ED BRAIN, P269; SATTLER JM, 1988, ASSESSMENT CHILDREN, P127; SHAPIRO K, 1987, HEAD INJURY, P367; Stuss D.T., 1986, FRONTAL LOBES; STYNE DM, 1991, BASIC CLIN ENDOCRINO, P519; TAKAHASHI H, 1980, CHILD BRAIN, V7, P124; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; Tramontana M. G., 1989, HDB CLIN CHILD NEURO, P87; Tupper D, 1986, CHILD NEUROPSYCHOL, V2, P139; VARGHAKHADEM F, 1985, BRAIN, V108, P677, DOI 10.1093/brain/108.3.677; Ward J. D., 1989, TXB HEAD INJURY, P319; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; WINOGRAD P, 1988, TOP LANG DISORD, V8, P38, DOI 10.1097/00011363-198806000-00006; Witelson SF, 1988, BRAIN LATERALIZATION, P35	80	17	17	0	6	THIEME MEDICAL PUBL INC	NEW YORK	381 PARK AVE SOUTH, NEW YORK, NY 10016	0271-8235			SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					67	73		10.1055/s-2008-1041061			7	Clinical Neurology	Neurosciences & Neurology	NE151	WOS:A1994NE15100012	8029562				2021-06-18	
J	IKEDA, Y; WANG, M; NAKAZAWA, S				IKEDA, Y; WANG, M; NAKAZAWA, S			SIMPLE QUANTITATIVE-EVALUATION OF BLOOD-BRAIN-BARRIER DISRUPTION IN VASOGENIC BRAIN EDEMA	ACTA NEUROCHIRURGICA			English	Article						VASOGENIC BRAIN EDEMA; COLD INJURY; EVANS BLUE; BLOOD-BRAIN BARRIER	EVANS BLUE FLUORESCENCE; VASCULAR-PERMEABILITY	Traumatic damage to the brain results in blood-brain barrier disruption with subsequent formation of vasogenic brain edema. The goal of this study was to evaluate a colorimetric assay of Evans blue extravasation for quantitatively studying blood-brain barrier disruption. Vasogenic brain edema was produced by a cortical freezing lesion. 52 male Wistar rats were sacrificed and cardiac perfusion was performed. A volume of dimethylformamide, twice the brain weight, was added to the brain and this was incubated for 72 hours. The supernatant was analyzed spectrophotometrically. Evans blue contents in the lesioned hemisphere was significantly increased within one hour after the lesion production relative to the normal brain and continued to increase for 24 hours (p < 0.01). This quantitative assay of Evans blue is a simple method for evaluation of blood-brain barrier disruption in vasogenic brain edema.		IKEDA, Y (corresponding author), NIPPON MED COLL, DEPT NEUROSURG, 1-1-5 SENDAGI, BUNKYO KU, TOKYO 113, JAPAN.						Johansson B B, 1986, Acta Neurochir Suppl (Wien), V36, P137; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WEISSMAN DE, 1988, J NEUROSCI METH, V23, P207, DOI 10.1016/0165-0270(88)90004-0	5	17	22	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			119	120					2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600031	7976520				2021-06-18	
J	MOORE, D; GREER, BG; LI, L				MOORE, D; GREER, BG; LI, L			ALCOHOL AND OTHER SUBSTANCE USE ABUSE AMONG PEOPLE WITH DISABILITIES	JOURNAL OF SOCIAL BEHAVIOR AND PERSONALITY			English	Article							SPINAL-CORD INJURY	This paper reports findings of a multi-state survey on substance use/abuse among 916 people with disabilities. Self-report data suggest that respondents used alcohol at least as much as the general population, with a high incidence of substance abuse symptoms reported by some disability groups. People with quadriplegia, traumatic brain injury, and mental illness were significantly more likely to abuse alcohol than were people with other disabilities. Additional disability-related factors (e.g., acquired versus congenital, early versus late onset of disability, and attitude toward disability) were also significantly related to alcohol abuse. This study yielded some indications that disability-related factors, such as belief in entitlement to use due to the disability, and age of disability onset are culpable factors in the development of substance abuse among this population.	UNIV MEMPHIS,DEPT COUNSELING EDUC PSYCHOL & RES,MEMPHIS,TN 38163	MOORE, D (corresponding author), WRIGHT STATE UNIV,DEPT COMMUNITY HLTH,DAYTON,OH 45401, USA.						BUSS A, 1989, INCIDENCE ALCOHOL US; Cahalan D, 1969, AM DRINKING PRACTICE; DELOACH C, 1981, ADJUSTMENT SEVERE PH; DULL RT, 1983, J DRUG EDUC, V13, P49, DOI 10.2190/9HTX-V0BQ-JU5A-7UHB; GLASS EJ, 1980, ALCOHOL HLTH RES WOR, V8, P20; GREER BG, 1994, UNPUB ISSUES APPROAC; GREER BG, 1990, REHABIL ED, V4, P33; GREER BG, 1986, J REHABIL, V14, P34; HEINEMANN AW, 1989, REHABIL PSYCHOL, V34, P191, DOI 10.1037//0090-5550.34.3.191; HINDMAN MH, 1980, ALCOHOL HLTH RES WOR, V5, P5; JOHNSTON LD, 1986, PSYCHOTHERAPEUTIC LI; KAPLAN H, 1980, NIDA MONOGRAPH, V56; Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686; MOORE D, 1991, INT J ADDICT, V26, P65, DOI 10.3109/10826089109056240; MOORE D, 1991, RES DRUG ALCOHOL ABU; Moore D, 1989, ALCOHOL HEALTH RES W, V13, P118; PRENDERGAST M, 1990, PREVENTION RES UPDAT; ROHE DE, 1989, REHABIL PSYCHOL, V34, P25; SCHASCHL S, 1989, ALCOHOL HEALTH RES W, V13, P150; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010	21	17	17	0	0	SELECT PRESS	CORTE MADERA	PO BOX 37, CORTE MADERA, CA 94976	0886-1641			J SOC BEHAV PERS	J. Soc. Behav. Pers.		1994	9	5			SI		369	382					14	Psychology, Social	Psychology	PH940	WOS:A1994PH94000023					2021-06-18	
J	LEAF, LE				LEAF, LE			TRAUMATIC BRAIN INJURY - AFFECTING FAMILY RECOVERY	BRAIN INJURY			English	Article								Ongoing interest in how families adjust to traumatic events has enouraged much research, with varying results. Viewing the family process of adjustment from a systems perspective provides a workable model. The current article explores basic system tenets and provides data on varying adjustment issues for families. Results are consistent with current research trends and family data.		LEAF, LE (corresponding author), MEADOWBROOK CHICAGO,444 N NW HIGHWAY,SUITE 145,PK RIDGE,IL 60068, USA.						Bowen M., 1978, FAMILY THERAPY CLIN; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROOKS N, 1991, Brain Injury, V5, P103, DOI 10.3109/02699059109008082; Goldenberg I, 1980, FAMILY THERAPY OVERV; LIVINGSTON MG, 1990, REHABILITATION ADULT, V2, P225; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42	6	17	17	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1993	7	6					543	546		10.3109/02699059309008182			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	MA173	WOS:A1993MA17300009	8260958				2021-06-18	
J	MEYER, S; GIBB, T; JURKOVICH, GJ				MEYER, S; GIBB, T; JURKOVICH, GJ			EVALUATION AND SIGNIFICANCE OF THE PUPILLARY LIGHT REFLEX IN TRAUMA PATIENTS	ANNALS OF EMERGENCY MEDICINE			English	Article						NEUROTRAUMA		The pupillary light reflex is an important component of the neurologic examination of the trauma victim. Although the normal reflex can be predictably altered by specific head injuries, a variety of other factors common to trauma patients such as alcohol, illicit drugs, narcotics, paralyzing agents, hypothermia, and orbital or ophthalmic injury can confound the evaluation of the pupillary light reflex. This report reviews the anatomy and neurophysiology of the pupillary light reflex and discusses the impact these confounding variables may have on this key component of the initial trauma evaluation.	UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT SURG,SEATTLE,WA 98104								0	17	17	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	1993	22	6					1052	1057		10.1016/S0196-0644(05)82750-7			6	Emergency Medicine	Emergency Medicine	LE338	WOS:A1993LE33800016	8503525				2021-06-18	
J	OMALLEY, MB; MACLEISH, PR				OMALLEY, MB; MACLEISH, PR			INDUCTION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON ADULT PRIMATE RETINAL NEURONS	JOURNAL OF NEUROIMMUNOLOGY			English	Article						PRIMATE RETINA; TRAUMATIC INJURY; CNS REGENERATION; MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN	CENTRAL NERVOUS-SYSTEM; RAT MOTOR NEURONS; HLA-A; MONOCLONAL-ANTIBODIES; ALZHEIMERS-DISEASE; HUMAN ORGANS; CELL-LINES; EXPRESSION; BRAIN; RECEPTORS	The expression of class I major histocompatibility complex (MHC) antigens was examined on adult monkey and human retinal cells following injury caused by dissociation. In a panning assay, neurons and glia demonstrated a rapid induction of class I MHC antigens following enzymatic dissociation, and expression was sustained on regenerating neurons as well as on glia in culture. Class I MHC antigen expression was also enhanced following optic nerve crush of monkey eyes in vivo. These results suggest that the functions of class I MHC antigens may be relevant to primate CNS neurons and glia following injury.	ROCKEFELLER UNIV,NEUROBIOL LAB,NEW YORK,NY 10021					NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY-05201] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM07739-10] Funding Source: Medline		AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202; BACKES MG, 1990, J COMP NEUROL, V295, P428, DOI 10.1002/cne.902950307; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BARTLETT PF, 1978, J CELL BIOL, V77, P377, DOI 10.1083/jcb.77.2.377; BERAH M, 1970, TRANSPLANTATION, V9, P185, DOI 10.1097/00007890-197003000-00001; BRODSKY FM, 1982, J IMMUNOL, V128, P129; BURROUS M R, 1989, Society for Neuroscience Abstracts, V15, P334; BURROUS M R, 1988, Society for Neuroscience Abstracts, V14, P497; CURTIS ASG, 1979, NATURE, V281, P222, DOI 10.1038/281222a0; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; DRAGER UC, 1984, J NEUROSCI, V4, P2025; DUE C, 1986, P NATL ACAD SCI USA, V83, P6007, DOI 10.1073/pnas.83.16.6007; FEHLMANN M, 1985, P NATL ACAD SCI USA, V82, P8634, DOI 10.1073/pnas.82.24.8634; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; KIYONO H, 1982, P NATL ACAD SCI-BIOL, V79, P596, DOI 10.1073/pnas.79.2.596; LAMPSON LA, 1983, J IMMUNOL, V130, P2471; LAMPSON LA, 1986, J IMMUNOL, V136, P4054; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LAMPSON LA, 1986, J INTERFERON RES, V6, P257, DOI 10.1089/jir.1986.6.257; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; MACLEISH PR, 1983, P NATL ACAD SCI-BIOL, V80, P7014, DOI 10.1073/pnas.80.22.7014; MAEHLEN J, 1989, BRAIN RES, V481, P368, DOI 10.1016/0006-8993(89)90816-0; MAEHLEN J, 1988, NEUROSCI LETT, V92, P8, DOI 10.1016/0304-3940(88)90733-1; MAGE MG, 1977, J IMMUNOL METHODS, V15, P47, DOI 10.1016/0022-1759(77)90016-3; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARION DW, 1990, BRAIN RES, V519, P133, DOI 10.1016/0006-8993(90)90071-I; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MUCKE L, 1992, J NEUROIMMUNOL, V36, P193, DOI 10.1016/0165-5728(92)90050-U; OLSSON T, 1989, J NEUROSCI, V9, P3870; OMALLEY MB, 1993, IN PRESS J NEUROSCI; PARHAM P, 1977, J BIOL CHEM, V252, P7555; RICHMAN LK, 1981, CELL IMMUNOL, V62, P110, DOI 10.1016/0008-8749(81)90304-X; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; SCHREIBER AB, 1984, J CELL BIOL, V98, P725, DOI 10.1083/jcb.98.2.725; SCHULTZBERG M, 1989, J NEUROIMMUNOL, V24, P105, DOI 10.1016/0165-5728(89)90104-5; SKIAS DD, 1987, J IMMUNOL, V138, P3254; SOBEL RA, 1988, J NEUROPATH EXP NEUR, V47, P19, DOI 10.1097/00005072-198801000-00003; SOLANO AR, 1988, P NATL ACAD SCI USA, V85, P5087, DOI 10.1073/pnas.85.14.5087; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; TOOYAMA I, 1990, BRAIN RES, V523, P273, DOI 10.1016/0006-8993(90)91496-4; TRAUGOTT U, 1985, J NEUROL SCI, V69, P365, DOI 10.1016/0022-510X(85)90147-9; WHELAN JP, 1986, J IMMUNOL, V137, P2561; WILLIAMS KA, 1980, TRANSPLANTATION, V29, P274, DOI 10.1097/00007890-198004000-00002; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0	46	17	17	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728			J NEUROIMMUNOL	J. Neuroimmunol.	MAR	1993	43	1-2					45	57		10.1016/0165-5728(93)90074-9			13	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	KV485	WOS:A1993KV48500007	8458987				2021-06-18	
J	DELIAC, P; RICHER, E; BERTHOMIEU, J; PATY, J; COHADON, F; BENSCH, C				DELIAC, P; RICHER, E; BERTHOMIEU, J; PATY, J; COHADON, F; BENSCH, C			ELECTROPHYSIOLOGY UNDER THALAMIC-STIMULATION OF POST TRAUMATIC VEGETATIVE STATES	NEUROCHIRURGIE			French	Article						QUANTITATIVE EEG; EVOKED POTENTIALS; PERSISTENT VEGETATIVE STATE; THALAMIC STIMULATION	MULTIMODALITY EVOKED-POTENTIALS; HEAD-INJURY; BRAIN; COMA; COMPONENT; ADULTS	We have studied the electrophysiological evolution, with the aid of long-term, quantitative E.E.G. (Holter method) and sensory evoked potentials (visual, auditory and somatosensory) on 25 severe traumatic head injury patients (initial Glasgow scale - between 3 and 5) aged from 5 to 42 years having evolved towards a persistent vegetative state and being object of a protocol of thalamic stimulation. Electrophysiological exploration was practised before placement of the stimulation, then at 2 weeks, 1 month, 2 months and finally 3 months after. The electrophysiological parameters appear to have no predictive value on the clinical evolution after stimulation. However, changes such as long-term quantitative EEG as well as evoked potentials mostly precede-clinical progress when present. Cortical evoked potentials are the first to change significantly (J15) followed by long-term quantitative EEG and brain stem evoked potentials (J30); the latter improving more completely. Also the consideration of the chronobiological aspects of the recordings of the long term EEG allow the proposal of <<waking targeted>> stimulations at the most favorable moments of the nyctohemeral period.	HOP PELLEGRIN TRIPODE,SERV NEUROCHIRURG,F-33076 BORDEAUX,FRANCE	DELIAC, P (corresponding author), HOP PELLEGRIN TRIPODE,EXPLORAT FONCTIONELLES SYST NERVEUX LAB,F-33076 BORDEAUX,FRANCE.						BERGAMASCO B, 1968, ACTA NEUROL SCAND, V44, P495, DOI 10.1111/j.1600-0404.1968.tb05588.x; BRICOLO A, 1978, REANIMATION MED URGE, P174; CANT BR, 1984, NEUROLOGY, V34, P35, DOI 10.1212/WNL.34.1.35; CELESIA GG, 1985, EVOKED POTENTIAL TES, P1; DANZE F, 1989, Neurosurgical Review, V12, P477, DOI 10.1007/BF01790694; DANZE F, 1991, NEUROPSY, V6, P455; Davis H, 1985, EVOKED POTENTIAL TES, P55; DELIAC P, 1987, CONCILIA MED, V1, P40; DESMEDT JE, 1985, ELECTROMYOGRAPHY EVO; FACCO E, 1991, Brain Topography, V3, P447, DOI 10.1007/BF01129004; GARMA L, 1991, NEUROPSY, V6, P657; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GUERIT JM, 1990, NEUROLOGY EUROPE, P383; HANSOTIA PL, 1985, ARCH NEUROL-CHICAGO, V42, P1048, DOI 10.1001/archneur.1985.04060100030015; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1981, MANAGEMENT HEAD INJU; KANNO T, 1989, PACE, V12, P733, DOI 10.1111/j.1540-8159.1989.tb02724.x; KATAYAMA Y, 1991, PACE, V14, P116, DOI 10.1111/j.1540-8159.1991.tb04055.x; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; KURTZ D, 1989, REV PRAT; MAUGUIERE F, 1983, ELECTROEN CLIN NEURO, V56, P283, DOI 10.1016/0013-4694(83)90253-5; MAX J, 1981, METHODES TECHNIQUES; Momose T, 1989, Radiat Med, V7, P243; NAU HE, 1987, INTENS CARE MED, V13, P249, DOI 10.1007/BF00265113; PASSOUANT P, 1964, REV NEUROL, P111; PERONNET F, 1984, ELECTROEN CLIN NEURO, V59, P67, DOI 10.1016/0168-5597(84)90021-2; PLUM F, 1973, DIAGNOSTIC STUPEUR C; Rechtschaffen A, 1968, MANUAL STANDARDIZED; RICHER E, REV FR DOMMAGE CORP, V14, P205; RIFFEL B, 1989, ANAESTHESIST, V38, P51; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; SCHWARZ G, 1990, EEG-EMG-Z ELEK ELEKT, V21, P35; SHUCARD DW, 1987, ELECTROEN CLIN NEURO, V68, P303, DOI 10.1016/0168-5597(87)90051-7; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; TSUBOKAWA T, 1990, Brain Injury, V4, P315, DOI 10.3109/02699059009026185; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113	40	17	20	0	2	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie		1993	39	5					293	303					11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	MP793	WOS:A1993MP79300003	8065487				2021-06-18	
J	RESNICK, PJ				RESNICK, PJ			DEFROCKING THE FRAUD - THE DETECTION OF MALINGERING	ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES			English	Article							COMMAND HALLUCINATIONS; CLINICAL-SIGNIFICANCE	The purpose of this paper is to provide psychiatrists with practical advice on how to detect malingered mental illness. Various types of malingering are defined and the five major purposes of malingering are specified. The research literature on malingering is reviewed. Clinicians must be thoroughly grounded in the phenomenology of true mental disease to detect malingering. Detailed information about hallucinations is reviewed so that faked hallucinations that do not follow typical patterns can be more easily identified. Strategies for approaching persons suspected of malingering are suggested. Features of malingered mutism, mania, depression and mental retardation are described. The differential diagnosis of malingering, post-traumatic stress disorder, conversion disorder, and post-concussion syndromes after trauma is discussed. Clues to malingered psychoses and post-traumatic stress disorders are delineated. Finally, specific indicators of malingered insanity defenses are identified.	CASE WESTERN RESERVE UNIV, SCH MED, CLEVELAND, OH 44106 USA							ALBERT S, 1980, J PERS ASSESS, V44, P115, DOI 10.1207/s15327752jpa4402_1; ALTSHULER LL, 1986, AM J PSYCHIAT, V143, P1409; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ANDERSON EW, 1959, ACTA PSYCHIAT NEUROL, V34, P132; ASAAD G, 1986, AM J PSYCHIAT, V143, P1088; BASH IY, 1980, ANN NY ACAD SCI, V347, P86, DOI 10.1111/j.1749-6632.1980.tb21257.x; BEABER RJ, 1985, AM J PSYCHIAT, V142, P1478; Braverman M, 1978, Occup Health Saf, V47, P36; CHANEY HS, 1984, J CLIN PSYCHOL, V40, P1450; COLE ES, 1970, MED J AUSTRALIA, V1, P93, DOI 10.5694/j.1326-5377.1970.tb77752.x; Daniel A E, 1987, Bull Am Acad Psychiatry Law, V15, P301; DAVIDSON HA, 1965, FORENSIC PSYCHIATRY; Davidson HA, 1950, B MENNINGER CLIN, V14, P157; East N, 1927, INTRO FORENSIC PSYCH; ENGEL GL, 1970, SIGNS SYMPTOMS; EXNER JE, 1978, RORSCHACH COMPREHENS, V2; FALLOON IRH, 1981, PSYCHOL MED, V11, P329, DOI 10.1017/S0033291700052144; GARFIELD P, 1987, PSYCHIAT J U OTTAWA, V12, P93; GOODWIN DW, 1971, ARCH GEN PSYCHIAT, V24, P76; GOUGH HG, 1950, J CONSULT CLIN PSYCH, V46, P900; HALL HV, 1982, CRIM JUSTICE BEHAV, V9, P3, DOI 10.1177/0093854882009001001; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HELLERSTEIN D, 1987, AM J PSYCHIAT, V144, P219; HOFLING C K, 1965, GP, V31, P115; HUDDLESTON JH, 1932, ACCIDENTS NEUROSES C; INBAU FE, 1967, CRIMINAL INTERROGATI; Jones A. B., 1917, MALINGERING, P80; JUNGINGER J, 1990, AM J PSYCHIAT, V147, P245; KANAS N, 1984, ARCH GEN PSYCHIAT, V41, P919; LAYDEN M, 1966, PSYCHIATRIC PROGR, V1, P7; Lewinsohn P. M., 1970, ORIGIN MECHANISMS HA, P401; Lipman F. D., 1962, TEMPLE LAW Q, V35, P141; LISHMAN WA, 1978, ORGANIC PSYCHIATRY; MACDONALD J, 1976, PSYCHIATRY CRIMINAL, P425; MOTT RH, 1965, ARCH GEN PSYCHIAT, V12, P595; OSSIPOV VP, 1944, B MENNINGER CLIN, V8, P31; Resnick PJ., 1984, BEHAVIORAL SCI LAW, V2, P21, DOI 10.1002/bsl.2370020104; RITSON B, 1970, BRIT J MED PSYCHOL, V43, P31, DOI 10.1111/j.2044-8341.1970.tb02099.x; ROGERS R, 1987, LAW MENTAL HLTH INT, V3; Rogers Richard, 1990, BEHAVIORAL SCI LAW, V8, P85, DOI DOI 10.1002/BSL.2370080110; ROSANOFF AJ, 1920, MANUAL PSYCHIATRY, P310; ROSENHAN D, 1973, SCIENCE, V172, P250; SADOFF RL, 1978, WEEKLY PSYCHIATRIC U; SCHRETLEN DJ, 1988, CLIN PSYCHOL REV, V8, P451, DOI 10.1016/0272-7358(88)90074-8; SEIGEL RK, 1975, HALLUCINATIONS BEHAV; SHERMAN M, 1975, J CONSULT CLIN PSYCH, V43, P867; SMALL IF, 1966, DIS NERV SYST, V27, P349; SONIAT T L, 1960, South Med J, V53, P365; Trimble MR, 1981, POSTTRAUMATIC NEUROS; VANDERKOLK B, 1984, AM J PSYCHIAT, V141, P2; Wachspress M, 1953, PSYCHIAT QUART, V27, P463, DOI 10.1007/BF01562502; ZISKIN J, 1988, COPING PSYCHIATRIC P, V2; ZISKIN J, 1988, COPING PSYCHIATRIC P, V1	53	17	17	1	5	GEFEN PUBL HOUSE LTD	JERUSALEM	PO BOX 6056, JERUSALEM 91060, ISRAEL	0333-7308			ISRAEL J PSYCHIAT	Isr. J. Psychiatr. Relat. Sci.		1993	30	2					93	101					9	Psychiatry	Psychiatry	LM659	WOS:A1993LM65900005	8270391				2021-06-18	
J	SANDEL, ME; OLIVE, DA; RADER, MA				SANDEL, ME; OLIVE, DA; RADER, MA			CHLORPROMAZINE-INDUCED PSYCHOSIS AFTER BRAIN INJURY	BRAIN INJURY			English	Article							HEAD-INJURY; HALOPERIDOL; DELUSIONS; DRUGS	Antipsychotic agents, most often used for treatment of schizophrenia, are sometimes prescribed for the agitated patient with an organic brain disorder. We report the case of a brain-injured patient who was prescribed chlorpromazine for agitation and who developed a delusional state while taking this antipsychotic agent. The emergence of this delusional state coincided with the exacerbation of certain cognitive deficits. Possible mechanisms for this phenomenon are discussed. Caution is advised when prescribing neuroleptics for patients with traumatic brain injury, especially those agents with significant cognitive side-effects or with a significant potential to precipitate seizures.	MAGEE MEM REHABILITAT CTR,PHILADELPHIA,PA 19102; MEDIPLEX REHAB CAMDEN,CAMDEN,NJ 08103							ADAMS JH, 1982, NEUROPATHOLOGY APPLI, V11, P299; ALEXANDER MP, 1979, NEUROLOGY, V29, P334, DOI 10.1212/WNL.29.3.334; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; BRIMER A, 1964, BRIT J PSYCHIAT, V110, P723, DOI 10.1192/bjp.110.468.723; CARDENAS DD, 1987, J HEAD TRAUMA REHAB, V2, P43; COPE DN, 1987, J HEAD TRAUMA REHAB, V2, P1; COVINGTON JS, 1975, SOUTHERN MED J, V68, P719, DOI 10.1097/00007611-197506000-00015; CUMMINGS JL, 1985, BRIT J PSYCHIAT, V146, P184, DOI 10.1192/bjp.146.2.184; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; JOHNSON FN, 1969, PSYCHOPHARMACOLOGIA, V16, P105, DOI 10.1007/BF00403613; Klein DF, 1969, DIAGNOSIS DRUG TREAT; LEVINE DN, 1984, NEUROLOGY, V34, P577, DOI 10.1212/WNL.34.5.577; LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267; LONGO VG, 1966, PHARMACOL REV, V18, P965; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; SNYDER S, 1974, ARCH GEN PSYCHIAT, V31, P58; TUNE LE, 1982, AM J PSYCHIAT, V139, P1460; 1980, DIAGNOSTIC STATISTIC	22	17	17	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN-FEB	1993	7	1					77	83		10.3109/02699059309008159			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	KZ724	WOS:A1993KZ72400008	8425119				2021-06-18	
J	BULLOCK, R				BULLOCK, R			INTRODUCING NMDA ANTAGONISTS INTO CLINICAL-PRACTICE - WHY HEAD-INJURY TRIALS	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						HEAD INJURY; COMPETITIVE NMDA ANTAGONISTS; SUBDURAL HEMATOMA; ISCHEMIC BRAIN DAMAGE	TRAUMATIC BRAIN INJURY; ISCHEMIC NEURONAL DAMAGE; ACUTE SUBDURAL-HEMATOMA; GLUTAMATE; RAT; COMMON	1 Head injury is the major cause of death and severe disability in young adults. Evidence from clinical studies shows ischaemic brain damage to be the major determinant of bad outcome, and that a proportion of this (perhaps up to 40%) is delayed, thus offering an opportunity for 'prophylactic' therapy. 2 Laboratory studies in several relevant animal models of human head injury (fluid percussion, subdural haematoma, and focal ischaemia by middle cerebral occlusion) indicate that excitatory amino acids are important mediators of brain damage. Pretreatment with NMDA antagonists has shown that the extent of ischaemic damage may be dramatically reduced in these models (68% reduction in the cat MCA occlusion model, 54% in the rat subdural haematoma model). 3 Trials of NMDA antagonists in human head injury are therefore strongly indicated.		BULLOCK, R (corresponding author), UNIV GLASGOW,SO GEN HOSP,INST NEUROL SCI,DEPT NEUROSURG,GLASGOW G51 4TF,SCOTLAND.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BECKER DP, 1989, J CEREB BLOOD FLO S1, V9, pS302; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BULLOCK R, 1991, J CEREB BLOOD FLO S2, V11, pS109; BULLOCK R, 1990, STROKE S3, V21; BULLOCK R, 1990, VINKEN BRUYNS HDB CL, V24, P249; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; INGLIS FM, 1991, J CEREB BLOOD FLO S2, V11, pS307; INGLIS FM, 1991, J CEREB BLOOD FLO S2, V11, pS225; INGLIS FM, 1990, 8TH P INT S BRAIN OE, P277; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, IN PRESS J CEREB BLO; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; KURODA Y, 1991, J CBF METABOL S2, V11, pS74; KURODA Y, 1992, IN PRESS 8TH P INT S; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; MCCULLOCH J, 1991, EXCITATORY AMINO ACI, P287; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; WYPER DJ, 1991, J CEREB BLOOD FLOW M, V11, pS831	31	17	18	0	1	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0306-5251			BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	NOV	1992	34	5					396	401		10.1111/j.1365-2125.1992.tb05648.x			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	JX835	WOS:A1992JX83500003	1467133	Bronze, Green Published			2021-06-18	
J	RUIJS, MBM; KEYSER, A; GABREELS, FJM				RUIJS, MBM; KEYSER, A; GABREELS, FJM			ASSESSMENT OF POSTTRAUMATIC AMNESIA IN YOUNG-CHILDREN	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							SEVERE HEAD-INJURY; PRACTICAL SCALE; COMA SCALE; SEQUELAE; MEMORY	To assess the duration of post-traumatic amnesia (PTA) in children, a new procedure is described, derived from a method described previously for adults. The procedure was tested on 70 healthy children between 3.5 and 10 years of age, then applied in a longitudinal prospective study of 54 children with brain damage resulting from closed head-injury. The procedure consistently measured PTA in children of various ages. The duration of PTA was found to be as good a prognostic indicator for the occurrence of long-term residual sequelae as is duration of coma.	CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT CHILD NEUROL,6500 HB NIJMEGEN,NETHERLANDS	RUIJS, MBM (corresponding author), CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,INST NEUROL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.						ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; EVANS CD, 1977, INJURY, V8, P80; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JENNETT B, 1976, LANCET, V1, P1031; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1983, PAEDIATRIC HEAD TRAU; MINDERHOUD JM, 1984, TRAUMATISCHE HERSENL; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SIMPSON D, 1982, LANCET, V2, P450; SISLER G, 1975, CAN PSYCHIAT ASSOC J, V20, P333, DOI 10.1177/070674377502000502; TEASDALE G, 1974, LANCET, V2, P81; TODOROW S, 1975, SCAND J REHABIL MED, V7, P93; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300	26	17	18	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	OCT	1992	34	10					885	892					8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	JN729	WOS:A1992JN72900006	1397728				2021-06-18	
J	EIDE, PK; TYSNES, OB				EIDE, PK; TYSNES, OB			EARLY AND LATE OUTCOME IN HEAD-INJURY PATIENTS WITH RADIOLOGICAL EVIDENCE OF BRAIN-DAMAGE	ACTA NEUROLOGICA SCANDINAVICA			English	Article						HEAD INJURY; BRAIN CONTUSION; BRAIN CONCUSSION; COMPUTERIZED TOMOGRAPHY; OUTCOME	COMPUTERIZED-TOMOGRAPHY; SOCIAL-ADJUSTMENT; DISABILITY; LESION	This study examined the early and late outcome in head injury patients with focal or multifocal (unilateral or bilateral) brain contusions revealed by computerized tomography (CT) scanning. The outcome was also evaluated in patients hospitalized due to brain concussion. Three months after the injury (the early outcome) 43 % of the 86 cases with multifocal contusions on the CT scan were dead. As evaluated by the Glasgow Outcome Scale, all the 57 patients with a focal brain contusion, as well as the 117 cases with brain concussion, made a good recovery or were moderately disabled. The late outcome (1 to 5 years after injury) was evaluated in 78 cases with brain contusion and in 85 cases with brain concussion, and revealed that complaints and impaired adaptive functioning were frequent in both the contusion and concussion group. The occurrence of headache, dizziness and sleep problems did not significantly differ among the various head injury groups. However, focal or multifocal brain contusions on the CT scan increased the frequency of impaired memory, impaired concentration, speech problems, weakness in arms or legs and seizures with loss of consciousness. Cognitive deficits and speech problems were particularly common in patients with a focal contusion in the temporal lobe. The late adaptive and social functioning were most markedly impaired in cases with multifocal bilateral contusions.	HAUKELAND HOSP,DEPT NEUROSURG,N-5016 BERGEN,NORWAY; HAUKELAND HOSP,DEPT NEUROL,N-5016 BERGEN,NORWAY				Tysnes, Ole-Bjorn/0000-0002-7230-6426			ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; FORMISANO R, 1991, ACTA NEUROCHIR, V109, P1, DOI 10.1007/BF01405688; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P129; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; SNOEK J, 1979, J NEUROL NEUROSUR PS, V42, P215, DOI 10.1136/jnnp.42.3.215; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WELLER MPI, 1985, MED SCI LAW, V25, P11, DOI 10.1177/002580248502500103; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	23	17	18	0	5	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	AUG	1992	86	2					194	198		10.1111/j.1600-0404.1992.tb05065.x			5	Clinical Neurology	Neurosciences & Neurology	JL205	WOS:A1992JL20500016	1414231				2021-06-18	
J	YUAN, XQ; WADE, CE				YUAN, XQ; WADE, CE			TRAUMATIC BRAIN INJURY ATTENUATES THE EFFECTIVENESS OF LACTATED RINGERS SOLUTION RESUSCITATION OF HEMORRHAGIC-SHOCK IN RATS	SURGERY GYNECOLOGY & OBSTETRICS			English	Article							CEREBRAL BLOOD-FLOW; FLUID-PERCUSSION MODEL; HEAD-INJURY; INTRACRANIAL-PRESSURE; VOLUME; MORTALITY	Traumatic brain injury suppresses spontaneous cardiovascular compensation for hemorrhage, prompting us to examine the possibility that trauma to the brain modifies hemodynamic response to therapy in hemorrhage. Thirty rats that were anesthetized were randomly assigned to four groups-hemorrhagic shock (H), hemorrhagic shock after brain trauma (TH), hemorrhagic shock treated with lactated Ringer's (LR) solution (HR), and hemorrhagic shock after brain trauma treated with LR (THR). After hemorrhage, group TH had significantly lower mean arterial pressure (MAP), cardiac index (CI) and stroke volume index (SVI) than group H. Throughout the postresuscitative period, group HR had significantly higher MAP, CI, SVI and central venous pressure than group H. At 50 and 70 minutes after the start of hemorrhage, group THR showed significantly lower MAP, CI and SVI than group HR. This difference in hemodynamics is not because of transcapillary refill effect, because brain trauma did not cause changes in hematocrit and plasma protein levels. As heart rate, preload and afterload were not significantly different between groups THR and HR, the attenuation of fluid resuscitation can be attributed mainly to a depressed cardiac function. Furthermore, neither brain trauma nor fluid replacement altered the content of water in the brain in hemorrhaged rats. These data indicate that brain trauma not only suppresses spontaneous hemodynamic recovery from hemorrhage, but also impedes the efficacy of LR resuscitation. The results of the current study suggested that a more aggressive fluid replacement may be needed to treat hemorrhagic shock in individuals with brain injury.	LETTERMAN ARMY INST RES,DIV MIL TRAUMA RES,SAN FRANCISCO,CA 94129							Altman PL, 1974, BIOLOGY DATA BOOK, VIII, P1847; BAUE AE, 1988, HARDYS TXB SURGERY, P30; CRUICKSHANK JM, 1988, POSTGRAD MED, P140; DAVIS DH, 1980, J NEUROSURG, V52, P745, DOI 10.3171/jns.1980.52.6.0745; DAVIS RA, 1984, SURG GYNECOL OBSTET, V159, P597; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EISENBERG H, 1983, INTRACRANIAL PRESSUR, P549; GUNNAR W, 1988, SURGERY, V103, P398; HANNON JP, 1989, CIRC SHOCK, V29, P205; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; PILATI CF, 1990, P SOC EXP BIOL MED, V193, P225; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SALTER G, 1977, ANN SURG, V181, P1; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SMITH SD, 1982, J TRAUMA, V22, P588, DOI 10.1097/00005373-198207000-00011; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; WADE CE, 1989, CIRC SHOCK, V29, P193; WOOD JH, 1985, STROKE, V16, P765, DOI 10.1161/01.STR.16.5.765; WRIGHT CS, 1983, CAN J SURG, V26, P20; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	29	17	17	0	0	FRANKLIN H MARTIN FOUNDATION	CHICAGO	55 E ERIE ST, CHICAGO, IL 60611	0039-6087			SURG GYNECOL OBSTET	Surg. Gynecol. Obstet.	APR	1992	174	4					305	312					8	Obstetrics & Gynecology; Surgery	Obstetrics & Gynecology; Surgery	HM797	WOS:A1992HM79700008	1553610				2021-06-18	
J	MASANA, Y; TANEDA, M				MASANA, Y; TANEDA, M			DIRECT APPROACH TO A TRAUMATIC GIANT INTERNAL CAROTID-ARTERY ANEURYSM ASSOCIATED WITH A CAROTID-CAVERNOUS FISTULA - CASE-REPORT	JOURNAL OF NEUROSURGERY			English	Article						TRAUMATIC CEREBRAL ANEURYSM; INTERNAL CAROTID ARTERY; CAROTID-CAVERNOUS FISTULA	CEREBRAL-ARTERY; INJURY	The case is reported of a giant intracranial internal carotid artery aneurysm associated with a carotid-cavernous fistula following a closed head injury. The aneurysm and the fistula disappeared after only the neck of the aneurysm was clipped. This is the first case in which a direct surgical approach was successful in sparing the internal carotid flow. Reports of similar cases are reviewed.	HANWA MEM HOSP,DEPT NEUROSURG,OSAKA,JAPAN							ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; AJIR F, 1981, NEUROSURGERY, V9, P173, DOI 10.1227/00006123-198108000-00012; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BOUSQUET C, 1989, SURG NEUROL, V31, P319, DOI 10.1016/0090-3019(89)90059-1; BRIHAYE J, 1954, Acta Neurol Psychiatr Belg, V54, P411; DAY AL, 1990, J NEUROSURG, V72, P677, DOI 10.3171/jns.1990.72.5.0677; DOLENC VV, 1985, J NEUROSURG, V62, P667, DOI 10.3171/jns.1985.62.5.0667; ENOMOTO H, 1984, NEUROSURGERY, V15, P700, DOI 10.1227/00006123-198411000-00011; FIERSTIEN SB, 1978, SURG NEUROL, V9, P277; Giannotta SL, 1985, NEUROSURGERY, V2, P1678; HANDA J., 1967, ACTA NEURO CHIR, V17, P161; HAYAKAWA I, 1972, ACTA NEUROCHIR, V27, P45, DOI 10.1007/BF01402172; LAURENT JP, 1981, NEUROSURGERY, V9, P303, DOI 10.1227/00006123-198109000-00015; LIU MY, 1985, NEUROSURGERY, V17, P569, DOI 10.1227/00006123-198510000-00006; Nakao S, 1987, Neurol Med Chir (Tokyo), V27, P456, DOI 10.2176/nmc.27.456; NOTERMAN J, 1985, NEUROSURGERY, V17, P807, DOI 10.1097/00006123-198511000-00014; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; REDDY SVR, 1981, J NEUROSURG, V55, P813, DOI 10.3171/jns.1981.55.5.0813; SALCMAN M, 1985, NEUROSURGERY, V16, P218; SALMON JH, 1968, J THORAC CARDIOV SUR, V56, P28, DOI 10.1016/S0022-5223(19)42868-7; SARWAR M, 1976, NEURORADIOLOGY, V12, P79, DOI 10.1007/BF00333123; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; TERAO H, 1972, J NEUROSURG, V37, P352, DOI 10.3171/jns.1972.37.3.0352; WAGA S, 1978, SURG NEUROL, V9, P367; Waga S, 1979, No Shinkei Geka, V7, P933; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	28	17	18	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	1992	76	3					524	527		10.3171/jns.1992.76.3.0524			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	HF274	WOS:A1992HF27400021	1738034				2021-06-18	
J	LEVESQUE, MF; MARKHAM, CH				LEVESQUE, MF; MARKHAM, CH			VENTRAL INTERMEDIATE THALAMOTOMY FOR POSTTRAUMATIC HEMIBALLISMUS	STEREOTACTIC AND FUNCTIONAL NEUROSURGERY			English	Article; Proceedings Paper	MEETING ON STEREOTACTIC AND FUNCTIONAL NEUROSURGERY	JUN 16-19, 1991	PITTSBURGH, PA	AMER SOC STEREOTACT & FUNCT NEUROSURG		HEMIBALLISMUS; HEAD INJURY; STEREOTAXIC THALAMOTOMY; SUBTHALAMIC NUCLEUS		An unusual case of hemiballismus following closed head injury is presented. The abnormal movement persisted for 16 years despite medical treatment. Preoperative studies did not reveal a specific lesion within the subthalamic nucleus or within the basal ganglia. A stereotactic ventral intermediate thalamotomy was performed producing a complete resolution of the ballistic movement which persisted for the length of our 12-month follow-up.	UNIV CALIF LOS ANGELES,SCH MED,DIV NEUROSURG,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90024							JAKOB A, 1923, EXTRAPYRAMIDALEN ERK, P183; LOWNIE SP, 1990, CLIN NEUROPATHOL, V9, P46; MARTIN JP, 1959, BRAIN, V82, P104, DOI 10.1093/brain/82.1.104; SHANNON KM, 1990, CLIN NEUROPHARMACOL, V13, P413, DOI 10.1097/00002826-199010000-00003	4	17	17	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-6125			STEREOT FUNCT NEUROS	Stereotact. Funct. Neurosurg.		1992	58	1-4					26	29		10.1159/000098967			4	Neurosciences; Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	JQ014	WOS:A1992JQ01400005	1439355				2021-06-18	
J	YUAN, XQ; WADE, CE				YUAN, XQ; WADE, CE			INFLUENCES OF TRAUMATIC BRAIN INJURY ON THE OUTCOMES OF DELAYED AND REPEATED HEMORRHAGES	CIRCULATORY SHOCK			English	Article						FLUID PERCUSSION; HEAD INJURY; HEMORRHAGIC SHOCK; RAT; HEMODYNAMIC RECOVERY	FLUID-PERCUSSION MODEL; SEVERE HEAD-INJURY; INTRAVASCULAR COAGULATION; SHOCK; CATECHOLAMINES; COMPLICATIONS; SURGERY; RAT	Effects of traumatic brain injury (fluid percussion) on outcomes of hemorrhage, either delayed (70.5 min after the injury) or repeated (0.5 min after injury, then followed by a delayed hemorrhage), were examined in 4 groups of 10 anesthetized rats. Comparisons were made for delayed hemorrhage following sham injury (A1) vs. injury (A2) and for repeated hemorrhage following sham injury (B1) vs. injury (B2). No significant differences were observed in MAP, CI, HR, SVI, SVRI, and CVP between groups A1 and A2. Hemodynamic recovery was significantly better in B1 than B2 at 70 min after the initial hemorrhage. The respective values of MAP and CI for the groups B1 and B2 at 70 min were 65 +/- 3 vs. 56 +/- 4 mmHg and 220 +/- 15 vs. 182 +/- 15 ml/min/kg. Brain trauma did not affect survival rate (90 vs. 100%) following delayed hemorrhage, but significantly worsened the outcome of repeated hemorrhage. The 130 min survival rates for groups B1 and B2 were 50% and 10% (P = 0.08), respectively; their survival curves were significantly different (P = 0.02). Our data indicate that brain trauma has greater impact on responses to immediate hemorrhage than delayed hemorrhage, suggesting that traumatic brain injury may have a time-dependent effect on the response to hemorrhage.	LETTERMAN ARMY INST RES, DIV MIL TRAUMA RES, SAN FRANCISCO, CA 94129 USA	YUAN, XQ (corresponding author), CARE OF BRUTTIG SP, LETTERMAN ARMY INST RES, DIV MIL TRAUMA RES, SAN FRANCISCO, CA 94129 USA.						Altman PL, 1974, BIOL DATA BOOK, VIII; ANDREWS BT, 1987, SURG NEUROL, V28, P419, DOI 10.1016/0090-3019(87)90223-0; BROWN RB, 1988, CRIT CARE MED, V16, P1171, DOI 10.1097/00003246-198812000-00001; CARLSON TA, 1989, JAMA-J AM MED ASSOC, V261, P1943, DOI 10.1001/jama.261.13.1943; CHAN KH, 1989, NEUROSURGERY, V25, P378, DOI 10.1227/00006123-198909000-00010; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; DEMIRJIAN Z, 1974, CLIN ORTHOP RELAT R, P174; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EDELSON RJ, 1989, AM SURGEON, V55, P488; EGAN EL, 1974, MAYO CLIN PROC, V49, P658; FELICIANO DV, 1989, SURG CLIN N AM, V69, P273; FEUERSTEIN G, 1984, AM J PHYSIOL, V246, pR551; FRIEDMAN NJ, 1969, ARCH INTERN MED, V124, P341, DOI 10.1001/archinte.124.3.341; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; GUNDRY SR, 1989, AM SURGEON, V55, P162; HANNON JP, 1989, CIRC SHOCK, V29, P205; JONES SB, 1990, CIRC SHOCK, V30, P51; LEVEEN HH, 1974, ANN SURG, V180, P580, DOI 10.1097/00000658-197410000-00023; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MCLEOD AA, 1982, BRIT HEART J, V47, P221; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856; MULCARE RJ, 1976, SURG GYNECOL OBSTET, V143, P730; NISHIMURA N, 1984, RESUSCITATION, V12, P175, DOI 10.1016/0300-9572(84)90003-0; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PAPA MZ, 1984, AM J SURG, V147, P378, DOI 10.1016/0002-9610(84)90171-5; PEDOWITZ RA, 1989, J TRAUMA, V29, P219, DOI 10.1097/00005373-198902000-00012; POPP AJ, 1982, J SURG RES, V32, P416, DOI 10.1016/0022-4804(82)90121-4; RAYMOND RM, 1990, CIRC SHOCK, V30, P27; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SAIFI J, 1990, ARCH SURG-CHICAGO, V125, P119; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; WADE CE, 1989, CIRC SHOCK, V29, P193; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; YUAN XQ, 1991, IN PRESS J NEUROSURG	37	17	17	0	0	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0092-6213			CIRC SHOCK	Circ. Shock	DEC	1991	35	4					231	236					6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	GV218	WOS:A1991GV21800006	1777959				2021-06-18	
J	KUMAR, R; WEST, CGH; QUIRKE, C; HALL, L; TAYLOR, R				KUMAR, R; WEST, CGH; QUIRKE, C; HALL, L; TAYLOR, R			DO CHILDREN WITH SEVERE HEAD-INJURY BENEFIT FROM INTENSIVE-CARE	CHILDS NERVOUS SYSTEM			English	Article						SEVERE HEAD INJURY; CHILDREN; INTENSIVE MANAGEMENT; OUTCOME; COGNITIVE RECOVERY		Intensive management of severe closed head injury is pursued in most neurosurgical units, as it no doubt reduces mortality. However, the fate of those salvaged from death is less clearly defined. The impact of aggressive management on the psychological recovery is even less clear. This retrospective study of children admitted to a regional paediatric neurosurgical service attempts to address these issues. Eighty-four children between the ages of 3 to 16 years with severe head injuries were studied and categorized according to conservative or intensive treatment groups. The availability of intensive management led to a greater number of such children referred. The mortality in those children sustaining more severe injury, i.e. Glasgow Coma Score (GCS) 3 or 4, was halved (44%) with intensive management from 80% in the conservative group. For those with less severe injury (GCS 5-8), it was unchanged at about 23 %. The reduced mortality is at the expense of increased morbidity. Psychological testing showed that the cognitive recovery was comparable.	ROYAL MANCHESTER CHILDRENS HOSP, DEPT NEUROL SURG, MANCHESTER M27 1HA, LANCS, ENGLAND; ROYAL MANCHESTER CHILDRENS HOSP, DEPT CLIN PSYCHOL, MANCHESTER M27 1HA, LANCS, ENGLAND; ROYAL MANCHESTER CHILDRENS HOSP, DEPT MED PHYS, MANCHESTER M27 1HA, LANCS, ENGLAND							BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BECKER DP, 1982, NEUROLOGICAL SURGERY, V4, P1938; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; HAHN YS, 1988, CHILD NERV SYST, V4, P34; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, ARCH NEUROL-CHICAGO, V33, P595, DOI 10.1001/archneur.1976.00500090001001; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MIDDLETON J, 1989, J CHILD PSYCHOL PSYC, V30, P663, DOI 10.1111/j.1469-7610.1989.tb00780.x; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; TEASDALE G, 1974, LANCET, V2, P81	19	17	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	1991	7	6					299	304		10.1007/BF00304824			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	GT109	WOS:A1991GT10900001	1764703				2021-06-18	
J	CHESLER, M; SAKATANI, K; HASSAN, AZ				CHESLER, M; SAKATANI, K; HASSAN, AZ			ELEVATION AND CLEARANCE OF EXTRACELLULAR K+ FOLLOWING CONTUSION OF THE RAT SPINAL-CORD	BRAIN RESEARCH			English	Article						CONTUSION; EXTRACELLULAR SPACE; ION-SELECTIVE MICROELECTRODE; POTASSIUM; SPINAL CORD INJURY; VALINOMYCIN	MAGNETIC-RESONANCE SPECTROSCOPY; SPREADING DEPRESSION; TRAUMATIC INJURY; VOLUME FRACTION; IONIC ACTIVITY; BRAIN-TISSUE; BLOOD-FLOW; POTASSIUM; CALCIUM; METABOLISM	The elevation and clearance of extracellular potassium following a standard contusion injury was studied in the thoracic spinal cord of rats. Animals were anesthetized, paralyzed, laminectomized at T9-T11, then artificially ventilated. A 10-g rod was released 5.0 cm above the cord with the dura intact. After impact, the dura-arachnoid and pial membranes were incised to allow penetration of K+-selective microelectrodes. Electrodes utilized a valinomycin ionophore and were double-barreled, with tip diameters of 3-5-mu-m. Extracellular potassium activity ([K+]o) increased with the depth of penetration. The maximum values of [K+]o occurred at depths greater than 500-mu-m, and remained so with time after injury. These data indicate that a dorsal-ventral gradient of [K+]o develops in spinal cords contused from the dorsal surface, with the greatest elevation of [K+]o in the gray matter. In 8 preparations, the maximum [K+]o was 65 +/- 8 mM (mean +/- S.E.M.) at 5 +/- 1 min after injury. The [K+]o peak values decayed with a half-time of 11.0 +/- 3.4 min. Compared with data available for the injured cat spinal cord, the peak [K+]o recovered relatively rapidly. Although a simple diffusion model could account for the rapid clearance of [K+]o, the persistance of dorsal-ventral [K+]o gradients could not be explained by such a model. It is postulated that secondary injury processes contributed to the persistent [K+]o gradients.		CHESLER, M (corresponding author), NYU MED CTR,DEPT NEUROSURG,550 1ST AVE,NEW YORK,NY 10016, USA.			Sakatani, Kaoru/0000-0001-8656-2132; Chesler, Mitchell/0000-0002-3189-8234	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS027011, P50NS010164] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS10164, NS27011] Funding Source: Medline		Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; ARIAS MJ, 1987, SURG NEUROL, V23, P440; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BRAUGHLER JM, 1983, J NEUROSURG, V59, P256, DOI 10.3171/jns.1983.59.2.0256; CHESLER M, 1988, NEUROSCIENCE, V27, P941, DOI 10.1016/0306-4522(88)90197-2; CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E; CHESLER M, 1990, Society for Neuroscience Abstracts, V16, P1338; CORDINGLEY GE, 1978, BRAIN RES, V151, P291, DOI 10.1016/0006-8993(78)90886-7; Crank J, 1975, MATH DIFFUSION; CZEH G, 1989, Society for Neuroscience Abstracts, V15, P357; Eidelberg E, 1975, Surg Neurol, V3, P317; FADEN AI, 1987, J NEUROCHEM, V48, P1809, DOI 10.1111/j.1471-4159.1987.tb05740.x; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; KIMELBERG HK, 1986, ASTROCYTES, V3, P129; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; LEWIN MG, 1974, J NEUROSURG, V40, P65, DOI 10.3171/jns.1974.40.1.0065; MARTINEZ LJ, 1981, NEUROSURGERY, V8, P450, DOI 10.1227/00006123-198104000-00008; NICHOLSON C, 1985, BRAIN RES, V333, P325, DOI 10.1016/0006-8993(85)91586-0; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; PHILLIPS JM, 1979, BRAIN RES, V173, P567, DOI 10.1016/0006-8993(79)90254-3; SOMJEN GG, 1989, J NEUROSCI METH, V28, P35, DOI 10.1016/0165-0270(89)90007-1; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; SYKOVA E, 1983, NEUROSCI LETT, V43, P293, DOI 10.1016/0304-3940(83)90203-3; SYKOVA E, 1987, CAN J PHYSIOL PHARM, V65, P1058, DOI 10.1139/y87-167; VINK R, 1987, MAGNET RESON MED, V5, P390, DOI 10.1002/mrm.1910050413; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; WALZ W, 1989, PROG NEUROBIOL, V33, P309, DOI 10.1016/0301-0082(89)90005-1; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667; YOUNG W, 1982, BRAIN RES, V253, P115, DOI 10.1016/0006-8993(82)90678-3; YOUNG W, 1985, CENTRAL NERVOUS SYST, P463	40	17	17	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 9	1991	556	1					71	77		10.1016/0006-8993(91)90548-A			7	Neurosciences	Neurosciences & Neurology	GD897	WOS:A1991GD89700009	1933355				2021-06-18	
J	GIUNTA, G; PIAZZA, I				GIUNTA, G; PIAZZA, I			RECURRENT BACTERIAL-MENINGITIS OCCURRING 5 YEARS AFTER CLOSED HEAD-INJURY AND CAUSED BY AN INTRANASAL POSTTRAUMATIC MENINGO-ENCEPHALOCELE	POSTGRADUATE MEDICAL JOURNAL			English	Article							NASAL	A case of atypical presentation of a post-traumatic intranasal meningo-encephalocele is described in a patient with a history of recurrent bacterial meningitis occurring 5 years after closed head injury. The usefulness of the CT and MRI findings in diagnostic evaluation of this lesion is emphasized.	HOSP SAN DONA PIAVE,DEPT INTERNAL MED,VENICE,ITALY	GIUNTA, G (corresponding author), OSPED CIVILE,DIV MED 2,NAZARIO SAURO 25,30027 S DONA PIAVE,VENICE,ITALY.						BLUMENFELD R, 1965, ARCHIV OTOLARYNGOL, V82, P527; FRAZEE RC, 1988, POSTGRAD MED, V83, P267, DOI 10.1080/00325481.1988.11700238; Frazee RC, 1988, POSTGRAD MED, V83, P273; HEMMY DC, 1985, NEUROSSCIENCES, V12, P182; JONES RE, 1962, JAMA-J AM MED ASSOC, V181, P640, DOI 10.1001/jama.1962.03050330070019c; LOVE GL, 1983, ARCH OTOLARYNGOL, V109, P420; LUSK RP, 1986, OTOLARYNG HEAD NECK, V95, P303, DOI 10.1177/01945998860953P107; ROVIT RL, 1969, J NEUROSURG, V30, P406, DOI 10.3171/jns.1969.30.4.0406; SPETZLER RF, 1982, NEUROLOGICAL SURG, V4, P2209; VONESSEN C, 1981, ACTA NEUROCHIR, V59, P143, DOI 10.1007/BF01411199; Wilkins R. H., 1985, NEUROSURGERY, V14, P277	11	17	18	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0032-5473			POSTGRAD MED J	Postgrad. Med. J.	APR	1991	67	786					377	379		10.1136/pgmj.67.786.377			3	Medicine, General & Internal	General & Internal Medicine	FG645	WOS:A1991FG64500014	2068033	Green Published, Bronze			2021-06-18	
J	GLASSMAN, LR				GLASSMAN, LR			MUSIC-THERAPY AND BIBLIOTHERAPY IN THE REHABILITATION OF TRAUMATIC BRAIN INJURY - A CASE-STUDY	ARTS IN PSYCHOTHERAPY			English	Article																BERNSTEIN L, 1957, SOMEWHERE; CHARNIN M, 1977, TOMORROW; DAVIS M, 1970, I BELIEVE IN MUSIC; FEKARIS D, 1978, I WILL SURVIVE; FRANCOIS C, 1969, MY WAY; JOEL B, 1973, I ONLY HAD WORDS TEL; JOEL B, 1977, MOVIN OUT; JOEL B, 1978, MY LIFE; JOEL B, 1977, SHES ALWAYS WOMAN; JOEL B, 1986, GETTING CLOSER; KING C, 1971, YOUVE GOT FRIEND; LENNON J, 1965, YESTERDAY; PAGE R, 1985, BROKEN WINGS; RESWICK P, 1987, I LIVE YOUR LOVE; RICHARDS K, 1965, SATISFACTION; WEBBER AL, 1981, MEMORY	16	17	17	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0197-4556			ART PSYCHOTHER	Arts Psychother.		1991	18	2					149	156		10.1016/0197-4556(91)90022-3			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	FL385	WOS:A1991FL38500007					2021-06-18	
J	ALHADY, MRA; SHEHATA, O; ELMOUSLY, M; SALLAM, FS				ALHADY, MRA; SHEHATA, O; ELMOUSLY, M; SALLAM, FS			AUDIOLOGICAL FINDINGS FOLLOWING HEAD TRAUMA	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article							BRAIN-STEM RESPONSE; EVOKED-POTENTIALS; INJURIES	Traumatic head injury is the principal cause of death and serious physical disability in adolescents and young adult. Hearing loss is a common sequela of head trauma. The results of pure tone and auditory brainstem response (ABR) assessment of minor head injury revealed that 20 per cent of these cases showed impairment of hearing including both conductive and sensorineural hearing loss mostly in the high frequencies loss. ABR findings showed a significant difference of absolute wave V latency and interwave (III-V) latencies at repetition rate 11.1 click/sec., and a highly significant difference at a repetition rate of 51.1 click/sec., compared with the control group. In severe head injury, conductive hearing loss was found in only one case, in which a longitudinal fracture of the temporal bone was identified radiologically. No ABR could be recorded at a repetition rate of 11.1 click/sec. in either ear of this case; this patient died a few days later. Three cases were found with a mixed sensorineural hearing loss; one of them showed a longitudinal fracture radiologically. ABR findings in two cases showed prolongation of wave V and I-V interwave latencies, and the third case showed absence of ABR recording. In comatose patients, an ABR grading system is a more sensitive index of brainstem dysfunction than the simple division of normal versus abnormal ABR waves and interwave latencies. Presence or prolongation of wave V and interwave latency I-V even in one ear is of good prognostic value in the comatosed patient.		ALHADY, MRA (corresponding author), AL ZAHRAA UNIV HOSP,98 MOHAMED FARID ST,CAIRO,EGYPT.						BRAAKMANN R, 1980, NEUROSURGERY, V6, P360; DALY DM, 1977, ELECTROEN CLIN NEURO, V43, P151, DOI 10.1016/0013-4694(77)90123-7; ELWANY S, 1988, J LARYNGOL OTOL, V102, P755, DOI 10.1017/S0022215100106383; GERLING IJ, 1983, ANN OTO RHINOL LARYN, V92, P119, DOI 10.1177/000348948309200204; GROS JC, 1967, SOUTHERN MED J, V60, P705, DOI 10.1097/00007611-196707000-00006; HALL JW, 1983, OTOLARYNG HEAD NECK, V91, P50, DOI 10.1177/019459988309100110; HALL JW, 1982, LARYNGOSCOPE, V92, P833; MAJOEN S, 1983, ACTA OTOLARYNGOLOGIC, V95, P131; MONTGOMERY A, 1984, LANCET, V1, P1011; Nelson J R, 1979, Adv Neurol, V22, P107; OTTAVIANI F, 1986, ELECTROENCEPHALOGRAP, V62, P196; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, V44, P1181, DOI 10.1001/archneur.1987.00520230061015; SOLIMAN SM, 1976, AIN SHAMS MED J, V27, P273; TEASDALE G, 1974, LANCET, V2, P81	15	17	18	0	0	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD, KENT, ENGLAND TN24 8HH	0022-2151			J LARYNGOL OTOL	J. Laryngol. Otol.	DEC	1990	104	12					927	936		10.1017/S0022215100114410			10	Otorhinolaryngology	Otorhinolaryngology	EU344	WOS:A1990EU34400001	2280144				2021-06-18	
J	RUIJS, MBM; KEYSER, A; GABREELS, FJM				RUIJS, MBM; KEYSER, A; GABREELS, FJM			LONG-TERM SEQUELAE OF BRAIN-DAMAGE FROM CLOSED HEAD-INJURY IN CHILDREN AND ADOLESCENTS	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						CLOSED HEAD INJURY; PSYCHOLOGICAL SEQUELAE; POST-ACCIDENTAL SCHOOL PROBLEMS; POST-ACCIDENTAL BEHAVIORAL CHANGES	CHILDHOOD	A study was made of the sequelae of brain damage in young patients. Seventy patients between 4 and 18 years, admitted under the diagnosis "diffuse brain contusion", have been followed at least two years after head injury. The degree of function impairment in the fields of motor skills, cognition and behaviour was recorded. It was found that many patients with neurologically little or no function loss, nevertheless after the accident did suffer from psychosocial problems in the realm of family life, school or profession. Based on these findings, the authors recommend a consequent and systematic follow up of patients if they have been in coma for more than 1 hour, the objective being the early assessment of such dysfunctions, followed by adequate assistance.	CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT NEUROL,NIJMEGEN,NETHERLANDS; CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT CHILD NEUROL,NIJMEGEN,NETHERLANDS							BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; Deelman B, 1980, NEUROPSYCHOLOGIE NED; GOLDSTEIN K, 1942, AFTER EFFECTS BRAIN; Kleinpeter U, 1980, Psychiatr Neurol Med Psychol (Leipz), V32, P641; KLEINPETER U, 1975, ACTA PAEDOPSYCHIATR, V32, P68; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; LANSER JBK, 1985, THESIS LEIDEN; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1983, PAEDIATRIC HEAD TRAU; LEVINE DN, 1981, NEUROLOGY, V31, P257, DOI 10.1212/WNL.31.3.257; MINDERHOUD JM, 1982, CLIN NEUROL NEUROSUR, V1, P15; MINDERHOUD JM, 1984, TRAUMATISCHE HERSENL; OSSON D, 1979, NEUROPSYCHIAT ENFAN, V27, P401; REMSCHMIDT H, 1977, INTELLIGENZ LERNEN L, P143; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SCHAAPHUMMEL IJT, 1985, MED CONTACT, V3, P74; SHARLI AF, 1981, Z KINDER CHIR, V33, P212	20	17	17	0	5	VAN GORCUM CO BV	ASSEN	PO BOX 43, 9400 AA ASSEN, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.		1990	92	4					323	328		10.1016/0303-8467(90)90058-D			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	ER892	WOS:A1990ER89200004	1963822				2021-06-18	
J	KLINGBEIL, GEG				KLINGBEIL, GEG			AIRWAY PROBLEMS IN PATIENTS WITH TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article										KLINGBEIL, GEG (corresponding author), MED COLL WISCONSIN,MILWAUKEE CTY MED COMPLEX,DEPT PHYS MED & REHABIL,8700 W WISCONSIN AVE,MILWAUKEE,WI 53226, USA.						BLANC VF, 1974, ANESTH ANALG, V53, P202; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; FRIMAN L, 1976, ANAESTHESIA, V31, P479, DOI 10.1111/j.1365-2044.1976.tb12353.x; GOODPASTURE HC, 1977, J NEUROSURG, V47, P228, DOI 10.3171/jns.1977.47.2.0228; KLOSE R, 1978, PRAKT ANASTH WIED IN, V13, P249; MACKENZIE CF, 1984, CRITICAL CARE MONITO, V4, P1; MYERS EN, 1985, TRACHEOTOMY; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; WEICKER VW, 1982, ZBL CHIRURG, V107, P945; WHITED RE, 1984, LARYNGOSCOPE, V94, P367	10	17	18	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	1988	69	7					493	495					3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	P2181	WOS:A1988P218100003	3389987				2021-06-18	
J	LEVIN, HS; HIGH, WM; GOLDSTEIN, FC; WILLIAMS, DH				LEVIN, HS; HIGH, WM; GOLDSTEIN, FC; WILLIAMS, DH			SUSTAINED ATTENTION AND INFORMATION-PROCESSING SPEED IN CHRONIC SURVIVORS OF SEVERE CLOSED HEAD-INJURY	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article										LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 07377, NS 21889] Funding Source: Medline			0	17	17	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1988				17			33	40					8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	P5160	WOS:A1988P516000006	3165209				2021-06-18	
J	SHAH, KR; WEST, M				SHAH, KR; WEST, M			THE EFFECT OF CONCUSSION ON CEREBRAL UPTAKE OF 2-DEOXY-D-GLUCOSE IN RAT	NEUROSCIENCE LETTERS			English	Article										SHAH, KR (corresponding author), UNIV MANITOBA,DEPT PHYSIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; DELANOY RL, 1978, PHARMACOL BIOCHEM BE, V9, P21, DOI 10.1016/0091-3057(78)90007-2; GINSBERG MD, 1977, NEUROLOGY, V27, P1042, DOI 10.1212/WNL.27.11.1042; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P386; JANE JA, 1982, HEAD INJURY BASIC CL, P229; JOSEPH PD, 1971, BRAIN RES, V26, P15; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; MARSHALL WH, 1959, PHYSIOL REV, V39, P239; MEIBACH RC, 1980, BRAIN RES, V195, P167, DOI 10.1016/0006-8993(80)90874-4; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; ROSS DA, 1982, DEV BRAIN RES, V3, P341, DOI 10.1016/0165-3806(82)90002-5; SELLIER K, 1966, 3RD P INT C NEUR SUR, P87; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P27; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; TOWER DB, 1966, HEAD INJURY C P; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210	25	17	17	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.		1983	40	3					287	291		10.1016/0304-3940(83)90053-8			5	Neurosciences	Neurosciences & Neurology	RP493	WOS:A1983RP49300013	6646501				2021-06-18	
J	SMITH, E				SMITH, E			INFLUENCE OF SITE OF IMPACT ON COGNITIVE IMPAIRMENT PERSISTING LONG AFTER SEVERE CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									NATL HOSP NERVOUS DIS,DEPT PSYCHOL MED,MAIDA VALE,LONDON,ENGLAND							Anderson C, 1942, LANCET, V2, P1; BAUGHAN B, 1973, PROGRAM GUMMA; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; DARLEY FL, 1967, BRAIN MECHANISMS UND; DENCKER SJ, 1958, ACTA PSYCHIATRI S122, V33; DENCKER SJ, 1958, ACTA PSYCHIATRI S123, V33; ELITHORN A, 1963, AM J PSYCHOL, V76, P506, DOI 10.2307/1419799; FAHY TJ, 1967, LANCET, V2, P475; Gurdjian ES, 1943, SURGERY, V13, P333; GURDJIAN ES, 1958, HEAD INJURIES MECHAN; HEILBRUN AB, 1956, J COMP PHYSIOL PSYCH, V49, P10, DOI 10.1037/h0040140; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Holbourn AHS, 1943, LANCET, V2, P438; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; LEWIN W, 1967, P ROY SOC MED, V60, P1208, DOI 10.1177/003591576706011P204; LEWIN W, 1965, BIOCHEMICAL ASPECTS; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LONDON P S, 1967, Annals of the Royal College of Surgeons of England, V41, P460; LURIA AR, 1971, 19 P INT C PSYCH LON, P37; MILLER H, 1965, LANCET, V1, P225; MILNER B, 1969, LATE EFFECTS HEAD IN; MILNER B, ANALYSIS BEHAVIORAL; Newcombe F., 1969, MISSILE WOUNDS BRAIN; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; REUSCH J, 1944, AM J PSYCHIAT, V100, P480; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; ROBERTSON RCL, 1955, J NEUROSURG, V12, P13, DOI 10.3171/jns.1955.12.1.0013; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; STRICH SJ, 1961, LANCET, V2, P443; Symonds CP, 1943, LANCET, V1, P7; TEUBER HL, 1969, LATE EFFECTS HEAD IN; Thorndike EL., 1944, TEACHERS WORD BOOK 3; TOW PM, 1955, PERSONALITY CHANGES; VIGNOLO LA, 1968, J LEARN DISABIL, V1, P230, DOI 10.1177/002221946800100402; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Zangwill O., 1960, CEREBRAL DOMINANCE I	39	17	18	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1974	37	6					719	726		10.1136/jnnp.37.6.719			8	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	T5214	WOS:A1974T521400018	4844139	Green Published, Bronze			2021-06-18	
J	HEILBRUN, MP; RATCHESO.RA				HEILBRUN, MP; RATCHESO.RA			MULTIPLE EXTRACRANIAL VESSEL INJURIES FOLLOWING CLOSED HEAD AND NECK TRAUMA - CASE REPORT	JOURNAL OF NEUROSURGERY			English	Article																CALDWELL HW, 1948, ANN INTERN MED, V28, P1132, DOI 10.7326/0003-4819-28-6-1132; CARPENTER S, 1961, J NEUROSURG, V18, P849, DOI 10.3171/jns.1961.18.6.0849; DAVIS DO, 1972, PERSONAL COMMUNICATI; GURDJIAN ES, 1963, J NEUROSURG, V20, P418, DOI 10.3171/jns.1963.20.5.0418; HOLLIN SA, 1966, J NEUROSURG, V25, P526, DOI 10.3171/jns.1966.25.5.0526; HOUCK WS, 1964, ANN SURG, V159, P219, DOI 10.1097/00000658-196402000-00006; MURRAY DS, 1957, BRIT J SURG, V44, P556, DOI 10.1002/bjs.18004418803; SCHNEIDER RC, 1952, J NEUROSURG, V9, P495, DOI 10.3171/jns.1952.9.5.0495; SIMEONE FA, 1968, J NEUROSURG, V29, P540, DOI 10.3171/jns.1968.29.5.0540; TAVERAS J, 1972, PERSONAL COMMUNICATI; THOMSON JLG, 1963, BRIT J RADIOL, V36, P840, DOI 10.1259/0007-1285-36-431-840	11	17	17	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1972	37	2					219	&		10.3171/jns.1972.37.2.0219			0	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	N2351	WOS:A1972N235100015	4558254				2021-06-18	
J	HALLERVORDEN, J; QUADBECK, G				HALLERVORDEN, J; QUADBECK, G			BRAIN CONCUSSION AND ITS EFFECTS ON THE BRAIN	DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT			English	Article																ALLEGRANZA A, 1950, BIOL LAT, V3, P454; BAY E, 1953, HDB INN MED        3, V5, P373; Bergmann L., 1954, ULTRASCHALL; Bochnik HJ, 1952, FORTSCHR NEUROL P I, V20, P291; BONHOFFER, 1915, ARCH PSYCHIATR, V59, P330; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; BRAUN, 1912, HDB NEUROLOGIE, V3, P46; BROCK, 1949, INJURIES BRAIN SPINA; CAIRNS H, 1952, BRAIN, V75, P109, DOI 10.1093/brain/75.2.109; DEGE, 1920, NEUE DTSCH CHIRURG 1, V18; DEMORSIER G, 1941, SCHWEIZ ARCH NEUROL, V50, P162; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN, 1950, MED PHYS, V2, P127; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296; DOW RS, 1945, J NEUROPHYSIOL, V8, P161; DOW RS, 1945, J NEUROSURG, V2, P154, DOI 10.3171/jns.1945.2.2.0154; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; Eck H, 1940, BEITR PATHOL ANAT AL, V104, P390; Freundlich H, 1928, KOLLOID Z, V46, P289, DOI 10.1007/BF01422714; FREUNDLICH H, 1935, THIXOTROPY ACTUALITE; FREUNDLICH H, 1928, Z PHYS CHEM, V131, P284; Frey-Wyssling A., 1948, SUBMICROSCOPIC MORPH; FRIEDE R, 1955, Zentralbl Neurochir, V15, P73; GAMA, 1837, TRAITE PLAIES TETE; GAMPER, 1938, MSCHR PSYCHIATR, V99, P552; GERLACH J, 1953, Z NATURFORSCH B, V8, P578, DOI 10.1515/znb-1953-1006; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; Grunthal E, 1930, HDB GEISTESKRANKHEIT, V11, P638; GRUNTHAL E, 1930, HDB GEISTESKRANKH BU, V11, P654; HALLERVORDEN J, 1941, ZBL NEUROCHIR, P37; HELLENTHAL, 1933, DTSCH ZSCHR GERICHTL, V21, P231; HEYCK H, 1952, MSCHR PSYCHIATR, V123, P43; HUG O, 1954, Strahlentherapie, V94, P79; Janzen R, 1949, NERVENARZT, V20, P416; Jung R., 1953, HDB INNEREN MED, VV, P1206; KALBFLEISCH W, 1940, MUNCH MED WSCHR, P769; KATZENSTEIN E, 1950, DTSCH ZSCHR NERVENHK, V164, P259; KNAUER, 1922, J PSYCHOL, V29, P1; KOBCKE H, 1944, SCHADEL HIRN TRAUMA; KOCHER, 1907, HIRNERSCHUTTERUNG HI; KOCHERFERRARI, 1882, CHIRURGISCHE BEITRAG; Larsson LE, 1954, ACTA PSYCH NEUROL SC, V95, P7; LEONHARDT, 1949, MED KLIN; LOEW F, 1950, ZBL NEUROCHIR, P132; Lynn JG, 1944, AM J PATHOL, V20, P637; MARBURG O, 1936, HDB NEUROLOGIE, V11, P1; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; MEYER SJ, 1955, ELECTROENCEPHALOGR C, V7, P511; MEYERMICKELEIT RW, 1953, DEUT MED WOCHENSCHR, P480; MITTELBACH, 1929, BEITR PATH ANAT, V83, P445; NEUBURGER K, 1930, HDB GEISTESKRANKH BU, V11, P321; ORTHNER H, 1955, HDB SPEZ PATHOL ANAT, V13, P543; PETERFI, 1927, ARCH ENTWMECH ORGAN, V112, P660; PETERFI, 1927, ARCH EXPT ZELLFORSCH, V4, P419; Peters G, 1943, ARCH PSYCHIAT NERVEN, V116, P531, DOI 10.1007/BF01873678; PETERS G, 1955, HDB SPEZIELLEN PATHO, V13, P363; PETERS G, 1943, ZBL NEUROCHIR, V8, P112; PETERS G, 1949, STRAHLENTHERAPIE, V79, P653; Peters G, 1949, FORTSCHR NEUROL P I, V17, P85; PRYCEJONES J, 1952, KOLLOID Z Z POLYM, V129, P96, DOI 10.1007/BF01519693; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; QUADBECK G, 1955, Z NATURFORSCH PT B, V10, P328, DOI 10.1515/znb-1955-0608; QUADBECK G, 1955, Z NATURFORSCH PT B, V10, P168, DOI 10.1515/znb-1955-0310; Richards AG, 1943, J CELL COMPAR PHYSL, V21, P129, DOI 10.1002/jcp.1030210206; RICKER G, 1955, HDB SPEZ PATH ANAT H, V13, P177; RIEDERERVONPAAR, 1936, ARCH PSYCHIATR, V106, P71; RUSSELL LB, 1954, J CELL COMPAR PHYSL, V43, pA103; RUSSELL LB, 1952, RADIOLOGY, V58, P369, DOI 10.1148/58.3.369; SCHALTENBRAND, 1934, MED KLIN, V30, P1381; SCHILLER F, 1952, AMA ARCH NEUROL PSY, V67, P199, DOI 10.1001/archneurpsyc.1952.02320140067006; SCHNEIDER J, 1948, KLIN WOCHENSCHR, P43; Shelden CH, 1944, J NEUROSURG, V1, P67, DOI 10.3171/jns.1944.1.1.0067; SPATZ H, 1936, ARCH PSYCHIAT NERVEN, V105, P80; SPATZ H, 1929, ARCH PSYCHIATR, V90, P885; SPATZ H, 1951, ZBL GES NEUROL PSYCH, V113, P9; SPATZ H, 1941, ZBL NEUROCHIR, V6; SPIEGEL EA, 1946, AM J PHYSIOL, V146, P12; STEINMANN, 1950, ZBL NEUROCHIR, V10, P149; STOECKENIUS W, 1956, Ergeb Anat Entwicklungsgesch, V35, P420; Tonnis W, 1948, NERVENARZT, V19, P201; TONNIS, 1950, LANGENBECKS ARCH DTS, V264, P368; Uber Krauland W., 1950, DTSCH Z NERVENHEILK, V163, P265; von Braunmuhl A, 1932, Z GESAMTE NEUROL PSY, V142, P1; Voss R, 1953, NERVENARZT, V24, P155; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WANKE, 1948, PATHOLOGISCHE PHYSL; WCHNEIDER J, 1951, ARCH PSYCHIATR, V187, P253; WELTE E, 1948, ARCH PSYCHIATR, V79, P243; WELTE E, 1951, ZBL NEUR, V113; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; Witter H, 1952, FORTSCHR NEUROL P I, V20, P270; Zeh W, 1950, FORTSCHR NEUROL P I, V18, P1	93	17	17	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0012-0472	1439-4413		DEUT MED WOCHENSCHR	Dtsch. Med. Wochenschr.		1957	82	4					129	+		10.1055/s-0028-1114649			1	Medicine, General & Internal	General & Internal Medicine	WN599	WOS:A1957WN59900001	13404846				2021-06-18	
J	WINDLE, WF; RAMBACH, WA; DEARELLANO, MIRD; GROAT, RA; BECKER, RF				WINDLE, WF; RAMBACH, WA; DEARELLANO, MIRD; GROAT, RA; BECKER, RF			WATER CONTENT OF THE BRAIN AFTER CONCUSSION AND ITS NONCONTRIBUTORY RELATION TO THE HISTOPATHOLOGY OF CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																DENNYBROWN D, 1945, PHYSIOL REV, V25, P296; Ferraro A, 1930, J NERV MENT DIS, V71, P129, DOI 10.1097/00005053-193002000-00001; GROAT RA, 1945, SURG GYNECOL OBSTET, V81, P63; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; Paterson JH, 1943, J NEUROL PSYCHIATRY, V6, P87, DOI 10.1136/jnnp.6.3-4.87; Pilcher C, 1937, ARCH SURG-CHICAGO, V35, P512, DOI 10.1001/archsurg.1937.01190150095009; PILCHER C, 1941, SURG GYNECOL OBSTET, V72, P755; Rowntree LG, 1926, J PHARMACOL EXP THER, V29, P135; SNEDECOR GW, 1938, STATISTICAL METHODS, V13; WHITE JC, 1943, ANN SURG, V118, P619; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; Windle WF, 1943, STAIN TECHNOL, V18, P77, DOI 10.3109/10520294309105794	13	17	17	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1946	3	2					157	164		10.3171/jns.1946.3.2.0157			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	YD512	WOS:A1946YD51200006	21018505				2021-06-18	
J	GROAT, RA; RAMBACH, WA; WINDLE, WF				GROAT, RA; RAMBACH, WA; WINDLE, WF			CONCUSSION OF THE SPINAL CORD - AN EXPERIMENTAL STUDY AND A CRITIQUE OF THE USE OF THE TERM	SURGERY GYNECOLOGY & OBSTETRICS			English	Article																Baldwin RS, 1934, ARCH NEURO PSYCHIATR, V32, P493, DOI 10.1001/archneurpsyc.1934.02250090028002; Brock S., 1943, INJURIES SKULL BRAIN; CASAMAJOR L, 1921, N YORK STATE J M, V21, P99; CLARK FL, 1892, LANCET, V1, P1078; CLAUDE H, 1916, REV MED-PARIS, V35, P535; CLAUDE H, 1915, J ANN MED PAR, V2, P479; CLUTTON, 1891, LANCET, V2, P928; Davison C, 1933, ARCH NEURO PSYCHIATR, V30, P326, DOI 10.1001/archneurpsyc.1933.02240140090004; de Barenne JGD, 1941, J NEUROPHYSIOL, V4, P287; ERICHSEN JE, 1886, CONCUSSION SPINE; Ferraro A, 1927, ARCH NEURO PSYCHIATR, V18, P357, DOI 10.1001/archneurpsyc.1927.02210030037003; FERRARO A, 1922, CERVELLO ANNO, V1, P361; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Groat RA, 1944, AM J PHYSIOL, V141, P0117; HARTMANN F, 1900, JB PSYCHIAT NEUROL, V19, P380; Hassin GB, 1925, ARCH NEURO PSYCHIATR, V13, P369, DOI 10.1001/archneurpsyc.1925.02200090083003; Hassin GB, 1923, ARCH NEURO PSYCHIATR, V10, P194, DOI 10.1001/archneurpsyc.1923.02190260055004; Holmes G, 1915, Br Med J, V2, P769; JAKOB A, 1913, HISTOLOGISCHE HISTOP, V5, P182; Kirchgasser G., 1898, DEUT Z NERVENHEILKD, V13, P422; Kirchgasser G., 1897, DTSCH Z NERVENH, V11, P406; KNIGHT G, 1940, WAR WOUNDS INJURIES, P174; KOCH W, 1874, ARCH KLIN CHIR, V17, P190; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; KREMS A. D., 1942, PROC SOC EXP BIOL AND MED, V49, P73; LHERMITTE MJ, 1917, ANN MED PAR, V4, P295; Lloyd DPC, 1941, J NEUROPHYSIOL, V4, P525; MACDOUGALL JA, 1892, LANCET, V1, P863; Mairet A, 1919, REV NEUROL-FRANCE, V35, P97; MARBURG O, 1918, ARCH KLIN CHIR, V111, P71; MARBURG O, 1919, ARBEITEN NEUROL I, V22, P498; Marinesco G., 1918, REV NEUROL, V34, P329; MOTT FW, 1916, T MED SOC LONDON, V39, P157; OBERSTEINER H, 1879, MED JB, V4; OBERSTEINER H, 1879, MED JB, V3, P531; PAGE H, 1885, INJURIES SPINE SPINA; ROUSSY G, 1920, ANN MED, V8, P335; SCHEINKER IM, 1942, J NEUROPATH EXP NEUR, V1, P181; SCHMAUS H, 1890, ARCH PATH ANAT PHYSL, V122, P470; SCHMAUSS H, 1890, ARCH PATH ANAT, V122, P326; SPILLER WG, 1899, AM J M SC, V118, P190; SPILLER WG, 1903, U PENNSYLVANIA M B, V15, P483; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	44	17	17	0	0	FRANKLIN H MARTIN FOUNDATION	CHICAGO	55 E ERIE ST, CHICAGO, IL 60611	0039-6087			SURG GYNECOL OBSTET	Surg. Gynecol. Obstet.		1945	81	1					63	74					12	Obstetrics & Gynecology; Surgery	Obstetrics & Gynecology; Surgery	UP125	WOS:A1945UP12500007					2021-06-18	
J	Scotti, P; Seguin, C; Lo, BWY; de Guise, E; Troquet, JM; Marcoux, J				Scotti, Pasquale; Seguin, Chantal; Lo, Benjamin W. Y.; de Guise, Elaine; Troquet, Jean-Marc; Marcoux, Judith			Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes	JOURNAL OF NEUROSURGERY			English	Article						elderly population; antithrombotic agent; head injury; traumatic brain injury; intracranial hemorrhage	CHRONIC SUBDURAL HEMATOMAS; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; ANTIPLATELET AGENTS; HEAD-INJURY; ORAL ANTICOAGULATION; MORTALITY; THERAPY; REVERSAL; PATIENT	OBJECTIVE Among the elderly, use of antithrombotics (ATs), antiplatelets (APs; aspirin, clopidogrel), and/or anticoagulants (ACs; warfarin, direct oral ACs [DOACs; dabigatran, rivaroxaban, apixaban]) to prevent thromboembolic events must be carefully weighed against the risk of intracranial hemorrhage (ICH) with trauma. The goal of this study was to assess the risk of sustaining a traumatic brain injury (TBI), ICH, and poorer outcomes in relation to AT use among all patients 65 years or older presenting to a single institution with head trauma. METHODS Data were collected from all head trauma patients 65 years or older presenting to the authors' supraregional tertiary trauma center over a 24-month period and included age, sex, injury mechanism, medical history, international normalized ratio, Glasgow Coma Scale (GCS) score, ICH presence and type, hospital admission, reversal therapy, surgery, discharge destination, Extended Glasgow Outcome Scale (GOSE) score at discharge, and mortality. RESULTS A total of 1365 head trauma patients 65 years or older were included; 724 were on AT therapy (413 on APs, 151 on ACs, 59 on DOACs, 48 on 2 APs, 38 on AP+AC, and 15 on AP+DOAC) and 641 were not. Among all head trauma patients, the risk of sustaining a TBI was associated with AP use after adjusting for covariates. Of the 731 TBI patients, those using ATs had higher rates of ICH (p < 0.0001), functional dependency at discharge (GOSE score <= 4; p < 0.0001), and mortality (p < 0.0001). Elevated rates of ICH progression on follow-up CT scanning were observed in patients in the warfarin monotherapy (OR 5.30, p < 0.0001) and warfarin + AP (OR 6.15, p = 0.0011). Risk of mortality was not associated with single antiplatelet use but was notably high with 2 APs (OR 4.66, p = 0.0056), warfarin (OR 5.18, p = 0.0003), and DOAC use (OR 5.09, p = 0.0149). CONCLUSIONS Elderly trauma patients on ATs, especially combination therapy, are at elevated risk of ICH and poor outcomes compared with those not on AT therapy. While both AP and warfarin use alone and in combination were associated with significantly elevated odds of sustaining an ICH among TBI patients, only warfarin use was a predictor of hemorrhage progression on follow-up scans. The use of a single AP was not associated with mortality; however, the combination of both aspirin and clopidogrel was. Warfarin and DOAC users had comparable mortality rates; however, DOAC users had lower rates of ICH progression, and fewer survivors were functionally dependent at discharge than were warfarin users. DOACs are an overall safer alternative to warfarin for patients at high risk of falls.	[Scotti, Pasquale; Lo, Benjamin W. Y.; Marcoux, Judith] McGill Univ Hlth Ctr, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Seguin, Chantal] McGill Univ Hlth Ctr, Dept Hematol, Montreal, PQ, Canada; [Troquet, Jean-Marc] McGill Univ Hlth Ctr, Dept Emergency Med, Montreal, PQ, Canada; [de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ, Canada	Marcoux, J (corresponding author), Montreal Gen Hosp, Montreal, PQ, Canada.	judith.marcoux@mcgill.ca					Andreotti F, 2015, EUR HEART J, V36, P3238, DOI 10.1093/eurheartj/ehv304; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550; Bavishi C, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.05.029; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Cull JD, 2015, AM SURGEON, V81, P128; Do MT, 2015, HEALTH PROMOT CHRON, V35, P99, DOI 10.24095/hpcdp.35.7.01; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Dunham CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109473; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Fitzmaurice DA, 2002, BMJ-BRIT MED J, V325, P828, DOI 10.1136/bmj.325.7368.828; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Johnston SC, 2018, NEW ENGL J MED, V379, P215, DOI 10.1056/NEJMoa1800410; Julien J, 2017, J CLIN NEUROSCI, V38, P122, DOI 10.1016/j.jocn.2016.12.032; Karni A, 2001, AM SURGEON, V67, P1098; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Le Roux P, 2014, J NEUROSURG, V121, P1, DOI 10.3171/2014.8.paradigm; Lowenstern A, 2018, ANN INTERN MED, V169, P774, DOI 10.7326/M18-1523; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Maung AA, 2016, J TRAUMA ACUTE CARE, V81, P652, DOI 10.1097/TA.0000000000001189; Melorose J., 2015, UN, V1, P587, DOI DOI 10.1017/CB09781107415324.004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Narum S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0094-1; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pandya U, 2018, J CLIN NEUROSCI, V50, P88, DOI 10.1016/j.jocn.2018.01.073; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Pollack CV, 2017, NEW ENGL J MED, V377, P431, DOI 10.1056/NEJMoa1707278; Pozzessere A, 2015, AM SURGEON, V81, P1039; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; So CH, 2017, J THROMB THROMBOLYS, V43, P7, DOI 10.1007/s11239-016-1425-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Tollefsen MH, 2018, WORLD NEUROSURG, V114, pE209, DOI 10.1016/j.wneu.2018.02.167; Vandiver JW, 2018, J THROMB THROMBOLYS, V45, P423, DOI 10.1007/s11239-018-1635-0; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	45	16	16	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2020	133	2					486	495		10.3171/2019.4.JNS19252			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	OM5TQ	WOS:000586087300025	31277068				2021-06-18	
J	Kontos, AP; Jorgensen-Wagers, K; Trbovich, AM; Ernst, N; Emami, K; Gillie, B; French, J; Holland, C; Elbin, RJ; Collins, MW				Kontos, Anthony P.; Jorgensen-Wagers, Kendra; Trbovich, Alicia M.; Ernst, Nathan; Emami, Kouros; Gillie, Brandon; French, Jonathan; Holland, Cyndi; Elbin, R. J.; Collins, Michael W.			Association of Time Since Injury to the First Clinic Visit With Recovery Following Concussion	JAMA NEUROLOGY			English	Article							SPORTS-RELATED CONCUSSION; SYMPTOMS; GENDER; SCHOOL; IMPACT; REST	Question Do patients who receive clinical care sooner after concussion recover faster? Findings In this cross-sectional study of 162 adolescent and young adult athletes with concussion, those who initiated clinical care earlier (within 7 days) recovered faster and were less likely to have prolonged (>= 30-day) recovery times than those who initiated care later (at 8-20 days). Meaning Per this study, early initiation of care after a concussion may be warranted to expedite recovery time. This cross-sectional study investigates the association of the time from a sports injury to the initiation of clinical care with recovery time after concussion in adolescents and young adults. Importance Recovery after concussion varies, with adolescents taking longer (approximately 30 days) than adults. Many factors have been reported to influence recovery, including preinjury factors, perceptions about recovery, comorbid conditions, and sex. However, 1 factor that may play a role in recovery but has received little attention from researchers is the timeliness of clinical evaluation and care. Objective To investigate the association of time since injury with initiation of clinical care on recovery time following concussion. Design, Setting, and Participants This retrospective, cross-sectional study was conducted in a sports medicine clinic between August 2016 and March 2018. Eligible participants were aged 12 to 22 years and had a diagnosed, symptomatic concussion; patients were excluded if recovery data were incomplete. Participants were divided into 2 groups: those seen within 7 days of the injury (early) vs between 8 and 20 days of the injury (late). Data were analyzed between June 2019 and August 2019. Exposures Time from injury (concussion) to initiation of clinical care. Main Outcomes and Measures Recovery time; testing with the Post-Concussion Symptom Scale, Immediate Post-Concussion Assessment and Cognitive Testing, and Vestibular/Ocular Motor Screening instruments; demographic factors, medical history, and injury information. Results A total of 416 individuals were eligible, and 254 (61.1%) were excluded, leaving 162 (38.9%) in analyses. The early group (98 patients) and late group (64 patients) did not differ in age (mean [SD] age, early, 15.3 [1.6] years; late, 15.4 [1.6] years), number of female patients (early, 51 of 98 [52.0%]; late, 40 of 64 [62.5%]), or other demographic, medical history, or injury information. The groups also were similar on symptom severity, cognitive, ocular, and vestibular outcomes at the first clinic visit. Results from a logistical regression supported being in the late group (adjusted odds ratio, 5.8 [95% CI, 1.9-17.6]; P = .001) and visual motion sensitivity symptoms greater than 2 (adjusted odds ratio, 4.5 [95% CI, 1.1-18.0]; P = .04) as factors significantly associated with recovery time. Conclusions and Relevance Findings suggest that earlier initiation of clinical care is associated with faster recovery after concussion. Other factors may also influence recovery time. Further research is needed to determine the role of active rehabilitation and treatment strategies, as well as demographic factors, medical history, and injury characteristics on the current findings.	[Kontos, Anthony P.; Trbovich, Alicia M.; Ernst, Nathan; Emami, Kouros; French, Jonathan; Holland, Cyndi; Collins, Michael W.] Univ Pittsburgh, UPMC Sports Concuss Program, Pittsburgh, PA USA; [Kontos, Anthony P.; Trbovich, Alicia M.; Ernst, Nathan; Emami, Kouros; French, Jonathan; Holland, Cyndi; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Jorgensen-Wagers, Kendra] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Jorgensen-Wagers, Kendra] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Gillie, Brandon] UPMC Sports Med Concuss Program, Altoona, PA USA; [Elbin, R. J.] Univ Arkansas, Off Sport Concuss Res, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA	Kontos, AP (corresponding author), UPMC Freddie Fu Sports Med Ctr, UPMC Sports Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Elbin R, 2015, PERSPECT NEUROPHYSIO, V25, P4, DOI DOI 10.1044/NNSLD25.1.4; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	27	16	16	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	APR	2020	77	4					435	440		10.1001/jamaneurol.2019.4552			6	Clinical Neurology	Neurosciences & Neurology	LH2CS	WOS:000528595700007	31904763	Bronze, Green Published			2021-06-18	
J	Goetzl, EJ; Yaffe, K; Peltz, CB; Ledreux, A; Gorgens, K; Davidson, B; Granholm, AC; Mustapic, M; Kapogiannis, D; Tweedie, D; Greig, NH				Goetzl, Edward J.; Yaffe, Kristine; Peltz, Carrie B.; Ledreux, Aurelie; Gorgens, Kim; Davidson, Bradley; Granholm, Ann-Charlotte; Mustapic, Maja; Kapogiannis, Dimitrios; Tweedie, David; Greig, Nigel H.			Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins	FASEB JOURNAL			English	Article						extracellular vesicles; neurodegeneration; neuroinflammation	IDENTIFICATION; ATTACK	Possible involvement of complement (C) systems in the pathogenesis of traumatic brain injury (TBI) was investigated by quantifying Cproteins in plasma astrocyte-derived exosomes (ADEs) of subjects with sports-related TBI (sTBI) and TBI in military veterans (mtTBI) without cognitive impairment. All sTBI subjects (n = 24) had mild injuries, whereas eight of the mtTBI subjects had moderate, and 17 had mild injuries. Plasma levels of ADEs were decreased after acute sTBI and returned to normal within months. Cprotein levels in ADEs were from 12- to 35-fold higher than the corresponding levels in neuron-derived exosomes. CD81 exosome marker-normalized ADE levels of classical pathway C4b, alternative pathway factor D and Bb, lectin pathway mannose-binding lectin (MBL), and shared neurotoxic effectors C3b and C5b-9 terminal C complex were significantly higher and those of C regulatory proteins CR1 and CD59 were lower in the first week of acute sTBI (n = 12) than in controls (n = 12). Most C abnormalities were no longer detected in chronic sTBI at 3-12 months after acute sTBI, except for elevated levels of factor D, Bb, and MBL. In contrast, significant elevations of ADE levels of C4b, factor D, Bb, MBL, C3b and C5b-9 terminal C complex, and depressions of CR1 and CD59 relative to those of controls were observed after 1-4 years in early chronic mtTBI (n = 10) and persisted for decades except for normalization of Bb, MBL, and CD59 in late chronic mtTBI (n = 15). Complement inhibitors may be useful therapeutically in acute TBI and post-concussion syndrome.	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Med Ctr, Neurol Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine; Peltz, Carrie B.] San Francisco VA Med Ctr, Dept Psychiat, San Francisco, CA USA; [Peltz, Carrie B.] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Ledreux, Aurelie; Granholm, Ann-Charlotte] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO USA; [Gorgens, Kim] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA; [Davidson, Bradley] Univ Denver, Dept Mech & Mat Engn, Denver, CO USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Lab Clin Invest, Baltimore, MD 21224 USA; [Tweedie, David; Greig, Nigel H.] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA	Goetzl, EJ (corresponding author), UCSF, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Kapogiannis, Dimitrios/AAW-4934-2020; Mustapic, Maja/AAV-3212-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Gorgens, Kim/0000-0003-4413-0600	U.S. Department of Defense (DOD)United States Department of Defense [WB1XWH-14-2-0137]; University of Denver (DU) [999]; HHS \ NIH \ National Institute on Aging (NIA)	U.S. Department of Defense (DOD), Grant/Award Number: WB1XWH-14-2-0137; University of Denver (DU), Grant/Award Number: 999; HHS vertical bar NIH vertical bar National Institute on Aging (NIA)	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Carpanini SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00362; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Choi SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097093; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2020, J NEUROTRAUM, V37, P382, DOI 10.1089/neu.2019.6711; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2017, FASEB J, V31, P1792, DOI 10.1096/fj.201601221R; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harris ME, 2002, J CLIN EXP NEUROPSYC, V24, P214, DOI 10.1076/jcen.24.2.214.995; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Ivnik RJ, 2000, NEUROPSYCHOLOGY, V14, P163, DOI 10.1037/0894-4105.14.2.163; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Winston Charisse N, 2019, Alzheimers Dement (Amst), V11, P61, DOI 10.1016/j.dadm.2018.11.002; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	33	16	17	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3359	3366		10.1096/fj.201902842R		JAN 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	WOS:000506440100001	31916313	Green Accepted, Bronze			2021-06-18	
J	Marion, CM; McDaniel, DP; Armstrong, RC				Marion, Christina M.; McDaniel, Dennis. P.; Armstrong, Regina C.			Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						SARM1; Sterile alpha and TIR containing motif 1; Axon; Myelin; TBI; White matter; Corpus callosum; Myelin outfoldings; Demyelination; Traumatic axonal injury	WALLERIAN DEGENERATION; CORPUS-CALLOSUM; MYELIN SHEATHS; MILD; DEATH; PATHOLOGY; REPAIR; MODEL; ACTIVATION; NEUROINFLAMMATION	Traumatic brain injury (TBI) often damages axons in white matter tracts and causes corpus callosum (CC) atrophy in chronic TBI patients. Injured axons encounter irreversible damage if transected, or alternatively may maintain continuity and subsequently either recover or degenerate. Secondary mechanisms can cause further axon damage, myelin pathology, and neuroinflammation. Molecular mechanisms regulating the progression of white matter pathology indicate potential therapeutic targets. SARM1 is essential for execution of the conserved axon death pathway. We examined white matter pathology following mild TBI with CC traumatic axonal injury in mice with Sarml gene deletion (Sarm1 - / -). High resolution ultrastructural analysis at 3 days post-TBI revealed dramatically reduced axon damage in Sarm1 - / - mice, as compared to Sarm1 + / + wild-type controls. Sarml deletion produced larger axons with thinner myelin, and attenuated TBI induced demyelination, i.e. myelin loss along apparently intact axons. At 6 weeks post-TBI, Sarm1 - / - mice had less demyelination and thinner myelin than Sarm1 + / + mice, but axonal protection was no longer observed. We next used Thy1-YFP crosses to assess Sarml involvement in white matter neurodegeneration and neuroinflammation at 8 weeks post-TBI, when significant CC atrophy indicates chronic pathology. Thyl-YFP expression demonstrated continued CC axon damage yet absence of overt cortical pathology. Importantly, significant CC atrophy in Thy1-YFP/Sarm1 + / + mice was associated with reduced neurofilament immunolabeling of axons. Both effects were attenuated in Thy1-YFP/Sarm1 - / - mice. Surprisingly, Thy1-YFP/Sarm1 - / - mice had increased CC astrogliosis. This study demonstrates that Sarmi inactivation reduces demyelination, and white matter atrophy after TBI, while the post-injury stage impacts when axon protection is effective.	[Marion, Christina M.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [McDaniel, Dennis. P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Biomed Instrumentat Ctr, Bethesda, MD 20814 USA; [McDaniel, Dennis. P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Marion, Christina M.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Program Neurosci, Bethesda, MD 20814 USA	Armstrong, RC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	regina.armstrong@usuhs.edu	Marion, Christina M/B-8120-2015	Marion, Christina M/0000-0003-0381-4109; Armstrong, Regina/0000-0001-7296-6750	U.S. Department of Defense Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [CNRM703386, CNRM702720]; Defense Health Agency [ST7434918]	The authors thank Tuan Le and Xiaomei Zi for their technical assistance. These studies were funded by the U.S. Department of Defense Center for Neuroscience and Regenerative Medicine (CNRM703386; CNRM702720) and Defense Health Agency (ST7434918).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Blakemore W F, 1981, Prog Clin Biol Res, V59A, P105; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Desbois M, 2018, J BIOL CHEM, V293, P13897, DOI 10.1074/jbc.RA118.002176; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Duncan ID, 2017, P NATL ACAD SCI USA, V114, pE9685, DOI 10.1073/pnas.1714183114; Erwig MS, 2019, ELIFE, V8, DOI 10.7554/eLife.43888; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Filous AR, 2016, PROG NEUROBIOL, V144, P173, DOI 10.1016/j.pneurobio.2016.03.009; FRANSON P, 1984, J COMP NEUROL, V223, P138, DOI 10.1002/cne.902230111; Gamage KK, 2017, CURR BIOL, V27, P1250, DOI 10.1016/j.cub.2017.03.058; Geisler S, 2019, J EXP MED, V216, P294, DOI 10.1084/jem.20181040; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gilley J, 2019, HUM MOL GENET, V28, P448, DOI 10.1093/hmg/ddy356; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Goldstein EZ, 2016, EXP NEUROL, V283, P550, DOI 10.1016/j.expneurol.2016.05.001; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loreto A, 2015, CELL REP, V13, P2539, DOI 10.1016/j.celrep.2015.11.032; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Malapati H, 2017, MOL GENET GENOMICS, V292, P909, DOI 10.1007/s00438-017-1320-6; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; Mi S, 2011, NAT MED, V17, P816, DOI 10.1038/nm.2373; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Morrison BM, 2013, TRENDS CELL BIOL, V23, P644, DOI 10.1016/j.tcb.2013.07.007; Murata H, 2018, J BIOL CHEM, V293, P18933, DOI 10.1074/jbc.RA118.004578; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Neukomm LJ, 2017, NEURON, V95, P78, DOI 10.1016/j.neuron.2017.06.031; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Ontaneda D, 2017, MULT SCLER J, V23, P1627, DOI 10.1177/1352458517729465; Ontaneda D, 2017, LANCET, V389, P1357, DOI 10.1016/S0140-6736(16)31320-4; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Pan S, 2017, J CELL BIOL, V216, P3903, DOI 10.1083/jcb.201702150; Patzig J, 2016, ELIFE, V5, DOI 10.7554/eLife.17119; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Pieper AA, 2018, COLD SH Q B, V83, P207, DOI 10.1101/sqb.2018.83.037622; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROSENBLUTH J, 1966, J CELL BIOL, V28, P73, DOI 10.1083/jcb.28.1.73; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Simon DJ, 2018, CURR OPIN NEUROL, V31, P693, DOI 10.1097/WCO.0000000000000621; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; STURROCK RR, 1976, J GERONTOL, V31, P513, DOI 10.1093/geronj/31.5.513; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Summers DW, 2018, P NATL ACAD SCI USA, V115, pE8746, DOI 10.1073/pnas.1806933115; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; VIAL JD, 1958, J BIOPHYS BIOCHEM CY, V4, P551, DOI 10.1083/jcb.4.5.551; WEBSTER HDF, 1962, J CELL BIOL, V12, P361; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhou YX, 2012, NEUROBIOL DIS, V45, P196, DOI 10.1016/j.nbd.2011.08.004; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	91	16	16	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2019	321								113040	10.1016/j.expneurol.2019.113040			16	Neurosciences	Neurosciences & Neurology	JA1KF	WOS:000487575200011	31445042	Other Gold			2021-06-18	
J	Yao, MH; Gao, F; Xu, R; Zhang, JN; Chen, YH; Guan, FX				Yao, Minghao; Gao, Feng; Xu, Ru; Zhang, Junni; Chen, Yihao; Guan, Fangxia			A dual-enzymatically cross-linked injectable gelatin hydrogel loaded with BMSC improves neurological function recovery of traumatic brain injury in rats	BIOMATERIALS SCIENCE			English	Article							MESENCHYMAL STEM-CELLS; COLLAGEN SCAFFOLDS; HYALURONIC-ACID; IN-SITU; DIFFERENTIATION; TRANSPLANTATION; PREVENTION	Injectable hydrogels can perfectly fill defective areas and thereby show promise as therapeutic implants or cell/drug delivery vehicles in traumatic brain injury (TBI) or other tissue repair. In this study, an injectable gelatin hydrogel in situ dual-enzymatically cross-linked by glucose oxidase (GOX) and horseradish peroxidase (HRP) was synthesized and optimized, and the therapeutic effect of this hydrogel encapsulated with bone mesenchymal stem cells (BMSC) for TBI rats was investigated. By changing the GOX content, we found that this hydrogel cross-linked by 0.1 U mL(-1) GOX possesses better cytocompatibility than that with a higher GOX content, and minimized immune response in vivo. More importantly, this hydrogel loaded with BMSC could significantly accelerate the healing process of a damaged region, facilitate the survival and proliferation of endogenous nerve cells probably by nutrition supply and apoptosis suppression, and consequently promote the neurological function recovery of the TBI rat model. All these findings highlight that this injectable and BMSC-laden gelatin hydrogel has enormous potential for TBI therapy and other tissue regeneration strategies.	[Yao, Minghao; Gao, Feng; Xu, Ru; Zhang, Junni; Chen, Yihao; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Henan, Peoples R China; [Yao, Minghao; Guan, Fangxia] Zhengzhou Univ, Ctr Stem Cell & Regenerat Med, Affiliated Hosp 1, 40 Univ Rd, Zhengzhou 450052, Henan, Peoples R China	Yao, MH; Guan, FX (corresponding author), Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Henan, Peoples R China.; Yao, MH; Guan, FX (corresponding author), Zhengzhou Univ, Ctr Stem Cell & Regenerat Med, Affiliated Hosp 1, 40 Univ Rd, Zhengzhou 450052, Henan, Peoples R China.	yao453343550@126.com; fxguan@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1804198, NSFC 31700820]; National Natural Science Foundation of Henan province [U1804198]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M612420]; Key Scientific Research Projects of Higher Education Institutions in Henan Province [18A180003]	We acknowledge funding from the Joint Fund of the National Natural Science Foundation of China and Henan province (U1804198), the National Natural Science Foundation of China (NSFC 31700820), the China Postdoctoral Science Foundation (2017M612420), and the Key Scientific Research Projects of Higher Education Institutions in Henan Province (18A180003).	Arulmoli J, 2016, ACTA BIOMATER, V43, P122, DOI 10.1016/j.actbio.2016.07.043; Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h; Bertlein S, 2017, ADV MATER, V29, DOI 10.1002/adma.201703404; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Cosson S, 2015, STEM CELL TRANSL MED, V4, P156, DOI 10.5966/sctm.2014-0203; Dekmak A, 2018, BEHAV BRAIN RES, V340, P49, DOI 10.1016/j.bbr.2016.12.039; Dimatteo R, 2018, ADV DRUG DELIVER REV, V127, P167, DOI 10.1016/j.addr.2018.03.007; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; James S, 2015, STEM CELL REP, V4, P1004, DOI 10.1016/j.stemcr.2015.05.005; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kim BY, 2016, MACROMOL BIOSCI, V16, P1570, DOI 10.1002/mabi.201600312; Kim KS, 2011, ACTA BIOMATER, V7, P666, DOI 10.1016/j.actbio.2010.09.030; Kim SH, 2018, BIOMATERIALS, V178, P401, DOI 10.1016/j.biomaterials.2018.04.057; Lee Y, 2018, ACS APPL MATER INTER, V10, P18372, DOI 10.1021/acsami.8b04522; Li H, 2018, WIRELESS COMMUNICATI, V2018, P1, DOI DOI 10.5194/acp-2018-83; Lim KS, 2016, ACS BIOMATER SCI ENG, V2, P1752, DOI 10.1021/acsbiomaterials.6b00149; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Morris DC, 2017, NEUROSCI LETT, V659, P7, DOI 10.1016/j.neulet.2017.08.064; Munoz Z, 2014, BIOMATER SCI-UK, V2, P1063, DOI 10.1039/c4bm00070f; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Sakai S, 2015, ACTA BIOMATER, V24, P152, DOI 10.1016/j.actbio.2015.06.023; Santoro M, 2014, J CONTROL RELEASE, V190, P210, DOI 10.1016/j.jconrel.2014.04.014; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Su J, 2019, BIOMATERIALS, V201, P99, DOI 10.1016/j.biomaterials.2019.02.001; Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu GH, 2015, ACTA BIOMATER, V15, P55, DOI 10.1016/j.actbio.2014.12.016; Yao MH, 2014, J MATER CHEM B, V2, P3123, DOI 10.1039/c4tb00107a; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g	40	16	16	13	78	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2047-4830	2047-4849		BIOMATER SCI-UK	Biomater. Sci.	OCT 1	2019	7	10					4088	4098		10.1039/c9bm00749k			11	Materials Science, Biomaterials	Materials Science	JA3UJ	WOS:000487753500009	31355388				2021-06-18	
J	Xiong, Y; Cao, FQ; Hu, LC; Yan, CC; Chen, L; Panayi, AC; Sun, Y; Zhou, W; Zhang, P; Wu, QP; Xue, H; Liu, MF; Liu, Y; Liu, J; Abududilibaier, A; Mi, BB; Liu, GH				Xiong, Yuan; Cao, Faqi; Hu, Liangcong; Yan, Chenchen; Chen, Lang; Panayi, Adriana C.; Sun, Yun; Zhou, Wu; Zhang, Peng; Wu, Qipeng; Xue, Hang; Liu, Mengfei; Liu, Yi; Liu, Jing; Abududilibaier, Abudula; Mi, Bobin; Liu, Guohui			miRNA-26a-5p Accelerates Healing via Downregulation of PTEN in Fracture Patients with Traumatic Brain Injury	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							MICE LACKING PTEN; OSTEOBLAST DIFFERENTIATION; STEM-CELLS; BONE-FORMATION; OSTEOGENIC DIFFERENTIATION; PROLIFERATION; REGENERATION; MICRORNA-34A; INHIBITION; EXPRESSION	Patients who sustain a traumatic brain injury (TBI) are known to have a significantly quicker fracture healing time than patients with isolated fractures, but the underlying mechanism has yet to be identified. In this study, we found that the upregulation of miRNA-26a-5p induced by TBI correlated with a decrease in phosphatase and tensin homolog (PTEN) in callus formation. In vitro, overexpressing miRNA-26a-5p inhibited PTEN expression and accelerated osteoblast differentiation, whereas silencing of miRNA-26a-5p inhibited osteoblast activity. Reduction of PTEN facilitated osteoblast differentiation via the PI3K/AKT signaling pathway. Through luciferase assays, we found evidence that PTEN is a miRNA-26a-5p target gene that negatively regulates the differentiation of osteoblasts. Moreover, the present study confirmed that preinjection of agomiR-26a-5p leads to increased bone formation. Collectively, these results indicate that miRNA-26a-5p overexpression may be a key factor governing the improved fracture healing observed in TBI patients after the downregulation of PTEN and PI3K/AKT signaling. Upregulation of miRNA-26a-5p may therefore be a promising therapeutic strategy for promoting fracture healing.	[Xiong, Yuan; Cao, Faqi; Hu, Liangcong; Yan, Chenchen; Chen, Lang; Zhou, Wu; Xue, Hang; Liu, Mengfei; Liu, Yi; Liu, Jing; Abududilibaier, Abudula; Mi, Bobin; Liu, Guohui] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Panayi, Adriana C.] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02215 USA; [Sun, Yun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430022, Hubei, Peoples R China; [Wu, Qipeng] Huazhong Univ Sci & Technol, Puai Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan 430030, Hubei, Peoples R China; [Zhang, Peng] Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou 215006, Peoples R China	Mi, BB; Liu, GH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	mi19882@163.com; liuguohui@hust.edu.cn	Xiong, Yuan/AAQ-3642-2021; Panayi, Adriana C./AAF-1817-2020; chou, wu/AAI-1145-2019	Panayi, Adriana C./0000-0003-4053-9855; 	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772345]; Healthy Commission Key Project of Hubei Province [WJ2019Z009]; Science and Technology Department of Hubei Province [2016CFB424]; Development Center for Medical Science and Technology, National Health and Family Planning Commission of the People's Republic of China [ZX-01-C2016024]	Our work was supported by the National Science Foundation of China (81772345), the Healthy Commission Key Project of Hubei Province (WJ2019Z009), the Science and Technology Department of Hubei Province (2016CFB424), and the Development Center for Medical Science and Technology, National Health and Family Planning Commission of the People's Republic of China (ZX-01-C2016024).	Arfat Y, 2018, MOL THER-NUCL ACIDS, V11, P323, DOI 10.1016/j.omtn.2017.11.009; Baek D, 2018, MOL THER-NUCL ACIDS, V13, P322, DOI 10.1016/j.omtn.2018.09.015; Balani DH, 2017, J CLIN INVEST, V127, P3333, DOI 10.1172/JCI91699; Bashash D, 2019, INT J BIOCHEM CELL B, V108, P7, DOI 10.1016/j.biocel.2019.01.005; Castellano L, 2017, NUCLEIC ACIDS RES, V45, P4401, DOI 10.1093/nar/gkx022; Chai C, 2018, CNS NEUROSCI THER, V24, P369, DOI 10.1111/cns.12785; Chen L, 2014, STEM CELLS, V32, P902, DOI 10.1002/stem.1615; Collins CJ, 2015, J BIOMECH, V48, P310, DOI 10.1016/j.jbiomech.2014.11.028; D'Abundo L, 2017, ONCOGENE, V36, P6617, DOI 10.1038/onc.2017.269; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Fan YS, 2018, MOLECULES, V23, DOI 10.3390/molecules23092306; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fushimi S, 2018, GENES CELLS, V23, P517, DOI 10.1111/gtc.12591; Hamada K, 2019, BIOL PHARM BULL, V42, P130, DOI 10.1248/bpb.b18-00801; Hu ZB, 2015, SCI REP-UK, V5, DOI 10.1038/srep18655; Huang YP, 2015, STEM CELLS, V33, P3481, DOI 10.1002/stem.2225; Kim KM, 2012, J BONE MINER RES, V27, P1669, DOI 10.1002/jbmr.1604; Klaw MC, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.34; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052; Liu H, 2014, J CELL PHYSIOL, V229, P1494, DOI 10.1002/jcp.24591; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Luo FT, 2018, MOL THER-NUCL ACIDS, V13, P291, DOI 10.1016/j.omtn.2018.09.012; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; Ma XK, 2018, ONCOTARGETS THER, V11, P8399, DOI 10.2147/OTT.S182573; Malentacchi F, 2019, ONCOL REP, V41, P1560, DOI 10.3892/or.2018.6939; Matsumoto Toshio, 2004, Nihon Rinsho, V62 Suppl 2, P37; Millis SZ, 2019, CANCER-AM CANCER SOC, V125, P1185, DOI 10.1002/cncr.31921; Moses C, 2019, MOL THER-NUCL ACIDS, V14, P287, DOI 10.1016/j.omtn.2018.12.003; Neirijnck Y, 2019, ENDOCRINOLOGY, V160, P387, DOI 10.1210/en.2018-00892; Paquet J, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.05.28; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Seeliger C, 2016, STEM CELLS DEV, V25, P1261, DOI 10.1089/scd.2016.0133; Su Y, 2019, BIOL PSYCHIAT, V85, P769, DOI 10.1016/j.biopsych.2018.12.008; Tian LJ, 2017, GENE, V627, P32, DOI 10.1016/j.gene.2017.06.002; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; van der Horst G, 2005, J BONE MINER RES, V20, P2233, DOI 10.1359/JBMR.050821; Walker CL, 2019, J NEUROTRAUM, V36, P2676, DOI 10.1089/neu.2018.6294; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Yang JL, 2017, MOL THER-NUCL ACIDS, V7, P278, DOI 10.1016/j.omtn.2017.04.010; Ye L, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0030-y; Yu B, 2012, J BONE MINER RES, V27, P2001, DOI 10.1002/jbmr.1663; Zha XL, 2018, J ORTHOP RES, V36, P417, DOI 10.1002/jor.23613; Zhang R, 2018, THER CLIN RISK MANAG, V14, P2315, DOI 10.2147/TCRM.S182325; Zhang XH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15037674; Zhang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10376	56	16	17	4	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 6	2019	17						223	234		10.1016/j.omtn.2019.06.001			12	Medicine, Research & Experimental	Research & Experimental Medicine	JA6XF	WOS:000487984400019	31272072	DOAJ Gold, Green Published			2021-06-18	
J	Shekh-Ahmad, T; Lieb, A; Kovac, S; Gola, L; Wigley, WC; Abramov, AY; Walker, MC				Shekh-Ahmad, Tawfeeq; Lieb, Andreas; Kovac, Stjepana; Gola, Lukas; Wigley, W. Christian; Abramov, Andrey Y.; Walker, Matthew C.			Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy	REDOX BIOLOGY			English	Article						Epileptogenesis; Spontaneous seizures; Oxidative stress; Keap1-Nrf2 pathway; NADPH oxidase	OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; NADPH OXIDASE; STATUS EPILEPTICUS; RAT MODEL; SEIZURE; SUPEROXIDE; INHIBITION; ACTIVATION; MECHANISMS	Many epilepsies are acquired conditions following an insult to the brain such as a prolonged seizure, traumatic brain injury or stroke. The generation of reactive oxygen species (ROS) and induction of oxidative stress are common sequelae of such brain insults and have been shown to contribute to neuronal death and the development of epilepsy. Here, we show that combination therapy targeting the generation of ROS through NADPH oxidase inhibition and the endogenous antioxidant system through nuclear factor erythroid 2-related factor 2 (Nrf2) activation prevents excessive ROS accumulation, mitochondrial depolarisation and neuronal death during in vitro seizure-like activity. Moreover, this combination therapy prevented the development of spontaneous seizures in 40% of animals following status epilepticus (70% of animals were seizure free after 8 weeks) and modified the severity of epilepsy when given to chronic epileptic animals.	[Shekh-Ahmad, Tawfeeq; Lieb, Andreas; Abramov, Andrey Y.; Walker, Matthew C.] UCL, UCL Queen Sq Inst Neurol, Queen Sq, London WC1N, England; [Kovac, Stjepana; Gola, Lukas] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Wigley, W. Christian] Reata Pharmaceut, 2801 Gateway Dr,Suite 150, Irving, TX 75063 USA; [Shekh-Ahmad, Tawfeeq] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, Jerusalem, Israel; [Lieb, Andreas] Med Univ Innsbruck, Dept Pharmacol, Peter Mayr Str 1A, A-6020 Innsbruck, Austria	Walker, MC (corresponding author), UCL, UCL Queen Sq Inst Neurol, Queen Sq, London WC1N, England.	m.walker@ucl.ac.uk	Walker, Matthew C/C-1577-2008; Abramov, Andrey Y/H-9053-2012	Walker, Matthew C/0000-0002-0812-0352; Abramov, Andrey Y/0000-0002-7646-7235; Lieb, Andreas/0000-0001-9567-649X; Shekh-Ahmad, Tawfeeq/0000-0002-6165-2219	European UnionEuropean Commission [602102]; Epilepsy Research UK [P1301]; Ursula von Euch Stiftung; Innovative Medizinische Forschung (IMF) [KO111715]	European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no602102 (EPITARGET) Matthew C Walker; Epilepsy Research UK (Project Grant P1301) Matthew C Walker; Innovative Medizinische Forschung (IMF grant KO111715 grant to Stjepana Kovac) and Ursula von Euch Stiftung (fellowship to Stjepana Kovac).	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3; Bhatti J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00744; Buico A, 2009, REDOX REP, V14, P125, DOI 10.1179/135100009X392557; Chang PS, 2011, J NEUROSCI METH, V201, P106, DOI 10.1016/j.jneumeth.2011.07.018; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Haynes L.W., 1999, IBRO HDB SERIES; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Kovac S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.390; Kovacs R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002; Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pearson-Smith JN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112365; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; Puspita L, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0340-9; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Shekh-Ahmad T, 2018, BRAIN, V141, P1390, DOI 10.1093/brain/awy071; Waldbaum S, 2010, J BIOENERG BIOMEMBR, V42, P449, DOI 10.1007/s10863-010-9320-9; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Williams S, 2015, NEUROSCIENCE, V303, P160, DOI 10.1016/j.neuroscience.2015.07.005; Zhang RR, 2017, MOL NEUROBIOL, V54, P6006, DOI 10.1007/s12035-016-0111-0	30	16	16	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	SEP	2019	26								101278	10.1016/j.redox.2019.101278			7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	JI9ZE	WOS:000493821500011	31382215	DOAJ Gold, Green Published			2021-06-18	
J	Boutte, AM; Thangavelu, B; LaValle, CR; Nemes, J; Gilsdorf, J; Shear, DA; Kamimori, GH				Boutte, Angela M.; Thangavelu, Bharani; LaValle, Christina R.; Nemes, Jeffrey; Gilsdorf, Janice; Shear, Deborah A.; Kamimori, Gary H.			Brain-related proteins as serum biomarkers of acute, subconcussive blast overpressure exposure: A cohort study of military personnel	PLOS ONE			English	Article							AUTOMATED NEUROBEHAVIORAL ASSESSMENT; NEUROFILAMENT LIGHT; SERVICE MEMBERS; INJURY; PLASMA; DUTY; TAU; PERFORMANCE; CONCUSSION; SYMPTOMS	Repeated exposure to blast overpressure remains a major cause of adverse health for military personnel who, as a consequence, are at a higher risk for neurodegenerative disease and suicide. Acute, early tracking of blast related effects holds the promise of rapid health assessment prior to onset of chronic problems. Current techniques used to determine blast-related effects rely upon reporting of symptomology similar to that of concussion and neurocognitive assessment relevant to operational decrement. Here, we describe the results of a cross sectional study with pared observations. The concentration of multiple TBI-related proteins was tested in serum collected within one hour of blast exposure as a quantitative and minimally invasive strategy to augment assessment of blast-exposure effects that are associated with concussion-like symptomology and reaction time decrements. We determined that median simple reaction time (SRT) was slowed in accordance with serum Nf-L, tau, A beta-40, and A beta-42 elevation after overpressure exposure. In contrast, median levels of serum GFAP decreased. Individual, inter-subject analysis revealed positive correlations between changes in Nf-L and GFAP, and in A beta-40 compared to A beta-42. The change in Nf-L was negatively associated with tau, A beta-40, and A beta-42. Participants reported experiencing headaches, dizziness and taking longer to think. Dizziness was associated with reaction time decrements, GFAP or NfL suppression, as well as A beta peptide elevation. UCH-L1 elevation had a weak association with mTBI/concussion history. Multiplexed serum biomarker quantitation, coupled with reaction time assessment and symptomology determined before and after blast exposure, may serve as a platform for tracking adverse effects in the absence of a head wound or diagnosed concussion. We propose further evaluation of serum biomarkers, which are often associated with TBI, in the context of acute operational blast exposures.	[Boutte, Angela M.; Thangavelu, Bharani; Gilsdorf, Janice; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD 20910 USA; [LaValle, Christina R.; Nemes, Jeffrey; Kamimori, Gary H.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA	Boutte, AM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD 20910 USA.	angela.m.boutte.civ@mail.mil			Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3); Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award [W81XWH-16-2-0001]	This work was supported by the Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3), and Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award No. W81XWH-16-2-0001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Bazarian JJ, 2018, LANCET NEUROL; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Britt TW, 2000, J APPL SOC PSYCHOL, V30, P1599, DOI 10.1111/j.1559-1816.2000.tb02457.x; Bu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13917; Cao R, 2019, JOURNAL OF NEUROTRAU; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Di Battista AP, 2016, PLOS ONE, V11; Dobrowolska JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089998; Fear NT, 2012, J EPIDEMIOL COMMUN H, V66, pA35, DOI 10.1136/jech-2012-201753.091; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Hanas JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215762; Haran FJ, 2016, APPL NEUROPSYCH-ADUL, V23, P411, DOI 10.1080/23279095.2016.1166111; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P1591, DOI 10.1001/archneurol.2012.18107; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kovacs GG, 2017, EUR J NEUROL, V24, P1326, DOI 10.1111/ene.13389; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mishra V, 2016, SCI REPORTS, V6; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Ono K, 2018, NEUROCHEM INT, V119, P57, DOI 10.1016/j.neuint.2017.08.010; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Puig KL, 2013, EXP GERONTOL, V48, P608, DOI 10.1016/j.exger.2012.07.009; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Song HL, 2019, J NEUROTRAUM, V36, P1591, DOI 10.1089/neu.2018.6114; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Tate CM, 2013, J NEUROTRAUMA; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Wirsching A, 2018, J NEUROTRAUMA; Yang ZH, 2018, MOL NEUROBIOL, V55, P2174, DOI 10.1007/s12035-017-0424-7; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088	55	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221036	10.1371/journal.pone.0221036			16	Multidisciplinary Sciences	Science & Technology - Other Topics	IW5HO	WOS:000485009500034	31408492	DOAJ Gold, Green Published			2021-06-18	
J	Kramer, TJ; Hack, N; Bruhl, TJ; Menzel, L; Hummel, R; Griemert, EV; Klein, M; Thal, SC; Bopp, T; Schafer, MKE				Kraemer, Tobias J.; Hack, Nathalia; Bruehl, Till J.; Menzel, Lutz; Hummel, Regina; Griemert, Eva-Verena; Klein, Matthias; Thal, Serge C.; Bopp, Tobias; Schaefer, Michael K. E.			Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-gamma gene expression in acute experimental traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Inflammation; Cytokines; Immune response; T cells; Astrocytes; Microglia	ISCHEMIC-STROKE; INFLAMMATION; SYSTEM; NEUROPROTECTION; ASTROCYTES; MOTOR; MICE; NEUROINFLAMMATION; PATHOPHYSIOLOGY; PROGRANULIN	Background Traumatic brain injury (TBI) is a major cause of death and disability. T cells were shown to infiltrate the brain during the first days after injury and to exacerbate tissue damage. The objective of this study was to investigate the hitherto unresolved role of immunosuppressive, regulatory T cells (Tregs) in experimental TBI. Methods "Depletion of regulatory T cell" (DEREG) and wild type (WT) C57Bl/6 mice, treated with diphtheria toxin (DTx) to deplete Tregs or to serve as control, were subjected to the controlled cortical impact (CCI) model of TBI. Neurological and motor deficits were examined until 5 days post-injury (dpi). At the 5 dpi endpoint, (immuno-) histological, protein, and gene expression analyses were carried out to evaluate the consequences of Tregs depletion. Comparison of parametric or non-parametric data between two groups was done using Student's t test or the Mann-Whitney U test. For multiple comparisons, p values were calculated by one-way or two-way ANOVA followed by specific post hoc tests. Results The overall neurological outcome at 5 dpi was not different between DEREG and WT mice but more severe motor deficits occurred transiently at 1 dpi in DEREG mice. DEREG and WT mice did not differ in the extent of brain damage, blood-brain barrier (BBB) disruption, or neuronal excitotoxicity, as examined by lesion volumetry, immunoglobulin G (IgG) extravasation, or calpain-generated alpha II-spectrin breakdown products (SBDPs), respectively. In contrast, increased protein levels of glial fibrillary acidic protein (GFAP) and GFAP+ astrocytes in the ipsilesional brain tissue indicated exaggerated reactive astrogliosis in DEREG mice. T cell counts following anti-CD3 immunohistochemistry and gene expression analyses of Cd247 (CD3 subunit zeta) and Cd8a (CD8a) further indicated an increased number of T cells infiltrating the brain injury sites of DEREG mice compared to WT. These changes coincided with increased gene expression of pro-inflammatory interferon-gamma (Ifng) in DEREG mice compared to WT in the injured brain. Conclusions The results show that the depletion of Tregs attenuates T cell brain infiltration, reactive astrogliosis, interferon-gamma gene expression, and transiently motor deficits in murine acute traumatic brain injury.	[Kraemer, Tobias J.; Hack, Nathalia; Menzel, Lutz; Hummel, Regina; Griemert, Eva-Verena; Thal, Serge C.; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany; [Bruehl, Till J.; Klein, Matthias; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Langenbeckstr 1, D-55131 Mainz, Germany; [Klein, Matthias; Bopp, Tobias; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany	Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Thal, Serge/D-6593-2011; Schaefer, Michael K.E./S-1715-2019	Thal, Serge/0000-0002-1222-8729; Schaefer, Michael K.E./0000-0001-6055-6244; Kramer, Tobias/0000-0001-6900-3486	University Medical Center Mainz; Research Center for Immunotherapy (FZI) Mainz, Germany; Focus Program Translational Neurosciences (FTN) Mainz, Germany	This work was supported by the institutional funding from the University Medical Center Mainz to TB and MS; the Research Center for Immunotherapy (FZI) Mainz, Germany, to TB; and the Focus Program Translational Neurosciences (FTN) Mainz, Germany, to MS.	Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Barcia C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00058; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bopp T, 2007, ANN MED, V39, P322, DOI 10.1080/07853890701379700; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cauli O, 2009, J NEUROSCI RES, V87, P1369, DOI 10.1002/jnr.21947; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Clarkson BDS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09182-5; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Duffy SS, 2018, J NEUROSCI RES, V96, P951, DOI 10.1002/jnr.24073; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; FIERZ W, 1985, J IMMUNOL, V134, P3785; Gill D, 2016, CURR OPIN PHARMACOL, V26, P26, DOI 10.1016/j.coph.2015.09.009; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Li M, 2015, CHINESE MED J-PEKING, V128, P1072, DOI 10.4103/0366-6999.155094; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liesz A, 2016, TRANSL STROKE RES, V7, P313, DOI 10.1007/s12975-016-0465-7; Liesz A, 2015, STROKE, V46, P1422, DOI 10.1161/STROKEAHA.114.008608; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mao LL, 2017, CELL MOL NEUROBIOL, V37, P919, DOI 10.1007/s10571-016-0429-1; Mao LL, 2017, BRAIN, V140, P1914, DOI 10.1093/brain/awx111; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; McGill BE, 2018, J NEUROSCI, V38, P200, DOI 10.1523/JNEUROSCI.0936-17.2017; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Menzel L, 2016, ACTA NEUROPATHOL, V132, P703, DOI 10.1007/s00401-016-1607-4; Na SY, 2015, STROKE, V46, P212, DOI 10.1161/STROKEAHA.114.007756; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Prajeeth CK, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0978-3; Qu YY, 2007, TRANSPL IMMUNOL, V17, P153, DOI 10.1016/j.trim.2007.01.002; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Ren XF, 2011, METAB BRAIN DIS, V26, P87, DOI 10.1007/s11011-010-9226-6; Schafer MKE, 2018, MATRIX BIOL, V68-69, P571, DOI 10.1016/j.matbio.2017.10.002; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Soares HD, 1995, J NEUROSCI, V15, P8223; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tabares P, 2018, EUR J IMMUNOL, V48, P366, DOI 10.1002/eji.201747244; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Timaru-Kast R, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00063; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Toklu HZ, 2015, OXIDATIVE STRESS BRA; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Ulges A, 2016, ADV IMMUNOL, V132, P1, DOI 10.1016/bs.ai.2016.08.002; Walsh JT, 2014, J IMMUNOL, V193, P5013, DOI 10.4049/jimmunol.1302401; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xie LK, 2015, BRAIN RES, V1623, P63, DOI 10.1016/j.brainres.2015.03.026; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492; Xu XM, 2013, SCI WORLD J, DOI 10.1155/2013/174373	77	16	16	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	AUG 5	2019	16	1							163	10.1186/s12974-019-1550-0			14	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	IO3JI	WOS:000479276100002	31383034	DOAJ Gold, Green Published			2021-06-18	
J	Che, LB; Lei, ZY; Wu, PY; Song, DW				Che, Lingbin; Lei, Zhouyue; Wu, Peiyi; Song, Dianwen			A 3D Printable and Bioactive Hydrogel Scaffold to Treat Traumatic Brain Injury	ADVANCED FUNCTIONAL MATERIALS			English	Article						3D printing; bioactive; double-networks; hydrogels; traumatic brain injury	DOUBLE-NETWORK HYDROGELS; TOUGH HYDROGELS; DELIVERY; CALCIUM	Traumatic brain injury accompanied by intracranial hypertension remains one of the most fatal injuries worldwide. Usually, patients must undergo two surgeries, craniectomy and cranioplasty, to reduce the intracranial pressure and then repair the skull. Traditional biomaterials, such as autologous bones and titanium meshes, which have poor stretchability and very high Young's modulus values up to hundreds of GPa, tend to constrain intracranial tissue and cannot be implanted directly after craniectomy. Thus far, finding elastic and degradable biomaterials to be immediately implanted after a craniectomy has remained a great challenge, which should not only repair cranial defects but also avoid secondary surgery and reduce the risk of complications, has remained a great challenge. Herein, a 3D printable bioactive hydrogel scaffold with high elasticity that can protect brain tissue, adapt to intracranial pressure changes, allow for the transport of nutrients and the proliferation and osteogenic differentiation of bone mesenchymal stem cells is presented. As indicated by in vivo experiments, the hydrogel scaffold helps to treat traumatic brain injury within 8 weeks and degrades safely. With these advantages, this material shows the potential to open up new horizons for cranioplasty and to help patients survive traumatic brain injury.	[Che, Lingbin; Song, Dianwen] Shanghai Paotong Univ, Sch Med, Shanghai Gen Hosp, Dept Orthoped, Shanghai 200080, Peoples R China; [Lei, Zhouyue; Wu, Peiyi] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Coll Chem Chem Engn & Biotechnol, Ctr Adv Low Dimens Mat, Shanghai 201620, Peoples R China; [Lei, Zhouyue; Wu, Peiyi] Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China; [Lei, Zhouyue; Wu, Peiyi] Fudan Univ, Lab Adv Mat, Shanghai 200433, Peoples R China	Song, DW (corresponding author), Shanghai Paotong Univ, Sch Med, Shanghai Gen Hosp, Dept Orthoped, Shanghai 200080, Peoples R China.; Wu, PY (corresponding author), Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Coll Chem Chem Engn & Biotechnol, Ctr Adv Low Dimens Mat, Shanghai 201620, Peoples R China.; Wu, PY (corresponding author), Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.; Wu, PY (corresponding author), Fudan Univ, Lab Adv Mat, Shanghai 200433, Peoples R China.	wupeiyi@dhu.edu.cn; dianwen.song@shgh.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571828, 51733003, 21674025]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [14411963700]	L.C. and Z.L. contributed equally to this work. This work was supported from the National Natural Science Foundation of China (Nos. 81571828, 51733003, and 21674025) and Science and Technology Commission of Shanghai Municipality (No. 14411963700).	Addison WN, 2010, J BONE MINER RES, V25, P1191, DOI 10.1002/jbmr.110; Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6; Dan Y, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1669-1; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Holloway JL, 2014, J CONTROL RELEASE, V191, P63, DOI 10.1016/j.jconrel.2014.05.053; Hong SM, 2015, ADV MATER, V27, P4035, DOI [10.1002/adma.201501099, 10.1002/adma.201570182]; Lee MN, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0170-6; Lei ZY, 2018, ACS NANO, V12, P12860, DOI 10.1021/acsnano.8b08062; Lei ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03456-w; Lu BY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09003-5; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Marcellini S, 2012, BIOESSAYS, V34, P953, DOI 10.1002/bies.201200061; Pati F, 2015, BIOMATERIALS, V62, P164, DOI 10.1016/j.biomaterials.2015.05.043; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Sun TL, 2017, MACROMOLECULES, V50, P2923, DOI 10.1021/acs.macromol.7b00162; Tian K, 2017, ADV MATER, V29, DOI 10.1002/adma.201604827; Wang WH, 2014, J NEUROTRAUM, V31, P1444, DOI 10.1089/neu.2013.3142; Yan YF, 2019, BIOMATERIALS, V190, P97, DOI 10.1016/j.biomaterials.2018.10.033; Yu HC, 2019, MACROMOLECULES, V52, P629, DOI 10.1021/acs.macromol.8b02269; Zhang D, 2013, BIOMATERIALS, V34, P10258, DOI 10.1016/j.biomaterials.2013.09.027; Zhang YS, 2017, SCIENCE, V356, DOI 10.1126/science.aaf3627; Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e; Zheng SY, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201803366	27	16	16	31	248	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	SEP	2019	29	39							1904450	10.1002/adfm.201904450		AUG 2019	10	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	IZ8TR	WOS:000478852600001					2021-06-18	
J	Lippert, T; Borlongan, CV				Lippert, Trenton; Borlongan, Cesario V.			Prophylactic treatment of hyperbaric oxygen treatment mitigates inflammatory response via mitochondria transfer	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						hyperbaric; mitochondria transfer; preconditioning; stroke; traumatic brain injury	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; BARRIER BREAKDOWN; CELL THERAPY; TNF-ALPHA; STROKE; APOPTOSIS; RAT; MECHANISMS; INHIBITION	Aims Hyperbaric oxygen therapy (HBOT) has been widely used as postinjury treatment; however, we investigate its ability to mitigate potential damage as a preconditioning option. Here, we tested the hypothesis that HBOT preconditioning mitigates cell death in primary rat neuronal cells (PRNCs) through the transfer of mitochondria from astrocytes. Methods Primary rat neuronal cells were subjected to a 90-minute HBOT treatment at 2.5 absolute atmospheres prior to either tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) injury to simulate the inflammation-plagued secondary cell death associated with stroke and traumatic brain injury (TBI). After incubation with TNF-alpha or LPS, the cell viability of each group was examined. Results There was a significant increase of cell viability accompanied by mitochondrial transfer in the injury groups that received HBOT preconditioning compared to the injury alone groups (44 +/- 5.2 vs 68 +/- 4.48, n = 20, P < 0.05). The transfer of mitochondria directly after HBOT treatment was visualized by capturing images in 5-minute intervals, which revealed that the robust transfer of mitochondria begins soon after HBOT and persisted throughout the treatment. Conclusion This study shows that HBOT preconditioning stands as a robust prophylactic treatment for sequestration of inflammation inherent in stroke and TBI, possibly facilitating the transfer of resilient mitochondria from astrocytes to inflammation-susceptible neuronal cells in mitigating cell death.	[Lippert, Trenton; Borlongan, Cesario V.] USF Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA; [Lippert, Trenton] Univ S Florida, Honors Coll, Tampa, FL USA	Borlongan, CV (corresponding author), USF Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu			Center for Scientific ReviewUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS102395]	Center for Scientific Review, Grant/Award Number: R01NS102395	Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018; Andre-Levigne D, 2016, WOUND REPAIR REGEN, V24, P954, DOI 10.1111/wrr.12480; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bennett MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Bhutani S, 2012, INDIAN J PLAST SURG, V45, P316, DOI 10.4103/0970-0358.101309; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Borlongan CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078490; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2000, FASEB J, V14, P1307, DOI 10.1096/fj.14.10.1307; Chen SY, 2011, UNDERSEA HYPERBAR M, V38, P375; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Dougherty JE, 2013, CRIT CARE NURS Q, V36, P299, DOI 10.1097/CNQ.0b013e318294ea41; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Gamdzyk M, 2016, BRAIN RES, V1648, P257, DOI 10.1016/j.brainres.2016.07.025; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Nguyen H, 2016, EXPERT REV NEUROTHER, V16, P915, DOI 10.1080/14737175.2016.1184086; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liu B, 2015, INT J BIOL SCI, V11, P353, DOI 10.7150/ijbs.9813; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Muriach M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/102158; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Newman MB, 2005, STEM CELLS DEV, V14, P29, DOI 10.1089/scd.2005.14.29; Okazawa H, 2014, Q J NUCL MED MOL IM, V58, P387; Ostrowski RP, 2008, NEUROBIOL DIS, V29, P1, DOI 10.1016/j.nbd.2007.07.020; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Saporta S, 1997, EXP NEUROL, V146, P299, DOI 10.1006/exnr.1997.6493; Selcuk CT, 2013, J BURN CARE RES, V34, pE237, DOI 10.1097/BCR.0b013e318270092e; Seule M, 2015, FACIAL PLAST SURG, V31, P325, DOI 10.1055/s-0035-1562884; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Soejima Y, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-9; Stoekenbroek RM, 2014, EUR J VASC ENDOVASC, V47, P647, DOI 10.1016/j.ejvs.2014.03.005; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Xia CF, 2004, HUM GENE THER, V15, P1243, DOI 10.1089/hum.2004.15.1243; Xiang PC, 2018, ACTA CIR BRAS, V33, P341, DOI 10.1590/s0102-865020180040000006; Yang L, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165187; Yang LM, 2015, BRAIN RES, V1627, P21, DOI 10.1016/j.brainres.2015.08.011; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Zhai WW, 2016, MED GAS RES, V6, P111, DOI 10.4103/2045-9912.184721; Zuo W, 2014, NEUROPHARMACOLOGY, V86, P103, DOI 10.1016/j.neuropharm.2014.07.002	54	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	AUG	2019	25	8					815	823		10.1111/cns.13124			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	IJ0XJ	WOS:000475623000002	30972972	DOAJ Gold, Green Published			2021-06-18	
J	Spaite, DW; Bobrow, BJ; Keim, SM; Barnhart, B; Chikani, V; Gaither, JB; Sherrill, D; Denninghoff, KR; Mullins, T; Adelson, PD; Rice, AD; Viscusi, C; Hu, C				Spaite, Daniel W.; Bobrow, Bentley J.; Keim, Samuel M.; Barnhart, Bruce; Chikani, Vatsal; Gaither, Joshua B.; Sherrill, Duane; Denninghoff, Kurt R.; Mullins, Terry; Adelson, P. David; Rice, Amber D.; Viscusi, Chad; Hu, Chengcheng			Association of Statewide Implementation of the Prehospital Traumatic Brain Injury Treatment Guidelines With Patient Survival Following Traumatic Brain Injury The Excellence in Prehospital Injury Care (EPIC) Study	JAMA SURGERY			English	Article							ADVANCED LIFE-SUPPORT; RAPID-SEQUENCE INTUBATION; HOSPITAL CARDIAC-ARREST; GLASGOW COMA SCALE; AMERICAN-HEART-ASSOCIATION; ENDOTRACHEAL INTUBATION; CARDIOPULMONARY-RESUSCITATION; CLINICAL-TRIALS; RECOMMENDED GUIDELINES; EUROPEAN-RESUSCITATION	Importance Traumatic brain injury (TBI) is a massive public health problem. While evidence-based guidelines directing the prehospital treatment of TBI have been promulgated, to our knowledge, no studies have assessed their association with survival. Objective To evaluate the association of implementing the nationally vetted, evidence-based, prehospital treatment guidelines with outcomes in moderate, severe, and critical TBI. Design, Setting, and Participants The Excellence in Prehospital Injury Care (EPIC) Study included more than 130 emergency medical services systems/agencies throughout Arizona. This was a statewide, multisystem, intention-to-treat study using a before/after controlled design with patients with moderate to critically severe TBI (US Centers for Disease Control and Prevention Barell Matrix-Type 1 and/or Abbreviated Injury Scale Head region severity >= 3) transported to trauma centers between January 1, 2007, and June 30, 2015. Data were analyzed between October 25, 2017, and February 22, 2019. Interventions Implementation of the prehospital TBI guidelines emphasizing avoidance/treatment of hypoxia, prevention/correction of hyperventilation, and avoidance/treatment of hypotension. Main Outcomes and Measures Primary: survival to hospital discharge; secondary: survival to hospital admission. Results Of the included patients, the median age was 45 years, 14666 (67.1%) were men, 7181 (32.9%) were women; 16408 (75.1% ) were white, 1400 (6.4%) were Native American, 743 (3.4% ) were Black, 237 (1.1%) were Asian, and 2791 (12.8%) were other race/ethnicity. Of the included patients, 21852 met inclusion criteria for analysis (preimplementation phase [P1]: 15228; postimplementation [P3]: 6624). The primary analysis (P3 vs P1) revealed an adjusted odds ratio (aOR) of 1.06 (95% CI, 0.93-1.21; P = .40) for survival to hospital discharge. The aOR was 1.70 (95% CI, 1.38-2.09; P < .001) for survival to hospital admission. Among the severe injury cohorts (but not moderate or critical), guideline implementation was significantly associated with survival to discharge (Regional Severity Score-Head 3-4: aOR, 2.03; 95% CI, 1.52-2.72; P < .001; Injury Severity Score 16-24: aOR, 1.61; 95% CI, 1.07-2.48; P = .02). This was also true for survival to discharge among the severe, intubated subgroups (Regional Severity Score-Head 3-4: aOR, 3.14; 95% CI, 1.65-5.98; P < .001; Injury Severity Score 16-24: aOR, 3.28; 95% CI, 1.19-11.34; P = .02). Conclusions and Relevance Statewide implementation of the prehospital TBI guidelines was not associated with significant improvement in overall survival to hospital discharge (across the entire, combined moderate to critical injury spectrum). However, adjusted survival doubled among patients with severe TBI and tripled in the severe, intubated cohort. Furthermore, guideline implementation was significantly associated with survival to hospital admission. These findings support the widespread implementation of the prehospital TBI treatment guidelines.	[Spaite, Daniel W.; Bobrow, Bentley J.; Keim, Samuel M.; Barnhart, Bruce; Gaither, Joshua B.; Denninghoff, Kurt R.; Rice, Amber D.; Viscusi, Chad; Hu, Chengcheng] Univ Arizona, Coll Med, Arizona Emergency Med Res Ctr, Phoenix, AZ USA; [Spaite, Daniel W.; Bobrow, Bentley J.; Keim, Samuel M.; Gaither, Joshua B.; Denninghoff, Kurt R.; Rice, Amber D.; Viscusi, Chad] Univ Arizona, Dept Emergency Med, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Bobrow, Bentley J.; Chikani, Vatsal; Mullins, Terry] Arizona Dept Hlth Serv, Bur EMS, Phoenix, AZ 85007 USA; [Keim, Samuel M.; Sherrill, Duane; Hu, Chengcheng] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA; [Adelson, P. David] Univ Arizona, Coll Med, Dept Child Hlth Neurosurg, Barrow Neurol Inst,Phoenix Childrens Hosp, Phoenix, AZ USA	Spaite, DW (corresponding author), Univ Arizona, Dept Emergency Med, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	dan@aemrc.arizona.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS071049]	The EPIC Study is funded by a grant from the National Institutes of Health (1R01NS071049)	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; [Anonymous], 2017, GAMM4 GEN ADDITIVE M; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bell J, 2014, TRAUMATIC BRAIN INJU; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Feldman A, 2015, ANN EMERG MED, V65, P325, DOI 10.1016/j.annemergmed.2014.07.454; Finkelstein EA, 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; GENTLEMAN D, 1992, INT SURG, V77, P297; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, P496, DOI 10.1097/PCC.0b013e318259ee85; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schuttler J, 1995, ANAESTHESIST, V44, P850, DOI 10.1007/s001010050221; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Spaite DW, 2014, ANN EMERG MED, V64, P496, DOI 10.1016/j.annemergmed.2014.05.028; Spaite DW, 2014, ACAD EMERG MED, V21, P818, DOI 10.1111/acem.12411; SPAITE DW, 1995, ANN EMERG MED, V26, P146, DOI 10.1016/S0196-0644(95)70144-3; SPAITE DW, 1990, ANN EMERG MED, V19, P1270, DOI 10.1016/S0196-0644(05)82286-3; Spaite DW, 2009, EMERGENCY MED SERVIC; Spaite DW, 1993, PREHOSP DISASTER MED, V8, pS35; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stiell IG, 2007, NEW ENGL J MED, V356, P2156, DOI 10.1056/NEJMoa060334; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Stiell IG, 1999, ANN EMERG MED, V34, P256, DOI 10.1016/S0196-0644(99)70241-6; Stocchetti N, 2001, Eur J Emerg Med, V8, P215, DOI 10.1097/00063110-200109000-00009; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; US Centers for Disease Control and Prevention, BAR MATR CDC WEBS; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wang CH, 2014, RESUSCITATION, V85, P1219, DOI 10.1016/j.resuscitation.2014.06.022; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Wood S.N., 2017, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279, 10.1201/9781315370279.]; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V; Zornow MH, 2002, CRIT CARE MED, V30, P2774, DOI 10.1097/00003246-200212000-00026	91	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	JUL	2019	154	7							e191152	10.1001/jamasurg.2019.1152			11	Surgery	Surgery	IR6AU	WOS:000481522400029	31066879	Green Published			2021-06-18	
J	Sarkar, C; Jones, JW; Hegdekar, N; Thayer, JA; Kumar, A; Faden, AI; Kane, MA; Lipinski, MM				Sarkar, Chinmoy; Jones, Jace W.; Hegdekar, Nivedita; Thayer, Julia A.; Kumar, Alok; Faden, Alan I.; Kane, Maureen A.; Lipinski, Marta M.			PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma	AUTOPHAGY			English	Article						Amyloid beta; autophagy; cytosolic phospholipase A2 (cPLA2); lysosomal membrane permeabilization (LMP); membrane lipidomic analysis; traumatic brain injury (TBI)	CYTOSOLIC PHOSPHOLIPASE A(2); CELL-DEATH; ARACHIDONIC-ACID; MOUSE MODEL; PERMEABILIZATION; INJURY; NEUROPROTECTION; METABOLOMICS; CARDIOLIPIN; HOMEOSTASIS	Lysosomal membrane permeabilization (LMP) is observed under many pathological conditions, leading to cellular dysfunction and death. However, the mechanisms by which lysosomal membranes become leaky in vivo are not clear. Our data demonstrate that LMP occurs in neurons following controlled cortical impact induced (CCI) traumatic brain injury (TBI) in mice, leading to impaired macroautophagy (autophagy) and neuronal cell death. Comparison of LC-MS/MS lysosomal membrane lipid profiles from TBI and sham animals suggested a role for PLA2G4A/cPLA2 (phospholipase A2, group IVA [cytosolic, calcium-dependent]) in TBI-induced LMP. Activation of PLA2G4A caused LMP and inhibition of autophagy flux in cell lines and primary neurons. In vivo pharmacological inhibition of PLA2G4A attenuated TBI-induced LMP, as well as subsequent impairment of autophagy and neuronal loss, and was associated with improved neurological outcomes. Inhibition of PLA2G4A in vitro limited amyloid-beta-induced LMP and inhibition of autophagy. Together, our data indicate that PLA2G4A -mediated lysosomal membrane damage is involved in neuronal cell death following CCI-induced TBI and potentially in other neurodegenerative disorders.	[Sarkar, Chinmoy; Hegdekar, Nivedita; Thayer, Julia A.; Kumar, Alok; Faden, Alan I.; Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anesthesiol, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Jones, Jace W.; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Kumar, Alok] Sanjay Gandhi Postgrad Inst Med Sci SGPGIMS, Dept Mol Med & Biotechnol, Lucknow, UP, India; [Faden, Alan I.; Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Lipinski, MM (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol Anat & Neurobiol, Baltimore, MD 21201 USA.	mlipinski@som.umaryland.edu	Sarkar, Chinmoy/AAI-2461-2019	Jones, Jace/0000-0003-0460-0380; Kumar, Alok/0000-0003-3717-7435	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS 091218, R01NS 094527]; Maryland Stem Cell Research Fund [MSCRFE-2747]	This work was supported by R01NS 091218 and R01NS 094527 from National Institutes of Health to MML and MSCRFE-2747 from Maryland Stem Cell Research Fund to CS.	Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Corrotte M, 2015, METHOD CELL BIOL, V126, P139, DOI 10.1016/bs.mcb.2014.11.009; Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9; Damen CWN, 2014, J LIPID RES, V55, P1772, DOI 10.1194/jlr.D047795; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; DEDUVE C, 1969, PROC R SOC SER B-BIO, V173, P71, DOI 10.1098/rspb.1969.0039; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Farooqui AA, 2004, PROSTAG LEUKOTR ESS, V71, P161, DOI 10.1016/j.plefa.2004.03.004; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330; Gomez-Sintes R, 2016, AGEING RES REV, V32, P150, DOI 10.1016/j.arr.2016.02.009; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kilpatrick BS, 2015, METHOD CELL BIOL, V126, P1, DOI 10.1016/bs.mcb.2014.10.018; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Lee JCM, 2011, J NEUROCHEM, V116, P813, DOI 10.1111/j.1471-4159.2010.07033.x; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu NK, 2014, ANN NEUROL, V75, P644, DOI 10.1002/ana.24134; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McNeil PL, 2002, J CELL SCI, V115, P873; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Monteiro-Cardoso VF, 2015, J ALZHEIMERS DIS, V43, P1375, DOI 10.3233/JAD-141002; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ofengeim D, 2012, J BIOL CHEM, V287, P8714, DOI 10.1074/jbc.M111.290957; Paglia G, 2017, NAT PROTOC, V12, P797, DOI 10.1038/nprot.2017.013; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Rodriguez-Muela N, 2015, CELL DEATH DIFFER, V22, P476, DOI 10.1038/cdd.2014.203; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Slomiany Bronislaw L, 2010, Int J Biomed Sci, V6, P37; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Syrbu SI, 1999, J IMMUNOL, V162, P2334; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Ullio C, 2012, J LIPID RES, V53, P1134, DOI 10.1194/jlr.M022384; Walker MW, 2015, METHOD CELL BIOL, V126, P21, DOI 10.1016/bs.mcb.2014.10.019; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yakovlev AG, 2001, J NEUROSCI, V21, P7439; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Zhang ZJ, 2007, HUM MOL GENET, V16, P837, DOI 10.1093/hmg/ddm029; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu DH, 2006, J NEUROSCI, V26, P11111, DOI 10.1523/JNEUROSCI.3505-06.2006; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	72	16	16	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	MAR 3	2020	16	3					466	485		10.1080/15548627.2019.1628538		JUN 2019	20	Cell Biology	Cell Biology	LE0LH	WOS:000475190600001	31238788	Bronze, Green Published			2021-06-18	
J	Klein, AP; Tetzlaff, JE; Bonis, JM; Nelson, LD; Mayer, AR; Huber, DL; Harezlak, J; Mathews, VP; Ulmer, JL; Sinson, GP; Nencka, AS; Koch, KM; Wu, YC; Saykin, AJ; DiFiori, JP; Giza, CC; Goldman, J; Guskiewicz, KM; Mihalik, JP; Duma, SM; Rowson, S; Brooks, A; Broglio, SP; McAllister, T; McCrea, MA; Meier, TB				Klein, Andrew P.; Tetzlaff, Julie E.; Bonis, Joshua M.; Nelson, Lindsay D.; Mayer, Andrew R.; Huber, Daniel L.; Harezlak, Jaroslaw; Mathews, Vincent P.; Ulmer, John L.; Sinson, Grant P.; Nencka, Andrew S.; Koch, Kevin M.; Wu, Yu-Chien; Saykin, Andrew J.; DiFiori, John P.; Giza, Christopher C.; Goldman, Joshua; Guskiewicz, Kevin M.; Mihalik, Jason P.; Duma, Stefan M.; Rowson, Steven; Brooks, Alison; Broglio, Steven P.; McAllister, Thomas; McCrea, Michael A.; Meier, Timothy B.			Prevalence of Potentially Clinically Significant Magnetic Resonance Imaging Findings in Athletes with and without Sport-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; MRI; mTBI; sport; white matter hyperintensity	WHITE-MATTER HYPERINTENSITIES; INCIDENTAL FINDINGS; 1ST EXPOSURE; BRAIN; SYMPTOMS; FOOTBALL; MEMBERS; AGE	Previous studies have shown that mild traumatic brain injury (mTBI) can cause abnormalities in clinically relevant magnetic resonance imaging (MRI) sequences. No large-scale study, however, has prospectively assessed this in athletes with sport-related concussion (SRC). The aim of the current study was to characterize and compare the prevalence of acute, trauma-related MRI findings and clinically significant, non-specific MRI findings in athletes with and without SRC. College and high-school athletes were prospectively enrolled and participated in scanning sessions between January 2015 through August 2017. Concussed contact sport athletes (n = 138; 14 female [F]; 19.5 +/- 1.6 years) completed up to four scanning sessions after SRC. Non-concussed contact (n = 135; 15 F; 19.7 +/- 1.6) and non-contact athletes (n = 96; 15 F; 20.0 +/- 1.7) completed similar scanning sessions and served as controls. Board-certified neuroradiologists, blinded to SRC status, reviewed T-1-weighted and T-2-weighted fluid-attenuated inversion recovery and T-2*-weighted and T-2-weighted images for acute (i.e., injury-related) or non-acute findings that prompted recommendation for clinical follow-up. Concussed athletes were more likely to have MRI findings relative to contact (30.4% vs. 15.6%; odds ratio [OR] = 2.32; p = 0.01) and non-contact control athletes (19.8%; OR = 2.11; p = 0.04). Female athletes were more likely to have MRI findings than males (43.2% vs. 19.4%; OR = 2.62; p = 0.01). One athlete with SRC had an acute, injury-related finding; group differences were largely driven by increased rate of non-specific white matter hyperintensities in concussed athletes. This prospective, large-scale study demonstrates that <1% of SRCs are associated with acute injury findings on qualitative structural MRI, providing empirical support for clinical guidelines that do not recommend use of MRI after SRC.	[Klein, Andrew P.; Bonis, Joshua M.; Mathews, Vincent P.; Ulmer, John L.; Nencka, Andrew S.; Koch, Kevin M.] Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Tetzlaff, Julie E.] Med Coll Wisconsin, Dept Pathol, Pediat Div, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; Huber, Daniel L.; Sinson, Grant P.; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol,Dept Psychol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat,Dept Psychol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM 87131 USA; [Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Wu, Yu-Chien; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [DiFiori, John P.] Univ Calif Los Angeles, Dept Family Med & Orthoped, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat & Neurosurg, Los Angeles, CA USA; [Goldman, Joshua] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Duma, Stefan M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ Sch Med, Dept Psychiat, Bloomington, IN USA	Klein, AP (corresponding author), Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	AKlein@mcw.edu	Rowson, Steven/B-1270-2012; Koch, Kevin/AAD-6403-2021; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Huber, Daniel/0000-0003-2079-0647; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Center for Advancing Translational Sciences, National Institutes of Health,United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; U.S. Army Medical Research Acquisition Activity, (Fort Detrick); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG053993] Funding Source: NIH RePORTER	This project was funded with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, (820 Chandler Street, Fort Detrick, MD 21702-5014) is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. This work was also supported by the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research through Award No. W81XWH-14-1-0561. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DOD (DHP funds). The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award No. UL1TR001436. This research was completed, in part, with computational resources and technical support provided by the Research Computing Center at the Medical College of Wisconsin.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Bos D, 2016, RADIOLOGY, V281, P507, DOI 10.1148/radiol.2016160218; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haberg AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151080; Hamedani AG, 2013, NEUROLOGY, V81, P1308, DOI 10.1212/WNL.0b013e3182a8235b; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shoemaker JM, 2011, NEUROLOGY, V77, P2123, DOI 10.1212/WNL.0b013e31823d7687; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Wardlaw JM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001140; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	28	16	16	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1776	1785		10.1089/neu.2018.6055			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600008	30618331	Green Published			2021-06-18	
J	Raikes, AC; Athey, A; Alfonso-Miller, P; Killgore, WDS; Grandner, MA				Raikes, Adam C.; Athey, Amy; Alfonso-Miller, Pamela; Killgore, William D. S.; Grandner, Michael A.			Insomnia and daytime sleepiness: risk factors for sports-related concussion	SLEEP MEDICINE			English	Article						Sports-related concussion; Sleep quality; Insomnia severity index; Relative risk; Daytime sleepiness; College athletes	TRAUMATIC BRAIN-INJURY; SELF-REPORTED CONCUSSIONS; APNEA RISK; COLLEGIATE; DEPRIVATION; QUALITY; EPIDEMIOLOGY; PERFORMANCE; PREVALENCE; DURATION	Objective/Background: Poor quality and inadequate sleep are associated with impaired cognitive, motor, and behavioral components of sport performance and increased injury risk. While prior work identifies sports-related concussions as predisposing factors for poor sleep, the role of sleep as a sports-related concussion risk factor is unknown. The purpose of this study was to quantify the effect of poor sleep quality and insomnia symptoms on future sports-related concussion risk. Patients/Methods: In this study, 190 NCAA Division-1 athletes completed a survey battery, including the Insomnia Severity Index (ISI) and National Health and Nutrition Examination Survey (NHANES) Sleep module. Univariate risk ratios for future sports-related concussions were computed with ISI and NHANES sleepiness scores as independent predictors. An additional multiple logistic regression model including sport, sports-related concussion history, and significant univariate predictors jointly assessed the odds of sustaining a concussion. Results: Clinically moderate-to-severe insomnia severity (RR = 3.13, 95% CI: 1.320-7.424, p = 0.015) and excessive daytime sleepiness two or more times per month (RR = 2.856, 95% CI: 0.681-11.977, p = 0.037) increased concussion risk. These variables remained significant and comparable in magnitude in a multivariate model adjusted for sport participation. Conclusion: Insomnia and daytime sleepiness are independently associated with increased sports-related concussion risk. More completely identifying bidirectional relationships between concussions and sleep requires further research. Clinicians and athletes should be cognizant of this relationship and take proactive measures - including assessing and treating sleep-disordered breathing, limiting insomnia risk factors, improving sleep hygiene, and developing daytime sleepiness management strategies e to reduce sports-related concussion risk and support overall athletic performance. (C) 2019 Elsevier B.V. All rights reserved.	[Raikes, Adam C.; Killgore, William D. S.] Univ Arizona, Social Cognit & Affect Neurosci SCAN Lab, Tucson, AZ USA; [Athey, Amy] Univ Arizona, Dept Athlet, Tucson, AZ USA; [Alfonso-Miller, Pamela; Grandner, Michael A.] Univ Arizona, Sleep & Hlth Res Program, Tucson, AZ USA	Raikes, AC (corresponding author), 1501 N Campbell Ave,Rm 7304A,POB 245002, Tucson, AZ 85742 USA.	raikes.research@gmail.com	Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727	Innovations grant from the National Collegiate Athletic Association; US Army Medical Research and Materiel Command grantU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH14-1-0571];  [R01 MD011600]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [R01MD011600] Funding Source: NIH RePORTER	The study was funded by an Innovations grant from the National Collegiate Athletic Association. Dr. Grandner is also supported by R01 MD011600. Drs. Raikes and Killgore are also supported by a US Army Medical Research and Materiel Command grant (W81XWH14-1-0571) to Dr. Killgore.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; Anderson C, 2011, BEHAV BRAIN RES, V217, P463, DOI 10.1016/j.bbr.2010.09.020; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Ben Cheikh R, 2017, J SPORT MED PHYS FIT, V57, P752, DOI 10.23736/S0022-4707.16.06323-4; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for Disease Control and Prevention, 2017, NATL HLTH NUTR EXAMI; Chau K, 2015, ACCIDENT ANAL PREV, V81, P86, DOI 10.1016/j.aap.2015.04.031; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dobrosielski DA, 2016, RESP CARE, V61, P1144, DOI 10.4187/respcare.04520; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fowler P, 2015, INT J SPORT PHYSIOL, V10, P648, DOI 10.1123/ijspp.2014-0490; Fullagar HHK, 2016, INT J SPORT PHYSIOL, V11, P86, DOI 10.1123/ijspp.2015-0012; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Furtado F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163310; Gosselin N, 2016, SLEEP MED, V20, P155, DOI 10.1016/j.sleep.2015.10.011; Grolemond G, 2011, J STAT SOFTW, V40, P1; Gupta L, 2017, SPORTS MED, V47, P1317, DOI 10.1007/s40279-016-0650-6; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Heaton KJ, 2014, AVIAT SPACE ENVIR MD, V85, P497, DOI 10.3357/ASEM.3882.2014; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hoffman NL, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy222; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Juliff LE, 2015, J SCI MED SPORT, V18, P13, DOI 10.1016/j.jsams.2014.02.007; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Keyes KM, 2015, PEDIATRICS, V135, P460, DOI 10.1542/peds.2014-2707; Knowles OE, 2018, J SCI MED SPORT, V21, P959, DOI 10.1016/j.jsams.2018.01.012; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Kontos AP, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P315, DOI 10.1007/0-387-32565-4_14; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Liu Y, 2016, MMWR-MORBID MORTAL W, V65, P137, DOI 10.15585/mmwr.mm6506a1; Luyster FS, 2017, NAT SCI SLEEP, V9, P31, DOI 10.2147/NSS.S125228; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Mah CD, 2018, SLEEP HEALTH, V4, P251, DOI 10.1016/j.sleh.2018.02.005; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Palagini L, 2017, SLEEP MED, V40, pE47, DOI 10.1016/j.sleep.2017.11.130; Palmer CA, 2017, SLEEP MED REV, V31, P6, DOI 10.1016/j.smrv.2015.12.006; Patrick Y, 2017, SLEEP BIOL RHYTHMS, V15, P217, DOI 10.1007/s41105-017-0099-5; Peck B, 2019, J SPORT REHABIL, V28, P126, DOI 10.1123/jsr.2017-0127; R Core Team, 2017, R LANG ENV STAT COMP; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Renn RP, 2013, INT J PSYCHOPHYSIOL, V88, P64, DOI 10.1016/j.ijpsycho.2013.01.013; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Short MA, 2018, SLEEP MED REV, V41, P185, DOI 10.1016/j.smrv.2018.03.006; Smith CD, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12637; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Swinbourne R, 2016, EUR J SPORT SCI, V16, P850, DOI 10.1080/17461391.2015.1120781; Venables W.N., 2002, MODERN APPL STAT S; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P2059, DOI 10.1111/sms.12855; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P1364, DOI 10.1111/sms.12735; Wickham H., 2016, GGPLOT2, DOI [10.1007/978-3-319-24277-4, DOI 10.1007/978-3-319-24277-4]; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	72	16	16	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	JUN	2019	58						66	74		10.1016/j.sleep.2019.03.008			9	Clinical Neurology	Neurosciences & Neurology	IC3GC	WOS:000470846500011	31132574	Green Published, Green Accepted			2021-06-18	
J	Fino, PC; Becker, LN; Fino, NF; Griesemer, B; Goforth, M; Brolinson, PG				Fino, Peter C.; Becker, Lauren N.; Fino, Nora F.; Griesemer, Brett; Goforth, Michael; Brolinson, Per Gunnar			Effects of Recent Concussion and Injury History on Instantaneous Relative Risk of Lower Extremity Injury in Division I Collegiate Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; lower extremity injury; musculoskeletal injury; brain injury	TRAUMATIC BRAIN-INJURY; GAIT STABILITY; INTERNATIONAL-CONFERENCE; MUSCULOSKELETAL INJURY; CONSENSUS STATEMENT; LOCOMOTOR DEFICITS; DYNAMIC STABILITY; BALANCE CONTROL; SPORT HELD; ATTENTION	Background: Growing evidence suggests that concussion increases the risk of lower extremity (LE) musculoskeletal injury. However, it is unclear to how the effect of concussion on LE injury risk may be influenced by previous injuries. This study sought to examine the association between concussion, previous LE injuries, and the risk LE injury to the same previously injured limb (ipsilateral) or the opposite limb (contralateral). Methods: This retrospective study examined medical records from 110 concussed athletes and 110 matched controls for LE injuries in the 365 days before and after the concussion event. The effect of concussion on time to injury was assessed with a Cox proportional hazard model after adjusting for injury history. Fine and Gray subdistribution models assessed the cumulative risk of ipsilateral and contralateral injury by group. Results: Concussion was associated with an increased instantaneous relative risk of LE injury when adjusting for LE injury history [hazard ratio (HR) = 1.67, 95% confidence interval (CI) = 1.11-2.53], agreeing with previous results. Among individuals who had a history of LE injuries before the concussion event, a nonsignificant yet moderate effect of concussion on the instantaneous relative risk of ipsilateral injuries was found after adjusting for the competing risk of contralateral injuries and censored values (HR = 1.85, 95% CI = 0.76-4.46). Conclusions: This study provides independent confirmation of previous studies, reporting an association between concussion and LE injury risk. Furthermore, this study suggests that future large-scale studies should consider the competing risk of ipsilateral, contralateral, and new injuries in populations with an injury history.	[Fino, Peter C.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA; [Fino, Peter C.] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Becker, Lauren N.; Brolinson, Per Gunnar] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Fino, Nora F.] Oregon Hlth & Sci Univ, Biostat & Design Program, Portland, OR 97201 USA; [Griesemer, Brett; Goforth, Michael; Brolinson, Per Gunnar] Virginia Polytech Inst & State Univ, Dept Sports Med, Blacksburg, VA 24061 USA	Fino, PC (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA.	fino@ohsu.edu		Fino, Peter/0000-0002-8621-3706	National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE 0822220]	This material is based on work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 0822220.	Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Reed N., 2013, NEUROL NEUROPHYSIOL, V4, P171, DOI DOI 10.4172/2155-9562.1000171; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Tenenbaum G., 1993, HDB RES SPORT PSYCHO, P171; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	37	16	16	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2019	29	3					218	223		10.1097/JSM.0000000000000502			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	IQ4QT	WOS:000480736100008	31033615				2021-06-18	
J	Mohamed, AZ; Cumming, P; Gotz, J; Nasrallah, F				Mohamed, Abdalla Z.; Cumming, Paul; Gotz, Jurgen; Nasrallah, Fatima		Dept Def Alzheimers Dis	Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Traumatic brain injury; Posttraumatic stress disorder; Alzheimer's disease; Tau; Positron emission tomography; US Department of Defense Alzheimer's Disease Neuroimaging Initiative	AMYLOID-BETA PLAQUES; ALZHEIMERS-DISEASE; HIPPOCAMPAL VOLUME; TAU PATHOLOGY; ACCUMULATION; ONSET; RISK; PTSD; PET; MICROTUBULES	Purpose Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) have emerged as independent risk factors for an earlier onset of Alzheimer's disease (AD), although the pathophysiology underlying this risk is unclear. Postmortem studies have revealed extensive cerebral accumulation of tau following multiple and single TBI incidents. We hypothesized that a history of TBI and/or PTSD may induce an AD-like pattern of tau accumulation in the brain of nondemented war veterans. Methods Vietnam War veterans (mean age 71.4 years) with a history of war-related TBI and/or PTSD underwent [F-18]AV145 PET as part of the US Department of Defense Alzheimer's Disease Neuroimaging Initiative. Subjects were classified into the following four groups: healthy controls (n = 21), TBI (n = 10), PTSD (n = 32), and TBI+PTSD (n = 17). [F-18]AV1451 reference tissue-normalized standardized uptake value (SUVr) maps, scaled to the cerebellar grey matter, were tested for differences in tau accumulation between groups using voxel-wise and region of interest approaches, and the SUVr results were correlated with neuropsychological test scores. Results Compared to healthy controls, all groups showed widespread tau accumulation in neocortical regions overlapping with typical and atypical patterns of AD-like tau distribution. The TBI group showed higher tau accumulation than the other clinical groups. The extent of tauopathy was positively correlated with the neuropsychological deficit scores in the TBI+PTSD and PTSD groups. Conclusion A history of TBI and/or PTSD may manifest in neurocognitive deficits in association with increased tau deposition in the brain of nondemented war veterans decades after their trauma. Further investigation is required to establish the burden of increased risk of dementia imparted by earlier TBI and/or PTSD.	[Mohamed, Abdalla Z.; Gotz, Jurgen; Nasrallah, Fatima] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia; [Cumming, Paul] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld 4059, Australia; [Cumming, Paul] Queensland Univ Technol, IHBI, Brisbane, Qld 4059, Australia; [Cumming, Paul] QIMR Berghofer Inst, Brisbane, Qld 4006, Australia; [Gotz, Jurgen] Univ Queensland, Queensland Brain Inst, CJCADR, Brisbane, Qld 4072, Australia	Nasrallah, F (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	a.mohamed@uq.edu.au; f.nasrallah@uq.edu.au	Gotz, Jurgen/C-2448-2014; Mohamed, Abdalla Z/AAL-8721-2020; Nasrallah, Fatima/N-3398-2016	Gotz, Jurgen/0000-0001-8501-7896; Mohamed, Abdalla Z/0000-0003-4499-672X; Cumming, Paul/0000-0002-0257-9621; Nasrallah, Fatima/0000-0002-7385-9559	Motor Accident Insurance Commission (MAIC); Queensland Government, Australia [2014000857]; Wesley Hospital Medical Research Foundation, Brisbane, Australia; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; ADNI-DOD (Department of Defense) [W81XWH-12-2-0012]	This research was sponsored by the Motor Accident Insurance Commission (MAIC), the Queensland Government, Australia (grant 2014000857) and the Wesley Hospital Medical Research Foundation, Brisbane, Australia (grant 2016-19). Collection and sharing of data for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health grant U01 AG024904) and ADNI-DOD (Department of Defense award number W81XWH-12-2-0012).	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; Amen DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129659; Andersson JLR, 2007, TR07JA2 FMRIB, P21; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cho H, 2017, NEUROBIOL AGING, V53, P103, DOI 10.1016/j.neurobiolaging.2017.01.024; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Cummins T, 2016, J NUCL MED, V57; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Giannopoulos PF, 2013, AGING CELL, V12, P1082, DOI 10.1111/acel.12136; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0399-z; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2014, ACTA NEUROPATHOL, V128, P773, DOI 10.1007/s00401-014-1362-3; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Joshi S, 2017, MIL MED, V182, P124, DOI 10.7205/MILMED-D-16-00282; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kerbler GM, 2015, NEUROIMAGE-CLIN, V7, P105, DOI 10.1016/j.nicl.2014.11.015; Klein E, 2003, CAN J PSYCHIAT, V48, P28; Lemoine L, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0325-z; Li CZ, 2017, EMBO J, V36, P3120, DOI 10.15252/embj.201797724; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Lindauer RJL, 2005, PSYCHOL MED, V35, P1421, DOI 10.1017/S0033291705005246; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Marquie M, 2017, ACTA NEUROPATHOL, V134, P619, DOI 10.1007/s00401-017-1740-8; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; Miller MW, 2015, PSYCHONEUROENDOCRINO, V62, P359, DOI 10.1016/j.psyneuen.2015.09.003; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Phillips JS, 2018, HUM BRAIN MAPP, V39, P691, DOI 10.1002/hbm.23874; Polanco JC, 2018, NAT REV NEUROL, V14, P22, DOI 10.1038/nrneurol.2017.162; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Regehr C, 2017, J AM ACAD PSYCHIATRY, V45, P184; Schwarz AJ, 2016, BRAIN, V139, P1539, DOI 10.1093/brain/aww023; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Weiner MW, 2012, ALZHEIMERS DEMENT, V9, pe111; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yao YM, 2005, ANN NEUROL, V58, P623, DOI 10.1002/ana.20558	56	16	19	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	MAY	2019	46	5					1139	1151		10.1007/s00259-018-4241-7			13	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	HS2DW	WOS:000463672300014	30617964	Green Published, Other Gold			2021-06-18	
J	Sugarman, MA; McKee, AC; Stein, TD; Tripodis, Y; Besser, LM; Martin, B; Palmisano, JN; Steinberg, EG; O'Connor, MK; Au, R; McClean, M; Killiany, R; Mez, J; Weiner, MW; Kowall, NW; Stern, RA; Alosco, ML				Sugarman, Michael A.; McKee, Ann C.; Stein, Thor D.; Tripodis, Yorghos; Besser, Lilah M.; Martin, Brett; Palmisano, Joseph N.; Steinberg, Eric G.; O'Connor, Maureen K.; Au, Rhoda; McClean, Michael; Killiany, Ronald; Mez, Jesse; Weiner, Michael W.; Kowall, Neil W.; Stern, Robert A.; Alosco, Michael L.			Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Traumatic brain injury; Cognitive decline; Neurodegenerative disease; NACC; Concussion	MILD COGNITIVE IMPAIRMENT; DATA SET UDS; AMYLOID ANGIOPATHY; CLINICAL-DIAGNOSIS; HEAD IMPACTS; HISTORY; ENCEPHALOPATHY; RISK; CONSCIOUSNESS; ASSESSMENTS	Introduction: Recent research with neuropathologic or biomarker evidence of Alzheimer's disease (AD) casts doubt on traumatic brain injury (TBI) as a risk factor for AD. We leveraged the National Alzheimer's Coordinating Center to examine the association between self-reported TBI with loss of consciousness and AD neuropathologic changes, and with baseline and longitudinal clinical status. Methods: The sample included 4761 autopsy participants (453 with remote TBI with loss of consciousness; 2822 with AD neuropathologic changes) from National Alzheimer's Coordinating Center. Results: Self-reported TBI did not predict AD neuropathologic changes (P >. 10). Reported TBI was not associated with baseline or change in dementia severity or cognitive function in participants with or without autopsy-confirmed AD. Discussion: Self-reported TBI with loss of consciousness may not be an independent risk factor for clinical or pathological AD. Research that evaluates number and severity of TBIs is needed to clarify the neuropathological links between TBI and dementia documented in other large clinical databases. (C) 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.	[Sugarman, Michael A.; McKee, Ann C.; Stein, Thor D.; Tripodis, Yorghos; Martin, Brett; Palmisano, Joseph N.; Steinberg, Eric G.; O'Connor, Maureen K.; Killiany, Ronald; Mez, Jesse; Kowall, Neil W.; Stern, Robert A.; Alosco, Michael L.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Sugarman, Michael A.; McKee, Ann C.; Stein, Thor D.; Tripodis, Yorghos; Martin, Brett; Palmisano, Joseph N.; Steinberg, Eric G.; O'Connor, Maureen K.; Killiany, Ronald; Mez, Jesse; Kowall, Neil W.; Stern, Robert A.; Alosco, Michael L.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Sugarman, Michael A.; O'Connor, Maureen K.] Edith Nourse Rogers Mem Vet Hosp, Dept Neuropsychol, Bedford, MA USA; [McKee, Ann C.; Au, Rhoda; Mez, Jesse; Kowall, Neil W.; Stern, Robert A.; Alosco, Michael L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.; Kowall, Neil W.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, Boston, MA USA; [McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Tripodis, Yorghos] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA; [Besser, Lilah M.] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA; [Martin, Brett; Palmisano, Joseph N.] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Centel, Boston, MA USA; [Au, Rhoda] NHLBI, Framingham Heart Study, Boston, MA USA; [Au, Rhoda] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA; [Au, Rhoda; Killiany, Ronald; Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [McClean, Michael; Killiany, Ronald] Boston Univ, Dept Environm Hlth, Sch Publ Hlth, Boston, MA USA; [Killiany, Ronald] Boston Univ, Sch Med, Ctr Biomed Imaging, Boston, MA 02118 USA; [Weiner, Michael W.] Dept Vet Affairs Med Ctr, Ctr Imaging & Neurodegenerat Dis, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kowall, Neil W.] VA Boston Healthcare Syst, Neurol Serv, Boston, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA	Alosco, ML (corresponding author), Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA.; Alosco, ML (corresponding author), Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA.; Alosco, ML (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	malosco@bu.edu	, Bob/ABA-8507-2020; Besser, Lilah/AAD-3304-2020; Killiany, Ronald/Y-7251-2019	Killiany, Ronald/0000-0003-4740-2181; Tripodis, Yorghos/0000-0003-2190-7608	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P50 AG047366, P30 AG010129, P50 AG016573, P50 AG005131]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG13846, U01NS093334, U01NS086659-01, 1F32NS096803-01, K23NS102399, K23AG046377, RF1AG05416]; National Center for Advancing Translational Sciences, National Institutes of Health, through Boston University Clinical & Translational Science Institute (BU-CTSI) [1UL1TR001430]; NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG016976];  [P50 AG005142];  [P30 AG012300];  [P30 AG049638];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG053760];  [P30 AG010124];  [P50 AG005133]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS102399, U01NS093334, U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG062348, P50AG047270, P30AG008017, P30AG008051, P50AG005138, P50AG005133, U01AG016976, R01AG061028, P30AG049638, P50AG047366, P50AG047266, P30AG013846, P50AG005131, P30AG053760, P50AG025688, P50AG033514, P50AG023501, P50AG005134, K23AG046377, P50AG016574, P50AG016573, P30AG019610, P50AG005136, P50AG005146, P30AG062715, P30AG035982, P30AG010133, P30AG010161, P30AG010129, P30AG013854, P50AG005681, RF1AG054156, P50AG008702] Funding Source: NIH RePORTER	The National Alzheimer's Coordinating Center (NACC) database is funded by NIA/NIH GrantU01AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PINeilKowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), and P50 AG047270 (PI Stephen Strittmatter, MD, PhD). This work was supported by grants from the NIH (P30 AG13846; U01NS093334, U01NS086659-01; 1F32NS096803-01; K23NS102399; K23AG046377; RF1AG05416). This publication was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Boston University Clinical & Translational Science Institute (BU-CTSI) Grant Number 1UL1TR001430. The content is solely the responsibility of the authors. There is no sponsor.	Adams JW, 2019, J NEUROPATHOL EXP NE; Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Alafuzoff I, 2008, ACTA NEUROPATHOL, V115, P533, DOI 10.1007/s00401-008-0358-2; Alafuzoff I, 2006, J NEUROPATH EXP NEUR, V65, P740, DOI 10.1097/01.jnen.0000229986.17548.27; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P309, DOI 10.1007/s00401-009-0485-4; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco ML, 2017, J ALZHEIMERS DIS, V57, P953, DOI 10.3233/JAD-161205; [Anonymous], 2014, R LANG ENV STAT COMP; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Besser LM, 2018, J NEUROPATH EXP NEUR, V77, P717, DOI 10.1093/jnen/nly049; Besser LM, 2016, J NEUROPATH EXP NEUR, V75, P955, DOI 10.1093/jnen/nlw072; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Montine TJ, 2016, ALZHEIMERS DEMENT, V12, P164, DOI 10.1016/j.jalz.2015.07.492; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Olichney JM, 2000, ANN NY ACAD SCI, V903, P138, DOI 10.1111/j.1749-6632.2000.tb06360.x; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	62	16	16	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAY	2019	15	5					686	698		10.1016/j.jalz.2018.12.015			13	Clinical Neurology	Neurosciences & Neurology	HX2KN	WOS:000467220800009	30852157	Green Accepted			2021-06-18	
J	Wang, ZF; Gao, C; Chen, W; Gao, Y; Wang, HC; Meng, Y; Luo, CL; Zhang, MY; Chen, G; Chen, XP; Wang, T; Tao, LY				Wang, Zu-feng; Gao, Cheng; Chen, Wei; Gao, Yuan; Wang, Hao-chen; Meng, Ying; Luo, Cheng-liang; Zhang, Ming-yang; Chen, Guang; Chen, Xi-ping; Wang, Tao; Tao, Lu-yang			Salubrinal offers neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Traumatic brain injury; Salubrinal; Endoplasmic reticulum stress; Apoptosis; Autophagy	CONTROLLED CORTICAL IMPACT; INDUCED CELL-DEATH; ER-STRESS; REDUCES HISTOPATHOLOGY; ANIMAL-MODELS; PATHOPHYSIOLOGY; ACTIVATION; MECHANISMS; CASPASE-12; MANAGEMENT	Traumatic brain injury (TBI) is a complex injury that can cause severe disabilities and even death. TBI can induce secondary injury cascades, including but not limited to endoplasmic reticulum (ER) stress, apoptosis and autophagy. Although the investigators has previously shown that salubrinal, the selective phosphatase inhibitor of p-eIF2 alpha, ameliorated neurologic deficits in murine TBI model, the neuroprotective mechanisms of salubrinal need further research to warrant the preclinical value. This study was undertaken to characterize the effects of salubrinal on cell death and neurological outcomes following TBI in mice and the potential mechanisms. In the current study, ER stress-related proteins including p-eIF2 alpha, GRP78 and CHOP showed peak expressions both in the cortex and hippocampus from day 2 to day 3 after TBI, indicating ER stress was activated in our TBI model. Immunofluorescence staining showed that CHOP co-located NeuN-positive neuron, GFAP-positive astrocyte, Iba-1-positive microglia, CD31-positive vascular endothelial cell and PDGFR-beta-positive pericyte in the cortex on day 2 after TBI, and these cells mentioned above constitute the neurovascular unit (NVU). We also found TBI-induced plasmalemma permeability, motor dysfunction, spatial learning and memory deficits and brain lesion volume were alleviated by continuous intraperitoneal administration of salubrinal post TBI. To investigate the underlying mechanisms further, we determined that salubrinal suppressed the expression of ER stress, autophagy and apoptosis related proteins on day 2 after TBI. In addition, salubrinal administration decreased the number of CHOP + /TUNEL + and CHOP + /LC3 + cells on day 2 after TBI, detected by immunofluorescence. In conclusion, these data imply that salubrinal treatment improves morphological and functional outcomes caused by TBI in mice and these neuroprotective effects may be associated with inhibiting apoptosis, at least in part by suppressing ER stress-autophagy pathway.	[Wang, Zu-feng; Gao, Cheng; Chen, Wei; Wang, Hao-chen; Luo, Cheng-liang; Zhang, Ming-yang; Chen, Guang; Chen, Xi-ping; Wang, Tao; Tao, Lu-yang] Soochow Univ, Med Sch, Dept Forens Med, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China; [Gao, Yuan] Wenzhou Med Univ, Dept Forens Med, Wenzhou 325035, Peoples R China; [Meng, Ying] Suzhou Western Ecocity, Community Hlth Ctr, Suzhou 215161, Peoples R China; [Wang, Tao] Acad Forens Sci, Shanghai Forens Serv Platform, Shanghai Key Lab Forens Med, Shanghai 200063, Peoples R China	Wang, T; Tao, LY (corresponding author), Soochow Univ, Med Sch, Dept Forens Med, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China.	taowang@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601643, 81530062, 81871536]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020503]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M620226]; Shanghai Key Lab of Forensic Medicine [KF1701]; Jiangsu Planned Projects for Postdoctoral Research Funds [1701124C]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by grants 81601643, 81530062 and 81871536 from the National Natural Science Foundation of China, National High Technology Research and Development Program of China (863 Program, No. 2015AA020503), China Postdoctoral Science Foundation Funded Project (No. 2017M620226), Shanghai Key Lab of Forensic Medicine (No. KF1701), Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1701124C), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Balduini W, 2009, AUTOPHAGY, V5, P221, DOI 10.4161/auto.5.2.7363; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; Gao B, 2013, ACTA PHARMACOL SIN, V34, P657, DOI 10.1038/aps.2013.34; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Gao Y, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00423; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Lee WS, 2015, CURR MOL MED, V15, P735, DOI 10.2174/1566524015666150921105453; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubiolo JA, 2014, CELL SIGNAL, V26, P419, DOI 10.1016/j.cellsig.2013.10.004; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shibata M, 2003, NEUROSCIENCE, V118, P491, DOI 10.1016/S0306-4522(02)00910-7; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Su YC, 2016, INT J NEUROSCI, V126, P681, DOI 10.3109/00207454.2015.1059836; Torres M, 2015, VIRUS RES, V207, P69, DOI 10.1016/j.virusres.2014.12.018; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Wang T, 2013, NEUROSCIENCE, V231, P70, DOI 10.1016/j.neuroscience.2012.11.019; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Xiang CC, 2017, APOPTOSIS, V22, P1, DOI 10.1007/s10495-016-1296-4; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44	45	16	17	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	MAY	2019	161						12	25		10.1016/j.nlm.2019.03.002			14	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	IA9QU	WOS:000469892700002	30851432				2021-06-18	
J	Abdollahzadeh, A; Belevich, I; Jokitalo, E; Tohka, J; Sierra, A				Abdollahzadeh, Ali; Belevich, Ilya; Jokitalo, Eija; Tohka, Jussi; Sierra, Alejandra			Automated 3D Axonal Morphometry of White Matter	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SCANNING-ELECTRON-MICROSCOPY; MYELIN G-RATIO; UNMYELINATED AXONS; CORPUS-CALLOSUM; DIFFUSION; TISSUE; MODEL; RECONSTRUCTION; SEGMENTATION	Axonal structure underlies white matter functionality and plays a major role in brain connectivity. The current literature on the axonal structure is based on the analysis of two-dimensional (2D) cross-sections, which, as we demonstrate, is precarious. To be able to quantify three-dimensional (3D) axonal morphology, we developed a novel pipeline, called ACSON (AutomatiC 3D Segmentation and morphometry Of axoNs), for automated 3D segmentation and morphometric analysis of the white matter ultrastructure. The automated pipeline eliminates the need for time-consuming manual segmentation of 3D datasets. ACSON segments myelin, myelinated and unmyelinated axons, mitochondria, cells and vacuoles, and analyzes the morphology of myelinated axons. We applied the pipeline to serial block-face scanning electron microscopy images of the corpus callosum of sham-operated (n = 2) and brain injured (n = 3) rats 5 months after the injury. The 3D morphometry showed that cross-sections of myelinated axons were elliptic rather than circular, and their diameter varied substantially along their longitudinal axis. It also showed a significant reduction in the myelinated axon diameter of the ipsilateral corpus callosum of rats 5 months after brain injury, indicating ongoing axonal alterations even at this chronic time-point.	[Abdollahzadeh, Ali; Tohka, Jussi; Sierra, Alejandra] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, Kuopio, Finland; [Belevich, Ilya; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, Helsinki, Finland	Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, Kuopio, Finland.	alejandra.sierralopez@uef.fi	Tohka, Jussi/D-2385-2013; Abdollahzadeh, Ali/AAD-5145-2021; Jokitalo, Eija/C-8375-2009	Tohka, Jussi/0000-0002-1048-5860; Abdollahzadeh, Ali/0000-0001-6234-2012; Sierra Lopez, Alejandra/0000-0001-5399-2056; Jokitalo, Eija/0000-0002-4159-6934; Belevich, Ilya/0000-0003-2190-4909	Academy of FinlandAcademy of FinlandEuropean Commission; Biocenter Finland; University of Helsinki	This work was supported by the Academy of Finland (J.T. and A.S.), and Biocenter Finland and University of Helsinki (I.B., E.J., and SBEM imaging). We would like to thank Maarit Pulkkinen for her help with the animal handling, and Mervi Lindman and Antti Salminen for help preparing the samples for SBEM.	Achanta R., 2010, 149300 EPFL; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Berning M, 2015, NEURON, V87, P1193, DOI 10.1016/j.neuron.2015.09.003; Blum H., 1967, MODELS PERCEPTION SP, V1967, P362, DOI DOI 10.1142/S0218654308001154; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138, DOI [10.1017/S1431927610055170, DOI 10.1017/S1431927610055170]; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Dorkenwald S, 2017, NAT METHODS, V14, P435, DOI 10.1038/nmeth.4206; Dowding I, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00103; Fieremans E, 2016, NEUROIMAGE, V129, P414, DOI 10.1016/j.neuroimage.2016.01.018; Funke J, 2012, PROC CVPR IEEE, P1004, DOI 10.1109/CVPR.2012.6247777; GREENBERG MM, 1990, J NEUROCYTOL, V19, P978, DOI 10.1007/BF01186825; Guillery R., 1970, CONT RES METHODS NEU, P77; Haralick R M., 1992, COMPUTER ROBOT VISIO; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hassouna MS, 2007, IEEE T PATTERN ANAL, V29, P1563, DOI 10.1109/TPAMI.2007.1154; Hayworth KJ., 2006, MICROSC MICROANAL, V12, P86, DOI [10.1017/S1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Hodneland E, 2009, IEEE T MED IMAGING, V28, P720, DOI 10.1109/TMI.2008.2011522; Jaccard P., 1908, B SOCIETE VAUDOISE S, V163, P223, DOI [10.5169/seals-268384, DOI 10.5169/SEALS-268384]; Jain V., 2011, ADV NEURAL INFORM PR, P648; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Ju HW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29686; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Kamiya K, 2017, NEUROIMAGE-CLIN, V14, P663, DOI 10.1016/j.nicl.2017.03.003; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kaynig V, 2015, MED IMAGE ANAL, V22, P77, DOI 10.1016/j.media.2015.02.001; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim JHY, 1997, DEV BRAIN RES, V102, P77, DOI 10.1016/S0165-3806(97)00080-1; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kuhn H.W., 1955, NAV RES LOG, VVol. 2, P83, DOI 10.1002/nav.3800020109; Lakovic K, 2014, J CEREBR BLOOD F MET, V34, P1837, DOI 10.1038/jcbfm.2014.154; Lee HH, 2019, BRAIN STRUCT FUNCT, V224, P1469, DOI 10.1007/s00429-019-01844-6; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Liu T, 2012, PATT REC ICPR 2012 2, DOI [10.1097/MPG.0b013e3181a15ae8.Screening, DOI 10.1097/MPG.0B013E3181A15AE8.SCREENING]; Lucchi A, 2012, IEEE T MED IMAGING, V31, P474, DOI 10.1109/TMI.2011.2171705; Maggioni M, 2013, IEEE T IMAGE PROCESS, V22, P119, DOI 10.1109/TIP.2012.2210725; McDonald J. H, 2009, SPARKY HOUSE PUBL, V291, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Novikov DS, 2014, P NATL ACAD SCI USA, V111, P5088, DOI 10.1073/pnas.1316944111; Nunez-Iglesias J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071715; Palombo M, 2019, NEUROIMAGE, V188, P391, DOI 10.1016/j.neuroimage.2018.12.025; Parag T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125825; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; ROSENFEL.A, 1966, J ACM, V13, P471; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Shepherd GMG, 2002, P NATL ACAD SCI USA, V99, P6340, DOI 10.1073/pnas.052151299; Sim KS, 2004, SCANNING, V26, P36; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Stikov N, 2015, NEUROIMAGE, V118, P397, DOI 10.1016/j.neuroimage.2015.05.023; Stikov N, 2015, DATA BRIEF, V4, P368, DOI 10.1016/j.dib.2015.05.019; Topgaard D, 2017, J MAGN RESON, V275, P98, DOI 10.1016/j.jmr.2016.12.007; Torrealba F, 2004, BRAIN RES REV, V47, P5, DOI 10.1016/j.brainresrev.2004.06.004; van Heekeren RJ, 2007, LECT NOTES COMPUT SC, V4522, P263; Van Uitert R, 2007, MED PHYS, V34, P627, DOI 10.1118/1.2409238; Vazquez-Reina A, 2011, IEEE I CONF COMP VIS, P177, DOI 10.1109/ICCV.2011.6126240; VIRTANEN J, 1984, ACTA OPHTHALMOL, V62, P577; Wake H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8844; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P2, DOI 10.1167/iovs.02-0333; West KL, 2016, NEUROIMAGE, V125, P1155, DOI 10.1016/j.neuroimage.2015.08.017; Wilkins A, 2010, J NEUROPATH EXP NEUR, V69, P1256, DOI 10.1097/NEN.0b013e3181ffc317; Zaimi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22181-4	77	16	16	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 15	2019	9								6084	10.1038/s41598-019-42648-2			16	Multidisciplinary Sciences	Science & Technology - Other Topics	HT3XF	WOS:000464495800008	30988411	DOAJ Gold, Green Published			2021-06-18	
J	Zhang, LL; Zhang, WJ; Zheng, BB; Tian, NF				Zhang, Lilian; Zhang, Weijiang; Zheng, Binbin; Tian, Naifeng			Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway	NEUROCHEMICAL RESEARCH			English	Article						Sinomenine; Spinal cord injury; Oxidative stress; Inflammation; Nrf2	KEAP1/NRF2 PATHWAY; BRAIN-INJURY; ACTIVATION; INHIBITION; APOPTOSIS; PROTECTS; RECOVERY; MODEL; INVOLVEMENT; CELLS	Traumatic spinal cord injury (SCI) is a devastating condition with few efficacious drugs. Sinomenine, a bioactive alkaloid extracted from medicinal herb, has been used as a treatment of rheumatoid diseases. This present study explored the therapeutic effects of sinomenine on locomotor dysfunction and neuropathology in SCI. Our findings revealed that sinomenine mitigated neurological deficits and enhanced neuronal preservation, paralleled with a reduction of apoptosis. Also, sinomenine significantly reduced inflammatory cytokines and oxidative stress factors. We further examined erythroid-2-related factor 2 (Nrf2) nuclear translocation, which mainly controls the coordinated expression of important antioxidant and detoxification genes. An increase in Nrf2 translocation from cytoplasm to nucleus and Nrf2-mediated transactivation was observed after sinomenine administration. Knocking down Nrf2 by siRNA could counteract sinomenine-mediated anti-oxidant stress and anti-inflammation following H2O2-stimulated and LPS-stimulated PC12 cells. Together, our findings indicated that sinomenine has the potential to be an effective therapeutic agent for SCI by inhibiting inflammation and oxidative stress via Nrf2 activation.	[Zhang, Lilian; Zhang, Weijiang; Tian, Naifeng] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China; [Zhang, Lilian; Zhang, Weijiang; Tian, Naifeng] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China; [Zhang, Lilian; Zhang, Weijiang; Tian, Naifeng] Zhejiang Prov Key Lab Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China; [Zheng, Binbin] Wenzhou Med Univ, Taizhou Hosp, Dept Orthopaed, Linhai 317000, Zhejiang, Peoples R China	Tian, NF (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China.; Tian, NF (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China.; Tian, NF (corresponding author), Zhejiang Prov Key Lab Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China.; Zheng, BB (corresponding author), Wenzhou Med Univ, Taizhou Hosp, Dept Orthopaed, Linhai 317000, Zhejiang, Peoples R China.	zbb5161@163.com; tiannaifeng2016@163.com			Science and technology project of the National Natural Science Foundation of China [81401162]; Public Technology Research Program of Zhejiang Province [LGF18H060011]; Science and Technology Planning Program of Taizhou City [1702KY04]	This work was supported by the Science and technology project of the National Natural Science Foundation of China (NO. 81401162), the Public Technology Research Program of Zhejiang Province (LGF18H060011) and Science and Technology Planning Program of Taizhou City (1702KY04).	Agostini M, 2016, ONCOTARGET, V7, P29881, DOI 10.18632/oncotarget.8935; Cai YF, 2017, ONCOTARGET, V8, P45356, DOI 10.18632/oncotarget.17487; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Chauhan AK, 2016, MOL NEUROBIOL, V53, P5782, DOI 10.1007/s12035-015-9478-6; Chen L, 2016, ONCOTARGET, V7, P54691, DOI 10.18632/oncotarget.10579; Chen XJ, 2016, MOL NEUROBIOL, V53, P1565, DOI 10.1007/s12035-015-9118-1; Cheng P, 2014, NEUROPHARMACOLOGY, V85, P408, DOI 10.1016/j.neuropharm.2014.06.004; Childs EW, 2008, SHOCK, V29, P636, DOI 10.1097/SHK.0b013e318157f524; Choi JY, 2017, ONCOTARGET, V8; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Fabrizio FP, 2017, ONCOTARGET, V8, P11187, DOI 10.18632/oncotarget.14492; Fan H, 2017, CELL MOL NEUROBIOL, V37, P1387, DOI 10.1007/s10571-017-0469-1; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Hong JY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588871; Kao CH, 2008, RESUSCITATION, V77, P395, DOI 10.1016/j.resuscitation.2008.01.023; Khayrullina G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0391-8; Kumar H, 2017, MOL NEUROBIOL, V55; Li HT, 2016, MOL NEUROBIOL, V53, P4073, DOI 10.1007/s12035-015-9327-7; Long LH, 2010, ACTA PHARMACOL SIN, V31, P1508, DOI 10.1038/aps.2010.122; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Ozdemir US, 2016, MOL NEUROBIOL, V53, P3540, DOI 10.1007/s12035-015-9292-1; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-6; Pei JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0870-1; Qin T, 2016, TOXICOL APPL PHARM, V304, P1, DOI 10.1016/j.taap.2016.05.009; Qin T, 2016, FREE RADICAL BIO MED, V92, P90, DOI 10.1016/j.freeradbiomed.2016.01.011; Reigada D, 2015, NEUROSCIENCE, V300, P404, DOI 10.1016/j.neuroscience.2015.05.036; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Shi H, 2016, J NEUROIMMUNOL, V299, P28, DOI 10.1016/j.jneuroim.2016.08.010; Shukla SM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-117; Smith JR, 2016, BIOMATERIALS, V80, P96, DOI 10.1016/j.biomaterials.2015.11.062; Thompson CD, 2013, J NEUROTRAUM, V30, P1311, DOI 10.1089/neu.2012.2651; Tsai MJ, 2010, NEUROCHEM INT, V57, P867, DOI 10.1016/j.neuint.2010.09.005; Wang AL, 2007, INT IMMUNOPHARMACOL, V7, P1552, DOI 10.1016/j.intimp.2007.07.030; Wu WN, 2011, BRIT J PHARMACOL, V164, P1445, DOI 10.1111/j.1476-5381.2011.01487.x; Xun CH, 2017, EXP THER MED, V14, P431, DOI 10.3892/etm.2017.4505; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Yang Z, 2014, MOL IMMUNOL, V60, P109, DOI 10.1016/j.molimm.2014.03.005; Yin QQ, 2016, BIOCHEM BIOPH RES CO, V477, P881, DOI 10.1016/j.bbrc.2016.06.152; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1; Zhang Q, 2016, ONCOTARGET, V7, P80872, DOI 10.18632/oncotarget.12645; Zhang R, 2016, MOL NEUROBIOL, V54	42	16	17	1	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2019	44	4					763	775		10.1007/s11064-018-02706-z			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	HR2TP	WOS:000462990500003	30603983				2021-06-18	
J	Chao, LL				Chao, Linda L.			Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial	PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY			English	Article						dementia; Alzheimer's disease; photobiomodulation; LED; neuroimaging	MILD ALZHEIMERS-DISEASE; TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; LEVEL LIGHT THERAPY; BLOOD-FLOW; QUANTITATIVE-ANALYSIS; DONEPEZIL; IMPAIRMENT; FMRI; INCREASE	Objective: To examine the effects of transcranial and intranasal photobiomodulation (PBM) therapy, administered at home, in patients with dementia. Background: This study sought to replicate and build upon a previously published case series report describing improved cognitive function in five patients with mild-to-moderate dementia after 12 weeks of transcranial and intranasal near-infrared (NIR) PBM therapy. Materials and methods: Eight participants (mean age: 79.8 +/- 5.8 years old) diagnosed with dementia by their physicians were randomized to 12 weeks of usual care (UC, n = 4) or home PBM treatments (n = 4). The NIR PBM treatments were administered by a study partner at home three times per week with the Vielight Neuro Gamma device. The participants were assessed with the Alzheimer's Disease Assessment Scale-cognitive (ADAS-cog) subscale and the Neuropsychiatric Inventory (NPI) at baseline and 6 and 12 weeks, and with arterial spin-labeled perfusion magnetic resonance imaging ( MRI) and resting-state functional MRI at baseline and 12 weeks. Results: At baseline, the UC and PBM groups did not differ demographically or clinically. However, after 12 weeks, there were improvements in ADAS-cog (group x time interaction: F-1.6 = 16.35, p = 0.007) and NPI (group x time interaction: F-1.6 = 7.52, p = 0.03), increased cerebral perfusion (group x time interaction: F-1,F-6 = 8.46, p < 0.03), and increased connectivity between the posterior cingulate cortex and lateral parietal nodes within the default-mode network in the PBM group. Conclusions: Because PBM was well tolerated and associated with no adverse side effects, these results support the potential of PBM therapy as a viable home treatment for individuals with dementia.	[Chao, Linda L.] San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, 4150 Clement St 114M, San Francisco, CA 94121 USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	Chao, LL (corresponding author), San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, 4150 Clement St 114M, San Francisco, CA 94121 USA.	linda.chao@ucsf.edu					Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Asllani I, 2008, J CEREBR BLOOD F MET, V28, P725, DOI 10.1038/sj.jcbfm.9600570; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Birks JS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001190.pub3; Blautzik J, 2016, EUR NEUROPSYCHOPHARM, V26, P602, DOI 10.1016/j.euroneuro.2015.12.006; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Chirles TJ, 2017, J ALZHEIMERS DIS, V57, P845, DOI 10.3233/JAD-161151; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Deardorff WJ, 2015, DRUG AGING, V32, P537, DOI 10.1007/s40266-015-0273-x; Dennis EL, 2014, NEUROPSYCHOL REV, V24, P49, DOI 10.1007/s11065-014-9249-6; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Ding B, 2014, CLIN INTERV AGING, V9, P493, DOI 10.2147/CIA.S58879; Farlow MR, 2013, CNS NEUROSCI THER, V19, P745, DOI 10.1111/cns.12158; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goveas JS, 2011, J MAGN RESON IMAGING, V34, P764, DOI 10.1002/jmri.22662; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Grillo SL, 2013, J PHOTOCH PHOTOBIO B, V123, P13, DOI 10.1016/j.jphotobiol.2013.02.015; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Li WJ, 2012, NEUROIMAGE, V60, P1083, DOI 10.1016/j.neuroimage.2011.12.077; Lorenzi M, 2011, DRUG AGING, V28, P205, DOI 10.2165/11586440-000000000-00000; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; Mazza M, 2011, J ALZHEIMERS DIS, V23, P375, DOI 10.3233/JAD-2010-090700; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mevel Katell, 2011, Int J Alzheimers Dis, V2011, P535816, DOI 10.4061/2011/535816; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Nobili F, 2002, CLIN NEUROPHYSIOL, V113, P1241, DOI 10.1016/S1388-2457(02)00110-4; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Purushothuman S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt232; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; SCHAPIRO MB, 1993, J NEUROL NEUROSUR PS, V56, P859, DOI 10.1136/jnnp.56.8.859; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Sole-Padulles C, 2013, J CLIN PSYCHOPHARM, V33, P199, DOI 10.1097/JCP.0b013e3182825bfd; Sommer AP, 2012, PHOTOMED LASER SURG, V30, P54, DOI 10.1089/pho.2011.3073; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Staff RT, 2000, NUCL MED COMMUN, V21, P37, DOI 10.1097/00006231-200001000-00007; Stefanova E, 2006, J NEURAL TRANSM, V113, P205, DOI 10.1007/s00702-005-0312-6; Suo C, 2016, MOL PSYCHIATR, V21, P1645, DOI 10.1038/mp.2016.57; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Venneri A, 2002, NEUROREPORT, V13, P83, DOI 10.1097/00001756-200201210-00020; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wells RE, 2013, J AM GERIATR SOC, V61, P642, DOI 10.1111/jgs.12179; Weyer G, 1997, Int Psychogeriatr, V9, P123, DOI 10.1017/S1041610297004298; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilcock G, 2003, DRUG AGING, V20, P777, DOI 10.2165/00002512-200320100-00006; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Yoshiura T, 2009, AM J NEURORADIOL, V30, P1388, DOI 10.3174/ajnr.A1562; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012	73	16	16	6	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2578-5478		PHOTOBIOMODULATION P	Photobiomodulation Photomed. Laser Surg.	MAR	2019	37	3					133	141		10.1089/photob.2018.4555			9	Surgery	Surgery	JD0SZ	WOS:000489687900002	31050950				2021-06-18	
J	Li, QQ; Wu, X; Yang, YY; Zhang, Y; He, F; Xu, X; Zhang, ZW; Tao, LY; Luo, CL				Li, Qianqian; Wu, Xiao; Yang, Yanyan; Zhang, Yue; He, Fang; Xu, Xiang; Zhang, Ziwei; Tao, Luyang; Luo, Chengliang			Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Substance P; Traumatic brain injury; Neurokinin-1 receptor (NK1R); Oxidative stress; Cell death	IN-VITRO; MEMBRANE PERMEABILIZATION; BARRIER DISRUPTION; CORTICAL-NEURONS; CYTOCHROME-C; MITOCHONDRIAL; APOPTOSIS; EDEMA; CONTRIBUTES; AUTOPHAGY	Substance P (SP) is believed to play a role in traumatic brain injury (TBI), and the inhibition of binding of SP to the tachykinin neurokinin-1 receptor (NK1R) using NK1R antagonists had made favorable effects on TBI. Our current study addresses the functional roles and underlying mechanisms of SP and NK1R antagonist L-733,060 following TBI. Adult male wild type C57BL/6 J and SP knock out (SP-KO) mice received a controlled cortical impact and outcome parameters were assessed. The results showed that TBI-induced motor and spatial memory deficits, lesion volume, brain water content and blood-brain barrier disruption were alleviated both in L-733,060-treated C57BL/6 J mice and vehicle-treated SP-KO mice. L-733,060 treatment and SP deletion inhibited TBI-induced the release of cytochrome c from mitochondria to cytoplasm, activation of caspase-3, oxidative stress and neuroinflammation. Higher SP levels in serum and cortex were observed in wild type mice undergoing TBI relative to wild type sham group, but very little expression of cortical SP was detected in the SP-/- mice either TBI or not. Upregulation of NK1R expression after TBI was observed, and there was no significant difference between wild type and SP-KO groups. in vitro, L-733,060 and SP deletion inhibited scratch injury-induced cell death, loss of mitochondrial membrane potential and reactive oxygen species (ROS) production following TBI. Together, the results of this study implicate a functional role for NK1-R antagonist L-733,060 and deletion of SP in TBI-induced neurological outcome, oxidative damage, neuroinflammation and cell death. Upregulation of NK1R maybe a consequence of TBI, independent of the levels of substance P. This study raises the possibility that targeting SP through its receptor NK1R or genetic deletion may have therapeutic efficacy in TBI.	[Li, Qianqian; Wu, Xiao; Yang, Yanyan; Zhang, Yue; He, Fang; Xu, Xiang; Zhang, Ziwei] Wannan Med Coll, Sch Forens Med, Wuhu 241002, Anhui, Peoples R China; [Tao, Luyang; Luo, Chengliang] Soochow Univ, Med Coll, Dept Forens Med, 178 Ganjiang East St, Suzhou 215123, Jiangsu, Peoples R China	Luo, CL (corresponding author), Soochow Univ, Med Coll, Dept Forens Med, 178 Ganjiang East St, Suzhou 215123, Jiangsu, Peoples R China.	clluo@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400999, 81373251, 81530062]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2014M551660]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 81400999, No. 81373251, No. 81530062), China Postdoctoral Science Foundation (No. 2014M551660), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Babbitt SE, 2015, TRENDS BIOCHEM SCI, V40, P446, DOI 10.1016/j.tibs.2015.05.006; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Chang LK, 2002, J CELL BIOL, V157, P771, DOI 10.1083/jcb.200112130; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; Dang DK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1087-7; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Halima B, 2018, J MED FOOD, V21, P70, DOI 10.1089/jmf.2017.0039; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hokfelt T, 2001, J INTERN MED, V249, P27, DOI 10.1046/j.0954-6820.2000.00773.x; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Leonard Anna V, 2013, Acta Neurochir Suppl, V118, P303, DOI 10.1007/978-3-7091-1434-6_59; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lin Y., 2013, WORLD NEUROSURG, V81, P420; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Luo CL, 2015, J MOL NEUROSCI, V56, P988, DOI 10.1007/s12031-015-0568-8; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Park Sin-Young, 2014, Exp Neurobiol, V23, P104, DOI 10.5607/en.2014.23.1.104; Saffroy M, 2003, NEUROSCIENCE, V116, P761, DOI 10.1016/S0306-4522(02)00748-0; Santopietro John, 2015, N C Med J, V76, P96; Thornton E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034138; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39	50	16	16	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	FEB	2019	107						154	165		10.1016/j.biocel.2018.12.018			12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	HZ0TO	WOS:000468555000017	30593954				2021-06-18	
J	Tsushima, WT; Siu, AM; Ahn, HJ; Chang, BL; Murata, NM				Tsushima, William T.; Siu, Andrea M.; Ahn, Hyeong Jun; Chang, Bolin L.; Murata, Nathan M.			Incidence and Risk of Concussions in Youth Athletes: Comparisons of Age, Sex, Concussion History, Sport, and Football Position	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Risks; Sports; Youth	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; UNITED-STATES; RELATIVE RISK; EPIDEMIOLOGY; COLLEGIATE; SYMPTOMS; CHILDREN; IMPACT; RATES	Objective This study was designed to determine concussion incidence, risk, and relative risk among middle and high school athletes participating in various sports. Method Data were retrospectively obtained from 10,334 athletes of 12 different sports in Hawaii. In addition to determining the overall concussion incidence, comparisons of incidence, risk, and relative risk were made according to age, sex, concussion history, sport, and football position. Results The overall incidence of concussion among youth athletes was 1,250 (12.1%). The relative risk for a concussion was almost two times greater in 18-year olds than in 13-year-old athletes. In comparable sports, girls had a 1.5 times higher concussion risk than boys. Athletes with a prior concussion had 3-5 times greater risk to sustain a concussion than those with no history of a concussion. Among varied sports, wrestling and martial arts had the highest relative risk of a concussion, followed by cheerleading, football, and track and field. No differences in concussion risks were found among the football players in different positions. Conclusions Older youths, females, those with a history of concussion, and those participating in high contact sports were found to have higher risks of sustaining a concussion. The findings increase awareness of concussion patterns in young athletes and raise concerns regarding protective strategies and concussion management in youth sports.	[Tsushima, William T.] Straub Med Ctr, Psychiat & Psychol Dept, Honolulu, HI 96813 USA; [Siu, Andrea M.] Hawaii Pacific Hlth, Res Inst, Honolulu, HI 96813 USA; [Ahn, Hyeong Jun] Univ Hawaii, John A Burns Sch Med, Dept Complementary & Integrat Med, Honolulu, HI 96813 USA; [Chang, Bolin L.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Murata, Nathan M.] Univ Hawaii, Dept Kinesiol & Rehabil Sci, Honolulu, HI 96822 USA	Tsushima, WT (corresponding author), Straub Med Ctr, 888 South King St, Honolulu, HI 96813 USA.	tzking@gsu.edu			National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007584]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007601] Funding Source: NIH RePORTER	HJA was partially supported by grant U54MD007584 from the National Institute on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cohen J, 1988, NATL HIGH SCH SPORTS; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2011, HDB SPORT NEUROPSYCH, P58; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham R., 2014, SPORTS RELATED CONCU; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Strand S, 2015, APPL NEUROPSYCH-CHIL, V4, P58, DOI 10.1080/21622965.2013.802650; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	45	16	16	2	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2019	34	1					60	69		10.1093/arclin/acy019			10	Psychology, Clinical; Psychology	Psychology	HO0SQ	WOS:000460614800007	29554189	Bronze, Green Published			2021-06-18	
J	Cheng, WH; Martens, KM; Bashir, A; Cheung, H; Stukas, S; Gibbs, E; Namjoshi, DR; Button, EB; Wilkinson, A; Barron, CJ; Cashman, NR; Cripton, PA; Wellington, CL				Cheng, Wai Hang; Martens, Kris M.; Bashir, Asma; Cheung, Honor; Stukas, Sophie; Gibbs, Ebrima; Namjoshi, Dhananjay R.; Button, Emily B.; Wilkinson, Anna; Barron, Carlos J.; Cashman, Neil R.; Cripton, Peter A.; Wellington, Cheryl L.			CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice	ALZHEIMERS RESEARCH & THERAPY			English	Article						Traumatic brain injury; CHIMERA; Alzheimer disease mice; Post-traumatic stress disorder; Spatial memory Neuroinflammation; A beta metabolism	POSTTRAUMATIC-STRESS-DISORDER; FLUID PERCUSSION INJURY; HEAD IMPACT MODEL; AXONAL PATHOLOGY; FEAR EXTINCTION; COGNITIVE DEFICITS; ALZHEIMERS-DISEASE; CONDITIONED FEAR; TERM SURVIVORS; AMYLOID-BETA	Background: The annual incidence of traumatic brain injury (TBI) in the United States is over 2.5 million, with approximately 3-5 million people living with chronic sequelae. Compared with moderate-severe TBI, the long-term effects of mild TBI (mTBI) are less understood but important to address, particularly for contact sport athletes and military personnel who have high mTBI exposure. The purpose of this study was to determine the behavioural and neuropathological phenotypes induced by the Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA) model of mTBI in both wild-type (WT) and APP/PS1 mice up to 8 months post-injury. Methods: Male WT and APP/PS1 littermates were randomized to sham or repetitive mild TBI (rmTBI; 2 x 0.5 J impacts 24 h apart) groups at 5.7 months of age. Animals were assessed up to 8 months post-injury for acute neurological deficits using the loss of righting reflex (LRR) and Neurological Severity Score (NSS) tasks, and chronic behavioural changes using the passive avoidance (PA), Barnes maze (BM), elevated plus maze (EPM) and rotarod (RR) tasks. Neuropathological assessments included white matter damage; grey matter inflammation; and measures of A beta levels, deposition, and aducanumab binding activity. Results: The very mild CHIMERA rmTBI conditions used here produced no significant acute neurological or motor deficits in WT and APP/PS1 mice, but they profoundly inhibited extinction of fear memory specifically in APP/PS1 mice over the 8-month assessment period. Spatial learning and memory were affected by both injury and genotype. Anxiety and risk-taking behaviour were affected by injury but not genotype. CHIMERA rmTBI induced chronic white matter microgliosis, axonal injury and astrogliosis independent of genotype in the optic tract but not the corpus callosum, and it altered microgliosis in APP/PS1 amygdala and hippocampus. Finally, rmTBI did not alter long-term tau, A beta or amyloid levels, but it increased aducanumab binding activity. Conclusions: CHIMERA is a useful model to investigate the chronic consequences of rmTBI, including behavioural abnormalities consistent with features of post-traumatic stress disorder and inflammation of both white and grey matter. The presence of human A beta greatly modified extinction of fear memory after rmTBI.	[Cheng, Wai Hang; Martens, Kris M.; Bashir, Asma; Cheung, Honor; Stukas, Sophie; Namjoshi, Dhananjay R.; Button, Emily B.; Wilkinson, Anna; Barron, Carlos J.; Wellington, Cheryl L.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Gibbs, Ebrima; Cashman, Neil R.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Neurol, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Cripton, Peter A.] Univ British Columbia, Dept Mech Engn, Int Collaborat Repair Discoveries, 6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada	Wellington, CL (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	wcheryl@mail.ubc.ca	Cripton, Peter/AAC-8268-2020	Cripton, Peter/0000-0002-5067-0833; Cheung, Honor/0000-0002-9780-2522; Cheng, Wai Hang/0000-0002-3408-9184; Bashir, Asma/0000-0002-3616-9436	Weston Brain Institute [TRA140070]; Canadian Institutes of Health Research (CIHR) Masters Graduate Scholarship; University of British Columbia 4-year fellowship; CIHR Masters Graduate Scholarship; CIHR Doctoral Graduate Scholarship; Canadian Consortium for Neurodegeneration in Aging	Operating funding for this work was provided by a transformational grant from the Weston Brain Institute (TRA140070 [to CLW]). AB is supported by a Canadian Institutes of Health Research (CIHR) Masters Graduate Scholarship and a University of British Columbia 4-year fellowship. EBB is supported by a CIHR Masters Graduate Scholarship, a CIHR Doctoral Graduate Scholarship and a University of British Columbia 4-year fellowship. NRC and CLW are also supported by the Canadian Consortium for Neurodegeneration in Aging.	Acosta S.A., 2013, PLOS ONE, V8, P1; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Born HA, 2015, NEUROSCIENCE, V286, P251, DOI 10.1016/j.neuroscience.2014.11.051; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Centers for Disease Control and Prevention, 2014, TBI GET THE FACTS; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Corne R, 2019, PROG NEURO-PSYCHOPH, V88, P276, DOI 10.1016/j.pnpbp.2018.07.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Felmingham KL, 2018, PSYCHONEUROENDOCRINO, V91, P142, DOI 10.1016/j.psyneuen.2018.03.002; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gacsalyi I, 2017, NEUROPHARMACOLOGY, V125, P30, DOI 10.1016/j.neuropharm.2017.07.005; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gatson JW, 2016, J NEUROSURG, V124, P1646, DOI 10.3171/2015.6.JNS15639; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Illouz T, 2016, BIOINFORMATICS, V32, P3314, DOI 10.1093/bioinformatics/btw376; Izquierdo I, 2016, PHYSIOL REV, V96, P695, DOI 10.1152/physrev.00018.2015; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jorge RE, 2011, TXB TRAUMATIC BRAIN, P173; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kimura R, 2008, LEARN MEMORY, V15, P837, DOI 10.1101/lm.1049608; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lalonde R, 2012, REV NEUROSCIENCE, V23, P363, DOI 10.1515/revneuro-2012-0041; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Mantua J, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/7940832; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Morse AM, 2018, MED SCI BASEL, V6, pE15; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Osier ND, 2015, BRAIN NEUROTRAUMA MO, P177; Oyelami T, 2016, ACTA NEUROBIOL EXP, V76, P282, DOI 10.21307/ane-2017-027; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robert J, 2016, BBA-MOL BASIS DIS, V1862, P1027, DOI 10.1016/j.bbadis.2015.10.005; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rodriguez RA, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00132; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salinsky M, 2018, EPILEPSIA, V59, P1945, DOI 10.1111/epi.14542; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Shi L, 2018, SLEEP MED REV, V40, P4, DOI 10.1016/j.smrv.2017.06.010; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tierney KJ, 2016, J NEUROSURG, V124, P538, DOI 10.3171/2015.4.JNS142440; Wicking M, 2016, NEUROBIOL LEARN MEM, V136, P116, DOI 10.1016/j.nlm.2016.09.016; Wixted JT, 2007, PSYCHOL SCI, V18, P133, DOI 10.1111/j.1467-9280.2007.01862.x; Wixted JT, 2004, PSYCHOL REV, V111, P864, DOI 10.1037/0033-295x.111.4.864; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Zuj DV, 2016, NEUROSCI BIOBEHAV R, V69, P15, DOI 10.1016/j.neubiorev.2016.07.014	96	16	16	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-9193			ALZHEIMERS RES THER	Alzheimers Res. Ther.	JAN 12	2019	11								6	10.1186/s13195-018-0461-0			21	Clinical Neurology; Neurosciences	Neurosciences & Neurology	HI2PR	WOS:000456288100002	30636629	DOAJ Gold, Green Published			2021-06-18	
J	Xu, L; Xing, Q; Huang, TJ; Zhou, JK; Liu, TF; Cui, YB; Cheng, T; Wang, YP; Zhou, XK; Yang, B; Yang, GL; Zhang, JW; Zang, XX; Ma, SS; Guan, FX				Xu, Ling; Xing, Qu; Huang, Tuanjie; Zhou, Jiankang; Liu, Tengfei; Cui, Yuanbo; Cheng, Tian; Wang, Yaping; Zhou, Xinkui; Yang, Bo; Yang, Greta Luyuan; Zhang, Jiewen; Zang, Xingxing; Ma, Shanshan; Guan, Fangxia			HDAC1 Silence Promotes Neuroprotective Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Mouse Model of Traumatic Brain Injury via PI3K/AKT Pathway	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						histone deacetylase 1; human umbilical cord derived mesenchymal stem cells; traumatic brain injury; neuroprotection; PI3K/AKT	HIPPOCAMPAL NEUROGENESIS; MEMORY; REPAIR; PTEN; DISRUPTION; INHIBITORS; THERAPY; BARRIER; DISEASE; MICE	Stem cell transplantation is a promising therapy for traumatic brain injury (TBI), but low efficiency of survival and differentiation of transplanted stem cells limits its clinical application. Histone deacetylase 1 (HDAC1) plays important roles in self-renewal of stem cells as well as the recovery of brain disorders. However, little is known about the effects of HDAC1 on the survival and efficacy of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in vivo. In this study, our results showed that HDAC1 silence promoted hUC-MSCs engraftment in the hippocampus and increased the neuroprotective effects of hUC-MSCs in TBI mouse model, which was accompanied by improved neurological function, enhanced neurogenesis, decreased neural apoptosis, and reduced oxidative stress in the hippocampus. Further mechanistic studies revealed that the expressions of phosphorylated PTEN (p-PTEN), phosphorylated Akt (p-Akt), and phosphorylated GSK-3 beta (p-GSK-3 beta) were upregulated. Intriguingly, the neuroprotective effects of hUC-MSCs with HDAC1 silence on behavioral performance of TBI mice was markedly attenuated by LY294002, an inhibitor of the PI3K/AKT pathway. Taken together, our findings suggest that hUC-MSCs transplantation with HDAC1 silence may provide a potential strategy for treating TBI in the future.	[Xu, Ling; Xing, Qu; Huang, Tuanjie; Zhou, Jiankang; Liu, Tengfei; Cui, Yuanbo; Wang, Yaping; Zhou, Xinkui; Ma, Shanshan; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, Zhengzhou, Henan, Peoples R China; [Xu, Ling; Zhang, Jiewen; Guan, Fangxia] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Cui, Yuanbo] Zhengzhou Univ, Zhengzhou Cent Hosp, Translat Med Ctr, Zhengzhou, Henan, Peoples R China; [Cheng, Tian; Yang, Bo; Guan, Fangxia] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Yang, Greta Luyuan] Stuyvesant High Sch, New York, NY USA; [Zang, Xingxing] Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA	Ma, SS; Guan, FX (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou, Henan, Peoples R China.; Guan, FX (corresponding author), Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China.; Guan, FX (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	mashanshan84@163.com; guanfangxia@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1404313, 81601078, 81471306]; Innovative Research Team in Science and Technology of the University of Henan Province [15IRTSTHN022]; Plan for Scientific Innovation Talent of Henan Province [154200510008]; Key Research Project of Higher Education of Henan Province [17A310012]	This study was supported by the National Natural Science Foundation of China (U1404313, 81601078, 81471306), the Innovative Research Team in Science and Technology of the University of Henan Province (15IRTSTHN022), the Plan for Scientific Innovation Talent of Henan Province (154200510008), the Key Research Project of Higher Education of Henan Province (17A310012).	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Benito E, 2015, J CLIN INVEST, V125, P3572, DOI 10.1172/JCI79942; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Cai MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20004-0; Cerri S, 2015, STEM CELL TRANSL MED, V4, P1073, DOI 10.5966/sctm.2015-0023; Chen SB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1193-6; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cho Y, 2014, CURR OPIN NEUROBIOL, V27, P118, DOI 10.1016/j.conb.2014.03.008; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Cui YB, 2017, BEHAV BRAIN RES, V320, P291, DOI 10.1016/j.bbr.2016.12.021; Ganai SA, 2016, CURR NEUROPHARMACOL, V14, P55, DOI 10.2174/1570159X13666151021111609; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Jacob C, 2014, J NEUROSCI, V34, P6112, DOI 10.1523/JNEUROSCI.5212-13.2014; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Juliandi B, 2010, DEV GROWTH DIFFER, V52, P493, DOI 10.1111/j.1440-169X.2010.01175.x; Kang WC, 2016, KOREAN J PHYSIOL PHA, V20, P657, DOI 10.4196/kjpp.2016.20.6.657; Koh SH, 2008, BRAIN RES, V1229, P233, DOI 10.1016/j.brainres.2008.06.087; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Lebrun-Julien F, 2015, ASN NEURO, V7, DOI 10.1177/1759091415593066; Li DP, 2016, CELL MOL NEUROBIOL, V36, P1045, DOI 10.1007/s10571-015-0295-2; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Lv WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113262; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Park MJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0765-6; Qureshi IA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0506; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shein NA, 2011, MOL MED, V17, P448, DOI 10.2119/molmed.2011.00038; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032; Wang XX, 2016, MOL CELLS, V39, P418, DOI 10.14348/molcells.2016.2345; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Wen ZM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8678267; Xie ZH, 2016, CLIN EXP MED, V16, P89, DOI 10.1007/s10238-015-0375-0; Xu YA, 2012, J TISSUE ENG REGEN M, V6, P645, DOI 10.1002/term.468; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013	47	16	16	0	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JAN 4	2019	12								498	10.3389/fncel.2018.00498			14	Neurosciences	Neurosciences & Neurology	HG4LR	WOS:000454947500001	30662396	DOAJ Gold, Green Published			2021-06-18	
J	Moye, LS; Novack, ML; Tipton, AF; Krishnan, H; Pandey, SC; Pradhan, AAA				Moye, Laura S.; Novack, Madeline L.; Tipton, Alycia F.; Krishnan, Harish; Pandey, Subhash C.; Pradhan, Amynah A. A.			The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target	CEPHALALGIA			English	Article						Delta opioid receptor; hyperalgesia; migraine; nitroglycerin; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; HEADACHE; NITROGLYCERIN; PREVALENCE; CGRP; PAIN; ALLODYNIA; BEHAVIORS; DISORDER	Background Post-traumatic headache is the most common and long-lasting impairment observed following mild traumatic brain injury, and frequently has migraine-like characteristics. The mechanisms underlying progression from mild traumatic brain injury to post-traumatic headache are not fully understood. The aim of this study was to develop a mouse model of post-traumatic headache and identify mechanisms and novel targets associated with this disorder. Methods We combined the closed head weight-drop method and the nitroglycerin chronic migraine model. To induce mild traumatic brain injury, a weight was dropped onto intact crania of mildly anesthetized mice, and mechanical responses to chronic-intermittent administration of nitroglycerin, a human migraine trigger, were determined at multiple time points post-injury. Results Low dose nitroglycerin (0.1 mg/kg) evoked acute periorbital and hind paw allodynia in both mild traumatic brain injury and sham animals. However, only mild traumatic brain injury mice developed chronic hypersensitivity to low dose nitroglycerin. Migraine medications, sumatriptan and topiramate, inhibited post-traumatic headache-associated allodynia. In addition, the delta opioid receptor agonist, SNC80, also blocked post-traumatic headache-associated allodynia. Finally, we examined the expression of calcitonin gene-related peptide within this model and found that it was increased in trigeminal ganglia two weeks post-mild traumatic brain injury. Conclusions Overall, we have established a mouse model of post-traumatic headache and identified the delta opioid receptor as a novel therapeutic target for this disorder.	[Moye, Laura S.; Novack, Madeline L.; Tipton, Alycia F.; Krishnan, Harish; Pandey, Subhash C.; Pradhan, Amynah A. A.] Univ Illinois, Dept Psychiat, 1601 W Taylor St,MC 912, Chicago, IL 60612 USA; [Pandey, Subhash C.] Ctr Alcohol Res Epigenet UIC Psychiat, Chicago, IL USA; [Pandey, Subhash C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	Pradhan, AAA (corresponding author), Univ Illinois, Dept Psychiat, 1601 W Taylor St,MC 912, Chicago, IL 60612 USA.	pradhan4@uic.edu	Pradhan, Amynah/AAX-7719-2020	Pradhan, Amynah/0000-0001-9691-2976	DODUnited States Department of Defense [PR141746]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA040688]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA022538]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50AA022538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA040688] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research was supported by DOD grant PR141746 (AAP), NIH Grant DA040688 (AAP), and the NIAAA funded Center for Alcohol Research in Epigenetics - AA022538 (SCP). LM is a member of the UIC Graduate Program for Neuroscience.	Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Ben Aissa M, 2017, CEPHALALGIA; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2008, NEUROLOGY, V71, P559, DOI 10.1212/01.wnl.0000323925.29520.e7; Bigal ME, 2013, HEADACHE, V53, P1230, DOI 10.1111/head.12179; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Brennan KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005784; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Charles A, 2016, CURR OPIN NEUROL, V29, P314, DOI 10.1097/WCO.0000000000000311; Christiansen I, 1999, CEPHALALGIA, V19, P660, DOI 10.1046/j.1468-2982.1999.019007660.x; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; De Felice M, 2010, BRAIN, V133, P2475, DOI 10.1093/brain/awq159; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Edelmayer RM, 2012, PAIN, V153, P1949, DOI 10.1016/j.pain.2012.06.012; Edelmayer RM, 2012, METHODS MOL BIOL, V851, P109, DOI 10.1007/978-1-61779-561-9_7; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Farajdokht F, 2017, EUR J NEUROSCI, V45, P763, DOI 10.1111/ejn.13486; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Greco R, 2011, CEPHALALGIA, V31, P190, DOI 10.1177/0333102410379887; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hou M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0750-1; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lipton RB, 2013, HEADACHE, V53, P1300, DOI 10.1111/head.12154; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lutz PE, 2013, TRENDS NEUROSCI, V36, P195, DOI 10.1016/j.tins.2012.11.002; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Moye L.S., 2017, CURR PROTOC NEUROSCI, V80; Moye LS, 2017, J NEUROSCI RES, V95, P1347, DOI 10.1002/jnr.24001; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; O'Neil M.E., 2013, COMPLICATIONS MILD T; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Pradhan AA, 2014, BRIT J PHARMACOL, V171, P2375, DOI 10.1111/bph.12591; Pradhan AA, 2014, PAIN, V155, P269, DOI 10.1016/j.pain.2013.10.004; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Rice FL, 2017, CEPHALALGIA, V37, P1350, DOI 10.1177/0333102416677051; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Sufka KJ, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0624-y; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Tipton AF, 2016, CEPHALALGIA, V36, P1048, DOI 10.1177/0333102415623070; Tso AR, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0463-4; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Visser WH, 1996, HEADACHE, V36, P471, DOI 10.1046/j.1526-4610.1996.3608471.x; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	58	16	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JAN	2019	39	1					77	90		10.1177/0333102418777507			14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	HJ0YC	WOS:000456888100010	29771142	Green Accepted, Bronze			2021-06-18	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			White Matter Anisotropy for Impact Simulation and Response Sampling in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; tractography; traumatic brain injury; white matter anisotropy; Worcester Head Injury Model	FINITE-ELEMENT MODELS; HEAD IMPACT; CONSTITUTIVE FRAMEWORK; COMPUTATIONAL MODELS; AXONAL DAMAGE; STRAIN; MECHANICS; SPORTS; IMPLEMENTATION; DEFORMATION	Advanced neuroimaging provides new opportunities to enhance head injury models, including the incorporation of white matter (WM) structural anisotropy. Information from high-resolution neuroimaging, however, usually has to be down-sampled to match a typically coarse brain mesh. To understand how this mesh-image resolution mismatch affects impact simulation and subsequent response sampling, we compared three competing anisotropy implementations (using either voxels, tractography, or a multiscale submodeling) and two response sampling strategies (element-wise or tractography-based, using brain mesh or neuroimaging for region segmentation, respectively). Using the combination of high resolution options as a baseline, we studied how the choice in each individual category affected the resulting injury metrics. By simulating a recorded loss of consciousness head impact, we found that injury metrics including peak strain and injury susceptibility in the deep WM regions based on fiber strain, but not on maximum principal strain, were sensitive to the anisotropy implementation, response sampling, and region segmentation. Overall, it was recommended to use tractography for anisotropy implementation and response sampling, and to employ neuroimaging for region segmentation, because they led to more accurate injury metrics. Further refining mesh locally via submodeling was unnecessary. Brain strain responses were also parametrically found to be closer to that from minimum fiber reinforcement, consistent with the fact that the majority of WM had a rather high degree of fiber dispersion. Finally, the upgraded Worcester Head Injury Model incorporating WM anisotropy was successfully re-validated against cadaveric impacts and an in vivo head rotation (good to excellent validation with an average Correlation Analysis score of 0.437 and 0.509, respectively). These investigations may facilitate further continual development of head injury models to better study traumatic brain injury.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA	Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.	sji@wpi.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R01NS092853] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781.	Abaqus, 2016, AB ONL DOC; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bradshaw D., 2001, P 17 INT TECHN C ENH, P1; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Donnelly BR, 1983, STAPP CAR CRASH J, V27, P299; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Elkins JM, 2011, CLIN ORTHOP RELAT R, V469, P454, DOI 10.1007/s11999-010-1632-x; Feng Y, 2017, J BIOMECH, V57, P146, DOI 10.1016/j.jbiomech.2017.03.025; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garcia-Gonzalez D, 2018, J MECH PHYS SOLIDS, V112, P209, DOI 10.1016/j.jmps.2017.12.001; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gehre C., 2009, 21 ESV C STUTT; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2016, ANN BIOMED ENG, V44, P828, DOI 10.1007/s10439-015-1487-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Javid S, 2014, J MECH BEHAV BIOMED, V30, P290, DOI 10.1016/j.jmbbm.2013.11.010; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Ji SB, 2011, FINITE ELEM ANAL DES, V47, P1178, DOI 10.1016/j.finel.2011.05.007; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; King A. I., 2003, IRCOBI C LISB; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Leemans A., 2009, 17 AN M INT SOC MAGN; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Mohammadipour A, 2017, J BIOMECH, V65, P61, DOI 10.1016/j.jbiomech.2017.09.029; National Research Council I, 2014, SPORTS RELATED CONCU; Newman J A, 2000, Stapp Car Crash J, V44, P215; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Peden M., 2004, WORLD REPORT ROAD TR; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rasanen LP, 2016, COMPUT METHOD BIOMEC, V19, P1225, DOI 10.1080/10255842.2015.1124269; Rohlmann A, 2010, EUR SPINE J, V19, P1585, DOI 10.1007/s00586-010-1386-x; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2008, STAPP CAR C, V52, P1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yang King H, 2006, Stapp Car Crash J, V50, P429; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhao W, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0091; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007; Zonfrillo M., 2015, ACAD EMERG MED, V22, P872	85	16	16	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					250	263		10.1089/neu.2018.5634			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800008	29681212	Green Published			2021-06-18	
J	Zeiler, FA; Ercole, A; Cabeleira, M; Carbonara, M; Stocchetti, N; Menon, DK; Smielewski, P; Czosnyka, M; Anke, A; Beer, R; Bellander, BM; Buki, A; Chevallard, G; Chieregato, A; Citerio, G; Czeiter, E; Depreitere, B; Eapen, G; Frisvold, S; Helbok, R; Jankowski, S; Kondziella, D; Koskinen, LO; Meyfroidt, G; Moeller, K; Nelson, D; Piippo-Karjalainen, A; Radoi, A; Ragauskas, A; Raj, R; Rhodes, J; Rocka, S; Rossaint, R; Sahuquillo, J; Sakowitz, O; Stevanovic, A; Sundstrom, N; Takala, R; Tamosuitis, T; Tenovuo, O; Vajkoczy, P; Vargiolu, A; Vilcinis, R; Wolf, S; Younsi, A				Zeiler, Frederick A.; Ercole, Ari; Cabeleira, Manuel; Carbonara, Marco; Stocchetti, Nino; Menon, David K.; Smielewski, Peter; Czosnyka, Marek; Anke, Audny; Beer, Ronny; Bellander, Bo-Michael; Buki, Andras; Chevallard, Giorgio; Chieregato, Arturo; Citerio, Giuseppe; Czeiter, Endre; Depreitere, Bart; Eapen, George; Frisvold, Shirin; Helbok, Raimund; Jankowski, Stefan; Kondziella, Daniel; Koskinen, Lars-Owe; Meyfroidt, Geert; Moeller, Kirsten; Nelson, David; Piippo-Karjalainen, Anna; Radoi, Andreea; Ragauskas, Arminas; Raj, Rahul; Rhodes, Jonathan; Rocka, Saulius; Rossaint, Rolf; Sahuquillo, Juan; Sakowitz, Oliver; Stevanovic, Ana; Sundstrom, Nina; Takala, Riikka; Tamosuitis, Tomas; Tenovuo, Olli; Vajkoczy, Peter; Vargiolu, Alessia; Vilcinis, Rimantas; Wolf, Stefan; Younsi, Alexander		CENTER-TBI High Resolution HR ICU	Comparison of Performance of Different Optimal Cerebral Perfusion Pressure Parameters for Outcome Prediction in Adult Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; CPP optimum; ICP indices; outcome analysis	REACTIVITY	It has been postulated previously that individualized cerebral perfusion pressure (CPP) targets can be derived from cerebrovascular reactivity indices. Differences between real CPP and target CPP (named generically optimal CPP) has been linked to global outcome in adult traumatic brain injury (TBI). Different vascular reactivity indices can be utilized in the determination. The goal of this study is to evaluate CPPopt parameters, derived from three intracranial pressure (ICP)-derived cerebrovascular reactivity indices, and determine which one is superior for 6- to 12-month outcome prediction. Using the prospectively collected data from the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, the following indices of cerebrovascular reactivity were derived: pressure reactivity index (PRx; correlation between ICP and mean arterial pressure [MAP]), pulse amplitude index (PAx; correlation between pulse amplitude of ICP [AMP] and MAP), and RAC (correlation between AMP and CPP). CPPopt was derived using each index. Univariate logistic regression models were created to assess the association between CPPopt with global dichotomized outcome at 6 to 12 months, as assessed by Glasgow Outcome Score-Extended. Models were compared via area under the receiver operating curve (AUC) and Delong's Test. A total of 204 patients had available data. CPPopt derived from PRx, PAx, and RAC performed variably in their association with outcomes. PRx- and RAC-based CPPopt performed similarly, with RAC parameters trending towards highest AUC values. PAx-based CPPopt parameters failed to reach significant associations with dichotomized outcomes at 6 to 12 months. CPPopt parameters derived from PRx and RAC appear similar in their overall ability for 6- to 12-month outcome prediction in moderate/severe adult TBI.	[Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Univ Cambridge, Div Anesthesia, Addenbrookes Hosp, Cambridge, England; [Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Brain Phys Lab, Addenbrookes Hosp, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Clinician Investigator Program, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Carbonara, Marco] Granda Osped Maggiore Policlin, Neuro ICU Fdn IRCCS, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehab, Tromso, Norway; [Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Buki, Andras; Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, Janos Szentagothai Res Ctr, Pecs, Hungary; [Chevallard, Giorgio; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Citerio, Giuseppe; Vargiolu, Alessia] ASST Monza, NeuroIntens Care Unit, Dept Anesthesia & Intens Care, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Eapen, George; Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens Care, Tromso, Norway; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neurol, Copenhagen, Denmark; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Kondziella, Daniel; Moeller, Kirsten] Reg Hovedstaden Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Koskinen, Lars-Owe] Umea Univ Hosp, Dept Clin Neurosci, Umea, Sweden; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Nelson, David] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care mMed, Stockholm, Sweden; [Piippo-Karjalainen, Anna; Raj, Rahul] Helsinki Univ Cent Hosp, Helsinki, Finland; [Radoi, Andreea; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius] Kaunas Univ Technol, Dept Neurosurg, Vilnius, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rhodes, Jonathan] Crit Careand Pain Med NHS Lothian, Dept Anaesthesia, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rossaint, Rolf; Stevanovic, Ana] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Sakowitz, Oliver] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Sundstrom, Nina] Umea Univ Hosp, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Takala, Riikka] Turku Univ Cent Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka; Tenovuo, Olli] Univ Turku, Turku, Finland; [Tamosuitis, Tomas] Kaunas Univ Hlth Sci, Neurointens Care Unit, Kaunas, Lithuania; [Tenovuo, Olli] Turku Univ Cent Hosp, Rehabil & Brain Trauma, Turku, Finland; [Vajkoczy, Peter] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Vilcinis, Rimantas] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Wolf, Stefan] Charite Univ Med Berlin, Interdisciplinary Neuro Intens Care Unit, Berlin, Germany	Zeiler, FA (corresponding author), Univ Manitoba, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Younsi, Alexander/AAW-7869-2020; Raj, Rahul/K-7693-2012; Citerio, Giuseppe/B-1839-2015; Carbonara, Marco/N-3793-2015; Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Depreitere, Bart/AAA-9846-2020; Radoi, Andreea/N-5613-2019; Helbok, Raimund/AAA-8361-2021; Koskinen, Lars-Owe/AAQ-8957-2020; Moller, Kirsten/A-4751-2009	Younsi, Alexander/0000-0002-8218-9243; Raj, Rahul/0000-0003-4243-9591; Citerio, Giuseppe/0000-0002-5374-3161; Carbonara, Marco/0000-0002-1431-8322; Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Depreitere, Bart/0000-0002-7458-0648; Radoi, Andreea/0000-0002-0677-3544; Zeiler, Frederick/0000-0003-1737-0510; Moller, Kirsten/0000-0003-3058-1072	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra Life-Sciences Corporation (USA); NIHRNational Institute for Health Research (NIHR); Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust; NIHR Clinical Research network; Cambridge Commonwealth Trust Scholarship	This study was supported by The European Union seventh Framework Program (grant 602150) for Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI). Additional funding was obtained from Hannelore Kohl Stiftung (Germany), OneMind (USA), and Integra Life-Sciences Corporation (USA).; DKM also was supported by funding from the NIHR through a Senior Investigator award and the Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust. The study also received additional support from the NIHR Clinical Research network.; FAZ has received salary support for dedicated research time, during which this project was completed. Such salary support came from the Cambridge Commonwealth Trust Scholarship, the University of Manitoba Clinician Investigator Program, and the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2018, ACTA NEUROCHIR SUPPL, V126, P209, DOI 10.1007/978-3-319-65798-1_43; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Howells T, 2018, CRIT CARE MED, V46, pe235, DOI 10.1097/CCM.0000000000002930; LASSEN NA, 1959, PHYSIOL REV, V39, P183; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Thiara S, 2018, CAN J NEUROL SCI, V45, P313, DOI 10.1017/cjn.2017.292; Zeiler F.A., 2018, J NEUROTRAUMA; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	15	16	16	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1505	1517		10.1089/neu.2018.6182		DEC 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000453519400001	30384809				2021-06-18	
J	Zhao, HY; Liu, Y; Zeng, J; Li, DD; Huang, YH				Zhao, Hongyi; Liu, Yu; Zeng, Jing; Li, Dandan; Huang, Yonghua			Troxerutin cerebroprotein hydrolysate injection ameliorates neurovascular injury induced by traumatic brain injury - via endothelial nitric oxide synthase pathway regulation	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Endothelial nitric oxide synthase; neurovascular unit; traumatic brain injury; troxerutin	INDUCED COGNITIVE DEFICITS; NEURAL APOPTOSIS; OXIDATIVE DAMAGE; MEMORY DEFICITS; RUTIN; UNIT; DYSFUNCTION; STRESS; MODEL; MITOCHONDRIA	Background: Neurovascular dysfunction caused by traumatic brain injury (TBI) is characterized by cerebralvascular damage, blood-brain barrier (BBB) breakdown, brain edema, etc. This study was designed to assess the protective role of 5 days troxerutin cerebroprotein hydrolysate (TCH) injection treatment against TBI, as well as the potential mechanism. Methods: The weight-drop model of TBI in male Sprague-Dawley rats was chosen to induce TBI model, rats either with TCH or a vehicle via intraperitoneal injection were examined 3 days after TBI. Results: TCH resulted in alleviation of neurological deficits, reduction of infarct volume, improvement of regional cerebral blood flow (rCBF), amelioration of neuronal death, astrocyte proliferation, endothelial cell loss, and BBB dysintegrity. These effects of TCH treatment against TBI were through endothelial nitric oxide synthase (eNOS) coupling/decoupling status adjustment, which not only increased nitric oxide (NO) level, but also decreased peroxynitrate level expression. Conclusions: All the results indicated that TCH injection has multifaceted protective effects of neurovascular unit (NVU) against TBI via eNOS pathway regulation.	[Zhao, Hongyi; Zeng, Jing; Li, Dandan; Huang, Yonghua] Army Gen Hosp PLA, Dept Neurol, 5 Nanmencang Dongsishitiao St, Beijing 100700, Peoples R China; [Zhao, Hongyi; Liu, Yu] 261 Hosp PLA, Dept Neurol, Beijing, Peoples R China	Huang, YH (corresponding author), Army Gen Hosp PLA, Dept Neurol, 5 Nanmencang Dongsishitiao St, Beijing 100700, Peoples R China.	huangyonghua2017@126.com					Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Dong SY, 2013, NEURAL REGEN RES, V8, P3193, DOI 10.3969/j.issn.1673-5374.2013.34.003; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Feeney DM, 2011, BRAIN RES, V211, P66; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gu XH, 2016, BEHAV BRAIN RES, V311, P309, DOI 10.1016/j.bbr.2016.05.052; Gupta R, 2003, PHARMACOL RES, V48, P209, DOI 10.1016/S1043-6618(03)00102-6; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Jang JW, 2014, J NEUROL SCI, V339, P75, DOI 10.1016/j.jns.2014.01.024; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim H, 2005, PHARM RES-DORDR, V22, P1499, DOI 10.1007/s11095-005-6250-z; Kumar A, 2014, J SURG RES, V188, P268, DOI 10.1016/j.jss.2013.12.028; Lan R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/459467; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Lu J, 2013, J IMMUNOL, V190, P3466, DOI 10.4049/jimmunol.1202862; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Machawal L, 2014, PHARMACOL REP, V66, P15, DOI 10.1016/j.pharep.2013.08.001; Mellou F, 2006, PROCESS BIOCHEM, V41, P2029, DOI 10.1016/j.procbio.2006.05.002; Meng XE, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016933; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Ugusman A, 2014, SCI WORLD J, DOI 10.1155/2014/169370; Voigt C, 2012, NEUROPATH APPL NEURO, V38, P354, DOI 10.1111/j.1365-2990.2011.01211.x; Wang XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091476; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhai XF, 2016, NEUROIMMUNOMODULAT, V23, P179, DOI 10.1159/000448716; Zhang J, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1184-z; Zhao HY, 2016, NEUROREPORT, V27, P916, DOI 10.1097/WNR.0000000000000631; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhu W, 2008, NEUROCHEM INT, V52, P1086, DOI 10.1016/j.neuint.2007.11.005; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	42	16	17	3	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	DEC 2	2018	128	12					1118	1127		10.1080/00207454.2018.1486828			10	Neurosciences	Neurosciences & Neurology	HL2UL	WOS:000458562800003	29883225				2021-06-18	
J	Jahan-Abad, AJ; Negah, SS; Ravandi, HH; Ghasemi, S; Borhani-Haghighi, M; Stummer, W; Gorji, A; Ghadiri, MK				Jahan-Abad, Ali Jahanbazi; Negah, Sajad Sahab; Ravandi, Hassan Hosseini; Ghasemi, Sedigheh; Borhani-Haghighi, Maryam; Stummer, Walter; Gorji, Ali; Ghadiri, Maryam Khaleghi			Human Neural Stem/Progenitor Cells Derived From Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats	MOLECULAR NEUROBIOLOGY			English	Article						Tissue engineering; Human neural stem cells; Traumatic brain injury; Epilepsy; Inflammation	ADULT HUMAN BRAIN; MESENCHYMAL STEM-CELLS; TEMPORAL-LOBE EPILEPSY; MARROW STROMAL CELLS; PROGENITOR CELLS; IN-VITRO; NEURONAL DIFFERENTIATION; PRECURSOR CELLS; SUBVENTRICULAR ZONE; TRANSPLANTATION	Traumatic brain injury (TBI) is a disruption in the brain functions following a head trauma. Cell therapy may provide a promising treatment for TBI. Among different cell types, human neural stem cells cultured in self-assembling peptide scaffolds have been suggested as a potential novel method for cell replacement treatment after TBI. In the present study, we accessed the effects of human neural stem/progenitor cells (hNS/PCs) derived from epileptic human brain and human adipose-derived stromal/stem cells (hADSCs) seeded in PuraMatrix hydrogel (PM) on brain function after TBI in an animal model of brain injury. hNS/PCs were isolated from patients with medically intractable epilepsy undergone epilepsy surgery. hNS/PCs and hADSCs have the potential for proliferation and differentiation into both neuronal and glial lineages. Assessment of the growth characteristics of hNS/PCs and hADSCs revealed that the hNS/PCs doubling time was significantly longer and the growth rate was lower than hADSCs. Transplantation of hNS/PCs and hADSCs seeded in PM improved functional recovery, decreased lesion volume, inhibited neuroinflammation, and reduced the reactive gliosis at the injury site. The data suggest the transplantation of hNS/PCs or hADSCs cultured in PM as a promising treatment option for cell replacement therapy in TBI.	[Jahan-Abad, Ali Jahanbazi; Negah, Sajad Sahab; Ravandi, Hassan Hosseini; Ghasemi, Sedigheh; Borhani-Haghighi, Maryam; Gorji, Ali] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Jahan-Abad, Ali Jahanbazi] Shahid Beheshti Univ Med Sci, Dept Clin Biochem, Tehran, Iran; [Negah, Sajad Sahab; Gorji, Ali] Mashhad Univ Med Sci, Dept Neurosci, Fac Med, Mashhad, Iran; [Stummer, Walter; Gorji, Ali; Ghadiri, Maryam Khaleghi] Westfalische Wilhelms Univ Munster, Dept Neurosurg, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Dept Neurol, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Robert Koch Str 45, D-48149 Munster, Germany	Gorji, A (corresponding author), Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran.; Gorji, A (corresponding author), Mashhad Univ Med Sci, Dept Neurosci, Fac Med, Mashhad, Iran.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Dept Neurosurg, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Dept Neurol, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Robert Koch Str 45, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Stummer, Walter/AAA-3319-2020; Negah, Sajad Sahab/AAQ-5852-2020; Stummer, Walter/AAF-9043-2019	Gorji, Ali/0000-0002-4557-3270; naseri, shahrokh/0000-0001-8974-2120; Jahanbazi Jahanabad, Ali/0000-0001-8629-7762	Iran National Science Foundation (INSF)Iran National Science Foundation (INSF); National Institute for Medical Research Development; German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch Dienst (DAAD) [57348208, 57403633]	This study was supported by the Iran National Science Foundation (INSF), the National Institute for Medical Research Development, and the German Academic Exchange Service (DAAD; 57348208 and 57403633) to AG.	Abraham R, 2012, PROG BRAIN RES, V201, P17, DOI 10.1016/B978-0-444-59544-7.00002-0; Aligholi H, 2016, BRAIN RES, V1642, P197, DOI 10.1016/j.brainres.2016.03.043; Aligholi H, 2014, J NEUROSCI METH, V225, P81, DOI 10.1016/j.jneumeth.2013.12.008; Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI 10.1227/01.NEU.0000311081.50648.4C; Azevedo-Pereira RL, 2010, ARQ NEURO-PSIQUIAT, V68, P956, DOI 10.1590/S0004-282X2010000600023; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Cavalcanti BN, 2013, DENT MATER, V29, P97, DOI 10.1016/j.dental.2012.08.002; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Coulthard LG, 2017, J NEUROSCI, V37, P5395, DOI 10.1523/JNEUROSCI.0525-17.2017; Covacu R, 2017, NEUROSCIENTIST, V23, P27, DOI 10.1177/1073858415616559; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Dobrowolski S. a. G. L, 2013, AM J NEUROSCIENCE, P13, DOI DOI 10.3844/AMJNSP.2013.13.24; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Francis NL, 2016, ACS BIOMATER SCI ENG, V2, P1030, DOI 10.1021/acsbiomaterials.6b00156; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Gupta K, 2013, NEUROSCI LETT, V543, P95, DOI 10.1016/j.neulet.2013.03.010; Hansson A, 2017, TISSUE CELL, V49, P35, DOI 10.1016/j.tice.2016.12.004; Hunt RF, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022376; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P4225, DOI 10.1007/s12035-017-0642-z; Jahanbazi Jahan-Abad A, 2017, AVICENNA J PHYTOMED, P1; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Joo KM, 2013, EXP NEUROL, V240, P168, DOI 10.1016/j.expneurol.2012.11.021; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kizil C, 2015, EMBO REP, V16, P416, DOI 10.15252/embr.201439702; Knight VB, 2017, PEERJ, V5, DOI 10.7717/peerj.2829; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Li X., 2017, J BIOMEDICAL MAT R A, V106, P1082; Liedmann A, 2012, BIORESEARCH OPEN ACC, V1, P16, DOI 10.1089/biores.2012.0209; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120; Nam H, 2015, WORLD J STEM CELLS, V7, P126, DOI 10.4252/wjsc.v7.i1.126; Negah SS, 2018, CELL TISSUE RES, V371, P223, DOI 10.1007/s00441-017-2717-6; Negah SS, 2017, MOL NEUROBIOL, V54, P8050, DOI 10.1007/s12035-016-0295-3; Negah SS, 2016, IRAN J BASIC MED SCI, V19, P1271, DOI 10.22038/ijbms.2016.7907; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Olstorn H, 2007, NEUROSURGERY, V60, P1089, DOI 10.1227/01.NEU.0000255461.91892.0D; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pincus D W, 1997, Clin Neurosurg, V44, P17; Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shetty AK, 2011, NEUROTHERAPEUTICS, V8, P721, DOI 10.1007/s13311-011-0064-y; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Sun D, 2016, NEURAL REGEN RES, V11, P18, DOI 10.4103/1673-5374.169605; Takei J, 2006, AATEX, V11, P170, DOI DOI 10.11232/aatex.11.170; Tang CK, 2009, INT J MOL SCI, V10, P2136, DOI 10.3390/ijms10052136; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Varghese M, 2008, NEUROSURGERY, V63, P1022, DOI 10.1227/01.NEU.0000335792.85142.B0; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Weick JP, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4190438; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu HM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3656193; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yang LQ, 2011, NEUROREPORT, V22, P370, DOI 10.1097/WNR.0b013e3283469615; Zhang L, 2017, NEURAL REGEN RES, V12, P1103, DOI 10.4103/1673-5374.211189; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang S, 2005, TISSUE ENG, P217; Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhao YN, 2009, TISSUE ENG PT A, V15, P13, DOI 10.1089/ten.tea.2008.0039; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958; Zhou FW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120281	78	16	17	1	27	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2018	55	12					9122	9138		10.1007/s12035-018-1050-8			17	Neurosciences	Neurosciences & Neurology	GY3VF	WOS:000448483400026	29651746				2021-06-18	
J	Madathil, SK; Wilfred, BS; Urankar, SE; Yang, WH; Leung, LY; Gilsdorf, JS; Shear, DA				Madathil, Sindhu K.; Wilfred, Bernard S.; Urankar, Sarah E.; Yang, Weihong; Leung, Lai Yee; Gilsdorf, Janice S.; Shear, Deborah A.			Early Microglial Activation Following Closed-Head Concussive Injury Is Dominated by Pro-Inflammatory M-1 Type	FRONTIERS IN NEUROLOGY			English	Article						microglia; inflammation; polarization; concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; NEURODEGENERATION; FOOTBALL; STATES; MODEL; MICE; NEUROINFLAMMATION; NEUROPROTECTION; ENCEPHALOPATHY	Microglial activation is a pathological hallmark of traumatic brain injury (TBI) Following brain injury, activated microglia/macrophages adopt different phenotypes, generally categorized as M-1, or classically activated, and M-2, or alternatively activated. While the M-1, or pro-inflammatory phenotype is detrimental to recovery, M-2, or the anti-inflammatory phenotype, aids in brain repair. Recent findings also suggest the existence of mixed phenotype following brain injury, where activated microglia simultaneously express both M-1 and M-2 markers. The present study sought to determine microglial activation states at early time points (6-72h) following single or repeated concussive injury in rats. Closed-head concussive injury was modeled in rats using projectile concussive impact injury, with either single or repeated impacts (4 impacts, 1 h apart). Brain samples were examined using immunohistochemical staining, inflammatory gene profiling and real-time polymerase chain reaction analyses to detect concussive injury induced changes in microglial activation and phenotype in cortex and hippocampal regions. Our findings demonstrate robust microglial activation following concussive brain injury. Moreover, we show that multiple concussions induced a unique rod-shaped microglial morphology that was also observed in other diffuse brain injury models. Histological studies revealed a predominance of MHC-Il positive M-1 phenotype in the post-concussive microglial milieu following multiple impacts. Although there was simultaneous expression of M-1 and M-2 markers, gene expression results indicate a clear dominance in M-1 pro-inflammatory markers following both single and repeated concussions. While the increase in M-1 markers quickly resolved after a single concussion, they persisted following repeated concussions, indicating a pro-inflammatory environment induced by multiple concussions that may delay recovery and contribute to long-lasting consequences of concussion.	[Madathil, Sindhu K.; Wilfred, Bernard S.; Urankar, Sarah E.; Yang, Weihong; Leung, Lai Yee; Gilsdorf, Janice S.; Shear, Deborah A.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Leung, Lai Yee] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA	Madathil, SK (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	Sindhu.kizhakkemadathil.ctr@mail.mil	Madathil, Sindhu K/E-9407-2012; Wilfred, Bernard Srambical/AAC-8221-2020	Wilfred, Bernard Srambical/0000-0002-0674-0187	Combat Casualty Care Research ProgramUnited States Department of Defense [H_026_2014]; U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Programs [W81XWH-12-2-0134]	This research is funded by Combat Casualty Care Research Program (H_026_2014,) and U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Programs (W81XWH-12-2-0134). We thank Dr. Xi-Chun Lu and Ms. Savannah Barannikov for critical reading of the manuscript.	Ansari MA, 2015, J NEUROL SCI, V357, P41, DOI 10.1016/j.jns.2015.06.062; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bell-Temin H, 2015, MOL CELL PROTEOMICS, V14, P3173, DOI 10.1074/mcp.M115.053926; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Bugno M, 1999, FEBS LETT, V448, P9, DOI 10.1016/S0014-5793(99)00323-3; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen ZY, 2012, J NEUROTRAUM, V29, P268, DOI 10.1089/neu.2011.2057; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Gao M, 2017, BRAIN BEHAV IMMUN, V59, P288, DOI 10.1016/j.bbi.2016.09.020; Gao TL, 2018, BIOCHEM BIOPH RES CO, V497, P430, DOI 10.1016/j.bbrc.2018.02.102; Goldstein L.E., 2012, SCI TRANSL MED, V4; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heneka MT, 2001, J NEUROIMMUNOL, V114, P8, DOI 10.1016/S0165-5728(01)00246-6; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lange PS, 2004, J NUTR, V134, p2812S, DOI 10.1093/jn/134.10.2812S; Leung LY, 2014, ANN BIOMED ENG, V42, P1618, DOI 10.1007/s10439-014-1014-8; Li YN, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0657-4; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McPherson CA, 2014, NEUROTOX RES, V25, P45, DOI 10.1007/s12640-013-9422-3; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Potts Mathew B, 2006, NeuroRx, V3, P143; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang B, 2018, CEREBELLUM, V17, P477, DOI 10.1007/s12311-018-0934-5; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; XU X, 2017, J NEUROINFLAMM, V14; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	61	16	16	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 15	2018	9								964	10.3389/fneur.2018.00964			14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	HA4QJ	WOS:000450247500001	30498469	DOAJ Gold, Green Published			2021-06-18	
J	Bianchi, F; Malboubi, M; Li, YC; George, JH; Jerusalem, A; Szele, F; Thompson, MS; Ye, H				Bianchi, Fabio; Malboubi, Majid; Li, Yichen; George, Julian H.; Jerusalem, Antoine; Szele, Francis; Thompson, Mark S.; Ye, Hua			Rapid and efficient differentiation of functional motor neurons from human iPSC for neural injury modelling	STEM CELL RESEARCH			English	Article						Induced pluripotent stem cells (iPSC); Motor neuron differentiation; Electrophysiology; Neural injury	PLURIPOTENT STEM-CELLS; TRAUMATIC BRAIN-INJURY; NETWORK ACTIVITY; DIRECTED DIFFERENTIATION; PERIPHERAL-NERVES; HUMAN FIBROBLASTS; CORTICAL-NEURONS; ANIMAL-MODELS; ACUTE STRETCH; SPINAL-CORD	Primary rodent neurons and immortalised cell lines have overwhelmingly been used for in vitro studies of traumatic injury to peripheral and central neurons, but have some limitations of physiological accuracy. Motor neurons (MN) derived from human induced pluripotent stem cells (iPSCs) enable the generation of cell models with features relevant to human physiology. To facilitate this, it is desirable that MN protocols both rapidly and efficiently differentiate human iPSCs into electrophysiologically active MNs. In this study, we present a simple, rapid protocol for differentiation of human iPSCs into functional spinal (lower) MNs, involving only adherent culture and use of small molecules for directed differentiation, with the ultimate aim of rapid production of electrophysiologically functional cells for short-term neural injury experiments. We show successful differentiation in two unrelated iPSC lines, by quantifying neural-specific marker expression, and by evaluating cell functionality at different maturation stages by calcium imaging and patch clamping. Differentiated neurons were shown to be electrophysiologically altered by uniaxial mechanical deformation. Spontaneous network activity decreased with applied stretch, indicating aberrant network connectivity. These results demonstrate the feasibility of this rapid, simple protocol for differentiating iPSC-derived MNs, suitable for in vitro neural injury studies focussing on electrophysiological alterations caused by mechanical deformation or trauma.	[Bianchi, Fabio; Malboubi, Majid; George, Julian H.; Thompson, Mark S.; Ye, Hua] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX3 7DQ, England; [Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Li, Yichen; Szele, Francis] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	Ye, H (corresponding author), Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX3 7DQ, England.	hua.ye@eng.ox.ac.uk	Ye, Hua/L-5408-2019	Ye, Hua/0000-0001-7613-6041; George, Julian/0000-0002-0701-5040	China Regenerative Medicine Limited (CRMI); EPSRC DTPUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [1514540]; European Union's Seventh Framework Programme (FP7 2007-2013) ERC Grant [306587]	The authors would like to acknowledge Dr. Zameel Cader and Dr. Satyan Chintawar for kindly providing SB-AD3-1 cells through StemBANCC. Authors acknowledge China Regenerative Medicine Limited (CRMI) for funding and the EPSRC DTP award number 1514540 for F.B. funding. M.B. and A.J. acknowledge funding from the European Union's Seventh Framework Programme (FP7 2007-2013) ERC Grant Agreement No. 306587.	Abid A, 2016, ORTHOP TRAUMATOL-SUR, V102, pS125, DOI 10.1016/j.otsr.2015.05.008; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Biffi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083899; Bueno FR, 2008, TISSUE ENG PART B-RE, V14, P219, DOI 10.1089/ten.teb.2008.0020; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Clark AJ, 2017, BRAIN, V140, P898, DOI 10.1093/brain/awx012; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Faravelli I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt476; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kang WH, 2015, J NEUROTRAUM, V32, P1011, DOI 10.1089/neu.2014.3667; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kim DS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00109; Kobold S, 2015, STEM CELL REP, V4, P914, DOI 10.1016/j.stemcr.2015.03.002; Kurtoglu E., 2017, JBSE, V12; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Mann K, 2017, CURR BIOL, V27, P2389, DOI 10.1016/j.cub.2017.06.076; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Mazzara PG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14088; MILLER RG, 1987, MUSCLE NERVE, V10, P698, DOI 10.1002/mus.880100805; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Neely MD, 2012, ACS CHEM NEUROSCI, V3, P482, DOI 10.1021/cn300029t; OGATA K, 1986, J HAND SURG-BRIT EUR, V11B, P10, DOI 10.1016/0266-7681(86)90003-3; Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Rickett T, 2011, J MED SYST, V35, P787, DOI 10.1007/s10916-010-9468-1; Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0; Rostock C, 2018, NEUROSCIENCE, V387, P13, DOI 10.1016/j.neuroscience.2017.11.047; Salimi A, 2014, MOL BIOL REP, V41, P1713, DOI 10.1007/s11033-014-3020-1; Sances S, 2016, NAT NEUROSCI, V19, P542, DOI 10.1038/nn.4273; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Shimojo D, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0172-4; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Sun AX, 2016, CELL REP, V16, P1942, DOI 10.1016/j.celrep.2016.07.035; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Surmacz B, 2012, STEM CELLS, V30, P1875, DOI 10.1002/stem.1166; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Topp KS, 2006, PHYS THER, V86, P92, DOI 10.1093/ptj/86.1.92; Wang XS, 1997, BRAIN RES, V767, P239, DOI 10.1016/S0006-8993(97)00585-4; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853; Zhang PB, 2014, JOVE-J VIS EXP, DOI 10.3791/51737; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	54	16	16	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	OCT	2018	32						126	134		10.1016/j.scr.2018.09.006			9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	GW9JI	WOS:000447301200019	30278374	DOAJ Gold, Green Published			2021-06-18	
J	Hubbard, WB; Harwood, CL; Geisler, JG; Vekaria, HJ; Sullivan, PG				Hubbard, W. Brad; Harwood, Christopher L.; Geisler, John G.; Vekaria, Hemendra J.; Sullivan, Patrick G.			Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neurotrauma; novel object recognition; oxidative stress; oxygen consumption rate; therapeutics	PERMEABILITY TRANSITION; OXIDATIVE DAMAGE; MOUSE MODEL; CALCIUM; 2,4-DINITROPHENOL; DYSFUNCTION; HOMEOSTASIS; RELEASE; TRANSPORT; INCREASES	Traumatic brain injury (TBI) results in cognitive impairment, which can be long-lasting after moderate to severe TBI. Currently, there are no FDA-approved therapeutics to treat the devastating consequences of TBI and improve recovery. This study utilizes a prodrug of 2,4-dinitrophenol, MP201, a mitochondrial uncoupler with extended elimination time, that was administered after TBI to target mitochondrial dysfunction, a hallmark of TBI. Using a model of cortical impact in male C57/BL6 mice, MP201 (80 mg/kg) was provided via oral gavage 2-hr post-injury and daily afterwards. At 25-hr post-injury, mice were euthanized and the acute rescue of mitochondrial bioenergetics was assessed demonstrating a significant improvement in both the ipsilateral cortex and ipsilateral hippocampus after treatment with MP201. Additionally, oxidative markers, 4-hydroxyneneal and protein carbonyls, were reduced compared to vehicle animals after MP201 administration. At 2-weeks post-injury, mice treated with MP201 post-injury (80 mg/kg; q.d.) displayed significantly increased cortical sparing (p=.0059; 38% lesion spared) and improved cognitive outcome (p=.0133) compared to vehicle-treated mice. Additionally, vehicle-treated mice had significantly lower (p=.0019) CA3 neuron count compared to sham while MP201-treated mice were not significantly different from sham levels. These results suggest that acute mitochondrial dysfunction can be targeted to impart neuroprotection from reactive oxygen species, but chronic administration may have an added benefit in recovery. This study highlights the potential for safe, effective therapy by MP201 to alleviate negative outcomes of TBI.	[Hubbard, W. Brad; Harwood, Christopher L.; Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Coll Med, 800 Rose St,MN 150, Lexington, KY 40506 USA; [Hubbard, W. Brad; Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Geisler, John G.] Mitochon Pharmaceut Inc, Blue Bell, PA USA; [Sullivan, Patrick G.] Lexington VAMC, Lexington, KY USA	Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Coll Med, 800 Rose St,MN 150, Lexington, KY 40506 USA.	patsullivan@uky.edu	Vekaria, Hemendra/AAH-2100-2021; Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235; Vekaria, Hemendra/0000-0001-5945-5235	VA Merit AwardUS Department of Veterans Affairs [1I01BX003405-01A1]; National Science FoundationNational Science Foundation (NSF) [1539068]; NSF EPSCoR Seed [4978/111315]; NCI Cancer CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA177558]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA177558] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	VA Merit Award, Grant/Award Number: 1I01BX003405-01A1; National Science Foundation Grant No. 1539068; NSF EPSCoR Seed, Grant/Award Number: 4978/111315; NCI Cancer Center Support, Grant/Award Number: P30 CA177558	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Cutting WC, 1933, J AMER MED ASSOC, V101, P193, DOI 10.1001/jama.1933.02740280013006; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Geisler JG, 2011, DIABETOLOGIA, V54, P237, DOI 10.1007/s00125-010-1932-4; Geisler JG, 2017, ALZHEIMERS DEMENT, V13, P582, DOI 10.1016/j.jalz.2016.08.001; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Harris O., 1995, TOXICOLOGICAL PROFIL, P1; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hubbard W. B., 2018, ACUTE NEURONAL INJUR; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Jarmuszkiewicz W, 2004, ACTA BIOCHIM POL, V51, P533; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khan RS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7180632; Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Li GM, 2013, NEUROL SCI, V34, P963, DOI 10.1007/s10072-012-1173-z; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; da Costa RFM, 2010, J NEUROTRAUM, V27, P829, DOI 10.1089/neu.2009.1189; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Maragos WF, 2003, BRAIN RES, V966, P312, DOI 10.1016/S0006-8993(02)04225-7; Mattiasson G, 2004, CYTOM PART A, V62A, P89, DOI 10.1002/cyto.a.20089; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nicholls DG, 1998, BIOFACTORS, V8, P287, DOI 10.1002/biof.5520080317; Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Pivovarova NB, 2002, J NEUROSCI, V22, P10653; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Srodulski S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-30; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Stout AK, 1998, NAT NEUROSCI, V1, P366; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; TRUMP BF, 1995, FASEB J, V9, P219; Vekaria HJ, 2017, NEUROCHEM INT, V109, P117, DOI 10.1016/j.neuint.2017.04.004; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wu B, 2017, EXP NEUROL, V293, P83, DOI 10.1016/j.expneurol.2017.03.020; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	77	16	16	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2018	96	10					1677	1688		10.1002/jnr.24271			12	Neurosciences	Neurosciences & Neurology	GS8WI	WOS:000443994900005	30063076	Bronze, Green Accepted			2021-06-18	
J	Salinsky, M; Rutecki, P; Parko, K; Goy, E; Storzbach, D; O'Neil, M; Binder, L; Joos, S				Salinsky, Martin; Rutecki, Paul; Parko, Karen; Goy, Elizabeth; Storzbach, Daniel; O'Neil, Maya; Binder, Laurence; Joos, Sandra			Psychiatric comorbidity and traumatic brain injury attribution in patients with psychogenic nonepileptic or epileptic seizures: A multicenter study of US veterans	EPILEPSIA			English	Article						psychogenic seizures; PTSD; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; OUTCOMES; PTSD; IRAQ; DIAGNOSIS; SYMPTOMS; EXPOSURE; HEALTH; PNES	Objective To determine the frequency and severity of psychiatric disorders and attribution of seizures to traumatic brain injury (TBI) in veterans with verified psychogenic nonepileptic seizures (PNES) versus epileptic seizures (ES). Methods Results We studied 333 consecutive admissions to the monitoring units of three Veterans Administration epilepsy centers. All patients underwent continuous video-electroencephalographic recording to define definite PNES or ES. Evaluations included the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, 4th edition, PTSD Checklist, Beck Depression Inventory II, and Patient Seizure Etiology Questionnaire. Interviews and questionnaires were completed prior to final seizure type diagnosis and patient debriefing. The primary outcome measure was a comparison of Axis I psychiatric diagnoses in patients diagnosed with PNES versus ES. A total of 81 patients were diagnosed with PNES, and 70 with ES. PTSD was the most frequent Axis I diagnosis in veterans with PNES (64%, vs 13% of those with ES; P < 0.001). Posttraumatic stress disorder (PTSD) was common regardless of deployment to a war theater or combat exposure. Mood, substance abuse, and anxiety disorders were also more common in the PNES group. TBI was cited as a likely cause of seizures by 47% of veterans with PNES versus 25% of those with ES (P = 0.01). PTSD and attribution of seizures to TBI were found in 30% of veterans with PNES versus 3% of those with ES (P < 0.001). Significance In veterans referred for inpatient seizure evaluation, PTSD was strongly associated with a diagnosis of PNES versus ES. The association of PNES with PTSD, attribution of seizures to TBI, or both, may prompt early consideration of PNES.	[Salinsky, Martin; Goy, Elizabeth; Storzbach, Daniel; O'Neil, Maya; Joos, Sandra] VA Portland Hlth Care Syst, Portland, OR USA; [Salinsky, Martin; Binder, Laurence] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Rutecki, Paul] William S Middleton Mem Vet Affairs Med Ctr, Madison, WI USA; [Parko, Karen] San Francisco VA Med Ctr, San Francisco, CA USA	Salinsky, M (corresponding author), VA Portland Hlth Care Syst, P3ECOE, Epilepsy Ctr, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Salinsky@ohsu.edu			US Department of Veterans AffairsUS Department of Veterans Affairs [5101cx000721-04]	US Department of Veterans Affairs, Grant/Award Number: 5101cx000721-04	Annegers JF, 1996, TREATMENT EPILEPSY P, P166; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Ben-Porath Y. S., 2008, MINNESOTA MULTIPHASI; Benbadis SR, 1999, EUR NEUROL, V41, P114, DOI 10.1159/000008015; Benbadis SR, 2004, EPILEPSIA, V45, P1150, DOI 10.1111/j.0013-9580.2004.14504.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brown RJ, 2016, CLIN PSYCHOL REV, V45, P157, DOI 10.1016/j.cpr.2016.01.003; Department of Veterans Affairs Epilepsy Centers of Excellence, 2016, ANN SUMM; Diprose W, 2016, EPILEPSY BEHAV, V56, P123, DOI 10.1016/j.yebeh.2015.12.037; Dworetzky BA, 2005, EPILEPSIA, V46, P1418, DOI 10.1111/j.1528-1167.2005.13004.x; Ettinger AB, 1999, EPILEPSIA, V40, P1292, DOI 10.1111/j.1528-1157.1999.tb00860.x; Fiszman A, 2004, EPILEPSY BEHAV, V5, P818, DOI 10.1016/j.yebeh.2004.09.002; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Josephson CB, 2017, INT REV PSYCHIATR, V29, P409, DOI 10.1080/09540261.2017.1302412; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI DOI 10.1037/1040-3590.1.1.53; LaFrance WC, 2008, INT REV NEUROBIOL, V83, P347, DOI 10.1016/S0074-7742(08)00020-2; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; LaFrance WC, 2006, EPILEPSY BEHAV, V8, P451, DOI 10.1016/j.yebeh.2006.02.004; McKenzie P, 2010, NEUROLOGY, V74, P64, DOI 10.1212/WNL.0b013e3181c7da6a; Myers L, 2017, EPILEPSY BEHAV, V66, P86, DOI 10.1016/j.yebeh.2016.10.019; Myers L, 2013, EPILEPSY BEHAV, V28, P121, DOI 10.1016/j.yebeh.2013.03.033; O'Neil M.E., 2013, COMPLICATIONS MILD T; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Salinsky M, 2016, EPILEPSY BEHAV, V57, P141, DOI 10.1016/j.yebeh.2016.02.003; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Salinsky M, 2012, EPILEPSY BEHAV, V25, P345, DOI 10.1016/j.yebeh.2012.07.013; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; SCHLENGER WE, 1992, J TRAUMA STRESS, V5, P333, DOI 10.1002/jts.2490050303; Sharpe D, 2006, CLIN PSYCHOL REV, V26, P1020, DOI 10.1016/j.cpr.2005.11.011; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh TN, 2004, TOMM TESTS MEMORY MA; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	40	16	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	OCT	2018	59	10					1945	1953		10.1111/epi.14542			9	Clinical Neurology	Neurosciences & Neurology	GZ5TO	WOS:000449491800011	30144027				2021-06-18	
J	DiStefano, LJ; Dann, CL; Chang, CJ; Putukian, M; Pierpoint, LA; Currie, DW; Knowles, SB; Wasserman, EB; Dompier, TP; Comstock, RD; Marshall, SW; Kerr, ZY				DiStefano, Lindsay J.; Dann, Catie L.; Chang, Cindy J.; Putukian, Margot; Pierpoint, Lauren A.; Currie, Dustin W.; Knowles, Sarah B.; Wasserman, Erin B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.; Kerr, Zachary Y.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Girls' Soccer (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Women's Soccer (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						female athletes; lower extremity injuries; concussions	CRUCIATE LIGAMENT INJURY; RANDOMIZED-CONTROLLED-TRIAL; FEMALE SOCCER; PREVENTION PROGRAMS; TRAINING-PROGRAM; RISK REDUCTION; WARM-UP; PLAYERS; RECONSTRUCTION; METAANALYSIS	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of girls' and women's soccer injury data. Objective: To describe the epidemiology of injuries sustained in high school girls' soccer in the 2005-2006 through 2013-2014 academic years and collegiate women's soccer in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from soccer teams in high school girls (annual average = 100) and collegiate women (annual average = 52). Patients or Other Participants: Female high school and collegiate soccer players who participated in practices or competitions during the 2004-2005 through 2013-2014 academic years. Main Outcome Measure(s): Athletic trainers collected timeloss (>= 24 hours) injury and exposure data. Injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (CIs), injury proportions by body site, and diagnoses were calculated. Results: The High School Reporting Information Online system documented 3242 time-loss injuries during 1 393 753 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 5092 time-loss injuries during 772 048 AEs. Injury rates were higher in college than in high school (6.60 versus 2.33/1000 AEs; IRR = 2.84; 95% CI = 2.71, 2.96), and during competitions than during practices in high school (IRR = 4.88; 95% CI = 4.54, 5.26) and college (IRR = 2.93; 95% CI = 2.77, 3.10). Most injuries at both levels affected the lower extremity and were ligament sprains or muscle/tendon strains. Concussions accounted for 24.5% of competition injuries in high school but 14.6% of competition injuries in college. More than one-third of competition injuries to high school goalkeepers were concussions. Conclusions: Injury rates were higher in college versus high school and during competitions versus practices. These differences may be attributable to differences in reporting, activity intensity, and game-play skill level. The high incidence of lower extremity injuries and concussions in girls' and women's soccer, particularly concussions in high school goalkeepers, merits further exploration and identification of prevention strategies.	[DiStefano, Lindsay J.] Univ Connecticut, Dept Kinesiol, Storrs, CT USA; [Dann, Catie L.] Univ Connecticut, Athlet Dept, Storrs, CT USA; [Chang, Cindy J.] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA; [Chang, Cindy J.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Putukian, Margot] Princeton Univ, Univ Hlth Serv, Princeton, NJ 08544 USA; [Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado Anschutz, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Marshall, Stephen W.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.; Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA	Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025754] Funding Source: NIH RePORTER	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention. The ISP was funded by the NCAA. Funding for HS RIO was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. We also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely our responsibility and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Al Attar WSA, 2017, SPORTS MED, V47, P907, DOI 10.1007/s40279-016-0638-2; [Anonymous], 2014 15 NCAA SPORTS; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Dick R, 2007, J ATHL TRAINING, V42, P278; Faude O, 2006, BRIT J SPORT MED, V40, P785, DOI 10.1136/bjsm.2006.027540; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Goode AP, 2015, BRIT J SPORT MED, V49, P349, DOI 10.1136/bjsports-2014-093466; Grooms DR, 2013, J ATHL TRAINING, V48, P782, DOI 10.4085/1062-6050-48.4.08; Herzog MM, 2017, JAMA PEDIATR, V171, P808, DOI 10.1001/jamapediatrics.2017.0740; Hickey J, 2014, BRIT J SPORT MED, V48, P729, DOI 10.1136/bjsports-2013-092884; Hootman JM, 2002, MED SCI SPORT EXER, V34, P838, DOI 10.1097/00005768-200205000-00017; Joy EA, 2013, J STRENGTH COND RES, V27, P2263, DOI 10.1519/JSC.0b013e31827ef12e; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kreck C, STATES ADDRESS CONCE; Kucera KL, 2011, J ATHL TRAINING, V46, P489; LaBella CR, 2011, ARCH PEDIAT ADOL MED, V165, P1033, DOI 10.1001/archpediatrics.2011.168; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Luc B, 2014, J ATHL TRAINING, V49, P806, DOI 10.4085/1062-6050-49.3.35; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; National Collegiate Athletic Association, STUD ATHL PART 1981; Norcross MF, 2016, J SCI MED SPORT, V19, P299, DOI 10.1016/j.jsams.2015.03.009; Participation statistics, 2016, PART STAT; Paterno MV, 2012, CLIN J SPORT MED, V22, P116, DOI 10.1097/JSM.0b013e318246ef9e; Peterson L, 2000, AM J SPORT MED, V28, pS51; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Shelbourne KD, 2009, AM J SPORT MED, V37, P246, DOI 10.1177/0363546508325665; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Sugimoto D, 2012, J ATHL TRAINING, V47, P714, DOI 10.4085/1062-6050-47.6.10; Sugimoto D, 2012, BRIT J SPORT MED, V46, P979, DOI 10.1136/bjsports-2011-090895; Tyler TF, 2001, AM J SPORT MED, V29, P124, DOI 10.1177/03635465010290020301; United States Census Bureau, CENS REG US; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Walden M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3042; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	42	16	16	0	12	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2018	53	9					880	892		10.4085/1062-6050-156-17			13	Sport Sciences	Sport Sciences	GY4NU	WOS:000448540500008	30372637	Green Published, Bronze			2021-06-18	
J	Wang, L; Zhao, CF; Wu, S; Xiao, GH; Xin, ZG; Lei, P; Xie, KL				Wang, Lu; Zhao, Chongfa; Wu, Shuang; Xiao, Guanghui; Xin Zhuge; Lei, Ping; Xie, Keliang			HYDROGEN GAS TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME AFTER TRAUMATIC BRAIN INJURY VIA INCREASING MIR-21 EXPRESSION	SHOCK			English	Article						Hydrogen gas (H-2); miR-21; neurological outcome; oxidative stress; traumatic brain injury (TBI)	MICRORNA EXPRESSION; RICH SALINE; IN-VITRO; MICE; IMPACT; DAMAGE; RATS; CORTEX; MODEL	Hydrogen gas (H-2) exerts a beneficial effect against traumatic brain injury (TBI). microRNA-21 (miR-21) is one of the most highly expressed members of small non-coding microRNA family in mammalian cells. miR-21 can improve the neurological outcome after TBI. In the present study, we investigated whether H-2 treatment could improve the neurological outcome after TBI via increasing miR-21 expression. TBI was induced by controlled cortical impact in rats. H-2 treatment was given by exposure to 2% H-2 from 30 min to 5 h after TBI operation. Here, we found that H-2 treatment significantly increased the expression of miR-21 in brain from 6 h to 3 d after TBI. The level of miR-21 expression in brain was significantly decreased after intracerebroventricular infusion of miR-21 antagomir in TBI-challenged rats with or without H-2 treatment. Moreover, we found that H-2 treatment conferred a better neurological outcome after TBI by improving neurological dysfunction, alleviating brain edema as well as decreasing lesion volume and blood-brain barrier permeability, which were significantly prevented by miR-21 antagomir. Furthermore, intracerebroventricular infusion of miR-21 agomir increased the level of miR-21 expression and decreased the lesion volume after TBI. In addition, H-2 treatment decreased the levels of oxidative products (malondialdehyde and 8-iso-prostaglandin F2a) and increased the activities of endogenous antioxidant enzymes (superoxide dismutase and catalase) in brain after TBI, which were prevented by miR-21 antagomir. Taken together, these data indicate that H-2 treatment improves the neurological outcome after TBI via increasing miR-21 expression.	[Wang, Lu; Xiao, Guanghui; Xin Zhuge; Lei, Ping] Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Tianjin 300052, Peoples R China; [Zhao, Chongfa] Tianjin Haihe Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Wu, Shuang] Tianjin Stomatol Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Xie, Keliang] Tianjin Med Univ, Dept Anesthesiol, Tianjin Inst Anesthesiol, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China	Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Tianjin 300052, Peoples R China.; Xie, KL (corresponding author), Tianjin Med Univ, Dept Anesthesiol, Tianjin Inst Anesthesiol, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	leiping1974@163.com; xiekeliang2009@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471842, 81772043]; Natural Science Foundation of Tianjin, ChinaNatural Science Foundation of Tianjin [17JCYBJC24800]	This work was supported by research grants from the National Natural Science Foundation of China (81471842, 81772043) and Natural Science Foundation of Tianjin, China (17JCYBJC24800).	Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kumar A, 2008, NEONATOLOGY, V94, P96, DOI 10.1159/000116633; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu GD, 2013, INT J OPHTHALMOL-CHI, V6, P280, DOI 10.3980/j.issn.2222-3959.2013.03.05; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Nagatani K, 2012, SHOCK, V37, P645, DOI 10.1097/SHK.0b013e31824ed57c; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sakamoto M, 2002, NEUROL RES, V24, P301, DOI 10.1179/016164102101199783; Sun L, 2014, NEUROREPORT, V25, P718, DOI 10.1097/WNR.0000000000000181; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	35	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2018	50	3					308	315		10.1097/SHK.0000000000001018			8	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	HF2AB	WOS:000454035600009	29028768	Bronze			2021-06-18	
J	Gil-Jardine, C; Evrard, G; Al Joboory, S; Saint Jammes, JT; Masson, F; Ribereau-Gayon, R; Galinski, M; Salmi, LR; Revel, P; Regis, CA; Valdenaire, G; Lagarde, E				Gil-Jardine, Cedric; Evrard, Gregoire; Al Joboory, Samantha; Saint Jammes, Juliane Tortes; Masson, Francoise; Ribereau-Gayon, Regis; Galinski, Michel; Salmi, Louis-Rachid; Revel, Philippe; Regis, Cyril Alexandre; Valdenaire, Guillaume; Lagarde, Emmanuel			Emergency room intervention to prevent post concussion-like symptoms and post-traumatic stress disorder. A pilot randomized controlled study of a brief eye movement desensitization and reprocessing intervention versus reassurance or usual care	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; PREDICTORS; IMPAIRMENT; WORKPLACE; EXPOSURE; HEALTH; TRIAL; EMDR; PAIN	Up to 20% of patients presenting at an emergency room (ER) after a stressful event will for several months suffer from very diverse long-lasting symptoms and a potentially significant decline in quality of life, often described as post concussion-like symptoms (PCLS). The objectives of our randomized open-label single-center study were to assess the feasibility of psychologist-led interventions in the context of the ER and to compare the effect of eye movement desensitization and reprocessing (EMDR) with reassurance and usual care. Conducted in the ER of Bordeaux University Hospital, the study included patients with a high risk of PCLS randomized in three groups: a 15-min reassurance session, a 60-min session of EMDR, and usual care. Main outcomes were the proportion of interventions that could be carried out and the prevalence of PCSL and post-traumatic stress disorder (PTSD) three months after the ER visit. One hundred and thirty patients with a high risk of PCLS were randomized. No logistic problem or patient refusal was observed. In the EMDR, reassurance and control groups, proportions of patients with PCLS at three months were 18%, 37% and 65% and those with PTSD were 3%, 16% and 19% respectively. The risk ratio for PCLS adjusted for the type of event (injury, non-injury) for the comparison between EMDR and control was 0.36 [95% CI 0.20-0.66]. This is the first randomized controlled trial that shows that a short EMDR intervention is feasible and potentially effective in the context of the ER. The study was registered at ClinicalTrials.gov (NCT03194386).	[Gil-Jardine, Cedric; Evrard, Gregoire; Galinski, Michel; Revel, Philippe; Valdenaire, Guillaume] Univ Hosp Bordeaux, Pole Emergency Med, F-33000 Bordeaux, France; [Gil-Jardine, Cedric; Evrard, Gregoire; Masson, Francoise; Ribereau-Gayon, Regis; Galinski, Michel; Salmi, Louis-Rachid; Revel, Philippe; Valdenaire, Guillaume; Lagarde, Emmanuel] Bordeaux Populat Hlth Res Ctr, INSERM, ISPED, Injury Epidemiol Transport Occupat Team,U1219, F-33076 Bordeaux, France; [Ribereau-Gayon, Regis] Univ Hosp Bordeaux, Pole Med, F-33000 Bordeaux, France; [Al Joboory, Samantha; Saint Jammes, Juliane Tortes; Regis, Cyril Alexandre] Hosp Ctr Cadillac, CASPERTT, 31 Rue Cavailles, F-33310 Lormont, France; [Salmi, Louis-Rachid] Univ Hosp Bordeaux, Pole Publ Hlth, F-33000 Bordeaux, France; [Masson, Francoise] Univ Hosp Bordeaux, Pole Anesthesia & Intens Care, F-33000 Bordeaux, France	Gil-Jardine, C (corresponding author), Univ Hosp Bordeaux, Pellegrin Hosp, Emergency Dept, Pl Amelie Raba Leon, F-33000 Bordeaux, France.	cedric.gil-jardine@chu-bordeaux.fr	Gil-Jardine, Cedric/T-5552-2019; Regis, RIBEREAU-GAYON/U-5423-2019; Jammes, Juliane Tortes saint/U-5420-2019; Salmi, Louis-Rachid/T-1982-2019; Lagarde, Emmanuel/F-7132-2013; VALDENAIRE, GUILLAUME/U-5426-2019	Gil-Jardine, Cedric/0000-0001-5329-6405			Absolom K, 2007, BREAST, V16, P590, DOI 10.1016/j.breast.2007.05.001; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.5555/appi.books.9780890425596.x00pre, DOI 10.5555/APPI.BOOKS.9780890425596.X00PRE]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Carrasco V, 2003, ETUDES RESULTATS, V8; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Iyadurai L, 2018, MOL PSYCHIATR, V23, P674, DOI 10.1038/mp.2017.23; Jarero I, 2011, J EMDR PRACT RES, V5, P82, DOI 10.1891/1933-3196.5.3.82; Jeffries FW, 2013, BEHAV COGN PSYCHOTH, V41, P290, DOI 10.1017/S1352465812000793; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Manners JL, 2016, J NEUROTRAUM, V33, P1796, DOI 10.1089/neu.2015.4245; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Odeen M, 2013, J OCCUP REHABIL, V23, P209, DOI 10.1007/s10926-013-9451-z; Pincus T, 2013, PAIN, V154, P2407, DOI 10.1016/j.pain.2013.07.019; Price M, 2014, J CONSULT CLIN PSYCH, V82, P336, DOI 10.1037/a0035537; Quinn G., 2013, IMPLEMENTING EMDR EA; Rose S., 2002, COCHRANE DB SYST REV, V2, pCD000560, DOI [10.1002/14651858.CD000560, DOI 10.1002/14651858.CD000560]; Sack M, 2016, PSYCHOTHER PSYCHOSOM, V85, P357, DOI 10.1159/000447671; Samara OA, 2011, SAUDI J KIDNEY DIS T, V22, P515; Schmulson MJ, 2006, J PSYCHOSOM RES, V61, P461, DOI 10.1016/j.jpsychores.2006.02.011; Shapiro E., 2013, IMPLEMENTING EMDR EA; SHAPIRO F, 1989, J BEHAV THER EXP PSY, V20, P211, DOI 10.1016/0005-7916(89)90025-6; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Solomon SD, 1997, J CLIN PSYCHIAT, V58, P5; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Tarquinio C, 2016, ISSUES MENT HEALTH N, V37, P787, DOI 10.1080/01612840.2016.1224282; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; van den Hout M.A., 2012, J EXP PSYCHOPATHOL, V3, P724, DOI [https://doi.org/10.5127/jep.028212, DOI 10.5127/JEP.028212]; Vuagnat A., 2013, PANORAMA ETABLISSEME, P11; WHO, INT CLASS DIS	38	16	16	3	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	AUG	2018	103						229	236		10.1016/j.jpsychires.2018.05.024			8	Psychiatry	Psychiatry	GM3LA	WOS:000438004900031	29894921				2021-06-18	
J	Shah, FA; Park, DJ; Koh, PO				Shah, Fawad-Ali; Park, Dong-Ju; Koh, Phil-Ok			Identification of Proteins Differentially Expressed by Quercetin Treatment in a Middle Cerebral Artery Occlusion Model: A Proteomics Approach	NEUROCHEMICAL RESEARCH			English	Article						Middle cerebral artery occlusion; Proteomics; Quercetin; Stroke	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; TERMINAL HYDROLASE; RAT-BRAIN; ISOCITRATE DEHYDROGENASES; MOLECULAR CHAPERONES; PARKINSONS-DISEASE; SIGNALING PATHWAY; GENE-EXPRESSION	Cerebral ischemia is a major cause of death and neurological disability. It also leads to severe brain tissue damage by excessive generation of oxidative stress. Quercetin is a bioflavonoid substance that acts an antioxidant agent and exerts a neuroprotective effect against cerebral ischemia. The aim of this study was to detect specific proteins that are differentially expressed in response to quercetin treatment in focal cerebral ischemia. Adult male rats were intraperitoneally injected with vehicle or quercetin (10 mg/kg) 30 min prior to right middle cerebral artery occlusion (MCAO). Brain tissues were collected 24 h after MCAO surgery and right cerebral cortices proteins were identified by two-dimensional gel electrophoresis and mass spectrometry. MCAO leads to neurological behavior disorders, infarction, and histopathological change. However, quercetin treatment alleviated MCAO-induced neuronal deficits and damages. We identified specific proteins differentially expressed between vehicle- and quercetin-treated animals. Among these detected proteins, isocitrate dehydrogenase [NAD(+)], adenosylhomocysteinase, pyruvate kinase, and ubiquitin carboxy terminal hydrolase L1 were decreased in vehicle-treated animals, while quercetin administration alleviated the MCAO-induced decreases in these proteins. However, 60 kDa heat shock protein and collapsin response mediator protein 2 were increased in the vehicle-treated animals, and quercetin treatment attenuated increases in these proteins. The expression changes in these proteins were confirmed by Western blot and reverse transcription-PCR analyses. These proteins are associated with cellular differentiation, metabolism, and oxidative stress related proteins. These results suggest that quercetin reduces ischemic injury by modulating the expression of various proteins in focal cerebral ischemia.	[Shah, Fawad-Ali; Park, Dong-Ju; Koh, Phil-Ok] Gyeongsang Natl Univ, Coll Vet Med, Res Inst Life Sci, Dept Anat, 501 Jinjudaero, Jinju 52828, South Korea	Koh, PO (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Res Inst Life Sci, Dept Anat, 501 Jinjudaero, Jinju 52828, South Korea.	pokoh@gnu.ac.kr		Shah, Fawad Ali/0000-0002-5415-2179	National Research Foundation of Korea (NRF) Grant - Korea government (MEST) [NRF-2015R1D1A1A01058270]	This research was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea government (MEST)(NRF-2015R1D1A1A01058270).	Ahmad A, 2011, NEUROCHEM RES, V36, P1360, DOI 10.1007/s11064-011-0458-6; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Andoh T, 2006, BRAIN RES, V1124, P55, DOI 10.1016/j.brainres.2006.09.085; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; BROCH OJ, 1980, J NEUROCHEM, V35, P484, DOI 10.1111/j.1471-4159.1980.tb06291.x; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Cho JY, 2006, NEUROSCI LETT, V404, P330, DOI 10.1016/j.neulet.2006.06.010; DAVIS EJ, 1969, J BIOL CHEM, V244, P161; DECKERT J, 1988, J NEUROSCI, V8, P2338; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Grubbs R, 2010, J INHERIT METAB DIS, V33, P705, DOI 10.1007/s10545-010-9171-x; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Ho L, 2013, FASEB J, V27, P769, DOI 10.1096/fj.12-212118; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Izaki K, 2001, MOL BRAIN RES, V88, P14, DOI 10.1016/S0169-328X(01)00012-2; Jang Ah-Ram, 2016, Lab Anim Res, V32, P194, DOI 10.5625/lar.2016.32.4.194; Jeon Seong-Jun, 2017, Lab Anim Res, V33, P308, DOI 10.5625/lar.2017.33.4.308; Jin ZQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0264-1; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Lindner MD, 2003, J NEUROSCI, V23, P10913; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Magalingam KB, 2015, J MOL NEUROSCI, V55, P609, DOI 10.1007/s12031-014-0400-x; Michalski D, 2009, BRAIN RES, V1303, P161, DOI 10.1016/j.brainres.2009.09.038; Minich T, 2003, J NEUROCHEM, V86, P605, DOI 10.1046/j.1471-4159.2003.01871.x; Morand C, 1998, AM J PHYSIOL-REG I, V275, pR212; Pandey AK, 2011, BRAIN RES, V1383, P289, DOI 10.1016/j.brainres.2011.01.085; Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.3.CO;2-S; Ryou MG, 2012, STROKE, V43, P1101, DOI 10.1161/STROKEAHA.111.620088; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Shamsaei N, 2017, BASIC CLIN NEUROSCI, V8, P77, DOI 10.15412/J.BCN.03080110; Shen HX, 2010, NEUROBIOL DIS, V37, P711, DOI 10.1016/j.nbd.2009.12.010; Shutenko Z, 1999, BIOCHEM PHARMACOL, V57, P199, DOI 10.1016/S0006-2952(98)00296-2; Siesjo BK, 2008, J NEUROSURG, V108, P616, DOI 10.3171/JNS/2008/108/3/0616; Sun JH, 2008, BIOCHEM BIOPH RES CO, V366, P539, DOI 10.1016/j.bbrc.2007.11.176; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Woodlee MT, 2008, EXP NEUROL, V211, P511, DOI 10.1016/j.expneurol.2008.02.024; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Yang XD, 2003, BIOCHEMISTRY-US, V42, P1900, DOI 10.1021/bi0262350; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Zanini C, 2007, J NEUROCHEM, V103, P1344, DOI 10.1111/j.1471-4159.2007.04835.x; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	55	16	19	0	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2018	43	8					1608	1623		10.1007/s11064-018-2576-x			16	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	GM9GO	WOS:000438554800012	29926355				2021-06-18	
J	Algamal, M; Ojo, JO; Lungmus, CP; Muza, P; Cammarata, C; Owens, MJ; Mouzono, BC; Diamond, DM; Mullan, M; Crawford, F				Algamal, Moustafa; Ojo, Joseph O.; Lungmus, Carlyn P.; Muza, Phillip; Cammarata, Constance; Owens, Margaret J.; Mouzono, Benoit C.; Diamond, David M.; Mullan, Michael; Crawford, Fiona			Chronic Hippocampal Abnormalities and Blunted HPA Axis in an Animal Model of Repeated Unpredictable Stress	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						PTSD; animal model; stress; HPA axis; corticosterone	TRAUMATIC BRAIN-INJURY; ELEVATED PLUS-MAZE; SOCIAL DEFEAT STRESS; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; MAJOR DEPRESSION; DISORDER; ANXIETY; VOLUME; MICE	Incidence of post-traumatic stress disorder (PTSD) ranges from 3 to 30% in individuals exposed to traumatic events, with the highest prevalence in groups exposed to combat, torture, or rape. To date, only a few FDA approved drugs are available to treat PTSD, which only offer symptomatic relief and variable efficacy. There is, therefore, an urgent need to explore new concepts regarding the biological responses causing PTSD. Animal models are an appropriate platform for conducting such studies. Herein, we examined the chronic behavioral and neurobiological effects of repeated unpredictable stress (RUS) in a mouse model. 12 weeks-old C57BL/6J male mice were exposed to a 21-day RUS paradigm consisting of exposures to a predator odor (TMT) whilst under restraint, unstable social housing, inescapable footshocks and social isolation. Validity of the model was assessed by comprehensive examination of behavioral outcomes at an acute timepoint, 3 and 6 months post-RUS; and molecular profiling was also conducted on brain and plasma samples at the acute and 6 months timepoints. Stressed mice demonstrated recall of traumatic memories, passive stress coping behavior, acute anxiety, and weight gain deficits when compared to control mice. Immunoblotting of amygdala lysates showed a dysregulation in the p75NTR/ProBDNF, and glutamatergic signaling in stressed mice at the acute timepoint. At 6 months after RUS, stressed mice had lower plasma corticosterone, reduced hippocampal CA1 volume and reduced brain-derived neurotrophic factor levels. In addition, glucocorticoid regulatory protein FKBP5 was downregulated in the hypothalamus of stressed mice at the same timepoint, together implicating an impaired hypothalamus-pituitary-adrenal-axis. Our model demonstrates chronic behavioral and neurobiological outcomes consistent with those reported in human PTSD cases and thus presents a platform through which to understand the neurobiology of stress and explore new therapeutic interventions.	[Algamal, Moustafa; Ojo, Joseph O.; Lungmus, Carlyn P.; Muza, Phillip; Cammarata, Constance; Owens, Margaret J.; Mouzono, Benoit C.; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Algamal, Moustafa; Ojo, Joseph O.; Mullan, Michael; Crawford, Fiona] Open Univ, Life Hearth & Chem Sci, Milton Keynes, Bucks, England; [Lungmus, Carlyn P.; Mouzono, Benoit C.; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Diamond, David M.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Diamond, David M.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL USA	Algamal, M (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Algamal, M (corresponding author), Open Univ, Life Hearth & Chem Sci, Milton Keynes, Bucks, England.	maigamal@roskampinstitute.net		Algamal, Moustafa/0000-0002-6215-0122	Roskamp Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH109655-0]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH109655] Funding Source: NIH RePORTER	We thank Dr. Tanja Emmerich and Dr. Laila Abdullah (Roskamp Institute) for helpful discussions. This project was funded by The Roskamp Foundation. FC is a VA research career scientist. DD was supported by NIH grant R01 MH109655-0.	Abd El Wahab MG, 2018, AM J ALZHEIMERS DIS, V33, P221, DOI 10.1177/1533317518755993; Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; American Psychiatric Association, 2013, DSM 5; Angelucci F, 2014, BRAIN COGNITION, V84, P118, DOI 10.1016/j.bandc.2013.11.012; Arndt SS, 2009, PHYSIOL BEHAV, V97, P385, DOI 10.1016/j.physbeh.2009.03.008; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Balu DT, 2018, BIOL PSYCHIAT, V83, P273, DOI 10.1016/j.biopsych.2017.08.012; Beitia G, 2005, BRAIN BEHAV IMMUN, V19, P530, DOI 10.1016/j.bbi.2004.11.002; Berridge C. W., 2009, BRAIN RES, V75, P1781; Bonne O, 2004, NEUROSCI BIOBEHAV R, V28, P65, DOI 10.1016/j.neubiorev.2003.12.001; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Brooks SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082707; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Cooper O, 2017, J ENDOCR SOC, V1, P577, DOI 10.1210/js.2017-00069; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Endres T, 2009, J EXP BIOL, V212, P2324, DOI 10.1242/jeb.028498; Flandreau E. I., 2017, CURR TOP BEHAV NEURO, DOI [10.1007/7854-2016-65, DOI 10.1007/7854-2016-65]; Fragkaki I, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.30915; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gill JM, 2009, PERSPECT PSYCHIATR C, V45, P262, DOI 10.1111/j.1744-6163.2009.00229.x; Girgenti MJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0841-3; Gold PW, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/581976; Grassi-Oliveira R, 2008, BIOL PSYCHIAT, V64, P281, DOI 10.1016/j.biopsych.2008.02.023; Griffin GD, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.26; Hall CS, 1932, U CALIFORNIA PUBLICA, V6, P1; Harris RBS, 2015, AM J PHYSIOL-REG I, V308, pR250, DOI 10.1152/ajpregu.00361.2014; Hartmann J, 2012, NEUROPHARMACOLOGY, V62, P332, DOI 10.1016/j.neuropharm.2011.07.041; Harvey BH, 2006, PHYSIOL BEHAV, V87, P881, DOI 10.1016/j.physbeh.2006.01.033; Holmes SE, 2017, P NATL ACAD SCI USA, V114, P8390, DOI 10.1073/pnas.1701749114; Hussin AT, 2012, NEUROPHARMACOLOGY, V63, P883, DOI 10.1016/j.neuropharm.2012.06.033; Janitzky K, 2015, BRAIN RES, V1599, P1, DOI 10.1016/j.brainres.2014.12.030; Ji JZ, 2008, LEARN MEMORY, V15, P244, DOI 10.1101/lm.794808; Johnson PL, 2012, PROG BRAIN RES, V198, P133, DOI 10.1016/B978-0-444-59489-1.00009-4; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kim EJ, 2015, LEARN MEMORY, V22, P411, DOI 10.1101/lm.037291.114; Koelsch S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23008; Krystal JH, 2017, BIOL PSYCHIAT, V82, pE51, DOI 10.1016/j.biopsych.2017.03.007; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Levy-Gigi E, 2013, BIOL PSYCHIAT, V74, P793, DOI 10.1016/j.biopsych.2013.05.017; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Monteiro S, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fpsyt.2015.00006, 10.3389/fpsyt.2015.0006]; Morey RA, 2016, NEUROPSYCHOPHARMACOL, V41, P791, DOI 10.1038/npp.2015.205; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Palazidou E, 2012, BRIT MED BULL, V101, P127, DOI 10.1093/bmb/lds004; Park CR, 2008, LEARN MEMORY, V15, P271, DOI 10.1101/lm.721108; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PHILLIPS C, 2017, NEURAL PLAST, DOI DOI 10.1155/2017/7260130; Roth MK, 2012, NEUROPHARMACOLOGY, V63, P1118, DOI 10.1016/j.neuropharm.2012.07.034; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Schneider P, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00043; Schoner J, 2017, J CELL MOL MED, V21, P2248, DOI 10.1111/jcmm.13161; Schoenfeld TJ, 2017, BIOL PSYCHIAT, V82, P914, DOI 10.1016/j.biopsych.2017.05.013; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Strohle A, 2008, J PSYCHIATR RES, V42, P1185, DOI 10.1016/j.jpsychires.2008.01.015; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang ZW, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00222; Whitaker AM, 2014, BEHAV PHARMACOL, V25, P398, DOI 10.1097/FBP.0000000000000069; Yasmin F, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13002; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Young KA, 2015, NEUROBIOL STRESS, V2, P67, DOI 10.1016/j.ynstr.2015.07.002; Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184; Zhou JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094075; Zoladz PR, 2015, PHYSIOL BEHAV, V147, P183, DOI 10.1016/j.physbeh.2015.04.032; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	82	16	16	2	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUL 20	2018	12								150	10.3389/fnbeh.2018.00150			16	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	GN8EU	WOS:000439392100001	30079015	DOAJ Gold, Green Published			2021-06-18	
J	Wardlaw, C; Hicks, AJ; Sherer, M; Ponsford, JL				Wardlaw, Carla; Hicks, Amelia J.; Sherer, Mark; Ponsford, Jennie L.			Psychological Resilience Is Associated With Participation Outcomes Following Mild to Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; TBI; resilience; participation; depression; anxiety	VERBAL-LEARNING TEST; QUALITY-OF-LIFE; 1ST 5 YEARS; PSYCHIATRIC-DISORDERS; COMMUNITY INTEGRATION; POSTTRAUMATIC AMNESIA; CLINICAL UTILITY; HOSPITAL ANXIETY; TBI-QOL; AXIS-I	Traumatic brain injury (TBI) causes physical and cognitive-behavioral impairments that reduce participation in employment, leisure, and social relationships. Demographic and injury-related factors account for a small proportion of variance in participation post-injury. Personal factors such as resilience may also impact outcomes. This study aimed to examine the association of resilience alongside demographic, injury-related, cognitive, emotional, and family factors with participation following TBI. It was hypothesized that resilience would make an independent contribution to participation outcomes after TBI. Participants included 245 individuals with mild-severe TBI [M-age = 44.41, SDage = 16.09; post traumatic amnesia (PTA) duration M 24.95 days, SD 45.99] who completed the Participation Assessment with Recombined Tools-Objective (PART-O), TBI Quality of Life Resilience scale, Family Assessment Device General Functioning Scale, Rey Auditory Verbal Learning Test, National Adult Reading Test, and Hospital Anxiety and Depression Scale an average 4.63 years post-injury (SD 3.02, R 0.5-13). Multiple regression analyses were used to examine predictors of PART-O scores as the participation measure. Variables in the model accounted for a significant 38% of the variability in participation outcomes, F-(13,F- 211) = 9.93, p < 0.05, R-2 = 0.38, adjusted R-2 = 0.34. Resilience was a significant predictor of higher participation, along with shorter PTA duration, more years since injury, higher education and IQ, and younger age. Mediation analyses revealed depression mediated the relationship between resilience and participation. As greater resilience may protect against depression and enhance participation this may be a focus of intervention.	[Wardlaw, Carla; Hicks, Amelia J.; Ponsford, Jennie L.] Monash Univ, Monash Epworth Rehabil Res Ctr, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA	Hicks, AJ (corresponding author), Monash Univ, Monash Epworth Rehabil Res Ctr, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.	amelia.hicks@monash.edu	Hicks, Amelia/AAQ-7743-2020	Hicks, Amelia/0000-0002-1152-0576	Institute for Safety, Compensation and Recovery Research	This work was supported by the Institute for Safety, Compensation and Recovery Research.	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN, P55; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bonanno GA, 2008, HEALTH PSYCHOL, V27, P659, DOI 10.1037/0278-6133.27.5.659; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CALLAHAN CD, 1994, J CLIN PSYCHOL MED S, V1, P261, DOI 10.1007/BF01989627; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cook R.D., 1982, RESIDUALS INFLUENCE; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Erler K, 2016, ARCH PHYS MED REHAB, V97, pe16, DOI [10.1016/j.apmr.2016.09.042, DOI 10.1016/J.APMR.2016.09.042]; Field A., 2013, DISCOVERING STAT USI, V4; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; GEFFEN GM, 1994, ARCH CLIN NEUROPSYCH, V9, P303, DOI 10.1016/0887-6177(94)90018-3; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hayes A., 2016, PROCESS V2 16; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Jose P., 2013, DOING STAT MEDIATION; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; MacDonald RR, 2002, BRIT J MATH STAT PSY, V55, P193; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; National Institute of Neurological Disorders and Stroke, 2017, COMM DAT EL TBI; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Nightingale EJ, 2007, BRAIN IMPAIR, V8, P101, DOI [10.1375/brim.8.2.101, DOI 10.1375/BRIM.8.2.101]; Parent MC, 2013, COUNS PSYCHOL, V41, P568, DOI 10.1177/0011000012445176; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Ridenour TA, 1999, FAM PROCESS, V38, P497, DOI 10.1111/j.1545-5300.1999.00497.x; Robottom BJ, 2012, PARKINSONISM RELAT D, V18, P174, DOI 10.1016/j.parkreldis.2011.09.021; Ruddle JA., 2011, SOCIAL CARE NEURODIS, V2, P200, DOI [10.1108/20420911111188452, DOI 10.1108/20420911111188452]; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Schipper K, 2011, BRAIN INJURY, V25, P832, DOI 10.3109/02699052.2011.589796; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schonberger M, 2007, PREDICTION EMPLOYMEN; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Senathi-Raja D, 2009, J REHABIL MED, V41, P666, DOI 10.2340/16501977-0396; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, pE17, DOI 10.1097/HTR.0000000000000290; Shin JI, 2012, ANN REHABIL MED-ARM, V36, P815, DOI 10.5535/arm.2012.36.6.815; Sigurdardottir S, 2014, BRAIN INJURY, V28, P1542, DOI 10.3109/02699052.2014.934285; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Tabachnick BG, 2007, USING MULTIVARIATE S; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wilson, 1991, NATL ADULT READING T; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	109	16	16	1	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 16	2018	9								563	10.3389/fneur.2018.00563			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GN1KI	WOS:000438748300001	30061858	DOAJ Gold, Green Published			2021-06-18	
J	Smith, NM; Giacci, MK; Gough, A; Bailey, C; McGonigle, T; Black, AMB; Clarke, TO; Bartlett, CA; Iyer, KS; Dunlop, SA; Fitzgerald, M				Smith, Nicole M.; Giacci, Marcus K.; Gough, Alexander; Bailey, Charlotte; McGonigle, Terence; Black, Anna M. B.; Clarke, Thomas O.; Bartlett, Carole A.; Iyer, K. Swaminathan; Dunlop, Sarah A.; Fitzgerald, Melinda			Inflammation and blood-brain barrier breach remote from the primary injury following neurotrauma	JOURNAL OF NEUROINFLAMMATION			English	Article						Neurotrauma; Secondary degeneration; Microglia; Macrophages; Cytokines; Blood-brain barrier	SPINAL-CORD-INJURY; SECONDARY DEGENERATION; CNS REMYELINATION; OXIDATIVE STRESS; M2 MICROGLIA; MACROPHAGES; INTEGRITY; TRANSECTION; DYNAMICS; PASSAGE	Background: Following injury to the central nervous system, increased microglia, secretion of pro-and anti-inflammatory cytokines, and altered blood-brain barrier permeability, a hallmark of degeneration, are observed at and immediately adjacent to the injury site. However, few studies investigate how regions remote from the primary injury could also suffer from inflammation and secondary degeneration. Methods: Adult female Piebald-Viral-Glaxo (PVG) rats underwent partial transection of the right optic nerve, with normal, age-matched, unoperated animals as controls. Perfusion-fixed brains and right optic nerves were harvested for immunohistochemical assessment of inflammatory markers and blood-brain barrier integrity; fresh-frozen brains were used for multiplex cytokine analysis. Results: Immediately ventral to the optic nerve injury, immunointensity of both the pro-inflammatory biomarker inducible nitric oxide synthase (iNOS) and the anti-inflammatory biomarker arginase-1 (Arg1) increased at 7 days post-injury, with colocalization of iNOS and Arg1 immunoreactivity within individual cells. CD11b+ and CD45+ cells were increased 7 days post-injury, with altered BBB permeability still evident at this time. In the lower and middle optic tract and superior colliculus, IBA1+ resident microglia were first increased at 3 days; ED1+ and CD11b+ cells were first increased in the middle and upper tract and superior colliculus 7 days post-injury. Increased fibrinogen immunoreactivity indicative of altered BBB permeability was first observed in the contralateral upper tract at 3 days and middle tract at 7 days post-injury. Multiplex cytokine analysis of brain homogenates indicated significant increases in the pro-inflammatory cytokines, IL-2 and TNF alpha, and anti-inflammatory cytokine IL-10 1 day post-injury, decreasing to control levels at 3 days for TNF alpha and 7 days for IL-2. IL-10 was significantly elevated at 1 and 7 days post-injury with a dip at 3 days post-injury. Conclusions: Partial injury to the optic nerve induces a complex remote inflammatory response, characterized by rapidly increased pro- and anti-inflammatory cytokines in brain homogenates, increased numbers of IBA1+ cells throughout the visual pathways, and increased CD11b+ and ED1+ inflammatory cells, particularly towards the synaptic terminals. BBB permeability can increase prior to inflammatory cell infiltration, dependent on the brain region.	[Smith, Nicole M.; Bailey, Charlotte; Iyer, K. Swaminathan] Univ Western Australia, Sch Mol Sci, Perth, WA 6009, Australia; [Giacci, Marcus K.; Gough, Alexander; Bartlett, Carole A.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [McGonigle, Terence; Black, Anna M. B.; Clarke, Thomas O.; Bartlett, Carole A.; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Verdun St, Nedlands, WA, Australia; [Fitzgerald, Melinda] Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Verdun St, Nedlands, WA, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011; Smith, Nicole/L-2502-2013	Fitzgerald, Melinda/0000-0002-4823-8179; Smith, Nicole/0000-0002-5519-8152; Giacci, Marcus/0000-0002-8330-678X; Dunlop, Sarah/0000-0002-1306-3962	National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia [APP1082403]; Neurotrauma Research Program, WA; NHMRCNational Health and Medical Research Council of Australia [APP1087114]	National Health and Medical Research Council (NHMRC), Australia (APP1082403), and Neurotrauma Research Program, WA. MF is supported by an NHMRC Career Development Fellowship (APP1087114). The funding bodies played no part in the conduct of the study.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Chan KC, 2015, INVEST OPHTH VIS SCI, V56, P1, DOI 10.1167/iovs.14-14287; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; DEMEURISSE G, 1990, EUR NEUROL, V30, P67, DOI 10.1159/000117313; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Evangelho K, 2019, INT OPHTHALMOL, V39, P259, DOI 10.1007/s10792-017-0795-9; Finger S, 2004, ARCH NEUROL-CHICAGO, V61, P283, DOI 10.1001/archneur.61.2.283; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Harvey AR, 2006, PROG RETIN EYE RES, V25, P449, DOI 10.1016/j.preteyeres.2006.07.002; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kastin AJ, 2003, MOL BRAIN RES, V114, P168, DOI 10.1016/S0169-328X(03)00167-0; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Lawlor M, 2017, SURV OPHTHALMOL, P1; LEENAERTS PL, 1994, CLIN EXP IMMUNOL, V97, P478; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Perego C, 2016, NEUROBIOL DIS, V96, P284, DOI 10.1016/j.nbd.2016.09.017; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Ryu JK, 2015, NAT COMMUN, P6; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Smith NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22595; Thiel A, 2010, J NUCL MED, V51, P1404, DOI 10.2967/jnumed.110.076612; Turtzo LC, 2014, J NEUROINFLAMM, V11, P1742; Viscomi MT, 2014, MOL NEUROBIOL, V50, P368, DOI 10.1007/s12035-013-8629-x; Vogel DY, 2013, J NEUROINFLAMM, V10, P1742; WAGUESPACK PJ, 1994, BRAIN RES BULL, V34, P103, DOI 10.1016/0361-9230(94)90005-1; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weishaupt N, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00081; Xu N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00209	52	16	17	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUL 7	2018	15								201	10.1186/s12974-018-1227-0			18	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	GM2FX	WOS:000437899400001	29981582	DOAJ Gold, Green Published			2021-06-18	
J	Poulin, A; Imboden, M; Sorba, F; Grazioli, S; Martin-Olmos, C; Rosset, S; Shea, H				Poulin, Alexandre; Imboden, Matthias; Sorba, Francesca; Grazioli, Serge; Martin-Olmos, Cristina; Rosset, Samuel; Shea, Herbert			An ultra-fast mechanically active cell culture substrate	SCIENTIFIC REPORTS			English	Article							DIELECTRIC ELASTOMER ACTUATORS; TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; STRETCHING DEVICE; MITRAL-VALVE; STRAIN; MECHANOBIOLOGY	We present a mechanically active cell culture substrate that produces complex strain patterns and generates extremely high strain rates. The transparent miniaturized cell stretcher is compatible with live cell microscopy and provides a very compact and portable alternative to other systems. A cell monolayer is cultured on a dielectric elastomer actuator (DEA) made of a 30 mu m thick silicone membrane sandwiched between stretchable electrodes. A potential difference of several kV's is applied across the electrodes to generate electrostatic forces and induce mechanical deformation of the silicone membrane. The DEA cell stretcher we present here applies up to 38% tensile and 12% compressive strain, while allowing real-time live cell imaging. It reaches the set strain in well under 1 ms and generates strain rates as high as 870 s(-1), or 87%/ms. With the unique capability to stretch and compress cells, our ultra-fast device can reproduce the rich mechanical environment experienced by cells in normal physiological conditions, as well as in extreme conditions such as blunt force trauma. This new tool will help solving lingering questions in the field of mechanobiology, including the strain-rate dependence of axonal injury and the role of mechanics in actin stress fiber kinetics.	[Poulin, Alexandre; Imboden, Matthias; Sorba, Francesca; Rosset, Samuel; Shea, Herbert] Ecole Polytech Fed Lausanne, Inst Microengn, CH-2002 Neuchatel, Switzerland; [Sorba, Francesca; Martin-Olmos, Cristina] Swiss Ctr Elect & Microtechnol CSEM, CH-2002 Neuchatel, Switzerland; [Grazioli, Serge] Univ Hosp Geneva, Div Neonatol & Pediat Intens Care Med, CH-1211 Geneva, Switzerland; [Grazioli, Serge] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Rosset, Samuel] Univ Auckland, Bioengn Inst, Auckland 1010, New Zealand	Shea, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Microengn, CH-2002 Neuchatel, Switzerland.	herbert.shea@epfl.ch	Imboden, Matthias/B-5159-2008; Rosset, Samuel/X-9800-2019; Shea, Herbert/C-4744-2008	Imboden, Matthias/0000-0003-4629-4246; Rosset, Samuel/0000-0003-0624-1537; Shea, Herbert/0000-0003-3527-3036; Poulin, Alexandre/0000-0003-0792-9149; Sorba, Francesca/0000-0003-3584-3174	Swiss National Science Foundation (SNSF)Swiss National Science Foundation (SNSF) [CR32I3_166326, 200020_165993, PZ00P2_154900, 205321_153365]; Marie Sklodowska-Curie Action [H2020-MSCA-IF-2015, 701614]; Gertrude von Meissner Foundation [ME10683]	This work was supported by the Swiss National Science Foundation (SNSF) under the grants No. CR32I3_166326, 200020_165993, PZ00P2_154900 and 205321_153365, by the Marie Sklodowska-Curie Action H2020-MSCA-IF-2015 under the grant No. 701614, and by the Gertrude von Meissner Foundation under the grant No. ME10683.	Agrawal A, 2015, J MATER RES, V30, P453, DOI 10.1557/jmr.2014.392; Akbari S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793420; Akbari S, 2012, SENSOR ACTUAT A-PHYS, V186, P236, DOI 10.1016/j.sna.2012.01.030; Anderson IA, 2012, J APPL PHYS, V112, DOI 10.1063/1.4740023; Balakrisnan B., 2010, P SOC PHOTO-OPT INS; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Bidan CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19804-1; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Carpi F, 2005, SMART MATER STRUCT, V14, P1210, DOI 10.1088/0964-1726/14/6/014; Carpi F, 2007, SMART MATER STRUCT, V16, pS300, DOI 10.1088/0964-1726/16/2/S15; Cei D, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/12/1/016001; Davis CA, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029016; de Saint-Aubin C. A., 2017, SMART MATER STRUCT, V15; Deguchi S, 2015, AIP ADV, V5, DOI 10.1063/1.4922220; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Huang J, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3699261; Huang YL, 2013, BIOMED MICRODEVICES, V15, P1043, DOI 10.1007/s10544-013-9796-2; Imboden M., 2016, EUROEAP 2016; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Keplinger C, 2012, SOFT MATTER, V8, P285, DOI 10.1039/c1sm06736b; Khalili AA, 2015, INT J MOL SCI, V16, P18149, DOI 10.3390/ijms160818149; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Koh SJA, 2011, J POLYM SCI POL PHYS, V49, P504, DOI 10.1002/polb.22223; Kreutzer J, 2014, MED ENG PHYS, V36, P496, DOI 10.1016/j.medengphy.2013.09.008; Maffli L, 2015, ADV FUNCT MATER, V25, P1656, DOI 10.1002/adfm.201403942; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Marette A, 2017, ADV MATER, V29, DOI 10.1002/adma.201700880; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; O'Halloran A, 2008, J APPL PHYS, V104, DOI 10.1063/1.2981642; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Poulin A., 2018, P SOC PHOTO-OPT INS; Poulin A, 2016, LAB CHIP, V16, P3788, DOI 10.1039/c6lc00903d; Poulin A, 2015, PROC SPIE, V9430, DOI 10.1117/12.2083837; Rizzello G, 2015, J VIB ACOUST, V137, DOI 10.1115/1.4028456; Rosset S, 2016, APPL PHYS REV, V3, DOI 10.1063/1.4963164; Rosset S, 2016, JOVE-J VIS EXP, DOI 10.3791/53423; Rosset S, 2013, APPL PHYS A-MATER, V110, P281, DOI 10.1007/s00339-012-7402-8; Rosset S, 2009, ADV FUNCT MATER, V19, P470, DOI 10.1002/adfm.200801218; Sacks MS, 2002, ANN BIOMED ENG, V30, P1281, DOI 10.1114/1.1529194; Schurmann S, 2016, BIOSENS BIOELECTRON, V81, P363, DOI 10.1016/j.bios.2016.03.015; Seriani S, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4959884; Shian S, 2015, ADV MATER, V27, P6814, DOI 10.1002/adma.201503078; Simmons CS, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054016; Svennersten K, 2011, LAB CHIP, V11, P3287, DOI 10.1039/c1lc20436j; Tremblay D, 2014, BIOTECHNOL LETT, V36, P657, DOI 10.1007/s10529-013-1381-5; van Helvert S, 2018, NAT CELL BIOL, V20, P8, DOI 10.1038/s41556-017-0012-0; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Xu C, 2010, AM J PHYSIOL-HEART C, V299, pH1790, DOI 10.1152/ajpheart.00370.2010	52	16	17	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 2	2018	8								9895	10.1038/s41598-018-27915-y			10	Multidisciplinary Sciences	Science & Technology - Other Topics	GL2LX	WOS:000436953900004	29967520	DOAJ Gold, Green Published			2021-06-18	
J	Irvine, KA; Clark, JD				Irvine, Karen-Amanda; Clark, J. David			Chronic Pain After Traumatic Brain Injury: Pathophysiology and Pain Mechanisms	PAIN MEDICINE			English	Article						Traumatic Brain Injury; Neuroinflammation; Chronic Pain; Descending Pain Modulation; Neurodegeneration; Epigenetics	POSTTRAUMATIC-STRESS-DISORDER; INFLAMMATION-MEDIATED NEURODEGENERATION; INTERLEUKIN-1 RECEPTOR ANTAGONIST; HISTONE H3 ACETYLATION; SPINAL-CORD-INJURY; HEAD-INJURY; NEUROPATHIC PAIN; PARKINSON DISEASE; EXTRACRANIAL INJURIES; CONCOMITANT INJURIES	Background. Traumatic brain injury refers to a broad range of neurological, cognitive, and emotional factors that result from the application of an external force to the head. Individuals recovering from traumatic brain injury will frequently experience acute and chronic pain. Objective. The objective of this paper is to discuss the pathophysiological changes resulting from traumatic brain injury and how these may be involved in the development and persistence of pain after injury. Methods. We based our review on articles retrieved from the MEDLINE database of references and abstracts on life sciences and biomedical topics (1966 to present) using the search engine PubMed United States National Library of Medicine). The published literature focused on traumatic brain injury and pain. Conclusions. This review presents evidence that pain is common after traumatic brain injury. However, while there are many potential mechanisms explaining this problem such as neuroinflammation, excitotoxicity, and axonal degeneration, we have no clear understanding of which of them contribute in individual patients. The authors highlight the priorities for research that will expand our knowledge and that may lead to the rational design of therapies that both reduce pain and provide optimal overall outcomes after traumatic brain injury.	[Irvine, Karen-Amanda; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, Palo Alto, CA 94304 USA; [Irvine, Karen-Amanda; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol Pain & Perioperat Med, Stanford, CA USA	Irvine, KA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	kairvine@stanford.edu			Department of Veterans AffairsUS Department of Veterans Affairs [RX001776]; Department of DefenseUnited States Department of Defense [MR130295]; Veterans AffairsUS Department of Veterans Affairs [I01RX001776] Funding Source: NIH RePORTER	This material is based on work supported by the Department of Veterans Affairs RX001776 and the Department of Defense, MR130295.	Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Alfano DP, 2006, BRAIN COGNITION, V60, P194; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; ARAKAWA S, 1995, LIFE SCI, V57, P1803, DOI 10.1016/0024-3205(95)02158-F; Bailey Zachary S, 2015, Biomed Sci Instrum, V51, P423; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bali KK, 2014, TRENDS MOL MED, V20, P437, DOI 10.1016/j.molmed.2014.05.006; Baltas I, 1998, J Neurosurg Sci, V42, P85; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Boccard SGJ, 2015, J CLIN NEUROSCI, V22, P1537, DOI 10.1016/j.jocn.2015.04.005; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Cole LJ, 2006, BRAIN, V129, P2957, DOI 10.1093/brain/awl228; Cole LJ, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.10.010; Conte A, 2013, NAT REV NEUROL, V9, P687, DOI 10.1038/nrneurol.2013.224; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cury RG, 2016, EUR J PAIN, V20, P151, DOI 10.1002/ejp.745; Defazio G, 2013, EUR J NEUROL, V20, P1517, DOI 10.1111/ene.12260; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Farber K, 2005, MOL CELL NEUROSCI, V29, P128, DOI 10.1016/j.mcn.2005.01.003; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; ffgen GB, 2014, J NEUROTRAUM, P1202; Frese A, 2006, CLIN J PAIN, V22, P252, DOI 10.1097/01.ajp.0000173020.10483.13; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gassner M, 2009, PAIN, V145, P204, DOI 10.1016/j.pain.2009.06.021; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hunsche S, 2013, STEREOT FUNCT NEUROS, V91, P328, DOI 10.1159/000350024; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kim SK, 2016, J CLIN INVEST, V126, P1983, DOI 10.1172/JCI82859; Kitisomprayoonkul Wasuwat, 2010, Journal of the Medical Association of Thailand, V93, P594; Klein RC, 2016, J NEUROSCI RES, V94, P579, DOI 10.1002/jnr.23702; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Krause T, 2012, J NEUROL NEUROSUR PS, V83, P776, DOI 10.1136/jnnp-2011-301936; Kumar A, 2015, CLIN J PAIN; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Liang DY, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-59; Liang DY, TBI INDUCED NOCICEPT; Liang LL, 2015, EPIGENOMICS-UK, V7, P235, DOI [10.2217/epi.14.75, 10.2217/EPI.14.75]; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loggia ML, 2015, BRAIN, V138, P604, DOI 10.1093/brain/awu377; Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Manners MT, 2015, FEBS OPEN BIO, V5, P733, DOI 10.1016/j.fob.2015.08.010; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Manresa JAB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100241; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Marmarou A, 2003, ACT NEUR S, V86, P7; Marques A, 2013, NEUROLOGY, V81, P633, DOI 10.1212/WNL.0b013e3182a08d00; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pertovaara A, 2013, EUR J PHARMACOL, V716, P2, DOI 10.1016/j.ejphar.2013.01.067; Petersen KK, 2016, PAIN, V157, P1400, DOI 10.1097/j.pain.0000000000000531; Pizza V, 2011, CNS NEUROL DISORD-DR, V10, P621, DOI 10.2174/187152711796235014; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rauh MJ, 2013, J REHABIL RES DEV, V50, P161, DOI 10.1682/JRRD.2011.11.0212; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Ruff Robert L, 2016, F1000Res, V5, DOI 10.12688/f1000research.9017.1; Ruscheweyh R, 2014, PAIN, V155, P1303, DOI 10.1016/j.pain.2014.04.006; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1001/jama.279.5.381; Segatore M, 1996, J Neurosci Nurs, V28, P28; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Tajerian M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055259; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vardeh D, 2016, J PAIN, V17, pT50, DOI 10.1016/j.jpain.2016.03.001; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willemen HLDM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-143; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yasuno F, 2014, BRAIN COGNITION, V84, P63, DOI 10.1016/j.bandc.2013.11.005; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhou YQ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0607-6; Zhu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091303	181	16	17	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	JUL	2018	19	7					1315	1333		10.1093/pm/pnx153			19	Anesthesiology; Medicine, General & Internal	Anesthesiology; General & Internal Medicine	GT1XV	WOS:000444271900004	29025157	Bronze			2021-06-18	
J	Dreizin, D; Bodanapally, U; Boscak, A; Tirada, N; Issa, G; Nascone, JW; Bivona, L; Mascarenhas, D; O'Toole, RV; Nixon, E; Chen, R; Siegel, E				Dreizin, David; Bodanapally, Uttam; Boscak, Alexis; Tirada, Nikki; Issa, Ghada; Nascone, Jason W.; Bivona, Louis; Mascarenhas, Daniel; O'Toole, Robert V.; Nixon, Erika; Chen, Rong; Siegel, Eliot			CT Prediction Model for Major Arterial Injury after Blunt Pelvic Ring Disruption	RADIOLOGY			English	Article							MULTIDETECTOR CT; ACTIVE EXTRAVASATION; COMPUTED-TOMOGRAPHY; ABDOMINAL-TRAUMA; HEMORRHAGE; FRACTURE; ANGIOGRAPHY; EMBOLIZATION; MANAGEMENT; UPDATE	Purpose: To develop and test a computed tomography (CT)-based predictive model for major arterial injury after blunt pelvic ring disruptions that incorporates semiautomated pelvic hematoma volume quantification. Materials and Methods: A multivariable logistic regression model was developed in patients with blunt pelvic ring disruptions who underwent arterial phase abdominopelvic CT before angiography from 2008 to 2013. Arterial injury at angiography requiring transarterial embolization (TAE) served as the outcome. Areas under the receiver operating characteristic (ROC) curve (AUCs) for the model and for two trauma radiologists were compared in a validation cohort of 36 patients from 2013 to 2015 by using the Hanley-McNeil method. Hematoma volume cutoffs for predicting the need for TAE and probability cutoffs for the secondary outcome of mortality not resulting from closed head injuries were determined by using ROC analysis. Correlation between hematoma volume and transfusion was assessed by using the Pearson coefficient. Results: Independent predictor variables included hematoma volume, intravenous contrast material extravasation, atherosclerosis, rotational instability, and obturator ring fracture. In the validation cohort, the model (AUC, 0.78) had similar performance to reviewers (AUC, 0.69-0.72; P =.40-. 80). A hematoma volume cutoff of 433 mL had a positive predictive value of 87%-100% for predicting major arterial injury requiring TAE. Hematoma volumes correlated with units of packed red blood cells transfused (r = 0.34-0.57; P =.0002-. 0003). Predicted probabilities of 0.64 or less had a negative predictive value of 100% for excluding mortality not resulting from closed head injuries. Conclusion: A logistic regression model incorporating semiautomated hematoma volume segmentation produced objective probability estimates of major arterial injury. Hematoma volumes correlated with 48-hour transfusion requirement, and low predicted probabilities excluded mortality from causes other than closed head injury. (C) RSNA, 2018	[Dreizin, David; Bodanapally, Uttam; Boscak, Alexis; Tirada, Nikki; Issa, Ghada; Nixon, Erika; Chen, Rong; Siegel, Eliot] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Diagnost Radiol & Nucl Med Trauma & Emergenc, 22 S Greene St, Baltimore, MD 21201 USA; [Nascone, Jason W.; Bivona, Louis; Mascarenhas, Daniel; O'Toole, Robert V.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Orthoped,Div Orthoped Traumatol, 22 S Greene St, Baltimore, MD 21201 USA	Dreizin, D (corresponding author), Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Diagnost Radiol & Nucl Med Trauma & Emergenc, 22 S Greene St, Baltimore, MD 21201 USA.	daviddreizin@gmail.com			RSNA Research and Education Foundation [RSCH1605]	D.D. supported by RSNA Research and Education Foundation (RSCH1605).	Anderson SW, 2008, RADIOLOGY, V246, P410, DOI 10.1148/radiol.2462070082; Baghdanian AH, 2016, RADIOGRAPHICS, V36, P872, DOI 10.1148/rg.2016150160; BENMENACHEM Y, 1991, AM J ROENTGENOL, V157, P1005, DOI 10.2214/ajr.157.5.1927786; Blackmore CC, 2006, J TRAUMA, V61, P346, DOI 10.1097/01.ta.0000226151.88369.c9; Blackmore CC, 2003, ARCH SURG-CHICAGO, V138, P504, DOI 10.1001/archsurg.138.5.504; Bohning D, 2011, STAT METHODS MED RES, V20, P541, DOI 10.1177/0962280210374532; Brasel KJ, 2007, J TRAUMA, V62, P1149, DOI 10.1097/TA.0b013e3180479827; Brown CVR, 2005, AM SURGEON, V71, P759; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cullinane DC, 2011, J TRAUMA, V71, P1850, DOI 10.1097/TA.0b013e31823dca9a; Dreizin D, 2016, AM J ROENTGENOL, V207, P1244, DOI 10.2214/AJR.16.16630; Dreizin D, 2016, ABDOM RADIOL, V41, P2203, DOI 10.1007/s00261-016-0822-8; Dreizin D, 2012, RADIOGRAPHICS, V32, P609, DOI 10.1148/rg.323115099; Frevert S, 2008, INJURY, V39, P1290, DOI 10.1016/j.injury.2008.07.004; Hamilton JD, 2008, RADIOGRAPHICS, V28, P1603, DOI 10.1148/rg.286085522; Han K, 2016, KOREAN J RADIOL, V17, P339, DOI 10.3348/kjr.2016.17.3.339; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hosmer DW, 2000, APPL LOGISTIC REGRES, P143, DOI 10.1002/0471722146; Kaatee R, 1996, RADIOLOGY, V199, P637, DOI 10.1148/radiology.199.3.8637979; Kimbrell BJ, 2004, ARCH SURG-CHICAGO, V139, P728, DOI 10.1001/archsurg.139.7.728; Lucey BC, 2007, EMERG RADIOL, V14, P65, DOI [10.1007/s10140-007-0594-0, 10.1007/s10140-007-0600-6]; Miller PR, 2003, J TRAUMA, V54, P437, DOI 10.1097/01.TA.0000053397.33827.DD; Ryan MF, 2004, CAN ASSOC RADIOL J, V55, P160; Sheridan Meghan Kelly, 2002, Emerg Radiol, V9, P188; Soto JA, 2012, RADIOLOGY, V265, P678, DOI 10.1148/radiol.12120354; Spanjersberg WR, 2009, INJURY, V40, P1031, DOI 10.1016/j.injury.2009.06.164; Stephen DJG, 1999, J TRAUMA, V47, P638, DOI 10.1097/00005373-199910000-00006; Tile, 1996, J Am Acad Orthop Surg, V4, P143; TILE M, 1988, J BONE JOINT SURG BR, V70, P1; Willmann JK, 2002, AM J ROENTGENOL, V179, P437, DOI 10.2214/ajr.179.2.1790437; Yoon W, 2004, RADIOGRAPHICS, V24, P1591, DOI 10.1148/rg.246045028	31	16	16	0	5	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2018	287	3					1061	1069		10.1148/radiol.2018170997			9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	GH7ZM	WOS:000433883400040	29558295	Bronze			2021-06-18	
J	Grassin-Delyle, S; Theusinger, OM; Albrecht, R; Mueller, S; Spahn, DR; Urien, S; Stein, P				Grassin-Delyle, S.; Theusinger, O. M.; Albrecht, R.; Mueller, S.; Spahn, D. R.; Urien, S.; Stein, P.			Optimisation of the dosage of tranexamic acid in trauma patients with population pharmacokinetic analysis	ANAESTHESIA			English	Article						antifibrinolytic agents; pharmacokinetics; tranexamic acid; trauma	FRESH-FROZEN PLASMA; CARDIAC-SURGERY; BLOOD-LOSS; HYPERFIBRINOLYSIS; COAGULOPATHY; PLASMINOGEN; MANAGEMENT; MORTALITY; CHILDREN; RESUSCITATION	Tranexamic acid is used both pre-hospital and in-hospital as an antifibrinolytic drug to treat or prevent hyperfibrinolysis in trauma patients; dosing, however, remains empirical. We aimed to measure plasma levels of tranexamic acid in patients receiving pre-hospital anti-hyperfibrinolytic therapy and to build a population pharmacokinetic model to propose an optimised dosing regimen. Seventy-three trauma patients were enrolled and each received tranexamic acid 1g intravenously pre-hospital. A blood sample was drawn after arrival in the emergency department, and we measured the plasma tranexamic acid concentration using liquid chromatography-mass spectrometry, and modelled the data using non-linear mixed effect modelling. Tranexamic acid was administered at a median (IQR [range]) time of 43 (30-55 [5-135]) min after trauma. Plasma tranexamic acid levels were determined on arrival at hospital, 57 (43-70 [20-148])min after pre-hospital administration of the drug. The measured concentration was 28.7 (21.5-38.5 [8.7-89.0])g.ml(-1). Our subjects had sustained severe trauma; injury severity score 20 (16-29 [5-75]), including penetrating injury in 2.8% and isolated traumatic brain injury in 19.7%. The pharmacokinetics were ascribed a two-compartment open model with body-weight as the main covariate. As tranexamic acid concentrations may fall below therapeutic levels during initial hospital treatment, we propose additional dosing schemes to maintain a specific target blood concentration for as long as required. This is the first study to investigate plasma level and pharmacokinetics of tranexamic acid after pre-hospital administration in trauma patients. Our proposed dosing regimen could be used in subsequent clinical trials to better study efficacy and tolerance profiles with controlled blood concentrations.	[Grassin-Delyle, S.] Univ Paris Saclay, Univ Versailles St Quentin, Plateforme Spectrometrie Masse MasSpecLab, INSERM UMR 1173,UFR Sci Sante Simone Veil,Pharmac, Montigny Le Bretonneux, France; [Grassin-Delyle, S.] Hop Foch, Dept Malad Resp, Pharmacol, Suresnes, France; [Theusinger, O. M.] Univ Hosp Balgrist, Dept Anaesthesiol, Zurich, Switzerland; [Theusinger, O. M.] Univ Zurich, Zurich, Switzerland; [Albrecht, R.; Stein, P.] Rega Rettungsflugwacht Garde Aerienne, Swiss Air Ambulance, Zurich, Switzerland; [Mueller, S.] Schutz & Rettung Zurich, Zurich, Switzerland; [Spahn, D. R.; Stein, P.] Univ Zurich, Inst Anesthesiol, Zurich, Switzerland; [Spahn, D. R.; Stein, P.] Univ Hosp Zurich, Zurich, Switzerland; [Urien, S.] URC Paris Ctr, AP HP, CIC Inserm Necker Cochin 0901, Paris, France; [Urien, S.] Univ Paris 05, Sorbonne Paris Cite, EA 7323, Paris, France	Grassin-Delyle, S (corresponding author), Univ Paris Saclay, Univ Versailles St Quentin, Plateforme Spectrometrie Masse MasSpecLab, INSERM UMR 1173,UFR Sci Sante Simone Veil,Pharmac, Montigny Le Bretonneux, France.; Grassin-Delyle, S (corresponding author), Hop Foch, Dept Malad Resp, Pharmacol, Suresnes, France.	stanislas.grassin-delyle@uvsq.fr	Grassin-Delyle, Stanislas/AAC-5921-2021; Urien, Saik/G-3240-2013	Grassin-Delyle, Stanislas/0000-0001-5747-4432; 	Swiss National Science Foundation, Berne, SwitzerlandSwiss National Science Foundation (SNSF); Ministry of Health (Gesundheitsdirektion) of the Canton of Zurich, Switzerland for Highly Specialized Medicine; Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland; Swiss Foundation for Anesthesia Research, Zurich, Switzerland; Bundesprogramm Chancengleichheit, Berne, Switzerland; CSL Behring, Berne, Switzerland; Vifor SA, Villars-sur-Glane, Switzerland; Novo Nordisk Health Care AG, Zurich, Switzerland; CSL Behring GmbH, Marburg, Germany; LFB Biomedicaments, Courtaboeuf Cedex, France	SD, OT, SU and PS contributed equally to this work. OT has received honoraria or travel support for consulting or lecturing from the following companies: CSL Behring Schweiz, Zurich, Switzerland; Vifor SA, Villars-sur-Glane, Switzerland; Roche Pharma (Switzerland) AG, Reinach, Switzerland; Pentapharm AG, Munchen, Germany; TEM International GmbH, Munchen, Germany; Boehringer Ingelheim (Switzerland); and Octapharma AG Lachen (Switzerland) and Instrumentation Laboratory, Bedford, MA, USA. DS's academic department is receiving grant support from the following: the Swiss National Science Foundation, Berne, Switzerland; the Ministry of Health (Gesundheitsdirektion) of the Canton of Zurich, Switzerland for Highly Specialized Medicine; the Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland; the Swiss Foundation for Anesthesia Research, Zurich, Switzerland; Bundesprogramm Chancengleichheit, Berne, Switzerland; CSL Behring, Berne, Switzerland; and Vifor SA, Villars-sur-Glane, Switzerland. DRS was the chair of the ABC Faculty and is the co-chair of the ABC-Trauma Faculty, both of which are managed by Physicians World Europe GmbH, Mannheim, Germany, and sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, Zurich, Switzerland; CSL Behring GmbH, Marburg, Germany; and LFB Biomedicaments, Courtaboeuf Cedex, France. In the past fiveyears, DS has received honoraria or travel support for consulting or lecturing from the following companies and organisations: Danube University of Krems, Austria; US Department of Defense, Washington, USA; European Society of Anesthesiology, Brussels, BE; Baxter AG, Volketswil, Switzerland, Baxter S.p.A., Roma, Italy; Bayer (Schweiz) AG, Zurich, Switzerland; Bayer Pharma AG, Berlin, Germany; B. Braun Melsungen AG, Melsungen, Germany; Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland; Bristol-Myers-Squibb, Rueil-Malmaison Cedex, France and Baar, Switzerland; CSL Behring GmbH, Hattersheim am Main, Germany and Berne, Switzerland; Curacyte AG, Munich, Germany; Daiichi Sankyo (Schweiz) AG, Thalwil, Switzerland; Ethicon Biosurgery, Sommerville, New Jersey, USA; Fresenius SE, Bad Homburg v.d.H., Germany; Galenica AG, Bern, Switzerland (including Vifor SA, Villars-sur-Glane, Switzerland); GlaxoSmithKline GmbH & Co. KG, Hamburg, Germany; Haemonetics, Braintree, MA, USA; Janssen-Cilag AG, Baar, Switzerland; Janssen-Cilag EMEA, Beerse, Belgium; LFB Biomedicaments, Courtaboeuf Cedex, France; Merck Sharp & Dohme AG, Luzern, Switzerland; Novo Nordisk A/S, Bagsvard, Denmark; Octapharma AG, Lachen, Switzerland; Oxygen Biotherapeutics, Costa Mesa, CA; PAION Deutschland GmbH, Aachen, Germany; Pharmacosmos A/S, Holbaek, Denmark; Photonics Healthcare B.V., Utrecht, Netherlands; ratiopharm Arzneimittel Vertriebs-GmbH, Vienna, Austria; Roche Diagnostics International Ltd, Reinach, Switzerland; Roche Pharma (Schweiz) AG, Reinach, Switzerland; Sarstedt AG and Co., Sevelen, Switzerland and Numbrecht, Germany; Schering-Plough International, Inc., Kenilworth, New Jersey, USA; Tem International GmbH, Munich, Germany; Verum Diagnostica GmbH, Munich, Germany; Vifor Pharma Deutschland GmbH, Munich, Germany; Vifor Pharma osterreich GmbH, Vienna, Austria; Vifor (International) AG, St. Gallen, Switzerland. PS received honoraria for lecturing by Vifor Pharma (Munich, Germany). SGD, RA, SM and SU have no competing interests to declare.	Anderson BJ, 2008, ANNU REV PHARMACOL, V48, P303, DOI 10.1146/annurev.pharmtox.48.113006.094708; ANDERSSON L, 1968, ANN NY ACAD SCI, V146, P642, DOI 10.1111/j.1749-6632.1968.tb20322.x; [Anonymous], 2011, BRIT MED J, V343, pd3795; Ausset S, 2015, J TRAUMA ACUTE CARE, V78, pS70, DOI 10.1097/TA.0000000000000640; Brecher ME, 1997, TRANSFUSION, V37, P1070, DOI 10.1046/j.1537-2995.1997.371098016448.x; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Bulutcu FS, 2005, PEDIATR ANESTH, V15, P41, DOI 10.1111/j.1460-9592.2004.01366.x; Cardenas JC, 2014, SHOCK, V41, P514, DOI 10.1097/SHK.0000000000000161; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dowd NP, 2002, ANESTHESIOLOGY, V97, P390, DOI 10.1097/00000542-200208000-00016; Fabresse N, 2017, J PHARMACEUT BIOMED, V141, P149, DOI 10.1016/j.jpba.2017.04.024; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Gertler R, 2017, BRIT J CLIN PHARMACO, V83, P1745, DOI 10.1111/bcp.13274; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grassin-Delyle S, 2013, BRIT J ANAESTH, V111, P916, DOI 10.1093/bja/aet255; Grassin-Delyle S, 2013, ANESTHESIOLOGY, V118, P853, DOI 10.1097/ALN.0b013e318283c83a; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; HOYLAERTS M, 1981, BIOCHIM BIOPHYS ACTA, V673, P75; Hunt BJ, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12910; Kashuk JL, 2008, J TRAUMA, V65, P261, DOI 10.1097/TA.0b013e31817de3e1; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Ker K, 2015, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD004896.PUB4; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kuhn E, 2005, COMPUT STAT DATA AN, V49, P1020, DOI 10.1016/j.csda.2004.07.002; Lin Z, 2016, SEIZURE-EUR J EPILEP, V36, P70, DOI 10.1016/j.seizure.2016.02.011; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; MARKUS G, 1979, J BIOL CHEM, V254, P1211; McCune JS, 2014, CLIN CANCER RES, V20, P754, DOI 10.1158/1078-0432.CCR-13-1960; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Ortmann E, 2013, BRIT J ANAESTH, V111, P549, DOI 10.1093/bja/aet154; Reid RW, 1997, ANESTH ANALG, V84, P990, DOI 10.1097/00000539-199705000-00008; Roberts I, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1750-1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schochl H, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12901; Schoemaker RC, 1996, BRIT J CLIN PHARMACO, V42, P283, DOI 10.1046/j.1365-2125.1996.04231.x; Sigaut S, 2014, ANESTHESIOLOGY, V120, P590, DOI 10.1097/ALN.0b013e3182a443e8; SOSLAU G, 1991, AM J HEMATOL, V38, P113, DOI 10.1002/ajh.2830380208; Stein P, 2017, ANAESTHESIA, V72, P1317, DOI 10.1111/anae.13920; Stief TW, 2009, HEMOST LAB, V2, P73; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Theusinger OM, 2014, BLOOD TRANSFUS-ITALY, V12, P195, DOI 10.2450/2014.0306-13; Theusinger OM, 2011, ANESTH ANALG, V113, P1003, DOI 10.1213/ANE.0b013e31822e183f; Wafaisade A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1322-5; Wesley MC, 2015, ANESTHESIOLOGY, V122, P746, DOI 10.1097/ALN.0000000000000570; Yee BE, 2013, ANESTH ANALG, V117, P767, DOI 10.1213/ANE.0b013e3182a22258; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	49	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	JUN	2018	73	6					719	729		10.1111/anae.14184			11	Anesthesiology	Anesthesiology	GF4XB	WOS:000431966200009	29411358	Bronze			2021-06-18	
J	Lucas, S; Ahn, AH				Lucas, Sylvia; Ahn, Andrew H.			Posttraumatic Headache: Classification by Symptom-Based Clinical Profiles	HEADACHE			English	Article						posttraumatic headache; traumatic brain injury; International Classification of Headache Disorders; secondary headache disorders	TRAUMATIC BRAIN-INJURY; US SOLDIERS; NATURAL-HISTORY; CONCUSSION; PREVALENCE; VETERANS; OUTCOMES; COHORT	There are currently no accepted therapies for posttraumatic headache (PTH). In order to meet the urgent need for effective therapies for PTH, we must continue to address fundamental gaps in our understanding of the clinical course and impact of PTH. Here we examine the existing schema used to characterize the clinical characteristics of PTH, including the International Classification of Headache Disorders (ICHD). There remain unresolved questions about whether to classify patients based on the extent of brain injury or on clinical symptom profiles. There also remain problematic issues of definition such as continuous headache, and chronic daily headache with features of embedded migraine-type within these headaches, which will need to be studied further. We make the case that a symptom-based classification is needed to begin an examination of these unresolved questions, and to establish clinically relevant endpoints for research and clinical trials for effective therapies.	[Lucas, Sylvia] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Ahn, Andrew H.] Elli Lilly & Co, Indianapolis, IN USA	Lucas, S (corresponding author), Univ Washington, Neurol Surg, 325 9th Ave,Box 359721, Seattle, WA 98104 USA.	lucass@uw.edu			Wadsworth Term Professorship in Headache Research and Practice at the University of Washington; National Institute for Disability, Independent Living and Rehabilitation Research; AmgenAmgen; AllerganAbbVieAllergan; Impel Biosciences	Sylvia Lucas receives research funding from the Wadsworth Term Professorship in Headache Research and Practice at the University of Washington and the National Institute for Disability, Independent Living and Rehabilitation Research. She has received research support from Amgen, Allergan, and Impel Biosciences, and honoraria for advisory board or consultation from Amgen, Teva, Lilly, Impel, and Kineta. Andrew H. Ahn is a Medical Fellow and full time employee at Eli Lilly and Company. He has reviewed for the NINDS, NCAM, and DoD.	Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Couch JR, 2009, EUR J NEUROL, V16, DOI 10.1111/j.1468-1331.2008.02362.x; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Finkel AG, 2017, HEADACHE, V57, P719, DOI 10.1111/head.13056; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Friedman DI, 2017, HEADACHE, V57, P119; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; VA/DoD, 2009, CLIN PRACT GUID MAN; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	27	16	16	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2018	58	6					873	882		10.1111/head.13311			10	Clinical Neurology	Neurosciences & Neurology	GK0EI	WOS:000435779900009	29737529				2021-06-18	
J	Russell, AL; Richardson, MR; Bauman, BM; Hernandez, IM; Saperstein, S; Handa, RJ; Wu, TJ				Russell, Ashley L.; Richardson, M. Riley; Bauman, Bradly M.; Hernandez, Ian M.; Saperstein, Samantha; Handa, Robert J.; Wu, T. John			Differential Responses of the HPA Axis to Mild Blast Traumatic Brain Injury in Male and Female Mice	ENDOCRINOLOGY			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; RECEPTOR-LIKE IMMUNOREACTIVITY; CORTICOTROPIN-RELEASING FACTOR; SEX-DIFFERENCES; GLUCOCORTICOID-RECEPTOR; CYTOARCHITECTONIC SUBDIVISIONS; PITUITARY DYSFUNCTION; GENDER-DIFFERENCES; OXIDATIVE STRESS; MALE-MOUSE	Traumatic brain injury (TBI) affects 10 million people worldwide, annually. TBI is linked to increased risk of psychiatric disorders. TBI, induced by explosive devices, has a unique phenotype. Over one-third of people exposed to blast-induced TBI (bTBI) have prolonged neuroendocrine deficits, shown by anterior pituitary dysfunction. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is linked to increased risk for psychiatric disorders. Not only is there limited information on how the HPA axis responds to mild bTBI (mbTBI), sex differences are understudied. We examined central and peripheral HPA axis reactivity, 7 to 10 days after mbTBI in male and female mice. Males exposed to mbTBI had increased restraint-induced serum corticosterone (CORT), but attenuated restraint-induced corticotropin-releasing factor (CRF)/c-Fos-immunoreactivity (ir) in the paraventricular nucleus of the hypothalamus (PVN). Females displayed an opposite response, with attenuated restraint-induced CORT and enhanced restraint-induced PVN CRF/c-Fos-ir. We examined potential mechanisms underlying this dysregulation and found that mbTBI did not affect pituitary (proopiomelanocortin and CRF receptor subtype 1) or adrenal (11 beta-hydroxylase, 11 beta-dehydrogenase 1, and melanocortin 2 receptor) gene expression. mbTBI did not alter mineralocorticoid or glucocorticoid gene expression in the PVN or relevant limbic structures. In females, but not males, mbTBI decreased c-Fos-ir in non-neuroendocrine (presumably preautonomic) CRF neurons in the PVN. Whereas we demonstrated a sex-dependent link to stress dysregulation of preautonomic neurons in females, we hypothesize that mbTBI may disrupt limbic pathways involved in HPA axis coordination in males. Overall, mbTBI altered the HPA axis in a sex-dependent manner, highlighting the importance of developing therapies to target individual strategies that males and females use to cope with mbTBI.	[Russell, Ashley L.; Wu, T. John] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Russell, Ashley L.; Wu, T. John] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Me, Bethesda, MD 20814 USA; [Richardson, M. Riley; Bauman, Bradly M.; Hernandez, Ian M.; Saperstein, Samantha; Wu, T. John] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20184 USA; [Handa, Robert J.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Wu, TJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	twu@usuhs.edu	Wu, John/ABI-3578-2020	Bauman, Bradly/0000-0002-4471-0966; Wu, Tao-Yiao/0000-0002-8274-0226; Russell, Ashley/0000-0003-1137-2769	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This work was funded by the Department of Defense in the Center for Neuroscience and Regenerative Medicine.	Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; AHIMA RS, 1990, NEUROSCIENCE, V39, P579, DOI 10.1016/0306-4522(90)90244-X; ANTONI FA, 1986, ENDOCR REV, V7, P351, DOI 10.1210/edrv-7-4-351; ARMSTRONG WE, 1980, NEUROSCIENCE, V5, P1931, DOI 10.1016/0306-4522(80)90040-8; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; CECCATELLI S, 1989, EXP BRAIN RES, V78, P33; Chen YC, 2015, ENDOCRINOLOGY, V156, P4769, DOI 10.1210/en.2015-1673; Cho-Clark M, 2014, MOL ENDOCRINOL, V28, P80, DOI 10.1210/me.2013-1203; CRITCHLOW V, 1963, AM J PHYSIOL, V205, P807; DALLMAN MF, 1973, ENDOCRINOLOGY, V92, P1367, DOI 10.1210/endo-92-5-1367; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Dedovic K, 2015, NEUROPSYCH DIS TREAT, V11, P1181, DOI 10.2147/NDT.S62289; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Geerling JC, 2010, J COMP NEUROL, V518, P1460, DOI 10.1002/cne.22283; Goel N, 2008, ENDOCRINOLOGY, V149, P6399, DOI 10.1210/en.2008-0433; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Harpaz I, 2013, EUR J IMMUNOL, V43, P758, DOI 10.1002/eji.201242613; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KISS JZ, 1991, J COMP NEUROL, V313, P563, DOI 10.1002/cne.903130403; KOEGLERMULY SM, 1993, J NEUROENDOCRINOL, V5, P95, DOI 10.1111/j.1365-2826.1993.tb00367.x; Licona NE, 2017, ARCH PHYS MED REHAB, V98, P391, DOI 10.1016/j.apmr.2016.09.131; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LUITEN PGM, 1985, BRAIN RES, V329, P374, DOI 10.1016/0006-8993(85)90554-2; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2015, SLEEP MED CLIN, V10, P1, DOI 10.1016/j.jsmc.2014.11.007; McGivern RF, 2009, PHYSIOL BEHAV, V98, P416, DOI 10.1016/j.physbeh.2009.07.004; McKlveen JM, 2013, BIOL PSYCHIAT, V74, P672, DOI 10.1016/j.biopsych.2013.03.024; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Merswolken M, 2013, INT J BEHAV MED, V20, P461, DOI 10.1007/s12529-012-9233-6; National Center for Biotechnology Information, PRIM BLAST; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nelson NW, 2015, BRAIN NEUROTRAUMA MO; Oyola MG, 2017, J COMP NEUROL, V525, P3666, DOI 10.1002/cne.24295; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Pyner S, 2000, NEUROSCIENCE, V100, P549, DOI 10.1016/S0306-4522(00)00283-9; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; ROLAND BL, 1993, J COMP NEUROL, V332, P123, DOI 10.1002/cne.903320109; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; SAWCHENKO PE, 1987, BRAIN RES, V403, P213, DOI 10.1016/0006-8993(87)90058-8; SAWCHENKO PE, 1987, BRAIN RES, V437, P253, DOI 10.1016/0006-8993(87)91641-6; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Sweis BM, 2016, BEHAV BRAIN RES, V296, P149, DOI 10.1016/j.bbr.2015.09.015; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Thompson CI, 2003, PHYSIOL BEHAV, V80, P103, DOI 10.1016/S0031-9384(03)00224-5; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Varghese Femina P., 2001, Prim Care Companion J Clin Psychiatry, V3, P151; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; Wamsteeker Cusulin JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064943; Weinstock M, 1998, INT J DEV NEUROSCI, V16, P289, DOI 10.1016/S0736-5748(98)00021-5; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; WHITNALL MH, 1993, PROG NEUROBIOL, V40, P573, DOI 10.1016/0301-0082(93)90035-Q; Wilkinson Charles W, 2012, Front Neurol, V3, P11, DOI 10.3389/fneur.2012.00011; Woodruff ER, 2016, ENDOCRINOLOGY, V157, P1522, DOI 10.1210/en.2015-1884; WU TJ, 1992, ENDOCRINOLOGY, V131, P2045, DOI 10.1210/en.131.5.2045; Yan L, 2016, J STEROID BIOCHEM, V160, P118, DOI 10.1016/j.jsbmb.2015.10.007	79	16	16	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	JUN	2018	159	6					2363	2375		10.1210/en.2018-00203			13	Endocrinology & Metabolism	Endocrinology & Metabolism	GM9XU	WOS:000438610400011	29701827	Bronze			2021-06-18	
J	Zanier, ER; Zoerle, T; Di Lernia, D; Riva, G				Zanier, Elisa R.; Zoerle, Tommaso; Di Lernia, Daniele; Riva, Giuseppe			Virtual Reality for Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; virtual reality; brain protection; neurorepair; rehabilitation	COGNITIVE REHABILITATION; NEURAL REORGANIZATION; THERAPY; DEFICITS; STROKE	In this perspective, we discuss the potential of virtual reality (VR) in the assessment and rehabilitation of traumatic brain injury, a silent epidemic of extremely high burden and no pharmacological therapy available. VR, endorsed by the mobile and gaming industries, is now available in more usable and cheaper tools allowing its therapeutic engagement both at the bedside and during the daily life at chronic stages after injury with terrific potential for a longitudinal disease modifying effect.	[Zanier, Elisa R.] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Zoerle, Tommaso] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci ICU, Milan, Italy; [Di Lernia, Daniele] Univ Cattolica Sacro Cuore, Dipartimento Psicol, Milan, Italy; [Riva, Giuseppe] Ist Auxol Italiano, Appl Technol Neuropsychol Lab, Milan, Italy; [Riva, Giuseppe] Univ Cattolica Sacro Cuore, Ctr Studi & Ric Psicol Comunicaz, Milan, Italy	Zanier, ER (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy.	elisa.zanier@marionegri.it	Zanier, Elisa/AAA-8095-2020; Riva, Giuseppe/C-5917-2008	Riva, Giuseppe/0000-0003-3657-106X; Zanier, Elisa/0000-0002-3011-8718; Zoerle, Tommaso/0000-0001-8713-8085			Besnard J, 2016, APPL NEUROPSYCH-ADUL, V23, P223, DOI 10.1080/23279095.2015.1048514; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Castelvecchi D, 2016, NATURE, V533, P153, DOI 10.1038/533153a; Cherniack EP, 2011, DISABIL REHABIL-ASSI, V6, P283, DOI 10.3109/17483107.2010.542570; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cuthbert JP, 2014, BRAIN INJURY, V28, P181, DOI 10.3109/02699052.2013.860475; Dahdah MN, 2017, NEUROREHABILITATION, V41, P721, DOI 10.3233/NRE-172183; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Laver KE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008349.pub4; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Miller KJ, 2014, AGE AGEING, V43, P188, DOI 10.1093/ageing/aft194; Orihuela-Espina F, 2013, TOP STROKE REHABIL, V20, P197, DOI 10.1310/tsr2003-197; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Robitaille N, 2017, DISABIL REHABIL-ASSI, V12, P758, DOI 10.1080/17483107.2016.1229048; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Saywell N, 2017, CLIN REHABIL, V31, P145, DOI 10.1177/0269215516631384; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Serino S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00240; Shin H, 2015, J PHYS THER SCI, V27, P2999, DOI 10.1589/jpts.27.2999; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; Wang ZR, 2017, NEURAL REGEN RES, V12, P1823, DOI 10.4103/1673-5374.219043; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; WHO, 2018, NEUR DIS PUBL HLTH C; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354	35	16	16	0	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 16	2018	9								345	10.3389/fneur.2018.00345			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GG0WP	WOS:000432401500001	29867748	DOAJ Gold, Green Published			2021-06-18	
J	Salo, RA; Belevich, I; Manninen, E; Jokitalo, E; Grohn, O; Sierra, A				Salo, Raimo A.; Belevich, Ilya; Manninen, Eppu; Jokitalo, Eija; Grohn, Olli; Sierra, Alejandra			Quantification of anisotropy and orientation in 3D electron microscopy and diffusion tensor imaging in injured rat brain	NEUROIMAGE			English	Article							FOURIER-ANALYSIS; MRI; MICROSTRUCTURE; VALIDATION; LIGHT; WHITE; MATTER; TRACTOGRAPHY; DISPERSION	Diffusion tensor imaging (DTI) reveals microstructural features of grey and white matter non-invasively. The contrast produced by DTI, however, is not fully understood and requires further validation. We used serial block-face scanning electron microscopy (SBEM) to acquire tissue metrics, i.e., anisotropy and orientation, using three-dimensional Fourier transform-based (3D-FT) analysis, to correlate with fractional anisotropy and orientation in DTI. SBEM produces high-resolution 3D data at the mesoscopic scale with good contrast of cellular membranes. We analysed selected samples from cingulum, corpus callosum, and perilesional cortex of sham-operated and traumatic brain injury (TBI) rats. Principal orientations produced by DTI and 3D-FT in all samples were in good agreement. Anisotropy values showed similar patterns of change in corresponding DTI and 3D-FT parameters in sham-operated and TBI rats. While DTI and 3D-FT anisotropy values were similar in grey matter, 3D-FT anisotropy values were consistently lower than fractional anisotropy values from DTI in white matter. We also evaluated the effect of resolution in 3D-FT analysis. Despite small angular differences in grey matter samples, lower resolution datasets provided reliable results, allowing for analysis of larger fields of view. Overall, 3D SBEM allows for more sophisticated validation studies of diffusion imaging contrast from a tissue microstructural perspective.	[Salo, Raimo A.; Manninen, Eppu; Grohn, Olli; Sierra, Alejandra] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, POB 1627, FI-70211 Kuopio, Finland; [Belevich, Ilya; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, POB 56, FI-00014 Helsinki, Finland	Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, POB 1627, FI-70211 Kuopio, Finland.	alejandra.sierralopez@uef.fi	Jokitalo, Eija S/C-8375-2009	Jokitalo, Eija S/0000-0002-4159-6934; Manninen, Eppu/0000-0002-9353-6079; Sierra Lopez, Alejandra/0000-0001-5399-2056; Belevich, Ilya/0000-0003-2190-4909	Academy of FinlandAcademy of FinlandEuropean Commission [275453, 298007]	This work was supported by the Academy of Finland (#275453 AS, #298007 OG), and Biocenter Finland and University of Helsinki (IB, EJ, and SBEM imaging). We would like to thank Maarit Pulkkinen for her help with the animal handling, Mervi Lindman and Antti Salminen for help preparing the samples for SBEM, and Dr. Jaakko Paasonen for video editing.	Aggarwal M, 2015, NEUROIMAGE, V105, P198, DOI 10.1016/j.neuroimage.2014.10.053; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Axer M., 2016, FRONT NEUROANAT, V10; Markus A, 2011, NEUROIMAGE, V54, P1091, DOI 10.1016/j.neuroimage.2010.08.075; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chang EH, 2017, NEUROIMAGE, V147, P253, DOI 10.1016/j.neuroimage.2016.11.068; Chang EH, 2017, DATA BRIEF, V10, P438, DOI 10.1016/j.dib.2016.12.018; Chazotte B., 2011, COLD SPRING HARB PRO, V2011; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Dauguet J, 2007, J NEUROSCI METH, V164, P191, DOI 10.1016/j.jneumeth.2007.04.017; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138, DOI [10.1017/S1431927610055170, DOI 10.1017/S1431927610055170]; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/NMETH.2476, 10.1038/nmeth.2476]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Jespersen SN, 2012, IEEE T MED IMAGING, V31, P16, DOI 10.1109/TMI.2011.2162099; Josso B, 2005, MECH SYST SIGNAL PR, V19, P1152, DOI 10.1016/j.ymssp.2004.07.005; Khan AR, 2015, NEUROIMAGE, V111, P192, DOI 10.1016/j.neuroimage.2015.01.061; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Lehto LJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3678; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Salo RA, 2017, NEUROIMAGE, V152, P221, DOI 10.1016/j.neuroimage.2017.03.003; Scherrer B, 2016, MAGN RESON MED, V76, P963, DOI 10.1002/mrm.25912; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang H, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.036003; Wang H, 2014, NEUROIMAGE, V100, P395, DOI 10.1016/j.neuroimage.2014.06.032; White NS, 2013, HUM BRAIN MAPP, V34, P327, DOI 10.1002/hbm.21454; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	47	16	17	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 15	2018	172						404	414		10.1016/j.neuroimage.2018.01.087			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GD2WK	WOS:000430364100032	29412154	Green Accepted, Green Published, Other Gold			2021-06-18	
J	Evanson, NK; Guilhaume-Correa, F; Herman, JP; Goodman, MD				Evanson, Nathan K.; Guilhaume-Correa, Fernanda; Herman, James P.; Goodman, Michael D.			Optic tract injury after closed head traumatic brain injury in mice: A model of indirect traumatic optic neuropathy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ENGINEERED ROTATIONAL ACCELERATION; AXONAL INJURY; MOUSE MODEL; NEURONAL DEGENERATION; IMPACT MODEL; FLUORO-JADE; NERVE; DEFICITS; MICROGLIA	Adult male C57BL/6J mice have previously been reported to have motor and memory deficits after experimental closed head traumatic brain injury (TBI), without associated gross pathologic damage or neuroimaging changes detectable by magnetic resonance imaging or diffusion tensor imaging protocols. The presence of neurologic deficits, however, suggests neural damage or dysfunction in these animals. Accordingly, we undertook a histologic analysis of mice after TBI. Gross pathology and histologic analysis using Nissl stain and NeuN immunohistochemistry demonstrated no obvious tissue damage or neuron loss. However, Luxol Fast Blue stain revealed myelin injury in the optic tract, while Fluoro Jade B and silver degeneration staining revealed evidence of axonal neurodegeneration in the optic tract as well as the lateral geniculate nucleus of the thalamus and superior colliculus (detectable at 7 days, but not 24 hours, after injury). Fluoro Jade B staining was not detectable in other white matter tracts, brain regions or in cell somata. In addition, there was increased GFAP staining in these optic tract, lateral geniculate, and superior colliculus 7 days post-injury, and morphologic changes in optic tract microglia that were detectable 24 hours after injury but were more prominent 7 days post-injury. Interestingly, there were no findings of degeneration or gliosis in the suprachiasmatic nucleus, which is also heavily innervated by the optic tract. Using micro-computed tomography imaging, we also found that the optic canal appears to decrease in diameter with a dorsal-ventral load on the skull, which suggests that the optic canal may be the site of injury. These results suggest that there is axonal degeneration in the optic tract and a subset of directly innervated areas, with associated neuroinflammation and astrocytosis, which develop within 7 days of injury, and also suggest that this weight drop injury may be a model for studying indirect traumatic optic neuropathy.	[Evanson, Nathan K.; Guilhaume-Correa, Fernanda] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Evanson, Nathan K.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45220 USA; [Herman, James P.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA	Evanson, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA.; Evanson, NK (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45220 USA.	nathan.evason@cchmc.org		Guilhaume Correa, Fernanda/0000-0002-3878-5283; Evanson, Nathan/0000-0003-2474-9764	National Institutes of Health - Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD001097]; Cincinnati Children's Hospital Medical Center Division of Pediatric Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health - Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov), grant HD001097 (NE) and by the Cincinnati Children's Hospital Medical Center Division of Pediatric Rehabilitation Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Cui Q, 2015, NEUROSCIENCE, V284, P845, DOI 10.1016/j.neuroscience.2014.11.002; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dharmarajan S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0855-0; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Erskine L, 2014, ASN NEURO, V6, DOI 10.1177/1759091414562107; Finkelstein E, 2006, INCIDENCE EC BURDEN, Vxiii; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GROSS CE, 1981, J NEUROSURG, V55, P963, DOI 10.3171/jns.1981.55.6.0963; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAWRENCE PM, 2014, J COMP NEUROL, V522, P3733, DOI DOI 10.1002/CNE.23635; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Martersteck EM, 2017, CELL REP, V18, P2058, DOI 10.1016/j.celrep.2017.01.075; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Patel VC, 2017, EXP NEUROL, V289, P85, DOI 10.1016/j.expneurol.2016.12.012; Pilati N, 2008, J HISTOCHEM CYTOCHEM, V56, P539, DOI 10.1369/jhc.2008.950246; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rizzo JR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00227; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Steinsapir K D, 1999, Curr Opin Ophthalmol, V10, P340, DOI 10.1097/00055735-199910000-00011; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	64	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197346	10.1371/journal.pone.0197346			20	Multidisciplinary Sciences	Science & Technology - Other Topics	GF3JM	WOS:000431851700105	29746557	DOAJ Gold, Green Published			2021-06-18	
J	Michailidou, I; Jongejan, A; Vreijling, JP; Georgakopoulou, T; de Wissel, MB; Wolterman, RA; Ruizendaal, P; Klar-Mohamad, N; Grootemaat, AE; Picavet, DI; Kumar, V; van Kooten, C; Woodruff, TM; Morgan, BP; Van der Wel, NN; Ramaglia, V; Fluiter, K; Baas, F				Michailidou, Iliana; Jongejan, Aldo; Vreijling, Jeroen P.; Georgakopoulou, Theodosia; de Wissel, Marit B.; Wolterman, Ruud A.; Ruizendaal, Patrick; Klar-Mohamad, Ngaisah; Grootemaat, Anita E.; Picavet, Daisy I.; Kumar, Vinod; van Kooten, Cees; Woodruff, Trent M.; Morgan, B. Paul; Van der Wel, Nicole N.; Ramaglia, Valeria; Fluiter, Kees; Baas, Frank			Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Complement; Inflammasome; Neuroinflammation	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; TRAUMATIC BRAIN-INJURY; BIOZZI ABH MOUSE; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; INFLAMMASOME ACTIVATION; WALLERIAN DEGENERATION; MENINGOCOCCAL DISEASE	The complement system is a key driver of neuroinflammation. Activation of complement by all pathways, results in the formation of the anaphylatoxin C5a and the membrane attack complex (MAC). Both initiate pro-inflammatory responses which can contribute to neurological disease. In this study, we delineate the specific roles of C5a receptor signaling and MAC formation during the progression of experimental autoimmune encephalomyelitis (EAE)-mediated neuroinflammation. MAC inhibition was achieved by subcutaneous administration of an antisense oligonucleotide specifically targeting murine C6 mRNA (5 mg/kg). The C5a receptor 1 (C5aR1) was inhibited with the C5a receptor antagonist PMX205 (1.5 mg/kg). Both treatments were administered systemically and started after disease onset, at the symptomatic phase when lymphocytes are activated. We found that antisense-mediated knockdown of C6 expression outside the central nervous system prevented relapse of disease by impeding the activation of parenchymal neuroinflammatory responses, including the Nod-like receptor protein 3 (NLRP3) inflammasome. Furthermore, C6 antisense-mediated MAC inhibition protected from relapse-induced axonal and synaptic damage. In contrast, inhibition of C5aR1-mediated inflammation diminished expression of major proinflammatory mediators, but unlike C6 inhibition, it did not stop progression of neurological disability completely. Our study suggests that MAC is a key driver of neuroinflammation in this model, thereby MAC inhibition might be a relevant treatment for chronic neuroinflammatory diseases.	[Michailidou, Iliana; Georgakopoulou, Theodosia; de Wissel, Marit B.; Wolterman, Ruud A.; Ruizendaal, Patrick; Ramaglia, Valeria] Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [Michailidou, Iliana; Vreijling, Jeroen P.; Fluiter, Kees; Baas, Frank] Leiden Univ, Dept Clin Genet, Med Ctr, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands; [Jongejan, Aldo] Acad Med Ctr, Dept Bioinformat, Amsterdam, Netherlands; [Klar-Mohamad, Ngaisah; van Kooten, Cees] Leiden Univ, Dept Nephrol, Med Ctr, Leiden, Netherlands; [Grootemaat, Anita E.; Picavet, Daisy I.; Van der Wel, Nicole N.] Acad Med Ctr, Electron Microscopy Ctr Amsterdam, Dept Med Biol, Amsterdam, Netherlands; [Kumar, Vinod; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Morgan, B. Paul] Cardiff Univ, Syst Immun Univ Res Inst, Sch Med, Cardiff, S Glam, Wales; [Ramaglia, Valeria] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Baas, F (corresponding author), Leiden Univ, Dept Clin Genet, Med Ctr, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	F.Baas@lumc.nl	Woodruff, Trent M./B-4861-2009; Woodruff, Trent/AAS-4629-2020; Van Der Wel, Nicole/AAE-7569-2020; Kumar, Vinod/AAM-3705-2020; Fluiter, Kees/H-2828-2015; W, T/ABF-1428-2020	Woodruff, Trent M./0000-0003-1382-911X; Woodruff, Trent/0000-0003-1382-911X; Kumar, Vinod/0000-0002-7263-9917; Fluiter, Kees/0000-0003-0898-7260; W, T/0000-0003-1382-911X; van der Wel, Nicole/0000-0001-6392-3417; Morgan, Paul/0000-0003-4075-7676	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG 4775A1/1]	This work was funded by the National Multiple Sclerosis Society grant no. RG 4775A1/1 to F.B. and V.R.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Barnett MH, 2009, ANN NEUROL, V65, P32, DOI 10.1002/ana.21524; Biggins PJC, 2017, J NEUROTRAUM, V34, P2075, DOI 10.1089/neu.2016.4701; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Burm SM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0605-8; Carroll MC, 2008, VACCINE, V26, pI28, DOI 10.1016/j.vaccine.2008.11.022; CHU AC, 1980, BRIT J DERMATOL, V103, P607, DOI 10.1111/j.1365-2133.1980.tb01682.x; Craft JM, 2005, EXPERT OPIN THER TAR, V9, P887, DOI 10.1517/14728222.9.5.887; El Idrissi NB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0538-2; El Idrissi NB, 2015, ACTA NEUROPATHOL, V129, P653, DOI 10.1007/s00401-015-1404-5; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; FIGUEROA J, 1993, IMMUNOL RES, V12, P295, DOI 10.1007/BF02918259; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608; Furlan R, 1999, J IMMUNOL, V163, P2403; Gasque P, 1997, AM J PATHOL, V150, P31; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAUSER SL, 1990, NEUROLOGY, V40, P1735, DOI 10.1212/WNL.40.11.1735; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; HOBART MJ, 1977, J EXP MED, V146, P629, DOI 10.1084/jem.146.2.629; Ingram G, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-53; Inoue M, 2016, NAT NEUROSCI, V19, P1599, DOI 10.1038/nn.4421; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Jackson SJ, 2009, J NEUROPATH EXP NEUR, V68, P616, DOI 10.1097/NEN.0b013e3181a41d23; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kilgore KS, 1997, AM J PATHOL, V150, P2019; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kotimaa J, 2016, MOL IMMUNOL, V76, P13, DOI 10.1016/j.molimm.2016.06.004; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lassmann H, 2007, J NEUROL SCI, V259, P3, DOI 10.1016/j.jns.2006.08.016; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; Lassmann H, 2015, NEUROINFLAMMATION: NEW INSIGHTS INTO BENEFICIAL AND DETRIMENTAL FUNCTIONS, P3; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lee JD, 2017, BRIT J PHARMACOL, V174, P689, DOI 10.1111/bph.13730; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; Mead RJ, 2002, J IMMUNOL, V168, P458, DOI 10.4049/jimmunol.168.1.458; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mellergard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044739; Michailidou I, 2017, GLIA, V65, P264, DOI 10.1002/glia.23090; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Morgan BP, 2004, CLIN EXP IMMUNOL, V138, P430, DOI 10.1111/j.1365-2249.2004.02646.x; Niculescu T, 2004, J IMMUNOL, V172, P5702, DOI 10.4049/jimmunol.172.9.5702; PAPADIMITRIOU JC, 1994, CELL CALCIUM, V15, P217, DOI 10.1016/0143-4160(94)90061-2; Peelen E, 2015, MOL IMMUNOL, V63, P521, DOI 10.1016/j.molimm.2014.10.008; Ramaglia V, 2015, CLIN EXP IMMUNOL, V180, P432, DOI 10.1111/cei.12595; Ramaglia V, 2007, J NEUROSCI, V27, P7663, DOI 10.1523/JNEUROSCI.5623-06.2007; Ramaglia V, 2009, MOL IMMUNOL, V46, P1892, DOI 10.1016/j.molimm.2009.01.017; Reiman R, 2005, NEUROSCI LETT, V390, P134, DOI 10.1016/j.neulet.2005.08.022; Reiman R, 2002, EUR J IMMUNOL, V32, P1157, DOI 10.1002/1521-4141(200204)32:4<1157::AID-IMMU1157>3.3.CO;2-D; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ronchi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11541; Rossi S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-32; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Schellenberg AE, 2007, MAGN RESON MED, V58, P298, DOI 10.1002/mrm.21289; Seppi D, 2014, J NEUROIMMUNOL, V270, P56, DOI 10.1016/j.jneuroim.2014.02.014; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Stokowska A, 2017, BRAIN, V140, P353, DOI 10.1093/brain/aww314; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tran GT, 2002, J IMMUNOL, V168, P4293, DOI 10.4049/jimmunol.168.9.4293; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Triantafilou M, 2016, IMMUNOLOGY, V147, P152, DOI 10.1111/imm.12556; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; Watkins LM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0611-x; Weerth SH, 2003, AM J PATHOL, V163, P1069, DOI 10.1016/S0002-9440(10)63466-9; Wong EKS, 2015, TRANSL RES, V165, P306, DOI 10.1016/j.trsl.2014.10.010; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; WURZNER R, 1991, CLIN EXP IMMUNOL, V83, P430; Zhang T, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8193932	87	16	16	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	MAY 3	2018	6								36	10.1186/s40478-018-0536-y			17	Neurosciences	Neurosciences & Neurology	GE8ZT	WOS:000431520400001	29724241	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Ganau, M; Lavinio, A; Prisco, L				Ganau, Mario; Lavinio, Andrea; Prisco, Lara			Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options	MINERVA ANESTESIOLOGICA			English	Article						Traumatic brain injuries; Delirium; Psychomotor agitation	CRITICALLY-ILL PATIENTS; PLACEBO-CONTROLLED TRIAL; DYSFUNCTION; ATTENTION; PATHOPHYSIOLOGY; DEXMEDETOMIDINE; RECOMMENDATIONS; MANAGEMENT; CONFUSION; SYMPTOMS	Traumatic brain injury (TBI) is a global public health epidemic. It represents the principal cause of death and disability in individuals aged under 35 in the USA. In the subacute phase, severe TBI patients who recover consciousness go through a state of agitation and delirium. However, there is only limited research exploring the characteristics of post-traumatic delirium (PTD) although it is likely to be more frequent than in general Intensive Care Unit (ICU) patients. Evidence suggest the incidence of delirium in non-TBI ICU patients is up to 86%. The exact pathophysiological mechanisms underlying the development and progression of delirium in critically ill patients is still unclear. Many hypotheses have been proposed to play a role: neuroinflammation, neurotransmitter imbalance, structural and functional brain damage. TBI patients are at high risk of post-traumatic cognitive impairment, and up to two thirds of patients who survive TBI develop agitation and delirium which is associated with increased disability and long term cognitive impairment. Recommendation for the treatment of PTD in patients admitted to ICU are not clearly identified. Despite the high prevalence of PTD, the condition often goes misrecognized and attributed . primarily to the injury itself. There is increasing evidence that certain drugs such as antipsychotics can reduce the incidence and severity of delirium, whereas other drugs such as dexmedetomidine and remifentanil are associated with decreased risk of developing delirium in general ICU patients. However, there is a lack of high quality studies exploring treatment strategies for PTD in the acute setting.	[Ganau, Mario] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada; [Ganau, Mario] Univ Toronto, Toronto, ON, Canada; [Lavinio, Andrea] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Prisco, Lara] John Radcliffe Hosp, Neurosci Intens Care Unit, Headley Way, Oxford OX3 9DU, England	Prisco, L (corresponding author), John Radcliffe Hosp, Neurosci Intens Care Unit, Headley Way, Oxford OX3 9DU, England.	lara.prisco@ouh.nhs.uk	Prisco, Lara/I-9267-2019; Prisco, Lara/X-9310-2018; Ganau, Mario/AAY-7233-2020	Prisco, Lara/0000-0001-6727-7870; Ganau, Mario/0000-0002-8676-1147			Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Cerejeira J, 2010, ACTA NEUROPATHOL, V119, P737, DOI 10.1007/s00401-010-0674-1; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Deb S, 1999, AM J PSYCHIAT, V156, P374; Devlin JW, 2011, CRIT CARE, V15, DOI 10.1186/cc10450; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; FLEMINGER S, 2006, COCHRANE DB SYST REV, V18, DOI DOI 10.1002/14651858.CD003299.PUB2; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099; Hawkins KA, 2000, AGGRESS VIOLENT BEH, V5, P147, DOI 10.1016/S1359-1789(98)00033-0; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Hshieh TT, 2008, J GERONTOL A-BIOL, V63, P764, DOI 10.1093/gerona/63.7.764; Hughes CG, 2012, CURR OPIN CRIT CARE, V18, P518, DOI 10.1097/MCC.0b013e328357effa; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Maneewong J, 2017, NEUROPSYCH DIS TREAT, V13, DOI 10.2147/NDT.S128138; Mittal D, 2004, J CLIN PSYCHIAT, V65, P662; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naidech AM, 2016, NEUROCRIT CARE, V24, P397, DOI 10.1007/s12028-015-0210-1; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Page VJ, 2013, LANCET RESP MED, V1, P515, DOI 10.1016/S2213-2600(13)70166-8; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Prisco L, 2012, CRIT CARE, V16, DOI 10.1186/cc11891; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Syrmos N, 2013, CASE REP SURG, V2013, DOI 10.1155/2013/209750; Trzepacz P T, 2000, Semin Clin Neuropsychiatry, V5, P132; Trzepacz PT, 1999, DEMENT GERIATR COGN, V10, P330, DOI 10.1159/000017164; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vasilevskis EE, 2010, CHEST, V138, P1224, DOI 10.1378/chest.10-0466; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Zaal IJ, 2012, DRUGS, V72, P1457, DOI 10.2165/11635520-000000000-00000; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	49	16	17	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	MAY	2018	84	5					632	640		10.23736/S0375-9393.18.12294-2			9	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	GU4RZ	WOS:000445273100015	29479930				2021-06-18	
J	Stewart, WF; Kim, N; Ifrah, C; Sliwinski, M; Zimmerman, ME; Kim, M; Lipton, RB; Lipton, ML				Stewart, Walter F.; Kim, Namhee; Ifrah, Chloe; Sliwinski, Martin; Zimmerman, Molly E.; Kim, Mimi; Lipton, Richard B.; Lipton, Michael L.			Heading Frequency Is More Strongly Related to Cognitive Performance Than Unintentional Head Impacts in Amateur Soccer Players	FRONTIERS IN NEUROLOGY			English	Article						risk factors in epidemiology; brain trauma; heading; sports; soccer	CHRONIC TRAUMATIC ENCEPHALOPATHY; NEUROCOGNITIVE PERFORMANCE; NEUROPSYCHOLOGICAL IMPAIRMENT; BRAIN-INJURY; CONCUSSION; SPORTS; SYMPTOMS; DEMENTIA; ABNORMALITIES; CONSEQUENCES	Objective: Compared to heading, unintentional head impacts (e.g., elbow to head, head to head, head to goalpost) in soccer are more strongly related to risk of moderate to very severe Central Nervous System (CNS) symptoms. But, most head impacts associated with CNS symptoms that occur in soccer are mild and are more strongly related to heading. We tested for a differential relation of heading and unintentional head impacts with neuropsychological (NP) test performance. Method: Active adult amateur soccer players were recruited in New York City and the surrounding areas for this repeated measures longitudinal study of individuals who were enrolled if they had 5+ years of soccer play and were active playing soccer 6+ months/year. All participants completed a baseline validated questionnaire ("HeadCount-2w"), reporting 2-week recall of soccer activity, heading and unintentional head impacts. In addition, participants also completed NP tests of verbal learning, verbal memory, psychomotor speed, attention, and working memory. Most participants also completed one or more identical follow-up protocols (i.e., HeadCount-2w and NP tests) at 3-to 6-month intervals over a 2-year period. Repeated measures General Estimating Equations (GEE) linear models were used to determine if variation in NP tests at each visit was related to variation in either heading or unintentional head impacts in the 2-week period before testing. Results: 308 players (78% male) completed 741 HeadCount-2w. Mean (median) heading/2-weeks was 50 (17) for men and 26 (7) for women. Heading was significantly associated with poorer performance on psychomotor speed (p < 0.001) and attention (p = 0.02) tasks and was borderline significant with poorer performance on the working memory (p = 0.06) task. Unintentional head impacts were not significantly associated with any NP test. Results did not differ after excluding 22 HeadCount-2w with reported concussive or borderline concussive symptoms. Conclusion: Poorer NP test performance was consistently related to frequent heading during soccer practice and competition in the 2 weeks before testing. In contrast, unintentional head impacts incurred during soccer were not related to cognitive performance.	[Stewart, Walter F.] Sutter Hlth Res, Walnut Creek, CA USA; [Kim, Namhee; Ifrah, Chloe; Lipton, Michael L.] Gruss Magnet Resonance Res Ctr, Bronx, NY 10461 USA; [Kim, Namhee; Ifrah, Chloe; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Sliwinski, Martin] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Zimmerman, Molly E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Zimmerman, Molly E.] Fordham Univ, Bronx, NY 10458 USA; [Kim, Mimi; Lipton, Richard B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Lipton, Richard B.; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Lipton, ML (corresponding author), Gruss Magnet Resonance Res Ctr, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard B/B-5060-2011		NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001073] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER		Allen B, 2017, NEUROLOGY, V88, pE74, DOI 10.1212/WNL.0000000000003669; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; *FIFA, 2007, FIFA MAGAZINE, P10; Filley CM, 2010, NEUROPSYCHOL REV, V20, P158, DOI 10.1007/s11065-010-9127-9; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	43	16	16	2	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 24	2018	9								240	10.3389/fneur.2018.00240			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GD8FN	WOS:000430748400001	29740384	DOAJ Gold, Green Published			2021-06-18	
J	Kawata, K; Mitsuhashi, M; Aldret, R				Kawata, Keisuke; Mitsuhashi, Masato; Aldret, Randy			A Preliminary Report on Brain-Derived Extracellular Vesicle as Novel Blood Biomarkers for Sport-Related Concussions	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; concussion; neurotrauma; ice hockey; subconcussion; microvesicle	SERUM NEUROFILAMENT LIGHT; INTRACRANIAL LESIONS; INJURY; EXOSOMES; MILD; REHABILITATION; PROTEINS; PLAYERS; TAU	The purpose of the study was to test the utility of unique panel of blood biomarkers as a means to reflect one's recovery process after sport-related neurotrauma. We established a panel of biomarkers that reacted positive with CD81 (extracellular vesicle marker) and various neuron-and glia-specific antigens [e.g., neurofilament light polypeptide (NF-L), tau, synaptosome-associated protein 25 (SNAP25), glial fibrillary acidic protein, and myelin basic protein]. We first evaluated test-retest reliabilities of brain-derived exosome markers, followed by an application of these markers in eight professional ice hockey players to detect cumulative neuronal burden from a single ice hockey season. During the season, two players were diagnosed with concussions by team physician based on an exhibition of symptoms as well as abnormality in balance and ocular motor testing. One player reached symptom-free status 7 days after the concussion, while the other player required 36 days for symptoms to completely resolve. Blood samples and clinical assessments including balance error scoring system and near point of convergence throughout recovery process were obtained. Biomarkers indicative of axonal damage, neuronal inflammation, and glial activation showed excellent test-retest reliabilities (intra-class correlation coefficient: 0.713-0.998, p's < 0.01). There was a statistically significant increase in the NF-L marker at post-season follow-up compared to pre-season baseline (Z = -2.100, P = 0.036); however the statistical significance did not withstand Bonferroni correction for multiple comparisons. In concussion cases, neuronal and microglia markers notably increased after concussions, with the unique expression patterns being similar to that of concussion recovery process. These longitudinal data coupled with excellent test-retest reliabilities of novel array of blood biomarkers potentially reflect the damage in neural cell structures and metabolic crisis due to concussion. However, future studies with larger sample size and appropriate control groups to evaluate sensitivity and specificity of these markers are needed. This preliminary case report suggests the potential utility of multimodal blood biomarkers for concussion prognosis and recovery assessment.	[Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Mitsuhashi, Masato] NanoSomiX Inc, Aliso Viejo, CA USA; [Aldret, Randy] Univ Louisiana Lafayette, Sch Kinesiol, Lafayette, LA 70504 USA	Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA.	kkawata@indiana.edu			Indiana State Department of Health [ISCBIRF 0019939]	The authors would like to thank Dr. Stephanie N. Aldret for her assistance in data collection. This work was partly supported by the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (to K. Kawata: ISCBIRF 0019939). Sponsors had no role in the design or execution of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, J ATHL TRAINING, V42, P509; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nekludov M, 2017, BRAIN INJURY, V31, P1856, DOI 10.1080/02699052.2017.1358395; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yoshioka Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20424; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang H, 2010, EURASIP J ADV SIG PR, V2010, P7, DOI DOI 10.1016/J.NEUR0IMAGE.2010.12.007; Zhang XF, 2015, J INEQUAL APPL, DOI 10.1186/1029-242X-2015-1	40	16	16	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 12	2018	9								239	10.3389/fneur.2018.00239			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GC5IY	WOS:000429822000001	29706930	DOAJ Gold, Green Published			2021-06-18	
J	Godoy, DA; Lubillo, S; Rabinstein, AA				Agustin Godoy, Daniel; Lubillo, Santiago; Rabinstein, Alejandro A.			Pathophysiology and Management of Intracranial Hypertension and Tissular Brain Hypoxia After Severe Traumatic Brain Injury An Integrative Approach	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Intracranial pressure; Intracranial hypertension; Acute brain injury; Cerebral perfusion pressure; Cerebral oxygenation; Brain hypoxia; Multimodal monitoring; Traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; RANDOMIZED CONTROLLED-TRIALS; HYPERTONIC SODIUM SOLUTIONS; DECOMPRESSIVE CRANIECTOMY; OXYGEN-PRESSURE; THERAPEUTIC HYPOTHERMIA; METABOLIC CRISIS; LUMBAR DRAINAGE; BLOOD-FLOW	Monitoring intracranial pressure in comatose patients with severe traumatic brain injury (TBI) is considered necessary by most experts. Acute intracranial hypertension (IHT), when severe and sustained, is a life-threatening complication that demands emergency treatment. Yet, secondary anoxic-ischemic injury after brain trauma can occur in the absence of IHT. In such cases, adding other monitoring modalities can alert clinicians when the patient is in a state of energy failure. This article reviews the mechanisms, diagnosis, and treatment of IHT and brain hypoxia after TBI, emphasizing the need to develop a physiologically integrative approach to the management of these complex situations.	[Agustin Godoy, Daniel] San Juan Bautista Hosp, Intens Care Unit, Catamarca, Argentina; [Agustin Godoy, Daniel] Sanatorio Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina; [Lubillo, Santiago] Hosp Univ NS Candelaria, Intens Care Unit, Tenerife, Spain; [Rabinstein, Alejandro A.] Mayo Clin, Neurosci Crit Care Unit, Rochester, MN USA	Godoy, DA (corresponding author), Sanatorio Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina.	dagodoytorres@yahoo.com.ar					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aramendi I, 2016, MED INTENSIVA, V40, P113, DOI 10.1016/j.medin.2015.09.002; Artru F, 1998, NEUROL RES, V20, pS48; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bassin SL, 2008, CRIT CARE, V12, DOI 10.1186/cc7020; Bellemare P, 2007, INTENS CARE MED, V33, P2004, DOI 10.1007/s00134-007-0842-5; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Celis-Rodriguez E, 2013, MED INTENSIVA, V37, P519, DOI 10.1016/j.medin.2013.04.001; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 2007, Neurosurg Focus, V22, pE10; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gillman LM, 2014, CASE REP CRIT CARE, V2014; Godoy DA, 2015, MED INTENSIVA, V39, P445, DOI 10.1016/j.medin.2014.10.009; Godoy DA, 2005, ACTA ANAESTH SCAND, V49, P1577, DOI 10.1111/j.1399-6576.2005.00885_49_10.x; Godoy DA, 2014, NEUROCRIT CARE, V141, P616; Godoy DA, 2014, GREEN BOOK CUIDADOS, P19; Godoy DA, 2016, CURR OPIN CRIT CARE, V22, P120, DOI 10.1097/MCC.0000000000000292; Godoy DA, 2012, NEUROSURGERY, V71, P245, DOI 10.1227/NEU.0b013e318256b9f5; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; Honda M, 2017, NEUROCRIT CARE; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerr M E, 1998, Am J Crit Care, V7, P205; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Lauerman MH, 2014, CURR OPIN ANESTHESIO, V27, P219, DOI 10.1097/ACO.0000000000000044; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Lee TT, 1997, SURG NEUROL, V48, P333, DOI 10.1016/S0090-3019(96)00483-1; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Lelubre C, 2016, MINERVA ANESTESIOL, V82, P112; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Li M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000736; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Malbrain MLNG, 2011, AM SURGEON, V77, pS6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marin-Caballos AJ, 2008, MED INTENSIVA, V32, P81, DOI 10.1016/S0210-5691(08)70912-4; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martini RP, 2013, RESP CARE, V58, P162, DOI 10.4187/respcare.01942; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Mirski MA, 2008, SEMIN NEUROL, V28, P611, DOI 10.1055/s-0028-1105970; Monro A., 1823, OBSERVATIONS STRUCTU, P5; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Munch EC, 2001, CRIT CARE MED, V29, P976; Murad A, 2008, ACT NEUR S, V102, P89, DOI 10.1007/978-3-211-85578-2_18; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Perez-Barcena J, 2014, CRIT CARE CLIN, V30, P735, DOI 10.1016/j.ccc.2014.06.005; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; Poca MA, 2005, NEUROCIRUGIA, V16, P385; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts R G, 2002, Crit Care Resusc, V4, P271; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Ortega MAR, 2014, MED INTENSIVA, V38, P41, DOI 10.1016/j.medin.2013.03.008; Rosenthal R J, 1998, J Gastrointest Surg, V2, P415, DOI 10.1016/S1091-255X(98)80031-0; Rosner MJ, 1989, INTRACRANIAL PRESSUR, P611; Sader N, 2015, NEUROCRIT CARE, V22, P437, DOI 10.1007/s12028-014-0088-3; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Sanfilippo F, 2015, NEUROCRIT CARE, V22, P325, DOI 10.1007/s12028-014-0061-1; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; SIGGAARDANDERSEN O, 1995, CRIT CARE MED, V23, P1284, DOI 10.1097/00003246-199507000-00020; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steingrub JS, 2014, CRIT CARE MED, V42, P90, DOI 10.1097/CCM.0b013e31829eb7c9; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Willemse RB, 1998, ACT NEUR S, V71, P37; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	132	16	19	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2018	29	2					195	+		10.1016/j.nec.2017.12.001			19	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GB6MJ	WOS:000429183000002	29502711				2021-06-18	
J	Georgoff, PE; Nikolian, VC; Higgins, G; Chtraklin, K; Eidy, H; Ghandour, MH; Williams, A; Athey, B; Alam, HB				Georgoff, Patrick E.; Nikolian, Vahagn C.; Higgins, Gerald; Chtraklin, Kiril; Eidy, Hassan; Ghandour, Mohamed H.; Williams, Aaron; Athey, Brian; Alam, Hasan B.			Valproic acid induces prosurvival transcriptomic changes in swine subjected to traumatic injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Valproic acid; histone deacetylase inhibitor; genomics; RNA sequencing; trauma; hemorrhage; traumatic brain injury	HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION PROFILES; BRAIN-INJURY; PHARMACOLOGICAL RESUSCITATION; CHROMATIN-STRUCTURE; LESION SIZE; MODEL; MECHANISMS; BIOCONDUCTOR; INFLAMMATION	BACKGROUND: Valproic acid (VPA) is a histone deacetylase inhibitor that improves outcomes in large animal models of trauma. However, its protective mechanism of action is not completely understood. We sought to characterize the genetic changes induced by VPA treatment following traumatic injuries. METHODS: Six female Yorkshire swine were subjected to traumatic brain injury (controlled cortical impact), polytrauma (liver and splenic laceration, rib fracture, rectus crush), and hemorrhagic shock (HS, 40% total blood volume). Following 2 hours of HS, animals were randomized to resuscitation with normal saline (NS) or NS + 150 mg/kg of intravenous VPA (n = 3/cohort, 18 samples total). Blood samples were collected for isolation of peripheral blood mononuclear cells at three distinct time points: baseline, 6 hours following injuries, and on postinjury day 1. RNA was extracted from peripheral blood mononuclear cells and sequenced. Differential expression analysis (false discovery rate < 0.001 and p value <0.001) and gene set enrichment (Panther Gene Ontology and Ingenuity Pathway Analysis) was used to compare VPA to non-VPA-treated animals. RESULTS: A total of 628 differentially expressed RNA transcripts were identified, 412 of which were used for analysis. There was no difference between treatment groups at baseline. The VPA-induced genetic changes were similar at 6 hours and on postinjury day 1. Upregulated genes were associated with gene expression (p 2.13E-34), cellular development (1.19E-33), cellular growth and proliferation (1.25E-30), and glucocorticoid receptor signaling (8.6E-21). Downregulated genes were associated with cell cycle checkpoint regulation (3.64E-22), apoptosis signaling (6.54E-21), acute phase response signaling (5.84E-23), and the inflammasome pathway (1.7E-19). CONCLUSION: In injured swine, VPA increases the expression of genes associated with cell survival, proliferation, and differentiation and decreases those associated with cell death and inflammation. These genetic changes could explain the superior clinical outcomes in VPA-treated animals, including smaller brain lesion size and improved neurologic recovery. (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Georgoff, Patrick E.; Nikolian, Vahagn C.; Chtraklin, Kiril; Eidy, Hassan; Ghandour, Mohamed H.; Williams, Aaron; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Higgins, Gerald; Athey, Brian] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465	US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0520]; Massey Foundation	Funded by research grants from the US Army Medical Research and Material Command (W81XWH-09-1-0520) to HBA and the Massey Foundation to HBA and PEG.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; ANDERS S, 2010, GENOME BIOL, V11, DOI [10.1186/gb-2010-11-10-r106, DOI 10.1186/GB-2010-11-10-R106]; Bose P, 2014, PHARMACOL THERAPEUT, V143, P323, DOI 10.1016/j.pharmthera.2014.04.004; BOYUM A, 1977, LYMPHOLOGY, V10, P71; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Felisbino MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029144; Fukudome EY, 2010, J SURG RES, V163, P118, DOI 10.1016/j.jss.2010.04.013; Gao LY, 2011, BIOINFORMATICS, V27, P662, DOI 10.1093/bioinformatics/btr005; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Georgoff PE, 2017, CLIN PHARMACOKINET; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Gray SG, 2004, INT J ONCOL, V24, P773; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Li YQ, 2010, SURGERY, V148, P246, DOI 10.1016/j.surg.2010.05.003; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lv L, 2011, BRAIN RES, V1396, P60, DOI 10.1016/j.brainres.2011.03.040; Maier RV, 2014, J TRAUMA ACUTE CARE, V77, P912; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Nikolian VC, 2016, J AM COLL SURGEONS, V223, pS83, DOI 10.1016/j.jamcollsurg.2016.06.162; Nueda MJ, 2014, BIOINFORMATICS, V30, P2598, DOI 10.1093/bioinformatics/btu333; Peart MJ, 2003, CANCER RES, V63, P4460; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Sauaia A, 2017, CRIT CARE CLIN, V33, P167, DOI 10.1016/j.ccc.2016.08.006; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Sillesen M, 2016, J TRAUMA ACUTE CARE, V80, P26, DOI 10.1097/TA.0000000000000896; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhao T, 2013, SURGERY, V154, P206, DOI 10.1016/j.surg.2013.04.003	48	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2018	84	4					642	649		10.1097/TA.0000000000001763			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	GE4IT	WOS:000431179700013	29251706				2021-06-18	
J	Sieber, M; Dressler, J; Franke, H; Pohlers, D; Ondruschka, B				Sieber, Monique; Dressler, Jan; Franke, Heike; Pohlers, Dirk; Ondruschka, Benjamin			Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Autopsy; Cerebrospinal fluid; NSE; Post-mortem biochemistry; S100B; Traumatic brain injury	NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; S-100B PROTEIN; SERUM; BIOMARKERS; MARKER; HEMOLYSIS; BLOOD; TIME; CSF	Purpose: Traumatic brain injury (TBI) is a very common entity that leads to numerous fatalities all over the world. Therefore, forensic pathologists are in desperate need of supplemental methodological tools for the diagnosis of TBI in everyday practice besides the standard autopsy. The present study determined post-mortem neuron specific enolase (NSE) and S100 calcium-binding protein B (S100B) levels as biological markers of an underlying TBI in autopsy cases. Methods: Paired serum and CSF samples of 92 fatalities were collected throughout routine autopsies. Afterwards, the marker levels were assessed using commercially available immunoassays (ECLIA, Roche Diagnostics). For statistical analysis, we compared the TBI cases to three control groups (sudden natural death by acute myocardial infarction, traumatic death without impact on the head, cerebral hypoxia). Moreover, the TBI cases were subdivided according to their survival time of the trauma. Brain specimens have been collected and stained immunohistochemically against the aforementioned proteins to illustrate their typical cellular staining patterns with an underlying TBI compared to non-TBI fatalities. Principal results: CSF NSE and S100B levels were elevated after TBI compared to all control groups (p < 0.001). Although this finding can already be investigated among the TBI cases dying immediately subsequent to the trauma, the marker levels in CSF increase with longer survival times until a peak level within the first three days after trauma. There is a strong correlation between both marker levels in CSF (r=0.67). The presence or absence of cerebral tissue contusion following the initial trauma does not seem to affect the CSF levels of both proteins (p > 0.05). Post-mortem serum levels of both proteins were not elevated in TBI cases compared to controls (p > 0.05). Former elaborated cut-off values in CSF were confirmed and were only exceeded when a TBI survival time of at least 30 min was reached. Major conclusions: The present results report that post-mortem NSE and S100B CSF levels are significantly elevated subsequent to a fatal TBI.	[Sieber, Monique; Dressler, Jan; Ondruschka, Benjamin] Univ Leipzig, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Pohlers, Dirk] Klinikum Chemnitz, Ctr Diagnost GmbH, Chemnitz, Germany	Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizinuni-leipzig.de					Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; BARGER SW, 1992, J BIOL CHEM, V267, P9689; Beaudeux JL, 2000, CLIN CHEM, V46, P989; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Franke H, 2012, PURINERG SIGNAL, V8, P629, DOI 10.1007/s11302-012-9300-0; Gao F, 1997, PERFUSION-UK, V12, P171, DOI 10.1177/026765919701200305; Goede A, 2015, RECHTSMEDIZIN, V25, P261, DOI 10.1007/s00194-015-0040-7; HAIMOTO H, 1985, LAB INVEST, V52, P257; Hajdukova L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/379071; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2009, Leg Med (Tokyo), V11 Suppl 1, pS273, DOI 10.1016/j.legalmed.2009.02.042; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Maeda H, 2009, LEG MED, V11, P46, DOI DOI 10.1016/J.LEGALMED.2009.01.048; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Oehmichen Manfred, 2003, Leg Med (Tokyo), V5, P190, DOI 10.1016/S1344-6223(03)00077-4; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Ondruschka B, 2017, ROM J LEG MED, V25, P301, DOI 10.4323/rjlm.2017.301; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Penkowa M, 1999, GLIA, V25, P343; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Schiavi Paolo, 2012, Acta Biomed, V83, P5; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wojtczak-Soska K, 2010, CARDIOL J, V17, P532; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	52	16	17	2	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	APR	2018	55						65	73		10.1016/j.jflm.2018.02.016			9	Medicine, Legal	Legal Medicine	FZ6AH	WOS:000427677700010	29471249				2021-06-18	
J	Wu, J; Vogel, T; Gao, X; Lin, B; Kulwin, C; Chen, JH				Wu, Jin; Vogel, Todd; Gao, Xiang; Lin, Bin; Kulwin, Charles; Chen, Jinhui			Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury	SCIENTIFIC REPORTS			English	Article							AGONIST; NEURONS; DEATH; ERYTHROPOIETIN; MECHANISMS; PROPOFOL; SEDATION; DAMAGE; MICE; UNIT	No FDA approved pharmacological therapy is available that would reduce cell death following traumatic brain injury (TBI). Dexmedetomidine (Dex) is a highly selective agonist of alpha-2 adrenergic receptors and has demonstrated neuroprotective effects in hippocampal slice cultures undergoing direct impact. However, no one has tested whether Dex, in addition to its sedative action, has neuroprotective effects in an animal model of TBI. Thus, in the present study, we investigated the effects of Dex on an animal model of TBI. Mice received different doses of Dex (1, 10, or 100 mu g/kg bodyweight, n = 10 each group) or saline as control at 1 hour and 12 hours following TBI. The mice treated with Dex lost less cortical tissue than the control mice. Further analysis found that Dex treatment reduced cell death in the cortex and the hippocampus measured by Fluoro-Jade B (FJB) staining, prevented axonal degeneration detected by immunostaining with antibody against beta-amyloid precursor protein (beta-APP), and protected synapses from elimination with synaptophysin staining. Taken together, in an in vivo murine model of TBI, Dex at the dose of 100 mu g/kg not only prevented tissue lesion and cell death, but also reduced axonal injury and synaptic degeneration caused by TBI.	[Wu, Jin; Lin, Bin] Xiamen Univ, Affiliated Southeast Hosp, Dept Orthopaed, Zhangzhou, Peoples R China; [Vogel, Todd; Kulwin, Charles; Chen, Jinhui] Indiana Univ, Dept Neurosurg, Indianapolis, IN 46204 USA; [Gao, Xiang; Chen, Jinhui] Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA	Chen, JH (corresponding author), Indiana Univ, Dept Neurosurg, Indianapolis, IN 46204 USA.; Chen, JH (corresponding author), Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA.	chen204@iupui.edu			Goodman Campbell Foundation; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81402217]	This study was supported by the Goodman Campbell Foundation and the Natural Science Foundation of China (No. 81402217).	Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bejian S, 2009, CARDIOL YOUNG, V19, P98, DOI 10.1017/S1047951109003515; Cai Y, 2014, MOL MED REP, V9, P1542, DOI 10.3892/mmr.2014.2034; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Flower O, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/637171; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22490; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; GENTLEMAN D, 1992, INT SURG, V77, P297; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Keating GM, 2015, DRUGS, V75, P1119, DOI 10.1007/s40265-015-0419-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laudenbach V, 2002, ANESTHESIOLOGY, V96, P134, DOI 10.1097/00000542-200201000-00026; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Miao YF, 2010, BIOMED PHARMACOTHER, V64, P583, DOI 10.1016/j.biopha.2010.03.006; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Sigel Erwin, 2002, Current Topics in Medicinal Chemistry, V2, P833, DOI 10.2174/1568026023393444; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z	43	16	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 21	2018	8								4935	10.1038/s41598-018-23003-3			10	Multidisciplinary Sciences	Science & Technology - Other Topics	FZ9IV	WOS:000427925000015	29563509	DOAJ Gold, Green Published			2021-06-18	
J	Zhang, WQ; Cui, Y; Gao, JL; Li, R; Jiang, XH; Tian, YX; Wang, KJ; Cui, JZ				Zhang, Wenqian; Cui, Ying; Gao, Junling; Li, Ran; Jiang, Xiaohua; Tian, Yanxia; Wang, Kaijie; Cui, Jianzhong			Recombinant Osteopontin Improves Neurological Functional Recovery and Protects Against Apoptosis via PI3K/Akt/GSK-3 beta Pathway Following Intracerebral Hemorrhage	MEDICAL SCIENCE MONITOR			English	Article						Apoptosis; Cerebral Hemorrhage; Osteopontin; Phosphatidylinositol 3-Kinases	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; GLYCOGEN-SYNTHASE KINASE-3; PI3K/AKT/GSK3-BETA PATHWAY; CELL-SURVIVAL; MOUSE MODEL; INHIBITION; EXPRESSION; STROKE; CANCER	Background: This study aimed to investigate the potential neuroprotective effect of recombinant osteopontin (r-OPN) on apoptotic changes via modulating phosphoinositide-3-kinase/Akt/glycogen synthase kinase 3 beta (PI3K/Akt/GSK-3 beta) signaling in a rat model of intracerebral hemorrhage (ICH). Material/Methods: We subjected 10-12-week-old Sprague-Dawley male rats (n=120) to injection of autologous blood into the right basal ganglia to induce ICH or sham surgery. ICH animals received vehicle administration, r-OPN (4 mu L/pup), or r-OPN combined with phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin (86 ng/pup) at 30 min after injury. Neurological scores and rotarod latencies were evaluated on days 1-5 post-ICH. Brain water content was evaluated on days 1-3 post-ICH. The number of apoptotic cells changes were evaluated by terminal deoxynucleotidyl transferase-mediated 2-deoxyuridine 5-triphosphate-biotin nick-end labeling (TUNEL) and hematoxylin staining. Apoptosis-related proteins Bcl-2, Bax, and cleaved caspase-3 (CC3), and the phosphorylation levels of Akt and GSK-3 beta were assayed by Western blot. Results: Neurological deficits, rotarod latencies, and brain water content following ICH were reduced in the r-OPN group compared to the vehicle group. r-OPN also attenuated cell death in ICH. Furthermore, treatment with r-OPN significantly increased p-Akt expression and decreased p-GSK-3 beta. These effects were associated with a decrease in the Bax/Bcl-2 ratio and the suppression of CC3 at 24 h after ICH. Importantly, all the beneficial effects of r-OPN in ICH were abrogated by the PI3K inhibitor wortmannin. Conclusions: r-OPN may provide a wide range of neuroprotection by suppressing apoptosis through the PI3K/Akt/GSK-3 beta signaling pathway after ICH.	[Zhang, Wenqian; Cui, Jianzhong] Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China; [Cui, Ying; Wang, Kaijie; Cui, Jianzhong] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan, Hebei, Peoples R China; [Gao, Junling; Li, Ran; Jiang, Xiaohua; Tian, Yanxia] North China Univ Sci & Technol, Sch Basic Med Sci, Tangshan, Hebei, Peoples R China; [Gao, Junling; Li, Ran; Jiang, Xiaohua; Tian, Yanxia] Tangshan Key Lab Preclin & Basic Res Chron Dis, Hebei Key Lab Chron Dis, Tangshan, Hebei, Peoples R China	Cui, JZ (corresponding author), Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China.; Cui, JZ (corresponding author), Tangshan Gongren Hosp, Dept Neurosurg, Tangshan, Hebei, Peoples R China.	jianzhongcuidoctor@163.com		, Wenqian Zhang/0000-0002-4757-5253	Natural Science Foundation of Hebei, ChinaNatural Science Foundation of Hebei Province [H2012401071, H2014105079]	This study was supported by a grant from the Natural Science Foundation of Hebei, China (grant no. H2012401071 and H2014105079)	Belur PK, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1317; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen L, 2014, NEUROCHEM INT, V66, P27, DOI 10.1016/j.neuint.2014.01.006; Chen L, 2013, NEUROCHEM RES, V38, P2268, DOI 10.1007/s11064-013-1135-8; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Garwood ER, 2010, BREAST CANCER RES TR, V119, P137, DOI 10.1007/s10549-009-0507-x; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He JC, 2015, BRAIN RES, V1611, P74, DOI 10.1016/j.brainres.2015.03.015; Hua Y, 2009, STROKE, V40, pS88, DOI 10.1161/STROKEAHA.108.533281; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Lee SH, 2017, MED SCI MONITOR, V23, P1401, DOI 10.12659/MSM.899309; Lu QH, 2016, MED SCI MONITOR, V22, P1716, DOI 10.12659/MSM.898642; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Matusan-Ilijas K, 2008, PATHOL ONCOL RES, V14, P293, DOI 10.1007/s12253-008-9058-4; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Reis CR, 2015, EMBO J, V34, P2132, DOI 10.15252/embj.201591518; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Spencer RL, 2000, BRAIN RES, V868, P275, DOI 10.1016/S0006-8993(00)02341-6; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Wu BH, 2011, NEUROCRIT CARE, V14, P109, DOI 10.1007/s12028-010-9372-z; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yang DM, 2011, J NEUROSURG, V114, P1110, DOI 10.3171/2010.6.JNS091856; Yang JT, 2011, ACTA NEUROCHIR, V153, P2197, DOI 10.1007/s00701-011-1122-2; Zhang S, 2013, NEUROCHEM INT, V63, P522, DOI 10.1016/j.neuint.2013.08.008; Zhu H, 2018, MED SCI MONITOR, V24, P366	46	16	17	4	8	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAR 18	2018	24						1588	1596		10.12659/MSM.905700			9	Medicine, Research & Experimental	Research & Experimental Medicine	GA1PV	WOS:000428090200001	29550832	Green Published			2021-06-18	
J	Bedi, SS; Aertker, BM; Liao, GP; Caplan, HW; Bhattarai, D; Mandy, F; Mandy, F; Fernandez, LG; Zelnick, P; Mitchell, MB; Schiffer, W; Johnson, M; Denson, E; Prabhakara, K; Xue, H; Smith, P; Uray, K; Olson, SD; Mays, RW; Cox, CS				Bedi, Supinder S.; Aertker, Benjamin M.; Liao, George P.; Caplan, Henry W.; Bhattarai, Deepa; Mandy, Fanni; Mandy, Franciska; Fernandez, Luis G.; Zelnick, Pamela; Mitchell, Matthew B.; Schiffer, Walter; Johnson, Margaret; Denson, Emma; Prabhakara, Karthik; Xue, Hasen; Smith, Philippa; Uray, Karen; Olson, Scott D.; Mays, Robert W.; Cox, Charles S., Jr.			Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglia; Neuroinflammation; Spatial learning and blood-brain barrier	ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; CONTROLLED CORTICAL IMPACT; MICROGLIAL ACTIVATION; CELLS; RATS; RECRUITMENT; NEUROINFLAMMATION; TRANSPLANTATION; EXPRESSION; INFARCTION	Background: Traumatic brain injury (TBI) is a major cause of death and disability. TBI results in a prolonged secondary central neuro-inflammatory response. Previously, we have demonstrated that multiple doses (2 and 24 h after TBI) of multipotent adult progenitor cells (MAPC) delivered intravenously preserve the blood-brain barrier (BBB), improve spatial learning, and decrease activated microglia/macrophages in the dentate gyrus of the hippocampus. In order to determine if there is an optimum treatment window to preserve the BBB, improve cognitive behavior, and attenuate the activated microglia/macrophages, we administered MAPC at various clinically relevant intervals. Methods: We administered two injections intravenously of MAPC treatment at hours 2 and 24 (2/24), 6 and 24 (6/24), 12 and 36 (12/36), or 36 and 72 (36/72) post cortical contusion injury (CCI) at a concentration of 10 million/kg. For BBB experiments, animals that received MAPC at 2/24, 6/24, and 12/36 were euthanized 72 h post injury. The 36/72 treated group was harvested at 96 h post injury. Results: Administration of MAPC resulted in a significant decrease in BBB permeability when administered at 2/24 h after TBI only. For behavior experiments, animals were harvested post behavior paradigm. There was a significant improvement in spatial learning (120 days post injury) when compared to cortical contusion injury (CCI) in groups when MAPC was administered at or before 24 h. In addition, there was a significant decrease in activated microglia/macrophages in the dentate gyrus of hippocampus of the treated group (2/24) only when compared to CCI. Conclusions: Intravenous injections of MAPC at or before 24 h after CCI resulted in improvement of the BBB, improved cognitive behavior, and attenuated activated microglia/macrophages in the dentate gyrus.	[Bedi, Supinder S.; Aertker, Benjamin M.; Liao, George P.; Caplan, Henry W.; Bhattarai, Deepa; Mandy, Fanni; Mandy, Franciska; Fernandez, Luis G.; Zelnick, Pamela; Mitchell, Matthew B.; Schiffer, Walter; Johnson, Margaret; Denson, Emma; Prabhakara, Karthik; Xue, Hasen; Smith, Philippa; Uray, Karen; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Michael E DeBakey Inst Comparat Cardiovasc Sci &, Cleveland, OH USA; [Cox, Charles S., Jr.] Athersys Inc, Cleveland, OH USA	Bedi, SS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA.	Supinder.Bedi@uth.tmc.edu		Cardenas, Fanni/0000-0002-2026-5351; Zelnick, Pamela/0000-0002-2781-9791; Olson, Scott/0000-0001-8032-3755; Caplan, Henry/0000-0003-0012-1606	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [4U44NS077511-03, 2T32 GM0879201-11A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44NS077511] Funding Source: NIH RePORTER	d This study is supported by NIH grants 4U44NS077511-03 (Cox/Mays) and 2T32 GM0879201-11A1 (Cox).	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Aloisi F, 2001, ANN MED, V33, P510, DOI 10.3109/07853890108995960; Aranda P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007809; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Belarbi K, 2012, BRAIN BEHAV IMMUN, V26, P18, DOI 10.1016/j.bbi.2011.07.225; Boozer Sherry, 2009, J Stem Cells, V4, P17, DOI jsc.2009.4.1.17; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Burrows GG, 2013, STEM CELL TRANSL MED, V2, P745, DOI 10.5966/sctm.2013-0031; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kalla R, 2001, J COMP NEUROL, V436, P182; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Ma Y., 2016, PROG NEUROBIOL; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rekha J, 2009, BEHAV NEUROSCI, V123, P1197, DOI 10.1037/a0017655; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Smith HS, 2010, PAIN PHYSICIAN, V13, P295; Soares HD, 1995, J NEUROSCI, V15, P8223; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Terry AV, 2009, FRONT NEUROSCI, P267; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker Peter A, 2011, World J Stem Cells, V3, P9, DOI 10.4252/wjsc.v3.i2.9; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005	48	16	17	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAR 16	2018	15								84	10.1186/s12974-018-1122-8			13	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	FZ9BN	WOS:000427904700001	29548333	DOAJ Gold, Green Published			2021-06-18	
J	Gabler, LF; Joodaki, H; Crandall, JR; Panzer, MB				Gabler, Lee F.; Joodaki, Hamed; Crandall, Jeff R.; Panzer, Matthew B.			Development of a Single-Degree-of-Freedom Mechanical Model for Predicting Strain-Based Brain Injury Responses	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						brain injury criteria; rotational head kinematics; finite element modeling; brain deformation; parametric study	HEAD IMPACT; CONCUSSION; TOLERANCE; KINEMATICS; FOOTBALL	Linking head kinematics to injury risk has been the focus of numerous brain injury criteria. Although many early forms were developed using mechanics principles, recent criteria have been developed using empirical methods based on subsets of head impact data. In this study, a single-degree-of-freedom (sDOF) mechanical analog was developed to parametrically investigate the link between rotational head kinematics and brain deformation. Model efficacy was assessed by comparing the maximum magnitude of displacement to strain-based brain injury predictors from finite element (FE) human head models. A series of idealized rotational pulses covering a broad range of acceleration and velocity magnitudes (0.1-15 krad/s(2) and 1-100 rad/s) with durations between 1 and 3000 ms were applied to the mechanical models about each axis of the head. Results show that brain deformation magnitude is governed by three categories of rotational head motion each distinguished by the duration of the pulse relative to the brain's natural period: for short-duration pulses, maximum brain deformation depended primarily on angular velocity magnitude; for long-duration pulses, brain deformation depended primarily on angular acceleration magnitude; and for pulses relatively close to the natural period, brain deformation depended on both velocity and acceleration magnitudes. These results suggest that brain deformation mechanics can be adequately explained by simple mechanical systems, since FE model responses and experimental brain injury tolerances exhibited similar patterns to the sDOF model. Finally, the sDOF model was the best correlate to strain-based responses and highlighted fundamental limitations with existing rotational-based brain injury metrics.	[Gabler, Lee F.; Joodaki, Hamed; Crandall, Jeff R.; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, POB 400237, Charlottesville, VA 22904 USA	Panzer, MB (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, POB 400237, Charlottesville, VA 22904 USA.	lfg4dc@virginia.edu; hj2vq@eservices.virginia.edu; jrc2h@virginia.edu; mbp2q@virginia.edu			Partnership for Dummy Technology and Biomechanics (PDB)	The Partnership for Dummy Technology and Biomechanics (PDB).	Bandak F. A., 2001, 2001060222 SAE; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; CDC, 2010, RAT TBI REL EM DEP V; CDC, 2016, REP C TRAUM BRAIN IN; DVBIC, 2016, DOD WORLDW NUMB TBI; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Fan W. R, 1971, 710870 SAE; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gadd CW., 1966, 660793 SAE; GOLDSMITH W, 1972, BIOMECHANICS HEAD IN; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Kimpara H., 2011, INT J AUTOMOT ENG, V2, P13; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King W., 2013, HUMAN IMPACT RESPONS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KORNHAUSER M, 1961, PLANET SPACE SCI, V7, P386, DOI 10.1016/0032-0633(61)90316-6; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Newman J A, 2000, Stapp Car Crash J, V44, P215; NOCSAE, 2012, ND00115M17 NOCSAE; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Patrick L. M., 1963, P 7 STAPP CAR CRASH, P483; Payne P. R., 1962, IMP ACC STRESS S SAN, P195; Rao S.S., 1995, MECH VIBRATIONS, V5th; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; SAE International, 1995, J2111199503 SAE INT; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Staffeld S. E., 1970, 700902 SAE; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tauffkirchen W, 1970, 700426 SAE; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thibault L. E., 1985, 856022 SAE; Versace J., 1971, 710881 SAE; von Gierke H. E, 1964, BIOASTRONAUTICS, P61; Yanaoka T., 2015, 2015011439 SAE; Zhao W., 2017, BIOMECH MODEL MECHAN, V16, P1; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	48	16	16	0	6	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAR	2018	140	3							031002	10.1115/1.4038357			13	Biophysics; Engineering, Biomedical	Biophysics; Engineering	FV9OJ	WOS:000424917600003	29114772				2021-06-18	
J	Kontos, AP; Collins, MW; Holland, CL; Reeves, VL; Edelman, K; Benso, S; Schneider, W; Okonkwo, D				Kontos, Anthony P.; Collins, Michael W.; Holland, Cyndi L.; Reeves, Valerie L.; Edelman, Kathryn; Benso, Steven; Schneider, Walter; Okonkwo, David			Preliminary Evidence for Improvement in Symptoms, Cognitive, Vestibular, and Oculomotor Outcomes Following Targeted Intervention with Chronic mTBI Patients	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS; CONCUSSION; AFGHANISTAN; MOTOR; BLAST; IRAQ; TBI	Introduction: To determine if targeted, active interventions would improve symptoms and impairment in previously intractable patients with chronic mild traumatic brain injury (mTBI). Materials and Methods: Twenty-six (20 males; 6 females) out of 51 (51%) former military and civilian patients with chronic (1-3 yr) mTBI enrolled in the TEAM traumatic brain injury (TBI) study completed both an initial and 6-mo post-intervention comprehensive mTBI assessment including symptoms (Post-concussion Symptom Scale [PCSS], Dizziness Handicap Inventory [DHI]), cognitive (Immediate Post-concussion Assessment and Cognitive Testing [ImPACT]), vestibular/oculomotor (Vestibular/Ocular Motor Screening [VOMS]), balance (Activities-specific Balance Confidence [ABC] scale, Balance Error Scoring System [BESS]), and cervical (Neck Disability Index [NDI]). Patients were prescribed progressive, targeted interventions and therapies (e.g., behavioral, vestibular, vision, and exertion) that matched their mTBI clinical profile. A series of paired t-tests adjusted for multiple corrections were used to compare pre- and post-intervention assessment scores. Results: Patients demonstrated significant improvement from pre-to post-intervention on total symptoms (t = 2.69, p = 0.01), verbal memory (t = -1.96, p = 0.05), ABC balance score (t = -2.05, p = 0.05), smooth pursuits (t = 2.32, p = 0.04), near-point convergence distance (t = -3.58, p = 0.01), vestibular ocular reflex (t = 2.31, p = 0.03), and visual motion sensitivity (t = 2.43, p = 0.03). Conclusions: Previously recalcitrant patients with chronic complex mTBI demonstrated significant improvement in symptoms, cognitive, vestibular, oculomotor, and balance function following targeted interventions.	[Kontos, Anthony P.; Collins, Michael W.; Reeves, Valerie L.] Univ Pittsburgh, Dept Orthopaed Surg, 4200 5th Ave, Pittsburgh, PA 15260 USA; [Kontos, Anthony P.; Collins, Michael W.; Holland, Cyndi L.] UPMC, Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Edelman, Kathryn; Benso, Steven; Okonkwo, David] Univ Pittsburgh, Dept Neurol Surg, 4200 5th Ave, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, 4200 5th Ave, Pittsburgh, PA 15260 USA	Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 4200 5th Ave, Pittsburgh, PA 15260 USA.; Kontos, AP (corresponding author), UPMC, Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.				Department of DefenseUnited States Department of Defense [W81XWH-14-2-0002]	This research was funded by Department of Defense W81XWH-14-2-0002.	Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manners JL, 2016, J NEUROTRAUM, V33, P1796, DOI 10.1089/neu.2015.4245; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; O'Neil M.E., 2013, COMPLICATIONS MILD T; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	20	16	16	1	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			333	338		10.1093/milmed/usx172			6	Medicine, General & Internal	General & Internal Medicine	GC0JM	WOS:000429463600047	29635578	Bronze			2021-06-18	
J	Nicol, LSC; Thornton, P; Hatcher, JP; Glover, CP; Webster, CI; Burrell, M; Hammett, K; Jones, CA; Sleeman, MA; Billinton, A; Chessell, I				Nicol, Louise S. C.; Thornton, Peter; Hatcher, Jon P.; Glover, Colin P.; Webster, Carl I.; Burrell, Matthew; Hammett, Kessia; Jones, Clare A.; Sleeman, Matthew A.; Billinton, Andrew; Chessell, Iain			Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain	PAIN			English	Article						Granulocyte-macrophage colony-stimulating factor; Neuropathic pain; Inflammation; Microglia; Astrocyte; Blood-brain barrier; Cytokine	GM-CSF RECEPTOR; PERIPHERAL-NERVE INJURY; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; MICROGLIAL ACTIVATION; SPINAL-CORD; EXPRESSION; CYTOKINES; MECHANISMS; INTERLEUKIN-1-BETA	With less than 50% of patients responding to the current standard of care and poor efficacy and selectivity of current treatments, neuropathic pain continues to be an area of considerable unmet medical need. Biological therapeutics such as monoclonal antibodies (mAbs) provide better intrinsic selectivity; however, delivery to the central nervous system (CNS) remains a challenge. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is well described in inflammation-induced pain, and early-phase clinical trials evaluating its antagonism have exemplified its importance as a peripheral pain target. Here, we investigate the role of this cytokine in a murine model of traumatic nerve injury and show that deletion of the GM-CSF receptor or treatment with an antagonizing mAb alleviates pain. We also demonstrate enhanced analgesic efficacy using an engineered construct that has greater capacity to penetrate the CNS. Despite observing GM-CSF receptor expression in microglia and astrocytes, the gliosis response in the dorsal horn was not altered in nerve injured knockout mice compared with wild-type littermate controls as evaluated by ionized calcium binding adapter molecule 1 (Iba1) and glial fibrillary acidic protein, respectively. Functional analysis of glial cells revealed that pretreatment with GM-CSF potentiated lipopolysaccharide-induced release of proinflammatory cytokines. In summary, our data indicate that GM-CSF is a proinflammatory cytokine that contributes to nociceptive signalling through driving spinal glial cell secretion of proinflammatory mediators. In addition, we report a successful approach to accessing CNS pain targets, providing promise for central compartment delivery of analgesics.	[Nicol, Louise S. C.; Glover, Colin P.; Jones, Clare A.; Sleeman, Matthew A.] MedImmune, Resp Inflammat & Autoimmun Res, Cambridge, England; [Thornton, Peter; Hatcher, Jon P.; Billinton, Andrew; Chessell, Iain] AstraZeneca, IMED, Neurosci, Cambridge, England; [Webster, Carl I.; Burrell, Matthew] MedImmune, Antibody Discovery & Prot Engn, Cambridge, England; [Hammett, Kessia] Kings Coll London, Wolfson Ctr Age Related Dis, London, England	Nicol, LSC (corresponding author), MedImmune Ltd, Res & Dev, Cambridge CB21 6GH, England.	nicoll@medimmune.com			MedImmuneAstraZeneca	The authors thank all the staff of MedImmune's Biological Services unit for their invaluable help and technical assistance in performing the surgeries. All work described in this article was funded by MedImmune.	ALVAROGRACIA JM, 1991, J IMMUNOL, V146, P3365; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Backonja MM, 2008, J NEUROIMMUNOL, V195, P157, DOI 10.1016/j.jneuroim.2008.01.005; BALDWIN GC, 1993, BLOOD, V82, P3279; BERENBAUM F, 1994, EUR CYTOKINE NETW, V5, P43; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Cook AD, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4037; Cook AD, 2013, ANN RHEUM DIS, V72, P265, DOI 10.1136/annrheumdis-2012-201703; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Dame JB, 1999, PEDIATR RES, V46, P358, DOI 10.1203/00006450-199910000-00002; Daramola O, 2014, BIOTECHNOL PROGR, V30, P132, DOI 10.1002/btpr.1809; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Fleetwood AJ, 2005, CRIT REV IMMUNOL, V25, P405, DOI 10.1615/CritRevImmunol.v25.i5.50; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; Greven DEA, 2015, ANN RHEUM DIS, V74, P1924, DOI 10.1136/annrheumdis-2014-205234; Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2017, NAT REV DRUG DISCOV, V16, P53, DOI 10.1038/nrd.2016.231; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hansen RR, 2013, EUR J PHARMACOL, V716, P120, DOI 10.1016/j.ejphar.2013.03.023; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Lanfranconi S, 2011, J CELL MOL MED, V15, P1645, DOI 10.1111/j.1582-4934.2009.00987.x; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Mirski R, 2003, J NEUROIMMUNOL, V140, P88, DOI 10.1016/S0165-5728(03)00179-6; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Ni Mingwei, 2010, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1217s43; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; SAWADA M, 1993, NEUROSCI LETT, V160, P131, DOI 10.1016/0304-3940(93)90396-3; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schroeder GD, 2017, SPINE J, V17, P129, DOI 10.1016/j.spinee.2016.08.006; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Weber KT, 2015, IMMUNOL RES, V63, P170, DOI 10.1007/s12026-015-8709-2; Webster CI, 2017, PAIN, V158, P660, DOI 10.1097/j.pain.0000000000000810; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wright HL, 2012, RHEUMATOLOGY, V51, P451, DOI 10.1093/rheumatology/ker338; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617	56	16	17	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	MAR	2018	159	3					550	559		10.1097/j.pain.0000000000001130			10	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	GB3ZN	WOS:000428999500017	29351125	Green Published			2021-06-18	
J	Schmidt, JL; Tweten, DJ; Badachhape, AA; Reiter, AJ; Okamoto, RJ; Garbow, JR; Bayly, PV				Schmidt, J. L.; Tweten, D. J.; Badachhape, A. A.; Reiter, A. J.; Okamoto, R. J.; Garbow, J. R.; Bayly, P. V.			Measurement of anisotropic mechanical properties in porcine brain white matter ex vivo using magnetic resonance elastography	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						MR elastography; Shear waves; Anisotropy; Transversely isotropic material; White matter brain tissue	FAST SHEAR-WAVES; VISCOELASTIC PROPERTIES; MR ELASTOGRAPHY; INJURY; TISSUE; PARAMETERS; STRAIN; SLOW; STEM	The mechanical properties of brain tissue, particularly those of white matter (WM), need to be characterized accurately for use in finite element (FE) models of brain biomechanics and traumatic brain injury (TBI). Magnetic resonance elastography (MRE) is a powerful tool for non-invasive estimation of the mechanical properties of soft tissues. While several studies involving direct mechanical tests of brain tissue have shown mechanical anisotropy, most MRE studies of brain tissue assume an isotropic model. In this study, an incompressible transversely isotropic (TI) material model parameterized by minimum shear modulus (22), shear anisotropy parameter (phi), and tensile anisotropy parameter (zeta) is applied to analyze MRE measurements of ex vivo porcine white matter (WM) brain tissue. To characterize shear anisotropy, "slow" (pure transverse) shear waves were propagated at 100, 200 and 300 Hz through sections of ex vivo brain tissue including both WM and gray matter (GM). Shear waves were found to propagate with elliptical fronts, consistent with TI material behavior. Shear wave fields were also analyzed within regions of interest (ROI) to find local shear wavelengths parallel and perpendicular to fiber orientation. FE simulations of a TI material with a range of plausible shear modulus (mu(2)) and shear anisotropy parameters (zeta) were run and the results were analyzed in the same fashion as the experimental case. Parameters of the FE simulations which most closely matched each experiment were taken to represent the mechanical properties of that particular sample. Using this approach, WM in the ex vivo porcine brain was found to be mildly anisotropic in shear with estimates of minimum shear modulus (actuation frequencies listed in parenthesis): mu(2) = 1.04 +/- 0.12 kPa (at 100 Hz), mu(2),= 1.94 +/- 0.29 kPa (at 200 Hz), and mu(2)= 2.88 +/- 0.34 kPa (at 300 Hz) and corresponding shear anisotropy factors of phi = 0.27 +/- 0.09 (at 100 Hz), phi= 0.29 +/- 0.14 (at 200 Hz) and phi = 0.34 +/- 0.13 (at 300 Hz). Future MRE studies will focus on tensile anisotropy, which will require both slow and fast shear waves for accurate estimation.	[Schmidt, J. L.; Tweten, D. J.; Reiter, A. J.; Okamoto, R. J.; Bayly, P. V.] Washington Univ, Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Badachhape, A. A.; Bayly, P. V.] Washington Univ, Biomed Engn, St Louis, MO 63130 USA; [Garbow, J. R.] Washington Univ, Radiol, St Louis, MO 63130 USA	Schmidt, JL (corresponding author), Washington Univ, Campus Box 1185,One Brookings Dr, St Louis, MO 63130 USA.	jlschmidt@wustl.edu		Badachhape, Andrew/0000-0002-5857-9495; Okamoto, Ruth/0000-0002-3085-3878	National Science FoundationNational Science Foundation (NSF) [CMMI-1332433]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS-055951]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	This work was supported by National Science Foundation grant CMMI-1332433 (Bayly) and National Institutes of Health grant R01 NS-055951 (Bayly).	Anderson AT, 2016, J MECH BEHAV BIOMED, V59, P538, DOI 10.1016/j.jmbbm.2016.03.005; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Coronado V.G., 2011, MORBIDITY MORTALITY; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Green MA, 2013, NMR BIOMED, V26, P1387, DOI 10.1002/nbm.2964; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guo J., 2015, MAGN RESON MED; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Jones RM, 1998, MAT SCI ENG SERIES; Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mariappan YK, 2009, MAGN RESON MED, V62, P1457, DOI 10.1002/mrm.22091; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Namani R, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006848; Namani R, 2009, J BIOMECH, V42, P2047, DOI 10.1016/j.jbiomech.2009.06.007; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014; Papazoglou S, 2006, MAGN RESON MED, V56, P489, DOI 10.1002/mrm.20993; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Qin EC, 2013, J MAGN RESON IMAGING, V37, P217, DOI 10.1002/jmri.23797; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Spencer A.J.M, 1984, CONTINUUM THEORY MEC; Tweten D. J., 2017, MAGN RESON MED; Tweten DJ, 2015, J BIOMECH, V48, P4002, DOI 10.1016/j.jbiomech.2015.09.009; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Van Houten EEW, 2001, MAGNET RESON MED, V45, P827, DOI 10.1002/mrm.1111; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	40	16	16	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	MAR	2018	79						30	37		10.1016/j.jmbbm.2017.11.045			8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	FW1PQ	WOS:000425072300004	29253729	Green Accepted			2021-06-18	
J	Vasterling, JJ; Jacob, SN; Rasmusson, A				Vasterling, Jennifer J.; Jacob, Shawna N.; Rasmusson, Ann			Traumatic Brain Injury and Posttraumatic Stress Disorder: Conceptual, Diagnostic, and Therapeutic Considerations in the Context of Co-Occurrence	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PROLONGED EXPOSURE THERAPY; PLACEBO-CONTROLLED TRIAL; TREATMENT RESPONSE; OEF/OIF VETERANS; QUANTITATIVE METAANALYSIS; M-CHLOROPHENYLPIPERAZINE; PROSPECTIVE COHORT; TREATMENT PROGRAM; VERBAL MEMORY; PTSD	The events leading to traumatic brain injury (TBI) are often psychologically traumatic (e.g., motor vehicle accidents) or occur within a broader context of psychological trauma, such as military combat or recurrent interpersonal violence. In such cases, posttraumatic stress disorder (PTSD) may develop and serve to complicate TBI recovery. Likewise, brain trauma may impede emotional resolution following psychological trauma exposure. This article addresses comorbid PTSD and TBI, including the epidemiology of PTSD following TBI; the clinical presentation of the comorbidity; potential mechanisms that complicate recovery from psychological trauma and TBI when they co-occur; and considerations for the clinical management of PTSD in the context of TBI, including implications for both psychosocial and psychopharmacological PTSD treatments. Although the authors address the full spectrum of TBI severity, because PTSD more commonly co-occurs with mild TBI, compared with moderate and severe TBI, the authors focus in particular on mild TBI.	[Vasterling, Jennifer J.; Jacob, Shawna N.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA; [Vasterling, Jennifer J.; Rasmusson, Ann] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Vasterling, Jennifer J.; Jacob, Shawna N.; Rasmusson, Ann] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Rasmusson, Ann] VA Boston Healthcare Syst, Psychiat Serv, Boston, MA USA	Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA.	jennifer.vasterling@va.gov					American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2004, PRACT GUID TREATM PA; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Batki SL, 2014, ALCOHOL CLIN EXP RES, V38, P2169, DOI 10.1111/acer.12496; Bernardy NC, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0564-2; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CHARNEY DS, 1987, PSYCHOPHARMACOLOGY, V92, P14, DOI 10.1007/BF00215473; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Felger JC, 2017, NEUROPSYCHOPHARMACOL, V42, P216, DOI 10.1038/npp.2016.143; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Ipser JC, 2012, INT J NEUROPSYCHOPH, V15, P825, DOI 10.1017/S1461145711001209; Isaacs K, 2017, J PSYCHIATR RES, V84, P301, DOI 10.1016/j.jpsychires.2016.10.017; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Phillips KM, 2016, J REHABIL RES DEV, V53, P413, DOI 10.1682/JRRD.2014.05.0126; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rasmusson AM, 2017, NEUROSCI LETT, V649, P156, DOI 10.1016/j.neulet.2017.01.054; Rotzinger S, 1998, DRUG METAB DISPOS, V26, P572; Rotzinger S, 1998, BIOL PSYCHIAT, V44, P1185, DOI 10.1016/S0006-3223(97)00483-6; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Schneier FR, 2015, DEPRESS ANXIETY, V32, P570, DOI 10.1002/da.22384; Scott JC, 2017, BEHAV RES THER, V91, P24, DOI 10.1016/j.brat.2017.01.004; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Singh Balwinder, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.16r01943; Smith K, 2000, BEHAV RES THER, V38, P709, DOI 10.1016/S0005-7967(99)00096-0; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vasterling JJ, J INT NEUROPSYCHOL S; Verfaellie M, 2016, J HEAD TRAUMA REHAB, V31, P309, DOI 10.1097/HTR.0000000000000197; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Wessel I, 2008, BEHAV RES THER, V46, P496, DOI 10.1016/j.brat.2008.01.016; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	73	16	17	0	5	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2018	30	2					91	100		10.1176/appi.neuropsych.17090180			10	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	GM3DZ	WOS:000437980100002	29132272	Bronze			2021-06-18	
J	Zhao, HL; Wang, YY; Chen, LY; Shi, J; Ma, K; Tang, LH; Xu, DG; Yao, JQ; Feng, H; Chen, TN				Zhao, Hengli; Wang, Yuye; Chen, Linyu; Shi, Jia; Ma, Kang; Tang, Longhuang; Xu, Degang; Yao, Jianquan; Feng, Hua; Chen, Tunan			High-sensitivity terahertz imaging of traumatic brain injury in a rat model	JOURNAL OF BIOMEDICAL OPTICS			English	Article						traumatic brain injury; terahertz imaging; terahertz spectroscopy	CEREBRAL EDEMA; PATHOPHYSIOLOGY; IMPACT; DEVICE	We demonstrated that different degrees of experimental traumatic brain injury (TBI) can be differentiated clearly in fresh slices of rat brain tissues using transmission-type terahertz (THz) imaging system. The high absorption region in THz images corresponded well with the injured area in visible images and magnetic resonance imaging results. The THz image and absorption characteristics of dehydrated paraffin-embedded brain slices and the hematoxylin and eosin (H&E)-stained microscopic images were investigated to account for the intrinsic differences in the THz images for the brain tissues suffered from different degrees of TBI and normal tissue aside from water. The THz absorption coefficients of rat brain tissues showed an increase in the aggravation of brain damage, particularly in the high-frequency range, whereas the cell density decreased as the order of mild, moderate, and severe TBI tissues compared with the normal tissue. Our results indicated that the different degrees of TBI were distinguishable owing to the different water contents and probable hematoma components distribution rather than intrinsic cell intensity. These promising results suggest that THz imaging has great potential as an alternative method for the fast diagnosis of TBI. (C) 2018 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Zhao, Hengli; Wang, Yuye; Ma, Kang; Feng, Hua; Chen, Tunan] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China; [Zhao, Hengli; Wang, Yuye; Ma, Kang; Feng, Hua; Chen, Tunan] Key Lab Neurotrauma, Chongqing, Peoples R China; [Wang, Yuye; Chen, Linyu; Shi, Jia; Tang, Longhuang; Xu, Degang; Yao, Jianquan] Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Inst Laser & Optoelect, Tianjin, Peoples R China; [Wang, Yuye; Chen, Linyu; Shi, Jia; Tang, Longhuang; Xu, Degang; Yao, Jianquan] Tianjin Univ, Minist Educ, Key Lab Optoelect Informat Technol, Tianjin, Peoples R China	Feng, H; Chen, TN (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China.; Feng, H; Chen, TN (corresponding author), Key Lab Neurotrauma, Chongqing, Peoples R China.; Xu, DG (corresponding author), Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Inst Laser & Optoelect, Tianjin, Peoples R China.; Xu, DG (corresponding author), Tianjin Univ, Minist Educ, Key Lab Optoelect Informat Technol, Tianjin, Peoples R China.	xudegang@tju.edu.cn; fenghua8888@vip.163.com; ctn@tmmu.edu.cn	Yuye, Wang/AAT-9799-2020; Shi, Jia/T-6002-2017	Shi, Jia/0000-0001-7563-9982	National Basic Research Program of China (973)National Basic Research Program of China [2015CB755400]; National Key Research and Development Projects [2016YFC0101000]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61775160]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M602954]; Postdoctoral Science Foundation of Chongqing [Xm2016021]; Joint Incubation Project of Southwest Hospital [SWH2016LHJC04, SWH2016LHJC01]	This work was supported by the National Basic Research Program of China (973) (2015CB755400), the National Key Research and Development Projects (2016YFC0101000), the National Natural Science Foundation of China (61775160), China Postdoctoral Science Foundation (2016M602954), Postdoctoral Science Foundation of Chongqing (Xm2016021), and Joint Incubation Project of Southwest Hospital (SWH2016LHJC04, SWH2016LHJC01).	Bajwa N, 2017, BIOMED OPT EXPRESS, V8, P460, DOI 10.1364/BOE.8.000460; Bin Ji Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36040; Brabazon F, 2017, J NEUROTRAUM, V34, P1074, DOI 10.1089/neu.2016.4540; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grootendorst MR, 2017, BIOMED OPT EXPRESS, V8, P2932, DOI 10.1364/BOE.8.002932; Joseph CS, 2014, J BIOPHOTONICS, V7, P295, DOI 10.1002/jbio.201200111; Kang DG, 2012, SPINE J, V12, P849, DOI 10.1016/j.spinee.2011.11.014; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Masson JB, 2006, P NATL ACAD SCI USA, V103, P4808, DOI 10.1073/pnas.0510945103; Meng K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.077001; Oh SJ, 2014, BIOMED OPT EXPRESS, V5, P2837, DOI 10.1364/BOE.5.002837; Reid CB, 2013, IEEE J BIOMED HEALTH, V17, P774, DOI 10.1109/JBHI.2013.2255306; Reid CB, 2011, PHYS MED BIOL, V56, P4333, DOI 10.1088/0031-9155/56/14/008; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rong L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08445; Ruggiero MT, 2015, PHYS CHEM CHEM PHYS, V17, P9326, DOI 10.1039/c5cp01195g; Ryu JH, 2013, NEUROCRIT CARE, V19, P222, DOI 10.1007/s12028-013-9824-3; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Shi J., 2016, 41 INT C INFR MILL T; Shi LY, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.1.015014; Sim YC, 2013, BIOMED OPT EXPRESS, V4, P1413, DOI 10.1364/BOE.4.001413; Wang YY, 2011, PHYS MED BIOL, V56, P4517, DOI 10.1088/0031-9155/56/14/018; Wang YY, 2010, OPT EXPRESS, V18, P15504, DOI 10.1364/OE.18.015504; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yamaguchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30124; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zou Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05554-z	32	16	16	4	12	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	MAR	2018	23	3							036015	10.1117/1.JBO.23.3.036015			7	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	GB7IT	WOS:000429248800029	29595016	Bronze			2021-06-18	
J	Ren, HL; Lv, CN; Xing, Y; Geng, Y; Zhang, F; Bu, W; Wang, MW				Ren, Hui Ling; Lv, Chao Nan; Xing, Ying; Geng, Yuan; Zhang, Feng; Bu, Wei; Wang, Ming Wei			Downregulated Nuclear Factor E2-Related Factor 2 (Nrf2) Aggravates Cognitive Impairments via Neuroinflammation and Synaptic Plasticity in the Senescence-Accelerated Mouse Prone 8 (SAMP8) Mouse: A Model of Accelerated Senescence	MEDICAL SCIENCE MONITOR			English	Article						Aging; Inflammation; Mild Cognitive Impairment	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; SIGNALING PATHWAY; MEMORY FORMATION; MICE; INVOLVEMENT; DYSFUNCTION; ACTIVATION; MECHANISM; PATHOLOGY	Background: We observed the effects of nuclear factor E2-related factor 2 (Nrf2) downregulation via intrahippocampal injection of a lentiviral vector on cognition in senescence-accelerated mouse prone 8 (SAMP8) to investigate the role of the (Nrf2)/antioxidant response element (ARE) pathway in age-related changes. Material/Methods: Control lentivirus and Nrf2-shRNA-lentivirus were separately injected into the hippocampus of 4-month-old SAMR1 and SAMP8 mice and then successfully downregulated Nrf2 expression in this brain region. Five months later, cognitive function tests, including the novel object test, the Morris water maze test, and the passive avoidance task were conducted. Glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (Iba1) immunohistochemistry was performed to observe an inflammatory response. Presynaptic synapsin (SYN) were observed by immunofluorescence. We then determined the Nrf2-regulated, heme oxygenase-1 (HO-1), P65, postsynaptic density protein (PSD), and SYN protein levels. The ultrastructure of neurons and synapses in the hippocampal CA1 region was observed by transmission electron microscopy. Results: Aging led to a decline in cognitive function compared with SAMR1 mice and the Nrf2-shRNA-lentivirus further exacerbated the cognitive impairment in SAMP8 mice. Nrf2, HO-1, PSD, and SYN levels were significantly reduced (all P<0.05) but high levels of inflammation were detected in SAMP8 mice with low expression of Nrf2. Furthermore, neurons were vacuolated, the number of organelles decreased, and the number of synapses decreased. Conclusions: Downregulation of Nrf2 suppressed the Nrf2/ARE pathway, activated oxidative stress and neuroinflammation, and accelerated cognitive impairment in SAMP8 mice. Downregulation of Nrf2 accelerates the aging process through neuroinflammation and synaptic plasticity.	[Ren, Hui Ling; Lv, Chao Nan; Geng, Yuan; Wang, Ming Wei] Hebei Med Univ, Hosp 3, Dept Neurol, Shijiazhuang, Hebei, Peoples R China; [Lv, Chao Nan; Geng, Yuan; Wang, Ming Wei] Brain Aging & Cognit Neurosci Key Lab Hebei, Shijiazhuang, Hebei, Peoples R China; [Xing, Ying; Zhang, Feng] Hebei Med Univ, Hosp 3, Dept Rehabil Med, Shijiazhuang, Hebei, Peoples R China; [Bu, Wei] Hebei Med Univ, Hosp 3, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China	Wang, MW (corresponding author), Hebei Med Univ, Hosp 3, Dept Neurol, Shijiazhuang, Hebei, Peoples R China.; Wang, MW (corresponding author), Brain Aging & Cognit Neurosci Key Lab Hebei, Shijiazhuang, Hebei, Peoples R China.	drwangmingwei@126.com			Provincial Major Medical Programs [ZD2013077, ZD2013079]; Hebei Health and Family Planning Commission Directive Program [ZL20140184]	This work was supported by Provincial Major Medical Programs (ZD2013077, ZD2013079) and the Hebei Health and Family Planning Commission Directive Program (ZL20140184)	Akiguchi I, 2017, NEUROPATHOLOGY, V37, P293, DOI 10.1111/neup.12373; Baltanas A, 2013, J PHYSIOL BIOCHEM, V69, P927, DOI 10.1007/s13105-013-0271-6; Branca C, 2017, HUM MOL GENET, V26, P4823, DOI 10.1093/hmg/ddx361; Brodziak A, 2014, MED SCI MONITOR, V20, P2733, DOI 10.12659/MSM.891056; Buendia I, 2016, PHARMACOL THERAPEUT, V157, P84, DOI 10.1016/j.pharmthera.2015.11.003; Cao HM, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00244; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; d'Isa R, 2014, METHODS MOL BIOL, V1120, P131, DOI 10.1007/978-1-62703-791-4_9; Deshmukh Prashant, 2017, Biophys Rev, V9, P41, DOI 10.1007/s12551-016-0244-4; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dinkova-Kostova A. T., 2018, FEBS J; Farr SA, 2014, FREE RADICAL BIO MED, V67, P387, DOI 10.1016/j.freeradbiomed.2013.11.014; Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1; Gan L, 2012, J NEUROSCI, V32, P17775, DOI 10.1523/JNEUROSCI.3049-12.2012; Grinan-Ferre C, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00241; Grinan-Ferre C, 2016, EXP GERONTOL, V80, P57, DOI 10.1016/j.exger.2016.03.014; Heidari MH, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/290414; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004; Kandimalla R, 2016, HUM MOL GENET, V25, P4881, DOI 10.1093/hmg/ddw312; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Karkkainen V, 2014, STEM CELLS, V32, P1904, DOI 10.1002/stem.1666; Kwon SH, 2015, NEUROSCIENCE, V304, P14, DOI 10.1016/j.neuroscience.2015.07.030; Liddell JR, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0515-9; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu YG, 2016, PHARMACOL BIOCHEM BE, V150, P207, DOI 10.1016/j.pbb.2016.11.002; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Mottahedin A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00190; Pajares M, 2016, AUTOPHAGY, V12, P1902, DOI 10.1080/15548627.2016.1208889; Pan WS, 2016, EXP THER MED, V12, P1455, DOI 10.3892/etm.2016.3470; Qiang M, 2014, J ALZHEIMERS DIS, V40, P1039, DOI 10.3233/JAD-131595; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; Rojo AI, 2017, REDOX BIOL, V13, P444, DOI 10.1016/j.redox.2017.07.006; Sardari M, 2015, BRAIN RES, V1625, P54, DOI 10.1016/j.brainres.2015.08.015; Tabassum S, 2017, PAK J PHARM SCI, V30, P1013; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang JH, 2016, CELL PHYSIOL BIOCHEM, V39, P1078, DOI 10.1159/000447816; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Yanai S, 2016, BEHAV BRAIN RES, V308, P187, DOI 10.1016/j.bbr.2016.04.026; Ye F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18636; Zhao MY, 2017, FOOD CHEM TOXICOL, V106, P25, DOI 10.1016/j.fct.2017.05.007; Zhao XJ, 2013, EXP GERONTOL, V48, P869, DOI 10.1016/j.exger.2013.05.063; Zou CY, 2016, ACTA NEUROPATHOL, V131, P235, DOI 10.1007/s00401-015-1527-8	45	16	18	0	12	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	FEB 23	2018	24						1132	1144		10.12659/MSM.908954			13	Medicine, Research & Experimental	Research & Experimental Medicine	FX6QU	WOS:000426211500002	29474348	Green Published			2021-06-18	
J	Sangobowale, MA; Grin'kina, NM; Whitney, K; Nikulina, E; St Laurent-Ariot, K; Ho, JS; Bayzan, N; Bergold, PJ				Sangobowale, Michael A.; Grin'kina, Natalia M.; Whitney, Kristen; Nikulina, Elena; St. Laurent-Ariot, Karrah; Ho, Johnson S.; Bayzan, Narek; Bergold, Peter J.			Minocycline plus N-Acetylcysteine Reduce Behavioral Deficits and Improve Histology with a Clinically Useful Time Window	JOURNAL OF NEUROTRAUMA			English	Article						animal behavior; drug synergy; hippocampus; mouse closed head injury; myelin; pre-clinical testing; rat controlled cortical impact; time to first dose	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; COGNITIVE IMPAIRMENT; SPATIAL INFORMATION; MEMORY; MILD; ACTIVATION; AVOIDANCE; DAMAGE; PLACE	There are no drugs to manage traumatic brain injury (TBI) presently. A major problem in developing therapeutics is that drugs to manage TBI lack sufficient potency when dosed within a clinically relevant time window. Previous studies have shown that minocycline (MINO, 45mg/kg) plus N-acetylcysteine (NAC, 150mg/kg) synergistically improved cognition and memory, modulated inflammation, and prevented loss of oligodendrocytes that remyelinated damaged white matter when first dosed 1h after controlled cortical impact (CCI) in rats. We show that MINO (45mg/kg) plus NAC (150mg/kg) also prevent brain injury in a mouse closed head injury (CHI) TBI model. Using the CHI model, the concentrations of MINO and NAC were titrated to determine that MINO (22.5mg/kg) plus NAC (75mg/kg) was more potent than the original formulation. MINO (22.5mg/kg) plus NAC (75mg/kg) also limited injury in the rat CCI model. The therapeutic time window of MINO plus NAC was then tested in the CHI and CCI models. Mice and rats could acquire an active place avoidance task when MINO plus NAC was first dosed at 12h post-injury. A first dose at 12h also limited gray matter injury in the hippocampus and preserved myelin in multiple white matter tracts. Mice and rats acquired Barnes maze when MINO plus NAC was first dosed at 24h post-injury. These data suggest that MINO (22.5mg/kg) plus NAC (75mg/kg) remain potent when dosed at clinically useful time windows. Both MINO and NAC are drugs approved by the Food and Drug Administration and have been administered safely to patients in clinical trials at the doses in the new formulation. This suggests that the drug combination of MINO plus NAC may be effective in treating patients with TBI.	[Sangobowale, Michael A.; Whitney, Kristen] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Nikulina, Elena; St. Laurent-Ariot, Karrah; Ho, Johnson S.; Bayzan, Narek; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11203 USA; [Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sangobowale, Michael A.] Penn Presbyterian Med Ctr, Philadelphia, PA USA	Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Whitney, Kristen/0000-0002-1578-6339	USAMRCC [09127004]	This work was supported by an award from the USAMRCC (09127004) to P.J.B.	Abdel Baki S.G., 2010, PLOS ONE, V5; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Deepmala, 2015, NEUROSCI BIOBEHAV R, V55, P294, DOI 10.1016/j.neubiorev.2015.04.015; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Garrido-Mesa N, 2013, PHARMACOL RES, V67, P18, DOI 10.1016/j.phrs.2012.10.006; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Haber M., 2017, J CEREB BLOOD FLOW M; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lante F, 2008, HIPPOCAMPUS, V18, P602, DOI 10.1002/hipo.20421; Li M., 2016, AUSTIN NEUROL NEUROS, V1, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Sunyer B., 2007, NAT PROTOC, P390; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067	40	16	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					907	917		10.1089/neu.2017.5348		FEB 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000424831700001	29187031				2021-06-18	
J	Kovacs, G; Sowers, N				Kovacs, George; Sowers, Nicholas			Airway Management in Trauma	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Airway; Trauma; Airway management	RAPID-SEQUENCE INTUBATION; CERVICAL-SPINE INJURY; ADVANCED LIFE-SUPPORT; NATIONAL AUDIT PROJECT; DIFFICULT AIRWAY; TRACHEAL INTUBATION; ENDOTRACHEAL INTUBATION; EMERGENCY-DEPARTMENT; MAJOR TRAUMA; CARDIOVASCULAR COLLAPSE	Airway management in the trauma patient presents numerous unique challenges beyond placement of an endotracheal tube, and outcomes are dependent on the provider's ability to anticipate difficulty. Airway management strategies for the care of the patient with polytrauma are reviewed, with specific considerations for those presenting with traumatic brain injury, suspected c-spine injury, the contaminated airway, the agitated trauma patient, maxillofacial trauma, and the traumatized airway. An approach to airway management that considers the potential anatomic and physiologic challenges in caring for these patients with complicated trauma is presented.	[Kovacs, George; Sowers, Nicholas] Dalhousie Univ, Div Med Educ, Dept Emergency Med, 3rd Floor,HI Site,Suite 355,Room 364D, Halifax, NS B3H 3A7, Canada; [Kovacs, George] Dalhousie Univ, Div Med Educ, Dept Anaesthesia, 3rd Floor,HI Site,Suite 355,Room 364D, Halifax, NS B3H 3A7, Canada; [Kovacs, George] Dalhousie Univ, Div Med Educ, Dept Med Neurosci, 3rd Floor,HI Site,Suite 355,Room 364D, Halifax, NS B3H 3A7, Canada; [Kovacs, George; Sowers, Nicholas] QEII Hlth Sci Ctr, Charles V Keating Trauma & Emergency Ctr, 1799 Robie St, Halifax, NS B3H 3G1, Canada	Kovacs, G (corresponding author), QEII Hlth Sci Ctr, Charles V Keating Trauma & Emergency Ctr, 1799 Robie St, Halifax, NS B3H 3G1, Canada.	gkovacs@dal.ca					Algie CM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011656.pub2; APRAHAMIAN C, 1984, ANN EMERG MED, V13, P584, DOI 10.1016/S0196-0644(84)80278-4; Bathory I, 2009, ANAESTHESIA, V64, P1337, DOI 10.1111/j.1365-2044.2009.06075.x; Bodily JB, 2015, ANN EMERG MED, P1; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; Bowman-Howard M., 2000, HDB DIFFICULT AIRWAY, P199; Brainard C, 2015, JEMS, V40, P32; Brainard Criss, 2015, JEMS, V40, P26; Brindley PG, 2017, CAN J ANAESTH; Brown CA, 2015, ANN EMERG MED, V65, P363, DOI 10.1016/j.annemergmed.2014.10.036; Choudhary D. K., 2015, J PLANT GROWTH REGUL, P1; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Conroy MJ, 2014, AM J EMERG MED, V32, P541, DOI 10.1016/j.ajem.2014.02.006; Cook TM, 2011, BRIT J ANAESTH, V106, P632, DOI 10.1093/bja/aer059; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; Cowley R A, 1975, Md State Med J, V24, P37; Crosby Edward T, 2007, Anesthesiol Clin, V25, P511, DOI 10.1016/j.anclin.2007.05.001; Crosby ET, 2006, ANESTHESIOLOGY, V104, P1293, DOI 10.1097/00000542-200606000-00026; Driver BE, 2017, ANN EMERG MED, V69, P1, DOI 10.1016/j.annemergmed.2016.06.018; Dronen S, 1999, ACAD EMERG MED, V6, P1, DOI 10.1111/j.1553-2712.1999.tb00084.x; DuCanto J, 2017, WEST J EMERG MED, V18, DOI [10.5811/westjem.2016.9.30891, 10.5811/WESTJEM.2016.9.30891]; Duggan LV, 2015, ANAESTHESIA, V70, P769, DOI 10.1111/anae.13163; Dugganh LV, 2016, BRIT J ANAESTH, V117, P28, DOI 10.1093/bja/aew192; Dupanovic M, 2010, CURR OPIN ANAESTHESI; Durga P, 2014, INDIAN J ANAESTH, V58, P684, DOI 10.4103/0019-5049.147132; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Ehrenfeld JM, 2012, ANESTH ANALG, V115, P95, DOI 10.1213/ANE.0b013e31822dac35; Farmer J, 1998, J SPINAL DISORD, V11, P192; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Gebremedhn EG, 2014, WORLD J EMERG MED, V5, P279, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.007; GOLD CR, 1987, ANN EMERG MED, V16, P797, DOI 10.1016/S0196-0644(87)80578-4; Green RS, 2012, CAN J EMERG MED, V14, P74, DOI 10.2310/8000.2012.110548; Green RS, 2015, J CRIT CARE; Gu Y, 2016, CAN J ANAESTH, V63; Hamaekers AE, 2011, ANAESTHESIA, V66, P65, DOI 10.1111/j.1365-2044.2011.06936.x; Hardy G, 2016, EMERG MED J, V33, P439, DOI 10.1136/emermed-2016-205871.2; Heffner AC, 2013, RESUSCITATION, V84, P1500, DOI 10.1016/j.resuscitation.2013.07.022; Heffner AC, 2012, J CRIT CARE, V27, P587, DOI 10.1016/j.jcrc.2012.04.022; Heffner AC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.011; Higgs A, 2016, BR J ANAESTH; Hindman BJ, 2016, J NEUROSURG-SPINE, V25, P545, DOI 10.3171/2016.3.SPINE1640; Hindman BJ, 2015, ANESTHESIOLOGY, V123, P1042, DOI 10.1097/ALN.0000000000000830; Horton CL, 2014, J EMERG MED, V46, P814, DOI 10.1016/j.jemermed.2013.11.085; HUTCHISON I, 1990, BRIT MED J, V301, P595, DOI 10.1136/bmj.301.6752.595; Jain U, 2016, ANESTHESIOLOGY, V124, P199, DOI 10.1097/ALN.0000000000000903; Jose Anson, 2016, J Emerg Trauma Shock, V9, P73, DOI 10.4103/0974-2700.179456; Kerslake D, 2015, RESUSCITATION, V89, P20, DOI 10.1016/j.resuscitation.2015.01.005; Kill C, 2013, J EMERG MED, V44, P750, DOI 10.1016/j.jemermed.2012.07.080; Kleine-Brueggeney M, 2016, BRIT J ANAESTH, V116, P670, DOI 10.1093/bja/aew058; Kovacs G, 2016, LIGHTS CAMERA ACTION; Krausz Amir A, 2009, World J Emerg Surg, V4, P21, DOI 10.1186/1749-7922-4-21; Kummer C, 2007, INJURY, V38, P27, DOI 10.1016/j.injury.2006.09.002; Kwan I, 2001, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858; Lai WH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060528; Langvad S, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-43; Lapinsky SE, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0964-z; Law JA, 2013, CAN J ANESTH, V60, P1089, DOI 10.1007/s12630-013-0019-3; Law JA, 2013, CAN J ANESTH, V60, P1119, DOI 10.1007/s12630-013-0020-x; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Leeuwenburg T, 2015, CRIT CARE HORIZONS, V1, P1; LeGrand SA, 2007, ANESTHESIOLOGY, V107, P884, DOI 10.1097/01.anes.0000291461.62404.46; Levitan R, 2013, PHARM PREHOSPITAL RE; Levitan R., 2015, ACEP NOW; Lockwood DNJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1136; Mace SE, 2008, EMERG MED CLIN N AM, V26, P1043, DOI 10.1016/j.emc.2008.10.002; Manoach S, 2007, ANN EMERG MED, V50, P236, DOI 10.1016/j.annemergmed.2007.01.009; Marshall SD, 2016, ACAD EMERG MED, V23, P1074, DOI 10.1111/acem.13037; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Mercer SJ, 2016, BRIT J ANAESTH, V117, P49, DOI 10.1093/bja/aew193; Michailidou M, 2015, WORLD J SURG, V39, P782, DOI 10.1007/s00268-014-2845-z; Mihara R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806243; Miller M, 2016, ANN EMERG MED, V68, P181, DOI 10.1016/j.annemergmed.2016.03.041; Miraflor E, 2011, J SURG RES, V170, P286, DOI 10.1016/j.jss.2011.03.044; Mosier JM, 2017, INTENS CARE MED, V43, P226, DOI 10.1007/s00134-016-4426-0; Mosier JM, 2015, WEST J EMERG MED, V16, P1109, DOI 10.5811/westjem.2015.8.27467; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Murphy M, 2005, CAN J ANAESTH, V52, P231, DOI 10.1007/BF03016055; Nimmagadda U, 2017, ANESTH ANALG, V124, P507, DOI 10.1213/ANE.0000000000001589; Norris A, 2016, BRIT J ANAESTH, V117, P148, DOI 10.1093/bja/aew122; Norskov AK, 2016, BRIT J ANAESTH, V116, P680, DOI 10.1093/bja/aew057; Ohchi F, 2016, AM J EMERG MED; Oteir AO, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041080; Perbet S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0975-9; Petrosoniak A, 2013, CURR OPIN ANESTHESIO, V26, P699, DOI 10.1097/ACO.0000000000000007; Pieters BMA, 2016, ANAESTHESIA, V71, P556, DOI 10.1111/anae.13413; Pracy JP, 2016, BRIT J ANAESTH, V117, P426, DOI 10.1093/bja/aew221; Rogers FB, 2015, INJURY, V46, P525, DOI 10.1016/j.injury.2014.08.043; Sakles JC, 2017, ACAD EMERG MED, V38, P42; Sakles JC, 2016, ACAD EMERG MED, V23, P703, DOI 10.1111/acem.12931; Salem MR, 2013, ANESTH ANALG, V116, P264, DOI 10.1213/ANE.0b013e31827696fa; Salem MR, 2017, ANESTHESIOLOGY, V9, P378; Sirian R, 2009, BJA EDUC, V9, P105, DOI 10.1093/bjaceaccp/mkp018; Sise MJ, 2009, J TRAUMA, V66, P32, DOI 10.1097/TA.0b013e318191bb0c; Smith KA, 2015, ACAD EMERG MED, V22, P989, DOI 10.1111/acem.12717; Sowers N, 2016, J EMERG MED, V50, P315, DOI 10.1016/j.jemermed.2015.10.010; Spaite DW, 2017, ANN EMERG MED; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Suppan L, 2016, BRIT J ANAESTH, V116, P27, DOI 10.1093/bja/aev205; Teoh WH, 2016, BRIT J ANAESTH, V117, P1, DOI 10.1093/bja/aew148; Thiboutot F, 2009, CAN J ANAESTH, V56, P412, DOI 10.1007/s12630-009-9089-7; Thompson WL, 2009, CAN J EMERG MED, V11, P14; Tobias JD, 2014, SAUDI J ANAESTH, V8, P153, DOI 10.4103/1658-354X.130672; Tran DTT, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub3; Trivedi S, 2015, J CRIT CARE, V30; Upchurch CP, 2017, ANN EMERG MED, V69, P24, DOI 10.1016/j.annemergmed.2016.08.009; Vannucci A, 2016, MINERVA ANESTESIOL, V82, P69; Vu M, 2011, AIRWAY MANAGEMENT EM, P299; Wang HE, 2014, EMERG MED J, V31, P186, DOI 10.1136/emermed-2012-202101; Weingart SD, 2015, ANN EMERG MED, V65, P349, DOI 10.1016/j.annemergmed.2014.09.025; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Welch JL, 2016, ANN EMERG MED; Wilson MH, 2016, RESUSCITATION, V105, P52, DOI 10.1016/j.resuscitation.2016.05.007; Wong DT, 2017, CAN J ANAESTH; Woodall N, 2011, ANAESTHESIA, V66, P27, DOI 10.1111/j.1365-2044.2011.06931.x; Yentis SM, 2002, ANAESTHESIA, V57, P105, DOI 10.1046/j.0003-2409.2001.02515.x; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y	118	16	18	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2018	36	1					61	+		10.1016/j.emc.2017.08.006			25	Emergency Medicine	Emergency Medicine	FQ8TD	WOS:000418635200006	29132582	Other Gold			2021-06-18	
J	Pieracci, FM; Agarwal, S; Doben, A; Shiroff, A; Lottenberg, L; Whitbeck, SA; White, TW				Pieracci, Fredric M.; Agarwal, Suresh; Doben, Andrew; Shiroff, Adam; Lottenberg, Larwence; Whitbeck, Sarah Ann; White, Thomas W.			Indications for surgical stabilization of rib fractures in patients without flail chest: surveyed opinions of members of the Chest Wall Injury Society	INTERNATIONAL ORTHOPAEDICS			English	Article						Rib fractures; Survey; Surgical stabilization of rib fractures	INTERNAL-FIXATION; OPEN REDUCTION; POLYTRAUMA PATIENTS; MANAGEMENT; OUTCOMES; TRAUMA; METAANALYSIS; DISABILITY; BENEFIT; REPAIR	Purpose There are currently no evidence-based indications for surgical stabilization of rib fractures (SSRF) in patients without flail chest. The purpose of this survey was to identify patients for whom there is relative equipoise (operative vs. non-operative) in order to assist in designing a randomized clinical trial. Methods Members of the Chest Wall Injury Society were sent an online survey, in which 18 patient scenarios were presented. The baseline patient had >= three displaced, contiguous fractures and had no other contraindications for surgery. This default scenario was then varied based upon patient age, degree of traumatic brain injury (TBI), fracture series location, and number of abnormal pulmonary physiologic variables (oxygen requirement, respiratory rate, incentive spirometry ability, cough, and numeric pain score). Results Thirty respondents provided a total of 540 answers. Overall, the majority of responses were in favor of SSRF (n = 413, 84.1%). Furthermore, the vast majority of responses indicated that some degree of pulmonary compromise was necessary to recommend SSRF (n = 44, 90.4%), with >= two abnormal parameters being the most common threshold (n = 156, 31.8%). Decision to recommend SSRF varied significantly by number of abnormal clinical variables, age, and degree of TBI, but not by fracture series location. Patients aged 85 years old and those with moderate TBI were the least likely to be recommended for SSRF, regardless of abnormal pulmonary physiologic variables. The most appropriate cutoff for equipoise appeared to be a patient aged 21-79 years old, with no or mild TBI, >= two abnormal pulmonary parameters, and regardless of fracture location (44.8% consensus for SSRF). Conclusion SSRF was recommended for most patients with non-flail, displaced rib fractures. However, this recommendation was contingent upon patient age, degree of TBI, and pulmonary clinical status. Results of this survey may be used to inform inclusion criteria for a future randomized, clinical trial.	[Pieracci, Fredric M.] Denver Hlth Med Ctr, Denver, CO 80204 USA; [Agarwal, Suresh] Duke Univ, Sch Med, Durham, NC USA; [Doben, Andrew] Baystate Med Ctr, Springfield, MA USA; [Shiroff, Adam] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Lottenberg, Larwence] St Marys Hosp, W Palm Beach, FL USA; [Whitbeck, Sarah Ann; White, Thomas W.] Intermt Med Ctr, Salt Lake City, UT USA	Pieracci, FM (corresponding author), Denver Hlth Med Ctr, Denver, CO 80204 USA.	Fredric.pieracci@dhha.org					Bhatnagar A, 2012, J AM COLL SURGEONS, V215, P201, DOI 10.1016/j.jamcollsurg.2012.02.023; Bottlang M, 2010, EUR J TRAUMA EMERG S, V36, P417, DOI 10.1007/s00068-010-0047-4; Coughlin TA, 2016, BONE JOINT J, V98B, P1119, DOI 10.1302/0301-620X.98B8.37282; DeFreest L, 2016, AM J SURG, V211, P761, DOI 10.1016/j.amjsurg.2015.11.014; Dehghan N, 2014, J TRAUMA ACUTE CARE, V76, P462, DOI 10.1097/TA.0000000000000086; Doben AR, 2017, AM J SURG, V213, P1189, DOI 10.1016/j.amjsurg.2016.07.029; Doben AR, 2014, J CRIT CARE, V29, P139, DOI 10.1016/j.jcrc.2013.08.003; Drummond MF., 1997, METHODS EC EVALUATIO, V2nd; Farquhar J, 2016, CAN J SURG, V59, P299, DOI 10.1503/cjs.000515; Granetzny Andreas, 2005, Interact Cardiovasc Thorac Surg, V4, P583, DOI 10.1510/icvts.2005.111807; Hasenboehler EA, 2011, J TRAUMA, V71, P494, DOI 10.1097/TA.0b013e3182255d30; Kane ED, 2017, 47 ANN M W TRAUM ASS; Kasotakis G, 2017, J TRAUMA ACUTE CARE, V82, P618, DOI [10.1097/TA.0000000000001350, 10.1097/TA.0000000000001389]; Lafferty PM, 2011, J BONE JOINT SURG AM, V93A, P97, DOI 10.2106/JBJS.I.00696; LANDERCASPER J, 1984, J TRAUMA, V24, P410, DOI 10.1097/00005373-198405000-00007; Leinicke JA, 2013, ANN SURG, V258, P914, DOI 10.1097/SLA.0b013e3182895bb0; Majercik S, 2014, AM J SURG, V208, P88, DOI 10.1016/j.amjsurg.2013.08.051; Marasco S, 2014, J TRAUMA ACUTE CARE, V77, P452, DOI 10.1097/TA.0000000000000375; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; Mayberry JC, 2009, AM SURGEON, V75, P389; Mayberry JC, 2009, J TRAUMA, V66, P875, DOI 10.1097/TA.0b013e318190c3d3; Pieracci Fredric M, 2015, Trauma Case Rep, V1, P39, DOI 10.1016/j.tcr.2015.10.001; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Pieracci FM, 2016, J TRAUMA ACUTE CARE, V80, P187, DOI 10.1097/TA.0000000000000925; Pieracci FM, 2015, J TRAUMA ACUTE CARE, V78, P883, DOI 10.1097/TA.0000000000000581; Slobogean GP, 2013, J AM COLL SURGEONS, V216, P302, DOI 10.1016/j.jamcollsurg.2012.10.010; Tanaka H, 2002, J TRAUMA, V52, P727, DOI 10.1097/00005373-200204000-00020; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011	28	16	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	FEB	2018	42	2					401	408		10.1007/s00264-017-3612-1			8	Orthopedics	Orthopedics	FU2WV	WOS:000423711600024	28852836				2021-06-18	
J	Trevena-Peters, J; McKay, A; Spitz, G; Suda, R; Renison, B; Ponsford, J				Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Suda, Rachel; Renison, Belinda; Ponsford, Jennie			Efficacy of Activities of Daily Living Retraining During Posttraumatic Amnesia: A Randomized Controlled Trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Activities of daily living; Brain injuries; traumatic; Occupational therapy; Neuropsychology; Rehabilitation	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; EARLY REHABILITATION; AGITATION; MEMORY; SCALE; ORIENTATION; RECOVERY; DURATION; MODERATE	Objective: To assess the efficacy of activities of daily living (ADL) retraining during posttraumatic amnesia (PTA) compared with ADL retraining commencing after emergence from PTA. Design: Randomized controlled trial. Setting: Inpatient rehabilitation center. Participants: Participants with severe TBI (N=104), admitted to rehabilitation and remaining in PTA for >7 days, were randomized to receive either treatment as usual (TAU) with daily ADL retraining (treatment), or TAU alone (physiotherapy and/or necessary speech therapy) during PTA. Interventions: ADL retraining was manualized, followed errorless and procedural learning principles, and included individualized goals. Both groups received occupational therapy as usual after PTA. Main Outcome Measures: Primary outcome was the FIM completed at admission, PTA emergence, discharge, and 2-month follow-up. Secondary outcomes included length of rehabilitation inpatient stay, PTA duration, Agitated Behavior Scale scores, and Community Integration Questionnaire (CIQ) scores at follow-up. Groups did not significantly differ in baseline characteristics. Results: On the primary outcome, FIM total change, random effects regression revealed a significant interaction of group and time (P<.01). The treatment group had greater improvement in FIM scores from baseline to PTA emergence, which was maintained at discharge, but not at follow-up. Twenty-seven percent more of the treatment group reliably changed on FIM scores at PTA emergence. Group differences in length of stay, PTA duration, agitation, and CIQ scores were not significant; however, TAU trended toward longer length of stay and PTA duration. Conclusions: Individuals in PTA can benefit from skill retraining. (C) 2017 by the American Congress of Rehabilitation Medicine	[Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Renison, Belinda; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [McKay, Adam; Suda, Rachel] Epworth HealthCare, Richmond, Vic, Australia	Trevena-Peters, J (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia.; Trevena-Peters, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia.; Trevena-Peters, J (corresponding author), Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia.	jessica.trevena-peters@monash.edu	McKay, Adam/M-6003-2017	McKay, Adam/0000-0002-0479-7681	Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research [N-13-089]; Epworth Research Institute Grant; William Buckland Foundation Grant	Supported by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research (grant no: N-13-089); a Epworth Research Institute Grant; and a William Buckland Foundation Grant.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GILES GM, 1993, BRAIN INJURY REHABIL; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; Granger CV, 1986, TOP GERIATR REHABIL, V1, P59, DOI 10.1097/00013614-198604000-00007; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Langhorn L, 2015, J NEUROSCI NURS, V47, pE2, DOI 10.1097/JNN.0000000000000106; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; Legg LA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003585.pub2; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Rebeiro K L, 1999, Can J Occup Ther, V66, P14; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Symonds CP, 1943, LANCET, V1, P7; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; TERRACE HS, 1963, SCIENCE, V140, P318, DOI 10.1126/science.140.3564.318; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Watanabe TK, 1998, BRAIN INJURY, V12, P81; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006	49	16	16	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2					329	337		10.1016/j.apmr.2017.08.486			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FU7YX	WOS:000424069800015	28947165				2021-06-18	
J	Nordhaug, LH; Hagen, K; Vik, A; Stovner, LJ; Follestad, T; Pedersen, T; Gravdahl, GB; Linde, M				Nordhaug, Lena Hoem; Hagen, Knut; Vik, Anne; Stovner, Lars Jacob; Follestad, Turid; Pedersen, Torunn; Gravdahl, Goril Bruvik; Linde, Mattias			Headache following head injury: a population-based longitudinal cohort study (HUNT)	JOURNAL OF HEADACHE AND PAIN			English	Article						Headache attributed to head injury; Head injury; Traumatic brain injury; Secondary headache disorders; Post-traumatic headache; Population-based	TRAUMATIC BRAIN-INJURY; QUESTIONNAIRE; COMMUNITY	Background: Headache is the most frequent symptom following head injury, but long-term follow-up of headache after head injury entails methodological challenges. In a population-based cohort study, we explored whether subjects hospitalized due to a head injury more often developed a new headache or experienced exacerbation of previously reported headache compared to the surrounding population. Methods: This population-based historical cohort study included headache data from two large epidemiological surveys performed with an 11-year interval. This was linked with data from hospital records on exposure to head injury occurring between the health surveys. Participants in the surveys who had not been hospitalized because of a head injury comprised the control group. The head injuries were classified according to the Head Injury Severity Scale (HISS). Multinomial logistic regression was performed to investigate the association between head injury and new headache or exacerbation of pre-existing headache in a population with known pre-injury headache status, controlling for potential confounders. Results: The exposed group consisted of 294 individuals and the control group of 25,662 individuals. In multivariate analyses, adjusting for age, sex, anxiety, depression, education level, smoking and alcohol use, mild head injury increased the risk of new onset headache suffering (OR 1.74, 95% CI 1.05-2.87), stable headache suffering (OR 1.70, 95% CI 1.15-2.50) and exacerbation of previously reported headache (OR 1.93, 95% CI 1.24-3.02). The reference category was participants without headache in both surveys. Conclusion: Individuals hospitalized due to a head injury were more likely to have new onset and worsening of pre-existing headache and persistent headache, compared to the surrounding general population. The results support the entity of the ICHD-3 beta diagnosis "persistent headache attributed to traumatic injury to the head".	[Nordhaug, Lena Hoem; Hagen, Knut; Vik, Anne; Stovner, Lars Jacob; Linde, Mattias] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, INB, Dept Neuromed & Movement Sci, Postbox 8905, N-7491 Trondheim, Norway; [Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Hagen, Knut; Stovner, Lars Jacob; Gravdahl, Goril Bruvik; Linde, Mattias] St Olavs Univ Hosp, Norwegian Advisory Unit Headaches, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway; [Pedersen, Torunn] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway	Nordhaug, LH (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, INB, Dept Neuromed & Movement Sci, Postbox 8905, N-7491 Trondheim, Norway.	lena.h.nordhaug@ntnu.no		Gravdahl, Goril/0000-0001-7507-2082			Abu Bakar N, 2016, CEPHALALGIA, V36, P67, DOI 10.1177/0333102415580099; [Anonymous], 2011, ATLAS HEADACHE DISOR; [Anonymous], 2013, GUIDELINES CONCUSSIO; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hagen K, 2000, CEPHALALGIA, V20, P244, DOI 10.1046/j.1468-2982.2000.00049.x; Hagen K, 2010, J HEADACHE PAIN, V11, P67, DOI 10.1007/s10194-009-0174-7; Heskestad B, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-32; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0774-6; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0755-9; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lebedeva ER, 2016, HEADACHE, V56, P341, DOI 10.1111/head.12757; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Linde M, 2012, EUR J NEUROL, V19, P703, DOI 10.1111/j.1468-1331.2011.03612.x; Linde M, 2011, CEPHALALGIA, V31, P585, DOI 10.1177/0333102410391488; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nestvold K, 2007, NEUROEPIDEMIOLOGY, V29, P113, DOI 10.1159/000109825; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Xu HM, 2016, WORLD NEUROSURG, V88, P289, DOI 10.1016/j.wneu.2015.12.028	43	16	16	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	JAN 22	2018	19								8	10.1186/s10194-018-0838-2			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FT4ZN	WOS:000423163900001	29356960	DOAJ Gold, Green Published			2021-06-18	
J	Wen, J; Jones, M; Tanaka, M; Selvaraj, P; Symes, AJ; Cox, B; Zhang, YM				Wen, Jie; Jones, Melissa; Tanaka, Mikiei; Selvaraj, Prabhuanand; Symes, Aviva J.; Cox, Brian; Zhang, Yumin			WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms	JOURNAL OF NEUROINFLAMMATION			English	Article						Endocannabinoids; ABHD6; Chronic constriction injury; Neuroinflammation; Cyclooxygenase-2; Prostaglandin E synthase; PGE2; Neuropathic pain	PERIPHERAL-NERVE INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DORSAL-ROOT GANGLIA; MONOACYLGLYCEROL LIPASE; SPINAL-CORD; RAT MODEL; ENDOCANNABINOID SYSTEM; SELECTIVE-INHIBITION; INDUCED HYPERALGESIA; ALZHEIMERS-DISEASE	Background: Targeting the endocannabinoid system has emerged as an effective strategy for the treatment of inflammatory and neurological diseases. Unlike the inhibition of the principal 2-arachidonyl glycerol (2-AG) hydrolytic enzyme monoacylglycerol lipase (MAGL), which leads to 2-AG overload and cannabinoid receptor desensitization, selective inhibition of the minor 2-AG hydrolytic enzyme alpha, beta-hydrolase domain 6 (ABHD6) can provide therapeutic benefits without producing cannabimimetic side effects. We have shown that inhibition of ABHD6 significantly reduces neuroinflammation and exerts neuroprotection in animal models of traumatic brain injury and multiple sclerosis. However, the role of ABHD6 inhibition on neuropathic pain has not been explored. Methods: Neuropathic pain was induced by chronic constriction injury (CCI) of the mouse sciatic nerve and examined by Hargreaves and Von Frey tests. Activation of inflammatory cells and the production of cytokines and chemokines in the spinal cord dorsal horn, dorsal root ganglion (DRG), and sciatic nerve were assessed by qRT-PCR, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry. The levels of 2-AG and arachidonic acid (AA) in sciatic nerve were quantified by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Results: Treatment with the selective ABHD6 inhibitor WWL70 significantly alleviated CCI-induced thermal hyperalgesia and mechanical allodynia. Microglia activation, macrophage infiltration, and the production of nociceptive mediators were reduced in the ipsilateral lumbar spinal cord dorsal horn, DRG, and sciatic nerve of WWL70-treated animals. The diminished cytokine and chemokine production is likely due to the inhibitory effect of WWL70 on NF-.B phosphorylation. Surprisingly, the anti-nociceptive and anti-inflammatory effects of WWL70 were not reversed by addition of the cannabinoid receptor antagonists. Treatment with WWL70 did not alter the levels of 2-AG, AA, and the phosphorylation of cytosolic phospholipase A(2) (cPLA(2)), but significantly reduced the production of prostaglandin E-2 (PGE(2)) and the expression of cyclooxygenase-2 (COX-2) and prostaglandin E synthase-2 (PGES2) in the injured sciatic nerve. Conclusions: This study reveals a novel mechanism for the antinociceptive effect of the 2-AG catabolic enzyme ABHD6 inhibitor WWL70. Understanding the interaction between endocannabinoid and eicosanoid pathways might provide a new avenue for the treatment of inflammatory and neuropathic pain.	[Wen, Jie; Jones, Melissa; Tanaka, Mikiei; Selvaraj, Prabhuanand; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Symes, Aviva J.; Cox, Brian] Dept Pharmacol & Mol Therapeut, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Symes, Aviva J.; Cox, Brian; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	yumin.zhang@usuhs.edu	Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939	Defense Medical Research and Development Program [0130-10-00003-00002]	This work was supported by the grant from the Defense Medical Research and Development Program (0130-10-00003-00002).	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P295, DOI 10.1016/j.drudis.2013.07.009; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; Bennett DLH, 2001, NEUROSCIENTIST, V7, P13, DOI 10.1177/107385840100700105; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; BERGJOHNSEN J, 1993, EXP BRAIN RES, V96, P241; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Crowe MS, 2015, BRIT J PHARMACOL, V172, P1700, DOI 10.1111/bph.13012; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Denk F, 2016, CELL REP, V15, P1771, DOI 10.1016/j.celrep.2016.04.063; Drew GM, 2009, J NEUROSCI, V29, P7220, DOI 10.1523/JNEUROSCI.4362-08.2009; Durrenberger PF, 2004, J PERIPHER NERV SYST, V9, P15, DOI 10.1111/j.1085-9489.2004.09104.x; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Ghosh S, 2015, J PHARMACOL EXP THER, V354, P111, DOI 10.1124/jpet.115.222851; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Gu N, 2016, CELL REP, V16, P605, DOI 10.1016/j.celrep.2016.06.018; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Ignatowska-Jankowska Bogna, 2015, J Pharmacol Exp Ther, V353, P424, DOI 10.1124/jpet.114.222315; Jergova S, 2007, J MOL HISTOL, V38, P245, DOI 10.1007/s10735-007-9094-5; Ji RR, 2016, SCIENCE, V354, P572, DOI 10.1126/science.aaf8924; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Khasabova IA, 2011, PHARMACOL RES, V64, P60, DOI 10.1016/j.phrs.2011.03.007; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kinsey SG, 2013, J PHARMACOL EXP THER, V345, P492, DOI 10.1124/jpet.112.201426; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Menetski J, 2007, NEUROSCIENCE, V149, P706, DOI 10.1016/j.neuroscience.2007.08.014; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Muja N, 2004, GLIA, V46, P116, DOI 10.1002/glia.10349; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Petrosino S, 2007, NEUROPHARMACOLOGY, V52, P415, DOI 10.1016/j.neuropharm.2006.08.011; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Sagar DR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-59; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schafers M, 2004, EXP NEUROL, V185, P160, DOI 10.1016/j.expneurol.2003.09.015; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Smits H, 2006, NEUROSCIENCE, V143, P541, DOI 10.1016/j.neuroscience.2006.08.007; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Souza GR, 2015, PHARMACOL BIOCHEM BE, V134, P49, DOI 10.1016/j.pbb.2015.04.005; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Tanaka M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0783-4; Tanaka T, 2004, NEUROSCI RES, V48, P463, DOI 10.1016/j.neures.2004.01.004; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wagner R, 1996, NEUROREPORT, V7, P2897, DOI 10.1097/00001756-199611250-00018; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Watkins LR, 1997, PAIN, V71, P225, DOI 10.1016/S0304-3959(97)03369-1; Wen J, 2015, NEUROPHARMACOLOGY, V99, P196, DOI 10.1016/j.neuropharm.2015.07.010; Wilkerson JL, 2016, J PHARMACOL EXP THER, V357, P145, DOI 10.1124/jpet.115.229971; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Woodhams SG, 2017, NEUROPHARMACOLOGY, V124, P105, DOI 10.1016/j.neuropharm.2017.06.015; Zhang J, 2006, J NEUROCHEM, V97, P772, DOI 10.1111/j.1471-4159.2006.03746.x; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007; Zuo YX, 2003, PAIN, V105, P467, DOI 10.1016/S0304-3959(03)00261-6	72	16	16	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 8	2018	15								9	10.1186/s12974-017-1045-9			16	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	FS1HS	WOS:000419527500002	29310667	DOAJ Gold, Green Published			2021-06-18	
J	Ramirez, BJ; Gupta, V				Ramirez, B. J.; Gupta, V.			Evaluation of novel temperature-stable viscoelastic polyurea foams as helmet liner materials	MATERIALS & DESIGN			English	Article						Viscoelastic foams; Polyurea; Football helmets; Impact mitigation; Strain rate sensitivity	GLASS COMPOSITE JOINTS; HIGH-STRAIN RATES; DYNAMIC TENSILE-STRENGTH; PROFESSIONAL FOOTBALL; PRESSURE-SENSITIVITY; CONSTITUTIVE MODEL; POLYMERIC FOAMS; BEHAVIOR; DEFORMATION; CONCUSSION	Viscoelastic polyurea foams with densities of 98, 170, and 230 kg/m(3) were manufactured and integrated into helmet shells and tested using the NOCSAE and FMVSS 218 standards for football and motorcycle helmets, respectively. For football helmet testing, a Riddell Revolution helmet shell was used. The helmets with a foam liner thickness of 28 mm were dropped using a NOCSAE medium headform (4.9 kg) from heights ranging from 0.305 to 1.524 m. All impact tests were done on the crown of the helmet and dropped on a 12.7 mm modular elastomer programmer pad. Use of PU98 foam resulted in a reduction of 22% in peak g's and 25% in Severity Index and Head Injury Criteria values when compared to helmets with the original VN600 foams under ambient conditions. These tests were repeated under varying temperatures along with a reduced liner thickness of 22.2 mm. In these tests, PU98 foam reduced the peak g's by 18% at 23 degrees C, 26% at - 15 degrees C, and 20%, at 50 degrees C when compared to VN600 helmets. The FMVSS motorcycle helmet tests demonstrated the success of using an additional layer of polyurea foam liner on top of the existing expanded polystyrene liner in reducing the peak g's by 17%. (C) 2017 Elsevier Ltd. All rights reserved.	[Ramirez, B. J.; Gupta, V.] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA	Ramirez, BJ; Gupta, V (corresponding author), Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA.	bjramirez@ucla.edu; vgupta@ucla.edu			Office of Naval ResearchOffice of Naval Research [N0008]	This work was supported by the Office of Naval Research under grant number N0008 for which we are grateful to Dr. Roshdy Barsoum of the agency.	Amini MR, 2010, MECH MATER, V42, P628, DOI 10.1016/j.mechmat.2009.09.008; Amini MR, 2010, INT J IMPACT ENG, V37, P82, DOI 10.1016/j.ijimpeng.2009.04.002; Amirkhizi AV, 2006, PHILOS MAG, V86, P5847, DOI 10.1080/14786430600833198; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Choi T, 2012, MACROMOLECULES, V45, P3581, DOI 10.1021/ma300128d; Fragiadakis D, 2010, POLYMER, V51, P178, DOI 10.1016/j.polymer.2009.11.028; Gadd C. W., 1966, 660793 SAE, P164; Gibson L.J., 1999, CELLULAR SOLIDS STRU; Grujicic M, 2010, MAT SCI ENG A-STRUCT, V527, P7741, DOI 10.1016/j.msea.2010.08.042; Gupta V, 2014, EXP MECH, V54, P1133, DOI 10.1007/s11340-014-9854-6; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; He Y, 2014, J MATER SCI, V49, P7339, DOI 10.1007/s10853-014-8458-y; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Holzworth K, 2013, POLYMER, V54, P3079, DOI 10.1016/j.polymer.2013.03.067; Jain A, 2013, J ADHES SCI TECHNOL, V27, P403, DOI 10.1080/01694243.2012.705545; Jain A, 2012, MECH MATER, V46, P16, DOI 10.1016/j.mechmat.2011.11.003; Jeong KY, 2012, J MECH SCI TECHNOL, V26, P2033, DOI 10.1007/s12206-012-0509-1; Jia Z., 2014, C P SOC EXPT MECH SE, V2, P17; Jiao T, 2007, AIP CONF PROC, V955, P707, DOI 10.1063/1.2833212; Jiao T, 2009, AIP CONF PROC, V1195, P1229; Kim H, 2012, MECH MATER, V45, P10, DOI 10.1016/j.mechmat.2011.08.017; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Mills NJ, 2007, POLYMER FOAMS HANDBOOK: ENGINEERING AND BIOMECHANICS APPLICATIONS AND DESIGN GUIDE, P1; Moss W. C., 2011, LLNLSR464951; Nagy A., 1974, J CELL PLAST, V10, P127, DOI DOI 10.1177/0021955X7401000306; National Operating Committee on Standards for Athletic Equipment, 1998, 00298M03 NOCSAE; National Operating Committee on Standards for Athletic Equipment, 2004, 00104M05 NOCSAE; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ramirez BJ, 2017, J APPL PHYS, V121, DOI 10.1063/1.4985280; Roland CM, 2007, POLYMER, V48, P574, DOI 10.1016/j.polymer.2006.11.051; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; RUSCH KC, 1970, J APPL POLYM SCI, V14, P1433, DOI 10.1002/app.1970.070140603; RUSCH KC, 1969, J APPL POLYM SCI, V13, P2297, DOI 10.1002/app.1969.070131106; Sarva SS, 2007, POLYMER, V48, P2208, DOI 10.1016/j.polymer.2007.02.058; Shariatmadari MR, 2012, MATER DESIGN, V37, P543, DOI 10.1016/j.matdes.2011.10.045; Shim J, 2009, INT J IMPACT ENG, V36, P1116, DOI 10.1016/j.ijimpeng.2008.12.010; Versace J, 1971, P 15 STAPP CAR CRASH, DOI [DOI 10.4271/710881, 10.4271/710881]; Yi J, 2006, POLYMER, V47, P319, DOI 10.1016/j.polymer.2005.10.107; Youssef G, 2012, J MATER RES, V27, P494, DOI 10.1557/jmr.2011.405; Zhang J, 1997, J ENG MATER-T ASME, V119, P284, DOI 10.1115/1.2812258	44	16	17	7	65	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	JAN 5	2018	137						298	304		10.1016/j.matdes.2017.10.037			7	Materials Science, Multidisciplinary	Materials Science	FM0PO	WOS:000414669500029					2021-06-18	
J	Dong, HJ; Li, G; Shang, CZ; Yin, HJ; Luo, YC; Meng, HP; Li, XH; Wang, YL; Lin, L; Zhao, ML				Dong, Huajiang; Li, Gang; Shang, Chongzhi; Yin, Huijuan; Luo, Yuechen; Meng, Huipeng; Li, Xiaohong; Wang, Yali; Lin, Ling; Zhao, Mingliang			Umbilical cord mesenchymal stem cell (UC-MSC) transplantations for cerebral palsy	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Cerebral palsy; umbilical cord; mesenchymal stem cell; transplantation	TRAUMATIC BRAIN-INJURY; STROMAL CELLS; BONE-MARROW; THERAPY; EXOSOMES; RECOVERY; RATS	This study reports a case of a 4-year-old boy patient with abnormalities of muscle tone, movement and motor skills, as well as unstable gait leading to frequent falls. The results of the electroencephalogram (EEG) indicate moderately abnormal EEG, accompanied by irregular seizures. Based on these clinical characteristics, the patient was diagnosed with cerebral palsy (CP) in our hospital. In this study, the patient was treated with umbilical cord mesenchymal stem cell (UC-MSC) transplantation therapy. This patient received UC-MSC transplantation 3 times (5.3*10(7)) in total. After three successive cell transplantations, the patient recovered well and showed obvious improvements in EEG and limb strength, motor function, and language expression. However, the improvement in intelligence quotient (IQ) was less obvious. These results indicate that UC-MSC transplantation is a promising treatment for cerebral palsy.	[Dong, Huajiang; Li, Gang; Meng, Huipeng; Wang, Yali; Lin, Ling] Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin, Peoples R China; [Dong, Huajiang; Yin, Huijuan] Chinese Acad Med Sci, Laser Med Lab, Inst Biomed Engn, Tianjin 300192, Peoples R China; [Dong, Huajiang; Yin, Huijuan; Luo, Yuechen] Peking Union Med Coll, Tianjin 300192, Peoples R China; [Shang, Chongzhi; Li, Xiaohong; Zhao, Mingliang] Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China; [Shang, Chongzhi; Li, Xiaohong; Zhao, Mingliang] Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Dept Neurol & Neurosurg, Tianjin, Peoples R China; [Luo, Yuechen] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Wang, Yali] Shulan Hangzhou Hosp, Dongxin Rd 848, Hangzhou, Zhejiang, Peoples R China	Dong, HJ; Lin, L (corresponding author), Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin, Peoples R China.; Dong, HJ; Yin, HJ (corresponding author), Chinese Acad Med Sci, Laser Med Lab, Inst Biomed Engn, Tianjin 300192, Peoples R China.; Dong, HJ; Yin, HJ (corresponding author), Peking Union Med Coll, Tianjin 300192, Peoples R China.; Zhao, ML (corresponding author), Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China.; Zhao, ML (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Dept Neurol & Neurosurg, Tianjin, Peoples R China.; Wang, YL (corresponding author), Shulan Hangzhou Hosp, Dongxin Rd 848, Hangzhou, Zhejiang, Peoples R China.	donghj424@163.com; yinzi490@163.com; wangyali72@163.com; linling@tju.edu.cn; neuro_zhaoml@163.com	Zhao, Mingliang/AAN-1293-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401295, 81401067, 81771352]; Tianjin Research Program of Application Foundation and Advanced Technology [15JCQNJC45200, 16-JCYBJC27600]; PUMC Youth Fund; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [3332015126]	This work was supported by the National Natural Science Foundation of China (81401295, 81401067, 81771352), the Tianjin Research Program of Application Foundation and Advanced Technology (15JCQNJC45200 and 16-JCYBJC27600), the PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (3332015126).	Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Berardis S, 2015, WORLD J GASTROENTERO, V21, P742, DOI 10.3748/wjg.v21.i3.742; Borger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450; Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841; Dong H, 2017, TURK NEUROSURG; Dong HJ, 2017, J CRANIOFAC SURG, V28, P1615, DOI 10.1097/SCS.0000000000003563; El Omar R, 2014, TISSUE ENG PART B-RE, V20, P523, DOI [10.1089/ten.teb.2013.0664, 10.1089/ten.TEB.2013.0664]; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gulati S., 2017, INDIAN J PEDIAT; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Jia YX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0604-4; Komaki M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0660-9; Li G, 2017, TURK NEUROSURG; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Lu K, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0563-9; Oh SH, 2015, CYTOTHERAPY, V17, P1090, DOI 10.1016/j.jcyt.2015.04.007; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Savukinas UB, 2016, STEM CELLS, V34, P1437, DOI 10.1002/stem.2357; Wang ZG, 2017, EXP THER MED, V13, P3613, DOI 10.3892/etm.2017.4423; Zhang QH, 2015, AM J TRANSL RES, V7, P2176; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	23	16	17	1	10	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2018	10	3					901	+					7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	GB5IO	WOS:000429097900025	29636880				2021-06-18	
S	Dwyer, B; Katz, DI		Hainline, B; Stern, RA		Dwyer, Brigid; Katz, Douglas I.			Postconcussion syndrome	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; SPORT-RELATED CONCUSSION; POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; EMOTIONAL RISK-FACTORS; HEAD-INJURY; HIGH-SCHOOL; MISERABLE MINORITY; PROLONGED RECOVERY	Postconcussion syndrome (PCS) is a heterogeneous condition comprised of a set of signs and symptoms in somatic, cognitive, and emotional domains. PCS is a controversial concept because of differing consensus criteria, variability in presentation, and lack of specificity to concussion. Whereas symptoms of concussion resolve in most individuals over days to weeks, a minority of individuals experience symptoms persisting months to years. The clinical consequences of concussion may be best conceptualized as two multidimensional disorders: (1) a constellation of acute symptoms termed early-phase posttraumatic disorder (commonly headache, dizziness, imbalance, fatigue, sleep disruption, impaired cognition, photo- and phonophobia); and (2) late-phase posttraumatic disorder, consisting of somatic, emotional, and cognitive symptoms. This phase is highly influenced by various psychosocial factors and is much less specific to the brain injury itself. Risk factors for development of a late-phase disorder include a high early symptom burden (e.g., headache, fatigue), a history of multiple concussions, psychiatric conditions (anxiety, depression), longer duration of unconsciousness or amnesia, and younger age. Successful treatment requires thoughtful differential diagnosis, including consideration of comorbid and premorbid conditions and other possible contributing factors. Treatment should include a hierarchic, sequential approach to management of treatable symptoms that impact functioning, such as depression, anxiety, insomnia, headache, musculoskeletal pain, and vertigo. A guided prescription of aerobic exercise is beneficial for early- and late-phase disorders after concussion.	[Dwyer, Brigid; Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, 72 E Concord St C3, Boston, MA 02118 USA	Katz, DI (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St C3, Boston, MA 02118 USA.	dkatz@bu.edu	Dwyer, Brigid/AAI-6199-2020	Dwyer, Brigid/0000-0002-6446-8054			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arendt-Nielsen L, 2000, Prog Brain Res, V129, P343; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V1, P9; Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Charmaz K, 2002, OCCUP THER J RES, V22, P31, DOI DOI 10.1177/15394492020220S105; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Davis J D, 2007, Minerva Endocrinol, V32, P49; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; FEE CRA, 1988, ARCH EMERG MED, V5, P12; Fenech AM, 2013, LIFELONG THERAPEUTIC; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Ganti L, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0091-4; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Guilmette T, 2013, ROLE CLIN JUDGMENT S; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Heinmiller L, 2016, CURR OPIN OPHTHALMOL, V27, P407, DOI 10.1097/ICU.0000000000000296; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horn LJ, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P932; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Iverson GL, 2013, BRAIN INJURY MED PRI; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jacob S, 2008, CEPHALALGIA, V28, P991, DOI 10.1111/j.1468-2982.2008.01622.x; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; King ML, 1997, BRAIN INJURY, V11, P445; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Lovell MR., 2000, IMPACT IMMEDIATE POS; Lucas S, 2017, NEUROL CLIN, V35, P501, DOI 10.1016/j.ncl.2017.03.012; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Merritt VC, 2016, J CLIN EXP NEUROPSYC, V38, P941, DOI 10.1080/13803395.2016.1177491; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Paniak C, 2000, BRAIN INJURY, V14, P219; Pardini D., 2004, BR J SPORTS MED, V38, P661; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Putzki N, 2005, CEPHALALGIA, V25, P395, DOI 10.1111/j.1468-2982.2004.00860.x; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shepard N, 2013, BRAIN INJURY MED; Siavoshi S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010003; Siedlik JA, 2016, J SPORT MED PHYS FIT, V56, P1086; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Sufrinko A, 2017, J ATHL TRAINING, V52, P676, DOI 10.4085/1062-6050-52.4.01; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Swartz R, 2005, AM FAM PHYSICIAN, V71, P1115; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD 10 INT STAT CLAS; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	132	16	16	1	2	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						163	178		10.1016/B978-0-444-63954-7.00017-3			16	Clinical Neurology; Sport Sciences	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100019	30482344				2021-06-18	
J	Gibson, TJ; Rebelo, CB; Gowers, TA; Chancellor, NM				Gibson, T. J.; Rebelo, C. B.; Gowers, T. A.; Chancellor, N. M.			Electroencephalographic assessment of concussive non-penetrative captive bolt stunning of turkeys	BRITISH POULTRY SCIENCE			English	Article						Animal welfare; behaviour; brainstem reflexes; captive bolt; electroencephalogram (EEG); non-penetrative; stunning; turkey	SOMATOSENSORY-EVOKED POTENTIALS; HALOTHANE-ANESTHETIZED CALVES; CERVICAL DISLOCATION; ON-FARM; BLUNT TRAUMA; WATER BATH; RESPONSES; POULTRY; HEAD; SLAUGHTER	1. The aim of this study was to evaluate the electroencephalographic (EEG) and behavioural responses of turkeys stunned with three different concussive non-penetrative captive-bolt guns prior to slaughter.2. A total of 31 slaughter weight ex-breeding female turkeys (29weeks of age; mean body weight 13.32 SD 0.65kg) were stunned with the Cash Poultry Killer (CPK) (n=10), Turkey Euthanasia Device (TED) (n=10) and Zephyr EXL (n=11).3. Mean peak kinetic energy was highest for the CPK compared to the TED and Zephyr EXL (75.94.5, 28.4 +/- 0.4 and 24.4 +/- 0.7J, respectively).4. A total of 29 (94%) of the turkeys were rendered unconscious following captive bolt stunning, with total power of the EEG (Ptot) significantly reduced from baseline values (reductions of 67% CPK, 84% TED and 76% Zephyr EXL, p<0.01) and waveforms becoming isoelectric after periods of transitional EEG. However, two birds shot with the CPK and Zephyr EXL had periods of behavioural/reflexes (rhythmic respiration, nictitating membrane reflex, neck tension) and EEG activity (43-47 and 36-60+s after the shot, respectively) indicating incomplete concussion and return of consciousness. In one bird, the shot was incorrectly positioned (Zephyr EXL), while the other appeared to be related to a defective cartridge (CPK).5. In conclusion, all three captive bolt gun models were effective in producing unconsciousness in turkeys, provided they were positioned correctly and power loads performed according to their specifications.	[Gibson, T. J.; Rebelo, C. B.; Gowers, T. A.; Chancellor, N. M.] Univ London, Dept Pathobiol & Populat Sci, Royal Vet Coll, Hatfield AL9 7TA, Herts, England	Gibson, TJ (corresponding author), Univ London, Dept Pathobiol & Populat Sci, Royal Vet Coll, Hatfield AL9 7TA, Herts, England.	tgibson@rvc.ac.uk	Gibson, Troy/AAA-8687-2019	Gibson, Troy/0000-0002-1242-2695	Humane Slaughter Association	Carlos Rebelo was supported by a grant from the Humane Slaughter Association.	Authie E, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3745; BAGER F, 1990, MEAT SCI, V27, P211, DOI 10.1016/0309-1740(90)90052-8; Beyssen C, 2004, BRIT POULTRY SCI, V45, P409, DOI 10.1080/00071660410001730923; Beyssen C, 2004, ANIM RES, V53, P155, DOI 10.1051/animres:2004002; Casey-Trott TM, 2013, J ANIM SCI, V91, P5477, DOI 10.2527/jas.2013-6320; DEFRA, 2017, UK POULTR POULTR MEA; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Gibson TJ, 2016, BRIT POULTRY SCI, V57, P295, DOI 10.1080/00071668.2016.1156648; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2009, NEW ZEAL VET J, V57, P96, DOI 10.1080/00480169.2009.36885; Gibson TJ, 2009, NEW ZEAL VET J, V57, P90, DOI 10.1080/00480169.2009.36884; Gibson TJ, 2015, J APPL ANIM WELF SCI, V18, P222, DOI 10.1080/10888705.2014.980579; Gibson TJ, 2015, MEAT SCI, V100, P227, DOI 10.1016/j.meatsci.2014.10.022; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; GREGORY NG, 1990, VET REC, V126, P570; Grist A, 2017, ANIM WELFARE, V26, P111, DOI 10.7120/09627286.26.1.111; Hillebrand SJW, 1996, POULTRY SCI, V75, P664, DOI 10.3382/ps.0750664; Hindle VA, 2010, POULTRY SCI, V89, P401, DOI 10.3382/ps.2009-00297; Lines JA, 2011, BRIT POULTRY SCI, V52, P432, DOI 10.1080/00071668.2011.587180; Martin JE, 2016, ANIM WELFARE, V25, P227, DOI 10.7120/09627286.25.2.227; McKeegan DEF, 2013, POULTRY SCI, V92, P1145, DOI 10.3382/ps.2012-02587; McKeegan DEF, 2011, BRIT POULTRY SCI, V52, P645, DOI 10.1080/00071668.2011.640307; Raj ABM, 2006, ANIM WELFARE, V15, P7; Raj ABM, 2004, ANIM WELFARE, V13, P159; Raj ABM, 2001, BRIT POULTRY SCI, V42, P295, DOI 10.1080/00071660120055232; Sparrey J, 2014, WORLD POULTRY SCI J, V70, P737, DOI 10.1017/S0043933914000816; Terlouw C, 2016, MEAT SCI, V118, P147, DOI 10.1016/j.meatsci.2016.03.010	28	16	17	2	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0007-1668	1466-1799		BRIT POULTRY SCI	Br. Poult. Sci.		2018	59	1					13	20		10.1080/00071668.2017.1401215			8	Agriculture, Dairy & Animal Science	Agriculture	FW5MU	WOS:000425362300003	29099622	Green Accepted			2021-06-18	
J	Hausser, N; Johnson, K; Parsley, MA; Guptarak, J; Spratt, H; Sell, SL				Hausser, Nicole; Johnson, Kathia; Parsley, Margaret A.; Guptarak, Jutatip; Spratt, Heidi; Sell, Stacy L.			Detecting Behavioral Deficits in Rats After Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 131; Behavior; neuroscore; beam-balance; beam-walk; working memory; brain injury; fluid-percussion injury; Morris water maze; rat		With the increasing incidence of traumatic brain injury (TBI) in both civilian and military populations, TBI is now considered a chronic disease; however, few studies have investigated the long-term effects of injury in rodent models of TBI. Shown here are behavioral measures that are well-established in TBI research for times early after injury, such as two weeks, until two months. Some of these methods have previously been used at later times after injury, up to one year, but by very few laboratories. The methods demonstrated here are a short neurological assessment to test reflexes, a Beam-Balance to test balance, a Beam-Walk to test balance and motor coordination, and a working memory version of the Morris water maze that can be sensitive to deficits in reference memory. Male rats were handled and pre-trained to neurological, balance, and motor coordination tests prior to receiving parasagittal fluid percussion injury (FPI) or sham injury. Rats can be tested on the short neurological assessment (neuroscore), the beam-balance, and the Beam-Walk multiple times, while testing on the water maze can only be done once. This difference is because rats can remember the task, thus confounding the results if repeated testing is attempted in the same animal. When testing from one to three days after injury, significant differences are detected in all three non-cognitive tasks. However, differences in the Beam-Walk task were not detectable at later time points (after 3 months). Deficits were detected at 3 months in the Beam-Balance and at 6 months in the neuroscore. Deficits in working memory were detected out to 12 months after injury, and a deficit in a reference memory first appeared at 12 months. Thus, standard behavioral tests can be useful measures of persistent behavioral deficits after FPI.	[Hausser, Nicole; Johnson, Kathia; Parsley, Margaret A.; Guptarak, Jutatip; Spratt, Heidi; Sell, Stacy L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	Sell, SL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	slsell@utmb.edu		Spratt, Heidi/0000-0002-9420-5028	Moody Project for Translational Traumatic Brain Injury Research	We thank Ian Bolding for assistance with surgical preparation of subjects and Elizabeth Sumner for her meticulous editing. These studies were completed as part of a team funded by The Moody Project for Translational Traumatic Brain Injury Research.	Bramlett H. M., 2015, J NEUROTRAUM, V32, P1; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Ferguson S. A., 2003, PHYSIOL BEHAV, V119, P130; Fujimoto S. T., 2004, NEUROSCI BIOBEHAV RE; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; R Core Team, 2017, R LANG ENV STAT COMP; RUIS JF, 1991, PHYSIOL BEHAV, V50, P1233, DOI 10.1016/0031-9384(91)90588-F; Schallert T, 2003, ILAR J, V44, P130, DOI 10.1093/ilar.44.2.130; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Verma P, 2010, PHYSIOL BEHAV, V99, P276, DOI 10.1016/j.physbeh.2009.11.002	21	16	16	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JAN	2018		131							e56044	10.3791/56044			11	Multidisciplinary Sciences	Science & Technology - Other Topics	FX5CM	WOS:000426095700016	29443022	Green Published, Bronze			2021-06-18	
J	Kerr, ZY; Register-Mihalik, JK; Kay, MC; DeFreese, JD; Marshall, SW; Guskiewicz, KM				Kerr, Zachary Y.; Register-Mihalik, Johna K.; Kay, Melissa C.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.			Concussion Nondisclosure During Professional Career Among a Cohort of Former National Football League Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; sport; underreporting; traumatic brain injury	SELF-REPORTED CONCUSSIONS; RECURRENT CONCUSSION; ATTITUDES; RISK; CONCORDANCE; DEPRESSION; QUALITY; HISTORY; RATES; RACE	Background: Despite a focus on the incidence and effects of concussion, nondisclosure of sports-related concussions among retired players from the National Football League (NFL) has yet to be examined. Purpose: Examine the prevalence of and factors associated with nondisclosure of sports-related concussions in former NFL athletes. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A sample of 829 former NFL players completed a general health survey. This historical cohort included players who had played before World War II to 2001. Respondents retrospectively recalled sports-related concussions that they sustained during their professional careers and whether at least one of these sports-related concussions was not reported to medical staff. We computed the prevalence of nondisclosure among those recalling sport-related concussions during their professional careers. Multivariable binomial regression estimated adjusted prevalence ratios (PR) with 95% confidence intervals (CIs) controlling for race/ethnicity, number of years played, primary position played, professional career concussion history, and playing era. Playing era was categorized by whether the majority of a player's career was before or after a 1976 rule change to limit contact ("spearing"). Results: Overall, 417 (50.3%) respondents reported they had sustained a concussion and did not inform medical staff at least once during their professional playing career. Nonwhite respondents had a higher prevalence of nondisclosure than white/non-Hispanic respondents (adjusted PR = 1.19; 95% CI, 1.02-1.38). An interaction between professional career concussion history and playing era was also found (P = .08). Compared with those in the pre-spearing rule change group with 1 or 2 concussions, all other groups had larger prevalences of nondisclosure (increases ranging from 41% to 153% in multivariable models). Across concussion strata, nondisclosure prevalence was generally higher in the post-spearing rule change group than the pre-spearing rule change group, with the largest differences found among those with 1 or 2 concussions or those with 3 or 4 concussions. Conclusion: A large proportion of former NFL players in this historical cohort reported at least one instance of not disclosing sports-related concussions to medical staff. Future research on concussion nondisclosure needs to identify mechanisms to improve football players' intentions to disclose concussion-related symptoms to health care providers and to equip health care providers with more effective strategies for timely identification of concussion.	[Kerr, Zachary Y.; Register-Mihalik, Johna K.; Kay, Melissa C.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; DeFreese, J. D.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; Kay, Melissa C.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Kay, Melissa C.; Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA	Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research Center; Center for the Study of Retired Athletes; NFL Players Association	The authors acknowledge the support of the Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research Center, the Center for the Study of Retired Athletes, and the NFL Players Association. The Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research Center and the Center for the Study of Retired Athletes are funded by private donations and various grant funding agencies interested in understanding the late-life consequences and benefits of playing sports.	Association of American Medical Colleges, 2014, DIV PHYS WORKF FACTS; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guskiewicz K. M., 2003, Medicine & Science in Sports & Exercise, V35, pS50, DOI 10.1097/00005768-200305001-00277; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hagiwara N, 2013, SOC SCI MED, V87, P123, DOI 10.1016/j.socscimed.2013.03.016; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Malat J, 2009, J NATL MED ASSOC, V101, P800, DOI 10.1016/S0027-9684(15)31009-9; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; National Football League, PROT PLAYERS NFL HEA; National Football League, 2016, NFL NFLPA ANN POL EN; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sabin JA, 2008, MED CARE, V46, P678, DOI 10.1097/MLR.0b013e3181653d58; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; University of Central Florida College of Business Administration, 2016 RAC GEND REP CA; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	16	16	1	22	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JAN	2018	46	1					22	29		10.1177/0363546517728264			8	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	FR4FG	WOS:000419020500002	28942673				2021-06-18	
J	Nikolian, VC; Dekker, SE; Bambakidis, T; Higgins, GA; Dennahy, IS; Georgoff, PE; Williams, AM; Andjelkovic, AV; Alam, HB				Nikolian, Vahagn C.; Dekker, Simone E.; Bambakidis, Ted; Higgins, Gerald A.; Dennahy, Isabel S.; Georgoff, Patrick E.; Williams, Aaron M.; Andjelkovic, Anuska V.; Alam, Hasan B.			Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	102nd Annual Clinical Congress and Scientific Forum of the American-College-of-Surgeons (ACS)/Excelsior-Society	OCT 16-20, 2016	Washington, DC	Amer Coll Surg, Excelsior Soc		blood-brain barrier; endothelial permeability; fresh frozen plasma; traumatic brain injury; valproic acid	LARGE ANIMAL-MODEL; LYOPHILIZED PLASMA; PHARMACOLOGICAL RESUSCITATION; TIGHT JUNCTION; EXPRESSION; TRANSFUSION; INHIBITION; DISRUPTION; PHENOTYPE; APOPTOSIS	Objective: Combined traumatic brain injury and hemorrhagic shock are highly lethal. Following injuries, the integrity of the blood-brain barrier can be impaired, contributing to secondary brain insults. The status of the blood-brain barrier represents a potential factor impacting long-term neurologic outcomes in combined injuries. Treatment strategies involving plasma-based resuscitation and valproic acid therapy have shown efficacy in this setting. We hypothesize that a component of this beneficial effect is related to blood-brain barrier preservation. Design: Following controlled traumatic brain injury, hemorrhagic shock, various resuscitation and treatment strategies were evaluated for their association with blood-brain barrier integrity. Analysis of gene expression profiles was performed using Porcine Gene ST 1.1 microarray. Pathway analysis was completed using network analysis tools (Gene Ontology, Ingenuity Pathway Analysis, and Parametric Gene Set Enrichment Analysis). Subjects: Female Yorkshire swine were subjected to controlled traumatic brain injury and 2 hours of hemorrhagic shock (40% blood volume, mean arterial pressure 30-35 mmHg). Interventions: Subjects were resuscitated with 1) normal saline, 2) fresh frozen plasma, 3) hetastarch, 4) fresh frozen plasma + valproic acid, or 5) hetastarch + valproic acid (n = 5 per group). After 6 hours of observation, brains were harvested for evaluation. Measurements and Main Results: Immunofluoroscopic evaluation of the traumatic brain injury site revealed significantly increased expression of tight-junction associated proteins (zona occludin-1, claudin-5) following combination therapy (fresh frozen plasma + valproic acid and hetastarch + valproic acid). The extracellular matrix protein laminin was found to have significantly improved expression with combination therapies. Pathway analysis indicated that valproic acid significantly modulated pathways involved in endothelial barrier function and cell signaling. Conclusions: Resuscitation with fresh frozen plasma results in improved expression of proteins essential for blood-brain barrier integrity. The addition of valproic acid provides significant improvement to these protein expression profiles. This is likely secondary to activation of key pathways related to endothelial functions.	[Nikolian, Vahagn C.; Dekker, Simone E.; Bambakidis, Ted; Dennahy, Isabel S.; Georgoff, Patrick E.; Williams, Aaron M.; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Higgins, Gerald A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Andjelkovic, Anuska V.] Univ Michigan, Med Sch, Dept Pathol, Ann Arbor, MI USA	Alam, HB (corresponding author), Univ Michigan Hosp, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465; Dennahy, Isabel/0000-0002-4778-8910	U.S. Army Material and Research Command [W81XWH-09-1-0520]; Massey Foundation grant; Department of DefenseUnited States Department of Defense; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Supported by the U.S. Army Material and Research Command, Contract W81XWH-09-1-0520.; Dr. Higgins received support for article research from a Massey Foundation grant. Dr. Dennahy disclosed off-label product use of valproic acid in traumatic brain injury. Dr. Williams' institution received grant funding from the Department of Defense. Dr. Andjelkovic received support for article research from the National Institutes of Health. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467; Banjara M, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/8385961; Cartotto R, 2016, CRIT CARE CLIN, V32, P507, DOI 10.1016/j.ccc.2016.06.002; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chang ZG, 2016, J TRAUMA ACUTE CARE, V81, P512, DOI 10.1097/TA.0000000000001137; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/ip.2005.010983rep, 10.1136/injuryprev-2015-041862]; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gautam J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36450; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Joannidis M, 2017, INTENS CARE MED, V43, P730, DOI 10.1007/s00134-017-4832-y; Kangwantas K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0495-9; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kim YJ, 2014, NEUROSCIENCE, V275, P146, DOI 10.1016/j.neuroscience.2014.06.005; Lee TH, 2013, J TRAUMA ACUTE CARE, V75, P369, DOI 10.1097/TA.0b013e31829bb67c; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Reinhold AK, 2017, PFLUG ARCH EUR J PHY, V469, P123, DOI 10.1007/s00424-016-1920-8; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Ying GY, 2016, NEUROSURGERY, V79, P286, DOI 10.1227/NEU.0000000000001264	40	16	17	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2018	46	1					E59	E66		10.1097/CCM.0000000000002800			8	Critical Care Medicine	General & Internal Medicine	FW6LU	WOS:000425430600007	29095204				2021-06-18	
J	Rauch, SAM; Simon, NM; Kim, HM; Acierno, R; King, AP; Norman, SB; Venners, MR; Porter, K; Phan, KL; Tuerk, PW; Allard, C; Liberzon, I; Rothbaum, BO; Martis, B; Stein, MB; Hoge, CW				Rauch, Sheila A. M.; Simon, Naomi M.; Kim, H. Myra; Acierno, Ron; King, Anthony P.; Norman, Sonya B.; Venners, Margaret R.; Porter, Katherine; Phan, K. Luan; Tuerk, Peter W.; Allard, Carolyn; Liberzon, Israel; Rothbaum, Barbara O.; Martis, Brian; Stein, Murray B.; Hoge, Charles W.			Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial)	CONTEMPORARY CLINICAL TRIALS			English	Article						Randomized controlled trial; Posttraumatic stress disorder; Biomarkers; Mechanisms; Methods	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; SOCIAL ANXIETY DISORDER; ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; PSYCHOMETRIC PROPERTIES; EMOTION REGULATION; NEURAL PREDICTORS; SOMATIC SYMPTOMS	Increased emphasis on mechanisms of treatment effectiveness, biomarker predictors, and objective indicators of treatment response has sparked interest in integrated, translational treatment outcomes trials. The PROlonGed ExpoSure and Sertraline Trial (PROGrESS) is one such randomized controlled trial (RCT) focused on a key question in clinical management of posttraumatic stress disorder (PTSD) - the comparative and combined effectiveness of medication and psychotherapy. PROGrESS employs a state of the art trial design to examine psychotherapy and medication effects across three conditions: 1) Prolonged Exposure (PE) plus pill placebo, 2) Sertraline (SERT) plus Enhanced Medication Management (EMM), and 3) Combined treatment (PE/SERT). Innovative measures will capture potential biomarker predictors and indicators of treatment response within and across these three treatment conditions in Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) service members and veterans with PTSD. Assessments include clinician-rated measures, self-report outcome measures, saliva for salivary cortisol and cortisol response to awakening at six assessment points, blood at baseline and week 24 for genetic and genomic analysis, as well as resting state connectivity and emotion processing and regulation using functional Magnetic Resonance Imaging (fMRI) paradigms in a subsample of veterans. Accordingly, the current study is designed to provide pragmatic clinical direction for the delivery of PTSD treatment through its primary outcomes in an effectiveness design, and will also provide informative results to elucidate underlying mechanisms and biomarkers involved in PTSD treatment response.	[Rauch, Sheila A. M.] Atlanta VA Med Ctr, 1670 Clairmont Rd, Atlanta, GA 30033 USA; [Rauch, Sheila A. M.; Rothbaum, Barbara O.] Emory Univ, Sch Med, 12 Execut Pk,3rd Floor, Atlanta, GA 30029 USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Dept Psychiat, One Bowdoin Sq,6th Floor, Boston, MA 02114 USA; [Simon, Naomi M.] NYU, Med Sch, Dept Psychiat, One Pk Ave,8th Floor, New York, NY 10016 USA; [Kim, H. Myra; King, Anthony P.; Venners, Margaret R.; Porter, Katherine; Liberzon, Israel; Martis, Brian] VA Ann Arbor Healthcare Syst, 2215 Fuller Rd, Ann Arbor, MI 48105 USA; [Kim, H. Myra] Univ Michigan, Consulting Stat Comp & Analyt Res, 3550 Rackham,950 E Washington St, Ann Arbor, MI 48109 USA; [King, Anthony P.; Porter, Katherine; Liberzon, Israel; Martis, Brian] Univ Michigan, Dept Psychiat, 4250 Plymouth Rd, Ann Arbor, MI 48109 USA; [Acierno, Ron; Tuerk, Peter W.] Ralph H Johnson VA Med Ctr, 109 Bee St, Charleston, SC 29401 USA; [Acierno, Ron] Med Univ South Carolina, Coll Nursing, Jonathan Lucas St, Charleston, SC 29425 USA; [Tuerk, Peter W.] Med Univ South Carolina, Dept Psychiat, 67 President St, Charleston, SC 29425 USA; [Allard, Carolyn; Stein, Murray B.] VA San Diego Healthcare Syst, 3350 Villa La Jolla Dr, San Diego, CA 92161 USA; [Norman, Sonya B.] Natl Ctr PTSD, 215 N Main St, White River Jct, VT 05009 USA; [Norman, Sonya B.] VA Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,MC116B, San Diego, CA 92161 USA; [Norman, Sonya B.; Allard, Carolyn; Stein, Murray B.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92037 USA; [Allard, Carolyn] Solara Mental Hlth San Diego, San Diego, CA USA; [Phan, K. Luan] Univ Illinois, Dept Psychiat, 1747 W Roosevelt Rd, Chicago, IL 60608 USA; [Phan, K. Luan] Jesse Brown VA Med Ctr, 820 S Damen Ave, Chicago, IL 60612 USA; [Hoge, Charles W.] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA	Rauch, SAM (corresponding author), Emory Univ, Sch Med, 12 Execut Pk,3rd Floor, Atlanta, GA 30329 USA.	sheila.a.m.rauch@emory.edu	, Anthony/AAG-9308-2019; Rauch, Sheila A.M./K-4450-2015; Allard, Carolyn B./B-3521-2013	Allard, Carolyn B./0000-0002-7803-2243; King, Anthony/0000-0002-0764-9625; Liberzon, Israel/0000-0002-4990-556X	U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC) [W81XWH-11-1-0073]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433] Funding Source: NIH RePORTER	This work was supported by the U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC; Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy, and Their Combination in OEF/OIF Combat Veterans with PTSD); (Award #W81XWH-11-1-0073; PI: Rauch); the National Center for Advancing Translational Sciences of the National Institutes of Health (Award #UL1TR000433). This material is the result of work supported with resources and the use of facilities at Massachusetts General Hospital, the VA Ann Arbor Healthcare System, Ralph H. Johnson VA Medical Center, and VA San Diego Healthcare System. The views expressed in this article presentation are solely those of the author(s) and do not reflect an endorsement by or the official policy of the Department of Veterans Affairs, Department of Defense, or the U.S. Government, or the official views of the National Institutes of Health.	Adkins JW, 2008, J ANXIETY DISORD, V22, P1393, DOI 10.1016/j.janxdis.2008.02.002; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Association A. P., 2017, CLIN PRACT GUID TREA; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Breen MS, 2015, MOL PSYCHIATR, V20, P1538, DOI 10.1038/mp.2015.9; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Chen AC, 2010, NEUROIMAGE, V51, P930, DOI 10.1016/j.neuroimage.2010.02.044; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Cisler JM, 2016, PSYCHOL MED, V46, P3013, DOI 10.1017/S0033291716001847; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Duncan L. E, 2017, MOL PSYCHIAT; Ekman P., 1976, PICTURES FACIAL AFFE; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Foa EB, 2004, J CONSULT CLIN PSYCH, V72, P879, DOI 10.1037/0022-006X.72.5.879; Foa EB, 2007, PROLONGED EXPOSURE T; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Gur RC, 2002, NEUROIMAGE, V16, P651, DOI 10.1006/nimg.2002.1097; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Hosmer D, 1989, APPL LOGISTIC REGRES; Jacobson N.S., 1992, CLIN SIGNIFICANCE ST, P631; Jayawickreme N, 2014, DEPRESS ANXIETY, V31, P412, DOI 10.1002/da.22225; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI DOI 10.1037/1040-3590.1.1.53; King AP, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00154; Klumpp H, 2017, NEUROIMAGE-CLIN, V15, P25, DOI 10.1016/j.nicl.2017.04.006; Klumpp H, 2017, PROG NEURO-PSYCHOPH, V75, P106, DOI 10.1016/j.pnpbp.2017.01.010; Klumpp H, 2013, PROG NEURO-PSYCHOPH, V45, P83, DOI 10.1016/j.pnpbp.2013.05.004; Klumpp H, 2012, BIOL PSYCHOL, V89, P273, DOI 10.1016/j.biopsycho.2011.10.010; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lang M.M., 1997, INT AFFECTIVE PICTUR; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; Ma ST, 2017, COGN AFFECT BEHAV NE, V17, P437, DOI 10.3758/s13415-016-0489-1; MacNamara A, 2016, NEUROPSYCHOPHARMACOL, V41, P611, DOI 10.1038/npp.2015.190; Marciniak M, 2004, DEPRESS ANXIETY, V19, P112, DOI 10.1002/da.10131; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Rauch SAM, 2015, DEPRESS ANXIETY, V32, P204, DOI 10.1002/da.22331; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Schneier FR, 2012, AM J PSYCHIAT, V169, P80, DOI 10.1176/appi.ajp.2011.11020321; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith G.R., 1996, SUBSTANCE ABUSE OUTC; Sripada RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00672; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; VA/DOD, 2017, VET AFF DEP DEF CLIN; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002	59	16	16	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2018	64						128	138		10.1016/j.cct.2017.10.013			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	FU1ZE	WOS:000423647200017	29081351				2021-06-18	
J	Saldert, C; Jensen, LR; Johansson, MB; Simmons-Mackie, N				Saldert, C.; Jensen, L. R.; Johansson, M. Blom; Simmons-Mackie, N.			Complexity in measuring outcomes after communication partner training: alignment between goals of intervention and methods of evaluation	APHASIOLOGY			English	Article						Communication partner training; aphasia; outcome measures; patient-relevant outcome; core outcome set	APHASIA TREATMENT RESEARCH; TRAUMATIC BRAIN-INJURY; ITEM BANK CALIBRATION; SUPPORTED CONVERSATION; PSYCHOMETRIC PROPERTIES; MEDICAL-STUDENTS; NURSES WORKING; HEALTH-CARE; STROKE; PARTICIPATION	Background: Researchers are currently discussing the need for consensus on a core set of outcome measures to assess interventions in aphasia. For indirect, environmental approaches to aphasia intervention, such as communication partner training (CPT), the roadmap to obtaining consensus on core outcome measures seems especially complex. While the purpose of CPT is to improve communication for people with communication disorders, the intervention is aimed at the communication partner. There is also a variety of goals, activities, and possible settings for CPT. This complexity increases the risk of a mismatch between the goals and content of the intervention and measures used to evaluate the outcome. Aims: The purpose of this paper is to describe the complexity of measuring outcomes from CPT. The aim is to enable clinicians and researchers to reflect on the outcomes to be measured and also on how different types of measures may or may not be aligned with the goals and content of a specific CPT intervention. Main contribution: The current proliferation of outcome measures used in CPT is considered in the light of a survey of general factors to be considered in evaluating intervention outcomes. The complexity of measuring outcomes in CPT is illustrated and the importance of alignment of main objectives, intervention tasks, and projected outcomes is exemplified by referencing two common types of CPT approaches. Objectives relating to knowledge of aphasia, interactional behaviour, and feelings and attitudes are considered in relation to specific outcome measurements. It is suggested that both study-specific and more general measures are needed for capturing and comparing outcomes. The measurement of relevant outcome in CPT is discussed along with implications for future research and clinical practice. Conclusions: Different CPT approaches share the same purpose of facilitating communication in aphasia, but their application in research studies or in the clinic, is specific to the particular context. Special care must thus be taken in both clinical practice and research to safeguard the alignment between objectives, tasks, and projected intervention outcomes and the actual measures used. Further, it is concluded that there is a need for the development of new measures based on a consensus on key outcomes to be measured in CPT.	[Saldert, C.] Univ Gothenburg, Speech Language Pathol Unit, Inst Neurosci & Physiol, Gothenburg, Sweden; [Jensen, L. R.] Univ Copenhagen, Dept Nord Studies & Linguist, Copenhagen, Denmark; [Johansson, M. Blom] Uppsala Univ, Dept Neurosci, Speech Language Pathol, Uppsala, Sweden; [Simmons-Mackie, N.] Southeastern Louisiana Univ, Dept Hlth & Human Sci, Hammond, LA USA	Saldert, C (corresponding author), Univ Gothenburg, Speech Language Pathol Unit, Inst Neurosci & Physiol, Gothenburg, Sweden.	charlotta.saldert@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020; Johansson, Monica Blom/AAN-1593-2020; Jensen, Lise Randrup/D-8342-2017	Saldert, Charlotta/0000-0001-8808-3610; Johansson, Monica Blom/0000-0002-6095-6130; Jensen, Lise Randrup/0000-0001-8784-6962			Ahlsen E., APHASIOLOGY; Ali M, 2013, INT J STROKE, V8, P18, DOI 10.1111/j.1747-4949.2012.00973.x; American Speech-Language Hearing Association, PRACT PORT; Baylor C, 2017, APHASIOLOGY, V31, P861, DOI 10.1080/02687038.2016.1225274; Baylor C, 2013, J SPEECH LANG HEAR R, V56, P1190, DOI 10.1044/1092-4388(2012/12-0140); Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P269, DOI 10.1044/1058-0360(2011/10-0084); Baylor CR, 2009, J SPEECH LANG HEAR R, V52, P1302, DOI 10.1044/1092-4388(2009/07-0275); Beeke S., 2013, BETTER CONVERSATIONS; Best W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2076.00562; BLOMERT L, 1994, APHASIOLOGY, V8, P381, DOI 10.1080/02687039408248666; Booth S, 1999, APHASIOLOGY, V13, P283, DOI 10.1080/026870399402109; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Brady MC, 2014, APHASIOLOGY, V28, P1385, DOI 10.1080/02687038.2014.930261; Brandenburg C, 2015, DISABIL REHABIL, V37, P1113, DOI 10.3109/09638288.2014.955132; Cherney LR, 2013, INT J SPEECH-LANG PA, V15, P535, DOI 10.3109/17549507.2013.763289; Correll A, 2010, APHASIOLOGY, V24, P612, DOI 10.1080/02687030902732752; Coster WJ, 2013, AM J OCCUP THER, V67, P162, DOI 10.5014/ajot.2013.006015; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Croteau C, 2018, APHASIOLOGY, V32, P247, DOI 10.1080/02687038.2017.1350629; Cruice M., APHASIOLOGY; De Los Reyes A, 2011, CLIN PSYCHOL REV, V31, P829, DOI 10.1016/j.cpr.2011.03.011; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Doyle PJ, 2008, APHASIOLOGY, V22, P718, DOI 10.1080/02687030701803093; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; Eriksson K, 2016, DISABIL REHABIL, V38, P1187, DOI 10.3109/09638288.2015.1089952; Fox S, 2009, APHASIOLOGY, V23, P951, DOI 10.1080/02687030802669526; Friedman LM, 2015, FUNDAMENTALS CLIN TR; Genereux S, 2004, APHASIOLOGY, V18, P1161, DOI 10.1080/02687030444000507; Geroin C, 2013, J REHABIL MED, V45, P987, DOI 10.2340/16501977-1234; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Hausberg MC, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-16; Hays R D, 1992, Qual Life Res, V1, P73, DOI 10.1007/BF00435438; Hebert D, 2016, INT J STROKE, V11, P459, DOI 10.1177/1747493016643553; Hilari K, 2009, CLIN REHABIL, V23, P544, DOI 10.1177/0269215508101729; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Horton S., 2014, 16 INT APH REH C HAG; Horton S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011207; Hula WD, 2015, J SPEECH LANG HEAR R, V58, P906, DOI 10.1044/2015_JSLHR-L-14-0235; Hula WD, 2014, APHASIOLOGY, V28, P1396, DOI 10.1080/02687038.2014.930264; Hutchby I., 1998, CONVERSATION ANAL PR; Jensen LR, 2015, APHASIOLOGY, V29, P57, DOI 10.1080/02687038.2014.955708; Johansson MB, 2011, DISABIL REHABIL, V33, P51, DOI 10.3109/09638288.2010.486465; Johansson MB, 2013, APHASIOLOGY, V27, P201, DOI 10.1080/02687038.2012.744808; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan A., 2012, CLIN APH C LAK TAH C; Kagan A, 2011, ASSESSMENT LIVING AP; Kagan A, 2017, ARCH PHYS MED REHAB, V98, P2228, DOI 10.1016/j.apmr.2017.04.017; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kerckhofs E, 2010, CLIN REHABIL, V24, P479, DOI 10.1177/0269215509353266; Kiresuk T., 1994, GOAL ATTAINMENT SCAL; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; LOCK S, 2001, SUPPORTING PARTNERS; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Long AF, 2008, CLIN REHABIL, V22, P1083, DOI 10.1177/0269215508090091; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Lyon JG, 1997, APHASIOLOGY, V11, P693, DOI 10.1080/02687039708249416; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Mc Dowell I., 2006, MEASURING HLTH GUIDE, V3rd; Mc Menamin R, 2015, APHASIOLOGY, V29, P914, DOI 10.1080/02687038.2015.1006564; McGilton KS, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-61; Meinert CL, 2013, CLIN TRIALS HDB DESI; Moran P, 2017, J FAM THER, V39, P41, DOI 10.1111/1467-6427.12082; National Institute for Health and Care Excellence (NICE), 2013, STR REH AD CLIN GUID; Nykanen A, 2013, APHASIOLOGY, V27, P1159, DOI 10.1080/02687038.2013.802284; Perkins L., 1997, CONVERSATION ANAL PE; Purdy M, 2005, APHASIOLOGY, V19, P377, DOI 10.1080/02687030444000822; Rautakoski P, 2008, APHASIOLOGY, V22, P1269, DOI 10.1080/02687030802374788; Saldert C, 2016, INT J SPEECH-LANG PA, V18, P571, DOI 10.3109/17549507.2016.1143975; Saldert C, 2013, APHASIOLOGY, V27, P271, DOI 10.1080/02687038.2012.710317; Schegloff Emanuel A., 1993, RES LANG SOC INTERAC, V26, P99, DOI DOI 10.1207/S15327973RLSI2601_5; SHEWAN CM, 1984, J COMMUN DISORD, V17, P175, DOI 10.1016/0021-9924(84)90010-8; Silverman D., 2001, INTERPRETING QUALITA; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Simmons-Mackie N, 2014, INT J LANG COMM DIS, V49, P511, DOI 10.1111/1460-6984.12097; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P39, DOI 10.1080/02687030600798287; Sirman N, 2017, APHASIOLOGY, V31, P465, DOI 10.1080/02687038.2017.1278739; Socialstyrelsen, 2018, NAT RIKTL VARD VID S; Sorin-Peters R, 2010, APHASIOLOGY, V24, P1511, DOI 10.1080/02687038.2010.494829; SORINPETERS R, 1995, APHASIOLOGY, V9, P565, DOI 10.1080/02687039508248715; Staniszewska S, 2012, PATIENT, V5, P79, DOI 10.2165/11597150-000000000-00000; Swinburn K, 2012, INT J STROKE, V7, P30; Tennant A, 2007, DISABIL REHABIL, V29, P1583, DOI 10.1080/09638280701618828; TINSLEY HEA, 1975, J COUNS PSYCHOL, V22, P358, DOI 10.1037/h0076640; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; Van de Velde D, 2017, CLIN REHABIL, V31, P379, DOI 10.1177/0269215516644310; van der Meulen I, 2010, INT J LANG COMM DIS, V45, P424, DOI 10.3109/13682820903111952; Visch-Brink E., 2017, COLL APH TRIAL C ROT; Wallace S. J., 2016, INT APH REH C LOND U; Wallace SJ, 2017, APHASIOLOGY, V31, P643, DOI 10.1080/02687038.2016.1186265; Wallace SJ, 2017, DISABIL REHABIL, V39, P1364, DOI 10.1080/09638288.2016.1194899; Wallace SJ, 2016, AM J SPEECH-LANG PAT, V25, pS729, DOI 10.1044/2016_AJSLP-15-0150; Wallace SJ, 2014, APHASIOLOGY, V28, P1364, DOI 10.1080/02687038.2014.930262; Wiering B, 2017, HEALTH EXPECT, V20, P11, DOI 10.1111/hex.12442; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson R, 2015, APHASIOLOGY, V29, P257, DOI 10.1080/02687038.2014.974138; Wilkinson R, 2012, ARCH PHYS MED REHAB, V93, pS70, DOI 10.1016/j.apmr.2011.07.206; Wilkinson R, 2011, INT J SPEECH-LANG PA, V13, P74, DOI 10.3109/17549507.2011.551140; WILLIAMS SE, 1986, ARCH PHYS MED REHAB, V67, P250; Worral L., 1999, FCTP FUNCT COMM THER; Wright D.B., 1997, UNDERSTANDING STAT I	105	16	16	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2018	32	10			SI		1167	1193		10.1080/02687038.2018.1470317			27	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	GT8TR	WOS:000444813200003		Green Published			2021-06-18	
J	Wang, X; Lan, YL; Xing, JS; Lan, XQ; Wang, LT; Zhang, B				Wang, Xun; Lan, Yu-Long; Xing, Jin-Shan; Lan, Xiao-Qiang; Wang, Li-Tao; Zhang, Bo			Alantolactone plays neuroprotective roles in traumatic brain injury in rats via anti-inflammatory, anti-oxidative and anti-apoptosis pathways	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Alantolactone; traumatic brain injury; inflammation; apoptosis	NF-KAPPA-B; CLOSED-HEAD INJURY; OXIDATIVE STRESS; INFLAMMATION; EXPRESSION; PATHOPHYSIOLOGY; PROGESTERONE; NEURONS; TARGETS; IMPACT	Traumatic brain injury (TBI) is a common disease associated with a high rate of morbidity and mortality. Secondary brain injury following TBI triggers pathological, physiological, and biological reactions that lead to neurological dysfunctions. Alantolactone (ATL) is a well-known Chinese medicine that possesses strong anti-inflammatory properties, but its role in TBI remains poorly understood. The objective of this study was to evaluate the protective effect of ATL in a rat model of controlled cortical impact (CCI). We observed the neurological scores, brain water content, oxidative stress, neuroinflammation and apoptosis by performing an enzyme-linked immunosorbent assay, western blotting, quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR), immunohistochemical (IHC) staining and other methods after CCI. The neurological scores, brain water content, levels of oxidative stress and inflammatory cytokines, and apoptosis index were markedly decreased following the ATL treatment in rats after TBI. Moreover, the antioxidant and anti-inflammatory effects of ATL in TBI may be partially mediated by inhibition of the NF-kappa B pathway and suppression of Cyclooxygenase 2 (COX-2). In addition, ATL attenuated TBI-induced neuronal apoptosis by suppressing the cytochrome c/caspase-dependent apoptotic pathway. Thus, ATL could exert neuroprotection in rats in a TBI model. Importantly, ATL has great potential in the clinical treatment of TBI.	[Wang, Xun; Lan, Yu-Long; Xing, Jin-Shan; Lan, Xiao-Qiang; Zhang, Bo] Dalian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Dalian 116023, Peoples R China; [Wang, Xun; Wang, Li-Tao] Dalian Med Univ, Nondirectly Affiliated Hosp, Dept Neurosurg, Peoples Hosp Dalian 3, Dalian 116033, Peoples R China; [Wang, Xun; Lan, Yu-Long; Xing, Jin-Shan] Dalian Med Univ, Dept Pharm, Dalian 116044, Peoples R China; [Lan, Yu-Long] Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China	Zhang, B (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Dalian 116023, Peoples R China.	zhangbodlykdx@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372714, 81672480]; Liaoning Provincial Natural Science Foundation of China [201602244]; Distinguished Professor Project of Liaoning Province; Special Grant for Translational Medicine, Dalian Medical University [2015002]; Traditional Chinese Medicine Foundation of Dalian [17Z1007]	This work is supported by grants from National Natural Science Foundation of China (Nos. 81372714, 81672480), Liaoning Provincial Natural Science Foundation of China (No. 201602244), Distinguished Professor Project of Liaoning Province, Special Grant for Translational Medicine, Dalian Medical University (No. 2015002), Traditional Chinese Medicine Foundation of Dalian (17Z1007).	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chung MH, 2014, MUTAT RES-FUND MOL M, V768, P74, DOI [1, 10.1016/j.mrfmmm.2014.04.003]; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dixon DJ, 2017, PHYS MED REH CLIN N, V28, P215; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hasegawa Y, 2015, TRANSL STROKE RES, V6, P458, DOI 10.1007/s12975-015-0423-9; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jung KT, 2014, KOREAN J PAIN, V27, P365, DOI 10.3344/kjp.2014.27.4.365; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Khalaj L, 2013, BRAIN RES, V1527, P117, DOI 10.1016/j.brainres.2013.06.041; Khan M, 2012, IUBMB LIFE, V64, P783, DOI 10.1002/iub.1068; Kim HN, 2014, CANCER LETT, V351, P41, DOI 10.1016/j.canlet.2014.03.037; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee JY, 2016, BIOPHARM DRUG DISPOS, V37, P156, DOI 10.1002/bdd.2005; Lehmann GL, 2004, CURR NEUROVASC RES, V1, P293, DOI 10.2174/1567202043362081; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo Chun, 2002, Chin J Traumatol, V5, P299; Luo Chun, 1999, Chin J Traumatol, V2, P101; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Seifert HA, 2014, TRANSL STROKE RES, V5, P543, DOI 10.1007/s12975-014-0349-7; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Wang D, 2012, MOLECULES, V17, P9803, DOI 10.3390/molecules17089803; Wang QS, 2005, NEUROCHEM RES, V30, P1387, DOI 10.1007/s11064-005-8391-1; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Wang X, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0563-8; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Xiong XY, 2014, TRANSL STROKE RES, V5, P429, DOI 10.1007/s12975-013-0317-7; Yang Shu-Yuan, 2004, Chin J Traumatol, V7, P159; Yang Xiao-feng, 2005, Chin J Traumatol, V8, P96; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	54	16	16	0	7	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2018	10	2					368	380					13	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	FW3NJ	WOS:000425214200003	29511431				2021-06-18	
J	Wojtowicz, M; Gardner, AJ; Stanwell, P; Zafonte, R; Dickerson, BC; Iverson, GL				Wojtowicz, Magdalena; Gardner, Andrew J.; Stanwell, Peter; Zafonte, Ross; Dickerson, Bradford C.; Iverson, Grant L.			Cortical thickness and subcortical brain volumes in professional rugby league players	NEUROIMAGE-CLINICAL			English	Article						Volumetric MRI; Cortical thickness; Concussion; Brain morphometry; Athletes; Rugby	ALCOHOL DEPENDENCE; HIGH-SCHOOL; CONCUSSION; COLLEGIATE; SPORTS; HISTORY; CORTEX	Purpose: The purpose of this study was to examine cortical thickness and subcortical volumes in professional rugby players with an extensive history of concussions compared to control subjects. Method: Participants included 24 active and former professional rugby league players [Age M(SD) = 33.3(6.3); Range = 21-44] with an extensive history of concussion and 18 age-and education-matched controls with no history of neurotrauma or participation in contact sports. Participants underwent T1-weighted imaging and completed a neuropsychological battery, including two tests of memory. Whole brain cortical thickness analysis and structural volume analysis was performed using FreeSurfer version 6.0. Results: Professional rugby league players reported greater alcohol consumption (p < .001) and had significantly worse delayed recall of a visually complex design (p = . 04). They did not differ from controls on other clinical outcome measures. There were no differences in cortical thickness between the groups. Professional players had smaller whole brain (p = . 003), bilateral hippocampi (ps = . 03), and left amygdala volumes (p = . 01) compared to healthy controls. Within the players group, there were significant associations between greater alcohol use and smaller bilateral hippocampi and left amygdala volumes. There were no associations between structural volumes and history of concussions or memory performance. Conclusions: The literature examining cortical thickness in athletes with a history of multiple concussions is mixed. We did not observe differences in cortical thickness in professional rugby league players compared to controls. However, smaller subcortical volumes were found in players that were, in part, associated with greater alcohol consumption.	[Wojtowicz, Magdalena] York Univ, Dept Psychol, Behav Hlth Sci Bldg Room 282,4700 Keele St, Toronto, ON M3J 1P, Canada; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW 2308, Australia; [Stanwell, Peter] Univ Newcastle, Fac Hlth, Sch Hlth Sci, Callaghan, NSW 2308, Australia; [Zafonte, Ross; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross; Iverson, Grant L.] Home Base, Boston, MA USA; [Dickerson, Bradford C.] Harvard Med Sch, Dept Neurol, Boston, MA 02114 USA; [Iverson, Grant L.] MassGen Hosp Children Sport Concuss Program, Boston, MA 02114 USA	Wojtowicz, M (corresponding author), York Univ, Dept Psychol, Behav Hlth Sci Bldg Room 282,4700 Keele St, Toronto, ON M3J 1P, Canada.	magdawoj@yorku.ca; andrew.gardner@neurogard.com.au; peter.stanwell@newcastle.edu.au; rzafonte@mgh.harvard.edu; bradd@nmr.mgh.harvard.edu; giverson@mgh.harvard.edu	Stanwell, Peter/F-9136-2012	Stanwell, Peter/0000-0002-4780-0393; Iverson, Grant/0000-0001-7348-9570	New South Wales Sporting Injuries Committee; Brain Foundation Australia	New South Wales Sporting Injuries Committee; Brain Foundation Australia.	Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cummins C, 2015, INT J SPORT PHYSIOL, V10, P732, DOI 10.1123/ijspp.2014-0541; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; Fein G, 2013, NEUROIMAGE-CLIN, V3, P47, DOI 10.1016/j.nicl.2013.06.018; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kuhn S, 2014, JAMA PSYCHIAT, V71, P806, DOI 10.1001/jamapsychiatry.2014.352; Lee J, 2016, PSYCHIAT RES-NEUROIM, V258, P16, DOI 10.1016/j.pscychresns.2016.10.009; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Meyers J., 1995, REY COMPLEX FIGURE T; Mitrushina M., 2005, HDB NORMATIVE DATA N; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1964, EXAMEN CLIN PSYCHOL; Strain J. F., 2015, JAMA NEUROL, V9044, P1; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102	22	16	16	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						377	381		10.1016/j.nicl.2018.01.005			5	Neuroimaging	Neurosciences & Neurology	GH1NG	WOS:000433169000037	29487794	DOAJ Gold, Green Published			2021-06-18	
J	Zeiler, FA; Cardim, D; Donnelly, J; Menon, DK; Czosnyka, M; Smielewski, P				Zeiler, Frederick A.; Cardim, Danilo; Donnelly, Joseph; Menon, David K.; Czosnyka, Marek; Smielewski, Peter			Transcranial Doppler Systolic Flow Index and ICP-Derived Cerebrovascular Reactivity Indices in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebrovascular reactivity; continuous autoregulation indices; co-variance; critical thresholds; TCD	CEREBRAL AUTOREGULATION; PRESSURE	The purpose of our study was to explore relationships between transcranial Doppler (TCD) indices of cerebrovascular reactivity and those derived from intracranial pressure (ICP). Goals included: A) confirming previously described co-variance patterns of TCD/ICP indices, and B) describing thresholds for systolic flow index (Sx; correlation between systolic flow velocity [FVs] and cerebral perfusion pressure [CPP]) associated with outcome. In a retrospective cohort of traumatic brain injury (TBI) patients: with TCD and ICP monitoring, we calculated various continuous indices of cerebrovascular reactivity: A) ICP (pressure reactivity index [PRx]: correlation between ICP and mean arterial pressure [MAP]; PAx: correlation between pulse amplitude of ICP [AMP] and MAP; RAC: correlation between AMP and CPP) and B) TCD (mean flow index [Mx]: correlation between mean flow velocity [FVm] and CPP; Mx_a: correlation between FVm and MAP; Sx: correlation between FVs and CPP; Sx_a: correlation between FVs and MAP; Dx: correlation between diastolic flow velocity [FVd] and CPP; Dx_a: correlation between FVd and MAP). We assessed the relationships via various statistical techniques, including: principal component analysis, agglomerative hierarchal clustering, and k-means cluster analysis (KMCA). We performed sequential chi(2) testing to define thresholds associated with outcome for Sx/Sx_a. Outcome was assessed at 6 months via dichotomized Glasgow Outcome Score (GOS): A) Favorable (GOS 4 or 5) versus Unfavorable (GOS 3 or less), B) Alive versus Dead. We analyzed 410 recordings in 347 patients. All analyses confirmed our previously described co-variance of Sx/Sx_a with ICP-derived indices. Sx displayed thresholds of -0.15 for unfavorable outcome (p < 0.0001) and -0.20 for mortality (p < 0.0001). Sx_a displayed thresholds of +0.05 (p = 0.019) and -0.10 (p = 0.0001) for alive/dead and favorable/unfavorable outcomes. TCD systolic indices are most closely associated with ICP indices. Sx and Sx_a likely provide better approximation of ICP indices, compared with Mx/Mx_a/Dx/Dx_a. Sx provides superior outcome prediction, versus Mx, with defined thresholds.	[Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Cardim, Danilo; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Sect Brain Phys, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland	Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca	Donnelly, Joseph/E-9235-2018; Cardim, Danilo Augusto/B-8447-2012; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Cardim, Danilo Augusto/0000-0002-9261-1321; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Traveling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba-Faculty of Medicine Dean's Fellowship Fund; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Center, an NIHR Senior Investigator Award; European Union Framework Program 7 grant (CENTER-TBI) [602150]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI17C1790]; Woolf Fisher Scholarship (NZ); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Traveling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba-Faculty of Medicine Dean's Fellowship Fund.; These studies were supported by the National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Center, an NIHR Senior Investigator Award to DKM. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).; MC is supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number : HI17C1790).; JD is supported by a Woolf Fisher Scholarship (NZ).	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Crawley M.J., 2013, R BOOK, P809; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Pandey M., 2015, BIOSTATISTICS BASIC, P454; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002	13	16	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					314	322		10.1089/neu.2017.5364		DEC 2017	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000418126600001	29050524				2021-06-18	
J	Eaton, J; Hanif, AB; Grudziak, J; Charles, A				Eaton, Jessica; Hanif, Asma Bilal; Grudziak, Joanna; Charles, Anthony			Epidemiology, Management, and Functional Outcomes of Traumatic Brain Injury in Sub-Saharan Africa	WORLD NEUROSURGERY			English	Article						Functional outcomes; Low-incomesettings; Trauma; Traumatic brain injury	PERSPECTIVE; COUNTRIES; MORTALITY	BACKGROUND: Trauma accounts for 4.7 million deaths each year, with an estimated 90% of these occurring in low-and middle-income countries (LMICs). Approximately half of trauma-related deaths are caused by central nervous system injury. Because a thorough understanding of traumatic brain injury (TBI) in LMICs is essential to mitigate TBI-related mortality, we established a clinical and radiographic database to characterize TBI in our low-income setting. METHODS: This is a review of prospectively collected data from Kamuzu Central Hospital, a tertiary care center in the capital of Malawi. All patients admitted from October 2016 through May 2017 with a history of head trauma, altered consciousness, and/or radiographic evidence TBI were included. We performed descriptive statistics, a Cox regression analysis, and a survival analysis. RESULTS: There were 280 patients who met inclusion criteria; of these, 80.5% were men. The mean age was 28.8 +/- 16.3 years. Median Glasgow Coma Scale (GCS) score was 12 (interquartile range, 8-15). Road traffic crashes constituted the most common injury mechanism (60.7%). There were 148 (52.3%) patients who received a computed tomography scan, with the most common findings being contusions (26.1%). Of the patients, 88 (33.0%) had severe TBI, defined as a GCS score <= 8, of whom 27.6% were intubated and 10.3% received tracheostomies. Overall mortality was 30.9%. Of patients who survived, 80.1% made a good recovery. Female sex was protective, and the only significant predictor of poor functional outcome was presence of severe TBI (hazard ratio, 2.98; 95% confidence interval, 1.79-4.95). CONCLUSIONS: TBI represents a significant part of the global neurosurgical burden of disease. Implementation of proven in-hospital interventions for these patients is critical to attenuate TBI-related morbidity and mortality.	[Eaton, Jessica; Charles, Anthony] UNC Project Malawi, Lilongwe, Malawi; [Hanif, Asma Bilal; Charles, Anthony] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi; [Grudziak, Joanna; Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA	Charles, A (corresponding author), UNC Project Malawi, Lilongwe, Malawi.; Charles, A (corresponding author), Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi.; Charles, A (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA.	anthchar@med.unc.edu			Department of Surgery at Kamuzu Central Hospital; UNC-Project Malawi	The authors wish to thank the Department of Surgery at Kamuzu Central Hospital and UNC-Project Malawi for their support of this work.	Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS3; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Greenberg MS, 2010, HDB NEUROSURGERY, V7, P850; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hode L, 2017, WORLD NEUROSURG, V99, P210, DOI 10.1016/j.wneu.2016.11.083; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kapapa T., 2014, East and Central African Journal of Surgery, V19, P55; Kraus J. F., 2005, TXB TRAUMATIC BRAIN, P3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Mwita CC, 2016, J NEUROSCI RURAL PRA, V7, P97, DOI 10.4103/0976-3147.165390; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Tyson Anna F, 2015, J Surg Educ, V72, pe66, DOI 10.1016/j.jsurg.2014.09.010; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877	25	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2017	108						650	655		10.1016/j.wneu.2017.09.084			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FN3CU	WOS:000415874900086	28943422	Green Published			2021-06-18	
J	Gerbatin, RD; Cassol, G; Dobrachinski, F; Ferreira, APO; Quines, CB; Della Pace, ID; Busanello, GL; Gutierres, JM; Nogueira, CW; Oliveira, MS; Soares, FA; Morsch, VM; Fighera, MR; Royes, LFF				Gerbatin, Rogerio da Rosa; Cassol, Gustavo; Dobrachinski, Fernando; Ferreira, Ana Paula O.; Quines, Caroline B.; Della Pace, Iuri D.; Busanello, Guilherme L.; Gutierres, Jessie M.; Nogueira, Cristina W.; Oliveira, Mauro S.; Soares, Felix A.; Morsch, Vera M.; Fighera, Michele R.; Royes, Luiz Fernando F.			Guanosine Protects Against Traumatic Brain Injury-Induced Functional Impairments and Neuronal Loss by Modulating Excitotoxicity, Mitochondrial Dysfunction, and Inflammation	MOLECULAR NEUROBIOLOGY			English	Article						Motor deficit; Neurotoxicity; Glutamate; Fluid percussion injury; Nucleoside; Neuroprotection	PENTYLENETETRAZOL-INDUCED SEIZURES; DECREASES GLUTAMATE UPTAKE; OXIDATIVE STRESS; HIPPOCAMPAL SLICES; RATS; SYNTHETASE; RECEPTORS; ACID; NEUROPROTECTION; TRANSPORTERS	Traumatic brain injury (TBI) is one of the most common types of brain injuries that cause death or persistent neurological disturbances in survivors. Most of the promising experimental drugs were not effective in clinical trials; therefore, the development of TBI drugs represents a huge unmet need. Guanosine, an endogenous neuroprotective nucleoside, has not been evaluated in TBI to the best of our knowledge. Therefore, the present study evaluated the effect of guanosine on TBI-induced neurological damage. Our findings showed that a single dose of guanosine (7.5 mg/kg, intraperitoneally (i.p.) injected 40 min after fluid percussion injury (FPI) in rats protected against locomotor and exploratory impairments 8 h after injury. The treatment also protected against neurochemical damage to the ipsilateral cortex, glutamate uptake, Na+/K+-ATPase, glutamine synthetase activity, and alterations in mitochondrial function. The inflammatory response and brain edema were also reduced by this nucleoside. In addition, guanosine protected against neuronal death and caspase 3 activation. Therefore, this study suggests that guanosine plays a neuroprotective role in TBI and can be exploited as a new pharmacological strategy.	[Gerbatin, Rogerio da Rosa; Cassol, Gustavo; Ferreira, Ana Paula O.; Della Pace, Iuri D.; Busanello, Guilherme L.; Fighera, Michele R.; Royes, Luiz Fernando F.] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, Santa Maria, RS, Brazil; [Dobrachinski, Fernando; Gutierres, Jessie M.; Soares, Felix A.; Morsch, Vera M.] Univ Fed Santa Maria, Dept Bioquim & Biol Mol, Ctr Ciencias Nat & Exatas, Santa Maria, RS, Brazil; [Quines, Caroline B.; Nogueira, Cristina W.] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Lab Sintese Reatividade & Avaliacao Farmacol & To, Santa Maria, RS, Brazil; [Oliveira, Mauro S.] Univ Fed Santa Maria, Ctr Ciencias Saude, Lab Neurotoxicidade & Psicofarmacol, Santa Maria, RS, Brazil; [Fighera, Michele R.] Univ Fed Santa Maria, Dept Neuropsiquiatria, Ctr Ciencias Saude, Santa Maria, RS, Brazil	Gerbatin, RD (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, Santa Maria, RS, Brazil.	rogeriogerbatin@hotmail.com	Gutierres, Jessie M/D-6938-2013; Dobrachinski, Fernando/C-4316-2014; Nogueira, Cristina W/H-1581-2012; Soares, Felix AA/K-7611-2012; Morsch, Vera M.M./M-6215-2014; Fighera, Michele R/J-9576-2014; Soares, Felix/AAE-6251-2020; Oliveira, Mauro Schneider/G-3437-2012	Gutierres, Jessie M/0000-0002-9574-4007; Dobrachinski, Fernando/0000-0002-3948-1273; Nogueira, Cristina W/0000-0003-2950-3632; Soares, Felix AA/0000-0002-6453-7902; Soares, Felix/0000-0002-6453-7902; Oliveira, Mauro Schneider/0000-0002-5381-1208	Universidade Federal de Santa Maria (UFSM); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS); Programa de Apoio a Nucleos Emergentes (PRONEM) [11/2082-4]	We gratefully acknowledged the Universidade Federal de Santa Maria (UFSM), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Programa de Apoio a Nucleos Emergentes (PRONEM) 11/2082-4 for the financial support.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Bellaver B, 2015, PURINERG SIGNAL, V11, P571, DOI 10.1007/s11302-015-9475-2; Bettio LEB, 2016, PURINERG SIGNAL, V12, P411, DOI 10.1007/s11302-016-9509-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho FB, 2015, J NUTR BIOCHEM, V26, P378, DOI 10.1016/j.jnutbio.2014.11.006; Cittolin-Santos GF, 2017, MOL NEUROBIOL, V54, P3137, DOI 10.1007/s12035-016-9892-4; Cunha GMA, 2006, NEUROSCIENCE, V141, P1775, DOI 10.1016/j.neuroscience.2006.05.024; Dal-Cim T, 2016, NEUROTOX RES, V29, P460, DOI 10.1007/s12640-015-9595-z; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Oliveira DL, 2004, BRAIN RES, V1018, P48, DOI 10.1016/j.brainres.2004.05.033; Dobrachinski F, 2014, NEUROTOX RES, V26, P317, DOI 10.1007/s12640-014-9463-2; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Funck VR, 2014, EPILEPSY RES, V108, P1705, DOI 10.1016/j.eplepsyres.2014.09.025; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; GRAY EG, 1962, J ANAT, V96, P79; HACHIMORI A, 1975, J BIOCHEM-TOKYO, V78, P1235, DOI 10.1093/oxfordjournals.jbchem.a131021; Hansel G, 2015, MOL NEUROBIOL, V52, P1791, DOI 10.1007/s12035-014-8978-0; Hansel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090693; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; HOCHSTRATE P, 1994, GLIA, V12, P268; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang SC, 2007, PURINERG SIGNAL, V3, P411, DOI 10.1007/s11302-007-9079-6; Jorgensen OS, 1997, EXP NEUROL, V144, P326, DOI 10.1006/exnr.1996.6372; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Migues PV, 1999, NEUROREPORT, V10, P67, DOI 10.1097/00001756-199901180-00013; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Paniz LG, 2014, METAB BRAIN DIS, V29, P645, DOI 10.1007/s11011-014-9548-x; PETITO CK, 1992, BRAIN RES, V569, P275, DOI 10.1016/0006-8993(92)90639-Q; Rambo LM, 2013, AMINO ACIDS, V44, P857, DOI 10.1007/s00726-012-1408-6; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Soares FA, 2004, BRAIN RES, V1005, P182, DOI 10.1016/j.brainres.2004.01.053; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tavares RG, 2008, NEUROCHEM RES, V33, P97, DOI 10.1007/s11064-007-9421-y; Thomazi AP, 2004, MECH AGEING DEV, V125, P475, DOI 10.1016/j.mad.2004.04.005; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wehr NB, 2012, ANAL BIOCHEM, V423, P241, DOI 10.1016/j.ab.2012.01.031; Whishaw IQ, 2003, J NEUROSCI METH, V126, P13, DOI 10.1016/S0165-0270(03)00049-9; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	62	16	16	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2017	54	10					7585	7596		10.1007/s12035-016-0238-z			12	Neurosciences	Neurosciences & Neurology	FM8MF	WOS:000415341900003	27830534				2021-06-18	
J	Su, WS; Wu, CH; Chen, SF; Yang, FY				Su, Wei-Shen; Wu, Chun-Hu; Chen, Szu-Fu; Yang, Feng-Yi			Low-intensity pulsed ultrasound improves behavioral and histological outcomes after experimental traumatic brain injury	SCIENTIFIC REPORTS			English	Article							FOCUSED ULTRASOUND; HEAD-INJURY; RAT MODEL; EDEMA; STIMULATION; BARRIER; DAMAGE; PATHOPHYSIOLOGY; IMPACT; FLOW	The purpose of this study was to investigate the neuroprotective effects of low-intensity pulsed ultrasound (LIPUS) on behavioral and histological outcomes in a mouse model of traumatic brain injury (TBI). Mice subjected to controlled cortical impact injury were treated with LIPUS in the injured region daily for a period of 4 weeks. The effects of LIPUS on edema were observed by MR imaging in the mouse brain at 1 and 4 days following TBI. Brain water content, blood-brain barrier permeability, histology analysis, and behavioral studies were performed to assess the effects of LIPUS. Two-way analysis of variance and Student t test were used for statistical analyses, with a significant level of 0.05. Treatment with LIPUS significantly attenuated brain edema, blood-brain barrier permeability, and neuronal degeneration beginning at day 1. Compared with the TBI group, LIPUS also significantly improved functional recovery and reduced contusion volumes up to post-injury day 28. Post-injury LIPUS treatment reduced brain edema and improved behavioral and histological outcomes following TBI. The neuroprotective effects of LIPUS may be a promising new technique for treating TBI.	[Su, Wei-Shen; Yang, Feng-Yi] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Wu, Chun-Hu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan; [Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan	Yang, FY (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.; Chen, SF (corresponding author), Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan.; Chen, SF (corresponding author), Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan.; Chen, SF (corresponding author), Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Yang, FY (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan.	szufuchen@yahoo.com.tw; fyyang@ym.edu.tw	WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 105-2221-E-010-003, MOST 104-2314-B-010-003-MY3, 101-2314-B-350-001-MY3]; Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST106-G7-6-1]; Cheng Hsin General Hospital Foundation [CY10622, CY10418, CHGH103-34]; Taiwan Ministry of Education's Aim for the Top University Plan	This study was supported by grants from the Ministry of Science and Technology of Taiwan (no. MOST 105-2221-E-010-003, MOST 104-2314-B-010-003-MY3, and 101-2314-B-350-001-MY3), the Veterans General Hospitals University System of Taiwan Joint Research Program (#VGHUST106-G7-6-1), the Cheng Hsin General Hospital Foundation (no. CY10622, CY10418 and CHGH103-34), and the Taiwan Ministry of Education's Aim for the Top University Plan.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115694; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Crisci AR, 2002, ULTRASOUND MED BIOL, V28, P1335, DOI 10.1016/S0301-5629(02)00576-8; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; FRY WJ, 1968, J ACOUST SOC AM, V44, P919, DOI 10.1121/1.1911230; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Hou CH, 2009, J CELL BIOCHEM, V106, P7, DOI 10.1002/jcb.21934; Huang SL, 2017, RADIOLOGY, V282, P113, DOI 10.1148/radiol.2016160095; Karmacharya MB, 2015, NEUROPATH APPL NEURO, V41, pe80, DOI 10.1111/nan.12182; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kovacs ZI, 2017, P NATL ACAD SCI USA, V114, pE75, DOI 10.1073/pnas.1614777114; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lin WT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09671; Liu SH, 2017, CEREB CORTEX, V27, P3152, DOI 10.1093/cercor/bhw169; Lu HB, 2006, AM J SPORT MED, V34, P1287, DOI 10.1177/0363546506286788; Marmarou A, 1980, Adv Neurol, V28, P345; Marmarou A, 2003, ACT NEUR S, V86, P7; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Yang FY, 2015, BRAIN STIMUL, V8, P465, DOI 10.1016/j.brs.2014.11.017; Yang FY, 2012, J CONTROL RELEASE, V160, P652, DOI 10.1016/j.jconrel.2012.02.023; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yoon SH, 2012, PEDIATR NEUROSURG, V48, P102, DOI 10.1159/000343011; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	33	16	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 14	2017	7								15524	10.1038/s41598-017-15916-2			10	Multidisciplinary Sciences	Science & Technology - Other Topics	FM6MF	WOS:000415166000020	29138458	DOAJ Gold, Green Published			2021-06-18	
J	Cohen, ML; Tulsky, DS; Holdnack, JA; Carlozzi, NE; Wong, A; Magasi, S; Heaton, RK; Heinemann, AW				Cohen, Matthew L.; Tulsky, David S.; Holdnack, James A.; Carlozzi, Noelle E.; Wong, Alex; Magasi, Susan; Heaton, Robert K.; Heinemann, Allen W.			Cognition Among Community-Dwelling Individuals With Spinal Cord Injury	REHABILITATION PSYCHOLOGY			English	Article						spinal cord injuries; cognition; neuropsychological tests	TRAUMATIC BRAIN-INJURY; NIH TOOLBOX COGNITION; CLOSED HEAD-INJURY; QUALITY-OF-LIFE; EXECUTIVE FUNCTION; CHRONIC PAIN; BATTERY; CB; DEPRESSION; PREVALENCE	Purpose/Objective: To compare the cognitive profiles of a well-characterized sample of adults with and without spinal cord injury (SCI) using the NIH Toolbox Cognition Battery NIHTB-CB. Research Method/Design: Participants were 156 community-dwelling individuals with SCI recruited from 3 academic medical centers, and 156 individuals without SCI selected from the NIHTB-CB normative database (N = 312). The main outcome measures were the demographically adjusted NIHTB-CB subtest and composite scores. Results: Individuals with and without SCI performed equivalently on the NIHTB-CB crystallized composite score, suggesting comparable premorbid functioning. Individuals with SCI produced lower scores on the NIHTB-CB fluid composite score by an average of 4.5 T-score points (Cohen's d = 0.50; a medium effect size). As a group, individuals with SCI had the most difficulty on tests of processing speed and executive functions, and some difficulty on a test of episodic memory, although effect sizes were small. These differences remained even after accounting for fine motor speed and dexterity. Individuals with tetraplegia produced lower scores than individuals with paraplegia on tests of processing speed and executive functioning. Conclusion/Implications: Community-dwelling individuals with SCI are at elevated risk of mild cognitive difficulties, particularly on tasks that rely on processing speed and executive functions. The NIHTB-CB is relatively brief, samples important cognitive domains, has good normative data, and is appropriate for some individuals with SCI (those who have functional use of one hand). The battery has standardized accommodations for individuals with minor motor limitations, but timed tests are inaccessible for individuals who are unable to perform rapid button presses.	[Cohen, Matthew L.; Tulsky, David S.; Holdnack, James A.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19713 USA; [Cohen, Matthew L.] Univ Delaware, Dept Commun Sci & Disorders, 540 South Coll Ave, Newark, DE 19713 USA; [Tulsky, David S.] Kessler Fdn, E Hanover, NJ USA; [Holdnack, James A.] Pearson Assessment, San Antonio, TX USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Wong, Alex] Washington Univ, Program Occupat Therapy, St Louis, MO USA; [Wong, Alex] Washington Univ, Dept Neurol, St Louis, MO USA; [Magasi, Susan] Univ Illinois, Dept Occupat Therapy, Chicago, IL 60680 USA; [Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA	Cohen, ML (corresponding author), Univ Delaware, Dept Commun Sci & Disorders, 540 South Coll Ave, Newark, DE 19713 USA.	mlcohen@udel.edu	Heinemann, Allen W./AAI-2790-2021; Cohen, Mathew/W-3982-2019	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Cohen, Matthew/0000-0001-9609-2461; Tulsky, David/0000-0002-4335-4509	United States Department of Health and Human Services [H133B090024]; National Institutes of Health (NIH), National Institute on Disability, Independent Living, and Research Rehabilitation (NIDILRR); Psychosocial Research Postdoctoral Fellowships from Craig H. Neilsen Foundation [290474, 364962]; Institutional Development Award (IDeA) from NIH, National Institute of General Medical Sciences [U54-GM104941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	An abstract based on earlier data was accepted for presentation as a poster at the 2016 Annual Conference of the International Spinal Cord Society. These data were also presented at the 2017 Annual Conference of the American Psychological Association's Division 22 (Rehabilitation Psychology). This research was supported by Grant H133B090024, Principal Investigator (PI): Allen W. Heinemann, from the United States Department of Health and Human Services, National Institutes of Health (NIH), National Institute on Disability, Independent Living, and Research Rehabilitation (NIDILRR), as well as Psychosocial Research Postdoctoral Fellowships from the Craig H. Neilsen Foundation (Grant 290474, PI: Alex Wong and Grant 364962, PI: Matthew L. Cohen). Salary support for Matthew L. Cohen was also provided by an Institutional Development Award (IDeA) from the NIH, National Institute of General Medical Sciences, Grant U54-GM104941 (PI: Binder-Macleod). We thank their talented and dedicated research staff: Ana Miskovic, Arielle Goldsmith, Sara Jerousek, Sue Tucker, Jessica Dashner, Cathy Crawley, Ben Aziz, Julie Grech, Livia Vanden Belt, and Angela Miciura.	Akshoomoff N, 2013, MONOGR SOC RES CHILD, V78, P119, DOI 10.1111/mono.12038; American Psychological Association, 2014, STAND ED PSYCH TEST; Avluk OC, 2014, ANN SAUDI MED, V34, P211, DOI 10.5144/0256-4947.2014.211; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Block C. K., 2016, PM&R, V8, pe4; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Boyer BA, 2000, TOP SPINAL CORD IN S, V6, P125, DOI DOI 10.1310/4FJ8-3VCH-EE0N-HNCD; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Cullum CM, 2001, NEUROPSY NEUROPSY BE, V14, P103; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Dikmen SS, 2014, J INT NEUROPSYCH SOC, V20, P611, DOI 10.1017/S1355617714000460; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Ghobrial GM, 2014, CLIN NEUROL NEUROSUR, V123, P174, DOI 10.1016/j.clineuro.2014.05.013; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hassanijirdehi M, 2015, KOREAN J PAIN, V28, P129, DOI 10.3344/kjp.2015.28.2.129; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HERRICK S, 1994, J CLIN PSYCHOL MED S, V1, P269, DOI 10.1007/BF01989628; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Krause JS, 2010, ARCH PHYS MED REHAB, V91, P1182, DOI 10.1016/j.apmr.2010.05.012; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Magasi S., 2017, TEST ACCOMMODA UNPUB; Masri R, 2012, ADV EXP MED BIOL, V760, P74; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Migliorini C, 2015, INTERN MED J, V45, P1014, DOI 10.1111/imj.12825; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Slotkin J., 2012, TECHNICAL MANUAL NIH; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tulsky DS, 2015, J SPINAL CORD MED, V38, P251, DOI [10.1179/2045772315Y.0000000035, 10.1179/2045772315Y.0000000023]; United States Department of Health and Human Services National Institutes of Health, 2012, NIH TOOLB REAS ACC G; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	63	16	17	0	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					425	434		10.1037/rep0000140			10	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	FT1CK	WOS:000422871400003	29265863	Green Accepted, Bronze			2021-06-18	
J	Mukhamedshina, YO; Akhmetzyanova, ER; Martynova, EV; Khaiboullina, SF; Galieva, LR; Rizvanov, AA				Mukhamedshina, Yana O.; Akhmetzyanova, Elvira R.; Martynova, Ekaterina V.; Khaiboullina, Svetlana F.; Galieva, Luisa R.; Rizvanov, Albert A.			Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis	FRONTIERS IN NEUROLOGY			English	Article						spinal cord injury; acute and subacute periods; multiplex analysis; cytokine profile; rats	CHEMOATTRACTANT PROTEIN-1 EXPRESSION; INDUCED NEUTROPHIL CHEMOATTRACTANT; TRAUMATIC BRAIN-INJURY; ISCHEMIC BRAIN; CHEMOKINE; INFLAMMATION; RECEPTOR; ASTROCYTES; STROKE; CELLS	Our study of the changes in cytokine profile in blood serum and in the spinal cord after traumatic spinal cord injury (SCI) has shown that an inflammatory reaction and immunological response are not limited to the CNS, but widespread. This fact was confirmed by changes detected in a cytokine profile in blood serum samples [MIP-1 alpha, interleukin 1 (IL-1) alpha, IL-2, IL-5, IL-1 beta, MCP-1, RANTES]. There were also changes in the levels of MIP-1 alpha, IL-1 alpha, IL-2, IL-5, IL-18, GM-colony-stimulating factor, IL-17 alpha, IFN-gamma, IL-10, IL-13, MCP-1, and GRO KC CINC-1 in samples of the rat injured spinal cord. The results underscore the complex cytokine network imbalance exhibited after SCI and show significant changes in the concentrations of 14 cytokines/chemokines with different inflammatory and immunological activities.	[Mukhamedshina, Yana O.; Akhmetzyanova, Elvira R.; Martynova, Ekaterina V.; Khaiboullina, Svetlana F.; Galieva, Luisa R.; Rizvanov, Albert A.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Mukhamedshina, Yana O.] Kazan State Med Univ, Kazan, Russia; [Khaiboullina, Svetlana F.] Univ Nevada, Reno, NV 89557 USA	Mukhamedshina, YO (corresponding author), Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.; Mukhamedshina, YO (corresponding author), Kazan State Med Univ, Kazan, Russia.	yana.k-z-n@mail.ru	Rizvanov, Albert/H-4486-2013; Khaiboullina, Svetlana/M-4793-2016; Akhmetzyanova, Elvira/Q-8062-2017	Rizvanov, Albert/0000-0002-9427-5739; Khaiboullina, Svetlana/0000-0002-5064-570X; Akhmetzyanova, Elvira/0000-0002-5751-6759	Russian FederationRussian Federation [MK-1894.2017.7]; Ministry of Education and Science of Russian FederationMinistry of Education and Science, Russian Federation [20.5175.2017/6.7]	The study was supported by a Presidential Grant for government support of young scientists (PhD, YM) from the Russian Federation (MK-1894.2017.7). AR was supported by state assignment 20.5175.2017/6.7 ("Leading Researcher") of the Ministry of Education and Science of Russian Federation. This work was performed in accordance with the Program of Competitive Growth of the Kazan Federal University and a subsidy allocated to the Kazan Federal University for the state assignment in the sphere of scientific activities.	Alberts B, 2002, HELPER T CELLS LYMPH; Arakelyan A, 2005, MEDIAT INFLAMM, P175, DOI 10.1155/MI.2005.175; BARNA BP, 1994, J NEUROIMMUNOL, V50, P101, DOI 10.1016/0165-5728(94)90220-8; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; BROWN Z, 1992, KIDNEY INT, V42, P95, DOI 10.1038/ki.1992.266; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Deo SS, 2010, LUNG INDIA, V27, P66, DOI 10.4103/0970-2113.63609; Dickensheets HL, 1997, J IMMUNOL, V159, P6226; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Imitola J, 2005, PHARMACOL THERAPEUT, V106, P163, DOI 10.1016/j.pharmthera.2004.11.007; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Konyuchenko EA, 2014, FUNDAM RES, V7, P974; Kothur K, 2016, CYTOKINE, V77, P227, DOI 10.1016/j.cyto.2015.10.001; Laliberte AM, 2013, EXP NEUROL, V247, P282, DOI 10.1016/j.expneurol.2013.01.008; Lobo-Silva D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0763-8; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Odinak MM, 2003, B RUSSIAN MIL MED AC, V2, P97; Othieno C, 1999, INFECT IMMUN, V67, P5730, DOI 10.1128/IAI.67.11.5730-5735.1999; Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Romagnani S, 2002, MOL IMMUNOL, V38, P881, DOI 10.1016/S0161-5890(02)00013-5; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P3387, DOI 10.1167/iovs.08-1691; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; VOJDANI A, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP063; WANG XK, 1995, STROKE, V26, P661, DOI 10.1161/01.STR.26.4.661; WU XB, 1994, J CLIN INVEST, V94, P337, DOI 10.1172/JCI117326; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002; Zhou XL, 2015, J NEUROCHEM, V134, P125, DOI 10.1111/jnc.13111; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	43	16	18	0	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 31	2017	8								581	10.3389/fneur.2017.00581			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FL1XL	WOS:000414007600001	29163344	DOAJ Gold, Green Published			2021-06-18	
J	Dall'Acqua, P; Johannes, S; Mica, L; Simmen, HP; Glaab, R; Fandino, J; Schwendinger, M; Meier, C; Ulbrich, EJ; Muller, A; Jancke, L; Hanggi, J				Dall'Acqua, Patrizia; Johannes, Sonke; Mica, Ladislav; Simmen, Hans-Peter; Glaab, Richard; Fandino, Javier; Schwendinger, Markus; Meier, Christoph; Ulbrich, Erika Jasmin; Mueller, Andreas; Jancke, Lutz; Hanggi, Jurgen			Prefrontal Cortical Thickening after Mild Traumatic Brain Injury: A One-Year Magnetic Resonance Imaging Study	JOURNAL OF NEUROTRAUMA			English	Article						cortical thickness; group-by-time interaction; longitudinal analysis; mild traumatic brain injury; recovery	GRAY-MATTER ABNORMALITIES; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; LONGITUDINAL CHANGES; THICKNESS; PLASTICITY; VOLUME; SEGMENTATION; ACTIVATION; SYMPTOMS	The objective of this study was to evaluate group-by-time interactions between gray matter morphology of healthy controls and that of patients with mild traumatic brain injury (mTBI) as they transitioned from acute to chronic stages, and to relate these findings to long-term cognitive alterations to identify distinct recovery trajectories between good outcome (GO) and poor outcome (PO). High-resolution T1-weighted magnetic resonance images were acquired in 49 mTBI patients within 7 days and 1 year post-injury and at equivalent times in 49 healthy controls. Using linear mixed-effects models, we performed mass-univariate analyses and associated the results of the interaction with changes in cognitive performance. Morphological alterations indexed by increased or decreased cortical thickness have been expected mainly in frontal, parietal, and temporal brain regions. A significant interaction was found in cortical thickness, spatially restricted to bilateral structures of the prefrontal cortex, showing thickening in mTBI and normal developmental thinning in controls. A discrete thickness increase that can interpreted as the absence of cortical thinning typically seen in the healthy population was associated with cognitive recovery in the GO subgroup, while the exaggerated cortical thickening in the PO patients was linked to worsening cognitive performance. Thickness of the prefrontal cortex is subject to structural alterations during the first year after mTBI. Beside beneficial neuroplasticity, a prolonged state of neuroinflammation for symptomatic patients (maladaptive neuroplasticity) cannot be excluded. If the underlying cellular processes responsible for cortical thickening following mTBI have been determined, brain stimulation or even pharmacological intervention targeting the prefrontal cortex might promote endogenous neural restoration.	[Dall'Acqua, Patrizia; Johannes, Sonke] Bellikon Rehabil Clin, Mutschellenstr 2, CH-5454 Bellikon, Switzerland; [Dall'Acqua, Patrizia; Mueller, Andreas; Jancke, Lutz; Hanggi, Jurgen] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, Univ Res Prior Program, Dynam Hlth Aging, Zurich, Switzerland; [Mica, Ladislav; Simmen, Hans-Peter] Univ Zurich Hosp, Div Trauma Surg, Zurich, Switzerland; [Ulbrich, Erika Jasmin] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Glaab, Richard] Kantonsspital Aarau, Dept Traumatol, Aarau, Switzerland; [Fandino, Javier] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland; [Schwendinger, Markus] Baden Cantonal Hosp, Interdisciplinary Emergency Ctr, Baden, Switzerland; [Meier, Christoph] Waid Hosp Zurich, Dept Surg, Zurich, Switzerland; [Mueller, Andreas] Brain & Trauma Fdn Grisons, Chur, Switzerland	Dall'Acqua, P (corresponding author), Bellikon Rehabil Clin, Mutschellenstr 2, CH-5454 Bellikon, Switzerland.	patrizia.dallacqua@rehabellikon.ch		Hanggi, Jurgen/0000-0001-8124-6018; Simmen, Hans-Peter/0000-0002-5201-4549	Research Fund of Swiss Accident (SUVA)	This study was supported by Research Fund of Swiss Accident (SUVA).	Amlien IK, 2016, CEREB CORTEX, V26, P257, DOI 10.1093/cercor/bhu214; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Govindarajan K. A., 2016, J NEUROTRAUMA; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kerr AL, 2011, J COMMUN DISORD, V44, P538, DOI 10.1016/j.jcomdis.2011.04.011; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kolb B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00015; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Tamnes CK, 2013, NEUROIMAGE, V68, P63, DOI 10.1016/j.neuroimage.2012.11.039; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Walhovd K. B., 2016, CEREB CORTEX, P1; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Westlye LT, 2010, NEUROIMAGE, V52, P172, DOI 10.1016/j.neuroimage.2010.03.056; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	55	16	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3270	3279		10.1089/neu.2017.5124		OCT 2017	10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000414461500001	28847215				2021-06-18	
J	Hellstrom, T; Westlye, LT; Kaufmann, T; Doan, NT; Soberg, HL; Sigurdardottir, S; Nordhoy, W; Helseth, E; Andreassen, OA; Andelic, N				Hellstrom, Torgeir; Westlye, Lars T.; Kaufmann, Tobias; Nhat Trung Doan; Soberg, Helene L.; Sigurdardottir, Solrun; Nordhoy, Wibeke; Helseth, Eirik; Andreassen, Ole A.; Andelic, Nada			White matter microstructure is associated with functional, cognitive and emotional symptoms 12 months after mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MINOR HEAD-INJURY; POSTCONCUSSIVE SYNDROME; SPATIAL STATISTICS; DIFFUSION MRI; IMPAIRMENT; IMAGES; SCALE; NEUROPATHOLOGY; ABNORMALITIES; REGISTRATION	Identifying patients at risk of poor outcome after mild traumatic brain injury (MTBI) is essential to aid prognostics and treatment. Diffuse axonal injury (DAI) may be the primary pathologic feature of MTBI but is normally not detectable by conventional imaging technology. This lack of sensitivity of clinical imaging techniques has impeded a pathophysiologic understanding of the long-term cognitive and emotional consequences of MTBI, which often remain unnoticed and are attributed to factors other than the injury. Diffusion tensor imaging (DTI) is sensitive to microstructural properties of brain tissue and has been suggested to be a promising candidate for the detection of DAI in vivo. In this study, we report strong associations between brain white matter DTI and self-reported cognitive, somatic and emotional symptoms at 12 months post-injury in 134 MTBI patients. The anatomical distribution suggested global associations, in line with the diffuse symptomatology, although the strongest effects were found in frontal regions including the genu of the corpus callosum and the forceps minor. These findings support the hypothesis that DTI may provide increased sensitivity to the diffuse pathophysiology of MTBI and suggest an important role of advanced Magnetic Resonance Imaging (MRI) in trauma care.	[Hellstrom, Torgeir; Soberg, Helene L.; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Hellstrom, Torgeir; Helseth, Eirik; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Westlye, Lars T.; Kaufmann, Tobias; Nhat Trung Doan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Westlye, Lars T.; Kaufmann, Tobias; Nhat Trung Doan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Nordhoy, Wibeke] Oslo Univ Hosp, Dept Diagnost Phys, Clin Radiol & Nucl Med, Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Fac Med, Oslo, Norway	Hellstrom, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Hellstrom, T (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	torgeir.hellstrom@ous-hf.no	Helseth, Eirik/AAH-2466-2020; Andreassen, Ole A./AAY-7531-2020; Kaufmann, Tobias/M-8972-2017	Kaufmann, Tobias/0000-0002-4003-1018; Westlye, Lars T./0000-0001-8644-956X; Andelic, Nada/0000-0002-3719-4406	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; Research Council of NorwayResearch Council of Norway [204966/F20, 249795/F20]; South-Eastern Norway Regional Health Authority [2014097]; European Community's 7th Framework Programme (IMAGEMEND) [602450]	The authors thank all of the patients who participated in the study. We also thank radiographer Anne-Hilde Farstad for practical MRI assistance and the Department of Physical Medicine and Rehabilitation, Oslo University Hospital for institutional and financial support. The study was supported by research funding from Research Council of Norway (204966/F20, 249795/F20), the South-Eastern Norway Regional Health Authority (2014097), and European Community's 7th Framework Programme (602450, IMAGEMEND).	Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; [Anonymous], 2014, R LANG ENV STAT COMP; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dikmen S, 2016, J NEUROTRAUMA; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hellstrom T, 2016, BRAIN INJURY, V30, P1683, DOI 10.1080/02699052.2016.1199905; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lingsma HF, 2014, J NEUROTRAUMA; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Newcombe VFJ, 2015, NEUROREHABILITATION; Doan NT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45131; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Spitz G., 2016, J NEUROTRAUMA; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; TEASDALE G, 1974, LANCET, V2, P81; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Westlye LT, 2011, ARCH GEN PSYCHIAT, V68, P369, DOI 10.1001/archgenpsychiatry.2011.24; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	72	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 23	2017	7								13795	10.1038/s41598-017-13628-1			14	Multidisciplinary Sciences	Science & Technology - Other Topics	FK3QH	WOS:000413400500070	29061970	DOAJ Gold, Green Published			2021-06-18	
J	Kannan, G; Kambhampati, SP; Kudchadkar, SR				Kannan, Gokul; Kambhampati, Siva P.; Kudchadkar, Sapna R.			Effect of anesthetics on microglial activation and nanoparticle uptake: Implications for drug delivery in traumatic brain injury	JOURNAL OF CONTROLLED RELEASE			English	Article; Proceedings Paper	14th International Nanomedicine and Drug Delivery Symposium (NanoDDS)	SEP 16-18, 2016	Johns Hopkins Univ, Baltimore, MD		Johns Hopkins Univ		PENTOBARBITAL COMA; DENDRIMERS; CLEARANCE; NANOMEDICINE; THERAPY; PATHWAY; ADULT	Traumatic brain injury (TBI) is a serious public health problem, often with devastating consequences for patients and their families. Affordable and timely therapies can have a substantial impact on outcomes in severe TBI. Despite the common use of sedatives and anesthetics in the acute phase of TBI management, their effect on glial cells is not well understood. We investigated the effect of a commonly used sedative, pentobarbital, on glial cells and their uptake of nanoparticles. First, we studied how pentobarbital affects BV2 mouse microglial cells in culture. The cell morphology was imaged by confocal microscopy and analyzed. Our results suggest that microglia change to a more swollen, 'activated' shape with pentobarbital (cell area increased by approximately 20%, p < 0.001). Such glial activation may have negative implications for the ability of the injured brain to clear edema. Second, we investigated how pentobarbital treatment affected nanoparticle uptake. BV-2 mouse microglial cells in the presence and absence of pentobarbital were treated with fluorescently-labeled, hydroxyl-functionalized poly(amidoamine) dendrimer nanoparticles (Dendrimer-Cy5). We demonstrated that the presence of pentobarbital increased the dendrimer nanoparticle uptake significantly (similar to 2-fold both 2 and 6 h following treatment). This semi-quantitative fluorescence assessment was broadly consistent among confocal image analysis, flow cytometry, and fluorescence quantification of cell-extracted dendrimer-Cy5. Although anesthetics appear to activate microglia, the increased uptake of dendrimer nanoparticles in their presence can be exploited to deliver drug-loaded nanoparticles directly to microglia after TBI. These drugs could restore glial and glymphatic function, enabling efficient drainage of waste and fluid from the brain and effectively improving recovery after TBI. A key future direction is to validate these findings in TBI models.	[Kannan, Gokul] River Hill High Sch, Columbia, MD 21029 USA; [Kannan, Gokul; Kambhampati, Siva P.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Ctr Nanomed,Wilmer Eye Inst, Baltimore, MD 21205 USA; [Kudchadkar, Sapna R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Kudchadkar, Sapna R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Kudchadkar, SR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Kudchadkar, SR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	skudcha1@jhmi.edu	Kudchadkar, Sapna R./AAT-2855-2020; Kambhampati, Siva Pramodh/AAK-6269-2020	Kudchadkar, Sapna R./0000-0003-3089-0318; 			Balakrishnan B, 2013, INT J NANOMED, V8, P4183, DOI 10.2147/IJN.S35979; Burd I, 2016, ADV PHARMACOL, V76, P85, DOI 10.1016/bs.apha.2016.02.003; Carney N, 2016, NEUROSURGERY; Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Dai H, 2010, NANOMEDICINE-UK, V5, P1317, DOI [10.2217/nnm.10.89, 10.2217/NNM.10.89]; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iezzi R, 2012, BIOMATERIALS, V33, P979, DOI 10.1016/j.biomaterials.2011.10.010; Iliff JJ, 2015, LANCET NEUROL, V14, P977, DOI 10.1016/S1474-4422(15)00221-5; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Kambhampati SP, 2015, INVEST OPHTH VIS SCI, V56, P4413, DOI 10.1167/iovs.14-16250; Kambhampati SP, 2015, EUR J PHARM BIOPHARM, V95, P239, DOI 10.1016/j.ejpb.2015.02.013; Kannan RM, 2014, J INTERN MED, V276, P579, DOI 10.1111/joim.12280; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Koob A., 2009, ROOT THOUGHT UNLOCKI; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Lescot T., 2006, PRESSE MED PARIS FRA, V36, P1117; Lesniak WG, 2013, MOL PHARMACEUT, V10, P4560, DOI 10.1021/mp400371r; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k; Mendelsohn AR, 2013, REJUV RES, V16, P518, DOI 10.1089/rej.2013.1530; Mishra MK, 2014, ACS NANO, V8, P2134, DOI 10.1021/nn404872e; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Nakki R, 1996, EXP NEUROL, V137, P234, DOI 10.1006/exnr.1996.0022; Nance E, 2016, BIOMATERIALS, V101, P96, DOI 10.1016/j.biomaterials.2016.05.044; Nance E, 2015, J CONTROL RELEASE, V214, P112, DOI 10.1016/j.jconrel.2015.07.009; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Remsen LG, 1999, ANESTH ANALG, V88, P559, DOI 10.1097/00000539-199903000-00018; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tanaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082930; Tanaka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029378; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vutskits L, 2014, CURR PHARM DESIGN, V20, P4203; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107	44	16	16	3	26	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	OCT 10	2017	263				SI		192	199		10.1016/j.jconrel.2017.03.032			8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	FH5JQ	WOS:000411202400020	28336376				2021-06-18	
J	Buckley, TA; Oldham, JR; Munkasy, BA; Evans, KM				Buckley, Thomas A.; Oldham, Jessie R.; Munkasy, Barry A.; Evans, Kelsey M.			Decreased Anticipatory Postural Adjustments During Gait Initiation Acutely Postconcussion	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain Injury; Locomotion; Rehabilitation	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; PROFESSIONAL FOOTBALL PLAYERS; MANAGEMENT PRACTICE PATTERNS; CONTROL FOLLOWING CONCUSSION; CHRONIC ANKLE INSTABILITY; SPORT-RELATED CONCUSSION; COGNITIVE DUAL-TASKS; BALANCE CONTROL; PARKINSONS-DISEASE	Objective: To investigate anticipatory postural adjustments (APAs) during the transitional movement task of gait initiation (GI) in individuals acutely after a concussion. Design: Cohort study. Setting: University research center. Participants: A population-based sample of participants (N=84) divided into 2 equal groups of acutely postconcussion and healthy student athletes. Intervention: Participants were tested on 2 occasions: a preinjury baseline test and then the concussion group was retested acutely postconcussion and the healthy student athlete group again at a similar time. All participants completed 5 trials of GI on 4 forceplates. Main Outcome Measures: The dependent variables were the displacement and velocity of the center of pressure (COP) during the APA phase and initial step kinematics. Comparisons were made with a 2 (group) x 2 (time) repeated-measures analysis of variance. Results: There was a significant interaction for COP posterior displacement (P<.001) and lateral displacement (P<.001). Posteriorly, post hoc testing identified a significant reduction in the concussion group (pretest: 5.7 +/- 1.6cm; posttest: 2.6 +/- 2.1cm; P<.001), but no difference in the healthy student athlete group (pretest: 4.0 +/- 1.6cm; posttest: 4.0 +/- 2.5cm; P=.921). Laterally, post hoc testing identified a significant reduction in the concussion group (pretest: 5.8 +/- 2.1cm; posttest: 3.8 +/- 1.8cm; P<.001), but no difference in the healthy student athlete group (pretest: 5.0 +/- 2.5cm; posttest: 5.2 +/- 2.4cm; P=.485). Conclusions: The results of this study suggest difficulty in the planning and execution of GI acutely postconcussion, and posterior APA displacement and velocity are highly effective measures of impaired postural control. Finally, the APA phase is linked to the supplementary motor area, which suggests a supraspinal contribution to postconcussion impaired postural control. (C) 2017 by the American Congress of Rehabilitation Medicine	[Buckley, Thomas A.; Oldham, Jessie R.] Univ Delaware, Dept Kinesiol & Appl Physiol, 150 Human Performance Lab,541 S Coll Ave, Newark, DE 19711 USA; [Buckley, Thomas A.] Univ Delaware, Binterdisciplinary Program Biomech & Movement Sci, Newark, DE 19711 USA; [Munkasy, Barry A.] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA USA; [Evans, Kelsey M.] East Carolina Univ, Brody Sch Med, Greenville, NC USA	Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 150 Human Performance Lab,541 S Coll Ave, Newark, DE 19711 USA.	Tbuckley@UDel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Oldham, Jessie/0000-0003-2801-2110	National Institute of Health/Neurological Disorders and Stroke [NINDS 1R15NS070744-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS070744] Funding Source: NIH RePORTER	Supported in part by the National Institute of Health/Neurological Disorders and Stroke (grant no. NINDS 1R15NS070744-01A1).	Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Caccese JB, 2016, J APPL BIOMECH, V32, P329, DOI 10.1123/jab.2015-0273; Caderby T, 2014, J BIOMECH, V47, P417, DOI 10.1016/j.jbiomech.2013.11.011; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Cau N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-82; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chang HA, 1999, ARCH PHYS MED REHAB, V80, P490; Chang WH, 2010, GAIT POSTURE, V32, P487, DOI 10.1016/j.gaitpost.2010.07.007; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Elble RJ, 1996, BRAIN, V119, P1705, DOI 10.1093/brain/119.5.1705; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hartley EM, 2016, GAIT POSTURE, V49, P86, DOI 10.1016/j.gaitpost.2016.06.022; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; Hass CJ, 2012, GAIT POSTURE, V35, P669, DOI 10.1016/j.gaitpost.2011.12.022; Hass CJ, 2010, AM J SPORT MED, V38, P829, DOI 10.1177/0363546509351562; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Honeine JL, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00445; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2015, J HEAD TRAUMA REHAB, V19, P19; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Melzer I, 2010, J ELECTROMYOGR KINES, V20, P1082, DOI 10.1016/j.jelekin.2010.07.001; Munkasy B. A, 2017, CLIN J SPORT MED; Nocera JR, 2013, J REHABIL RES DEV, V50, P699, DOI 10.1682/JRRD.2012.06.0114; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Oldham JR, 2016, SPORTS HLTH; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Polcyn AF, 1998, ARCH PHYS MED REHAB, V79, P1582, DOI 10.1016/S0003-9993(98)90425-7; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Vallabhajosula S, 2013, GAIT POSTURE, V37, P280, DOI 10.1016/j.gaitpost.2012.07.018; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wang JJ, 2009, J NEURAL TRANSM, V116, P1087, DOI 10.1007/s00702-009-0269-y	60	16	16	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2017	98	10					1962	1968		10.1016/j.apmr.2017.05.002			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FJ5LZ	WOS:000412794300007	28583462	Green Accepted			2021-06-18	
J	Chandrasekar, A; Heuvel, FO; Palmer, A; Linkus, B; Ludolph, AC; Boeckers, TM; Relja, B; Huber-Lang, M; Roselli, F				Chandrasekar, Akila; Heuvel, Florian Olde; Palmer, Annette; Linkus, Birgit; Ludolph, Albert C.; Boeckers, Tobias M.; Relja, Borna; Huber-Lang, Markus; Roselli, Francesco			Acute ethanol administration results in a protective cytokine and neuroinflammatory profile in traumatic brain injury	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Traumatic brain injury; Ethanol; Cytokines; Microglia	BLOOD-ALCOHOL CONCENTRATION; LUNG EPITHELIAL-CELLS; SYSTEMIC INTERLEUKIN-6; UNITED-STATES; HEAD-INJURY; MICE; INTOXICATION; EXPRESSION; MORTALITY; RATS	Ethanol intoxication is a common comorbidity in traumatic brain injury. To date, the effect of ethanol on TBI pathogenic cascades and resulting outcomes remains debated. A closed blunt weight-drop murine TBI model has been implemented to investigate behavioral (by sensorimotor and neurological tests), and neuro-immunological (by tissue cytokine arrays and immuno-histology) effects of ethanol intoxication on TBI. The effect of the occurrence of traumatic intracerebral hemorrhage was also studied. The results indicate that ethanol pretreatment results in a faster and better recovery after TBI with reduced infiltration of leukocytes and reduced microglia activation. These outcomes correspond to reduced parenchymal levels of GM-CSF, IL-6 and IL-3 and to the transient upregulation of IL-13 and VEGF, indicating an early shift in the cytokine profile towards reduced inflammation. A significant difference in the cytokine profile was still observed 24 h post injury in the ethanol pretreated mice, as shown by the delayed peak in IL-6 and by the suppression of GM-CSF, IFN-gamma, and IL-3. Seven days post-injury, ethanol-pretreated mice displayed a significant decrease both in CD45 + cells infiltration and in microglial activation. On the other hand, in the case of traumatic intracerebral hemorrhage, the cytokine profile was dominated by KC, CCL5, M-CSF and several interleukins and ethanol pretreatment did not produce any modification. We can thus conclude that ethanol intoxication suppresses the acute neuro-inflammatory response to TBI, an effect which is correlated with a faster and complete neurological recovery, whereas, the presence of traumatic intracerebral hemorrhage overrides the effects of ethanol.	[Chandrasekar, Akila; Heuvel, Florian Olde; Linkus, Birgit; Ludolph, Albert C.; Roselli, Francesco] Univ Ulm, Sch Med, Dept Neurol, Ulm, Germany; [Palmer, Annette; Huber-Lang, Markus] Univ Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Boeckers, Tobias M.] Ulm Univ, Sch Med, Dept Anat & Cell Biol, Ulm, Germany; [Relja, Borna] Goethe Univ, Dept Gen & Visceral Surg, Frankfurt, Germany	Roselli, F (corresponding author), Ulm Univ, Dept Neurol, Sch Med, Ctr Biomed Res ZBF, Helinholtzstr 8-2,R1-44, D-89081 Ulm, Germany.	akila.chandrasekar@uni-ulm.de; annette.palmer@uniklinik-ulm.de; birgit.linkus@uni-ulm.de; albert.ludolph@rku.de; tobias.boeckers@uni-ulm.de; info@bornarelja.com; markus.huber-lang@uniklinik-ulm.de; francesco.roselli@uni-ulm.de	roselli, francesco/O-8847-2019; Huber-Lang, Markus/AAJ-2209-2020; Relja, Borna/B-6642-2016	roselli, francesco/0000-0001-9935-6899; Relja, Borna/0000-0002-5625-8823	DFGGerman Research Foundation (DFG)European Commission [SFB1149-B05]; ERANET-NEURON initiative as part of MICRONET consortium; Ulm University	This work has been supported by the DFG (SFB1149-B05) "Dangerresponse, disturbance factors and regenerative potential after acute trauma"-subproject B05. FR is also supported by the ERANET-NEURON initiative "European Research Projects on External Insults to the Nervous System" as part of the MICRONET consortium, and by the Ulm University-Medical Faculty Baustein Program.	Alonso M, 2012, INT J IMMUNOPATH PH, V25, P645, DOI 10.1177/039463201202500311; Berry C, 2011, AM SURGEON, V77, P1416; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bouchard JC, 2012, AM J PATHOL, V181, P845, DOI 10.1016/j.ajpath.2012.05.020; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Brombacher TM, 2017, J IMMUNOL, V198, P2681, DOI 10.4049/jimmunol.1601546; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cho JS, 2016, ALCOHOL CLIN EXP RES, V40, P1290, DOI 10.1111/acer.13065; Corne J, 2000, J CLIN INVEST, V106, P783, DOI 10.1172/JCI9674; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Dooley D, 2016, STEM CELL REP, V7, P1099, DOI 10.1016/j.stemcr.2016.11.005; FAULKNER TP, 1990, ALCOHOL CLIN EXP RES, V14, P82, DOI 10.1111/j.1530-0277.1990.tb00451.x; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Greiffenstein P, 2007, ALCOHOL CLIN EXP RES, V31, P704, DOI 10.1111/j.1530-0277.2007.00355.x; Gu JW, 2001, AM J PHYSIOL-REG I, V281, pR365; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P403, DOI 10.1097/TA.0000000000000504; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kiguchi N, 2017, J PHARMACOL SCI, V133, P53, DOI 10.1016/j.jphs.2016.11.005; Leo P., 2016, TRANSLATIONAL RES TR; Livy DJ, 2003, ALCOHOL, V29, P165, DOI 10.1016/S0741-8329(03)00025-9; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mori S, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020018; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Radek KA, 2005, AM J PHYSIOL-HEART C, V289, pH1084, DOI 10.1152/ajpheart.00080.2005; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Relja B, 2016, INJURY, V47, P640, DOI 10.1016/j.injury.2016.01.016; Relja B, 2016, INT J MOL MED, V37, P517, DOI 10.3892/ijmm.2015.2431; Relja B, 2015, MOL MED REP, V12, P2991, DOI 10.3892/mmr.2015.3764; Relja B, 2013, SCAND J GASTROENTERO, V48, P448, DOI 10.3109/00365521.2013.772228; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Soares HD, 1995, J NEUROSCI, V15, P8223; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Vaagenes IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120356; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; WILKINSON PK, 1980, ALCOHOL CLIN EXP RES, V4, P6, DOI 10.1111/j.1530-0277.1980.tb04785.x; Won SY, 2013, J NEUROIMMUNOL, V265, P36, DOI 10.1016/j.jneuroim.2013.09.014; Wu WC, 2014, BRIT J NEUROSURG, V28, P739, DOI 10.3109/02688697.2014.915007; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	52	16	16	2	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2017	51						66	75		10.1016/j.intimp.2017.08.002			10	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	FI2MC	WOS:000411772000009	28806641				2021-06-18	
J	Chari, A; Dasgupta, D; Smedley, A; Craven, C; Dyson, E; Matloob, S; Thompson, S; Thorne, L; Toma, AK; Watkins, L				Chari, Aswin; Dasgupta, Debayan; Smedley, Alexander; Craven, Claudia; Dyson, Edward; Matloob, Samir; Thompson, Simon; Thorne, Lewis; Toma, Ahmed K.; Watkins, Laurence			Intraparenchymal intracranial pressure monitoring for hydrocephalus and cerebrospinal fluid disorders	ACTA NEUROCHIRURGICA			English	Article						Intracranial pressure; Hydrocephalus; Cerebrospinal fluid dynamics	CHIARI MALFORMATION TYPE-1; SINGLE-CENTER EXPERIENCE; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; PULSATILE; HYPERTENSION; ADULTS; TRIAL	Elective intraparenchymal intracranial pressure (ICP) monitoring is useful for the diagnosis and treatment of hydrocephalus and cerebrospinal fluid (CSF) disorders. This retrospective study analyzes median ICP and pulse amplitude (PA) recordings in neurosurgically na < ve patients undergoing elective ICP monitoring for suspected CSF disorders. Retrospective review of prospectively collated database of neurosurgically na < ve patients undergoing elective ICP monitoring for suspected hydrocephalus and CSF disorders. Following extraction of the median ICP and PA values (separated into all, day and night time recordings), principal component analysis (PCA) was performed to identify the principal factors determining the spread of the data. Exploratory comparisons and correlations of ICP and PA values were explored, including by post hoc diagnostic groupings and age. A total of 198 patients were identified in six distinct diagnostic groups (n = 21-47 in each). The PCA suggested that there were two main factors accounting for the spread in the data, with 61.4% of the variance determined largely by the PA and 33.0% by the ICP recordings. Exploratory comparisons of PA and ICP between the diagnostic groups showed significant differences between the groups. Specifically, significant differences were observed in PA between a group managed conservatively and the Chiari/syrinx, IIH, and NPH/LOVA groups and in the ICP between the conservatively managed group and high-pressure, IIH, and low-pressure groups. Correlations between ICP and PA revealed some interesting trends in the different diagnostic groups and correlations between ICP, PA, and age revealed a decreasing ICP and increasing PA with age. This study provides insights into hydrodynamic disturbances in different diagnostic groups of patients with CSF hydrodynamic disorders. It highlights the utility of analyzing both median PA and ICP recordings, stratified into day and night time recordings.	[Chari, Aswin; Dasgupta, Debayan; Smedley, Alexander; Craven, Claudia; Dyson, Edward; Matloob, Samir; Thompson, Simon; Thorne, Lewis; Toma, Ahmed K.; Watkins, Laurence] Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England; [Chari, Aswin] Imperial Coll London, Fac Med, Div Brain Sci, London, England	Chari, A (corresponding author), Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England.; Chari, A (corresponding author), Imperial Coll London, Fac Med, Div Brain Sci, London, England.	aswinchari@gmail.com	Watkins, Laurence/AAH-6973-2021	Watkins, Laurence/0000-0003-0678-3774; Thorne, Lewis/0000-0002-7692-0378; Dasgupta, Debayan/0000-0002-1064-0541; Thompson, Simon/0000-0001-9575-9711; CRAVEN, CLAUDIA/0000-0002-6199-0090			Andresen M, 2016, ACTA NEUROCHIR SUPPL, V122, P45, DOI 10.1007/978-3-319-22533-3_9; Andresen M, 2015, ACTA NEUROCHIR, V157, P109, DOI 10.1007/s00701-014-2250-2; Andresen M, 2014, J NEUROSURG, V121, P797, DOI 10.3171/2014.2.JNS132209; Chari A, 2015, FLUIDS BARRIERS CNS, V12, pO14, DOI DOI 10.1186/2045-8118-12-S1-O14; Chari A, 2014, J NEUROSURG, V120, P697, DOI 10.3171/2013.11.JNS121895; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Eide PK, 2016, WORLD NEUROSURG, V86, P186, DOI 10.1016/j.wneu.2015.09.067; Eide PK, 2011, CLIN NEUROL NEUROSUR, V113, P123, DOI 10.1016/j.clineuro.2010.10.008; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Eide PK, 2003, ACTA NEUROL SCAND, V108, P381, DOI 10.1034/j.1600-0404.2003.00163.x; Fric R, 2016, J NEUROSURG, V24, P1, DOI DOI 10.3171/2016.4.JNS152862; Fric R, 2016, ACTA NEUROCHIR, V158, P2295, DOI 10.1007/s00701-016-2979-x; Fric R, 2016, ACTA NEUROCHIR, V158, P341, DOI 10.1007/s00701-015-2669-0; Fric R, 2015, ACTA NEUROCHIR, V157, P1411, DOI 10.1007/s00701-015-2465-x; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Matloob SA, 2015, FLUIDS BARRIERS CNS, V12, pO62; Matloob SA, 2015, ACTA NEUROCHIR, V157, P2099, DOI 10.1007/s00701-015-2600-8; Thompson SD, 2017, ACTA NEUROCHIR; Toma AK, 2010, J NEUROSURG, V113, P1326, DOI 10.3171/2010.8.JNS1067; Toma AK, 2010, BRIT J NEUROSURG, V24, P584, DOI 10.3109/02688697.2010.495169	21	16	16	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2017	159	10					1967	1978		10.1007/s00701-017-3281-2			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FG2GK	WOS:000409907500020	28799016	Other Gold, Green Published			2021-06-18	
J	Gao, L; Smielewski, P; Czosnyka, M; Ercole, A				Gao, Lei; Smielewski, Peter; Czosnyka, Marek; Ercole, Ari			Early Asymmetric Cardio-Cerebral Causality and Outcome after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						complexity; granger causality; network; outcome; traumatic brain injury	HEART-RATE-VARIABILITY; INTRACRANIAL-PRESSURE; GRANGER CAUSALITY; BAROREFLEX SENSITIVITY; CRITICAL ILLNESS; CONNECTIVITY; COMPLEXITY; DYSFUNCTION; PHYSIOLOGY; NETWORKS	The brain and heart are two vital systems in health and disease, increasingly recognized as a complex, interdependent network with constant information flow in both directions. After severe traumatic brain injury (TBI), the causal, directed interactions between the brain, heart, and autonomic nervous system have not been well established. Novel methods are needed to probe unmeasured, potentially prognostic information in complex biological networks that are not revealed by traditional means. In this study, we examined potential bidirectional causality between intracranial pressure (ICP), mean arterial pressure (MAP), and heart rate (HR) and its relationship to mortality in a 24-h period early post-TBI. We applied Granger causality (GC) analysis to cardio-cerebral monitoring data from 171 severe TBI patients admitted to a single neurocritical care center over a 10-year period. There was significant bidirectional causality between ICP and MAP, MAP and HR, and ICP and HR in the majority of patients (p < 0.01). MAP influenced both ICP and HR to a greater extent (higher GC, p < 0. 00001), but there was no dominant unidirectional causality between ICP and HR (p = 0.85). Those who died had significantly lower GC for ICP causing MAP and HR causing ICP (p = 0.006 and p = 0.004, respectively) and were predictors of mortality independent of age, sex, and traditional intracranial variables (ICP, cerebral perfusion pressure, GCS, and pressure reactivity index). Examining the brain and heart with GC-based features for the first time in severe TBI patients has confirmed strong interdependence and reveals a significant relationship between select causality pairs and mortality. These results support the notion that impaired causal information flow between the cerebrovascular, autonomic, and cardiovascular systems are of central importance in severe TBI.	[Gao, Lei] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Cambridge, England; [Ercole, Ari] Univ Cambridge, Dept Anesthesia, Cambridge, England	Gao, L (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	lgao4@partners.org	Gao, Lei/AAL-1683-2020; Ercole, Ari/B-6288-2009	Gao, Lei/0000-0003-1476-1460; Ercole, Ari/0000-0001-8350-8093	Academy of Medical SciencesAcademy of Medical Sciences (AMS); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish	A.E. acknowledges the financial support of the Academy of Medical Sciences in this work.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett AB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041907; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Bishop SM, 2012, ANESTHESIOLOGY, V117, P810, DOI 10.1097/ALN.0b013e31826a4aa2; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Claassen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149878; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Ding M., 2006, HDB TIME SERIES ANAL, V437., DOI [DOI 10.1002/9783527609970.CH17, 10.1002/9783527609970.ch17]; Duggento A, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0185; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Gao L, 2016, J NEUROTRAUM, V33, P2011, DOI 10.1089/neu.2015.4228; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hu X, 2007, IEEE T BIO-MED ENG, V54, P1407, DOI 10.1109/TBME.2007.900802; Iberall A.S., 1965, CR2019 NASA; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jenkins G.E.P.B.G.C.R.G.M., 2008, TIME SERIES ANAL FOR; JENNETT B, 1975, LANCET, V1, P480; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Maeda M, 1998, ACT NEUR S, V71, P293; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Norris PR, 2008, J CRIT CARE, V23, P399, DOI 10.1016/j.jcrc.2007.08.001; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Pollonini L, 2010, BRAIN TOPOGR, V23, P221, DOI 10.1007/s10548-010-0139-9; Porta A, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0517; Porta A, 2012, IEEE T BIO-MED ENG, V59, P832, DOI 10.1109/TBME.2011.2180379; Robinson TG, 1997, STROKE, V28, P1671, DOI 10.1161/01.STR.28.9.1671; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Seth A., 2007, SCHOLARPEDIA, V2, P1667, DOI DOI 10.4249/SCHOLARPEDIA.1667; Seth AK, 2015, J NEUROSCI, V35, P3293, DOI 10.1523/JNEUROSCI.4399-14.2015; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Valenza G, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2016.0020; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	48	16	16	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2743	2752		10.1089/neu.2016.4787			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700009	28330412				2021-06-18	
J	Henry, LC; Tremblay, S; De Beaumont, L				Henry, Luke C.; Tremblay, Sebastien; De Beaumont, Louis			Long-Term Effects of Sports Concussions: Bridging the Neurocognitive Repercussions of the Injury with the Newest Neuroimaging Data	NEUROSCIENTIST			English	Article						concussion; chronic traumatic encephalopathy; neuroimaging; pathophysiology; dementia	TRAUMATIC BRAIN-INJURY; PROFESSIONAL SOCCER PLAYERS; FOOTBALL PLAYERS; AXONAL INJURY; ENCEPHALOPATHY; HISTORY; ABNORMALITIES; DYSFUNCTION; DEPRESSION; RECOVERY	Little is known of the long-term effects of sports-related concussion. Within the scientific literature, conclusions vary substantially where some work suggests there are no long-term consequences at all and other studies show rampant neurodegeneration thought to be caused by sometimes even a single concussive blow to the head. There is growing evidence that supports multiple long-term outcomes, showing both subclinical and clinically relevant changes in the brains of athletes, young and old alike. This article reviews the pathohistology of cerebral concussions and examines the extant literature with a focus on electrophysiological and neuroimaging findings. Neurobehavioral and neurocognitive changes are also reviewed, particularly as they are related to chronic traumatic encephalopathy. Lacunae within the literature are explored, and future research directions are proposed.	[Henry, Luke C.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Henry, Luke C.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Tremblay, Sebastien] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Quebec Trois Rivieres, 3351 Blvd Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada; [De Beaumont, Louis] Hop Sacre Coeur, Montreal, PQ, Canada	De Beaumont, L (corresponding author), Univ Quebec Trois Rivieres, 3351 Blvd Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	louis.debeaumont@uqtr.ca					Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI 10.1586/ERN.11.19; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fjell AM, 2001, BRAIN TOPOGR, V14, P25, DOI 10.1023/A:1012563605837; Fjell AM, 2007, BIOL PSYCHOL, V75, P87, DOI 10.1016/j.biopsycho.2006.12.004; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Henry LC, 2014, PROG NEUROL SURG, V28, P63, DOI 10.1159/000358763; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; JORDAN BD, 1990, NEUROLOGY, V40, P727; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meier TB, 2016, J NEUROTRAUMA; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839	86	16	16	3	60	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	OCT	2017	23	5					567	578		10.1177/1073858416651034			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FI8RO	WOS:000412270000015	27188455				2021-06-18	
J	Vekaria, HJ; Watts, LT; Lin, AL; Sullivan, PG				Vekaria, Hemendra J.; Watts, Lora Talley; Lin, Ai-Ling; Sullivan, Patrick G.			Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?	NEUROCHEMISTRY INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; CYCLOSPORINE-A; CELL-DEATH; PERMEABILITY TRANSITION; OXYGEN-CONSUMPTION; ENERGY-METABOLISM; RATS; BIOENERGETICS; NEUROPROTECTION; DAMAGE	Complex, multi-factorial secondary injury cascades are initiated following traumatic brain injury, which makes this a difficult disease to treat. The secondary injury cascades following the primary mechanical tissue damage, are likely where effective therapeutic interventions may be targeted. One promising therapeutic target following brain injury are mitochondria. Mitochondria are complex organelles found within the cell, which act as powerhouses within all cells by supplying ATP. These organelles are also necessary for calcium cycling, redox signaling and play a major role in the initiation of cell death pathways. When mitochondria become dysfunctional, there is a tendency for the cell to loose cellular homeostasis and can lead to eventual cell death. Targeting of mitochondrial dysfunction in various diseases has proven a successful approach, lending support to mitochondria as a pivotal player in TBI cell death. and loss of behavioral function. Within this mixed mini review/research article there will be a general discussion of mitochondrial bioenergetics, followed by a brief discussion of traumatic brain injury and how mitochondria play an integral role in the neuropathological sequelae following an injury. We will also give an overview of one relatively new TBI therapeutic approach, Methylene Blue, currently being studied to ameliorate mitochondrial dysfunction following brain injury. We will also present novel experimental findings, that for the first time, characterize the ex vivo effect of Methylene Blue on mitochondrial function in synaptic and non-synaptic populations of mitochondria. (C) 2017 Elsevier Ltd. All rights reserved.	[Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Watts, Lora Talley] Univ Texas Hlth San Antonio, Dept Cell Syst & Anat, Neurol & Res Imaging Inst, San Antonio, TX USA; [Lin, Ai-Ling] Univ Kentucky, Dept Biomed Engn, Dept Pharmacol & Nutr Sci, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Sullivan, Patrick G.] Lexington VAMC, Lexington, KY USA	Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Chandler Coll Med, 475 BBSRB,741 South Limestone St, Lexington, KY 40536 USA.	patsull@uky.edu	Vekaria, Hemendra/AAQ-7450-2020; Vekaria, Hemendra/AAH-2100-2021	Vekaria, Hemendra/0000-0001-5945-5235; Vekaria, Hemendra/0000-0001-5945-5235	Kentucky Spinal Cord and Head Injury Research Trust [15-14A]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000117]; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [I01BX003405]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG040164]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG040164] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), part of this work was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH CTSA UL1TR000117 (PGS). This work was supported in part by a Merit Review Award #I01BX003405 to (PGS) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. This work is also supported in part by a NIH/NIA K01 Mentored Career Development Award (K01AG040164) to (A-LL).	Adelson PD, 1998, ACT NEUR S, V71, P104; Akoachere M, 2005, ANTIMICROB AGENTS CH, V49, P4592, DOI 10.1128/AAC.49.11.4592-4597.2005; Ashurst John, 2011, Del Med J, V83, P203; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Auchter A, 2014, J ALZHEIMERS DIS, V42, pS525, DOI 10.3233/JAD-141527; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brooks M., 1936, SCI MON, V43, P585; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Collange O, 2013, EUR J VASC ENDOVASC, V45, P168, DOI 10.1016/j.ejvs.2012.11.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Draize J H, 1933, Science, V78, P145, DOI 10.1126/science.78.2016.145; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Geddes JW, 2009, EXP NEUROL, V218, P169, DOI 10.1016/j.expneurol.2009.05.011; Gensini GF, 2007, J INFECTION, V54, P221, DOI 10.1016/j.jinf.2004.05.022; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Gureev AP, 2016, NEUROSCI RES, V113, P19, DOI 10.1016/j.neures.2016.07.006; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hosseinian L, 2016, ANESTH ANALG, V122, P194, DOI 10.1213/ANE.0000000000001045; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Huang SL, 2013, NEUROIMAGE, V72, P237, DOI 10.1016/j.neuroimage.2013.01.027; Keir SL, 2000, STROKE, V31, P2723, DOI 10.1161/01.STR.31.11.2723; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kwok Edmund S H, 2006, J Intensive Care Med, V21, P359, DOI 10.1177/0885066606290671; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; Marr AL., 2004, CENTRAL NERVOUS SYST; Maslow AD, 2006, ANESTH ANALG, V103, P2, DOI 10.1213/01.ane.0000221261.25310.fe; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315; Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Paciullo CA, 2010, PHARMACOTHERAPY, V30, P702, DOI 10.1592/phco.30.7.702; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Pellock J. M., 2001, PEDIAT EPILEPSY DIAG, pxv; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2005, EPILEPSY BEHAV, V7, pS12, DOI 10.1016/j.yebeh.2005.08.004; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; TBI, 2003, REP C MILD TRAUM BRA; The CDC NI H DoD and VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Vutskits L, 2008, ANESTHESIOLOGY, V108, P684, DOI 10.1097/ALN.0b013e3181684be4; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Watts LT, 2016, J NEUROTRAUM, V33, P194, DOI 10.1089/neu.2015.3904; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Watts LT, 2013, BRAIN SCI, V3, P540, DOI 10.3390/brainsci3020540; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wiklund L, 2007, ANN NY ACAD SCI, V1122, P231, DOI 10.1196/annals.1403.016; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; Xie LK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00056; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007	93	16	16	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	OCT	2017	109				SI		117	125		10.1016/j.neuint.2017.04.004			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	FM3ER	WOS:000414887600013	28396091	Green Published, Green Accepted			2021-06-18	
J	Pakkanen, T; Kamarainen, A; Huhtala, H; Silfvast, T; Nurmi, J; Virkkunen, I; Yli-Hankala, A				Pakkanen, Toni; Kamarainen, Antti; Huhtala, Heini; Silfvast, Tom; Nurmi, Jouni; Virkkunen, Ilkka; Yli-Hankala, Arvi			Physician-staffed helicopter emergency medical service has a beneficial impact on the incidence of prehospital hypoxia and secured airways on patients with severe traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Prehospital emergency care (MeSH); Emergency medical services (MeSH); Critical care (MeSH); Traumatic brain injury (MeSH); Airway management (MeSH); Endotracheal intubation (MeSH); Patient outcome assessment (MeSH); Glasgow outcome scale (MeSH)	SEVERE HEAD-INJURY; RAPID-SEQUENCE INTUBATION; PRACTICAL SCALE; SURVIVAL; MORTALITY; MANAGEMENT	Background: After traumatic brain injury (TBI), hypotension, hypoxia and hypercapnia have been shown to result in secondary brain injury that can lead to increased mortality and disability. Effective prehospital assessment and treatment by emergency medical service (EMS) is considered essential for favourable outcome. The aim of this study was to evaluate the effect of a physician-staffed helicopter emergency medical service (HEMS) in the treatment of TBI patients. Methods: This was a retrospective cohort study. Prehospital data from two periods were collected: before (EMS group) and after (HEMS group) the implementation of a physician-staffed HEMS. Unconscious prehospital patients due to severe TBI were included in the study. Unconsciousness was defined as a Glasgow coma scale (GCS) score <= 8 and was documented either on-scene, during transportation or by an on-call neurosurgeon on hospital admission. Modified Glasgow Outcome Score (GOS) was used for assessment of six-month neurological outcome and good neurological outcome was defined as GOS 4-5. Results: Data from 181 patients in the EMS group and 85 patients in the HEMS group were available for neurological outcome analyses. The baseline characteristics and the first recorded vital signs of the two cohorts were similar. Good neurological outcome was more frequent in the HEMS group; 42% of the HEMS managed patients and 28% (p = 0.022) of the EMS managed patients had a good neurological recovery. The airway was more frequently secured in the HEMS group (p < 0.001). On arrival at the emergency department, the patients in the HEMS group were less often hypoxic (p = 0.024). In univariate analysis HEMS period, lower age and secured airway were associated with good neurological outcome. Conclusion: The introduction of a physician-staffed HEMS unit resulted in decreased incidence of prehospital hypoxia and increased the number of secured airways. This may have contributed to the observed improved neurological outcome during the HEMS period.	[Pakkanen, Toni; Virkkunen, Ilkka] FinnHEMS Ltd, Res & Dev Unit, Vantaa, Finland; [Pakkanen, Toni; Yli-Hankala, Arvi] Tampere Univ Hosp, Dept Anaesthesia, Tampere, Finland; [Kamarainen, Antti] Tampere Univ Hosp, FinnHEMS 30, Tays Emergency Med Serv, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Fac Social Sci, Tampere, Finland; [Silfvast, Tom] Univ Helsinki, Helsinki Univ Hosp, Dept Anaesthesia & Intens Care, Helsinki, Finland; [Nurmi, Jouni] Helsinki Univ Hosp, Dept Emergency Med & Serv, Helsinki, Finland; [Nurmi, Jouni] Univ Helsinki, Emergency Med, Helsinki, Finland; [Yli-Hankala, Arvi] Univ Tampere, Fac Med & Life Sci, Tampere, Finland	Pakkanen, T (corresponding author), FinnHEMS Ltd, Res & Dev Unit, Vantaa, Finland.; Pakkanen, T (corresponding author), Tampere Univ Hosp, Dept Anaesthesia, Tampere, Finland.	toni.pakkanen@fimnet.fi			FinnHEMS ltd, Research and Development Unit	This study was supported by a study grant from FinnHEMS ltd, Research and Development Unit.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Haltmeier T, 2016, EUR J TRAUMA EMERG S; Iirola TT, 2006, EUR J EMERG MED, V13, P335, DOI 10.1097/01.mej.0000224429.51623.fb; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Traumatic Brain Injury, TRAUM BRAIN INJ ONL; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	25	16	16	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	SEP 15	2017	25								94	10.1186/s13049-017-0438-1			7	Emergency Medicine	Emergency Medicine	FH1UY	WOS:000410926400001	28915898	DOAJ Gold, Green Published			2021-06-18	
J	Alice, P; Meghan, L; Elizabeth, B; Alberto, A; Kenji, I; Demetrios, D				Alice, Piccinini; Meghan, Lewis; Elizabeth, Benjamin; Alberto, Aiolfi; Kenji, Inaba; Demetrios, Demetriades			Intracranial pressure monitoring in severe traumatic brain injuries: a closer look at level 1 trauma centers in the United States	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Isolated severe head trauma; ICP monitoring; Level 1 trauma center; Outcomes	SEVERE HEAD-INJURY; OUTCOMES; MORTALITY	Introduction: The Brain Trauma Foundation (BTF) recently updated recommendations for intracranial pressure (ICP) monitoring in severe traumatic brain injury (TBI). The effect of ICP monitoring on outcomes is controversial, and compliance with BTF guidelines is variable. The purpose of this study was to assess both compliance and outcomes at level I trauma centers. Materials and methods: The American College of Surgeons Trauma Quality Improvement Program database was queried for all patients admitted to level I trauma centers with isolated blunt severe TBI (AIS > 3, GCS < 9) who met criteria for ICP monitoring. Patients who had severe extracranial injuries, craniectomy, or death in the first 24 h were excluded. Comparison between groups with and without ICP monitoring was made, analyzing demographics, comorbidities, mechanism of injury, head Abbreviated Injury Scale (AIS), vital signs on admission, head CT scan findings. Outcomes included in-hospital mortality, mechanical ventilation days, intensive care unit (ICU) length of stay, hospital length of stay, systemic complications, and functional independence at discharge. Multivariable analysis was used to identify independent risk factors for each of the outcomes. Results: Overall, 4880 patients were included. ICP monitoring was used in 529 patients (10.8%). Stepwise logistic regression analysis identified ICP monitor placement as an independent risk factor for mortality (OR 1.63; 95% CI 1.28-2.07; p < 0.001), mechanical ventilation (OR 5.74 95% CI 4.42-7.46; p < 0.001), ICU length of stay (OR 4.03; 95% CI 2.94-5.52; p < 0.001), systemic complications (OR 2.78; 95% CI 2.29-3.37; p < 0.001), and decreased functional independence at discharge (OR 1.71 95% CI 1.29-2.26; p < 0.001). Subgroup analysis of patients with head AIS 3, 4, and 5 confirmed that ICP monitors remained an independent risk factor for mortality in both head AIS 4 and 5. Conclusions: Compliance with BTF guidelines for ICP monitoring is low, even at level I trauma centers. In this study, ICP monitoring was associated with poor outcomes, and was found to be an independent risk factor for mortality. Further studies are needed to determine the optimal role of ICP monitoring in the management of severe TBI. (C) 2017 Elsevier Ltd. All rights reserved.	[Alice, Piccinini; Meghan, Lewis; Elizabeth, Benjamin; Alberto, Aiolfi; Kenji, Inaba; Demetrios, Demetriades] Univ Sourhern Calif, Div Trauma Emergency Surg & Surg Crit Care, Los Angeles, CA 90033 USA	Demetrios, D (corresponding author), Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	Aiolfi, Alberto/ABA-7242-2020	Aiolfi, Alberto/0000-0002-7764-6075			Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Aiolfi A, J NEUROSURG IN PRESS; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alkhoury F, 2011, AM SURGEON, V77, P277; Barmparas G, 2012, AM SURGEON, V78, P1166; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2016, NEUROSURGERY; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Lane PL, 2000, CAN J SURG, V43, P442; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Task Force of the Committee on Trauma American College of Surgeons, 1990, B AM COLL SURG, V75, P20; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9	22	16	16	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2017	48	9					1944	1950		10.1016/j.injury.2017.04.033			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FE2LA	WOS:000408046600015	28495204				2021-06-18	
J	Bell, JM; Breiding, MJ; DePadilla, L				Bell, Jeneita M.; Breiding, Matthew J.; DePadilla, Lara			CDC's efforts to improve traumatic brain injury surveillance	JOURNAL OF SAFETY RESEARCH			English	Article						Traumatic; Brain; Injury; Sports; Survey	LONG-TERM DISABILITY; UNITED-STATES; POPULATION; PREVALENCE	Introduction: Youth sports concussion has become a prominent public health issue due to growing concern about the risk of long-term health effects. Method: A broad spectrum of stakeholders has convened to propose solutions, including a committee of the National Academy of Sciences (NAS) who systematically examined the issue and, in a 2014 report, made a series of recommendations to better address this public health problem. Results: Among these recommendations, the NAS committee called for CDC to develop a plan for a comprehensive surveillance system to better quantify the incidence and outcomes of youth sports concussion among children 5 to 21 years of age. Since the release of the NAS report, CDC has taken action to address this recommendation and, in the process, develop strategies to improve traumatic brain injury (TBI) surveillance more broadly. The challenges outlined by the NAS committee with respect to producing comprehensive incidence estimates of youth sports concussion are not exclusive to youth sports concussion, but also apply to TBI surveillance overall. In this commentary, we will discuss these challenges, the process CDC has undertaken to address them and describe our plan for improving TBI and youth sports concussion surveillance.	[Bell, Jeneita M.; Breiding, Matthew J.; DePadilla, Lara] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Breiding, Matthew J.; DePadilla, Lara] Ctr Dis Control & Prevent, 4770 Buford Highway,MS-F62, Atlanta, GA 30341 USA	Bell, JM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS-A24, Atlanta, GA 30329 USA.	jbell2@cdc.gov; mbreiding@cdc.gov; ldepadilla@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Centers for Disease Control and Prevention, 2015, BRFSS COMB LANDL CEL; Centers for Disease Control and Prevention, 2011, MATR E COD GROUP; Comstock RD., SUMMARY REPORT NATL; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Dick R, 2007, J ATHL TRAINING, V42, P173; Gaskell GD, 2000, PUBLIC OPIN QUART, V64, P77, DOI 10.1086/316761; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greby S. M., 2012, ADDING HOUSEHOLDS CE; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS RELATED CONCU; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Rowhani-Rahbar A., 2015, J NEUROTRAUM, P784; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schroeder T., 2001, NEISS SAMPLE DESIGN; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	19	16	16	1	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2017	62						253	256		10.1016/j.jsr.2017.04.002			4	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	FH9PF	WOS:000411543500027	28882274	Green Accepted			2021-06-18	
J	Castranio, EL; Mounier, A; Wolfe, CM; Nam, KN; Fitz, NF; Letronne, F; Schug, J; Koldamova, R; Lefterov, I				Castranio, Emilie L.; Mounier, Anais; Wolfe, Cody M.; Nam, Kyong Nyon; Fitz, Nicholas F.; Letronne, Florent; Schug, Jonathan; Koldamova, Radosveta; Lefterov, Iliya			Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Apolipoprotein E; Traumatic brain injury; Trem2; Tyrobp; Myelination; Immune response; Fyn; Innate immune response	CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; APOLIPOPROTEIN E4; NEUROINFLAMMATORY RESPONSES; MYELOID CELLS; DEFICIENCY; PATHOLOGY; MILD; ALPHA-1-ANTICHYMOTRYPSIN; REPLACEMENT	Traumatic brain injury (TBI) is strongly linked to an increased risk of developing dementia, including chronic traumatic encephalopathy and possibly Alzheimer's disease (AD). APOE epsilon 4 allele of human Apolipoprotein E (APOE) gene is the major genetic risk factor for late onset AD and has been associated with chronic traumatic encephalopathy and unfavorable outcome following TBI. To determine if there is an APOE isoform-specific response to TBI we performed controlled cortical impact on 3-month-old mice expressing human APOE3 or APOE4 isoforms. Following injury, we used several behavior paradigms to test for anxiety and learning and found that APOE3 and APOE4 targeted replacement mice demonstrate cognitive impairments following moderate TBI. Transcriptional profiling 14 days following injury revealed a significant effect of TBI, which was similar in both genotypes. Significantly upregulated by injury in both genotypes were mRNA expression and protein level of ABCA1 transporter and APOJ, but not APOE. To identify gene-networks correlated to injury and APOE isoform, we performed Weighted Gene Co-expression Network Analysis. We determined that the network mostly correlated to TBI in animals expressing both isoforms is immune response with major hub genes including Trem2, Tyrobp, Clec7a and Cd68. We also found a significant increase of TREM2, IBA-1 and GFAP protein levels in the brains of injured mice. We identified a network representing myelination that correlated significantly with APOE isoform in both injury groups. This network was significantly enriched in oligodendrocyte signature genes, such as Mbp and Plp1. Our results demonstrate unique and distinct gene networks at this acute time point for injury and APOE isoform, as well as a network driven by APOE isoform across TBI groups. (C) 2017 Elsevier Inc. All rights reserved.	[Castranio, Emilie L.; Mounier, Anais; Wolfe, Cody M.; Nam, Kyong Nyon; Fitz, Nicholas F.; Letronne, Florent; Koldamova, Radosveta; Lefterov, Iliya] Univ Pittsburgh, Dept Environm & Occupat Hlth, 100 Technol Dr,BRIDG Bldg, Pittsburgh, PA 15219 USA; [Schug, Jonathan] Univ Penn, Dept Genet, Funct Genom Core, Philadelphia, PA 19104 USA	Koldamova, R; Lefterov, I (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, 100 Technol Dr,BRIDG Bldg, Pittsburgh, PA 15219 USA.	radak@pitt.edu; iliyal@pitt.edu	Lefterov, Iliya/B-4767-2008	Nam, Kyongnyon/0000-0002-5140-6014; Lefterov, Iliya/0000-0002-0249-0280; Fitz, Nicholas/0000-0001-6938-6536; Letronne, Florent/0000-0002-5330-0395	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG037481, R01AG037919, K01AG044490, R01ES024233]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-13-1-0384]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES024233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037919, R01AG037481, K01AG044490] Funding Source: NIH RePORTER	Supported by National Institutes of Health (R01AG037481, R01AG037919, K01AG044490, R01ES024233) and U.S. Department of Defense (W81XWH-13-1-0384). We would like to thank Dr. H. I. Kamboh for technical assistance.	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Alderson NL, 2006, J LIPID RES, V47, P2772, DOI 10.1194/jlr.M600362-JLR200; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Bennett RE, 2013, J NEUROPATH EXP NEUR, V72, P396, DOI 10.1097/NEN.0b013e31828e24ab; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Cartagena CM, 2008, J NEUROTRAUM, V25, P1087, DOI 10.1089/neu.2007.0444; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fitz NF, 2015, BRAIN, V138, P3699, DOI 10.1093/brain/awv293; Fitz NF, 2012, J NEUROSCI, V32, P13125, DOI 10.1523/JNEUROSCI.1937-12.2012; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Ghroubi S, 2016, ANN PHYS REHABIL MED, V59, P87, DOI 10.1016/j.rehab.2016.01.005; Guan FL, 2012, MOL BIOL REP, V39, P6661, DOI 10.1007/s11033-012-1472-8; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Haile Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0376-7; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hooli BV, 2015, NATURE, V520, pE7, DOI 10.1038/nature14040; Hsu I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.423; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan Barry D, 2014, Continuum (Minneap Minn), V20, P1588, DOI 10.1212/01.CON.0000458972.94013.e1; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Lau DHW, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0317-4; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Mannix RC, 2016, J CEREB BLOOD FLOW M, V31, P351; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Nam KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep24048; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Osisami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033341; Panicker N, 2015, J NEUROSCI, V35, P10058, DOI 10.1523/JNEUROSCI.0302-15.2015; Perez-Garcia G., 2016, BEHAV BRAIN RES; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Richter F, 2014, NEUROBIOL DIS, V69, P263, DOI 10.1016/j.nbd.2014.05.012; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Saber M., 2016, J NEUROTRAUMA; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Saher G, 2015, BBA-MOL CELL BIOL L, V1851, P1083, DOI 10.1016/j.bbalip.2015.02.010; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; Schiza N, 2015, HUM MOL GENET, V24, P2049, DOI 10.1093/hmg/ddu725; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai PC, 2016, ANN CLIN TRANSL NEUR, V3, P854, DOI 10.1002/acn3.347; Venables W. N., 2002, MODERN APPL STAT S S; Wang C, 2015, J ALZHEIMERS DIS, V46, P491, DOI 10.3233/JAD-150110; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	76	16	16	1	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2017	105						1	14		10.1016/j.nbd.2017.05.006			14	Neurosciences	Neurosciences & Neurology	FC3JG	WOS:000406734300001	28502803	Green Accepted			2021-06-18	
J	Heim, LR; Bader, M; Edut, S; Rachmany, L; Baratz-Goldstein, R; Lin, R; Elpaz, A; Qubty, D; Bikovski, L; Rubovitch, V; Schreiber, S; Pick, CG				Heim, Leore R.; Bader, Miaad; Edut, Shahaf; Rachmany, Lital; Baratz-Goldstein, Renana; Lin, Ran; Elpaz, Aviya; Qubty, Doaa; Bikovski, Lior; Rubovitch, Vardit; Schreiber, Shaul; Pick, Chaim G.			The Invisibility of Mild Traumatic Brain Injury: Impaired Cognitive Performance as a Silent Symptom	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; behavioral assessment; cognitive function; head trauma; traumatic brain injury	CLOSED-HEAD-INJURY; CONTROLLED CORTICAL IMPACT; BEHAVIORAL SEQUELAE; EXPERIMENTAL-MODEL; AXONAL OUTGROWTH; OXIDATIVE STRESS; MOTOR DEFICITS; MOUSE MODEL; MICE; RAT	The present study was designed to tackle two notorious features of mild traumatic brain injury (mTBI)-heterogeneity and invisibility-by characterizing the full scope of mTBI symptoms. Mice were exposed to brain injuries of different intensities utilizing a weight-drop model (10, 30, 50, and 70 g) and subsequently subjected to a comprehensive battery of behavioral tests at different time points and immunohistochemical examination of cortical slices. Whereas the physiological, neurological, emotional, and motor function of mTBI mice (i.e., their well-being) remained largely intact, cognitive deficits were identified by the y-maze and novel object recognition. Results from these two cognitive tests were combined and a dose-response relationship was established between injury intensity and cognitive impairment, ranging from an 85% decline after a 70-g impact (p < 0.001) to a 20% decline after a 10-g impact (essentially no effect). In addition, higher intensities of injury were accompanied by decreased expression of axonal and synaptic markers. Thus, our mTBI mice showed a clear discrepancy between performance (poor cognitive function) and appearance (healthy demeanor). This is of major concern given that diagnosis of mTBI is established on the presence of clinical symptoms and emphasizes the need for an alternative diagnostic modality.	[Heim, Leore R.; Bader, Miaad; Edut, Shahaf; Rachmany, Lital; Baratz-Goldstein, Renana; Lin, Ran; Elpaz, Aviya; Qubty, Doaa; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, 55 Chaim Levanon St, IL-69978 Tel Aviv, Israel; [Heim, Leore R.] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, Tel Aviv, Israel; [Schreiber, Shaul; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel; [Bikovski, Lior] Tel Aviv Univ, Sackler Sch Med, Myers Neurobehav Core Facil, Tel Aviv, Israel	Heim, LR (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, 55 Chaim Levanon St, IL-69978 Tel Aviv, Israel.	leoreheim@mail.tau.ac.il	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693	Ari and Regine Aprijaskis Fund, Tel-Aviv University, Tel-Aviv, Israel	This work was supported, in part, by the Ari and Regine Aprijaskis Fund, Tel-Aviv University, Tel-Aviv, Israel.	Aggleton JP, 1997, BRAIN RES BULL, V43, P279, DOI 10.1016/S0361-9230(97)00007-5; [Anonymous], 2016, EST FUND VAR RES CON; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Baratz-Goldstein R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157064; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Committee for the update of the guide for the care and use of laboratory animals, 2011, GUIDE CARE USE LAB A; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Klein F. C., 1982, WALL STREET J, V12, P1; Klonoff PS, 2004, ARCH CLIN NEUROPSYCH, V19, P1095, DOI 10.1016/j.acn.2003.12.012; Koerte I.K., 2016, TRANSLATIONAL RES TR; Kosaka B., 2006, BRIT COLOMBIA MEDICA, V48, P447; Lee S, 2014, BIOL OPEN, V3, P974, DOI 10.1242/bio.20149779; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; Schreiber S, 2017, WORLD J BIOL PSYCHIA, V18, P300, DOI 10.3109/15622975.2015.1086492; Schreiber S, 2009, SLEEP MED, V10, P13, DOI 10.1016/j.sleep.2008.02.003; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; TEASDALE G, 1974, LANCET, V2, P81; Teresa L. S., 2001, BRAIN INJURY, V15, P149; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	71	16	16	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2518	2528		10.1089/neu.2016.4909			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200004	28514188				2021-06-18	
J	Hosseini-Zare, MS; Gu, F; Abdulla, A; Powell, S; Ziburkus, J				Hosseini-Zare, Mahshid Sadat; Gu, Feng; Abdulla, Ahmad; Powell, Simon; Ziburkus, Jokubas			Effects of experimental traumatic brain injury and impaired glutamate transport on cortical spreading depression	EXPERIMENTAL NEUROLOGY			English	Article						Cortical spreading depression; Traumatic brain injury; Astrocytic glutamate transporter	PERIINFARCT DEPOLARIZATIONS; CLINICAL-RELEVANCE; CEREBRAL-CORTEX; IN-VIVO; RAT; RELEASE; ASPARTATE; EXCITOTOXICITY; ASTROCYTES; RECEPTORS	Cortical spreading depression (CSD) is associated with traumatic brain injury (TBI), stroke, migraines, and seizures. Typically, following TBIs and other insults, neuronal excitability in and around the area of the injury is affected, with reported increases in local glutamate signaling. Astrocytic glutamate transporters are critical for precise regulation of the extracellular glutamate availability. However, it remains unclear how impaired astrocytic glutamate transport or an acute TBI affect characteristics of the CSD. We quantified the properties of CSD using whole-cell and extracellular electrophysiological recordings, and voltage-sensitive dye imaging (VSDI) in rat visual cortex in vitro. To model impaired astrocytic glutamate transport, we used astrocytic glutamate transporter blocker (2S, 35)-3-1.3[4-(trifluoromethyl) benzoylamino] benzyloxy] aspartate (TFB-TBOA). In addition, an acute incision through the superficial cortical layers was used to model the effects of acute traumatic brain injury (TBI) on CSD characteristics. Both manipulations; impaired glutamate cycling and acute cut profoundly affected the physiological properties of cell firing, latency to CSD formation, and its frequency of occurrence. VSD imaging analysis revealed significant changes in spatiotemporal dynamics and propagation of the CSD, suggesting that the cut itself may not initiate CSD depolarizing waves, but rather attract them. Blockade of GLT-1 caused significant reduction in whole-cell sodium currents and changes in CSD wave spatiotemporal characteristics as well, slowing it or even 'trapping' its propagation. Our results reveal new information about CSD properties in these pathological conditions and demonstrate an important role of GLT-1 in regulation of CSD. (C) 2017 Elsevier Inc. All rights reserved.	[Hosseini-Zare, Mahshid Sadat; Gu, Feng; Abdulla, Ahmad; Powell, Simon; Ziburkus, Jokubas] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Hosseini-Zare, Mahshid Sadat; Abdulla, Ahmad; Ziburkus, Jokubas] TIMES, Houston, TX 77024 USA; [Gu, Feng] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Ziburkus, J (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.; Ziburkus, J (corresponding author), TIMES, Houston, TX 77204 USA.	jziburkus@uh.edu			Dravet Syndrome Foundation; University of Houston's Grants	This research was sponsored by the Dravet Syndrome Foundation and University of Houston's Grants to Advance and Enhance Research (GEAR) funds. We thank Dr. Steven J. Schiff for the invaluable discussions about the role of CSD.	Basarsky TA, 1999, J NEUROSCI, V19, P6439; Bozzo L, 2010, BRAIN RES, V1316, P27, DOI 10.1016/j.brainres.2009.12.028; BURES J, 1957, ELECTROEN CLIN NEURO, V9, P121, DOI 10.1016/0013-4694(57)90116-5; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; DELUCA B, 1977, DEV PSYCHOBIOL, V10, P289, DOI 10.1002/dev.420100402; Dulla CG, 2013, NEUROBIOL DIS, V49, P232, DOI 10.1016/j.nbd.2012.09.001; Eikermann-Haerter K, 2010, CURR NEUROL NEUROSCI, V10, P167, DOI 10.1007/s11910-010-0099-1; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Gu F, 2014, EPILEPSIA, V55, P245, DOI 10.1111/epi.12487; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hazra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064318; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Larrosa B, 2006, NEUROSCIENCE, V141, P1057, DOI 10.1016/j.neuroscience.2006.04.005; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Malkov A, 2014, J CEREBR BLOOD F MET, V34, P1540, DOI 10.1038/jcbfm.2014.121; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Obrenovitch TP, 1996, BRIT J PHARMACOL, V117, P931, DOI 10.1111/j.1476-5381.1996.tb15283.x; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimamoto K, 2004, MOL PHARMACOL, V65, P1008, DOI 10.1124/mol.65.4.1008; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Somjen GG., 2004, IONS BRAIN NORMAL FU; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Torrente D, 2014, NEUROSCI LETT, V565, P2, DOI 10.1016/j.neulet.2013.12.058; Torrente D, 2014, NEUROSCI LETT, V558, P87, DOI 10.1016/j.neulet.2013.11.004; Tozzi A, 2012, P NATL ACAD SCI USA, V109, P18985, DOI 10.1073/pnas.1215435109; Van Harreveld A, 1970, J Neurobiol, V2, P13, DOI 10.1002/neu.480020103; Vilagi I, 2001, BRAIN RES, V898, P288, DOI 10.1016/S0006-8993(01)02196-5; Zhang Y, 2014, EUR J PHARMACOL, V736, P55, DOI 10.1016/j.ejphar.2014.04.036; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	44	16	16	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						155	161		10.1016/j.expneurol.2017.05.002			7	Neurosciences	Neurosciences & Neurology	FC4OS	WOS:000406820900015	28479338				2021-06-18	
J	Leal-Noval, SR; Arellano-Orden, V; Munoz-Gomez, M; Cayuela, A; Marin-Caballos, A; Rincon-Ferrari, MD; Garcia-Alfaro, C; Amaya-Villar, R; Casado-Mendez, M; Dusseck, R; Murillo-Cabezas, F				Leal-Noval, Santiago R.; Arellano-Orden, Victoria; Munoz-Gomez, Manuel; Cayuela, Aurelio; Marin-Caballos, Antonio; Rincon-Ferrari, Maria D.; Garcia-Alfaro, Claudio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Dusseck, Reginal; Murillo-Cabezas, Francisco			Red Blood Cell Transfusion Guided by Near Infrared Spectroscopy in Neurocritically Ill Patients with Moderate or Severe Anemia: A Randomized, Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						anemia; intracerebral hemorrhage; neurocritically ill; NIRS; RBCT; subarachnoid hemorrhage; transcranial oxygen saturation; rSO(2); traumatic brain injury	TRAUMATIC BRAIN-INJURY; TISSUE OXYGEN-SATURATION; CEREBRAL OXYGENATION; HEMOGLOBIN CONCENTRATION; SUBARACHNOID HEMORRHAGE; GUIDELINES; MANAGEMENT; MORTALITY; STROKE; IMPACT	In neurocritically ill patients (NCPs), the use of hemoglobin level as the sole indicator for red blood cell transfusion (RBCT) can result in under-or over-transfusion. This randomized controlled trial was conducted to ascertain whether a transcranial oxygen saturation (rSO(2)) threshold, as measured by near-infrared spectroscopy, reduces RBCT requirements in anemic NCPs (closed traumatic brain injury, subarachnoid, or intracerebral hemorrhage), compared with a hemoglobin threshold alone. Patients with hemoglobin 70-100 g/L received RBCTs to attain an rSO(2) > 60% (rSO(2) arm) or to maintain hemoglobin between 85 and 100 g/L (hemoglobin arm). A total of 102NCPs (51 in each group) were included in the intention-to-treat analysis, and 97 were included in the per-protocol analysis (51 and 46, respectively). Compared with those from the hemoglobin arm, patients in rSO(2) arm received fewer RBC units (1.0 +/- 0.1 vs. 1.5 +/- 1.4 units/patient; p < 0.05) and showed lower hemoglobin levels while in protocol. There were no differences between the study arms regarding the percentage of transfused patents (59% vs. 71%; relative risk 0.83 [95% CI 0.62-1.11]), stay on neurocritical care unit (21 vs. 20 days), unfavorable Glasgow Outcome Scale scores on hospital discharge (57% vs. 71%), in-hospital mortality (6% vs. 10%), or 1 year mortality (24% vs. 24%). Among NCPs with hemoglobin concentrations of 70-85 g/L, withholding transfusion until rSO(2) is < 60% may result in reduced RBCs requirements compared with routinely transfusing to attain a hemoglobin level > 85 g/L. Further studies are required to confirm this finding and its possible impact on clinically significant outcomes.	[Leal-Noval, Santiago R.; Arellano-Orden, Victoria; Marin-Caballos, Antonio; Rincon-Ferrari, Maria D.; Garcia-Alfaro, Claudio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Dusseck, Reginal; Murillo-Cabezas, Francisco] Univ Hosp Virgen del Rocio, Neurocrit Care Unit, Avda Manuel Siurot S-N, Seville 41013, Spain; [Munoz-Gomez, Manuel] Univ Malaga, Sch Med, Perioperat Transfus Med, Malaga, Spain; [Cayuela, Aurelio] Univ Hosp Virgen del Valme, Dept Publ Hlth, Stat & Design Div, Seville, Spain	Leal-Noval, SR (corresponding author), Univ Hosp Virgen del Rocio, Neurocrit Care Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.	srlealnoval@gmail.com	Murillo-Cabezas, Francisco/AAO-3348-2021; Cayuela, Aurelio/C-6698-2012; Cayuela, Aurelio/AAZ-1294-2020; Noval, Santiago/K-4515-2019	Cayuela, Aurelio/0000-0002-4936-9402; 	Fondo de Investigacion Sanitaria (FIS)Instituto de Salud Carlos III [PI 08/1069, PI 15/00512]; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission; Government of Spain; European Regional Development Fund (FEDER Funds)European Commission	This study was supported by Fondo de Investigacion Sanitaria (FIS) PI 08/1069 and PI 15/00512, Instituto de Salud Carlos III, Health Minister, Government of Spain, and by the European Regional Development Fund (FEDER Funds).	Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carson JL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub4; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Dhabangi A, 2015, JAMA-J AM MED ASSOC, V314, P2514, DOI 10.1001/jama.2015.13977; Dunham CM, 2002, J TRAUMA, V52, P40, DOI 10.1097/00005373-200201000-00009; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2016, NEUROCRIT CARE, V24, P371, DOI 10.1007/s12028-015-0220-z; Leal-Noval SR, 2013, BLOOD TRANSFUS-ITALY, V11, P585, DOI 10.2450/2013.0029-13; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Llau JV, 2015, MED INTENSIVA, V39, P483, DOI [10.1016/j.medin.2015.05.002, 10.1016/j.medine.2015.10.001]; McCredie VA, 2017, NEUROCRIT CARE, V26, P247, DOI 10.1007/s12028-016-0310-6; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Naidech AM, 2010, NEUROCRIT CARE, V13, P313, DOI 10.1007/s12028-010-9424-4; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sheth KN, 2011, NEUROSURGERY, V68, P1286, DOI 10.1227/NEU.0b013e31820cccb2; Smith J, 2008, AM SURGEON, V74, P1006; Spahn DR, 2006, ANESTHESIOLOGY, V104, P905, DOI 10.1097/00000542-200605000-00002; Stein M, 2015, J CLIN NEUROSCI, V22, P530, DOI 10.1016/j.jocn.2014.08.026; Torella F, 2003, J SURG RES, V110, P217, DOI 10.1016/S0022-4804(03)00037-4; Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7; Vretzakis G, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-145; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	30	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2553	2559		10.1089/neu.2016.4794			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200008	28486023				2021-06-18	
J	Yue, JK; Robinson, CK; Burke, JF; Winkler, EA; Deng, HS; Cnossen, MC; Lingsma, HF; Ferguson, AR; McAllister, TW; Rosand, J; Burchard, EG; Sorani, MD; Sharma, S; Nielson, JL; Satris, GG; Talbott, JF; Tarapore, PE; Korley, FK; Wang, KKW; Yuh, EL; Mukherjee, P; Diaz-Arrastia, R; Valadka, AB; Okonkwo, DO; Manley, GT				Yue, John K.; Robinson, Caitlin K.; Burke, John F.; Winkler, Ethan A.; Deng, Hansen; Cnossen, Maryse C.; Lingsma, Hester F.; Ferguson, Adam R.; McAllister, Thomas W.; Rosand, Jonathan; Burchard, Esteban G.; Sorani, Marco D.; Sharma, Sourabh; Nielson, Jessica L.; Satris, Gabriela G.; Talbott, Jason F.; Tarapore, Phiroz E.; Korley, Frederick K.; Wang, Kevin K. W.; Yuh, Esther L.; Mukherjee, Pratik; Diaz-Arrastia, Ramon; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	Apolipoprotein E epsilon 4 (APOE-epsilon 4) genotype is associated with decreased 6-month verbal memory performance after mild traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						apolipoprotein E; genetic factors; human studies; outcome measures; traumatic brain injury; verbal memory	COMMON DATA ELEMENTS; HEAD-INJURY; LEARNING TEST; E EPSILON-4; E POLYMORPHISM; APOE GENOTYPE; RECOVERY; MODERATE; ALLELE; AGE	Introduction: The apolipoprotein E (APOE) epsilon 4 allele associates with memory impairment in neurodegenerative diseases. Its association with memory after mild traumatic brain injury (mTBI) is unclear. Methods: mTBI patients (Glasgow Coma Scale score 13-15, no neurosurgical intervention, extracranial Abbreviated Injury Scale score <= 1) aged >= 18 years with APOE genotyping results were extracted from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study. Cohorts determined by APOE-epsilon 4(+/-) were assessed for associations with 6-month verbal memory, measured by California Verbal Learning Test, Second Edition (CVLT-II) subscales: Immediate Recall Trials 1-5 (IRT), Short-Delay Free Recall (SDFR), Short-Delay Cued Recall (SDCR), Long-Delay Free Recall (LDFR), and Long-Delay Cued Recall (LDCR). Multivariable regression controlled for demographic factors, seizure history, loss of consciousness, posttraumatic amnesia, and acute intracranial pathology on computed tomography (CT). Results: In 114 mTBI patients (APOE-epsilon 4(-) = 79; APOE-epsilon 4(+)=35), ApoE-epsilon 4(+) was associated with long-delay verbal memory deficits (LDFR: B = -1.17 points, 95% CI [-2.33, -0.01], p = .049; LDCR: B = -1.58 [-2.63, -0.52], p = .004), and a marginal decrease on SDCR (B = -1.02 [-2.05, 0.00], p = .050). CT pathology was the strongest predictor of decreased verbal memory (IRT: B = -8.49, SDFR: B = -2.50, SDCR: B = -1.85, LDFR: B = -2.61, LDCR: B = -2.60; p < .001). Seizure history was associated with decreased short-term memory (SDFR: B = -1.32, p = .037; SDCR: B = -1.44, p = .038). Conclusion: The APOE-epsilon 4 allele may confer an increased risk of impairment of 6-month verbal memory for patients suffering mTBI, with implications for heightened surveillance and targeted therapies. Acute intracranial pathology remains the driver of decreased verbal memory performance at 6 months after mTBI.	[Yue, John K.; Robinson, Caitlin K.; Burke, John F.; Winkler, Ethan A.; Deng, Hansen; Ferguson, Adam R.; Sorani, Marco D.; Sharma, Sourabh; Nielson, Jessica L.; Satris, Gabriela G.; Tarapore, Phiroz E.; Yuh, Esther L.; Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Yue, John K.; Robinson, Caitlin K.; Burke, John F.; Winkler, Ethan A.; Deng, Hansen; Ferguson, Adam R.; Sorani, Marco D.; Nielson, Jessica L.; Satris, Gabriela G.; Tarapore, Phiroz E.; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Cnossen, Maryse C.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Rosand, Jonathan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Rosand, Jonathan] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sharma, Sourabh] Loyola Univ, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA; [Talbott, Jason F.; Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Korley, Frederick K.] Univ Michigan Ann Arbor, Dept Emergency Med, Ann Arbor, MI USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Gainesville, FL USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Gainesville, FL USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA	Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	manleyg@neurosurg.ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Nielson, Jessica/0000-0002-3677-3959; Ferguson, Adam/0000-0001-7102-1608; Burke, John/0000-0002-6190-5116; Wang, Kevin/0000-0002-9343-6473	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US DODUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03; US DOD W81XWH-13-1-0441, US DOD W81XWH-14-2-0176 (to G. T. M.)	Albert SM, 1999, AM J PUBLIC HEALTH, V89, P95, DOI 10.2105/AJPH.89.1.95; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Berl MM, 2005, NEUROLOGY, V65, P1604, DOI 10.1212/01.wnl.0000184502.06647.28; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Blake RV, 2000, BRAIN, V123, P472, DOI 10.1093/brain/123.3.472; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Davis JJ, 2016, ARCH CLIN NEUROPSYCH, V31, P802, DOI 10.1093/arclin/acw058; Delis DC, 2000, CALIFORNIA VERBAL LE; Dotson VM, 2009, J INT NEUROPSYCH SOC, V15, P580, DOI 10.1017/S1355617709090821; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Fagan AM, 2000, MICROSC RES TECHNIQ, V50, P297, DOI 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gasquoine PG, 2009, NEUROPSYCHOL REV, V19, P250, DOI 10.1007/s11065-009-9090-5; Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Grocott HP, 2001, J THORAC CARDIOV SUR, V122, P622, DOI 10.1067/mtc.2001.115152; Gu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123743; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hanks RA, 2016, CLIN NEUROPSYCHOL, V30, P1074, DOI 10.1080/13854046.2016.1194479; Hauser PS, 2013, CURR ALZHEIMER RES, V10, P809; Howell DC., 2013, STAT METHODS PSYCHOL, V8th ed; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kaup AR, 2015, JAMA NEUROL, V72, P340, DOI 10.1001/jamaneurol.2014.3978; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kern S, 2015, AM J EPIDEMIOL, V181, P214, DOI 10.1093/aje/kwu442; Kerr ME, 1999, ADV EXP MED BIOL, V471, P117; Lange KL, 2002, J INT NEUROPSYCH SOC, V8, P943, DOI 10.1017/S1355617702870096; Lenihan MW, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0541-5; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Paolo AM, 1997, J CLIN EXP NEUROPSYC, V19, P220, DOI 10.1080/01688639708403853; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Saito H, 2003, J BIOL CHEM, V278, P40723, DOI 10.1074/jbc.M304814200; Schefft BK, 2008, EPILEPSY BEHAV, V13, P162, DOI 10.1016/j.yebeh.2008.01.012; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Strittmatter WJ, 2002, CURR OPIN LIPIDOL, V13, P119, DOI 10.1097/00041433-200204000-00002; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Treble-Barna A, 2016, J INT NEUROPSYCH SOC, V22, P859, DOI 10.1017/S1355617716000631; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; WIENS AN, 1994, CLIN NEUROPSYCHOL, V8, P75, DOI 10.1080/13854049408401545; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zlatar ZZ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00151	92	16	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	SEP	2017	7	9							e00791	10.1002/brb3.791			13	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FH7KZ	WOS:000411368500022	28948085	DOAJ Gold, Green Published			2021-06-18	
J	Sun, LQ; Zhao, MM; Zhang, JB; Liu, AH; Ji, WJ; Li, YX; Yang, XJ; Wu, ZX				Sun, Liqian; Zhao, Manman; Zhang, Jingbo; Liu, Aihua; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue			MiR-144 promotes beta-amyloid accumulation-induced cognitive impairments by targeting ADAM10 following traumatic brain injury	ONCOTARGET			English	Article						miR-144; ADAM10; TBI; cognitive impairment; beta-amyloid	NEURONIC AUTOPHAGY; MICRORNAS; EXPRESSION; HIPPOCAMPUS; ACTIVATION; DISINTEGRIN; ASTROCYTES; RESPONSES	The dysregulation expression of microRNAs (miRNAs) including miR-144, has been widely documented in TBI. However, little is known about the potential roles of miR-144 in the pathogenesis of TBI. In this study, we investigated the potential effects of miR-144 on cognitive function in vivo and in vitro. The results indicated that inhibition of miR-144 conferred a better neurological outcome after TBI in vivo, as evidenced by reduced lesion volume, alleviated brain edema and increased mNSS, of particular importance, improved cognitive deficits. In vitro, miR-144 knockdown protected neuron against Glu-induced injury, by enhancing cell viability, suppressing LDH release and caspase-3 activity, and reducing cognitive-related proteins levels. However, overexpression of miR-144 in vivo and in vitro showed the opposite effects. To further explore the molecular mechanisms underlying miR-144-induced cognitive dysfunctions, we found a significant inverse correlation between miR-144 and ADAM10 expression. Moreover, the direct interaction between miR-144 and ADAM10 3'-UTR was identified by dual-luciferase reporter assay. Also, we found miR-144 negatively regulated ADAM10 protein expression. Additionally, ADAM10 could modulate beta-amyloid formation involved in cognitive deficits. Notably, ADAM10 knockdown by siRNA apparently abrogated miR-144 inhibitor-mediated neuroprotection. Taken together, these findings demonstrated that elevated miR-144 promoted cognitive impairments induced by beta-amyloid accumulation post-TBI through suppressing of ADAM10 expression.	[Sun, Liqian; Zhang, Jingbo; Liu, Aihua; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China; [Sun, Liqian; Zhang, Jingbo; Liu, Aihua; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Zhao, Manman] North China Univ Sci & Technol, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Peoples R China	Sun, LQ (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China.	slq20000@126.com		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672481]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M580117]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2015ZZ-49, 2016ZZ-38]	This work was supported by a grant from the National Natural Science Foundation of China (No. 81672481), the China Postdoctoral Science Foundation (No. 2015M580117), and the Project supported by Beijing Postdoctoral Research Foundation (No. 2015ZZ-49 and No. 2016ZZ-38).	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Anuj S, 2014, PLOS ONE, V9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cai H, 2015, ONCOTARGET, V6, P19759, DOI 10.18632/oncotarget.4331; Chen RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050957; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; Codocedo JF, 2016, MOL NEUROBIOL, V53, P2320, DOI 10.1007/s12035-015-9201-7; Cohen SM, 2009, NAT METHODS, V6, P873, DOI 10.1038/nmeth1209-873; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng G, 2015, TUMOR BIOL, P1; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatson J, 2012, CIRCULATION, V2795; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gizem D, 2014, CELL, V158, P959; Goedeke L, 2014, NEUROBIOL DIS, V72, P48, DOI 10.1016/j.nbd.2014.05.034; Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Kannangara TS, 2015, CEREB CORTEX, V25, P2102, DOI 10.1093/cercor/bhu017; Kapai NA, 2012, CELL MOL NEUROBIOL, V32, P219, DOI 10.1007/s10571-011-9751-9; Kim KM, 2013, BIOMATERIALS, V34, P2694, DOI 10.1016/j.biomaterials.2013.01.012; Kosik KS, 2010, CELL, V143, P21, DOI 10.1016/j.cell.2010.09.008; Kumar A, 2013, J NEUROSCI, V33, P15710, DOI 10.1523/JNEUROSCI.2176-13.2013; Lan FM, 2015, J NEUROCHEM, V135, P274, DOI 10.1111/jnc.13272; Lee ST, 2011, J MOV DISORD, V4, P55, DOI 10.14802/jmd.11011; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li WG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-55; Liang L, 2014, PLOS ONE, V9; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Nicholls RE, 2016, P NATL ACAD SCI USA, V113, P3347, DOI 10.1073/pnas.1521018113; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Rahn KA, 2012, CURR MED CHEM, V19, P1335; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sachser RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22771; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sun E, 2015, EXP NEUROL, V268, P46, DOI 10.1016/j.expneurol.2014.08.005; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Tian-Hao B, 2014, J MOL NEUROSCI, V54, P1; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Yu D, 2014, J MOL NEUROSCI, V53, P242, DOI 10.1007/s12031-014-0293-8; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang X, 2013, J NANOMATER, V2013, P1, DOI DOI 10.1155/2013/803150	63	16	16	1	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	AUG 29	2017	8	35					59181	59203		10.18632/oncotarget.19469			23	Oncology; Cell Biology	Oncology; Cell Biology	FF4RD	WOS:000408941900103	28938628	Green Published, Other Gold			2021-06-18	
J	Lawrence, TP; Pretorius, PM; Ezra, M; Cadoux-Hudson, T; Voets, NL				Lawrence, Tim P.; Pretorius, Pieter M.; Ezra, Martyn; Cadoux-Hudson, Tom; Voets, Natalie L.			Early detection of cerebral microbleeds following traumatic brain injury using MRI in the hyper-acute phase	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Traumatic cerebral microbleeds; Susceptibility weighted imaging; Hyper-acute	DIFFUSE AXONAL INJURY; HEAD-INJURY; HYPOTENSION; CHILDREN; LESIONS	Background: Traumatic brain injury (TBI) is a leading cause of death and disability in people under 45. Advanced imaging techniques to identify injury and classify severity in the first few hours and days following trauma could improve patient stratification and aid clinical decision making. Traumatic cerebral microbleeds (TCMBs), detectable on magnetic resonance susceptibility weighted imaging (SWI), can be used as markers of long-term clinical outcome. However, the relationship between TCMBs and injury severity in the first few hours after injury, and their natural evolution, is unknown. Methods: We obtained SWI scans in 10 healthy controls, and 13 patients scanned 3-24 h following TBI and again at 7-15 days. TCMBs were identified and total volume quantified for every lesion in each scan. Results: TCMBs were present in 6 patients, all with more severe injury classified by GCS. No lesions were identified in patients with an initial GCS of 15. Improvement in GCS in the first 15 days following injury was significantly associated with a reduction in microbleed volume over the same time-period. Conclusion: MRI is feasible in severely injured patients in the first 24 h after trauma. Detection of TCMBs using SWI provides an objective early marker of injury severity following trauma. TCMBs revealed in this time frame, offer the potential to help determine the degree of injury, improving stratification, in order to identify patients who require admission to hospital, transfer to a specialist center, or an extended period of intubation on intensive care. (C) 2017 The Authors. Published by Elsevier Ireland Ltd.	[Lawrence, Tim P.; Ezra, Martyn; Voets, Natalie L.] Univ Oxford, NDCN, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford, England; [Lawrence, Tim P.; Cadoux-Hudson, Tom; Voets, Natalie L.] Oxford Univ Hosp NHS Fdn Trust, Dept Neurosurg, Oxford, England; [Pretorius, Pieter M.] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford, England	Lawrence, TP (corresponding author), John Radcliffe Hosp, Dept Neurosurg, Level 3 West Wing, Oxford OX3 9DU, England.	Tim.lawrence@ndcn.ox.ac.uk; Pieter.pretorius@ouh.nhs.uk; Martyn.ezra@ndcn.ox.ac.uk; Thomas.cadoux-hudson@ndm.ox.ac.uk; Natalie.voets@ndcn.ox.ac.uk			NIHR Biomedical Research Centre, based at Oxford University Hospitals Trust, Oxford; Wellcome TrustWellcome TrustEuropean Commission [203139/Z/16/Z]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0900806] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2012-13-005] Funding Source: researchfish	Supported by the NIHR Biomedical Research Centre, based at Oxford University Hospitals Trust, Oxford. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This work was supported by core funding from the Wellcome Trust [203139/Z/16/Z].	Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Fazlollahi A, 2015, COMPUT MED IMAG GRAP, V46, P269, DOI 10.1016/j.compmedimag.2015.10.001; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; National Institute for Health and Clinical Excellence (NICE), 2014, HEAD INJ ASS EARL MA; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; Watanabe J, 2016, ACTA NEUROCHIR, V158, P1247, DOI 10.1007/s00701-016-2805-5	23	16	16	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 10	2017	655						143	150		10.1016/j.neulet.2017.06.046			8	Neurosciences	Neurosciences & Neurology	FD6UK	WOS:000407663200022	28663054	Other Gold, Green Published			2021-06-18	
J	Hoffer, ME; Balaban, C; Szczupak, M; Buskirk, J; Snapp, H; Crawford, J; Wise, S; Murphy, S; Marshall, K; Pelusso, C; Knowles, S; Kiderman, A				Hoffer, Michael E.; Balaban, Carey; Szczupak, Mikhaylo; Buskirk, James; Snapp, Hillary; Crawford, James; Wise, Sean; Murphy, Sara; Marshall, Kathryn; Pelusso, Constanza; Knowles, Sean; Kiderman, Alex			The use of oculomotor, vestibular, and reaction time tests to assess mild traumatic brain injury (mTBI) over time	LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY			English	Article						mTBI; Concussion; Vestibular Disorders; Point of Injury Testing	UNITED-STATES; CONCUSSION; VISITS; SPORTS	ObjectivesThe objective of this work is to examine the outcomes of a set of objective measures for evaluating individuals with minor traumatic brain injury (mTBI) over the sub-acute time period. These methods involve tests of oculomotor, vestibular, and reaction time functions. This work expands upon published work examining these test results at the time of presentation. Study DesignThis study is a prospective age- and sex-matched controlled study. Materials and MethodsThe subject group was composed of 106 individuals with mTBI and 300 age- and sex-matched controls without a history of mTBI. All individuals agreeing to participate in the study underwent a battery of oculomotor, vestibular, and reaction time tests (OVRT). Those subjects with mTBI underwent these tests at presentation (within 6 days of injury) and 1 and 2weeks post injury. These outcomes were compared to each other over time as well as to results from the controls that underwent 1 test session. ResultsSix measures from 5 tests can classify the control and mTBI during Session 1 with a true positive rate (sensitivity) of 84.9% and true negative rate (specificity) of 97.0%. Patterns of abnormalities changed over time in the mTBI group and overall normalized in a subset of individuals at the third (final) testing session. ConclusionsWe describe an objective and effective second generation testing algorithm for diagnosing and following the prognosis of mTBI/concussion. This testing paradigm will allow investigators to institute better treatments and provide more accurate return to activity advice. Level of Evidence3	[Hoffer, Michael E.; Szczupak, Mikhaylo; Buskirk, James; Snapp, Hillary; Murphy, Sara; Pelusso, Constanza; Knowles, Sean] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Hoffer, Michael E.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Hoffer, Michael E.; Szczupak, Mikhaylo; Buskirk, James; Pelusso, Constanza] Univ Miami, Sports Performance & Wellness Inst, Miami, FL USA; [Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Crawford, James; Marshall, Kathryn] Madigan Army Med Ctr, Dept Otolaryngol, Tacoma, WA 98431 USA; [Wise, Sean; Murphy, Sara] Naval Med Ctr, San Diego, CA USA; [Kiderman, Alex] Neurokinetics Inc, Pittsburgh, PA USA	Hoffer, ME (corresponding author), Otolaryngol Dept, 1120 NW 14th St,5th Floor, Miami, FL 33136 USA.	michael.hoffer@miami.edu	Buskirk, James/ABF-8288-2020; Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Hoffer, Michael/0000-0002-5574-4387; Szczupak, Mikhaylo/0000-0002-2569-2184			Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffer ME, 2016, PLOS ONE, V11; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hosek B, 2011, DEPLOYMENT IRAQ AFGH; Kerr Zachary Y, 2014, N C Med J, V75, P8; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Olson D, 2013, CURR SPORT MED REP, V12, P381, DOI 10.1249/JSR.0000000000000015; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	17	16	17	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2378-8038			LARYNGOSCOPE INVEST	Laryngoscope Investig. Otol.	AUG	2017	2	4					157	165		10.1002/lio2.74			9	Otorhinolaryngology	Otorhinolaryngology	FE0WY	WOS:000407941600003	28894835	DOAJ Gold, Green Published			2021-06-18	
J	Juengst, SB; Switzer, G; Oh, BM; Arenth, PM; Wagner, AK				Juengst, Shannon B.; Switzer, Galen; Oh, Byung Mo; Arenth, Patricia M.; Wagner, Amy K.			Conceptual model and cluster analysis of behavioral symptoms in two cohorts of adults with traumatic brain injuries	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Behavioral symptoms; Brain injuries; Emotions; Cluster analysis; Cognition	SEVERE TBI; COPING STRATEGIES; NEGATIVE AFFECT; SCALE FRSBE; DEPRESSION; VALIDITY; MODERATE; ASSOCIATIONS; PREDICTORS; PANAS	Introduction. Behavioral changes often occur after moderate-to-severe traumatic brain injury (TBI) and can lead to poor health, psychosocial functioning, and quality of life. Challenges in evaluating these behaviors often result from the complexity and variability in the way they are conceptualized and defined. We propose and test a conceptual model that is specific to behavioral symptoms after TBI, to serve as a basis for better assessment and treatment. We hypothesized that clusters of individuals, with unique emotional, cognitive, and behavioral characteristics, would emerge that would illustrate this conceptual model. Methods. We conducted model-based cluster analyses in two cohorts, 6-months post-injury (n=79) and >6months post-injury (n=62), of adults with moderate-to-severe TBI to explore the face validity of our conceptual model by evaluating how participants clustered with regard to emotional (Patient Health Questionnaire 9, Positive and Negative Affect Schedule), cognitive (neuropsychological test battery), and frontal behavioral (Frontal Systems Behavior Scale) symptoms. Results. In each cohort, unique clusters of participants emerged that differed significantly with regard to emotional state, cognition, and behavior (ps<.05). Those 6-months post-injury clustered along a general continuum of symptom severity in emotional and behavioral symptom domains, from no impairment to severe impairment. Clusters in the chronic cohort (>6months) demonstrated a more complex pattern of symptoms; the most severe behavioral symptoms occurred in the context of severe emotional symptoms, even in the absence of cognitive impairment. However, problematic behavioral symptoms were also present in the context of severe cognitive impairment, even in the absence of emotional symptoms. Conclusions. Emotional, cognitive, and behavioral characteristics were represented as expected, based on the proposed conceptual model of behavior. This conceptual model provides the basis for evaluating behavioral changes after moderate-to-severe TBI and identifying modifiable targets and relevant subpopulations for behavioral intervention, with the goal of improved evidence-based personalized medicine for this population.	[Juengst, Shannon B.; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Switzer, Galen] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Switzer, Galen] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Oh, Byung Mo] Seoul Natl Univ Hosp, Dept Rehabil, Seoul, South Korea; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA	Juengst, SB (corresponding author), CRC Kaufmann Med Bldg,Suite 202,3471 Fifth Ave, Pittsburgh, PA 15213 USA.	sbj7@pitt.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon/0000-0003-4709-545X	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0041]; National Science FoundationNational Science Foundation (NSF) [DGE-0549352]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-071-0701]; University of Pittsburgh School of Health and Rehabilitation Sciences Research Development Fund	This work was supported by the Centers for Disease Control and Prevention [Grant Number R49 CCR 323155]; National Institute on Disability, Independent Living, and Rehabilitation Research [Grant Number 90DP0041]; the National Science Foundation [Grant Number DGE-0549352]; the U.S. Department of Defense [Grant Number W81XWH-071-0701], and by the University of Pittsburgh School of Health and Rehabilitation Sciences Research Development Fund.	Ahlquist JS, 2012, POLIT ANAL, V20, P92, DOI 10.1093/pan/mpr039; American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Duclot F, 2015, J EXP BIOL, V218, P21, DOI 10.1242/jeb.107086; Failla M. D., 2015, NEUROREHABILITATION, DOI [10.1177/1545968315600525, DOI 10.1177/1545968315600525]; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Finset A, 2000, BRAIN INJURY, V14, P887; Fonseca JRS, 2007, INTELL DATA ANAL, V11, P155, DOI 10.3233/IDA-2007-11204; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Fraley C., 2012, 597 U WASH; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gray E.K., 2001, EMOTIONS WORK THEORY, P21; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Juengst S, 2014, ARCH PHYS MED REHAB, V95, pE71, DOI [10.1016/j.apmr.2014.07.227, DOI 10.1016/J.APMR.2014.07.227]; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Markos SM, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000224; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; Nievergelt CM, 2015, PSYCHONEUROENDOCRINO, V51, P459, DOI 10.1016/j.psyneuen.2014.10.017; Pett M., 2003, MAKING SENSE FACTOR; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Singh-Taylor A, 2015, NEUROBIOL STRESS, V1, P109, DOI 10.1016/j.ynstr.2014.10.007; TEASDALE G, 1974, LANCET, V2, P81; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Wagner AK, 2012, BRAIN INJURY, V26, P1658, DOI 10.3109/02699052.2012.700089; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	45	16	16	0	25	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	2017	39	6					513	524		10.1080/13803395.2016.1240758			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	ES7QM	WOS:000399745400001	27750469				2021-06-18	
J	Nishijima, DK; Gaona, SD; Waechter, T; Maloney, R; Bair, T; Blitz, A; Elms, AR; Farrales, RD; Howard, C; Montoya, J; Bell, JM; Faul, M; Vinson, DR; Garzon, H; Holmes, JF; Ballard, DW				Nishijima, Daniel K.; Gaona, Samuel D.; Waechter, Trent; Maloney, Ric; Bair, Troy; Blitz, Adam; Elms, Andrew R.; Farrales, Roel D.; Howard, Calvin; Montoya, James; Bell, Jeneita M.; Faul, Mark; Vinson, David R.; Garzon, Hernando; Holmes, James F.; Ballard, Dustin W.		Sacramento County Prehosp Res	Out-of-Hospital Triage of Older Adults With Head Injury: A Retrospective Study of the Effect of Adding "Anticoagulation or Antiplatelet Medication Use" as a Criterion	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	National Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY 10-13, 2016	New Orleans, LA	Soc Acad Emergency Med			TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; STATISTICAL-METHODS; PREINJURY WARFARIN; STANDARD; OUTCOMES; IMPACT; CARE; REHABILITATION; MANAGEMENT	Study objective: Field triage guidelines recommend that emergency medical services (EMS) providers consider transport of head-injured older adults with anticoagulation use to trauma centers. However, the triage patterns and the incidence of intracranial hemorrhage or neurosurgery in these patients are unknown. Our objective is to describe the characteristics and outcomes of older adults with head trauma who are transported by EMS, particularly for patients who do not meet physiologic, anatomic, or mechanism-of-injury (steps 1 to 3) field triage criteria but are receiving anticoagulant or antiplatelet medications. Methods: This was a retrospective study at 5 EMS agencies and 11 hospitals (4 trauma centers, 7 nontrauma centers). Patients aged 55 years or older with head trauma who were transported by EMS were included. The primary outcome was the presence of intracranial hemorrhage. The secondary outcome was a composite measure of inhospital death or neurosurgery. Results: Of the 2,110 patients included, 131 (6%) had intracranial hemorrhage and 41 (2%) had inhospital death or neurosurgery. There were 162 patients (8%) with steps 1 to 3 criteria. Of the remaining 1,948 patients without steps 1 to 3 criteria, 566 (29%) had anticoagulant or antiplatelet use. Of these patients, 52 (9%) had traumatic intracranial hemorrhage and 15 (3%) died or had neurosurgery. The sensitivity (adjusted for clustering by EMS agency) of steps 1 to 3 criteria was 19.8% (26/131; 95% confidence interval [CI] 5.5% to 51.2%) for identifying traumatic intracranial hemorrhage and 34.1% (14/41; 95% CI 9.9% to 70.1%) for death or neurosurgery. The additional criterion of anticoagulant or antiplatelet use improved the sensitivity for intracranial hemorrhage (78/131; 59.5%; 95% CI 42.9% to 74.2%) and death or neurosurgery (29/41; 70.7%; 95% CI 61.0% to 78.9%). Conclusion: Relatively few patients met steps 1 to 3 triage criteria. For individuals who did not have steps 1 to 3 criteria, nearly 30% had anticoagulant or antiplatelet use. A relatively high proportion of these patients had intracranial hemorrhage, but a much smaller proportion died or had neurosurgery during hospitalization. Use of steps 1 to 3 triage criteria alone is not sufficient in identifying intracranial hemorrhage and death or neurosurgery in this patient population. The additional criterion of anticoagulant or antiplatelet use improves the sensitivity of the instrument, with only a modest decrease in specificity.	[Nishijima, Daniel K.; Gaona, Samuel D.; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Waechter, Trent] City Sacramento Fire Dept, Sacramento, CA USA; [Maloney, Ric] Sacramento Metropolitan Fire Dept, Sacramento, CA USA; [Bair, Troy] Cosumnes Community Serv, Dist Fire Dept, Elk Grove, CA USA; [Blitz, Adam] Amer Med Response, Sacramento, CA USA; [Elms, Andrew R.] Kaiser Permanente South Sacramento Med Ctr, Sacramento, CA USA; [Farrales, Roel D.] Mercy Gen Hosp, Sacramento, CA USA; [Howard, Calvin] City Folsom Fire Dept, Folsom, CA USA; [Montoya, James] Sutter Community Hosp, Sacramento, CA USA; [Bell, Jeneita M.; Faul, Mark] Ctr Dis Control & Prevent, Atlanta, GA USA; [Vinson, David R.; Garzon, Hernando] Kaiser Permanente Sacramento Med Ctr, Sacramento, CA USA; [Ballard, Dustin W.] Kaiser Permanente San Rafael Med Ctr, San Rafael, CA USA	Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu	Vinson, David R/AAK-3227-2020	Vinson, David R/0000-0001-6559-1858; Faul, Mark/0000-0002-7683-0348	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177]; Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001860, KL2TR000134, UL1TR000002] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177] Funding Source: NIH RePORTER	Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. This work was funded by the Centers for Disease Control and Prevention (CDC), grant U01CE002177. Dr. Nishijima was supported through a Mentored Clinical Research Training Program Award (grant UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	American Trauma Society, TRAUM CTR LEV EXPL; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; California EMS Authority, RETR REG NETW WORKGR; Caterino JM, 2016, J AM GERIATR SOC, V64, P1944, DOI 10.1111/jgs.14376; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hill AD, J TRAUMA; Jakobsson U, 2005, SCAND J CARING SCI, V19, P427, DOI 10.1111/j.1471-6712.2005.00368.x; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Lerner EB, 2014, J TRAUMA ACUTE CARE, V76, P1157, DOI 10.1097/TA.0000000000000189; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Miller SL, 2008, ANN EMERG MED, V52, P483, DOI 10.1016/j.annemergmed.2008.03.021; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Newgard CD, 2012, J TRAUMA ACUTE CARE, V72, P1239, DOI 10.1097/TA.0b013e3182468b51; Newgard CD, 2011, J TRAUMA, V70, P1345, DOI 10.1097/TA.0b013e3182191a1b; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Nishijima DK, 2016, PREHOSP EMERG CARE; Patel PA, 2015, CIRC-CARDIOVASC QUAL, V8, P383, DOI 10.1161/CIRCOUTCOMES.114.000907; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Platts-Mills TF, 2016, J AM GERIATR SOC, V64, P1941, DOI 10.1111/jgs.14405; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Starke RM, 2015, NEUROSURGERY, V77, pN11, DOI 10.1227/01.neu.0000473806.53232.3e; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Thibault N., 2016, AM J THER; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Viera AJ, 2005, FAM MED, V37, P360; Wears RL, 2002, ACAD EMERG MED, V9, P330, DOI 10.1111/j.1553-2712.2002.tb01332.x; Willenbring BD, 2016, PREHOSP EMERG CARE, V20, P1, DOI 10.3109/10903127.2015.1056896; Yasuda CL, 2003, ARQ NEURO-PSIQUIAT, V61, P1011, DOI 10.1590/S0004-282X2003000600023	50	16	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	AUG	2017	70	2					127	138		10.1016/j.annemergmed.2016.12.018			12	Emergency Medicine	Emergency Medicine	FD1OI	WOS:000407306200002	28238499	Green Accepted, Bronze			2021-06-18	
J	Guo, S; Zhou, D; Zhang, M; Li, TJ; Liu, YJ; Xu, YP; Chen, TJ; Li, ZL				Guo, Shuai; Zhou, Dan; Zhang, Mo; Li, Tiejun; Liu, Yujie; Xu, Yupin; Chen, Tianjing; Li, Zhili			Monitoring changes of docosahexaenoic acid-containing lipids during the recovery process of traumatic brain injury in rat using mass spectrometry imaging	SCIENTIFIC REPORTS			English	Article							DESORPTION ELECTROSPRAY-IONIZATION; SPRAY IONIZATION; FATTY-ACIDS; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; ENCEPHALOPATHY; EPIDEMIOLOGY; METABOLITES; COMPLEXES; PHASE	Brain lipid homoeostasis is critical during recovery process after traumatic brain injury (TBI). In this study, we integrated liquid extraction and electrosonic spray ionization technology to develop an ionization device coupled with a Fourier transform ion cyclotron resonance mass spectrometer for imaging of docosahexaenoic acid (DHA)-containing lipids on rat brain tissues. The ion images of the brain tissue sections from the normal rats and the rats after TBI at acute phase (0 and 1 day) and chronic phase (3, 5, and 7 days) were obtained. The imaging results indicate that the levels of DHA and lysophosphatidylethanolamine (22:6) in the injury area of TBI rats increased significantly at the acute phase and subsequently decreased at the chronic phase. But the levels of DHA-containing phospholipids including phosphatidylethanolamine (PE)(P-18:0/22:6), PE(18:0/22:6), and phosphatidylserine (18:0/22:6) decreased at the acute phase and gradually increased at the chronic phase in the injury area accompanied by the morphogenesis and wound healing. These findings indicate that the DHA may participate in the recovery process of brain injury. This is the first report to in situ detect the changes in the levels of DHA and DHA-containing lipids in the TBI model.	[Guo, Shuai; Zhou, Dan; Zhang, Mo; Liu, Yujie; Xu, Yupin; Chen, Tianjing; Li, Zhili] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Beijing, Peoples R China; [Guo, Shuai; Zhou, Dan; Zhang, Mo; Liu, Yujie; Xu, Yupin; Chen, Tianjing; Li, Zhili] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Li, Tiejun] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Li, ZL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Beijing, Peoples R China.; Li, ZL (corresponding author), Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China.	lizhili@ibms.pumc.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91542101]	This study was funded by the National Natural Science Foundation of China (Grant No. 91542101) to Z.Li.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Chen SM, 2015, NAT NANOTECHNOL, V10, P176, DOI [10.1038/NNANO.2014.282, 10.1038/nnano.2014.282]; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Guo S, 2015, ANAL CHEM, V87, P5860, DOI 10.1021/ac504761t; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Guo S, 2014, ANAL BIOANAL CHEM, V406, P4357, DOI 10.1007/s00216-014-7846-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Hanrieder J, 2013, ACS CHEM NEUROSCI, V4, P666, DOI 10.1021/cn400053c; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Heijs B, 2015, ANAL CHEM, V87, P11978, DOI 10.1021/acs.analchem.5b03610; Ifa DR, 2010, ANALYST, V135, P669, DOI 10.1039/b925257f; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Lanekoff I, 2012, ANAL CHEM, V84, P8351, DOI 10.1021/ac301909a; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laskin J, 2016, ANAL CHEM, V88, P52, DOI 10.1021/acs.analchem.5b04188; Laskin J, 2012, ANAL CHEM, V84, P141, DOI 10.1021/ac2021322; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Nefliu M, 2006, CHEM COMMUN, P888, DOI 10.1039/b514057a; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pan N, 2014, ANAL CHEM, V86, P9376, DOI 10.1021/ac5029038; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Shariatgorji M, 2014, NEUROPSYCHOPHARMACOL, V39, P34, DOI 10.1038/npp.2013.215; Singh Meharban, 2005, Indian Journal of Pediatrics, V72, P239, DOI 10.1007/BF02859265; Soltwisch J, 2015, SCIENCE, V348, P211, DOI 10.1126/science.aaa1051; Takats Z, 2004, ANAL CHEM, V76, P4050, DOI 10.1021/ac049848m; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Van Berkel GJ, 2008, J MASS SPECTROM, V43, P500, DOI 10.1002/jms.1340; van Hove ERA, 2010, J CHROMATOGR A, V1217, P3946, DOI 10.1016/j.chroma.2010.01.033; Wang XD, 2015, CHEM SCI, V6, P729, DOI 10.1039/c4sc01850h; Wiseman JM, 2005, ANGEW CHEM INT EDIT, V44, P913, DOI 10.1002/anie.200461672; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu CP, 2013, MASS SPECTROM REV, V32, P218, DOI 10.1002/mas.21360; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	49	16	16	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 11	2017	7								5054	10.1038/s41598-017-05446-2			9	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1BI	WOS:000405172600021	28698592	DOAJ Gold, Green Published			2021-06-18	
J	Abreu, V; Vaz, R; Rebelo, V; Rosas, MJ; Chamadoira, C; Gillies, MJ; Aziz, TZ; Pereira, EAC				Abreu, Vasco; Vaz, Rui; Rebelo, Virginia; Rosas, Maria Jose; Chamadoira, Clara; Gillies, Martin J.; Aziz, Tipu Z.; Pereira, Erlick A. C.			Thalamic Deep Brain Stimulation for Neuropathic Pain: Efficacy at Three Years' Follow-Up	NEUROMODULATION			English	Article						Amputation; brachial plexus injury; Brief Pain Inventory; deep brain stimulation; neuropathic pain; SF-36; ventral posterolateral thalamus; visual analog scale; University of Washington Neuropathic Pain Score	MOTOR CORTEX STIMULATION; ROOT ENTRY ZONE; BRACHIAL-PLEXUS AVULSION; CHRONIC NONCANCER PAIN; LONG-TERM OUTCOMES; INTRACTABLE PAIN; SPINAL-CORD; ELECTRICAL-STIMULATION; PRIMARY-CARE; NEUROSTIMULATION	ObjectChronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a serious burden to society. Deep Brain Stimulation (DBS) is already established for movement disorders and also used to treat some off-label conditions. However, DBS for the treatment of chronic, drug refractory, neuropathic pain, has shown variable outcomes with few studies performed in the last decade. Thus, this procedure has consensus approval in parts of Europe but not the USA. This study prospectively evaluated the efficacy at three years of DBS for neuropathic pain. MethodsSixteen consecutive patients received 36 months post-surgical follow-up in a single-center. Six had phantom limb pain after amputation and ten deafferentation pain after brachial plexus injury, all due to traumas. To evaluate the efficacy of DBS, patient-reported outcome measures were collated before and after surgery, using a visual analog scale (VAS) score, University of Washington Neuropathic Pain Score (UWNPS), Brief Pain Inventory (BPI), and 36-Item Short-Form Health Survey (SF-36). ResultsContralateral, ventroposterolateral sensory thalamic DBS was performed in sixteen patients with chronic neuropathic pain over 29 months. A postoperative trial of externalized DBS failed in one patient with brachial plexus injury. Fifteen patients proceeded to implantation but one patient with phantom limb pain after amputation was lost for follow-up after 12 months. No surgical complications or stimulation side effects were noted. After 36 months, mean pain relief was sustained, and the median (and interquartile range) of the improvement of VAS score was 52.8% (45.4%) (p=0.00021), UWNPS was 30.7% (49.2%) (p=0.0590), BPI was 55.0% (32.0%) (p=0.00737), and SF-36 was 16.3% (30.3%) (p=0.4754). ConclusionsDBS demonstrated efficacy at three years for chronic neuropathic pain after traumatic amputation and brachial plexus injury, with benefits sustained across all pain outcomes measures and slightly greater improvement in phantom limb pain.	[Abreu, Vasco; Vaz, Rui; Chamadoira, Clara] Univ Porto, Fac Med, Oporto, Portugal; [Vaz, Rui; Chamadoira, Clara; Aziz, Tipu Z.; Pereira, Erlick A. C.] Hosp Sao Joao, Dept Neurocirugia, Oporto, Portugal; [Vaz, Rui; Rosas, Maria Jose] Ctr Neurosci CUF Porto, Oporto, Portugal; [Rebelo, Virginia] Hosp Sao Joao, Dept Psicol, Oporto, Portugal; [Rosas, Maria Jose] Hosp Sao Joao, Dept Neurol, Oporto, Portugal; [Gillies, Martin J.; Aziz, Tipu Z.] Oxford Univ Hosp, Dept Neurosurg, Oxford, England; [Gillies, Martin J.; Aziz, Tipu Z.] Oxford Univ Hosp, Nuffield Dept Surg, Oxford, England; [Pereira, Erlick A. C.] St Georges Univ London, Acad Neurosurg Unit, London, England	Abreu, V (corresponding author), Univ Porto, Fac Med Neurosurg, P-4200319 Oporto, Portugal.	vrlsa1993@gmail.com	Pereira, Erlick/AAB-5335-2020	Pereira, Erlick/0000-0003-0452-4023; Vaz, Rui/0000-0001-7527-8187; Gillies, Martin/0000-0002-4391-713X	Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-SGCL12-Gillies] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2013-13-001] Funding Source: researchfish		Aichaoui F, 2011, PAIN, V152, P1923, DOI 10.1016/j.pain.2011.03.037; Ali M, 2011, NEUROSURGERY, V68, P1252, DOI 10.1227/NEU.0b013e31820c04a9; Ashburn MA, 1999, LANCET, V353, P1865, DOI 10.1016/S0140-6736(99)04088-X; Boccard SGJ, 2013, NEUROSURGERY, V72, P221, DOI 10.1227/NEU.0b013e31827b97d6; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Coffey RJ, 2001, PAIN MED, V2, P183, DOI 10.1046/j.1526-4637.2001.01029.x; Coffey RJ, 2006, J NEUROSURG, V105, P175, DOI 10.3171/jns.2006.105.2.175; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; FRIEDMAN AH, 1988, NEUROSURGERY, V22, P369, DOI 10.1227/00006123-198802000-00016; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Green AL, 2006, CEPHALALGIA, V26, P561, DOI 10.1111/j.1468-2982.2005.01068.x; Green AL, 2004, NEUROMODULATION, V7, P76, DOI 10.1111/j.1094-7159.2004.04010.x; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Gybels J.M., 1989, PHYSL PATHOLOGICAL M, V11; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; HEATH RG, 1954, STUDIES SCHIZOPHRENI; HOSOBUCHI Y, 1977, SCIENCE, V197, P183, DOI 10.1126/science.301658; HOSOBUCHI Y, 1973, ARCH NEUROL-CHICAGO, V29, P158, DOI 10.1001/archneur.1973.00490270040005; HOSOBUCHI Y, 1986, J NEUROSURG, V64, P543, DOI 10.3171/jns.1986.64.4.0543; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Katayama Y, 2001, STEREOT FUNCT NEUROS, V77, P183, DOI 10.1159/000064618; Katayama Y, 2001, STEREOT FUNCT NEUROS, V77, P159, DOI 10.1159/000064593; Kim J, 2015, J KOREAN NEUROSURG S, V57, P6, DOI 10.3340/jkns.2015.57.1.6; Ko AL, 2016, J NEUROSURG, V124, P1470, DOI 10.3171/2015.2.JNS142572; Konrad P, 2014, NEUROSURG CLIN N AM, V25, P699, DOI 10.1016/j.nec.2014.07.010; Kreitler S, 2007, PAIN, V15, P1; Kumar K, 1997, NEUROSURGERY, V40, P736, DOI 10.1097/00006123-199704000-00015; Lefaucheur JP, 2009, BRAIN, V132, P1463, DOI 10.1093/brain/awp035; LEVY RM, 1987, NEUROSURGERY, V21, P885, DOI 10.1227/00006123-198712000-00017; Levy RM, 2003, NEUROSURG CLIN N AM, V14, P389, DOI 10.1016/S1042-3680(03)00036-6; Levy R, 2010, PAIN PHYSICIAN, V13, P157; Marchand S, 2003, PAIN, V105, P481, DOI 10.1016/S0304-3959(03)00265-3; MARK VH, 1965, POSTGRAD MED, V37, P563, DOI 10.1080/00325481.1965.11695514; Mazars G, 1979, ADV PAIN RES THER, V3, P541; NARAKAS A, 1978, CLIN ORTHOP RELAT R, P71; Nizard J, 2012, DISCOV MED, V14, P237; Owen SLF, 2006, PAIN, V120, P202, DOI 10.1016/j.pain.2005.09.035; Papuc E, 2013, ANN AGR ENV MED, P14; PARRY CBW, 1984, NEUROSURGERY, V15, P960; Pereira E.A., 2011, NEUROSTIMULATION TRE, V22, P187; Pereira EAC, 2007, EXPERT REV MED DEVIC, V4, P591, DOI 10.1586/17434440.4.5.591; Pereira EAC, 2014, NEUROTHERAPEUTICS, V11, P496, DOI 10.1007/s13311-014-0278-x; Pereira EAC, 2009, NEUROMODULATION, VOLS 1 AND 2, P499, DOI 10.1016/B978-0-12-374248-3.00039-2; Rasche Dirk, 2006, Neurosurg Focus, V21, pE8; Richardson D E, 1977, Neurosurgery, V1, P199; Rokyta R, 2012, PHYSIOL RES, V61, pS23, DOI 10.33549/physiolres.932392; Sachs AJ, 2014, NEUROMODULATION, V17, P303, DOI 10.1111/ner.12181; Sindou M, 2001, PAIN, V92, P159, DOI 10.1016/S0304-3959(00)00487-5; Sindou MP, 2005, J NEUROSURG, V102, P1018, DOI 10.3171/jns.2005.102.6.1018; Son BC, 2014, STEREOT FUNCT NEUROS, V92, P218, DOI 10.1159/000362933; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Viswanathan A, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.6.FOCUS13236; Wilkinson HA, 1999, NEUROSURGERY, V45, P1129, DOI 10.1097/00006123-199911000-00023; WYNNPARRY CB, 1980, PAIN, V9, P41, DOI 10.1016/0304-3959(80)90027-5; Yamamoto T, 2006, STEREOT FUNCT NEUROS, V84, P180, DOI 10.1159/000094958; Young RF, 1997, NEUROSURGICAL MANAGE, P283	58	16	16	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	JUL	2017	20	5					504	513		10.1111/ner.12620			10	Medicine, Research & Experimental; Clinical Neurology	Research & Experimental Medicine; Neurosciences & Neurology	EZ7AC	WOS:000404870500015	28631870				2021-06-18	
J	Boudreau, RM; Johnson, M; Veile, R; Friend, LA; Goetzman, H; Pritts, TA; Caldwell, CC; Makley, AT; Goodman, MD				Boudreau, Ryan M.; Johnson, Mark; Veile, Rosalie; Friend, Lou Ann; Goetzman, Holly; Pritts, Timothy A.; Caldwell, Charles C.; Makley, Amy T.; Goodman, Michael D.			Impact of tranexamic acid on coagulation and inflammation in murine models of traumatic brain injury and hemorrhage	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Association-for-Academic-Surgery/Society-of-University-Surgeons 12th Annual Meeting of the Academic-Surgical-Congress (ASC)	FEB 07-09, 2017	Las Vegas, NV	Acad Surg Congress, Assoc Acad Surg, Soc Univ Surg			RESUSCITATION; COAGULOPATHY; PARAMETERS	Background: Posttraumatic coagulopathy and inflammation can exacerbate secondary cerebral damage after traumatic brain injury (TBI). Tranexamic acid (TXA) has been shown clinically to reduce mortality in hemorrhaging and head-injured trauma patients and has the potential to mitigate secondary brain injury with its reported antifibrinolytic and antiinflammatory properties. We hypothesized that TXA would improve posttraumatic coagulation and inflammation in a murine model of TBI alone and in a combined injury model of TBI and hemorrhage (TBI/H). Methods: An established murine weight drop model was used to induce a moderate TBI. Mice were administered intraperitoneal injections of 10mg/kg TXA or equivalent volume of saline 10 min after injury. An additional group of mice was subjected to TBI followed by hemorrhagic shock using a pressure-controlled model. TBI/Hmice were given intraperitoneal injections of TXA or saline during resuscitation. Blood was collected at intervals after injury to assess coagulation by rotational thromboelastometry (ROTEM) and inflammation by Multiplex cytokine analysis. Soluble P-selectin, a biomarker of platelet activation, and serumneuron-specific enolase, a biomarker of cerebral injury, were measured at intervals. Brain homogenates were analyzed for inflammatory changes by Multiplex enzyme-linked immunosorbent assay, and splenic tissue was collected for splenic cell population assessment by flow cytometry. Results: There were no coagulation, serum or cerebral cytokine, P-selectin, or neuron-specific enolase differences between mice treated with TXA or saline after TBI. After the addition of hemorrhagic shock and resuscitation to TBI, TXA administration still did not affect coagulation parameters, systemic or cerebral inflammation, or platelet activation, as compared with saline alone. At 24 hours after TBI, mice given TXA demonstrated lower splenic total cell counts central memory CD8, effector CD8, B cell, and increased naive CD4 cell populations. By contrast, TXA did not affect splenic leukocyte populations after combined TBI/H. Conclusions: Despite clinical data suggesting a mortality benefit, TXA did not modulate coagulation, inflammation, or biomarker generation in either the TBI or TBI/H murine models. Administration of TXA after TBI altered splenic leukocyte populations, which may contribute to a change in posttraumatic immune status. Future studies should be done to investigate the role of TXA in the development of posttraumatic immunosuppression and risk of nosocomial infections. (C) 2017 Elsevier Inc. All rights reserved.	[Boudreau, Ryan M.; Johnson, Mark; Veile, Rosalie; Friend, Lou Ann; Goetzman, Holly; Pritts, Timothy A.; Caldwell, Charles C.; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Coll Med, Dept Surg, Div Trauma Crit Care, Cincinnati, OH 45267 USA	Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Div Trauma Crit Care, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	michael.goodman@uc.edu		Goodman, Michael/0000-0001-7218-4855; Caldwell, Charles/0000-0003-1692-4550	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK060444] Funding Source: NIH RePORTER		Bambakidis T, 2016, TRAUMA INDUCED COAGU, P545, DOI DOI 10.1007/978-3-319-28308-1_34; Centers for Disease Control and Prevention, 2014, C REP, P19; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Fiechtner BK, 2001, ANESTH ANALG, V92, P1131; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Gorlinger K, 2016, TRAUMA INDUCED COAGU, P267, DOI 10.1007/978-3-319-28308-1_18; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harvin JA, 2015, J TRAUMA ACUTE CARE, V78, P905, DOI 10.1097/TA.0000000000000612; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hsia TY, 2010, ANN THORAC SURG, V89, P1843, DOI 10.1016/j.athoracsur.2010.02.069; Johnson BL, 2016, SHOCK, V46, P541, DOI 10.1097/SHK.0000000000000648; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Liou DZ, 2016, NEUROCRIT CARE, V25, P145, DOI 10.1007/s12028-015-0223-9; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Makley AT, 2012, J SURG RES, V175, pE75, DOI 10.1016/j.jss.2011.11.1028; Makley AT, 2010, J TRAUMA, V68, P305, DOI 10.1097/TA.0b013e3181cb4472; May S, PREHOSPITAL TRANEXAM; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Paterson HM, 2003, J IMMUNOL, V171, P1473, DOI 10.4049/jimmunol.171.3.1473; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Pfeifer R, 2013, CYTOKINE, V61, P585, DOI 10.1016/j.cyto.2012.10.022; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Roy M, 2017, J SURG RES, V208, P104, DOI 10.1016/j.jss.2016.09.023; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wu X, 2016, SHOCK, V47, P500; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	35	16	16	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2017	215						47	54		10.1016/j.jss.2017.03.031			8	Surgery	Surgery	FA3RZ	WOS:000405363400008	28688660				2021-06-18	
J	Kim, H; Yu, T; Cam-Etoz, B; van Groen, T; Hubbard, WJ; Chaudry, IH				Kim, Harrison; Yu, Tao; Cam-Etoz, Betul; van Groen, Thomas; Hubbard, William J.; Chaudry, Irshad H.			Treatment of traumatic brain injury with 17 alpha-ethinylestradiol-3-sulfate in a rat model	JOURNAL OF NEUROSURGERY			English	Article						TBI; traumatic brain injury; intracranial pressure; T2 mapping; diffusion tensor imaging; positron emission tomography; behavioral test	ORGANS THERAPEUTIC APPROACH; DIFFUSE AXONAL INJURY; ETHINYL ESTRADIOL; ORAL-CONTRACEPTIVES; MU-G; ESTROGEN; PHARMACOKINETICS; PARAMETERS; NEUROPROTECTION; HIPPOCAMPUS	OBJECTIVE 17 alpha-ethynylestradiol-3-sulfate (EE-3-SO4) is a highly water-soluble synthetic estrogen that has an extended half-life (10 hours) over that of naturally occurring estrogen (similar to 10 minutes). In this study, EE-3-SO4 was evaluated in a lateral fluid percussion induced traumatic brain injury (TBI) model in rats. METHODS A total of 9 groups of Sprague-Dawley rats underwent craniectomy. Twenty-four hours later, lateral fluid percussion was applied to 6 groups of animals to induce TBI; the remaining 3 groups served as sham control groups. EE-3-SO4 (1 mg/kg body weight in 0.4 ml/kg body weight) or saline (vehicle control) was injected intravenously 1 hour after TBI; saline was injected in all sham animals. One day after EE-3-SO4/saline injection, intracranial pressure (ICP), cerebral perfusion pressure (CPP), and partial brain oxygen pressure (PbtO(2)) were measured in Groups 1-3 (2 TBI groups and 1 sham group), and brain edema, diffusion axonal injury, and cerebral glycolysis were assessed in Groups 4-6 using MRI T2 mapping, diffusion tensor imaging (DTI), and FDG-PET imaging, respectively. Four days after dosing, the open-field anxiety of animals was assessed in Groups 7-9 by measuring the duration that each animal spent in the center area of an open chamber during 4 minutes of monitoring. RESULTS EE-3-SO4 significantly lowered ICP while raising CPP and PbtO(2), compared with vehicle treatment in TBI-induced animals (p < 0.05). The mean size of cerebral edema of TBI animals treated with EE-3-SO4 was 25 3 mm(3) (mean SE), which was significantly smaller than that of vehicle-treated animals (67 +/- 6 mm(3), p < 0.001). Also, EE-3-SO4 treatment significantly increased the fractional anisotropy of the white matter in the ipsilateral side (p = 0.003) and cerebral glycolysis (p = 0.014). The mean duration that EE-3-SO4 treated animals spent in the center area was 12 +/- 2 seconds, which was significantly longer than that of vehicle-treated animals (4 1 seconds; p = 0.008) but not different from that of sham animals (11 +/- 3 seconds; p > 0.05). CONCLUSIONS These data support the clinical use of EE-3-SO4 for early TBI treatment.	[Kim, Harrison] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Yu, Tao; Hubbard, William J.; Chaudry, Irshad H.] Univ Alabama Birmingham, Dept Surg, VH G094,1670 Univ Blvd, Birmingham, AL 35294 USA; [van Groen, Thomas] Univ Alabama Birmingham, Dept Dev & Integrat Biol, Birmingham, AL USA; [Cam-Etoz, Betul] Uludag Univ, Dept Physiol, Bursa, Turkey	Chaudry, IH (corresponding author), Univ Alabama Birmingham, Dept Surg, VH G094,1670 Univ Blvd, Birmingham, AL 35294 USA.	ichaudry@uab.edu			US Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program of the Department of Defense [W81XWH-08-2-0153]	We thank Dr Ahmar Ayub for inducing TBI in the rats and Dr. Guihua Zhai and Sharon Samuel for data collection and analyses. This study was supported by the US Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program in W81XWH-08-2-0153 of the Department of Defense to I.H.C.	Abrams LS, 2001, J CLIN PHARMACOL, V41, P1301, DOI 10.1177/00912700122012887; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; BACK DJ, 1980, CONTRACEPTION, V21, P145, DOI 10.1016/0010-7824(80)90126-2; Bodanapally UK, 2013, NEURORADIOLOGY, V55, P771, DOI 10.1007/s00234-013-1166-5; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Charlier TD, 2013, J EXP NEUROSCI, V7, P31, DOI 10.4137/JEN.S11268; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DeWitt D S, 1995, New Horiz, V3, P376; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; GOLDZIEHER JW, 1990, AM J OBSTET GYNECOL, V163, P2114, DOI 10.1016/0002-9378(90)90550-Q; GUENGERICH FP, 1990, AM J OBSTET GYNECOL, V163, P2159, DOI 10.1016/0002-9378(90)90557-N; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hubbard W, 2015, J SURG RES, V193, P355, DOI 10.1016/j.jss.2014.06.047; Jick SS, 2006, CONTRACEPTION, V73, P223, DOI 10.1016/j.contraception.2006.01.001; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; JONES GE, 1976, ACTA ENDOCRINOL-COP, V82, P706, DOI 10.1530/acta.0.0820706; JUNGHOFFMANN C, 1991, HORM RES, V36, P238, DOI 10.1159/000182172; Kawasaki T, 2012, J ANESTH, V26, P883, DOI 10.1007/s00540-012-1425-3; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; LINDBERG UB, 1988, MATURITAS, V10, P343, DOI 10.1016/0378-5122(88)90069-2; LINDBERG UB, 1989, THROMB HAEMOSTASIS, V61, P65; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Manthey D, 2006, NEUROSCIENCE, V138, P845, DOI 10.1016/j.neuroscience.2005.10.058; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Miller M, 2014, J TRAUMA ACUTE CARE, V76, P1409, DOI 10.1097/TA.0000000000000237; Morales T, 2011, J NEUROENDOCRINOL, V23, P994, DOI 10.1111/j.1365-2826.2011.02141.x; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Neter J., 1996, APPL LINEAR STAT MOD; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; ORTIZDEMONTELLANO PR, 1980, J BIOL CHEM, V255, P5578; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Santollo J, 2015, FRONT SYST NEUROSCI, V9, DOI [10.3369/fusys.2015.00025, 10.3389/fnsys.2015.00025]; Schindler AE, 2013, INT J ENDOCRINOL MET, V11, P41, DOI 10.5812/ijem.4158; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Shah N, 2012, MOL IMAGING BIOL, V14, P237, DOI 10.1007/s11307-011-0491-5; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, P1; TOFTS PS, 1990, NEURORADIOLOGY, V32, P407, DOI 10.1007/BF00588474; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	51	16	17	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2017	127	1					23	31		10.3171/2016.7.JNS161263			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EY6JB	WOS:000404087500004	27662529				2021-06-18	
J	Lele, AV; Hoefnagel, AL; Schloemerkemper, N; Wyler, DA; Chaikittisilpa, N; Vavilala, MS; Naik, BI; Williams, JH; Raghavan, LV; Koerner, IP				Lele, Abhijit V.; Hoefnagel, Amie L.; Schloemerkemper, Nina; Wyler, David A.; Chaikittisilpa, Nophanan; Vavilala, Monica S.; Naik, Bhiken I.; Williams, James H.; Raghavan, Lakshmikumar Venkat; Koerner, Ines P.			Perioperative Management of Adult Patients With External Ventricular and Lumbar Drains: Guidelines From the Society for Neuroscience in Anesthesiology and Critical Care	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						external ventricular drain; ventriculostomy; lumbar drain; guidelines; perioperative; management; leveling; transport; checklist; competency	CEREBROSPINAL-FLUID DRAINAGE; THORACOABDOMINAL AORTIC-ANEURYSM; TRAUMATIC BRAIN-INJURY; ASSOCIATION/AMERICAN STROKE ASSOCIATION; TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL PERFUSION-PRESSURE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC SUBDURAL-HEMATOMA; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE	External ventricular drains and lumbar drains are commonly used to divert cerebrospinal fluid and to measure cerebrospinal fluid pressure. Although commonly encountered in the perioperative setting and critical for the care of neurosurgical patients, there are no guidelines regarding their management in the perioperative period. To address this gap in the literature, The Society for Neuroscience in Anesthesiology & Critical Care tasked an expert group to generate evidence-based guidelines. The document generated targets clinicians involved in perioperative care of patients with indwelling external ventricular and lumbar drains.	[Lele, Abhijit V.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pain Med,Neurocrit Care Serv, Seattle, WA 98104 USA; [Chaikittisilpa, Nophanan] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pediat, Seattle, WA 98104 USA; [Hoefnagel, Amie L.] Univ Florida, Dept Anesthesiol, UF Hlth, Jacksonville, FL USA; [Schloemerkemper, Nina] Univ Calif Davis, Med Ctr, Dept Anesthesiol & Pain Med, Sacramento, CA 95817 USA; [Wyler, David A.] Thomas Jefferson Univ, Jefferson Hosp Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Naik, Bhiken I.] Univ Virginia Hlth Syst, Dept Anesthesiol & Neurosurg, Charlottesville, VA USA; [Williams, James H.] Univ North Carolina Chapel Hill, Dept Anesthesiol, N2201 UNC Hosp, Chapel Hill, NC USA; [Raghavan, Lakshmikumar Venkat] Toronto Western Hosp, Dept Anesthesia & Pain Med, Toronto, ON, Canada; [Koerner, Ines P.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Neurosci ICU, Portland, OR USA	Lele, AV (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Neurocrit Care Serv, 325,9th Ave, Seattle, WA 98104 USA.	abhijit2@uw.edu	Naik, Bhiken/AAH-3831-2019		Mizuho OSI	A.L.H. has received honoraria from Design Science Consulting Inc.; N.S. has received consulting fee from Mizuho OSI. The other authors have no conflicts of interest to disclose.	Abdoh MG, 2012, ACTA NEUROCHIR, V154, P153, DOI 10.1007/s00701-011-1136-9; Acikbas SC, 2002, ACTA NEUROCHIR, V144, P475, DOI 10.1007/s007010200068; Aghamohamadi Davood, 2013, Anesth Pain Med, V2, P159, DOI 10.5812/aapm.6510; Albu S, 2016, CLIN NEUROL NEUROSUR, V142, P43, DOI 10.1016/j.clineuro.2016.01.019; Amato A, 2011, NURS CRIT CARE, V16, P252, DOI 10.1111/j.1478-5153.2010.00444.x; American Society of Anesthesiologists, 2011, GUID PAT CAR AN; American Society of Anesthesiologists , 2015, STAND BAS AN MON; Andrews CM, 2012, NEUROCRIT CARE, V17, P37, DOI 10.1007/s12028-012-9757-2; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; ANDREWS RJ, 1993, NEUROSURGERY, V33, P1052; Antunes P, 2016, ACTA ANAESTH SCAND, V60, P1323, DOI 10.1111/aas.12763; Atkinson RA, 2016, J HOSP INFECT, V92, P263, DOI 10.1016/j.jhin.2015.09.014; Australasian College for Emergency Medicine (ACEM) Australian and New Zealand College of Anaesthetists (ANZCA) College of Intensive Care Medicine of Australia and New Zealand (CICM), 2015, GUID TRANSP CRIT PAT; Bakhsheshian J, 2015, LARYNGOSCOPE, V125, P2245, DOI 10.1002/lary.25379; Basauri LT, 1999, CRIT REV NEUROSURG, V9, P21, DOI 10.1007/s003290050104; Bateman BT, 2013, ANESTH ANALG, V116, P1380, DOI 10.1213/ANE.0b013e318251daed; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bhargava D, 2013, ACTA NEUROCHIR, V155, P2129, DOI 10.1007/s00701-013-1735-8; Bien AG, 2007, SKULL BASE-INTERD AP, V17, P133, DOI 10.1055/s-2007-970562; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Birch AA, 2006, NEUROCRIT CARE, V5, P51, DOI 10.1385/NCC:5:1:51; Bisnaire D, 1997, J Neurosci Nurs, V29, P261; Bloch J, 2003, J NEUROL NEUROSUR PS, V74, P992, DOI 10.1136/jnnp.74.7.992; Bohl MA, 2016, NEUROSURGERY, V79, P296, DOI 10.1227/NEU.0000000000001164; Borire AA, 2015, J NEURO-OPHTHALMOL, V35, P293, DOI 10.1097/WNO.0000000000000239; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P37, DOI DOI 10.1089/NEU.2007.9990; Bruder M, 2015, WORLD NEUROSURG, V84, P1653, DOI 10.1016/j.wneu.2015.07.003; Camacho EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050708; Carney N, 2016, NEUROSURGERY; Center for Professional Practice of Nursing, 2016, ASS MAN EXT VENTR DR; Chai FY, 2013, TURK NEUROSURG, V23, P561, DOI 10.5137/1019-5149.JTN.5724-12.1; Chaikittisilpa N, 2016, NEUROCRIT CARE; Chaney MA, 2006, ANESTH ANALG, V102, P45, DOI 10.1213/01.ane.0000183650.16038.f6; Chatzi M, 2014, CRIT CARE MED, V42, P66, DOI 10.1097/CCM.0b013e31829a70a5; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Cheung AT, 2003, ANN THORAC SURG, V76, P1190, DOI 10.1016/S0003-4975(03)00881-6; Chung DY, 2016, NEUROCRIT CARE; Cinibulak Z, 2016, ACTA NEUROCHIR, V158, P847, DOI 10.1007/s00701-016-2747-y; Civelek E, 2007, TURK NEUROSURG, V17, P289; Cohen-Gadol AA, 2013, INT J SURG CASE REP, V4, P834, DOI 10.1016/j.ijscr.2013.06.014; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Coselli JS, 2002, J VASC SURG, V35, P631, DOI 10.1067/mva.2002.122024; Crowson MG, 2016, ANN OTO RHINOL LARYN, V125, P63, DOI 10.1177/0003489415597917; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2003, NEUROSURGERY, V52, P619, DOI 10.1227/01.NEU.0000049956.11888.6D; Dagnew E, 2002, NEUROSURGERY, V51, P823, DOI 10.1227/01.NEU.0000024285.50494.83; Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624; Dey M, 2012, CURR CARDIOL REP, V14, P754, DOI 10.1007/s11886-012-0316-4; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Doring B L, 1999, J Neurosci Nurs, V31, P80; Drake James M, 2005, Neurosurgery, V56, pE1161; Elvy J, 2008, J ANTIMICROB CHEMOTH, V61, P461, DOI 10.1093/jac/dkm501; Estrera AL, 2003, J THORAC CARDIOV SUR, V126, P1288, DOI 10.1016/S0022-5223(03)00962-0; Estrera AL, 2009, ANN THORAC SURG, V88, P9, DOI 10.1016/j.athoracsur.2009.03.039; Etz CD, 2015, EUR J CARDIO-THORAC, V47, P943, DOI 10.1093/ejcts/ezv142; Evans JM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-222; Fan Jun-Yu, 2004, J Neurosci Nurs, V36, P278; Fanara B, 2010, CRIT CARE, V14, DOI 10.1186/cc9018; Fargen KM, 2016, J NEUROSURG, V124, P1805, DOI 10.3171/2015.5.JNS15299; Farling PA, 2006, RECOMMENDATIONS SAFE; Fields JD, 2006, NEUROLOGY, V67, P1513, DOI 10.1212/01.wnl.0000242889.02957.b6; Flint AC, 2013, NEUROSURGERY, V72, P993, DOI 10.1227/NEU.0b013e31828e8dfd; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; Fountas KN, 2006, NEUROSURG REV, V29, P14, DOI 10.1007/s10143-005-0423-4; Francel P C, 1992, J Craniofac Surg, V3, P145, DOI 10.1097/00001665-199211000-00006; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Ghajar J, 1995, New Horiz, V3, P395; Goodson K, 2008, NEUROCRIT CARE, V8, P247, DOI 10.1007/s12028-007-9017-z; Grady RE, 1999, ANESTH ANALG, V88, P388; Great Ormond Street Hospital for Children, 2015, EXT VENTR DRAIN; Hagel S, 2014, Interdiscip Perspect Infect Dis, V2014, P708531, DOI 10.1155/2014/708531; HASAN D, 1991, STROKE, V22, P190, DOI 10.1161/01.STR.22.2.190; Hellingman CA, 2007, STROKE, V38, P96, DOI 10.1161/01.STR.0000251841.51332.1d; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hepburn-Smith M, 2016, J NEUROSCI NURS, V48, P54, DOI 10.1097/JNN.0000000000000174; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Hirono S, 2015, J NEUROL SURG REP, V76, P83, DOI 10.1055/s-0035-1547369; Hoh BL, 2005, NEUROSURGERY, V57, P845, DOI 10.1227/01.NEU.0000180814.95032.07; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Howell S, 2008, ANESTH ANALG, V106, P520, DOI 10.1213/ane.0b013e3181606ae5; Hulou MM, 2016, BRIT J NEUROSURG, V30, P438, DOI 10.3109/02688697.2015.1122172; Jacob AK, 2008, ANESTH ANALG, V107, P229, DOI 10.1213/ane.0b013e318174dfbe; Jeong YB, 2009, ACTA ANAESTH SCAND, V53, P1221, DOI 10.1111/j.1399-6576.2009.01984.x; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kalisch B J, 1995, J Neurosci Nurs, V27, P69; KASUYA H, 1991, NEUROSURGERY, V28, P56, DOI 10.1227/00006123-199101000-00009; Kawahara I, 2013, ACTA NEUROCHIR, V155, P1543, DOI 10.1007/s00701-013-1755-4; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Khan NR, 2016, J NEUROSURG-SPINE, V25, P383, DOI 10.3171/2016.1.SPINE151199; Kim GS, 2011, NEUROCRIT CARE, V14, P68, DOI 10.1007/s12028-010-9401-y; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Kitchen WJ, 2011, BRIT J NEUROSURG, V25, P632, DOI 10.3109/02688697.2011.578770; Kleffmann J, 2016, NEUROCRIT CARE, V25, P440, DOI 10.1007/s12028-016-0274-6; Ko JK, 2014, NEUROL MED-CHIR, V54, P545, DOI 10.2176/nmc.oa.2013-0178; Kocan Mary Jo, 2002, Crit Care Nurse, V22, P70; Komotar RJ, 2005, NEUROSURGERY, V57, P286, DOI 10.1227/01.NEU.0000166661.96546.33; Kosty J, 2013, NEUROSURGERY S, V72; Kosty J, 2013, NEUROSURGERY S, V72; Kosty JA, 2013, ANESTH ANALG, V117, P694, DOI 10.1213/ANE.0b013e31829cc765; Kwon YM, 2015, INT J NEUROSCI, V125, P742, DOI 10.3109/00207454.2015.1012665; Lahner D, 2007, WIEN KLIN WOCHENSCHR, V119, P412, DOI 10.1007/s00508-007-0813-4; Lang EW, 1999, EUR J ANAESTH, V16, P204, DOI 10.1046/j.1365-2346.1999.00442.x; Langan-Fox J, 2000, HUM FACTORS, V42, P242, DOI 10.1518/001872000779656534; Lescot T, 2012, NEUROCHIRURGIE, V58, P235, DOI 10.1016/j.neuchi.2012.03.010; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Leyvi G, 2005, J CARDIOTHOR VASC AN, V19, P392, DOI 10.1053/j.jvca.2005.03.024; Liang HS, 2016, NEUROCRIT CARE, V25, P243, DOI 10.1007/s12028-015-0239-1; Ling E, 2000, ANESTHESIOLOGY, V93, P1115, DOI 10.1097/00000542-200010000-00037; Littlejohns LR, 2009, AACN AANN PROTOCOLS; Lu N, 2012, NEUROCRIT CARE, V16, P368, DOI 10.1007/s12028-011-9659-8; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Makar G, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0525-8; Mancio J, 2014, OXF MED CASE REP, P55, DOI 10.1093/omcr/omu019; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Manley GT, 2000, J NEUROSURG, V92, P469, DOI 10.3171/jns.2000.92.3.0469; Matsuda H, 2010, ANN THORAC SURG, V90, P561, DOI 10.1016/j.athoracsur.2010.04.067; Mavrocordatos P, 2000, J NEUROSURG ANESTH, V12, P10, DOI 10.1097/00008506-200001000-00003; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Miller C, 2017, J NEUROSURG, V126, P289, DOI 10.3171/2015.12.JNS152341; Mura J, 2013, J NEUROL SURG PART A, V74, P146, DOI 10.1055/s-0032-1330122; Murakami H, 2004, J VASC SURG, V39, P243, DOI 10.1016/j.jvs.2003.07.013; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Muraskin SI, 2007, ANESTH ANALG, V105, P1519, DOI 10.1213/01.ane.0000286081.49295.f3; Narouze S, 2015, REGION ANESTH PAIN M, V40, P182, DOI 10.1097/AAP.0000000000000223; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Niimura Manabu, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-206654; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Olivar H, 2007, CAN J ANAESTH, V54, P829, DOI 10.1007/BF03021711; Olson DM, 2013, J NEUROSURG, V119, P974, DOI 10.3171/2013.6.JNS122403; Paldor I, 2015, J CLIN NEUROSCI, V22, P79, DOI 10.1016/j.jocn.2014.07.006; PAPO I, 1981, ACTA NEUROCHIR, V56, P191, DOI 10.1007/BF01407230; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; Park S, 2015, J KOREAN NEUROSURG S, V57, P167, DOI 10.3340/jkns.2015.57.3.167; Park YG, 2011, J KOREAN NEUROSURG S, V50, P317, DOI 10.3340/jkns.2011.50.4.317; Patil V, 2015, STEREOT FUNCT NEUROS, V93, P50, DOI 10.1159/000368906; Petrosoniak A, 2013, CURR OPIN ANESTHESIO, V26, P699, DOI 10.1097/ACO.0000000000000007; Phillips SB, 2014, WORLD NEUROSURG, V82, P739, DOI 10.1016/j.wneu.2013.08.030; Picetti E, 2013, NEUROCRIT CARE, V18, P298, DOI 10.1007/s12028-012-9802-1; Pongudom S, 2011, J MED ASS THAI, V94, P258; Pope W, 1998, J Neurosci Nurs, V30, P185; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Priebe HJ, 2007, BRIT J ANAESTH, V99, P102, DOI 10.1093/bja/aem119; Quenot JP, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-1; Raabe A, 1998, NEUROSURGERY, V42, P74, DOI 10.1097/00006123-199801000-00015; Raabe A, 1998, ACT NEUR S, V71, P59; Rafiq Mirza Faisal Ahmed, 2011, J Ayub Med Coll Abbottabad, V23, P106; Ramakrishna R, 2010, NEUROSURGERY, V67, P110, DOI 10.1227/01.NEU.0000370920.44359.91; Rehman T, 2012, CLIN NEUROL NEUROSUR, V114, P651, DOI 10.1016/j.clineuro.2011.12.040; Remes F, 2013, J NEUROSURG, V119, P1596, DOI 10.3171/2013.6.JNS122126; Riley SP, 2015, J ANESTH, V29, P544, DOI 10.1007/s00540-015-1990-3; Rosenbaum BP, 2014, J CLIN NEUROSCI, V21, P623, DOI 10.1016/j.jocn.2013.09.001; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; Safi HJ, 1996, J VASC SURG, V23, P223, DOI 10.1016/S0741-5214(96)70266-5; Saito K, 2009, NEUROL MED-CHIR, V49, P252, DOI 10.2176/nmc.49.252; Sakowitz OW, 2006, NEUROSURGERY, V58, P137, DOI 10.1227/01.NEU.0000194532.47239.7C; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Salunke P, 2012, NEUROL INDIA, V60, P254, DOI 10.4103/0028-3886.96433; Samadani U, 2003, NEUROSURGERY, V52, P148, DOI 10.1097/00006123-200301000-00019; Sarrafzadeh A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-478; Scheithauer S, 2010, INFECTION, V38, P205, DOI 10.1007/s15010-010-0006-3; Scholz C, 2013, CLIN NEUROL NEUROSUR, V115, P1399, DOI 10.1016/j.clineuro.2013.01.023; Shekhar H, 2016, BRIT J NEUROSURG, V30, P64, DOI 10.3109/02688697.2015.1096903; Simmerman SR, 1997, J NEUROSURG ANESTH, V9, P159, DOI 10.1097/00008506-199704000-00010; Sims-Williams HP, 2014, BRIT J NEUROSURG, V28, P782, DOI 10.3109/02688697.2014.915006; Singh S, 2016, A A CASE REP, V6, P121, DOI 10.1213/XAA.0000000000000230; Sladky John H, 2015, Atlas Oral Maxillofac Surg Clin North Am, V23, P169, DOI 10.1016/j.cxom.2015.05.005; Slazinski T, 2011, CARE OF THE PATIENT, P1; Soehle M, 2007, ACTA NEUROCHIR, V149, P575, DOI 10.1007/s00701-007-1149-6; Solter VV, 2014, ACTA CLIN CROAT, V53, P113; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Stangl AP, 1998, SURG NEUROL, V50, P77, DOI 10.1016/S0090-3019(97)00301-7; Sugrue PA, 2009, J NEUROSURG, V110, P800, DOI 10.3171/2008.5.17568; Sunderland NE, 2016, J NEUROSCI NURS, V48, P274, DOI 10.1097/JNN.0000000000000255; Sussman ES, 2014, J NEUROSURG, V120, P931, DOI 10.3171/2013.12.JNS131685; Tan VES, 2013, ENT-EAR NOSE THROAT, V92, P513, DOI 10.1177/0145561313092010-1112; Tanweer O, 2013, J NEUROSURG, V119, P1309, DOI 10.3171/2013.7.JNS13313; TELISCHI FF, 1995, LARYNGOSCOPE, V105, P219, DOI 10.1288/00005537-199502000-00023; The American Board of Anesthesiology, 2015, PRIM CERT AN; The Royal Children's Hospital Melbourne, 2016, EXT VENTR DRAINS INT; Thompson H J, 2000, Crit Care Nurse, V20, P59; Tiefenthaler W, 2006, ANAESTHESIA, V61, P1208, DOI 10.1111/j.1365-2044.2006.04836.x; Tien DA, 2016, OTOLARYNG CLIN N AM, V49, P119, DOI 10.1016/j.otc.2015.09.007; Ting HYZ, 2014, CAN J ANESTH, V61, P1004, DOI 10.1007/s12630-014-0219-5; TRONNIER V, 1991, ACTA NEUROCHIR, V110, P49, DOI 10.1007/BF01402048; Varelas PN, 2005, NEUROSURGERY, V56, P205, DOI 10.1227/01.neu.0000147973.83688.D8; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Walker CT, 2012, PEDIATR NEUROSURG, V48, P342, DOI 10.1159/000353608; Wang JH, 2014, J MICROBIOL IMMUNOL, V47, P204, DOI 10.1016/j.jmii.2012.08.028; Wang K, 2013, TURK NEUROSURG, V23, P653, DOI 10.5137/1019-5149.JTN.7954-13.0; Wang QP, 2014, NEUROL INDIA, V62, P79, DOI 10.4103/0028-3886.128337; Wang X, 2013, CRIT CARE, V17, DOI 10.1186/cc12608; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; Weaver KD, 2001, J VASC SURG, V34, P623, DOI 10.1067/mva.2001.117334; Webb A, 2010, NEUROCRIT CARE, V12, P159, DOI 10.1007/s12028-009-9307-8; Weisenberg SH, 2016, J NEUROSURG, V125, P1504, DOI 10.3171/2015.12.JNS151181; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; WILKINSON HA, 1989, NEUROSURGERY, V24, P348, DOI 10.1227/00006123-198903000-00007; Winkler KML, 2013, NEUROCRIT CARE, V18, P161, DOI 10.1007/s12028-013-9816-3; Wong AI, 2016, J NEUROINTERV SURG, V8, P865, DOI 10.1136/neurintsurg-2015-011864; Woodward S, 2002, Br J Nurs, V11, P47; Yasuda T, 2002, PEDIATR NEUROSURG, V36, P22, DOI 10.1159/000048344; Yuan XH, 2014, J CRANIOFAC SURG, V25, P1551, DOI 10.1097/SCS.0000000000000855; Zhao JC, 2015, CLIN NEUROL NEUROSUR, V133, P6, DOI 10.1016/j.clineuro.2015.03.010; Ziai W, 2013, NEUROCRIT CARE, V18, P354, DOI 10.1007/s12028-013-9826-1	209	16	18	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2017	29	3					191	210		10.1097/ANA.0000000000000407			20	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	EX4UJ	WOS:000403230100001	28169966	Green Published			2021-06-18	
J	Mammadova, N; Ghaisas, S; Zenitsky, G; Sakaguchi, DS; Kanthasamy, AG; Greenlee, JJ; Greenlee, MHW				Mammadova, Najiba; Ghaisas, Shivani; Zenitsky, Gary; Sakaguchi, Donald S.; Kanthasamy, Anumantha G.; Greenlee, Justin J.; Greenlee, M. Heather West			Lasting Retinal Injury in a Mouse Model of Blast-Induced Trauma	AMERICAN JOURNAL OF PATHOLOGY			English	Article							INDUCED OCULAR TRAUMA; PRIMARY OVERPRESSURE BLAST; CLOSED-HEAD MODEL; MULLER GLIAL-CELL; UP-REGULATION; TAU; MICROGLIA; PATHOPHYSIOLOGY; DEGENERATION; ACTIVATION	Traumatic brain injury due to blast exposure is currently the most prevalent of war injuries. Although secondary ocular blast injuries due to flying debris are more common, primary ocular blast exposure resulting from blast wave pressure has been reported among survivors of explosions, but with Limited understanding of the resulting retinal pathologies. Using a compressed air-driven shock tube system, adult male and female C57BL/6 mice were exposed to blast wave pressure of 300 kPa (43.5 psi) per day for 3 successive days, and euthanized 30 days after injury. We assessed retinal tissues using immunofluorescence for Oa fibrilLary acidic protein, microglia-specific proteins Iba1 and CD68, and phosphorylated tau (AT-270 pThr181 and AT-180 pThr231). Primary blast wave pressure resulted in activation of Muller glia, Loss of photoreceptor cells, and an increase in phosphorylated tau in retinal neurons and glia. We found that 300-kPa blasts yielded no detectable cognitive or motor deficits, and no neurochemical or biochemical evidence of injury in the striatum or prefrontal cortex, respectively. These changes were detected 30 days after blast exposure, suggesting the possibility of long-lasting retinal injury and neuronal inflammation after primary blast exposure.	[Mammadova, Najiba; Sakaguchi, Donald S.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Mammadova, Najiba; Ghaisas, Shivani; Greenlee, M. Heather West] Iowa State Univ, Immunobiol Grad Program, Ames, IA 50011 USA; [Mammadova, Najiba; Sakaguchi, Donald S.; Greenlee, M. Heather West] Iowa State Univ, Neurosci Grad Program, Ames, IA 50011 USA; [Ghaisas, Shivani; Zenitsky, Gary; Kanthasamy, Anumantha G.; Greenlee, M. Heather West] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, 1800 Christensen Dr,Room 2008, Ames, IA 50011 USA; [Greenlee, Justin J.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	Greenlee, MHW (corresponding author), Iowa State Univ, Coll Vet Med, Dept Biomed Sci, 1800 Christensen Dr,Room 2008, Ames, IA 50011 USA.	mheather@iastate.edu	Ghaisas, Shivani/AAO-7105-2020; Greenlee, Justin/Y-5732-2019; West Greenlee, Heather/B-5342-2016	Ghaisas, Shivani/0000-0001-7827-8190; Greenlee, Justin/0000-0003-2202-3054; Kanthasamy, Anumantha/0000-0002-6454-4264; Sakaguchi, Donald/0000-0003-4537-0972; Zenitsky, Gary/0000-0003-1214-3247; West Greenlee, Heather/0000-0002-6622-0044	US Army Medical Research and Materiel Command grantU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0700]; Stem Cell Research Fund; Departfrients of Genetics, Development, and Cell Biology; Department of Biomedical Sciences at Iowa State University	Supported by a US Army Medical Research and Materiel Command grant under contract W81XWH-11-1-0700 (A.G.K.); the Stem Cell Research Fund (D.S.S.); and the Departfrients of Genetics, Development, and Cell Biology (N.M.) and Department of Biomedical Sciences at Iowa State University (M.H.W.G.).	BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bringmann A, 2001, FRONT BIOSCI-LANDMRK, V6, pE77, DOI 10.2741/Bringman; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; Dyer MA, 2000, NAT NEUROSCI, V3, P873; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Ghosh A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444224; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Harischandra DS, 2015, TOXICOL SCI, V143, P454, DOI 10.1093/toxsci/kfu247; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jackman SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001057; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Komori T, 1999, BRAIN PATHOL, V9, P663; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; ODAWARA T, 1995, NEUROSCI LETT, V192, P145, DOI 10.1016/0304-3940(95)11595-N; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Reichenbach A, 1997, OPHTHALMIC RES, V29, P326, DOI 10.1159/000268031; Shah MA, 2011, BIOMED SCI INSTRUM, V48, P393; Sonntag S, 2012, J NEUROSCI, V32, P10713, DOI 10.1523/JNEUROSCI.0442-12.2012; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Tynan RJ, 2013, ACTA NEUROPATHOL, V126, P75, DOI 10.1007/s00401-013-1102-0; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	40	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUL	2017	187	7					1459	1472		10.1016/j.ajpath.2017.03.005			14	Pathology	Pathology	EY9LQ	WOS:000404320500004	28606756	Green Published, Bronze			2021-06-18	
J	Gao, WW; Li, F; Zhou, ZW; Xu, X; Wu, YG; Zhou, S; Yin, DP; Sun, DD; Xiong, JH; Jiang, RC; Zhang, JN				Gao, Weiwei; Li, Fei; Zhou, Ziwei; Xu, Xin; Wu, Yingang; Zhou, Shuai; Yin, Dongpei; Sun, Dongdong; Xiong, Jianhua; Jiang, Rongcai; Zhang, Jianning			IL-2/Anti-IL-2 Complex Attenuates Inflammation and BBB Disruption in Mice Subjected to Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; IL-2/anti-IL-2; regulatory T cells; microglia; inflammation; blood-brain barrier	REGULATORY T-CELLS; CONTROLLED CORTICAL IMPACT; INTRACEREBRAL HEMORRHAGE; CEREBRAL-ISCHEMIA; IMMUNE-SYSTEM; SPINAL-CORD; TGF-BETA; MICROGLIA; STROKE; ACTIVATION	Traumatic brain injury (TBI) induces the excessive inflammation and disruption of blood-brain barrier, both of which are partially mediated by the activation of microglia and release of inflammatory cytokines. Previous reports showed that administration of regulatory T cells (Tregs) could suppress inflammation and promote neurological function recovery, and that the IL-2/anti-IL-2 complex (IL-2C) could increase the number of Tregs. Thus, we hypothesized that IL-2C-mediated expansion of Tregs would be beneficial in mice subjected to TBI. In this study, mice received an intraperitoneal injection of IL-2C for three consecutive days. We observed that IL-2C dose-dependently increased Tregs without affecting the populations of CD4, CD8, or natural killer cells. IL-2C could improve the neurological recovery and reduce brain edema, tissue loss, neutrophils infiltration, and tight junction proteins degradation. Furthermore, this complex could also reduce the expression of CD16/32, IL-1 beta, or TNF-alpha, and elevate the expression of CD206, arginase 1, or TGF-beta. These results suggest that IL-2C could be a potential therapeutic method to alleviate excessive inflammation and maintain blood vessel stability after TBI.	[Gao, Weiwei; Li, Fei; Zhou, Ziwei; Xu, Xin; Wu, Yingang; Zhou, Shuai; Yin, Dongpei; Sun, Dongdong; Xiong, Jianhua; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Key Lab Postneurotrauma Neurorepair & Regenerat C, Dept Neurosurg,Minist Educ & Tianjin City, Tianjin, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Key Lab Postneurotrauma Neurorepair & Regenerat C, Dept Neurosurg,Minist Educ & Tianjin City, Tianjin, Peoples R China.	jianningzhang@hotmail.com		Xu, Xin/0000-0003-3395-9923; Dongpei, Yin/0000-0003-2572-3689	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271361, 81330029]; Natural Science Foundations of TianjinNatural Science Foundation of Tianjin [13JCZDJC30800, 15JCYBJC50500]	This work was supported by the National Natural Science Foundation of China (Grants 81271361 and 81330029) and the Natural Science Foundations of Tianjin (Grant 13JCZDJC30800 and 15JCYBJC50500).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li PY, 2013, STROKE, V44, P3509, DOI 10.1161/STROKEAHA.113.002637; Liesz A, 2013, J NEUROSCI, V33, P17350, DOI 10.1523/JNEUROSCI.4901-12.2013; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin J, 2010, J LIPID RES, V51, P1208, DOI 10.1194/jlr.D000497; Liu RL, 2010, EUR J IMMUNOL, V40, P1577, DOI 10.1002/eji.200939792; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maeda Toshihiko, 2013, Nihon Rinsho, V71, P789; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Nico B, 2012, CURR DRUG METAB, V13, P50, DOI 10.2174/138920012798356970; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Dinh TN, 2012, CIRCULATION, V126, P1256, DOI 10.1161/CIRCULATIONAHA.112.099044; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang Z, 2014, INT IMMUNOPHARMACOL, V22, P522, DOI 10.1016/j.intimp.2014.06.037; Yu YH, 2016, MOL MED REP, V14, P5556, DOI 10.3892/mmr.2016.5954; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	48	16	16	1	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 30	2017	8								281	10.3389/fneur.2017.00281			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EZ1YD	WOS:000404505800001	28713327	DOAJ Gold, Green Published			2021-06-18	
J	Grasman, JM; Kaplan, DL				Grasman, Jonathan M.; Kaplan, David L.			Human endothelial cells secrete neurotropic factors to direct axonal growth of peripheral nerves	SCIENTIFIC REPORTS			English	Article							VOLUMETRIC MUSCLE LOSS; SKELETAL-MUSCLE; MACROPHAGE PHENOTYPE; STEM-CELLS; IN-VITRO; REGENERATION; NEURONS; BRAIN; GUIDANCE; DELIVERY	Understanding how nerves spontaneously innervate tissues or regenerate small injuries is critical to enhance material-based interventions to regenerate large scale, traumatic injuries. During embryogenesis, neural and vascular tissues form interconnected, complex networks as a result of signaling between these tissue types. Here, we report that human endothelial cells (HUVECs) secrete brain-derived neurotrophic factor (BDNF), which significantly stimulated axonal growth from chicken or rat dorsal root ganglia (DRGs). HUVEC-conditioned medium was sufficient to enhance axonal growth, demonstrating that direct cell-cell contact was not required. When BDNF was neutralized, there was a significant reduction in axonal growth when incubated in HUVEC-conditioned medium and in direct co-culture with HUVECs. These data show that HUVECs secrete neurotrophic factors that significantly enhance axonal growth, and can inform future in vivo studies to direct or pattern the angiogenic response in regenerating tissues to encourage re-innervation.	[Grasman, Jonathan M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu		Grasman, Jonathan/0000-0001-8289-9627	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41EB002520, R01-AR055993, F32-DE026058]; WM Keck FoundationW.M. Keck Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR055993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [F32DE026058] Funding Source: NIH RePORTER	The authors thank Siran (Maggie) Wang for her instruction on the isolation of DRGs and Dana M. Cairns for helpful discussions. This research was funded in part by the NIH (P41EB002520, R01-AR055993, and F32-DE026058) and the WM Keck Foundation.	Ai LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046287; Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]; Blais M, 2013, TISSUE ENG PT A, V19, P1655, DOI 10.1089/ten.tea.2012.0745; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; DELAPEYRIERE O, 1993, DEVELOPMENT, V118, P601; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Ehret F, 2015, STEM CELL RES, V15, P514, DOI 10.1016/j.scr.2015.09.010; Faroni A, 2015, ADV DRUG DELIVER REV, V82-83, P160, DOI 10.1016/j.addr.2014.11.010; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Grasman JM, 2015, ACTA BIOMATER, V25, P2, DOI 10.1016/j.actbio.2015.07.038; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Hobson MI, 1997, BRIT J PLAST SURG, V50, P125, DOI 10.1016/S0007-1226(97)91325-4; Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029; Israeli D, 2004, J CELL PHYSIOL, V201, P409, DOI 10.1002/jcp.20088; James JM, 2011, SEMIN CELL DEV BIOL, V22, P1019, DOI 10.1016/j.semcdb.2011.09.010; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Liu YM, 2013, NEUROSCI LETT, V551, P79, DOI 10.1016/j.neulet.2013.07.012; Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073; Marquardt LM, 2015, TISSUE ENG PT A, V21, P2852, DOI [10.1089/ten.tea.2015.0311, 10.1089/ten.TEA.2015.0311]; Michaelson MD, 1996, DEV BIOL, V179, P251, DOI 10.1006/dbio.1996.0255; Miknyoczki SJ, 2002, CLIN CANCER RES, V8, P1924; Mills CD, 2007, MOL CELL NEUROSCI, V36, P185, DOI 10.1016/j.mcn.2007.06.011; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]; Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Pagel CN, 2014, J CELL COMMUN SIGNAL, V8, P95, DOI 10.1007/s12079-013-0217-3; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Rabenstein M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0098-x; Sawada M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00053; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; Shvartsman D, 2014, MOL THER, V22, P1243, DOI 10.1038/mt.2014.76; Sivak WN, 2017, J TISSUE ENG REGEN M, V11, P733, DOI 10.1002/term.1970; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Wang SR, 2015, J BIOMED MATER RES A, V103, P3339, DOI 10.1002/jbm.a.35465; Wirth MJ, 2005, P NATL ACAD SCI USA, V102, P3064, DOI 10.1073/pnas.0404712102; Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zhang WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052849	44	16	16	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 22	2017	7								4092	10.1038/s41598-017-04460-8			12	Multidisciplinary Sciences	Science & Technology - Other Topics	EY3MF	WOS:000403874900075	28642578	DOAJ Gold, Green Published			2021-06-18	
J	Hides, JA; Smith, MMF; Mendis, MD; Smith, NA; Cooper, AJ; Treleaven, J; Leung, F; Gardner, AJ; McCrory, P; Choy, NLL				Hides, Julie A.; Smith, Melinda M. Franettovich; Mendis, M. Dilani; Smith, Nigel A.; Cooper, Andrew J.; Treleaven, Julia; Leung, Felix; Gardner, Andrew J.; McCrory, Paul; Choy, Nancy L. Low			A prospective investigation of changes in the sensorimotor system following sports concussion. An exploratory study	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Motor control; Vestibular system; Balance; Cervical proprioception; Trunk muscles; Rugby	LOW-BACK-PAIN; PAROXYSMAL POSITIONAL VERTIGO; LUMBAR MULTIFIDUS MUSCLE; TRAUMATIC BRAIN-INJURY; AUSTRALIAN RULES FOOTBALL; MILD HEAD-INJURY; MOTOR CONTROL; NECK-PAIN; POSTURAL STABILITY; VESTIBULAR REHABILITATION	Background: Sports concussion is a risk for players involved in high impact, collision sports. Postconcussion, the majority of symptoms subside within 7e10 days, but can persist in 10e20% of athletes. Understanding the effects of sports concussion on sensorimotor systems could inform physiotherapy treatment. Objective: To explore changes in sensorimotor function in the acute phase following sports concussion. Design: Prospective cohort study. Methods: Fifty-four players from elite rugby union and league teams were assessed at the start of the playing season. Players who sustained a concussion were assessed three to five days later. Measures included assessments of balance (sway velocity), vestibular system function (vestibular ocular reflex gain; right-left asymmetry), cervical proprioception (joint position error) and trunk muscle size and function. Results: During the playing season, 14 post-concussion assessments were performed within 3-5 days of injury. Significantly decreased sway velocity and increased size/contraction of trunk muscles, were identified. Whilst not significant overall, large inter-individual variation of test results for cervical proprioception and the vestibular system was observed. Limitations: The number of players who sustained a concussion was not large, but numbers were comparable with other studies in this field. There was missing baseline data for vestibular and cervical proprioception testing for some players. Conclusions: Preliminary findings post-concussion suggest an altered balance strategy and trunk muscle control with splinting/over-holding requiring consideration as part of the development of appropriate physiotherapy management strategies. (C) 2017 Elsevier Ltd. All rights reserved.	[Hides, Julie A.; Smith, Melinda M. Franettovich; Mendis, M. Dilani; Smith, Nigel A.; Cooper, Andrew J.; Leung, Felix] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Musculoskeletal Res, Brisbane, Qld 4102, Australia; [Mendis, M. Dilani] Mater Hlth Serv, Physiotherapy Dept, South Brisbane, Qld 4101, Australia; [Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW 2310, Australia; [Gardner, Andrew J.] John Hunter Hosp, Hunter New England Local Hlth Dist Sports Concuss, New Lambton Hts, NSW 2305, Australia; [McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Choy, Nancy L. Low] Australian Catholic Univ, Sch Physiotherapy, Brisbane, Qld 4014, Australia	Hides, JA (corresponding author), Level 1,631 Stanley St, Woolloongabba, Qld 4102, Australia.	Julie.hides@acu.edu	Smith, Melinda Franettovich/AAK-1568-2021; Treleaven, Julia M/F-8734-2010; Hides, Julie Anne/F-2141-2011; Treleaven, Julia/N-1379-2019; McCrory, Paul/Q-8688-2019	Smith, Melinda Franettovich/0000-0002-0098-7656; Treleaven, Julia M/0000-0002-6258-3972; Hides, Julie Anne/0000-0002-1830-8121; Treleaven, Julia/0000-0002-6258-3972; McCrory, Paul/0000-0003-4850-0568	Collaborative Research Network/Australian Catholic University Research Fund [2013000523]	This work was funded by a Collaborative Research Network/Australian Catholic University Research Fund [Grant number: 2013000523].	Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Davisson C, 2014, TEST RETEST RELIABIL; Dubois JD, 2011, J ELECTROMYOGR KINES, V21, P774, DOI 10.1016/j.jelekin.2011.05.004; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Falla D, 2007, MANUAL THER, V12, P139, DOI 10.1016/j.math.2006.06.003; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fu S, 2009, CLIMACTERIC, V12, P165, DOI 10.1080/13697130802506614; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; HAIN TC, 1987, AM J OTOLARYNG, V8, P36, DOI 10.1016/S0196-0709(87)80017-0; Hain TC, 2011, NEUROREHABILITATION, V29, P127, DOI 10.3233/NRE-2011-0687; Hall Courtney D, 2006, J Neurol Phys Ther, V30, P74; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hides J., 2016, SCAND J MED SCI SPOR; Hides J. A., 2015, EUR SPINE J; HIDES JA, 1995, SPINE, V20, P54, DOI 10.1097/00007632-199501000-00010; Hides J, 2012, J ATHL TRAINING, V47, P314, DOI 10.4085/1062-6050-47.3.03; Hides JA, 2007, J ORTHOP SPORT PHYS, V37, P480, DOI 10.2519/jospt.2007.2416; Hides JA, 2016, MANUAL THER, V24, P46, DOI 10.1016/j.math.2016.05.001; Hides JA, 2012, MED SCI SPORT EXER, V44, P1141, DOI 10.1249/MSS.0b013e318244a321; Hodges PW, 2003, J ELECTROMYOGR KINES, V13, P361, DOI 10.1016/S1050-6411(03)00042-7; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Jacobs JV, 2009, BEHAV NEUROSCI, V123, P455, DOI 10.1037/a0014479; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jorns-Haderli M, 2007, J NEUROL NEUROSUR PS, V78, P1113, DOI 10.1136/jnnp.2006.109512; Karayannis NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067779; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; L'Heureux-Lebeau B, 2014, OTOL NEUROTOL, V35, P1858, DOI 10.1097/MAO.0000000000000506; Lanska DJ, 1997, NEUROLOGY, V48, P1167, DOI 10.1212/WNL.48.5.1167; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lee PJ, 2006, J ELECTROMYOGR KINES, V16, P51, DOI 10.1016/j.jelekin.2005.06.006; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDevitt J, 2016, BRAIN INJURY, V30, P494; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Miller EM, 2013, J BIOMECH, V46, P801, DOI 10.1016/j.jbiomech.2012.11.023; Moseley GL, 2006, BEHAV NEUROSCI, V120, P474, DOI 10.1037/0735-7044.120.2.474; Mossman B, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0081-7; Murnaghan CD, 2011, NEUROSCIENCE, V195, P54, DOI 10.1016/j.neuroscience.2011.08.020; Murnaghan CD, 2013, GAIT POSTURE, V38, P734, DOI 10.1016/j.gaitpost.2013.03.012; Nilssen RM, 1999, PAIN, V83, P477, DOI 10.1016/S0304-3959(99)00153-0; Nitz J. C., 2004, AGE AGEING, V33; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Perez N, 2003, OTOL NEUROTOL, V24, P913, DOI 10.1097/00129492-200311000-00016; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Petrak M. R., 2013, VIDEO HEAD IMPULSE T; Pinsault N, 2010, PHYS THER SPORT, V11, P66, DOI 10.1016/j.ptsp.2010.02.004; Pinsault N, 2010, SPINE, V35, P294, DOI 10.1097/BRS.0b013e3181b0c889; Radebold A, 2000, SPINE, V25, P947, DOI 10.1097/00007632-200004150-00009; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roren A, 2009, MANUAL THER, V14, P270, DOI 10.1016/j.math.2008.03.002; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Smith M, 2005, EXP BRAIN RES, V166, P109, DOI 10.1007/s00221-005-2352-4; Swait G, 2007, SPINE, V32, pE692, DOI 10.1097/BRS.0b013e31815a5a1b; van Dieen JH, 2003, SPINE, V28, P834, DOI 10.1097/00007632-200304150-00018; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008; Wallwork TL, 2007, J ORTHOP SPORT PHYS, V37, P608, DOI 10.2519/jospt.2007.2418; Wallwork TL, 2009, MANUAL THER, V14, P496, DOI 10.1016/j.math.2008.09.006; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Wilder DG, 1996, SPINE, V21, P2628, DOI 10.1097/00007632-199611150-00013; Yang CJ, 2016, CLIN OTOLARYNGOL, V41, P532, DOI 10.1111/coa.12558	87	16	16	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUN	2017	29						7	19		10.1016/j.msksp.2017.02.003			13	Rehabilitation	Rehabilitation	FO9WZ	WOS:000417250400009	28259770				2021-06-18	
J	Mayer, AR; Ling, JM; Dodd, AB; Meier, TB; Hanlon, FM; Klimaj, SD				Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Meier, Timothy B.; Hanlon, Faith M.; Klimaj, Stefan D.			A prospective microstructure imaging study in mixed-martial artists using geometric measures and diffusion tensor imaging: methods and findings	BRAIN IMAGING AND BEHAVIOR			English	Article						Diffusion tensor imaging; NODDI; Concussion; Repetitive injury; Edema; Water fractions	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; VOXEL-BASED MORPHOMETRY; WHITE-MATTER INTEGRITY; SPATIAL STATISTICS; WATER DIFFUSION; ARTS FIGHTERS; WISE ANALYSIS; DATA SETS; MRI DATA	Although diffusion magnetic resonance imaging (dMRI) has been widely used to characterize the effects of repetitive mild traumatic brain injury (rmTBI), to date no studies have investigated how novel geometric models of microstructure relate to more typical diffusion tensor imaging (DTI) sequences. Moreover, few studies have evaluated the sensitivity of different registration pipelines (non-linear, linear and tract-based spatial statistics) for detecting dMRI abnormalities in clinical populations. Results from single-subject analyses in healthy controls (HC) indicated a strong negative relationship between fractional anisotropy (FA) and orientation dispersion index (ODI) in both white and gray matter. Equally important, only moderate relationships existed between all other estimates of free/intracellular water volume fractions and more traditional DTI metrics (FA, mean, axial and radial diffusivity). These findings suggest that geometric measures provide differential information about the cellular microstructure relative to traditional DTI measures. Results also suggest greater sensitivity for non-linear registration pipelines that maximize the anatomical information available in T-1-weighted images. Clinically, rmTBI resulted in a pattern of decreased FA and increased ODI, largely overlapping in space, in conjunction with increased intracellular and free water fractions, highlighting the potential role of edema following repeated head trauma. In summary, current results suggest that geometric models of diffusion can provide relatively unique information regarding potential mechanisms of pathology that contribute to long-term neurological damage.	[Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Meier, Timothy B.; Hanlon, Faith M.; Klimaj, Stefan D.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA	Mayer, AR (corresponding author), Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA.; Mayer, AR (corresponding author), Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	amayer@mrn.org	Klimaj, Stefan/AAV-4060-2020		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS098494] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098494] Funding Source: NIH RePORTER		Adluru G, 2014, IEEE ENG MED BIO, P742, DOI 10.1109/EMBC.2014.6943697; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants B. B., 2009, INSIGHT J, P1; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chung SW, 2008, NEUROIMAGE, V39, P1693, DOI 10.1016/j.neuroimage.2007.10.039; COX R, 2006, P INT SOC MAGN RES M; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; GENTRY LR, 1994, RADIOLOGY, V191, P1; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Harel O, 2009, J APPL STAT, V36, P1109, DOI 10.1080/02664760802553000; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Holbourn AHS, 1943, LANCET, V2, P438; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Koay C. G., 2015, 151002934 ARXIV; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mayer AR, 2007, J INT NEUROPSYCH SOC, V13, P839, DOI 10.1017/S1355617707071081; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Schlaffke L, 2014, NEUROSCIENCE, V259, P35, DOI 10.1016/j.neuroscience.2013.11.046; Schwarz CG, 2014, NEUROIMAGE, V94, P65, DOI 10.1016/j.neuroimage.2014.03.026; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Skare S, 2000, J MAGN RESON, V147, P340, DOI 10.1006/jmre.2000.2209; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Storey P, 2007, MAGN RESON MED, V57, P614, DOI 10.1002/mrm.21132; Tustison NJ, 2014, HUM BRAIN MAPP, V35, P745, DOI 10.1002/hbm.22211; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	66	16	16	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2017	11	3					698	711		10.1007/s11682-016-9546-1			14	Neuroimaging	Neurosciences & Neurology	EY0VE	WOS:000403676400009	27071950	Green Accepted			2021-06-18	
J	Zuckerman, SL; Zalneraitis, BH; Totten, DJ; Rubel, KE; Kuhn, AW; Yengo-Kahn, AM; Bonfield, CM; Sills, AK; Solomon, GS				Zuckerman, Scott L.; Zalneraitis, Brian Holt; Totten, Douglas J.; Rubel, Kolin E.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Sills, Allen K.; Solomon, Gary S.			Socioeconomic status and outcomes after sport-related concussion: a preliminary investigation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						socioeconomic status; sports-related concussion; traumatic brain injury; football; basketball; soccer; athletics; postconcussion syndrome; trauma	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; PROLONGED RECOVERY; HIGH-SCHOOL; SHORT-TERM; PREDICTORS; HEALTH; PREVALENCE; SYMPTOMS; CHILDREN	OBJECTIVE. A significant proportion of patients experience long-term symptoms after sport-related concussion (SRC), and several factors have been associated with this protracted recovery. Limited data exist on the role of socioeconomic status (SES) on SRC outcomes. The objective in this study was to conduct a preliminary investigation to determine the effect of SES on outcomes after SRC in student-athletes treated at a regional sports concussion center. METHODS. A retrospective cohort study of 282 middle school, high school, and collegiate student-athletes was conducted. An attempt was made to contact all patients seen at a comprehensive SRC center between January 2012 and May 2015 for, in-depth interviews. Subsequent demographic data were collected. The SES was defined as follows: cost of living percentile, median income percentile, percentage of college graduates, percentage of homeowners, county type, and insurance status. Outcomes after SRC were defined as follows: days of symptom duration, days of missed school, and days of missed practice. Statistically controlled covariates included sex, race, age, body mass index, concussion history, neuropsychiatric history, and type of sport. RESULTS. A total of 282 student-athletes consented and were studied. The median age was 15.8 years (range 11.6-22.2 years) and 61.4% of student-athletes were male. A previous concussion was incurred by 34.0% of student-athletes. Football was the most common sport (32.3%), followed by soccer (16.3%), and basketball (15.6%). The median symptom duration was 21 days (range 1-365 days); the median missed school days was 2 (range 0-90 days); and median for days of missed practice was 10 (range 0-150 days). After multivariate Cox regression analysis, no relationship between any of the 6 SES variables and symptom duration or missed practice was seen. However, individuals with private insurance had more missed days of school than those with public insurance (hazard ratio 0.46, 95% CI 0.26-0.83, p = 0.009). CONCLUSIONS. In a preliminary study of middle school, high school, and collegiate student-athletes,. SES had no impact on the outcomes of symptom duration and missed practice. However, for individuals with private insurance, the return to school was slower than for those with public insurance. This pilot study reveals the complex relationship between SES and SRC recovery, which demands further study with more accurate and validated assessments of SES.	[Zuckerman, Scott L.; Zalneraitis, Brian Holt; Totten, Douglas J.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Rubel, Kolin E.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr, North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Solomon, Gary/K-9011-2019; Yengo-Kahn, Aaron/AAV-7647-2020	Kuhn, Andrew W/0000-0003-1836-7575; Yengo-Kahn, Aaron/0000-0002-5989-3064	Tennessee Titans (National Football League [NFL]); Nashville Predators (National Hockey League); athletic departments for several universities (University of Tennessee, Tennessee Tech)	Dr. Solomon receives consulting fees from the Tennessee Titans (National Football League [NFL]), the Nashville Predators (National Hockey League), and the athletic departments for several universities (University of Tennessee, Tennessee Tech fees paid to institution). In addition he is a member of the ImPACT Scientific Advisory Board and receives reimbursement for expenses to board meetings. Dr. Sills is a consulting physician to the Nashville Predators (uncompensated) and also serves as an unaffiliated neurotrauma consultant for the NFL. Dr. Bonfield serves as an unaffiliated neurotrauma consultant for the NFL. Dr. Zuckerman, Mr. Totten. Mr. Rubel, Mr. Kuhn, Mr. Zalneraitis, and Dr. Yengo-Kahn report no conflicts.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Doocy Shannon, 2006, World Health Popul, V8, P32; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ingram DD., 2014, 2013 NCHS URBAN RURA; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu W. M., 2001, INTERSECTION RACE CL; Marcin JP, 2003, AM J PUBLIC HEALTH, V93, P461, DOI 10.2105/AJPH.93.3.461; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Penson DF, 2001, J CLIN EPIDEMIOL, V54, P350, DOI 10.1016/S0895-4356(00)00312-7; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wijtzes AI, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0155-3; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zuckerman SL, NEUROSURG FOCUS, V40, pE13	33	16	16	1	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2017	19	6					652	661		10.3171/2017.1.PEDS16611			10	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	EV6OW	WOS:000401889700006	28338445	Bronze			2021-06-18	
J	Ducharme-Crevier, L; Press, CA; Kurz, JE; Mills, MG; Goldstein, JL; Wainwright, MS				Ducharme-Crevier, Laurence; Press, Craig A.; Kurz, Jonathan E.; Mills, Michele G.; Goldstein, Joshua L.; Wainwright, Mark S.			Early Presence of Sleep Spindles on Electroencephalography Is Associated With Good Outcome After Pediatric Cardiac Arrest	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cardiac arrest; critical care outcomes; electroencephalography; sleep spindles	TRAUMATIC BRAIN-INJURY; INITIAL NEUROLOGIC EXAMINATION; PROGNOSTIC VALUE; CONTINUOUS EEG; CHILDREN; PREDICTION; FEATURES; COMA; COMBINATION; HYPOTHERMIA	Objectives: The role of sleep architecture as a biomarker for prognostication after resuscitation from cardiac arrest in children hospitalized in an ICU remains poorly defined. We sought to investigate the association between features of normal sleep architecture in children after cardiac arrest and a favorable neurologic outcome at 6 months. Design: Retrospective review of medical records and continuous electroencephalography monitoring. Setting: Cardiac and PICU of a tertiary children's hospital. Patients: All patients from 6 months to 18 years old resuscitated from cardiac arrest who underwent continuous electroencephalography monitoring in the first 24 hours after in-or out-of-hospital cardiac arrest from January 2010 to June 2015. Interventions: None. Measurements and Main Results: Thirty-four patients underwent continuous electroencephalography monitoring after cardiac arrest. The median age was 6.1 years (interquartile range, 1.5-12.5 yr), 20 patients were male (59%). Most cases (n = 23, 68%) suffered from in-hospital cardiac arrest. Electroencephalography monitoring was initiated a median of 9.3 hours (5.8-14.9 hr) after return of spontaneous circulation, for a median duration of 14.3 hours (6.0-16.0 hr) within the first 24-hour period after the cardiac arrest. Five patients had normal spindles, five had abnormal spindles, and 24 patients did not have any sleep architecture. The presence of spindles was associated with a favorable neurologic outcome at 6-month postcardiac arrest (p = 0.001). Conclusions: Continuous electroencephalography monitoring can be used in children to assess spindles in the ICU. The presence of spindles on continuous electroencephalography monitoring in the first 24 hours after resuscitation from cardiac arrest is associated with a favorable neurologic outcome. Assessment of sleep architecture on continuous electroencephalography after cardiac arrest could improve outcome prediction.	[Ducharme-Crevier, Laurence; Press, Craig A.; Kurz, Jonathan E.; Mills, Michele G.; Goldstein, Joshua L.; Wainwright, Mark S.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Feinberg Sch Med, Chicago, IL 60611 USA; [Kurz, Jonathan E.; Goldstein, Joshua L.; Wainwright, Mark S.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Neurol, Chicago, IL 60611 USA	Wainwright, MS (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Feinberg Sch Med, Chicago, IL 60611 USA.; Wainwright, MS (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Neurol, Chicago, IL 60611 USA.	m-wainwright@northwestern.edu	Press, Craig Adam/K-1307-2019; Ducharme-Crevier, Laurence/AAJ-6728-2020	Press, Craig Adam/0000-0003-4435-206X; Kurz, Jonathan/0000-0002-2259-4263	Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program; Lyndsey Whittingham Foundation; Sage Therapeutics	Supported, in part, by the Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program and by the Lyndsey Whittingham Foundation.; Dr. Wainwright received funding from Sage Therapeutics, received support for article research from the Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program and Lyndsey Whittingham Foundation, and disclosed that he was a scientific consultant to TransMed Systems. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Berry RB, 2016, AL AASM SCORING MANU; CHELIOUT-HERAUT F, 1991, Neurophysiologie Clinique, V21, P121, DOI 10.1016/S0987-7053(05)80066-8; Cheliout-Heraut F, 2001, NEUROPHYSIOL CLIN, V31, P283, DOI 10.1016/S0987-7053(01)00270-2; Cote KA, 2015, AIMS NEUROSCI, V2, P203, DOI 10.3934/Neuroscience.2015.4.203; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; Fink EL, 2013, NEUROCRIT CARE, V19, P31, DOI 10.1007/s12028-012-9706-0; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hofmeijer J, 2015, NEUROLOGY, V85, P137, DOI 10.1212/WNL.0000000000001742; Kessler SK, 2011, NEUROCRIT CARE, V14, P37, DOI 10.1007/s12028-010-9450-2; Manchester LC, 2016, J PEDIATR-US, V169, P28, DOI 10.1016/j.jpeds.2015.10.003; Mandel R, 2002, J PEDIATR-US, V141, P45, DOI 10.1067/mpd.2002.125005; Meyer L, 2012, CIRCULATION, V126, P1363, DOI 10.1161/CIRCULATIONAHA.111.076810; Moler FW, 2011, CRIT CARE MED, V39, P141, DOI 10.1097/CCM.0b013e3181fa3c17; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Nishisaki A, 2007, PEDIATR CRIT CARE ME, V8, P10, DOI 10.1097/01.pcc.0000256621.63135.4b; Ostendorf AP, 2016, PEDIATR CRIT CARE ME, V17, P667, DOI 10.1097/PCC.0000000000000791; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Topjian AA, 2016, PEDIATR CRIT CARE ME, V17, P547, DOI 10.1097/PCC.0000000000000740; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Youn CS, 2017, RESUSCITATION, V110, P120, DOI 10.1016/j.resuscitation.2016.10.024; Youn CS, 2015, RESUSCITATION, V94, P73, DOI 10.1016/j.resuscitation.2015.06.016	35	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2017	18	5					452	460		10.1097/PCC.0000000000001137			9	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	EW8BF	WOS:000402742400013	28328788				2021-06-18	
J	Hoffman, JR; Zuckerman, A; Ram, O; Sadot, O; Stout, JR; Ostfeld, I; Cohen, H				Hoffman, Jay R.; Zuckerman, Amitai; Ram, Omri; Sadot, Oren; Stout, Jeffrey R.; Ostfeld, Ishay; Cohen, Hagit			Behavioral and inflammatory response in animals exposed to a low-pressure blast wave and supplemented with beta-alanine	AMINO ACIDS			English	Article						Supplementation; Carnosine; Mild traumatic brain injury; GFAP BDNF	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROTROPHIC FACTOR; NEUROPEPTIDE-Y; MEMORY DEFICITS; SPATIAL MEMORY; HIPPOCAMPAL; MODEL; RAT; PTSD	This study investigated the benefit of beta-alanine (BA) supplementation on behavioral and cognitive responses relating to mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) in rats exposed to a low-pressure blast wave. Animals were fed a normal diet with or without (PL) BA supplementation (100 mg kg(-1)) for 30-day, prior to being exposed to a low-pressure blast wave. A third group of animals served as a control (CTL). These animals were fed a normal diet, but were not exposed to the blast. Validated cognitive-behavioral paradigms were used to assess both mTBI and PTSD-like behavior on days 7-14 following the blast. Brain-derived neurotrophic factor (BDNF), neuropeptide Y, glial fibrillary acidic protein (GFAP) and tau protein expressions were analyzed a day later. In addition, brain carnosine and histidine content was assessed as well. The prevalence of animals exhibiting mTBI-like behavior was significantly lower (p = 0.044) in BA than PL (26.5 and 46%, respectively), but no difference (p = 0.930) was noted in PTSD-like behavior between the groups (10.2 and 12.0%, respectively). Carnosine content in the cerebral cortex was higher (p = 0.048) for BA compared to PL, while a trend towards a difference was seen in the hippocampus (p = 0.058) and amygdala (p = 0.061). BDNF expression in the CA1 subregion of PL was lower than BA (p = 0.009) and CTL (p < 0.001), while GFAP expression in CA1 (p = 0.003) and CA3 (p = 0.040) subregions were higher in PL than other groups. Results indicated that BA supplementation for 30-day increased resiliency to mTBI in animals exposed to a low-pressure blast wave.	[Hoffman, Jay R.; Stout, Jeffrey R.] Univ Cent Florida, Burnett Sch Biomed Sci, Inst Exercise Physiol & Wellness Sport & Exercise, Orlando, FL 32816 USA; [Zuckerman, Amitai; Cohen, Hagit] Ben Gurion Univ Negev, Beer Sheva Mental Hlth Ctr, Fac Hlth Sci, Div Psychiat,Anxiety & Stress Res Unit, Beer Sheva, Israel; [Ram, Omri; Sadot, Oren] Ben Gurion Univ Negev, Dept Mech Engn, Beer Sheva, Israel; [Ostfeld, Ishay] Med Corps, Israel Def Forces, Tel Aviv, Israel	Hoffman, JR (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Inst Exercise Physiol & Wellness Sport & Exercise, Orlando, FL 32816 USA.	jay.hoffman@ucf.edu	ostfeld, ishay/AAC-3781-2020; Hoffman, Jay/AAF-2005-2019; Stout, Jeffrey R/F-5805-2014	Hoffman, Jay/0000-0002-0073-6603; Stout, Jeffrey R/0000-0001-6114-1649; Sadot, Oren/0000-0002-2627-550X	Natural Alternatives International (Carlsbad, CA, USA)	The authors would like to thank Natural Alternatives International (Carlsbad, CA, USA) for providing support for this study.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bellia F, 2014, MOLECULES, V19, P2299, DOI 10.3390/molecules19022299; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Casetta B, 2000, CLIN CHEM LAB MED, V38, P391, DOI 10.1515/CCLM.2000.057; Chesnoy-Marchais D, 2016, NEUROSCIENCE, V330, P191, DOI 10.1016/j.neuroscience.2016.05.048; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 2010, J NEUROENDOCRINOL, V22, P889, DOI 10.1111/j.1365-2826.2010.02003.x; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2014, EUR NEUROPSYCHOPHARM, V24, P1925, DOI 10.1016/j.euroneuro.2014.09.009; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Croce N, 2012, ACS CHEM NEUROSCI, V3, P312, DOI 10.1021/cn200127e; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; dos Santos VV, 2013, BEHAV BRAIN RES, V244, P107, DOI 10.1016/j.bbr.2013.01.039; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gotzsche CR, 2016, NEUROPEPTIDES, V55, P79, DOI 10.1016/j.npep.2015.09.010; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Hoffman JR, 2015, MED SCI SPORT EXER, V47, P2043, DOI 10.1249/MSS.0000000000000642; Hoffman JR, 2015, AMINO ACIDS, V47, P1247, DOI 10.1007/s00726-015-1952-y; Hoge CW, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Koponen E, 2004, MOL BRAIN RES, V130, P81, DOI 10.1016/j.molbrainres.2004.07.010; Kozlovsky N, 2007, INT J NEUROPSYCHOPH, V10, P741, DOI 10.1017/S1461145707007560; KUNZE N, 1986, EUR J BIOCHEM, V160, P605, DOI 10.1111/j.1432-1033.1986.tb10081.x; Malva JO, 2012, NEUROPEPTIDES, V46, P299, DOI 10.1016/j.npep.2012.09.001; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Ozawa T, 2014, BEHAV BRAIN RES, V263, P210, DOI 10.1016/j.bbr.2014.01.034; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Ram O, 2012, EXP FLUIDS, V53, P1335, DOI 10.1007/s00348-012-1339-8; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	60	16	19	0	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	MAY	2017	49	5					871	886		10.1007/s00726-017-2383-8			16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ER9VV	WOS:000399176200003	28161798	Other Gold, Green Published			2021-06-18	
J	Kenardy, J; Heron-Delaney, M; Hendrikz, J; Warren, J; Edmed, SL; Brown, E				Kenardy, Justin; Heron-Delaney, Michelle; Hendrikz, Joan; Warren, Jacelle; Edmed, Shannon L.; Brown, Erin			Recovery trajectories for long-term health-related quality of life following a road traffic crash injury: Results from the UQ SuPPORT study	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Quality of life; Road traffic crash; Posttraumatic stress disorder	INTERNATIONAL DIAGNOSTIC INTERVIEW; TRAUMATIC BRAIN-INJURY; WHIPLASH INJURY; SEVERITY SCORE; MENTAL-HEALTH; ESPARR COHORT; 1ST YEAR; OUTCOMES; PREDICTORS; EMERGENCY	Background: Diminished physical and mental health-related quality of life (HRQoL) is a common consequence of road traffic crash (RTC) injury. This study aimed to (a) determine the probable recovery trajectories in physical and mental HRQoL; (b) examine the impact of posttraumatic stress disorder (PTSD) on HRQoL scores within these trajectory groups; and (c) examine the influence of predictor covariates on trajectory group membership. Methods: 336 (63% female, M-age = 44.72; SD = 14.77) injured RTC survivors completed the SF-36v2 at approximately 6, 12, and 24 months after sustaining a RTC injury. Participants also completed telephone interviews to assess prior history of psychological disorder and current PTSD at each wave. Results: Three trajectories were identified for SF-36v2 Physical Component Score (PCS): "gradual recovery" (27.3%);"low but improving" (54.7%); and "severe and chronic" (17.9%). Four trajectories were defined for SF36v2 Mental Component Score (MCS): "unaffected" (19.1%);"severe but improving" (24.1%);"severe and declining" (17.3%); and"low but improving" (39.5%). A PTSD diagnosis significantly reduced SF36v2 component scores only in trajectories associated with poorer outcome. Age was predictive of trajectory group membership for PCS, whereas injury severity was predictive of trajectory group membership for MCS. Limitations: Use of a compensation seeking sample affects generalizability to the general RTC population. Conclusions: This study identified a concerning subgroup of individuals who have chronic and/or declining physical and mental HRQoL that can be impacted by a diagnosis of PTSD. The development of interventions with a special focus on associated psychological injury is needed to improve the HRQoL of at-risk individuals following RTC injury.	[Kenardy, Justin; Hendrikz, Joan; Warren, Jacelle; Edmed, Shannon L.; Brown, Erin] Univ Queensland, Recover Injury Res Ctr, Brisbane, Qld, Australia; [Kenardy, Justin] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Heron-Delaney, Michelle] Australian Catholic Univ, Sch Psychol, Brisbane, Qld, Australia	Kenardy, J (corresponding author), UQ Oral Hlth Ctr, Level 7,288 Herston Rd, Herston, Qld 4006, Australia.	j.kenardy@uq.edu.au	Warren, Jacelle/G-2125-2010; Kenardy, Justin/F-2085-2010; Kenardy, Justin A/H-6603-2014; Heron-Delaney, Michelle/M-7540-2014	Warren, Jacelle/0000-0002-2273-1846; Kenardy, Justin A/0000-0001-9475-8450; Heron-Delaney, Michelle/0000-0003-1332-9385	Motor Accident Insurance Commission (MAIC)	This research was funded by the Motor Accident Insurance Commission (MAIC), however, the views in this paper do not necessarily reflect those of the funder.	Alghnam S, 2014, QUAL LIFE RES, V23, P119, DOI 10.1007/s11136-013-0444-3; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRESLAU N, 1998, INT J METH PSYCH RES, V7, P121, DOI DOI 10.1002/MPR.41; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Economic Commission for Europe, 1995, STAT ROAD TRAFF ACC; Fitzharris M, 2010, AUST NZ J PUBL HEAL, V34, P153, DOI 10.1111/j.1753-6405.2010.00500.x; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; Gopinath B, 2015, INJURY, V46, P909, DOI 10.1016/j.injury.2015.01.002; Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Nhac-Vu HT, 2014, TRAFFIC INJ PREV, V15, P138, DOI 10.1080/15389588.2013.804180; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Hours M, 2014, J RHEUMATOL, V41, P528, DOI 10.3899/jrheum.130406; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kenardy J, 2015, INJURY, V46, P883, DOI 10.1016/j.injury.2014.11.006; Kenardy J, 2015, ARCH PHYS MED REHAB, V96, P410, DOI 10.1016/j.apmr.2014.10.007; Kenardy J, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.22612; Khati I, 2013, J TRAUMA ACUTE CARE, V74, P301, DOI 10.1097/TA.0b013e318270d967; Littleton SM, 2011, INJURY, V42, P927, DOI 10.1016/j.injury.2010.02.011; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Organization W H, 2013, WHO GLOB STAT REP RO; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Smith B, 2007, COUNS PSYCHOL Q, V20, P149, DOI 10.1080/09515070701403679; Sterling M, 2003, PAIN, V106, P481, DOI 10.1016/j.pain.2003.09.013; Ware JE., 2000, SCORE VERSION 2 SF 3; WARE JE, 1993, SF 36 HLTH SURV MAN	38	16	16	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	MAY	2017	214						8	14		10.1016/j.jad.2017.02.031			7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	ET1NY	WOS:000400037300002	28260620				2021-06-18	
J	Neumann, D; Malec, JF; Hammond, FM				Neumann, Dawn; Malec, James F.; Hammond, Flora M.			The Relations of Self-Reported Aggression to Alexithymia, Depression, and Anxiety After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; alexithymia; anxiety; brain injury; depression; emotion	IMPULSIVE AGGRESSION; EMOTION RECOGNITION; FACIAL EXPRESSIONS; HEAD-INJURY; ANGER; MANAGEMENT; BEHAVIOR; VALIDITY; PEOPLE; IMPACT	Objectives: To compare self-reported aggression in people with and without traumatic brain injury (TBI) and examine the relations of aggression to alexithymia (poor emotional insight), depression, and anxiety. Setting: Rehabilitation hospital. Participants: Forty-six adults with moderate to severe TBI who were at least 3 months postinjury; 49 healthy controls (HCs); groups were frequency matched for age and gender. Design: Cross-sectional study using a quasi-experimental design. Main Measures: Aggression (Buss-Perry Aggression Questionnaire); alexithymia (Toronto Alexithymia Scale-20); depression (Patient Health Questionnaire-9); and trait anxiety (State-Trait Anxiety Inventory). Results: Participants with TBI had significantly higher aggression scores than HCs. For participants with TBI, 34.2% of the adjusted variance of aggression was significantly explained by alexithymia, depression, and anxiety; alexithymia accounted for the largest unique portion of the variance in this model (16.2%). Alexithymia, depression, and anxiety explained 46% of the adjusted variance of aggression in HCs; in contrast to participants with TBI, depression was the largest unique contributor to aggression (15.9%). Conclusion: This was the first empirical study showing that poor emotional insight (alexithymia) significantly contributes to aggression after TBI. This relation, and the potential clinical implications it may have for the treatment of aggression, warrants further investigation.	[Neumann, Dawn; Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA	Neumann, D (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu			National Institute on Disability, Independent Living, and Rehabilitation Research Switzer Research Fellowships Program Priority (CFDA) [84.133F-1]; Indiana Spinal Cord and Brain Injury Research Fund; Indiana University Brain Rehabilitation, Advanced Imaging, and Neuroscience Signature Center Initiative; National Institutes of Health, NICHD STTR [1R41HD077967-01A1]	This research was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research Switzer Research Fellowships Program Priority (CFDA no. 84.133F-1); the Indiana Spinal Cord and Brain Injury Research Fund; and the Indiana University Brain Rehabilitation, Advanced Imaging, and Neuroscience Signature Center Initiative.; Dr Dawn Neumann is a small business owner that currently receives federal grant funding from the National Institutes of Health, NICHD STTR (grant no. 1R41HD077967-01A1), to develop and investigate an intervention related to concepts discussed in this article.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bagby RM, 1997, DISORDERS AFFECT REG, P26, DOI DOI 10.1017/CBO9780511526831.005; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Berenbaum H, 1996, PSYCHOTHER PSYCHOSOM, V65, P203, DOI 10.1159/000289076; Besharat MA, 2010, PROCD SOC BEHV, V5, P614, DOI 10.1016/j.sbspro.2010.07.152; BURKE WH, 1988, INT J REHABIL RES, V11, P235, DOI 10.1097/00004356-198809000-00003; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Einspruch BC, 1998, JAMA-J AM MED ASSOC, V279, P555; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; Fakra E, 2008, SCHIZOPHR RES, V100, P191, DOI 10.1016/j.schres.2007.11.040; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Foland-Ross LC, 2010, J NEUROSCI, V30, P16673, DOI 10.1523/JNEUROSCI.4578-09.2010; Greve KW, 2001, BRAIN INJURY, V15, P255; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harris JA, 1997, J BUS PSYCHOL, V12, P39, DOI 10.1023/A:1025058032195; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; HOLM S, 1979, SCAND J STAT, V6, P65; Holtzworth-Munroe A, 2001, BEHAV THER, V31, P603; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Jessimer M, 1997, BRAIN COGNITION, V34, P246, DOI 10.1006/brcg.1997.0900; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kokkonen P, 2001, COMPR PSYCHIAT, V42, P471, DOI 10.1053/comp.2001.27892; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Levant R.F., 2009, J MENS STUDIES, V17, P75, DOI DOI 10.3149/JMS.1701.75; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2011, BRAIN IMPAIR, V12, P165; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Messina A, 2014, J PSYCHOPATHOL, V20, P38; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Palmer EJ, 2005, AGGRESSIVE BEHAV, V31, P56, DOI 10.1002/ab.20072; Prince L, 2012, 9 C NEUR REH SPEC IN; Sansone RA, 2013, COMPR PSYCHIAT, V54, P70, DOI 10.1016/j.comppsych.2012.06.005; Spielberger C.D., 1970, STATE TRAIT ANXIETY; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Teten AL, 2008, BEHAV SCI LAW, V26, P823, DOI 10.1002/bsl.843; Velasco C, 2006, PSICOTHEMA, V18, P89; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029	69	16	16	2	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					205	213		10.1097/HTR.0000000000000261			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900007	28476059				2021-06-18	
J	Scheenen, ME; van der Horn, HJ; de Koning, ME; van der Naalt, J; Spikman, JM				Scheenen, Myrthe E.; van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje; Spikman, Jacoba M.			Stability of coping and the role of self-efficacy in the first year following mild traumatic brain injury	SOCIAL SCIENCE & MEDICINE			English	Article						Mild traumatic brain injury; Coping; Stability; Self-efficacy	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; SOCIAL SUPPORT; BREAST-CANCER; STRATEGIES; PERSONALITY; VALIDITY; STRESS; STYLES; HEALTH	Background and aims: Coping, the psychological adaptation to stressors and serious life events, has been found to have a great influence on the development and persistence of posttraumatic complaints. Coping has received much attention for having been found to be modifiable in treatment following mild traumatic brain injury (mTBI) and for its potential to identify the Patients who are at risk of suffering from long-term complaints. Currently, coping styles are assumed to be stable over time. Although interventions to facilitate adaptive coping are given at different time intervals after the injury, little is known about spontaneous changes in preferred strategies over time following mTBI. This study aimed to investigate the stability of different coping styles over a one-year period following mTBI (at two weeks', six and twelve months' post-injury) and to investigate the relation between coping styles and feelings of self-efficacy. Methods: We included 425 mTBI patients (Glasgow Coma Scale [GCS] score 13-15) admitted to three Level-1 trauma centers in the Netherlands as part of a prospective follow-up study. All participants filled out The Utrecht Coping List (UCL) to determine their position on seven coping subscales. Results: Most coping styles showed a decrease over time, except for positive reframing, which showed a decrease and then increased. Interestingly, the passive coping style was found to stabilize over time within the year after injury. High feelings of self-efficacy were related to a high active coping style (r = 0.36), and low feelings of self-efficacy with passive coping (r =-032). Conclusions: These results hold important possibilities for the use of the passive coping strategy as an inclusion criterion for intervention studies and an entry point for treatment itself. Considering the intertwinement of coping with self-efficacy, improving feelings of self-efficacy could form an effective part of an intervention to improve outcome. (C) 2017 Elsevier Ltd. All rights reserved.	[Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands	van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	m.e.scheenen@umcg.nl; h.j.van.der.horn@umcg.nl; m.e.de.koning@umcg.nl; j.van.der.naalt@umcg.nl; j.m.spikman@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation (Hersenstichting Nederland) [PS2012-06]; Dutch Brain Foundation	This study is funded by the Dutch Brain Foundation (PS2012-06) (Hersenstichting Nederland). The Dutch Brain Foundation is a charitable foundation that supports projects that promote recovery and quality of life of TBI patients in the Netherlands. The funders did not peer review the study, and had no role in study design, data collection, decision to publish or preparation of the article.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bandura A., 2010, ENCY HUMAN BEHAV, V4th, P1534; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bonnett G. D., 2010, Proceedings of the 2010 Conference of the Australian Society of Sugar Cane Technologists held at Bundaberg, Queensland, Australia, 11-14 May 2010, P1; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Corporation IBM, 2013, IBM SPSS STAT WINDOW; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2006, BRAIN COGNITION, V60, P214; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; DeLongis A, 2005, J PERS, V73, P1633, DOI 10.1111/j.1467-6494.2005.00361.x; Eisenbarth C., 2012, N AM J PSYCHOL, V14, P485; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Geyer S, 2015, SOC SCI MED, V135, P92, DOI 10.1016/j.socscimed.2015.04.027; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; HEIM E, 1993, J PSYCHOSOM RES, V37, P523, DOI 10.1016/0022-3999(93)90008-4; KENDALL E, 2001, BRAIN IMPAIR, V2, P81; King C.Y, 2008, THESIS; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Lazarus R.S., 1984, STRESS APPRAISAL COP; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Nielsen MB, 2014, SCAND J PSYCHOL, V55, P142, DOI 10.1111/sjop.12103; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Regier N. G., 2015, AGING MENT HEALTH, P1; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Schophaus M., 2000, SELF EFFICACY RAW DA; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Schwarzer R, 1995, MEASURES HLTH PSYCHO, P35; Schwarzer R., 2013, RESILIENCE CHILDREN, P139, DOI DOI 10.1007/978-1-4614-4939-3_10; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; TEASDALE G, 1974, LANCET, V2, P81; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Verhage F, 1964, THESIS; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	16	16	1	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	MAY	2017	181						184	190		10.1016/j.socscimed.2017.03.025			7	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	EU7JL	WOS:000401211000021	28381344				2021-06-18	
J	Suzuki, Y; Khoury, S; El-Khatib, H; Chauny, JM; Paquet, J; Giguere, JF; Denis, R; Gosselin, N; Lavigne, GJ; Arbour, C				Suzuki, Yoshitaka; Khoury, Samar; El-Khatib, Hejar; Chauny, Jean-Marc; Paquet, Jean; Giguere, Jean-Francois; Denis, Ronald; Gosselin, Nadia; Lavigne, Gilles J.; Arbour, Caroline			Individuals with pain need more sleep in the early stage of mild traumatic brain injury	SLEEP MEDICINE			English	Article						Traumatic brain injury; Pain; Sleep; Actigraphy	PSYCHOMETRIC PROPERTIES; HEALTH SURVEY; QUALITY; HYPERSOMNIA; PREVALENCE; INVENTORY; SYMPTOMS; HEADACHE	Objective: Hypersomnia is frequently reported after mild traumatic brain injury (mTBI), but its cause(s) remain elusive. This study examined sleep/wake activity after mTBI and its association with pain, a comorbidity often associated with insomnia. Methods: Actigraphy recording was performed for 7 2 consecutive days in 56 individuals at one month post-mTBI (64% male; 38 +/- 12 years), 24 individuals at one year post-mTBI (58% male; 44 +/- 11years), and in 20 controls (50% male; 37 12 years). Pain intensity and its effect on quality of life was assessed with a visual analogue scale and the Short Form Health Survey (SF-36) bodily pain subscale. Results: Overall, few differences in sleep/wake patterns were found between mTBI patients and controls. However, higher percentages of mTBI individuals with moderate-to-severe pain were found to require more than eight hours of sleep per day (37% vs11%; p = 0.04) and to be frequent nappers (defined as those who took three or more naps per week) (42% vs 22%; p = 0.04) compared to those with mild or no pain at one month postinjury. Correcting for age and depression, The SF-36 score was found to be a significant predictor of sleep duration exceeding eight hours per day at one month (odds ratio = 0.95; 95% confidence interval = 0.92-0.99; p = 0.01), but not at one year post-mTBI. Pain and increased sleep need (in terms of hours per day or napping frequency) were found to co-exist in as much as 29% of mTBI patients at one month postinjury. Conclusion: Pain could be associated with more pronounced sleep need in about one-third of mTBI patients during early recovery. Unalleviated pain, found in more than 60% of mTBI patients, should therefore be looked for in all mTBI patients reporting new onset of sleep disorder, not only in those with insomnia. (C) 2016 Elsevier B.V. All rights reserved.	[Suzuki, Yoshitaka; El-Khatib, Hejar; Chauny, Jean-Marc; Paquet, Jean; Giguere, Jean-Francois; Denis, Ronald; Gosselin, Nadia; Lavigne, Gilles J.; Arbour, Caroline] Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Suzuki, Yoshitaka; Lavigne, Gilles J.] Univ Montreal, Fac Dent Med, Montreal, PQ, Canada; [Khoury, Samar] McGill Univ, Fac Dent, Montreal, PQ, Canada; [El-Khatib, Hejar; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Arbour, Caroline] Univ Montreal, Fac Nursing, Montreal, PQ, Canada	Arbour, C (corresponding author), Hop Sacre Coeur Montreal, Montreal, PQ, Canada.; Arbour, C (corresponding author), Univ Montreal, Fac Nursing, Montreal, PQ, Canada.	caroline.arbour@umontreal.ca			Quebec Pain Research Network of the Fonds de Recherche du Quebec-Sante (FRQ-S); trauma fund (R. Denis Foundation); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [115172]; Canada Research Chair on Pain, Sleep, and Traumatic Injuries	The authors would like to thank J.F.G. for his work on confirming mTBI diagnoses. This study was funded by the Quebec Pain Research Network of the Fonds de Recherche du Quebec-Sante (FRQ-S), a trauma fund (R. Denis Foundation), and our Hospital's Research Centre. Part of this study was also supported by the Canadian Institutes of Health Research (CIHR grant 115172) to N.G. G.L. holds a Canada Research Chair on Pain, Sleep, and Traumatic Injuries.	American Academy of Sleep Medicine, 2014, ICSD 3 INT CLASS SLE; Barloese M, 2015, CEPHALALGIA, V35, P869, DOI 10.1177/0333102414562971; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Boivin DB, 2004, SLEEP, V27, P417, DOI 10.1093/sleep/27.3.417; Boyne K, 2013, SLEEP BREATH, V17, P411, DOI 10.1007/s11325-012-0709-z; Buchanan DT, 2014, J CLIN SLEEP MED, V10, P1003, DOI 10.5664/jcsm.4038; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Carney N, 2014, NEUROSURGERY, V75, pS1, DOI 10.1227/NEU.0000000000000434; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dauvilliers Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-78; Dauvilliers Yves, 2005, Dialogues Clin Neurosci, V7, P347; Doan L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/504691; Faul M.D., 2010, TRAUMATIC BRAIN INJU; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Kosinski M, 1999, MED CARE, V37, pMS10, DOI 10.1097/00005650-199905001-00002; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Sleep Foundation (NSF), 2005, AD SLEEP HAB; Orlando JA, 1986, PAVLOVIAN J BIOL SCI, V21, P50; Pollak C. P., 2009, ENCY SLEEP SLEEP DIS; Quinto C, 2000, NEUROLOGY, V54, P250, DOI 10.1212/WNL.54.1.250; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Stone KL., 2011, PRINCIPLES PRACTICE, P1668, DOI [10.1016/B978-1-4160-6645-3.00147-X, DOI 10.1016/B978-1-4160-6645-3.00147-X]; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	39	16	16	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAY	2017	33						36	42		10.1016/j.sleep.2016.06.033			7	Clinical Neurology	Neurosciences & Neurology	EV3SS	WOS:000401680000007	28449903				2021-06-18	
J	Weinstein, AA; Chin, LMK; Collins, J; Goel, D; Keyser, RE; Chan, L				Weinstein, Ali A.; Chin, Lisa M. K.; Collins, John; Goel, Divya; Keyser, Randall E.; Chan, Leighton			Effect of Aerobic Exercise Training on Mood in People With Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affect; brain injuries; exercise therapy; rehabilitation	PHYSICAL-ACTIVITY; MODERATE EXERCISE; AFFECTIVE RESPONSES; SELF-EFFICACY; UNITED-STATES; PROFILE; INDIVIDUALS; DEPRESSION; HEALTH; EPIDEMIOLOGY	Background: Exercise training is associated with elevations in mood in patients with various chronic illnesses and disabilities. However, little is known regarding the effect of exercise training on short and long-term mood changes in those with traumatic brain injury (TBI). Objective: The purpose of this study was to examine the time course of mood alterations in response to a vigorous, 12-week aerobic exercise training regimen in ambulatory individuals with chronic TBI (>6 months postinjury). Methods: Short and long-term mood changes were measured using the Profile of Mood States-Short Form, before and after specific aerobic exercise bouts performed during the 12-week training regimen. Results: Ten subjects with nonpenetrating TBI (6.6 6.8 years after injury) completed the training regimen. A significant improvement in overall mood was observed following 12 weeks of aerobic exercise training (P = .04), with moderate to large effect sizes observed for short-term mood improvements following individual bouts of exercise. Conclusions: Specific improvements in long-term mood state and short-term mood responses following individual exercise sessions were observed in these individuals with TBI. The largest improvement in overall mood was observed at 12 weeks of exercise training, with improvements emerging as early as 4 weeks into the training regimen.	[Weinstein, Ali A.; Goel, Divya] George Mason Univ, Ctr Study Chron Illness & Disabil, 4400 Univ Dr MS 2G7, Fairfax, VA 22030 USA; [Chin, Lisa M. K.; Collins, John; Keyser, Randall E.] George Mason Univ, Coll Hlth & Human Serv, Dept Rehabil Sci, 4400 Univ Dr MS 2G7, Fairfax, VA 22030 USA; [Chin, Lisa M. K.; Collins, John; Keyser, Randall E.; Chan, Leighton] NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA; [Chan, Leighton] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Chin, LMK (corresponding author), George Mason Univ, Coll Hlth & Human Serv, Dept Rehabil Sci, 4400 Univ Dr MS 2G7, Fairfax, VA 22030 USA.	lchin2@gmu.edu	Chin, Lisa MK/O-4706-2014	Chin, Lisa MK/0000-0002-0178-739X; Collins, John/0000-0002-3863-0329; Weinstein, Ali/0000-0002-3371-6086	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G192HI-H]; Intramural Research Program of the National Institutes of Health, Clinical Center (Rehabilitation Medicine Department intramural funds)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Support for this work included funding from Department of Defense in the Center for Neuroscience and Regenerative Medicine (grant no. G192HI-H) and the Intramural Research Program of the National Institutes of Health, Clinical Center (Rehabilitation Medicine Department intramural funds).	Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Bellon K, 2014, BRAIN INJURY, V29, P1; Berger BG, 2000, J APPL SPORT PSYCHOL, V12, P69, DOI 10.1080/10413200008404214; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bodin T, 2004, J SPORT EXERCISE PSY, V26, P623, DOI 10.1123/jsep.26.4.623; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chin LMK, 2015, J HEAD TRAUMA REHAB, V30, P382, DOI 10.1097/HTR.0000000000000062; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; CRAMER SR, 1991, J PSYCHOSOM RES, V35, P437, DOI 10.1016/0022-3999(91)90039-Q; Cunningham LLC, 1998, HEALTH PSYCHOL, V17, P371, DOI 10.1037/0278-6133.17.4.371; CURRAN SL, 1995, PSYCHOL ASSESSMENT, V7, P80, DOI 10.1037/1040-3590.7.1.80; DiLorenzo TM, 1999, PREV MED, V28, P75, DOI 10.1006/pmed.1998.0385; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Ernst C, 2006, J PSYCHIATR NEUROSCI, V31, P84; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Faul M, 2010, TRAUMATIC BRAIN INJU, P74; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Guszkowska Monika, 2004, Psychiatr Pol, V38, P611; HASKELL WL, 1994, MED SCI SPORT EXER, V26, P649, DOI 10.1249/00005768-199406000-00001; Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597; Hay EL, 2010, PSYCHOL AGING, V25, P118, DOI 10.1037/a0018747; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LeUnes A, 2000, J APPL SPORT PSYCHOL, V12, P5, DOI 10.1080/10413200008404210; Lutgendorf SK, 1999, J GERONTOL A-BIOL, V54, pM434, DOI 10.1093/gerona/54.9.M434; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MARTINSEN EW, 1990, SPORTS MED, V9, P380, DOI 10.2165/00007256-199009060-00006; McCabe MP, 2009, J CLIN PSYCHOL MED S, V16, P355, DOI 10.1007/s10880-009-9168-5; McGuirk M., MOOD ANXIETY RPE MHR; McNair D, 1971, MANUAL PROFILE MOOD; Monshouwer K, 2013, CLIN PSYCHOL SCI, V1, P67, DOI 10.1177/2167702612450485; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Ryan MP, 2008, PSYCHOL HEALTH, V23, P279, DOI 10.1080/14768320601185502; Rzezak P, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00839; Schrepf A, 2013, BRAIN BEHAV IMMUN, V30, pS126, DOI 10.1016/j.bbi.2012.07.022; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; Stanton JM, 1996, J PSYCHOSOM RES, V40, P637, DOI 10.1016/0022-3999(95)00643-5; Stark R, 2012, NEUROPSYCHIATRIE, V26, P166, DOI 10.1007/s40211-012-0033-7; Szabo Attila, 2003, J Sports Sci Med, V2, P77; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; Unick JL, 2012, PSYCHOL SPORT EXERC, V13, P528, DOI 10.1016/j.psychsport.2012.02.012; Van Schaik P, 2008, CYBERPSYCHOL BEHAV, V11, P103, DOI 10.1089/cpb.2007.9925; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841; Weinstein A. A., 2014, POSITIVE HUMAN FUNCT, V2, P147; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wolfe GI, 2004, MUSCLE NERVE, V30, P3, DOI 10.1002/mus.20057; Wolman RL, 1994, CLIN REHABIL, V8, P253; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	66	16	17	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					E49	E56		10.1097/HTR.0000000000000253			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900012	27603762	Green Accepted			2021-06-18	
J	Giorgi-Coll, S; Amaral, AI; Hutchinson, PJA; Kotter, MR; Carpenter, KLH				Giorgi-Coll, Susan; Amaral, Ana I.; Hutchinson, Peter J. A.; Kotter, Mark R.; Carpenter, Keri L. H.			Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ENERGY-METABOLISM; MICRODIALYSIS; MECHANISMS; ASTROCYTES; CHEMISTRY; RISK	Mitochondrial dysfunction, the inability to efficiently utilise metabolic fuels and oxygen, contributes to pathological changes following traumatic spinal cord or traumatic brain injury (TBI). In the present study, we tested the hypothesis that succinate supplementation can improve cellular energy state under metabolically stressed conditions in a robust, reductionist in vitro model of mitochondrial dysfunction in which primary mixed glial cultures (astrocytes, microglia and oligodendrocytes) were exposed to the mitochondrial complex I inhibitor rotenone. Cellular response was determined by measuring intracellular ATP, extracellular metabolites (glucose, lactate, pyruvate), and oxygen consumption rate (OCR). Rotenone produced no significant changes in glial ATP levels. However, it induced metabolic deficits as evidenced by lactate/pyruvate ratio (LPR) elevation (a clinically-established biomarker for poor outcome in TBI) and decrease in OCR. Succinate addition partially ameliorated these metabolic deficits. We conclude that succinate can improve glial oxidative metabolism, consistent our previous findings in TBI patients' brains. The mixed glial cellular model may be useful in developing therapeutic strategies for conditions involving mitochondrial dysfunction, such as TBI.	[Giorgi-Coll, Susan; Hutchinson, Peter J. A.; Kotter, Mark R.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Amaral, Ana I.; Kotter, Mark R.] Univ Cambridge, Anne McLaren Lab, Wellcome Trust MRC Cambridge Stem Cell Inst, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England; [Amaral, Ana I.; Kotter, Mark R.] Univ Cambridge, Dept Clin Neurosci, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England	Giorgi-Coll, S; Kotter, MR; Carpenter, KLH (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Kotter, MR (corresponding author), Univ Cambridge, Anne McLaren Lab, Wellcome Trust MRC Cambridge Stem Cell Inst, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England.; Kotter, MR (corresponding author), Univ Cambridge, Dept Clin Neurosci, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England.	sv377@cam.ac.uk; mrk25@cam.ac.uk; klc1000@wbic.cam.ac.uk		Carpenter, Keri/0000-0001-8236-7727	UK Multiple Sclerosis Society; Qatar Foundation; core funding from the Wellcome Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, CS-2015-15-023] Funding Source: researchfish	This work was supported by grants from the UK Multiple Sclerosis Society and from Qatar Foundation. The work was further supported by core funding from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. Authors' support: AIA - UK Multiple Sclerosis Society; SGC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); PJAH - National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge. MRK - National Institute for Health Research Clinician Scientist Award. The authors also acknowledge Mr Matthew Stovell (Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge) for fruitful discussions. We also acknowledge Dr Tony Vidal's lab (Institute of Metabolic Science, University of Cambridge) for the access to the XF24 Flux Analyser and, in particular, Dr Sergio Rodriguez-Cuenca for the technical support and fruitful discussions regarding the implementation of the OCR-based assays. We also thank Nicholas Howe (Agilent Technologies UK Ltd) for advice on analysis of data acquired on the Seahorse Flux Analyser.	Amaral AI, 2016, GLIA, V64, P21, DOI 10.1002/glia.22900; Berg J.M., 2002, BIOCHEMISTRY; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529; Falkowska A, 2015, INT J MOL SCI, V16, P25959, DOI 10.3390/ijms161125939; Ferreira FL, 2000, HORM METAB RES, V32, P335, DOI 10.1055/s-2007-978647; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hertz L, 2015, METAB BRAIN DIS, V30, P317, DOI 10.1007/s11011-014-9536-1; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; Okon EB, 2013, J NEUROTRAUM, V30, P1564, DOI 10.1089/neu.2013.2956; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Protti A, 2006, CRITICAL CARE, V10, P1, DOI DOI 10.1186/CC5014; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	27	16	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 21	2017	7								1003	10.1038/s41598-017-01149-w			9	Multidisciplinary Sciences	Science & Technology - Other Topics	ET0SD	WOS:000399972900002	28432362	DOAJ Gold, Green Published			2021-06-18	
J	Vargas, BB; Shepard, M; Hentz, JG; Kutyreff, C; Hershey, LG; Starling, AJ				Vargas, Bert B.; Shepard, Morgan; Hentz, Joseph G.; Kutyreff, Cherisse; Hershey, L. George; Starling, Amaal J.			Feasibility and accuracy of teleconcussion for acute evaluation of suspected concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DIAGNOSIS; NEUROLOGY	Objective: To assess the feasibility and accuracy of telemedical concussion evaluations (teleconcussion) for real-time athletic sideline assessment of concussion, as such assessment may address the gap in access some populations of athletes have to providers with expertise in concussion evaluation. Methods: A cohort of 11 consecutive male collegiate football players with suspected concussion was assessed using Standardized Assessment of Concussion (SAC), King-Devick test (K-D), and modified Balance Error Scoring System (mBESS). A remote neurologist assessed each athlete using a telemedicine robot with real-time, 2-way audiovisual capabilities, while a sideline provider performed a simultaneous face-to-face assessment. After the assessment, a remove-from-play (RFP) determination was made. The remote and the face-to-face providers were blinded to each other's examination findings and RFP decision until the end of the assessment. Results: The teleconcussion and face-to-face SAC were in agreement 100% of the time (6/6; 95% confidence interval [CI] 54%-100%). The mean (SD) difference between remote and sideline K-D times was 0.7 (1.4) seconds. Remote and sideline K-D times were within a 3-second difference 100% of the time (11/11; 95% CI 72%-100%). Remote and sideline mBESS scores were within 3 points 100% of the time (6/6; 95% CI 54%-100%). RFP decisions were in agreement 100% of the time (11/11; 95% CI 72%-100%). Conclusions: The aim of this study was to investigate the feasibility of teleconcussion for sideline concussion assessments. These data suggest a high level of agreement between remote and face-to-face providers with regard to examination findings and RFP determinations.	[Vargas, Bert B.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Shepard, Morgan; Starling, Amaal J.] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ USA; [Hentz, Joseph G.] Mayo Clin Arizona, Dept Biostat, Scottsdale, AZ USA; [Kutyreff, Cherisse; Hershey, L. George] No Arizona Univ, Dept Sports Med, Flagstaff, AZ USA	Vargas, BB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	bert.vargas@UTSouthwestern.edu			Mayo Clinic Center for Innovation	No governmental sponsorship or funding was used for this study. This study was funded by the Mayo Clinic Center for Innovation.	Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Goodell Roger, 2014, Neurosurgery, V75 Suppl 4, pS119, DOI 10.1227/NEU.0000000000000498; Grosch MC, 2015, PSYCHIAT RES, V225, P734, DOI 10.1016/j.psychres.2014.12.040; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Mutgi SA, 2015, NEUROLOGY, V84, pE191, DOI 10.1212/WNL.0000000000001634; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Snyder TD, 2015, NCES2015011 US DEP E; Vargas BB, 2012, TELEMED E-HEALTH, V18, P803, DOI 10.1089/tmj.2012.0118; Yurkiewicz IR, 2012, NEUROLOGY, V79, P1237, DOI 10.1212/WNL.0b013e31826aac33	10	16	16	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 18	2017	88	16					1580	1583		10.1212/WNL.0000000000003841			4	Clinical Neurology	Neurosciences & Neurology	ES1NF	WOS:000399293600017	28341642	Bronze			2021-06-18	
J	Ferguson, S; Mouzon, B; Paris, D; Aponte, D; Abdullah, L; Stewart, W; Mullan, M; Crawford, F				Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Aponte, Destinee; Abdullah, Laila; Stewart, William; Mullan, Michael; Crawford, Fiona			Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; inflammation; therapeutic approaches for the treatment of CNS injury; traumatic brain injury	MICROGLIAL ACTIVATION; CLINICAL-TRIALS; MOUSE MODEL; HEAD-INJURY; INFLAMMATION; RECOVERY; NERVE	Traumatic brain injury (TBI) has chronic and long-term consequences for which there are currently no approved pharmacological treatments. We have previously characterized the chronic neurobehavioral and pathological sequelae of a mouse model of repetitive mild TBI (r-mTBI) through to 2 years post-TBI. Despite the mild nature of the initial insult, secondary injury processes are initiated that involve neuroinflammatory and neurodegenerative pathways persisting and progressing for weeks and months post-injury and providing a potential window of opportunity for therapeutic intervention. In this study we examined the efficacy of a novel anti-inflammatory compound, anatabine, in modifying outcome after TBI. Our model of r-mTBI involves a series of five mild impacts (midline impact at 5 m/sec, 1mm strike depth, 200 msec dwell time) with an interval of 48 h. Anatabine treatment was administered starting 30 min after injury and was delivered continuously through drinking water. At 6 months after TBI, anatabine treatment improved spatial memory in injured mice. Nine months after TBI, a cohort of mice was euthanized for pathological analysis that revealed reductions in astroglial (glial fibrillary acid protein, GFAP) and microglial (ionized calcium-binding adapter molecule 1, IBA1) responses in treated, injured animals. Treatments for the remaining mice were then crossed-over to assess the effects of late treatment administration and the effects of treatment termination. Nine months following crossover the remaining mice showed no effect of injury on their spatial memory, and whereas pathological analysis showed improvements in mice that had received delayed treatment, corpus callosum IBA1 increased in post-crossover placebo r-mTBI mice. These data demonstrate efficacy of both early and late initiation of treatment with anatabine in improving long term behavioral and pathology outcomes after mild TBI. Future studies will characterize the treatment window, the time course of treatment needed, and the dose needed to achieve therapeutic levels of anatabine in humans after injury.	[Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Aponte, Destinee; Abdullah, Laila; Mullan, Michael; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Stewart, William] Queen Elizabeth Glasgow Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Mullan, Michael] Rock Creek Pharmaceut, Sarasota, FL USA; [Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL USA	Ferguson, S (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	sferguson@rfdn.org		Stewart, William/0000-0003-2199-2582	Roskamp Foundation; VA Career Scientist Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS094003]; DODUnited States Department of Defense [PT110785]; NHS Research Scotland Career Researcher Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS038104] Funding Source: NIH RePORTER	This study was paid for by the Roskamp Foundation. Dr. Fiona Crawford holds a VA Career Scientist Award. Dr. William Stewart is supported by NIH grants NS038104 and NS094003, DOD grant PT110785, and by a NHS Research Scotland Career Researcher Fellowship.	Andersson C., 2003, NICOTINE ALKALOIDS S; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Thompson Hilaire J, 2005, Evid Based Nurs, V8, P51, DOI 10.1136/ebn.8.2.51; Thurman D, 2001, EPIDEMIOLOGY EC HEAD, V327, P347; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32	32	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1676	1691		10.1089/neu.2016.4636			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500019	27889957	Green Accepted, Green Published			2021-06-18	
J	Galetta, KM; Chapman, KR; Essis, MD; Alosco, ML; Gillard, D; Steinberg, E; Dixon, D; Martin, B; Chaisson, CE; Kowall, NW; Tripodis, Y; Balcer, LJ; Stern, RA				Galetta, Kristin M.; Chapman, Kimberly R.; Essis, Maritza D.; Alosco, Michael L.; Gillard, Danielle; Steinberg, Eric; Dixon, Diane; Martin, Brett; Chaisson, Christine E.; Kowall, Neil W.; Tripodis, Yorghos; Balcer, Laura J.; Stern, Robert A.			Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia	ALZHEIMER DISEASE & ASSOCIATED DISORDERS			English	Article						Alzheimer disease; dementia; mild cognitive impairment; saccadic eye movements; King-Devick test; screening test	DIAGNOSTIC-ACCURACY; EYE-MOVEMENTS; SACCADE; RECOMMENDATIONS; BIOMARKERS; BATTERY; TOOL	The King-Devick (K-D) test is a 1 to 2 minute, rapid number naming test, often used to assist with detection of concussion, but also has clinical utility in other neurological conditions (eg, Parkinson disease). The K-D involves saccadic eye and other eye movements, and abnormalities thereof may be an early indicator of Alzheimer disease (AD)-associated cognitive impairment. No study has tested the utility of the K-D in AD and we sought to do so. The sample included 206 [ 135 controls, 39 mild cognitive impairment (MCI), and 32 AD dementia] consecutive subjects from the Boston University Alzheimer's Disease Center registry undergoing their initial annual evaluation between March 2013 and July 2015. The K-D was administered during this period. Areas under the receiver operating characteristic curves generated from logistic regression models revealed the K-D test distinguished controls from subjects with cognitive impairment (MCI and AD dementia) [ area under the curve (AUC) - 0.72], MCI (AUC - 0.71) and AD dementia (AUC - 0.74). K-D time scores between 48 and 52 seconds were associated with high sensitivity (> 90.0%) and negative predictive values (> 85.0%) for each diagnostic group. The K-D correlated strongly with validated attention, processing speed, and visual scanning tests. The K-D test may be a rapid and simple effective screening tool to detect cognitive impairment associated with AD.	[Galetta, Kristin M.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Galetta, Kristin M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Chapman, Kimberly R.; Essis, Maritza D.; Alosco, Michael L.; Gillard, Danielle; Steinberg, Eric; Dixon, Diane; Martin, Brett; Chaisson, Christine E.; Kowall, Neil W.; Tripodis, Yorghos; Stern, Robert A.] Boston Univ, Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA; [Kowall, Neil W.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kowall, Neil W.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg & Anat & Neurobiol, Boston, MA USA; [Dixon, Diane; Martin, Brett; Chaisson, Christine E.] Data Coordinating Ctr, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kowall, Neil W.] VA Boston Healthcare Syst, Boston, MA USA; [Balcer, Laura J.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Balcer, Laura J.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA	Stern, RA (corresponding author), Boston Univ, Alzheimers Dis & CTE Ctr, Sch Med, 72 East Concord St,B7800, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020; Kowall, Neil/M-5378-2019	Kowall, Neil/0000-0002-6624-0213; Tripodis, Yorghos/0000-0003-2190-7608	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG13846, R01 NS 078337, U01 NS093334]; Avid Radiopharmaceuticals Inc. (Philadelphia, PA); Biogen (Cambridge, MA); Amarantus BioScience Holdings Inc. (San Francisco, CA); Avanir Pharmaceuticals Inc. (Aliso Viejo, CA);  [T32-AG06697]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337, U01NS093334, F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, T32AG036697] Funding Source: NIH RePORTER	Supported by grants from the NIH (P30 AG13846; R01 NS 078337; U01 NS093334). M.L.A. is supported by the T32-AG06697 postdoctoral fellowship.; R.A.S. has received research funding from Avid Radiopharmaceuticals Inc. (Philadelphia, PA). He is a member of the Mackey-White Committee of the NFL Players Association. He is a paid consultant to Amarantus BioScience Holdings Inc. (San Francisco, CA), Avanir Pharmaceuticals Inc. (Aliso Viejo, CA), and Biogen (Cambridge, MA). He receives royalties for published neuropsychological tests from Psychological Assessment Resources Inc. (Lutz, FL), as well as compensation from expert legal opinion. L.J.B. has received consulting fees from Biogen (Cambridge, MA). The remaining authors declare no conflicts of interest.	Alzheimer's Association, 2015, 2015 ALZH DIS FACTS; Ashendorf L, 2009, J CLIN EXP NEUROPSYC, V31, P605, DOI 10.1080/13803390802375557; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Chang LYL, 2014, ALZHEIMERS DEMENT, V10, P251, DOI 10.1016/j.jalz.2013.06.004; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohn J., 1998, STAT POWER ANAL BEHA; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Cordell CB, 2013, ALZHEIMERS DEMENT, V9, P141, DOI 10.1016/j.jalz.2012.09.011; Fernandez G, 2013, INVEST OPHTH VIS SCI, V54, P8345, DOI 10.1167/iovs.13-12877; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gavett BE, 2012, APPL NEUROPSYCH-ADUL, V19, P108, DOI 10.1080/09084282.2011.643947; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Geldmacher DS, 2013, PRIM CARE COMPANION, V15; Heuer HW, 2013, NEUROLOGY, V81, P1235, DOI 10.1212/WNL.0b013e3182a6cbfe; Jefferson AL, 2007, APPL NEUROPSYCHOL, V14, P215, DOI 10.1080/09084280701509166; Karantzoulis S, 2011, EXPERT REV NEUROTHER, V11, P1579, DOI [10.1586/ERN.11.155, 10.1586/ern.11.155]; King AT., 1976, PROPOSED KING DEVICK; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2010, AM J GERIAT PSYCHIAT, V18, P759, DOI 10.1097/JGP.0b013e3181cdecb8; Molitor RJ, 2015, J ALZHEIMERS DIS, V44, P1, DOI 10.3233/JAD-141173; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Palmqvist S, 2015, NEUROLOGY, V85, P1240, DOI 10.1212/WNL.0000000000001991; Panza F, 2005, AM J GERIAT PSYCHIAT, V13, P633, DOI 10.1176/appi.ajgp.13.8.633; Peltsch A, 2011, NEUROBIOL AGING, V32, P669, DOI 10.1016/j.neurobiolaging.2009.04.001; Peltsch A, 2014, EUR J NEUROSCI, V39, P2000, DOI 10.1111/ejn.12617; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Shakespeare TJ, 2015, BRAIN, V138, P1976, DOI 10.1093/brain/awv103; Spering CC, 2012, J GERONTOL A-BIOL, V67, P890, DOI 10.1093/gerona/gls006; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yang Q, 2013, AGE, V35, P1287, DOI 10.1007/s11357-012-9420-z	40	16	16	2	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0893-0341			ALZ DIS ASSOC DIS	Alzheimer Dis. Assoc. Dis.	APR-JUN	2017	31	2					152	158		10.1097/WAD.0000000000000157			7	Clinical Neurology; Pathology	Neurosciences & Neurology; Pathology	EV6RL	WOS:000401899300011	27299935	Green Accepted			2021-06-18	
J	Zhang, M; Wu, JY; Ding, HJ; Wu, WT; Xiao, GM				Zhang, Mei; Wu, Jianyue; Ding, Haojun; Wu, Wentian; Xiao, Guomin			Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway	NEUROCRITICAL CARE			English	Article						Progesterone; Nrf2/ARE signaling pathway; Traumatic brain injury; Neuroprotection; Nrf2 gene knockout; In vivo	SPINAL-CORD; CELL-DEATH; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; RAT-BRAIN; IN-VIVO; ACTIVATION; NEUROSTEROIDS; MECHANISMS; RECEPTOR	This study was to investigate the role of Nrf2/ARE signaling pathway in the pleiotropic neuroprotective effect of progesterone (PROG) on traumatic brain injury (TBI). The Nrf2-knockout (Nrf2-/-) and C57 mice were respectively subjected to a lateral cortical impact injury caused by a free-falling object and randomly divided into three groups: sham-operated, trauma, and trauma + PROG treatment group. The PROG treatment group was given PROG (32 mg/kg of body weight, intraperitoneal injection) immediately after injury. For all groups, a series of brain samples were obtained after trauma at 24 and 72 h, respectively. The cerebral edema was evaluated; the expression of IL-1 beta, IL-6, and TNF-alpha was measured using ELISA array, and the apoptosis index was detected by TUNEL. Flow cytometry was used to detect the intracellular calcium concentration. The water content, the apoptosis index, the levels of inflammatory cytokine, and the intracellular calcium ion were significantly decreased with the PROG treatment in C57 mice with TBI model. However, the effect of PROG on TBI was not found in the Nrf2-/- mouse model of TBI. PROG reduced cerebral edema, apoptosis, inflammatory reaction, and intracellular calcium ion overload effects after TBI. These beneficial effects were not seen in the Nrf2-/- mouse model of TBI. The results from this study suggested that the Nrf2/ARE signal pathway may be involved in the pleiotropic neuroprotective effect of PROG on TBI.	[Zhang, Mei; Wu, Jianyue; Ding, Haojun; Wu, Wentian; Xiao, Guomin] Hangzhou Normal Univ, Affiliated Hosp, Dept Neurosurg, Hangzhou 310015, Zhejiang, Peoples R China	Xiao, GM (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Dept Neurosurg, Hangzhou 310015, Zhejiang, Peoples R China.	xiao_gm@126.com			Zhejiang provincial natural science foundationNatural Science Foundation of Zhejiang Province; Hangzhou science and technology development plans; Zhejiang provincial and Hangzhou medical and health science and technology project; Zhejiang key laboratory of organ development and regeneration, China	This work was supported by Grants from Zhejiang provincial natural science foundation; Hangzhou science and technology development plans; Zhejiang provincial and Hangzhou medical and health science and technology project; and Zhejiang key laboratory of organ development and regeneration, China.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; COLLADO ML, 1985, PHARMACOL BIOCHEM BE, V23, P501, DOI 10.1016/0091-3057(85)90408-3; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; KATO J, 1994, HORM BEHAV, V28, P454, DOI 10.1006/hbeh.1994.1043; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Limmroth V, 1996, BRIT J PHARMACOL, V117, P99, DOI 10.1111/j.1476-5381.1996.tb15160.x; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; McIntosh TK, 1996, LAB INVEST, V74, P315; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Shen H, 2005, NEUROPHARMACOLOGY, V49, P573, DOI 10.1016/j.neuropharm.2005.04.026; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	45	16	19	1	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					292	300		10.1007/s12028-016-0342-y			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300019	27995513	Green Published, Other Gold			2021-06-18	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			Brain strain uncertainty due to shape variation in and simplification of head angular velocity profiles	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Head impact; Head angular motion; Brain strains; Pre-computation	FINITE-ELEMENT-ANALYSIS; INJURY PREDICTORS; AMERICAN FOOTBALL; CONTACT SPORTS; IMPACT; RESPONSES; ACCELERATION; MODEL; CONCUSSION; KINEMATICS	Head angular velocity, instead of acceleration, is more predictive of brain strains. Surprisingly, no study exists that investigates how shape variation in angular velocity profiles affects brain strains, beyond characteristics such as peak magnitude and impulse duration. In this study, we evaluated brain strain uncertainty due to variation in angular velocity profiles and further compared with that resulting from simplifying the profiles into idealized shapes. To do so, we used reconstructed head impacts from American National Football League for shape extraction and simulated head uniaxial coronal rotations from onset to full stop. The velocity profiles were scaled to maintain an identical peak velocity magnitude and duration in order to isolate the shape for investigation. Element-wise peak maximum principal strains from 44 selected impacts were obtained. We found that the shape of angular velocity profile could significantly affect brain strain magnitude (e.g., percentage difference of 4.29-17.89 % in the whole brain relative to the group average, with cumulative strain damage measure (CSDM) uncertainty range of 23.9 %) but not pattern (correlation coefficient of 0.94-0.99). Strain differences resulting from simplifying angular velocity profiles into idealized shapes were largely within the range due to shape variation, in both percentage difference and CSDM (signed difference of 3.91 % on average, with a typical range of 0-6 %). These findings provide important insight into the uncertainty or confidence in the performance of kinematics-based injury metrics. More importantly, they suggest the feasibility to simplify head angular velocity profiles into idealized shapes, at least within the confinements of the profiles evaluated, to enable real-time strain estimation via pre-computation in the future.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01605 USA; [Ji, Songbai] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01605 USA.; Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	sji@wpi.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853, R21NS088781] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781. The authors are grateful to the National Football League (NFL) Committee on Mild Traumatic Brain Injury (MTBI) and Biokinetics and Associates Ltd. for providing the reconstructed head impact kinematics data. In addition, the authors thank Dr. Richard M. Greenwald and Mr. Jonathan Beckwith at Simbex, LLC, for their help.	Abaqus, 2016, AB ONL DOC; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A.I., 2003, IRCOBI C LISB PORT, P1; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Nahum A. M., 1977, 770922 SAE; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Ogden R.W., 1984, NONLINEAR ELASTIC DE; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; The CDC NI H DoD and VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Trosseille X., 1992, P 36 STAPP CAR CRASH, DOI 10.4271/922527; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhao W, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0091; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0	41	16	16	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	APR	2017	16	2					449	461		10.1007/s10237-016-0829-7			13	Biophysics; Engineering, Biomedical	Biophysics; Engineering	EQ5HF	WOS:000398112800006	27644441	Green Accepted			2021-06-18	
J	Rodriguez-Millan, M; Tan, LB; Tse, KM; Lee, HP; Miguelez, MH				Rodriguez-Millan, M.; Tan, L. B.; Tse, K. M.; Lee, H. P.; Miguelez, M. H.			Effect of full helmet systems on human head responses under blast loading	MATERIALS & DESIGN			English	Article						Combat helmet design; Mandibular guard; Visor; Blast simulation; Head modeling; Traumatic brain injury (TBI); Intracranial pressure (ICP)	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; METHODOLOGY; VALIDATION	This paper focuses on helmet design for head protection under blast threats. It is presented a numerical investigation of the head response accruing to blast loads on helmet protective systems. Various combinations of the helmet, visor and mandible guard were numerically analyzed for a given mass of TNT at a distance to the target representing an anti-vehicle buried mine threat. Limited published articles on the subject are available in the scientific literature. In this paper, a 3D head helmet numerical model for blast analyses is developed in the finite element code ABAQUS/Explicit. The results showed that individual protective systems are not effective enough to mitigate the damage caused by blast loading. The complete protective equipment reduces the pressures on the brain by up to 5 times and ensures that no fracture in the skull appears. This numerical study aims to provide helmet manufacturers and users with some insight in what possible brain injuries are to be expected in various blast scenarios so as to help in better diagnosis of unsuspected brain injury. (C) 2016 Elsevier Ltd. All rights reserved.	[Rodriguez-Millan, M.; Miguelez, M. H.] Univ Carlos III Madrid, Dept Mech Engn, Avda Univ 30, Madrid 28917, Spain; [Tan, L. B.; Tse, K. M.; Lee, H. P.] Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore; [Tse, K. M.] Univ Melbourne, Dept Mech Engn, Biomech Res Grp, Parkville, Vic 3010, Australia	Rodriguez-Millan, M (corresponding author), Univ Carlos III Madrid, Dept Mech Engn, Avda Univ 30, Madrid 28917, Spain.	mrmillan@ing.uc3m.es	Tse, Kwong Ming/D-8669-2011; Miguelez, Maria Henar/L-3097-2014; Lee, Heow Pueh/I-7834-2014; Millan, Marcos Rodriguez/A-3945-2012	Tse, Kwong Ming/0000-0002-8170-0775; Miguelez, Maria Henar/0000-0001-5227-1425; Lee, Heow Pueh/0000-0002-4380-3888; Millan, Marcos Rodriguez/0000-0002-9081-8425; Tan, Long Bin/0000-0002-3897-7365	Ministry of Economy and Competitiveness of Spain [RTC-2015-3887-8]; FEDER programEuropean Commission [RTC-2015-3887-8]	The authors acknowledge the Ministry of Economy and Competitiveness of Spain and FEDER program under the Project RTC-2015-3887-8 for the financial support of the work.	Bin Tan L, 2012, INT J IMPACT ENG, V50, P99, DOI 10.1016/j.ijimpeng.2012.06.003; Binder M. D. Sue, 2003, REP C MILD TRAUM BRA; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Coelho RM, 2013, MATER DESIGN, V43, P384, DOI 10.1016/j.matdes.2012.07.020; Dassault Systernes, 2012, AB V6 12 DOC ABAQUS; Dwivedi A., 2012, MECH RESPONSE POLYCA; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fallah AS, 2014, INT J IMPACT ENG, V73, P91, DOI 10.1016/j.ijimpeng.2014.06.014; Friedlander FG, 1976, WAVE EQUATION CURVED; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Hardy W N, 2001, Stapp Car Crash J, V45, P337; HASHIN Z, 1980, J APPL MECH-T ASME, V47, P329, DOI 10.1115/1.3153664; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Jenson D, 2015, COMPOS STRUCT, V121, P211, DOI 10.1016/j.compstruct.2014.08.028; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kleiven S., 2008, MTBI PREC S LISB POR; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Lee HP, 2010, COMPUT METHOD BIOMEC, V13, P537, DOI 10.1080/10255840903337848; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Mott, 2014, 52 AER SCI M, V11, P9142; Nahum AM., 1977, P 21 STAPP CAR CRASH, P339, DOI [10.4271/770922., DOI 10.4271/770922]; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pinnoji PK, 2010, MATER DESIGN, V31, P3716, DOI 10.1016/j.matdes.2010.03.011; Pintar FA, 2013, MED ENG PHYS, V35, P1682, DOI 10.1016/j.medengphy.2013.04.015; RISLING M, 2012, FRONT NEUROL, V3, P1; Millan MR, 2016, J REINF PLAST COMP, V35, P124, DOI 10.1177/0731684415608004; Rodriguez-Millan M, 2016, MATER DESIGN, V110, P391, DOI 10.1016/j.matdes.2016.08.015; Ruan J. S., 1994, IMPACT BIOMECHANICS; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Santiuste C, 2014, COMPOS STRUCT, V116, P423, DOI 10.1016/j.compstruct.2014.05.031; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Stuhmiller J.H., 2008, TXB MILITARY MED; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tan L. B., 2014, INT J NUMER METHODS, P1; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Trosseille X., 1992, P 36 STAPP CAR CRASH, DOI 10.4271/922527; Tse K. M., 2016, MED BIOL ENG COMPUT, P1; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Tse Kwong Ming, 2014, AM J ENG TECHNOLOGY, V1, P28; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Ward C., 1980, STAPP CAR CRASH J, V801304, P163; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	55	16	16	2	22	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	MAR 5	2017	117						58	71		10.1016/j.matdes.2016.12.081			14	Materials Science, Multidisciplinary	Materials Science	EK6XG	WOS:000394068800007		Green Accepted			2021-06-18	
J	Shumskaya, E; van Gerven, MAJ; Norris, DG; Vos, PE; Kessels, RPC				Shumskaya, Elena; van Gerven, Marcel A. J.; Norris, David G.; Vos, Pieter E.; Kessels, Roy P. C.			Abnormal connectivity in the sensorimotor network predicts attention deficits in traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Neuropsychology; Resting-state fMRI; Functional connectivity; Independent component analysis	FUNCTIONAL CONNECTIVITY; NORMATIVE DATA; DYSFUNCTION; MOTION; MODE; EDUCATION; ARTIFACT; ACCURATE; MEMORY; ROBUST	The aim of this study was to explore modifications of functional connectivity in multiple resting-state networks (RSNs) after moderate to severe traumatic brain injury (TBI) and evaluate the relationship between functional connectivity patterns and cognitive abnormalities. Forty-three moderate/severe TBI patients and 34 healthy controls (HC) underwent resting-state fMRI. Group ICA was applied to identify RSNs. Between-subject analysis was performed using dual regression. Multiple linear regressions were used to investigate the relationship between abnormal connectivity strength and neuropsychological outcome. Forty (93%) TBI patients showed moderate disability, while 2 (5%) and 1 (2%) upper severe disability and low good recovery, respectively. TBI patients performed worse than HC on the domains attention and language. We found increased connectivity in sensorimotor, visual, default mode (DMN), executive, and cerebellar RSNs after TBI. We demonstrated an effect of connectivity in the sensorimotor RSN on attention (p < 10(-3)) and a trend towards a significant effect of the DMN connectivity on attention (p = 0.058). A group-by-network interaction on attention was found in the sensorimotor network (p = 0.002). In TBI, attention was positively related to abnormal connectivity within the sensorimotor RSN, while in HC this relation was negative. Our results show altered patterns of functional connectivity after TBI. Attention impairments in TBI were associated with increased connectivity in the sensorimotor network. Further research is needed to test whether attention in TBI patients is directly affected by changes in functional connectivity in the sensorimotor network or whether the effect is actually driven by changes in the DMN.	[Shumskaya, Elena; van Gerven, Marcel A. J.; Norris, David G.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Norris, David G.] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Norris, David G.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands; [Vos, Pieter E.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Ctr Cognit, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands	Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, Nijmegen, Netherlands.; Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Donders Ctr Cognit, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands.	elena.shumskaya@donders.ru.nl; m.vangerven@donders.ru.nl; d.norris@donders.ru.nl; p.vos@slingeland.nl; r.kessels@donders.ru.nl	Kessels, Roy P.C./D-1902-2010; van Gerven, Marcel A. J./D-7800-2012; Norris, David G/A-1937-2010	Kessels, Roy P.C./0000-0001-9500-9793; van Gerven, Marcel A. J./0000-0002-2206-9098; Norris, David G/0000-0002-3699-6917	Netherlands Brain Foundation (Hersenstichting Nederland) [2009(1)-20]	This study was funded by the Netherlands Brain Foundation (Hersenstichting Nederland) [2009(1)-20].	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312; Bucks RSWJ, 2011, LOCATION LEARNING TE; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koerts JAC, 2012, HDB NEUROPSYCHOLOGIC, P543; Lee MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040370; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Schmand B., 1992, NEDERLANDSE LEESTEST; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Loon-Vervoorn W.A., 2006, TIJDSCHRIFT NEUROPSY, V1, P30; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wester AJ, 2013, NEUROPSYCH DIS TREAT, V9, P875, DOI 10.2147/NDT.S44973; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	42	16	17	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	MAR	2017	235	3					799	807		10.1007/s00221-016-4841-z			9	Neurosciences	Neurosciences & Neurology	EM1HO	WOS:000395068900014	27885406	Green Published, Other Gold			2021-06-18	
J	Speck, V; Schlereth, T; Birklein, F; Maihofner, C				Speck, V.; Schlereth, T.; Birklein, F.; Maihoefner, C.			Increased prevalence of posttraumatic stress disorder in CRPS	EUROPEAN JOURNAL OF PAIN			English	Article							REGIONAL PAIN SYNDROME; SYNDROME TYPE-I; REFLEX SYMPATHETIC DYSTROPHY; SYNDROME TYPE-1; PSYCHOLOGICAL DYSFUNCTION; SUBARACHNOID HEMORRHAGE; LONGITUDINAL COURSE; DIAGNOSTIC SCALE; BRAIN-INJURY; RISK-FACTORS	Background: Although specific psychological disorders in complex regional pain syndrome (CRPS) have not been identified, studies suggest that CRPS patients may have increased rates of traumatic life events. Because these events do not always lead to apparent psychological symptoms, we systematically screened CRPS patients for posttraumatic stress disorder (PTSD) to determine if PTSD could be a risk factor for CRPS. Methods: Consecutive CRPS patients referred to two university hospital centres (University of Erlangen, UMC Mainz) between December 2011 and April 2013 were prospectively examined using a diagnostic PTSD instrument (Post-traumatic Stress Diagnostic Scale (PDS). We also tested maladaptive coping strategies (brief-COPE inventory) and the PDS severity score as predictors for CRPS. Patients with non-CRPS extremity pain and healthy individuals were used as control groups. Results: We collected data from 152 patients with CRPS, 55 control patients and 55 age-and sex-matched healthy individuals. Fifty-eight CRPS patients (38%), six non-CRPS pain patients (10%) and two healthy individuals (4%) met diagnostic criteria for PTSD. Initial PTSD symptom onset was prior to CRPS in 50 CRPS patients (86%) and during the course of CRPS in eight patients. Results of a logistic regression revealed that the PTSD severity score was associated with CRPS (p < 0.0001). Maladaptive coping strategies (p < 0.0001) were related to PTSD. Conclusions: posttraumatic stress disorder (PTSD) is more frequent in patients with CRPS than it is in the general population. Significance: Research has not yet provided support for specific psychological predictors for CRPS.	[Speck, V.; Schlereth, T.; Birklein, F.] Univ Hosp Mainz, Dept Neurol, Mainz, Germany; [Maihoefner, C.] Univ Erlangen Nurnberg, Gen Hosp Furth, Dept Neurol, Erlangen, Germany	Speck, V (corresponding author), Univ Hosp Mainz, Dept Neurol, Mainz, Germany.	verena.speck@unimedizin-mainz.de			German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF)	Supported by BGW, Mainz and by German Federal Ministry of Education and Research (BMBF, NIVIL-Project/Maihofner).	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Barkin R L, 1996, Dis Mon, V42, P457, DOI 10.1016/S0011-5029(96)90013-9; Beerthuizen A, 2011, EUR J PAIN, V15, P971, DOI 10.1016/j.ejpain.2011.02.008; Beerthuizen A, 2009, PAIN, V145, P52, DOI 10.1016/j.pain.2009.05.003; BENEDIKT RA, 1986, AM J PSYCHIAT, V143, P908; Bennett GJ, 2003, PAIN, V106, P209, DOI 10.1016/S0304-3959(03)00313-0; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bruehl S, 2006, CLIN J PAIN, V22, P430, DOI 10.1097/01.ajp.0000194282.82002.79; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; Bryant RA, 2007, J CONSULT CLIN PSYCH, V75, P812, DOI 10.1037/0022-006X.75.5.812; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Ciccone DS, 1997, PAIN, V71, P323, DOI 10.1016/S0304-3959(97)00009-2; COOPER J, 1995, BRIT J PSYCHIAT, V166, P4, DOI 10.1192/bjp.166.1.4; de Jong JR, 2011, J PAIN, V12, P1209, DOI 10.1016/j.jpain.2011.06.010; de Mos M, 2009, PAIN PRACT, V9, P86, DOI 10.1111/j.1533-2500.2009.00262.x; DEGOOD DE, 1993, PAIN, V54, P317, DOI 10.1016/0304-3959(93)90031-J; Dijkstra PU, 2003, CLIN REHABIL, V17, P454, DOI 10.1191/0269215503cr631oa; Dilek B, 2012, RHEUMATOL INT, V32, P915, DOI 10.1007/s00296-010-1714-9; Feliu MH, 2010, CLIN J PAIN, V26, P258, DOI 10.1097/AJP.0b013e3181bff815; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Frettloh J., 2003, PSYCHOL SCHMERZTHERA, P467; Geertzen JHB, 1998, CLIN J PAIN, V14, P143, DOI 10.1097/00002508-199806000-00009; Gil S, 2006, CNS SPECTRUMS, V11, P603, DOI 10.1017/S1092852900013651; Griesel D, 2006, PSYCHOL ASSESSMENT, V18, P262, DOI 10.1037/1040-3590.18.3.262; Hauser W, 2013, PAIN, V154, P1216, DOI 10.1016/j.pain.2013.03.034; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Hauffa R, 2011, J NERV MENT DIS, V199, P934, DOI 10.1097/NMD.0b013e3182392c0d; Hutter BO, 1999, ACT NEUR S, V72, P157; Lohnberg JA, 2013, J CLIN PSYCHOL MED S, V20, P247, DOI 10.1007/s10880-012-9322-3; Marinus J, 2013, CLIN J PAIN, V29, P563, DOI 10.1097/AJP.0b013e31826f9a8a; McFarlane AC, 2000, J CLIN PSYCHIAT, V61, P15; Moeller-Bertram T, 2012, NEUROPHARMACOLOGY, V62, P586, DOI 10.1016/j.neuropharm.2011.04.028; Monti DA, 1998, CLIN J PAIN, V14, P295, DOI 10.1097/00002508-199812000-00005; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Moseley GL, 2014, J PAIN, V15, P16, DOI 10.1016/j.jpain.2013.08.009; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; Perkonigg A, 2005, AM J PSYCHIAT, V162, P1320, DOI 10.1176/appi.ajp.162.7.1320; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Puchalski P, 2005, J HAND SURG-BRIT EUR, V30B, P574, DOI 10.1016/j.jhsb.2005.06.023; SCARINCI IC, 1994, AM J MED, V97, P108, DOI 10.1016/0002-9343(94)90020-5; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; van der Laan L, 1999, J PAIN SYMPTOM MANAG, V17, P357, DOI 10.1016/S0885-3924(99)00009-3	46	16	16	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-3801	1532-2149		EUR J PAIN	Eur. J. Pain	MAR	2017	21	3					466	473		10.1002/ejp.940			8	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	EK4MS	WOS:000393901600007	27650922				2021-06-18	
J	Roy, N; Veetil, DK; Khajanchi, MU; Kumar, V; Solomon, H; Kamble, J; Basak, D; Tomson, G; von Schreeb, J				Roy, Nobhojit; Veetil, Deepa Kizhakke; Khajanchi, Monty Uttam; Kumar, Vineet; Solomon, Harris; Kamble, Jyoti; Basak, Debojit; Tomson, Goran; von Schreeb, Johan			Learning from 2523 trauma deaths in India-opportunities to prevent in-hospital deaths	BMC HEALTH SERVICES RESEARCH			English	Article							MIDDLE-INCOME COUNTRIES; QUALITY-IMPROVEMENT; CARE; GUIDELINES; MORTALITY; INJURIES; BURDEN	Background: A systematic analysis of trauma deaths is a step towards trauma quality improvement in Indian hospitals. This study estimates the magnitude of preventable trauma deaths in five Indian hospitals, and uses a peer-review process to identify opportunities for improvement (OFI) in trauma care delivery. Methods: All trauma deaths that occurred within 30 days of hospitalization in five urban university hospitals in India were retrospectively abstracted for demography, mechanism of injury, transfer status, injury description by clinical, investigation and operative findings. Using mixed methods, they were quantitatively stratified by the standardized Injury Severity Score (ISS) into mild (1-8), moderate (9-15), severe (16-25), profound (26-75) ISS categories, and by time to death within 24 h, 7, or 30 days. Using peer-review and Delphi methods, we defined optimal trauma care within the Indian context and evaluated each death for preventability, using the following categories: Preventable (P), Potentially preventable (PP), Non-preventable (NP) and Non-preventable but care could have been improved (NPI). Results: During the 18 month study period, there were 11,671 trauma admissions and 2523 deaths within 30 days (21.6%). The overall proportion of preventable deaths was 58%, among 2057 eligible deaths. In patients with a mild ISS score, 71% of deaths were preventable. In the moderate category, 56% were preventable, and 60% in the severe group and 44% in the profound group were preventable. Traumatic brain injury and burns accounted for the majority of non-preventable deaths. The important areas for improvement in the preventable deaths subset, inadequacies in airway management (14.3%) and resuscitation with hemorrhage control (16.3%). System-related issues included lack of protocols, lack of adherence to protocols, pre-hospital delays and delays in imaging. Conclusion: Fifty-eight percent of all trauma deaths were classified as preventable. Two-thirds of the deaths with injury severity scores of less than 16 were preventable. This large subgroup of Indian urban trauma patients could possibly be saved by urgent attention and corrective action. Low-cost interventions such as airway management, fluid resuscitation, hemorrhage control and surgical decision-making protocols, were identified as OFI. Establishment of clinical protocols and timely processes of trauma care delivery are the next steps towards improving care.	[Roy, Nobhojit; Tomson, Goran; von Schreeb, Johan] Karolinska Inst, Dept Publ Hlth Sci, Hlth Syst & Policy, Stockholm, Sweden; [Roy, Nobhojit] Bhabha Atom Res Ctr Hosp, Dept Surg, Bombay, Maharashtra, India; [Roy, Nobhojit; Veetil, Deepa Kizhakke; Kamble, Jyoti; Basak, Debojit] Tata Inst Social Sci, Sch Habitat, Bombay, Maharashtra, India; [Khajanchi, Monty Uttam] King Edward Mem Hosp, Dept Surg, Bombay, Maharashtra, India; [Kumar, Vineet] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Dept Surg, Bombay, Maharashtra, India; [Solomon, Harris] Duke Univ, Dept Cultural Anthropol & Global Hlth, Global Hlth Inst, 205 Friedl Bldg,Box 90091, Durham, NC 27708 USA; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth LIME & Pu, Stockholm, Sweden	Roy, N (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Hlth Syst & Policy, Stockholm, Sweden.; Roy, N (corresponding author), Bhabha Atom Res Ctr Hosp, Dept Surg, Bombay, Maharashtra, India.; Roy, N (corresponding author), Tata Inst Social Sci, Sch Habitat, Bombay, Maharashtra, India.	nobhojit.roy@ki.se		Solomon, Harris/0000-0002-8792-469X; Roy, Nobhojit/0000-0003-2022-7416	Swedish National Board of Health and Welfare; Laerdal Foundation for Acute Care Medicine, Norway	The TITCO dataset by the research consortium of Indian Universities [4] was funded by grants from the Swedish National Board of Health and Welfare and the Laerdal Foundation for Acute Care Medicine, Norway. The funding agencies had no influence on the conduct of the study, the contents of the manuscript, or the decision to send the manuscript for publication.	Abioye IA, 2012, INT J SURG, V10, P209, DOI 10.1016/j.ijsu.2012.03.003; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Berbiglia L, 2013, AM SURGEON, V79, P764; Chadbunchachai Witaya, 2001, Journal of the Medical Association of Thailand, V84, P782; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Costa Carlos Dario da Silva, 2012, Rev. Col. Bras. Cir., V39, P249; Crowley-Matoka M, 2012, CULT ANTHROPOL, V27, P689, DOI 10.1111/j.1548-1360.2012.01167.x; Donabedian A, 1997, ARCH PATHOL LAB MED, V121, P1145; Gerdin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090064; Gruen RL, 2006, T MEET AM SURG ASS, V124, P37; Haghparast-Bidgoli Hassan, 2013, J Inj Violence Res, V5, P28, DOI 10.5249/jivr.v5i1.195; Hashmi ZG, 2013, J TRAUMA ACUTE CARE, V75, P60, DOI 10.1097/TA.0b013e31829880a0; Hoogervorst EM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-79; Hsiao M, 2012, PLOS ONE, V7, P1; Inaba K, 2013, AM SURGEON, V79, P1134; Jat Afzal Ali, 2004, Asian J Surg, V27, P58, DOI 10.1016/S1015-9584(09)60247-5; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Kleber C, 2010, WORLD J SURG, V2013, P1154; Kumar GA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-285; Laing G, 2015, WORLD J SURG, V39, P70, DOI 10.1007/s00268-014-2766-x; Lashoher A, 2017, WORLD J SURG, V41, P954, DOI 10.1007/s00268-016-3759-8; Latifi R, 2014, WORLD J SURG, V38, P1898, DOI 10.1007/s00268-014-2538-7; Martin BT, 2007, J TRAUMA, V62, P69, DOI 10.1097/TA.0b013e31802d08e5; Mock C, 2009, INJURY PREV, V15, P359, DOI 10.1136/ip.2009.024315; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Mock C, 2009, B WORLD HEALTH ORGAN, V87, P382, DOI 10.2471/BLT.08.057059; Montmany S, 2015, INJURY ELSEVIER LTD, V47, P669; O'Reilly D, 2013, BRIT J SURG, V100, P749, DOI 10.1002/bjs.9096; Parra MW, 2013, TELEMED E-HEALTH, V19, P699, DOI 10.1089/tmj.2012.0254; Roy N, 2016, WORLD J SURG, V40, P1299, DOI 10.1007/s00268-016-3452-y; Saltzherr TP, 2011, INJURY, V42, P870, DOI 10.1016/j.injury.2010.04.007; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; Santana MJ, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.010; Shah MT, 2015, WORLD J SURG, V39, P363, DOI 10.1007/s00268-014-2805-7; Stelfox HT, 2012, J TRAUMA ACUTE CARE, V72, P962, DOI 10.1097/TA.0b013e31824a7bd8; Stelfox HT, 2012, WORLD J SURG, V36, P1978, DOI 10.1007/s00268-012-1593-1; Stewart BT, 2016, INJURY, V47, P211, DOI 10.1016/j.injury.2015.09.007; Stewart BT, 2015, WORLD J SURG, V39, P2428, DOI 10.1007/s00268-015-3132-3; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Tsang B, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-39; Vioque SM, 2014, AM J SURG, V208, P187, DOI 10.1016/j.amjsurg.2014.02.006; Willett K, 2010, PUBLIC HEALTH, V124, P180, DOI 10.1016/j.puhe.2010.01.011; Yeboah D, 2014, WORLD J SURG, V38, P1707, DOI 10.1007/s00268-014-2452-z	43	16	17	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	FEB 16	2017	17								142	10.1186/s12913-017-2085-7			8	Health Care Sciences & Services	Health Care Sciences & Services	EK7MV	WOS:000394110800001	28209192	DOAJ Gold, Green Published			2021-06-18	
J	Stern, RA; Seichepine, D; Tschoe, C; Fritts, NG; Alosco, ML; Berkowitz, O; Burke, P; Howland, J; Olshaker, J; Cantu, RC; Baugh, CM; Holsapple, JW				Stern, Robert A.; Seichepine, Daniel; Tschoe, Christine; Fritts, Nathan G.; Alosco, Michael L.; Berkowitz, Oren; Burke, Peter; Howland, Jonathan; Olshaker, Jonathan; Cantu, Robert C.; Baugh, Christine M.; Holsapple, James W.			Concussion Care Practices and Utilization of Evidence-Based Guidelines in the Evaluation and Management of Concussion: A Survey of New England Emergency Departments	JOURNAL OF NEUROTRAUMA			English	Article						clinical practice guidelines; concussion; emergency department; New England; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSIONS; RETURN-TO-PLAY; HEALTH-CARE; MILD; PHYSICIANS; QUALITY; KNOWLEDGE; POLICY; ADULTS	Evidence-based clinical practice guidelines can facilitate proper evaluation and management of concussions in the emergency department (ED), often the initial and primary point of contact for concussion care. There is no universally adopted set of guidelines for concussion management, and extant evidence suggests that there may be variability in concussion care practices and limited application of clinical practice guidelines in the ED. This study surveyed EDs throughout New England to examine current practices of concussion care and utilization of evidence-based clinical practice guidelines in the evaluation and management of concussions. In 2013, a 32-item online survey was e-mailed to 149/168 EDs throughout New England (Connecticut, Rhode Island, Massachusetts, Vermont, New Hampshire, Maine). Respondents included senior administrators asked to report on their EDs use of clinical practice guidelines, neuroimaging decision-making, and discharge instructions for concussion management. Of the 72/78 respondents included, 35% reported absence of clinical practice guidelines, and 57% reported inconsistency in the type of guidelines used. Practitioner preference guided neuroimaging decision-making for 57%. Although 94% provided written discharge instructions, there was inconsistency in the recommended time frame for follow-up care (13% provided no specific time frame), the referral specialist to be seen (25% did not recommend any specialist), and return to activity instructions were inconsistent. There is much variability in concussion care practices and application of evidence-based clinical practice guidelines in the evaluation and management of concussions in New England EDs. Knowledge translational efforts will be critical to improve concussion management in the ED setting.	[Stern, Robert A.; Cantu, Robert C.; Baugh, Christine M.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Stern, Robert A.; Tschoe, Christine; Cantu, Robert C.; Baugh, Christine M.; Holsapple, James W.] Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Stern, Robert A.; Berkowitz, Oren; Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Seichepine, Daniel; Fritts, Nathan G.] Boston Univ, Alzheimers Dis & CTE Ctr, Boston, MA USA; [Alosco, Michael L.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Berkowitz, Oren] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Burke, Peter] Boston Univ, Sch Med, Boston Med Ctr, Dept Surg,Div Gen Surg,Sect Acute Care & Trauma S, Boston, MA 02118 USA; [Howland, Jonathan] Boston Univ, Sch Med, Boston Med Ctr, Injury Prevent Ctr, Boston, MA 02118 USA; [Howland, Jonathan; Olshaker, Jonathan] Boston Univ, Sch Med, Dept Emergency Med, Boston, MA 02118 USA; [Olshaker, Jonathan] Boston Med Ctr, Dept Emergency Med, Boston, MA USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA	Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurosurg, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020; Baugh, Christine/AAG-2324-2020; Berkowitz, Oren/L-5006-2019	Baugh, Christine/0000-0002-9340-6338; Berkowitz, Oren/0000-0002-4919-4921	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 078337, R56 NS 078337, P30 AG13846]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG06697]; National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG036697, P30AG013846] Funding Source: NIH RePORTER	This study was supported by grants from the National Institutes of Health (R01 NS 078337; R56 NS 078337; P30 AG13846). Michael L. Alosco is supported by the National Institute on Aging under award number T32AG06697. Christine Baugh is currently supported by the National Institutes of Mental Health under award number T32MH019733. There were no restrictions on the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication. There is no sponsor.	American Hospital Association, 1999, AHA GUID HLTH CAR FI; Bay E, 2011, ADV EMERG NURS J, V33, P181, DOI 10.1097/TME.0b013e318217c958; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Chinn NR, 2013, COMMUNITY COLL J RES, V37, P409, DOI 10.1080/10668926.2012.710127; Colorado Medical Society Sports Medicine Committee, 1994, P MILD BRAIN INJ SPO, P106; Donaldson A., 2014, AM J LIFESTYLE MED; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; Kelly JP, 1997, NEUROLOGY, V48, P581; Kroshus E., 2015, CLIN J SPORT MED; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Poulos RG, 2012, BRIT J SPORT MED, V46, P585, DOI 10.1136/bjsports-2011-090469; Rivara FP, 2015, JAMA-J AM MED ASSOC, V314, P2629, DOI 10.1001/jama.2015.17298; Schuster MA, 2005, MILBANK Q, V83, P843, DOI 10.1111/j.1468-0009.2005.00403.x; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	47	16	16	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					861	868		10.1089/neu.2016.4475			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200013	27112592	Green Published			2021-06-18	
J	Doherty, C; Zhao, L; Ryan, J; Komaba, Y; Inomata, A; Caulfield, B				Doherty, Cailbhe; Zhao, Liang; Ryan, John; Komaba, Yusuke; Inomata, Akihiro; Caulfield, Brian			Quantification of postural control deficits in patients with recent concussion: An inertial-sensor based approach	CLINICAL BIOMECHANICS			English	Article						Brain concussion [MeSH]; Biomechanics [MeSH]; Kinetics [MeSH]; Postural balance [MeSH]	ERROR SCORING SYSTEM; GAIT BALANCE CONTROL; MILD HEAD-INJURY; HEALTHY-YOUNG; RECOVERY; ADULTS; ACCELEROMETER; ADOLESCENTS; STATEMENT; SPORT	Background: The aim of this study was to quantify postural control ability in a group with concussion compared with a healthy control group. Method: Fifteen concussion patients (4 females, 11 males) and a group of fifteen age-and sex-matched controls were recruited. Participants were tested during the performance of the three stance variants (bilateral, tandem and unilateral) of the balance error scoring system standing on a force place, while wearing an inertial measurement unit placed at the posterior aspect of the sacrum. Findings: The area of postural sway was computed using the force-plate and the '95% ellipsoid volume of sway' was computed from the accelerometer data. Concussed patients exhibited increased sway area (1513 mm(2) [95% CI: 935 to 2091 mm(2)] vs 646 mm(2) [95% CI: 519 to 772 mm(2)]; p = 0.02) and sway volume (9.46 m(3) S-6 [95% CI: 8.02 to 19.94 m3 s(-6)] vs 2.68 m(3) s(-6) [95% CI: 1.81 to 3.55 m(3) s(-6)]; p = 0.01) in the bilateral stance position of the balance error scoring system. The sway volume metric also had excellent accuracy in identifying task 'errors' (tandem stance: 91% accuracy [95% CI: 85-96%], p < 0.001; unilateral stance: 91% accuracy [95% CI: 86-96%], p < 0.001). Interpretation: Individuals with concussion display increased postural sway during bilateral stance. The sway volume that was calculated from the accelerometer data not only differentiated a group with concussion from a healthy control group, but successfully identified when task errors had occurred. This may be of value in the development of a pitch-side assessment system for concussion. (C) 2017 Elsevier Ltd. All rights reserved.	[Doherty, Cailbhe; Zhao, Liang; Caulfield, Brian] Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland; [Ryan, John] St Vincents Univ Hosp, Dublin, Ireland; [Komaba, Yusuke; Inomata, Akihiro] Fujitsu Labs Ltd, Tokyo, Japan	Doherty, C; Zhao, L (corresponding author), Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland.	Cailbhe.doherty@insight-centre.org; liang.zhao@insight-centre.org		Caulfield, Brian/0000-0003-0290-9587; Doherty, Cailbhe/0000-0002-5284-856X	Fujitsu Laboratories Ltd., Japan, KIDUKU project	This study was supported by Fujitsu Laboratories Ltd., Japan as part of the KIDUKU project. We have no conflicts of interest to declare.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Doherty C, 2016, AM J SPORT MED, V44, P995, DOI 10.1177/0363546516628870; Downey Daniel J, 2007, Curr Sports Med Rep, V6, P328; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Johnston W., 2017, CONCUSSION IN PRESS; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mayagoitia RE, 2002, GAIT POSTURE, V16, P55, DOI 10.1016/S0966-6362(01)00199-0; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Winter D. A., 2009, BIOMECHANICS MOTOR C, V4th; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	32	16	16	0	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	FEB	2017	42						79	84		10.1016/j.clinbiomech.2017.01.007			6	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	EM9AP	WOS:000395603500012	28110244				2021-06-18	
J	Dunser, MW; Towey, RM; Amito, J; Mer, M				Duenser, M. W.; Towey, R. M.; Amito, J.; Mer, M.			Intensive care medicine in rural sub-Saharan Africa	ANAESTHESIA			English	Article						Africa; epidemiology; intensive care medicine; mechanical ventilation; mortality	LOW-INCOME COUNTRIES; SEVERE SEPSIS; UNITED-STATES; ANESTHESIA; ZAMBIA	We undertook an audit in a rural Ugandan hospital that describes the epidemiology and mortality of 5147 patients admitted to the intensive care unit. The most frequent admission diagnoses were postoperative state (including following trauma) (2014/5147; 39.1%), medical conditions (709; 13.8%) and traumatic brain injury (629; 12.2%). Intensive care unit mortality was 27.8%, differing between age groups (p < 0.001). Intensive care unit mortality was highest for neonatal tetanus (29/37; 78.4%) and lowest for foreign body aspiration (4/204; 2.0%). Intensive care unit admission following surgery (333/1431; 23.3%), medical conditions (327/1431; 22.9%) and traumatic brain injury (233/1431; 16.3%) caused the highest number of deaths. Of all deaths in the hospital, (1431/11,357; 12.6%) occurred in the intensive care unit. Although the proportion of hospitalised patients admitted to the intensive care unit increased over time, from 0.7% in 2005/6 to 2.8% in 2013/4 (p < 0.001), overall hospital mortality decreased (2005/6, 4.8%; 2013/14, 4.0%; p < 0.001). The proportion of intensive care patients whose lungs were mechanically ventilated was 18.7% (961/5147). This subgroup of patients did not change over time (2006, 16%; 2015, 18.4%; p = 0.12), but their mortality decreased (2006, 59.5%; 2015, 44.3%; p < 0.001).	[Duenser, M. W.] Salzburg Univ Hosp, Dept Anesthesiol Perioperat Med & Gen Intens Care, Intens Care, Salzburg, Austria; [Duenser, M. W.; Mer, M.] Paracelsus Private Med Univ, Salzburg, Austria; [Towey, R. M.] European Soc Intens Care Med, Global Intens Care Working Grp, Brussels, Belgium; [Amito, J.] St Marys Hosp Lacor, Dept Anaesthet & Intens Care, Gulu, Uganda; [Mer, M.] Charlotte Maxeke Johannesburg Acad Hosp, Intens Care Unit, Intens Care, Johannesburg, South Africa; [Mer, M.] Univ Witwatersrand, Johannesburg, South Africa	Dunser, MW (corresponding author), Salzburg Univ Hosp, Dept Anesthesiol Perioperat Med & Gen Intens Care, Intens Care, Salzburg, Austria.; Dunser, MW (corresponding author), Paracelsus Private Med Univ, Salzburg, Austria.	martin.duenser@i-med.ac.at					Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Baker T, 2009, PEDIATR ANESTH, V19, P23, DOI 10.1111/j.1460-9592.2008.02868.x; Baker T, 2009, TROP MED INT HEALTH, V14, P143, DOI 10.1111/j.1365-3156.2008.02202.x; Dondorp AM, 2016, JAMA-J AM MED ASSOC, V315, P753, DOI 10.1001/jama.2016.0976; Dunser MW, 2008, WIEN KLIN WOCHENSCHR, V120, P600, DOI 10.1007/s00508-008-1064-8; Fernando Jlin, 2012, Int J Crit Illn Inj Sci, V2, P11, DOI 10.4103/2229-5151.94884; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Jochberger S, 2008, ANESTH ANALG, V106, P942, DOI 10.1213/ane.0b013e318166ecb8; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P73, DOI 10.1097/PCC.0b013e3181ce74ef; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; Sawe HR, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-26; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; UNAIDS, 2015, 2015 PROGR REP GLOB	15	16	16	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	FEB	2017	72	2					181	189		10.1111/anae.13710			9	Anesthesiology	Anesthesiology	EJ6EZ	WOS:000393313100006	27868190				2021-06-18	
J	Formisano, R; Longo, E; Azicnuda, E; Silvestro, D; D'Ippolito, M; Truelle, JL; von Steinbuchel, N; von Wild, K; Wilson, L; Rigon, J; Barba, C; Forcina, A; Giustini, M				Formisano, Rita; Longo, Eloise; Azicnuda, Eva; Silvestro, Daniela; D'Ippolito, Mariagrazia; Truelle, Jean-Luc; von Steinbuechel, Nicole; von Wild, Klaus; Wilson, Lindsay; Rigon, Jessica; Barba, Carmen; Forcina, Antonio; Giustini, Marco			Quality of life in persons after traumatic brain injury as self-perceived and as perceived by the caregivers	NEUROLOGICAL SCIENCES			English	Article						Caregiver; Health-related quality of life; Self-awareness; Traumatic brain injury	EXECUTIVE FUNCTION; COGNITIVE-FACTORS; SCALE; QOLIBRI; AWARENESS; EMPATHY; REHABILITATION; SATISFACTION; ADULTS; MIND	The primary aim of the study was to adopt QOLIBRI (quality of life after brain injury) questionnaire in a proxy version (Q-Pro), i.e., to use caregivers for comparison and to evaluate whether TBI patients' judgment corresponds to that of their caregivers since the possible self-awareness deficit of the persons with TBI. A preliminary sample of 19 outpatients with TBI and their proxies was first evaluated with the Patient Competency Rating Scale to assess patients' self-awareness; then they were evaluated with the QOLIBRI Patient version (Q-Pt) and a patient-centered version of the Q-Pro. Subsequently, 55 patients and their caregivers were evaluated using the patient-centered and the caregiver-centered Q-Pro versions. Q-Pt for assessing Quality of Life (QoL) after TBI, as patients' subjective perspective and Q-Pro to assess the QoL of patients as perceived by the caregivers. The majority of patients (62.2%) showed better self-perception of QoL than their proxies; however, patients with low self-awareness were less satisfied than patients with adequate self-awareness. Low self-awareness does not impair the ability of patients with TBI to report on satisfaction with QoL as self-perceived.	[Formisano, Rita; Azicnuda, Eva; Silvestro, Daniela; D'Ippolito, Mariagrazia] Rehabil Hosp Santa Lucia Fdn, IRCCS, Rome, Italy; [Longo, Eloise; Giustini, Marco] Natl Inst Hlth, Viale Regina Elena 299, I-00161 Rome, Italy; [Silvestro, Daniela; D'Ippolito, Mariagrazia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Truelle, Jean-Luc] CHU Raymonde Poincare, Serv Med Phys & Readapt, Garches, France; [von Steinbuechel, Nicole] Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany; [von Wild, Klaus] Westfalian Wilhelms Univ Munster, Clemens Hosp, Dept Neurosurg & Early Neurotraumatol Rehabil, Psychol, Munster, Germany; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling, Scotland; [Rigon, Jessica] IRCCS San Camillo Hosp Fdn, Venice, Italy; [Barba, Carmen] Univ Florence, A Meyer Childrens Hosp, Pediat Neurol Unit, Florence, Italy; [Forcina, Antonio] Univ Naples Federico II, Dept Engn, Naples, Italy	Giustini, M (corresponding author), Natl Inst Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.giustini@iss.it	Azicnuda, Eva/K-9010-2016; Wilson, Lindsay/A-3659-2009; D'Ippolito, Mariagrazia/K-4010-2016; Giustini, Marco/Q-3166-2017	Wilson, Lindsay/0000-0003-4113-2328; D'Ippolito, Mariagrazia/0000-0001-7818-7352; Giustini, Marco/0000-0003-2691-1956; barba, carmen/0000-0001-5445-5842	Italian Ministry of HealthMinistry of Health, Italy [31]; G.B. Baroni Foundation	This research was partially supported by the Italian Ministry of Health (Grant RF2008, No. 31) and a Grant from the G.B. Baroni Foundation.	Altman D. G., 1991, PRACTICAL STAT MED R, V610; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; BROTHERS L, 1992, J COGNITIVE NEUROSCI, V4, P107, DOI 10.1162/jocn.1992.4.2.107; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Formisano R, 2016, INT EMERG MED; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Heaton RK, 2000, FORMA COMPLETA REVIS, P1; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; JENNETT B, 1975, LANCET, V1, P480; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Mehrabian A, 2000, MANUAL BALANCED EMOT, V2000, P93040; Muehlan H, 2016, ASSESSMENT, V23, P124, DOI 10.1177/1073191115569844; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Orsini A., 2003, B PSICOL APPL, V239, P73; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; TEASDALE G, 1974, LANCET, V2, P81; Tramonti F, 2015, PSYCHOL HEALTH MED, V10, P1, DOI DOI 10.1080/13548506.2015.1009380; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2016, J NEUROTRAUMA; World Health Organization, 2011, INT STAT CLASS DIS R, VI-III; Zimmerman P., 1992, TEST BATTERIE AUFMER	42	16	16	0	8	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2017	38	2					279	286		10.1007/s10072-016-2755-y			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EL1NB	WOS:000394386000010	27826793				2021-06-18	
J	Hearps, SJC; Takagi, M; Babl, FE; Bressan, S; Truss, K; Davis, GA; Godfrey, C; Clarke, C; Doyle, M; Rausa, V; Dunne, K; Anderson, V				Hearps, Stephen J. C.; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Truss, Katherine; Davis, Gavin A.; Godfrey, Celia; Clarke, Cathriona; Doyle, Melissa; Rausa, Vanessa; Dunne, Kevin; Anderson, Vicki			Validation of a Score to Determine Time to Postconcussive Recovery	PEDIATRICS			English	Article							POST-CONCUSSIVE SYMPTOMS; TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; HIGH-SCHOOL; CHILDREN; PREDICTORS; EPIDEMIOLOGY; DURATION; SPORT	BACKGROUND: A reliable, developmentally appropriate and standardized method for assessing postconcussive symptoms (PCS) is essential to accurately determine recovery postconcussion and to effectively manage return to normal activities. The aim of this study was to develop an evidence-based, psychometrically validated approach to determining clinically useful cutoff scores by using a commonly administered PCS measure. METHODS: The current study was a prospective, longitudinal observational study conducted between July 2013 and November of 2015 at a statewide tertiary pediatric hospital. Participants were 120 children (5-18 years of age) presenting to the emergency department with a concussion within 48 hours of injury. PCS were assessed by using the Postconcussion Symptom Inventory (PCSI), acutely, 1 to 4 days postinjury and 2 weeks postinjury. Using comprehensive clinical assessment as gold standard, we assessed the clinical cutoff discrimination ability of PCSI at 2 weeks postinjury by using published approaches, and then varying each approach to optimize their discrimination ability. RESULTS: Existing and potential clinical cutoff scores were explored in predicting delayed recovery. Receiver operating characteristic curve results returned acceptable discrimination and sensitivity when PCSI items increased in severity from preinjury by 1 or more. Compared with a published cutoff score being 3+ items with increased severity, the current study suggests a more stringent cutoff requirement of 2+ is better able to accurately classify symptomatic children. CONCLUSIONS: This study provides the first validated index (2+ items, 1+ severity) of concussion recovery for children and youth. Further studies in more varied samples are needed to establish the effectiveness of this method.	[Hearps, Stephen J. C.; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Truss, Katherine; Davis, Gavin A.; Godfrey, Celia; Clarke, Cathriona; Doyle, Melissa; Rausa, Vanessa; Dunne, Kevin; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Takagi, Michael; Truss, Katherine; Doyle, Melissa; Rausa, Vanessa; Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Dunne, Kevin; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Med Res, Level 4 West,50 Flemington Rd, Parkville, Vic 3012, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Visser, Melissa/0000-0002-5313-3347	Royal Children's Hospital Research Foundation; Victorian Government Operational Infrastructure Scheme; Australian National Health and Medical Research Council (NHMRC) Development grantNational Health and Medical Research Council of Australia; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	This study was funded by the Royal Children's Hospital Research Foundation and the Victorian Government Operational Infrastructure Scheme. Mr Hearps was funded by an Australian National Health and Medical Research Council (NHMRC) Development grant, Dr Babl was funded by the Royal Children's Hospital Research Foundation, and Dr Anderson by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J INT NEUROPSYCH SOC, V14, P204; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	26	16	16	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	FEB	2017	139	2							e20162003	10.1542/peds.2016-2003			10	Pediatrics	Pediatrics	EJ2JC	WOS:000393035100024	28138006	Green Published, Bronze			2021-06-18	
J	Verhelst, H; Vander Linden, C; Vingerhoets, G; Caeyenberghs, K				Verhelst, Helena; Vander Linden, Catharine; Vingerhoets, Guy; Caeyenberghs, Karen			How to Train an Injured Brain? A Pilot Feasibility Study of Home-Based Computerized Cognitive Training	GAMES FOR HEALTH JOURNAL			English	Article						Cognitive training; Attention; Working memory; Brain injury; Neuroplasticity; Feasibility	WORKING-MEMORY; CONTROLLED-TRIAL; ATTENTION; REHABILITATION; METAANALYSIS; CHILDREN; INFORMATION; TASK; ADHD	Objective: Computerized cognitive training programs have previously shown to be effective in improving cognitive abilities in patients suffering from traumatic brain injury (TBI). These studies often focused on a single cognitive function or required expensive hardware, making it difficult to be used in a home-based environment. This pilot feasibility study aimed to evaluate the feasibility of a newly developed, home-based, computerized cognitive training program for adolescents who suffered from TBI. Additionally, feasibility of study design, procedures, and measurements were examined. Design: Case series, longitudinal, pilot, feasibility intervention study with one baseline and two follow-up assessments. Materials and Methods: Nine feasibility outcome measures and criteria for success were defined, including accessibility, training motivation/user experience, technical smoothness, training compliance, participation willingness, participation rates, loss to follow-up, assessment timescale, and assessment procedures. Five adolescent patients (four boys, mean age=16 years 7 months, standard deviation=9 months) with moderate to severe TBI in the chronic stage were recruited and received 8 weeks of cognitive training with BrainGames. Effect sizes (Cohen's d) were calculated to determine possible training-related effects. Results: The new cognitive training intervention, BrainGames, and study design and procedures proved to be feasible; all nine feasibility outcome criteria were met during this pilot feasibility study. Estimates of effect sizes showed small to very large effects on cognitive measures and questionnaires, which were retained after 6 months. Conclusion: Our pilot study shows that a longitudinal intervention study comprising our novel, computerized cognitive training program and two follow-up assessments is feasible in adolescents suffering from TBI in the chronic stage. Future studies with larger sample sizes will evaluate training-related effects on cognitive functions and underlying brain structures.	[Verhelst, Helena; Vingerhoets, Guy] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Ghent, Belgium; [Vander Linden, Catharine] Ghent Univ Hosp, Dept Phys Med & Rehabil, Child Rehabil Ctr, Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Sydney, NSW 2059, Australia	Verhelst, H (corresponding author), Univ Ghent, Dept Expt Psychol, Henri Dunantlaan 2, B-9000 Ghent, Belgium.	helena.verhelst@ugent.be		Caeyenberghs, Karen/0000-0001-7009-6843; Verhelst, Helena/0000-0002-6861-0249	Special Research Fund (BOF) [01N00214]	Helena Verhelst is currently receiving a grant (#01N00214) from the Special Research Fund (BOF). The authors are very grateful to the participants and their parents and the staff from the Child Rehabilitation Centre of the Ghent University Hospital and Pulderbos.	[Anonymous], 2005, CAMBRIDGE NEUROPSYCH; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ballard K, 2012, TRAINING RELATED IMP; Beatty EL, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00086; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Corsi P. M, 1972, HUMAN MEMORY MEDIAL; Cumming G., 2012, UNDERSTANDING NEW ST; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Finn M, 2011, BRAIN IMPAIR, V12, P187; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Hauke J, 2011, NEUROPSYCHOL REHABIL, V21, P164, DOI 10.1080/09602011.2010.541792; Hellgren L., 2015, OPEN J THERAPY REHAB, V3, P46, DOI DOI 10.4236/OJTR.2015.32007; Huizinga M, 2009, BRIEF VRAGENLIJST EX; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kort W, 2005, WISC III NL WECHSLER; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson K, 2015, CHILD NEUROPSYCHOL, P1; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shipstead Z, 2012, J APPL RES MEM COGN, V1, P185, DOI 10.1016/j.jarmac.2012.06.003; Sitzer DI, 2006, ACTA PSYCHIAT SCAND, V114, P75, DOI 10.1111/j.1600-0447.2006.00789.x; Sonuga-Barke E, 2014, CHILD ADOL PSYCH CL, V23, P807, DOI 10.1016/j.chc.2014.05.009; Sturm W, 2003, Z NEUROPSYCHOL, V14, P283, DOI [DOI 10.1024/1016-264X.14.4.283, 10.1024/1016-264X.14.4.283]; Tayal F, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00044; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; YNTEMA DB, 1963, HUM FACTORS, V5, P7, DOI 10.1177/001872086300500102; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484	44	16	17	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2161-783X	2161-7856		GAMES HEALTH J	Games Health J.	FEB	2017	6	1					28	38		10.1089/g4h.2016.0043			11	Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	EM5ZQ	WOS:000395393000004	27991840				2021-06-18	
J	Weickenmeier, J; Butler, CAM; Young, PG; Goriely, A; Kuhl, E				Weickenmeier, J.; Butler, C. A. M.; Young, P. G.; Goriely, A.; Kuhl, E.			The mechanics of decompressive craniectomy: Personalized simulations	COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING			English	Article						Neuromechanics; Neurosurgery; Finite element analysis; Decompressive craniectomy; Hemicraniectomy	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; TISSUE; HEAD; ACCURATE	Decompressive craniectomy is a traditional but controversial surgical procedure that removes part of the skull to allow an injured and swollen brain to expand outward. Recent studies suggest that mechanical strain is associated with its undesired, high failure rates. However, the precise strain fields induced by the craniectomy are unknown. Here we create a personalized craniectomy model from magnetic resonance images to quantify the strains during a decompressive craniectomy using finite element analysis. We swell selected regions of the brain and remove part of the skull to allow the brain to bulge outward and release the intracranical swelling pressure. Our simulations reveal three potential failure mechanisms associated with the procedure: axonal stretch in the center of the bulge, axonal compression at the edge of the craniectomy, and axonal shear around the opening. Strikingly, for a swelling of only 10%, axonal strain, compression, and shear reach local maxima of up to 30%, and exceed the reported functional and morphological damage thresholds of 18% and 21%. Our simulations suggest that a collateral craniectomy with the skull opening at the side of swelling is less invasive than a contralateral craniectomy with the skull opening at the opposite side: It induces less deformation, less rotation, smaller strains, and a markedly smaller midline shift. Our computational craniectomy model can help quantify brain deformation, tissue strain, axonal stretch, and shear with the goal to identify high-risk regions for brain damage on a personalized basis. While computational modeling is beyond clinical practice in neurosurgery today, simulations of neurosurgical procedures have the potential to rationalize surgical process parameters including timing, location, and size, and provide standardized guidelines for clinical decision making and neurosurgical planning. (C) 2016 Elsevier B.V. All rights reserved.	[Weickenmeier, J.; Kuhl, E.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Butler, C. A. M.] Simpleware Ltd, Bradninch Hall,Castle St, Exeter EX4 3PL, Devon, England; [Young, P. G.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Goriely, A.] Univ Oxford, Math Inst, Oxford, England; [Kuhl, E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X; Weickenmeier, Johannes/0000-0003-1889-5976	Wolfson/Royal Society Merit AwardRoyal Society of London; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 HL119578]	The authors thank Allan L. Reiss and his group for providing the MRI scans. This work was supported by the Wolfson/Royal Society Merit Award to Alain Goriely and by the National Institutes of Health grant U01 HL119578 to Ellen Kuhl.	[Anonymous], 2014, AB 6 14 AN US MAN SI; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Budday S., 2016, MECH CHARACTER UNPUB; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Fletcher T.L., MODELLING BRAI UNPUB; Fletcher TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110408; Fletcher TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102131; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Goriely A., 2016, PHYS REV LE IN PRESS; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Holland MA, 2015, ANN BIOMED ENG, V43, P1640, DOI 10.1007/s10439-015-1312-9; Holzapfel G., 2000, NONLINEAR SOLID MECH; Hu JW, 2007, J NEUROSURG, V106, P164, DOI 10.3171/jns.2007.106.1.164; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Jones H.R., 2013, NETTER COLLECTION 1, V7; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kocher T, 1901, HIRNERSCHUTTERUNG HI; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Komotar R., 2011, AM ASS NEUROLOG SURG; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; Lejeune E, 2016, SOFT MATTER, V12, P5613, DOI 10.1039/c6sm00526h; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; Ogden R.W., 1972, P ROY SOC LOND A MAT, V326; Ploch CC, 2016, WORLD NEUROSURG, V90, P668, DOI 10.1016/j.wneu.2016.02.081; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024; Saggar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10894; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; van den Bedem H, 2015, BIOPHYS J, V109, P2215, DOI 10.1016/j.bpj.2015.10.020; von Holst H, 2014, ACTA NEUROCHIR, V156, P1961, DOI 10.1007/s00701-014-2195-5; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weickenmeier J, 2016, J MECH PHYS SOLIDS, V96, P572, DOI 10.1016/j.jmps.2016.08.009; Wright RM, 2011, BIOMECH MODEL MECHAN, V11, P245; Young PG, 2008, PHILOS T R SOC A, V366, P3155, DOI 10.1098/rsta.2008.0090	52	16	17	0	8	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0045-7825	1879-2138		COMPUT METHOD APPL M	Comput. Meth. Appl. Mech. Eng.	FEB 1	2017	314				SI		180	195		10.1016/j.cma.2016.08.011			16	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Engineering; Mathematics; Mechanics	EI8UF	WOS:000392782900011		Green Accepted			2021-06-18	
J	Leary, JB; Bondi, CO; LaPorte, MJ; Carlson, LJ; Radabaugh, HL; Cheng, JP; Kline, AE				Leary, Jacob B.; Bondi, Corina O.; LaPorte, Megan J.; Carlson, Lauren J.; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Kline, Anthony E.			The Therapeutic Efficacy of Environmental Enrichment and Methylphenidate Alone and in Combination after Controlled Cortical Impact Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavioral outcome; controlled cortical impact; dopamine agonist; environmental enrichment; functional recovery; learning and memory; Morris water maze; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RECEPTOR AGONIST 8-OH-DPAT; WATER MAZE PERFORMANCE; NEUROBEHAVIORAL BENEFIT; FUNCTIONAL IMPROVEMENT; MODERATE HYPOTHERMIA; VOLUNTARY EXERCISE; COGNITIVE FUNCTION; TREATMENT REGIMEN; CLINICAL-TRIALS	Environmental enrichment (EE) and methylphenidate (MPH) independently confer significant benefit to behavioral recovery after controlled cortical impact (CCI) injury. Given that combinational therapies may be more clinically translatable than monotherapies, the aim of the current study was to test the hypothesis that a combined treatment regimen of EE and MPH would provide greater therapeutic efficacy than either one alone. Anesthetized adult male rats received either a CCI of moderate severity or sham injury and were then randomly assigned to EE or standard (STD) housing where they received either intraperitoneal (ip) MPH (5 mg/kg) or vehicle (VEH; 1.0 mL/kg; ip) beginning 24 h after injury and once daily for 19 days. Motor and cognitive assessments were conducted on post-injury days 1-5 and 14-19, respectively. No differences were observed in sham controls regardless of treatments, and thus their data were pooled. The traumatic brain injury (TBI)+EE+VEH and TBI+EE+MPH groups exhibited enhanced beam balance and beam walk performance relative to the TBI+STD+VEH group (p < 0.05), but did not differ from one another (p > 0.05). No effect of MPH treatment alone was observed in either motor task. In contrast, MPH improved spatial learning and memory when presented alone and also when combined with EE relative to VEH-treated STD controls (p < 0.05). In addition, both EE groups performed significantly better than the TBI+STD+MPH group (p < 0.05), but did not differ from one another (p > 0.05). These data replicate previous findings that both EE and MPH confer cognitive benefits after TBI and extend the findings by revealing that combining EE and MPH does not produce effects greater than either treatment alone, which does not support the hypothesis. The lack of an additive effect may be because of the robustness of the EE.	[Leary, Jacob B.; Bondi, Corina O.; LaPorte, Megan J.; Carlson, Lauren J.; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Leary, Jacob B.; Bondi, Corina O.; LaPorte, Megan J.; Carlson, Lauren J.; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA	Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Phys Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Crit Care Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resusciat Res, Dept Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS060005, R01HD069620, HD069620-S1, R01NS084967]; University of Pittsburgh Physicians / UPMC Academic Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants R01NS060005, R01HD069620, HD069620-S1, R01NS084967 (AEK) and the University of Pittsburgh Physicians / UPMC Academic Foundation (COB).	Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bondi C.O., 2015, BRAIN NEUROTRAUMA MO; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Carmack SA, 2014, NEUROSCI LETT, V567, P45, DOI 10.1016/j.neulet.2014.03.029; Cheng J. P., 2015, BRAIN RES; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Darna M, 2015, BRAIN RES, V1599, P115, DOI 10.1016/j.brainres.2014.12.034; de la Tremblaye Patricia B, J NEUROTRAUMA; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; Falchook AD, 2015, J CLIN EXP NEUROPSYC, V37, P1062, DOI 10.1080/13803395.2015.1077930; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Juarez J, 2015, BEHAV NEUROSCI, V129, P756, DOI 10.1037/bne0000109; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee MY, 2013, NEUROREHAB NEURAL RE, V27, P561, DOI 10.1177/1545968313481277; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mala Hana, 2016, RESTORATIVE NEUROLOG, P1; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Motaghinejad Majid, 2015, Adv Biomed Res, V4, P134, DOI 10.4103/2277-9175.161528; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Perry JL, 2008, BEHAV BRAIN RES, V193, P48, DOI 10.1016/j.bbr.2008.04.019; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weeks J. J., 2016, BEHAV BRAIN RES; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	74	16	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					444	+		10.1089/neu.2016.4438			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800020	26972895	Green Published			2021-06-18	
J	Silverberg, ND; Crane, PK; Dams-O'Connor, K; Holdnack, J; Ivins, BJ; Lange, RT; Manley, GT; McCrea, M; Iverson, GL				Silverberg, Noah D.; Crane, Paul K.; Dams-O'Connor, Kristen; Holdnack, James; Ivins, Brian J.; Lange, Rael T.; Manley, Geoffrey T.; McCrea, Michael; Iverson, Grant L.			Developing a Cognition Endpoint for Traumatic Brain Injury Clinical Trials	JOURNAL OF NEUROTRAUMA			English	Article						clinical trials; cognition; craniocerebral trauma; neuropsychological tests; outcome assessment; psychometrics	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; NEUROIMAGING INITIATIVE ADNI; PATIENT-REPORTED OUTCOMES; MINOR HEAD-INJURY; PREDICTIVE-VALIDITY; RANDOMIZED-TRIAL; COMPOSITE SCORE; NIH TOOLBOX; MILD; REHABILITATION	Cognitive impairment is a core clinical feature of traumatic brain injury (TBI). After TBI, cognition is a key determinant of post-injury productivity, outcome, and quality of life. As a final common pathway of diverse molecular and microstructural TBI mechanisms, cognition is an ideal endpoint in clinical trials involving many candidate drugs and nonpharmacological interventions. Cognition can be reliably measured with performance-based neuropsychological tests that have greater granularity than crude rating scales, such as the Glasgow Outcome Scale-Extended, which remain the standard for clinical trials. Remarkably, however, there is no well-defined, widely accepted, and validated cognition endpoint for TBI clinical trials. A single cognition endpoint that has excellent measurement precision across a wide functional range and is sensitive to the detection of small improvements (and declines) in cognitive functioning would enhance the power and precision of TBI clinical trials and accelerate drug development research. We outline methodologies for deriving a cognition composite score and a research program for validation. Finally, we discuss regulatory issues and the limitations of a cognition endpoint.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Dept Med, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC, Canada; [Silverberg, Noah D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Silverberg, Noah D.; Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Silverberg, Noah D.; Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Holdnack, James] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Ivins, Brian J.] DVBIC, Silver Spring, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, DVBIC, Bethesda, MD USA; [Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, MassGen Hosp Children, Sports Concuss Program,Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Natl Intrepid Ctr Excellence, Def & Vet Brain Injury Ctr, Bethesda, MD USA	Silverberg, ND (corresponding author), Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Iverson, Grant/0000-0001-7348-9570	Vancouver Coastal Health Research Institute Clinician-Scientist Career Development Award; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]; Harvard Integrated Program to Protect and Improve the Health of NFLPA Members; Mooney-Reed Charitable Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS086090-01]; DOD USAMRAAUnited States Department of Defense [W81XWH-13-1-0441]; DODUnited States Department of Defense [W81XWH-14-2-0176]; One Mind; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER	NDS receives salary support from a Vancouver Coastal Health Research Institute Clinician-Scientist Career Development Award. GLI acknowledges support from the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD), Harvard Integrated Program to Protect and Improve the Health of NFLPA Members, and the Mooney-Reed Charitable Foundation. GTM acknowledges support from NIH U01 NS086090-01, DOD USAMRAA W81XWH-13-1-0441, DOD W81XWH-14-2-0176, and One Mind. This work is related to the TBI Endpoints Development Initiative and a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Carter CS, 2007, SCHIZOPHRENIA BULL, V33, P1131, DOI 10.1093/schbul/sbm081; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Chiaravalloti N. D., 2015, NEUROREHABIL NEURAL; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Crane PK, 2008, J INT NEUROPSYCH SOC, V14, P746, DOI 10.1017/S1355617708081162; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P254, DOI 10.1080/09084280903297594; Ivins BJ, 2015, ARCH CLIN NEUROPSYCH, V30, P26, DOI 10.1093/arclin/acu072; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Rohling ML, 2015, ARCH CLIN NEUROPSYCH, V30, P611, DOI 10.1093/arclin/acv039; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Russell E. W., 2011, SCI FDN NEUROPSYCHOL; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Strauss E, 2006, ADM NORMS COMMENTARY, P1216; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Testa SM, 2009, J INT NEUROPSYCH SOC, V15, P1012, DOI 10.1017/S1355617709990713; Vacha-Haase T, 2004, J COUNS PSYCHOL, V51, P473, DOI 10.1037/0022-0167.51.4.473; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wheaton P, 2011, J PSYCHOPHARMACOL, V25, P1581, DOI 10.1177/0269881110388331; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS17, DOI 10.1016/j.apmr.2013.02.029; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	92	16	16	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					363	371		10.1089/neu.2016.4443			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800011	27188248	Green Published			2021-06-18	
J	Wilke, S; List, J; Mekle, R; Lindenberg, R; Bukowski, M; Ott, S; Schubert, F; Ittermann, B; Floel, A				Wilke, Skadi; List, Jonathan; Mekle, Ralf; Lindenberg, Robert; Bukowski, Martin; Ott, Stefanie; Schubert, Florian; Ittermann, Bernd; Floeel, Agnes			No Effect of Anodal Transcranial Direct Current Stimulation on Gamma-Aminobutyric Acid Levels in Patients with Recurrent Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; GABA; MR spectroscopy; transcranial magnetic stimulation	SPORTS-RELATED CONCUSSION; MOTOR CORTEX; IN-VIVO; LONG-TERM; MAGNETIC STIMULATION; PROFESSIONAL FOOTBALL; COGNITIVE FUNCTION; MR SPECTROSCOPY; RESISTANT RULES; SYMPTOMS	In patients in the chronic phase after recurrent mild traumatic brain injury (mTBI), alterations in gamma-aminobutyric acid (GABA) concentration and receptor activity have been reported, possibly mediating subtle but persistent cognitive deficits and increased rate of dementia in older age. We evaluated whether anodal transcranial direct current stimulation (atDCS) over the primary motor cortex reduces GABA concentration and GABA(B) receptor activity in patients with recurrent mTBI. Seventeen patients (mean age 25, two women) in the chronic phase after recurrent mTBI and 22 healthy control subjects (mean age 26, two women) were included. All participants received comprehensive cognitive testing and detailed questionnaires on post-concussive symptoms at baseline. Subsequently, they participated in four experimental sessions, consisting of either magnetic resonance spectroscopy (MRS)/atDCS/MRS, transcranial magnetic stimulation (TMS)/atDCS/TMS, MRS/sham/MRS, or TMS/sham/TMS to determine GABA concentration (from MRS) and GABAB receptor activity (from TMS) after atDCS and after sham stimulation. Patients with mTBI scored significantly lower on verbal fluency tasks compared with healthy control subjects. GABA concentration at baseline was associated with the number of mTBI, although no group differences in GABA concentration and GABAB receptor activity were found. Moreover, no effects of atDCS on GABA concentration and receptor activity were seen in patients with mTBI or healthy control subjects. GABA concentration may increase with the number of mTBI, but atDCS did not modulate GABA concentration and receptor activity, as has been reported previously. Specifics of experimental design and analysis, but also characteristics of the respective samples, may account for these differential findings, and should be addressed in future larger studies.	[Wilke, Skadi; List, Jonathan; Lindenberg, Robert; Bukowski, Martin; Ott, Stefanie; Floeel, Agnes] Charite, Dept Neurol, CharitePl 1, D-10117 Berlin, Germany; [Floeel, Agnes] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Floeel, Agnes] Charite, NeuroCure Cluster Excellence, Berlin, Germany; [Mekle, Ralf; Schubert, Florian; Ittermann, Bernd] PTB, Berlin, Germany	Wilke, S; Floel, A (corresponding author), Charite, Dept Neurol, CharitePl 1, D-10117 Berlin, Germany.	skadi.wilke@charite.de; agnes.floeel@charite.de	Floel, Agnes/A-9426-2017; Mekle, Ralf/S-6542-2019	Mekle, Ralf/0000-0001-6821-7722; Wilke, Skadi/0000-0002-1424-516X	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [AF: 379-10/1, 379-11/1, DFG-Exc-257]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [01EO0801, 01GQ1424A, 01GQ1420B]; Charite Universitatsmedizin Berlin; Berlin Institute of Health	This work was supported by grants from the Deutsche Forschungsgemeinschaft (AF: 379-10/1; 379-11/1; DFG-Exc-257), Bundesministerium fur Bildung und Forschung (AF: 01EO0801, 01GQ1424A, 01GQ1420B). JL is participant in the Charite Clinical Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Bachtiar V, 2015, ELIFE, V4, DOI 10.7554/eLife.08789; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chollet F., 2013, NEUROSCIENCE, V15, P67; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cousijn H, 2014, P NATL ACAD SCI USA, V111, P9301, DOI 10.1073/pnas.1321072111; Das S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00550; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Edden RAE, 2012, J MAGN RESON IMAGING, V35, P229, DOI 10.1002/jmri.22865; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hautzinger M., 2006, BECK DEPRESSION INVE; Helmstaedter C., 2001, VERBALER LERNUND MER; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hotting K, 2013, NEUROSCI BIOBEHAV R, V37, P2243, DOI 10.1016/j.neubiorev.2013.04.005; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kidgell DJ, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/603502; Kim S, 2014, NEUROIMAGE, V99, P237, DOI 10.1016/j.neuroimage.2014.05.070; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; List J, 2015, NEUROLOGY, V84, P626, DOI 10.1212/WNL.0000000000001230; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Meinzer M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00253; Meinzer M, 2013, J NEUROSCI, V33, P12470, DOI 10.1523/JNEUROSCI.5743-12.2013; Mekle R, 2009, MAGN RESON MED, V61, P1279, DOI 10.1002/mrm.21961; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Mlynarik V, 2006, MAGN RESON MED, V56, P965, DOI 10.1002/mrm.21043; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Near J, 2013, NMR BIOMED, V26, P1353, DOI 10.1002/nbm.2960; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2013, J MAGN RESON IMAGING, V37, P999, DOI 10.1002/jmri.23817; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Stagg Charlotte J, 2011, Commun Integr Biol, V4, P573, DOI 10.4161/cib.4.5.16213; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Suzuki K, 2012, INT J NEUROSCI, V122, P675, DOI 10.3109/00207454.2012.707715; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, NEUROREPORT, V24, P46, DOI 10.1097/WNR.0b013e32835c36b8; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Ulm L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00550; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilke S, 2017, J NEUROTRAUM, V34, P281, DOI 10.1089/neu.2016.4399; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	108	16	18	1	26	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					281	+		10.1089/neu.2016.4399			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800003	27393381				2021-06-18	
J	Kucera, KL; Yau, RK; Register-Mihalik, J; Marshall, SW; Thomas, LC; Wolf, S; Cantu, RC; Mueller, FO; Guskiewicz, KM				Kucera, Kristen L.; Yau, Rebecca K.; Register-Mihalik, Johna; Marshall, Stephen W.; Thomas, Leah C.; Wolf, Susanne; Cantu, Robert C.; Mueller, Frederick O.; Guskiewicz, Kevin M.			Traumatic Brain and Spinal Cord Fatalities Among High School and College Football Players - United States, 2005-2014	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article							AMERICAN FOOTBALL; INJURIES; SPORTS; HEAD		[Kucera, Kristen L.; Yau, Rebecca K.; Thomas, Leah C.; Wolf, Susanne; Mueller, Frederick O.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Natl Ctr Catastroph Sport Injury Res, Chapel Hill, NC 27514 USA; [Yau, Rebecca K.; Marshall, Stephen W.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Register-Mihalik, Johna; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Cantu, Robert C.] Emerson Hosp, Concord, MA USA; [Cantu, Robert C.] Boston Univ, Boston, MA 02215 USA	Kucera, KL (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Natl Ctr Catastroph Sport Injury Res, Chapel Hill, NC 27514 USA.	kkucera@email.unc.edu			American Football Coaches Association; National Athletic Trainers' Association; National Collegiate Athletic Association; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; American Medical Society for Sports Medicine	Julie Gilchrist, MD, National Center for Injury Prevention and Control, CDC; R. Dawn Comstock, PhD, Douglas J. Casa, PhD, Tom P. Dompier, PhD, Jonathan A. Drezner, MD, Zackary Y. Kerr, PhD, David Klossner, PhD, Rebecca L. Stearns, PhD, Consortium for Catastrophic Injury Monitoring in Sport. The National Center for Catastrophic Sport Injury Research is funded by the following organizations: the American Football Coaches Association, the National Athletic Trainers' Association, the National Collegiate Athletic Association, the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, and the American Medical Society for Sports Medicine.	Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Cantu RC, 2009, BRIT J SPORT MED, V43, P981, DOI 10.1136/bjsm.2009.067728; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; HADDON W, 1973, J TRAUMA, V13, P321, DOI 10.1097/00005373-197304000-00011; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; MUELLER FO, 1987, CLIN SPORT MED, V6, P185; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03	10	16	16	1	9	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	JAN 6	2017	65	52					1465	1469					5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	EH6UF	WOS:000391908700002	28056008	Bronze			2021-06-18	
J	Ahmed, OH; Hall, EE				Ahmed, Osman Hassan; Hall, Eric E.			"It was only a mild concussion": Exploring the description of sports concussion in online news articles	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Sports medicine; Media; Internet	HIGH-SCHOOL; KNOWLEDGE TRANSFER; INFLUENCING POLICY; RUGBY PLAYERS; MEDIA; EDUCATION; LEAGUE; MANAGEMENT; AWARENESS; PROGRAM	Background/aims: Concussion is widely discussed in online sports news articles, but the terms used to report this injury vary. This study aimed to use a systematic search strategy and explore the description of sports concussion in online sports news articles. Methods: A systematic approach was employed to obtain online articles related to sports concussion from four sports associated with concussion (hockey, football, soccer, and rugby). Included articles were evaluated for the descriptors used in relation to concussion and possible consequences associated with concussion. Data was analysed to determine trends between each sport as well between the countries of origin of the articles. Results: From 200 articles retrieved, 153 were included for analysis. The terms "Head injury" (30.1%) and "Brain injury" (20.9%) were most used to describe a concussive injury, and the most frequently mentioned consequence of concussion was "Chronic Traumatic Encephalopathy" (15%). Modifiers which potentially play down the importance of the injury were noted in 9.8% of the articles, with journalists the primary source of these terms. Conclusions: The variability in reporting of concussion by online news articles may limit the transmission of correct concussion information to the public. To improve the consistency of this reporting, the "Media Concussion Checklist" was developed. (C) 2016 The Authors. Published by Elsevier Ltd.	[Ahmed, Osman Hassan] Bournemouth Univ, Fac Hlth & Social Sci, Royal London House, Bournemouth BH1 3LT, Dorset, England; [Ahmed, Osman Hassan] Poole Hosp NHS Fdn Trust, Dept Physiotherapy, Poole, Dorset, England; [Ahmed, Osman Hassan] FA Ctr Disabil Football Res, St Georges Pk, Burton Upon Trent, England; [Hall, Eric E.] Elan Univ, Dept Exercise Sci, Elon, NC USA	Ahmed, OH (corresponding author), Bournemouth Univ, Fac Hlth & Social Sci, Royal London House, Bournemouth BH1 3LT, Dorset, England.	osman.hassan.ahmed@gmail.com					Ahmed OH, 2014, PM&R, V6, P1071, DOI 10.1016/j.pmrj.2014.08.945; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Asplund CA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1381; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Burns J., 2014, NY TIMES; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chapman S, 2014, J HEALTH COMMUN, V19, P260, DOI 10.1080/10810730.2013.811327; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Croker J. M. B., 2015, COMMUNICATION; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Geller G, 2002, JAMA-J AM MED ASSOC, V287, P773, DOI 10.1001/jama.287.6.773; Goff S., 2015, WASHINGTON POST; Gollust SE, 2012, SOC SCI MED, V74, P1544, DOI 10.1016/j.socscimed.2012.01.021; Ho SS, 2008, INT J PUBLIC OPIN R, V20, P171, DOI 10.1093/ijpor/edn017; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Maese R., 2014, WASHINGTON POST; Mc Fie S., 2015, CLIN J SPORTS MED; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; McNamee M, 2014, SPORT ETHICS PHILOS, V8, P113, DOI 10.1080/17511321.2014.946269; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Petersen A, 2001, SOC SCI MED, V52, P1255, DOI 10.1016/S0277-9536(00)00229-X; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sharp David J, 2015, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Sullivan SJ, 2012, PHYS THER SPORT, V13, P209, DOI 10.1016/j.ptsp.2011.10.004; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313	39	16	16	1	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2017	23						7	13		10.1016/j.ptsp.2016.07.003			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	EJ5ML	WOS:000393262200002	27639135	Other Gold, Green Accepted			2021-06-18	
S	Brouwer, MC; van de Beek, D		Wijdicks, EFM; Kramer, AH		Brouwer, M. C.; van de Beek, D.			Management of bacterial central nervous system infections	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							INVASIVE MENINGOCOCCAL DISEASE; RANDOMIZED CONTROLLED TRIAL; REAL-TIME PCR; PNEUMOCOCCAL MENINGITIS; BRAIN-ABSCESS; STREPTOCOCCUS-PNEUMONIAE; LISTERIA-MONOCYTOGENES; NEISSERIA-MENINGITIDIS; DIFFERENTIAL-DIAGNOSIS; HAEMOPHILUS-INFLUENZAE	Bacterial infections of the central nervous system present as a medical emergency, thus requiring rapid diagnosis and immediate treatment. The most prevalent bacterial infections seen in the intensive care unit can be summarized as acute bacterial meningitis, subdural empyema, intracerebral abscess, and ventriculitis, which all commonly involve the brain parenchyma. The infections can either be community-acquired or hospital-acquired, e.g., after neurosurgical intervention, as a complication of severe neurotrauma or related to indwelling cerebrospinal fluid drains. Community-acquired bacterial meningitis is most commonly caused by the pneumococcus (Streptococcus pneumoniae) and meningococcus (Neisseria meningtidis), and is often complicated by hearing loss, cerebrovascular complications, and seizures. Brain abscesses are frequently associated with contiguous or metastatic foci of infection such as otitis, sinusitis, pneumonia, or endocarditis which need to be detected and treated early during disease course. Despite optimal treatment, many patients are at risk for both major systemic and neurologic complications, leading to a substantial mortality and risk of major disability in survivors. Empiric treatment depends on regional antibiotic resistance patterns of common pathogens. For subdural empyema and brain abscesses, neurosurgical drainage of the infection is required alongside prolonged antibiotic treatment.	[Brouwer, M. C.; van de Beek, D.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, Dept Neurol, Amsterdam, Netherlands	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Neurol, POB 22660, NL-1100 DD Amsterdam, Netherlands.	D.vandeBeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X			Abulhasan YB, 2013, NEUROCRIT CARE, V19, P199, DOI 10.1007/s12028-013-9853-y; Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Al Masalma M, 2012, CLIN INFECT DIS, V54, P202, DOI 10.1093/cid/cir797; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; Bijlsma MW, 2014, LANCET INFECT DIS, V14, P805, DOI 10.1016/S1473-3099(14)70806-0; Blaser C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-84; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2016, INTENS CARE MED, V42, P415, DOI 10.1007/s00134-015-4057-x; Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5; Brouwer MC, 2015, CLIN INFECT DIS, V61, P664, DOI 10.1093/cid/civ328; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Brown EM, 2000, BRIT J NEUROSURG, V14, P7; Castelblanco RL, 2014, LANCET INFECT DIS, V14, P813, DOI 10.1016/S1473-3099(14)70805-9; Choi SH, 2013, INFECT CHEMOTHER, V45, P308, DOI 10.3947/ic.2013.45.3.308; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; de Louvois J, 2000, BRIT J NEUROSURG, V14, P525; Dubos F, 2008, ARCH PEDIAT ADOL MED, V162, P1157, DOI 10.1001/archpedi.162.12.1157; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Edberg M, 2011, ACTA ANAESTH SCAND, V55, P732, DOI 10.1111/j.1399-6576.2011.02460.x; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Heckenberg SGB, 2012, CLIN MICROBIOL INFEC, V18, P849, DOI 10.1111/j.1469-0691.2011.03668.x; Heinsbroek E, 2013, J INFECTION, V67, P385, DOI 10.1016/j.jinf.2013.06.007; Hoen B, 1993, Eur J Med, V2, P28; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Jim KK, 2012, NEUROLOGY, V79, P2133, DOI 10.1212/WNL.0b013e3182752d0e; Kasanmoentalib ES, 2013, CURR OPIN NEUROL, V26, P282, DOI 10.1097/WCO.0b013e328360415c; Kasanmoentalib ES, 2010, NEUROLOGY, V75, P918, DOI 10.1212/WNL.0b013e3181f11e10; Koomen I, 2004, ACTA PAEDIATR, V93, P1378, DOI 10.1080/08035250410033349; Koopmans MM, 2013, CLIN INFECT DIS, V57, P247, DOI 10.1093/cid/cit250; Le Monnier A, 2011, J CLIN MICROBIOL, V49, P3917, DOI 10.1128/JCM.01072-11; Liu S, 2011, CRIT CARE MED, V39, P1467, DOI 10.1097/CCM.0b013e3182120d13; Lucas MJ, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000009; Lucas MJ, 2013, CIRCULATION, V127, P2056, DOI 10.1161/CIRCULATIONAHA.113.001545; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Mitja O, 2009, J ANTIMICROB CHEMOTH, V64, P416, DOI 10.1093/jac/dkp180; Moisi JC, 2009, CLIN INFECT DIS, V48, pS49, DOI 10.1086/596481; Molyneux EM, 2014, PEDIATR INFECT DIS J, V33, P214, DOI 10.1097/INF.0000000000000122; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; Munoz-Almagro C, 2009, DIAGN MICR INFEC DIS, V63, P148, DOI 10.1016/j.diagmicrobio.2008.10.008; Munoz-Gomez S, 2015, HEART LUNG, V44, P158, DOI 10.1016/j.hrtlng.2015.01.003; Mylonakis E, 1998, MEDICINE, V77, P313, DOI 10.1097/00005792-199809000-00002; Nathoo N, 1999, NEUROSURGERY, V44, P529, DOI 10.1097/00006123-199903000-00055; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Nigrovic LE, 2004, PEDIATR INFECT DIS J, V23, P786, DOI 10.1097/01.inf.0000135679.98790.14; Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275; Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436; Pelkonen T, 2011, LANCET INFECT DIS, V11, P613, DOI 10.1016/S1473-3099(11)70055-X; Peltola H, 2007, CLIN INFECT DIS, V45, P1277, DOI 10.1086/522534; Pfausler B, 2003, J NEUROSURG, V98, P1040, DOI 10.3171/jns.2003.98.5.1040; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Reddy JS, 2006, SURG NEUROL, V66, P246, DOI 10.1016/j.surneu.2006.03.032; Saha SK, 2005, PEDIATR INFECT DIS J, V24, P1093, DOI 10.1097/01.inf.0000190030.75892.78; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Schmand B, 2010, J INFECTION, V61, P330, DOI 10.1016/j.jinf.2010.07.006; Schut ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034311; Schut ES, 2012, NEUROCRIT CARE, V16, P421, DOI 10.1007/s12028-011-9634-4; Sormunen P, 1999, J PEDIATR-US, V134, P725, DOI 10.1016/S0022-3476(99)70288-X; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Tunkel A, 2010, PRINCIPLES PRACTICE; Tzanakaki G, 2005, CLIN MICROBIOL INFEC, V11, P386, DOI 10.1111/j.1469-0691.2005.01109.x; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2016, CLIN MICROBIOL INFEC, V22, pS37, DOI 10.1016/j.cmi.2016.01.007; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Vergouwen MDI, 2010, NEUROCRIT CARE, V13, P217, DOI 10.1007/s12028-010-9387-5; Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8; Weisfelt M, 2008, ANN NEUROL, V63, P90, DOI 10.1002/ana.21216; Wong AM, 2004, AM J NEURORADIOL, V25, P1016; Wong GKC, 2002, J NEUROL NEUROSUR PS, V73, P759, DOI 10.1136/jnnp.73.6.759; Worsoe L, 2010, CLIN INFECT DIS, V51, P917, DOI 10.1086/656409; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169; Zoons E, 2008, NEUROLOGY, V70, P2109, DOI 10.1212/01.wnl.0000288178.91614.5d	89	16	19	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						349	364		10.1016/B978-0-444-63600-3.00019-2			16	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500021	28187809				2021-06-18	
J	Erdodi, LA; Lichtenstein, JD; Rai, JK; Flaro, L				Erdodi, Laszlo A.; Lichtenstein, Jonathan D.; Rai, Jaspreet K.; Flaro, Lloyd			Embedded validity indicators in Conners' CPT-II: Do adult cutoffs work the same way in children?	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Conners' CPT-II; pediatric neuropsychology; performance validity assessment; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERFORMANCE TEST-II; SYMPTOM VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; PEDIATRIC SAMPLE; TEST FAILURE; TESTS; EXAGGERATION; DISORDER; CURVE	In previous research, several subscales of Conners' CPT-II were found to be useful as performance validity tests (PVTs) when administered to adults with traumatic brain injury (TBI). Furthermore, invalid response sets were associated with inflated scores on several CPT-II scales. The present study proposed to investigate whether these findings would replicate in a pediatric sample. The analyses were based on archival data from 15 children with TBI. The Omissions, Hit RT, Perseverations, and Hit RT BC scales proved effective at differentiating valid and invalid response sets. However, Commission errors were unrelated to scores on PVTs. A composite measure based on these four scores was a superior and more stable validity indicator than individual scales. Two or more T-scores >65 on any of these scales resulted in acceptable overall specificity (.86-1.00) and variable sensitivity (.00-1.00). Scores on CPT-II scales were generally higher among those who failed the reference PVTs. Results suggest that embedded CPT-II validity indices developed in adult TBI samples function similarly in children with TBI, with some notable exceptions. Although the use of adult PVT cutoffs in pediatric assessment is a common practice, and broadly supported by the present findings, there remains a clear need for the independent empirical validation of adult PVTs in children.	[Erdodi, Laszlo A.; Rai, Jaspreet K.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA	Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com					Babikian T., 2007, ASSESSMENT FEIGNED C, P103; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Baron I., 2004, NEUROPSYCHOLOGICAL E; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Conners K. C., 2004, CONNERS CONTINUOUS P; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Dunn L. M., 1997, PPVT 3 PEABODY PICTU; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Gioia G. A., 2000, BRIEF BEHAV RATING I; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2003, MANUAL COMPUTERIZED; Green P., 2004, MANUAL MED SYMPTOM V; Green P., 2008, MANUAL GREENS NONVER; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hanczar B, 2010, BIOINFORMATICS, V26, P822, DOI 10.1093/bioinformatics/btq037; Heaton R., 1993, WISCONSIN CARD SORTI; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Meyers J., 1995, REY COMPLEX FIGURE T; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Morey L. C., 1991, PERSONALITY ASSESSME; Morey LC., 2007, PERSONALITY ASSESSME; Nagle AM, 2006, ARCH CLIN NEUROPSYCH, V21, P777, DOI 10.1016/j.acn.2006.06.011; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Reitan RM., 1985, HALSTEAD REITAN NEUR; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Sweet J. J., 2007, ASSESSMENT FEIGNED C, P152; Wald NJ, 2014, J MED SCREEN, V21, P51, DOI 10.1177/0969141313517497; Wechsler D., 1991, WECHSLER INTELLIGENC; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME	51	16	16	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2017	6	4					355	363		10.1080/21622965.2016.1198908			9	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	FK7SD	WOS:000413706600012	27383142				2021-06-18	
J	Goldstein, FC; Caveney, AF; Hertzberg, VS; Silbergleit, R; Yeatts, SD; Palesch, YY; Levin, HS; Wright, DW				Goldstein, Felicia C.; Caveney, Angela F.; Hertzberg, Vicki S.; Silbergleit, Robert; Yeatts, Sharon D.; Palesch, Yuko Y.; Levin, Harvey S.; Wright, David W.		NETT Investigators	Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical trial; cognitive function; head trauma; prospective study	PRACTICAL SCALE; CLINICAL-TRIAL; HEAD-INJURY	A Phase III, double-blind, placebo-controlled trial (ProTECT III) found that administration of progesterone did not reduce mortality or improve functional outcome as measured by the Glasgow Outcome Scale Extended (GOSE) in subjects with moderate to severe traumatic brain injury. We conducted a secondary analysis of neuropsychological outcomes to evaluate whether progesterone is associated with improved recovery of cognitive and motor functioning. ProTECT III was conducted at 49 level I trauma centers in the United States. Adults with moderate to severe TBI were randomized to receive intravenous progesterone or placebo within 4 h of injury for a total of 4 days. At 6 months, subjects underwent evaluation of memory, attention, executive functioning, language, and fine motor coordination/dexterity. Chi-square analysis revealed no significant difference in the proportion of subjects (263/280 progesterone, 283/295 placebo) with Galveston Orientation and Amnesia Test scores >= 75. Analyses of covariance did not reveal significant treatment effects for memory (Buschke immediate recall, p = 0.53; delayed recall, p = 0.94), attention (Trails A speed, p = 0.81 and errors, p = 0.22; Digit Span Forward length, p = 0.66), executive functioning (Trails B speed, p = 0.97 and errors, p = 0.93; Digit Span Backward length, p = 0.60), language (timed phonemic fluency, p = 0.05), and fine motor coordination/dexterity (Grooved Pegboard dominant hand time, p = 0.75 and peg drops, p = 0.59; nondominant hand time, p = 0.74 and peg drops, p = 0.61). Pearson Product Moment Correlations demonstrated significant (p < 0.001) associations between better neuropsychological performance and higher GOSE scores. Similar to the ProTECT III trial's results of the primary outcome, the secondary outcomes do not provide evidence of a neuroprotective effect of progesterone.	[Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, 12 Execut Pk Dr, Atlanta, GA 30329 USA; [Hertzberg, Vicki S.] Emory Univ, Sch Med, Sch Nursing, Atlanta, GA USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Caveney, Angela F.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Sch Med, Ann Arbor, MI USA; [Yeatts, Sharon D.; Palesch, Yuko Y.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA	Goldstein, FC (corresponding author), Emory Univ, Sch Med, Dept Neurol, 12 Execut Pk Dr, Atlanta, GA 30329 USA.	fgoldst@emory.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062778, 5U10NS059032, U01NS056975]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS059032, U01NS062778] Funding Source: NIH RePORTER	Supported by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NS062778, 5U10NS059032, and U01NS056975) and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454) and by the Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital.	Army Individual Test Battery, 1944, MAN DIR SCOR; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton A., 1994, MULTILINGUAL APHASIA; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Gregoire J, 1997, AGING NEUROPSYCHOL C, V4, P140, DOI 10.1080/13825589708256642; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; JENNETT B, 1975, LANCET, V1, P480; Klove H, 1963, CLIN NEUROPSYCHOLOGY; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUSS D. T., 1988, CLIN NEUROPSYCHOL, V2, P246, DOI DOI 10.1080/13854048808520107; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	26	16	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					115	120		10.1089/neu.2015.4313			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100014	26973025	Green Published			2021-06-18	
J	Guo, SW; Zhen, YW; Wang, AR				Guo, Shewei; Zhen, Yingwei; Wang, Anran			Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						TBI; BMSCs; angiogenesis; neurological function	MARROW STROMAL CELLS; MONONUCLEAR-CELLS; CEREBRAL-ISCHEMIA; RATS; THERAPY; MICE; STROKE; DIFFERENTIATION; NEUROGENESIS; ATORVASTATIN	Traumatic brain injury (TBI) has emerged as a leading cause of mortality and morbidity worldwide. Transplantation of bone mesenchymal stem cells (BMSCs) has emerged as a promising treatment for various central nervous system diseases. This study aims to evaluate the effect of BMSCs transplantation by intravenous injection on neurological function and angiogenesis of the TBI mice. C57BL/6 male mice were randomly divided into four groups: control, sham, TBI, and BMSC. Functional neurological evaluation was performed 1, 4, 7, 14, and 21 days after TBI using neurological severity scores. The impairment of learning and memory in mice was evaluated 14 days after TBI by Morris water maze experiment. Mice were sacrificed 14 days after TBI, and then brain sections were stained by terminal deoxyribonucle-otidyl transferase (TDT)-mediated dUTP-digoxigenin nick end labeling staining to assess brain neuronal apoptosis. Immunohistochemistry was conducted to evaluate caspase-3 activity and identify vascular distribution and microvessel density. Protein and mRNA levels of vascular endothelial growth factor (VEGF) and angiogenin-1 (Ang-1) in brain tissues were analyzed by Western blot and quantitative real-time polymerase chain reaction, respectively. BMSCs transplantation promoted recovery of neurological function, ameliorated impairment of learning and memory, attenuated neuronal apoptosis, and diminished caspase-3 activation in mice after TBI. Also, BMSCs transplantation upregulated expressions of VEGF and Ang-1 and promoted the formation of microvessels in brain tissues after TBI. Our study demonstrated the important role of BMSCs transplantation in TBI mouse and indicated that the underlying mechanism was through promoting angiogenesis and improving neurological function. This provides a novel and effective strategy for cell-based therapy in the treatment of TBI.	[Guo, Shewei; Zhen, Yingwei; Wang, Anran] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Jianshe East Rd, Zhengzhou 450000, Henan, Peoples R China	Guo, SW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Jianshe East Rd, Zhengzhou 450000, Henan, Peoples R China.	gswfeicui@sohu.com					Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Bao CF, 2015, CELL PHYSIOL BIOCHEM, V37, P901, DOI 10.1159/000430217; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Ding SG, 2006, HUM PATHOL, V37, P861, DOI 10.1016/j.humpath.2006.02.006; Fouillard L, 2007, LEUKEMIA, V21, P568, DOI 10.1038/sj.leu.2404550; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; James S, 2015, STEM CELL REP, V4, P1004, DOI 10.1016/j.stemcr.2015.05.005; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Malgieri A, 2010, INT J CLIN EXP MED, V3, P248; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Misra V, 2011, STEM CELLS BIOL REG, P143, DOI 10.1007/978-1-60761-965-9_7; Nandoe RDS, 2006, CELL TRANSPLANT, V15, P563, DOI 10.3727/000000006783981602; Pandya NM, 2006, VASC PHARMACOL, V44, P265, DOI 10.1016/j.vph.2006.01.005; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sandu N, 2010, MOL MED, V16, P433, DOI 10.2119/molmed.2010.00035; Sharma A, 2014, STROKE RES TREAT, V2014, DOI 10.1155/2014/234095; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sun YX, 2013, NEUROL SCI, V34, P345, DOI 10.1007/s10072-012-1007-z; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu BH, 2016, NEUROBIOL AGING, V39, P46, DOI 10.1016/j.neurobiolaging.2015.11.029; Yalvac ME, 2011, NEUROCHEM RES, V36, P2227, DOI 10.1007/s11064-011-0546-7; Yang B, 2011, J NEUROSCI RES, V89, P833, DOI 10.1002/jnr.22614; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061	41	16	19	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2017	13						2757	2765		10.2147/NDT.S141534			9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	FL7TD	WOS:000414452500001	29158675	DOAJ Gold, Green Published			2021-06-18	
J	Nijsse, B; van Heugten, CM; van Mierlo, ML; Post, MWM; de Kort, PLM; Visser-Meily, JMA				Nijsse, Britta; van Heugten, Caroline M.; van Mierlo, Marloes L.; Post, Marcel W. M.; de Kort, Paul L. M.; Visser-Meily, Johanna M. A.			Psychological factors are associated with subjective cognitive complaints 2 months post-stroke	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Stroke; Rehabilitation; Cognitive complaints; Psychological factors	ANEURYSMAL SUBARACHNOID HEMORRHAGE; QUALITY-OF-LIFE; IMPAIRMENT HARMONIZATION STANDARDS; STROKE-CANADIAN STROKE; TRAUMATIC BRAIN-INJURY; MEMORY COMPLAINTS; NEUROLOGICAL DISORDERS; NATIONAL INSTITUTE; SELF-EFFICACY; CHRONIC PAIN	The aim of this study was to investigate which psychological factors are related to post-stroke subjective cognitive complaints, taking into account the influence of demographic and stroke-related characteristics, cognitive deficits and emotional problems. In this cross-sectional study, 350 patients were assessed at 2 months post-stroke, using the Checklist for Cognitive and Emotional consequences following stroke (CLCE-24) to identify cognitive complaints. Psychological factors were: proactive coping, passive coping, self-efficacy, optimism, pessimism, extraversion, and neuroticism. Associations between CLCE-24 cognition score and psychological factors, emotional problems (depressive symptoms and anxiety), cognitive deficits, and demographic and stroke characteristics were examined using Spearman correlations and multiple regression analyses. Results showed that 2 months post-stroke, 270 patients (68.4%) reported at least one cognitive complaint. Age, sex, presence of recurrent stroke(s), comorbidity, cognitive deficits, depressive symptoms, anxiety, and all psychological factors were significantly associated with the CLCE-24 cognition score in bivariate analyses. Multiple regression analysis showed that psychological factors explained 34.7% of the variance of cognitive complaints independently, and 8.5% (p < .001) after taking all other factors into account. Of all psychological factors, proactive coping was independently associated with cognitive complaints (p < .001), showing that more proactive coping related to less cognitive complaints. Because cognitive complaints are common after stroke and are associated with psychological factors, it is important to focus on these factors in rehabilitation programmes.	[Nijsse, Britta; de Kort, Paul L. M.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands; [van Mierlo, Marloes L.; Post, Marcel W. M.; Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, POB 85500, NL-3508 GA Utrecht, Netherlands; [van Mierlo, Marloes L.; Post, Marcel W. M.; Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, POB 85500, NL-3508 GA Utrecht, Netherlands; [van Mierlo, Marloes L.; Post, Marcel W. M.; Visser-Meily, Johanna M. A.] De Hoogstr Rehabil, Utrecht, Netherlands	Visser-Meily, JMA (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, POB 85500, NL-3508 GA Utrecht, Netherlands.; Visser-Meily, JMA (corresponding author), Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, POB 85500, NL-3508 GA Utrecht, Netherlands.	j.m.a.visser-meily@umcutrecht.nl			VSB foundation	This research project is funded by the VSB foundation and co-ordinated by ZonMw (Dutch Organization for Health Research and Development).	Aben I, 2002, STROKE, V33, P2391, DOI 10.1161/01.STR.0000029826.41672.2E; Aben L, 2011, CEREBROVASC DIS, V31, P566, DOI 10.1159/000324627; Antikainen R, 2001, EUR ARCH PSY CLIN N, V251, P6, DOI 10.1007/s004060170060; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Bode C, 2008, PSYCHOL GEZONDH, V36, P81, DOI 10.1007/BF03077476; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Collin C, 1988, Int Disabil Stud, V10, P61; Duits A, 2008, J NEUROL NEUROSUR PS, V79, P143, DOI 10.1136/jnnp.2007.114595; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; HANNINEN T, 1994, J AM GERIATR SOC, V42, P1; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Hopko DR, 2011, J CONSULT CLIN PSYCH, V79, P834, DOI 10.1037/a0025450; Koski L, 2013, CEREBROVASC DIS, V36, P6, DOI 10.1159/000352051; Lamb F, 2013, ARCH PHYS MED REHAB, V94, P1747, DOI 10.1016/j.apmr.2013.02.026; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Meijer R, 2006, INT J REHABIL RES, V29, P1, DOI 10.1097/01.mrr.0000175269.59788.41; Merlijn VPBM, 2005, PATIENT EDUC COUNS, V59, P126, DOI 10.1016/j.pec.2004.10.010; Narasimhalu K, 2013, EUR J NEUROL, V20, P547, DOI 10.1111/ene.12032; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niederehe G, 1998, PL S ADULT DEV AGING, P417; Passier PECA, 2012, NEUROREHABILITATION, V30, P137, DOI 10.3233/NRE-2012-0737; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Sanderman R, 1995, METEN PERSOONLIJKHEI; Sato T, 2005, J PSYCHOL, V139, P545, DOI 10.3200/JRLP.139.6.545-552; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242; Schreurs P. J. G., 1993, UTRECHTSE COPING LIJ; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tielemans NS, 2014, INT J STROKE, V9, P818, DOI 10.1111/ijs.12127; Uijl SG, 2006, SEIZURE-EUR J EPILEP, V15, P242, DOI 10.1016/j.seizure.2006.02.009; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; van Heugten C, 2007, CLIN NEUROL NEUROSUR, V109, P257, DOI 10.1016/j.clineuro.2006.10.002; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; van Mierlo ML, 2014, INT J STROKE, V9, P148, DOI 10.1111/j.1747-4949.2012.00882.x; Verhage F, 1964, INTELLIGENTIE LEEFTI; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Winkens I, 2009, NEUROPSYCHOL REHABIL, V19, P64, DOI 10.1080/09602010801913650; Xiong YY, 2011, INT J GERIATR PSYCH, V26, P1144, DOI 10.1002/gps.2652	47	16	16	0	30	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	1					99	115		10.1080/09602011.2015.1065280			17	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	EB0SL	WOS:000387055700007	26207868				2021-06-18	
J	Peeters, S; Blaine, C; Vycheth, I; Nang, S; Vuthy, D; Park, KB				Peeters, Sophie; Blaine, Caitlin; Vycheth, Iv; Nang, Sam; Vuthy, Din; Park, Kee B.			Epidemiology of Traumatic Brain Injuries at a Major Government Hospital in Cambodia	WORLD NEUROSURGERY			English	Article						Cambodia; Helmet; Low-income countries; Neurosurgery; Road traffic accidents; Traumatic brain injury	MOTORCYCLE HELMET USE; HEAD-INJURIES; VIETNAM; HEMATOMAS; DISEASE; IMPACT; LAW	BACKGROUND: Traumatic brain injury (TBI) is a critical public health problem worldwide with a significant socioeconomic burden. Although improved safety regulations in high-income countries have resulted in a decline in traffic-related TBI, the incidence of TBI in low-income countries is on the rise. We illustrate the trends and factors involved in TBI in a large Cambodian governmental hospital in Phnom Penh. In addition, suggestions for improvement of the country's road traffic safety are discussed. METHODS: This is a cross-sectional study of all patients who presented with traumatic brain injury to Department of Neurosurgery at Preah Kossamak Hospital in Phnom Penh, Cambodia between November 2013 and March 2016. RESULTS: TBIs in Cambodia are on the rise; 34% occur during rush hour, 5-9 PM, and 40% during the weekend. The vast majority (74%) occur as the result of road traffic accidents, of which 81% are motorcycle related. Helmet wear remains low at 13%, and recent alcohol use was reported as 38%. The most common diagnosis is skull fracture. The subdural to epidural hematoma ratio was 1:1.05. Lastly, in both subdural and epidural hematomas the frontal lobe was most commonly involved, with 60% of epidural hematomas associated with a lucid interval. CONCLUSIONS: Our study suggests prevention and management of TBIs can have a measurable public health impact in Cambodia. Initiative examples include helmet safety awareness campaigns, stricter penalties, improvement of prehospital care, and more efficient triage. A high proportion of unhelmeted motorcycle accidents correlates with an increase in epidural hematomas.	[Peeters, Sophie] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Peeters, Sophie; Blaine, Caitlin; Vycheth, Iv; Nang, Sam; Vuthy, Din; Park, Kee B.] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia; [Park, Kee B.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA	Peeters, S (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.; Peeters, S (corresponding author), Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia.	Sophie.Peeters@UTsouthwestern.edu		Peeters, Sophie/0000-0002-9548-644X	Foundation of the World Federation of Neurosurgical Societies; Korean American Medical Foundation	This research received partial funding support from the Foundation of the World Federation of Neurosurgical Societies and the Korean American Medical Foundation.	Adeolu A. A., 2005, INTERNET J EPIDEMIOL, V2, P2; [Anonymous], 2010, ANN REPORT; Bachani AM, 2013, INJURY, V44, pS24, DOI 10.1016/S0020-1383(13)70210-9; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Enserink M, 2014, SCIENCE, V345, P1261, DOI 10.1126/science.345.6202.1261; Eze K C, 2011, West Afr J Med, V30, P404; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Hung DV, 2008, ACCIDENT ANAL PREV, V40, P1627, DOI 10.1016/j.aap.2008.05.002; Jeng TC, 2008, MALAYS J MED SCI, V15, P56; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Letourneau-Guillon L, 2013, AM J NEURORADIOL, V34, P773, DOI 10.3174/ajnr.A3309; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Olson Z, 2016, INJURY PREV, V22, P233, DOI 10.1136/injuryprev-2015-041650; Passmore J, 2010, TRAFFIC INJ PREV, V11, P202, DOI 10.1080/15389580903497121; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Rastogi Devarshi, 2014, Int J Crit Illn Inj Sci, V4, P298, DOI 10.4103/2229-5151.147523; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Tallon JM, 2008, CAN J SURG, V51, P339; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; World Health Organization, 2013, GLOB STAT REP ROAD S; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5	25	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						580	589		10.1016/j.wneu.2016.09.127			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400079	27773857				2021-06-18	
J	Rigon, A; Voss, MW; Turkstra, LS; Mutlu, B; Duff, MC				Rigon, A.; Voss, M. W.; Turkstra, L. S.; Mutlu, B.; Duff, M. C.			Relationship between individual differences in functional connectivity and facial-emotion recognition abilities in adults with traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Emotion recognition; Facial affect; Emotion labeling; Resting state; Network-based statistics	SOCIAL COMMUNICATION; WHITE-MATTER; STRUCTURAL CONNECTIVITY; INTRINSIC CONNECTIVITY; NEURAL SYSTEMS; AXONAL INJURY; HEAD-INJURY; NETWORKS; DEFICITS; PERCEPTION	Although several studies have demonstrated that facial-affect recognition impairment is common following moderate-severe traumatic brain injury (TBI), and that there are diffuse alterations in large-scale functional brain networks in TBI populations, little is known about the relationship between the two. Here, in a sample of 26 participants with TBI and 20 healthy comparison participants (HC) we measured facial-affect recognition abilities and resting-state functional connectivity (rs-FC) using fMRI. We then used network-based statistics to examine (A) the presence of rs-FC differences between individuals with TBI and HC within the facial-affect processing network, and (B) the association between inter-individual differences in emotion recognition skills and rs-FC within the facial-affect processing network. We found that participants with TBI showed significantly lower rs-FC in a component comprising homotopic and within-hemisphere, anterior-posterior connections with in the facial-affect processing network. In addition, within the TBI group, participants with higher emotion-labeling skills showed stronger rs-FC within a network comprised of intra-and inter-hemispheric bilateral connections. Findings indicate that the ability to successfully recognize facial-affect after TBI is related to rs-FC within components of facial-affective networks, and provide new evidence that further our understanding of the mechanisms underlying emotion recognition impairment in TBI. (C) 2016 The Authors. Published by Elsevier Inc.	[Rigon, A.; Voss, M. W.; Duff, M. C.] Univ Iowa, Interdisciplinary Neurosci Program, Iowa City, IA 52242 USA; [Voss, M. W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA; [Turkstra, L. S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Turkstra, L. S.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Mutlu, B.] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Duff, M. C.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Duff, M. C.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	Rigon, A (corresponding author), W506 Seashore Hall,328 Iowa Ave, Iowa City, IA 52242 USA.	Arianna-rigon@uiowa.edu			NICHD/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; University of Iowa Magnetic Resonance Research Facilities; University of Iowa Graduate and Professional Student Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This work was supported by NICHD/NCMRR grant R01 HD071089, the University of Iowa Magnetic Resonance Research Facilities and a research grant from the University of Iowa Graduate and Professional Student Government. The authors wish to thank Ruth Hanson, Katherine Jones and Kristina Warndahl for their help in scheduling participants.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cox CL, 2012, SOC COGN AFFECT NEUR, V7, P727, DOI 10.1093/scan/nsr051; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; FLEISS JL, 1983, J PERIODONTAL RES, V18, P601, DOI 10.1111/j.1600-0765.1983.tb00397.x; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Germine LT, 2011, PSYCHOL MED, V41, P937, DOI 10.1017/S0033291710001571; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martins AT, 2012, NEURAL REGEN RES, V7, P101, DOI 10.3969/j.issn.1673-5374.2012.02.004; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Neumann D., 2015, BRAIN IMAGING BEHAV; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Palermo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068126; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/pms.1991.73.3f.1139; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rigon A., 2016, COGN AFFECT BEHAV NE; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sours C, 2014, BRAIN IMAGING BEHAV; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tamamiya Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057325; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zar J.H., 1996, BIOSTATISTICAL ANAL	71	16	16	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	13						370	377		10.1016/j.nicl.2016.12.010			8	Neuroimaging	Neurosciences & Neurology	EV0FK	WOS:000401413700043	28123948	DOAJ Gold, Green Published			2021-06-18	
J	Wijenberg, MLM; Stapert, SZ; Verbunt, JA; Ponsford, JL; Van Heugten, CM				Wijenberg, Melloney L. M.; Stapert, Sven Z.; Verbunt, Jeanine A.; Ponsford, Jennie L.; Van Heugten, Caroline M.			Does the fear avoidance model explain persistent symptoms after traumatic brain injury?	BRAIN INJURY			English	Article						Catastrophizing; chronic phase; fear avoidance behaviour; persistent symptoms; post concussional syndrome; Traumatic brain injury	PAIN CATASTROPHIZING SCALE; CONCUSSION SYMPTOMS; HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; MUSCULOSKELETAL PAIN; MULTIPLE-SCLEROSIS; DEPRESSION SCALE; CROSS-VALIDATION; HOSPITAL ANXIETY; CHRONIC TINNITUS	Background: A minority of patients with mild traumatic brain injury (mTBI) experience a persistent symptom complex also known as post-concussion syndrome. Explanations for this syndrome are still lacking.Objective: To investigate if the fear avoidance model, including catastrophizing thoughts and fear avoidance behaviour, poses a possible biopsychosocial explanation for lingering symptoms and delay in recovery after traumatic brain injury (TBI) with special focus on mTBI.Design: Cross-sectional study.Participants: 48 patients with TBI, of which 31 patients with mTBI, had persistent symptoms (mean time since injury 48.2months); 92% of the entire sample fulfilled the criteria for post-concussion syndrome.Outcome variables: catastrophizing, fear-avoidance, depression and post-concussion symptoms.Results: High levels of catastrophizing were found in 10% and high levels of fear avoidance behaviour were found in 35%. Catastrophizing, fear avoidance behaviour, depressive symptoms and post-concussion symptoms correlated significantly with each other (p<0.05).Conclusion: The fear-avoidance model proposes a possible explanation for persistent symptoms. Validation and normative data are needed for suitable measures of catastrophizing and fear avoidance of post-concussion symptoms after TBI. Longitudinal prospective cohort studies are needed to establish its causal and explanatory nature.	[Wijenberg, Melloney L. M.; Stapert, Sven Z.; Van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands; [Wijenberg, Melloney L. M.; Van Heugten, Caroline M.] Limburg Brain Injury Ctr, Limburg, Netherlands; [Stapert, Sven Z.] Zuyderland Med Ctr, Dept Med Psychol, Sittard Geleen, Netherlands; [Verbunt, Jeanine A.] Adelante, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Ponsford, Jennie L.] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Maastricht, Netherlands; [Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands	Stapert, SZ (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands.	s.stapert@maastrichtuniversity.nl	; Ponsford, Jennie/H-8341-2014	Verbunt, Jeanine/0000-0002-9060-9455; Ponsford, Jennie/0000-0003-0430-125X			Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bol Y, 2010, J BEHAV MED, V33, P355, DOI 10.1007/s10865-010-9266-8; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Cima RFF, 2011, EAR HEARING, V32, P634, DOI 10.1097/AUD.0b013e31821106dd; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Crombez G, 1996, PAIN CATASTROP UNPUB; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Goubert L, 2000, GEDRAG GEZOND, V28, P54; Houben RMA, 2005, J BEHAV MED, V28, P415, DOI 10.1007/s10865-005-9011-x; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kamper SJ, 2012, PAIN, V153, P113, DOI 10.1016/j.pain.2011.09.023; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleinstauber M, 2013, COGN BEHAV THERAPY, V42, P84, DOI 10.1080/16506073.2012.717301; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Martelli MF, 1999, ARCH CLIN NEUROPSYCH, V14, P804, DOI 10.1016/S0887-6177(99)80356-4; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Miller RPKS, 1991, UNPUB; Miro J, 2008, J PAIN, V9, P397, DOI 10.1016/j.jpain.2007.12.004; Nieto R, 2013, REHABIL PSYCHOL, V58, P361, DOI 10.1037/a0034267; Nieto R, 2009, EUR J PAIN, V13, P518, DOI 10.1016/j.ejpain.2008.06.005; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rivest K, 2010, MANUAL THER, V15, P154, DOI 10.1016/j.math.2009.10.001; Roelofs J, 2011, PAIN, V152, P1090, DOI 10.1016/j.pain.2011.01.028; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schmidt AJM, 2003, BEHAV RES THER, V41, P1243, DOI 10.1016/S0005-7967(03)00155-4; Severeijns R, 2002, PAIN, V99, P367, DOI 10.1016/S0304-3959(02)00219-1; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Sterling M, 2008, CLIN J PAIN, V24, P124, DOI 10.1097/AJP.0b013e31815ca293; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Todd D., 1998, COGNIPHOBIA SCALE C, pdomain; Van Damme S, 2000, GEDRAGSTHERAPIE, V33, P209; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Velthuis MJ, 2012, ARCH PHYS MED REHAB, V93, P332, DOI 10.1016/j.apmr.2011.08.014; Verhage F., 1983, CODEREN OPLEIDINGSNI; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Vlaeyen JWS, 1995, J OCCUP REHABIL, V5, P235, DOI 10.1007/BF02109988; Volders S, 2015, BEHAV RES THER, V64, P31, DOI 10.1016/j.brat.2014.11.003; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wijenberg MLM, 2016, J BEHAV MED, V39, P815, DOI 10.1007/s10865-016-9749-3; Wood RL, 2007, J NEUROL NEUROSUR PS, V78, P552, DOI 10.1136/jnnp.2006.113845; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	67	16	16	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1597	1604		10.1080/02699052.2017.1366551			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200005	28980825	Other Gold			2021-06-18	
J	Gao, ZL; Chen, L; Fan, RC; Lu, W; Wang, DG; Cui, S; Huang, L; Zhao, SD; Guan, SD; Zhu, Y; Wang, JH				Gao, Zilong; Chen, Lei; Fan, Ruicheng; Lu, Wei; Wang, Dangui; Cui, Shan; Huang, Li; Zhao, Shidi; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui			Associations of Unilateral Whisker and Olfactory Signals Induce Synapse Formation and Memory Cell Recruitment in Bilateral Barrel Cortices: Cellular Mechanism for Unilateral Training Toward Bilateral Memory	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						memory; glutamate; GABA; neuron; synapse; barrel cortex; whisker; olfaction	CORPUS-CALLOSUM EVIDENCE; TRAUMATIC BRAIN-INJURY; CORTEX; PLASTICITY; COORDINATION; NEURONS; LOCALIZATION; ORGANIZATION; INFORMATION; RETRIEVAL	Somatosensory signals and operative skills learned by unilateral limbs can be retrieved bilaterally. In terms of cellular mechanism underlying this unilateral learning toward bilateral memory, we hypothesized that associative memory cells in bilateral cortices and synapse innervations between them were produced. In the examination of this hypothesis, we have observed that paired unilateral whisker and odor stimulations led to odorant-induced whisker motions in bilateral sides, which were attenuated by inhibiting the activity of barrel cortices. In the mice that showed bilateral cross-modal responses, the neurons in both sides of barrel cortices became to encode this new odor signal alongside the innate whisker signal. Axon projections and synapse formations from the barrel cortex, which was co-activated with the piriform cortex, toward its contralateral barrel cortex (CBC) were upregulated. Glutamatergic synaptic transmission in bilateral barrel cortices was upregulated and GABAergic synaptic transmission was downregulated. The associative activations of the sensory cortices facilitate new axon projection, glutamatergic synapse formation and GABAergic synapse downregulation, which drive the neurons to be recruited as associative memory cells in the bilateral cortices. Our data reveal the productions of associative memory cells and synapse innervations in bilateral sensory cortices for unilateral training toward bilateral memory.	[Gao, Zilong; Wang, Dangui; Cui, Shan; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Gao, Zilong; Wang, Jin-Hui] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Chen, Lei; Fan, Ruicheng; Huang, Li; Zhao, Shidi; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui] Bengbu Med Coll, Dept Pathophysiol, Bengbu, Peoples R China; [Lu, Wei; Wang, Jin-Hui] Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China	Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Bengbu Med Coll, Dept Pathophysiol, Bengbu, Peoples R China.; Wang, JH (corresponding author), Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China.	jhw@sun5.ibp.ac.cn			National Basic Research ProgramNational Basic Research Program of China [2013CB531304, 2016YFC1307101]; Natural Science Foundation ChinaNational Natural Science Foundation of China (NSFC) [81671071, 81471123]	We thank Dr. Tom Sudhof for pAAV-SynaptoTag-mCherry-GFP, and Kim Davis for proof reading. This study is supported by National Basic Research Program (2013CB531304 and 2016YFC1307101) and Natural Science Foundation China (81671071 and 81471123) to J-HW.	Alloway KD, 2004, J COMP NEUROL, V480, P299, DOI 10.1002/cne.20339; Alloway KD, 2009, J COMP NEUROL, V515, P548, DOI 10.1002/cne.22073; ARMSTRONGJAMES M, 1988, EXP BRAIN RES, V70, P155; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Bracha V, 2009, NEUROSCIENCE, V162, P787, DOI 10.1016/j.neuroscience.2008.12.042; Burhans LB, 2008, BEHAV NEUROSCI, V122, P1191, DOI 10.1037/a0013599; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; CLARK CR, 1989, BRAIN, V112, P165, DOI 10.1093/brain/112.1.165; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Diamond ME, 2013, PROG NEUROBIOL, V103, P28, DOI 10.1016/j.pneurobio.2012.05.013; Diamond ME, 2003, J PHYSIOL-PARIS, V97, P529, DOI 10.1016/j.jphysparis.2004.01.010; Dubb A, 2003, NEUROIMAGE, V20, P512, DOI 10.1016/S1053-8119(03)00313-6; Erickson RL, 2014, NEUROPSYCHOLOGIA, V60, P121, DOI 10.1016/j.neuropsychologia.2014.06.003; Ge RJ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-26; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Glazewski S, 2007, J NEUROSCI, V27, P3910, DOI 10.1523/JNEUROSCI.0181-07.2007; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Hasegawa I, 1999, ANN MED, V31, P380, DOI 10.3109/07853899908998795; Hasegawa I, 2000, REV NEUROSCIENCE, V11, P113; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; KAWAGUCHI Y, 1992, EXP BRAIN RES, V88, P33, DOI 10.1007/BF02259126; Kozlovskiy SA, 2012, INT J PSYCHOPHYSIOL, V85, P396, DOI 10.1016/j.ijpsycho.2012.07.092; Lansner A, 2009, TRENDS NEUROSCI, V32, P178, DOI 10.1016/j.tins.2008.12.002; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-38; Lum C, 2011, J NEUROIMAGING, V21, P65, DOI 10.1111/j.1552-6569.2009.00430.x; Ma K, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.181; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Ni H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013736; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Pashaie R, 2013, BIOMED OPT EXPRESS, V4, P122, DOI 10.1364/BOE.4.000122; Paxinos G., 2005, MOUSE BRAIN STEREOTA; Peltier J, 2012, J NEUROL, V259, P1860, DOI 10.1007/s00415-012-6421-x; Perkowski JJ, 2011, J NEUROSCI, V31, P46, DOI 10.1523/JNEUROSCI.2634-10.2011; Piercy M, 1967, Mod Trends Neurol, V4, P106; Pietrasanta M, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/838672; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Suzuki WA, 2008, PROG BRAIN RES, V169, P305, DOI 10.1016/S0079-6123(07)00019-2; Takatoh J, 2013, NEURON, V77, P346, DOI 10.1016/j.neuron.2012.11.010; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wang DG, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00320; Wang J.-H., 2013, SOC NEUROSCI, V653; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 2016, BIOPHYS J, V110, p481A, DOI 10.1016/j.bpj.2015.11.2571; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wang JH, 2014, BIOPHYS J, V106, p191A, DOI 10.1016/j.bpj.2013.11.1114; Wasserman EA, 1997, ANNU REV PSYCHOL, V48, P573, DOI 10.1146/annurev.psych.48.1.573; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Wen B, 2015, CNS NEUROSCI THER, V21, P204, DOI 10.1111/cns.12336; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; Wong CW, 2000, MED HYPOTHESES, V55, P177, DOI 10.1054/mehy.1999.0934; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006; Xu AP, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv122; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Ye B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041986; Zhang FY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-20; Zhang GJ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-2; Zhao J, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-12; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	72	16	16	0	19	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	DEC 16	2016	10								285	10.3389/fncel.2016.00285			16	Neurosciences	Neurosciences & Neurology	EE7IS	WOS:000389789700001	28018178	DOAJ Gold, Green Published			2021-06-18	
J	Brady, RD; Shultz, SR; Sun, MJ; Romano, T; van der Poel, C; Wright, DK; Wark, JD; O'Brien, TJ; Grills, BL; McDonald, SJ				Brady, Rhys D.; Shultz, Sandy R.; Sun, Mujun; Romano, Tania; van der Poel, Chris; Wright, David K.; Wark, John D.; O'Brien, Terence J.; Grills, Brian L.; McDonald, Stuart J.			Experimental Traumatic Brain Injury Induces Bone Loss in Rats	JOURNAL OF NEUROTRAUMA			English	Article						bone homeostasis; femur; fluid percussion injury; bone loss; traumatic brain injury	MINERAL DENSITY; HEAD-INJURY; GROWTH-HORMONE; LEUKOCYTE MOBILIZATION; FRACTURE; FLUID; NEUROINFLAMMATION; MODEL; DYSFUNCTION; DESTRUCTION	Few studies have investigated the influence of traumatic brain injury (TBI) on bone homeostasis; however, pathophysiological mechanisms involved in TBI have potential to be detrimental to bone. The current study assessed the effect of experimental TBI in rats on the quantity and quality of two different weight-bearing bones, the femur and humerus. Rats were randomly assigned into either sham or lateral fluid percussion injury (FPI) groups. Open-field testing to assess locomotion was conducted at 1, 4, and 12 weeks post-injury, with the rats killed at 1 and 12 weeks post-injury. Bones were analyzed using peripheral quantitative computed tomography (pQCT), histomorphometric analysis, and three-point bending. pQCT analysis revealed that at 1 and 12 weeks post-injury, the distal metaphyseal region of femora from FPI rats had reduced cortical content (10% decrease at 1 week, 8% decrease at 12 weeks; p < 0.01) and cortical thickness (10% decrease at 1 week, 11% decrease at 12 weeks p < 0.001). There was also a 23% reduction in trabecular bone volume ratio at 1 week post-injury and a 27% reduction at 12 weeks post-injury in FPI rats compared to sham (p < 0.001). There were no differences in bone quantity and mechanical properties of the femoral midshaft between sham and TBI animals. There were no differences in locomotor outcomes, which suggested that post-TBI changes in bone were not attributed to immobility. Taken together, these findings indicate that this rat model of TBI was detrimental to bone and suggests a link between TBI and altered bone remodeling.	[Brady, Rhys D.; Romano, Tania; van der Poel, Chris; Grills, Brian L.; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Shultz, Sandy R.; Sun, Mujun; Wark, John D.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Wright, David K.] Univ Melbourne, Anat & Neurosci, Parkville, Vic, Australia; [Wright, David K.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	McDonald, SJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Hlth Sci 2, Bundoora, Vic 3086, Australia.	stuart.mcdonald@latrobe.edu.au		Sun, Mujun/0000-0002-9923-9913; O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179; Wright, David/0000-0002-7535-8651	NHMRC of AustraliaNational Health and Medical Research Council of Australia	Funding for this project was provided by the NHMRC of Australia.	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brady RD, 2014, J ORTHOP RES, V32, P1277, DOI 10.1002/jor.22686; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Ciucci T, 2015, GUT, V64, P1072, DOI 10.1136/gutjnl-2014-306947; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Grills BL, 1997, J ORTHOPAED RES, V15, P235, DOI 10.1002/jor.1100150212; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; HOLMES SJ, 1994, J CLIN ENDOCR METAB, V78, P669, DOI 10.1210/jc.78.3.669; Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Lin HL, 2015, ACTA NEUROL SCAND, V131, P158, DOI 10.1111/ane.12301; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; McDonald SJ, 2011, J ORTHOP RES, V29, P740, DOI 10.1002/jor.21302; MUNDY GR, 1991, J PERIODONTAL RES, V26, P213, DOI 10.1111/j.1600-0765.1991.tb01647.x; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Oppl B, 2014, J BONE MINER RES, V29, P1096, DOI 10.1002/jbmr.2122; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Romano T, 2014, REPROD FERT DEVELOP, V26, P385, DOI 10.1071/RD12378; Romano T, 2010, BONE, V47, P1054, DOI 10.1016/j.bone.2010.08.020; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith EM, 2009, ARCH PHYS MED REHAB, V90, P1127, DOI 10.1016/j.apmr.2008.09.578; Szulc P, 2009, OSTEOPOROSIS INT, V20, P1281, DOI 10.1007/s00198-009-0994-y; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	53	16	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2154	2160		10.1089/neu.2014.3836			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800011	25686841				2021-06-18	
J	Gu, XC; Zhang, XB; Hu, B; Zi, Y; Li, M				Gu, Xiao-chuan; Zhang, Xiao-Bin; Hu, Bing; Zi, Ying; Li, Ming			Neuropeptide Y accelerates post-fracture bone healing by promoting osteogenesis of mesenchymal stem cells	NEUROPEPTIDES			English	Article						NRY; MSCs; Fracture; Bone healing	TIBIAL SHAFT FRACTURE; KNOCKOUT MICE; OSTEOBLAST DIFFERENTIATION; ENERGY HOMEOSTASIS; RAT-BRAIN; RECEPTORS; NPY; EXPRESSION; INSIGHTS; LEPTIN	Fracture repair is a complex yet well orchestrated regenerative process involving numerous signaling and cell types including osteoblasts. Here we showed that NPY, a neurotransmitter with regulatory functions in bone homeostasis, may contribute to the post-fracture bone healing in patients with traumatic brain injury-fracture combined injuries. Our results suggested NPY levels were increased in patients with the combined injuries, accomplished by arising of bone healing markers, such as ALP, OC, PICP and ICTP, than in those with simple fractures, and NPY have direct actions on MSCs to promote their osteogenic differentiation. Our results provided clinical evidences for NPY participating in the bone healing process in a nonhypothalamic manner, most probably by directly promoting osteogenesis of mesenchymal stem cells. (C) 2016 Published by Elsevier Ltd.	[Gu, Xiao-chuan; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [Zhang, Xiao-Bin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Emergency Med, Shanghai, Peoples R China; [Hu, Bing] Shanghai Minhang Dist Hosp Tradit Chinese Med, Dept Med Oncol, Shanghai, Peoples R China; [Zi, Ying] 463rd Hosp PLA, Dept Emergency, Shenyang 110042, Peoples R China	Li, M (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China.; Zi, Y (corresponding author), 463rd Hosp PLA, Dept Emergency, Shenyang 110042, Peoples R China.	ziying008@hotmail.com; limingch@21cn.com			Natural Science Foundation Project of Liaoning, China [201602762]	This work was supported by Natural Science Foundation Project of Liaoning, China (201602762).	Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baht GS, 2014, J ORTHOP RES, V32, P581, DOI 10.1002/jor.22562; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI200214588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Bowles SA, 1996, ANN CLIN BIOCHEM, V33, P196, DOI 10.1177/000456329603300304; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; DUMONT Y, 1990, EUR J PHARMACOL, V191, P501, DOI 10.1016/0014-2999(90)94189-5; Einhorn T. A., 1998, CLIN ORTHOP RELAT R, V355, P57; Franquinho F, 2010, FEBS J, V277, P3664, DOI 10.1111/j.1742-4658.2010.07774.x; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JOERRING S, 1992, ARCH ORTHOP TRAUM SU, V111, P265, DOI 10.1007/BF00571521; JOERRING S, 1994, ARCH ORTHOP TRAUM SU, V113, P334, DOI 10.1007/BF00426183; Knoch H G, 1973, Zentralbl Chir, V98, P505; Lee NJ, 2015, MOL METAB, V4, P164, DOI 10.1016/j.molmet.2014.12.010; Lee NJ, 2009, NEUROPEPTIDES, V43, P457, DOI 10.1016/j.npep.2009.08.006; Liao KH, 2016, J CHIN MED ASSOC, V79, P58, DOI 10.1016/j.jcma.2015.10.002; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Nunes AF, 2010, FEBS J, V277, P263, DOI 10.1111/j.1742-4658.2009.07482.x; OBRANT KJ, 1990, CLIN ORTHOP RELAT R, P300; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reichelt A, 1967, Hefte Unfallheilkd, V91, P250; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shi YC, 2012, BONE, V50, P430, DOI 10.1016/j.bone.2011.10.001; Sousa C. P., 2015, AN ACAD BRAS CIENC; Stoffel K, 2007, CLIN CHEM, V53, P131, DOI 10.1373/clinchem.2006.076976; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Veitch SW, 2006, OSTEOPOROSIS INT, V17, P364, DOI 10.1007/s00198-005-2025-y; Victoria G, 2009, INDIAN J ORTHOP, V43, P117, DOI 10.4103/0019-5413.50844; Zengin A, 2010, TRENDS ENDOCRIN MET, V21, P411, DOI 10.1016/j.tem.2010.02.004	39	16	18	1	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	DEC	2016	60						61	66		10.1016/j.npep.2016.09.005			6	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	EE2FJ	WOS:000389398800009	27720230				2021-06-18	
J	Halaweish, I; Bambakidis, T; Nikolian, VC; Georgoff, P; Bruhn, P; Piascik, P; Buckley, L; Srinivasan, A; Liu, BL; Li, YQ; Alam, HB				Halaweish, Ihab; Bambakidis, Ted; Nikolian, Vahagn C.; Georgoff, Patrick; Bruhn, Peter; Piascik, Patryk; Buckley, Lisa; Srinivasan, Ashok; Liu, Baoling; Li, Yongqing; Alam, Hasan B.			Early resuscitation with lyophilized plasma provides equal neuroprotection compared with fresh frozen plasma in a large animal survival model of traumatic brain injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Hemorrhagic shock; lyophilized plasma; neuroprotection; traumatic brain injury; Yorkshire swine	SEVERE HEAD-INJURY; VALPROIC ACID; MAJOR TRAUMA; DRIED PLASMA; SWINE MODEL; COAGULOPATHY; COAGULATION; PERSPECTIVE; INSULTS; PROMMTT	BACKGROUND: Combined traumatic brain injury (TBI) and hemorrhagic shock (HS) is highly lethal. In previous models of combined TBI + HS, we showed that early resuscitation with fresh frozen plasma (FFP) improves neurologic outcomes. Delivering FFP, however, in austere environments is difficult. Lyophilized plasma (LP) is a logistically superior alternative to FFP, but data are limited regarding its efficacy for treatment of TBI. We conducted this study to determine the safety and long-term outcomes of early treatment with LP in a large animal model of TBI + HS. METHODS: Adult anesthetized swine underwent TBI and volume-controlled hemorrhage (40% blood volume) concurrently. After 2 hours of shock, animals were randomized (n = 5 per /group) to FFP or LP (1x shed blood) treatment. Serial blood gases were drawn, and thromboelastography was performed on citrated, kaolin-activated whole-blood samples. Five hours after treatment, packed red blood cells were administered, and animals recovered. A 32-point Neurologic Severity Score was assessed daily for 30 days (0 = normal, 32 = most severe injury). Cognitive functions were tested by training animals to retrieve food from color-coded boxes. Brain lesion size was measured on serial magnetic resonance imaging, and an autopsy was performed at 30 days. RESULTS: The severity of shock and the degree of resuscitation were similar in both groups. Administration of FFP and LP was well tolerated with no differences in reversal of shock or thromboelastography parameters. Animals in both groups displayed the worst Neurologic Severity Score on postoperative Day 1 with rapid recovery and return to baseline within 7 days of injury. Lesion size on Day 3 in FFP-treated animals was 645 +/- 85 versus 219 +/- 20 mm(3) in LP-treated animals (p < 0.05). There were no differences in cognitive functions or delayed treatment-related complications. CONCLUSIONS: Early treatment with LP in TBI + HS is safe and provides neuroprotection that is comparable to FFP. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Halaweish, Ihab; Bambakidis, Ted; Nikolian, Vahagn C.; Georgoff, Patrick; Piascik, Patryk; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Bruhn, Peter] Univ Copenhagen Hosp, Dept Surg Gastroenterol, Rigshosp, Copenhagen, Denmark; [Buckley, Lisa] Oregon Hlth & Sci Univ, Ctr Regenerat Med, Portland, OR 97201 USA; [Srinivasan, Ashok] Univ Michigan, Dept Radiol, Neuroradiol Sect, Ann Arbor, MI 48109 USA	Alam, HB (corresponding author), Univ Michigan Hosp, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Buckley, Lisa/U-7467-2018	Buckley, Lisa/0000-0003-1542-938X			Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Chapman MP, 2015, SHOCK, V44, P63, DOI 10.1097/SHK.0000000000000376; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS24, DOI 10.1097/TA.0b013e31828fa3b9; Difede J, 2010, ANN NY ACAD SCI, V1208, P1, DOI 10.1111/j.1749-6632.2010.05795.x; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; McSwain NE, 2011, J TRAUMA, V70, pS2, DOI 10.1097/TA.0b013e31821b201d; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Shuja F, 2008, J TRAUMA, V65, P975, DOI 10.1097/TA.0b013e3181801cd9; Shuja F, 2011, J TRAUMA, V70, P664, DOI 10.1097/TA.0b013e31820e83be; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; Velik-Salchner C, 2006, THROMB RES, V117, P597, DOI 10.1016/j.thromres.2005.05.015; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012	25	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2016	81	6					1080	1087		10.1097/TA.0000000000001204			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	EE0BH	WOS:000389237900012	27893618				2021-06-18	
J	Yan, FF; Zhang, MM; Meng, Y; Li, HJ; Yu, L; Fu, XJ; Tang, YC; Jiang, C				Yan, Fangfang; Zhang, Meimei; Meng, Yan; Li, Huijuan; Yu, Lie; Fu, Xiaojie; Tang, Youcai; Jiang, Chao			Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis	BRAIN RESEARCH			English	Article						Erythropoietin; Anoxia; Angiogenesis; VEGF; Neonatal Rats	ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; DOSE RECOMBINANT ERYTHROPOIETIN; INCREASES NEUROGENESIS; RECEPTOR; VEGF; MODEL; EXPRESSION; PROMOTES; OUTCOMES	Erythropoietin (EPO) is important for angiogenesis after hypoxia/ischemia. In this study, we investigated whether recombinant human erythropoietin (rhEPO) can enhance angiogenesis, and promote cognitive function through vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) signaling pathway in a rat model of hypoxic-ischemic encephalopathy (HIE). RhEPO, selective VEGFR2 inhibitor (SU5416) or vehicle was administrated by intraperitoneal injection. The assessment for cognitive function begins on day 60 after anoxia. Vascular density in hippocampus and white matter damage within corpus callosum were examined on day 28 after anoxia. The expression of erythropoietin receptor (EPOR), VEGF, rapidly accelerated fibrosarcoma 1 (Raf1), and extracellular-signal-regulated kinases 1 and 2 (ERK1/2) in hippocampus were evaluated on day 7 after anoxia. RhEPO-treated anoxia rats had better cognitive recovery, higher vascular density, and less white matter damage than in the vehicle anoxia rats. These protective effects associated with increased expression of EPOR, VEGF; and increased phosphorylation of Raf1 and ERK1/2. While this up-regulation, and changes in the histopathologic and functional outcomes were abolished by SU5416. Our data indicate that rhEPO can enhance angiogenesis, reduce white matter damage, and promote cognitive recovery through VEGF/VEGFR2 signaling pathway in anoxia rats. (C) 2016 Elsevier B.V. All rights reserved.	[Yan, Fangfang; Li, Huijuan; Yu, Lie; Fu, Xiaojie; Tang, Youcai; Jiang, Chao] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [Zhang, Meimei; Meng, Yan] Zhengzhou Univ, Affiliated Hosp 5, Dept Pediat Neurol, Zhengzhou 450052, Henan, Peoples R China	Jiang, C (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.; Zhang, MM (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, Dept Pediat Neurol, Zhengzhou 450052, Henan, Peoples R China.	mmzhangzzu@163.com; chaojzzu@126.com		Tang, Youcai/0000-0003-2087-6029	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301006]; Education Department of Henan Province [13A320633]	This work was supported by grants from the National Natural Science Foundation of China (81301006), and the Education Department of Henan Province (13A320633).	Adamczak J, 2015, STROKE, V46, pE103, DOI 10.1161/STROKEAHA.114.007642; BACIC M, 1995, GROWTH FACTORS, V12, P11, DOI 10.3109/08977199509003209; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Cechetti F, 2010, BRAZ J MED BIOL RES, V43, P1178, DOI 10.1590/S0100-879X2010007500124; Chun PT, 2015, DEV NEUROSCI-BASEL, V37, P161, DOI 10.1159/000370147; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Dixon BJ, 2015, INT J MOL SCI, V16, P22368, DOI 10.3390/ijms160922368; DOBBING J, 1971, PSYCHIAT NEUROL NEUR, V74, P433; Fan XY, 2011, PEDIATR RES, V69, P56, DOI 10.1203/PDR.0b013e3181fcbef3; Freitag MT, 2015, J NEUROIMAGING, V25, P582, DOI 10.1111/jon.12202; Gonzalez FF, 2013, STROKE, V44, P753, DOI 10.1161/STROKEAHA.111.000104; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grojean S, 2003, NEUROBIOL DIS, V14, P265, DOI 10.1016/S0969-9961(03)00082-2; Harrigan MR, 2002, NEUROSURGERY, V50, P589, DOI 10.1097/00006123-200203000-00030; Itokawa T, 2002, MOL CANCER THER, V1, P295; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Kaji T, 2006, BBA-GEN SUBJECTS, V1760, P1465, DOI 10.1016/j.bbagen.2006.06.010; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kertmen H, 2015, ARCH MED SCI, V11, P1119, DOI 10.5114/aoms.2015.54869; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lee MS, 2015, CELL SIGNAL, V27, P1439, DOI 10.1016/j.cellsig.2015.04.001; Li WL, 2011, EXP BRAIN RES, V214, P503, DOI 10.1007/s00221-011-2849-y; Ma QY, 2015, PROG NEUROBIOL, V124, P28, DOI 10.1016/j.pneurobio.2014.11.001; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller Aaron J, 2014, Neoreviews, V15, pe177; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Nyakas C, 1996, PROG NEUROBIOL, V49, P1; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Okazaki T, 2008, NEOPLASIA, V10, P932, DOI 10.1593/neo.08140; Pan CH, 2015, TOXICOL APPL PHARM, V282, P215, DOI 10.1016/j.taap.2014.11.009; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Pulera MR, 1998, STROKE, V29, P2622, DOI 10.1161/01.STR.29.12.2622; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Shea KL, 2015, CURR OPIN ANESTHESIO, V28, P261, DOI 10.1097/ACO.0000000000000184; Spandou E, 2004, BRAIN RES, V1021, P167, DOI 10.1016/j.brainres.2004.06.057; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Tang YH, 2016, AGING DIS, V7, P326, DOI 10.14336/AD.2015.1125; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Torun YA, 2014, BRAIN DEV-JPN, V36, P864, DOI 10.1016/j.braindev.2014.01.005; Traudt CM, 2013, DEV NEUROSCI-BASEL, V35, P491, DOI 10.1159/000355460; Trincavelli ML, 2013, INT J MOL SCI, V14, P2258, DOI 10.3390/ijms14022258; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tsui AKY, 2014, AM J PHYSIOL-REG I, V307, pR13, DOI 10.1152/ajpregu.00411.2013; Tufro A, 2015, J AM SOC NEPHROL, V26, P997, DOI 10.1681/ASN.2014101004; Wang J., 2015, MOL NEUROBIOL; Wang JP, 2014, BEHAV BRAIN RES, V265, P171, DOI 10.1016/j.bbr.2014.02.033; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Westenbrink BD, 2010, CARDIOVASC RES, V87, P30, DOI 10.1093/cvr/cvq041; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu YW, 2015, DEV MED CHILD NEUROL, V57, P34, DOI 10.1111/dmcn.12730; Wu YW, 2012, PEDIATRICS, V130, P683, DOI 10.1542/peds.2012-0498; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yang ZH, 2014, AM J PATHOL, V184, P1230, DOI 10.1016/j.ajpath.2013.12.023; Yeganeh F, 2013, J MOL NEUROSCI, V50, P551, DOI 10.1007/s12031-013-9996-5; Zacharias R, 2010, BRAIN RES, V1343, P14, DOI 10.1016/j.brainres.2010.04.081; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao J, 2013, INT J DEV NEUROSCI, V31, P543, DOI 10.1016/j.ijdevneu.2013.06.008; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	72	16	18	2	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2016	1651						104	113		10.1016/j.brainres.2016.09.024			10	Neurosciences	Neurosciences & Neurology	EB6WU	WOS:000387527100012	27659964				2021-06-18	
J	Antonenko, YN; Denisov, SS; Silachev, DN; Khailova, LS; Jankauskas, SS; Rokitskaya, TI; Danilina, TI; Kotova, EA; Korshunova, GA; Plotnikov, EY; Zorov, DB				Antonenko, Yuri N.; Denisov, Stepan S.; Silachev, Denis N.; Khailova, Ljudmila S.; Jankauskas, Stanislovas S.; Rokitskaya, Tatyana I.; Danilina, Tatyana I.; Kotova, Elena A.; Korshunova, Galina A.; Plotnikov, Egor Y.; Zorov, Dmitry B.			A leng-linker conjugate of fluorescein and triphenylphosphonium as mitochondria-targeted uncoupler and fluorescent neuroand nephroprotector	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Mitochondria; Mild uncoupler; Protonophore; Fluorescein; Membrane potential	TRAUMATIC BRAIN-INJURY; OXIDATIVE-PHOSPHORYLATION; LIPOPHILIC DICATIONS; ANTIOXIDANT SKQR1; SERUM PROTEINS; RHODAMINE 19; MEMBRANE; DINITROPHENOL; HOMEOSTASIS; DERIVATIVES	Background: Limited uncoupling of oxidative phosphorylation is known to be beneficial in various laboratory models of diseases. Linking a triphenyl-phosphonium cation to fluorescein through a decyl (C-10) spacer yields a fluorescent uncoupler, coined mitoFluo, that selectively accumulates in energized mitochondria (Denisov et al., Chem.Commun. 2014). Methods: Proton-transport activity of mitoFluo was tested in liposomes reconstituted with bacteriorhodopsin. To examine the uncoupling action on mitochondria, we monitored mitochondrial membrane potential in parallel with oxygen consumption. Neuro- and nephroprotecting activity was detected by a limb-placing test and a kidney ischemia/reperfusion protocol, respectively. Results: We compared mitoFluo properties with those of its newly synthesized analog having a short (butyl) spacer (C-4-mitoFluo). MitoFluo, but not C-4-mitoFluo, caused collapse of mitochondrial membrane potential resulting in stimulation of mitochondrial respiration. The dramatic difference in the uncoupling activity of mitoFluo and C-4-mitoFluo was in line with the difference in their protonophoric activity on a lipid membrane. The accumulation of mitoFluo in mitochondria was more pronounced than that of C-4-mitoFluo. MitoFluo decreased the rate of ROS production in mitochondria. MitoFluo was effective in preventing consequences of brain trauma in rats: it suppressed trauma-induced brain swelling and reduced a neurological deficit. Besides, mitoFluo attenuated acute kidney injury after ischemia/reperfusion in rats. Conclusions: A long alkyl linker was proved mandatory for mitoFluo to be a mitochondria- targeted uncoupler. MitoFluo showed high protective efficacy in certain models of oxidative stress-related diseases. General significance: MitoFluo is a candidate for developing therapeutic and fluorescence imaging agents to treat brain and kidney pathologies. (C) 2016 Elsevier B.V. All rights reserved.	[Antonenko, Yuri N.; Denisov, Stepan S.; Silachev, Denis N.; Khailova, Ljudmila S.; Jankauskas, Stanislovas S.; Rokitskaya, Tatyana I.; Danilina, Tatyana I.; Kotova, Elena A.; Korshunova, Galina A.; Plotnikov, Egor Y.; Zorov, Dmitry B.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Denisov, Stepan S.] Lomonosov Moscow State Univ, Fac Chem, Moscow 119991, Russia	Antonenko, YN (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia.	antonen@genebee.msu.ru	Rokitskaya, Tatyana/J-3541-2013; Silachev, Denis/ABE-8515-2020; Jankauskas, Stanislovas/W-2744-2019; Plotnikov, Egor Y/F-8592-2019; Denisov, Stepan/AAJ-4022-2020; Zorov, Dmitry/AAQ-8922-2020; Silachev, Denis N/C-9464-2012; Zorov, Dmitry/AAB-1738-2019	Plotnikov, Egor Y/0000-0003-2838-3704; Jankauskas, Stanislovas/0000-0002-0843-5098; Rokitskaya, Tatyana/0000-0002-7719-1875; Silachev, Denis/0000-0003-0581-9755; Denisov, Stepan/0000-0001-5460-940X	Russian Science FoundationRussian Science Foundation (RSF) [16-14-10025]	The authors are grateful to Professor Vladimir Skulachev for valuable discussions. This work was financially supported by the Russian Science Foundation grant 16-14-10025.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Antonenko YN, 2015, BBA-BIOMEMBRANES, V1848, P995, DOI 10.1016/j.bbamem.2015.01.005; Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902; Antonenko YN, 2012, J BIOENERG BIOMEMBR, V44, P453, DOI 10.1007/s10863-012-9449-9; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Biasutto L, 2010, BBA-BIOENERGETICS, V1797, P189, DOI 10.1016/j.bbabio.2009.10.001; Blaikie FH, 2006, BIOSCIENCE REP, V26, P231, DOI 10.1007/s10540-006-9018-8; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; Cunha FM, 2011, CURR DRUG TARGETS, V12, P783; Dalla Via L, 2014, CURR PHARM DESIGN, V20, P253, DOI 10.2174/13816128113199990028; Denisov SS, 2014, CHEM COMMUN, V50, P15366, DOI 10.1039/c4cc04996a; Dikalov SI, 2016, CURR OPIN NEPHROL HY, V25, P73, DOI 10.1097/MNH.0000000000000198; DROBNICA L, 1979, BIOCHIM BIOPHYS ACTA, V585, P462, DOI 10.1016/0304-4165(79)90091-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng XX, 2015, P NATL ACAD SCI USA, V112, pE7073, DOI 10.1073/pnas.1521988112; Figarola JL, 2015, J BIOL CHEM, V290, P30321, DOI 10.1074/jbc.M115.686352; Fugit KD, 2014, J CONTROL RELEASE, V174, P88, DOI 10.1016/j.jconrel.2013.11.003; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; HAYASHI H, 1975, BIOCHIM BIOPHYS ACTA, V394, P145, DOI 10.1016/0005-2736(75)90213-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; HUANG KS, 1980, P NATL ACAD SCI-BIOL, V77, P323, DOI 10.1073/pnas.77.1.323; ILIVICKY J, 1969, BIOCHEM PHARMACOL, V18, P1389, DOI 10.1016/0006-2952(69)90252-4; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Johnson D., 1967, METHODS ENZYMOL, V10, P94, DOI 10.1016/0076-6879(67)10018-9; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kalinovich AV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P620, DOI 10.1134/S0006297915050156; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Khailova LS, 2014, BBA-BIOENERGETICS, V1837, P1739, DOI 10.1016/j.bbabio.2014.07.006; Klotzsch E, 2015, P NATL ACAD SCI USA, V112, P130, DOI 10.1073/pnas.1415261112; KONISHI T, 1986, BIOCHIM BIOPHYS ACTA, V862, P278, DOI 10.1016/0005-2736(86)90229-4; Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krishna YR, 2011, CAN J GASTROENTEROL, V25, P157; LARIS PC, 1975, BIOCHIM BIOPHYS ACTA, V376, P415, DOI 10.1016/0005-2728(75)90163-2; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; OSORIO C, 1962, J PHYSIOL-LONDON, V163, P151, DOI 10.1113/jphysiol.1962.sp006963; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Perevoshchikova IV, 2008, BBA-BIOMEMBRANES, V1778, P2182, DOI 10.1016/j.bbamem.2008.04.008; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Severina II, 2007, BBA-BIOENERGETICS, V1767, P1164, DOI 10.1016/j.bbabio.2007.05.010; Shchepinova MM, 2014, BBA-BIOENERGETICS, V1837, P149, DOI 10.1016/j.bbabio.2013.09.011; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Silachev DN, 2014, BBA-GEN SUBJECTS, V1840, P3434, DOI 10.1016/j.bbagen.2014.09.002; Skulachev VP, 2010, BBA-BIOENERGETICS, V1797, P878, DOI 10.1016/j.bbabio.2010.03.015; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; STARKOV AA, 1994, FEBS LETT, V355, P305, DOI 10.1016/0014-5793(94)01211-3; Starkov AA, 2006, CHEM-BIOL INTERACT, V163, P133, DOI 10.1016/j.cbi.2006.08.015; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Wen R, 2016, ADV DRUG DELIVER REV, V99, P52, DOI 10.1016/j.addr.2015.12.024; WOLFF J, 1961, J CLIN INVEST, V40, P1373, DOI 10.1172/JCI104368	64	16	18	1	30	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2016	1860	11	A				2463	2473		10.1016/j.bbagen.2016.07.014			11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	DW7IR	WOS:000383824900013	27450891				2021-06-18	
J	Dahdah, MN; Barnes, S; Buros, A; Dubiel, R; Dunklin, C; Callender, L; Harper, C; Wilson, A; Diaz-Arrastia, R; Bergquist, T; Sherer, M; Whiteneck, G; Pretz, C; Vanderploeg, RD; Shafi, S				Dahdah, Marie N.; Barnes, Sunni; Buros, Amy; Dubiel, Rosemary; Dunklin, Cynthia; Callender, Librada; Harper, Caryn; Wilson, Amy; Diaz-Arrastia, Ramon; Bergquist, Thomas; Sherer, Mark; Whiteneck, Gale; Pretz, Christopher; Vanderploeg, Rodney D.; Shafi, Shahid			Variations in Inpatient Rehabilitation Functional Outcomes Across Centers in the Traumatic Brain Injury Model Systems Study and the Influence of Demographics and Injury Severity on Patient Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Inpatients; Rehabilitation; Treatment outcome	LENGTH-OF-STAY; LOCALIZED PROSTATE-CANCER; OLDER-ADULTS; DIFFERENTIAL OUTCOMES; COMMUNITY INTEGRATION; CARE INDICATORS; HEAD-INJURY; STROKE; IMPACT; VARIABLES	Objective: To compare patient functional outcomes across Traumatic Brain Injury Model Systems (TBIMS) rehabilitation centers using an enhanced statistical model and to determine factors that influence those outcomes. Design: Multicenter observational cohort study. Setting: TBIMS centers. Participants: Patients with traumatic brain injury (TBI) admitted to 19 TBIMS rehabilitation centers from 2003-2012 (N=5505). Interventions: Not applicable. Main Outcome Measures: Functional outcomes of patients with TBI. Results: Individuals with lower functional status at the time of admission, longer duration of posttraumatic amnesia, and higher burden of medical comorbidities continued to have worse functional outcomes at discharge from inpatient rehabilitation and at the 1-year follow-up, whereas those who were employed at the time of injury had better outcomes at both time periods. Risk-adjusted patient functional outcomes for patients in most TBIMS centers were consistent with previous research. However, there were wide performance differences for a few centers even after using more recently collected data, improving on the regression models by adding predictors known to influence functional outcomes, and using bootstrapping to eliminate confounds. Conclusions: Specific patient, injury, and clinical factors are associated with differences in functional outcomes within and across TBIMS rehabilitation centers. However, these factors did not explain all the variance in patient outcomes, suggesting a role of some other predictors that remain unknown. (C) 2016 by the American Congress of Rehabilitation Medicine	[Dahdah, Marie N.; Dubiel, Rosemary; Wilson, Amy] Baylor Inst Rehabil, Dallas, TX USA; [Dahdah, Marie N.; Dubiel, Rosemary; Dunklin, Cynthia; Callender, Librada; Harper, Caryn; Diaz-Arrastia, Ramon; Shafi, Shahid] North Texas Traumat Brain Injury Model Syst Ctr, Dallas, TX USA; [Dahdah, Marie N.] Baylor Reg Med Ctr Plano, Ctr Med Psychol, Plano, TX USA; [Barnes, Sunni; Buros, Amy; Shafi, Shahid] Baylor Inst Hlth Care Res & Improvement, 8080 North Cent Expressway,Suite 900, Dallas, TX 75206 USA; [Diaz-Arrastia, Ramon] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Bergquist, Thomas] Mayo Clin Traumat Brain Injury Model Syst, Rochester, MN USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Whiteneck, Gale] Rocky Mt Reg Brain Injury Syst, Englewood, CO USA; [Pretz, Christopher] Craig Hosp, Natl Data & Stat Ctr, Englewood, CO USA; [Vanderploeg, Rodney D.] James A Haley Vet Hosp, Tampa, FL USA	Shafi, S (corresponding author), Baylor Inst Hlth Care Res & Improvement, 8080 North Cent Expressway,Suite 900, Dallas, TX 75206 USA.	shahid.shafi@baylorhealth.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133A120098-11]	Supported by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant no H133A120098-11). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the federal government.	Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Borkar SA, 2011, INDIAN J NEUROTRAUM, V8, P77, DOI 10.1016/S0973-0508(11)80004-3; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Corrigan J, PROBLEMATIC SUBSTANC; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; HAHN B, 1994, MED CARE, V32, P227, DOI 10.1097/00005650-199403000-00004; Hawkins ML, 2005, AM SURGEON, V71, P920; Hawkins ML, 2005, AM SURGEON, V71, P9; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoenig H, 2001, HEALTH SERV RES, V35, P1293; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Irdesel J, 2007, NEUROCIRUGIA, V18, P5; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Kuhne CA, 2007, UNFALLCHIRURG, V110, P341, DOI 10.1007/s00113-007-1244-4; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Mayer SA, 2011, CRIT CARE MED, V39, P2330, DOI 10.1097/CCM.0b013e3182227238; Mazurek M, 2011, INT J THER REHABIL, V18, P551, DOI 10.12968/ijtr.2011.18.10.551; McNaughton H, 2005, ARCH PHYS MED REHAB, V86, pS115, DOI 10.1016/j.apmr.2005.08.115; *MEDPAC, 2001, REP C MED RUR AM; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pasquale MD, 2005, CRIT CARE MED, V33, pA40, DOI 10.1097/00003246-200512002-00148; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Tewari A, 2006, UROLOGY, V68, P1268, DOI 10.1016/j.urology.2006.08.1059; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Treadwell J, 2012, SURG OPTIONS INGUINA; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; Wood RI, 1998, BRAIN INJURY, V13, P69; Wudhikarn K, 2014, J COMP EFFECT RES, V3, P95, DOI 10.2217/cer.13.86; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	58	16	16	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2016	97	11					1821	1831		10.1016/j.apmr.2016.05.005			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	EB8IK	WOS:000387634500001	27246623				2021-06-18	
J	Kim, SC; Ro, YS; Shin, SD; Kim, JY				Kim, Sang Chul; Ro, Young Sun; Shin, Sang Do; Kim, Joo Yeong			Preventive Effects of Safety Helmets on Traumatic Brain Injury after Work-Related Falls	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						occupational injuries; accidental falls; traumatic brain injury	OCCUPATIONAL INJURIES; PROGNOSTIC-FACTORS; UNITED-STATES; CONSTRUCTION; MORTALITY; EFFICACY	Introduction: Work-related traumatic brain injury (TBI) caused by falls is a catastrophic event that leads to disabilities and high socio-medical costs. This study aimed to measure the magnitude of the preventive effect of safety helmets on clinical outcomes and to compare the effect across different heights of fall. Methods: We collected a nationwide, prospective database of work-related injury patients who visited the 10 emergency departments between July 2010 and October 2012. All of the adult patients who experienced work-related fall injuries were eligible, excluding cases with unknown safety helmet use and height of fall. Primary and secondary endpoints were intracranial injury and in-hospital mortality. We calculated adjusted odds ratios (AORs) of safety helmet use and height of fall for study outcomes, and adjusted for any potential confounders. Results: A total of 1298 patients who suffered from work-related fall injuries were enrolled. The industrial or construction area was the most common place of fall injury occurrence, and 45.0% were wearing safety helmets at the time of fall injuries. The safety helmet group was less likely to have intracranial injury comparing with the no safety helmet group (the adjusted odds ratios (ORs) (95% confidence interval (CI)): 0.42 (0.24-0.73)), however, there was no statistical difference of in-hospital mortality between two groups (the adjusted ORs (95% CI): 0.83 (0.34-2.03). In the interaction analysis, preventive effects of safety helmet on intracranial injury were significant within 4 m height of fall. Conclusions: A safety helmet is associated with prevention of intracranial injury resulting from work-related fall and the effect is preserved within 4 m height of fall. Therefore, wearing a safety helmet can be an intervention for protecting fall-related intracranial injury in the workplace.	[Kim, Sang Chul] Konkuk Univ, Sch Med, Dept Emergency Med, Chungju 27376, South Korea; [Kim, Sang Chul] Chungju Hosp, Chungju 27376, South Korea; [Kim, Sang Chul; Ro, Young Sun; Shin, Sang Do; Kim, Joo Yeong] Seoul Natl Univ, Hosp Biomed Res, Lab Emergency Med Serv, Seoul 03080, South Korea; [Shin, Sang Do] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul 03080, South Korea; [Kim, Joo Yeong] Korea Univ, Dept Emergency Med, Ansan Hosp, Ansan 15355, South Korea	Ro, YS (corresponding author), Seoul Natl Univ, Hosp Biomed Res, Lab Emergency Med Serv, Seoul 03080, South Korea.	arahan@kku.ac.kr; Ro.youngsun@gmail.com; shinsangdo@gmail.com; blj01he@gmail.com	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085	Konkuk University	This paper was supported by the Konkuk University.	[Anonymous], 2014, CENS FAT OCC INJ CFO; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Baron SL, 2013, MMWR-MORBID MORTAL W, V62, P35; Bennett MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Cattledge GH, 1996, ACCIDENT ANAL PREV, V28, P655, DOI 10.1016/0001-4575(96)00026-7; Chi CF, 2005, APPL ERGON, V36, P391, DOI 10.1016/j.apergo.2004.09.011; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; El Sayed I., 2016, NEUROSURG R IN PRESS; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Health and Safety Executive, 2015, PERS PROT EQUIPM WOR; Icer M, 2013, ULUS TRAVMA ACIL CER, V19, P529, DOI 10.5505/tjtes.2013.77535; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Lapostolle F, 2005, CRIT CARE MED, V33, P1239, DOI 10.1097/01.CCM.0000164564.11989.C3; Liberty Mutual Research Institute for Safety, 2015, 2015 ANN REP SCI ACT; Liu B, 2008, COCHRANE DATABASE SY, V1; Liu CC, 2009, INJURY, V40, P595, DOI 10.1016/j.injury.2008.11.014; Mangharam J., 2016, ERGONOMICS; McCurley L., 2013, FALLS HEIGHT GUIDE R, P95; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Occupational Safety and Branch Labour Department, 2004, GUID NOT SEL US MAIN; SafetyWork Manitoba, 2008, FALL PROT GUID WORKP; Sise RG, 2014, J TRAUMA ACUTE CARE, V76, P913, DOI 10.1097/TA.0000000000000169; Smedley J., 2013, OXFORD HDB OCCUPATIO, P138; Smith G S, 2001, Inj Prev, V7 Suppl 1, pi3, DOI 10.1136/ip.7.suppl_1.i3; Socias C. M., 2014, MMWR-MORBID MORTAL W, V63, P341; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Waehrer GM, 2007, ACCIDENT ANAL PREV, V39, P1258, DOI 10.1016/j.aap.2007.03.012; Yoon HY, 2006, INT J IND ERGONOM, V36, P83, DOI 10.1016/j.ergon.2005.08.005	29	16	16	0	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2016	13	11							1063	10.3390/ijerph13111063			15	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EE4KR	WOS:000389571300022		DOAJ Gold, Green Published			2021-06-18	
J	Pasto, L; Portaccio, E; Goretti, B; Ghezzi, A; Lori, S; Hakiki, B; Giannini, M; Righini, I; Razzolini, L; Niccolai, C; Moiola, L; Falautano, M; Simone, M; Viterbo, RG; Patti, F; Cilia, S; Pozzilli, C; Bianchi, V; Roscio, M; Martinelli, V; Comi, G; Trojano, M; Amato, MP				Pasto, Luisa; Portaccio, Emilio; Goretti, Benedetta; Ghezzi, Angelo; Lori, Silvia; Hakiki, Bahia; Giannini, Marta; Righini, Isabella; Razzolini, Lorenzo; Niccolai, Claudia; Moiola, Lucia; Falautano, Monica; Simone, Marta; Viterbo, Rosa Gemma; Patti, Francesco; Cilia, Sabina; Pozzilli, Carlo; Bianchi, Valentina; Roscio, Marco; Martinelli, Vittorio; Comi, Giancarlo; Trojano, Maria; Amato, Maria Pia		Italian Neurological Soc	The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis	MULTIPLE SCLEROSIS JOURNAL			English	Article						Pediatric-onset multiple sclerosis; cognitive reserve; cognitive impairment; intelligence quotient	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; PSYCHOSOCIAL FEATURES; JUVENILE MS; IMPAIRMENT; CHILDHOOD; CHILDREN; EDUCATION; PREDICTORS; MODERATOR	Background: The study of cognitive reserve (CR) in relationship with cognitive impairment (CI) in pediatric-onset multiple sclerosis (POMS) may provide cues to identifying subjects at higher risk of impairment and scope for therapeutic strategies. Objectives: To assess the potential impact of CR on cognition in a cohort of POMS patients. Methods: In all, 48 POMS patients were followed up for 4.7 +/- 0.4 years. CI was defined as the failure of >= 3 tests on an extensive neuropsychological battery. Change of neuropsychological performance was assessed through the Reliable Change Index (RCI) method. At baseline, CR was estimated by measuring the intelligence quotient (IQ). The relationships were assessed through multivariable regression analyses. Results: At baseline, CI was detected in 14/48 (29.2%) patients. Two out of 57 healthy control (HC; 3.5%) met the same criteria of CI (p < 0.001). A deteriorating cognitive performance using the RCI method was observed in 18/48 patients (37.6%). Among the 34 cases who were cognitively preserved at baseline, a higher reserve predicted stable/improving performance (odds ratio (OR) = 1.11; 95% confidence interval (CI): 1.03-1.20; p = 0.006). Conclusion: Our results suggest that higher CR in POMS patients may protect from CI, particularly in subjects with initial cognitive preservation, providing relevant implications for counseling and rehabilitation strategies.	[Pasto, Luisa; Portaccio, Emilio; Goretti, Benedetta; Lori, Silvia; Hakiki, Bahia; Giannini, Marta; Righini, Isabella; Razzolini, Lorenzo; Niccolai, Claudia; Amato, Maria Pia] Univ Florence, Dept NEUROFARBA, Viale Pieraccini 6, I-50134 Florence, Italy; [Portaccio, Emilio; Hakiki, Bahia] Don Carlo Gnocchi Fdn, Florence, Italy; [Ghezzi, Angelo; Roscio, Marco] Hosp Gallarate, MS Ctr, Gallarate, Italy; [Moiola, Lucia; Falautano, Monica; Martinelli, Vittorio; Comi, Giancarlo] Ist Sci San Raffaele, Dept Neurol, Milan, Italy; [Simone, Marta; Viterbo, Rosa Gemma; Trojano, Maria] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Patti, Francesco] Univ Catania, Dept Med & Surg Sci & Adv Technol, Div Neurosci, Catania, Italy; [Patti, Francesco] Univ Catania, Dept GF Ingrassia Multiple Sclerosis Ctr, Catania, Italy; [Cilia, Sabina] ASP Trapani, Dept Psychol, Trapani, Italy; [Pozzilli, Carlo; Bianchi, Valentina] Sapienza Univ Rome, Dept Neurol & Psychiat, Rome, Italy	Amato, MP (corresponding author), Univ Florence, Dept NEUROFARBA, Viale Pieraccini 6, I-50134 Florence, Italy.	mariapia.amato@unifi.it	amato, Maria Pia/AAL-5998-2020; Moiola, Lucia/AAN-5568-2020; ghezzi, angelo/AAJ-9606-2020; Simone, Marta/AAE-9877-2020; Martinelli, Vittorio/AAN-7240-2020	amato, Maria Pia/0000-0003-3325-3760; Simone, Marta/0000-0003-4381-4613; Simone, Marta/0000-0001-6556-3355; patti, francesco/0000-0002-6923-0846; Niccolai, Claudia/0000-0003-2746-7500; Hakiki, Bahia/0000-0001-8540-7405; Trojano, Maria/0000-0002-6329-8946; moiola, lucia/0000-0001-6313-4952	Fondazione Italiana Sclerosi MultiplaFondazione Italiana Sclerosi Multipla (FISM) [2014/R/2]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by Fondazione Italiana Sclerosi Multipla (Grant No. 2014/R/2).	Amato MP, 2008, NEUROLOGY, V70, P1891, DOI 10.1212/01.wnl.0000312276.23177.fa; Amato MP, 2010, NEUROLOGY, V75, P1134, DOI 10.1212/WNL.0b013e3181f4d821; Amato MP, 2014, NEUROLOGY, V83, P1432, DOI 10.1212/WNL.0000000000000885; Amato MP, 2013, NEUROLOGY, V80, P1728, DOI 10.1212/WNL.0b013e3182918c6f; Amato MP, 2012, NEUROPEDIATRICS, V43, P174, DOI 10.1055/s-0032-1324400; AMATO MP, 1995, ARCH NEUROL-CHICAGO, V52, P168, DOI 10.1001/archneur.1995.00540260072019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Banwell B, 2007, LANCET NEUROL, V6, P887, DOI 10.1016/S1474-4422(07)70242-9; Brant AM, 2009, BEHAV GENET, V39, P393, DOI 10.1007/s10519-009-9268-x; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Gorman MP, 2009, ARCH NEUROL-CHICAGO, V66, P54, DOI 10.1001/archneurol.2008.505; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; Hosseini B, 2014, J INT NEUROPSYCH SOC, V20, P796, DOI 10.1017/S1355617714000642; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kesler SR, 2010, BRAIN IMAGING BEHAV, V4, P256, DOI 10.1007/s11682-010-9104-1; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kovacs M, 1988, CDI CHILDREN DEPRESS; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Pietschnig J, 2015, PERSPECT PSYCHOL SCI, V10, P282, DOI 10.1177/1745691615577701; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rocca MA, 2014, HUM BRAIN MAPP, V35, P4180, DOI 10.1002/hbm.22469; Rocca MA, 2014, NEUROLOGY, V82, P1314, DOI 10.1212/WNL.0000000000000309; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2013, MULT SCLER J, V19, P1122, DOI 10.1177/1352458513498834; Sumowski JF, 2013, NEUROLOGY, V80, P2186, DOI 10.1212/WNL.0b013e318296e98b; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Till C, 2011, NEUROPSYCHOLOGY, V25, P319, DOI 10.1037/a0022051; Till C, 2013, NEUROPSYCHOLOGY, V27, P210, DOI 10.1037/a0031665; Vernon-Feagans L, 2008, J APPL DEV PSYCHOL, V29, P213, DOI 10.1016/j.appdev.2008.02.007; Wechsler D., 1974, WISC R MANUAL WECHSL	38	16	17	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	NOV	2016	22	13					1741	1749		10.1177/1352458516629559			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EF8JT	WOS:000390575800014	26869527				2021-06-18	
J	Pope, CN; Ross, LA; Stavrinos, D				Pope, Caitlin N.; Ross, Lesley A.; Stavrinos, Despina			Association Between Executive Function and Problematic Adolescent Driving	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						adolescent; executive function; driving; problematic driving outcomes; injury prevention	BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NOVICE DRIVERS; NORMATIVE DATA; CHILDREN; CRASHES; ADULTS; SAFETY; AGE	Objective: Motor vehicle collisions (MVCs) are one of the leading causes of injury and death for adolescents. Driving is a complex activity that is highly reliant on executive function (EF) to safely navigate through the environment. Little research has examined the efficacy of using self-reported EF measures for assessing adolescent driving risk. This study examined the Behavior Rating Inventory of Executive Function (BRIEF) questionnaire and performance-based EF tasks as potential predictors of problematic driving outcomes in adolescents. Methods: Forty-six adolescent drivers completed the (1) BRIEF, (2) Trail Making Test, (3) Backwards Digit Span, and (4) self-report on 3 problematic driving outcomes: the number of times of having been pulled over by a police officer, the number of tickets issued, and the number of MVCs. Results: Greater self-reported difficulty with planning and organization was associated with greater odds of having a MVC, whereas inhibition difficulties were associated with greater odds of receiving a ticket. Greater self-reported difficulty across multiple BRIEF subscales was associated with greater odds of being pulled over. Conclusion: Overall findings indicated that the BRIEF, an ecological measure of EF, showed significant association with self-reported problematic driving outcomes in adolescents. No relationship was found between performance-based EF measures and self-reported driving outcomes. The BRIEF could offer unique and quick insight into problematic driving behavior and potentially be an indicator of driving risk in adolescent drivers during clinical evaluations.	[Pope, Caitlin N.; Stavrinos, Despina] Univ Alabama Birmingham, Dept Psychol, 916 Bldg,19th St South, Birmingham, AL 35294 USA; [Ross, Lesley A.] Penn State Univ, Coll Hlth & Human Dev, Dept Human Dev & Family Studies, University Pk, PA 16802 USA	Stavrinos, D (corresponding author), Univ Alabama Birmingham, Dept Psychol, 916 Bldg,19th St South, Birmingham, AL 35294 USA.	dstavrin@uab.edu	Pope, Caitlin N./W-7730-2019; Ross, Lesley/B-4842-2019	Pope, Caitlin N./0000-0003-1576-9763; Ross, Lesley/0000-0002-3794-158X	Southeastern Transportation Research, Innovation, Development and Education (STRIDE) Center; Alabama Department of Transportation (ALDOT); Florida Department of Transportation (FDOT); University of Alabama at Birmingham; Edward R. Roybal Center for Translational Research in Aging and Mobility, National Institute on Aging at the National Institutes of Health [2 P30 AG022838]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG022838] Funding Source: NIH RePORTER	This work was supported, in part, by the Southeastern Transportation Research, Innovation, Development and Education (STRIDE) Center; Alabama Department of Transportation (ALDOT); Florida Department of Transportation (FDOT), University of Alabama at Birmingham Faculty Development Grant Program, and the Edward R. Roybal Center for Translational Research in Aging and Mobility, National Institute on Aging at the National Institutes of Health (2 P30 AG022838). The opinions, views, or comments expressed in this paper are those of the authors and do not necessarily represent the official positions of funding departments.	af Wahlberg AE, 2015, SAFETY SCI, V76, P67, DOI 10.1016/j.ssci.2015.02.020; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Alderson RM, 2010, J ABNORM CHILD PSYCH, V38, P497, DOI 10.1007/s10802-010-9387-0; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Asimakopulos J, 2012, AUST OCCUP THER J, V59, P402, DOI 10.1111/j.1440-1630.2011.00963.x; Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Beanland V, 2013, SAFETY SCI, V51, P127, DOI 10.1016/j.ssci.2012.06.021; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bonett DG, 2002, J EDUC BEHAV STAT, V27, P335, DOI 10.3102/10769986027004335; Boschloo A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00287; Centers for Disease Control and Prevention, 2013, WEB BAS INJ STAT QUE; Chan M, 2013, ACCIDENT ANAL PREV, V50, P147, DOI 10.1016/j.aap.2012.04.004; Eichelberger AH, 2015, J SAFETY RES, V55, P1, DOI 10.1016/j.jsr.2015.07.006; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fischer M, 2007, ACCIDENT ANAL PREV, V39, P94, DOI 10.1016/j.aap.2006.06.008; Fisher DL, 2006, INJURY PREV, V12, P25, DOI 10.1136/ip.2006.012021; Fisher D.L., 2011, HDB DRIVING SIMULATI; Garner AA, 2014, J ATTEN DISORD, V18, P496, DOI 10.1177/1087054711431699; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Guy S.C., 2004, BRIEF SR BEHAV RATIN; HOLM S, 1979, SCAND J STAT, V6, P65; Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4; Isquith PK, 2014, APPL NEUROPSYCH-CHIL, V3, P197, DOI 10.1080/21622965.2013.870014; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Ker K, 2005, ACCIDENT ANAL PREV, V37, P305, DOI 10.1016/j.aap.2004.09.004; Laapotti S, 2001, ACCIDENT ANAL PREV, V33, P759, DOI 10.1016/S0001-4575(00)00090-7; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Mantyla T, 2009, APPL NEUROPSYCHOL, V16, P11, DOI 10.1080/09084280802644086; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; McCandless Stephen, 2007, J Atten Disord, V10, P381, DOI 10.1177/1087054706292115; McCartt AT, 2003, ACCIDENT ANAL PREV, V35, P311, DOI 10.1016/S0001-4575(02)00006-4; McDonald CC, 2015, J ADOLESCENT HEALTH, V57, pS15, DOI 10.1016/j.jadohealth.2015.02.013; O'Brien F, 2013, ACCIDENT ANAL PREV, V51, P238, DOI 10.1016/j.aap.2012.11.024; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Pharo H, 2011, BEHAV NEUROSCI, V125, P970, DOI 10.1037/a0025768; Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008; Reimer B, 2006, BEHAV RES METHODS, V38, P314, DOI 10.3758/BF03192783; Rike PO, 2015, TRANSPORT RES F-TRAF, V29, P34, DOI 10.1016/j.trf.2015.01.004; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Roberts SE, 2008, ACCIDENT ANAL PREV, V40, P559, DOI 10.1016/j.aap.2007.08.017; Romer D, 2014, J ADOLESCENT HEALTH, V54, pS6, DOI 10.1016/j.jadohealth.2013.10.202; Rosenbloom T, 2008, ACCIDENT ANAL PREV, V40, P697, DOI 10.1016/j.aap.2007.09.007; Ross V, 2015, APPL NEUROPSYCH-ADUL, V22, P61, DOI 10.1080/23279095.2013.838958; Roth R.M., 2005, BEHAV RATING INVENTO; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schiebener J, 2015, CHILD NEUROPSYCHOL, V21, P759, DOI 10.1080/09297049.2014.934216; SEAMAN MA, 1991, PSYCHOL BULL, V110, P577, DOI 10.1037/0033-2909.110.3.577; Shope JT, 2008, AM J PREV MED, V35, pS261, DOI 10.1016/j.amepre.2008.06.022; Tabibi Z, 2015, TRANSPORT RES F-TRAF, V34, P18, DOI 10.1016/j.trf.2015.07.015; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Underwood G, 2007, ERGONOMICS, V50, P1235, DOI 10.1080/00140130701318707; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; Wechsler D., 1999, MANUAL WECHSLER ABBR; Welburn SC, 2010, DEV SELF REPORT MEAS	63	16	17	2	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	NOV-DEC	2016	37	9					702	711		10.1097/DBP.0000000000000353			10	Behavioral Sciences; Psychology, Developmental; Pediatrics	Behavioral Sciences; Psychology; Pediatrics	EC1IZ	WOS:000387859400005	27661394	Green Accepted			2021-06-18	
J	Waldum, ER; Dufault, CL; McDaniel, MA				Waldum, Emily R.; Dufault, Carolyn L.; McDaniel, Mark A.			Prospective Memory Training: Outlining a New Approach	JOURNAL OF APPLIED GERONTOLOGY			English	Article						aging; event-based; time-based; intervention; prospective memory	AGE-RELATED DIFFERENCES; ATTENTIONAL CONTROL; OLDER-ADULTS; IMPLEMENTATION INTENTIONS; IMPROVING MEMORY; SELF-EFFICACY; PERFORMANCE; TASK; IMPACT; INTERVENTION	Prospective memory (PM) tasks are those that must be performed in the future (e.g., attend an appointment). While these everyday tasks can be especially relevant for older adults (i.e., medication adherence), and have been associated with age-related decline, PM has been virtually overlooked in the cognitive training domain. This article describes the first comprehensive PM training intervention. Older adults (age 55 to 75) who received training completed 8 weekly PM training sessions that consisted of variable PM training tasks, strategy-focused discussion, and homework assignments. Those assigned to a control group completed only the first and last training task. On both a real-world proxy PM transfer task and the training tasks detailed here, there was a positive impact of PM training, suggesting practical benefits of the current training package for older adults. Benefits may also extend to other special populations who experience PM impairments (e.g., traumatic brain injury [TBI], Parkinson's).	[Waldum, Emily R.; Dufault, Carolyn L.; McDaniel, Mark A.] Washington Univ, St Louis, MO 63130 USA	Waldum, ER (corresponding author), Washington Univ, Dept Psychol, Campus Box 1125,One Brookings Dr, St Louis, MO 63130 USA.	ewaldum@artsci.wustl.edu			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034581, 5T32AG000030]; Harvey A. Friedman Center for Aging; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000030, R01AG034581] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by Grant R01AG034581 from the National Institute on Aging and by the Harvey A. Friedman Center for Aging. Emily Waldum was supported by National Institute on Aging grant 5T32AG000030.	Bagwell DK, 2008, CLIN INTERV AGING, V3, P371; Bherer L, 2005, PSYCHOL AGING, V20, P695, DOI 10.1037/0882-7974.20.4.695; Breneiser J., 2007, THESIS; Craik F.I., 2000, HDB AGING COGNITION, V3rd; Craik F. I. M., 2008, HDB AGING COGNITION; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Jennings JM, 2003, NEUROPSYCHOL REHABIL, V13, P417, DOI 10.1080/09602010244000390; KRAMER AF, 1995, J EXP PSYCHOL-APPL, V1, P50, DOI 10.1037/1076-898X.1.1.50; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; MacKay-Brandt A, 2011, AGING NEUROPSYCHOL C, V18, P432, DOI 10.1080/13825585.2011.568046; MAYLOR EA, 1993, PSYCHOL AGING, V8, P420, DOI 10.1037/0882-7974.8.3.420; Maylor EA, 1996, PSYCHOL AGING, V11, P74, DOI 10.1037/0882-7974.11.1.74; McDaniel M. A., 2007, PROSPECTIVE MEMORY O; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2014, PSYCHOL AGING, V29, P717, DOI 10.1037/a0037363; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; REBOK GW, 1989, DEV PSYCHOL, V25, P714, DOI 10.1037/0012-1649.25.5.714; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Rose N. S., 2012, ANN M PSYCH SOC MINN; Schmidt IW, 2001, EDUC GERONTOL, V27, P455, DOI 10.1080/036012701316894162; Schnitzspahn KM, 2009, EUR J AGEING, V6, P147, DOI 10.1007/s10433-009-0116-x; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Stine-Morrow EAL, 2007, J GERONTOL B-PSYCHOL, V62, P62, DOI 10.1093/geronb/62.special_issue_1.62; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; VERHAEGHEN P, 1992, PSYCHOL AGING, V7, P242, DOI 10.1037/0882-7974.7.2.242; West RL, 2008, AGING NEUROPSYCHOL C, V15, P302, DOI 10.1080/13825580701440510	32	16	17	1	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0733-4648	1552-4523		J APPL GERONTOL	J. Appl. Gerontol.	NOV	2016	35	11					1211	1234		10.1177/0733464814559418			24	Gerontology	Geriatrics & Gerontology	DZ6GP	WOS:000385960000005	25480795	Green Accepted			2021-06-18	
J	Taheri, S; Tanriverdi, F; Zararsiz, G; Elbuken, G; Ulutabanca, H; Karaca, Z; Selcuklu, A; Unluhizarci, K; Tanriverdi, K; Kelestimur, F				Taheri, Serpil; Tanriverdi, Fatih; Zararsiz, Gokmen; Elbuken, Gulsah; Ulutabanca, Halil; Karaca, Zuleyha; Selcuklu, Ahmet; Unluhizarci, Kursad; Tanriverdi, Kahraman; Kelestimur, Fahrettin			Circulating MicroRNAs as Potential Biomarkers for Traumatic Brain Injury-Induced Hypopituitarism	JOURNAL OF NEUROTRAUMA			English	Article						hypopituitarism; miRNA; TBI	ANTERIOR-PITUITARY FUNCTION; ACUTE-PHASE; DYSFUNCTION	Traumatic brain injury (TBI), a worldwide public health problem, has recently been recognized as a common cause of pituitary dysfunction. Circulating microRNAs (miRNAs) present in the sera are characteristically altered in many pathological conditions and have been used as diagnostic markers for specific diseases. It is with this goal that we planned to study miRNA expression in patients with TBI-induced hypopituitarism. Thirty-eight patients (27 male, 11 female; mean age, 43 +/- 18 years) who had been admitted to the neurosurgery intensive care unit due to TBI were included in the acute phase of the study. In the chronic phase, miRNA expression profile blood samples were drawn from 25 patients who had suffered TBI 5 years ago. In the acute phase (on Days 1, 7, and 28), a substantial amount of patients (26%, 40%, and 53%; respectively) had hypopituitarism (acute adrenocorticotropic hormone deficiency). In the chronic phase eight of 25 patients (32%) had TBI-induced-hypopituitarism. Forty-seven age-gender-similar healthy controls (25 male, 22 female, mean age: 41 +/- 14 years) were included in the study. In order to identify potential candidate miRNA/miRNAs whose levels had been altered in response to TBI-induced hypopituitarism, 740 miRNA expression analyses were performed in the sera of TBI patients by high throughput real-time polymerase chain reaction. Statistical analyses showed that miRNA-126-3p (miR-126-3p) and miRNA-3610 (miR-3610) were detected in the sera of patients who developed hypopituitarism on the 1st, 7th, and 28th days, and in the 5th year following TBI. In addition, miRNA-3907 showed statistically significant and constant dynamic changes on the 1st, 7th, and 28th days, and in the 5th year in the patients with TBI. Our results indicated that altered expression of miR-126-3p and miR-3610 may play an important role in the development of TBI-induced hypopituitarism.	[Taheri, Serpil] Erciyes Univ, Betul Ziya Eren Genome & Stem Cell Ctr, Kayseri, Turkey; [Tanriverdi, Fatih; Elbuken, Gulsah; Karaca, Zuleyha; Unluhizarci, Kursad; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Zararsiz, Gokmen] Erciyes Univ, Sch Med, Dept Biostat, Kayseri, Turkey; [Ulutabanca, Halil; Selcuklu, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, Kayseri, Turkey; [Tanriverdi, Kahraman] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	Zararsiz, Gokmen/E-8818-2013; ZARARSIZ, GOKMEN/ABH-7959-2020; Taheri, Serpil/AAL-8870-2021; Elbuken, Gulsah/ABD-5689-2020	Zararsiz, Gokmen/0000-0001-5801-1835; Elbuken, Gulsah/0000-0002-0920-6895			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang P, 2015, CLIN LUNG CANCER, V16, P313, DOI 10.1016/j.cllc.2014.12.006; Wang W, 2015, J ZHEJIANG UNIV-SC B, V16, P18, DOI 10.1631/jzus.B1400184	23	16	18	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1818	1825		10.1089/neu.2015.4281			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300002	27027233				2021-06-18	
J	McCulloch, KL; de Joya, AL; Hays, K; Donnelly, E; Johnson, TK; Nirider, CD; Roth, H; Saliga, S; Ward, I				McCulloch, Karen L.; de Joya, Anna Lisa; Hays, Kaitlin; Donnelly, Erin; Johnson, Tammie Keller; Nirider, Coby D.; Roth, Heidi; Saliga, Sue; Ward, Irene			Outcome Measures for Persons With Moderate to Severe Traumatic Brain Injury: Recommendations From the American Physical Therapy Association Academy of Neurologic Physical Therapy TBI EDGE Task Force	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						measurement; human movement system; standardization	QUALITY-OF-LIFE; DISABILITY RATING-SCALE; COMMON DATA ELEMENTS; PSYCHOMETRIC PROPERTIES; PARTICIPATION ASSESSMENT; INTERRATER RELIABILITY; PREDICTIVE-VALIDITY; RETEST RELIABILITY; INITIAL VALIDATION; SERIAL MEASUREMENT	Background and Purpose: The use of standardized outcome measures (OMs) is essential in assessing the effectiveness of physical therapy (PT) interventions. The purposes of this article are (1) to describe the process used by the TBI EDGE task force to assess the psychometrics and clinical utility of OMs used with individuals with moderate to severe traumatic brain injury (TBI); (2) to describe the consensus recommendations for OM use in clinical practice, research, and professional (entry-level) PT education; and (3) to make recommendations for future work. Methods: An 8-member task force used a modified Delphi process to develop recommendations on the selection of OMs for individuals with TBI. A 4-point rating scale was used to make recommendations based on practice setting and level of ambulation. Recommendations for appropriateness for research use and inclusion in entry-level education were also provided. Results: The TBIEDGEtask force reviewed 88 OMs across the International Classification of Functioning, Disability, and Health (ICF) domains: 15 measured body functions/structure only, 21 measured activity only, 23 measured participation only, and 29 OMs covered more than 1 ICF domain. Discussion and Conclusions: Recommendations made by the TBI EDGE task force provide clinicians, researchers, and educators with guidance for the selection of OMs. The use of these recommendations may facilitate identification of appropriate OMs in the population with moderate to severe TBI. TBI EDGE task force recommendations can be used by clinicians, researchers, and educators when selecting OMs for their respective needs. Future efforts to update the recommendations are warranted in order to ensure that recommendations remain current and applicable. Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, http://links.lww.com/JNPT/A140).	[McCulloch, Karen L.] Univ N Carolina, Div Phys Therapy, Dept Allied Hlth Sci, Sch Med, 321 S Columbia St Bondurant Hall Suite 3024, Chapel Hill, NC 27599 USA; [McCulloch, Karen L.] Univ N Carolina, Div Phys Therapy, Chapel Hill, NC USA; [de Joya, Anna Lisa] TIRR Mem Hermann, Houston, TX USA; [Hays, Kaitlin] Craig Hosp, Denver, CO USA; [Donnelly, Erin] Kessler Inst Rehabil, Saddle Brook, NJ USA; [Johnson, Tammie Keller] Casa Colina Ctr Rehabil, Pomona, CA USA; [Nirider, Coby D.] Touchstone Neurorecovery Ctr, Conroe, TX USA; [Roth, Heidi] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Saliga, Sue] Oakland Univ, Rochester, MI 48063 USA; [Ward, Irene] Kessler Inst Rehabil, W Orange, NJ USA	McCulloch, KL (corresponding author), Univ N Carolina, Div Phys Therapy, Dept Allied Hlth Sci, Sch Med, 321 S Columbia St Bondurant Hall Suite 3024, Chapel Hill, NC 27599 USA.	kmac@med.unc.edu					Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; *AM PHYS THER ASS, 2002, INT GUID PHYS THER P; American Physical TherapyAssociation, 2011, NEUR ENTR LEV CURR C; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P314, DOI 10.1097/HTR.0b013e3182562f04; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bodiam C., 1999, BR J OCCUP THER, V62, P123, DOI DOI 10.1177/030802269906200310; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2015, J HEAD TRAUMA REHAB, V30, P337; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Boonstra AM, 2012, INT J REHABIL RES, V35, P153, DOI 10.1097/MRR.0b013e328352ab28; Boulgarides LK, 2003, PHYS THER, V83, P328, DOI 10.1093/ptj/83.4.328; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cardol M, 2001, ARCH PHYS MED REHAB, V82, P210, DOI 10.1053/apmr.2001.18218; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Commission on Accreditation in Physical Therapy Education, EV CRIT PT PROGR VER; de Hoon EW, 2003, ARCH PHYS MED REHAB, V84, P838, DOI 10.1016/S0003-9993(02)04951-1; Demers L, 1996, Assist Technol, V8, P3; DIFABIO RP, 1990, PHYS THER, V70, P542, DOI 10.1093/ptj/70.9.542; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Donnelly E, 2014, ARCH PHYS MED REHAB, V95, P1417; Duarte E, 2002, J REHABIL MED, V34, P267, DOI 10.1080/165019702760390356; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Franchignoni F, 2003, CLIN REHABIL, V17, P273, DOI 10.1191/0269215503cr608oa; Fujiwara T, 2004, AM J PHYS MED REHAB, V83, P681, DOI 10.1097/01.PHM.0000137308.10562.20; Gandek B, 2007, AM J PHYS MED REHAB, V86, P57, DOI 10.1097/01.PHM.0000233200.43822.21; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Gorman SL, 2010, J NEUROL PHYS THER, V34, P150, DOI 10.1097/NPT.0b013e3181f0065f; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Gray DB, 2006, ARCH PHYS MED REHAB, V87, P189, DOI 10.1016/j.apmr.2005.09.014; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Haley SM, 2004, MED CARE, V42, P49, DOI 10.1097/01.mlr.0000103520.43902.6c; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Harker WF, 2002, INT J REHABIL RES, V25, P93, DOI 10.1097/00004356-200206000-00003; Hobart JC, 2001, J NEUROL NEUROSUR PS, V71, P225, DOI 10.1136/jnnp.71.2.225; Hofheinz M, 2010, CLIN REHABIL, V24, P831, DOI 10.1177/0269215510367993; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; HSU CC, 2007, PRACTICAL ASSESSMENT, V12, DOI DOI 10.1145/1255456.1255458; Huijbregts M, 2002, PHYSIOTHER CAN, V54, P25; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jette DU, 2009, PHYS THER, V89, P125, DOI 10.2522/ptj.20080234; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Jonsdottir J, 2007, ARCH PHYS MED REHAB, V88, P1410, DOI 10.1016/j.apmr.2007.08.109; Keysor JJ, 2005, J REHABIL MED, V37, P37, DOI 10.1080/16501970410014830; Kirby RL, 2002, ARCH PHYS MED REHAB, V83, P10, DOI 10.1053/apmr.2002.26823; Klein PJ, 2011, PHYSIOTHER CAN, V63, P115, DOI 10.3138/ptc.2009-51; Lancu Iulian, 2006, Harefuah, V145, P687; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; May LA, 2003, ARCH PHYS MED REHAB, V84, P578, DOI 10.1053/apmr.2003.50021; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; McDonnell M, 2008, AUST J PHYSIOTHER, V54, P220, DOI 10.1016/S0004-9514(08)70034-5; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Mehrholz J, 2007, ARCH PHYS MED REHAB, V88, P1314, DOI 10.1016/j.apmr.2007.06.764; Mellick D., 2012, CRAIG HANDICAP ASSES; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Newman AC, 2000, BRAIN INJURY, V14, P333; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Noreau L, 2004, DISABIL REHABIL, V26, P346, DOI 10.1080/09638280410001658649; Ontario Neurotrauma Foundation, EV BAS REV MOD SEV A; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Potter K, 2014, PHYS THER, V94, P593, DOI 10.2522/ptj.20130149; Potter K, 2011, J NEUROL PHYS THER, V35, P57, DOI 10.1097/NPT.0b013e318219a51a; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Sullivan JE, 2013, PHYS THER, V93, P1383, DOI 10.2522/ptj.20120492; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Temkin NR, 1998, MED CARE S, V27, pS44; Toyinbo PA, 2016, J HEAD TRAUMA REHAB, V31, P52, DOI 10.1097/HTR.0000000000000089; Tulsky D, 2010, ARCH PHYS MED REHAB, V92, pS1; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tyson SF, 2007, NEUROREHAB NEURAL RE, V21, P341, DOI 10.1177/1545968306296966; VANAGT HME, 1994, SOC SCI MED, V39, P1537, DOI 10.1016/0277-9536(94)90005-1; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Ward Irene, 2014, Arch Phys Med Rehabil, V95, P2229; Wedge Frances M., 2012, Physiotherapy Theory and Practice, V28, P119, DOI 10.3109/09593985.2011.578706; Weightman M, 2014, MILD TRAUMATIC BRAIN; Whitall J, 2006, ARCH PHYS MED REHAB, V87, P656, DOI 10.1016/j.apmr.2006.02.004; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P966, DOI 10.1016/j.apmr.2007.12.031; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; World Health Organization, COMM LANG FUNCT DIS; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	120	16	16	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	OCT	2016	40	4					269	280		10.1097/NPT.0000000000000145			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EC8BG	WOS:000388364300008	27576089				2021-06-18	
J	Salas, CE; Castro, O; Yuen, KSL; Radovic, D; d'Avossa, G; Turnbull, OH				Salas, Christian E.; Castro, Osvaldo; Yuen, Kenneth S. L.; Radovic, Darinka; d'Avossa, Giovanni; Turnbull, Oliver H.			'Just can't hide it': a behavioral and lesion study on emotional response modulation after right prefrontal damage	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						response modulation; suppression; emotion; emotion regulation; prefrontal cortex; insula; brain injury	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; DECISION-MAKING; DUCHENNE SMILE; FRONTAL LOBES; NEURAL BASIS; INHIBITION; CORTEX	Introduction: Historically, emotion regulation problems have been reported as a common consequence of right prefrontal cortex (rPFC) damage. It has been proposed that the rPFC, particularly the rIFG, has a key role inhibiting prepotent reflexive actions, thus contributing to emotion regulation and self-regulation. This study is the first to directly explore this hypothesis, by testing whether damage to the rIFG compromises the voluntary modulation of emotional responses, and whether performance on inhibition tasks is associated with emotion regulation. Method: 10 individuals with unilateral right prefrontal damage and 15 matched healthy controls were compared on a well-known response modulation task. During the task participants had to amplify and suppress their facial emotional expressions, while watching film clips eliciting amusement. Measures of executive control, emotion regulation strategies usage and symptomatology were also collected. Results: As a group, individuals with rPFC damage presented a significantly reduced range of response modulation compared with controls. In addition, performance in the suppression task was associated with measures of cognitive inhibition and suppression usage. Interestingly, these effects were driven primarily by a subgroup of individuals with rPFC damage, all of whom also had damage to the right posterior insula, and who presented a marked impairment in suppressing facial emotional expressions	[Salas, Christian E.] Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social LaNCyS, Vergara 275, Santiago, Chile; [Salas, Christian E.; d'Avossa, Giovanni; Turnbull, Oliver H.] Bangor Univ, Sch Psychol, Brigantia Bldg, Bangor LL57 2AS, Gwynedd, Wales; [Castro, Osvaldo] Univ Autonoma Chile, Escuela Terapia Ocupac, San Miguel 3369, Santiago, Chile; [Yuen, Kenneth S. L.] Johannes Gutenberg Univ Mainz, Med Ctr, Neuroimaging Ctr, EG, Langenbeckstr 1 Geb 701,R 0-035, D-55131 Mainz, Germany; [Radovic, Darinka] Univ Manchester, Manchester M13 9PL, Lancs, England	Salas, CE (corresponding author), Withington Methodist Church, Head Forward Ctr, 439 Wimslow Rd, Manchester M20 4AN, Withington, England.	salasriquelme@gmail.com			CONICYT -Chile-Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); NEUROPSYCHOANALYSIS FOUNDATION	This research has been funded by CONICYT -Chile- and the NEUROPSYCHOANALYSIS FOUNDATION.	Abreau B. C., 2009, LIFE BALANCE MULTIDI, P223; Ambadar Z, 2009, J NONVERBAL BEHAV, V33, P17, DOI 10.1007/s10919-008-0059-5; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barrash J., 2011, J CLIN EXPT NEUROPSY, V33, P1; Barrett L., 2008, HDB EMOTIONS, P272; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Beer JS., 2007, HDB EMOTION REGULATI, P69; Bowen C., 2010, RELATIONAL APPROACH; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Coan J. A., 2007, SERIES AFFECTIVE SCI, P267; Cummings JL, 1997, BRAIN LANG, V57, P22, DOI 10.1006/brln.1997.1832; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Demaree HA, 2004, COGNITION EMOTION, V18, P1079, DOI 10.1080/02699930441000085; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dillon DG, 2007, APPL PREV PSYCHOL, V12, P99, DOI 10.1016/j.appsy.2007.09.004; DREWE E A, 1975, Cortex, V11, P8; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2002, FACIAL ACTION CODING; Feinberg TE, 2011, CONSCIOUS COGN, V20, P75, DOI 10.1016/j.concog.2010.09.017; Feinberg TE, 2010, J NEUROL NEUROSUR PS, V81, P276, DOI 10.1136/jnnp.2009.188946; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; Gable SL, 2004, J PERS SOC PSYCHOL, V87, P228, DOI 10.1037/0022-3514.87.2.228; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goodkind MS, 2010, PSYCHOL AGING, V25, P30, DOI 10.1037/a0018519; Gross J. J, 2014, HDB EMOTION REGULATI; Gross J. J., 1998, REV GEN PSYCHOL VOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Gross J.J., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gross JJ, 1999, COGNITION EMOTION, V13, P551, DOI 10.1080/026999399379186; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Gyurak A, 2009, COGN AFFECT BEHAV NE, V9, P144, DOI 10.3758/CABN.9.2.144; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Henry JD, 2009, PSYCHOL AGING, V24, P252, DOI 10.1037/a0014001; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hilz MJ, 2006, BRAIN, V129, P3343, DOI 10.1093/brain/awl299; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; KELTNER D, 1995, J PERS SOC PSYCHOL, V68, P441, DOI 10.1037/0022-3514.68.3.441; Kuhn S., 2011, PLOS ONE, V6, P4; Lee TW, 2008, CEREB CORTEX, V18, P104, DOI 10.1093/cercor/bhm035; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lewis MD, 2006, J COGNITIVE NEUROSCI, V18, P430, DOI 10.1162/jocn.2006.18.3.430; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; Niven K, 2009, EMOTION, V9, P498, DOI 10.1037/a0015962; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Quirk G. J., 2007, HDB EMOTION REGULATI, P27; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; ROVNER BW, 1987, HOSP PRACT, V22, P99; Royzman EB, 2006, EMOTION, V6, P82, DOI 10.1037/1528-3542.6.1.82; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Salas C.E., 2012, NEUROPSYCHOANALYSIS, V14, P77, DOI DOI 10.1080/15294145.2012.10773691; Salas CE, 2014, REV CHIL NEUROPSICOL, V9, P38, DOI 10.5839/rcnp.2014.0901E.07; Salas CE, 2014, B MENNINGER CLIN, V78, P301, DOI 10.1521/bumc.2014.78.4.301; Salas CE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00242; Salas CE, 2013, NEUROPSYCHOL REHABIL, V23, P467, DOI 10.1080/09602011.2013.784709; Salas CE, 2012, EMOTION, V12, P568, DOI 10.1037/a0025811; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Simmons WK, 2013, HUM BRAIN MAPP, V34, P2944, DOI 10.1002/hbm.22113; Simons G, 2003, COGNITION EMOTION, V17, P759, DOI 10.1080/02699930302280; Smith RH, 1996, PERS SOC PSYCHOL B, V22, P158, DOI 10.1177/0146167296222005; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; STERN RA, 1994, CLIN NEUROPSYCHOL, V8, P309, DOI 10.1080/13854049408404137; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2000, AFFECTIVE MINDS, P13; Stuss DT, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P215; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; van Dijk WW, 2011, COGNITION EMOTION, V25, P360, DOI 10.1080/02699931.2010.487365; Watson D, 1994, PANAS X MANUAL UNPUB; WESCHLER D, 1987, WECHSLER MEMORY SCAL; WESCHLER D, 1981, WESCHLER ADULT INTEL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	94	16	17	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	OCT	2016	11	10					1528	1540		10.1093/scan/nsw075			13	Neurosciences; Psychology; Psychology, Experimental	Neurosciences & Neurology; Psychology	ED6BR	WOS:000388939700003	27317928	Green Published			2021-06-18	
J	Zuercher, P; Groen, JL; Aries, MJH; Steyerberg, EW; Maas, AIR; Ercole, A; Menon, DK				Zuercher, Patrick; Groen, Justus L.; Aries, Marcel J. H.; Steyerberg, Ewout W.; Maas, Andrew I. R.; Ercole, Ari; Menon, David K.			Reliability and Validity of the Therapy Intensity Level Scale: Analysis of Clinimetric Properties of a Novel Approach to Assess Management of Intracranial Pressure in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						clinimetrics; ICP; TIL scale; TBI	HYPOTHERMIA; MULTICENTER	We aimed to assess the reliability and validity of the Therapy Intensity Level scale (TIL) for intracranial pressure (ICP) management. We reviewed the medical records of 31 patients with traumatic brain injury (TBI) in two European intensive care units (ICUs). The ICP TIL was derived over a 4-day period for 4-h (TIL4) and 24-h epochs (TIL24). TIL scores were compared with historical schemes for TIL measurement, with each other, and with clinical variables. TIL24 scores in ICU patients with TBI were compared with two control groups: patients with extracranial trauma necessitating intensive care (Trauma_ICU; n = 20) and patients with TBI not needing ICU care (TBI_WARD; n = 19), to further determine the discriminative validity of the TIL for ICP-related ICU interventions. Interrater and intraobserver agreement were excellent for TIL4 and TIL24 (Cohen kappa: 0.98-0.99; intraclass correlation coefficient: 0.99-1; p < 0.0005). The mean + standard deviation (SD) TIL24 in the ICU TBI cohort was significantly higher than the Trauma_ICU patients and the TBI_WARD patients (8.2 +/- 3.2 vs. 2.2 +/- 0.9 and 0.1 +/- 0.1, respectively; p < 0.005 for both comparisons). Correlations between the TIL scale scores and historical TIL scores, between TIL24 and the Glasgow Coma Scale, and between a range of TIL metrics and summary measures of ICP over the 4-day period, were all highly significant (p < 0.01). The results were consistent with the expected direction. A linear mixed effect analysis, accounting for within-subjects repeated measures, showed strong correlation between TIL4 and 4-h ICP (p < 0.0000005). The TIL scale is a reliable measurement instrument with a high degree of validity for assessing the therapeutic intensity level of ICP management in patients with TBI.	[Zuercher, Patrick; Groen, Justus L.; Aries, Marcel J. H.; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England; [Zuercher, Patrick] Inselspital Bern, Univ Hosp, Dept Intens Care Med, Bern, Switzerland; [Groen, Justus L.] UMC Leiden, Dept Neurosurg, Leiden, Netherlands; [Aries, Marcel J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [Steyerberg, Ewout W.] Erasmus MC, Dept PH, Ctr Med Decis Sci, Rotterdam, Netherlands; [Maas, Andrew I. R.] Univ Antwerp, Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium	Zuercher, P (corresponding author), Inselspital Bern, Univ Hosp Bern, Dept Intens Care Med, Freiburgstr, CH-3010 Bern, Switzerland.	pz257@cam.ac.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093			Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; de Vet H.C.W., 2011, MEASUREMENT MED PRAC, P338; JENNETT B, 1975, LANCET, V1, P480; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Munch E, 2000, NEUROSURGERY, V47, P315; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	19	16	16	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2016	33	19					1768	1774		10.1089/neu.2015.4266			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DY8KP	WOS:000385379100005		Green Accepted			2021-06-18	
J	Zhao, JB; Chen, HD; Zhang, MJ; Zhang, YH; Qian, CF; Liu, Y; He, SX; Zou, YJ; Liu, HY				Zhao, Jinbing; Chen, Haodong; Zhang, Meijuan; Zhang, Yuhai; Qian, Chunfa; Liu, Yong; He, Shengxue; Zou, Yuanjie; Liu, Hongyi			Early expression of serum neutrophil gelatinase-associated lipocalin (NGAL) is associated with neurological severity immediately after traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						NGAL; Neurological severity; Traumatic brain injury	INTRACEREBRAL HEMORRHAGE; POTENTIAL ROLE; RENAL INJURY; RAT-BRAIN; IRON; BIOMARKER; CELLS; MEDIATOR; PROTEIN; MOUSE	Purpose: Intracranial bleeding and inflammatory reactions are common consequences of traumatic brain injury (TBI). Neutrophil gelatinase-associated lipocalin (NGAL), an iron-handling and acute phase protein, may participate in the pathogenesis of TBI. Therefore, we hypothesize that NGAL may be of high diagnostic and therapeutic relevance in the prognosis of TBI. Methods: 74 subjects were recruited in this study. 30 TBI patients receiving emergent operation were designated as severe TBI group (sTBI), 24 TBI patients receiving conservative treatment as mild TBI group (mTBI), while 20 age-matched healthy volunteers as healthy controls (CNT). We detected the expression and localization of NGAL in brain tissue by Q-PCR, western blotting, and immunofluorescence. Serum NGAL was evaluated by ELISA. Clinical manifestations and outcomes were measured by Glasgow Score (GCS), Trauma score (TS), Revised Trauma score (RTS), APACHEII, Sequential Organ Failure Assessment (SOFA), and Abbreviated Injury Scale (AIS) 85 at admission. Glasgow outcome score (GOS) and Karnofsky Performance Score (IKPS) were documented at discharge. Results: NGAL mRNA and protein levels in brain tissue from sTBI group were profoundly higher than control tissue. Double labeled NGAL with GFAP, NeuN and Iba-1 by immunofluroscence demonstrated that increased NGAL was mainly located in neurons. Compared to CNT and mTBI groups, serum NGAL were significantly increased in sTBI group (sTBI: 532.6 +/- 71.77 ng/ml vs. mTBI: 230.5 +/- 29.59 ng/ml, p < 0.01; sTBI: 532.6 71.77 ng/ml vs. CNT 178.0 +/- 19.83 ng/ml, p <0.01). Linear regression analysis indicated that there was a negative correlation between the NGAL levels and GCS (r = -0.427,p = 0.033), TS (r = -0.429,p = 0.032), RTS (r = -0.413, p = 0.040) in sTBI group. However, NGAL levels did not correlated with GOS and KPS scores. The NAGL cut-off value of 244.13 ng/ml yielded good sensitivity at 84% and specificity at 78.9%. Conclusion: NGAL may be a novel biomarker reflecting TBI severity, which increased obviously and negatively correlated with GCS, TS, and RTS scores; additionally, this characteristic of NGAL may be helpful in guiding clinical TBI therapeutic strategies. (C) 2016 Elsevier B.V. All rights reserved.	[Zhao, Jinbing; Zhang, Yuhai; Qian, Chunfa; Liu, Yong; He, Shengxue; Zou, Yuanjie; Liu, Hongyi] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, 264 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Haodong] Peoples Hosp Luhe, Dept Neurosurg, 9 Jiankang Lane, Nanjing 211500, Jiangsu, Peoples R China; [Zhang, Meijuan] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China	Zhao, JB; Liu, HY (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, 264 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	zjbbrain@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301049, 81571135]; Natural Science Foundation of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu Province [BK20130085]	This study was supported by the National Natural Science Foundation of China (Grants No. 81301049, 81571135), the Natural Science Foundation of Jiangsu Province of China (Grants No. BK20130085).	Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Chia WJ, 2011, NEUROCHEM INT, V59, P591, DOI 10.1016/j.neuint.2011.04.007; Chun BY, 2015, INVEST OPHTH VIS SCI, V56, P3691, DOI 10.1167/iovs.15-16851; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dong M, 2013, BRAIN RES, V1505, P86, DOI 10.1016/j.brainres.2013.02.008; Egashira Y, 2014, STROKE, V45, P2141, DOI 10.1161/STROKEAHA.114.005307; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; HRABARENEVEY S, 1989, ONCOGENE, V4, P601; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Jha Mithilesh Kumar, 2013, Immune Netw, V13, P289, DOI 10.4110/in.2013.13.6.289; Jin M, 2014, J CEREBR BLOOD F MET, V34, P1306, DOI 10.1038/jcbfm.2014.83; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowland J. B., 1997, GENOMICS, V45, P17; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Naude P. J., 2012, FASEB J; Ni W, 2015, J CEREBR BLOOD F MET, V35, P1454, DOI 10.1038/jcbfm.2015.52; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Wu L, 2015, J NEUROCHEM, V132, P622, DOI 10.1111/jnc.13023; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xing CH, 2014, STROKE, V45, P2085, DOI 10.1161/STROKEAHA.114.005733; Zhao JB, 2016, ACTA NEUROCHIR SUPPL, V121, P291, DOI 10.1007/978-3-319-18497-5_50; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y; Zhao JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058730; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018	33	16	16	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2016	368						392	398		10.1016/j.jns.2016.07.060			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DU7SU	WOS:000382415700079	27538670				2021-06-18	
J	Breedlove, KM; Breedlove, EL; Bowman, TG; Nauman, EA				Breedlove, Katherine M.; Breedlove, Evan L.; Bowman, Thomas G.; Nauman, Eric A.			Impact attenuation capabilities of football and lacrosse helmets	JOURNAL OF BIOMECHANICS			English	Article						Protective equipment; Gadd severity index; Head impact; Drop test; Helmet evaluation	AMERICAN FOOTBALL; HEAD IMPACT; CONCUSSION; PLAYERS; ACCELERATION; EPIDEMIOLOGY; BIOMECHANICS; INJURIES; BOYS; MASS	Although the National Operating Committee on Standards for Athletic Equipment (NOCSAE) standards are similar for football and lacrosse helmets, it remains unknown how helmets for each sport compare on drop tests. Due to the increased concern over head injury in sport and the rapid growth in lacrosse participation, it is useful to compare the performance of various football and lacrosse helmets. Therefore, the goal of this study was to document the impact attenuation properties of football and lacrosse helmets and to identify the relative performance between helmets for the two sports. Six models of football and six models of lacrosse helmets were tested using a drop tower at three prescribed velocities and six locations on the helmets. A repeated measures ANOVA was conducted to determine the effect of sport on Gadd Severity Index (GSI) scores and linear accelerations. The interaction between location and sport was significant at the low (F-2.64,F-89.71=7.68, P<.001, eta(2)=.025), medium (F-2.85,F-98.85=16.78, P<.001, eta(2)=.085), and high (F-2.96,F-100.69=16.67, P<.001, eta(2)=.093) velocities for GSI scores. When comparing peak acceleration results, we found a significant interaction between location and sport for the medium (F-3.40,F-115.616=5.57, P=.001, omega(2)=.031) and high (F-3.46,F-117.50=6.42, P<.001, omega(2)=.047) velocities. Features of football helmet design provide superior protection compared to lacrosse helmets. Further investigation of helmet design features across sports will yield insight into how design features influence helmet performance during laboratory testing. (C) 2016 Elsevier Ltd. All rights reserved.	[Breedlove, Katherine M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA; [Bowman, Thomas G.] Lynchburg Coll, Dept Athlet Training, Lynchburg, VA 24501 USA; [Nauman, Eric A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Nauman, EA (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	enauman@purdue.edu	Bowman, Thomas/AAA-3036-2020; Bowman, Tom/AAU-6473-2020	Bowman, Thomas/0000-0002-0034-2946; 	Indiana State Department of Health Spinal Cord and Brain Injury Research Fund; Indiana Clinical and Translational Sciences Institute, Purdue's Office of the Vice President for Research; Lynchburg College; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE-1333468]	This work was supported in part by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Research Fund, a Core Facility Grant from the Indiana Clinical and Translational Sciences Institute, Purdue's Office of the Vice President for Research, and a faculty development grant from Lynchburg College. This material is also based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1333468. Xenith helmets were provided by Xenith, Inc. We would like to thank the Lynchburg College men's lacrosse program for donating the used helmets tested in the current study. In addition, we thank Jay Hertel, Ph.D., ATC, FNATA, FACSM for his assistance with the statistical approach to data analysis.	Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; Bower D.T., 2016, J ATHL TRAI IN PRESS; Bowman TG, 2015, J BIOMECH, V48, P3782, DOI 10.1016/j.jbiomech.2015.08.026; Breedlove E.L., 2013, FAILED CASCADE HELME; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Dick R, 2007, J ATHL TRAINING, V42, P255; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd CW, 1966, P 10 STAPP CAR CRASH; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Higgins M.J., 2015, J ATHL TRAINING, V50, pS; Hillman K, 2005, INTRO ATHLETIC TRAIN; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hutchinson TP, 2014, EUR J SPORT SCI, V14, pS377, DOI 10.1080/17461391.2012.705334; Koehling E.M., 2015, J ATHL TRAINING, V50, pS; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; MARTIN RB, 1994, J BIOMECH, V27, P361, DOI 10.1016/0021-9290(94)90011-6; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; NCAA,, 2013, NCAA SPORTS SPONS PA; Newman J.A., 2015, DESIGN TESTING SPORT, P755; NOCSAE, 2013, DOCND00213M13 NOCSAE; NOCSAE, 2013, DOCND00111M13 NOCSAE; NOCSAE,, 2011, DOCND04204M11A NOCSA; NOCSAE, 2012, DOCND04111M12 NOCSAE; NOCSAE, 2006, DOCND80104M04 NOCSAE; O'Day K.M., 2015, J ATHL TRAINING, V50, pS242; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Scher I., 2008, J ASTM INT, V5, P1; STX, RES REC NOCSAE STAND; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vollavanh L.R., 2015, J ATHL TRAINING, V50, pS	38	16	16	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 6	2016	49	13					2838	2844		10.1016/j.jbiomech.2016.06.030			7	Biophysics; Engineering, Biomedical	Biophysics; Engineering	DY9RH	WOS:000385472300037	27416777	Bronze			2021-06-18	
J	Alosco, ML; Aslan, M; Du, MT; Ko, J; Grande, L; Proctor, SP; Concato, J; Vasterling, JJ				Alosco, Michael L.; Aslan, Mihaela; Du, Mengtian; Ko, John; Grande, Laura; Proctor, Susan P.; Concato, John; Vasterling, Jennifer J.			Consistency of Recall for Deployment-Related Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						OIF; PTSD; recall consistency; TBI screening; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; NATIONAL-GUARD; MEMORY; VETERANS; IRAQ; STABILITY; VALIDITY; EVENTS; EXPOSURE; OUTCOMES	Objective: To examine the temporal consistency of self-reported deployment-related traumatic brain injury (TBI) and its association with posttraumatic stress disorder (PTSD) symptom severity. Setting: In-person interviews at US Army installations (postdeployment); phone interviews (long-term follow-up). Participants: A total of 378 US Army soldiers and veterans deployed to Iraq; 14.3% (n = 54) reported TBI with loss of consciousness during an index deployment. Design: Participants were evaluated after returning from deployment and again 5 to 9 years later. Main Measures: Temporal consistency of TBI endorsement based on TBI screening interviews; PTSD Checklist, Civilian Version. Results: The concordance of deployment-related TBI endorsement from the postdeployment to long-term follow-up assessment was moderate (kappa = 0.53). Of the 54 participants reporting (predominantly mild) TBI occurring during an index deployment, 32 endorsed TBI inconsistently over time. More severe PTSD symptoms at postdeployment assessment were independently associated with discordant reporting (P =.0004); each 10-point increase in PCL scores increasing odds of discordance by 69% (odds ratio = 1.69; 95% confidence interval, 1.26-2.26). Conclusions: Deployment-related TBI may not be reported reliably over time, particularly among war-zone veterans with greater PTSD symptoms. Results of screening evaluations for TBI history should be viewed with caution in the context of PTSD symptom history.	[Alosco, Michael L.; Grande, Laura; Vasterling, Jennifer J.] VA Boston Healthcare Syst, Psychol Serv, 150 S Huntington Ave, Boston, MA 02130 USA; [Aslan, Mihaela; Ko, John; Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA; [Aslan, Mihaela; Ko, John; Concato, John] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Du, Mengtian] Yale Grad Sch Arts & Sci, Dept Publ Hlth, New Haven, CT USA; [Grande, Laura; Vasterling, Jennifer J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Proctor, Susan P.] US Army Res Inst Environm Med, Natick, MA USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Natl Ctr PTSD, 150 S Huntington Ave, Boston, MA 02130 USA; [Alosco, Michael L.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA	Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Psychol Serv 116B, 150 S Huntington Ave, Boston, MA 02130 USA.	jennifer.vasterling@va.gov			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD 17-03-0020]; Department of Veterans Affairs (VA) Clinical Sciences Research and Development; VA Cooperative Studies Program (VA CSP) [566]	Funding for the collection of postdeployment data was provided by the US Army Medical Research and Materiel Command (DAMD 17-03-0020) and the Department of Veterans Affairs (VA) Clinical Sciences Research and Development. Funding for all other aspects of the work was provided by VA Cooperative Studies Program (VA CSP# 566). The authors are grateful to the soldiers and military veterans who comprise the Neurocognition Deployment Health Study cohort for their long-standing participation in the research and for their military service more generally.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2008, MILD TRAUM BRAIN INJ; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Boake C, 1996, J HEAD TRAUMA REHAB, V11, P98; Brohawn KH, 2010, BIOL PSYCHIAT, V68, P1023, DOI 10.1016/j.biopsych.2010.07.018; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; El Khoury-Malhame M, 2011, BEHAV RES THER, V49, P796, DOI 10.1016/j.brat.2011.08.006; Engelhard IM, 2008, MEMORY, V16, P3, DOI 10.1080/09658210701334022; Felmingham KL, 2011, J ANXIETY DISORD, V25, P668, DOI 10.1016/j.janxdis.2011.02.010; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gittins CB, 2015, J BEHAV THER EXP PSY, V46, P19, DOI 10.1016/j.jbtep.2014.07.006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, RET HOM IR AFGH ASS; King DW, 2000, J ABNORM PSYCHOL, V109, P624, DOI 10.1037//0021-843X.109.4.624; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000095; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Verfaellie M, 2009, NEUROBIOLOGY PTSD, P105; Weber Darren L, 2008, Open Neuroimag J, V2, P29, DOI 10.2174/1874440000802010029; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wilson ALG, 2010, ANN EPIDEMIOL, V20, P939, DOI 10.1016/j.annepidem.2010.08.007	33	16	16	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					360	368		10.1097/HTR.0000000000000201			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600014	26580696				2021-06-18	
J	Fisher, JAN; Huang, S; Ye, MJ; Nabili, M; Wilent, WB; Krauthamer, V; Myers, MR; Welle, CG				Fisher, Jonathan A. N.; Huang, Stanley; Ye, Meijun; Nabili, Marjan; Wilent, W. Bryan; Krauthamer, Victor; Myers, Matthew R.; Welle, Cristin G.			Real-Time Detection and Monitoring of Acute Brain Injury Utilizing Evoked Electroencephalographic Potentials	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Animal models; biomarkers; focused ultrasound; somatosensory evoked potentials (SSEPs); traumatic brain injury (TBI)	INTENSITY FOCUSED ULTRASOUND; CLOSED-HEAD-INJURY; TRANSCALLOSAL INHIBITION; APPROXIMATE ENTROPY; SPREADING DEPRESSION; SPECTRAL-ANALYSIS; NETWORK ACTIVITY; GOLDEN HOUR; IN-VIVO; EEG	Rapid detection and diagnosis of a traumatic brain injury (TBI) can significantly improve the prognosis for recovery. Helmet-mounted sensors that detect impact severity based on measurements of acceleration or pressure show promise for aiding triage and transport decisions in active, field environments such as professional sports or military combat. The detected signals, however, report on the mechanics of an impact rather than directly indicating the presence and severity of an injury. We explored the use of cortical somatosensory evoked electroencephalographic potentials (SSEPs) to detect and track, in real-time, neural electrophysiological abnormalities within the first hour following head injury in an animal model. To study the immediate electrophysiological effects of injury in vivo, we developed an experimental paradigm involving focused ultrasound that permits continuous, real-time measurements and minimizes mechanical artifact. Injury was associated with a dramatic reduction of amplitude over the damaged hemisphere directly after the injury. The amplitude systematically improved over time but remained significantly decreased at one hour, compared with baseline. In contrast, at one hour there was a concomitant enhancement of the cortical SSEP amplitude evoked from the uninjured hemisphere. Analysis of the inter-trial electroencephalogram (EEG) also revealed significant changes in low-frequency components and an increase in EEG entropy up to 30 minutes after injury, likely reflecting altered EEG reactivity to somatosensory stimuli. Injury-induced alterations in SSEPs were also observed using noninvasive epidermal electrodes, demonstrating viability of practical implementation. These results suggest cortical SSEPs recorded at just a few locations by head-mounted sensors and associated multiparametric analyses could potentially be used to rapidly detect and monitor brain injury in settings that normally present significant levels of mechanical and electrical noise.	[Fisher, Jonathan A. N.; Huang, Stanley; Ye, Meijun; Nabili, Marjan; Krauthamer, Victor; Myers, Matthew R.; Welle, Cristin G.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Fisher, Jonathan A. N.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Wilent, W. Bryan] Sentient Med Syst, Hunt Halley, MD 20131 USA	Welle, CG (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	jonathan_fisher@nymc.edu; Stanley.huang@fda.hhs.gov; meijun.ye@fda.hhs.gov; marjan.nabili@fda.hhs.gov; bwilent@gmail.com; victor.krauthamer@fda.hhs.gov; matthew.myers@fda.hhs.gov; cristin.welle@ucdenver.edu			FDA Medical Countermeasures Initiative [274]; New York Medical College	The work of C. G. Welle was supported by FDA Medical Countermeasures Initiative 274. The work of J. A. N. Fisher was supported by the New York Medical College. (Corresponding author: Cristin G. Welle.)	BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bein B, 2006, BEST PRACT RES-CLIN, V20, P101, DOI 10.1016/j.bpa.2005.07.009; Bezerianos A, 2003, ANN BIOMED ENG, V31, P221, DOI 10.1114/1.1541013; Brodie SM, 2014, J NEUROPHYSIOL, V112, P1470, DOI 10.1152/jn.00074.2014; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chen J, 2012, ELECTROPHYSIOLOGICAL; CHILDERS DG, 1987, CRIT REV BIOMED ENG, V14, P185; Coutin-Churchman P, 2003, CLIN NEUROPHYSIOL, V114, P2294, DOI 10.1016/S1388-2457(03)00228-1; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; He XF, 2015, PHYSIOL BEHAV, V151, P502, DOI 10.1016/j.physbeh.2015.08.026; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knuth T., 2005, GUIDELINES FIELD MAN; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kumar V, 2015, J ULTRAS MED, V34, P1351, DOI 10.7863/ultra.34.8.1351; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; McCabe JT, 2014, ULTRASOUND MED BIOL, V40, P965, DOI 10.1016/j.ultrasmedbio.2013.11.023; McCahery JA, 2010, PRIVATE COMPANY LAW REFORM: INTERNATIONAL AND EUROPEAN PERSPECTIVES, P1, DOI 10.1007/978-90-6704-477-6_1; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Misic B, 2016, J NEUROSCI, V36, P419, DOI 10.1523/JNEUROSCI.1506-15.2016; Mitra P, 2007, OBSERVED BRAIN DYNAM; Monteforte M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268104; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P142, DOI 10.1016/S0013-4694(97)00117-X; Ouckama R, 2011, J BIOMECH, V44, P904, DOI 10.1016/j.jbiomech.2010.11.035; Paxinos G., 2004, MOUSE BRAIN STEREOTA; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Prichep L. S., 2013, Field deployable concussion assessment device, Patent No. [U. S. 8478394 B2, 8478394]; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SAKATANI K, 1990, STROKE, V21, P124, DOI 10.1161/01.STR.21.1.124; Sawant-Pokam P. M., 2016, CEREB CORTEX N Y N 1; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Steward W., 1999, Helmet system including at least three accelerometers and mass memory and method for recording in real-time orthogonal acceleration data of a head, Patent No. [U. S. 5,978,972, 5978972]; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Takechi U, 2014, CLIN NEUROPHYSIOL, V125, P2055, DOI 10.1016/j.clinph.2014.01.034; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Tomkins Oren, 2011, Cardiovasc Psychiatry Neurol, V2011, P765923, DOI 10.1155/2011/765923; Tong S, 2002, PHYSICA A, V305, P619, DOI 10.1016/S0378-4371(01)00621-5; Tong SB, 2003, PHYS LETT A, V314, P354, DOI 10.1016/S0375-9601(03)00949-6; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Wahab R., 2010, J ACOUST SOC AM, V127, P1789; Wallace D, 2012, J MIL VETERANS HEALT, V20, P10; WALSER H, 1986, J NEUROL, V233, P34, DOI 10.1007/BF00313989; Wang J., 2015, P NIH IEEE 2015 STRA; Wu D, 2010, NEUROSCI LETT, V485, P157, DOI 10.1016/j.neulet.2010.08.086	76	16	16	2	18	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	SEP	2016	24	9					1003	1012		10.1109/TNSRE.2016.2529663			10	Engineering, Biomedical; Rehabilitation	Engineering; Rehabilitation	DX2QZ	WOS:000384217100009	26955039				2021-06-18	
J	Myers, RB; Lazaridis, C; Jermaine, CM; Robertson, CS; Rusin, CG				Myers, Risa B.; Lazaridis, Christos; Jermaine, Christopher M.; Robertson, Claudia S.; Rusin, Craig G.			Predicting Intracranial Pressure and Brain Tissue Oxygen Crises in Patients With Severe Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						brain tissue hypoxia; forecasting; data mining; intracranial pressure; neuromonitoring; prediction algorithm; traumatic brain injury	CARE	Objectives: To develop computer algorithms that can recognize physiologic patterns in traumatic brain injury patients that occur in advance of intracranial pressure and partial brain tissue oxygenation crises. The automated early detection of crisis precursors can provide clinicians with time to intervene in order to prevent or mitigate secondary brain injury. Design: A retrospective study was conducted from prospectively collected physiologic data. intracranial pressure, and partial brain tissue oxygenation crisis events were defined as intracranial pressure of greater than or equal to 20 mm Hg lasting at least 15 minutes and partial brain tissue oxygenation value of less than 10 mm Hg for at least 10 minutes, respectively. The physiologic data preceding each crisis event were used to identify precursors associated with crisis onset. Multivariate classification models were applied to recorded data in 30-minute epochs of time to predict crises between 15 and 360 minutes in the future. Setting: The neurosurgical unit of Ben Taub Hospital (Houston, TX). Subjects: Our cohort consisted of 817 subjects with severe traumatic brain injury. Measurements and Main Results: Our algorithm can predict the onset of intracranial pressure crises with 30-minute advance warning with an area under the receiver operating characteristic curve of 0.86 using only intracranial pressure measurements and time since last crisis. An analogous algorithm can predict the start of partial brain tissue oxygenation crises with 30-minute advanced warning with an area under the receiver operating characteristic curve of 0.91. Conclusions: Our algorithms provide accurate and timely predictions of intracranial hypertension and tissue hypoxia crises in patients with severe traumatic brain injury. Almost all of the information needed to predict the onset of these events is contained within the signal of interest and the time since last crisis.	[Myers, Risa B.; Jermaine, Christopher M.] Rice Univ, Dept Comp Sci, Houston, TX USA; [Lazaridis, Christos] Baylor Coll Med, Dept Neurol, Div Neurocrit Care, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Rusin, Craig G.] Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA	Rusin, CG (corresponding author), Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA.	crusin@bcm.edu		Rusin, Craig/0000-0003-3812-8133	Keck Center of the Gulf Coast Consortia, on Rice University's NLM Training Program in Biomedical Informatics [T15LM007093]; NSFNational Science Foundation (NSF) [0964526]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Science FoundationNational Science Foundation (NSF); NIH, National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM); US National Science FoundationNational Science Foundation (NSF); NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007093] Funding Source: NIH RePORTER	Supported, in part, by a training fellowship from the Keck Center of the Gulf Coast Consortia, on Rice University's NLM Training Program in Biomedical Informatics (grant number T15LM007093) and by the NSF under grant number 0964526.; Dr. Myers received support for article research from the National Institutes of Health (NIH) and the National Science Foundation. Her institution received funding from the NIH, National Library of Medicine, and from the National Science Foundation. She received supported, in part, by the Keck Center of the Gulf Coast Consortia, on Rice University's NLM Training Program in Biomedical Informatics (grant T15LM007093) and by the NSF (grant 0964526). Dr. Jermaine received support for article research from the US National Science Foundation. His institution received funding from the US National Science Foundation. Dr. Rusin is a co-founder of Medical Informatics; however, MIC has no interests in this work. All other authors report no conflicts of interest. The remaining authors have disclosed that they do not have any potential conflicts of interest.	ALLEN R, 1983, J BIOMED ENG, V5, P103, DOI 10.1016/0141-5425(83)90027-4; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Buchman TG, 2009, CRIT CARE MED, V37, P1167, DOI 10.1097/CCM.0b013e3181987bbc; Efron B., 1994, INTRO BOOTSTRAP; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; JENNETT B, 1975, LANCET, V1, P480; Koknar-Tezel S, 2009, DAT MIN 2009 ICDM 09, P59; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; LEWIS D, 1995, P 18 ANN INT ACM SIG; Mladenic D, 1999, ICML 99 P 16 NEUR CR; Myers R. B., 2015, SOC IND APPL MATH SI; Narotam PK, 2014, J NEUROTRAUM, V31, P630, DOI 10.1089/neu.2013.3104; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; Van Rijsbergen C, 1979, INFORM RETRIEVAL, V2nd; Wakeland W, 2009, CRIT CARE MED, V37, P1079, DOI 10.1097/CCM.0b013e31819b629d; Weiss GM., 2004, ACM SIGKDD EXPLORATI, V6, P7, DOI DOI 10.1145/1007730.1007734	19	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2016	44	9					1754	1761		10.1097/CCM.0000000000001838			8	Critical Care Medicine	General & Internal Medicine	DT8CZ	WOS:000381718000015	27315192	Green Accepted			2021-06-18	
J	Yang, LY; Huang, CC; Chiu, WT; Huang, LT; Lo, WC; Wang, JY				Yang, Ling-Yu; Huang, Chao-Ching; Chiu, Wen-Ta; Huang, Li-Tung; Lo, Wei-Cheng; Wang, Jia-Yi			Association of traumatic brain injury in childhood and attention-deficit/hyperactivity disorder: a population-based study	PEDIATRIC RESEARCH			English	Article							DEFICIT-HYPERACTIVITY DISORDER; OF-THE-LITERATURE; HEAD-INJURY; YOUNG-ADULTS; CHILDREN; ADHD; ADOLESCENTS; COHORT; RISK; PREDICTORS	BACKGROUND: We evaluated the risk of attention-deficit hyperactivity disorder (ADHD) following childhood traumatic brain injury (TBI). METHODS: Using Taiwan's National Health Insurance Research Database, we included 10,416 newly diagnosed TBI children (aged <= 2 y) between 2001 and 2002 and 41,664 children without TBI, who were frequency matched by sex, age, and year of the index medical service with each TBI child, as controls. Children who had been diagnosed with ADHD prior to their medical service index were excluded. Each individual was followed for 9 y to identify ADHD diagnosis. We also compared the ADHD risk in children who were treated for fractures but not TBI as sensitivity analysis. RESULTS: During the 9-y follow-up Period, children with TBI had a higher ADHD risk (adjusted hazard ratio (AHR) = 1.32, 95% confidence interval (CI) = 1.19, 1.45) than did those without TBI. Furthermore, children with mild and severe TBI had higher AHRs for ADHD than did those without TBI (AHR = 1.30; 95% CI = 1.10, 1.53; and AHR = 1.37; 95% CI = 1.22, 1.55). However, no significant association was observed between fractures and ADHD. CONCLUSION: TBI in childhood is associated with a greater likelihood of developing ADHD.	[Yang, Ling-Yu; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Chao-Ching] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan; [Huang, Chao-Ching] Coll Med, Tainan, Taiwan; [Huang, Chao-Ching] Taipei Med Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Huang, Li-Tung] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Huang, Li-Tung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lo, Wei-Cheng] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan	Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan.	jywang2010@tmu.edu.tw		Huang, Chao-Ching/0000-0003-2799-7181; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST-104-2320-B-038-057-MY3, MOST-104-2923-B-038-001- MY3]	This study was supported in part by a grant from the Ministry of Science and Technology (MOST-104-2320-B-038-057-MY3 and MOST-104-2923-B-038-001- MY3 to JY Wang), Taiwan.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barkley RA, 1997, J DEV BEHAV PEDIATR, V18, P271; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Chen MH, 2015, BIPOLAR DISORD, V17, P315, DOI 10.1111/bdi.12266; Chou IC, 2014, DEV MED CHILD NEUROL, V56, P1111, DOI 10.1111/dmcn.12501; Chou PH, 2013, EUR CHILD ADOLES PSY, V22, P301, DOI 10.1007/s00787-012-0369-3; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; Fischer M, 2007, ACCIDENT ANAL PREV, V39, P94, DOI 10.1016/j.aap.2006.06.008; Glascoe F P, 2000, Pediatr Rev, V21, P272, DOI 10.1542/pir.21-8-272; Glascoe FP, 2000, PEDIAT REV, V21; Halmoy A, 2012, BIOL PSYCHIAT, V71, P474, DOI 10.1016/j.biopsych.2011.11.013; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Konrad KN, 2000, BRAIN INJURY, V14, P859; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Olazagasti MAR, 2013, J AM ACAD CHILD PSY, V52, P153, DOI 10.1016/j.jaac.2012.11.012; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Robison LM, 2004, INT CLIN PSYCHOPHARM, V19, P17, DOI 10.1097/00004850-200401000-00003; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shank LK, 2010, REHABIL PSYCHOL, V55, P188, DOI 10.1037/a0019601; Shyu CS, 2012, J MICROBIOL IMMUNOL, V45, P237, DOI 10.1016/j.jmii.2011.11.008; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Thomas CR, 2004, BURNS, V30, P221, DOI 10.1016/j.burns.2003.10.013; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	38	16	16	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	SEP	2016	80	3					356	362		10.1038/pr.2016.85			7	Pediatrics	Pediatrics	DV0HI	WOS:000382598200005	27064246	Bronze			2021-06-18	
J	Brolliar, SM; Moore, M; Thompson, HJ; Whiteside, LK; Mink, RB; Wainwright, MS; Groner, JI; Bell, MJ; Giza, CC; Zatzick, DF; Ellenbogen, RG; Boyle, LN; Mitchell, PH; Rivara, FP; Vavilala, MS				Brolliar, Sarah M.; Moore, Megan; Thompson, Hilaire J.; Whiteside, Lauren K.; Mink, Richard B.; Wainwright, Mark S.; Groner, Jonathan I.; Bell, Michael J.; Giza, Christopher C.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Vavilala, Monica S.			A Qualitative Study Exploring Factors Associated with Provider Adherence to Severe Pediatric Traumatic Brain Injury Guidelines	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; evidence-based medicine; guideline adherence; injury; pediatrics; trauma	INTENSIVE-CARE-UNIT; CLINICAL-PRACTICE GUIDELINES; MEASURABLE OUTCOMES; IMPROVEMENT; CHILDREN; IMPLEMENTATION; MANAGEMENT; PHYSICIANS; CHECKLIST; TRIAGE	Despite demonstrated improvement in patient outcomes with use of the Pediatric Traumatic Brain Injury (TBI) Guidelines (Guidelines), there are differential rates of adherence. Provider perspectives on barriers and facilitators to adherence have not been elucidated. This study aimed to identify and explore in depth the provider perspective on factors associated with adherence to the Guidelines using 19 focus groups with nurses and physicians who provided acute management for pediatric patients with TBI at five university-affiliated Level 1 trauma centers. Data were examined using deductive and inductive content analysis. Results indicated that three inter-related domains were associated with clinical adherence: 1) perceived guideline credibility and applicability to individual patients, 2) implementation, dissemination, and enforcement strategies, and 3) provider culture, communication styles, and attitudes towards protocols. Specifically, Guideline usefulness was determined by the perceived relevance to the individual patient given age, injury etiology, and severity and the strength of the evidence. Institutional methods to formally endorse, codify, and implement the Guidelines into the local culture were important. Providers wanted local protocols developed using interdisciplinary consensus. Finally, a culture of collaboration, including consistent, respectful communication and interdisciplinary cooperation, facilitated adherence. Provider training and experience, as well as attitudes towards other standardized care protocols, mirror the use and attitudes towards the Guidelines. Adherence was determined by the interaction of each of these guideline, institutional, and provider factors acting in concert. Incorporating provider perspectives on barriers and facilitators to adherence into hospital and team protocols is an important step toward improving adherence and ultimately patient outcomes.	[Brolliar, Sarah M.; Moore, Megan; Thompson, Hilaire J.; Whiteside, Lauren K.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Mink, Richard B.] Harbor Univ Calif, Los Angeles, CA USA; [Mink, Richard B.] Los Angeles BioMed Res Inst, Los Angeles, CA USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Bell, Michael J.] Univ Pittsburgh, Pittsburgh, PA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA	Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, 325 Ninth Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Whiteside, Lauren/0000-0002-0284-5336	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000421, KL2 TR002317] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421, KL2TR002317] Funding Source: NIH RePORTER		Abrahamson KA, 2012, AM J NURS, V112, P26, DOI 10.1097/01.NAJ.0000415957.46932.bf; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; [Anonymous], BRAIN INJ US EM DEP; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Byrnes MC, 2009, CRIT CARE MED, V37, P2775, DOI 10.1097/CCM.0b013e3181a96379; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cahill NE, 2010, JPEN-PARENTER ENTER, V34, P616, DOI 10.1177/0148607110361904; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Curtis JR, 2006, CRIT CARE MED, V34, P211, DOI 10.1097/01.CCM.0000190617.76104.AC; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; DuBose JJ, 2008, J TRAUMA, V64, P22, DOI 10.1097/TA.0b013e318161b0c8; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Fernandez R, 2008, ACAD EMERG MED, V15, P1025, DOI 10.1111/j.1553-2712.2008.00232.x; Fernandez R, 2008, ACAD EMERG MED, V15, P1104, DOI 10.1111/j.1553-2712.2008.00250.x; Francl L.J., 2001, PLANT HLTH INSTR, V10, DOI [10.1094/PHI-T-2001-0517-01, DOI 10.1094/PHI-T-2001-0517-01]; Freeman T, 2006, J ADV NURS, V56, P491, DOI 10.1111/j.1365-2648.2006.04043.x; Goossens A, 2008, MED DECIS MAKING, V28, P138, DOI 10.1177/0272989X07308749; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Institute for Safe Medication Practices, 2010, ISMP GUID STAND ORD; Janssen MAP, 2012, J CLIN NURS, V21, P437, DOI 10.1111/j.1365-2702.2011.03921.x; JENNETT B, 1976, LANCET, V1, P1031; Jones AE, 2007, ACAD EMERG MED, V14, P1072, DOI 10.1197/j.aem.2007.04.014; Kalpin P., 2005, CRIT CARE NURSE, V25, P80; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kernic MA, 2013, J NEUROTRAUM, V30, P1129, DOI 10.1089/neu.2012.2716; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LeBlanc JM, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.012; March A., 2006, FACILITATING IMPLEME; McCabe Pamela J, 2005, Crit Care Nurse, V25, P76; McCabe PJ, 2005, CRIT CARE NURSE, V25, P84; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; McIlvoy L, 2001, J NEUROSCI NURS, V33, P82, DOI DOI 10.1097/01376517-200104000-00002; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Sinuff T, 2003, CLIN CHEST MED, V24, P739, DOI 10.1016/S0272-5231(03)00098-4; Sinuff T, 2007, CAN J ANAESTH, V54, P728, DOI 10.1007/BF03026869; Sinuff T, 2007, CRIT CARE MED, V35, P2083, DOI 10.1097/01.ccm.0000281446.15342.74; Swennen MHJ, 2013, ACAD MED, V88, P1384, DOI 10.1097/ACM.0b013e31829ed3cc; Teixeira PGR, 2013, J TRAUMA ACUTE CARE, V75, P717, DOI 10.1097/TA.0b013e31829d27b6; Thorne S., 2006, INT J QUAL METH, V5, P73, DOI DOI 10.1177/160940690600500210; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507	45	16	16	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1554	1560		10.1089/neu.2015.4183			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900009	26760283	Green Published			2021-06-18	
J	Na, JY; Song, K; Lee, JW; Kim, S; Kwon, J				Na, Ji-Young; Song, Kibbeum; Lee, Ju-Woon; Kim, Sokho; Kwon, Jungkee			6-Shogaol has anti-amyloidogenic activity and ameliorates Alzheimer's disease via CysLT1R-mediated inhibition of cathepsin B	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						6-Shogaol; Alzheimer's disease; Cysteinyl leukotriene 1 receptor; Cathepsin B; Ginger	TRAUMATIC BRAIN-INJURY; LEUKOTRIENE RECEPTOR 1; BETA-SECRETASE; PRECURSOR PROTEIN; CELL-DEATH; IN-VITRO; MICE; MODEL; EXPRESSION; DEFICITS	Although 6-shogaol, a constituent of ginger, has been reported to have anti-inflammatory and antioxidant effects on neuronal cells, the effects of 6-shogaol on Alzheimer's disease (AD) have not yet been investigated. Here we aimed to determine whether 6-shogaol exerts neuroprotective effects against AD. Specifically, we investigated the effects of 6-shogaol on the cysteinyl leukotriene 1 receptor (CysLT1R), a major factor in AD pathogenesis. Moreover, we clarified the relationship between CysLT1R and cathepsin B, a cysteine protease. We used in vitro and in vivo models to determine whether 6-shogaol inhibits CysLT1R/cathepsin B in an amyloid-beta (A beta; 1-42)-induced model of neurotoxicity. We first confirmed that CysLT1R and cathepsin B are upregulated by A beta (1-42) and that CysLT1R activation induces cathepsin B. In contrast, we found that 6-shogaol-mediated inhibition of CysLT1R downregulates cathepsin B in both in vitro and in vivo models. Furthermore, we found that 6-shogaol-mediated inhibition of CysLT1R/cathepsin B reduces A beta deposition in the brain and ameliorates behavioral deficits in APPSw/PS1-dE9 Tg mice. Our results indicate that 6-shogaol is a CysLT1R/cathepsin B inhibitor and is a novel potential therapeutic agent for the treatment of various neurodegenerative diseases, including AD. (C) 2016 Elsevier Inc. All rights reserved.	[Na, Ji-Young; Song, Kibbeum; Kim, Sokho; Kwon, Jungkee] Chonbuk Natl Univ, Dept Lab Anim Med, Coll Vet Med, 79 Gobongro, Iksan 54596, South Korea; [Lee, Ju-Woon; Kwon, Jungkee] Between Co LTD, Cent Res & Dev, Iksan 54596, South Korea	Kim, S; Kwon, J (corresponding author), Chonbuk Natl Univ, Dept Lab Anim Med, Coll Vet Med, 79 Gobongro, Iksan 54596, South Korea.	raios@hanmail.net; jkwon@jbnu.ac.kr			Jeonbuk Research & Development Program [2013HA-A12]; National Research Foundation of Korea - Korean governmentNational Research Foundation of KoreaKorean Government [NRF-2015R1D1A1A01057696]	This research was supported by a grant (2013HA-A12) from the Jeonbuk Research & Development Program. This work was also supported by a grant from the National Research Foundation of Korea, funded by the Korean government (NRF-2015R1D1A1A01057696).	Azizi G, 2012, IMMUNOPHARM IMMUNOT, V34, P881, DOI 10.3109/08923973.2012.705292; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Deacon RMJ, 2008, BEHAV BRAIN RES, V189, P126, DOI 10.1016/j.bbr.2007.12.024; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kim DSHL, 2004, BIOORG MED CHEM LETT, V14, P1287, DOI 10.1016/j.bmcl.2003.12.041; Kim S, 2013, PHYTOTHER RES, V27, P1795, DOI 10.1002/ptr.4946; Kyung KS, 2006, EUR J NEUROSCI, V24, P1042, DOI 10.1111/j.1460-9568.2006.04908.x; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Martinez E, 2012, J ALZHEIMERS DIS, V30, P233, DOI 10.3233/JAD-2012-112102; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; Rosano C, 2012, AGING DIS, V3, P16; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Seo JS, 2010, J ETHNOPHARMACOL, V128, P206, DOI 10.1016/j.jep.2010.01.014; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Tang SS, 2014, NEUROBIOL AGING, V35, P590, DOI 10.1016/j.neurobiolaging.2013.09.036; Tang SS, 2013, NEUROPHARMACOLOGY, V65, P182, DOI 10.1016/j.neuropharm.2012.08.026; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yu SY, 2014, ACTA PHARMACOL SIN, V35, P33, DOI 10.1038/aps.2013.130; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	26	16	19	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 12	2016	477	1					96	102		10.1016/j.bbrc.2016.06.026			7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	DS0OQ	WOS:000380297000015	27286707				2021-06-18	
J	Delgado, T; Wolfe, B; Davis, G; Ansari, S				Delgado, Tim; Wolfe, Brianne; Davis, Gary; Ansari, Safdar			Safety of peripheral administration of phenylephrine in a neurologic intensive care unit: A pilot study	JOURNAL OF CRITICAL CARE			English	Article						Vasopressor; Traumatic brain injury; Ischemic stroke; Blood pressure augmentation; Hypotension; Cerebral perfusion pressure	NOREPINEPHRINE; MANAGEMENT; COMPLICATIONS; HYPERTENSION; GUIDELINES; DOPAMINE; PRESSURE; INJURY	Integral to the management of the neurocritically injured patient are the prevention and treatment of hypotension, maintenance of cerebral perfusion pressure, and occasionally blood pressure augmentation. When adequate volume resuscitation fails to meet perfusion needs, vasopressors are often used to restore end-organ perfusion. This has historically necessitated central venous access given well-documented incidence of extravasation injuries associated with peripheral administration of vasopressors. In this pilot study, we report our 6-month experience with peripheral administration of low-concentration phenylephrine (40 mu g/mL) in our neurocritical care unit. We were able to administer peripheral phenylephrine, up to a dose of 2 mu g/(kg min), for an average of 14.29 hours (1-54.3) in 20 patients with only 1 possible minor complication and no major complications. This was achieved by adding additional safety measures in our computerized physician order entry system and additional nurse-driven safety protocols. Thus, with careful monitoring and safety precautions, peripheral administration of phenylephrine at an optimized concentration appears to have an acceptable safety profile for use in the neurocritical care unit up to a mean infusion time of 14 hours. (C) 2016 Elsevier Inc. All rights reserved.	[Delgado, Tim; Wolfe, Brianne; Davis, Gary; Ansari, Safdar] Univ Utah, Salt Lake City, UT 84112 USA	Delgado, T (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	tim.delgado@hsc.utah.edu; Brianne.wolfe@hsc.utah.edu; Gary.Davis@hsc.utah.edu; Safdar.Ansari@hsc.utah.edu					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bunker N, 2006, CRIT CARE MED, V34, P935, DOI 10.1097/01.CCM.0000202202.85087.37; Chen JL, 1998, ANN PHARMACOTHER, V32, P545, DOI 10.1345/aph.17184; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper BE, 2008, AACN ADV CRIT CARE, V19, P5, DOI 10.1097/01.AACN.0000310743.32298.1d; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dugger B, 1997, J Intraven Nurs, V20, P95; GREGORY JS, 1991, CRIT CARE MED, V19, P1395, DOI 10.1097/00003246-199111000-00016; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Havel C, 2011, COCHRANE DB SYST REV, P11; HENGSTMANN JH, 1982, EUR J CLIN PHARMACOL, V21, P335, DOI 10.1007/BF00637623; Hollenberg SM, 2004, CRIT CARE MED, V32, P1928, DOI 10.1097/01.CCM.0000139761.05492.D6; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jia XF, 2013, J INTENSIVE CARE MED, V28, P12, DOI 10.1177/0885066611403270; Kahn JM, 2002, CRIT CARE MED, V30, P1899, DOI 10.1097/00003246-200208000-00038; Leone M, 2004, INTENS CARE MED, V30, P984, DOI 10.1007/s00134-004-2172-1; Lim TS, 2011, J NEUROL SCI, V308, P72, DOI 10.1016/j.jns.2011.06.009; Marzan AS, 2004, NEUROLOGY, V62, P1193, DOI 10.1212/01.WNL.0000118303.45735.04; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; MCGINN JT, 1956, AM J SURG, V92, P594, DOI 10.1016/S0002-9610(56)80091-3; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Mistri AK, 2006, STROKE, V37, P1565, DOI 10.1161/01.STR.0000222002.57530.05; Myburgh J A, 2005, Crit Care Resusc, V7, P200; Patel GP, 2010, SHOCK, V33, P375, DOI 10.1097/SHK.0b013e3181c6ba6f; PELNER L, 1958, AM J MED SCI, V236, P755, DOI 10.1097/00000441-195812000-00008; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; Rordorf G, 2001, NEUROLOGY, V56, P1210, DOI 10.1212/WNL.56.9.1210; TAGER IB, 1983, AM J EPIDEMIOL, V118, P839; Taylor RW, 2007, CRIT CARE MED, V35, P1390, DOI 10.1097/01.CCM.0000260241.80346.1B; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Wityk RJ, 2007, J NEUROL SCI, V261, P63, DOI 10.1016/j.jns.2007.04.033; YAMAZAKI T, 1982, CRIT CARE MED, V10, P432, DOI 10.1097/00003246-198207000-00003	34	16	16	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	AUG	2016	34						107	110		10.1016/j.jcrc.2016.04.004			4	Critical Care Medicine	General & Internal Medicine	DO3TK	WOS:000377704200022	27288620				2021-06-18	
J	Hayward, R; Britto, J; Dunaway, D; Jeelani, O				Hayward, Richard; Britto, Jonathan; Dunaway, David; Jeelani, Owase			Connecting raised intracranial pressure and cognitive delay in craniosynostosis: many assumptions, little evidence	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article							CEREBRAL-BLOOD-FLOW; SINGLE-SUTURE CRANIOSYNOSTOSIS; TRANSCRANIAL DOPPLER SONOGRAPHY; TRAUMATIC BRAIN-INJURY; SYNDROMIC CRANIOSYNOSTOSIS; PLATEAU WAVES; COMPLEX CRANIOSYNOSTOSIS; SEVOFLURANE ANESTHESIA; VENOUS HYPERTENSION; MENTAL FUNCTION		[Hayward, Richard; Jeelani, Owase] Great Ormond St Children NHS Trust, Dept Neurosurg, London, England; [Britto, Jonathan; Dunaway, David] Great Ormond St Children NHS Trust, Dept Craniofacial Surg, London, England	Hayward, R (corresponding author), Great Ormond St Children NHS Trust, Dept Neurosurg, London, England.			Dunaway, David/0000-0001-5063-9943; Jeelani, Noor/0000-0002-3240-681X			Abu-Sittah GS, 2016, J NEUROSURG-PEDIATR, V17, P469, DOI 10.3171/2015.6.PEDS15177; Aicardi J, 2009, DIS NERVOUS SYSTEM C, P531; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Arnaud E, 2002, PLAST RECONSTR SURG, V110, P6, DOI 10.1097/00006534-200207000-00002; Avery RA, 2010, NEW ENGL J MED, V363, P891, DOI 10.1056/NEJMc1004957; Barkovich AJ, 2007, DIAGNOSTIC IMAGING P, P26; Bartels MC, 2004, J CRANIOFAC SURG, V15, P1019, DOI 10.1097/00001665-200411000-00026; Bottero L, 1998, PLAST RECONSTR SURG, V102, P952, DOI 10.1097/00006534-199809040-00002; Bowler JV, 2000, NEUROSURGERY SCI BAS, P127; BRINKMANN G, 1993, AM J MED GENET, V47, P800, DOI 10.1002/ajmg.1320470540; Ciasca SM, 2001, ARQ NEURO-PSIQUIAT, V59, P342, DOI 10.1590/S0004-282X2001000300006; Cohen SR, 1998, CLEFT PALATE-CRAN J, V35, P194, DOI 10.1597/1545-1569(1998)035<0194:IPISSC>2.3.CO;2; Collmann H, 2005, CHILD NERV SYST, V21, P902, DOI 10.1007/s00381-004-1116-y; David LR, 1996, J CRANIOFAC SURG, V7, P177, DOI 10.1097/00001665-199605000-00003; David LR, 1999, J CRANIOFAC SURG, V10, P38, DOI 10.1097/00001665-199901000-00008; Di Rocco F, 2014, HUM MOL GENET, V23, P2914, DOI 10.1093/hmg/ddu004; Dwyer CM, 2013, J NEUROSURG-PEDIATR, V11, P144, DOI 10.3171/2012.10.PEDS1299; Eide PK, 2007, PEDIATR NEUROSURG, V43, P472, DOI 10.1159/000108790; Eide PK, 2003, ACTA NEUROCHIR, V145, P351, DOI 10.1007/s00701-003-0029-y; Eide PK, 2002, PEDIATR NEUROSURG, V37, P310, DOI 10.1159/000066311; Eley KA, 2012, PLAST RECONSTR SURG, V130, p690E, DOI 10.1097/PRS.0b013e318267d5ae; Feinsod M, 2003, NEUROSURGERY, V53, P723, DOI 10.1227/01.NEU.0000079627.28240.63; Florisson JMG, 2014, J CRANIOMAXILLOFAC S, V43, P312; FOK H, 1992, BRIT J PLAST SURG, V45, P394, DOI 10.1016/0007-1226(92)90013-N; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Gonsalez S, 1997, EUR RESPIR J, V10, P367, DOI 10.1183/09031936.97.10020367; GRADY MS, 1986, J NEUROSURG, V65, P199, DOI 10.3171/jns.1986.65.2.0199; HAYASHI M, 1985, J NEUROSURG, V63, P556, DOI 10.3171/jns.1985.63.4.0556; HAYREH SS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1553, DOI 10.1001/archopht.1977.04450090075006; Hayward R, 2005, CHILD NERV SYST, V21, P880, DOI 10.1007/s00381-004-1114-0; Hayward R, 2005, J NEUROSURG, V102, P16, DOI 10.3171/ped.2005.102.1.0016; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hecht Jacqueline T, 2014, Handb Clin Neurol, V119, P551, DOI 10.1016/B978-0-7020-4086-3.00036-9; Horinek D, 2008, BRIT J NEUROSURG, V22, P219, DOI 10.1080/02688690701882014; IQBAL JB, 1994, CHILD NERV SYST, V10, P259, DOI 10.1007/BF00301165; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; JOHNSTON IH, 1973, J NEUROL NEUROSUR PS, V36, P161, DOI 10.1136/jnnp.36.2.161; JOHNSTON IH, 1972, J NEUROL NEUROSUR PS, V35, P285, DOI 10.1136/jnnp.35.3.285; Julliand S, 2012, AM J MED GENET A, V158A, P1987, DOI 10.1002/ajmg.a.35441; Kabeya R, 2000, NEUROL MED-CHIR, V40, P287, DOI 10.2176/nmc.40.287; Khan SH, 2005, BRIT J OPHTHALMOL, V89, P1643, DOI 10.1136/bjo.2005.075978; Kim SG, 2012, NEUROIMAGE, V62, P672, DOI 10.1016/j.neuroimage.2012.01.015; King JAJ, 2009, J NEUROSURG-PEDIATR, V4, P297, DOI 10.3171/2009.3.PEDS08344; Krishnakumar D, 2014, DEV MED CHILD NEUROL, V56, P749, DOI 10.1111/dmcn.12475; Lee AG, 2012, CURR NEUROL NEUROSCI, V12, P334, DOI 10.1007/s11910-012-0257-8; LUNDBERG N, 1972, P ROY SOC MED, V65, P19, DOI 10.1177/003591577206500108; Martini M, 2014, CHILD NERV SYST, V30, P1367, DOI 10.1007/s00381-014-2418-3; Marucci DD, 2008, PLAST RECONSTR SURG, V122, P1162, DOI 10.1097/PRS.0b013e31818458f0; MILLER NR, 1982, WALSH HOYTS CLIN NEU, P175; Mursch K, 1999, CHILD NERV SYST, V15, P110, DOI 10.1007/s003810050344; Naumann HL, 2012, PEDIATR ANESTH, V22, P1053, DOI 10.1111/j.1460-9592.2012.03843.x; Patel A, 2014, PLAST RECONSTR SURG, V134, p608E, DOI 10.1097/PRS.0000000000000511; Randhawa PS, 2011, J CRANIOFAC SURG, V22, P125, DOI 10.1097/SCS.0b013e3181f6f82c; Renier D, 1996, J NEUROSURG, V85, P66, DOI 10.3171/jns.1996.85.1.0066; RENIER D, 1988, Annals Academy of Medicine Singapore, V17, P415; RENIER D, 1982, J NEUROSURG, V57, P370, DOI 10.3171/jns.1982.57.3.0370; Rich PM, 2003, AM J NEURORADIOL, V24, P45; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAINTEROSE C, 1984, J NEUROSURG, V60, P727, DOI 10.3171/jns.1984.60.4.0727; SATOH M, 1990, Kaku Igaku, V27, P1411; Schaller BJ, 2012, J CRANIO MAXILL SURG, V40, P195, DOI 10.1016/j.jcms.2011.04.003; SEN A, 1995, J NUCL MED, V36, P394; Sgouros S, 1999, J NEUROSURG, V91, P617, DOI 10.3171/jns.1999.91.4.0617; Shipster C, 2002, INT J LANG COMM DIS, V37, P325, DOI 10.1080/13682820210138816; SILBERSTEIN SD, 1992, HEADACHE, V32, P84, DOI 10.1111/j.1526-4610.1992.hed3202084.x; Soiberman U, 2011, CHILD NERV SYST, V27, P1913, DOI 10.1007/s00381-011-1470-5; Speltz ML, 2007, PLAST RECONSTR SURG, V119, P1874, DOI 10.1097/01.prs.0000259184.88265.3f; Spruijt B, 2015, PLAST RECONSTR SURG, V136, P331, DOI 10.1097/PRS.0000000000001434; Standridge SM, 2010, PEDIATR NEUROL, V43, P377, DOI 10.1016/j.pediatrneurol.2010.08.001; Starr JR, 2007, J NEUROSURG, V107, P103, DOI 10.3171/PED-07/08/103; STEINBOK P, 1989, J NEUROSURG, V71, P42, DOI 10.3171/jns.1989.71.1.0042; Swift D, 2012, J NEUROSURG-PEDIATR, V9, P73, DOI 10.3171/2011.10.PEDS1169; Taki Y, 2011, HUM BRAIN MAPP, V32, P1973, DOI 10.1002/hbm.21163; Taylor WJ, 2001, J NEUROSURG, V94, P377, DOI 10.3171/jns.2001.94.3.0377; THOMPSON DNP, 1995, CHILD NERV SYST, V11, P269, DOI 10.1007/BF00301758; Tuite GF, 1996, NEUROSURGERY, V38, P272, DOI 10.1097/00006123-199602000-00009; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Varier S, 2011, J INT NEUROPSYCH SOC, V17, P1030, DOI 10.1017/S1355617711000993; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003; Vavilala MS, 2003, BRIT J ANAESTH, V90, P636, DOI 10.1093/bja/aeg119; Virtanen R, 1999, PEDIATRICS, V103, P791, DOI 10.1542/peds.103.4.791; Wall SA, 2014, J NEUROSURG-PEDIATR, V14, P674, DOI 10.3171/2014.8.PEDS1425; WALSH TJ, 1969, AM J OPHTHALMOL, V67, P954, DOI 10.1016/0002-9394(69)90094-4; Wang BY, 2010, J CRANIOFAC SURG, V21, P432, DOI 10.1097/SCS.0b013e3181cfa7bf; WHITTLE IR, 1984, SURG NEUROL, V21, P367, DOI 10.1016/0090-3019(84)90116-2; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Youroukos S, 2000, J CHILD NEUROL, V15, P453, DOI 10.1177/088307380001500706; Yri HM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004376	88	16	16	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2016	18	2					242	250		10.3171/2015.6.PEDS15144			9	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	DS4LX	WOS:000380753700018	27176895	Bronze			2021-06-18	
J	Johnson, U; Engquist, H; Howells, T; Nilsson, P; Ronne-Engstrom, E; Lewen, A; Rostami, E; Enblad, P				Johnson, Ulf; Engquist, Henrik; Howells, Tim; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Lewen, Anders; Rostami, Elham; Enblad, Per			Bedside Xenon-CT Shows Lower CBF in SAH Patients with Impaired CBF Pressure Autoregulation as Defined by Pressure Reactivity Index (PRx)	NEUROCRITICAL CARE			English	Article						Cerebrovascular pressure reactivity; Xenon-CT; Cerebral blood flow; Subarachnoid; Hemorrhage; Monitoring	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL-ISCHEMIA; CASE-FATALITY RATES; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; PERFUSION-PRESSURE; VASOSPASM; INFARCTION; TIME; METAANALYSIS	Subarachnoid hemorrhage (SAH) is a disease with a high rate of unfavorable outcome, often related to delayed cerebral ischemia (DCI), i.e., ischemic injury that develops days-weeks after onset, with a multifactorial etiology. Disturbances in cerebral pressure autoregulation, the ability to maintain a steady cerebral blood flow (CBF), despite fluctuations in systemic blood pressure, have been suggested to play a role in the development of DCI. Pressure reactivity index (PRx) is a well-established measure of cerebral pressure autoregulation that has been used to study traumatic brain injury, but not extensively in SAH. To study the relation between PRx and CBF in SAH patients, and to examine if PRx can be used to predict DCI. Retrospective analysis of prospectively collected data. PRx was calculated as the correlation coefficient between mean arterial blood pressure (MABP) and intracranial pressure (ICP) in a 5 min moving window. CBF was measured using bedside Xenon-CT (Xe-CT). DCI was diagnosed clinically. 47 poor-grade mechanically ventilated patients were studied. Patients with disturbed pressure autoregulation (high PRx values) had lower CBF, as measured by bedside Xe-CT; both in the early (day 0-3) and late (day 4-14) acute phase of the disease. PRx did not differ significantly between patients who developed DCI or not. In mechanically ventilated and sedated SAH patients, high PRx (more disturbed CBF pressure autoregulation) is associated with low CBF, both day 0-3 and day 4-14 after onset. The role of PRx as a monitoring tool in SAH patients needs further studying.	[Johnson, Ulf; Engquist, Henrik; Howells, Tim; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Lewen, Anders; Rostami, Elham; Enblad, Per] Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden; [Johnson, Ulf] Uppsala Univ, Dept Surg Sci Radiol, Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Dept Surg Sci Anesthesia & Intens Care, Uppsala, Sweden	Johnson, U (corresponding author), Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden.; Johnson, U (corresponding author), Uppsala Univ, Dept Surg Sci Radiol, Uppsala, Sweden.	ulf.johnson@neuro.uu.se	Engquist, Henrik/S-1890-2016; Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Johnson, Ulf/0000-0002-3879-6476; Engquist, Henrik/0000-0002-9826-1422			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; ALLCOCK JM, 1963, J NEUROSURG, V20, P752, DOI 10.3171/jns.1963.20.9.0752; Aries MJH, 2015, NEUROCRIT CARE, V23, P347, DOI 10.1007/s12028-015-0107-z; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Calviere L, 2015, NEUROCRIT CARE, V23, P253, DOI 10.1007/s12028-015-0125-x; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; DOCZI T, 1985, ACTA NEUROCHIR, V77, P110, DOI 10.1007/BF01476215; Dupont SA, 2009, NEUROCRIT CARE, V11, P172, DOI 10.1007/s12028-009-9247-3; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; Eide PK, 2012, J NEUROSURG, V116, P961, DOI 10.3171/2012.1.JNS111313; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fontana J, 2016, J NEUROIMAGING, V26, P339, DOI 10.1111/jon.12295; Friedman JA, 2003, NEUROSURGERY, V52, P1025, DOI 10.1227/01.NEU.0000058222.59289.F1; HARDERS AG, 1987, J NEUROSURG, V66, P718, DOI 10.3171/jns.1987.66.5.0718; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; Koffijberg H, 2008, J NEUROL NEUROSUR PS, V79, P294, DOI 10.1136/jnnp.2007.123901; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; LASSEN NA, 1964, CIRC RES, V15, P201; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00089; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Sarrafzadeh A, 2013, ACTA NEUROCHIR SUPPL, V115, P143, DOI 10.1007/978-3-7091-1192-5_28; Soehle M, 2004, STROKE, V35, P1393, DOI 10.1161/01.STR.0000128411.07036.a9; Stein SC, 2006, NEUROSURGERY, V59, P787; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010; Yundt KD, 1998, J CEREBR BLOOD F MET, V18, P419, DOI 10.1097/00004647-199804000-00010; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73	45	16	16	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2016	25	1					47	55		10.1007/s12028-016-0240-3			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	DR8LZ	WOS:000380150700007	26842717				2021-06-18	
J	Rezai, AR; Sederberg, PB; Bogner, J; Nielson, DM; Zhang, J; Mysiw, WJ; Knopp, MV; Corrigan, JD				Rezai, Ali R.; Sederberg, Per B.; Bogner, Jennifer; Nielson, Dylan M.; Zhang, Jun; Mysiw, W. Jerry; Knopp, Michael V.; Corrigan, John D.			Improved Function After Deep Brain Stimulation for Chronic, Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Adult brain injury; Deep brain stimulation; Nucleus accumbens; Traumatic brain injury	DISABILITY	BACKGROUND: Severe traumatic brain injury (TBI) damages the frontal lobes and connecting networks, which impairs executive functions, including the ability to self-regulate. Despite significant disabling effects, there are few treatment options in the chronic phase after injury. OBJECTIVE: To investigate the safety and potential effectiveness of deep brain stimulation (DBS) for individuals with chronic, disabling TBI and problems of behavioral and emotional self-regulation. METHODS: This study was an open-label, prospective design with serial assessments of behavioral outcomes and positron emission tomography 2 years after DBS implantation. Four participants 6 to 21 years after severe TBIs from automobile crashes were included. Although alert and volitional, all experienced significant executive impairments, including either impulsivity or reduced initiation. DBS implants were placed bilaterally in the nucleus accumbens and anterior limb of the internal capsule to modulate the prefrontal cortex. RESULTS: The procedure was safe, and all participants had improved functional outcomes. Two years after implantation, 3 met a priori criteria for improvement on the Mayo-Portland Adaptability Inventory-4. Improvement was due largely to better emotional adjustment, although 1 participant showed marked increases in multiple domains. Significant improvement in a composite score of functional capacity indicated improved independence in self-care and activities of daily living. The pattern of change in cognition corresponded with changes in activation of the prefrontal cortex observed in serial scanning. CONCLUSION: This first study of DBS to this target for severe TBI supports its safety and suggests potential effectiveness to improve function years after injury. The primary impact was on behavioral and emotional adjustment, which in turn improved functional independence.	[Rezai, Ali R.] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Rezai, Ali R.] Ohio State Univ, Ctr Neuromodulat, Columbus, OH 43210 USA; [Sederberg, Per B.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Bogner, Jennifer; Nielson, Dylan M.; Mysiw, W. Jerry; Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH USA; [Zhang, Jun; Knopp, Michael V.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA	Corrigan, JD (corresponding author), 2145 Dodd Hall,480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu		zhang, jun/0000-0002-6515-601X; Nielson, Dylan/0000-0003-4613-6643	Ohio State University Wexner Medical Center; Wright Center of Innovation in Biomedical Imaging [OTF TECH 11-044]	Funding was provided by The Ohio State University Wexner Medical Center and Wright Center of Innovation in Biomedical Imaging, OTF TECH 11-044. Dr Rezai is a Member of the Board of Directors and an equity shareholder for Autonomic Technologies, Inc. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Baker KB, 2007, NEUROSURGERY, V61, P367, DOI 10.1227/01.neu.0000303995.66902.36; Bauer R, 2008, FORTSCHR NEUROL PSYC, V76, P396, DOI 10.1055/s-2008-1038217; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Brasure M, 2013, AHRQ PUBLICATION, V13-ehc047-ef; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Dougherty DD, 2015, BIOL PSYCHIAT, V78, P240, DOI 10.1016/j.biopsych.2014.11.023; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Granger CV, 1986, TOP GERIATR REHABIL, V1, P59, DOI 10.1097/00013614-198604000-00007; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Kuhn J, 2009, EUR ADDICT RES, V15, P196, DOI 10.1159/000228930; Lane SD, 2004, PSYCHOPHARMACOLOGY, V172, P68, DOI 10.1007/s00213-003-1628-2; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rauch SL, 2006, J NEUROSURG, V104, P558, DOI 10.3171/jns.2006.104.4.558; Salgado S, 2015, STEREOT FUNCT NEUROS, V93, P75, DOI 10.1159/000368279; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; The Psychological Corporation, 1997, WAIS 3 WMS 3 TECHNIC; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	27	16	19	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2016	79	2					204	210		10.1227/NEU.0000000000001190			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DU6OS	WOS:000382335100021	26702839	Bronze			2021-06-18	
J	Siracusa, R; Paterniti, I; Bruschetta, G; Cordaro, M; Impellizzeri, D; Crupi, R; Cuzzocrea, S; Esposito, E				Siracusa, Rosalba; Paterniti, Irene; Bruschetta, Giuseppe; Cordaro, Marika; Impellizzeri, Daniela; Crupi, Rosalia; Cuzzocrea, Salvatore; Esposito, Emanuela			The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury	MOLECULAR NEUROBIOLOGY			English	Article						Neuroprotection; Anti-inflammatory; Anti-oxidant; Autophagy; Spinal compression	BRAIN-INJURY; CELL-DEATH; NEURONS; PATHOGENESIS; LIFE; LC3	Spinal cord injury (SCI) is a devastating condition of the central nervous system (CNS) often resulting in severe functional impairment and for which there are not yet restorative therapies. In the present study, we performed a widely used model of SCI to determine the neuroprotective propriety of palmitoylethanolamide (PEA) and the antioxidant effect of a flavonoid luteolin (Lut), given as a co-ultramicronized compound co-ultraPEALut. In particular, by western blot analysis and immunofluorescence staining, we investigated whether this compound (at the dose of 1 mg/kg) was able to modulate autophagy. Our results showed that treatment with co-ultraPEALut after SCI reduced the expression of proteins promoter of autophagy such as Beclin-1 and microtubule-associated protein 1A/1B-light chain 3 (MAP-LC3). In contrast, this compound decreased the levels of mammalian target of rapamycin (mTOR), p-Akt, and p-70S6K which are proteins that inhibit autophagy. These data confirmed that the protective role of co-ultraPEALut is associated with inhibition of excessive autophagy and regulation of protein degradation. Therefore, treatment with co-ultraPEALut could be considered as a possible therapeutic approach in an acute traumatic lesion like SCI.	[Siracusa, Rosalba; Paterniti, Irene; Bruschetta, Giuseppe; Cordaro, Marika; Impellizzeri, Daniela; Crupi, Rosalia; Cuzzocrea, Salvatore; Esposito, Emanuela] Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA	Esposito, E (corresponding author), Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	eesposito@unime.it	Cordaro, Marika/K-7329-2016; Crupi, Rosalia/U-4364-2019	Cordaro, Marika/0000-0002-3980-0043; Cuzzocrea, Salvatore/0000-0001-6131-3690; Siracusa, Rosalba/0000-0001-7868-2505; Impellizzeri, Daniela/0000-0001-9492-3161; Crupi, Rosalia/0000-0002-7629-3132	PON [01_02512]	The authors would like to thank Maria Antonietta Medici for her excellent technical assistance during this study and Mr Francesco Soraci for his secretarial and administrative assistance and Miss Valentina Malvagni for her editorial assistance with the manuscript. This study was supported by PON 01_02512.	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu G, 2012, EXP NEUROL, V233, P447, DOI 10.1016/j.expneurol.2011.11.018; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Park JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100819; Park JM, 2013, CANCER BIOL THER, V14, P100, DOI 10.4161/cbt.22954; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	34	16	19	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2016	53	6					3783	3792		10.1007/s12035-015-9328-6			10	Neurosciences	Neurosciences & Neurology	DR2AO	WOS:000379707600023	26143261	Other Gold, Green Published			2021-06-18	
J	Tremoleda, JL; Thau-Zuchman, O; Davies, M; Foster, J; Khan, I; Vadivelu, KC; Yip, PK; Sosabowski, J; Trigg, W; Michael-Titus, AT				Tremoleda, J. L.; Thau-Zuchman, O.; Davies, M.; Foster, J.; Khan, I.; Vadivelu, K. C.; Yip, P. K.; Sosabowski, J.; Trigg, W.; Michael-Titus, A. T.			In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [F-18]GE-180 and effect of docosahexaenoic acid	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Spinal cord injury; Neuroinflammatory respone; [F-18]GE-180; Ratmodel; Docosahexaenoic acid	POSITRON-EMISSION-TOMOGRAPHY; PROTEIN 18 KDA; TRANSLOCATOR PROTEIN; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; BRAIN; MODEL; MACROPHAGES; NEUROPROTECTION; RADIOTRACER	Purpose Traumatic spinal cord injury (SCI) is a devastating condition which affects millions of people worldwide causing major disability and substantial socioeconomic burden. There are currently no effective treatments. Modulating the neuroinflammatory (NI) response after SCI has evolved as a major therapeutic strategy. PET can be used to detect the upregulation of the 18-kDa translocator protein (TSPO), a hallmark of activated microglia in the CNS. We investigated whether PET imaging using the novel TSPO tracer [F-18]GE-180 can be used as a clinically relevant biomarker for NI in a contusion SCI rat model, and we present data on the modulation of NI by the lipid docosahexaenoic acid (DHA). Methods A total of 22 adult male Wistar ratswere subjected to controlled spinal cord contusion at the T10 spinal cord level. Six non-injured and ten T10 laminectomy only (LAM) animals were used as controls. A subset of six SCI animals were treated with a single intravenous dose of 250 nmol/ kg DHA (SCI-DHA group) 30 min after injury; a saline-injected group of six animals was used as an injection control. PET and CT imaging was carried out 7 days after injury using the [F-18]GE-180 radiotracer. After imaging, the animals were killed and the spinal cord dissected out for biodistribution and autoradiography studies. In vivo data were correlated with ex vivo immunohistochemistry for TSPO. Results In vivo dynamic PET imaging revealed an increase in tracer uptake in the spinal cord of the SCI animals compared with the non-injured and LAM animals from 35 min after injection (P < 0.0001; SCI vs. LAM vs. non-injured). Biodistribution and autoradiography studies confirmed the high affinity and specific [F-18] GE-180 binding in the injured spinal cord compared with the binding in the control groups. Furthermore, they also showed decreased tracer uptake in the T10 SCI area in relation to the non-injured remainder of the spinal cord in the SCI-DHA group compared with the SCIsaline group (P< 0.05), supporting a NI modulatory effect of DHA. Immunohistochemistry showed a high level of TSPO expression (38 %) at the T10 injury site in SCI animals compared with that in the non-injured animals (6 %). Conclusion [F-18] GE-180 PET imaging can reveal areas of increased TSPO expression that can be visualized and quantified in vivo after SCI, offering a minimally invasive approach to the monitoring of NI in SCI models and providing a translatable clinical readout for the testing of new therapies.	[Tremoleda, J. L.; Thau-Zuchman, O.; Davies, M.; Vadivelu, K. C.; Yip, P. K.; Michael-Titus, A. T.] Blizard Inst, Ctr Trauma Sci, London, England; [Foster, J.; Sosabowski, J.] Queen Mary Univ London, Barts Canc Inst, London, England; [Khan, I.; Trigg, W.] GE Healthcare Ltd, Amersham, England	Tremoleda, JL (corresponding author), Blizard Inst, Ctr Trauma Sci, London, England.	j.lopez-tremoleda@qmul.ac.uk		Trigg, William/0000-0003-4046-0813; Thau-Zuchman, Orli/0000-0003-0403-7962	Centre for Trauma Sciences - Barts & The London Charity; GE Healthcare Ltd; Blizard Institute; Imaging Centre at the Barts Cancer Institute	This work was supported by the Centre for Trauma Sciences, funded by the Barts & The London Charity, GE Healthcare Ltd, the Experimental Medicine Awards from the Blizard Institute and the Imaging Centre at the Barts Cancer Institute.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Airas L, 2015, J NUCL MED, V56, P305, DOI 10.2967/jnumed.114.149955; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Boutin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056441; Bowes AL, 2014, J NEUROTRAUM, V31, P1753, DOI 10.1089/neu.2014.3429; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Cruz CD, 2015, ADV DRUG DELIVER REV, V82-83, P153, DOI 10.1016/j.addr.2014.11.007; Dickens AM, 2014, J NUCL MED, V55, P466, DOI 10.2967/jnumed.113.125625; Faria DD, 2014, J NUCL MED, V55, P1330, DOI 10.2967/jnumed.114.137216; Fehlings MG, 2011, J NEUROTRAUM, V28, P1329, DOI 10.1089/neu.2011.1955; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Imaizumi M, 2008, NEUROIMAGE, V39, P1289, DOI 10.1016/j.neuroimage.2007.09.063; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P1770, DOI 10.1016/j.apmr.2011.05.024; Krishna V, 2013, JOVE-J VIS EXP, DOI 10.3791/50111; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Larochelle A, 2016, BBA-MOL BASIS DIS, V1862, P310, DOI 10.1016/j.bbadis.2015.09.017; Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015; Liu B, 2015, J NEUROSCI, V35, P15716, DOI 10.1523/JNEUROSCI.0996-15.2015; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu HL, 2010, J CEREBR BLOOD F MET, V30, P177, DOI 10.1038/jcbfm.2009.179; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Marquardt G, 2009, NEUROL RES, V31, P265, DOI 10.1179/174313209X382287; Nariai Tadashi, 2013, Acta Neurochir Suppl, V118, P251, DOI 10.1007/978-3-7091-1434-6_47; O'Brien ER, 2014, J NUCL MED, V55, P275, DOI 10.2967/jnumed.113.127449; Ostuni MA, 2009, BIOL CELL, V101, P573, DOI 10.1042/BC20080231; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-6; Pottier G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4508; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Su ZJ, 2015, J NUCL MED, V56, P512, DOI 10.2967/jnumed.114.151621; Takano A, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-30; Tewarie RDSN, 2010, MOL IMAGING, V9, P108, DOI 10.2310/7290.2010.00011; Varley J, 2015, ALZHEIMERS DEMENT, V11, P1110, DOI 10.1016/j.jalz.2014.08.105; Venneti S, 2013, GLIA, V61, P10, DOI 10.1002/glia.22357; Wadsworth H, 2012, BIOORG MED CHEM LETT, V22, P1308, DOI 10.1016/j.bmcl.2011.12.084; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Wickstrom T, 2014, J LABELLED COMPD RAD, V57, P42, DOI 10.1002/jlcr.3112; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457	54	16	16	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	AUG	2016	43	9					1710	1722		10.1007/s00259-016-3391-8			13	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	DQ2FK	WOS:000379017500017	27154521	Green Published, Other Gold			2021-06-18	
J	Kurz, JE; Poloyac, SM; Abend, NS; Fabio, A; Bell, MJ; Wainwright, MS				Kurz, Jonathan E.; Poloyac, Samuel M.; Abend, Nicholas S.; Fabio, Anthony; Bell, Michael J.; Wainwright, Mark S.		Investigators Approaches	Variation in Anticonvulsant Selection and Electroencephalographic Monitoring Following Severe Traumatic Brain Injury in Children-Understanding Resource Availability in Sites Participating in a Comparative Effectiveness Study	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						anticonvulsant; electroencephalography; neurological monitoring; pediatric neurocritical care; traumatic brain injury	CRITICALLY-ILL CHILDREN; POSTTRAUMATIC SEIZURES; ELECTROGRAPHIC SEIZURES; STATUS EPILEPTICUS; HEAD TRAUMA; LEVETIRACETAM; PROPHYLAXIS; PHENYTOIN; PREDICTORS; MANAGEMENT	Objectives: Early posttraumatic seizures may contribute to worsened outcomes after traumatic brain injury. Evidence to guide the evaluation and management of early posttraumatic seizures in children is limited. We undertook a survey of current practices of continuous electroencephalographic monitoring, seizure prophylaxis, and the management of early posttraumatic seizures to provide essential information for trial design and the development of posttraumatic seizure management pathways. Design: Surveys were sent to site principal investigators at all 43 sites participating in the Approaches and Decisions in Acute Pediatric TBI trial at the time of the survey. Surveys consisted of 12 questions addressing strategies to 1) implement continuous electroencephalographic monitoring, 2) posttraumatic seizure prophylaxis, 3) treat acute posttraumatic seizures, 4) treat status epilepticus and refractory status epilepticus, and 5) monitor antiseizure drug levels. Setting: Institutions comprised a mixture of free-standing children's hospitals and university medical centers across the United States and Europe. Subjects: Site principal investigators of the Approaches and Decisions in Acute Pediatric TBI trial. Interventions: None. Measurements and Main Results: Continuous electroencephalographic monitoring was available in the PICU in the overwhelming majority of clinical sites (98%); however, the plans to operationalize such monitoring for children varied considerably. A similar majority of sites report that administration of prophylactic antiseizure medications is anticipated in children (93%); yet, a minority reports that a specified protocol for treatment of posttraumatic seizures is in place (43%). Reported medication choices varied substantially between sites, but the majority of sites reported pentobarbital for refractory status epilepticus (81%). The presence of treatment protocols for seizure prophylaxis, early posttraumatic seizures, posttraumatic status epilepticus, and refractory status epilepticus was associated with decreased reported medications (all p < 0.05). Conclusions: This study reports the current management practices for early posttraumatic seizures in select academic centers after pediatric severe traumatic brain injury. The substantial variation in continuous electroencephalographic monitoring implementation, choice of seizure prophylaxis medications, and management of early posttraumatic seizures across institutions was reported, signifying the areas of clinical uncertainty that will help provide focused design of clinical trials. Although sites with treatment protocols reported a decreased number of medications for the scenarios described, completion of the Approaches and Decisions in Acute Pediatric TBI trial will be able to determine if these protocols lead to decreased variability in medication administration in children at the clinical sites.	[Kurz, Jonathan E.; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Poloyac, Samuel M.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Abend, Nicholas S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Fabio, Anthony] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA	Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA.	bellmj4@upmc.edu		Fabio, Anthony/0000-0002-6808-4939; Figaji, Anthony/0000-0002-3357-6490; Bennett, Tellen/0000-0003-1483-4236; Kurz, Jonathan/0000-0002-2259-4263	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 081041]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041] Funding Source: NIH RePORTER; Great Ormond Street Hospital Childrens Charity [V2216] Funding Source: researchfish	Dr. Bell received support for article research from the National Institutes of Health (NIH). His institution received funding from National Institute of Neurological Disorders and Stroke - NS 081041. Dr. Abend received support for article research from the NIH. Dr. Fabio received support for article research from the NIH. His institution received funding from the NIH. Dr. Wainwright received support for article research from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Bansal S, 2014, J NEUROSURG-PEDIATR, V13, P209, DOI 10.3171/2013.10.PEDS13256; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cook AM, 2012, NEUROCRIT CARE, V17, P24, DOI 10.1007/s12028-012-9711-3; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kernic MA, 2013, J NEUROTRAUM, V30, P1129, DOI 10.1089/neu.2012.2716; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kruessell MA, 2012, PEDIATR CRIT CARE ME, V13, pE150, DOI 10.1097/PCC.0b013e3182388a95; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Newey CR, 2013, NEUROCRIT CARE, V18, P261, DOI 10.1007/s12028-011-9650-4; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	34	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2016	17	7					649	657		10.1097/PCC.0000000000000765			9	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	DR0LV	WOS:000379599900011	27243415	Green Accepted			2021-06-18	
J	Rumrill, P; Wehman, P; Cimera, R; Kaya, C; Dillard, C; Chan, F				Rumrill, Phillip; Wehman, Paul; Cimera, Robert; Kaya, Cahit; Dillard, Chad; Chan, Fong			Vocational Rehabilitation Services and Outcomes for Transition-Age Youth With Traumatic Brain Injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						transition-age youth; traumatic brain injuries; vocational rehabilitation	EMPLOYMENT OUTCOMES; PREDICTORS; ADULTS; WORK	Objective: This study examined data provided by the US Department of Education's Rehabilitation Services Administration (RSA) in an effort to evaluate the relationship between (a) demographic variables and vocational rehabilitation (VR) services and (b) the employment outcomes of transition-age youth with traumatic brain injuries. Setting: Not applicable. Participants: Data for 1546 transition-age youth (ie, 16-25 years of age) with traumatic brain injuries were examined. Design: Purposeful selection of multivariate logistic regression was employed to analyze the data. Main Measures: Not applicable. Results: Receipt of more VR services at higher expenditure levels over shorter periods of time was related to case closure in successful competitive employment status. Also, higher levels of education at the time of enrollment in the VR program (ie, bachelor's degrees or higher); nonreceipt of social security disability benefits at the time of enrollment in the VR program; and receipt of VR services such as occupational/vocational training, job search, job placement, on-the-job support, maintenance, and information/referral were associated with competitive employment outcomes. Conclusion: Client demographic and VR service-related variables significantly predict competitive employment outcomes for transition-age youth with traumatic brain injuries. Vocational rehabilitation services should focus on the specific interventions that are most closely associated with successful rehabilitation.	[Rumrill, Phillip; Cimera, Robert] Kent State Univ, Ctr Disabil Studies, 413 White Hall,150 Terrace Dr, Kent, OH 44242 USA; [Wehman, Paul; Dillard, Chad] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Kaya, Cahit; Chan, Fong] Univ Wisconsin, Dept Rehabil Psychol & Special Educ, Madison, WI 53706 USA	Rumrill, P (corresponding author), Kent State Univ, Dept Rehabil Counseling, 413 White Hall,150 Terrace Dr, Kent, OH 44242 USA.	prumrill@kent.edu	kaya, cahit/Q-6568-2018	kaya, cahit/0000-0003-0757-320X	United States Department of EducationUS Department of Education; NIDRR [H133A130066, H133A100007]	The contents of this article were developed under 2 grants from the United States Department of Education, NIDRR grant #H133A130066 and NIDRR grant #H133A100007. However, those contents do not necessarily represent the policy of the Department of Education, and readers should not assume endorsement by the Federal Government.	Ashman TA, 2006, MT SINAI J MED, V73, P999; Brown J, 2013, IOWA NOW; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Carter EW, 2011, INTELLECT DEV DISAB, V49, P233, DOI 10.1352/1934-9556-49.4.233; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chiu CY, 2013, MULT SCLER J, V19, P1655, DOI 10.1177/1352458513482372; Cimera RE, 2013, RES PRACT PERS SEV D, V38, P88, DOI 10.2511/027494813807714474; Ditchman N., 2013, CAREER DEV EMPLOYMEN, P343; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gamble D, 2003, J VOCATIONAL REHABIL, V19, P19; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Graham CW, 2014, CAMPBELL SYSTEMATIC; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; JOHNSTONE B, 1994, J CLIN PSYCHOL MED S, V1, P375, DOI 10.1007/BF01991080; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Marini Irmo, 2003, Work, V21, P37; National Association of State Head Injury Administrators, 2006, TRAUM BRAIN INJ FACT; Rumrill P., 2014, AM PSYCHOL ASS HDB C, P139; Siperstein GN, 2014, J VOCAT REHABIL, V41, P165, DOI 10.3233/JVR-140711; Stock S., 2006, EMPLOYMENT PERSONS B; Strauser D., 2013, CAREER DEV EMPLOYMEN; SUPER DE, 1980, J VOCAT BEHAV, V16, P282, DOI 10.1016/0001-8791(80)90056-1; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Toriello P., 2012, NEW DIRECTIONS REHAB; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wehman P., 2013, LIFE CLASSROOM; Wehman P., J POSTSECON IN PRESS; Wehman P, 2015, J OCCUP REHABIL, V25, P323, DOI 10.1007/s10926-014-9541-6; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029	32	16	16	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					288	295		10.1097/HTR.0000000000000186			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000014	26360004				2021-06-18	
J	Schiff, ND				Schiff, Nicholas D.			Central thalamic deep brain stimulation to support anterior forebrain mesocircuit function in the severely injured brain	JOURNAL OF NEURAL TRANSMISSION			English	Article						Mesocircuit; Severe-to-moderate traumatic brain injury; Consciousness; Intralaminar nuclei; Executive function impairment	STATISTICAL IMAGE-ANALYSIS; ELECTRICAL-STIMULATION; AROUSAL REGULATION; MECHANISMS; CONSCIOUSNESS; ORGANIZATION; SYSTEM; NUCLEI; STATE; NEUROMODULATION	This integrative review frames a general rationale for the use of central thalamic deep brain stimulation (CT-DBS) to support arousal regulation mechanisms in the severely injured brain. The organizing role of the anterior forebrain mesocircuit in recovery mechanisms following widespread deafferentation produced by multi-focal structural brain injuries is emphasized. The mesocircuit model provides the conceptual foundation for the key role of the central thalamus as a privileged node for neuromodulation to support forebrain arousal regulation. In this context, cellular mechanisms arising at the neocortical, striatal, and thalamic population level are considered in the assessment of an individual patient's capacity for harboring underlying reserve that could be recruited for further recovery. Recent preclinical studies and pilot clinical results are compared to frame the detailed rationale for CT-DBS. Application of CT-DBS across the range of outcomes following severe-to-moderate brain injuries is discussed with the aim of improving consciousness and cognition in patients with non-progressive brain injuries.	[Schiff, Nicholas D.] Weill Cornell Med Coll, Lab Cognit Neuromodulat, Neurol & Neurosci, 1300 York Ave, New York, NY 10065 USA	Schiff, ND (corresponding author), Weill Cornell Med Coll, Lab Cognit Neuromodulat, Neurol & Neurosci, 1300 York Ave, New York, NY 10065 USA.	nds2001@med.cornell.edu					Baker JL, 2012, SOC NEUR ABSTR, V597, P14; Baker JL, 2011, SOC NEUR ABSTR, V197, P26; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Chatelle C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00917; COHADON F, 1985, NEUROSTIMULATION OVE; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; DELIAC P, 1993, NEUROCHIRURGIE, V39, P293; Deschenes M, 1996, NEUROSCIENCE, V72, P679, DOI 10.1016/0306-4522(96)00001-2; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ellender TJ, 2013, J PHYSIOL-LONDON, V591, P257, DOI 10.1113/jphysiol.2012.245233; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Fridman EA, 2014, CURR OPIN NEUROBIOL, V29, P172, DOI 10.1016/j.conb.2014.09.008; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; Hosobuchi Y, 1993, Adv Neurol, V63, P247; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu J, 2015, ELIFE, V4, DOI 10.7554/eLife.09215; Mair RG, 2011, DOSE-RESPONSE, V9, P313, DOI 10.2203/dose-response.10-017.Mair; Mair RG, 2008, J NEUROSCI, V28, P14293, DOI 10.1523/JNEUROSCI.3301-08.2008; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; McLardy T, 1968, Trans Am Neurol Assoc, V93, P25; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Narayanan NS, 2009, J NEUROPHYSIOL, V101, P2859, DOI 10.1152/jn.90615.2008; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Quinkert AW, 2012, BEHAV BRAIN RES, V229, P349, DOI 10.1016/j.bbr.2012.01.025; Quinkert AW, 2010, BEHAV BRAIN RES, V214, P377, DOI 10.1016/j.bbr.2010.06.009; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2013, J NEUROPHYSIOL, V109, P1152, DOI 10.1152/jn.00317.2011; Schiff ND, 2016, BRAIN FUNCTION RESPO, DOI [10.1007/978-3-319-21425-2_15, DOI 10.1007/978-3-319-21425-2_15]; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2012, ANN NY ACAD SCI, V1265, P56, DOI 10.1111/j.1749-6632.2012.06712.x; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Shah SA, 2010, EUR J NEUROSCI, V32, P1135, DOI 10.1111/j.1460-9568.2010.07420.x; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Smith AC, 2009, J NEUROSCI METH, V183, P267, DOI 10.1016/j.jneumeth.2009.06.028; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969; Steriade M, 1997, THALAMUS; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; Stuss D.T., 2013, PRINCIPLES FRONTAL L; Tabansky I, 2014, BEHAV BRAIN RES, V273, P123, DOI 10.1016/j.bbr.2014.07.026; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Tsubokawa T, 1990, Brain Inj, V4, P315; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	57	16	18	1	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	JUL	2016	123	7			SI		797	806		10.1007/s00702-016-1547-0			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DQ1XA	WOS:000378992700013	27113938				2021-06-18	
J	Xiong, C; Martin, T; Sravanapudi, A; Colantonio, A; Mollayeva, T				Xiong, Chen; Martin, Tickalyn; Sravanapudi, Aneesha; Colantonio, Angela; Mollayeva, Tatyana			Factors associated with return to work in men and women with work-related traumatic brain injury	DISABILITY AND HEALTH JOURNAL			English	Article						Occupational injury; Head trauma; Sex differences; Occupational outcomes	GENDER-DIFFERENCES; MILD; PREDICTION; MODERATE; HOSPITALIZATION; MULTICENTER; VARIABLES; TBI	Background: Symptoms that persist subsequent to a work-related traumatic brain injury (wrTBI) influence the ability to return to work (RTW) and indicate areas of functional disability, as classified in the International Classification of Functioning, Disability and Health (ICF) framework. Objective: The purpose of this study was to describe the relationship between RTW status and ICF framework domains in men and women with a wrTBI. Methods: A retrospective chart review of 209 consecutive workers with TBI (mild TBI: 71.8%; mean age: 40.2 +/- 11.1, men: 71.3%) was conducted. Workers were assessed during the chronic post-injury phase, at the neurology service of a large rehabilitation hospital in Ontario, Canada in 2003. Frequency distributions were calculated and chi-square tests performed. Results: At the point of assessment, 78.0% of workers were in receipt of disability benefits, while the remainder had returned to work on a full-or part-time basis. Significant differences were observed in the Body Functions and Structures domain of the ICF model, specifically clinical diagnoses of depression, anxiety, pain disorders; self-perceived cognitive disturbance, and certain psychosocial factors (p < 0.05), between workers who had returned to work and those who had not. When stratified according to sex, these associations remained significant only in men. Conclusions: The factors outlined above should be subject to further TBI research, as indicators for RTW. The lack of significant findings in women warrants further exploration of variables within the physical and social environmental domains of the ICF. (C) 2015 Elsevier Inc. All rights reserved.	[Xiong, Chen; Colantonio, Angela; Mollayeva, Tatyana] Univ Toronto, Rehabil Sci Inst, Rehabil Sci Bldg,500 Univ Ave,Room 260, Toronto, ON M5G 1V7, Canada; [Martin, Tickalyn; Sravanapudi, Aneesha; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela; Mollayeva, Tatyana] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	Xiong, C (corresponding author), Univ Toronto, Rehabil Sci Inst, Rehabil Sci Bldg,500 Univ Ave,Room 260, Toronto, ON M5G 1V7, Canada.	chen.xiong@mail.utoronto.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Tatyana/0000-0002-2787-1848	Frederick Banting and Charles Best Graduate Scholarship from the Canadian Institutes of Health Research; Frederick Banting and Charles Best Doctoral Research Award; Work Disability Prevention Fellowship from the Canadian Institutes of Health Research; Saunderson Family Chair in Acquired Brain Injury Research; Canadian Institutes for Health Research Grant - Institute for Gender and Health [CGW-126580]	Role of the funding source: Our study had no external funding source. Chen Xiong was supported by the 2015/2016 Frederick Banting and Charles Best Graduate Scholarship from the Canadian Institutes of Health Research. Tatyana Mollayeva was supported by the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award and the Work Disability Prevention Fellowship from the Canadian Institutes of Health Research. Angela Colantonio was supported by the Saunderson Family Chair in Acquired Brain Injury Research and the Canadian Institutes for Health Research Grant - Institute for Gender and Health (#CGW-126580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bootes Kylie, 2002, Work, V19, P255; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FRASER RT, 1994, TOP LANG DISORD, V15, P55, DOI 10.1097/00011363-199411000-00006; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Health Canada, 2010, HLTH PORTF SEX GEND; Hoefsmit N, 2014, WORK, V48, P203, DOI 10.3233/WOR-131657; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kim H, 2006, NEUROREHABILITATION, V21, P269; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Workplace Safety Insurance Board of Ontario, 2013, NUMB 2012 WSIB STAT; World Health Organization ( WHO ), 2002, COMM LANG FUNCT DIS; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	40	16	16	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JUL	2016	9	3					439	448		10.1016/j.dhjo.2015.12.002			10	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	DN9RP	WOS:000377418100011	26817582				2021-06-18	
J	Cheng, TA; Bell, JM; Haileyesus, T; Gilchrist, J; Sugerman, DE; Coronado, VG				Cheng, Tabitha A.; Bell, Jeneita M.; Haileyesus, Tadesse; Gilchrist, Julie; Sugerman, David E.; Coronado, Victor G.			Nonfatal Playground-Related Traumatic Brain Injuries Among Children, 2001-2013	PEDIATRICS			English	Article							UNITED-STATES; EQUIPMENT; PROGRAM; SPORTS; TRENDS; NEISS	OBJECTIVE: To describe the circumstances, characteristics, and trends of emergency department (ED) visits for nonfatal, playground-related traumatic brain injury (TBI) among persons aged <= 14 years. METHODS: The National Electronic Injury Surveillance System-All Injury Program from January 1, 2001, through December 31, 2013, was examined. US Census bridged-race population estimates were used as the denominator to compute rates per 100000 population. SAS and Joinpoint linear weighted regression analyses were used to analyze the best-fitting join-point and the annual modeled rate change. These models were used to indicate the magnitude and direction of rate trends for each segment or period. RESULTS: During the study period, an annual average of 21101 persons aged <= 14 years were treated in EDs for playground-related TBI. The ED visit rate for boys was 39.7 per 100000 and 53.5 for persons aged 5-9 years. Overall, 95.6% were treated and released, 33.5% occurred at places of recreation or sports, and 32.5% occurred at school. Monkey bars or playground gyms (28.3%) and swings (28.1%) were the most frequently associated with TBI, but equipment involvement varied by age group. The annual rate of TBI ED visits increased significantly from 2005 to 2013 (P < .05). CONCLUSIONS: Playgrounds remain an important location of injury risk to children. Strategies to reduce the incidence and severity of playground-related TBIs are needed. These may include improved adult supervision, methods to reduce child risk behavior, regular equipment maintenance, and improvements in playground surfaces and environments.	[Cheng, Tabitha A.; Bell, Jeneita M.; Gilchrist, Julie; Sugerman, David E.; Coronado, Victor G.] Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA USA; [Cheng, Tabitha A.] Ctr Dis Control & Prevent, CDC Experience Appl Epidemiol Fellowship, Div Sci Educ & Profess Dev, Natl Ctr Injury Prevent, Atlanta, GA USA; [Haileyesus, Tadesse] Ctr Dis Control & Prevent, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent, Atlanta, GA USA	Cheng, TA (corresponding author), UCLA Emergency Med, 924 Westwood Blvd,Ste 300, Los Angeles, CA 90095 USA.	tacheng@mednet.ucla.edu			External Medical Affairs, Pfizer Inc.Pfizer	The CDC Experience is a 1-year fellowship in applied epidemiology at the Centers for Disease Control and Prevention made possible by a public/private partnership supported by a grant to the Centers for Disease Control and Prevention Foundation from External Medical Affairs, Pfizer Inc.	American Society for Testing and Materials International, F148711 ASTM; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; [Anonymous], F129299 ASTM; [Anonymous], 2015, NEISS NAT EL INJ SUR; Centers for Disease Control and Prevention, HEADS UP CONC; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Frost J., 2004, DEV BENEFITS PLAYGRO; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; ILLINGWORTH C, 1975, BRIT MED J, V4, P332, DOI 10.1136/bmj.4.5992.332; Loder RT, 2008, J PEDIATR SURG, V43, P691, DOI 10.1016/j.jpedsurg.2007.12.061; Mack MG, 1997, INJURY PREV, V3, P100; Morrongiello BA, 2013, LIFESTYLE MEDICINE, 2ND EDITION, P1473; Morrongiello BA, 2015, PREV SCI, V16, P61, DOI 10.1007/s11121-014-0484-0; National Center for Health Statistics, US CENS POP BRIDG RA; Norton C, 2004, ARCH DIS CHILD, V89, P103, DOI 10.1136/adc.2002.013045; Phelan KJ, 2001, AMBUL PEDIATR, V1, P227, DOI 10.1367/1539-4409(2001)001<0227:TAPOPI>2.0.CO;2; Rivara FP, 2011, PEDIATRICS, V128; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; RIVERS RPA, 1978, COMMUNITY HEALTH, V9, P178; Taylor HG., 2006, EXCEPTIONALITY, V14, P141, DOI [10.1207/s15327035ex1403_3, DOI 10.1207/S15327035EX1403_3, DOI 10.1207/S15327035EX1403_]; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; U. S. Consumer Product Safety Commission, 2016, NEISS NAT EL INJ SUR; United States Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; US Consumer Product Safety Commission, 2015, PUBL PLAYGR SAF HDB; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	27	16	16	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2016	137	6							e20152721	10.1542/peds.2015-2721			9	Pediatrics	Pediatrics	DP5EZ	WOS:000378520100011	27244845	Green Accepted, Bronze			2021-06-18	
J	Jang, SH; Park, SM; Kwon, HG				Jang, Sung Ho; Park, So Min; Kwon, Hyeok Gyu			Relation between injury of the periaqueductal gray and central pain in patients with mild traumatic brain injury: Observational study	MEDICINE			English	Article						central pain; diffusion tensor imaging; mild traumatic brain injury; periaqueductal gray	CENTRAL POSTSTROKE PAIN; NEUROPATHIC PAIN; SENSORY ABNORMALITIES; AXONAL INJURY; MECHANISMS; TRACTOGRAPHY; STIMULATION; MANAGEMENT; MIDBRAIN; MATTER	The periaqueductal gray (PAG) plays a pivotal role in pain modulation. We attempted to examine the relation between injury of the PAG and central pain in patients with mild traumatic brain injury (TBI).Sixty-one patients with mild TBI with central pain and 31 healthy control subjects were recruited for this study. Visual analog scale (VAS) was used for evaluation of central pain. The region of interest was defined for the PAG and the fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were measured.The FA value was significantly lower in the patient group than in the control group (P<0.05). However, no significant difference in the ADC value was observed between the patient and control groups (P>0.05). VAS score of the patient group showed significant moderate negative correlation with the FA (r = -0.38), while no significant correlation was observed between VAS score and the ADC value (P<0.05).We demonstrated injury of the PAG in patients with central pain following mild TBI and the degree of injury of the PAG was closely related to the degree of central pain.	[Jang, Sung Ho; Park, So Min; Kwon, Hyeok Gyu] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Daegu 705717, South Korea	Kwon, HG (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Daegu 705717, South Korea.	khg0715@hanmail.net			Medical Research Center Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Ab Aziz CB, 2006, MALAYS J MED SCI, V13, P11; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barad M., 2009, CONTINUUM MINNEAP MI, V15, P30, DOI 10.1212/01.con.0000348853.20265.b7; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; CESARO P, 1991, PAIN, V47, P329, DOI 10.1016/0304-3959(91)90224-L; DaSilva AFM, 2007, NEUROREPORT, V18, P301, DOI 10.1097/WNR.0b013e32801776bb; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Ezra M, 2015, HUM BRAIN MAPP, V36, P3459, DOI 10.1002/hbm.22855; Hoskin KL, 2001, J ANAT, V198, P29, DOI 10.1046/j.1469-7580.2001.19810029.x; Ito K, 2016, NEURORADIOLOGY, V58, P115, DOI 10.1007/s00234-015-1603-8; Jang SH, 2016, BRAIN INJ; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lee SK, 2005, RADIOGRAPHICS, V25, P68; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Merskey H, 1994, CLASSIFICATION CHRON; Miller M D, 1993, Fam Pract Res J, V13, P15; NASHOLD BS, 1969, J NEUROSURG, V30, P14, DOI 10.3171/jns.1969.30.1.0014; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Owen SLF, 2006, PAIN, V120, P202, DOI 10.1016/j.pain.2005.09.035; Petrovic P, 1999, PAIN, V83, P459, DOI 10.1016/S0304-3959(99)00150-5; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Satpute AB, 2013, P NATL ACAD SCI USA, V110, P17101, DOI 10.1073/pnas.1306095110; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Topolovec JC, 2004, J COMP NEUROL, V471, P446, DOI 10.1002/cne.20033; VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	45	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JUN	2016	95	26							e4017	10.1097/MD.0000000000004017			4	Medicine, General & Internal	General & Internal Medicine	DS1PV	WOS:000380369300046	27368020	DOAJ Gold, Green Published			2021-06-18	
J	Jimenez, N; Symons, RG; Wang, J; Ebel, BH; Vavilala, MS; Buchwald, D; Temkin, N; Jaffe, KM; Rivara, FP				Jimenez, Nathalia; Symons, Rebecca G.; Wang, Jin; Ebel, Beth H.; Vavilala, Monica S.; Buchwald, Dedra; Temkin, Nancy; Jaffe, Kenneth M.; Rivara, Frederick P.			Outpatient Rehabilitation for Medicaid-Insured Children Hospitalized With Traumatic Brain Injury	PEDIATRICS			English	Article							OUTCOMES; INSURANCE; CARE; AVAILABILITY; STATES	OBJECTIVES: To describe the prevalence of postdischarge outpatient rehabilitation among Medicaid-insured children hospitalized with a traumatic brain injury (TBI) and to identify factors associated with receipt of services. METHODS: Retrospective cohort of children <21 years, hospitalized for a TBI between 2007 and 2012, from a national Medicaid claims database. Outcome measures were receipt of outpatient rehabilitation (physical, occupational, or speech therapies or physician visits to a rehabilitation provider) 1 and 3 years after discharge. Multivariable regression analyses determined the association of demographic variables, injury severity, and receipt of inpatient services with receipt of outpatient rehabilitation at 1 and 3 years. The mean number of services was compared between racial/ethnic groups. RESULTS: Among 9361 children, only 29% received any type of outpatient rehabilitation therapy during the first year after injury, although 62% sustained a moderate to severe TBI. The proportion of children receiving outpatient therapies declined to 12% in the second and third years. The most important predictor of receipt of outpatient rehabilitation was receipt of inpatient therapies or consultation with a rehabilitation physician during acute care. Compared with children of other racial/ethnic groups, Hispanic children had lower rates of receipt of outpatient speech therapy. CONCLUSIONS: Hospitalized children who received inpatient assessment of rehabilitation needs were more likely to continue outpatient rehabilitation care. Hispanic children with TBI were less likely than non-Hispanics to receive speech therapy. Interventions to increase inpatient rehabilitation during acute care might increase outpatient rehabilitation and improve outcomes for all children.	[Jimenez, Nathalia; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Jimenez, Nathalia; Symons, Rebecca G.; Wang, Jin; Ebel, Beth H.; Vavilala, Monica S.; Jaffe, Kenneth M.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Ebel, Beth H.; Vavilala, Monica S.; Jaffe, Kenneth M.; Rivara, Frederick P.] Univ Washington, Pediat, Seattle, WA 98195 USA; [Ebel, Beth H.; Rivara, Frederick P.] Univ Washington, Epidemiol, Seattle, WA 98195 USA; [Buchwald, Dedra] Univ Washington, Ctr Clin & Epidemiol Res, Seattle, WA 98195 USA; [Temkin, Nancy; Jaffe, Kenneth M.] Univ Washington, Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Biostat, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Rehabil Med, Seattle, WA 98195 USA	Jimenez, N (corresponding author), Dept Anesthesiol & Pain Med, Box 9824,4800 Sand Point Way NE, Seattle, WA 98105 USA.	nathalia.jimenez@seattlechildrens.org		Jimenez, Nathalia/0000-0002-6785-8330	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD078453-01]; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention grant [R49 CE 001021]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development (grant 1K23HD078453-01 to Dr Jimenez) and National Center for Injury Prevention and Control, Centers for Disease Control and Prevention grant R49 CE 001021. Funded by the National Institutes of Health (NIH).	Adams PF, 2013, VITAL HLTH STAT SERI, V10; Bennett TD, ARCH PHYS MED REHABI; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, ARCH PHYS MED REHABI; Clark DE, 2009, STAT SOFTWARE COMPON; Decker SL, 2015, HEALTH SERV RES, V50, P1508, DOI 10.1111/1475-6773.12288; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Fairbrother G, 2011, ACAD PEDIATR, V11, P318, DOI 10.1016/j.acap.2011.05.004; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Sommers BD, 2005, HEALTH SERV RES, V40, P59, DOI 10.1111/j.1475-6773.2005.00342.x; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	22	16	16	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2016	137	6							e20153500	10.1542/peds.2015-3500			9	Pediatrics	Pediatrics	DP5EZ	WOS:000378520100022	27244850	Green Published, Green Accepted, Bronze			2021-06-18	
J	Larson, MJ; Clayson, PE; Kirwan, CB; Weissman, DH				Larson, Michael J.; Clayson, Peter E.; Kirwan, C. Brock; Weissman, Daniel H.			Event-related potential indices of congruency sequence effects without feature integration or contingency learning confounds	PSYCHOPHYSIOLOGY			English	Article						Conflict adaptation; Congruency sequence effects; Gratton effect; N450; Conflict SP; Event-related potential; ERP	ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL ADJUSTMENTS; TRAUMATIC BRAIN-INJURY; CONFLICT ADAPTATION; STROOP TASK; SIMON TASK; PROPORTION CONGRUENT; PREFRONTAL CORTEX; TIME-COURSE; INTERFERENCE	The congruency effect in Stroop-like tasks (i.e., increased response time and reduced accuracy in incongruent relative to congruent trials) is often smaller when the previous trial was incongruent as compared to congruent. This congruency sequence effect (CSE) is thought to reflect cognitive control processes that shift attention to the target and/or modulate the response engendered by the distracter differently after incongruent relative to congruent trials. The neural signatures of CSEs are therefore usually attributed to cognitive control processes that minimize distraction from irrelevant stimuli. However, CSEs in previous functional neuroimaging studies were ubiquitously confounded with feature integration and/or contingency learning processes. We therefore investigated whether a neural CSE can be observed without such confounds in a group of healthy young adults (n=56). To this end, we combined a prime-probe task that lacks such confounds with high-density ERPs to identify, for the first time, the neural time course of confound-minimized CSEs. Replicating recent behavioral findings, we observed strong CSEs in this task for mean response time and mean accuracy. Critically, conceptually replicating prior ERP results from confounded tasks, we also observed a CSE in both the parietal conflict slow potential (conflict SP) and the frontomedial N450. These findings indicate for the first time that neural CSEs as indexed by ERPs can be observed without the typical confounds. More broadly, the present study provides a confound-minimized protocol that will help future researchers to better isolate the neural bases of control processes that minimize distraction from irrelevant stimuli.	[Larson, Michael J.; Kirwan, C. Brock] Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA; [Larson, Michael J.; Kirwan, C. Brock] Brigham Young Univ, Ctr Neurosci, 244 TLRB, Provo, UT 84602 USA; [Clayson, Peter E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Weissman, Daniel H.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.; Larson, MJ (corresponding author), Brigham Young Univ, Ctr Neurosci, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Clayson, Peter E/F-5438-2011; Larson, Michael J/C-8543-2012; Kirwan, Brock/B-1520-2014	Clayson, Peter E/0000-0003-4437-6598; Larson, Michael J/0000-0002-8199-8065; Kirwan, Brock/0000-0003-0768-1446	College of Family, Home, and Social Sciences at Brigham Young University	We gratefully acknowledge Christina Catron, Katie Slinn, Whitney Badal, Tyshae Davis, Randy Beck, Travis Johnson, Nathan Killpack, and Curtis Killpack for their assistance in data collection. This study was funded in part by the College of Family, Home, and Social Sciences at Brigham Young University.	Baldwin SA, 2015, PSYCHOPHYSIOLOGY, V52, P790, DOI 10.1111/psyp.12401; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Clawson A, 2013, PSYCHOPHYSIOLOGY, V50, P711, DOI 10.1111/psyp.12066; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Compton RJ, 2012, PSYCHOPHYSIOLOGY, V49, P583, DOI 10.1111/j.1469-8986.2012.01354.x; Dien J, 2010, BRAIN RES, V1355, P126, DOI 10.1016/j.brainres.2010.07.099; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; Dreisbach G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00342; Duthoo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110462; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Freitas AL, 2015, PSYCHOL RES-PSYCH FO, V79, P143, DOI 10.1007/s00426-014-0540-1; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Huffmeijer R, 2014, PHYSIOL BEHAV, V130, P13, DOI 10.1016/j.physbeh.2014.03.008; Jimenez L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01042; Jimenez L, 2013, J EXP PSYCHOL HUMAN, V39, P271, DOI 10.1037/a0027734; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim S, 2014, ACTA PSYCHOL, V149, P60, DOI 10.1016/j.actpsy.2014.03.004; Larson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140770; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Larson MJ, 2013, BIOL PSYCHOL, V94, P408, DOI 10.1016/j.biopsycho.2013.08.006; Larson MJ, 2012, DEV NEUROPSYCHOL, V37, P343, DOI 10.1080/87565641.2011.650337; Larson MJ, 2012, J CHILD PSYCHOL PSYC, V53, P440, DOI 10.1111/j.1469-7610.2011.02498.x; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mordkoff JT, 2012, PSYCHON B REV, V19, P750, DOI 10.3758/s13423-012-0257-3; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; SCHIMMEL H, 1967, SCIENCE, V157, P92, DOI 10.1126/science.157.3784.92; Schmidt JR, 2008, J EXP PSYCHOL LEARN, V34, P514, DOI 10.1037/0278-7393.34.3.514; Schmidt JR, 2007, CONSCIOUS COGN, V16, P421, DOI 10.1016/j.concog.2006.06.010; Schmidt JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102337; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Suarez-Pellicioni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099579; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Weissman DH, 2015, ACTA PSYCHOL, V156, P8, DOI 10.1016/j.actpsy.2015.01.003; Weissman DH, 2014, J EXP PSYCHOL HUMAN, V40, P2022, DOI 10.1037/a0037454; Wendt M, 2006, J EXP PSYCHOL HUMAN, V32, P644, DOI 10.1037/0096-1523.32.3.644; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; West R, 2012, NEUROPSYCHOLOGIA, V50, P3450, DOI 10.1016/j.neuropsychologia.2012.10.011; West R, 2012, PSYCHOPHYSIOLOGY, V49, P1309, DOI 10.1111/j.1469-8986.2012.01464.x; Worsham W, 2015, AUTISM, V19, P897, DOI 10.1177/1362361314553280	66	16	17	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	JUN	2016	53	6					814	822		10.1111/psyp.12625			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	DQ1CW	WOS:000378939700006	26854028				2021-06-18	
J	Litofsky, NS; Martin, S; Diaz, J; Ge, B; Petroski, G; Miller, DC; Barnes, SL				Litofsky, N. Scott; Martin, Simon; Diaz, Jenna; Ge, Bin; Petroski, Greg; Miller, Douglas C.; Barnes, Stephen L.			The Negative Impact of Anemia in Outcome from Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Anemia; Glasgow Outcome Score; Hemoglobin; Injury Severity Score; Traumatic brain injury	BLOOD-CELL TRANSFUSION; GENDER-DIFFERENCES; HEAD-INJURY; MODERATE; OXYGENATION; MORTALITY; WORSE	BACKGROUND: Whether anemia complicating traumatic brain injury (TBI) has an impact on patient outcomes is controversial; therefore, recommendations for blood transfusions for such patients are inconsistent. We hypothesized that patient outcome after TBI would be worse in patients with lower hemoglobin levels. METHODS: We retrospectively reviewed records of patients with TBI and head Abbreviated Injury Scale >3 with abnormal head computed tomography findings and neurologic injury. The relationships between initial hemoglobin and lowest hemoglobin during hospitalization at threshold values of <= 7, <= 8, <= 9, and <= 10 g/dL were investigated relative to Glasgow Outcome Score at last follow-up not exceeding 1 year. RESULTS: Of 939 patients meeting inclusion criteria, initial and lowest hemoglobin concentrations were significant predictors of poor outcome (P < 0.0001). For each 1 g/dL higher hemoglobin value, the likelihood of a good outcome increased by 33%. More severe levels of initial anemia were associated with lower Glasgow Coma Scale, greater head Abbreviated Injury Scale, and greater Injury Severity Score (P < 0.0001). Female patients had worse outcome than male patients only for initial hemoglobin between 7 and 8 g/dL (P < 0.05). Blood transfusion was associated with poorer outcome at hemoglobin levels <= 9 and <= 10 g/dL (P < 0.05), but not at lower hemoglobin thresholds. CONCLUSIONS: Patient outcome after TBI is worse in patients with lower hemoglobin. Initial hemoglobin and lowest hemoglobin after admission are independently associated with poor outcome. Our data support consideration of blood transfusion when hemoglobin is <= 8 g/dl.	[Litofsky, N. Scott; Martin, Simon; Diaz, Jenna] Univ Missouri, Sch Med, Div Neurol Surg, Columbia, MO 65211 USA; [Ge, Bin; Petroski, Greg] Univ Missouri, Sch Med, Off Med Res, Columbia, MO USA; [Miller, Douglas C.] Univ Missouri, Sch Med, Dept Pathol, Columbia, MO 65212 USA; [Barnes, Stephen L.] Univ Missouri, Sch Med, Div Acute Care Surg, Columbia, MO USA	Litofsky, NS (corresponding author), Univ Missouri, Sch Med, Div Neurol Surg, Columbia, MO 65211 USA.	litofskyn@health.missouri.edu		Barnes, Stephen/0000-0001-6186-1435; Diaz, Jenna/0000-0002-2514-9739	Division of Neurological Surgery of the University of Missouri School of Medicine; Medical Student Summer Research Fellowship from the University of Missouri School of Medicine	Supported by research funds from Division of Neurological Surgery of the University of Missouri School of Medicine and a Medical Student Summer Research Fellowship from the University of Missouri School of Medicine for S.M.	Ariza M, 2004, J NEUROTRAUM, V21, P864, DOI 10.1089/0897715041526203; Bellapart J, 2012, J TRAUMA ACUTE CARE, V73, P997, DOI 10.1097/TA.0b013e318265cede; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Blissitt PA, 2012, AACN ADV CRIT CARE, V23, P186, DOI 10.1097/NCI.0b013e31824db4f3; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Dexter F, 2007, BRIT J ANAESTH, V79, P346; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Ekegren CL, 2016, INJURY, V47, P130, DOI 10.1016/j.injury.2015.08.002; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Ely EW, 1999, NEW ENGL J MED, V340, P467, DOI 10.1056/NEJM199902113400610; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Goodnough LT, 2003, CRIT CARE MED, V31, pS678, DOI 10.1097/01.CCM.0000100124.50579.D9; Gruenbaum SE, 2014, CURR OPIN ANESTHESIO, V27, P470, DOI 10.1097/ACO.0000000000000109; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kumar MA, 2012, NEUROTHERAPEUTICS, V9, P56, DOI 10.1007/s13311-011-0094-5; Lei C, 2012, ANESTHESIOLOGY, V117, P1190, DOI 10.1097/ALN.0b013e318272d866; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; McCrossan L, 2012, BRIT J ANAESTH, V88, P6; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Reddy GD, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0379-9; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schirmer-Mikalsen K, 2012, ACTA ANAESTH SCAND, V57, P46; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Winn HR, 2004, CRITICAL CARE MANAGE, P3411; Yang C-J, 2011, J TRAUMA, V71, P132; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	45	16	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2016	90						82	90		10.1016/j.wneu.2016.02.076			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DS1MS	WOS:000380360500012	26921698				2021-06-18	
J	Mao, WF; Yi, X; Qin, JB; Tian, ML; Jin, GH				Mao, Weifeng; Yi, Xin; Qin, Jianbing; Tian, Meiling; Jin, Guohua			CXCL12/CXCR4 Axis Improves Migration of Neuroblasts Along Corpus Callosum by Stimulating MMP-2 Secretion After Traumatic Brain Injury in Rats	NEUROCHEMICAL RESEARCH			English	Article						CXCL12; CXCR4; Migration; MMP-2; Traumatic brain injury	NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; MATRIX-METALLOPROTEINASE; ADULT NEUROGENESIS; DIRECTED MIGRATION; PROGENITOR CELLS; STROKE; PROLIFERATION; INVOLVEMENT; STRIATUM	To investigate the effect of CXCL12 on migration of neural precursor cells after traumatic brain injury (TBI). We randomly divided 48 rats into four groups: (1) the sham group, rats were performed craniotomy only, (2) the control group, saline were injected into the ipsilateral cortex after TBI, (3) the CXCL12 group, CXCL12 were injected into the ipsilateral cortex after TBI, and (4) the CXCL12 + AMD3100 group, CXCL12 and AMD3100 were mixed together and injected into the ipsilateral cortex after TBI. At 7 days after TBI, the brain tissues were subjected to immunofluorescent double-labeled staining with the antibodies of CXCR4/DCX, MMP-2/DCX, MMP-2/GFAP, MMP-2/NeuN. Western blot assay was used to measure the protein levels of MMP-2. Compared with the control group, the number of CXCR4/DCX and MMP-2 positive cells around the injured corpus callosum area were significantly increased in the CXCL12 treatment group. The area occupied by these cells expanded and the shape changed from chain distribution to radial. CXCL12 + AMD3100 treatment significantly decreased the number and distribution area of CXCR4/DCX and MMP-2 positive cells compared with the CXCL12 treatment and control group. The DCX positive cells could not form chain or radial distribution. The protein expressions of MMP-2 had the similar change trends as the results of immunofluorescent staining. MMP-2 could be secreted by DCX, GFAP and NeuN positive cells. CXCL12/CXCR4 axis can improve the migration of the neuroblasts along the corpus callosum by stimulating the MMP-2 secretion of different types of cells.	[Mao, Weifeng; Yi, Xin; Qin, Jianbing; Tian, Meiling; Jin, Guohua] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China	Jin, GH (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jguohua@163.com					Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102; Anstotz M, 2014, BRAIN STRUCT FUNCT, V219, P2119, DOI 10.1007/s00429-013-0627-2; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Belmadani A, 2015, HIPPOCAMPUS, V25, P1224, DOI 10.1002/hipo.22428; Bovetti S, 2007, EUR J NEUROSCI, V25, P2021, DOI 10.1111/j.1460-9568.2007.05441.x; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Merino JJ, 2015, J CELL PHYSIOL, V230, P27, DOI 10.1002/jcp.24695; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Lee SR, 2006, J NEUROSCI, V26, P3491, DOI 10.1523/JNEUROSCI.4085-05.2006; Leong SY, 2011, NEUROCHEM INT, V59, P382, DOI 10.1016/j.neuint.2010.12.024; Lewellis SW, 2012, SEMIN CELL DEV BIOL, V23, P333, DOI 10.1016/j.semcdb.2012.03.009; Machado VM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00022; Martoncikova M, 2014, CURR NEUROVASC RES, V11, P321, DOI 10.2174/1567202611666140903121253; Ozawa PMM, 2016, INT J CANCER, V138, P10, DOI 10.1002/ijc.29333; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Shen XY, 2009, J HUAZHONG U SCI-MED, V29, P363, DOI 10.1007/s11596-009-0320-0; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Yin W, 2013, CNS NEUROSCI THER, V19, P145, DOI 10.1111/cns.12049; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	16	18	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2016	41	6					1315	1322		10.1007/s11064-016-1831-2			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DM1AB	WOS:000376076300012	26801174				2021-06-18	
J	Alm, KH; Rolheiser, T; Olson, IR				Alm, Kylie H.; Rolheiser, Tyler; Olson, Ingrid R.			Inter-individual variation in fronto-temporal connectivity predicts the ability to learn different types of associations	NEUROIMAGE			English	Article						Orbitofrontal cortex; White matter; Limbic; Diffusion imaging; Faces; Proper names; Associative memory; Temporal pole; Uncinate fasciculus	SUPERIOR LONGITUDINAL FASCICULUS; INFERIOR TEMPORAL CORTEX; TRAUMATIC BRAIN-INJURY; WHITE-MATTER; UNCINATE FASCICULUS; PREFRONTAL CORTEX; EPISODIC MEMORY; DIFFUSION MRI; LOBE EPILEPSY; TRACTOGRAPHY	The uncinate fasciculus connects portions of the anterior and medial temporal lobes to the lateral orbitofrontal cortex, so it has long been thought that this limbic fiber pathway plays an important role in episodic memory. Some types of episodic memory are impaired after damage to the uncinate, while others remain intact. Because of this, the specific role played by the uncinate fasciculus in episodic memory remains undetermined. In the present study, we tested the hypothesis that the uncinate fasciculus is involved in episodic memory tasks that have high competition between representations at retrieval. To test this hypothesis, healthy young adults performed three tasks: Experiment 1 in which they learned to associate names with faces through feedback provided at the end of each trial; Experiment 2 in which they learned to associate fractals with cued locations through feedback provided at the end of each trial; and Experiment 3 in which unique faces were remembered in a paradigm with low retrieval competition. Diffusion tensor imaging and deterministic tractography methods were used to extract measures of uncinate fasciculus microstructure. Results revealed that microstructural properties of the uncinate, but not a control tract, the inferior longitudinal fasciculus, significantly predicted individual differences in performance on the face-name and fractal-location tasks. However, no relationship was observed for simple face memory (Experiment 3). These findings suggest that the uncinate fasciculus may be important for adjudicating between competing memory representations at the time of episodic retrieval. (C) 2016 Elsevier Inc. All rights reserved.	[Alm, Kylie H.; Rolheiser, Tyler; Olson, Ingrid R.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA	Olson, IR (corresponding author), Temple Univ, Weiss Hall,1701 N 13th St, Philadelphia, PA 19122 USA.	iolson@temple.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 MH091113]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH091113] Funding Source: NIH RePORTER	We would like to thank Ashley Unger, Tehila Nugiel, Hyden Zhang, and Vanessa Troiani for assistance with participant testing and tract tracing. This work was supported by a National Institute of Health grant to I. Olson [RO1 MH091113]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The authors declare no competing financial interests.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Alm KH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00343; Barredo J, 2015, CEREB CORTEX, V25, P1004, DOI 10.1093/cercor/bht291; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Browning PGF, 2005, EUR J NEUROSCI, V22, P3281, DOI 10.1111/j.1460-9568.2005.04477.x; Browning PGF, 2008, BEHAV NEUROSCI, V122, P477, DOI 10.1037/0735-7044.122.2.477; Bussey TJ, 2002, BEHAV NEUROSCI, V116, P703, DOI 10.1037//0735-7044.116.4.703; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2013, NEUROSCI BIOBEHAV R, V37, P1724, DOI 10.1016/j.neubiorev.2013.07.001; Chance SA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00820; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Delis DC, 2000, CALIFORNIA VERBAL LE; Drane DL, 2008, NEUROPSYCHOLOGIA, V46, P1242, DOI 10.1016/j.neuropsychologia.2007.11.034; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duffau H, 2009, J NEUROL, V256, P382, DOI 10.1007/s00415-009-0053-9; Easton A, 2000, BEHAV NEUROSCI, V114, P1041, DOI 10.1037/0735-7044.114.6.1041; Elmer S, 2011, HUM BRAIN MAPP, V32, P2064, DOI 10.1002/hbm.21169; GAFFAN D, 1995, EXP BRAIN RES, V105, P175; Gaffan D, 2002, J NEUROSCI, V22, P7288; GAFFAN EA, 1988, J NEUROSCI, V8, P3144; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Grabowski TJ, 2001, HUM BRAIN MAPP, V13, P199, DOI 10.1002/hbm.1033.abs; Gutnikov SA, 1997, EUR J NEUROSCI, V9, P1524, DOI 10.1111/j.1460-9568.1997.tb01507.x; Hirni DI, 2013, NEUROPSYCHOLOGIA, V51, P930, DOI 10.1016/j.neuropsychologia.2013.01.013; Hiyoshi-Taniguchi K, 2015, J NEUROIMAGING, V25, P748, DOI 10.1111/jon.12196; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; LEIRER VO, 1990, EXP AGING RES, V16, P155, DOI 10.1080/07340669008251544; Mabbott DJ, 2009, BRAIN RES, V1294, P80, DOI 10.1016/j.brainres.2009.07.046; MacKay D.G, 1987, THE ORGANIZATION OF; MARKOWITSCH HJ, 1982, NEUROSCI BIOBEHAV R, V6, P351, DOI 10.1016/0149-7634(82)90046-X; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mundform DJ., 2006, MULTIPLE LINEAR REGR, V32, P1, DOI 10.4135/9781412961288.n33; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nomura K, 2013, BEHAV NEUROL, V27, P229, DOI [10.3233/BEN-110249, 10.1155/2013/267408]; Oechslin MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.076.2009; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Olson IR, 2015, DEV COGN NEUROS-NETH, V14, P50, DOI 10.1016/j.dcn.2015.06.003; Olson IR, 2015, NEUROCASE, V21, P554, DOI 10.1080/13554794.2014.959025; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Papagno C, 2016, BRAIN STRUCT FUNCT, V221, P687, DOI 10.1007/s00429-014-0920-8; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Parker A, 1998, NEUROPSYCHOLOGIA, V36, P259, DOI 10.1016/S0028-3932(97)00112-7; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Pyles JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061611; Ross LA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00016; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Scholz J, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P237, DOI 10.1016/B978-0-12-374709-9.00011-0; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Social Security Administration, 2014, TOP NAM 2000S; Tavor I, 2014, NEUROIMAGE, V86, P123, DOI 10.1016/j.neuroimage.2013.07.085; Thomas C, 2015, CORTEX, V72, P65, DOI 10.1016/j.cortex.2015.01.023; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Unger A, 2016, J INT NEUROPSYCH SOC, V22, P180, DOI 10.1017/S1355617715001009; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Von Der Heide R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00017; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang R, 2007, P INT SOC MAG RESON, V15, P3720; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wendelken C, 2015, CEREB CORTEX, V25, P2574, DOI 10.1093/cercor/bhu059; Zhang JB, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/673165, 10.1186/s13661-014-0257-5]	77	16	16	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 15	2016	132						213	224		10.1016/j.neuroimage.2016.02.038			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DK3QK	WOS:000374832200023	26908315	Green Accepted			2021-06-18	
J	Kasprowicz, M; Burzynska, M; Melcer, T; Kuebler, A				Kasprowicz, Magdalena; Burzynska, Malgorzata; Melcer, Tomasz; Kuebler, Andrzej			A comparison of the Full Outline of UnResponsiveness (FOUR) score and Glasgow Coma Score (GCS) in predictive modelling in traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Full Outline of UnResponsiveness score; Glasgow Coma Score; predictive modelling; traumatic brain injury	SCALE; VALIDATION; CONSCIOUSNESS; PROGNOSIS; MORTALITY	Objectives: To compare the performance of multivariate predictive models incorporating either the Full Outline of UnResponsiveness (FOUR) score or Glasgow Coma Score (GCS) in order to test whether substituting GCS with the FOUR score in predictive models for outcome in patients after TBI is beneficial. Material and methods: A total of 162 TBI patients were prospectively enrolled in the study. Stepwise logistic regression analysis was conducted to compare the prediction of (1) in-ICU mortality and (2) unfavourable outcome at 3 months post-injury using as predictors either the FOUR score or GCS along with other factors that may affect patient outcome. The areas under the ROC curves (AUCs) were used to compare the discriminant ability and predictive power of the models. The internal validation was performed with bootstrap technique and expressed as accuracy rate (AcR). Results: The FOUR score, age, the CT Rotterdam score, systolic ABP and being placed on ventilator within day one (model 1: AUC: 0.906 +/- 0.024; AcR: 80.3 +/- 4.8%) performed equally well in predicting in-ICU mortality as the combination of GCS with the same set of predictors plus pupil reactivity (model 2: AUC: 0.913 +/- 0.022; AcR: 81.1 +/- 4.8%). The CT Rotterdam score, age and either the FOUR score (model 3) or GCS (model 4) equally well predicted unfavourable outcome at 3 months post-injury (AUC: 0.852 +/- 0.037 vs. 0.866 +/- 0.034; AcR: 72.3 +/- 6.6% vs. 71.9%+/- 6.6%, respectively). Adding the FOUR score or GCS at discharge from ICU to predictive models for unfavourable outcome increased significantly their performances (AUC: 0.895 +/- 0.029, p=0.05; AcR: 76.1 +/- 6.5%; p<0.004 when compared with model 3; and AUC: 0.918 +/- 0.025, p<0.05; AcR: 79.6 +/- 7.2%, p<0.009 when compared with model 4), but there was no benefit from substituting GCS with the FOUR score. Conclusion: Results showed that FOUR score and GCS perform equally well in multivariate predictive modelling in TBI.	[Kasprowicz, Magdalena; Melcer, Tomasz] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland; [Burzynska, Malgorzata; Kuebler, Andrzej] Wroclaw Med Univ, Dept Anaesthesiol, Borowska 213, PL-50556 Wroclaw, Poland; [Burzynska, Malgorzata; Kuebler, Andrzej] Wroclaw Med Univ, Intens Care Unit, Borowska 213, PL-50556 Wroclaw, Poland	Kuebler, A (corresponding author), Wroclaw Med Univ, Dept Anaesthesiol, Borowska 213, PL-50556 Wroclaw, Poland.; Kuebler, A (corresponding author), Wroclaw Med Univ, Intens Care Unit, Borowska 213, PL-50556 Wroclaw, Poland.	andrzej.kubler@anest.am.wroc.pl		Burzynska, Malgorzata/0000-0003-2318-7130; Kasprowicz, Magdalena/0000-0002-2271-7737	National Science Centre (Poland) [2013/09/B/NZ4/01343]	This study was partially supported by National Science Centre (Poland) Grant no. 2013/09/B/NZ4/01343.	Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heidegger CP, 2005, INTENS CARE MED, V31, P1676, DOI 10.1007/s00134-005-2831-x; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; JENNETT B, 1975, LANCET, V1, P480; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	30	16	18	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					211	220		10.3109/02688697.2016.1161173			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900010	27001246				2021-06-18	
J	Cruz, LJ; Que, I; Aswendt, M; Chan, A; Hoehn, M; Lowik, C				Cruz, Luis Javier; Que, Ivo; Aswendt, Markus; Chan, Alan; Hoehn, Mathias; Lowik, Clemens			Targeted nanoparticles for the non-invasive detection of traumatic brain injury by optical imaging and fluorine magnetic resonance imaging	NANO RESEARCH			English	Article						imaging; nanoparticles; contrast agents; magnetic resonance imaging; brain injury; stroke	PERFLUOROOCTYL BROMIDE; CELL-DEATH; DENDRITIC CELLS; MRI; QUANTIFICATION; MICROCAPSULES; APOPTOSIS; DELIVERY; AGENTS; PET	Necrosis is a form of cell death that occurs only under pathological conditions such as ischemic diseases and traumatic brain injury (TBI). Non-invasive imaging of the affected tissue is a key component of novel therapeutic interventions and measurement of treatment responses in patients. Here, we report a bimodal approach for the detection and monitoring of TBI. PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs), encapsulating both near infrared (NIR) fluorophores and perfluorocarbons (PFCs), were targeted to necrotic cells. We used cyanine dyes such as IRDye 800CW, for which we have previously demonstrated specific targeting to intracellular proteins of cells that have lost membrane integrity. Here, we show specific in vivo detection of necrosis by optical imaging and fluorine magnetic resonance imaging (F-19 MRI) using newly designed PLGA NP(NIR700 + PFC)-PEG-800CW. Quantitative ex vivo optical imaging and F-19 MR spectroscopy of NIR-PFC content in injured brain regions and in major organs were well correlated. Both modalities allowed the in vivo identification of necrotic brain lesions in a mouse model of TBI, with optical imaging being more sensitive than F-19 MRI. Our results confirm increased blood pool residence time of PLGA NPs coated with a PEG layer and the successful targeting of TBI-damaged tissue. A single PLGA NP containing NIR-PFC enables both rapid qualitative optical monitoring of the TBI state and quantitative 3D information from deeper tissues on the extent of the lesion by MRI. These necrosis-targeting PLGA NPs can potentially be used for clinical diagnosis of brain injuries.	[Cruz, Luis Javier; Que, Ivo; Chan, Alan; Hoehn, Mathias; Lowik, Clemens] Leiden Univ, Dept Radiol, Nanomed & Mol Imaging, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Aswendt, Markus; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, Gleueler Str 50, D-50931 Cologne, Germany; [Chan, Alan] Percuros, NL-7522 NB Enschede, Netherlands	Cruz, LJ; Lowik, C (corresponding author), Leiden Univ, Dept Radiol, Nanomed & Mol Imaging, Med Ctr, NL-2333 ZA Leiden, Netherlands.	L.J.Cruz_Ricondo@lumc.nl; c.lowik@erasmusmc.nl	Aswendt, Markus/L-2743-2019	Aswendt, Markus/0000-0003-1423-0934; Chan, Alan/0000-0001-6949-9274	EU-FP7 program TargetBraIn [HEALTH-F2-2012-279017]; EU-FP7 program BrainPath [PIAPP-GA-2013-612360]; EU-FP7 program CTMM project Cancer Vaccine Tracking [03O-302]	The authors wish to thank the technicians of the LUMC Radiology Department and Andreas Beyrau (MPI for Neurological Research in Cologne) for assistance. This work was financially supported by the EU-FP7 programs TargetBraIn (No. HEALTH-F2-2012-279017), BrainPath (No. PIAPP-GA-2013-612360), and CTMM project Cancer Vaccine Tracking (No. 03O-302).	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Aswendt M, 2012, NEUROIMAGE, V62, P1685, DOI 10.1016/j.neuroimage.2012.05.029; Blankenberg FG, 2008, CURR PHARM DESIGN, V14, P2974, DOI 10.2174/138161208786404353; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745; Caruthers SD, 2006, INVEST RADIOL, V41, P305, DOI 10.1097/01.rli.0000199281.60135.6a; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Cruz LJ, 2011, MOL PHARMACEUT, V8, P520, DOI 10.1021/mp100356k; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Diaz-Lopez R, 2008, J PHARMACEUT BIOMED, V48, P702, DOI 10.1016/j.jpba.2008.06.027; Diaz-Lopez R, 2010, BIOMATERIALS, V31, P1723, DOI 10.1016/j.biomaterials.2009.11.044; Diaz-Lopez R, 2009, BIOMATERIALS, V30, P1462, DOI 10.1016/j.biomaterials.2008.11.032; Ferenz KB, 2013, J MICROENCAPSUL, V30, P632, DOI 10.3109/02652048.2013.770098; Giraudeau C, 2012, NMR BIOMED, V25, P654, DOI 10.1002/nbm.1781; Gomez-Graete C, 2007, INT J PHARMACEUT, V331, P153, DOI 10.1016/j.ijpharm.2006.11.028; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Keereweer S, 2014, MOL IMAGING BIOL, V16, P10, DOI 10.1007/s11307-013-0684-1; Laufer EM, 2009, Q J NUCL MED MOL IM, V53, P26; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x; Medarova Z, 2005, DIABETES, V54, P1780, DOI 10.2337/diabetes.54.6.1780; Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2; Pamula E, 2011, ANN BIOMED ENG, V39, P2114, DOI 10.1007/s10439-011-0307-4; Park J, 2009, NANOMED-NANOTECHNOL, V5, P410, DOI 10.1016/j.nano.2009.02.002; Pisani E, 2008, J COLLOID INTERF SCI, V326, P66, DOI 10.1016/j.jcis.2008.07.013; Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570; Shaffer TH, 1996, EUR J PEDIATR, V155, pS30, DOI 10.1007/BF01958078; Smith BA, 2012, BIOCONJUGATE CHEM, V23, P1989, DOI 10.1021/bc3003309; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, BIOMATERIALS, V31, P7070, DOI 10.1016/j.biomaterials.2010.05.069; Tacken PJ, 2011, BLOOD, V118, P6836, DOI 10.1182/blood-2011-07-367615; Waters EA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-43; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Wolters SL, 2007, EUR J NUCL MED MOL I, V34, pS86, DOI 10.1007/s00259-007-0443-0; Xie BW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.207; Xie BW, 2015, ONCOTARGET, V6, P39036, DOI 10.18632/oncotarget.5498	37	16	16	4	53	TSINGHUA UNIV PRESS	BEIJING	B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	MAY	2016	9	5					1276	1289		10.1007/s12274-016-1023-z			14	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	DL4RH	WOS:000375624400006					2021-06-18	
J	Rodgman, C; Verrico, CD; Holst, M; Thompson-Lake, D; Haile, CN; De La Garza, R; Raskind, MA; Newton, TF				Rodgman, Christopher; Verrico, Christopher D.; Holst, Manuela; Thompson-Lake, Daisy; Haile, Colin N.; De La Garza, Richard, II; Raskind, Murray A.; Newton, Thomas F.			Doxazosin XL Reduces Symptoms of Posttraumatic Stress Disorder in Veterans With PTSD: A Pilot Clinical Trial	JOURNAL OF CLINICAL PSYCHIATRY			English	Article						Posttraumatic Stress Disorder; Veterans and Military Issues	TRAUMATIC BRAIN-INJURY; SEXUAL DYSFUNCTION; COMBAT VETERANS; DOUBLE-BLIND; ANTAGONIST DOXAZOSIN; MEDICATION ADHERENCE; PLACEBO; NIGHTMARES; SERTRALINE; PRAZOSIN	Background: Serotonin and norepinephrine reuptake inhibitors are effective first-line agents for the treatment of posttraumatic stress disorder (PTSD), but treatment is associated with a range of side effects that limit treatment adherence. Prazosin, an alpha(1)-noradrenergic antagonist with a half-life of roughly 2-3 hours, has shown promise in the treatment of sleep disturbance and nightmares. Doxazosin extended release (XL) is also an alpha(1)-noradrenergic antagonist but with a half-life of approximately 15-19 hours. Methods: We conducted a double-blind, placebo-controlled, within-subjects trial to characterize the impact of doxazosin XL on PTSD symptoms. Participants (N = 8) were diagnosed using DSM-IV criteria. They completed the study twice, once during treatment with doxazosin XL and once during treatment with matched placebo, with a 2-week washout separating the 2 episodes. Doxazosin XL was titrated from 4 mg/d to 16 mg/d over 12 days. After 4 days of treatment at 16 mg/d or the equivalent number of placebo capsules, PTSD symptoms were assessed using the Clinician-Administered PTSD Scale (CAPS(17)) and the PTSD Checklist-Military version (PCL-M). Repeated measures analysis of variance were used to evaluate effects of treatment, time, and treatment x time. This study was run from November 20, 2013, to June 31, 2014. Results: Doxazosin XL treatment was associated with a nonsignificant treatment x time reduction in ratings on the CAPS hyperarousal subscale (P < .10) (but not on the CAPS Total score) and with significant treatment x time reductions in PCL-M ratings (P = .002). Conclusions: Doxazosin XL may be an effective alternative to prazosin for the treatment of some PTSD symptoms. (C) Copyright 2016 Physicians Postgraduate Press, Inc.	[Rodgman, Christopher; Verrico, Christopher D.; Holst, Manuela; Thompson-Lake, Daisy; Haile, Colin N.; De La Garza, Richard, II; Newton, Thomas F.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Rodgman, Christopher; Verrico, Christopher D.; Holst, Manuela; Thompson-Lake, Daisy; Haile, Colin N.; De La Garza, Richard, II; Newton, Thomas F.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA; [De La Garza, Richard, II] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX USA; [Raskind, Murray A.] VISN 20 Northwest Network Mental Illness Res Educ, Seattle, WA USA; [Raskind, Murray A.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Newton, TF (corresponding author), Baylor Coll Med, Dept Psychiat, Michael E DeBakey VA Med Ctr, 2002 Holcombe, Houston, TX 77030 USA.	tnewton@bcm.edu	Verrico, Christopher/I-4552-2013; De La Garza, Richard/B-2489-2014	Verrico, Christopher/0000-0002-8272-0778; De La Garza, Richard/0000-0003-1943-4469; Thompson-Lake, Daisy/0000-0003-3096-0910	Michael E. DeBakey VA Medical CenterUS Department of Veterans Affairs; NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25DA028976]	This study was conducted at and funded by a grant from the Michael E. DeBakey VA Medical Center. NIH grant R25DA028976 also provided financial support.	Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cassano Paolo, 2004, Ann Clin Psychiatry, V16, P15, DOI 10.1080/10401230490281618; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; CUBEDDU LX, 1988, AM HEART J, V116, P133, DOI 10.1016/0002-8703(88)90261-X; Davidson J, 2001, AM J PSYCHIAT, V158, P1974, DOI 10.1176/appi.ajp.158.12.1974; De Jong J, 2010, J CLIN PSYCHOPHARM, V30, P84, DOI 10.1097/JCP.0b013e3181c827ae; Department of Defense, 2007, ACH VIS REP DEP DEF; ELLIOTT HL, 1982, BRIT J CLIN PHARMACO, V13, P699, DOI 10.1111/j.1365-2125.1982.tb01439.x; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; GUO TZ, 1991, ANESTHESIOLOGY, V75, P252, DOI 10.1097/00000542-199108000-00013; Haile CN, 2012, BRAIN SCI, V2, P619, DOI 10.3390/brainsci2040619; Higgins A, 2010, DRUG HEALTHC PATIENT, V2, P141, DOI 10.2147/DHPS.S7634; KAYE B, 1986, BRIT J CLIN PHARMACO, V21, pS19, DOI 10.1111/j.1365-2125.1986.tb02849.x; Kronish IM, 2012, J PSYCHIATR RES, V46, P1595, DOI 10.1016/j.jpsychires.2012.06.011; Liu XC, 2011, CLINICOECONOMIC OUTC, V3, P63, DOI 10.2147/CEOR.S17846; Lockwood A, 2009, ANN PHARMACOTHER, V43, P1227, DOI 10.1345/aph.1M017; McNally RJ, 2012, SCIENCE, V336, P872, DOI 10.1126/science.1222069; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Newton TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030854; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Raskind MA, 2002, J CLIN PSYCHIAT, V63, P565, DOI 10.4088/JCP.v63n0705; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Raskind MA, 2013, AM J PSYCHIAT, V170, P1003, DOI 10.1176/appi.ajp.2013.12081133; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Sanchez S, 2014, OCCUP ENV MED S1, V71, pA68; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shorter D, 2013, DRUG ALCOHOL DEPEN, V131, P66, DOI 10.1016/j.drugalcdep.2012.11.021; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; VANDERKOLK BA, 1994, J CLIN PSYCHIAT, V55, P517; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Weathers FW, PTSD CHECKLIST DSM 4; Zohar J, 2002, J CLIN PSYCHOPHARM, V22, P190, DOI 10.1097/00004714-200204000-00013	43	16	16	0	11	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	MAY	2016	77	5					E561	E565		10.4088/JCP.14m09681			5	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	DQ6GH	WOS:000379302000003	27249080				2021-06-18	
J	Wan, XY; Liu, SW; Wang, S; Zhang, SJ; Yang, HK; Ou, YB; Zhao, M; James, L; Shu, K; Chen, JC; Lei, T				Wan, Xueyan; Liu, Shengwen; Wang, Sheng; Zhang, Suojun; Yang, Hongkuan; Ou, Yibo; Zhao, Min; James, Lubuulwa; Shu, Kai; Chen, Jincao; Lei, Ting			Elderly Patients with Severe Traumatic Brain Injury Could Benefit from Surgical Treatment	WORLD NEUROSURGERY			English	Article						Elderly; Prognosis; Surgery; Therapeutic approach; Traumatic brain injury	SEVERE HEAD-INJURY; OLDER-ADULTS; DECOMPRESSIVE CRANIECTOMY; MORTALITY; AGE; MANAGEMENT; DIAGNOSIS; INCREASES; OUTCOMES; RISK	OBJECTIVE: In elderly patients with severe traumatic brain injury, the use of aggressive versus conservative management remains controversial. The aim of this study was to assess the outcome of surgical alternatives for treatment of severe traumatic intracranial hematoma in patients >= 65 years old and identify factors that may contribute to the outcome. METHODS: This retrospective study included 112 patients with traumatic intracranial hematoma. Logistic regression analysis was used to identify independent predictors of unfavorable outcome. The Glasgow Outcome Scale was used to evaluate the outcome. RESULTS: Surgery was performed in 70 (62.5%) patients >= 65 years old. A favorable outcome occurred in 33 (47.1%) surgical patients, and 23 (32.9%) surgical patients died. Patients who underwent surgery were less likely to have an unfavorable outcome (52.9% vs. 95.2%) and less likely to die (32.9% vs. 88.1%) at 6 months postinjury compared with patients treated conservatively. Multivariate logistic regression analysis revealed that lower Glasgow Coma Scale score (<= 5) was a significant factor associated with unfavorable outcome (odds ratio [OR] = 18.7, 95% confidence interval [CI] = 5.2-95.5, P < 0.001) and mortality (OR = 10.7, 95% CI = 4.4-28.5, P < 0.001). However, neurosurgical intervention was a significant factor to negatively predict unfavorable outcome (OR = 0.03, 95% CI = 0.01-0.1, P < 0.001) and mortality (OR = 0.04, 95% CI = 0.01-0.1, P < 0.001). CONCLUSIONS: This study showed that Glasgow Coma Scale score (<= 5) was a major determinant of outcome in elderly patients with severe traumatic brain injury. However, surgical treatment reduced mortality and improved outcome in the elderly patients in this study.	[Wan, Xueyan; Liu, Shengwen; Wang, Sheng; Zhang, Suojun; Yang, Hongkuan; Ou, Yibo; Zhao, Min; James, Lubuulwa; Shu, Kai; Chen, Jincao; Lei, Ting] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China	Wang, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China.	wangsheng@tjh.tjmu.edu.cn	Lubuulwa, James/M-2924-2016	Lubuulwa, James/0000-0002-4671-2607; Wan, Xueyan/0000-0002-7148-9857	"Dawn" Program of Science and Technology for Young Scientists of Wuhan, China [201150431121]; National Clinical Key Specialty Construction Project	This work was supported by the "Dawn" Program of Science and Technology for Young Scientists of Wuhan, China (Grant No. 201150431121), and National Clinical Key Specialty Construction Project. The authors thank Wenhua Liu (Clinical and Translational Medical Center) for statistical assistance.	Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; R Core Team, R A LANG ENV STAT CO; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Stieg PE, 1998, NEUROL CLIN, V16, P373, DOI 10.1016/S0733-8619(05)70069-4; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wang ZC., 1974, NEUROSURGERY	31	16	16	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2016	89						147	152		10.1016/j.wneu.2016.01.084			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DM6GM	WOS:000376448700023	26855305				2021-06-18	
J	Wu, Y; Kim, J; Chan, ST; Zhou, IY; Guo, Y; Igarashi, T; Zheng, HR; Guo, G; Sun, PZ				Wu, Yin; Kim, Jinsuh; Chan, Suk-Tak; Zhou, Iris Yuwen; Guo, Yingkun; Igarashi, Takahiro; Zheng, Hairong; Guo, Gang; Sun, Phillip Zhe			Comparison of image sensitivity between conventional tensor-based and fast diffusion kurtosis imaging protocols in a rodent model of acute ischemic stroke	NMR IN BIOMEDICINE			English	Article						acute stroke; contrast-to-noise ratio; diffusion kurtosis imaging; mean diffusion; mean kurtosis	NON-GAUSSIAN DIFFUSION; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MICROSTRUCTURAL ALTERATIONS; WATER DIFFUSION; TISSUE; MRI; TIME; PH	Diffusion kurtosis imaging (DKI) can offer a useful complementary tool to routine diffusion MRI for improved stratification of heterogeneous tissue damage in acute ischemic stroke. However, its relatively long imaging time has hampered its clinical application in the emergency setting. A recently proposed fast DKI approach substantially shortens the imaging time, which may help to overcome the scan time limitation. However, to date, the sensitivity of the fast DKI protocol for the imaging of acute stroke has not been fully described. In this study, we performed routine and fast DKI scans in a rodent model of acute stroke, and compared the sensitivity of diffusivity and kurtosis indices (i.e. axial, radial and mean) in depicting acute ischemic lesions. In addition, we analyzed the contrast-to-noise ratio (CNR) between the ipsilateral ischemic and contralateral normal regions using both conventional and fast DKI methods. We found that the mean kurtosis shows a relative change of 47.1 +/- 7.3% between the ischemic and contralateral normal regions, being the most sensitive parameter in revealing acute ischemic injury. The two DKI methods yielded highly correlated diffusivity and kurtosis measures and lesion volumes (R(2)0.90, p<0.01). Importantly, the fast DKI method exhibited significantly higher CNR of mean kurtosis (1.6 +/- 0.2) compared with the routine tensor protocol (1.3 +/- 0.2, p<0.05), with its CNR per unit time (CNR efficiency) approximately doubled when the scan time was taken into account. In conclusion, the fast DKI method provides excellent sensitivity and efficiency to image acute ischemic tissue damage, which is essential for image-guided and individualized stroke treatment. Copyright (c) 2016 John Wiley & Sons, Ltd.	[Wu, Yin; Chan, Suk-Tak; Zhou, Iris Yuwen; Guo, Yingkun; Igarashi, Takahiro; Sun, Phillip Zhe] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Wu, Yin; Chan, Suk-Tak; Zhou, Iris Yuwen; Guo, Yingkun; Igarashi, Takahiro; Sun, Phillip Zhe] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Wu, Yin; Zheng, Hairong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen Key Lab MRI, Shenzhen, Guangdong, Peoples R China; [Kim, Jinsuh; Sun, Phillip Zhe] Univ Illinois, Dept Radiol, Chicago, IL USA; [Guo, Gang] Xiamen 2nd Hosp, Dept Radiol, Xiamen, Fujian, Peoples R China	Sun, PZ (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.; Sun, PZ (corresponding author), Harvard Univ, Sch Med, Charlestown, MA 02129 USA.	pzhesun@mgh.harvard.edu	Chan, Suk-tak/G-5846-2015; Zhou, Iris Yuwen/A-2089-2017	Zhou, Iris Yuwen/0000-0002-4351-7398; CHAN, SUK-TAK/0000-0001-6627-3173; Sun, Phillip Zhe/0000-0003-4872-1192	National Basic Research Program of ChinaNational Basic Research Program of China [2015CB755500]; National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81571668, 81471721]; Shenzhen Science and Technology Program [JCYJ20140610151856743]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21NS085574, 1R01NS083654]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS085574, R01NS083654, R21NS061119] Funding Source: NIH RePORTER	This study received funding from the National Basic Research Program of China (2015CB755500), National Natural Science Foundation of China (NSFC) (81571668 and 81471721), Shenzhen Science and Technology Program (JCYJ20140610151856743) and National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) (1R21NS085574 and 1R01NS083654).	Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fukunaga I, 2013, RADIOL PHYS TECHNOL, V6, P343, DOI 10.1007/s12194-013-0206-5; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Gooijers J, 2014, BRAIN STRUCT FUNCT, V219, P1627, DOI 10.1007/s00429-013-0590-y; Grinberg F, 2012, NMR BIOMED, V25, P1295, DOI 10.1002/nbm.2802; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hansen B, 2014, MAGN RESON MED, V71, P2250, DOI 10.1002/mrm.25090; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hui ES, 2012, BRAIN RES, V1451, P100, DOI 10.1016/j.brainres.2012.02.044; Jensen JH, 2014, NMR BIOMED, V27, P363, DOI [10.1002/nbm.3094, 10.1002/nbm.3030]; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kidwell CS, 2004, STROKE, V35, P2662, DOI 10.1161/01.STR.0000143222.13069.70; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Nael K, 2015, STROKE, V46, P413, DOI 10.1161/STROKEAHA.114.007000; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Rosenkrantz AB, 2012, MAGN RESON IMAGING, V30, P1534, DOI 10.1016/j.mri.2012.04.020; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1336, DOI 10.1038/sj.jcbfm.9600126; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Sun PZ, 2014, NMR BIOMED, V27, P1413, DOI 10.1002/nbm.3188; Sun PZ, 2013, PHYS MED BIOL, V58, pN229, DOI 10.1088/0031-9155/58/17/N229; Sun PZ, 2012, NEUROIMAGE, V60, P1, DOI 10.1016/j.neuroimage.2011.11.091; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tax CMW, 2015, MAGN RESON MED, V73, P794, DOI 10.1002/mrm.25165; Tietze A, 2015, AM J NEURORADIOL, V36, P1472, DOI 10.3174/ajnr.A4311; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Vanhoutte G, 2013, MAGN RESON MED, V69, P1115, DOI 10.1002/mrm.24680; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Wu O, 2007, J CEREBR BLOOD F MET, V27, P196, DOI 10.1038/sj.jcbfm.9600328; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	51	16	18	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	MAY	2016	29	5					625	630		10.1002/nbm.3506			6	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	DJ8XA	WOS:000374495900010	26918411	Green Accepted			2021-06-18	
J	Schmid, AA; Miller, KK; van Puymbroeck, M; Schalk, N				Schmid, Arlene A.; Miller, Kristine K.; van Puymbroeck, Marieke; Schalk, Nancy			Feasibility and results of a case study of yoga to improve physical functioning in people with chronic traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Balance; yoga; traumatic brain injury	MOTOR REHABILITATION; UNITED-STATES; CHRONIC PAIN; PILOT; BALANCE; PREVALENCE; STROKE; SWAY; RELIABILITY	Purpose: The purpose of this mixed-methods case study was to investigate whether an 8-week 1:1 yoga program was feasible and beneficial to people with traumatic brain injury (TBI). Method: This was a mixed-methods case study of one-to-one yoga for people with TBI included three people. We completed assessments before and after the 8-week yoga intervention and included measures of balance, balance confidence, pain, range of motion, strength and mobility. Qualitative interviews were included at the post-assessment. We include a percent change calculation and salient quotes that represent the perceived impact of the yoga intervention. Results: All participants completed the yoga intervention and all demonstrated improvements in physical outcome measures. For the group, balance increased by 36%, balance confidence by 39%, lower extremity strength by 100% and endurance by 105%. Qualitative data support the use of yoga to improve multiple aspects of physical functioning, one participant stated: "I mean it's rocked my world. It's changed my life. I mean all the different aspects. I mean physically, emotionally, mentally, it's given me you know my life back horizontal ellipsis ". Conclusions: Yoga, delivered in a one-to-one setting, appears to be feasible and beneficial to people with chronic TBI. Implications for Rehabilitation Chronic traumatic brain injury (TBI) leads to many aspects of physical functioning impairment. Yoga delivered in a one-to-one setting may be feasible and beneficial for people with chronic TBI.	[Schmid, Arlene A.] Colorado State Univ, Coll Hlth & Human Sci, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Miller, Kristine K.] Indiana Univ, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Indianapolis, IN 46204 USA; [Miller, Kristine K.] Roudebush Vet Adm VA Med Ctr, Ctr Implementing Evidence Based Practice, HSR&D, Indianapolis, IN USA; [van Puymbroeck, Marieke] Clemson Univ, Coll Hlth & Human Dev, Dept Pk Recreat & Tourism Management, Clemson, SC USA; [Schalk, Nancy] Heartland Yoga Therapy, Indianapolis, IN USA	Schmid, AA (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.	arlene.schmid@colostate.edu		Schmid, Arlene/0000-0002-7755-199X; Van Puymbroeck, Marieke/0000-0002-5881-8409	VA Career Development Award [VA RRD CDA D6174W]	Dr. Schmid and this study were supported by a VA Career Development Award (VA RR&D CDA D6174W).	Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; BROWN DR, 1995, MED SCI SPORT EXER, V27, P765; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Cantor JB, 2013, CURR PHYS MED REHABI, V1, P159; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feld JA, 2001, NEUROREHAB NEURAL RE, V15, P239, DOI 10.1177/154596830101500312; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Hager, 2008, BEN SUN SAL TRAUM BR; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Page SJ, 2012, ARCH PHYS MED REHAB, V93, P1395, DOI 10.1016/j.apmr.2012.03.005; Paveza GJ, 1990, BEHAV HLTH AGING, V1, P133; Rikil R., 2001, SENIOR FITNESS TEST; Schmid AA, 2014, COMPLEMENT THER MED, V22, P994, DOI 10.1016/j.ctim.2014.09.005; Schmid AA, 2012, STROKE, V43, P2402, DOI 10.1161/STROKEAHA.112.658211; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P1101, DOI 10.1016/j.apmr.2012.01.020; Schmid AA, 2010, ARCH PHYS MED REHAB, V91, P576, DOI 10.1016/j.apmr.2009.12.018; Silverthorne Colin, 2012, Int J Yoga Therap, P47; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Van Puymbroeck M, 2014, J RECREAT THER, V13, P23; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	31	16	16	1	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	APR 23	2016	38	9					914	920		10.3109/09638288.2015.1062927			7	Rehabilitation	Rehabilitation	DE5CB	WOS:000370647400014	26208245				2021-06-18	
J	Basrai, HS; Christie, KJ; Turbic, A; Bye, N; Turnley, AM				Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.			Suppressor of Cytokine Signaling-2 (SOCS2) Regulates the Microglial Response and Improves Functional Outcome after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CD40 GENE-EXPRESSION; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; ERYTHROPOIETIN; NEUROGENESIS; PROLIFERATION; CELLS; DIFFERENTIATION; RECOVERY	Traumatic brain injury (TBI) is frequently characterized by neuronal, axonal and myelin loss, reactive gliosis and neuroinflammation, often associated with functional deficits. Endogenous repair mechanisms include production of new neurons from precursor cells, but usually the new neurons fail to integrate and survive more than a few weeks. This is in part mediated by the toxic and inflammatory environment present in the injured brain which activates precursor cells to proliferate and differentiate but limits survival of the newborn progeny. Therefore, an understanding of mechanisms that regulate production and survival of newborn neurons and the neuroinflammatory response after brain injury may lead to therapeutic options to improve outcomes. Suppressor of Cytokine Signaling 2 (SOCS2) promotes hippocampal neurogenesis and survival of newborn neurons in the adult brain and regulates anti-inflammatory responses in the periphery, suggesting it may be a useful candidate to improve outcomes of TBI. In this study the functional and cellular responses of SOCS2 over-expressing transgenic (SOCS2Tg) mice were compared to wildtype litter-mates following mild or moderately severe TBI. Unlike wildtype controls, SOCS2Tg mice showed functional improvement on a ladder test, with a smaller lesion volume at 7d post injury and increased numbers of proliferative CD11b(+) microglia/macrophages at 35d post-injury in the mild injury paradigm. At 7d post-moderately severe injury there was an increase in the area covered by cells expressing an anti-inflammatory M2 phenotype marker (CD206(+)) but no difference in cells with a pro-inflammatory M1 phenotype marker (CD16/32(+)). No effect of SOCS2 overexpression was observed in production or survival of newborn neurons, even in the presence of the neuroprotective agent erythropoietin (EPO). Therefore, SOCS2 may improve outcome of TBI in mice by regulating aspects of the neuroinflammatory response, promoting a more anti-inflammatory environment, although this was not sufficient to enhance survival of newborn cortical neurons.	[Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia	Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au			National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [1045125, 628344]; Stem Cells Australia	This work was supported by funding from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au): Project grant 1045125 to AMT and Fellowship 628344 to AMT, as well as support from Stem Cells Australia (www.stemcellsaustralia.edu.au) to HSB and AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baciu I, 2000, Rom J Physiol, V37, P3; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Choi JS, 2009, J NEUROTRAUM, V26, P2097, DOI [10.1089/neu.2008.0793, 10.1089/neu.2008-0793]; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Esper L, 2012, AM J PATHOL, V181, P130, DOI 10.1016/j.ajpath.2012.03.042; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; HU XM, 2012, STROKE, V43, P3063, DOI DOI 10.1161/STR0KEAHA.112.659656; Iverson GL, 2005, CURRENT OPINION PSYC, DOI [10.1097/00001504-200505000-00013, DOI 10.1097/00001504-200505000-00013]; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511; Koketsu D, 2006, EXP NEUROL, V199, P92, DOI 10.1016/j.expneurol.2006.03.012; Krantz S B, 1988, Contrib Nephrol, V66, P25; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qin HW, 2006, FASEB J, V20, P985, DOI 10.1096/fj.05-5493fje; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ransome MI, 2007, J NEUROCHEM, V102, P1953, DOI 10.1111/j.1471-4159.2007.04684.x; Ransome MI, 2005, NEUROSCIENCE, V132, P673, DOI 10.1016/j.neuroscience.2004.12.041; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Uren RT, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00039, 10.3389/fnmol.2014.00039]; Uren RT, 2014, J NEUROCHEM, V129, P614, DOI 10.1111/jnc.12671; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wei ZX, 2015, NEUROSCI LETT, V606, P48, DOI 10.1016/j.neulet.2015.08.032; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu XB, 2002, DEVELOPMENT, V129, P505; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	64	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153418	10.1371/journal.pone.0153418			24	Multidisciplinary Sciences	Science & Technology - Other Topics	DJ0NI	WOS:000373900700065	27071013	DOAJ Gold, Green Published			2021-06-18	
J	Murphy, PB; Sothilingam, N; Stewart, TC; Batey, B; Moffat, B; Gray, DK; Parry, NG; Vogt, KN				Murphy, Patrick B.; Sothilingam, Niroshan; Stewart, Tanya Charyk; Batey, Brandon; Moffat, Brad; Gray, Daryl K.; Parry, Neil G.; Vogt, Kelly N.			Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safe	CANADIAN JOURNAL OF SURGERY			English	Article							PRACTICE MANAGEMENT GUIDELINE; MOLECULAR-WEIGHT HEPARIN; TRAUMATIC BRAIN-INJURY; NONOPERATIVE MANAGEMENT; EASTERN ASSOCIATION; MAJOR TRAUMA; THROMBOSIS; ANTICOAGULATION; PREVENTION; SURGERY	Background The optimal timing of initiating low-molecular weight heparin (LMWH) in patients who have undergone nonoperative management (NOM) of blunt solid organ injuries (SOIs) remains controversial. We describe the safety of early initiation of chemical venous thromboembolism (VTE) prophylaxis among patients undergoing NOM of blunt SOIs. Methods We retrospectively studied severely injured adults who sustained blunt SOI without significant intracranial hemorrhage and underwent an initial NOM at a Canadian lead trauma hospital between 2010 and 2014. Safety was assessed based on failure of NOM, defined as the need for operative intervention, in patients who received early (< 48 h) or late LMWH (>= 48 h, or early discharge [< 72 h] without LMWH). Results We included 162 patients in our analysis. Most were men (69%), and the average age was 42 +/- 18 years. The median injury severity score was 17, and splenic injuries were most common (97 [60%], median grade 2), followed by liver (57 [35%], median grade 2) and kidney injuries (31 [19%], median grade 1). Combined injuries were present in 14% of patients. A total of 78 (48%) patients received early LMWH, while 84 (52%) received late LMWH. The groups differed only in percent of high-grade splenic injury (14% v. 32%). Overall 2% of patients failed NOM, none after receiving LMWH. Semielective angiography was performed in 23 (14%) patients. The overall rate of confirmed VTE on imaging was 1.9%. Conclusion Early initiation of medical thromboembolic prophylaxis appears safe in select patients with isolated SOI following blunt trauma. A prospective multicentre study is warranted.	[Murphy, Patrick B.; Sothilingam, Niroshan; Moffat, Brad; Gray, Daryl K.; Parry, Neil G.; Vogt, Kelly N.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Surg, London, ON, Canada; [Sothilingam, Niroshan; Stewart, Tanya Charyk; Batey, Brandon; Gray, Daryl K.; Parry, Neil G.; Vogt, Kelly N.] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Parry, Neil G.] Ctr Crit Illness Res, London, ON, Canada	Vogt, KN (corresponding author), Victoria Hosp, London Hlth Sci Ctr, Div Gen Surg, Rm E2-214,800 Commissioners Rd East, London, ON N6A 5W9, Canada.	kelly.vogt@lhsc.on.ca	Murphy, Patrick/T-5337-2019				Alejandro KV, 2003, AM SURGEON, V69, P1006; Bertens KA, 2015, EUR J TRAUMA EMERG S, V41, P81, DOI 10.1007/s00068-014-0431-6; Chapman BC, 2013, AM J SURG, V206, P917, DOI 10.1016/j.amjsurg.2013.07.024; Datta Indraneel, 2009, J Trauma Manag Outcomes, V3, P7, DOI 10.1186/1752-2897-3-7; DeMuro JP, 2013, J BLOOD DISORD TRANS, P04; Eberle BM, 2011, J TRAUMA, V70, P141, DOI 10.1097/TA.0b013e3182032f45; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; HILL SL, 1994, AM SURGEON, V60, P405; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Joseph B, 2013, AM J SURG, V206, P922; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Phelan HA, 2013, SEMIN THROMB HEMOST, V39, P541, DOI 10.1055/s-0033-1343356; Piotrowski JJ, 1996, AM J SURG, V172, P210, DOI 10.1016/S0002-9610(96)00154-7; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS288, DOI 10.1097/TA.0b013e318270160d	18	16	16	0	2	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	APR	2016	59	2					118	122		10.1503/cjs.010815			5	Surgery	Surgery	DI8TI	WOS:000373774400004	26820318	Green Published, Bronze			2021-06-18	
J	Yoon, KJ; Lee, YT; Chae, SW; Park, CR; Kim, DY				Yoon, Kyung Jae; Lee, Yong-Taek; Chae, Seoung Wan; Park, Chae Ri; Kim, Dae Yul			Effects of anodal transcranial direct current stimulation (tDCS) on behavioral and spatial memory during the early stage of traumatic brain injury in the rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Direct current stimulation; tDCS; Neuromodulation; Traumatic brain injury; TBI; BDNF; Memory	NONINVASIVE CORTICAL STIMULATION; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN MOTOR CORTEX; VOLUNTARY EXERCISE; DC-STIMULATION; UP-REGULATION; EXCITABILITY; PLASTICITY; NEURONS; MODEL	Transcranial direct current stimulation (tDCS) is a noninvasive technique to modulate the neural membrane potential. Its effects in the early stage of traumatic brain injury (TBI) have rarely been investigated. This study assessed the effects of anodal tDCS on behavioral and spatial memory in a rat model of traumatic brain injury. Thirty six rats underwent lateral fluid percussion and were then randomly assigned to one of three groups: control (n = 12), five-day tDCS over peri-lesional cortex at one (1W, n = 12), or two (2W, n = 12) weeks post injury. The Barnes maze (BM) and Rotarod (RR) tests were evaluated in a blind manner on day 1, week 3 and week 5 post-injury. After three weeks, both the 1W and 2W groups showed significant improvements in the BM ratio (P < 0.05), whereas only group 2W obtained a significant improvement in the RR ratio compared with the control group (P < 0.05). However, there were no significant differences between any of the groups at five weeks after TBI. Immunohistochemistry revealed that only group 2W had a significantly higher brain derived neurotrophic factor (BDNF) expression in the peri-lesional cortex, which was significantly correlated with the improvement of the Rotarod test at 3-week post-injury. However, BDNF expression in the ipsilesional hippocampus was not significantly different among the three groups. Group 1W tended to have increased choline/creatine ratios, as measured by magnetic resonance spectroscopy in the peri-lesional cortex, than the control group (P = 0.051). Neither regimen aggravated the lesion volume or brain edema measured by MRI. These beneficial effects were not observed with either regimen at five weeks post-injury. In conclusions, anodal tDCS ameliorated behavioral and spatial memory function in the early phase after TBI when it is delivered two weeks post-injury. Earlier stimulation (one week post-injury) improves spatial memory only. However, the beneficial effects did not persist after cessation of the anodal stimulation. (C) 2016 Elsevier B.V. All rights reserved.	[Yoon, Kyung Jae; Lee, Yong-Taek] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Seoul, South Korea; [Yoon, Kyung Jae; Lee, Yong-Taek] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Regenerat & Neurosci Lab, Med Res Inst, Seoul, South Korea; [Chae, Seoung Wan] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Pathol, Seoul, South Korea; [Park, Chae Ri] Univ Ulsan, Coll Med, Asan Inst Life Sci, Ulsan, South Korea; [Kim, Dae Yul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Asanbyeongwon Gil 86, Seoul 138736, South Korea	Kim, DY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Asanbyeongwon Gil 86, Seoul 138736, South Korea.	kysmart@amc.seoul.kr			Asan Institute for Life Science, Seoul, Korea [2009-454]; Kangbuk Samsung Hospital; Samsung Biomedical Research Institute [SMX1132351]	This study was supported and funded by the Asan Institute for Life Science, Seoul, Korea (Task No.: 2009-454) and by Medical Research Funds from the Kangbuk Samsung Hospital and a grant from the Samsung Biomedical Research Institute [#SMX1132351].	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; de Berker AO, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00613; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Floel A, 2012, NEUROBIOL AGING, V33, P1682, DOI 10.1016/j.neurobiolaging.2011.05.007; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GARTSIDE IB, 1968, NATURE, V220, P382, DOI 10.1038/220382a0; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; ISLAM N, 1995, EXP NEUROL, V133, P25, DOI 10.1006/exnr.1995.1004; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Jiang T, 2012, NEUROSCIENCE, V226, P421, DOI 10.1016/j.neuroscience.2012.09.035; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Merzagora AC, 2010, NEUROIMAGE, V49, P2304, DOI 10.1016/j.neuroimage.2009.10.044; MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Yoon KJ, 2012, BRAIN RES, V1452, P61, DOI 10.1016/j.brainres.2012.02.062	37	16	16	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2016	362						314	320		10.1016/j.jns.2016.02.005			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DH1PW	WOS:000372558400062	26944170				2021-06-18	
J	Wong, TH; Krishnaswamy, G; Nadkarni, NV; Nguyen, HV; Lim, GH; Bautista, DCT; Chiu, MT; Chow, KY; Ong, MEH				Wong, Ting Hway; Krishnaswamy, Gita; Nadkarni, Nivedita Vikas; Nguyen, Hai V.; Lim, Gek Hsiang; Bautista, Dianne Carrol Tan; Chiu, Ming Terk; Chow, Khuan Yew; Ong, Marcus Eng Hock			Combining the new injury severity score with an anatomical polytrauma injury variable predicts mortality better than the new injury severity score and the injury severity score: a retrospective cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Injury severity score; New injury severity score; Polytrauma; Mortality; Outcome prediction	TRAUMATIC BRAIN-INJURY; MAJOR TRAUMA; BODY REGIONS; VALIDATION; DEFINITION; CARE; AGE; CLASSIFICATION; PERFORMANCE; ADMISSION	Background: Anatomy-based injury severity scores are commonly used with physiological scores for reporting severity of injury in a standardized manner. However, there is lack of consensus on choice of scoring system, with the commonly used injury severity score (ISS) performing poorly for certain sub-groups, eg head-injured patients. We hypothesized that adding a dichotomous variable for polytrauma (yes/no for Abbreviated Injury Scale (AIS) scores of 3 or more in at least two body regions) to the New Injury Severity Score (NISS) would improve the prediction of in-hospital mortality in injured patients, including head-injured patients-a subgroup that has a disproportionately high mortality. Our secondary hypothesis was that the ISS over-estimates the risk of death in polytrauma patients, while the NISS under-estimates it. Methods: Univariate and multivariable analysis was performed on retrospective cohort data of blunt injured patients aged 18 and over with an ISS over 9 from the Singapore National Trauma Registry from 2011-2013. Model diagnostics were tested using discrimination (c-statistic) and calibration (Hosmer-Lemeshow goodness-of-fit statistic). All models included age, gender, and comorbidities. Results: Our results showed that the polytrauma and NISS model outperformed the other models (polytrauma and ISS, NISS alone or ISS alone) in predicting 30-day and in-hospital mortality. The NISS underestimated the risk of death for patients with polytrauma, while the ISS overestimated the risk of death for these patients. When used together with the NISS and polytrauma, categorical variables for deranged physiology (systolic blood pressure of 90 mmHg or less, GCS of 8 or less) outperformed the traditional 'ISS and RTS (Revised Trauma Score)' model, with a c-statistic of greater than 0.90. This could be useful in cases when the RTS cannot be scored due to missing respiratory rate. Discussion: The NISS and polytrauma model is superior to current scores for prediction of 30-day and in-hospital mortality. We propose that this score replace the ISS or NISS in institutions using AIS-based scores. Conclusions: Adding polytrauma to the NISS or ISS improves prediction of 30-day mortality. The superiority of the NISS or ISS depends on the proportion of polytrauma and head-injured patients in the study population.	[Wong, Ting Hway] Singapore Gen Hosp, Dept Gen Surg, Outram Rd, Singapore 169608, Singapore; [Wong, Ting Hway; Krishnaswamy, Gita; Nadkarni, Nivedita Vikas; Nguyen, Hai V.; Bautista, Dianne Carrol Tan; Ong, Marcus Eng Hock] Duke Natl Univ Singapore, Singapore, Singapore; [Lim, Gek Hsiang; Chow, Khuan Yew] Hlth Promot Board, Singapore, Singapore; [Chiu, Ming Terk] Tan Tock Seng Hosp, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore 169608, Singapore	Wong, TH (corresponding author), Singapore Gen Hosp, Dept Gen Surg, Outram Rd, Singapore 169608, Singapore.; Wong, TH (corresponding author), Duke Natl Univ Singapore, Singapore, Singapore.	wong.ting.hway@singhealth.com.sg			Ministry of Health, SingaporeMinistry of Health-Singapore	The authors received no specific individual funding for this work. The collection and management of data for the National Trauma Registry is funded by the Ministry of Health, Singapore.	[Anonymous], 2012, HCUP CCS FACT SHEET; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balogh ZJ, 2003, J ORTHOP TRAUMA, V17, P508, DOI 10.1097/00005131-200308000-00006; Bouamra O, 2006, INJURY, V37, P1092, DOI 10.1016/j.injury.2006.07.029; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Butcher NE, 2014, J TRAUMA ACUTE CARE, V77, P620, DOI 10.1097/TA.0000000000000404; Caterino JM, 2010, AM J EMERG MED, V28, P151, DOI 10.1016/j.ajem.2008.10.027; CDC (CentersforDiseaseControlandPrevention), 2013, INT CLASS DIS 9 REV; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Di Bartolomeo S, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-26; Dillon B, 2006, EUR J TRAUMA, V32, P538; Gabbe BJ, 2003, ANZ J SURG, V73, P944, DOI 10.1046/j.1445-1433.2003.02833.x; Groven S, 2011, J TRAUMA, V70, P569, DOI 10.1097/TA.0b013e31820d1a9b; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hannan EL, 2005, J TRAUMA, V58, P244, DOI 10.1097/01.TA.0000141995.44721.44; Harwood PJ, 2006, J TRAUMA, V60, P334, DOI 10.1097/01.ta.0000197148.86271.13; Ho AFW, 2015, PREHOSP EMERG CARE, V19, P409, DOI 10.3109/10903127.2014.980477; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Jones JM, 2014, ACTA ANAESTH SCAND, V58, P303, DOI 10.1111/aas.12256; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lim J., 2013, MYTH MAGIC SINGAPORE; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; (MOH) MoH, 2014, POP VIT STAT; Moore L, 2006, J TRAUMA, V60, P802, DOI 10.1097/01.ta.0000200838.55420.ad; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; National Registry of Diseases Office (NRDO) HPB Singapore, 2014, SING NAT TRAUM REG A; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2015, INJURY, V46, P86, DOI 10.1016/j.injury.2014.08.026; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Samin OA, 1999, P ANN C ASS, P1; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; Whitaker Iveth Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P301; Wong TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137127; Wong TH, 2013, J TRAUMA ACUTE CARE, V74, P780, DOI 10.1097/TA.0b013e3182826d5f	48	16	18	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 8	2016	24								25	10.1186/s13049-016-0215-6			11	Emergency Medicine	Emergency Medicine	DF8FI	WOS:000371592400002	26955863	DOAJ Gold, Green Published			2021-06-18	
J	Fang, F; Hallmarker, U; James, S; Ingre, C; Michaelsson, K; Ahlbom, A; Feychting, M				Fang, Fang; Hallmarker, Ulf; James, Stefan; Ingre, Caroline; Michaelsson, Karl; Ahlbom, Anders; Feychting, Maria			Amyotrophic lateral sclerosis among cross-country skiers in Sweden	EUROPEAN JOURNAL OF EPIDEMIOLOGY			English	Article						Amyotrophic lateral sclerosis; Cross-country ski; Physical activity; Longitudinal study	CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL PLAYERS; MOTOR-NEURON DISEASE; GULF-WAR VETERANS; BRAIN-INJURY; PHYSICAL-ACTIVITY; INCREASED RISK; HEAD-INJURY; ALS; MORTALITY	A highly increased risk of amyotrophic lateral sclerosis (ALS) has been suggested among professional athletes. We aimed to examine whether long distance cross-country skiers have also a higher risk of ALS and whether the increased risk was modified by skiing performance. We followed 212,246 cross-country skiers in the Swedish Vasaloppet cohort and a random selection of 508,176 general Swedes not participating in the Vasaloppet during 1989-2010. The associations between cross-country skiing as well as skiing performance (i.e., type of race, finishing time and number of races) and the consequent risk of ALS were estimated through hazard ratios (HRs) derived from Cox model. During the study, 39 cases of ALS were ascertained among the skiers. The fastest skiers (100-150 % of winner time) had more than fourfold risk of ALS (HR 4.31, 95 % confidence interval [CI] 1.78-10.4), as compared to skiers that finished at > 180 % of winner time. Skiers who participated > 4 races during this period had also a higher risk (HR 3.13, 95 % CI 1.37-7.17) than those participated only one race. When compared to the non-skiers, the fastest skiers still had a higher risk (HR 2.08, 95 % CI 1.12-3.84), as skiers who had > 4 races (HR 1.88, 95 % CI 1.05-3.35), but those finishing at > 180 % of winner time had a lower risk (HR 0.46, 95 % CI 0.24-0.87). In conclusion, long distance cross-country skiing is associated with a higher risk of ALS, but only among the best skiers; recreational skiers appear to have a largely reduced risk.	[Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden; [Hallmarker, Ulf] Mora Hosp, Dept Internal Med, Mora, Sweden; [Hallmarker, Ulf; James, Stefan] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Hallmarker, Ulf; James, Stefan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Ingre, Caroline] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Ingre, Caroline] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Michaelsson, Karl] Uppsala Univ, Sect Orthoped, Dept Surg Sci, Uppsala, Sweden; [Ahlbom, Anders; Feychting, Maria] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	fang.fang@ki.se	Hallmarker, Ulf/ABC-5527-2020; James, Stefan K/J-4554-2014; Michaelsson, Karl/AAM-9094-2021	Ingre, Caroline/0000-0001-5327-7204; Michaelsson, Karl/0000-0003-2815-1217	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Society for Medical Research; Karolinska InstitutetKarolinska Institutet	This study was supported by the Swedish Research Council, the Swedish Society for Medical Research and the Karolinska Institutet.	Abel EL, 2007, PERCEPT MOTOR SKILL, V104, P1251, DOI 10.2466/PMS.104.4.1251-1254; Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; Bassini A, 2014, BIOCHEM BIOPH RES CO, V445, P708, DOI 10.1016/j.bbrc.2013.12.137; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Carlsson Sofia, 2007, Lakartidningen, V104, P670; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2002, J CLIN EPIDEMIOL, V55, P723, DOI 10.1016/S0895-4356(02)00409-2; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P205, DOI 10.1080/17482960902721634; del Aguila MA, 2003, NEUROLOGY, V60, P813, DOI 10.1212/01.WNL.0000049472.47709.3B; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029749; Farahmand BY, 2003, J INTERN MED, V253, P276, DOI 10.1046/j.1365-2796.2003.01122.x; FELMUS MT, 1976, NEUROLOGY, V26, P167, DOI 10.1212/WNL.26.2.167; GRANIERI E, 1988, NEUROLOGY, V38, P1604, DOI 10.1212/WNL.38.10.1604; GREGOIRE N, 1991, REV NEUROL-FRANCE, V147, P706; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Huisman MHB, 2013, J NEUROL NEUROSUR PS, V84, P976, DOI 10.1136/jnnp-2012-304724; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; ROELOFSIVERSON RA, 1984, NEUROLOGY, V34, P393, DOI 10.1212/WNL.34.3.393; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9	31	16	17	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0393-2990	1573-7284		EUR J EPIDEMIOL	Eur. J. Epidemiol.	MAR	2016	31	3					247	253		10.1007/s10654-015-0077-7			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	DI6WX	WOS:000373642000004	26220522				2021-06-18	
J	Fotakopoulos, G; Tsianaka, E; Siasios, G; Vagkopoulos, K; Fountas, K				Fotakopoulos, George; Tsianaka, Eleni; Siasios, Giannis; Vagkopoulos, Konstantinos; Fountas, Kostas			Posttraumatic Hydrocephalus after Decompressive Craniectomy in 126 Patients with Severe Traumatic Brain Injury	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						posttraumatic hydrocephalus; decompressive craniectomy	SEVERE HEAD-INJURY; RISK-FACTORS; INTERHEMISPHERIC HYGROMA; INTRACRANIAL-PRESSURE; SHUNT IMPLANTATION; MANAGEMENT	Objective Severe traumatic brain injuries (TBIs) occur frequently. In some of these patients decompressive craniectomy (DC) must be performed. Posttraumatic hydrocephalus (PTH) can develop after TBI further damaging the brain. DC is considered to be one of the causes of PTH. This study defines the incidence of PTH in TBI patients who underwent DC and tries to determine associated factors. Materials and Methods We conducted a retrospective study (2009-2013) that included 126 patients with severe TBI and DC. The collected data were demographics, the craniectomy size, the presence or absence of hydrocephalus, the need for changing the opening pressure of the valve of the cerebrospinal fluid (CSF) shunt or replacing all or parts of the CSF shunt, and the interval between cranioplasty and shunt placement. We excluded patients with additional intraventricular hemorrhage and those with bilateral or bifrontal DC. Results Ten of the 126 patients (7.9%) developed PTH and were treated with a CSF shunt. There was no statistical correlation between development of PTH and age or sex, but a statistically significant correlation between development of PTH and the size of DC. Conclusion Our study suggests that PTH development is multifactorial and shows that PTH is not that rare. We showed a correlation between craniectomy size and the incidence of PTH.	[Fotakopoulos, George; Tsianaka, Eleni; Siasios, Giannis; Vagkopoulos, Konstantinos; Fountas, Kostas] Univ Hosp Thesaly, Dept Neurosurg, Larisa 41110, Thesaly, Greece	Fotakopoulos, G (corresponding author), Univ Hosp Thesaly, Dept Neurosurg, Larisa 41110, Thesaly, Greece.	gfotakop@yahoo.gr	Siasios, Ioannis/AAQ-7123-2020	Siasios, Ioannis/0000-0001-7945-9604; fotakopoulos, george/0000-0002-2491-2886			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cho BR, 2012, KOREAN J NEUROTRAUMA, V8, P110; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Dandy WE, 1914, AM J DIS CHILD, V8, P406; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FOROGLOU G, 1972, Acta Radiologica Diagnosis, V13, P524; GAAB MR, 1990, ACT NEUR S, V51, P326; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guyot LL, 2000, NEUROL RES, V22, P25; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Iencean S, 2009, ROMANIAN NEUROSURG, V16, P17; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; Matsumoto S, 1990, ANN REV HYDROCEPHALU, V6, P147; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Pangilinan II PH, POSTTRAUMATIC HYDROC; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sarkari A, 2010, INDIAN J NEUROTRAUM, V7, P135, DOI 10.1016/S0973-0508(10)80028-0; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Snell RS, 2008, CLIN ANATOMY REGIONS, P450; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P281, DOI 10.1007/978-3-7091-1434-6_54; Takeuchi S, 2012, J NEUROTRAUM, V29, P1028, DOI 10.1089/neu.2010.1743; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Tribl G, 2000, BRAIN INJURY, V14, P345; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	46	16	23	0	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAR	2016	77	2					88	92		10.1055/s-0035-1558411			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DF1CE	WOS:000371075200002	26351868				2021-06-18	
J	Li, SJ; Eisenstadt, R; Kumasaka, K; Johnson, VE; Marks, J; Nagata, K; Browne, KD; Smith, DH; Pascual, JL				Li, Shengjie; Eisenstadt, Rachel; Kumasaka, Kenichiro; Johnson, Victoria E.; Marks, Joshua; Nagata, Katsuhiro; Browne, Kevin D.; Smith, Douglas H.; Pascual, Jose L.			Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	74th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 09-12, 2015	Las Vegas, NV	Amer Assoc Surg Trauma		Enoxaparin; HMGB1; TBI; Leukocyte; mice	TRAUMATIC BRAIN-INJURY; MOLECULAR-WEIGHT HEPARIN; MOBILITY GROUP BOX-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VIVO; LUNG INJURY; LEUKOCYTE EXTRAVASATION; STERILE INFLAMMATION; RATS; HEMORRHAGE	BACKGROUND Enoxaparin (ENX) has been shown to reduce cerebral edema and improve neurologic recovery after traumatic brain injury (TBI), through blunting of cerebral leukocyte (LEU) recruitment. High mobility group box 1 (HMGB1) protein may induce inflammation through LEU activation. We hypothesized that ENX after TBI reduces LEU-mediated edema through blockade of HMGB1 signaling. METHODS Twenty-three CD1 mice underwent severe TBI by controlled cortical impact and were randomized to one of four groups receiving either monoclonal antibody against HMGB1 (MAb) or isotype (Iso) and either ENX (1 mg/kg) or normal saline (NS): NS + Iso (n = 5), NS + MAb (n = 6), ENX + Iso (n = 6), ENX + MAb (n = 6). ENX or NS was administered 2, 8, 14, 23 and 32 hours after TBI. MAb or Iso (25 g) was administered 2 hours after TBI. At 48 hours, cerebral intravital microscopy served to visualize live LEU interacting with endothelium and microvascular fluorescein isothiocyanate-albumin leakage. The Neurological Severity Score (NSS) graded neurologic recovery; wet-to-dry ratios determined cerebral/lung edema. Analysis of variance with Bonferroni correction was used for statistical analyses. RESULTS ENX and MAb similarly reduced in vivo pial LEU rolling without demonstrating additive effect. In vivo albumin leakage was greatest in vehicle-treated animals but decreased by 25% with either MAb or ENX but by 50% when both were combined. Controlled cortical impact-induced cerebral wet-to-dry ratios were reduced by MAb or ENX without additive effect. Postinjury lung water was reduced by ENX but not by MAb. Neurologic recovery at 24 hours and 48 hours was similarly improved with ENX, MAb, or both treatments combined. CONCLUSION Mirroring ENX, HMGB1 signaling blockade reduces LEU recruitment, cerebrovascular permeability, and cerebral edema following TBI. ENX further reduced lung edema indicating a multifaceted effect beyond HMGB1 blockade. Further study is needed to determine how ENX may play a role in blunting HMGB1 signaling in brain injury patients.	[Li, Shengjie; Eisenstadt, Rachel; Kumasaka, Kenichiro; Marks, Joshua; Nagata, Katsuhiro; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Browne, Kevin D.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Li, Shengjie] Shandong Univ, Qianfoshan Hosp, Dept Neurosurg, Jinan 250100, Peoples R China	Pascual, JL (corresponding author), Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Dept Surg, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS094003, R01 NS092398] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092398, R01NS094003] Funding Source: NIH RePORTER		Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Daley MJ, 2015, AM SURGEON, V81, P207; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Li L, 2015, CYTOKINE, V72, P36, DOI 10.1016/j.cyto.2014.12.010; Li LF, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-90; Li LF, 2009, CRIT CARE, V13, DOI 10.1186/cc7949; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Liu Y, 2014, INT J CARDIOL, V176, P543, DOI 10.1016/j.ijcard.2014.07.027; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Maugeri N, 2007, THROMB HAEMOSTASIS, V97, P965, DOI 10.1160/TH06-12-0680; Miller SJ, 1998, THROMB HAEMOSTASIS, V80, P481; Ning FY, 2015, GENE, V557, P88, DOI 10.1016/j.gene.2014.12.018; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; RANA MW, 1992, J TRAUMA, V32, P420, DOI 10.1097/00005373-199204000-00003; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Robinson AP, 2013, J AUTOIMMUN, V43, P32, DOI 10.1016/j.jaut.2013.02.005; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; Uzawa A, 2013, CLIN EXP IMMUNOL, V172, P37, DOI 10.1111/cei.12036; Valle EJ, 2014, J TRAUMA ACUTE CARE, V77, P243, DOI 10.1097/TA.0000000000000307; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; WANG P, 1990, AM J PHYSIOL, V259, pR645; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	50	16	16	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2016	80	3					381	387		10.1097/TA.0000000000000935			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	DF7XT	WOS:000371571900007	26670109	Green Accepted			2021-06-18	
J	Mofid, B; Soltani, Z; Khaksari, M; Shahrokhi, N; Nakhaee, N; Karamouzian, S; Ahmadinejad, M; Maiel, M; Khazaeli, P				Mofid, Behshad; Soltani, Zahra; Khaksari, Mohammad; Shahrokhi, Nader; Nakhaee, Nouzar; Karamouzian, Saeed; Ahmadinejad, Mehdi; Maiel, Masoud; Khazaeli, Payam			What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Diffuse axonal injury; Interleukin-1 beta; Interleukin-6; Progesterone; Transforming growth factor-beta 1; Oxidant activity	TRAUMATIC BRAIN-INJURY; SEX STEROID-HORMONES; CLINICAL-TRIAL; HEAD-INJURY; DAMAGE; NEUROPROTECTION; EXPRESSION; CONTUSION; EDEMA; S100B	To permit appropriate targeted therapy, the present clinical study was aimed to investigate the effects of progesterone on the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury (DAI). Forty-eight male DAI patients were divided into two groups (control and progesterone). Progesterone group received progesterone in dose of 1 mg/kg per 12 h for five days. The outcome was investigated using Extended Glasgow Outcome Scale (GOS-E) and functional independence measure (FIM). The markers of inflammation Iinterleukin-1 beta (IL-1 beta), IL-6, transforming growth factor-beta 1 (TGF-beta 1)], injury (brain protein of S-100B), and oxidant activity [malondialdehyde (MDA)] were evaluated in the serum of the patients. Higher GOS-E and FIM scores were observed in progesterone group at the six-month follow-up (P < 0.05 and P < 0.01, respectively). Meanwhile, a reduction in the serum levels of IL-1 beta, MDA and S-100B was noticed in progesterone group 24 h after injury (P < 0.05, P < 0.001 and P < 0.05, respectively), and there was an increase in serum levels of IL-6 and TGF-beta 1 (P < 0.01 and P < 0.05, respectively). Also, lower levels of MDA and S-100B, and higher levels of TGF-beta 1 were observed in progesterone group six days after injury (P < 0.05). According to these findings, progesterone may improve the outcome in DAI patients probably through modulation in the levels of cytokines, and reduction in the injury and oxidant activity. (C) 2016 Elsevier B.V. All rights reserved.	[Mofid, Behshad; Karamouzian, Saeed] Kerman Univ Med Sci, Dept Neurosurg, Kerman, Iran; [Soltani, Zahra; Khazaeli, Payam] Kerman Univ Med Sci, Afzalipour Sch Med, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Khaksari, Mohammad; Nakhaee, Nouzar] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Ahmadinejad, Mehdi] Kerman Univ Med Sci, Dept Intens Care Unit, Kerman, Iran; [Maiel, Masoud] Kerman Univ Med Sci, Dept Emergency Med, Kerman, Iran	Soltani, Z (corresponding author), Kerman Univ Med Sci, Afzalipour Sch Med, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran.	soltaniy@yahoo.com	ahmadinejad, mehdi/AAK-1149-2020; khazaeli, Payam/AAP-5842-2021; Haddad, Mohammad Khaksari/AAB-9025-2019; Soltani, Zahra/AAC-1350-2019; Shahrokhi, Nader/AAV-3747-2020; Khazaeli, Payam/L-1837-2018; Nakhaee, Nouzar/AAZ-2677-2020	khazaeli, Payam/0000-0001-8914-3187; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Soltani, Zahra/0000-0002-8423-6189; Shahrokhi, Nader/0000-0002-0149-7819; Nakhaee, Nouzar/0000-0001-5808-6503			Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Clark D. D., 1999, BASIC NEUROCHEMISTRY, P637; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Hanafy KA, 2012, NEUROTHERAPEUTICS, V9, P44, DOI 10.1007/s13311-011-0085-6; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Herrmann M, 2004, RESTOR NEUROL NEUROS, V22, P57; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI 10.1139/y10-103; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Mertsch K, 2001, NEUROSCI LETT, V314, P135, DOI 10.1016/S0304-3940(01)02299-6; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stein D., 2014, HDB CLIN NEUROL, V127, P433; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	73	16	17	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	MAR	2016	32						103	110		10.1016/j.intimp.2016.01.015			8	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	DF2QM	WOS:000371188900014	26803522	Green Accepted			2021-06-18	
J	Yellinek, S; Cohen, A; Merkin, V; Shelef, I; Benifla, M				Yellinek, Shlomi; Cohen, Avi; Merkin, Vladimir; Shelef, Ilan; Benifla, Mony			Clinical significance of skull base fracture in patients after traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Brain injury; CSF leak; Skull base fractures	CEREBROSPINAL-FLUID FISTULA; TEMPORAL BONE-FRACTURES; HEAD-INJURY; MANAGEMENT; MENINGITIS; METAANALYSIS; GUIDELINES; LEAKAGE	About 4% of all head injuries include skull base fractures. Most of these fractures (90%) are secondary to closed head trauma; the remainder are due to penetrating trauma. We reviewed the records from January 2006 through December 2008 of all patients older than 18 years of age who arrived at Soroka Medical Center in Be'er-Sheva, Israel, with skull base fractures following a traumatic brain injury (TBI). We identified 107 patients with a mean age of 42 years at the time of TBI. Glasgow Coma score on arrival predicted the clinical outcome. We observed temporal fractures in 30% of these patients, occipital fractures in 20%, pyramidal fractures in 19%, anterior skull base fractures in 17%, and multiple fractures in 14%. Cerebrospinal fluid (CSF) leak was observed in 16 patients (15%). Of the patients experiencing CSF leaks, otorrhea occurred in 10 (62%) and rhinorrhea occurred in six (37%). Three patients required surgical intervention to repair the leak. Meningitis occurred in four patients with clinically evident CSF leak. Multiple skull base fractures are associated with poor neurological outcome. The low rate of meningitis in this patient sample implies that there is no indication to administer prophylactic antibiotics to patients with skull base fractures. (C) 2015 Elsevier Ltd. All rights reserved.	[Yellinek, Shlomi; Cohen, Avi; Merkin, Vladimir] Soroka Med Ctr, Dept Neurosurg, IL-84101 Beer Sheva, Israel; [Yellinek, Shlomi; Cohen, Avi; Merkin, Vladimir; Shelef, Ilan] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Shelef, Ilan] Soroka Med Ctr, Neuroradiol Div, IL-84101 Beer Sheva, Israel; [Benifla, Mony] Hadassah Med Ctr, Dept Neurosurg, Kiryat Haddasah, IL-91120 Jerusalem, Israel	Benifla, M (corresponding author), Hadassah Med Ctr, Dept Neurosurg, Kiryat Haddasah, IL-91120 Jerusalem, Israel.	Benifla@hadassah.org.il		shelef, ilan/0000-0002-8398-6455			Abuabara Allan, 2007, Med Oral Patol Oral Cir Bucal, V12, pE397; APPELBAUM E, 1960, JAMA-J AM MED ASSOC, V173, P1818, DOI 10.1001/jama.1960.03020340036010; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Brodie HA, 1997, AM J OTOL, V18, P188; CHEE CP, 1991, AUST NZ J SURG, V61, P597, DOI 10.1111/j.1445-2197.1991.tb00299.x; Connor SEJ, 2005, CLIN RADIOL, V60, P878, DOI 10.1016/j.crad.2005.04.003; Dalgic A, 2008, MINIM INVAS NEUROSUR, V51, P154, DOI 10.1055/s-2008-1042437; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; Friedman J A, 2000, Neurosurg Focus, V9, pe1, DOI 10.3171/foc.2000.9.1.1; GLARNER H, 1994, J TRAUMA, V36, P198, DOI 10.1097/00005373-199402000-00009; Iacob G, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P643; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; Kerman M, 2002, NEUROSURG QUART, V12, P23, DOI 10.1097/00013414-200203000-00003; LEECH PJ, 1973, LANCET, V1, P1013; Legros B, 2000, J TRAUMA, V48, P342, DOI 10.1097/00005373-200002000-00031; Liu CC, 2009, INJURY, V40, P595, DOI 10.1016/j.injury.2008.11.014; Mandrioli S, 2008, J CRANIOFAC SURG, V19, P713, DOI 10.1097/SCS.0b013e31816aac44; MCGUIRT WF, 1995, LARYNGOSCOPE, V105, P359, DOI 10.1288/00005537-199504000-00003; Rocchi G, 2005, SURG NEUROL, V63, P559, DOI 10.1016/j.surneu.2004.07.047; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Schuknecht B, 2005, EUR RADIOL, V15, P560, DOI 10.1007/s00330-004-2631-7; Servais L, 2005, CHILD NERV SYST, V21, P339, DOI 10.1007/s00381-004-1022-3; Shohet MR, 2008, FACIAL PLAST SURG, V24, P129, DOI 10.1055/s-2008-1037454; Tasdemiroglu E, 2002, NEUROSURG QUART, V12, P42; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Yidirim A, 2005, PEDIATR EMERG CARE, V21, P440, DOI 10.1097/01.pec.0000169435.36938.6d; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	30	16	18	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2016	25						111	115		10.1016/j.jocn.2015.10.012			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DE0HA	WOS:000370304500021	26724846				2021-06-18	
J	Liu, CX; Ye, YJ; Zhou, Q; Zhang, RJ; Zhang, H; Liu, W; Xu, C; Liu, L; Huang, SL; Chen, L				Liu, Chunxiao; Ye, Yangjing; Zhou, Qian; Zhang, Ruijie; Zhang, Hai; Liu, Wen; Xu, Chong; Liu, Lei; Huang, Shile; Chen, Long			Crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR signaling pathway leading to neuronal apoptosis	ONCOTARGET			English	Article						rotenone; apoptosis; calcium ion; CaMKII; H2O2; mTOR; Pathology	PROTEIN-KINASE-II; TRAUMATIC BRAIN-INJURY; MEDIATED S6K1; OXIDATIVE STRESS; CELL-DEATH; CALCIUM; ACTIVATION; INVOLVEMENT; SUPPRESSION; DAMAGE	Rotenone, a neurotoxic pesticide, induces loss of dopaminergic neurons related to Parkinson's disease. Previous studies have shown that rotenone induces neuronal apoptosis partly by triggering hydrogen peroxide (H2O2)-dependent suppression of mTOR pathway. However, the underlying mechanism is not fully understood. Here, we show that rotenone elevates intracellular free calcium ion ([Ca2+](i)) level, and activates CaMKII, resulting in inhibition of mTOR signaling and induction of neuronal apoptosis. Chelating [Ca2+](i) with BAPTA/AM, preventing extracellular Ca2+ influx using EGTA, inhibiting CaMKII with KN93, or silencing CaMKII significantly attenuated rotenone-induced H2O2 production, mTOR inhibition, and cell death. Interestingly, using TTFA, antimycin A, catalase or Mito-TEMPO, we found that rotenone-induced mitochondrial H2O2 also in turn elevated [Ca2+](i) level, thereby stimulating CaMKII, leading to inhibition of mTOR pathway and induction of neuronal apoptosis. Expression of wild type mTOR or constitutively active S6K1, or silencing 4E-BP1 strengthened the inhibitory effects of catalase, Mito-TEMPO, BAPTA/AM or EGTA on rotenone-induced [Ca2+](i) elevation, CaMKII phosphorylation and neuronal apoptosis. Together, the results indicate that the crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR-mediated S6K1 and 4E-BP1 pathways. Our findings suggest that how to control over-elevation of intracellular Ca2+ and overproduction of mitochondrial H2O2 may be a new approach to deal with the neurotoxicity of rotenone.	[Liu, Chunxiao; Ye, Yangjing; Zhou, Qian; Zhang, Ruijie; Zhang, Hai; Liu, Wen; Xu, Chong; Chen, Long] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Liu, Lei; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Chen, L (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.; Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.; Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.	shuan1@lsuhsc.edu; lchen@njnu.edu.cn	Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271416]; Project for the Priority Academic Program Development; Natural Science Foundation of Jiangsu Higher Education Institutions of China [10KJA180027]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA115414]; American Cancer SocietyAmerican Cancer Society [RSG-08-135-01-CNE]; Louisiana Board of Regents [NSF-2009-PFUND-144]; Innovative Research Program of Jiangsu College Graduate of China [KYLX15_0733]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA115414] Funding Source: NIH RePORTER	This work was supported in part by the grants from National Natural Science Foundation of China (81271416; L.C.), Project for the Priority Academic Program Development and Natural Science Foundation of Jiangsu Higher Education Institutions of China (10KJA180027; L.C.), NIH (CA115414; S.H.), American Cancer Society (RSG-08-135-01-CNE; S.H.). Louisiana Board of Regents (NSF-2009-PFUND-144; S.H.), and Innovative Research Program of Jiangsu College Graduate of China (KYLX15_0733; C.L.).	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Bao L, 2005, J NEUROSCI, V25, P10029, DOI 10.1523/JNEUROSCI.2652-05.2005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bian XP, 1997, AM J PHYSIOL-CELL PH, V272, pC1241; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen L, 2011, FREE RADICAL BIO MED, V50, P624, DOI 10.1016/j.freeradbiomed.2010.12.032; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen S, 2014, NEUROPATH APPL NEURO, V40, P759, DOI 10.1111/nan.12103; Chen SJ, 2011, J NEUROCHEM, V119, P1108, DOI 10.1111/j.1471-4159.2011.07493.x; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; Fernandez M, 2011, INT J PHARMACEUT, V419, P271, DOI 10.1016/j.ijpharm.2011.07.029; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; Freestone PS, 2009, EUR J NEUROSCI, V30, P1849, DOI 10.1111/j.1460-9568.2009.06990.x; Gao HM, 2003, J NEUROSCI, V23, P1228; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hao BH, 2013, ANTIMICROB AGENTS CH, V57, P326, DOI 10.1128/AAC.01366-12; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Koopman WJH, 2010, ANTIOXID REDOX SIGN, V12, P1431, DOI 10.1089/ars.2009.2743; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Moreno-Sanchez R, 2013, FEBS J, V280, P927, DOI 10.1111/febs.12086; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Rodriguez-Rocha H, 2013, FREE RADICAL BIO MED, V61, P370, DOI 10.1016/j.freeradbiomed.2013.04.021; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Swarnkar S, 2010, TOXICOLOGY, V272, P17, DOI 10.1016/j.tox.2010.03.019; Swarnkar S, 2012, ARCH TOXICOL, V86, P1387, DOI 10.1007/s00204-012-0853-z; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Taetzsch T, 2013, J BIOCHEM MOL TOXIC, V27, P137, DOI 10.1002/jbt.21464; Tamilselvam K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/102741; Toescu EC, 2007, AGING CELL, V6, P265, DOI 10.1111/j.1474-9726.2007.00299.x; Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b; Wang XH, 2005, NEUROSCI LETT, V376, P127, DOI 10.1016/j.neulet.2004.11.041; Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Xu LJ, 2014, J APPL TOXICOL, V34, P651, DOI 10.1002/jat.2890; Xu YJ, 2014, CELL SIGNAL, V26, P1680, DOI 10.1016/j.cellsig.2014.04.009; Yamanaka A, 2007, ARCH BIOCHEM BIOPHYS, V466, P234, DOI 10.1016/j.abb.2007.06.009; Yeh YT, 2014, FREE RADICAL BIO MED, V74, P1, DOI 10.1016/j.freeradbiomed.2014.06.008; Zhou Q, 2015, TOXICOL SCI, V143, P81, DOI 10.1093/toxsci/kfu211	60	16	17	1	7	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	FEB 16	2016	7	7					7534	7549		10.18632/oncotarget.7183			16	Oncology; Cell Biology	Oncology; Cell Biology	DE0PD	WOS:000370325900015	26859572	Green Published, Other Gold			2021-06-18	
J	Cirulis, MM; Hamele, MT; Stockmann, CR; Bennett, TD; Bratton, SL				Cirulis, Meghan M.; Hamele, Mitchell T.; Stockmann, Chris R.; Bennett, Tellen D.; Bratton, Susan L.			Comparison of the New Adult Ventilator-Associated Event Criteria to the Centers for Disease Control and Prevention Pediatric Ventilator-Associated Pneumonia Definition (PNU2) in a Population of Pediatric Traumatic Brain Injury Patients	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; ventilator-associated condition; ventilator-associated event; ventilator-associated pneumonia	CARE-ASSOCIATED INFECTIONS; SAFETY NETWORK; BRONCHOALVEOLAR LAVAGE; SURVEILLANCE PARADIGM; CHILDREN; DIAGNOSIS; HYPOTHERMIA; COMPLICATIONS; PREVALENCE; VALIDATION	Objectives: The new Centers for Disease Control and Prevention paradigm for ventilator-associated events is intended to simplify surveillance of infectious and noninfectious complications of mechanical ventilation in adults. We assessed the ventilator-associated events algorithm in pediatric patients. Design: A retrospective observational cohort study. Setting: This single-center study took place in a PICU at an urban academic medical facility. Patients: Pediatric (ages 0-18 yr old) trauma patients with moderate-to-severe traumatic brain injury ventilated for greater than or equal to 2 days. Measurements and Main Results: We assessed for pediatric ventilator-associated pneumonia (as defined by current Centers for Disease Control and Prevention PNU2 guidelines), adult ventilator-associated events, and an experimental ventilator-associated events definition modified for pediatric patients. We compared ventilator-associated events to ventilator-associated pneumonia to calculate the test characteristics. Thirty-nine of 119 patients (33%) developed ventilator-associated pneumonia. Sensitivity of the adult ventilator-associated condition definition was 23% (95% CI, 11-39%), which increased to 56% (95% CI, 40-72%) using the modified pediatric ventilator-associated pneumonia criterion. Specificity reached 100% for both original and modified pediatric probable ventilator-associated pneumonia using ventilator-associated events criteria. Children who developed ventilator-associated pneumonia or ventilator-associated condition had similar baseline characteristics: age, mechanism of injury, injury severity scores, and use of an intracranial pressure monitor. Diagnosis of ventilator-associated pneumonia and ventilator-associated condition portended similarly unfavorable outcomes: longer median duration of ventilation, ICU and hospital length of stay, and more discharges to rehabilitation, home health, or nursing care compared with patients with no pulmonary complication. Conclusions: Both current and modified ventilator-associated events criteria have poor sensitivity but good specificity in identifying pediatric ventilator-associated pneumonia. Despite poor sensitivity, the high specificity of the ventilator-associated events diagnoses does provide a useful and objective metric for interinstitution ICU comparison. Ventilator-associated pneumonia and ventilator-associated condition were both associated with excess morbidity in pediatric traumatic brain injury patients.	[Cirulis, Meghan M.; Stockmann, Chris R.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Cirulis, Meghan M.] Univ Utah, Internal Med Pediat Residency Program, Salt Lake City, UT USA; [Hamele, Mitchell T.; Bratton, Susan L.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Bennett, Tellen D.] Univ Colorado, Dept Pediat, Sch Med, Pediat Crit Care, Aurora, CO USA	Cirulis, MM (corresponding author), Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA.; Cirulis, MM (corresponding author), Univ Utah, Internal Med Pediat Residency Program, Salt Lake City, UT USA.	meghan.cirulis@hsc.utah.edu	Sherwin, Catherine Mary Turner/B-2888-2012	Sherwin, Catherine Mary Turner/0000-0002-0844-3207; Bratton, Susan/0000-0002-4605-8078; Bennett, Tellen/0000-0003-1483-4236	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NICHD K23 HD074620]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	Dr. Cirulis received support for article research from the National Institutes of Health (NIH) (Dr. Bennett was supported by NICHD K23 HD074620). Dr. Hamele disclosed government work (This work was not part of his official duties for the U.S. government as an Army medical officer). He is an active duty United States Army officer. The views in the article do not reflect those of the Army, the Department of Defense, or the U.S. government and are those of the authors alone. Dr. Bennett received support for article research from the NIH. His institution received financial support from NICHD. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/NEU.2013.2904, 10.1089/neu.2013.2904]; Bigham MT, 2009, J PEDIAT, V154; Boyer AF, 2015, CHEST, V147, P68, DOI 10.1378/chest.14-0544; Conway P, ASL US EFFORTS REDUC; Curley MAQ, 2006, PEDIATR CLIN N AM, V53, P1231, DOI 10.1016/j.pcl.2006.09.001; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; Foglia E, 2007, CLIN MICROBIOL REV, V20, P409, DOI 10.1128/CMR.00041-06; Gauvin France, 2003, Pediatr Crit Care Med, V4, P437, DOI 10.1097/01.PCC.0000090290.53959.F4; Gupta S, 2015, PEDIATR CRIT CARE ME, V16, pE65, DOI 10.1097/PCC.0000000000000338; Hamele M, 2015, J NEUROTRAUMA; Hayashi Y, 2013, CLIN INFECT DIS, V56, P471, DOI 10.1093/cid/cis926; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kallel H, 2005, J TRAUMA, V59, P705, DOI 10.1097/01.ta.0000177749.09844.c6; Klompas M, 2007, ANN INTERN MED, V147, P803, DOI 10.7326/0003-4819-147-11-200712040-00013; Klompas M, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0430-0; Klompas M, 2012, CRIT CARE, V16, DOI 10.1186/cc11656; Klompas M, 2013, NEW ENGL J MED, V368, P1472, DOI 10.1056/NEJMp1300633; Klompas M, 2012, CRIT CARE MED, V40, P3154, DOI 10.1097/CCM.0b013e318260c6d9; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062; Klouwenberg PMCK, 2014, AM J RESP CRIT CARE, V189, P947, DOI 10.1164/rccm.201307-1376OC; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Labenne M, 1999, CRIT CARE MED, V27, P2537, DOI 10.1097/00003246-199911000-00035; Lilly CM, 2014, CRIT CARE MED, V42, P2019, DOI 10.1097/CCM.0000000000000396; Magill SS, 2014, CURR OPIN INFECT DIS, V27, P394, DOI 10.1097/QCO.0000000000000083; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magill Shelley S, 2013, Ann Am Thorac Soc, V10, pS220, DOI 10.1513/AnnalsATS.201309-314OT; Muscedere J, 2013, CHEST, V144, P1453, DOI 10.1378/chest.13-0853; Patrick SW, 2014, PEDIATRICS, V134, P705, DOI 10.1542/peds.2014-0613; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Septimus Edward, 2015, Crit Care Med, V43, pe59, DOI 10.1097/CCM.0000000000000638; Skrupky LP, 2012, CRIT CARE MED, V40, P281, DOI 10.1097/CCM.0b013e31822d7913; Stevens JP, 2014, CRIT CARE MED, V42, P497, DOI 10.1097/CCM.0b013e3182a66903; Stoeppel CM, 2014, J TRAUMA ACUTE CARE, V77, P934, DOI 10.1097/TA.0000000000000425; Taira BR, 2009, PEDIATR CRIT CARE ME, V10, P491, DOI 10.1097/PCC.0b013e3181a3108d; Wheeler Derek S, 2011, Open Inflamm J, V4, P4; Willson DF, 2014, PEDIATR CRIT CARE ME, V15, P299, DOI 10.1097/PCC.0000000000000106	40	16	17	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2016	17	2					157	164		10.1097/PCC.0000000000000590			8	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	DD1HW	WOS:000369672900008	26673842	Green Accepted			2021-06-18	
J	Custer, A; Sufrinko, A; Elbin, RJ; Covassin, T; Collins, M; Kontos, A				Custer, Aimee; Sufrinko, Alicia; Elbin, R. J.; Covassin, Tracey; Collins, Micky; Kontos, Anthony			High Baseline Postconcussion Symptom Scores and Concussion Outcomes in Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; baseline testing; neurocognitive impairment	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; SPORT; RECOVERY; CARE; SEX	Context: Some healthy athletes report high levels of baseline concussion symptoms, which may be attributable to several factors (eg, illness, personality, somaticizing). However, the role of baseline symptoms in outcomes after sport-related concussion (SRC) has not been empirically examined. Objective: To determine if athletes with high symptom scores at baseline performed worse than athletes without baseline symptoms on neurocognitive testing after SRC. Design: Cohort study. Setting: High school and collegiate athletic programs. Patients or Other Participants: A total of 670 high school and collegiate athletes participated in the study. Participants were divided into groups with either no baseline symptoms (Postconcussion Symptom Scale [PCSS] score = 0, n = 247) or a high level of baseline symptoms (PCSS score > 18 [top 10% of sample], n = 68). Main Outcome Measure(s): Participants were evaluated at baseline and 2 to 7 days after SRC with the Immediate Postconcussion Assessment and Cognitive Test and PCSS. Outcome measures were Immediate Post-concussion Assessment and Cognitive Test composite scores (verbal memory, visual memory, visual motor processing speed, and reaction time) and total symptom score on the PCSS. The groups were compared using repeated-measures analyses of variance with Bonferroni correction to assess interactions between group and time for symptoms and neurocognitive impairment. Results: The no-symptoms group represented 38% of the original sample, whereas the high-symptoms group represented 11% of the sample. The high-symptoms group experienced a larger decline from preinjury to postinjury than the no-symptoms group in verbal (P = .03) and visual memory (P = .05). However, total concussion-symptom scores increased from preinjury to postinjury for the no-symptoms group (P = .001) but remained stable for the high-symptoms group. Conclusions: Reported baseline symptoms may help identify athletes at risk for worse outcomes after SRC. Clinicians should examine baseline symptom levels to better identify patients for earlier referral and treatment for their injury. Additional investigation of baseline symptoms is warranted to help delineate the type and severity of premorbid symptoms.	[Custer, Aimee; Sufrinko, Alicia; Collins, Micky; Kontos, Anthony] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Elbin, R. J.] Univ Arkansas, Fayetteville, AR 72701 USA; [Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA	Kontos, A (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310	University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders [1K01DC012332-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by grants to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Dr Kontos.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; IVERSON G, 2014, BRAIN INJURY, V28, P667; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; LARSEN RJ, 1991, J PERS, V59, P387, DOI 10.1111/j.1467-6494.1991.tb00254.x; MACLEOD C, 1991, International Review of Psychiatry, V3, P279, DOI 10.3109/09540269109110407; Manassis K, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-4; Matthews G., 2009, PERSONALITY TRAITS, VThird; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Michal M, 2011, J AFFECT DISORDERS, V134, P396, DOI 10.1016/j.jad.2011.05.033; Owens M, 2014, BRIT J PSYCHOL, V105, P92, DOI 10.1111/bjop.12009; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	33	16	16	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2016	51	2					136	141		10.4085/1062-6050-51.2.12			6	Sport Sciences	Sport Sciences	DK2OW	WOS:000374755300005	26885702	Green Published			2021-06-18	
J	Donders, J; Strong, CAH				Donders, Jacobus; Strong, Carrie-Ann H.			Latent Structure of the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) After Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Executive functioning; Mild traumatic brain injury; Factor analysis	ECOLOGICAL VALIDITY; WORKING-MEMORY; OLDER-ADULTS; SELF-REPORT; SYMPTOMS; TESTS; SCHIZOPHRENIA; MULTITASKING; IMPACT	One hundred persons with mild traumatic brain injury (TBI) and their informants completed the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) within 1-12 months after injury. Exploratory maximum-likelihood factor analysis with oblique rotation revealed that although a traditional 2-factor model fit the informant-report data well, a 3-factor solution fit the self-report data relatively best. These factors were labeled Metacognition, Behavioral Regulation, and Emotional Regulation. The presence of a premorbid history of outpatient psychiatric treatment was strongly predictive of higher scores (reflecting more perceived problems) on each of these 3 factors. Lower educational attainment was associated with higher scores on the Behavioral Regulation factor, whereas absence of intracranial findings on neuroimaging was associated with higher scores on the Emotional Regulation factor. It is concluded that, after mild TBI, self-report data on the BRIEF-A can be interpreted along a 3-factorial model and that high elevations on this instrument are strongly affected by premorbid complications.	[Donders, Jacobus; Strong, Carrie-Ann H.] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA	Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					American Educational Research Association, 2014, STAND ED PSYCH TEST; Anderson PJ, 2010, STUD NEUROPSYCHOL NE, P3; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Culbertson WC, 2005, TOWER LONDON DREXEL; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Fox J., 1991, REGRESSION DIAGNOSTI; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Hatcher L., 1994, STEP BY STEP APPROAC; Heaton R., 1993, WISCONSIN CARD SORTI; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; Laloyaux J, 2014, PSYCHIAT RES, V217, P163, DOI 10.1016/j.psychres.2014.03.026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levens SM, 2010, J EXP PSYCHOL GEN, V139, P654, DOI 10.1037/a0020283; Llewellyn CD, 2013, PSYCHO-ONCOLOGY, V22, P97, DOI 10.1002/pon.2065; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Murphy KR, 2004, STAT POWER ANAL; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Pietrzak RH, 2013, DEPRESS ANXIETY, V30, P432, DOI 10.1002/da.22083; Power BD, 2012, J NEUROPSYCH CLIN N, V24, P215, DOI 10.1176/appi.neuropsych.11060145; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Roth R.M., 2005, BEHAV RATING INVENTO; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Van der Elst W, 2008, ARCH CLIN NEUROPSYCH, V23, P787, DOI 10.1016/j.acn.2008.09.002; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339	41	16	16	4	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2016	31	1					29	36		10.1093/arclin/acv048			8	Psychology, Clinical; Psychology	Psychology	DD8QQ	WOS:000370192400006	26209247				2021-06-18	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Injury of the Ascending Reticular Activating System in Patients With Fatigue and Hypersomnia Following Mild Traumatic Brain Injury Two Case Reports	MEDICINE			English	Article							AROUSAL SYSTEM; CONNECTIVITY; SLEEPINESS	We report on patients with post-traumatic fatigue and hypersomnia who showed injury of the lower portion of the ascending reticular activating system (ARAS) between the pontine reticular formation (RF) and the intralaminar thalamic nucleus (ILN) following mild traumatic brain injury (TBI), using diffusion tensor tractography (DTT). Two patients with mild TBI resulting from a car accident were enrolled in this study. Patient 1 was a 51-year-old woman showed abnormalities as 6.9 (cut off: 3.7 points) and 18 (cut off: 10) on the Fatigue Severity Scale and the Epworth Sleepiness Scale at 11 months after onset. Patient 2 was a 64-year-old woman who revealed abnormalities on the Fatigue Severity Scale and the Epworth Sleepiness Scale with 6.8 and 19 at 3 months after onset. In both patients, the upper ARAS in which the neural connectivity of the ILN to the cerebral cortex did not show significant abnormalities. However, we observed the narrowing of the left dorsal lower ARAS between the pontine RF and the ILN in both patients and the tearing (patient 1) and narrowing (patient 2) of the left ventral lower ARAS between the pontine RF and the hypothalamus. Injuries of the dorsal and ventral lower ARAS were demonstrated in patients with fatigue and hypersomnia following mild TBI. We believe that these injuries of the ARAS might be a pathogenetic mechanism of fatigue and hypersomnia in patients with TBI.	[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Taegu, South Korea	Kwon, HG (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Taegu, South Korea.	khg0715@hanmail.net			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2015R1A2A2A01004073]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A2A2A01004073).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Jang SH, 2015, NEUROSCI LETT, V590, P58, DOI 10.1016/j.neulet.2015.01.071; Jang SH, 2015, AM J PHYS MED REHAB, V94, P250, DOI 10.1097/PHM.0000000000000274; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; Menzler K, 2012, SLEEP MED, V13, P736, DOI 10.1016/j.sleep.2012.02.013; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tapia JA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.129; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yassin W, 2015, J CLIN SLEEP MED, V11, P581, DOI 10.5664/jcsm.4710; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	19	16	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2016	95	6							e2628	10.1097/MD.0000000000002628			3	Medicine, General & Internal	General & Internal Medicine	DE5CL	WOS:000370648500001	26871783	DOAJ Gold, Green Published			2021-06-18	
J	Wong, JC; Linn, KA; Shinohara, RT; Mateen, FJ				Wong, J. C.; Linn, K. A.; Shinohara, R. T.; Mateen, F. J.			Traumatic brain injury in Africa in 2050: a modeling study	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						acute brain injury; adolescent; adult; epidemiology	KENYA	Background and purposeOur aim was to provide estimates of traumatic brain injury (TBI) in 2050 for the African population by region, sex and age strata. MethodsA literature search was performed in October 2014 in PubMed for population-based studies of TBI in different geographical locations. Articles were selected from Kenya (model 1), New Zealand (model 2) and the USA (model 3). In model 1, rates of road traffic injury in Kenya were used to estimate TBI rates in the African continent. Models 2 and 3 used existing TBI incidence estimates from other locations to estimate the burden of TBI for Africa in 2050. The 2050 African population, as projected by the United Nations, was used as a base population. ResultsBased on rates from model 1, the estimated total TBI count in Africa in 2050 is 5.98 0.03 million, with the highest count in eastern (2.04 +/- 0.01 million) and lowest count in southern (0.15 +/- 0.00 million) Africa. A higher TBI count is predicted by models 2 (14.25 +/- 0.75 million) and 3 (10.40 +/- 0.02 million). Estimated TBI count is highest for males aged 15-34 (5.47 +/- 0.55 million in model 2 and 3.21 +/- 0.13 million in model 3). ConclusionsProjected estimates of TBI in Africa are high, with a burden of anywhere between approximately 6 and 14 million new cases in 2050. This emphasizes the importance of developing accurate surveillance systems of TBI at a population level and public health measures to mitigate the risk and burden of TBI.	[Wong, J. C.; Mateen, F. J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wong, J. C.; Mateen, F. J.] Harvard Univ, Sch Med, Boston, MA USA; [Wong, J. C.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Linn, K. A.; Shinohara, R. T.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	Mateen, FJ (corresponding author), Massachusetts Gen Hosp, Neurol Clin Res Inst, Dept Neurol, 165 Cambridge St,627, Boston, MA 02114 USA.	fmateen@partners.org		Mateen, Farrah/0000-0002-4293-8115			Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; [Anonymous], STAK AFF SAMRC; Bachani AM, 2012, TRAFFIC INJ PREV, V13, P24, DOI 10.1080/15389588.2011.633136; Chinda J Y, 2013, Afr J Paediatr Surg, V10, P358, DOI 10.4103/0189-6725.125448; Department of Economic and Social Affairs PD, 2012, WORLD POP PROSP 2012; Department of Economic and Social Affairs PD, 2004, WORLD POP 2300; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Mbakile-Mahlanza L, 2015, NEUROPSYCHOL REHABIL, V25, P936, DOI 10.1080/09602011.2014.999000; Muyembe VM, 1999, E AFR MED J, V76, P200; Saidi Hassan, 2014, J Trauma Manag Outcomes, V8, P4, DOI 10.1186/1752-2897-8-4; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043	16	16	16	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	FEB	2016	23	2					382	386		10.1111/ene.12877			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DB8WE	WOS:000368797100034	26435298				2021-06-18	
J	Scott, KL; Strong, CAH; Gorter, B; Donders, J				Scott, Katie L.; Strong, Carrie-Ann H.; Gorter, Bethany; Donders, Jacobus			Predictors of Post-concussion Rehabilitation Outcomes at Three-month Follow-up	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild traumatic brain injury; Rehabilitation.; Outcome measurement	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSIVE SYMPTOMS; METAANALYSIS; PERFORMANCE	Objective: To determine factors related to three-month follow-up outcomes for individuals participating in an outpatient rehabilitative treatment program for mild traumatic brain injury (TBI). Method: Fifty participants underwent neuropsychological screening prior to treatment initiation and completed the Mayo-Portland Adaptability Inventory-4 (MPAI-4) at treatment initiation, discharge from treatment, and three months following discharge. Results: Regression models indicated that information garnered from the neuropsychological screening prior to treatment initiation (e.g., mood symptoms and prior psychiatric history) accounted for unique variance in three-month post-discharge outcomes on several MPAI-4 subscales. Specifically, after controlling for baseline MPAI-4 ratings, higher Beck Depression Inventory-second edition (BDI-II) scores were associated with worse MPAI-4 Ability scores at three-month follow-up, and the presence of a psychiatric history was associated with worse MPAI-4 Adjustment scores at three-month follow-up. Conclusions: Neuropsychological screening prior to the initiation of treatment for mild TBI can help to identify patients who may be at greater risk for poorer rehabilitation outcomes, thus allowing for the implementation of specific interventions to address these risk factors.	[Scott, Katie L.; Strong, Carrie-Ann H.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA; [Gorter, Bethany] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA	Strong, CAH (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	carrie.strong@maryfreebed.com					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Beck A., 1996, BECK DEPRESSION INVE, DOI [DOI 10.1037/T00742-000, 10.1037/t00742-000]; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Fox J, 1991, QUANTITATIVE APPL SO; Harrell F.E., 2001, REGRESSION MODELING, P568, DOI [10.1007/978-1-4757-3462-1, DOI 10.1007/978-1-4757-3462-1]; Heaton RK, 2004, REVISED COMPREHENSIV; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Leininger S, 2014, J HEAD TRAUMA REHAB, V29, P109, DOI 10.1097/HTR.0b013e3182860506; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malec J., 2008, MANUAL MAYO PORTLAND; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; McCrea M, 2008, MILD TRAUMATIC BRAIN; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Murphy KR, 2004, STAT POWER ANAL; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reitan R. M., 1985, HALSTEED REITAN NEUR; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	41	16	16	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2016	30	1					66	81		10.1080/13854046.2015.1127427			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DH4CM	WOS:000372733100005	26732525				2021-06-18	
J	Adams, RS; Larson, MJ; Corrigan, JD; Ritter, GA; Horgan, CM; Bray, RM; Williams, TV				Adams, Rachel Sayko; Larson, Mary Jo; Corrigan, John D.; Ritter, Grant A.; Horgan, Constance M.; Bray, Robert M.; Williams, Thomas V.			Combat-Acquired Traumatic Brain Injury, Posttraumatic Stress Disorder, and Their Relative Associations With Postdeployment Binge Drinking	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol drinking; combat; military personnel; path analysis; posttraumatic stress disorder; traumatic brain injury	PERSISTENT POSTCONCUSSIVE SYMPTOMS; ALCOHOL-RELATED PROBLEMS; DUTY MILITARY PERSONNEL; SUBSTANCE USE DISORDERS; WAR VETERANS; DEPLOYMENT RISK; MILD TBI; AFGHANISTAN; IRAQ; SOLDIERS	Objective: To examine whether experiencing a traumatic brain injury (TBI) on a recent combat deployment was associated with postdeployment binge drinking, independent of posttraumatic stress disorder (PTSD). Methods: Using the 2008 Department of Defense Survey of Health Related Behaviors among Active Duty Military Personnel, an anonymous survey completed by 28 546 personnel, the study sample included 6824 personnel who had a combat deployment in the past year. Path analysis was used to examine whether PTSD accounted for the total association between TBI and binge drinking. Main Measures: The dependent variable, binge drinking days, was an ordinal measure capturing the number of times personnel drank 5+ drinks on one occasion (4+ for women) in the past month. Traumatic brain injury level captured the severity of TBI after a combat injury event exposure: TBI-AC (altered consciousness only), TBI-LOC of 20 or less (loss of consciousness up to 20 minutes), and TBI-LOC of more than 20 (loss of consciousness >20 minutes). A PTSD-positive screen relied on the standard diagnostic cutoff of 50+ on the PTSD Checklist-Civilian. Results: The final path model found that while the direct effect of TBI (0.097) on binge drinking was smaller than that of PTSD (0.156), both were significant. Almost 70% of the total effect of TBI on binge drinking was from the direct effect; only 30% represented the indirect effect through PTSD. Conclusion: Further research is needed to replicate these findings and to understand the underlying mechanisms that explain the relationship between TBI and increased postdeployment drinking.	[Adams, Rachel Sayko; Larson, Mary Jo; Horgan, Constance M.] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02453 USA; [Ritter, Grant A.] Brandeis Univ, Schneider Inst Hlth Policy, Waltham, MA 02453 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Bray, Robert M.] RTI Int, Res Triangle Pk, NC USA; [Williams, Thomas V.] Def Hlth Agcy, Def Hlth Cost Assessment & Program Evaluat, Dept Def, Falls Church, VA USA	Adams, RS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02453 USA.	radams@brandeis.edu	Adams, Rachel/AAH-4653-2020		NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31AA021030, T32AA007567]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31AA021030, T32AA007567] Funding Source: NIH RePORTER	Funding for this study was provided by NIAAA grant F31AA021030 and NIAAA institutional training grant T32AA007567.	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; Babor T., 2001, ALCOHOL USE DISORDER, V2nd ed.; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2011, DEPLOYMENT PSYCHOL E, P175; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Bray R.M., 2009, 2008 DEP DEFENSE SUR; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brown JM, 2006, 0209842 RTI INT; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Centers for Disease Control and Prevention, 2008, DOD VA COD PROP FIN; Colder CR, 2001, PSYCHOL ADDICT BEHAV, V15, P237, DOI 10.1037/0893-164X.15.3.237; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, AM J PSYCHIAT, V170, P351, DOI 10.1176/appi.ajp.2012.12121602; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Department of Defence, 2012, DOD POL GUID MAN MIL; Department of Defence Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Deployment Health Clinical Center, 2011, TRAUMATIC BRAIN INJU; DOD Deployment Health Clinical Center, 2010, ENH POSTD HLTH ASS P; Dolan CA, 2008, MIL PSYCHOL, V20, P151, DOI 10.1080/08995600802115987; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Foran HM, 2011, J CONSULT CLIN PSYCH, V79, P521, DOI 10.1037/a0024110; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hatch SL, 2013, SOCIOL HEALTH ILL, V35, P1045, DOI 10.1111/1467-9566.12022; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Institute of Medicine, 2012, SUBST US DIS US ARM; Institute of Medicine, 2012, TREATM POSTTR STRESS; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keith TZ, 2006, MULTIPLE REGRESSION; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lande RG, 2008, J ADDICT DIS, V27, P115, DOI 10.1080/10550880802122711; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; National Institute on Alcohol Abuse and Alcoholism, 2005, NIH PUBLICATION, V07-3769; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P1579, DOI 10.1016/j.jpsychires.2011.07.010; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; StataCorp, 2011, STAT STAT SOFTW REL; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling J. J., 2012, PTSD MILD TRAUMATIC, P3; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Williams JL, 2012, MIL MED, V177, P789, DOI 10.7205/MILMED-D-12-00019; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492	86	16	16	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					13	22		10.1097/HTR.0000000000000082			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000009	25310293	Green Accepted			2021-06-18	
J	Bjugstad, KB; Rael, LT; Levy, S; Carrick, M; Mains, CW; Slone, DS; Bar-Or, D				Bjugstad, Kimberly B.; Rael, Leonard T.; Levy, Stewart; Carrick, Matthew; Mains, Charles W.; Slone, Denetta S.; Bar-Or, David			Oxidation-Reduction Potential as a Biomarker for Severity and Acute Outcome in Traumatic Brain Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							GLASGOW COMA SCALE; SEVERE HEAD-INJURY; REDOX STATUS; PREDICTION; STRESS; SERUM; EXPRESSION; DAMAGE; GFAP	There are few reliable markers for assessing traumatic brain injury (TBI). Elevated levels of oxidative stress have been observed in TBI patients. We hypothesized that oxidation-reduction potential (ORP) could be a potent biomarker in TBI. Two types of ORP were measured in patient plasma samples: the static state of oxidative stress (sORP) and capacity for induced oxidative stress (icORP). Differences in ORP values as a function of time after injury, severity, and hospital discharge were compared using ANOVAs with significance at p <= 0.05. Logit regression analyses were used to predict acute outcome comparing ORP, Injury Severity Score (ISS), Abbreviated Injury Scale (AIS), and Glasgow Coma Scale (GCS). Antioxidant capacity (icORP) on day 4 was prognostic for acute outcomes (p < 0.05). An odds ratio of 4.08 was associated with poor acute outcome when (icORP) > 7.25 mu C. IcORP was a better predictor than ISS, AIS, or GCS scores. sORP increased in those with the highest ISS values (p < 0.05). Based on these findings ORP is useful biomarker for severity and acute outcome in TBI patients. Changes in ORP values on day 4 after injury were themost prognostic, suggesting that patients' response to brain injury over time is a factor that determines outcome.	[Bjugstad, Kimberly B.; Rael, Leonard T.; Slone, Denetta S.; Bar-Or, David] Swedish Med Ctr, Dept Trauma Res, Englewood, CO 80113 USA; [Levy, Stewart] St Anthony Hosp, InterMt Neurosurg, Lakewood, CO 80228 USA; [Carrick, Matthew] Med Ctr Plano, Plano, TX 75075 USA; [Mains, Charles W.; Bar-Or, David] St Anthony Hosp, Dept Trauma Res, Lakewood, CO 80228 USA; [Mains, Charles W.; Slone, Denetta S.; Bar-Or, David] Rocky Vista Univ, Dept Biomed Sci, Aurora, CO 80134 USA; [Mains, Charles W.; Bar-Or, David] Penrose St FrancisHealth Serv, Colorado Springs, CO 80907 USA	Bar-Or, D (corresponding author), Swedish Med Ctr, Dept Trauma Res, Englewood, CO 80113 USA.; Bar-Or, D (corresponding author), St Anthony Hosp, Dept Trauma Res, Lakewood, CO 80228 USA.; Bar-Or, D (corresponding author), Rocky Vista Univ, Dept Biomed Sci, Aurora, CO 80134 USA.; Bar-Or, D (corresponding author), Penrose St FrancisHealth Serv, Colorado Springs, CO 80907 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020	Bjugstad, Kimberly/0000-0002-0473-5413	Trauma Research, LLC (Englewood, CO); Swedish Medical Center (Englewood, CO); St. Anthony Central Hospital (Denver, CO); Institute for Molecular Medicine (Englewood, CO)	The authors gratefully acknowledge the collection of patient samples and maintenance of patient records by Rachel Aumann, RN, and Anita Leyden, RN. This study was supported by Trauma Research, LLC (Englewood, CO), the Swedish Medical Center (Englewood, CO), St. Anthony Central Hospital (Denver, CO), and the Institute for Molecular Medicine (Englewood, CO).	Bains M., 2012, BIOCHIM BIOPHYS ACTA, V1822, P675; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bembea MM, 2015, CRIT CARE MED, V43, P2202, DOI 10.1097/CCM.0000000000001145; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Copeland A, 2014, J AM WATER WORKS ASS, V106, pE10, DOI 10.5942/jawwa.2014.106.0002; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Milic S, 2015, ENVIRON SCI TECHNOL, V49, P4245, DOI 10.1021/es5053396; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2015, ELECTROANAL, V27, P2567, DOI 10.1002/elan.201500178; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI [10.1089/neu.2008.0816, 10.1089/neu.2008-0816]; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Spanidis Y, 2016, EXP THER MED, V11, P895, DOI 10.3892/etm.2016.2968; Spanidis Y, 2016, EXP THER MED, V11, P147, DOI 10.3892/etm.2015.2843; Spanidis Y, 2015, IN VIVO, V29, P595; Stagos D, 2015, REDOX REP, V20, P154, DOI 10.1179/1351000214Y.0000000118; Stagos D, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/204615; Stahel PF, 2012, BRIT J SURG, V99, P131, DOI 10.1002/bjs.7709; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TEASDALE G, 1974, LANCET, V2, P81; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vertuani S, 2004, CURR PHARM DESIGN, V10, P1677, DOI 10.2174/1381612043384655; VICTORIN K, 1974, J HYG-CAMBRIDGE, V72, P101, DOI 10.1017/S0022172400023263; VICTORIN K, 1972, J HYG-CAMB, V70, P313, DOI 10.1017/S0022172400022361; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; WHO, 2017, GUIDELINES DRINKING; Yu CG, 2015, J NEUROSCI RES, V93, P199, DOI 10.1002/jnr.23503; Yu L, 2014, NEUROL INDIA, V62, P498, DOI 10.4103/0028-3886.144439; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhi LZ, 2014, J CRIT CARE, V29, P1063, DOI 10.1016/j.jcrc.2014.06.013	50	16	16	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2016	2016								6974257	10.1155/2016/6974257			9	Cell Biology	Cell Biology	DV0VV	WOS:000382639600001	27642494	DOAJ Gold, Green Published			2021-06-18	
J	Darling, T; Muthuswamy, J; Rajan, SD				Darling, T.; Muthuswamy, J.; Rajan, S. D.			Finite element modeling of human brain response to football helmet impacts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Football helmet; finite element analysis; mTBI; brain injury; concussion; sports injury; brain tissue	ENGINE FAN BLADE; IN-VITRO; HEAD; DESIGN; TISSUE; BIOMECHANICS; CONCUSSION; VIVO	The football helmet is used to help mitigate the occurrence of impact-related traumatic (TBI) and minor traumatic brain injuries (mTBI) in the game of American football. While the current helmet design methodology may be adequate for reducing linear acceleration of the head and minimizing TBI, it however has had less effect in minimizing mTBI. The objectives of this study are (a) to develop and validate a coupled finite element (FE) model of a football helmet and the human body, and (b) to assess responses of different regions of the brain to two different impact conditions - frontal oblique and crown impact conditions. The FE helmet model was validated using experimental results of drop tests. Subsequently, the integrated helmet-human body FE model was used to assess the responses of different regions of the brain to impact loads. Strain-rate, strain, and stress measures in the corpus callosum, midbrain, and brain stem were assessed. Results show that maximum strain-rates of 27 and 19s(-1) are observed in the brain-stem and mid-brain, respectively. This could potentially lead to axonal injuries and neuronal cell death during crown impact conditions. The developed experimental-numerical framework can be used in the study of other helmet-related impact conditions.	[Darling, T.] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ USA; [Muthuswamy, J.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Rajan, S. D.] Arizona State Univ, Sch Sustainable Engn & Built Environm, Civil Mech & Aerosp Engn, Tempe, AZ 85281 USA	Rajan, SD (corresponding author), Arizona State Univ, Sch Sustainable Engn & Built Environm, Civil Mech & Aerosp Engn, Tempe, AZ 85281 USA.	s.rajan@asu.edu		Muthuswamy, Jit/0000-0003-3924-9869			Altair Engineering Inc, 2011, HYPERMESH VERS 110 P; Bansal S, 2009, J AEROSPACE ENG, V22, P249, DOI 10.1061/(ASCE)0893-1321(2009)22:3(249); Bilston LE, 2011, STUD MECHANOBIOL TIS, V3, P11, DOI 10.1007/8415_2010_36; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Deck C, 2006, INT J CRASHWORTHINES, V11, P561, DOI 10.1533/ijcr.2006.0149; Deivanayagam A, 2013, ASCE J AEROSP ENG, V27, P484, DOI [10.1061/(ASCE)AS.1943-5525, DOI 10.1061/(ASCE)AS.1943-5525]; efunda Inc, 2014, POL MAT PROP; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hodgson RV, 1970, 14 STAPP CAR CRASH; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Jazi MS, 2014, COMPUT METHOD BIOMEC, V17, P1368, DOI 10.1080/10255842.2012.748755; LSTC, 2015, LS DYNA VERS 971; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Moss WC, 2011, IMPACT RESPONSE US A, DOI [10.2172/1021058, DOI 10.2172/1021058]; Nahum A. M., 1977, P 21 STAPP CAR CRASH; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pinnoji PK, 2007, SADHANA-ACAD P ENG S, V32, P445, DOI 10.1007/s12046-007-0034-6; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Roache P.J., 1998, VERIFICATION VALIDAT; Roper WW, 1927, FOOTBALL TODAY TOMOR, P155; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rueda MAF, 2012, P I MECH ENG P-J SPO, V226, P208, DOI 10.1177/1754337112439171; SolidWorks Education Edition, 2014, DESS SYST; Stahlecker Z, 2009, INT J IMPACT ENG, V36, P447, DOI 10.1016/j.ijimpeng.2008.08.004; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang L, 2001, THESIS; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	37	16	17	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2016	19	13					1432	1442		10.1080/10255842.2016.1149574			11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Computer Science; Engineering	DS8CS	WOS:000381011100010	26867124				2021-06-18	
J	De Marco, AP; Broshek, DK				De Marco, Anthony P.; Broshek, Donna K.			Computerized Cognitive Testing in the Management of Youth Sports-Related Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						sports-related concussion; computerized testing; cognition	TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURIES; NEUROPSYCHOLOGICAL ASSESSMENT; HIGH-SCHOOL; FOOTBALL PLAYERS; ONLINE VERSION; UNITED-STATES; IMPACT; SPECIFICITY; SENSITIVITY	Computerized neurocognitive testing has become a growing practice across medical populations, but particularly within sports medicine and the management of sports-related concussion. Although traditional neuropsychological measures are solely administered and interpreted by neuropsychologists, computerized cognitive tests are marketed to and utilized by a wide range of professionals involved in the management of sports-related concussions, many of whom lack specialized psychometric training. Although the benefits of computerized testing allow for many youth athletes to be evaluated quickly, professionals implementing their use should be aware of the potential pitfalls and the high potential for misuse. After briefly reviewing the recommended guidelines set forth by the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology, we review the benefits/limitations of computerized testing in the management of sports-related concussion and the basic psychometric properties of some of the more widely used computerized measures. Lastly, we discuss the practical application of these devices.	[De Marco, Anthony P.; Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA	De Marco, AP (corresponding author), Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA.	Apd3e@virginia.edu	Meijer, Anna/K-5118-2016				American Educational Research Association, 1985, STAND ED PSYCH TEST; American Educational Research Association American Psychological Association and National Council on Measurement in Education, 1974, STAND ED PSYCH TEST; American Educational Research Association American Psychological Association & National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Barr W. B, 2008, TXB CLIN NEUROPSYCHO; Barth JT., 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bleiberg J, 2002, AM AC NEUR DENV CO; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; CogState, 2011, COGST RES MAN VERS 6; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2013, BRIT J SPORT MED, V47, P44; Gioia GA, PROFESSIONAL M UNPUB; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Louey AG, 2013, BRIT J SPORT MED, V47, P15; Lovell MR., 2000, IMPACT IMMEDIATE POS; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Newman E., 1966, AM PSYCHOL, V21, P1151; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; ROME HP, 1962, MAYO CLIN PROC, V37, P61; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; United States Food and Drug Administration, FDA WORKSH SEIZ DET; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Woodard J, 2002, J INT NEUROPSYCH SOC, V8, P175	58	16	16	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		68	75		10.1177/0883073814559645			8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400007	25477270				2021-06-18	
J	Djordjevic, J; Sabbir, MG; Albensi, BC				Djordjevic, Jelena; Sabbir, Mohammad Golam; Albensi, Benedict C.			Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease: Is Inflammatory Signaling a Key Player?	CURRENT ALZHEIMER RESEARCH			English	Article						Alzheimer's disease; inflammation; mitochondria; NF-kappa B; Traumatic brain injury	NF-KAPPA-B; ABNORMAL MITOCHONDRIAL DYNAMICS; AMYLOID-BETA; MOUSE MODEL; MICROGLIAL PHENOTYPE; HEAD TRAUMA; A-BETA; TREM2; ASSOCIATION; DYSFUNCTION	Traumatic brain injury (TBI) has become a significant medical and social concern within the last 30 years. TBI has acute devastating effects, and in many cases, seems to initiate long-term neurodegeneration. With advances in medical technology, many people are now surviving severe brain injuries and their long term consequences. Post trauma effects include communication problems, sensory deficits, emotional and behavioral problems, physical complications and pain, increased suicide risk, dementia, and an increased risk for chronic CNS diseases, such as Alzheimer's disease (AD). In this review, we provide an introduction to TBI and hypothesize how it may lead to neurodegenerative disease in general and AD in particular. In addition, we discuss the evidence that supports the hypothesis that TBI may lead to AD. In particular, we focus on inflammatory responses as key processes in TBI-induced secondary injury, with emphasis on nuclear factor kappa B (NF-kappa B) signaling.	[Djordjevic, Jelena; Sabbir, Mohammad Golam; Albensi, Benedict C.] St Boniface Hosp Res Winnipeg, Div Neurodegenerat Disorders, Winnipeg, MB, Canada; [Djordjevic, Jelena; Albensi, Benedict C.] Univ Manitoba, Dept Pharmacol & Therapeut, Fac Hlth Sci, Coll Med, Winnipeg, MB R2H 2A6, Canada	Albensi, BC (corresponding author), St Boniface Hosp Res Winnipeg, Div Neurodegenerat Disorders, Winnipeg, MB, Canada.	balbensi@sbrc.ca	Sabbir, Mohammad/AAG-6238-2019; Albensi, Benedict/AAJ-2359-2021	Albensi, Benedict/0000-0002-7884-9261; Djordjevic, Jelena/0000-0001-9769-6857	National Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Everett Endowment Fund; St. Boniface General Hospital Research Foundation; Alzheimer's Society of Manitoba; Research Manitoba	This work was funded in part by the National Sciences and Engineering Research Council (to B.C.A.), the Everett Endowment Fund (to B.C.A.), the St. Boniface General Hospital Research Foundation (to B.C.A.) the Alzheimer's Society of Manitoba (to B.C.A.), and Research Manitoba (J.D. and B.C.A.). B.C.A. is a Research Affiliate at the University of Manitoba's Centre on Aging and holds the Honourable Douglas Everett, Patricia Everett and the Royal Canadian Properties Endowment Fund Chair and the Manitoba Dementia Research Chair.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Albensi BC, 2000, SYNAPSE, V35, P151; Albert MS, 1996, P NATL ACAD SCI USA, V93, P13547, DOI 10.1073/pnas.93.24.13547; Aragona CJD, 2012, NEUROREHABILITATION, V30, P55, DOI 10.3233/NRE-2011-0727; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Balistreri CR, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-24; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Carreiras MC, 2013, CURR TOP MED CHEM, V13, P1745, DOI 10.2174/15680266113139990135; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cunningham C, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0117-2; Das HK, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2723; Famakin BM, 2014, AGING DIS, V5, P307, DOI 10.14336/AD.2014.0500307; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Gonzalez H, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0201-8; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; ISHII T, 1976, ACTA NEUROPATHOL, V36, P243, DOI 10.1007/BF00685368; Jarvis B, 2003, DRUG AGING, V20, P465, DOI 10.2165/00002512-200320060-00005; Jarvis B, 2003, DRUGS AGING, V20, P77; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lee Sarah, 2013, J Alzheimers Dis Parkinsonism, V3, P128; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Lourbopoulos A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00054; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mullane K, 2013, BIOCHEM PHARMACOL, V85, P289, DOI 10.1016/j.bcp.2012.11.014; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Park HJ, 2004, NEUROSCI LETT, V357, P63, DOI 10.1016/j.neulet.2003.11.068; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pinto T, 2011, AGEING RES REV, V10, P404, DOI 10.1016/j.arr.2011.01.003; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P1766, DOI 10.1089/ars.2013.5745; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Sieber MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052982; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Tillement L, 2011, NEURODEGENER DIS, V8, P331, DOI 10.1159/000323264; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weitz Tara M, 2012, Int J Alzheimers Dis, V2012, P314185, DOI 10.1155/2012/314185; Wilkins HM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00311; Yu HM, 2012, NEUROIMMUNOMODULAT, V19, P131, DOI 10.1159/000330254; Zhang X, 2004, CNS NEUROL DISORD-DR, V3, P137, DOI 10.2174/1568007043482499; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zubko N, 2011, BEHAV HEALTHC, V31, P8; Zubko Nick, 2011, Behav Healthc, V31, P28	96	16	17	0	12	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050	1875-5828		CURR ALZHEIMER RES	Curr. Alzheimer Res.		2016	13	7					730	738		10.2174/1567205013666160222110320			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DM9NP	WOS:000376693300002	26899581				2021-06-18	
J	Faber, J; Wilde, EA; Hanten, G; Ewing-Cobbs, L; Aitken, ME; Yallampalli, R; MacLeod, MC; Mullins, SH; Chu, ZD; Li, X; Hunter, JV; Noble-Haeusslein, L; Levin, HS				Faber, J.; Wilde, E. A.; Hanten, G.; Ewing-Cobbs, L.; Aitken, M. E.; Yallampalli, R.; MacLeod, M. C.; Mullins, S. H.; Chu, Z. D.; Li, X.; Hunter, J. V.; Noble-Haeusslein, L.; Levin, H. S.			Ten-year outcome of early childhood traumatic brain injury: Diffusion tensor imaging of the ventral striatum in relation to executive functioning	BRAIN INJURY			English	Article						Neuroimaging; MRI; paediatric	CLOSED-HEAD INJURY; RECOVERY 10 YEARS; YOUNG-ADULTS; ATTENTION PROBLEMS; AXONAL INJURY; UNITED-STATES; CHILDREN; MODERATE; ADOLESCENTS; PREDICTORS	Primary objective: The long-term effects of TBI on verbal fluency and related structures, as well as the relation between cognition and structural integrity, were evaluated. It was hypothesized that the group with TBI would evidence poorer performance on cognitive measures and a decrease in structural integrity. Research design: Between a paediatric group with TBI and a group of typically-developing children, the long-term effects of traumatic brain injury were investigated in relation to both structural integrity and cognition. Common metrics for diffusion tensor imaging (DTI) were used as indicators of white matter integrity. Methods and procedures: Using DTI, this study examined ventral striatum (VS) integrity in 21 patients aged 10-18 years sustaining moderate-to-severe traumatic brain injury (TBI) 5-15 years earlier and 16 demographically comparable subjects. All participants completed Delis-Kaplan Executive Functioning System (D-KEFS) sub-tests. Main outcomes and results: The group with TBI exhibited lower fractional anisotropy (FA) and executive functioning performance and higher apparent diffusion coefficient (ADC). DTI metrics correlated with D-KEFS performance (right VS FA with Inhibition errors, right VS ADC with Letter Fluency, left VS FA and ADC with Category Switching). Conclusions: TBI affects VS integrity, even in a chronic phase, and may contribute to executive functioning deficits.	[Faber, J.] Rice Univ, Houston, TX USA; [Faber, J.; Wilde, E. A.; Hanten, G.; Yallampalli, R.; MacLeod, M. C.; Li, X.; Hunter, J. V.; Levin, H. S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, E. A.; Levin, H. S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, E. A.; Chu, Z. D.; Hunter, J. V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, E. A.; Yallampalli, R.; Levin, H. S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Ewing-Cobbs, L.] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA; [Ewing-Cobbs, L.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Aitken, M. E.; Mullins, S. H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Chu, Z. D.; Hunter, J. V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Noble-Haeusslein, L.] Univ Calif San Francisco, Dept Neurosurg Surg, San Francisco, CA 94143 USA; [Noble-Haeusslein, L.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA	Faber, J (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	jesfaber@gmail.com		Aitken, Mary/0000-0002-8318-9755	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS065937]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS065937] Funding Source: NIH RePORTER	This study was supported by the National Institute of Health grant R21 NS065937 ('Trauma to Developing Brain: Model Refinement and Therapeutic Intervention'; Levin, PI and Noble, PI). We thank the participants and their families for their participation in this research. The authors report no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Basar K, 2010, PROG NEUROBIOL, V92, P533, DOI 10.1016/j.pneurobio.2010.08.007; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Simard F, 2011, CEREB CORTEX, V21, P1084, DOI 10.1093/cercor/bhq182; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; TEASDALE G, 1974, LANCET, V2, P81; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	47	16	16	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1635	1641		10.1080/02699052.2016.1199910			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800017	27680309				2021-06-18	
J	Grills, CE; Armistead-Jehle, P				Grills, Chad E.; Armistead-Jehle, Patrick			Performance validity test and neuropsychological assessment battery screening module performances in an active-duty sample with a history of concussion	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Medical symptom validity test; military; neuropsychological assessment battery; symptom validity testing; word memory test	TRAUMATIC BRAIN-INJURY; EVALUATION CONTEXT; POOR EFFORT; NAB; VETERANS; SCORES; INDEX	The current retrospective investigation sought to replicate previous findings demonstrating the significant impact of performance validity test (PVT) performance and evaluation context on neuropsychological testing. We examined differences on performance validity testing between active-duty service members undergoing neurocognitive screening for concussion who were seen in a clinical context and those who were seen in a disability-seeking context, as well as the overall impact of PVT performance on a neurocognitive screening battery. Overall, 38.2% of the sample failed the Word Memory Test (WMT). Of those involved in a disability evaluation, the failure rate was 51.9%, which was significantly higher than the 36.8% failure rate among those evaluated in a clinical context. The effect size of WMT performance on a cognitive screening measure was also large. The current retrospective analysis served to replicate previous work.	[Grills, Chad E.] Brain Injury Clin, 394 Glennan Rd,Bldg 672,1st Floor, Schofield Barracks, HI 96857 USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Behav Hlth, Ft Leavenworth, KS USA	Grills, CE (corresponding author), Brain Injury Clin, 394 Glennan Rd,Bldg 672,1st Floor, Schofield Barracks, HI 96857 USA.	chad.e.grills.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			American Psychological Association, 2002, ETHICAL PRINCIPLES P; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Casscells S. W., 2007, ASSISTANT SECRETARY; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Denning J., 2012, 10 AM AC CLIN NEUR A; Donders J, 2012, ARCH CLIN NEUROPSYCH, V27, P440, DOI 10.1093/arclin/acs043; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gavett BE, 2012, APPL NEUROPSYCH-ADUL, V19, P108, DOI 10.1080/09084282.2011.643947; Green, 2004, GREENS MED SYMPTOM V; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97, DOI DOI 10.1300/J151V02N03_05; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hill SW, 2012, EPILEPSY BEHAV, V24, P59, DOI 10.1016/j.yebeh.2012.02.021; Horner MD, 2014, CLIN NEUROPSYCHOL, V28, P703, DOI 10.1080/13854046.2014.925143; Iverson GL, 2007, APPL NEUROPSYCHOL, V14, P178, DOI 10.1080/09084280701508952; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Tombaugh TN, 1996, TEST MEMORY MALINGER; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Wynkoop T. F., 2005, J FORENSIC NEUROPSYC, V4, P101; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	46	16	16	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	4					295	301		10.1080/23279095.2015.1079713			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DQ7XA	WOS:000379420300006	26943837				2021-06-18	
J	Krivitzky, LS; Walsh, KS; Fisher, EL; Berl, MM				Krivitzky, Lauren S.; Walsh, Karin S.; Fisher, Evelyn L.; Berl, Madison M.			Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors	CHILD NEUROPSYCHOLOGY			English	Article						Executive functions; Pediatric; Working memory; Age at diagnosis; Medical disorders	ACUTE LYMPHOBLASTIC-LEUKEMIA; SLUGGISH COGNITIVE TEMPO; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; PARENT-REPORT; CHILDHOOD EPILEPSY; ATTENTION-DEFICIT; TUMOR SURVIVORS; CHILDREN; ADOLESCENTS	The objective of the study was to compare executive functioning (EF) profiles across several pediatric medical conditions and explore the influence of age of diagnosis and evaluation. A retrospective, cross-sectional study of 734 children aged 5 to 18 years was conducted across five medical groups (brain tumor, leukemia [ALL], epilepsy [EPI], neurofibromatosis type 1 [NF1], and ornithine transcarbamylase deficiency [OTC-D]), attention deficit hyperactivity disorder (ADHD) controls, and matched healthy controls. We compared groups across the scales of a parent-completed Behavior Rating Inventory of Executive Functioning (BRIEF) using a repeated measures analysis of variance (ANOVA). Separate ANOVAs were conducted to look at age factors. The results showed that the ADHD group differed from all other groups and had the highest level of reported EF problems. The NF1 and OTC-D groups differed significantly from the healthy comparison group for overall EF problems, while the EPI and cancer groups did not. Working memory was the most elevated scale across medical groups, followed by plan/organize. Children with medical disorders were two to four times more likely than healthy controls to have clinically significant problems in several EF domains. There was a main effect for age at diagnosis and age at evaluation. A subset of children with medical disorders were found to have parent-reported EF difficulties, with particular vulnerability noted in working memory and organizational/planning skills. This has relevance for the development of interventions that may be helpful across disorders. Children with particular diagnoses and earlier age of diagnosis and evaluation had greater reported EF problems.	[Krivitzky, Lauren S.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Krivitzky, Lauren S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Walsh, Karin S.; Fisher, Evelyn L.; Berl, Madison M.] Childrens Natl Hlth Syst, 111 Michigan Ave NW, Washington, DC 20010 USA; [Walsh, Karin S.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Fisher, Evelyn L.] Georgia State Univ, Atlanta, GA 30303 USA	Berl, MM (corresponding author), Childrens Natl Hlth Syst, 111 Michigan Ave NW, Washington, DC 20010 USA.	mberl@childrensnational.org		Berl, Madison/0000-0002-2469-1518	NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [U54HD061221]; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD061221]; O'Malley Foundation; Rotenberg Family Fund; Dietmar-Hopp Foundation; Kettering Fund; Gilbert Family Neurofibromatosis Institute; National Institutes of Neurological Disorders and Stroke, NIHs [R01NS44280, K23NS065121-01A2]; NICHD Intellectual and Developmental Disabilities Research Center; NICHD Children's National Medical Center [P30HD040677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677, U54HD061221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044280, K23NS065121] Funding Source: NIH RePORTER	Some data used in this manuscript was provided by the Urea Cycle Disorders Consortium (U54HD061221), part of the National Institute of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS) and the National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIHs. The Urea Cycle Disorders Consortium is also supported by the O'Malley Foundation, the Rotenberg Family Fund, the Dietmar-Hopp Foundation, and the Kettering Fund.; This work was supported by the Gilbert Family Neurofibromatosis Institute; the National Institutes of Neurological Disorders and Stroke, NIHs [grant numbers R01NS44280, K23NS065121-01A2]; NICHD Intellectual and Developmental Disabilities Research Center and Children's National Medical Center Grant [grant number P30HD040677].	Alloway TP, 2006, WORKING MEMORY AND NEURODEVELOPMENTAL DISORDERS, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Briere ME, 2008, PEDIATR BLOOD CANCER, V50, P337, DOI 10.1002/pbc.21223; Buizer AI, 2009, PEDIATR BLOOD CANCER, V52, P447, DOI 10.1002/pbc.21869; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Dahlin K., 2013, J ED LEARNING, V2, P118, DOI [DOI 10.5539/JEL.V2N1P118, 10.5539/jel.v2n1p118]; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Diaz GA, 2013, HEPATOLOGY, V57, P2171, DOI 10.1002/hep.26058; Duffner PK, 2004, NEUROLOGIST, V10, P293, DOI 10.1097/01.nrl.0000144287.35993.96; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faridi N, 2015, NEUROPSYCHOLOGY, V29, P82, DOI 10.1037/neu0000079; Gathercole S. E., 2008, APPL COGNITIVE RES K, P17; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Holmes J. D., 2010, PARKINSONS DIS, P1, DOI DOI 10.4061/2010/696492; Holmes J, 2014, EDUC PSYCHOL-UK, V34, P440, DOI 10.1080/01443410.2013.797338; Howarth RA, 2013, J INT NEUROPSYCH SOC, V19, P380, DOI 10.1017/S1355617712001567; Huijbregts S, 2010, DEV NEUROPSYCHOL, V35, P737, DOI 10.1080/87565641.2010.508670; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Kahalley LS, 2013, PSYCHO-ONCOLOGY, V22, P1979, DOI 10.1002/pon.3255; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Krivitzky L, 2009, PEDIATR RES, V66, P96, DOI 10.1203/PDR.0b013e3181a27a16; MacAllister WS, 2012, CHILD NEUROPSYCHOL, V18, P404, DOI 10.1080/09297049.2011.613812; Maddrey AM, 2005, J NEURO-ONCOL, V72, P245, DOI 10.1007/s11060-004-3009-z; Mahone EM, 2009, J INT NEUROPSYCH SOC, V15, P31, DOI 10.1017/S1355617708090164; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Mares D, 2007, CAN J PSYCHIAT, V52, P527, DOI 10.1177/070674370705200811; McCann JP, 2014, CHILD NEUROPSYCHOL, V20, P737, DOI 10.1080/09297049.2013.859663; Miller BL, 2007, HUMAN FRONTAL LOBES; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Olsson IT, 2014, PEDIATR NEUROL, V51, P515, DOI 10.1016/j.pediatrneurol.2014.06.011; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Payne JM, 2011, CHILD NEUROPSYCHOL, V17, P313, DOI 10.1080/09297049.2010.542746; Pickering S. J., 2003, ED CHILD PSYCHOL, V20, P109, DOI DOI 10.1037/A0036633; Pride N, 2010, J CHILD NEUROL, V25, P834, DOI 10.1177/0883073809350723; Reeves CB, 2007, J PEDIATR PSYCHOL, V32, P1050, DOI 10.1093/jpepsy/jsm063; Robinson KE, 2014, NEUROPSYCHOLOGY, V28, P791, DOI 10.1037/neu0000077; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Scott MN, 2012, J DEV BEHAV PEDIATR, V33, P202, DOI 10.1097/DBP.0b013e3182475287; Scott RB, 2001, DEV MED CHILD NEUROL, V43, P685, DOI 10.1017/S0012162201001232; Slick DJ, 2006, CHILD NEUROPSYCHOL, V12, P181, DOI 10.1080/09297040600611320; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Swanson JM, 2002, ATTENTION DEFICIT HY, V7, P7; Taylor HG, 2000, NEUROPSYCHOLOGY, V14, P509, DOI 10.1037/0894-4105.14.4.509; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Waber DP, 2006, PEDIATR NEUROL, V34, P13, DOI 10.1016/j.pediatrneurol.2005.06.002; Walsh KS, 2015, CHILD NEUROPSYCHOL, V21, P78, DOI 10.1080/09297049.2013.876491; Wang Y, 2012, PSYCHIAT RES-NEUROIM, V202, P245, DOI 10.1016/j.pscychresns.2012.01.005; Warren SL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00271; Willard VW, 2013, J NEURO-ONCOL, V114, P71, DOI 10.1007/s11060-013-1149-8; Winter AL, 2014, J CLIN EXP NEUROPSYC, V36, P818, DOI 10.1080/13803395.2014.943695; Wochos GC, 2014, CLIN NEUROPSYCHOL, V28, P1243, DOI 10.1080/13854046.2014.971875; Wolfe KR, 2013, CHILD NEUROPSYCHOL, V19, P370, DOI 10.1080/09297049.2012.669470; Wolfe KR, 2012, DEV NEUROPSYCHOL, V37, P153, DOI 10.1080/87565641.2011.632462; Ziegler G, 2013, NEUROIMAGE, V82, P284, DOI 10.1016/j.neuroimage.2013.05.088	58	16	16	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2016	22	7					870	888		10.1080/09297049.2015.1054272			19	Clinical Neurology	Neurosciences & Neurology	DV0BR	WOS:000382583200006	26143938	Green Accepted			2021-06-18	
J	Liu, KY; Khan, H; Geng, XK; Zhang, J; Ding, YC				Liu, Kaiyin; Khan, Hajra; Geng, Xiaokun; Zhang, Jun; Ding, Yuchuan			Pharmacological hypothermia: a potential for future stroke therapy?	NEUROLOGICAL RESEARCH			English	Article						Hypothermia; Ischemia-reperfusion injury	FOCAL CEREBRAL-ISCHEMIA; DRUG-INDUCED HYPOTHERMIA; OLIGODENDROCYTE PRECURSOR CELLS; CANNABINOID RECEPTOR AGONIST; TRAUMATIC BRAIN-INJURY; RAT MODEL; PROVIDES NEUROPROTECTION; BODY-TEMPERATURE; INFARCT SIZE; WIN 55,212-2	Mild physical hypothermia after stroke has been associated with positive outcomes. Despite the well-studied beneficial effects of hypothermia in the treatment of stroke, lack of precise temperature control, intolerance for the patient, and immunosuppression are some of the reasons which limit its clinical translation. Pharmacologically induced hypothermia has been explored as a possible treatment option following stroke in animal models. Currently, there are eight classes of pharmacological agents/agonists with hypothermic effects affecting a multitude of systems including cannabinoid, opioid, transient receptor potential vanilloid 1 (TRPV1), neurotensin, thyroxine derivatives, dopamine, gas, and adenosine derivatives. Interestingly, drugs in the TRPV1, neurotensin, and thyroxine families have been shown to have effects in thermoregulatory control in decreasing the compensatory hypothermic response during cooling. This review will briefly present drugs in the eight classes by summarizing their proposed mechanisms of action as well as side effects. Reported thermoregulatory effects of the drugs will also be presented. This review offers the opinion that these agents may be useful in combination therapies with physical hypothermia to achieve faster and more stable temperature control in hypothermia.	[Liu, Kaiyin; Khan, Hajra; Geng, Xiaokun; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI USA; [Geng, Xiaokun; Ding, Yuchuan] Capital Med Univ, Beijing Luhe Hosp, Dept Neurol, 82 Xinhua South Rd, Beijing 101149, Peoples R China; [Zhang, Jun] Capital Med Univ, Xuanwu Hosp, China Amer Inst Neurosci, Beijing, Peoples R China	Geng, XK (corresponding author), Capital Med Univ, Beijing Luhe Hosp, Dept Neurol, 82 Xinhua South Rd, Beijing 101149, Peoples R China.	xgeng@med.wayne.edu			American Heart AssociationAmerican Heart Association [14GRNT20460246]; US Department of Veterans Affairs Rehabilitation RD ServiceUS Department of Veterans Affairs [I01RX-001964-01]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501141]; Talent Training Program of Beijing Ministry of Organization [2013D008011000002]; Veterans AffairsUS Department of Veterans Affairs [I01RX001964] Funding Source: NIH RePORTER	This work was supported in part by American Heart Association Grant-in-Aid [grant number 14GRNT20460246], Merit Review Award [grant number I01RX-001964-01] from the US Department of Veterans Affairs Rehabilitation R&D Service, National Natural Science Foundation of China [grant number 81501141]; Talent Training Program of Beijing Ministry of Organization [grant number 2013D008011000002].	ADLER MW, 1988, ANNU REV PHARMACOL, V28, P429, DOI 10.1146/annurev.pa.28.040188.002241; Amantea D, 2007, FEBS J, V274, P4464, DOI 10.1111/j.1742-4658.2007.05975.x; American Heart Association, 2015, WEB BAS INT GUID CAR; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; [Anonymous], 2012, INC PREV 2012 CHART; Baena RC, 1997, NEUROLOGY, V48, P768, DOI 10.1212/WNL.48.3.768; Baker AK, 2002, J PHARMACOL EXP THER, V302, P1253, DOI 10.1124/jpet.102.037655; Benamar K, 2002, J PHARMACOL EXP THER, V303, P375, DOI 10.1124/jpet.102.036269; Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Berganza CJ, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-18; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Bonfils PK, 2006, NEUROCHEM INT, V49, P508, DOI 10.1016/j.neuint.2006.03.015; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; Cao ZJ, 2014, AM J PHYSIOL-REG I, V306, pR149, DOI 10.1152/ajpregu.00329.2013; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Chanda S, 2005, REGUL TOXICOL PHARM, V43, P66, DOI 10.1016/j.yrtph.2005.06.003; Chi OZ, 2012, PHARMACOLOGY, V89, P333, DOI 10.1159/000338755; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; COLBOC O, 1980, J PHARM PHARMACOL, V32, P624, DOI 10.1111/j.2042-7158.1980.tb13018.x; COLERIDGE HM, 1964, J PHYSIOL-LONDON, V170, P272, DOI 10.1113/jphysiol.1964.sp007330; Costa ACS, 2005, J NEUROSCI, V25, P7801, DOI 10.1523/JNEUROSCI.1699-05.2005; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Diaz M, 2010, ANESTH PROG, V57, P33; Diaz Marcos, 2010, Anesth Prog, V57, P25, DOI 10.2344/0003-3006-57.1.25; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doyle KP, 2007, STROKE, V38, P2569, DOI 10.1161/STROKEAHA.106.480277; Drabek T, 2008, RESUSCITATION, V77, P220, DOI 10.1016/j.resuscitation.2007.11.020; England TJ, 2015, J CEREBR BLOOD F MET, V35, P348, DOI 10.1038/jcbfm.2014.218; Feketa VV, 2013, AM J PHYSIOL-REG I, V305, pR1040, DOI 10.1152/ajpregu.00296.2013; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Fosgerau K, 2010, BMC CARDIOVASC DISOR, V10; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Glushakova Olena Y, 2016, Brain Circ, V2, P28, DOI 10.4103/2394-8108.178546; Gonzalez-Ibarra FP, 2011, FRONT NEUROL, V2; Goossens J, 2014, CURR NEUROPHARMACOL, V12, P399, DOI 10.2174/1570159X12666140424233036; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Gullapalli S, 2002, PHARMACOL BIOCHEM BE, V72, P93, DOI 10.1016/S0091-3057(01)00726-2; Guluma KZ, 2010, RESUSCITATION, V81, P1642, DOI 10.1016/j.resuscitation.2010.08.003; Hampson AJ, 2001, EUR J NEUROSCI, V13, P1529, DOI 10.1046/j.0953-816x.2001.01536.x; Hart ME, 2006, J MED CHEM, V49, P1101, DOI 10.1021/jm0505718; Hayakawa K, 2007, LIFE SCI, V80, P1466, DOI 10.1016/j.lfs.2007.01.014; Hillard CJ, 2008, CURR PHARM DESIGN, V14, P2347, DOI 10.2174/138161208785740054; Hoesch RE, 2007, NEUROLOGIST, V13, P331, DOI 10.1097/NRL.0b013e318154bb79; Ianculescu AG, 2010, MOL BIOSYST, V6, P1338, DOI 10.1039/b926583j; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; Jinka TR, 2015, ACS CHEM NEUROSCI, V6, P899, DOI 10.1021/acschemneuro.5b00056; Johansen FF, 2013, PATHOBIOLOGY, V81, P42, DOI 10.1159/000352026; Johansen Flemming Fryd, 2003, J Stroke Cerebrovasc Dis, V12, P97; Joseph C, 2012, J CEREBR BLOOD F MET, V32, P1632, DOI 10.1038/jcbfm.2012.65; Kao TK, 2008, NEUROCHEM INT, V52, P1256, DOI 10.1016/j.neuint.2008.01.007; Katz LM, 2012, THER HYPOTHERMIA TEM, V2, P61, DOI 10.1089/ther.2012.0011; Katz LM, 2001, ACAD EMERG MED, V8, P1115, DOI 10.1111/j.1553-2712.2001.tb01126.x; Kim J, 2015, BRAIN CIRC, V1, P14, DOI DOI 10.4103/2394-8108.164997; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Koronowski Kevin B, 2015, Brain Circ, V1, P69; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Kuric E, 2014, J NEUROIMMUNOL, V269, P94, DOI 10.1016/j.jneuroim.2014.02.009; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Leker RR, 2003, STROKE, V34, P2000, DOI 10.1161/01.STR.0000079817.68944.1E; Lin HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00029; Liu SM, 2015, NEUROL RES, V37, P454, DOI 10.1179/1743132815Y.0000000031; LIU XH, 1995, J NEUROL SCI, V129, P9, DOI 10.1016/0022-510X(94)00239-K; MACHIDA R, 1993, BIOL PHARM BULL, V16, P43; Marinelli S, 2002, J PHYSL, V543, P31; Martini WZ, 2009, J TRAUMA, V67, P202, DOI 10.1097/TA.0b013e3181a602a7; MELLER E, 1989, LIFE SCI, V44, P1019, DOI 10.1016/0024-3205(89)90553-5; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0000000000000152, 10.1161/CIR.0b013e31828124ad]; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; Muzzi M, 2013, J CEREBR BLOOD F MET, V33, P171, DOI 10.1038/jcbfm.2012.181; Muzzi M, 2012, J CEREBR BLOOD F MET, V32, P978, DOI 10.1038/jcbfm.2012.36; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Nunez E, 2008, NEUROSCIENCE, V151, P104, DOI 10.1016/j.neuroscience.2007.10.029; O'Neil RG, 2003, NEWS PHYSIOL SCI, V18, P226, DOI 10.1152/nips.01468.2003; O'Neill MJ, 1998, EUR J PHARMACOL, V352, P37, DOI 10.1016/S0014-2999(98)00333-1; Pan Y, 2007, EXP NEUROL, V205, P587, DOI 10.1016/j.expneurol.2007.03.023; Pan Y, 2011, NEUROSCI LETT, V497, P144, DOI 10.1016/j.neulet.2011.04.048; Panas HN, 2010, J NEUROSCI RES, V88, P1962, DOI 10.1002/jnr.22367; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Rawls Scott M, 2011, Front Biosci (Schol Ed), V3, P822; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Rittiner JE, 2012, J BIOL CHEM, V287, P5301, DOI 10.1074/jbc.M111.291666; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Sherman AL, 2014, PHYS MED REH CLIN N, V25, P519, DOI 10.1016/j.pmr.2014.04.003; Shimizu I, 2005, J PHARMACOL EXP THER, V314, P1378, DOI 10.1124/jpet.105.084277; Shirakawa H, 2008, BIOCHEM BIOPH RES CO, V377, P1211, DOI 10.1016/j.bbrc.2008.10.152; Sigg DC, 2002, AM J PHYSIOL-HEART C, V282, pH1953, DOI 10.1152/ajpheart.01045.2001; Sun J, 2013, ACTA PHARMACOL SIN, V34, P119, DOI 10.1038/aps.2012.141; Sun J, 2013, BRAIN RES, V1491, P225, DOI 10.1016/j.brainres.2012.11.006; Suzuki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040889; Suzuki N, 2012, BRAIN RES, V1430, P93, DOI 10.1016/j.brainres.2011.10.044; Swoap SJ, 2007, AM J PHYSIOL-REG I, V293, pR468, DOI 10.1152/ajpregu.00888.2006; Tansey EA, 2015, ADV PHYSIOL EDUC, V39, P139, DOI 10.1152/advan.00126.2014; Tao ZY, 2011, AM J TRANSL RES, V3, P351; Torup L, 2003, NEUROSCI LETT, V351, P173, DOI 10.1016/j.neulet.2003.08.008; Tyler BM, 1999, NEUROPHARMACOLOGY, V38, P1027, DOI 10.1016/S0028-3908(99)00011-8; Tyler-McMahon BM, 2000, REGUL PEPTIDES, V93, P125, DOI 10.1016/S0167-0115(00)00183-X; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Xu XS, 2011, STROKE, V42, P3245, DOI 10.1161/STROKEAHA.111.618306; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371; ZARRINDAST MR, 1989, ARCH INT PHARMACOD T, V298, P38; Zhang F, 2009, J CEREBR BLOOD F MET, V29, P1022, DOI 10.1038/jcbfm.2009.28; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zhang M, 2008, NEUROSCIENCE, V152, P753, DOI 10.1016/j.neuroscience.2008.01.022; Zhang M, 2013, J CEREB BLOOD FLOW M, V33; Zhang MJ, 2013, CNS NEUROL DISORD-DR, V12, P371, DOI 10.2174/1871527311312030010; Zhang Y, 2015, STROKE, V46, P2637, DOI 10.1161/STROKEAHA.115.009792; Zhang ZA, 2003, ANESTH ANALG, V97, P1776, DOI 10.1213/01.ANE.0000087800.56290.2E; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	130	16	17	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	6			SI		478	490		10.1080/01616412.2016.1187826			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DO9ZH	WOS:000378146300002	27320243				2021-06-18	
J	Lozic, I; Hartz, RV; Bartlett, CA; Shaw, JA; Archer, M; Naidu, PSR; Smith, NM; Dunlop, SA; Iyer, KS; Kilburn, MR; Fitzgerald, M				Lozic, I.; Hartz, R. V.; Bartlett, C. A.; Shaw, J. A.; Archer, M.; Naidu, P. S. R.; Smith, N. M.; Dunlop, S. A.; Iyer, K. Swaminathan; Kilburn, M. R.; Fitzgerald, M.			Enabling dual cellular destinations of polymeric nanoparticles for treatment following partial injury to the central nervous system	BIOMATERIALS			English	Article						Polymer nanoparticles; Central nervous system injury; Oxidative stress and aquaporin 4; Targeted drug delivery of antioxidants; Nanoscale secondary ion mass spectroscopy (NanoSIMS); Macrophages	TRAUMATIC BRAIN-INJURY; CHRONIC SECONDARY DEGENERATION; OPTIC-NERVE; OXIDATIVE STRESS; RESVERATROL PROTECTS; CANCER-CELLS; ASTROCYTES; PROTEINS; BINDING; STROKE	Following neurotrauma, oxidative stress is spread via the astrocytic syncytium and is associated with increased aquaporin 4 (AQP4), inflammatory cell infiltration, loss of neurons and glia and functional deficits. Herein we evaluate multimodal polymeric nanoparticles functionalized with an antibody to an extracellular epitope of AQP4, for targeted delivery of an anti-oxidant as a therapeutic strategy following partial optic nerve transection. Using fluorescence microscopy, spectrophotometry, correlative nanoscale secondary ion mass spectrometry (NanoSIMS) and transmission electron microscopy, in vitro and in vivo, we demonstrate that functionalized nanoparticles are coated with serum proteins such as albumin and enter both macrophages and astrocytes when administered to the site of a partial optic nerve transection in rat. Antibody functionalized nanoparticles synthesized to deliver the antioxidant resveratrol are effective in reducing oxidative damage to DNA, AQP4 immunoreactivity and preserving visual function. Non-fiinctionalized nanoparticles evade macrophages more effectively and are found more diffusely, including in astrocytes, however they do not preserve the optic nerve from oxidative damage or functional loss following injury. Our study highlights the need to comprehensively investigate nanoparticle location, interactions and effects, both in vitro and in vivo, in order to fully understand functional outcomes. (C) 2015 Elsevier Ltd. All rights reserved.	[Lozic, I.; Naidu, P. S. R.; Smith, N. M.; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Lozic, I.; Hartz, R. V.; Bartlett, C. A.; Archer, M.; Naidu, P. S. R.; Smith, N. M.; Dunlop, S. A.; Fitzgerald, M.] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Shaw, J. A.; Kilburn, M. R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, 35 Stirling Hwy, Crawley, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Shaw, Jeremy/AAH-5112-2020; Shaw, Jeremy A/B-4156-2011; Smith, Nicole/L-2502-2013; Kilburn, Matthew R/C-4515-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Shaw, Jeremy/0000-0002-5140-457X; Shaw, Jeremy A/0000-0002-5140-457X; Smith, Nicole/0000-0002-5519-8152; Kilburn, Matthew R/0000-0002-1858-8485; Lozic, Ivan/0000-0001-7441-743X; Dunlop, Sarah/0000-0002-1306-3962; Naidu, Priya/0000-0003-2241-9243	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [APP1028681, APP1082403]; NIH/NIBIB National Resource for Imaging Mass Spectrometry [NIH/NIBIB 5P41 EB001974-10]	This work was supported by the National Health and Medical Research Council of Australia (Grant ID: APP1028681 and APP1082403). We thank Associate Professor Gabriel A. Silva at the Shiley Eye Center at the University of San Diego, CA, for gifting us a sample of rMC1 retinal Muller cells; Igor Luzinov, University of North Carolina for donating PGMA; Mr Guy Ben-Ary of Cell Central, The University of Western Australia, for assistance with fluorescence microscopy; Mr John Murphy, The University of Western Australia, for assistance with confocal microscopy; Professor Martin Saunders for assistance with TEM, Dr Paul Guagliardo and Assistant Professor Jeremy Bougoure for assistance with NanoSIMS. The authors acknowledge the facilities, scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments. This work was made possible in part by the OpenMIMS software whose development is funded by the NIH/NIBIB National Resource for Imaging Mass Spectrometry, NIH/NIBIB 5P41 EB001974-10.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]; Bendszus M, 2003, J NEUROSCI, V23, P10892; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonnet-Duquennoy M, 2009, INT J CANCER, V125, P708, DOI 10.1002/ijc.24413; Cao SH, 2009, J SOLUTION CHEM, V38, P1193, DOI 10.1007/s10953-009-9439-7; Clode PL, 2007, MICROSC RES TECHNIQ, V70, P220, DOI 10.1002/jemt.20409; Clode PL, 2003, BIOL BULL-US, V204, P138, DOI 10.2307/1543549; Davidson SM, 2006, CELL CALCIUM, V40, P561, DOI 10.1016/j.ceca.2006.08.017; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Evans CW, 2012, NEW J CHEM, V36, P1457, DOI 10.1039/c2nj40016b; Evans CW, 2011, ACS NANO, V5, P8640, DOI 10.1021/nn2022149; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gardette M, 2011, INVEST NEW DRUG, V29, P1253, DOI 10.1007/s10637-010-9471-x; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; GROTTA J, 1995, STROKE, V26, P602, DOI 10.1161/01.STR.26.4.602; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Halonen SK, 1998, INT J PARASITOL, V28, P815, DOI 10.1016/S0020-7519(98)00035-6; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Harrison J, 2012, SMALL, V8, P1579, DOI 10.1002/smll.201102648; Ho D, 2011, NANOSCALE, V3, P907, DOI 10.1039/c0nr00666a; Hsieh Tze-chen, 2006, Med Chem, V2, P275, DOI 10.2174/157340606776930709; Huhn D, 2013, ACS NANO, V7, P3253, DOI 10.1021/nn3059295; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jannin B, 2004, BIOCHEM PHARMACOL, V68, P1113, DOI 10.1016/j.bcp.2004.04.028; Johnston APR, 2012, ACS NANO, V6, P6667, DOI 10.1021/nn3010476; Kohara A, 1998, J PHARM PHARMACOL, V50, P795, DOI 10.1111/j.2042-7158.1998.tb07142.x; Kopp C, 2015, ZOOLOGY, V118, P125, DOI 10.1016/j.zool.2014.06.006; Labarre P, 2008, NUCL MED BIOL, V35, P783, DOI 10.1016/j.nucmedbio.2008.07.003; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1602/neurorx.1.1.46; Larson TA, 2012, ACS NANO, V6, P9182, DOI 10.1021/nn3035155; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lee HJ, 2013, PHARM RES-DORDR, V30, P478, DOI 10.1007/s11095-012-0893-3; Legin AA, 2014, CHEM SCI, V5, P3135, DOI 10.1039/c3sc53426j; Lesniak A, 2010, BIOMATERIALS, V31, P9511, DOI 10.1016/j.biomaterials.2010.09.049; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu X, 2013, J NANOMATER, V2013, DOI 10.1155/2013/938370; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lozic I, 2014, METALLOMICS, V6, P455, DOI 10.1039/c3mt00336a; Lozie I., 2015, DATA BRIEF UNPUB; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; MORI S, 1969, J COMP NEUROL, V137, P197, DOI 10.1002/cne.901370206; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; N'soukpoe-Kossi CN, 2006, J BIOMOL STRUCT DYN, V24, P277, DOI 10.1080/07391102.2006.10507120; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Peixoto P, 2009, EUR J MED CHEM, V44, P4758, DOI 10.1016/j.ejmech.2009.06.034; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Perekatt AO, 2014, P NATL ACAD SCI USA, V111, P7695, DOI 10.1073/pnas.1400128111; Phokeo V, 2002, J COMP NEUROL, V451, P213, DOI 10.1002/cne.10330; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Reukov V, 2011, BIOTECHNOL BIOENG, V108, P243, DOI 10.1002/bit.22958; ROBINSON JM, 1982, J CELL BIOL, V95, P933, DOI 10.1083/jcb.95.3.933; Ruge CA, 2011, NANOMED-NANOTECHNOL, V7, P690, DOI 10.1016/j.nano.2011.07.009; RUTILI G, 1977, ACTA PHYSIOL SCAND, V99, P1, DOI 10.1111/j.1748-1716.1977.tb10345.x; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/NNANO.2012.237, 10.1038/nnano.2012.237]; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Sarfati G, 2011, BIOMATERIALS, V32, P152, DOI 10.1016/j.biomaterials.2010.09.014; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Shang L, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-5; Silva GA, 2010, ANN NY ACAD SCI, V1199, P221, DOI 10.1111/j.1749-6632.2009.05361.x; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Song CX, 1997, J CONTROL RELEASE, V43, P197, DOI 10.1016/S0168-3659(96)01484-8; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Tsyalkovsky V, 2008, CHEM MATER, V20, P317, DOI 10.1021/cm0718421; Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028; de Almeida LMV, 2008, ARCH BIOCHEM BIOPHYS, V480, P27, DOI 10.1016/j.abb.2008.09.006; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Xie J, 2010, ADV DRUG DELIVER REV, V62, P1064, DOI 10.1016/j.addr.2010.07.009; Yan Y, 2013, ACS NANO, V7, P10960, DOI 10.1021/nn404481f; 신진영, 2008, Clinical and Experimental Pediatrics, V51, P1102	82	16	16	5	52	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2016	74						200	216		10.1016/j.biomaterials.2015.10.001			17	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CV9MH	WOS:000364610800018	26461115				2021-06-18	
J	Meulenbroek, P; Bowers, B; Turkstra, LS				Meulenbroek, Peter; Bowers, Barbara; Turkstra, Lyn S.			Characterizing common workplace communication skills for disorders associated with traumatic brain injury: A qualitative study	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Traumatic brain injury; employment; vocational rehabilitation; social reintegration; communication disorders	HEAD-INJURY; PREDICTING RETURN; WORK; EMPLOYMENT; OUTCOMES; IMPAIRMENTS; PERFORMANCE; STABILITY; ABILITIES; MEMORY	BACKGROUND: Interpersonal skill deficits are the primary reason for workplace separation after traumatic brain injury (TBI). Communication is integral to interpersonal skills, but workplace communication demands are inadequately described in the rehabilitation literature. OBJECTIVE: This study describes inter-stakeholder examples of workplace communication behaviors for a level of employment to which people with TBI commonly attempt to return. METHODS: Setting: Mid-level workplaces. Design: Semi-structured interviews were audio recorded, transcribed verbatim, then analyzed using thematic content analysis. Findings were linked to common communication deficits in persons with TBI. Participants: A volunteer sample of twenty healthy individuals employed in the mid-level workplaces, ten employees and ten supervisors. Main Outcome Measure(s): Taxonomy of communication skill deficits common in persons with TBI and associated with mid-level workplaces. RESULTS: Interviews revealed seven communication-related skills associated with mid-level employment: 1) spoken language processing; 2) verbal memory; 3) reading and writing; 4) verbal reasoning; 5) expressive pragmatics; 6) multi-tasking; and 7) social cognition. CONCLUSION: Workers and supervisors from an assortment of mid-level jobs with differing job contents all identified similarly common and important cross-occupational communication-related skills. Findings provide a preliminary guide to assess and treat communication skills for patients who have work re-entry as a goal.	[Meulenbroek, Peter] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Meulenbroek, Peter] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Bowers, Barbara] Univ Wisconsin, Sch Nursing, Madison, WI USA; [Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA	Meulenbroek, P (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Rehabil Inst Chicago, 345 E Super St,Rm 1328, Chicago, IL 60611 USA.	peter.meulenbroek@northwestern.edu		Meulenbroek, Peter/0000-0003-4233-9910; Bowers, Barbara/0000-0002-3226-0718	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F31 DC011462] Funding Source: Medline		Ashcraft KL, 2003, COMMUN THEOR, V13, P5, DOI 10.1093/ct/13.1.5; Bailey T., 1997, WORKFORCE READINESS, P27; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; Beukelman D.R., 1991, COMMUNICATION DISCOU; Bowers D., 1991, FLORIDA AFFECT BATTE; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bryen DN, 2007, AUGMENT ALTERN COMM, V23, P126, DOI 10.1080/07434610600991175; Burnard P, 1991, Nurse Educ Today, V11, P461, DOI 10.1016/0260-6917(91)90009-Y; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; DeKay SH, 2012, BUS PROF COMMUN Q, V75, P449, DOI 10.1177/1080569912458966; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Downing J.R., 2011, J BUS COMMUN, V48, P409; Drew Paul, 1992, TALK WORK INTERACTIO, P3; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GREENSPAN S, 1981, APPL RES MENT RETARD, V2, P23, DOI 10.1016/0270-3092(81)90004-7; Guilmette TJ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P303, DOI 10.1007/0-387-28919-4_16; HANLEYMAXWELL C, 1986, J ASSOC PERS SEVERE, V11, P45; Hartley L. L., 1995, COGNITIVE COMMUNICAT; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Isaki E, 2000, BRAIN INJURY, V14, P441; Johansson U, 2001, DISABIL REHABIL, V23, P474; Johnson R, 1987, Int Disabil Stud, V9, P49; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Keyton J., 2013, J BUSINESS COMMUNICA, V50, P152, DOI [10.1177/0021943612474990, DOI 10.1177/0021943612474990]; Koester A., 2006, INVESTIGATING WORKPL; Konig CJ, 2005, HUM PERFORM, V18, P243, DOI 10.1207/s15327043hup1803_3; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Krippendorff K., 2013, CONTENT ANAL INTRO I, V3rd; Levinson S.C., 1983, PRAGMATICS; Lew H., 2004, ARCH PHYS MED REHAB, V83, P5; Lillie R., 2010, NEUROPSYCHOLOGY EVER, P302; MacDonald S., 2005, FAVRES FUNCTIONAL AS; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Maxwell JA., 1997, HDB APPL SOCIAL RES, P69; McConnell MM, 2000, AM ECON REV, V90, P1464, DOI 10.1257/aer.90.5.1464; McDonald S., 2012, DEV SOCIAL NEUROSCIE, P325; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Meadows LM., 2001, NATURE QUALITATIVE E, V2001, P187; Meulenbroek P., 2012, 9 WORLD C BRAIN INJ; Meulenbroek P., 2015, COMMUNICATION UNPUB; Meulenbroek P., 2011, ASHA CONV SAN DIEG C; Mikelson K.S., 2003, VIRGINIAS WORKFORCE; Miles M.B., 1994, QUALITATIVE DATA ANA; MUCHMORE J, 1983, COMMUN EDUC, V32, P207, DOI 10.1080/03634528309378531; Myers KK, 2010, J BUS PSYCHOL, V25, P225, DOI 10.1007/s10869-010-9172-7; National Center for O*NET Development, 2014, O NET ONLINE HELP JO; National Research Council, 1999, CHANG NAT WORK IMPL; Neuendorf K.A., 2002, DEFINING CONTENT ANA; Norman D, 2000, COGNITIVE NEUROSCIEN, P376; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Penn C, 2000, NEUROGENIC COMMUNICA, P103; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Robles MM, 2012, BUS PROF COMMUN Q, V75, P453, DOI 10.1177/1080569912460400; Sale P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, 10.1097/00001199-199109000-00004.]; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; SALZBERG CL, 1986, APPL RES MENT RETARD, V7, P299, DOI 10.1016/S0270-3092(86)80003-0; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Schnurr S., 2013, EXPLORING PROFESSION; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Shadish W.R., 2001, EXPT QUASIEXPERIMENT; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sullivan MP, 2014, J SPEECH LANG HEAR R, V57, P1731, DOI 10.1044/2014_JSLHR-L-13-0238; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Togher L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P603; Trabasso T, 1996, DISCOURSE PROCESS, V21, P255, DOI 10.1080/01638539609544959; Turner T, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P841; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Weber Robert Philip, 1990, SAGE U PAPERS SERIES, V07-049; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Winsor J.L., 1997, J ASS COMMUNICATION, V3, P170; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	87	16	16	1	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2016	44	1					15	31		10.3233/JVR-150777			17	Rehabilitation	Rehabilitation	EB7MV	WOS:000387572700002	31105415	Green Accepted			2021-06-18	
J	Missios, S; Bekelis, K				Missios, Symeon; Bekelis, Kimon			The association of insurance status and race with the procedural volume of traumatic brain injury patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Insurance coverage; Race; Procedural volume; Resource utilization; NTDB	DIAGNOSTIC-TESTS; OUTCOMES; DISPARITIES; CHILDREN; CARE	Introduction: The influence of non-medical factors on the volume of procedures undergone by TBI patients remains an issue of debate. We investigated the association of lack of insurance and African-American race with the procedural volume of TBI patients. Methods: We performed a retrospective cohort study involving TBI patients, who were registered in the National Trauma Data Bank (NTDB) between 2009 and 2011. Multivariable logistic regression with mixed effects to control for clustering at the hospital level was used to investigate the association of insurance status and race with high volume of procedures for TBI patients. Results: Of the 392,292 TBI patients, who were registered in NTDB and met the inclusion criteria, 9850 (3.8%) underwent high procedural volume, defined as 2 or more procedures during hospitalization (2 standard deviations over the mean). Multivariable logistic regression analysis demonstrated an association of uninsured patients with decreased possibility of high procedural volume (OR, 0.68; 95% CI, 0.63-0.73). This persisted after using a mixed effects model to control for clustering at the hospital level (OR, 0.66; 95% CI, 0.61-0.71). In stratified samples, uninsured patients demonstrated similar associations even for GCS below 8 (OR, 0.69; 95% CI, 0.64-0.75), or ISS above 15 (OR, 0.74; 95% CI, 0.69-0.79). Multivariable logistic regression analysis did not demonstrate an association of African Americans with procedural volume (OR, 0.93; 95% CI, 0.86-1.02). Conclusions: During the hospitalization of TBI patients, lack of insurance was associated with lower procedural volume. When controlling for insurance status, we did not observe any race associated disparities in procedural volume. (C) 2015 Elsevier Ltd. All rights reserved.	[Missios, Symeon] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA 71105 USA; [Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03756 USA	Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, One Med Ctr Dr, Lebanon, NH 03756 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019				American College of Surgeons, 2011, ANN REPORT; Bolorunduro OB, 2013, AM J SURG, V205, P365, DOI 10.1016/j.amjsurg.2012.10.026; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Fowler RA, 2010, AM J RESP CRIT CARE, V181, P1003, DOI 10.1164/rccm.200902-0281ST; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Halpern MT, 2009, ANN SURG ONCOL, V16, P562, DOI 10.1245/s10434-008-0205-7; Institute of Medicine (IOM), CAR COV TOO LITTL TO; Kelly DF, 2001, WORLD J SURG, V25, P1179; Quintana JM, 1997, INT J QUAL HEALTH C, V9, P419, DOI 10.1093/intqhc/9.6.419; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Traumatic Brain Injury in the United States, 2010, TRAUMATIC BRAIN INJU; WENNEKER MB, 1990, JAMA-J AM MED ASSOC, V264, P1255, DOI 10.1001/jama.264.10.1255	15	16	16	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					154	159		10.1016/j.injury.2015.06.037			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900028	26187434				2021-06-18	
J	Schumacher, R; Walder, B; Delhumeau, C; Muri, RM				Schumacher, Rahel; Walder, Bernhard; Delhumeau, Cecile; Muri, Rene M.			Predictors of inpatient (neuro)rehabilitation after acute care of severe traumatic brain injury: An epidemiological study	BRAIN INJURY			English	Article						Traumatic brain injury; clinical pathway; predictors; inpatient rehabilitation; neurorehabilitation	GLASGOW COMA SCALE; HEAD-INJURY; PARIS-TBI; REHABILITATION; DISCHARGE; MODERATE; OUTCOMES; ADULTS; VOLUME; AGE	Objective: To describe the discharge destination of patients with severe traumatic brain injury (sTBI) after acute care. To identify predictors associated with inpatient rehabilitation (vs discharge home) and to identify predictors associated with neurorehabilitation (vs general rehabilitation).Methods: A national, multi-centre, prospective study with adult survivors after sTBI (abbreviated injury scale head score > 3). Univariate and multivariate logistic regression models included patient characteristics, pre-injury conditions, initial neuro-physiological assessment, trauma mechanisms, severity of TBI and pre-hospital conditions to find predictors of discharge destination.Results: Out of the 566 included patients, 341 (60%) were referred to inpatient rehabilitation, thereof 249 (73%) to neurorehabilitation; 225 (40%) were discharged home or to a nursing home. Lower scores on the Glasgow Coma Scale at admission/at 14 days, higher injury severity scores and older age were predictors for inpatient rehabilitation. Younger age and male gender were predictors for neurorehabilitation.Conclusions: Patients' pathways after acute care are not only determined by the severity of their brain injury, but also by their overall injury severity and socio-biological factors. More than half of the patients after sTBI are not discharged to specialized inpatient neurorehabilitation and, therefore, efforts should be taken to optimize post-acute care.	[Schumacher, Rahel; Muri, Rene M.] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol,Div Cognit & Restorat Neurol, Bern, Switzerland; [Schumacher, Rahel; Muri, Rene M.] Univ Bern, Univ Hosp Bern, Inselspital, Percept & Eye Movement Lab,Dept Neurol, Bern, Switzerland; [Schumacher, Rahel; Muri, Rene M.] Univ Bern, Univ Hosp Bern, Inselspital, Percept & Eye Movement Lab,Dept Clin Res, Bern, Switzerland; [Walder, Bernhard; Delhumeau, Cecile] Univ Hosp Geneva, Dept Intens Care & Clin Pharmacol, Div Anaesthesiol, Geneva, Switzerland; [Muri, Rene M.] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland	Schumacher, R (corresponding author), Univ Hosp Bern, Inselspital, Div Cognit & Restorat Neurol, Dept Neurol, Freiburgstr, CH-3010 Bern, Switzerland.	rahel.schumacher@dkf.unibe.ch	; Muri, Rene/E-9320-2012	Schumacher, Rahel/0000-0001-7500-7491; Muri, Rene/0000-0001-6990-4188			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Graham JE, 2013, MED CARE, V51, P404, DOI 10.1097/MLR.0b013e318286e3c8; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kool B, 2012, NEUROEPIDEMIOLOGY, V38, P179, DOI 10.1159/000337261; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tillou A, 2014, JAMA SURG, V149, P83, DOI 10.1001/jamasurg.2013.4244; TURNERSTOKES L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	25	16	16	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1186	1193		10.1080/02699052.2016.1183821			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300003	27389772				2021-06-18	
J	Sveen, U; Soberg, HL; Ostensjo, S				Sveen, Unni; Soberg, Helene Lundgaard; Ostensjo, Sigrid			Biographical disruption, adjustment and reconstruction of everyday occupations and work participation after mild traumatic brain injury. A focus group study	DISABILITY AND REHABILITATION			English	Article						Daily life; work; occupations; participation; qualitative interviews; vocational rehabilitation	QUALITATIVE CONTENT-ANALYSIS; LIFE BALANCE; REHABILITATION; SEVERITY; PERCEPTIONS; DISABILITY; EXPERIENCE; THERAPY; FATIGUE; SLEEP	Purpose: To explore traumatic brain injury (TBI) as a biographical disruption and to study the reconstruction of everyday occupations and work participation among individuals with mild TBI. Methods: Seven focus groups were conducted with 12 women and 8 men (22-60 years) who had sustained mild TBI and participated in a return-to-work program. Interviews were analyzed using qualitative content analysis. Results: Four interrelated themes emerged: disruption of occupational capacity and balance; changes in self-perceptions; experience of time; and occupational adjustment and reconstruction. The meaning of the impairments lies in their impact on the individual's everyday occupations. The abandonment of meaningful daily occupations and the feeling of not recognizing oneself were experienced as threats to the sense of self. Successful integration of the past, present and future was paramount to continuing life activities. The unpredictability of the future seemed to permeate the entire process of adjustment and reconstruction of daily life. Conclusions: Our findings show that the concept of time is important in understanding and supporting the reconstruction of daily life after TBI. The fundamental work of rehabilitation is to ameliorate the disruptions caused by the injury, restoring a sense of personal narrative and supporting the ability to move forward with life. IMPLICATIONS FOR REHABILITATION Individuals with a protracted recovery after a mild traumatic brain injury must reconstruct a new way of being and acting in the world to achieve biographical continuity. The perceived anxiety regarding changes in self and occupational identity, as well as loss of control over the future, can be attenuated through informational sessions during the hospital stay and at follow-up visits. The significant personal costs of returning to full-time employment too early indicate the need for early and ongoing vocational support in achieving a successful return to work.	[Sveen, Unni; Soberg, Helene Lundgaard] Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950, N-0424 Oslo, Norway; [Sveen, Unni; Soberg, Helene Lundgaard; Ostensjo, Sigrid] Oslo & Akershus Univ Coll, Fac Hlth Sci, Oslo, Norway	Sveen, U (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950, N-0424 Oslo, Norway.	unni.sveen@hioa.no			Norwegian Ministry of Health and Care Services	The study is part of a 'return to work' project initiated by the Norwegian Directorate of Health and the Ministry of Labour and Social Affairs and funded by the Norwegian Ministry of Health and Care Services. The authors report no conflicts of interest.	Agan J, 2008, WORK, V31, P259; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-01561, 10.3233/WOR-2012-1561]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Corbin J, 1987, RES SOCIOLOGY HLTH C, V6, P249, DOI DOI 10.1046/J.1365-2648.2001.01767.X; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Darnell R, 2002, J OCCUPATIONAL SCI, V9, P5; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gullestad Marianne, 1996, EVERYDAY LIFE PHILOS; Hammell Karen Whalley, 2004, Can J Occup Ther, V71, P296; Hammell KW, 2006, PERSPECTIVES DISABIL; HOLZBERG E, 2001, WORK, V16, P245; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kantartzis S, 2011, J OCCUP SCI, V18, P62, DOI 10.1080/14427591.2011.566917; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kielhofner G, 2008, MODEL HUMAN OCCUPATI; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Livneh H, 2013, REHABIL COUNS BULL, V56, P71, DOI 10.1177/0034355212447878; Matuska KM, 2008, J OCCUP SCI, V15, P9, DOI 10.1080/14427591.2008.9686602; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Polatajko, 2007, ENABLING OCCUPATION; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Prigatano GP, 2003, INT REV PSYCHIATR, V15, P371, DOI 10.1080/09540260310001606755; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rudman DL, 2002, J OCCUPATIONAL SCI, V9, P12, DOI DOI 10.1080/14427591.2002.9686489; Soeker MS, 2012, WORK, V43, P313, DOI 10.3233/WOR-2012-1412; Soeker MS, 2012, WORK, V42, P589, DOI 10.3233/WOR-2012-1414; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; TEASDALE G, 1974, LANCET, V2, P81; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Wagman P, 2012, SCAND J OCCUP THER, V19, P322, DOI 10.3109/11038128.2011.596219; Wagman P, 2012, SCAND J OCCUP THER, V19, P377, DOI 10.3109/11038128.2011.645552; Wagman P, 2011, QUAL HEALTH RES, V21, P410, DOI 10.1177/1049732310379240; World Health Organization, 2001, INT CLASS FUNCT DIS	43	16	16	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2016	38	23					2296	2304		10.3109/09638288.2015.1129445			9	Rehabilitation	Rehabilitation	DU1AO	WOS:000381937400005	27007064				2021-06-18	
J	Szczygielski, J; Mautes, AE; Muller, A; Sippl, C; Glameanu, C; Schwerdtfeger, K; Steudel, WI; Oertel, J				Szczygielski, Jacek; Mautes, Angelika E.; Mueller, Andreas; Sippl, Christoph; Glameanu, Cosmin; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim			Decompressive Craniectomy Increases Brain Lesion Volume and Exacerbates Functional Impairment in Closed Head Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; closed head injury; decompressive craniectomy; mouse; traumatic brain injury	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; CEREBRAL OXYGENATION; COGNITIVE DEFICITS; RAT MODEL; PRESSURE; REACTIVITY; EDEMA; METABOLISM	Decompressive craniectomy has been widely used in patients with head trauma. The randomized clinical trial on an early decompression (DECRA) demonstrated that craniectomy did not improve the neurological outcome, in contrast to previous animal experiments. The goal of our study was to analyze the effect of decompressive craniectomy in a murine model of head injury. Male mice were assigned into the following groups: sham, decompressive craniectomy, closed head injury (CHI), and CHI followed by craniectomy. At 24h post-trauma, animals underwent the Neurological Severity Score test (NSS) and Beam Balance Score test (BBS). At the same time point, magnetic resonance imaging was performed, and volume of edema and contusion was assessed, followed by histopathological analysis. According to NSS, animals undergoing both trauma and craniectomy presented the most severe neurological impairment. Also, balancing time was reduced in this group compared with sham animals. Both edema and contusion volume were increased in the trauma and craniectomy group compared with sham animals. Histopathological analysis showed that all animals that underwent trauma presented substantial neuronal loss. In animals treated with craniectomy after trauma, a massive increase of edema with hemorrhagic transformation of contusion was documented. Decompressive craniectomy applied after closed head injury in mice leads to additional structural and functional impairment. The surgical decompression via craniectomy promotes brain edema formation and contusional blossoming in our model. This additive effect of combined mechanical and surgical trauma may explain the results of the DECRA trial and should be explored further in experiments.	[Szczygielski, Jacek; Mautes, Angelika E.; Sippl, Christoph; Glameanu, Cosmin; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim] Univ Saarland, Med Ctr, Dept Neurosurg, D-66421 Homburg, Germany; [Mueller, Andreas] Univ Saarland, Med Ctr, Dept Radiol, D-66421 Homburg, Germany; [Mueller, Andreas] Univ Saarland, Fac Med, D-66421 Homburg, Germany	Szczygielski, J (corresponding author), Univ Saarland, Med Ctr, Dept Neurosurg, Kirrberger St,Bldg 90-5, D-66421 Homburg, Germany.	jacek.szczygielski@uks.eu	Oertel, Joachim/AAO-5012-2021	Szczygielski, Jacek/0000-0002-3157-2824; Muller, Andreas/0000-0003-0924-3490	voluntary association "Friends of Saarland University Medical Center"	This work has been supported by a financial award of voluntary association "Friends of Saarland University Medical Center'' for J.S.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Abdullah J, 2005, ACT NEUR S, V95, P311; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bian JY, 2006, NEUROSURG REV, V29, P168, DOI 10.1007/s10143-005-0010-8; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; GAAB M, 1979, CHILD BRAIN, V5, P484; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Kocher T, 1901, HIRNERSCHUTTERUNG HI, P262; Kunze E, 1998, ACT NEUR S, V71, P16; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Makino H, 1979, Acta Neurochir Suppl (Wien), V28, P193; Manville J, 2007, J MOL NEUROSCI, V31, P95, DOI 10.1385/JMN/31:02:95; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RINALDI A, 1990, ACT NEUR S, V51, P394; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Szczygielski J, 2010, ACTA NEUROCHIR SUPPL, V106, P225, DOI 10.1007/978-3-211-98811-4_42; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zhao Z, 2007, NEUROCRIT CARE, V7, P263, DOI 10.1007/s12028-007-0074-0; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	68	16	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					122	131		10.1089/neu.2014.3835			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200015	26102497				2021-06-18	
J	Weaver, LK; Chhoeu, A; Lindblad, AS; Churchill, S; Wilson, SH				Weaver, Lindell K.; Chhoeu, Austin; Lindblad, Anne S.; Churchill, Susan; Wilson, Stefanie H.			Hyperbaric oxygen for mild traumatic brain injury: Design and baseline summary	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						hyperbaric oxygenation; brain concussion; post-concussive syndrome; methodology	PERSISTENT POSTCONCUSSION SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; OBSTRUCTIVE SLEEP-APNEA; QUESTIONNAIRE; HBO2	The Brain Injury and Mechanisms of Action of Hyperbaric Oxygen for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) (BIMA) study, sponsored by the Department of Defense, is a randomized double-blind, sham-controlled clinical trial that has a longer duration of follow-up and more comprehensive assessment battery compared to recent HBO2 studies. BIMA randomized 71 participants from September 2012 to May 2014. Primary results are expected in 2017. Randomized military personnel received hyperbaric oxygen (HBO2) at 1.5 atmospheres absolute (ATA) or sham chamber sessions at 1.2 ATA, air, for 60 minutes daily for 40 sessions. Outcomes include neuropsychological, neuroimaging, neurological, vestibular, autonomic function, electroencephalography, and visual systems evaluated at baseline, immediately following intervention at 13 weeks and six months with self-report symptom and quality of life questionnaires at 12 months, 24 months and 36 months. Characteristics include: median age 33 years (range 21-53), 99% male, 82% Caucasian, 49% diagnosed post-traumatic stress disorder, 28% with most recent injury three months to one year prior to enrollment, 32% blast injuries, and 73% multiple injuries. This manuscript describes the study design, outcome assessment battery, and baseline characteristics. Independent of a therapeutic role of HBO2, results of BIMA will aid understanding of mTBI.	[Weaver, Lindell K.; Churchill, Susan] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Weaver, Lindell K.; Churchill, Susan] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Chhoeu, Austin] US Army Med Mat Dev Act USAMMDA, Hyperbar Oxygen Res Program Management Off HBO2 P, Ft Detrick, MD USA; [Lindblad, Anne S.; Wilson, Stefanie H.] Emmes Corp, Rockville, MD USA	Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84132 USA.	lindell.weaver@imail.org			U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication has not yet been locked and is therefore subject to change.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Falck-Ytter Y, 2009, RATING EVIDENCE USIN; First MB., 1997, STRUCTURED CLIN INTE; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrary BF, 2013, UNDERSEA HYPERBAR M, V40, P443; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; National Research Council, 2009, SYST ENG IMPR TRAUM; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Weaver LK, 2013, UNDERSEA HYPERBAR M, V40, P439; Weaver LK, 2014, HYPERBARIC OXYGEN TH, V13th; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	25	16	16	0	7	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		491	509					19	Marine & Freshwater Biology; Medicine, Research & Experimental	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300002	28768069				2021-06-18	
J	Zhang, QY; Li, ZK; Wu, SC; Li, XF; Sang, Y; Li, J; Niu, YH; Ding, H				Zhang, Qianying; Li, Zhike; Wu, Shuangchan; Li, Xiaofei; Sang, Ying; Li, Jian; Niu, Yunhui; Ding, Hong			Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway	FOOD & FUNCTION			English	Article							NRF2/HO-1 DEFENSE PATHWAY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; ANTIINFLAMMATORY ACTIVITY; IN-VITRO; ACTIVATION; REMYELINATION	Multiple sclerosis (MS) is a demyelinating disease occurring in the central nervous system. In the present study, we evaluated the function of myricetin on the alleviation of behavioral dysfunction and myelin protection in the cuprizone-induced demyelination model. Mice were daily fed with fodder including 0.2% cuprizone and were administrated myricetin (100 mg kg(-1)) by gavage administration for 5 weeks. The treatment of myricetin ameliorated hyper-locomotion and behavior impairment induced by cuprizone toxicity. With the administration of myricetin, the demyelinating lesion was lessened via increasing the LFB staining area and myelin phosphatide protein (MBP) expression. In addition, myricetin evidently promoted Nrf2 translocation in the nuclear fraction and enhanced the HO-1 and NQO1 expression levels. Our data revealed that myricetin may be a potential candidate for mitigating motor defects and demyelination in a cuprizone-induced mouse model via activating the Nrf2 pathway.	[Zhang, Qianying; Li, Zhike; Wu, Shuangchan; Li, Xiaofei; Sang, Ying; Li, Jian; Niu, Yunhui; Ding, Hong] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan, Hubei, Peoples R China	Ding, H (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan, Hubei, Peoples R China.	dinghong1106@whu.edu.cn					Acs P, 2013, J NEUROIMMUNOL, V262, P128, DOI 10.1016/j.jneuroim.2013.06.012; Alfieri A, 2013, FREE RADICAL BIO MED, V65, P1012, DOI 10.1016/j.freeradbiomed.2013.08.190; Biancotti JC, 2008, NEUROCHEM RES, V33, P2615, DOI 10.1007/s11064-008-9792-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; Bruck W, 2012, ACTA NEUROPATHOL, V124, P411, DOI 10.1007/s00401-012-1009-1; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Chang Y, 2015, J MED FOOD, V18, P516, DOI 10.1089/jmf.2014.3219; Cheng L, 2015, INT J CLIN EXP MED, V8, P10420; Chis IC, 2016, PHYSIOL INT, V103, P49, DOI 10.1556/036.103.2016.1.5; Cho BO, 2016, BIOSCI BIOTECH BIOCH, V80, P1520, DOI 10.1080/09168451.2016.1171697; Nunes AKD, 2016, EXP NEUROL, V275, P143, DOI 10.1016/j.expneurol.2015.10.013; Ding Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07002; Esteras N, 2016, BIOL CHEM, V397, P383, DOI 10.1515/hsz-2015-0295; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Gan L, 2014, BBA-MOL BASIS DIS, V1842, P1208, DOI 10.1016/j.bbadis.2013.12.011; Gold R, 2012, CLIN IMMUNOL, V142, P44, DOI 10.1016/j.clim.2011.02.017; Guo Y, 2015, FREE RADICAL BIO MED, V88, P337, DOI 10.1016/j.freeradbiomed.2015.06.013; Hobbs CA, 2015, FOOD CHEM TOXICOL, V83, P283, DOI 10.1016/j.fct.2015.06.016; Hong C, 2014, INT J PHARMACEUT, V477, P251, DOI 10.1016/j.ijpharm.2014.10.044; Jhang KA, 2014, NEUROBIOL AGING, V35, P2465, DOI 10.1016/j.neurobiolaging.2014.05.020; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Krauthausen M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-109; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; Li T, 2015, FREE RADICAL RES, V49, P1269, DOI 10.3109/10715762.2015.1066784; Licht-Mayer S, 2015, ACTA NEUROPATHOL, V130, P263, DOI 10.1007/s00401-015-1452-x; Liu JL, 2015, J NEUROCHEM, V135, P347, DOI 10.1111/jnc.13242; Lu SH, 2015, INT IMMUNOPHARMACOL, V29, P770, DOI 10.1016/j.intimp.2015.08.042; Mendes V, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/782504; Miljkovic D, 2013, ANTIOXID REDOX SIGN, V19, P2286, DOI 10.1089/ars.2012.5068; Miron VE, 2009, AM J PATHOL, V174, P1880, DOI 10.2353/ajpath.2009.080947; Orije J, 2015, NEUROIMAGE, V114, P128, DOI 10.1016/j.neuroimage.2015.04.012; OZAWA K, 1994, BRAIN, V117, P1311, DOI 10.1093/brain/117.6.1311; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pasquali L, 2015, CLIN BIOCHEM, V48, P19, DOI 10.1016/j.clinbiochem.2014.09.024; Qin S, 2013, MOL NUTR FOOD RES, V57, P435, DOI 10.1002/mnfr.201200563; Semwal DK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020090; Shimizu H, 2015, BIOCHEM BIOPH RES CO, V457, P718, DOI 10.1016/j.bbrc.2015.01.059; Shinkai Y, 2016, TOXICOL APPL PHARM, V295, P37, DOI 10.1016/j.taap.2016.01.020; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; Suneetha A, 2016, J CHROMATOGR B, V1019, P15, DOI 10.1016/j.jchromb.2016.02.010; Tao L, 2014, BIOORG MED CHEM LETT, V24, P5385, DOI 10.1016/j.bmcl.2014.10.049; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Vakilzadeh G, 2015, MOL NEUROBIOL, V52, P130, DOI 10.1007/s12035-014-8857-8; van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570, DOI 10.2174/187152712801661284; Xie JH, 2015, FOOD CHEM, V186, P97, DOI 10.1016/j.foodchem.2014.06.106; Xu HY, 2014, EUR ARCH PSY CLIN N, V264, P121, DOI 10.1007/s00406-013-0414-3; Xu Haiyun, 2011, Front Behav Neurosci, V5, P31, DOI 10.3389/fnbeh.2011.00031; Xuan YH, 2015, NEUROCHEM INT, V90, P185, DOI 10.1016/j.neuint.2015.08.015; Xuan YH, 2014, NEUROCHEM INT, V69, P20, DOI 10.1016/j.neuint.2014.02.004; Yamamoto S, 2014, EUR J PHARMACOL, V741, P17, DOI 10.1016/j.ejphar.2014.07.040; Yang Y, 2015, CYTOKINE GROWTH F R, V26, P47, DOI 10.1016/j.cytogfr.2014.09.002; Zhang M, 2015, EXP BIOL MED, V240, P1183, DOI 10.1177/1535370214565975	56	16	16	0	23	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2042-6496	2042-650X		FOOD FUNCT	Food Funct.		2016	7	10					4332	4342		10.1039/c6fo00825a			11	Biochemistry & Molecular Biology; Food Science & Technology	Biochemistry & Molecular Biology; Food Science & Technology	DZ9XT	WOS:000386236000022	27713953				2021-06-18	
J	Buunk, AM; Groen, RJM; Veenstra, WS; Spikman, JM				Buunk, Anne M.; Groen, Rob J. M.; Veenstra, Wencke S.; Spikman, Jacoba M.			Leisure and social participation in patients 4-10 years after aneurysmal subarachnoid haemorrhage	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; EXECUTIVE DYSFUNCTION; FOLLOW-UP; HEALTH; SATISFACTION; IMPAIRMENT; PREDICTORS; DEPRESSION; COMPLAINTS		[Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, NL-9700 RB Groningen, Netherlands; [Groen, Rob J. M.; Veenstra, Wencke S.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, NL-9700 RB Groningen, Netherlands	Spikman, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1,Poortweg 4,2nd Floor,Room V2-210, NL-9700 RB Groningen, Netherlands.	j.m.spikman@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; Groen, Rob J.M./0000-0003-3067-763X	Stichting Catharina Heerdt	We gratefully acknowledge the financial support of Stichting Catharina Heerdt; this study is supported by funds of this charitable foundation. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P107; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dombovy ML, 1998, BRAIN INJURY, V12, P887; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Escartin G, 2012, NEUROPSYCHOLOGY, V26, P172, DOI 10.1037/a0024336; Fertl E, 1999, ACTA NEUROCHIR, V141, P571, DOI 10.1007/s007010050345; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; HOLM S, 1979, SCAND J STAT, V6, P65; Hutter BO, 2001, J NEUROSURG, V94, P241, DOI 10.3171/jns.2001.94.2.0241; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Manning L, 2005, EUR J NEUROL, V12, P466, DOI 10.1111/j.1468-1331.2005.01012.x; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Morris PG, 2004, NEUROSURGERY, V54, P47, DOI 10.1227/01.NEU.0000097198.94828.E1; O'Sullivan C, 2010, AUST OCCUP THER J, V57, P159, DOI 10.1111/j.1440-1630.2009.00833.x; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; Passier PECA, 2013, QUAL LIFE RES, V22, P1027, DOI 10.1007/s11136-012-0236-1; Passier PECA, 2012, NEUROREHABILITATION, V30, P137, DOI 10.3233/NRE-2012-0737; Passier PECA, 2011, J NEUROL, V258, P1091, DOI 10.1007/s00415-010-5891-y; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI 10.1080/09602011.2011.592099; Simons J.S., 2005, EFFECTIVENESS REHABI, V211, DOI [10.1093/acprof:oso/9780198526544.003.0018, DOI 10.1093/ACPROF:OSO/9780198526544.001.0001]; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Toomela A, 2004, J REHABIL MED, V36, P63, DOI 10.1080/16501970310017414; Uchikawa K, 2014, BRAIN INJURY, V28, P15, DOI 10.3109/02699052.2013.847209; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Verhage F, 1964, INTELLIGENTIE LEEFTI; Vetkas A, 2013, ACTA NEUROCHIR, V155, P1107, DOI 10.1007/s00701-013-1683-3; Vilkki JS, 2004, NEUROSURGERY, V55, P790, DOI 10.1227/01.NEU.0000137629.17424.6D; Vilkki J, 2012, ACTA NEUROCHIR, V154, P1437, DOI 10.1007/s00701-012-1417-y; Visser-Meily JMA, 2013, CEREBROVASC DIS, V36, P126, DOI 10.1159/000353642; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Wilson BA, 1996, BEHAV ASSESSMENT DYS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	16	16	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1589	1596		10.3109/02699052.2015.1073789			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800009	26362688				2021-06-18	
J	Chen, FQ; Zhou, J; Li, Y; Wang, YB; Li, LH; Yue, HZ				Chen, Fuqian; Zhou, Jun; Li, Yan; Wang, Yongbo; Li, Lihong; Yue, Hongzhi			Mechanical Properties of Porcine Brain Tissue in the Coronal Plane: Interregional Variations of the Corona Radiata	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Indentation; Hereditary integral; Viscoelasticity; Biomechanics; Heterogeneity	ELEMENT HEAD MODEL; IN-VIVO; INJURY; INDENTATION; DEFORMATION; MATTER; WHITE; TESTS	Most biomechanical models that aim to investigate traumatic brain injury consider the corona radiata as a homogeneous structure. To verify this, indentation-relaxation tests using a custom-designed indentation device were performed on the anterior, superior, and posterior region of the corona radiata in the coronal plane of the porcine brain. Using Boltzmann hereditary integral, a linear viscoelastic model with a Prony series approximation was fitted to the time-dependent shear modulus for different regions of the corona radiata, and the fit parameters were generated. The posterior region was the stiffest and the anterior region was the least stiff. A statistical analysis revealed a significant difference in biomedical properties between the anterior and superior regions, as well as between the anterior and posterior regions in the short time scale. However, the results showed that these differences faded away as the tissue approached equilibrium. No significant difference was observed between the superior and posterior regions along the total time history of relaxation. This is the first demonstration of the regional biomechanical heterogeneity of the corona radiata, and these results will improve future biomedical models of the porcine brain.	[Chen, Fuqian; Zhou, Jun; Li, Yan; Wang, Yongbo; Li, Lihong; Yue, Hongzhi] Shandong Univ, Sch Mech Engn, Jinan 250061, Peoples R China; [Chen, Fuqian; Zhou, Jun; Li, Yan; Wang, Yongbo; Li, Lihong; Yue, Hongzhi] Shandong Univ, Minist Educ, Key Lab High Efficiency & Clean Mech Mfg, Jinan 250061, Peoples R China	Zhou, J (corresponding author), Shandong Univ, Sch Mech Engn, Jinan 250061, Peoples R China.	zhoujun@sdu.edu.cn		Yue, Hongzhi/0000-0003-4101-9368	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51375268]; Independent Innovation Foundation of Shandong University [2012ZD009]	The authors thank Dr. Fei Gao and Dr. Xiaochen Wang for assistance with the slicing of porcine brain tissue and Dr. Qinhe Zhang and Dr. Renzhi Zhan for use of laboratory equipment. This research was supported financially by the National Natural Science Foundation of China (Grant No. 51375268) and the Independent Innovation Foundation of Shandong University (Grant No. 2012ZD009).	Allen M.P., 1997, UNDERSTANDING REGRES; Belingardi G, 2005, P 19 INT TECHN C ENH; Bonferroni C.E., 1935, STUDI ONORE PROFESSO, P13; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GURDJIAN ES, 1962, JAMA-J AM MED ASSOC, V182, P502; HARDING JW, 1945, P CAMB PHILOS SOC, V41, P16, DOI 10.1017/S0305004100022325; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Iwamoto M., 2000, SAE T J PASSENGER CA, V109, P846; Kang HS, 1997, P 41 STAPP CAR CRASH; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; King A. I., 2003, P IRCBOI INT RES COU; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lippert SA, 2004, BIORHEOLOGY, V41, P681; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Sahoo D, 2013, COMPUT METHOD BIOMEC, V16, P198, DOI 10.1080/10255842.2013.815908; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Versace J., 1971, REV SEVERITY INDEX; Zamir EA, 2004, J BIOMECH ENG-T ASME, V126, P276, DOI 10.1115/1.1695573	40	16	16	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2015	43	12					2903	2910		10.1007/s10439-015-1350-3			8	Engineering, Biomedical	Engineering	CV0LD	WOS:000363941300007	26048198				2021-06-18	
J	Guo, YJ; Liu, SM; Zhang, XH; Wang, LY; Gao, JG; Han, AQ; Hao, AJ				Guo, Yuji; Liu, Shangming; Zhang, Xianghong; Wang, Liyan; Gao, Jiangang; Han, Aiqing; Hao, Aijun			G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice	LABORATORY INVESTIGATION			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; FOCAL CEREBRAL-ISCHEMIA; CLOSED-HEAD INJURY; UP-REGULATION; MOUSE MODEL; CELL-DEATH; ACTIVATION; NEUROPROTECTION; RECOVERY	Granulocyte colony-stimulating factor (G-CSF) was investigated for its capacity to induce autophagy and related neuroprotective mechanisms in an acute spinal cord injury model. To accomplish this goal, we established a mouse spinal cord hemisection model to test the effects of recombinant human G-CSF. The results showed that autophagy was activated after spinal cord injury and G-CSF appears to induce a more rapid activation of autophagy within injured spinal cords as compared with that of non-treated animals. Apoptosis as induced in mechanically injured neurons with G-CSF treatment was enhanced after inhibiting autophagy by 3-methyladenine (3-MA), which partially blocked the neuroprotective effect of autophagy as induced by G-CSF. In addition, G-CSF inhibited the activity of the NF-kappa B signal pathway in neurons after mechanical injury. We conclude that G-CSF promotes autophagy by inhibiting the NF-kappa B signal pathway and protects neuronal structure after spinal cord injury. We therefore suggest that G-CSF, which rapidly induces autophagy after spinal cord injury to inhibit neuronal apoptosis, may thus provide an effective auxiliary therapeutic intervention for spinal cord injury.	[Guo, Yuji; Liu, Shangming; Zhang, Xianghong; Wang, Liyan; Hao, Aijun] Shandong Univ, Sch Med, Dept Histol & Embryol, Key Lab,Minist Educ Expt Teratol, Jinan 250012, Peoples R China; [Gao, Jiangang] Shandong Univ, Coll Life Sci, Inst Dev Biol, Jinan 250012, Peoples R China; [Han, Aiqing] Maternal & Children Hlth Hosp Jinan City, Dept Obstet, Jinan 250001, Shandong, Peoples R China	Han, AQ (corresponding author), Maternal & Children Hlth Hosp Jinan City, Dept Obstet, 2 Small Jingsan Rd, Jinan 250001, Shandong, Peoples R China.	haq6888@163.com; aijunhao@sdu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100919]; China postdoctoral science foundationChina Postdoctoral Science Foundation [2014170647]; postdoctoral science foundation of Shandong provinceChina Postdoctoral Science Foundation [201203050]; Scientific Research Foundation for Returned Scholars, Ministry of Education of ChinaScientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China [21300005451001]; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [BS2010YY041]; Natural Science Foundation of Shandong ProvinceNatural Science Foundation of Shandong Province [2012GSF11842, ZR2011HL070, ZR2015HM030]	This work is supported by the National Natural Science Foundation of China (grant no. 81100919); special financial grant from the China postdoctoral science foundation (2014170647); postdoctoral science foundation of Shandong province (201203050); the Scientific Research Foundation for Returned Scholars, Ministry of Education of China (21300005451001); Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (BS2010YY041); Natural Science Foundation of Shandong Province (2012GSF11842; ZR2011HL070, ZR2015HM030).	An HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114607; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Bartolini A, 2011, NEUROBIOL DIS, V41, P640, DOI 10.1016/j.nbd.2010.11.013; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bethea JR, 1998, J NEUROSCI, V18, P3251; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dittgen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029880; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Fan J, 2014, BRAIN RES, V1562, P76, DOI 10.1016/j.brainres.2014.03.019; Fujita S, 2015, J VASC SURG, V62, P1312, DOI 10.1016/j.jvs.2014.03.297; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Guo Y, 2013, NEUROSCIENCE, V238, P1, DOI 10.1016/j.neuroscience.2013.01.047; Guo YJ, 2014, J NEUROSCI RES, V92, P751, DOI 10.1002/jnr.23362; Henriques A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-25; Horner PJ, 2000, J NEUROSCI, V20, P2218; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, AUTOPHAGY, V5, P390, DOI 10.4161/auto.5.3.7724; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kim J, 2013, NEUROBIOL DIS, V59, P80, DOI 10.1016/j.nbd.2013.07.011; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Li WL, 2013, NEUROSCIENCE, V244, P16, DOI 10.1016/j.neuroscience.2013.03.045; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Miyata S, 2006, AM J PATHOL, V168, P386, DOI 10.2353/ajpath.2006.050137; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pan HC, 2008, J CLIN NEUROSCI, V15, P656, DOI 10.1016/j.jocn.2007.03.020; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sanli AM, 2010, J CLIN NEUROSCI, V17, P1548, DOI 10.1016/j.jocn.2010.03.043; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shulak L, 2014, J VIROL, V88, P2927, DOI 10.1128/JVI.03406-13; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yamasaki R, 2010, J NEUROIMMUNOL, V229, P51, DOI 10.1016/j.jneuroim.2010.07.002; Yan WJ, 2011, BRAIN RES, V1402, P109, DOI 10.1016/j.brainres.2011.05.049; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	53	16	18	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	DEC	2015	95	12					1439	1449		10.1038/labinvest.2015.120			11	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CX1LQ	WOS:000365458100010	26524416	Bronze			2021-06-18	
J	Arun, P; Oguntayo, S; Van Albert, S; Gist, I; Wang, Y; Nambiar, MP; Long, JB				Arun, Peethambaran; Oguntayo, Samuel; Van Albert, Stephen; Gist, Irene; Wang, Ying; Nambiar, Madhusoodana P.; Long, Joseph B.			Acute decrease in alkaline phosphatase after brain injury: A potential mechanism for tauopathy	NEUROSCIENCE LETTERS			English	Article						Blast exposure; Head impact/acceleration; Tauopathy; Chronic traumatic encephalopathy; Traumatic brain injury; Tissue non-specific alkaline phosphatase	AMYLOID PRECURSOR PROTEIN; TAU-PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; BLAST OVERPRESSURE; ALZHEIMERS-DISEASE; BETA-APP; EXPRESSION; MODEL; EXPOSURE; ACCUMULATION	Dephosphorylation of phosphorylated Tau (pTau) protein, which is essential for the preservation of neuronal microtubule assemblies and for protection against trauma-induced tauopathy and chronic traumatic encephalopathy (CTE), is primarily achieved in brain by tissue non-specific alkaline phosphatase (TNAP). Paired helical filaments (PHFs) and Tau isolated from Alzheimer's disease (AD) patients' brains have been shown to form microtubule assemblies with tubulin only after treatment with TNAP or protein phosphatase-2A, 2B and -1, suggesting that Tau protein in the PHFs of neurons in AD brain is hyperphosphorylated, which prevents microtubule assembly. Using blast or weight drop models of traumatic brain injury (TBI) in rats, we observed pTau accumulation in the brain as early as 6 h post-injury and further accumulation which varied regionally by 24 h post-injury. The pTau accumulation was accompanied by reduced TNAP expression and activity in these brain regions and a significantly decreased plasma total alkaline phosphatase activity after the weight drop. These results reveal that both blast- and impact acceleration-induced head injuries cause an acute decrease in the level/activity of TNAP in the brain, which potentially contributes to trauma-induced accumulation of pTau and the resultant tauopathy. The regional changes in the level/activity of TNAP or accumulation of pTau after these injuries did not correlate with the accumulation of amyloid precursor protein, suggesting that the basic mechanism underlying tauopathy in TBI might be distinct from that associated with AD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Arun, Peethambaran; Oguntayo, Samuel; Van Albert, Stephen; Gist, Irene; Wang, Ying; Nambiar, Madhusoodana P.; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA	Arun, P (corresponding author), Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil; joseph.b.long.civ@mail.mil			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0018, W81XWH-11-2-0127]	Technical help received from Rania Abu-Taleb, Andrea Edwards and Cory Riccio is greatly acknowledged. This work was supported by Congressionally Directed Medical Research Program awards W81XWH-08-2-0018 and W81XWH-11-2-0127 to JBL.	Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033798; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; BOSSI M, 1993, J BIOL CHEM, V268, P25409; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GREENBERG SM, 1994, P NATL ACAD SCI USA, V91, P7104, DOI 10.1073/pnas.91.15.7104; HANGER DP, 1991, BIOCHEM J, V275, P99, DOI 10.1042/bj2750099; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Le WD, 1997, J NEUROCHEM, V69, P978; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NARISAWA S, 1994, DEV DYNAM, V201, P227, DOI 10.1002/aja.1002010306; Negyessy L, 2011, NEUROSCIENCE, V172, P406, DOI 10.1016/j.neuroscience.2010.10.049; NISHIHARA Y, 1994, BBA-PROTEIN STRUCT M, V1209, P274, DOI 10.1016/0167-4838(94)90196-1; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Samura E, 2006, BRAIN RES, V1094, P192, DOI 10.1016/j.brainres.2005.12.134; Seino Y, 2010, J NEUROSCI RES, V88, P3547, DOI 10.1002/jnr.22516; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tomidokoro Y, 2001, NEUROSCI LETT, V299, P169, DOI 10.1016/S0304-3940(00)01767-5; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Wang Y, 2014, J NEUROTRAUM, V31, P498, DOI [10.1089/neu.2013.3074, 10.1089/NEU.2013.3074]; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Xia D, 2015, BBA-MOL BASIS DIS, V1852, P913, DOI 10.1016/j.bbadis.2014.12.017; Yamashita M, 1989, Neurol Med Chir (Tokyo), V29, P995, DOI 10.2176/nmc.29.995	36	16	18	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 16	2015	609						152	158		10.1016/j.neulet.2015.10.036			7	Neurosciences	Neurosciences & Neurology	CZ0CK	WOS:000366772500027	26483321	Bronze			2021-06-18	
J	de Kloet, AJ; Berger, MAM; Bedell, GM; Catsman-Berrevoets, CE; van Markus-Doornbosch, F; Vlieland, TPMV				de Kloet, Arend J.; Berger, Monique A. M.; Bedell, Gary M.; Catsman-Berrevoets, Coriene E.; van Markus-Doornbosch, Frederike; Vlieland, Thea P. M. Vliet			Psychometric evaluation of the Dutch language version of the Child and Family Follow-up Survey	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Acquired brain injury; adolescents; children; participation; traumatic brain injury; young adults	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; CROSS-CULTURAL ADAPTATION; INPATIENT REHABILITATION; PARTICIPATION OUTCOMES; PHYSICAL-DISABILITIES; PARENT PERSPECTIVES; RELIABILITY; VALIDITY	Aim: The Child and Family Follow-up Survey (CFFS) is developed to monitor long-term outcomes of children and youth with acquired brain injury (ABI). The aim of this study was to translate and adapt it into the Dutch language and to evaluate its reliability and validity.Methods: The CFFS includes the Child and Adolescent Scale of Participation (CASP), the Child and Adolescent Factors Inventory (CAFI) and the Child and Adolescent Scale of Environment (CASE). The CFFS was translated into Dutch following international guidelines and adapted. The internal consistency, validity and test-retest reliability were examined among two groups of patients (n=140 and n=27) in the age of 5-22 years with ABI and their parents.Results: The translation and adaptation resulted in the CFFS-DLV, Dutch language version. The CASP-DLV, CAFI-DLV and CASE-DLV had a good internal consistency, with Cronbach's alpha being 0.95, 0.89 and 0.83, respectively. There were statistically significant correlations among the three CFFS subscale scores. These scores were also significantly correlated with the total scores of the Pediatric Quality of Life Inventory (PedsQL, parent) and the Pediatric Stroke Outcome Measure, but not with the domain scores of the Children's Assessment of Participation and Enjoyment (CAPE). The test-retest reliability was good to moderate, with the intra-class correlation coefficients being 0.90 for the CASP-DLV, 0.95 for the CAFI-DLV and 0.81 for the CASE-DLV.Conclusions: The CFFS-DLV, as translation and adaptation of the CFFS into Dutch, proved to be a promising instrument to measure long-term outcomes of children and youth with ABI. Further research is needed to examine its responsiveness to change and potential in other patient groups.	[de Kloet, Arend J.; van Markus-Doornbosch, Frederike; Vlieland, Thea P. M. Vliet] Sophia Rehabil, NL-2543 SW The Hague, Netherlands; [de Kloet, Arend J.; Berger, Monique A. M.] Hague Univ Appl Sci, Dept Res & Dev, The Hague, Netherlands; [Bedell, Gary M.] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA; [Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Paediat Neurol, Rotterdam, Netherlands; [Vlieland, Thea P. M. Vliet] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands	de Kloet, AJ (corresponding author), Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	a.dekloet@sophiarevalidatie.nl	Vlieland, Thea Vliet/AAJ-8119-2020	Vlieland, Thea Vliet/0000-0001-6322-3859	Revalidatiefonds [2010/0029]; Johanna Kinder Fonds; Kinderrevalidatie Fonds Adriaanstichting [2009/0075-1403]	The Revalidatiefonds (Grant 2010/0029), Johanna Kinder Fonds and Kinderrevalidatie Fonds Adriaanstichting (Grant 2009/0075-1403) supported this project financially. The authors report no conflict of interest.	Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bedell G., 2012, MEASURES OUTCOMES TH; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2011, ARCH PHYS MED REHAB, V92, P765, DOI 10.1016/j.apmr.2010.12.029; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BROWN M, 1987, ARCH PHYS MED REHAB, V68, P828; Bult MK, 2010, CLIN REHABIL, V24, P843, DOI 10.1177/0269215510367545; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Engelmann KA, 2012, ARCH NEUROL-CHICAGO, V69, P23, DOI 10.1001/archneurol.2011.1015; Fitzsimmons D, 2009, EUR J CANCER, V45, P19, DOI 10.1016/j.ejca.2008.07.036; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Haley S.M., 1992, PEDIAT EVALUATION DI; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; IBM Corp, 2011, REL IBM SPSS STAT WI; King G., 2004, CAPE PAC CHILDRENS A; King G, 2006, CHILD HEALTH CARE, V35, P209, DOI 10.1207/s15326888chc3503_2; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; MacDougall J, 2012, YOUTH REPORT VERSION; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCauley SR, 2011, J NEUROTRAUM, V28, P1; Morrow AM, 2012, CHILD CARE HLTH DEV, V38, P186, DOI 10.1111/j.1365-2214.2011.01240.x; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Russell KMW, 2006, CANCER-AM CANCER SOC, V106, P2267, DOI 10.1002/cncr.21871; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Streiner DL., 2003, HLTH MEASUREMENT SCA, V3rd; TEASDALE G, 1974, LANCET, V2, P81; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2006, DEV MED CHILD NEUROL, V48, P442, DOI 10.1017/S001216220600096X; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization (WHO), 2004, INT CLASS FUNCT DIS; Ziviani J, 2010, BRAIN IMPAIR, V11, P93, DOI 10.1375/brim.11.2.93	50	16	16	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	NOV 2	2015	18	6					357	364		10.3109/17518423.2013.850749			8	Clinical Neurology; Pediatrics; Rehabilitation	Neurosciences & Neurology; Pediatrics; Rehabilitation	CX5CK	WOS:000365718800002	24304040				2021-06-18	
J	Adkins, DL; Ferguson, L; Lance, S; Pevtsov, A; McDonough, K; Stamschror, J; Jones, TA; Kozlowski, DA				Adkins, DeAnna L.; Ferguson, Lindsay; Lance, Steven; Pevtsov, Aleksandr; McDonough, Kevin; Stamschror, Justin; Jones, Theresa A.; Kozlowski, Dorothy A.			Combining Multiple Types of Motor Rehabilitation Enhances Skilled Forelimb Use Following Experimental Traumatic Brain Injury in Rats	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						exercise; motor rehabilitation; neuroplasticity; constraint-induced movement therapy; controlled cortical impact; recovery of function	CONSTRAINT-INDUCED MOVEMENT; SENSORIMOTOR CORTEX LESIONS; CONTROLLED CORTICAL IMPACT; LESS-AFFECTED FORELIMB; VOLUNTARY EXERCISE; FUNCTIONAL RECOVERY; STROKE REHABILITATION; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; UPPER EXTREMITY	Background. Neuroplasticity and neurorehabilitation have been extensively studied in animal models of stroke to guide clinical rehabilitation of stroke patients. Similar studies focused on traumatic brain injury (TBI) are lacking. Objective. The current study was designed to examine the effects of individual and combined rehabilitative approaches, previously shown to be beneficial following stroke, in an animal model of moderate/severe TBI, the controlled cortical impact (CCI). Methods. Rats received a unilateral CCI, followed by reach training, voluntary exercise, or unimpaired forelimb constraint, alone or in combination. Forelimb function was assessed at different time points post-CCI by tests of skilled reaching, motor coordination, and asymmetrical limb use. Results. Following CCI, skilled reaching and motor coordination were significantly enhanced by combinations of rehabilitation strategies, not by individual approaches. The return of symmetrical limb use benefited from forelimb constraint alone. None of the rehabilitation strategies affected the size of injury, suggesting that enhanced behavioral function was not a result of neuroprotection. Conclusions. The current study has provided evidence that individual rehabilitation strategies shown to be beneficial in animal models of stroke are not similarly sufficient to enhance behavioral outcome in a model of TBI. Motor rehabilitation strategies for TBI patients may need to be more intense and varied. Future basic science studies exploring the underlying mechanisms of combined rehabilitation approaches in TBI as well as clinical studies comparing rehabilitation approaches for stroke versus TBI would prove fruitful.	[Adkins, DeAnna L.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Ferguson, Lindsay; Lance, Steven; Pevtsov, Aleksandr; McDonough, Kevin; Stamschror, Justin; Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA; [Ferguson, Lindsay; Lance, Steven; Pevtsov, Aleksandr; McDonough, Kevin; Stamschror, Justin; Kozlowski, Dorothy A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Jones, Theresa A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA	Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, 2325 N Clifton, Chicago, IL 60614 USA.	dkozlows@depaul.edu	Jones, Theresa A/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Adkins, DeAnna L/0000-0002-3063-5731	DePaul University Research Council (DAK); Department of DefenseUnited States Department of Defense [W81XWH-08-1-0624]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065866] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study has been supported by DePaul University Research Council (DAK) and the Department of Defense #W81XWH-08-1-0624 (DAK, DLA, TAJ).	ADAMS FS, 1994, PHYSIOL BEHAV, V55, P947, DOI 10.1016/0031-9384(94)90084-1; Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Alaverdashvili M, 2008, BEHAV BRAIN RES, V192, P232, DOI 10.1016/j.bbr.2008.04.013; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Austin MW, 2014, NEUROSCI RES, V87, P8, DOI 10.1016/j.neures.2014.06.007; Belke TW, 2011, PSYCHOL REC, V61, P213, DOI 10.1007/BF03395757; Brazzelli M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub4; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fritz SL, 2012, EXPERT REV NEUROTHER, V12, P191, DOI [10.1586/ERN.11.201, 10.1586/ern.11.201]; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hotting K, 2013, NEUROSCI BIOBEHAV R, V37, P2243, DOI 10.1016/j.neubiorev.2013.04.005; Hsu JE, 2005, EUR J NEUROSCI, V22, P2069, DOI 10.1111/j.1460-9568.2005.04370.x; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jones T. A., 2010, BRAIN REPAIR STROKE; JONES TA, 1994, J NEUROSCI, V14, P2140; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Jones TA, 2009, STROKE, V40, pS136, DOI 10.1161/STROKEAHA.108.533653; Joo HW, 2012, EUR J NEUROSCI, V36, P3691, DOI 10.1111/ejn.12014; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; KRAUSS J, 2007, BRAIN INJURY MED PRI, P469; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; McIntyre A, 2012, TOP STROKE REHABIL, V19, P499, DOI 10.1310/tsr1906-499; MIKLYAEVA EI, 1994, J NEUROSCI, V14, P7148; Nishibe M, 2015, NEUROREHAB NEURAL RE, V29, P472, DOI 10.1177/1545968314543499; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tennant KA, 2015, NEUROREHAB NEURAL RE, V29, P193, DOI 10.1177/1545968314541329; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	63	16	17	0	22	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	NOV-DEC	2015	29	10					989	1000		10.1177/1545968315576577			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CU2BP	WOS:000363326800008	25761884	Green Accepted			2021-06-18	
J	Alatas, OD; Gurger, M; Atescelik, M; Yildiz, M; Demir, CF; Ekingen, E; Kalayci, M; Ilhan, N; Acar, E				Alatas, Omer Dogan; Gurger, Mehtap; Atescelik, Metin; Yildiz, Mustafa; Demir, Caner Feyzi; Ekingen, Evren; Kalayci, Mehmet; Ilhan, Nevin; Acar, Ethem			Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage	MEDICINE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; STRESS GENE; EXPRESSION; MARKERS; HSP70; SHOCK; PATTERNS; S-100B; DAMAGE	The authors evaluated neuron-specific enolase (NSE), S100 calcium-binding protein B (S100B), and heat shock protein 70 (HSP 70) levels and their relationships with in-hospital mortality, Glasgow Coma Scale (GCS) scores, and National Institute of Health Stroke Scale (NIHSS) scores.In total, 35 patients older than 18 years were presented to our emergency department and were diagnosed with non-traumatic intracranial hemorrhage (ICH) and 32 healthy controls were included. Blood samples were drawn on days 0 and 5.S100 calcium-binding protein B and HSP levels were significantly higher in patients than in controls on days 0 and 5. Neuron-specific enolase levels were higher in patients than in controls on day 0, but there was no significant difference on day 5.S100 calcium-binding protein B was negatively correlated with GCS, whereas it was positively correlated with NIHSS and bleeding volume. There was also a negative correlation between NSE and GCS, but it was not statistically significant. In addition, no significant correlation was found in terms of bleeding volume or NIHSS. Heat shock protein 70 was negatively correlated with GCS and positively correlated with bleeding volume and NIHSS, but these results were not statistically significant. S100 calcium-binding protein B and HSP 70 levels were significantly higher in those who died compared with survivors. The areas under the curve of S100 B, NSE, and HSP 70 for mortality were 0.635, 0.477, and 0.770, respectively.Neuron-specific enolase, S100B, and HSP 70 levels are simple, inexpensive, and objective measures in cases of ICH. These tests can be used to support an assessment for screening ICH patients with clinical scoring systems, such as GCS and NIHSS.	[Alatas, Omer Dogan; Acar, Ethem] Mugla Sitki Kocman Univ, Dept Emergency Med, Mugla, Turkey; [Gurger, Mehtap; Atescelik, Metin; Yildiz, Mustafa] Firat Univ, Sch Med, Dept Emergency Med, TR-23169 Elazig, Turkey; [Demir, Caner Feyzi] Firat Univ, Sch Med, Dept Neurol, TR-23169 Elazig, Turkey; [Ekingen, Evren] Batman Reg State Hosp, Dept Emergency Med, Batman, Turkey; [Kalayci, Mehmet] Elazig Training Hosp, Dept Biochem, Elazig, Turkey; [Ilhan, Nevin] Firat Univ, Dept Biochem, Sch Med, Elazig, Turkey	Alatas, OD (corresponding author), Mugla Sitki Kocman Univ, Sch Med, Dept Emergency, Med, Mugla, Turkey.	dr.alatas@hotmail.com	Gurger, Mehtap/V-8219-2018; Demir, Caner Feyzi/AAO-2045-2021; Ilhan, Nevin/J-5761-2017; Atescelik, Metin/V-8844-2018	Gurger, Mehtap/0000-0002-5209-2088; Demir, Caner Feyzi/0000-0002-2861-2418; Ilhan, Nevin/0000-0002-0208-8929; KALAYCI, Mehmet/0000-0001-9122-9289	Firat UniversityFirat University [TF.11.75]	This study was published as a poster at the 9th National Congress of Emergency Medicine in Turkey (23-26 May 2013, Antalya, Turkey). We received support from Firat University research funding for this study (number: TF.11.75).	Brea D, 2009, CLIN CHEM LAB MED, V47, P1513, DOI 10.1515/CCLM.2009.337; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; Brunswick AS, 2012, J NEUROL SCI, V321, P1, DOI 10.1016/j.jns.2012.06.008; CAPLAN LR, 1992, LANCET, V339, P656, DOI 10.1016/0140-6736(92)90804-C; Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad; Fang HY, 2007, J CLIN NEUROSCI, V14, P435, DOI 10.1016/j.jocn.2005.12.022; Herrmann M, 1999, EUR J CARDIO-THORAC, V16, P513, DOI 10.1016/S1010-7940(99)00245-6; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; HOMMEL M, 1990, STROKE, V21, P546, DOI 10.1161/01.STR.21.4.546; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Hu YY, 2010, SHOCK, V33, P134, DOI 10.1097/SHK.0b013e3181ad5c88; Janice AR, 1983, J NEUROL NEUROSUR PS, V46, P1031; Kartz BS, 2015, STROKE, V46, P1508; KELLY S, 2002, CURR MED RES OPIN, V18, P55; Manaenko A, 2010, NEUROCHEM INT, V57, P844, DOI 10.1016/j.neuint.2010.09.001; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; Matz P, 1996, STROKE, V27, P504, DOI 10.1161/01.STR.27.3.504; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Nikfarjam M, 2005, INT J HYPERTHER, V21, P319, DOI 10.1080/02656730500133736; O'Sullivan JC, 2007, J NEUROTRAUM, V24, P532, DOI 10.1089/neu.2006.0128; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rylander MN, 2005, ANN NY ACAD SCI, V1066, P222, DOI 10.1196/annals.1363.009; Schoerkhuber W, 1999, STROKE, V30, P1598, DOI 10.1161/01.STR.30.8.1598; Yuan X, 2004, J APOPLEXY IN PRESS, V2; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zubay G, 1983, BIOCHEMISTRY-US, P323	27	16	17	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2015	94	45							e2007	10.1097/MD.0000000000002007			5	Medicine, General & Internal	General & Internal Medicine	DC9JJ	WOS:000369537400051	26559295	DOAJ Gold, Green Published			2021-06-18	
J	Logan, TT; Rusnak, M; Symes, AJ				Logan, T. T.; Rusnak, M.; Symes, A. J.			Runx1 promotes proliferation and neuronal differentiation in adult mouse neurosphere cultures	STEM CELL RESEARCH			English	Article						Runx1; AML1; Adult neural stem cells; Neurosphere; Proliferation; Neuronal differentiation	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; TRANSCRIPTION FACTOR RUNX1; ACUTE MYELOID-LEUKEMIA; CENTRAL-NERVOUS-SYSTEM; CBF-BETA-SUBUNIT; SUBVENTRICULAR ZONE; PROGENITOR CELLS; GENE-EXPRESSION; GROWTH-FACTOR	Traumatic brain injury alters the signaling environment of the adult neurogenic niche and may activate unique proliferative cell populations that contribute to the post-injury neurogenic response. Runx1 is not normally expressed by adult neural stem or progenitor cells (NSPCs) but is induced in a subpopulation of putative NSPCs after brain injury in adult mice. In order to investigate the role of Runx1 in NSPCs, we established neurosphere cultures of adult mouse subventricular zone NSPCs. We show that Runx1 is basally expressed in neurosphere culture. Removal of the mitogen bFGF or addition of 1% FBS decreased Runxl expression. Inhibition of endogenous Runxl activity with either Ro5-3335 or shRNA-mediated Runx1 knockdown inhibited NSPC proliferation without affecting differentiation. Lentiviral mediated over-expression of Runx1 in neurospheres caused a significant change in cell morphology without reducing proliferation. Runx1-overexpressing neurospheres changed from floating spheres to adherent colonies or individual unipolar or bipolar cells. Flow cytometry analysis indicated that Runx1 over-expression produced a significant increase in expression of the neuronal marker TuJ1 and a minor increase in the astrocytic marker S100 beta. Thus, Runx1 expression drove adult NSPC differentiation, predominantly toward a neuronal lineage. These data suggest that Runx1 could be manipulated after injury to promote neuronal differentiation to facilitate repair of the CNS. Published by Elsevier B.V.	Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	aviva.symes@usuhs.edu	Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939	Centre for Neuroscience and Regenerative Medicine; Henry M. Jackson Foundation	This work was supported by a grant from the Centre for Neuroscience and Regenerative Medicine to AJS and by a fellowship from the Henry M. Jackson Foundation to TTL. We thank all members of the Symes lab for helpful discussions, Jill Shah and Sapna Gopolasubramanian for technical assistance with experiments and figures. We also thank Dr. Andrew Snow and his lab members, and Dr. Kateryna Lund and the USUHS Biomedical Instrumentation Facility for technical assistance with flow cytometry experiments. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as reflecting the views of the Uniformed Services University of the Health Sciences or the US Department of Defense. The authors report no conflicts of interest.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bonnert TP, 2006, EUR J NEUROSCI, V24, P661, DOI 10.1111/j.1460-9568.2006.04912.x; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Fischer JA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0283-z; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gil-Perotin S, 2013, ANAT REC, V296, P1435, DOI 10.1002/ar.22746; Hoi CSL, 2010, MOL CELL BIOL, V30, P2518, DOI 10.1128/MCB.01308-09; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Konig N, 2011, STEM CELLS DEV, V20, P1847, DOI 10.1089/scd.2010.0555; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Lopez-Juarez A, 2013, GENE DEV, V27, P1272, DOI 10.1101/gad.217539.113; Miao YS, 2015, CELL SIGNAL, V27, P156, DOI 10.1016/j.cellsig.2014.10.008; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Murthy M, 2014, GENE, V540, P191, DOI 10.1016/j.gene.2014.02.038; Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197; Ramasamy S, 2013, ARCH BIOCHEM BIOPHYS, V534, P71, DOI 10.1016/j.abb.2013.02.004; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Robertson AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003770; Rossetti S, 2013, INT J MOL SCI, V14, P1566, DOI 10.3390/ijms14011566; Scheitz CJF, 2013, J CELL BIOCHEM, V114, P985, DOI 10.1002/jcb.24453; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Stifani S, 2009, BLOOD CELL MOL DIS, V43, P20, DOI 10.1016/j.bcmd.2009.03.001; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Tang YY, 2000, J BIOL CHEM, V275, P39579, DOI 10.1074/jbc.M007350200; Tang YY, 2000, FEBS LETT, V470, P167, DOI 10.1016/S0014-5793(00)01312-0; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Voronov D, 2013, INVEST OPHTH VIS SCI, V54, P3115, DOI 10.1167/iovs.13-11791; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	54	16	16	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	NOV	2015	15	3					554	564		10.1016/j.scr.2015.09.014			11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	DC2GY	WOS:000369036400013	26473321	DOAJ Gold			2021-06-18	
J	Stone, JD; Hill, MK; Pan, ZX; Novais, EN				Stone, Joseph D.; Hill, Mary K.; Pan, Zhaoxing; Novais, Eduardo N.			Open Reduction of Pediatric Femoral Neck Fractures Reduces Osteonecrosis Risk	ORTHOPEDICS			English	Article							TERM-FOLLOW-UP; DISPLACED FRACTURE; AVASCULAR NECROSIS; CHILDREN; FEMUR; HIP; COMPLICATIONS; ADOLESCENTS; CLASSIFICATION; DECOMPRESSION	Pediatric femoral neck fractures are rare injuries that are associated with a high risk of osteonecrosis of the femoral head. This study compared pediatric patients with fully displaced femoral neck fractures treated with either open reduction and internal fixation (ORIF) or closed reduction and internal fixation (CRIF). After institutional review board approval was obtained, the authors identified 53 patients who were treated for femoral neck fracture between 2003 and 2012. Inclusion criteria were as follows: (1) diagnosis of a fully displaced femoral neck fracture with no anatomic cortical contact; (2) age of at least 4 years; and (3) clinical/radiographic follow-up of at least 1 year. Medical records and radiographs were retrospectively reviewed. Excluded from the study were 16 patients who had fractures that were not fully displaced, 4 who were outside of the eligible age range, 1 who had insufficient radiographs, and 10 who had insufficient follow-up. Of the 22 patients included, 6 were treated with ORIF and 16 were treated with CRIF. Treatment groups were compared with Fisher's exact test for categorical outcome data and the Wilcoxon rank-sum test for continuous variables. There was a significantly (P=.051) greater occurrence of osteonecrosis after CRIF (50%) than after ORIF (0%). Further, patients who underwent ORIF had a higher (P=.009) quality of reduction, a higher (P=.046) rate of anatomic union, and fewer (P=.009) complications than those who underwent CRIF. Major complications occurred in significantly fewer (P=.015) hips after ORIF than after CRIF. No significant difference (P=.477) was seen between groups, according to the Ratliff assessment of final results. Fully displaced pediatric femoral neck fractures treated with ORIF had a significantly higher quality of reduction, with fewer complications, including osteonecrosis, than those treated with CRIF.	[Stone, Joseph D.; Hill, Mary K.; Pan, Zhaoxing; Novais, Eduardo N.] Childrens Hosp Colorado, Aurora, CO 80045 USA	Novais, EN (corresponding author), Childrens Hosp Colorado, 13123 E 16th Ave,Box 060, Aurora, CO 80045 USA.	eduardo.novais@childrenscolorado.org					Beaty JH, 2006, ORTHOP CLIN N AM, V37, P223, DOI 10.1016/j.ocl.2005.11.003; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; CANALE ST, 1990, ORTHOP CLIN N AM, V21, P341; Canale ST, 1995, AAOS INSTR COURS LEC, V44, P255; Cheng JCY, 1999, J PEDIATR ORTHOPED, V19, P338; Colonna PC, 1929, AM J SURG, V6, P793, DOI [10.1016/S0002-9610(29)90726-1, DOI 10.1016/S0002-9610(29)90726-1, 10.1016/s0002-9610(29)90726-1]; Dendane MA, 2010, ORTHOP TRAUMATOL-SUR, V96, P161, DOI [10.1016/j.rcot.2010.02.004, 10.1016/j.otsr.2009.11.007]; Dhammi IK, 2005, J ORTHOP SCI, V10, P173, DOI 10.1007/s00776-004-0875-3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Flynn JM, 2002, J BONE JOINT SURG BR, V84B, P108, DOI 10.1302/0301-620X.84B1.11972; FORLIN E, 1992, J PEDIATR ORTHOPED, V12, P503, DOI 10.1097/01241398-199207000-00017; HEISER JM, 1980, CLIN ORTHOP RELAT R, P177; HUGHES LO, 1994, J BONE JOINT SURG AM, V76A, P283, DOI 10.2106/00004623-199402000-00019; JONES RW, 1936, BRIT J SURG, V23, P787; LEUNG PC, 1986, J BONE JOINT SURG BR, V68, P537; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Morsy HA, 2001, INJURY, V32, P45, DOI 10.1016/S0020-1383(00)00109-1; Ng GPK, 1996, INJURY, V27, P419, DOI 10.1016/0020-1383(96)00025-3; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528; Shrader MW, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000238794.82466.3d; Sink EL, 2012, CLIN ORTHOP RELAT R, V470, P2220, DOI 10.1007/s11999-012-2343-2; Song KS, 2010, J BONE JOINT SURG BR, V92B, P1148, DOI 10.1302/0301-620X.92B8.24482; Song KS, 2001, J PEDIATR ORTHOP B, V10, P205, DOI 10.1097/00009957-200107000-00009; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; Yeranosian M, 2013, BONE JOINT J, V95B, P135, DOI 10.1302/0301-620X.95B1.30161	25	16	25	1	7	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	NOV	2015	38	11					E983	E990		10.3928/01477447-20151020-06			8	Orthopedics	Orthopedics	DA5JT	WOS:000367840100006	26558678				2021-06-18	
J	Frieler, RA; Nadimpalli, S; Boland, LK; Xie, A; Kooistra, LJ; Song, JR; Chung, YT; Cho, KW; Lumeng, CN; Wang, MM; Mortensen, RM				Frieler, Ryan A.; Nadimpalli, Sameera; Boland, Lauren K.; Xie, Angela; Kooistra, Laura J.; Song, Jianrui; Chung, Yutein; Cho, Kae W.; Lumeng, Carey N.; Wang, Michael M.; Mortensen, Richard M.			Depletion of macrophages in CD11b diphtheria toxin receptor mice induces brain inflammation and enhances inflammatory signaling during traumatic brain injury	BRAIN RESEARCH			English	Article						Macrophage depletion; CD11b-DTR; Traumatic brain injury; Inflammation	TISSUE LOSS; RECOVERY; ACTIVATION; MECHANISMS; ABLATION; DISTINCT; REPAIR; EDEMA; CELLS; STATE	Immune cells have important roles during disease and are known to contribute to secondary, inflammation-induced injury after traumatic brain injury. To delineate the functional role of macrophages during traumatic brain injury, we depleted macrophages using transgenic CD11b-DTR mice and subjected them to controlled cortical impact. We found that macrophage depletion had no effect on lesion size assessed by T2-weighted MRI scans 28 days after injury. Macrophage depletion resulted in a robust increase in proinflammatory gene expression in both the ipsilateral and contralateral hemispheres after controlled cortical impact. Interestingly, this sizeable increase in inflammation did not affect lesion development. We also showed that macrophage depletion resulted in increased proinflammatory gene expression in the brain and kidney in the absence of injury. These data demonstrate that depletion of macrophages in CD11b-DTR mice can significantly modulate the inflammatory response during brain injury without affecting lesion formation. These data also reveal a potentially confounding inflammatory effect in CD11b-DTR mice that must be considered when interpreting the effects of macrophage depletion in disease models. (C) 2015 Elsevier B.V. All rights reserved.	[Frieler, Ryan A.; Nadimpalli, Sameera; Boland, Lauren K.; Xie, Angela; Kooistra, Laura J.; Song, Jianrui; Chung, Yutein; Lumeng, Carey N.; Wang, Michael M.; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Med Sci 2 7708, Ann Arbor, MI 48109 USA; [Frieler, Ryan A.; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Cho, Kae W.; Lumeng, Carey N.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Vet Adm Ann Arbor Healthcare Syst, Dept Neurol, Ann Arbor, MI 48105 USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	Mortensen, RM (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Med Sci 2 7708, 1137 E Catherine St, Ann Arbor, MI 48109 USA.	rmort@umich.edu		Boland, Lauren/0000-0003-1324-5827; Frieler, Ryan/0000-0003-2780-3244	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL112610, NS077780]; American Heart AssociationAmerican Heart Association [12GRNT11890006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL112610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS077780] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health Grant HL112610 and American Heart Association Grant-in-Aid 12GRNT11890006 to R.M.M., and National Institutes of Health fellowship NS077780 to R.A.F.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Bennett R.E., 2014, J NEUROTRAUMA; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ferreira L.C.B., 2014, BRAIN INJURY, P1; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hsieh C. L., 2014, J NEUROTRAUMA; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Lu L, 2012, AM J NEPHROL, V35, P181, DOI 10.1159/000335582; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Quintana A, 2007, J NEUROSCI RES, V85, P2668, DOI 10.1002/jnr.21126; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Zandbergen HR, 2009, J CARDIOVASC PHARM T, V14, P68, DOI 10.1177/1074248408329860	30	16	16	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 22	2015	1624						103	112		10.1016/j.brainres.2015.07.011			10	Neurosciences	Neurosciences & Neurology	CW5PY	WOS:000365050100011	26208897	Green Accepted			2021-06-18	
J	Sebastiani, A; Golz, C; Werner, C; Schafer, MKE; Engelhard, K; Thal, SC				Sebastiani, Anne; Goelz, Christina; Werner, Christian; Schaefer, Michael K. E.; Engelhard, Kristin; Thal, Serge C.			Proneurotrophin Binding to P75 Neurotrophin Receptor (P75ntr) Is Essential for Brain Lesion Formation and Functional Impairment after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						BDNF; CCI; neurotrophins; NGF; p75NTR; TBI; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; IN-VIVO; PROTEIN TRANSDUCTION; NEURONAL APOPTOSIS; NERVOUS-SYSTEM; CELL-SURVIVAL; SPINAL-CORD; P75(NTR); DEATH; MICE	Traumatic brain injury (TBI) initiates an excessive mediator release of e.g. neurotrophins, which promote neuronal survival, differentiation, and modulate synaptic plasticity. Paradoxically, mature forms of neurotrophins promote neuronal survival, whereas unprocessed forms of neurotrophins induce cell death through p75 neurotrophin receptor (p75NTR) signaling. p75NTR is widely expressed during synaptogenesis and is subsequently downregulated in adulthood. Repair mechanisms after acute cerebral insults can reactivate its expression. Therefore, the influence of p75NTR on secondary brain damage was addressed. mRNA levels of p75NTR and its ligands were quantified in brain tissue up to 7 days after experimental TBI (controlled cortical impact; CCI). Brain damage, motor function and inflammatory marker gene expression were determined in mice lacking the proneurotrophin-binding site of the p75NTR protein (NGFR(-/-)) and wild type littermates (NGFR(+/+)) 24h and 5 days after CCI. In addition, the effect of TAT-Pep5 (pharmacological inhibitor of the intracellular p75NTR death domain) on lesion volume was evaluated 24h after insult. p75NTR mRNA levels were induced nine-fold by TBI. In NGFR(-/-) mice, lesion volume was reduced by 29% at 24h and by 21% 5 days after CCI. Motor coordination was significantly improved 24h after trauma compared with the wild type. Pharmacological inhibition of the p75NTR signaling reduced lesion volume by 18%. The present study presents first time evidence that genetic mutation of the neurotrophin interaction site of p75NTR strongly limits post-traumatic cell death. In addition, we revealed pharmacological targeting of the intracellular p75NTR cell death domain as a promising approach to limit acute brain damage.	[Sebastiani, Anne; Goelz, Christina; Werner, Christian; Schaefer, Michael K. E.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55131 Mainz, Germany	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EO1003]; German Research Foundation (DFG)German Research Foundation (DFG) [TH1430/3-1, CRC1080/A9]; Focus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University; Johannes Gutenberg-University	This work was supported by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT, by the German Research Foundation (DFG) to SCT (TH1430/3-1) and KE (CRC1080/A9), by the Focus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University and Stage 1 funding of the Johannes Gutenberg-University to AS, MKES and SCT. Some data presented in this article are part of the doctoral thesis presented by CG to the Faculty of Veterinary Medicine of the Justus-Liebig-University Giessen, Germany.	Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Dietz GPH, 2002, MOL CELL NEUROSCI, V21, P29, DOI 10.1006/mcne.2002.1165; Ettinger K, 2012, CELL SIGNAL, V24, P2378, DOI 10.1016/j.cellsig.2012.08.008; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Heese K, 1998, J NEUROCHEM, V70, P699; Ilag LL, 1999, BIOCHEM BIOPH RES CO, V255, P104, DOI 10.1006/bbrc.1999.0101; Irmady K, 2014, J NEUROSCI, V34, P3419, DOI 10.1523/JNEUROSCI.1982-13.2014; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kilic E, 2002, ANN NEUROL, V52, P617, DOI 10.1002/ana.10356; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mysona BA, 2013, DIABETOLOGIA, V56, P2329, DOI 10.1007/s00125-013-2998-6; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Nguyen TVV, 2014, J ALZHEIMERS DIS, V42, P459, DOI 10.3233/JAD-140036; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ohlmann C. R., 2010, J NEUROCHEM, V112, P1015; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Otten U, 2000, ANN NY ACAD SCI, V917, P322; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; Shulga A, 2013, NEUROSCIENCE, V239, P241, DOI 10.1016/j.neuroscience.2012.12.007; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Skeldal S, 2012, J BIOL CHEM, V287, P43798, DOI 10.1074/jbc.M112.374710; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Uesugi N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.83; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	50	16	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1599	1607		10.1089/neu.2014.3751			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500008	25879397				2021-06-18	
J	Cook, AJ; Meyer, EC; Evans, LD; Vowles, KE; Klocek, JW; Kimbrel, NA; Gulliver, SB; Morissette, SB				Cook, Andrew J.; Meyer, Eric C.; Evans, Lianna D.; Vowles, Kevin E.; Klocek, John W.; Kimbrel, Nathan A.; Gulliver, Suzy Bird; Morissette, Sandra B.			Chronic pain acceptance incrementally predicts disability in polytrauma-exposed veterans at baseline and 1-year follow-up	BEHAVIOUR RESEARCH AND THERAPY			English	Article						Chronic pain; Acceptance; Functioning; Disability; Posttraumatic stress disorder; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COMORBID CHRONIC PAIN; VALUES-BASED ACTION; COMMITMENT THERAPY; OIF/OEF VETERANS; MENTAL-HEALTH; PRIMARY-CARE; PREVALENCE; PTSD	War veterans are at increased risk for chronic pain and co-occurring neurobehavioral problems, including posttraumatic stress disorder (PTSD), depression, alcohol-related problems, and mild traumatic brain injury (mTBI). Each condition is associated with disability, particularly when co-occurring. Pain acceptance is a strong predictor of lower levels of disability in chronic pain. This study examined whether acceptance of pain predicted current and future disability beyond the effects of these co-occurring conditions in war veterans. Eighty trauma-exposed veterans with chronic pain completed a PTSD diagnostic interview, clinician-administered mTBI screening, and self-report measures of disability, pain acceptance, depression, and alcohol use. Hierarchical regression-models showed pain acceptance to be incrementally associated with disability after accounting for symptoms of PTSD, depression, alcohol-related problems, and mTBI (total adjusted R-2 =.57, p <.001, Delta R-2 =.03, p =.02). At 1-year follow-up, the total variance in disability accounted for by the model decreased (total adjusted R-2 =.29, p <.001), whereas the unique contribution of pain acceptance increased (Delta R-2 =.07, p =.008). Pain acceptance remained significantly associated with 1-year disability when pain severity was included in the model. Future research should evaluate treatments that address chronic pain acceptance and co-occurring conditions to promote functional recovery in the context of polytrauma in war veterans. Published by Elsevier Ltd.	[Cook, Andrew J.; Meyer, Eric C.; Evans, Lianna D.; Morissette, Sandra B.] VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, Waco, TX USA; [Cook, Andrew J.; Meyer, Eric C.; Evans, Lianna D.; Morissette, Sandra B.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Cook, Andrew J.; Meyer, Eric C.; Gulliver, Suzy Bird; Morissette, Sandra B.] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA; [Vowles, Kevin E.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Klocek, John W.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Kimbrel, Nathan A.] Durham VA Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Gulliver, Suzy Bird] Baylor Scott & White Healthcare Syst, Warriors Res Inst, Waco, TX USA	Meyer, EC (corresponding author), Cent Texas Vet Healthcare Syst 151C, Ctr Excellence Res Returning War Vet, VA VISN 17, Waco, TX 76711 USA.	Eric.Meyer2@va.gov	Kimbrel, Nathan/P-3109-2016; Vowles, Kevin/AAD-4508-2019; Gulliver, Suzy/X-9776-2019	Kimbrel, Nathan/0000-0001-7218-1005; Cook, Andrew/0000-0001-7185-8328; Vowles, Kevin/0000-0003-4255-9067; Gulliver, Suzy Bird/0000-0002-6476-9447	Department of Veterans Affairs (VA) VISN 17 New Investigator AwardUS Department of Veterans Affairs; Rehabilitation Research & Development Service of the Department of Veterans Affairs Office of Research and Development (VA ORD) [I01 RX000304]; VISN 17 Center of Excellence for Research on Returning War Veterans; Central Texas Veterans Health Care System; Clinical Science Research and Development Service of VA ORD [IK2 CX000525]; Research & Development and Mental Health Services of the Durham VA Medical Center; VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center; Veterans AffairsUS Department of Veterans Affairs [I01RX000304, IK2CX000525] Funding Source: NIH RePORTER	This research was supported by a Department of Veterans Affairs (VA) VISN 17 New Investigator Award to Dr. Meyer, a Merit Award (I01 RX000304) to Dr. Morissette from the Rehabilitation Research & Development Service of the Department of Veterans Affairs Office of Research and Development (VA ORD), the VISN 17 Center of Excellence for Research on Returning War Veterans, and Central Texas Veterans Health Care System. Dr. Kimbrel was supported by a Career Development Award (IK2 CX000525) from the Clinical Science Research and Development Service of VA ORD, the Research & Development and Mental Health Services of the Durham VA Medical Center, and the VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center. Writing of this manuscript was further supported by the VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The authors also wish to thank our Veteran participants and research support staff.	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Alschuler KN, 2014, PSYCHOL SERV, V11, P273, DOI 10.1037/a0036201; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson HI, 2004, EUR J PAIN, V8, P47, DOI 10.1016/S1090-3801(03)00064-8; Barry LC, 2003, PAIN, V104, P131, DOI 10.1016/S0304-3959(02)00471-2; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bosco MA, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/174728; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Bricker J, 2013, NICOTINE TOB RES, V15, P1756, DOI 10.1093/ntr/ntt056; Butchart A, 2009, CLIN J PAIN, V25, P293, DOI 10.1097/AJP.0b013e31818bf574; Campbell W. I., 2008, CLIN PAIN MANAGEMENT, P12; Clancy C. M., 2014, COMMUNICATION; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Elliott AM, 2002, PAIN, V99, P299, DOI 10.1016/S0304-3959(02)00138-0; Fish RA, 2010, PAIN, V149, P435, DOI 10.1016/j.pain.2009.12.016; Gifford EV, 2004, BEHAV THER, V35, P689, DOI 10.1016/S0005-7894(04)80015-7; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goldberg J, 2014, QUAL LIFE RES, V23, P1579, DOI 10.1007/s11136-013-0585-4; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Hayes, 2005, CLIN CASE STUD, V4, DOI [https://doi.org/10.1177/1534650103259689, DOI 10.1177/1534650103259689, 10.1177/1534650103259689]; Hayes S.C., 6 CORE PROCESSES ACT; Hayes SC, 2004, BEHAV THER, V35, P667, DOI 10.1016/S0005-7894(04)80014-5; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hermann B.A., PILOT STUDY IN PRESS; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hill KG, 2000, ALCOHOL CLIN EXP RES, V24, P892, DOI 10.1097/00000374-200006000-00021; Holowka DW, 2011, OXFORD HDB TRAUMATIC; Jensen MP, 1992, HDB PAIN ASSESSMENT, P135; Kehle SM, 2012, PSYCHOL ADDICT BEHAV, V26, P42, DOI 10.1037/a0024663; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Konecky B, 2014, AM J PSYCHIAT, V171, P818, DOI 10.1176/appi.ajp.2014.14050587; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lewis JD, 2012, NEUROREHABILITATION, V31, P367, DOI 10.3233/NRE-2012-00805; Matthias MS, 2014, MIL MED, V179, P26, DOI 10.7205/MILMED-D-13-00196; McCracken LA, 2008, HEALTH PSYCHOL, V27, P215, DOI 10.1037/0278-6133.27.2.215; McCracken LM, 2014, AM PSYCHOL, V69, P178, DOI 10.1037/a0035623; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; McCracken LM, 2005, CONTEXTUAL COGNITIVE; Meyer EC, 2013, PSYCHOL TRAUMA-US, V5, P521, DOI 10.1037/a0030178; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Outcalt SD, 2014, PAIN MED, V15, P1872, DOI 10.1111/pme.12045; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Reneman MF, 2010, EUR J PAIN, V14, P457, DOI 10.1016/j.ejpain.2009.08.003; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Schwab KA, 2006, NEUROLOGY, V66, pA235; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thompson M, 2011, CURR PAIN HEADACHE R, V15, P144, DOI 10.1007/s11916-010-0170-2; U.S. Department of Veterans Affairs, 2014, TABL 1L VETPOP2014 L, P2013; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun TB, 2010, MEASURING HLTH DISAB; Vasterling J. J., 2008, TBI SCREENING UNPUB; Veterans Health Administration, 2006, VHA HDB; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Vowles KE, 2014, J CONTEXT BEHAV SCI, V3, P74, DOI 10.1016/j.jcbs.2014.04.003; Vowles KE, 2014, J PAIN, V15, P101, DOI 10.1016/j.jpain.2013.10.002; Vowles KE, 2008, PAIN, V140, P284, DOI 10.1016/j.pain.2008.08.012; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Walser RD, 2013, BEHAV RES THER, V51, P555, DOI 10.1016/j.brat.2013.05.009; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WHITE HR, 1989, J STUD ALCOHOL, V50, P30, DOI 10.15288/jsa.1989.50.30; Wicksell RK, 2009, EUR J PAIN, V13, P760, DOI 10.1016/j.ejpain.2008.09.003; World Health Organization, 2001, INT CLASS FUNCT DIS; Yunus MB, 2008, SEMIN ARTHRITIS RHEU, V37, P339, DOI 10.1016/j.semarthrit.2007.09.003	71	16	16	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	OCT	2015	73						25	32		10.1016/j.brat.2015.07.003			8	Psychology, Clinical	Psychology	CS5QI	WOS:000362132600004	26233854	Green Accepted			2021-06-18	
J	Samal, BB; Waites, CK; Almeida-Suhett, C; Li, Z; Marini, AM; Samal, NR; Elkahloun, A; Braga, MFM; Eiden, LE				Samal, Babru B.; Waites, Cameron K.; Almeida-Suhett, Camila; Li, Zheng; Marini, Ann M.; Samal, Nihar R.; Elkahloun, Abdel; Braga, Maria F. M.; Eiden, Lee E.			Acute Response of the Hippocampal Transcriptome Following Mild Traumatic Brain Injury After Controlled Cortical Impact in the Rat	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Hippocampus; Controlled cortical impact; Inflammation; Mild traumatic brain injury	CYCLASE-ACTIVATING POLYPEPTIDE; LENTIVIRAL INFECTION; EXPRESSION; SEQUELAE; STRESS; CELLS; MODEL	We have previously demonstrated that mild controlled cortical impact (mCCI) injury to rat cortex causes indirect, concussive injury to underlying hippocampus and other brain regions, providing a reproducible model for mild traumatic brain injury (mTBI) and its neurochemical, synaptic, and behavioral sequelae. Here, we extend a preliminary gene expression study of the hippocampus-specific events occurring after mCCI and identify 193 transcripts significantly upregulated, and 21 transcripts significantly downregulated, 24 h after mCCI. Fifty-three percent of genes altered by mCCI within 24 h of injury are predicted to be expressed only in the non-neuronal/glial cellular compartment, with only 13 % predicted to be expressed only in neurons. The set of upregulated genes following mCCI was interrogated using Ingenuity Pathway Analysis (IPA) augmented with manual curation of the literature (190 transcripts accepted for analysis), revealing a core group of 15 first messengers, mostly inflammatory cytokines, predicted to account for > 99 % of the transcript upregulation occurring 24 h after mCCI. Convergent analysis of predicted transcription factors (TFs) regulating the mCCI target genes, carried out in IPA relative to the entire Affymetrix-curated transcriptome, revealed a high concordance with TFs regulated by the cohort of 15 cytokines/cytokine-like messengers independently accounting for upregulation of the mCCI transcript cohort. TFs predicted to regulate transcription of the 193-gene mCCI cohort also displayed a high degree of overlap with TFs predicted to regulate glia-, rather than neuron-specific genes in cortical tissue. We conclude that mCCI predominantly affects transcription of non-neuronal genes within the first 24 h after insult. This finding suggests that early non-neuronal events trigger later permanent neuronal changes after mTBI, and that early intervention after mTBI could potentially affect the neurochemical cascade leading to later reported synaptic and behavioral dysfunction.	[Samal, Babru B.; Waites, Cameron K.; Eiden, Lee E.] NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Almeida-Suhett, Camila; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Li, Zheng] NIMH, Unit Synapse Dev & Plast, Bethesda, MD 20892 USA; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Elkahloun, Abdel] NHGRI, Microarray Core, Bethesda, MD 20892 USA	Eiden, LE (corresponding author), NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bldg 49,Room 5A-38,9000 Rockville Pike, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov	Li, Zheng/I-8016-2014; Samal, Babru/ABE-5931-2020; Almeida-Suhett, Camila/I-8045-2016	Li, Zheng/0000-0002-2978-2531; Almeida-Suhett, Camila/0000-0002-7588-9487; Waites, Cameron/0000-0001-6926-4643	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [Z01 MH002386-22]	We thank Chang-Mei Hsu for expert technical assistance in preparation of RNA for microarray and qRT-PCR analysis. This work was supported by the NIMH Intramural Research Program Project Z01 MH002386-22.	Ait-Ali D, 2010, CELL MOL NEUROBIOL, V30, P1441, DOI 10.1007/s10571-010-9620-y; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; Depboylu C, 2004, EUR J NEUROSCI, V19, P2997, DOI 10.1111/j.0953-816X.2004.03404.x; Depboylu C, 2012, J NEUROPATH EXP NEUR, V71, P15, DOI 10.1097/NEN.0b013e31823cfac5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eiden LE, 2008, ANN NY ACAD SCI, V1144, P6, DOI 10.1196/annals.1418.019; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Kovesdi E, 2008, NEUROTOX RES, V13, P71, DOI 10.1007/BF03033558; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; McCabe JT, 2014, ULTRASOUND MED BIOL, V40, P965, DOI 10.1016/j.ultrasmedbio.2013.11.023; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Samal B, 2007, PEPTIDES, V28, P1871, DOI 10.1016/j.peptides.2007.06.013; Samal BB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.131pt4; Serova LI, 2013, NEUROSCIENCE, V236, P298, DOI 10.1016/j.neuroscience.2013.01.040; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WEIHE E, 1993, NEUROREPORT, V4, P263, DOI 10.1097/00001756-199303000-00009	30	16	16	1	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	OCT	2015	57	2					282	303		10.1007/s12031-015-0626-2			22	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CR7VN	WOS:000361560000016	26319264				2021-06-18	
J	Yuan, RR; Wang, B; Lu, W; Maeda, Y; Dowling, P				Yuan, RuiRong; Wang, Bo; Lu, Wei; Maeda, Yasuhiro; Dowling, Peter			A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection	NEUROTHERAPEUTICS			English	Article						Multiple sclerosis; Experimental autoimmune encephalomyelitis; Immunomodulation; Erythropoietin; Peptide	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD8(+) T-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; MYELIN PROTEOLIPID PROTEIN; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ENCEPHALITOGENIC DETERMINANT; CARBAMYLATED ERYTHROPOIETIN; IMMUNE-RESPONSES	Beneficial effects of short-term whole-molecule erythropoietin (EPO) therapy have been demonstrated on several animal models of diverse central nervous system pathology. However, the increased hematocrit induced by EPO-driven marrow stimulation greatly limits its potential for side effect-free therapy. We created a library of EPO-derived fragments based on the hypothesis that 2 distinct functions, erythropoiesis and tissue protection, reside in different regions of the molecule. Several small EPO-derived peptides within the A beta loop of whole EPO molecule were screened for tissue protection in EAE mice. The 19-mer JM-4 peptide that contains 2 cysteine molecules consistently demonstrated the most potent clinical beneficial effects without producing hematocrit alterations in animal models of EAE. The JM-4-induced tissue protection was associated with modulation of the immunoregulatory process that drives inflammation and provokes subsequent autoimmune damage. Like the whole EPO molecule, JM-4 effectively modulated immune/inflammatory reaction within both the peripheral lymphatic tissue and central nervous system. The major effects induced by JM-4 include blocked expansion of monocyte/dendritic antigen presenting cell and T helper 17 cell populations, decreased proinflammatory cytokine production, and sharply enhanced expansion of the regulatory T-cell population. JM-4 shows promise for treatment of a broad spectrum of neural and non-neural conditions associated with inflammation.	[Yuan, RuiRong; Wang, Bo; Lu, Wei; Maeda, Yasuhiro; Dowling, Peter] VA Med Ctr East Orange, Neurol Serv, E Orange, NJ 07018 USA; [Yuan, RuiRong; Wang, Bo; Maeda, Yasuhiro; Dowling, Peter] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA	Dowling, P (corresponding author), VA Med Ctr East Orange, Neurol Serv, E Orange, NJ 07018 USA.	dowlinpc@njms.rutgers.edu	Wang, Bo/ABC-5571-2020		Veterans Affairs Office of Research and Development [IO1 RX000220-01, RX001305-01A2]; Segal Fund; National Institutes of Health Bridging Interventional Development Gaps award [1 X01 NS0073526-01A1]; Veterans AffairsUS Department of Veterans Affairs [I01RX000220, I01RX001305] Funding Source: NIH RePORTER	This work was supported by grants from the Veterans Affairs Office of Research and Development (IO1 RX000220-01; PD and RX001305-01A2; PD), the Segal Fund, and a National Institutes of Health Bridging Interventional Development Gaps (formerly National Institutes of Health RAID) award (1 X01 NS0073526-01A1; PD). Full conflict of interest disclosure is available in the electronic supplementary material for this article.	Abdul-Majid KB, 2003, J NEUROIMMUNOL, V141, P10, DOI 10.1016/S0165-5728(03)00210-8; Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Ahmet I, 2011, MOL MED, V17, P194, DOI 10.2119/molmed.2010.00235; Battistini L, 2003, BLOOD, V101, P4775, DOI 10.1182/blood-2002-10-3309; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bohlius J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007303.pub2; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Campana WM, 1998, INT J MOL MED, V1, P235; Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x; Chou YK, 2004, J NEUROSCI RES, V77, P670, DOI 10.1002/jnr.20201; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Crawford MP, 2004, BLOOD, V103, P4222, DOI 10.1182/blood-2003-11-4025; Dandekar AA, 2004, AM J PATHOL, V164, P363, DOI 10.1016/S0002-9440(10)63126-4; Davidson MG, 2013, J IMMUNOL, V191, P1175, DOI 10.4049/jimmunol.1203201; Dicato M, 2008, ONCOLOGIST, V13, P11, DOI 10.1634/theoncologist.13-S3-11; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Faunce DE, 2004, J IMMUNOL, V172, P1991, DOI 10.4049/jimmunol.172.4.1991; Fontoura P, 2005, INT REV IMMUNOL, V24, P415, DOI 10.1080/08830180500379655; Ford ML, 2005, EUR J IMMUNOL, V35, P76, DOI 10.1002/eji.200425660; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; GREER JM, 1992, J IMMUNOL, V149, P783; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Isaksson M, 2009, EUR J IMMUNOL, V39, P2925, DOI 10.1002/eji.200839179; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Linker RA, 2005, NEUROBIOL DIS, V19, P218, DOI 10.1016/j.nbd.2004.12.017; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Montero E, 2004, J AUTOIMMUN, V23, P1, DOI 10.1016/j.jaut.2004.05.001; Mun KC, 2000, BLOOD PURIFICAT, V18, P13, DOI 10.1159/000014403; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Savino C, 2006, J NEUROIMMUNOL, V172, P27, DOI 10.1016/j.jneuroim.2005.10.016; Shanmugam G, 2004, BIOPHYS J, V87, P622, DOI 10.1529/biophysj.104.040907; Siren AL, 2001, EUR ARCH PSY CLIN N, V251, P179, DOI 10.1007/s004060170038; SOBEL RA, 1986, J IMMUNOL, V136, P157; Sun DM, 2003, INT IMMUNOL, V15, P261, DOI 10.1093/intimm/dxg023; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Trajkovic V, 2004, GLIA, V47, P168, DOI 10.1002/glia.20046; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; WEN DY, 1994, J BIOL CHEM, V269, P22839; Xiong Y, 2009, NEUROL RES, V31, P496, DOI 10.1179/174313208X353703; YOSHIMURA T, 1985, J NEUROL SCI, V69, P47, DOI 10.1016/0022-510X(85)90006-1; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yuan RR, 2008, PLOS ONE, P3; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036	53	16	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	OCT	2015	12	4					850	861		10.1007/s13311-015-0379-1			12	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CT6XG	WOS:000362955800016	26271954	Green Published, Bronze			2021-06-18	
J	Cohen, T; Molinari, A				Cohen, Tal; Molinari, Alain			Dynamic cavitation and relaxation in incompressible nonlinear viscoelastic solids	INTERNATIONAL JOURNAL OF SOLIDS AND STRUCTURES			English	Article						Dynamic cavity expansion; Nonlinear viscoelasticity; Cavitation rheology; Relaxation; Thick-walled spherical shell	SPHERICAL CAVITY-EXPANSION; MODEL; GROWTH; RHEOLOGY; FRACTURE	Closed form analytical solutions for the dynamic expansion of a spherical void in a finite, spherically symmetric, nonlinearly viscoelastic medium are presented. We account for finite strains and application of load, both internally, at the cavity wall, and at the external surface. Hence, the present solution may apply to a wide range of known physical phenomena with examples from biomechanics, as in the appearance of cavitation bubbles due to traumatic brain injury or expansion of soft tissue due to an internal growth, to fracture initiation in soft materials and softening of seismic bearings in large scale structures. Specifically it is suggested that the present closed form analytical relations can be facilitated to measure the local viscoelastic properties of the material through controlled relaxation experiments. (C) 2015 Elsevier Ltd. All rights reserved.	[Cohen, Tal] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Molinari, Alain] Univ Lorraine, UMR CNRS, LEM3, F-57045 Metz 01, France	Cohen, T (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	talco@mit.edu			MIT-Technion Post-Doctoral Fellowship Program	A sincere thanks goes to Professor R Abeyaratne for his insightful comments during the course of this research. This research was supported by the MIT-Technion Post-Doctoral Fellowship Program (T.C).	BALL JM, 1982, PHILOS T R SOC A, V306, P557, DOI 10.1098/rsta.1982.0095; BISHOP RF, 1945, P PHYS SOC LOND, V57, P147, DOI 10.1088/0959-5309/57/3/301; CHOUWANG MS, 1989, INT J ENG SCI, V27, P967, DOI 10.1016/0020-7225(89)90037-2; Christensen R. M., 1982, THEORY VISCOELASTICI; Cohen T, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4007224; Cohen T, 2013, EUR J MECH A-SOLID, V37, P193, DOI 10.1016/j.euromechsol.2012.06.005; Cohen T, 2010, INT J PROT STRUCT, V1, P235, DOI 10.1260/2041-4196.1.2.235; Cohen T, 2010, J APPL MECH-T ASME, V77, DOI 10.1115/1.4000914; Cohen T, 2010, INT J ENG SCI, V48, P52, DOI 10.1016/j.ijengsci.2009.06.007; Cohen T, 2009, INT J SOLIDS STRUCT, V46, P3643, DOI 10.1016/j.ijsolstr.2009.06.013; Cristiano A, 2010, J POLYM SCI POL PHYS, V48, P1409, DOI 10.1002/polb.22026; Czarnota C, 2006, INT J FRACTURE, V141, P177, DOI 10.1007/s10704-006-0070-y; De Pascalis R, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2014.0058; Dorfmann A, 2000, J STRUCT ENG-ASCE, V126, P573, DOI 10.1061/(ASCE)0733-9445(2000)126:5(573); Drozdov A.D., 1996, COURSE NONLINEAR MEC, V434; Durban D, 1997, J APPL MECH-T ASME, V64, P743, DOI 10.1115/1.2788978; Durban D., 1974, International Journal of Non-Linear Mechanics, V9, P105, DOI 10.1016/0020-7462(74)90002-X; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Findley W.N., 1976, CREEP RELAXATION NON; FORRESTAL MJ, 1988, J APPL MECH-T ASME, V55, P275, DOI 10.1115/1.3173672; Fung Y.-C.B., 1972, BIOMECHANICS ITS FDN, P181, DOI 10.1007/978-1-349-01604-4_27; GENT AN, 1991, J MATER SCI, V26, P3392, DOI 10.1007/BF01124691; Horgan C, 1995, APPL MECH REV, V48, P471, DOI DOI 10.1115/1.3005108; HORGAN CO, 1986, J ELASTICITY, V16, P189, DOI 10.1007/BF00043585; Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060; Johnson GA, 1996, J BIOMECH ENG-T ASME, V118, P221, DOI 10.1115/1.2795963; Knowles J., 1965, ARCH RATION MECH AN, V18, P367; Kollmannsberger P, 2011, ANNU REV MATER RES, V41, P75, DOI 10.1146/annurev-matsci-062910-100351; Kumar M, 2014, EARTHQ ENG STRUCT D, V43, P1955, DOI 10.1002/eqe.2431; Lakes R. S., 1998, VISCOELASTIC SOLIDS, V9; Masri R, 2005, J APPL MECH-T ASME, V72, P887, DOI 10.1115/1.1985428; McMahon J, 2010, MATH MECH SOLIDS, V15, P57, DOI 10.1177/1081286508092010; ORTIZ M, 1992, J APPL MECH-T ASME, V59, P48, DOI 10.1115/1.2899463; Oyen M, 2005, MRS P, V898; Provenzano P, 2001, ANN BIOMED ENG, V29, P908, DOI 10.1114/1.1408926; Provenzano PP, 2002, BIOMECH MODEL MECHAN, V1, P45, DOI 10.1007/s10237-002-0004-1; Rodriguez-Martinez JA, 2014, INT J IMPACT ENG, V73, P43, DOI 10.1016/j.ijimpeng.2014.06.005; Volokh K., 2015, BIOMECH MODEL MECHAN, P1; Wang H., 2015, SOFT MATTER; Wineman A, 2009, MATH MECH SOLIDS, V14, P300, DOI 10.1177/1081286509103660; Wineman A., 2015, J ELASTICITY, P1; Wright TW, 2008, J MECH PHYS SOLIDS, V56, P336, DOI 10.1016/j.jmps.2007.05.012; Xu F, 2008, MATH COMPUT SCI ENG, P14; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a	44	16	16	0	28	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7683	1879-2146		INT J SOLIDS STRUCT	Int. J. Solids Struct.	SEP	2015	69-70						544	552		10.1016/j.ijsolstr.2015.04.029			9	Mechanics	Mechanics	CO5AM	WOS:000359172000044		Bronze			2021-06-18	
J	Drijkoningen, D; Caeyenberghs, K; Vander Linden, C; Van Herpe, K; Duysens, J; Swinnen, SP				Drijkoningen, David; Caeyenberghs, Karen; Vander Linden, Catharine; Van Herpe, Katrin; Duysens, Jacques; Swinnen, Stephan P.			Associations between Muscle Strength Asymmetry and Impairments in Gait and Posture in Young Brain-Injured Patients	JOURNAL OF NEUROTRAUMA			English	Article						balance control; traumatc brain injury; muscle strength; posture; gait	HAND-HELD DYNAMOMETRY; MILD HEAD-INJURY; BALANCE PERFORMANCE; HEMIPLEGIC GAIT; CEREBRAL-PALSY; CHILDREN; WALKING; STROKE; IMPROVEMENTS; VARIABILITY	Traumatic brain injury (TBI) can lead to deficits in gait and posture, which are often asymmetric. A possible factor mediating these deficits may be asymmetry in strength of the leg muscles. However, muscle strength in the lower extremities has rarely been investigated in (young) TBI patients. Here, we investigated associations between lower-extremity muscle weakness, strength asymmetry, and impairments in gait and posture in young TBI patients. A group of young patients with moderate-to-severe TBI (n=19; age, 14 years 11 months +/- 2 years) and a group of typically developing subjects (n=31; age, 14 years 1 month +/- 3 years) participated in this study. A force platform was used to measure postural sway to quantify balance control during normal standing and during conditions of compromised visual and/or somatosensory feedback. Spatiotemporal gait parameters were assessed during comfortable and fast-speed walking, using an electronic walkway. Muscle strength in four lower-extremity muscle groups was measured bilaterally using a handheld dynamometer. Findings revealed that TBI patients had poorer postural balance scores across all sensory conditions, as compared to typically developing subjects. During comfortable and fast gait, TBI patients demonstrated a lower gait velocity, longer double-support phase, and increased step-length asymmetry. Further, TBI patients had a reduced strength of leg muscles and an increased strength asymmetry. Correlation analyses revealed that asymmetry in muscle strength was predictive of a poorer balance control and a more variable and asymmetric gait. To the best of our knowledge, this is the first study to measure strength asymmetry in leg muscles of a sample of TBI patients and illustrate the importance of muscular asymmetry as a potential marker and possible risk factor of impairments in control of posture and gait.	[Drijkoningen, David; Duysens, Jacques; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia; [Caeyenberghs, Karen] Ghent Univ Hosp, Dept Phys Med & Rehabil, Child Rehabil Ctr, Ghent, Belgium; [Vander Linden, Catharine] Pulderbos Rehabil Ctr, Zandhoven, Belgium; [Van Herpe, Katrin] Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium	Swinnen, SP (corresponding author), Movement Control & Neuroplast Res Grp, Tervuursevest 101, B-3001 Louvain, Belgium.	stephan.swinnen@faber.kuleuven.be		Caeyenberghs, Karen/0000-0001-7009-6843; Duysens, Jacques/0000-0002-0043-8817	Research Foundation-Flanders (FWO)FWO [Levenslijn G.0482.10, G.A114.11, G.0721.12]; KU LeuvenKU Leuven [OT/11/071]; Belgian federal government [P7/11]	This work was supported by a grant from the Research Program of the Research Foundation-Flanders (FWO; Levenslijn G.0482.10 and G.A114.11 and G.0721.12). Additional support was provided by the Research Fund KU Leuven (OT/11/071) and the Interuniversity Attraction Poles program of the Belgian federal government [P7/11]. These funding sources had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Barbieri FA, 2014, GAIT POSTURE, V39, P985, DOI 10.1016/j.gaitpost.2013.12.021; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BRANDSTATER ME, 1983, ARCH PHYS MED REHAB, V64, P583; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Crompton J, 2007, DEV MED CHILD NEUROL, V49, P106, DOI 10.1111/j.1469-8749.2007.00106.x; Daubney ME, 1999, PHYS THER, V79, P1177, DOI 10.1093/ptj/79.12.1177; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Flansbjer UB, 2006, ARCH PHYS MED REHAB, V87, P974, DOI 10.1016/j.apmr.2006.03.008; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Granacher U, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-56; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P259, DOI 10.1097/PEP.0b013e3181824782; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lomaglio MJ, 2005, GAIT POSTURE, V22, P126, DOI 10.1016/j.gaitpost.2004.08.002; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; NAKAMURA R, 1985, TOHOKU J EXP MED, V145, P335, DOI 10.1620/tjem.145.335; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Pollock CL, 2011, CLIN REHABIL, V25, P693, DOI 10.1177/0269215510397394; RIDDLE DL, 1989, PHYS THER, V69, P182, DOI 10.1093/ptj/69.3.182; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roth EJ, 1997, AM J PHYS MED REHAB, V76, P128, DOI 10.1097/00002060-199703000-00008; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Toebes MJP, 2014, GAIT POSTURE, V40, P215, DOI 10.1016/j.gaitpost.2014.03.194; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	47	16	16	0	28	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1324	1332		10.1089/neu.2014.3787			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500006	25738975				2021-06-18	
J	Elbogen, EB; Wolfe, JR; Cueva, M; Sullivan, C; Johnson, J				Elbogen, Eric B.; Wolfe, James R.; Cueva, Michelle; Sullivan, Connor; Johnson, Jacqueline			Longitudinal Predictors of Criminal Arrest After Traumatic Brain Injury: Results From the Traumatic Brain Injury Model System National Database	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol abuse; criminal behavior; drug abuse; motor function; traumatic brain injury	SUBSTANCE-ABUSE; HEAD-INJURY; AGGRESSION; POPULATION; PREVALENCE; BEHAVIOR; CRIME	Objective: To examine how pre-traumatic brain injury (TBI) variables and TBI-related characteristics predict post-TBI criminal arrest, using longitudinal data from the Traumatic Brain Injury Model System National Database. Settings: Medical hospitals; rehabilitation facilities. Participants: Participants with documented TBI and nonmissing Traumatic Brain Injury Model System data, resulting in N = 6315 at 1 year post-TBI, N = 4982 at 2 years post-TBI, and N = 2690 at 5 years post-TBI. Design: Prospective cohort study with secondary data analysis of the relationship between pre-TBI/TBI factors and post-TBI criminal arrest as measured at 3 time points. Main Measures: Self-report of post-TBI criminal arrest. Results: Post-TBI criminal arrest was associated with gender, age, marital status, educational attainment, pre-TBI felony, pre-TBI drug abuse, pre-TBI alcohol abuse, and violent cause of TBI. Frontal, temporal, parietal, or occipital lobe lesions from computed tomographic scans did not predict post-TBI criminal arrests. Higher numbers of post-TBI arrests were predicted by loss of consciousness (>= 24 hours), combined with retention of motor function. Conclusion: Premorbid variables, especially pre-TBI felonies, were strongly linked to post-TBI criminal arrests. The relationship between TBI and arrest was complex, and different brain functions (eg, physical mobility) should be considered when understanding this association. Findings highlight that for post-TBI criminal behavior, many risk factors mirror those of the non-TBI general population.	[Elbogen, Eric B.; Wolfe, James R.; Cueva, Michelle; Sullivan, Connor; Johnson, Jacqueline] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA; [Elbogen, Eric B.] Durham VA Med Ctr, Mid Atlantic Mental Illness Res Educ & Clin Ctr M, Durham, NC USA	Elbogen, EB (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Forens Psychiat Program & Clin, Chapel Hill, NC 27599 USA.	eric.elbogen@unc.edu			U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; TBI Model Systems Centers; Department of DefenseUnited States Department of Defense [W81XWH1110796]	The TBI Model Systems National Database is supported by the U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) in collaboration with the TBI Model Systems Centers. However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDRR or the U.S. Department of Education. Preparation of the manuscript was supported by funding from the Department of Defense (W81XWH1110796). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Defense.	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Corrigan J, 2003, TECHNICAL REPORT PRO; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; FARRINGTON DP, 1973, J CRIM LAW CRIM, V64, P99, DOI 10.2307/1142661; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; HOLM S, 1979, SCAND J STAT, V6, P65; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Luiselli JK, 2000, INT J OFFENDER THER, V44, P647, DOI 10.1177/0306624X00446002; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Miller E, 1999, J FORENSIC PSYCHIATR, V10, P157, DOI 10.1080/09585189908402146; Miller E, 1999, PSYCHOL CRIME LAW, V5, P297, DOI 10.1080/10683169908401774; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Nieves K., 2000, J OFFENDER REHABIL, V30, P133, DOI [DOI 10.1300/J076V30N03_07, 10.1300/J076v30n03_07]; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Schiltz K, 2011, MINERVA PSICHIATR, V52, P187; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; VIRKKUNEN M, 1977, DIS NERV SYST, V38, P907; Volavka J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001148; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274	34	16	16	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					E3	E13		10.1097/HTR.0000000000000083			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400002	25310290				2021-06-18	
J	Gregson, BA; Rowan, EN; Francis, R; McNamee, P; Boyers, D; Mitchell, P; McColl, E; Chambers, IR; Unterberg, A; Mendelow, AD				Gregson, Barbara A.; Rowan, Elise N.; Francis, Richard; McNamee, Paul; Boyers, Dwayne; Mitchell, Patrick; McColl, Elaine; Chambers, Iain R.; Unterberg, Andreas; Mendelow, A. David		STITCH TRAUMA Investigators	Surgical Trial In Traumatic intraCerebral Haemorrhage (STITCH): a randomised controlled trial of Early Surgery compared with Initial Conservative Treatment	HEALTH TECHNOLOGY ASSESSMENT			English	Article							COST-EFFECTIVENESS; HEAD-INJURY; HEMATOMAS; DESIGN; SPINE; STICH	Background: While it is accepted practice to remove extradural (EDH) and subdural haematomas (SDH) following traumatic brain injury, the role of surgery in parenchymal traumatic intracerebral haemorrhage (TICH) is controversial. There is no evidence to support Early Surgery in this condition. Objectives: There have been a number of trials investigating surgery for spontaneous intracerebral haemorrhage but none for TICH. This study aimed to establish whether or not a policy of Early Surgery for TICH improves outcome compared with a policy of Initial Conservative Treatment. Design: This was an international multicentre pragmatic parallel group trial. Patients were randomised via an independent telephone/web-based randomisation service. Setting: Neurosurgical units in 59 hospitals in 20 countries registered to take part in the study. Participants: The study planned to recruit 840 adult patients. Patients had to be within 48 hours of head injury with no more than two intracerebral haematomas greater than 10 ml. They did not have a SDH or EDH that required evacuation or any severe comorbidity that would mean they could not achieve a favourable outcome if they made a complete recovery from their head injury. Interventions: Patients were randomised to Early Surgery within 12 hours or to Initial Conservative Treatment with delayed evacuation if it became clinically appropriate. Main outcome measures: The Extended Glasgow Outcome Scale (GOSE) was measured at 6 months via a postal questionnaire. The primary outcome was the traditional dichotomised split into favourable outcome (good recovery or moderate disability) and unfavourable outcome (severe disability, vegetative, dead). Secondary outcomes included mortality and an ordinal assessment of Glasgow Outcome Scale and Rankin Scale. Results: Patient recruitment began in December 2009 but was halted by the funding body because of low UK recruitment in September 2012. In total, 170 patients were randomised from 31 centres in 13 countries: 83 to Early Surgery and 87 to Initial Conservative Treatment. Six-month outcomes were obtained for 99% of 168 eligible patients (82 Early Surgery and 85 Initial Conservative Treatment patients). Patients in the Early Surgery group were 10.5% more likely to have a favourable outcome (absolute benefit), but this difference did not quite reach statistical significance because of the reduced sample size. Fifty-two (63%) had a favourable outcome with Early Surgery, compared with 45 (53%) with Initial Conservative Treatment [odds ratio 0.65; 95% confidence interval (CI) 0.35 to 1.21; p = 0.17]. Mortality was significantly higher in the Initial Conservative Treatment group (33% vs. 15%; absolute difference 18.3%; 95% CI 5.7% to 30.9%; p = 0.006). The Rankin Scale and GOSE were significantly improved with Early Surgery using a trend analysis (p = 0.047 and p = 0.043 respectively). Conclusions: This is the first ever trial of surgery for TICH and indicates that Early Surgery may be a valuable tool in the treatment of TICH, especially if the Glasgow Coma Score is between 9 and 12, as was also found in Surgical Trial In spontaneous intraCerebral Haemorrhage (STICH) and Surgical Trial In spontaneous lobar intraCerebral Haemorrhage (STICH II). Further research is clearly warranted.	[Gregson, Barbara A.; Rowan, Elise N.; Francis, Richard; Mitchell, Patrick; Mendelow, A. David] Newcastle Univ, Inst Neurosci, Neurosurg Trials Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McNamee, Paul; Boyers, Dwayne] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [McColl, Elaine] Newcastle Univ, Newcastle Clin Trials Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Chambers, Iain R.] James Cook Univ Hosp, South Tees Hosp Fdn Trust, Middlesbrough, Cleveland, England; [Unterberg, Andreas] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany	Gregson, BA (corresponding author), Newcastle Univ, Inst Neurosci, Neurosurg Trials Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	barbara.gregson@ncl.ac.uk	McColl, Elaine/V-9906-2019; Abdullah, J/C-2828-2011; Agrawal, Amit/C-1511-2011; Boyers, Dwayne/AAJ-8774-2021	McColl, Elaine/0000-0001-8300-3204; Abdullah, J/0000-0002-0258-7410; Agrawal, Amit/0000-0002-3287-5448; 	Chief Scientist Office [HERU1, HSRU1] Funding Source: Medline		Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Briggs AH, 1999, HLTH TECHNOL ASSESS, P3; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; D'Avella D, 2001, J Neurosurg Sci, V45, P29; Department of Health (DH), 2013, NHS PAYMENT BY RESUL; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Francis R, 2014, CHARACTERISTICS OF T; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; Glick H, 2007, ECONOMIC EVALUATION; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Hutchinson P, THE RESCUEICP STUDY; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kenyon GM, 2011, BRIT J NEUROSURG, V25, P352, DOI 10.3109/02688697.2010.551675; Kind P, 1999, CENTRE FOR HEALTH EC; Kind P, 1996, QUALITY LIFE PHARMAC, V2, P191; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Manca A, 2010, PHARMACOECONOMICS, V28, P1079, DOI 10.2165/11537760-000000000-00000; Marion DW, 2006, NEUROSURGERY, V58, P655; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Mendelow AD, 2005, LANCET, V365, P387; Mendelow AD, 2003, ACTA NEUROCHIR, V145, P679, DOI 10.1007/s00701-003-0063-9; MENDELOW AD, 1993, STROKE, V24, pI115; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; National Institute for Health and Care Excellence (NICE), 2003, NICE CLINICAL GUIDEL; National Institute for Health and Care Excellence (NICE), 2007, CLINICAL GUIDELINES; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Simon J, 2006, BJOG-INT J OBSTET GY, V113, P144, DOI 10.1111/j.1471-0528.2005.00785.x; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; World Bank, GNI PER CAPITA HOW W; World Health Organization, COST EFFECTIVENESS A; ZUMKELLER M, 1992, NEUROSURG REV, V15, P33, DOI 10.1007/BF02352065	44	16	18	0	1	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	SEP	2015	19	70								10.3310/hta19700			162	Health Care Sciences & Services	Health Care Sciences & Services	CR0DZ	WOS:000360989800001	26346805	DOAJ Gold, Green Published			2021-06-18	
J	Jang, SH; Seo, JP				Jang, Sung Ho; Seo, Jeong Pyo			Damage to the Optic Radiation in Patients With Mild Traumatic Brain Injury	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							TENSOR IMAGING FINDINGS; VISUAL DYSFUNCTION; ABNORMALITIES; DTI	Background:There are known limitations of conventional computed tomography and magnetic resonance imaging in detecting neural injury in patients with mild traumatic brain injury (TBI). Diffusion tensor imaging (DTI) provides a method to further assess cerebral injury in this patient population. We report 2 patients with mild TBI who showed injury of the optic radiation (OR) as demonstrated by DTI.Method:Two patients who complained of visual field loss after mild TBI and 9 age-matched normal control subjects were recruited for this study. Peripheral field defects were detected with automated perimetry in both patients.Results:Regarding the configuration of OR, the total volume of OR was decreased in the right OR of both patients compared with controls; in contrast, the left ORs were divided into 2 parts in both patients. The voxel numbers of both ORs in both patients were more than 2 standard deviations lower than that of normal control subjects. The apparent diffusion coefficient value of the right OR in patient 2 was more than 2 standard deviations higher than that of normal controls.Conclusions:We demonstrated injury of the OR using DTI in 2 patients who showed visual field defects after mild TBI.	[Jang, Sung Ho; Seo, Jeong Pyo] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea	Seo, JP (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	raphael0905@hanmail.net			DGIST R&D Program of the Ministry of Science, ICT and Future Planning [15-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (15-BD-0401).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; ELISEVICH KV, 1984, SURG NEUROL, V22, P565, DOI 10.1016/0090-3019(84)90433-6; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kelts EA, 2010, NEUROREHABILITATION, V27, P223, DOI 10.3233/NRE-2010-0601; Kwon HG, 2011, NEUROREHABILITATION, V28, P383, DOI 10.3233/NRE-2011-0667; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Ripley DL, 2010, NEUROREHABILITATION, V27, P215, DOI 10.3233/NRE-2010-0599; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Seo JP, 2013, EUR NEUROL, V69, P236, DOI 10.1159/000345271; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Staempfli P, 2007, J MAGN RESON IMAGING, V26, P886, DOI 10.1002/jmri.21098; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; TEASDALE G, 1974, LANCET, V2, P81; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2012, BRAIN INJURY, V26, P891, DOI 10.3109/02699052.2012.661119; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114	31	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	SEP	2015	35	3					270	273		10.1097/WNO.0000000000000249			4	Clinical Neurology; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CQ4DC	WOS:000360553500008	25887304				2021-06-18	
J	Jones, D				Jones, Danielle			A family living with Alzheimer's disease: The communicative challenges	DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE			English	Article						Alzheimer's disease; conversation analysis; communication; interaction; collaborative	TRAUMATIC BRAIN-INJURY; FRONTOTEMPORAL DEMENTIA; SENILE-DEMENTIA; CONVERSATION; DISCOURSE; DISORDER; LANGUAGE; CARE; IMPAIRMENT; DECEPTION	Alzheimer's disease irrevocably challenges a person's capacity to communicate with others. Earlier research on these challenges focused on the language disorders associated with the condition and situated language deficit solely in the limitations of a person's cognitive and semantic impairments. This research falls short of gaining insight into the actual interactional experiences of a person with Alzheimer's and their family. Drawing on a UK data set of 70 telephone calls recorded over a two-and-a-half year period (2006-2008) between one elderly woman with Alzheimer's disease, and her daughter and son-in-law, this paper explores the role which communication (and its degeneration) plays in family relationships. Investigating these interactions, using a conversation analytic approach, reveals that there are clearly communicative difficulties, but closer inspection suggests that they arise due to the contingencies that are generated by the other's contributions in the interaction. That being so, this paper marks a departure from the traditional focus on language level analysis and the assumption that deficits are intrinsic to the individual with Alzheimer's, and instead focuses on the collaborative communicative challenges that arise in the interaction itself and which have a profound impact on people's lives and relationships.	Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England	Jones, D (corresponding author), Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England.	d.k.jones1@bradford.ac.uk		Jones, Danielle/0000-0002-2875-781X	Economic and Social Research Council 1 + 3 PhD Studentship	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The PhD research, from which this work originated, was supported by the Economic and Social Research Council 1 + 3 PhD Studentship.	Aggarwal N, 2003, J Psychiatr Ment Health Nurs, V10, P187; APPELL J, 1982, BRAIN LANG, V17, P73, DOI 10.1016/0093-934X(82)90006-2; Bayles K. A., 1985, AGING BRAIN COMMUNIC, P157; Bayles KA, 2003, J COMMUN DISORD, V36, P209, DOI 10.1016/S0021-9924(03)00020-0; BAYLES KA, 1983, BRAIN LANG, V19, P98, DOI 10.1016/0093-934X(83)90057-3; BINETTI G, 1995, J CLIN EXP NEUROPSYC, V17, P82, DOI 10.1080/13803399508406584; Blair M, 2007, J INT NEUROPSYCH SOC, V13, P237, DOI 10.1017/S1355617707070269; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Body R, 2007, APHASIOLOGY, V21, P394, DOI 10.1080/02687030600911450; BRAY JT, 1984, BIOL TRACE ELEM RES, V6, P1, DOI 10.1007/BF02918315; Campbell-Taylor I., 1984, THESIS U NEW YORK BU; Curl TS, 2008, RES LANG SOC INTERAC, V41, P129, DOI 10.1080/08351810802028613; Day AM, 2011, AGING MENT HEALTH, V15, P822, DOI 10.1080/13607863.2011.569489; Drew P, 2005, LEA COMMUN SER, P71; Drew Paul, 2013, HDB CA, P131; Elvish R, 2010, AGING MENT HEALTH, V14, P255, DOI 10.1080/13607861003587610; Freeman M, 2008, ROUT STUD HLTH SOC W, V2, P169; FROMM D, 1989, J SPEECH HEAR DISORD, V54, P535, DOI 10.1044/jshd.5404.535; Garcia LJ, 1997, BRAIN LANG, V58, P92, DOI 10.1006/brln.1997.1871; GARDNER H, 1974, SHATTERED MIND PERSO; GARWICK AW, 1994, FAM PROCESS, V33, P327, DOI 10.1111/j.1545-5300.1994.00327.x; Goodwin C., 1979, EVERYDAY LANGUAGE ST, P97, DOI DOI 10.1111/J.1475-682X.1980.TB00024.X; Goodwin C., 2002, LANGUAGE TURN SEQUEN, P56; Goodwin Charles, 2003, CONVERSATION BRAIN D, P90; Guendouzi J, 2006, APPROACHES DISCOURSE; Hamilton H, 1994, CONVERSATIONS ALZHEI; Hamilton HE, 2008, ANNU REV APPL LINGUI, V28, P91, DOI 10.1017/S0267190508080069; Hasselkus BR, 1997, GERONTOLOGIST, V37, P640, DOI 10.1093/geront/37.5.640; Heritage J., 1984, STRUCTURES SOCIAL AC, P299; HERITAGE JC, 1995, RES LANG SOC INTERAC, V28, P1, DOI 10.1207/s15327973rlsi2801_1; HIER DB, 1985, BRAIN LANG, V25, P117, DOI 10.1016/0093-934X(85)90124-5; HUFF FJ, 1986, BRAIN LANG, V28, P235, DOI 10.1016/0093-934X(86)90103-3; Hutchinson J., 1980, LANGUAGE COMMUNICATI; James O., 2008, CONTENTED DEMENTIA 2; Jefferson G., 1983, TILBURG PAPERS LANGU, P1; Jefferson G., 2004, PRAGMATICS NEW SERIE, P13, DOI DOI 10.1075/PBNS.125.02JEF; Jones D., 2006, THESIS U YORK UK; Jones D., 2012, THESIS U YORK YORK; Kennard C., 2009, CAREGIVER TIPS MANAG; LAWSON JS, 1968, BRIT J MED PSYCHOL, V41, P411, DOI 10.1111/j.2044-8341.1968.tb02050.x; LOCAL J, 1995, CLIN LINGUIST PHONET, V9, P155, DOI 10.3109/02699209508985330; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; Marzanski M, 2000, WESTERN J MED, V173, P318, DOI 10.1136/ewjm.173.5.318; Mates A. W., 2010, LANGUAGE INTERACTION; MENTIS M, 1995, J SPEECH HEAR RES, V38, P1054, DOI 10.1044/jshr.3805.1054; Mikesell L, 2010, DISCOURSE STUD, V12, P465, DOI 10.1177/1461445610370127; Mikesell L, 2009, RES LANG SOC INTERAC, V42, P135, DOI 10.1080/08351810902864552; Muller N, 2008, CLIN LINGUIST PHONET, V22, P767, DOI 10.1080/02699200801948488; Muller N, 2005, CLIN LINGUIST PHONET, V19, P393, DOI 10.1080/02699200400027213; Muller N, 2002, CLIN LINGUIST PHONET, V16, P345, DOI 10.1080/02699200210135875; Nebes R. D., 1985, THE AGING BRAIN, P109; Orange JB, 1996, J SPEECH HEAR RES, V39, P881, DOI 10.1044/jshr.3904.881; Perkins L, 1998, J NEUROLINGUIST, V11, P33, DOI 10.1016/S0911-6044(98)00004-9; POMERANTZ A, 1986, HUM STUD, V9, P219, DOI 10.1007/BF00148128; RAMANATHANABBOTT V, 1994, LANG SOC, V23, P31, DOI 10.1017/S0047404500017668; RIPICH DN, 1991, BRAIN LANG, V40, P330, DOI 10.1016/0093-934X(91)90133-L; RIPICH DN, 1988, J SPEECH HEAR DISORD, V53, P8, DOI 10.1044/jshd.5301.08; RITCHIE K, 1992, J CLIN EPIDEMIOL, V45, P1391, DOI 10.1016/0895-4356(92)90201-W; Sabat S., 1991, EXPERIENCE ALZHEIMER; SABAT S, 1991, GEORGETOWN J LANGUAG, V2, P161; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; Schermer M, 2007, BIOETHICS, V21, P13, DOI 10.1111/j.1467-8519.2007.00519.x; SHUTTLEWORTH EC, 1988, BRAIN LANG, V34, P222, DOI 10.1016/0093-934X(88)90134-4; Sidnell J., 2010, CONVERSATION ANAL IN; Small JA, 2005, J SPEECH LANG HEAR R, V48, P125, DOI 10.1044/1092-4388(2005/010); Spilkin M., 2003, ADV SPEECH LANGUAGE, V5, P105, DOI DOI 10.1080/14417040510001669131; Stivers T., 2011, MORALITY KNOWLEDGE C; Stribling P, 2009, CLIN LINGUIST PHONET, V23, P555, DOI 10.1080/02699200802491165; Tuckett AG, 2012, NURS ETHICS, V19, P7, DOI 10.1177/0969733011412104; Watson CM, 1999, APHASIOLOGY, V13, P195, DOI 10.1080/026870399402181; Wechsler, 1981, WAIS R MANUAL; Wilensky A., 2000, PASSING FOR NORMAL; Wilkinson R, 1999, APHASIOLOGY, V13, P327, DOI 10.1080/026870399402127; Wilkinson R, 2010, RES LANG SOC INTERAC, V43, P57, DOI 10.1080/08351810903471506; Williams V., 2011, DISABILITY DISCOURSE; Wilson BT, 2007, CLIN LINGUIST PHONET, V21, P1001, DOI 10.1080/02699200701580175; Wood-Mitchell A., 2006, J DEMENTIA CARE, V14, P30; Wootton Anthony J., 1997, INTERACTION DEV MIND	78	16	16	1	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1471-3012	1741-2684		DEMENTIA-LONDON	Dement.-Int. J. soc. Res. Pract.	SEP	2015	14	5					555	573		10.1177/1471301213502213			19	Gerontology	Geriatrics & Gerontology	CS8LJ	WOS:000362338800001	24339113	Green Accepted			2021-06-18	
J	Joseph, B; Pandit, V; Haider, AA; Kulvatunyou, N; Zangbar, B; Tang, A; Aziz, H; Vercruysse, G; O'Keeffe, T; Freise, RS; Rhee, P				Joseph, Bellal; Pandit, Viraj; Haider, Ansab A.; Kulvatunyou, Narong; Zangbar, Bardiya; Tang, Andrew; Aziz, Hassan; Vercruysse, Gary; O'Keeffe, Terence; Freise, Randall S.; Rhee, Peter			Improving Hospital Quality and Costs in Nonoperative Traumatic Brain Injury The Role of Acute Care Surgeons	JAMA SURGERY			English	Article							HEAD COMPUTED-TOMOGRAPHY; CT; MANAGEMENT; UTILITY; MILD	IMPORTANCE The role of acute care surgeons is evolving; however, no guidelines exist for the selective treatment of patients with traumatic brain injury (TBI) exclusively by acute care surgeons. We implemented the Brain Injury Guidelines (BIG) for managing TBI at our institution on March 1, 2012. OBJECTIVE To compare the outcomes in patients with TBI before and after implementation of the BIG protocol. DESIGN, SETTING, AND PARTICIPANTS We conducted a 2-year analysis of our prospectively maintained database of all patients with TBI (findings of skull fracture and/or intracranial hemorrhage on an initial computed tomographic scan of the head) who presented to our level I trauma center. The pre-BIG group included patients with TBI from March 1, 2011, through February 29, 2012, and the post-BIG group included patients from July 1, 2012, through June 30, 2013. MAIN OUTCOMES AND MEASURES The primary outcome measureswere patients with repeated computed tomography of the head and neurosurgical consultations. Secondary outcome measures were findings of progression of intracranial hemorrhage on repeated computed tomographic scans, neurosurgical intervention, hospital admission, intensive care unit admission, hospital and intensive care unit length of stay, 30-day readmission rate, and hospital costs per patient. RESULTS A total of 796 patients (415 in the pre-BIG group and 381 in the post-BIG group) were included. Therewas a significant reduction (19.0%) in the rate of neurosurgical consultation (post-BIG group, 273 patients [71.7%]; pre-BIG group, 376 [90.6%]; P < .001), repeated computed tomography of the head (post-BIG group, 255 patients [66.9%]; pre-BIG group, 381 patients [91.8%]; P < .001), hospital (post-BIG group, 330 [86.6%]; pre-BIG group, 398 [95.9%]; P < .001) and intensive care unit admission (post-BIG group, 202 [53.0%]; pre-BIG group, 257 [61.9%]; P = .01), hospital length of stay (post-BIG group, 5.4 [4.5] days; pre-BIG group, 6.1 [4.8] days; P = .03), and hospital costs per patient ($4772 per patient; P = .03) with implementation of BIG. Therewas no difference in the in-hospital mortality rate (post-BIG group, 62 patients [16.3%]; pre-BIG group, 69 patients [16.6%]; P = .89), progression of intracranial hemorrhage on repeated scans (post-BIG group, 41 patients [10.8%]; pre-BIG group, 59 patients [14.2%]; P = .14), neurosurgical intervention (post-BIG group, 61 patients [16.0%]; pre-BIG group, 59 patients [14.2%]; P = .48), and 30-day readmission rate (post-BIG group, 31 patients [8.1%]; pre-BIG group, 37 patients [8.9%]; P = .69) after implementation of BIG. CONCLUSIONS AND RELEVANCE Implementation of BIG is safe and cost-effective. BIG defines the management of TBI without the need for neurosurgical consultation and unnecessary imaging. Establishing a national, multi-institutional study implementing the BIG protocol is warranted.	[Joseph, Bellal; Pandit, Viraj; Haider, Ansab A.; Kulvatunyou, Narong; Zangbar, Bardiya; Tang, Andrew; Aziz, Hassan; Vercruysse, Gary; O'Keeffe, Terence; Freise, Randall S.; Rhee, Peter] Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, Tucson, AZ 85727 USA	Joseph, B (corresponding author), Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu					Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Barker DE, 2006, AM SURGEON, V72, P1166; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Campbell D, DO ALL PATIENTS MILD; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Hoyt DB, 2004, J TRAUMA, V57, P410, DOI 10.1097/00005373-200408000-00038; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Nickoloff EL, 2001, AM J ROENTGENOL, V177, P285, DOI 10.2214/ajr.177.2.1770285; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	23	16	16	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	SEP	2015	150	9					866	872		10.1001/jamasurg.2015.1134			7	Surgery	Surgery	DA1VR	WOS:000367584100010	26107247	Bronze			2021-06-18	
J	Raji, CA; Willeumier, K; Taylor, D; Tarzwell, R; Newberg, A; Henderson, TA; Amen, DG				Raji, Cyrus A.; Willeumier, Kristen; Taylor, Derek; Tarzwell, Robert; Newberg, Andrew; Henderson, Theodore A.; Amen, Daniel G.			Functional neuroimaging with default mode network regions distinguishes PTSD from TBI in a military veteran population	BRAIN IMAGING AND BEHAVIOR			English	Article						Functional Neuroimaging; PTSD; SPECT; TBI	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; PROCEDURE GUIDELINE; RESTING-STATE; US VETERANS; SPECT; SOLDIERS; ANTIPSYCHOTICS; CONNECTIVITY	PTSD and TBI are two common conditions in veteran populations that can be difficult to distinguish clinically. The default mode network (DMN) is abnormal in a multitude of neurological and psychiatric disorders. We hypothesize that brain perfusion SPECT can be applied to diagnostically separate PTSD from TBI reliably in a veteran cohort using DMN regions. A group of 196 veterans (36 with PTSD, 115 with TBI, 45 with PTSD/TBI) were selected from a large multi-site population cohort of individuals with psychiatric disease. Inclusion criteria were peacetime or wartime veterans regardless of branch of service and included those for whom the traumatic brain injury was not service related. SPECT imaging was performed on this group both at rest and during a concentration task. These measures, as well as the baseline-concentration difference, were then inputted from DMN regions into separate binary logistic regression models controlling for age, gender, race, clinic site, co-morbid psychiatric diseases, TBI severity, whether or not the TBI was service related, and branch of armed service. Predicted probabilities were then inputted into a receiver operating characteristic analysis to compute sensitivity, specificity, and accuracy. Compared to PSTD, persons with TBI were older, male, and had higher rates of bipolar and major depressive disorder (p < 0.05). Baseline quantitative regions with SPECT separated PTSD from TBI in the veterans with 92 % sensitivity, 85 % specificity, and 94 % accuracy. With concentration scans, there was 85 % sensitivity, 83 % specificity and 89 % accuracy. Baseline-concentration (the difference metric between the two scans) scans were 85 % sensitivity, 80 % specificity, and 87 % accuracy. In separating TBI from PTSD/TBI visual readings of baseline scans had 85 % sensitivity, 81 % specificity, and 83 % accuracy. Concentration scans had 80 % sensitivity, 65 % specificity, and 79 % accuracy. Baseline-concentration scans had 82 % sensitivity, 69 % specificity, and 81 % accuracy. For separating PTSD from PTSD/TBI baseline scans had 87 % sensitivity, 83 % specificity, and 92 % accuracy. Concentration scans had 91 % sensitivity, 76 % specificity, and 88 % accuracy. Baseline-concentration scans had 84 % sensitivity, 64 % specificity, and 85 % accuracy. This study demonstrates the ability to separate PTSD and TBI from each other in a veteran population using functional neuroimaging.	[Raji, Cyrus A.] Univ Calif Los Angeles, Med Ctr, Dept Radiol, Los Angeles, CA 90095 USA; [Willeumier, Kristen; Taylor, Derek; Amen, Daniel G.] Amen Clin Inc, Dept Res, Costa Mesa, CA USA; [Tarzwell, Robert] Univ British Columbia, Fac Med, Sch Med, Dept Psychiat, Vancouver, BC, Canada; [Tarzwell, Robert] Lions Gate Hosp, Res Mental Hlth, Vancouver, BC, Canada; [Newberg, Andrew] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Henderson, Theodore A.] Synapt Space & Int Soc Appl Neuroimaging, Denver, CO USA	Raji, CA (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Radiol, 757 Westwood Blvd, Los Angeles, CA 90095 USA.	cyrusraji@gmail.com					Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P139, DOI 10.1080/02791072.2008.10400623; Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P131, DOI 10.1080/02791072.2008.10400622; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bowe A, 2015, J DUAL DIAGN, V11, P22, DOI 10.1080/15504263.2014.989653; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bryan CJ, 2013, DEPRESS ANXIETY, V30, P55, DOI 10.1002/da.22002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Castel-Lacanal E, 2014, ANN FR ANESTH, V33, P83, DOI 10.1016/j.annfar.2013.11.006; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; CHANG W, 1984, J NUCL MED, V25, P788; Congressional Budget Office, 2012, VET HLTH ADM TREATM, DOI [11-2012/reports/02-09-PTSD_0.pdf, DOI 11-2012/REPORTS/02-09-PTSD_0.PDF]; Davis P C, 2000, Radiology, V215 Suppl, P507; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Erickson HJ, 2014, J NEUROPSYCH CLIN N, V26, P188, DOI 10.1176/appi.neuropsych.260301; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Henderson TA, 2012, CNS SPECTRUMS, V17, P176, DOI 10.1017/S1092852912000636; Hermes E, 2014, EPIDEMIOL PSYCH SCI, V23, P281, DOI 10.1017/S2045796013000449; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Jain S, 2012, PSYCHIAT SERV, V63, P154, DOI 10.1176/appi.ps.201100199; Juni JE, 2009, J NUCL MED TECHNOL, V37, P191, DOI 10.2967/jnmt.109.067850; Juni JE, 1998, J NUCL MED, V39, P923; Kapucu OL, 2009, EUR J NUCL MED MOL I, V36, P2093, DOI 10.1007/s00259-009-1266-y; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lew H. L., 2005, J REHABILITATION RES, V42, pxii; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; Murphy D., 2014, EUROPEAN J PSYCHOTRA, V5, P1; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; Newberg AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087009; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peterson A, 2014, CAN J PSYCHIAT, V59, P294; Phelps T. I., 2014, J NEUROTRAUMA; Philip NS, 2014, JOVE-J VIS EXP, DOI 10.3791/51651; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rauch SAM, 2012, J REHABIL RES DEV, V49, P679, DOI 10.1682/JRRD.2011.08.0152; Sandrone S, 2012, J NEUROSCI, V32, P1915, DOI 10.1523/JNEUROSCI.5637-11.2012; Schnyder U, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.26520; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Silver JM, 2011, TEXTBOOK OF TRAUMATI, P609; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100108-02, 10.3928/02793695-20100107-01]; Stecker T, 2014, PSYCHIAT SERV, V65, P1232, DOI 10.1176/appi.ps.201300433; Stecker T, 2013, PSYCHIAT SERV, V64, P280, DOI 10.1176/appi.ps.001372012; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thomas JT, 1964, J AM STAT ASSOC, V61, P852; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Wang HR, 2013, CLIN NEUROPHARMACOL, V36, P216, DOI 10.1097/WNF.0b013e3182aa365f; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225	58	16	17	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					527	534		10.1007/s11682-015-9385-5			8	Neuroimaging	Neurosciences & Neurology	CR8LQ	WOS:000361604300013	25917871	Other Gold, Green Published			2021-06-18	
J	Schachar, RJ; Park, LS; Dennis, M				Schachar, Russell James; Park, Laura Seohyun; Dennis, Maureen			Mental Health Implications of Traumatic Brain Injury (TBI) in Children and Youth	JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						traumatic brain injury; mental illness; attention deficit hyperactivity disorder; children and adolescents	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; 1ST 6 MONTHS; POST-CONCUSSIVE SYMPTOMS; LONG-TERM DISABILITY; UNITED-STATES; HEAD-INJURY; PSYCHIATRIC-DISORDERS; PERSONALITY-CHANGE; SOCIAL OUTCOMES; PRE-INJURY	Traumatic brain injury (TBI) is the most common cause of death and disability in children and adolescents. Psychopathology is an established risk factor for, and a frequent consequence of, TBI. This paper reviews the literature relating psychopathology and TBI. Method: Selective literature review. Results: The risk of sustaining a TBI is increased by pre-existing psychopathology (particularly ADHD and aggression) and psychosocial adversity. Even among individuals with no psychopathology prior to the injury, TBI is frequently followed by mental illness especially ADHD, personality change, conduct disorder and, less frequently, by post-traumatic stress and anxiety disorders. The outcome of TBI can be partially predicted by pre-injury adjustment and injury severity, but less well by age at injury. Few individuals receive treatment for mental illness following TBI. Conclusion: TBI has substantial relevance to mental health professionals and their clinical practice. Available evidence, while limited, indicates that the risk for TBI in children and adolescents is increased in the presence of several, potentially treatable mental health conditions and that the outcome of TBI involves a range of mental health problems, many of which are treatable. Prevention and management efforts targeting psychiatric risks and outcomes are an urgent priority. Child and adolescent mental health professionals can play a critical role in the prevention and treatment of TBI through advocacy, education, policy development and clinical practice.	[Schachar, Russell James] Univ Toronto, Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Schachar, Russell James] Univ Toronto, Toronto Domin Bank Financial Grp, Dept Psychiat, Hosp Sick Children,Dept Psychiat,Fac Med, Toronto, ON, Canada; [Schachar, Russell James] Child & Adolescent Psychiat, Toronto, ON, Canada; [Park, Laura Seohyun] Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Hosp Sick Children, Program Neurosci & Mental Hlth, Res Inst,Dept Psychol,Dept Surg,Fac Med, Toronto, ON M5G 1X8, Canada	Schachar, RJ (corresponding author), Univ Toronto, Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada.	russell.schachar@sickkids.ca		Schachar, Russell/0000-0002-2015-4395	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); National Institute for Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Ontario Neurotrauma Foundation; Ontario Brain Institute; Ontario Research Development Foundation; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD35946, P01 HD35946-06]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1 HD04946]	Dr. Schachar is a consultant for Purdue Pharma, Eli Lilly Corp, Highland Therapeutics, and ehave and is supported by the Canadian Institutes of Health Research, National Institute for Neurological Diseases and Stroke, Ontario Neurotrauma Foundation, Ontario Brain Institute, and Ontario Research Development Foundation. Dr. Dennis is supported by the National Institute of Child Health and Human Development Grants P01 HD35946 & P01 HD35946-06, "Spina Bifida: Cognitive and Neurobiological Variability" and by National Institutes of Health Grant 1RO1 HD04946, "Social Outcomes in Pediatric Traumatic Brain Injury." This article is dedicated to the memory of our dear colleague and coauthor Dr. Maureen Dennis who recently deceased.	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; BIJUR P, 1988, AM J DIS CHILD, V142, P1307, DOI 10.1001/archpedi.1988.02150120061041; BIJUR PE, 1988, SOC SCI MED, V26, P839, DOI 10.1016/0277-9536(88)90176-1; Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA), 2011, CAN ADHD PRACT GUID, V3rd; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Colantonio Angela, 2010, Healthc Policy, V5, pe120; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; DSM-V American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Eme R, 2012, EXPERT REV NEUROTHER, V12, P475, DOI [10.1586/ern.12.15, 10.1586/ERN.12.15]; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Howard I, 2005, ETHNIC DIS, V15, pS5; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pastore V, 2011, DISABIL REHABIL, V33, P675, DOI 10.3109/09638288.2010.506239; Pickering A, 2012, EMERG MED J, V29, P451, DOI 10.1136/emj.2010.094755; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Richards D, 2012, ACCIDENT ANAL PREV, V47, P16, DOI 10.1016/j.aap.2012.01.009; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Taylor H. G., 2015, J HEAD TRAUMA REHABI; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Visser SN, 2007, PEDIATRICS, V119, pS99, DOI 10.1542/peds.2006-2089O; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	96	16	16	0	24	CANADIAN ACAD CHILD & ADOLESCENT PSYCHIATRY	OTTAWA	701-141 LAURIER AVE W, OTTAWA, ONTARIO K1P 5J3, CANADA	1719-8429			J CAN ACAD CHILD ADO	J. Can. Acad. Child Adolesc. Psychiatry	FAL	2015	24	2					100	108					9	Psychiatry	Psychiatry	CR5KO	WOS:000361380800004	26379721				2021-06-18	
J	Trivedi, RB; Humphreys, K				Trivedi, Ranak B.; Humphreys, Keith			Participant exclusion criteria in treatment research on neurological disorders: Are unrepresentative study samples problematic?	CONTEMPORARY CLINICAL TRIALS			English	Article						Effectiveness; Exclusion criteria; Neurological disorders	CLINICAL-TRIALS; ELIGIBILITY CRITERIA; ALZHEIMERS-DISEASE; IMPACT; RECRUITMENT; DEMENTIA; DESIGN	Objective: Exclusion criteria are an important determinant of the external validity of treatment research findings, yet the prevalence and impact of exclusion criteria have not been studied systematically. Our objective was to describe prevalent exclusion criteria in treatment research on neurological disorders and to analyze their impact on sample representativeness and generalizability of findings. Design: Narrative literature review of studies focusing on treatment for neurological disorders. Studies were identified from PubMed and bibliographies. Results: Eight studies were included in the narrative review:3 studies focused on Alzheimer's disease/dementia, 2 each focused on traumatic brain injury (TBI) and epilepsy, and 1 focused on amyotrophic lateral sclerosis (ALS). The total number of patients screened across all studies was 20,018, of which 14,721 (73.5%) were excluded. An average of 6 exclusion criteria was applied. The criteria that contributed most to exclusion were the presence of comorbid psychiatric conditions, a history of alcohol or other substance misuse, and cognitive impairments. Women and the elderly were underrepresented among included samples. Race/ethnicity proportions were seldom reported. Conclusion: Exclusion criteria are used extensively in neurological treatment research and prevent about 3 in 4 patients from participating in research. This limits the generalizability of current findings. Further, because excluded individuals are disproportionately from vulnerable populations, extensive exclusion also raises ethical concerns. Exclusion criteria should be used only in cases where there is a strong rationale so that neurological treatment research can make a greater impact on clinical care. Published by Elsevier Inc.	VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Palo Alto, CA USA; Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Trivedi, RB (corresponding author), Ctr Innovat Implementat, 795 Willow Rd,Bldg 324 MPD-152, Menlo Pk, CA 94025 USA.	Ranak.trivedi@va.gov			VA HSR&D Career Development Award [CDA-09-206]; VA HSR&D Senior Research Career Scientist award	Dr. Trivedi is supported by a VA HSR&D Career Development Award (CDA-09-206). Dr. Humphreys is supported by a VA HSR&D Senior Research Career Scientist award. None of the authors have conflicts of interest. The views expressed in this manuscript are those of the authors and do not represent the views of the Department of Veterans' Affairs.	Alliance Family Caregiver, 2013, INC PREV MAJ CAUS BR; Almici M, 2012, J AM GERIATR SOC, V60, P1596, DOI 10.1111/j.1532-5415.2012.04068.x; Anand R, 2003, AM J GERIAT PSYCHIAT, V11, P160, DOI 10.1176/appi.ajgp.11.2.160; Baquet CR, 2006, CANCER DETECT PREV, V30, P24, DOI 10.1016/j.cdp.2005.12.001; BRAWLEY OW, 1995, CONTROL CLIN TRIALS, V16, P293, DOI 10.1016/0197-2456(95)00131-X; Britton A, 1999, J Health Serv Res Policy, V4, P112; Chio A, 2011, NEUROLOGY, V77, P1432, DOI 10.1212/WNL.0b013e318232ab9b; CONDON JT, 1986, AUST NZ J PSYCHIAT, V20, P87, DOI 10.3109/00048678609158870; Cooper C, 2014, INT J GERIATR PSYCH, V29, P515, DOI 10.1002/gps.4034; da Conceicao PO, 2013, EPILEPSY BEHAV, V27, P310, DOI 10.1016/j.yebeh.2013.02.014; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; FREEDMAN LS, 1995, CONTROL CLIN TRIALS, V16, P277, DOI 10.1016/0197-2456(95)00048-8; Grill JD, 2014, ALZ DIS ASSOC DIS, V28, P1, DOI 10.1097/WAD.0000000000000016; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Humphreys K, 2005, ADDICTION, V100, P1249, DOI 10.1111/j.1360-0443.2005.01175.x; Humphreys K.N., 2015, CLIN SCHIZO IN PRESS; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Lyketsos Constantin G, 2007, Dialogues Clin Neurosci, V9, P111; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Moher D, 2009, PLOS MED, V6; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Schneider LS, 1997, J AM GERIATR SOC, V45, P923, DOI 10.1111/j.1532-5415.1997.tb02960.x; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d; Taylor JS, 2012, J AM GERIATR SOC, V60, P413, DOI 10.1111/j.1532-5415.2011.03847.x; Tlusta E, 2008, EPILEPSIA, V49, P1479, DOI 10.1111/j.1528-1167.2008.01618_2.x; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Yamal JM, 2014, CLIN TRIALS, V11, P187, DOI 10.1177/1740774514522560; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	32	16	16	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	SEP	2015	44						20	25		10.1016/j.cct.2015.07.009			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CT2FB	WOS:000362616300003	26188162				2021-06-18	
J	Ward, A; Iocono, JA; Brown, S; Ashley, P; Draus, JM				Ward, Austin; Iocono, Joseph A.; Brown, Samuel; Ashley, Phillip; Draus, John M., Jr.			Non-accidental Trauma Injury Patterns and Outcomes: A Single Institutional Experience	AMERICAN SURGEON			English	Article							CHILD MALTREATMENT; UNITED-STATES	Non-accidental trauma (NAT) victims account for a significant percentage of our pediatric trauma population. We sought to better understand the injury patterns and outcomes of NAT victims who were treated at our level I pediatric trauma center. Trauma registry data were used to identify NAT victims between January 2008 and December 2012. Demographic data, injury severity, hospital course, and outcomes were evaluated. One hundred and eighty-eight cases of suspected NAT were identified. Children were mostly male and white. The median age was 1.1 years; the median Injury Severity Score was 9. Traumatic brain injuries, lower extremity fractures, and skull fractures were the most common injuries. Twenty-seven per cent required medical procedures; most were performed by orthopedic surgery. Twenty-four per cent required admission to the pediatric intensive care unit. The median length of stay was two days. The mortality rate was 9.6 per cent. We generated a hot spot map of our catchment area and identified areas of our state where NAT occurs at increased rates. NAT victims sustain significant morbidity and mortality. Due to the severity of injuries, pediatric trauma surgeons should be involved in the evaluation and management of these children. Much work is needed to prevent the death and disability incurred by victims of child abuse.	[Ward, Austin] Univ Kentucky, Grad Med Educ, Gen Surg Residency Program, Lexington, KY 40536 USA; [Iocono, Joseph A.; Draus, John M., Jr.] Univ Kentucky, Dept Surg, Div Pediat Surg, Lexington, KY 40536 USA; [Brown, Samuel] Univ Kentucky, Coll Med, Lexington, KY 40536 USA; [Ashley, Phillip] Univ Kentucky, Grad Med Educ, Orthoped Surg Residency Program, Lexington, KY 40536 USA	Draus, JM (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, MN-102, Lexington, KY 40536 USA.	jmdr226@uky.edu					[Anonymous], 2009, 2009 2013 AM COMM SU; Eckenrode J, 2014, PEDIATRICS, V133, P454, DOI 10.1542/peds.2013-1707; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Lane WG, 2011, PEDIATRICS, V127, pE1400, DOI 10.1542/peds.2010-2096; Larimer EL, 2013, J PEDIATR SURG, V48, P1357, DOI 10.1016/j.jpedsurg.2013.03.035; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; U. S. Department of Health and Human Services, 2010, 4 NATL INCIDENCE STU; U. S. Department of Health and Human Services, 2013, CHILD MALTREATMENT	9	16	16	0	4	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2015	81	9					835	838					4	Surgery	Surgery	CQ4GK	WOS:000360562300012	26350656				2021-06-18	
J	Yang, J; Korley, FK; Dai, M; Everett, AD				Yang, Jun; Korley, Frederick K.; Dai, Min; Everett, Allen D.			Serum neurogranin measurement as a biomarker of acute traumatic brain injury	CLINICAL BIOCHEMISTRY			English	Article						ELISA; Neurogranin; Biomarker; Traumatic brain injury	PROTEIN-KINASE-C; CALMODULIN-BINDING PROTEIN; NITRIC-OXIDE MODIFICATION; RAT-BRAIN; SYNAPTIC PLASTICITY; TERMINAL HYDROLASE; MESSENGER-RNA; SUBSTRATE; PHOSPHORYLATION; RC3/NEUROGRANIN	Objectives: Neurogranin (NRGN) is a small neuronal protein that plays an important role in synaptic signaling by regulating calmodulin (CaM) availability. In this study, we developed an ELISA to measure NRGN quantitatively in serum samples from a cohort of acute traumatic brain injury (TBI) patients and a non-TBI control cohort, and explored the potential value of NRGN as a circulating biomarker for TBI. Design and methods: Recombinant His-NRGN protein was used to develop mouse monoclonal capture and rabbit polyclonal detection antibodies, and they were used to develop a sandwich ELISA. After validation, we used this ELISA to measure serum samples from a cohort of typical adult acute TBI patients (N = 76 TBI cases) and non-TBI control patients (N = 150 controls). Results: The NRGN ELISA lower limit of detection was 0.055 ng/mL, lower limit of quantification was 0.2 ng/mL, and interassay CVs were <= 10.7%. The average recovery was 99.9% (range from 97.2-102%). Serum NRGN concentrations in TBI cases were significantly higher than in controls (median values were 0.18 ng/mL vs. 0.02 ng/mL, p <0.0001), but did not discriminate TBI cases with intracranial hemorrhage (p = 0.09). Conclusions: We have developed a highly sensitive and reproducible ELISA for measuring circulating NRGN in blood samples. Serum NRGN concentrations in acute TBI patients were significantly higher than in controls, indicating that NRGN could have utility as a circulating biomarker for acute TBI. This report provides evidence to support larger and controlled TBI clinical studies for NRGN validation and prediction of outcomes. (C) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Yang, Jun; Everett, Allen D.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Korley, Frederick K.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21205 USA; [Dai, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Everett, AD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA.	aeveret3@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS050274] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30 NS050274] Funding Source: Medline		AlvarezBolado G, 1996, NEUROSCIENCE, V73, P565, DOI 10.1016/0306-4522(96)00061-9; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BAUDIER J, 1989, J BIOL CHEM, V264, P1824; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; COGGINS PJ, 1991, NEUROSCI RES COMMUN, V8, P49; de Arrieta CM, 1999, ENDOCRINOLOGY, V140, P335, DOI 10.1210/en.140.1.335; deArrieta CM, 1997, GENOMICS, V41, P243, DOI 10.1006/geno.1997.4622; DELOULME JC, 1991, FEBS LETT, V282, P183, DOI 10.1016/0014-5793(91)80473-G; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Goncalves CA, 2010, CARDIOVASC PSYCHIAT, V2010, P790431, DOI DOI 10.1155/2010/790431; Guadano-Ferraz A, 2005, J COMP NEUROL, V493, P554, DOI 10.1002/cne.20774; Gutierrez S., 2014, CRIT CARE MED, V42, pA1488, DOI [10.1097/01.ccm.0000458030.91776.65, DOI 10.1097/01.CCM.0000458030.91776.65]; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jin ZC, 2013, PROTEOMICS, V13, P2682, DOI 10.1002/pmic.201300064; Korley FK, 2014, ACAD EMERG MED, V21, P728, DOI 10.1111/acem.12417; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Kvartsberg H, 2014, ALZHEIMERS DEMENT, V19; Li GL, 2000, APMIS, V108, P98; Li JF, 1999, J BIOL CHEM, V274, P1294, DOI 10.1074/jbc.274.3.1294; Mahoney CW, 1996, J BIOL CHEM, V271, P28798, DOI 10.1074/jbc.271.46.28798; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Ramakers GMJ, 1999, J BIOL CHEM, V274, P1873, DOI 10.1074/jbc.274.4.1873; REPRESA A, 1990, J NEUROSCI, V10, P3782; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Sheu FS, 1996, J BIOL CHEM, V271, P22407, DOI 10.1074/jbc.271.37.22407; Singec I, 2004, J COMP NEUROL, V479, P30, DOI 10.1002/cne.20302; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; Wu JF, 2003, J NEUROCHEM, V86, P1524, DOI 10.1046/j.1471-4159.2003.01963.x; Yang HM, 2004, MOL BRAIN RES, V129, P171, DOI 10.1016/j.molbrainres.2004.06.039	40	16	19	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	SEP	2015	48	13-14					843	848		10.1016/j.clinbiochem.2015.05.015			6	Medical Laboratory Technology	Medical Laboratory Technology	CR3UX	WOS:000361259700005	26025774	Green Accepted			2021-06-18	
J	Beier, M; Amtmann, D; Ehde, DM				Beier, Meghan; Amtmann, Dagmar; Ehde, Dawn M.			Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS	REHABILITATION PSYCHOLOGY			English	Article						multiple sclerosis; metacognition	TRAUMATIC BRAIN-INJURY; FATIGUE IMPACT SCALE; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL PERFORMANCE; MEMORY COMPLAINTS; CANCER-PATIENTS; BREAST-CANCER; ITEM BANKS; DYSFUNCTION; IMPAIRMENT	Objective: To investigate the association between self-reported cognition and demographic/psychosocial variables in individuals with a self-reported diagnosis of multiple sclerosis (MS). Design: Secondary longitudinal analysis of mailed self-report surveys over a period of 2 years. Setting: Community. Participants: 407 community-dwelling individuals from the Pacific Northwest with a self-reported diagnosis of MS. Main Outcome Measures: Subjective general cognitive concerns and subjective executive difficulties as measured by the Neuro-QOL Applied Cognition-Executive Function-Short Form (SF) and the Applied Cognition-General Concerns-SF. Results: Univariate and multiple linear regression analyses were used to identify statistically significant longitudinal predictors of perceived cognitive difficulties 2 years later. Fatigue and anxiety were statistically significant predictors of general cognitive concerns. Fatigue and perceived stress were statistically significant predictors of perceived executive difficulties. Fatigue was the strongest predictor in both models. Conclusions: In MS, perceived cognitive impairment is frequently linked to depression without consideration of other possible contributors. This study suggests that in people with MS, fatigue is a stronger predictor of self-reported cognitive function 2 years later than depression.	[Beier, Meghan; Amtmann, Dagmar; Ehde, Dawn M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA	Beier, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Phipps Room 178,600 North Wolfe St, Baltimore, MD 21287 USA.	mbeier1@jhu.edu	Ehde, Dawn/K-1883-2016	Ehde, Dawn/0000-0002-9555-2347	Department of Education, NIDRR [H133B031129, H133B080025]; National Institutes of Health through NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01AR52171]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [MB 0008]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U01AR052171] Funding Source: NIH RePORTER	This work was previously presented at the May 2013 Consortium of Multiple Sclerosis Centers (CMSC) and Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Orlando, FL. No party having a direct interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which they are associated. The contents of this article were developed under grants from the Department of Education, NIDRR grants H133B031129 and H133B080025. However, these contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government. In addition, the work reported in this article was supported by a grant from the National Institutes of Health through the NIH Roadmap for Medical Research, Grant U01AR52171 to University of Washington, Amtmann (PI), and a grant from the National Multiple Sclerosis Society, Grant MB 0008, Ehde (PI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbar N, 2011, COGN BEHAV NEUROL, V24, P115, DOI 10.1097/WNN.0b013e31822a20ae; Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Bamer AM, 2007, MULT SCLER J, V13, P1033, DOI 10.1177/1352458507077624; Becker Heather, 2012, Int J MS Care, V14, P71; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2003, MULT SCLER J, V9, P95, DOI 10.1191/1352458503ms861oa; Benedict RHB, 2001, J NEUROPSYCH CLIN N, V13, P70, DOI 10.1176/appi.neuropsych.13.1.70; Bosma FK, 2002, NEUROPSY NEUROPSY BE, V15, P56; Bowen J, 2001, MULT SCLER, V7, P201, DOI 10.1191/135245801678438447; Bruce JM, 2010, ARCH CLIN NEUROPSYCH, V25, P39, DOI 10.1093/arclin/acp092; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Christodoulou C, 2005, J INT NEUROPSYCH SOC, V11, P614, DOI 10.1017/S1355617705050733; COHEN S, 1988, CLAR SYMP, P31; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Dufouil C, 2005, J AM GERIATR SOC, V53, P616, DOI 10.1111/j.1532-5415.2005.53209.x; Ehde Dawn M, 2005, Phys Med Rehabil Clin N Am, V16, P437, DOI 10.1016/j.pmr.2005.01.010; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hinkin CH, 1996, J CLIN EXP NEUROPSYC, V18, P431, DOI 10.1080/01688639608408999; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Jorm AF, 2001, PSYCHOL MED, V31, P441, DOI 10.1017/S0033291701003245; Julian L, 2007, MULT SCLER J, V13, P81, DOI 10.1177/1352458506070255; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Knoop H, 2007, J NEUROL NEUROSUR PS, V78, P434, DOI 10.1136/jnnp.2006.100974; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; Kraft GH, 2008, MULT SCLER J, V14, P1292, DOI 10.1177/1352458508093891; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Marrie RA, 2007, MULT SCLER, V13, P770, DOI 10.1177/1352458506075031; Metzger FA, 2002, ANN BEHAV MED, V24, P106, DOI 10.1207/S15324796ABM2402_07; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Mills RJ, 2008, QJM-INT J MED, V101, P49, DOI 10.1093/qjmed/hcm122; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FATIGUE AND MULTIPLE; National Institute of Neurological Disorders and Stroke (NINDS), 2010, USER MANUAL FOR THE, V1.0; Noonan VK, 2012, QUAL LIFE RES, V21, P1123, DOI 10.1007/s11136-011-0040-3; O'Brien A, 2007, ARCH CLIN NEUROPSYCH, V22, P933, DOI 10.1016/j.acn.2007.07.002; Olazaran J, 2009, EUR NEUROL, V61, P87, DOI 10.1159/000177940; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Poppelreuter M, 2004, EUR J CANCER, V40, P43, DOI 10.1016/j.ejca.2003.08.001; PROMIS, DYNAMIC TOOLS TO MEA; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Shin SY, 2013, ARTHRIT CARE RES, V65, P481, DOI 10.1002/acr.21814; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stewart A, 2008, PSYCHO-ONCOLOGY, V17, P122, DOI 10.1002/pon.1210; Stewart R, 2012, CURR OPIN PSYCHIATR, V25, P445, DOI 10.1097/YCO.0b013e3283586fd8; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Sullivan JJL, 1990, CANADIAN J REHABILIT, V4, P99; Tellez N, 2005, MULT SCLER J, V11, P198, DOI 10.1191/1352458505ms1148oa; Thornton AE, 2002, J INT NEUROPSYCH SOC, V8, P395, DOI 10.1017/S1355617702813200; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Warttig SL, 2013, J HEALTH PSYCHOL, V18, P1617, DOI 10.1177/1359105313508346; Weber MT, 2012, MENOPAUSE, V19, P735, DOI 10.1097/gme.0b013e318241fd22	66	16	16	0	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2015	60	3					254	262		10.1037/rep0000045			9	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	CR0UB	WOS:000361037600006	26192051	Green Accepted, Bronze			2021-06-18	
J	Hammond, FM; Horn, SD; Smout, RJ; Seel, RT; Beaulieu, CL; Corrigan, JD; Barrett, RS; Cullen, N; Sommerfeld, T; Brandstater, ME				Hammond, Flora M.; Horn, Susan D.; Smout, Randall J.; Seel, Ronald T.; Beaulieu, Cynthia L.; Corrigan, John D.; Barrett, Ryan S.; Cullen, Nora; Sommerfeld, Teri; Brandstater, Murray E.			Rehospitalization During 9 Months After Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comorbidity; Hospitalization; Patient readmission; Rehabilitation	PROSPECTIVE-PAYMENT; MULTICENTER ANALYSIS; AFTER-DISCHARGE; MORTALITY; CARE	Objective: To assess the frequency of, causes for, and factors associated with acute rehospitalization during 9 months after discharge from inpatient rehabilitation for traumatic brain injury (TBI). Design: Multicenter observational cohort. Setting: Community. Participants: Individuals with TBI (N=1850) admitted for inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Occurrences of proxy or self-report of postrehabilitation acute care rehospitalization, as well as length of and causes for rehospitalizations. Results: A total of 510 participants (28%) had experienced 775 acute rehospitalizations. All experienced 1 admission (510 participants [66%]), whereas 154(20%) had 2 admissions, 60(8%) had 3,23 (3%) had 4,27 had between Sand 11, and 1 had 12. The most common rehospitalization causes were infection (15%), neurological (13%), neurosurgical (11%), injury (7%), psychiatric (7%), and orthopedic (7%). The mean time from rehabilitation discharge to first rehospitalization was 113 days. The mean rehospitalization duration was 6.5 days. Logistic regression analyses revealed that older age, history of seizures before injury or during acute care or rehabilitation, history of brain injuries, and non brain injury medical severity increased the risk of rehospitalization. Injury etiology of motor vehicle collision and high motor functioning at discharge decreased rehospitalization risk. Conclusions: Approximately 28% of patients with TBI were rehospitalized within 9 months of TBI rehabilitation discharge owing to various medical and surgical reasons. Future research should evaluate whether some of these occurrences may be preventable (such as infections, injuries, and psychiatric disorders) and should evaluate the extent to which persons at risk may benefit from additional screening, surveillance, and treatment protocols. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Horn, Susan D.; Smout, Randall J.; Barrett, Ryan S.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA; [Cullen, Nora] Toronto Rehabil Inst, Toronto, ON, Canada; [Sommerfeld, Teri] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Brandstater, Murray E.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA	Hammond, FM (corresponding author), Indiana Univ Sch Med, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com		Cullen, Nora/0000-0001-6359-9418	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	[Anonymous], 2012, CMAJ, V184, pE651; [Anonymous], 2013, REV DOOR REP US HOSP; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Canadian Institute for Health Information, ALL CAUS READM AC CA; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Centers for Medicare & Medicaid Services, SPEC ALL CAUS UNPL R; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Heinemann AW, 1994, TOP STROKE REHABIL, V1, P1; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sood N, 2008, J HEALTH ECON, V27, P1046, DOI 10.1016/j.jhealeco.2008.01.003; Sood N, 2013, J HEALTH ECON, V32, P965, DOI 10.1016/j.jhealeco.2013.05.003; Stineman MG, 2002, ARCH PHYS MED REHAB, V83, P1802, DOI 10.1053/apmr.2002.36067; The Moran Company, 2011, UT TRENDS INPA REH U; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	25	16	16	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S330	S339		10.1016/j.apmr.2014.09.041			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100013	26212407	Green Accepted, Bronze			2021-06-18	
J	Jin, YC; Lin, YY; Feng, JF; Jia, F; Gao, GY; Jiang, JY				Jin, Yichao; Lin, Yingying; Feng, Jun-Feng; Jia, Feng; Gao, Guoyi; Jiang, Ji-Yao			Attenuation of Cell Death in Injured Cortex After Post-Traumatic Brain Injury Moderate Hypothermia: Possible Involvement of Autophagy Pathway	WORLD NEUROSURGERY			English	Article						Apoptosis; Autophagy; Necrosis; Hypothermia; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION MODEL; CLOSED-HEAD INJURY; REGULATES AUTOPHAGY; MILD HYPOTHERMIA; DNA-DAMAGE; BECLIN 1; RAT; APOPTOSIS; PHOSPHORYLATION	OBJECTIVE: Multiple mechanisms participated hi the cell death after fluid percussion traumatic brain injury (TB!). In the present study, we evaluated the effect on cell death in the injured cortex after fluid percussion TBI and investigated a possible role of autophagy. METHODS: TBI model was induced by a fluid percussion TBI device. Moderate hypothermia (32 degrees C) was achieved by partial immersion in a water bath (0 degrees C) under general anesthesia for 4 hours. All rats were killed at 6 or 24 hours after TBI. RESULTS: Cleaved caspase 3 evaluated with Western blotting and terminal deoxynincleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end labeling-positive cells in injured cortex were significantly increased 6 hours after fluid percussion TBI and were further up-regulated 24 hours after TB!, dramatic up-regulation of Beclin-1 and protein light chain-3 expression levels was also observed. Further up-regulation of biomarkers of autophagy, attenuation of caspase 3 up-regulation and reduction of cell death was observed after 4 hours of hypothermia. Immunofluorescence analysis for cell localization demonstrated that protein light chain-3- and Beclin-1-positive cells included neurons and glial cells in the injured cortex after TBI and hypothermic treatment. By ultrastructural observation, autolysosomes in injured cortex were significantly increased at 6 and 24 hours after TBI and were further up-regulated after TBI hypothermic treatment. CONCLUSIONS: These data suggest that hypothermic treatment could attenuate TBI-induced cell death in this fluid percussion TBI model, possibly through activation of autophagy pathway.	[Jin, Yichao; Lin, Yingying; Feng, Jun-Feng; Jia, Feng; Gao, Guoyi; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200030, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200030, Peoples R China.	jiyaojiang@126.com			National Science and Nature Grant [81271381, 81471856, 81471855]; National Key project [2012CB518100]	This work was supported by grants from National Science and Nature Grant (No. 81271381, 81471856, 81471855), and National Key project (No. 2012CB518100).	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Besson VC, 2005, BRAIN RES, V1041, P149, DOI 10.1016/j.brainres.2005.01.096; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Huang Q, 2009, AUTOPHAGY, V5, P273, DOI 10.4161/auto.5.2.7640; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RINK A, 1995, AM J PATHOL, V147, P1575; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Ye YC, 2011, J PHARMACOL SCI, V117, P160, DOI 10.1254/jphs.11105FP; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0	46	16	16	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2015	84	2					420	430		10.1016/j.wneu.2015.03.039			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CO7FL	WOS:000359324900044	25839396				2021-06-18	
J	Khajeh, L; Blijdorp, K; Heijenbrok-Kal, MH; Sneekes, EM; van den Berg-Emons, HJG; van der Lely, AJ; Dippel, DWJ; Neggers, SJCMM; Ribbers, GM; van Kooten, F				Khajeh, L.; Blijdorp, K.; Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.; van der Lely, A. J.; Dippel, D. W. J.; Neggers, S. J. C. M. M.; Ribbers, G. M.; van Kooten, F.			Pituitary dysfunction after aneurysmal subarachnoid haemorrhage: course and clinical predictors the HIPS study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; HIGH-RISK; HYPOPITUITARISM; DIAGNOSIS; PREVALENCE; DEFICIENCY; SURVIVORS	Objective We describe the occurrence and course of anterior pituitary dysfunction (PD) after aneurysmal subarachnoid haemorrhage (SAH), and identify clinical determinants for PD in patients with recent SAH. Methods We prospectively collected demographic and clinical parameters of consecutive survivors of SAH and measured fasting state endocrine function at baseline, 6 and 14 months. We included dynamic tests for growth-hormone function. We used logistic regression analysis to compare demographic and clinical characteristics of patients with SAH with and without PD. Results 84 patients with a mean age of 55.8 (11.9) were included. Thirty-three patients (39%) had PD in one or more axes at baseline, 22(26%) after 6 months and 6 (7%) after 14 months. Gonadotropin deficiency in 29 (34%) patients and growth hormone deficiency (GHD) in 26 (31%) patients were the most common deficiencies. PD persisted until 14 months in 6 (8%) patients: GHD in 5(6%) patients and gonadotropin deficiency in 4 (5%). Occurrence of a SAH-related complication was associated with PD at baseline (OR 2.6, CI 2.2 to 3.0). Hydrocephalus was an independent predictor of PD 6 months after SAH (OR 3.3 CI 2.7 to 3.8). PD was associated with a lower score on health-related quality of life at baseline (p=0.06), but not at 6 and 14 months. Conclusions Almost 40% of SAH survivors have PD. In a small but substantial proportion of patients GHD or gonadotropin deficiency persists over time. Hydrocephalus is independently associated with PD 6 months after SAH.	[Khajeh, L.; Dippel, D. W. J.; van Kooten, F.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Blijdorp, K.; van der Lely, A. J.; Neggers, S. J. C. M. M.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Med, Endocrinol Sect, NL-3000 CA Rotterdam, Netherlands; [Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.; Ribbers, G. M.] Erasmus MC, Univ Med Ctr, Dept Rehabil, NL-3000 CA Rotterdam, Netherlands; [Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.; Ribbers, G. M.] Rijndam Rehabil Ctr Rotterdam, Rotterdam, Netherlands	Khajeh, L (corresponding author), Erasmus MC, Univ Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.khajeh@erasmusmc.nl	Ribbers, Gerard M/C-1454-2014; Dippel, Diederik/AAJ-2192-2020; Ribbers, Gerard/N-3623-2019	Ribbers, Gerard M/0000-0002-6114-349X; Dippel, Diederik/0000-0002-9234-3515; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	PfizerPfizer; Dutch Brain Foundation	This study was financially supported by an unrestricted grant from Pfizer and by the Dutch Brain Foundation.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, HORM RES, V62, P26, DOI 10.1159/000080755; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Berry E, 1998, BRIT J CLIN PSYCHOL, V37, P365, DOI 10.1111/j.2044-8260.1998.tb01392.x; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Blijdorp K, 2013, EUR J ENDOCRINOL, V169, P497, DOI 10.1530/EJE-13-0436; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dutta P, 2012, NEUROL INDIA, V60, P390, DOI 10.4103/0028-3886.100729; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Gasco V, 2013, EUR J ENDOCRINOL, V168, P23, DOI 10.1530/EJE-12-0584; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Herschbach P, 2001, EUR J ENDOCRINOL, V145, P255, DOI 10.1530/eje.0.1450255; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Kioussi C, 1999, MECH DEVELOP, V81, P23, DOI 10.1016/S0925-4773(98)00229-9; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Popovic V, 2013, J CLIN ENDOCR METAB, V98, P1789, DOI 10.1210/jc.2013-1099; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277	29	16	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2015	86	8					905	910		10.1136/jnnp-2014-307897			6	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CM7ON	WOS:000357884300014	25378238	Other Gold, Green Published			2021-06-18	
J	McCutcheon, BA; Chang, DC; Marcus, L; Gonda, DD; Noorbakhsh, A; Chen, CC; Talamini, MA; Carter, BS				McCutcheon, Brandon A.; Chang, David C.; Marcus, Logan; Gonda, David D.; Noorbakhsh, Abraham; Chen, Clark C.; Talamini, Mark A.; Carter, Bob S.			Treatment biases in traumatic neurosurgical care: a retrospective study of the Nationwide Inpatient Sample from 1998 to 2009	JOURNAL OF NEUROSURGERY			English	Article						extraaxial intracranial hematoma; spinal vertebral fracture; surgical outcomes research; socioeconomic; trauma	INSURANCE STATUS; SOCIOECONOMIC DISPARITIES; INTRACRANIAL ANEURYSMS; MORTALITY; SURGERY; DATABASES; OUTCOMES	OBJECT This study was designed to assess the relationship between insurance status and likelihood of receiving a neurosurgical procedure following admission for either extraaxial intracranial hemorrhage or spinal vertebral fracture. METHODS A retrospective analysis of the Nationwide Inpatient Sample (NIS; 1998-2009) was performed. Cases of traumatic extraaxial intracranial hematoma and spinal vertebral fracture were identified using International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes. Within this cohort, those patients receiving a craniotomy or spinal fusion and/or decompression in the context of an admission for traumatic brain or spine injury, respectively, were identified using the appropriate ICD-9 procedure codes. RESULTS A total of 190,412 patients with extraaxial intracranial hematoma were identified between 1998 and 2009. Within this cohort, 37,434 patients (19.7%) received a craniotomy. A total of 477,110 patients with spinal vertebral fracture were identified. Of these, 37,302 (7.8%) received a spinal decompression and/or fusion. On multivariate analysis controlling for patient demographics, severity of injuries, comorbidities, hospital volume, and hospital characteristics, uninsured patients had a reduced likelihood of receiving a craniotomy (odds ratio [OR] 0.76, 95% confidence interval [CI] 0.71-0.82) and spinal fusion (OR 0.67, 95% CI 0.64-0.71) relative to insured patients. This statistically significant trend persisted when uninsured and insured patients were matched on the basis of mortality propensity score. Uninsured patients demonstrated an elevated risk-adjusted mortality rate relative to insured patients in cases of extraaxial intracranial hematoma. Among patients with spinal injury, mortality rates were similar between patients with and without insurance. CONCLUSIONS In this study, uninsured patients were consistently less likely to receive a craniotomy or spinal fusion for traumatic intracranial extraaxial hemorrhage and spinal vertebral fracture, respectively. This difference persisted after accounting for overall injury severity and patient access to high-or low-volume treatment centers, and potentially reflects a resource allocation bias against uninsured patients within the hospital setting. This information adds to the growing literature detailing the benefits of health reform initiatives seeking to expand access for the uninsured.	[McCutcheon, Brandon A.; Chang, David C.; Marcus, Logan; Noorbakhsh, Abraham; Talamini, Mark A.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Gonda, David D.; Chen, Clark C.; Carter, Bob S.] Univ Calif San Diego, Div Neurosurg, San Diego, CA 92103 USA	McCutcheon, BA (corresponding author), Univ Calif San Diego, Dept Surg, 200 W Arbor Dr, San Diego, CA 92103 USA.	bmccutch@ucsd.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000098] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR00098] Funding Source: Medline		Amaranto DJ, 2009, J VASC SURG, V50, P1340, DOI 10.1016/j.jvs.2009.07.089; Brinjikji W, 2012, STROKE, V43, P3200, DOI 10.1161/STROKEAHA.112.671214; Cucchiara BL, 2004, CRIT CARE MED, V32, P241, DOI 10.1097/01.CCM.0000104113.36384.81; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Curry WT, 2009, J NEURO-ONCOL, V93, P25, DOI 10.1007/s11060-009-9840-5; Farber NJ, 2010, MED CARE, V48, P498, DOI 10.1097/MLR.0b013e3181dbe932; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Leuven, 2003, PSMATCH2 STATA MODUL; Marion DW, 2006, NEUROSURGERY, V58, P655; Peterson CY, 2011, J SURG RES, V170, pE23, DOI 10.1016/j.jss.2011.04.017; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sanches Jose Eduardo Arantes, 2012, Open Orthop J, V6, P590, DOI 10.2174/1874325001206010590; Segev DL, 2009, J AM SOC NEPHROL, V20, P621, DOI 10.1681/ASN.2008060591; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Varela JE, 2011, SURG ENDOSC, V25, P1209, DOI 10.1007/s00464-010-1345-y; Woodworth GF, 2009, NEUROSURGERY, V65, P251, DOI 10.1227/01.NEU.0000347003.35690.7A	21	16	16	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2015	123	2					406	414		10.3171/2015.3.JNS131356			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS6OV	WOS:000362200800018	25955874	Bronze			2021-06-18	
J	Monti, G; Tondelli, M; Giovannini, G; Bedin, R; Nichelli, PF; Trenti, T; Meletti, S; Chiari, A				Monti, Giulia; Tondelli, Manuela; Giovannini, Giada; Bedin, Roberta; Nichelli, Paolo F.; Trenti, Tommaso; Meletti, Stefano; Chiari, Annalisa			Cerebrospinal fluid tau proteins in status epilepticus	EPILEPSY & BEHAVIOR			English	Article						Status epilepticus; Tau; Refractory status epilepticus; Epilepsy; Seizures; Biomarkers	NEURON-SPECIFIC ENOLASE; REFRACTORY STATUS EPILEPTICUS; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; TONIC-CLONIC SEIZURES; TRANSIENT INCREASE; ALZHEIMERS-DISEASE; S-100 PROTEIN; BIOMARKERS; ANESTHESIA	Tau protein is a phosphaylated microtubule-associated protein, principally localized at neuronal level in the central nervous system (CNS). Tau levels in the cerebrospinal fluid (CSF) are considered to index both axonal and neuronal damage. To date, however, no study has specifically evaluated the CSF levels of tau proteins in patients with status epileptic-us (SE). We evaluated these established biomarkers of neuronal damage in patients with SE who received a lumbar puncture during SE between 2007 and 2014. Status epilepticus cases due to acute structural brain damage, including CNS infection, were excluded. Clinical, biological, therapeutic, and follow-up data were collected. Group comparison between patients stratified according to SE response to antiepileptic drugs (AEDs), disability, and epilepsy outcomes were performed. Twenty-eight patients were considered for the analyses (mean age 56 years): 14 patients had abnormally high CSF t-tau level, six patients had abnormally high CSF p-tau level, and only three patients had abnormally low A beta(1-42) level. Cerebrospinal fluid t-tau value was higher in patients who developed a refractory SE compared to patients with seizures controlled by AED. Cerebrospinal fluid t-tau values were positively correlated with SE duration and were higher in patients treated with propofol anesthesia compared to patients that had not received this treatment. Patients with higher CSF t-tau had higher risk of developing disability (OR = 32.5, p = 0.004) and chronic epilepsy (OR 12; p = 0.016) in comparison with patients with lower CSF t-tau level. Our results suggest that CSF t-tau level might be proposed as a biomarker of SE severity and prognosis. Prospective studies are needed to evaluate the effects of propofol on tau pathology in this setting. (C) 2015 Elsevier Inc. All rights reserved.	[Monti, Giulia; Tondelli, Manuela; Giovannini, Giada; Nichelli, Paolo F.; Meletti, Stefano] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, I-41126 Modena, Italy; [Monti, Giulia; Tondelli, Manuela; Giovannini, Giada; Bedin, Roberta; Nichelli, Paolo F.; Meletti, Stefano; Chiari, Annalisa] AUSL Modena, NOCSAE Hosp, Neurol Unit, Modena, Italy; [Trenti, Tommaso] ASL Modena, NOCSAE Hosp, Clin Pathol Toxicol, Modena, Italy	Meletti, S (corresponding author), Univ Modena & Reggio Emilia, NOCSAE Hosp, Dept Biomed Metab & Neural Sci, Via Giardini 1355, I-41126 Modena, Italy.	stefano.meletti@unimore.it	Tondelli, Manuela/AAB-7054-2019; Nichelli, Paolo/F-7336-2015; Meletti, Stefano/O-3622-2015; Giovannini, Giada/J-8970-2018; Trenti, Tommaso/K-8457-2016	Nichelli, Paolo/0000-0001-9756-6796; Meletti, Stefano/0000-0003-0334-539X; Giovannini, Giada/0000-0002-3585-5872; Trenti, Tommaso/0000-0001-8093-4011; Annalisa, Chiari/0000-0003-3052-2865	Emilia Romagna RegionRegione Emilia Romagna	S. Meletti received research grant support from the Emilia Romagna Region, from the nonprofit organization CarisMo Foundation and has received personal compensation as a scientific advisory board member for UCB and EISAI. Other authors report no disclosures.	[Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Buttner T, 1999, J NEUROL, V246, P459, DOI 10.1007/s004150050383; Correale J, 1998, NEUROLOGY, V50, P1388, DOI 10.1212/WNL.50.5.1388; DEGIORGIO CM, 1995, NEUROLOGY, V45, P1134, DOI 10.1212/WNL.45.6.1134; Engel J, 2002, PROG BRAIN RES, V135, P509; Frisoni GB, 2013, LANCET NEUROL, V12, P126, DOI 10.1016/S1474-4422(12)70305-8; Gastaut H, 1973, DICT EPILEPSY 1; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; Hocker SE, 2013, JAMA NEUROL, V70, P72, DOI 10.1001/jamaneurol.2013.578; Kramer U, 2011, EPILEPSIA, V52, P28, DOI 10.1111/j.1528-1167.2011.03230.x; Krut JJ, 2013, J NEUROL, V260, P620, DOI 10.1007/s00415-012-6688-y; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Matsui T, 2007, J AM GERIATR SOC, V55, P2096, DOI 10.1111/j.1532-5415.2007.01440.x; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Neligan A, 2011, EPILEPSY RES, V93, P1, DOI 10.1016/j.eplepsyres.2010.09.003; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Palmio J, 2001, J NEUROL SCI, V183, P27, DOI 10.1016/S0022-510X(00)00478-0; Palmio J, 2009, SEIZURE-EUR J EPILEP, V18, P474, DOI 10.1016/j.seizure.2009.04.006; Pitkanen A, 2002, PROG BRAIN RES, V135, P67; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; Riemenschneider M, 2003, MOL PSYCHIATR, V8, P343, DOI 10.1038/sj.mp.4001220; Rosen C, 2013, CURR OPIN PSYCHIATR, V26, P276, DOI 10.1097/YCO.0b013e32835f6747; Rosenow F, 2012, NERVENARZT, V83, P1551, DOI 10.1007/s00115-012-3529-2; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; Run XQ, 2010, J ALZHEIMERS DIS, V22, pS49, DOI 10.3233/JAD-2010-100813; Shahim P, 2014, EUR J NEUROL, V21, P486, DOI 10.1111/ene.12336; Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215; Sjogren M, 2001, CLIN CHEM, V47, P1776; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; Tang JXX, 2011, ANESTHESIOLOGY, V115, P727, DOI 10.1097/ALN.0b013e31822e9306; Tondelli M, 2015, CLIN CHEM LAB MED, V53, P453, DOI 10.1515/cclm-2014-0414; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Whittington RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01388; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x	39	16	16	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2015	49						150	154		10.1016/j.yebeh.2015.04.030			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CO7CK	WOS:000359314900029	25958230				2021-06-18	
J	Niquet, J; Baldwin, R; Gezalian, M; Wasterlain, CG				Niquet, Jerome; Baldwin, Roger; Gezalian, Michael; Wasterlain, Claude G.			Deep hypothermia for the treatment of refractory status epilepticus	EPILEPSY & BEHAVIOR			English	Article						Status epilepticus; Hypothermia; EEG power	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; BARRIER PERMEABILITY; CIRCULATORY ARREST; MILD HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; PROFOUND HYPOTHERMIA; MODERATE HYPOTHERMIA; MEMBRANE-PROPERTIES; GENE-EXPRESSION	In a rat model of status epilepticus (SE) induced by lithium and pilocarpine and refractory to midazolam, deep hypothermia (20 "C for 30 min) reduced EEG power over 50-fold, stopped SE within 12 min, and reduced EEG spikes by 87%. Hypothermia deserves further investigation as a treatment of last resort for refractory SE. Published by Elsevier Inc.	[Niquet, Jerome; Wasterlain, Claude G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Niquet, Jerome; Baldwin, Roger; Gezalian, Michael; Wasterlain, Claude G.] Vet Affairs Greater Los Angeles Healthcare Syst, Epilepsy Res Lab 151, Los Angeles, CA USA; [Wasterlain, Claude G.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	Niquet, J (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Epilepsy Res Lab, 11301 Wilshire Blvd,Bldg 114,Room 139, West Los Angeles, CA 90073 USA.	jniquet@ucla.edu		Niquet, Jerome/0000-0002-1005-0517; Wasterlain, Claude/0000-0002-2100-9114	VHA Research Service; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UO1 NS074926]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS074926] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000273] Funding Source: NIH RePORTER	This study was supported by VHA Research Service (CW) and NINDS (grant UO1 NS074926, CW).	Aihara H, 2001, BRAIN RES, V893, P36, DOI 10.1016/S0006-8993(00)03285-6; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Azzopardi D, 2009, ARCH DIS CHILD-FETAL, V94, pF260, DOI 10.1136/adc.2008.146977; Bellinger DC, 2009, CARDIOL YOUNG, V19, P86, DOI 10.1017/S1047951108003454; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bickler PE, 2012, ANESTHESIOLOGY, V117, P280, DOI 10.1097/ALN.0b013e318260a7b9; Brandt C, 2015, NEUROBIOL DIS, V75, P78, DOI 10.1016/j.nbd.2014.12.015; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Elmas I, 2001, FORENSIC SCI INT, V119, P212, DOI 10.1016/S0379-0738(00)00429-1; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Fleck TM, 2003, ANN THORAC SURG, V76, P1198, DOI 10.1016/S0003-4975(03)00832-4; Fuller BJ, 2003, CRYOLETTERS, V24, P95; Gega A, 2007, ANN THORAC SURG, V84, P759, DOI 10.1016/j.athoracsur.2007.04.107; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; HJORTH B, 1991, J CLIN NEUROPHYSIOL, V8, P391, DOI 10.1097/00004691-199110000-00004; Holtkamp M, 2005, J NEUROL NEUROSUR PS, V76, P534, DOI 10.1136/jnnp.2004.041947; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kamps M, 2011, CRIT CARE, V15, DOI 10.1186/cc10012; Karkar KM, 2002, EPILEPSIA, V43, P932, DOI 10.1046/j.1528-1157.2002.03902.x; Kendall GS, 2012, PEDIATRICS, V130, pE451, DOI 10.1542/peds.2011-3496; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kowski AB, 2012, BRAIN RES, V1446, P119, DOI 10.1016/j.brainres.2012.01.022; Lansman SL, 1999, ANN THORAC SURG, V67, P1975, DOI 10.1016/S0003-4975(99)00419-1; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; Maeda T, 1999, BRAIN RES, V818, P228, DOI 10.1016/S0006-8993(98)01269-4; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Mazarati AM, 1998, BRAIN RES, V814, P179, DOI 10.1016/S0006-8993(98)01080-4; Mazarati AM, 1999, NEUROSCI LETT, V265, P187, DOI 10.1016/S0304-3940(99)00238-4; McCullough JN, 1999, ANN THORAC SURG, V67, P1895, DOI 10.1016/S0003-4975(99)00441-5; MORRISETT RA, 1987, EXP NEUROL, V97, P193, DOI 10.1016/0014-4886(87)90293-7; Nagel S, 2012, NEUROSCIENCE, V208, P109, DOI 10.1016/j.neuroscience.2012.01.048; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; ORLOWSKI JP, 1984, CRIT CARE MED, V12, P367, DOI 10.1097/00003246-198404000-00006; OZTAS B, 1994, EPILEPSY RES, V19, P221, DOI 10.1016/0920-1211(94)90065-5; Parissis H, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-153; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Pretre R, 2003, CARDIAC SURG ADULT, P401; Rubens FD, 2007, PERFUSION-UK, V22, P153, DOI 10.1177/0267659107078142; Sartorius CJ, 1998, J NEUROSURG, V88, P349, DOI 10.3171/jns.1998.88.2.0349; SCHIFF SJ, 1985, BRAIN RES, V345, P279, DOI 10.1016/0006-8993(85)91004-2; Schmitt FC, 2006, NEUROBIOL DIS, V23, P689, DOI 10.1016/j.nbd.2006.05.008; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; SHEN KF, 1988, BRAIN RES, V475, P305, DOI 10.1016/0006-8993(88)90619-1; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Suchomelova L, 2006, PEDIATR RES, V59, P237, DOI 10.1203/01.pdr.0000196333.16608.30; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Volgushev M, 2004, J NEUROPHYSIOL, V92, P212, DOI 10.1152/jn.01166.2003; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; Wypij D, 2003, J THORAC CARDIOV SUR, V126, P1397, DOI 10.1016/S0022-5223(03)00940-1; Yang XF, 2005, J PHYSIOL-LONDON, V567, P215, DOI 10.1113/jphysiol.2005.088948; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	68	16	16	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2015	49						313	317		10.1016/j.yebeh.2015.06.028			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CO7CK	WOS:000359314900058	26198217	Green Accepted			2021-06-18	
J	Seule, M; Brunner, T; Mack, A; Hildebrandt, G; Fournier, JY				Seule, Martin; Brunner, Thomas; Mack, Alexander; Hildebrandt, Gerhard; Fournier, Jean-Yves			Neurosurgical and Intensive Care Management of Traumatic Brain Injury	FACIAL PLASTIC SURGERY			English	Article						traumatic brain injury; neurosurgery; neurocritical care	FRONTAL-SINUS FRACTURES; CEREBRAL BLOOD-FLOW; INTRACRANIAL-PRESSURE; HEAD-INJURY; FACIAL FRACTURES; HYPERVENTILATION; HYPOTHERMIA; DISSECTION; DIAGNOSIS; OUTCOMES	Optimal management of patients with traumatic brain injury (TBI) remains a challenge, despite significant improvements in pathophysiologic understanding and treatment strategies in recent decades. Because primary brain injury sustained at the time of trauma is irreversible, the TBI management mainly aims for early detection and treatment of secondary brain injury such as space-occupying intracerebral hematomas and brain edema. Prevention of secondary brain injury requires a high standard of care and understanding of both medical and surgical treatment modalities. This review focuses on practical recommendations for neurosurgical and intensive care management in patients with severe TBI.	[Seule, Martin; Mack, Alexander; Hildebrandt, Gerhard; Fournier, Jean-Yves] Kantonsspital St Gallen, Dept Neurosurg, CH-9007 St Gallen, Switzerland; [Brunner, Thomas] Kantonsspital St Gallen, Surg Intens Care Unit, CH-9007 St Gallen, Switzerland	Seule, M (corresponding author), Kantonsspital St Gallen, Dept Neurosurg, Rorschacherstr 95, CH-9007 St Gallen, Switzerland.	martin.seule@kssg.ch					Ali J, 1996, WORLD J SURG, V20, P1121, DOI 10.1007/s002689900171; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BULLOCK MR, 2006, NEUROSURGERY S, V58; Castro B, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.3.FOCUS1266; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Erstad BL, 1999, AM J HEALTH-SYST PH, V56, P347; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion DW, 2006, NEUROSURGERY, V58, P655; Markus HS, 2015, LANCET NEUROL, V14, P361, DOI 10.1016/S1474-4422(15)70018-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin RCG, 2002, AM SURGEON, V68, P477; Maxeiner H, 2007, NEUROSURGERY S, V61, P272; Maxelner H, 2007, NEUROSURGERY, V61, P267, DOI 10.1227/01.neu.0000279222.76375.d4; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nedeltchev K, 2005, J NEUROL NEUROSUR PS, V76, P191, DOI 10.1136/jnnp.2004.040543; Nelson JA, 2011, ACAD EMERG MED, V18, P78, DOI 10.1111/j.1553-2712.2010.00949.x; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Purins K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00064; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; Ropper Allan H, 2014, Pract Neurol, V14, P152, DOI 10.1136/practneurol-2014-000811; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Seule M A, 2009, Praxis (Bern 1994), V98, P1021, DOI 10.1024/1661-8157.98.18.1021; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Strong EB, 2009, CRANIOMAX TRAUM REC, V2, P161, DOI 10.1055/s-0029-1234020; TEASDALE G, 1974, LANCET, V2, P81; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	54	16	17	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0736-6825	1098-8793		FACIAL PLAST SURG	Facial Plast. Surg.	AUG	2015	31	4					325	331		10.1055/s-0035-1562884			7	Surgery	Surgery	CR5UV	WOS:000361410800003	26372706	Green Published			2021-06-18	
J	Santo, KP; Berkowitz, ML				Santo, Kolattukudy P.; Berkowitz, Max L.			Shock Wave Induced Collapse of Arrays of Nanobubbles Located Next to a Lipid Membrane: Coarse-Grained Computer Simulations	JOURNAL OF PHYSICAL CHEMISTRY B			English	Article							TRAUMATIC BRAIN-INJURY; MOLECULAR-DYNAMICS; FORCE-FIELD; BIOLOGICAL-MEMBRANES; MODEL; CAVITIES; WATER	We used molecular dynamics simulations to study creation of pores in lipid bilayer membranes by inducing shock waves in systems containing arrays of nanobubbles next to these membranes. Shock waves impinged on the bubbles imploding them and produced nanojets that subsequently hit the bilayers making pores in them. Our simulations were performed using the MARTINI coarse-grained force field. The emphasis in our study was on the interaction of shock waves with two-bubble arrays when the bubbles were placed in different alignments. We observed that the largest damage to the bilayer was produced when two bubbles were positioned in a serial alignment and the bubbles touched each other. When two touching each other bubbles were located parallel to the membrane surface and at the same distance from the surface, the membrane damage was reduced, compared to the damage done by explosion of two independent nanobubbles. When two nanobubbles were placed in slanted configurations, the damage was intermediate between damages produced by two bubbles in parallel or serial alignment. Damage to the membrane produced by arrays containing more than two bubbles can be understood as a combination of damage produced by all three alignments of two bubbles.	[Santo, Kolattukudy P.; Berkowitz, Max L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	Santo, KP (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	santotheophys@gmail.com; maxb@unc.edu	Poulose, Santo/AAC-7499-2021	Poulose, Santo/0000-0001-6817-737X; Berkowitz, Max/0000-0002-9116-0362	Office of Naval ResearchOffice of Naval Research [N00014-14-1-0241]	The support by a grant N00014-14-1-0241 from the Office of Naval Research is gratefully acknowledged. Simulations were performed using the supercomputing facility at the Lawrence Livermore National Laboratory, Livermore, California.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bisazza A, 2011, SOFT MATTER, V7, P10590, DOI 10.1039/c1sm06070h; Bourne NK, 2002, SHOCK WAVES, V11, P447, DOI 10.1007/s001930200128; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; DEAR JP, 1988, NATURE, V332, P505, DOI 10.1038/332505a0; DEAR JP, 1988, J FLUID MECH, V190, P409, DOI 10.1017/S0022112088001387; Drikakis D, 2009, J COMPUT THEOR NANOS, V6, P1437, DOI 10.1166/jctn.2009.1190; Espinosa S, 2014, MICROFLUID NANOFLUID, V16, P613, DOI 10.1007/s10404-013-1258-x; Feller SE, 1997, LANGMUIR, V13, P6555, DOI 10.1021/la970746j; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Henderson L. F., 2001, HDB SHOCK WAVES, V1, P143; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Lauer E, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4719142; Lukianova-Hleb EY, 2012, BIOMATERIALS, V33, P5441, DOI 10.1016/j.biomaterials.2012.03.077; Lukianova-Hleb EY, 2011, J CONTROL RELEASE, V152, P286, DOI 10.1016/j.jconrel.2011.02.006; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Marrink SJ, 2010, PHYS CHEM CHEM PHYS, V12, P2254, DOI 10.1039/b915293h; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ng KY, 2002, MED RES REV, V22, P204, DOI 10.1002/med.10004; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RYBAKOV AP, 1995, EUR J MECH B-FLUID, V14, P323; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; TOMITA Y, 1984, J APPL PHYS, V56, P125, DOI 10.1063/1.333745; Vedadi M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.014503; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927	33	16	16	0	33	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1520-6106			J PHYS CHEM B	J. Phys. Chem. B	JUL 23	2015	119	29					8879	8889		10.1021/jp505720d			11	Chemistry, Physical	Chemistry	CN7OM	WOS:000358623900007	25117111				2021-06-18	
J	Brazinova, A; Majdan, M; Leitgeb, J; Trimmel, H; Mauritz, W				Brazinova, Alexandra; Majdan, Marek; Leitgeb, Johannes; Trimmel, Helmut; Mauritz, Walter		Austrian Working Grp Improvement E	Factors that may improve outcomes of early traumatic brain injury care: prospective multicenter study in Austria	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Prehospital care; Early care; Emergency care; Comparative effectiveness research	HEAD-INJURY; CONTROLLED-TRIAL; MAJOR TRAUMA; MANAGEMENT; EPIDEMIOLOGY; IMPACT; RESUSCITATION; CAPNOGRAPHY; VENTILATION; POPULATION	Background: Existing evidence concerning the management of traumatic brain injury (TBI) patients underlines the importance of appropriate treatment strategies in both prehospital and early in-hospital care. The objectives of this study were to analyze the current state of early TBI care in Austria with its physician-based emergency medical service. Subsequently, identified areas for improvement were transformed into treatment recommendations. The proposed changes were implemented in participating emergency medical services and hospitals and evaluated for their effect. Methods: 14 Austrian centers treating TBI patients participated in the study. Between 2009 and 2012 all patients with Glasgow Coma Scale score < 13 and/or AIS head > 2 within 48 h after the accident, were enrolled. Data were collected in 2 phases: in the first phase data of 408 patients were analyzed. Based on this, a set of recommendations expected to improve outcomes was developed by the study group and implemented in participating centers. Recommendations included time factors (transport to appropriate trauma center, avoiding secondary transfer), adequate treatment strategies (prehospital fluid and airway management, anesthesia, ventilation), monitoring (pulse oximetry and blood pressure monitoring in all patients, capnography in ventilated patients) for prehospital treatment. In the emergency department focus was on first CT scan as soon as possible, short interval between CT scan and surgery and early use of thrombelastometry to optimize coagulation. Following implementation of these recommendations, data on 325 patients were collected and analyzed in phase 2. Final analysis investigated the impact of the recommendations on patient outcomes. Results: Patients in both data collection phases showed comparable demographic and injury severity characteristics. Treatment changes, especially in terms of fluid management, monitoring and normoventilation as well as thrombelastometry measurements were implemented successfully in phase 2, and led to significant improvement of patient outcomes. Hospital mortality was reduced from 31 % to 23 %. We found a lower rate of unfavorable outcomes, a significant increase in unexpected survivors and more patients with unexpected favorable outcomes as well. Conclusions: The results of this study clearly demonstrate that the outcomes of TBI patients can be improved with appropriate early care.	[Brazinova, Alexandra; Majdan, Marek; Mauritz, Walter] INRO, A-1080 Vienna, Austria; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Trimmel, Helmut] Wiener Neustadt Reg Hosp, Dept Anesthesiol Intens Care & Emergency Med, A-2700 Wiener Neustadt, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Dept Anesthesiol & Intens Care Med, A-1200 Vienna, Austria	Brazinova, A (corresponding author), INRO, Molker Gasse 4-3, A-1080 Vienna, Austria.	abrazinova@igeh.org	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X	Austrian Ministry of Health; Austrian Worker's Compensation Board (AUVA) [FK 11/2008, FK 11/2010, FK 09/13]; Mrs. Ala Auersperg-Isham through Neurotrauma Foundation; Mr. Ralph Isham through Neurotrauma Foundation	The project was funded jointly by the Austrian Ministry of Health (Contract Oct. 15, 2008) and by the Austrian Worker's Compensation Board (AUVA; FK 11/2008 and FK 11/2010). Data analysis was supported by a grant from AUVA (FK 09/13). INRO is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham through Neurotrauma Foundation, and by small donations from various sources.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Auman KM, 2002, AM J PUBLIC HEALTH, V92, P1352, DOI 10.2105/AJPH.92.8.1352; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BULL JP, 1978, INJURY, V9, P184, DOI 10.1016/0020-1383(78)90004-9; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Edwards P, 2005, LANCET, V365, P1957; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Jin PHPFK, 2008, J NEUROTRAUM, V25, P1003, DOI 10.1089/neu.2007.0463; Lier H, 2009, ANAESTHESIST, V58, P1010, DOI 10.1007/s00101-009-1595-z; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Weninger P, 2007, J TRAUMA, V62, P584, DOI 10.1097/01.ta.0000221797.46249.ee; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2004, WORLD REPORT ON ROAD	33	16	16	1	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUL 16	2015	23								53	10.1186/s13049-015-0133-z			11	Emergency Medicine	Emergency Medicine	CN4KV	WOS:000358399900001	26179747	DOAJ Gold, Green Published			2021-06-18	
J	Kim, JY; Lee, YW; Kim, JH; Lee, WT; Park, KA; Lee, JE				Kim, Jae Young; Lee, Yong Woo; Kim, Jae Hwan; Lee, Won Taek; Park, Kyung Ah; Lee, Jong Eun			Agmatine Attenuates Brain Edema and Apoptotic Cell Death after Traumatic Brain Injury	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Agmatine; Traumatic Brain Injury; Brain Edema; Blood-Brain Barrier; Aquaporins; Mitogen-Activated Protein Kinases	FOCAL CEREBRAL-ISCHEMIA; FACTOR-KAPPA-B; CLONIDINE-DISPLACING SUBSTANCE; PROTEIN-KINASE PATHWAYS; COLD-INJURY; IN-VITRO; EXPRESSION; RATS; AQUAPORIN-4; ASTROCYTES	Traumatic brain injury (TBI) is associated with poor neurological outcome, including necrosis and brain edema. In this study, we investigated whether agmatine treatment reduces edema and apoptotic cell death after TBI. TBI was produced by cold injury to the cerebral primary motor cortex of rats. Agmatine was administered 30 min after injury and once daily until the end of the experiment. Animals were sacrificed for analysis at 1, 2, or 7 days after the injury. Various neurological analyses were performed to investigate disruption of the blood-brain barrier (BBB) and neurological dysfunction after TBI. To examine the extent of brain edema after TBI, the expression of aquaporins (AQPs), phosphorylation of mitogen-activated protein kinases (MAPKs), and nuclear translocation of nuclear factor-kappa B (NF-kappa B) were investigated. Our findings demonstrated that agmatine treatment significantly reduces brain edema after TBI by suppressing the expression of AQP1, 4, and 9. In addition, agmatine treatment significantly reduced apoptotic cell death by suppressing the phosphorylation of MAPKs and by increasing the nuclear translocation of NF-kappa B after TBI. These results suggest that agmatine treatment may have therapeutic potential for brain edema and neural cell death in various central nervous system diseases.	[Kim, Jae Young; Lee, Yong Woo; Kim, Jae Hwan; Lee, Won Taek; Park, Kyung Ah; Lee, Jong Eun] Yonsei Univ, Dept Anat, Coll Med, Seoul 120752, South Korea; [Kim, Jae Young; Lee, Jong Eun] Yonsei Univ, PLUS Project Med Sci BK21, Coll Med, Seoul 120752, South Korea; [Lee, Jong Eun] Yonsei Univ, Brain Res Inst, Coll Med, Seoul 120752, South Korea	Lee, JE (corresponding author), Yonsei Univ, Dept Anat, Coll Med, 50 Yonsei Ro, Seoul 120752, South Korea.	jelee@yuhs.ac		Lee, Jong Eun/0000-0001-6203-7413; Kim, Jae Young/0000-0001-5315-6015; Lee, Won Taek/0000-0001-7348-9562	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2014R1A2A2A01006556]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2014R1A2A2A01006556).	Ahmed KM, 2006, MOL CANCER RES, V4, P945, DOI 10.1158/1541-7786.MCR-06-0291; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Arndt MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1411, DOI 10.1152/ajpcell.00529.2008; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Condello S, 2011, J NEUROCHEM, V116, P67, DOI 10.1111/j.1471-4159.2010.07085.x; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Feng YZ, 2002, PEDIATR RES, V52, P606, DOI 10.1203/01.PDR.0000028057.79132.1F; GILAD GM, 1995, LIFE SCI, V58, pPL41, DOI 10.1016/0024-3205(95)02274-0; Gilad GM, 2000, NEUROSCI LETT, V296, P97, DOI 10.1016/S0304-3940(00)01625-6; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim JH, 2010, J CEREBR BLOOD F MET, V30, P943, DOI 10.1038/jcbfm.2009.260; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Lee WT, 2009, BRAIN RES, V1281, P64, DOI 10.1016/j.brainres.2009.05.046; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; Olmos G, 1999, BRIT J PHARMACOL, V127, P1317, DOI 10.1038/sj.bjp.0702679; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; PILETZ JE, 1995, J PHARMACOL EXP THER, V272, P581; Puurunen K, 2001, EXP NEUROL, V167, P348, DOI 10.1006/exnr.2000.7563; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Sugino T, 2000, NEUROSCI LETT, V278, P101, DOI 10.1016/S0304-3940(99)00906-4; Wang Che-Chuan, 2010, BMC Pharmacology, V10, P11, DOI 10.1186/1471-2210-10-11; Yang XC, 1999, J PHARMACOL EXP THER, V288, P544	39	16	17	0	2	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUL	2015	30	7					943	952		10.3346/jkms.2015.30.7.943			10	Medicine, General & Internal	General & Internal Medicine	CR4OA	WOS:000361312000018	26130959	DOAJ Gold, Green Published			2021-06-18	
J	Yuan, Q; Wu, X; Yu, J; Sun, YR; Li, ZQ; Du, ZY; Mao, Y; Zhou, LF; Hu, J				Yuan, Qiang; Wu, Xing; Yu, Jian; Sun, Yirui; Li, Zhiqi; Du, Zhuoying; Mao, Ying; Zhou, Liangfu; Hu, Jin			Effects and Clinical Characteristics of Intracranial Pressure Monitoring-Targeted Management for Subsets of Traumatic Brain Injury: An Observational Multicenter Study	CRITICAL CARE MEDICINE			English	Article						computed tomography; intracranial pressure monitoring; neuromonitoring; traumatic brain injury	SEVERE HEAD-INJURY; INTENSIVE-CARE; COMPLICATIONS; GUIDELINES; OUTCOMES; TRIAL	Objectives: To evaluate the efficacy of traumatic brain injury management guided by intracranial pressure monitoring and to explore the specific subgroups for which intracranial pressure monitoring might be significantly associated with improved outcomes based on a classification of the various traumatic brain injury pathophysiologies using the clinical features and CT scans. Design: Retrospective observational multicenter study. Setting: Twenty-two hospitals (16 level I trauma centers and six level II trauma centers) in nine provinces in China. Patients: Moderate or severe traumatic brain injury patients who were more than 14 years old. Interventions: Intracranial pressure monitoring. Measurements and Main Results: All data were collected by physicians from medical records. The 6-month mortality and favorable outcome were assessed with the Glasgow Outcome Scale Extended score. An intracranial pressure monitor was inserted into 838 patients (58.1%). The mean duration of intracranial pressure monitoring was 4.443.65 days. The significant predictors of intracranial pressure monitoring included the mechanism of injury, a Glasgow Coma Scale score of 9-12 at admission that dropped to a score of 3-8 within 24 hours after injury, a Marshall CT classification of III-IV, the presence of a major extracranial injury, subdural hematoma, intraparenchymal lesions, trauma center level, and intracranial pressure monitoring utilization of hospital. The intracranial pressure monitoring and no intracranial pressure monitoring groups did not significantly differ in terms of complications. For the total sample, the placement of intracranial pressure monitoring was not associated with either 6-month mortality (16.9% vs 20.5%; p = 0.086) or 6-month unfavorable outcome (49.4% vs 45.8%; p = 0.175). For patients with a Glasgow Coma Scale score of 3-8 at admission, intracranial pressure monitoring was also not significantly associated with 6-month mortality (20.9% vs 26.0%; p = 0.053) or an unfavorable outcome (56.9% vs 55.5%; p = 0.646). Multivariate logistic regression analyses showed that intracranial pressure monitoring resulted in a significantly lower 6-month mortality for patients who had a Glasgow Coma Scale score of 3-5 at admission (adjusted odds ratio, 0.57; 95% CI, 0.36-0.90; adjusted p = 0.016), those who had a Glasgow Coma Scale score of 9-12 at admission that dropped to 3-8 within 24 hours after injury (adjusted odds ratio, 0.28; 95% CI, 0.08-0.96; adjusted p = 0.043), and those who had a probability of death at 6 months greater than 0.6 (adjusted odds ratio, 0.55; 95% CI, 0.32-0.94; adjusted p = 0.029). Conclusions: There were multiple differences between the intracranial pressure monitoring and no intracranial pressure monitoring groups regarding patient characteristics, injury severity, characteristics of CT scan, and hospital type. Intracranial pressure monitoring in conjunction with intracranial pressure-targeted therapies is significantly associated with lower mortality in some special traumatic brain injury subgroups. The prospective randomized controlled trials specifically investigating these subgroups will be required to further characterize the effects of intracranial pressure monitoring on behavioral outcomes in patients with traumatic brain injury.	[Yuan, Qiang; Wu, Xing; Yu, Jian; Sun, Yirui; Li, Zhiqi; Du, Zhuoying; Mao, Ying; Zhou, Liangfu; Hu, Jin] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China	Hu, J (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China.	hujin_dana@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30371454, 81271375, 81171133]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	Supported, in part, by the National Natural Science Foundation of China (grants 30371454, 81271375, and 81171133), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), and Shanghai Nature Science Foundation (08411952000). The authors have disclosed that they do not have any potential conflicts of interest.	Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KANTER RK, 1985, CRIT CARE MED, V13, P837, DOI 10.1097/00003246-198510000-00012; Lane PL, 2000, CAN J SURG, V43, P442; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rapenne T, 1997, PRESSE MED, V26, P1661; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	30	16	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2015	43	7					1405	1414		10.1097/CCM.0000000000000965			10	Critical Care Medicine	General & Internal Medicine	CN2XK	WOS:000358285900008	25803654				2021-06-18	
J	Eckner, JT; Richardson, JK; Kim, H; Joshi, MS; Oh, YK; Ashton-Miller, JA				Eckner, James T.; Richardson, James K.; Kim, Hogene; Joshi, Monica S.; Oh, Youkeun K.; Ashton-Miller, James A.			RELIABILITY AND CRITERION VALIDITY OF A NOVEL CLINICAL TEST OF SIMPLE AND COMPLEX REACTION TIME IN ATHLETES	PERCEPTUAL AND MOTOR SKILLS			English	Article							TEST-RETEST RELIABILITY; NEUROPSYCHOLOGICAL TEST PROTOCOL; BRAIN-INJURY; CONCUSSION; SPORT; BATTERY; IMPACT; RECOVERY; PERFORMANCE; POPULATION	Slowed reaction time (RT) represents both a risk factor for and a consequence of sport concussion. The purpose of this study was to determine the reliability and criterion validity of a novel clinical test of simple and complex RT, called RTdin, in contact sport athletes. Both tasks were adapted from the well-known ruler drop test of RT and involve manually grasping a falling vertical shaft upon its release, with the complex task employing a go/no-go paradigm based on a light cue. In 46 healthy contact sport athletes (24 men; M = 16.3 yr., SD = 5.0; 22 women: M age = 15.0 yr., SD = 4.0) whose sports included soccer, ice hockey, American football, martial arts, wrestling, and lacrosse, the latency and accuracy of simple and complex RTdin had acceptable test-retest and inter-rater reliabilities and correlated with a computerized criterion standard, the Axon Computerized Cognitive Assessment Tool. Medium to large effect sizes were found. The novel RTdin tests have acceptable reliability and criterion validity for clinical use and hold promise as concussion assessment tools.	[Eckner, James T.; Richardson, James K.; Ashton-Miller, James A.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Eckner, James T.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48108 USA; [Kim, Hogene; Joshi, Monica S.; Oh, Youkeun K.; Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48108 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48108 USA	Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			Rehabilitation Medicine Scientist Training Program [5K12HD001097]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER	This project was supported by the Rehabilitation Medicine Scientist Training Program (5K12HD001097). The authors wish to thank Ms. Lea Franco for her editorial assistance in reviewing and submitting this manuscript. We would also like to thank Dr. Jason Cromer for his assistance in addressing our questions about the Axon CCAT.	Anastasi A., 1998, PSYCHOL TESTING; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; CHUDLER E. H., 2009, NEUROSCIENCE KIDS; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; DUERSON D., CLIN J SPORT MED; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Montare A, 2009, PERCEPT MOTOR SKILL, V108, P161, DOI 10.2466/PMS.108.1.161-172; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9	40	16	16	0	28	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	2015	120	3					841	859		10.2466/25.15.PMS.120v19x6			19	Psychology, Experimental	Psychology	CL3UD	WOS:000356875200013	26106803	Green Accepted			2021-06-18	
J	Friess, SH; Lapidus, JB; Brody, DL				Friess, Stuart H.; Lapidus, Jodi B.; Brody, David L.			Decompressive Craniectomy Reduces White Matter Injury after Controlled Cortical Impact in Mice	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; controlled cortical impact; intracranial pressure; traumatic brain injury; white matter	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; VEGETATIVE STATE; NEUROPATHOLOGY; ISOFLURANE; SEVOFLURANE; HIPPOCAMPUS	Reduction and avoidance of increases in intracranial pressure (ICP) after severe traumatic brain injury (TBI) continue to be the mainstays of treatment. Traumatic axonal injury is a major contributor to morbidity after TBI, but it remains unclear whether elevations in ICP influence axonal injury. Here we tested the hypothesis that reduction in elevations in ICP after experimental TBI would result in decreased axonal injury and white matter atrophy in mice. Six-week-old male mice (C57BL/6J) underwent either moderate controlled cortical impact (CCI) (n=48) or Sham surgery (Sham, n=12). Immediately after CCI, injured animals were randomized to a loose fitting plastic cap (Open) or replacement of the previously removed bone flap (Closed). Elevated ICP was observed in Closed animals compared with Open and Sham at 15min (21.4 +/- 4.2 vs. 12.3 +/- 2.9 and 8.8 +/- 1.8mm Hg, p<0.0001) and 1 day (17.8 +/- 3.7 vs. 10.6 +/- 2.0 and 8.9 +/- 1.9mm Hg, p<0.0001) after injury. Beta amyloid precursor protein staining in the corpus callosum and ipsilateral external capsule revealed reduced axonal swellings and bulbs in Open compared with Closed animals (32% decrease, p<0.01 and 40% decrease, p<0.001 at 1 and 7 days post-injury, respectively). Open animals were also found to have decreased neurofilament-200 stained axonal swellings at 7 days post-injury compared with Open animals (32% decrease, p<0.001). At 4 weeks post-injury, Open animals had an 18% reduction in white matter volume compared with 34% in Closed animals (p<0.01). Thus, our results indicate that CCI with decompressive craniectomy was associated with reductions in ICP and reduced pericontusional axonal injury and white matter atrophy. If similar in humans, therapeutic interventions that ameliorate intracranial hypertension may positively influence white matter injury severity.	[Friess, Stuart H.; Lapidus, Jodi B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Friess, SH (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, Campus Box 8028,5th Floor MPRB,660 S Euclid Ave, St Louis, MO 63110 USA.	Friess_S@kid.wustl.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR027552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065069, K08NS064051] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10 RR027552] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS064051, R01 NS065069] Funding Source: Medline		Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P571, DOI 10.1097/00000542-198910000-00016; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sponheim S, 2003, ACTA ANAESTH SCAND, V47, P932, DOI 10.1034/j.1399-6576.2003.00199.x; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Yanagawa Y, 2009, J TRAUMA, V66, P162, DOI 10.1097/TA.0b013e3181469857; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	48	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					791	800		10.1089/neu.2014.3564			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700004	25557588	Green Published			2021-06-18	
J	Peterson, TC; Hoane, MR; McConomy, KS; Farin, FM; Bammler, TK; MacDonald, JW; Kantor, ED; Anderson, GD				Peterson, Todd C.; Hoane, Michael R.; McConomy, Keith S.; Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.; Kantor, Eric D.; Anderson, Gail D.			A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; nicotinamide; polytherapy; progesterone; recovery of function; traumatic brain injury	CORTICAL CONTUSION INJURY; FLUID PERCUSSION INJURY; CELL-DEATH; MALE RATS; POLY(ADP-RIBOSE) POLYMERASE; BARRIER BREAKDOWN; GENE-EXPRESSION; NEURONAL DEATH; EDEMA; NEUROPROTECTION	Neuroprotection, recovery of function, and gene expression were evaluated in an animal model of traumatic brain injury (TBI) after a combination treatment of nicotinamide (NAM) and progesterone (Prog). Animals received a cortical contusion injury over the sensorimotor cortex, and were treated with either Vehicle, NAM, Prog, or a NAM/Prog combination for 72h and compared with a craniotomy only (Sham) group. Animals were assessed in a battery of behavioral, sensory, and both fine and gross motor tasks, and given histological assessments at 24h post-injury to determine lesion cavity size, degenerating neurons, and reactive astrocytes. Microarray-based transcriptional profiling was used to determine treatment-specific changes on gene expression. Our results confirm the beneficial effects of treatment with either NAM or Prog, demonstrating significant improvements in recovery of function and a reduction in lesion cavitation, degenerating neurons, and reactive astrocytes 24h post-injury. The combination treatment of NAM and Prog led to a significant improvement in both neuroprotection at 24h post-injury and recovery of function in sensorimotor related tasks when compared with individual treatments. The NAM/Prog-treated group was the only treatment group to show a significant reduction of cortical loss 24h post-injury. The combination appears to affect inflammatory and immune processes, reducing expression of a significant number of genes in both pathways. Further preclinical trials using NAM and Prog as a combination treatment should be conducted to identify the window of opportunity, determine the optimal duration of treatment, and evaluate the combination in other pre-clinical models of TBI.	[Peterson, Todd C.; Hoane, Michael R.; McConomy, Keith S.] So Illinois Univ, Dept Psychol, Carbondale, IL 62901 USA; [Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Kantor, Eric D.; Anderson, Gail D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA	Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Life Sci 2,MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD061944-01] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033, P30 ES007033] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER		Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Baker AB, 2012, J AM COLL CARDIOL, V59, P1551, DOI 10.1016/j.jacc.2011.11.057; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Bernier J, 1998, RADIOTHER ONCOL, V48, P123, DOI 10.1016/S0167-8140(98)00048-6; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; FASS B, 1980, PHYSIOL BEHAV, V25, P683, DOI 10.1016/0031-9384(80)90370-4; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GREGERSEN N, 1986, ACTA PAEDIATR SCAND, V75, P676, DOI 10.1111/j.1651-2227.1986.tb10272.x; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 1997, RESTOR NEUROL NEUROS, V11, P71, DOI 10.3233/RNN-1997-111208; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; HORSMAN MR, 1993, RADIOTHER ONCOL, V27, P131, DOI 10.1016/0167-8140(93)90133-S; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stratford MRL, 1996, ACTA ONCOL, V35, P213, DOI 10.3109/02841869609098504; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	70	16	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					765	779		10.1089/neu.2014.3530			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700002	25313690	Green Published			2021-06-18	
J	Schwarzmaier, SM; Terpolilli, NA; Dienel, A; Gallozzi, M; Schinzel, R; Tegtmeier, F; Plesnila, N				Schwarzmaier, Susanne M.; Terpolilli, Nicole A.; Dienel, Ari; Gallozzi, Micaela; Schinzel, Reinhard; Tegtmeier, Frank; Plesnila, Nikolaus			Endothelial Nitric Oxide Synthase Mediates Arteriolar Vasodilatation after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						eNOS; brain trauma; intracranial hypertension; vessel diameter; mice	CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; L-ARGININE; HEAD-INJURY; SELECTIVE-INHIBITION; TEMPORAL PROFILE; L-NAME; RAT; MICROCIRCULATION; CONTUSION	Brain edema and increased cerebral blood volume (CBV) contribute to intracranial hypertension and hence to unfavorable outcome after traumatic brain injury (TBI). The increased post-traumatic CBV may be caused in part by arterial vasodilatation. The aim of the current study was to uncover the largely unknown mechanisms of post-traumatic arteriolar vasodilatation. The diameter of pial arterioles and venules was monitored by intravital fluorescence microscopy before (baseline) and for 30 min after controlled cortical impact in C57BL/6 and endothelial nitric oxide synthase (eNOS)-/- mice (n=5-6/group) and in C57BL/6 mice (n=6/group) receiving vehicle (phosphate-buffered saline [PBS]) or 4-amino-tetrahydro-L-biopterine (VAS203), a NOS inhibitor previously shown to reduce post-traumatic intracranial hypertension. Temperature, end-tidal partial pressure of carbon dioxide (pCO(2)), and mean arterial blood pressure were kept within the physiological range throughout the experiments. Arteriolar diameters were stable during baseline monitoring but increased significantly in C57BL/6 mice after controlled cortical impact (136 +/- 7% of baseline; p<0.001 vs. baseline). This response was reduced by 78% in eNOS-/- mice (108 +/- 3% of baseline; p<0.005 vs. wild-type). Application of VAS203, a NOS inhibitor, or PBS did not affect vessels diameter before TBI. After trauma, however, administration of VAS203 reduced arteriolar diameter to 92 +/- 2% of baseline (p<0.05). The diameter of pial veins was not affected. Our results suggest that arteriolar vasodilatation after TBI is largely mediated by excess production of endothelial nitric oxide. Accordingly, our data may explain the beneficial effects of the NOS inhibitor VAS203 in the early phase after TBI and suggest that inhibition of excess endothelial nitric oxide production may represent a novel therapeutic strategy following TBI.	[Schwarzmaier, Susanne M.; Terpolilli, Nicole A.; Dienel, Ari; Plesnila, Nikolaus] Univ Munich, Med Ctr, Lab Expt Neurosurg, D-81377 Munich, Germany; [Schwarzmaier, Susanne M.] Univ Munich, Med Ctr, Dept Anesthesiol, D-81377 Munich, Germany; [Terpolilli, Nicole A.; Dienel, Ari] Univ Munich, Med Ctr, Dept Neurosurg, D-81377 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Schinzel, Reinhard; Tegtmeier, Frank] Vasopharm GmbH, Wurzburg, Germany; [Schwarzmaier, Susanne M.; Gallozzi, Micaela; Plesnila, Nikolaus] Royal Coll Surgeons Ireland, Dept Neurodegenerat, Dublin 2, Ireland; [Plesnila, Nikolaus] Munich Cluster Syst Neurol, Munich, Germany	Plesnila, N (corresponding author), Univ Munich, Med Ctr, Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019; Terpolilli, Nicole/AAG-3598-2021				BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Cherian L, 2004, J NEUROTRAUM, V21, P1196; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Friedrich B, 2012, J CEREBR BLOOD F MET, V32, P447, DOI 10.1038/jcbfm.2011.154; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gahm C, 2000, NEUROSURGERY, V46, P169; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Hua J, 2014, MOVEMENT DISORD, V29, P396, DOI 10.1002/mds.25591; Ito H, 2005, ANN NUCL MED, V19, P65, DOI 10.1007/BF03027383; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kontos H A, 1981, Trans Am Clin Climatol Assoc, V92, P111; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Lundblad C, 2007, MICROVASC RES, V74, P1, DOI 10.1016/j.mvr.2007.03.001; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mendez DR, 2004, J TRAUMA, V57, P244, DOI 10.1097/01.TA.0000103983.22362.67; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Stoffel M, 2000, ACTA NEUROCHIR SUPPL, V76, P357; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Werner ER, 1996, BIOCHEM J, V320, P193, DOI 10.1042/bj3200193; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	48	16	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					731	738		10.1089/neu.2014.3650			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200008	25363688				2021-06-18	
J	Sailors, PR				Sailors, Pamela R.			Personal Foul: an evaluation of the moral status of football	JOURNAL OF THE PHILOSOPHY OF SPORT			English	Article						objectification; violence; concussions; harm; football		The popularity and profitability of American gridiron football is beyond dispute. Recent polls put football as the overwhelming favorite of people who follow at least one sport and huge revenues are reported at both the professional and the university level. We know, however, that what is the case tells us little about what ought to be the case, and it is to the latter question that this paper is directed. I offer a three-pronged attack on the ethical acceptability of American football, both amateur and professional, based on (1) harm to the players, (2) objectification of the players, and (3) harm to others done by the players, leading to the conclusion that the sport, as currently constituted, is morally unacceptable.	Missouri State Univ, Dept Philosophy, Springfield, MO 65897 USA	Sailors, PR (corresponding author), Missouri State Univ, Dept Philosophy, 901 S Natl Ave, Springfield, MO 65897 USA.	pamela-sailors@missouristate.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Aristotle, 1999, NICOMACHEAN ETHICS; Belson K., 2014, NY TIMES; Benedict J., 2013, SYSTEM GLORY SCANDAL; Brady E., 2013, US TODAY; Branch Taylor, 2011, ATLANTIC, V308, P80; Breslow JM, 2014, 76 79 DECEASED NFL P; Corlett JA, 2014, SPORT ETHICS PHILOS, V8, P116, DOI 10.1080/17511321.2014.918167; Davis P., 1993, Journal of the Philosophy of Sport, V20/21, P48; Dixon N., 2001, SOCIAL THEORY PRACTI, V27, P323, DOI DOI 10.5840/SOCTHEORPRACT200127215; Easterbrook G., 2013, KING SPORTS FOOTBALL; Engber D., 2013, SLATE           1015; Fainaru-Wada M., 2013, LEAGUE DENIAL NFL CO; Feinberg J., 1986, HARM SELF MORAL LIMI; Gregor, 1991, METAPHYSICS MORALS; Herrera CD, 2002, J PHILOS SPORT, V29, P163, DOI 10.1080/00948705.2002.9714632; Kant I, 1964, GROUNDWORK METAPHYSI; Leclerc S, 1999, BRIT J SPORT MED, V33, P426, DOI 10.1136/bjsm.33.6.426; Lundberg G. D, 1986, JAMA-J AM MED ASSOC, V255, P2483, DOI [10.1001/jama.1986.03370180109044, DOI 10.1001/JAMA.1986.03370180109044]; Messner MA., 2007, OUT PLAY CRITICAL ES; MILL JS, 1962, UTILITARIANISM OTHER; Mill JS., 1989, LIBERTY OTHER WRITIN; Morris B., 2014, 538             0731; Parry Jim, 1998, ETHICS SPORT, P205; RADFORD C, 1988, PHILOSOPHY, V63, P63, DOI 10.1017/S0031819100043138; ROSENBERG D, 2014, BLOOMSBURY COMPANION, P262; Rovell D, 2014, NFL MOST POPULAR 30; Sabo D., 1990, SPORT MEN GENDER ORD, P115; Schneider A., 2001, Ethics in sport, P357; Simon R. L., 2007, Ethics in sport, P379; Simon R. L., 2010, FAIR PLAY ETHICS SPO; Sports Legacy Institute, 2014, FREQ ASK QUEST CHRON; Tamburrini C, 2011, J PHILOS SPORT, V38, P1; Teitelbaum S.H., 2010, ATHLETES WHO INDULGE; Wertheimer A., 2007, Ethics in sport, P365	35	16	16	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0094-8705	1543-2939		J PHILOS SPORT	J. Philos. Sport	MAY 4	2015	42	2					269	286		10.1080/00948705.2014.1000338			18	Ethics; Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Sciences - Other Topics; Sport Sciences	CI3EX	WOS:000354631500001					2021-06-18	
J	Coste, C; Navarro, B; Vallat-Azouvi, C; Brami, M; Azouvi, P; Piolino, P				Coste, Cecile; Navarro, Beatrice; Vallat-Azouvi, Claire; Brami, Marie; Azouvi, Philippe; Piolino, Pascale			Disruption of temporally extended self-memory system following traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						Self-memory system; Autobiographical memory; Future; Mental time travel; Self-concept; Executive function; Working memory binding; Verbal fluency; Traumatic brain injury	EPISODIC FUTURE THINKING; MENTAL TIME-TRAVEL; AUTOBIOGRAPHICAL MEMORY; WORKING-MEMORY; EXECUTIVE FUNCTIONS; PROJECTING ONESELF; SEMANTIC MEMORY; VISUAL-IMAGERY; OLDER-ADULTS; SIMULATION	We investigated for the first time the episodic/semantic distinction in remembering the past and imagining the future in traumatic brain injury (TB!), and explored cognitive mechanisms that may underlie their deficits. Fifteen severe TBI patients and 15 control participants performed a battery of neuropsychological tests and a set of verbal fluency tasks designed to assess semantic (personality traits knowledge and general events), and episodic (specific events and details) facets of self-representations according to three time periods (remote/retrograde past, recent/anterograde past, future). Compared to controls, TBI patients showed deficits in both semantic and episodic self-representations, regardless of the time period, and controlling for basic cognitive functions. By contrast, a subjective evaluation of self-concept measuring the degree of certitude and the valence of self did not differ between patients and controls. The deficits were mainly predicted by altered executive function (i.e., updating) for past periods, as well as by general semantic and feature binding in working memory for the future period, independently of the injury characteristics. For controls, only episodic self-representation for each time period was mediated by executive or working memory functions, while semantic self-representation was mediated by the certitude of the self. This study highlights the dual role of semantic and episodic representations in temporally extended self, and shows the global disruption of self-representations across extended time in severe TBI. This encourages the extension of past and future thinking research to TBI populations to provide important insights into the nature and origin of these deficits and their role in recovery and to suggest future lines of research on rehabilitation procedures. (C) 2015 Elsevier Ltd. All rights reserved.	[Coste, Cecile; Navarro, Beatrice; Piolino, Pascale] Paris Descartes Univ, Sorbonne Paris Cite, Inst Psychol, Memory & Cognit Lab, Paris, France; [Coste, Cecile; Navarro, Beatrice; Piolino, Pascale] Paris Descartes Univ, Inserm UMR S 894, Ctr Psychiat & Neurosci, Paris, France; [Coste, Cecile] Hop St Maurice, Adults Neurol Unity, St Maurice, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, UEROS UGECAM, Garches, France; [Brami, Marie] ADEP CICL, Puteaux La Defense, France; [Azouvi, Philippe] Hop Raymond Poincare, Phys Med & Rehabil Serv, Garches, France	Piolino, P (corresponding author), Ctr Psychiat & Neurosci, Memory & Cognit Lab, Inserm UMR 894, 2 Ter Rue Alesia, F-75014 Paris, France.	pascale.piolino@parisdescartes.fr			French Ministry of ResearchMinistry of Research, FranceEuropean Commission	The study was funded by a PhD allocation to CC from the French Ministry of Research. The authors would like to thank the participants and the patients for volunteering for this study, and all members of the French UEROS - Unity of Evaluation, Re-training and Social and Professional Orientation - and French CICL Unit Insertion unit for brain-injured patients for their valuable help.	Abram M, 2014, CONSCIOUS COGN, V29, P76, DOI 10.1016/j.concog.2014.07.011; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2010, PSYCHOL AGING, V25, P369, DOI 10.1037/a0017280; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2660, DOI 10.1016/j.neuropsychologia.2009.05.018; Addis DR, 2004, MEMORY, V12, P56, DOI 10.1080/09658210244000423; Anderson RJ, 2009, MEMORY, V17, P367, DOI 10.1080/09658210902751669; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Belleville S, 2006, BRAIN COGNITION, V62, P113, DOI 10.1016/j.bandc.2006.04.006; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Chessell Z.J., 2013, SELF IDENTITY, P1; Cole SN, 2013, Q J EXP PSYCHOL, V66, P1687, DOI 10.1080/17470218.2012.758157; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; D'Argembeau A, 2006, CONSCIOUS COGN, V15, P342, DOI 10.1016/j.concog.2005.09.001; D'Argembeau A, 2010, MEM COGNITION, V38, P809, DOI 10.3758/MC.38.6.809; de Vito S, 2012, NEUROPSYCHOLOGIA, V50, P1494, DOI 10.1016/j.neuropsychologia.2012.03.001; Delis DC, 1987, CALIFORNIA VERBAL LE; Deltour J, 1993, ECHELLE VOCABULAIRE; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Duval C, 2007, PSYCHOL NEUROPSYCHIA, V5, P179, DOI 10.1684/pnv.2007.0100; Duval C, 2012, NEUROPSYCHOLOGIA, V50, P254, DOI 10.1016/j.neuropsychologia.2011.11.019; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Fedio A, 2014, ARCH CLIN NEUROPSYCH, V29; Fitts W.H., 1996, TENNESSEE SELF CONCE, V2nd ed; Gueguen N., 2009, EUROPEAN J SCI RES, V38, P20; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Haslam C, 2011, BRIT J PSYCHOL, V102, P184, DOI 10.1348/000712610X508091; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hill PF, 2013, CONSCIOUS COGN, V22, P677, DOI 10.1016/j.concog.2013.04.002; Hughes DL, 2002, J CLIN EXP NEUROPSYC, V24, P642, DOI 10.1076/jcen.24.5.642.1002; Irish M, 2013, CORTEX, V49, P2377, DOI 10.1016/j.cortex.2013.03.002; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Irish M, 2012, NEUROPSYCHOLOGIA, V50, P3488, DOI 10.1016/j.neuropsychologia.2012.09.012; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Irish M, 2012, NAT REV NEUROL, V8, P152, DOI 10.1038/nrneurol.2012.11; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Klein SB, 2013, WIRES COGN SCI, V4, P63, DOI 10.1002/wcs.1210; Klein SB, 2010, WIRES COGN SCI, V1, P172, DOI 10.1002/wcs.25; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Kwan D, 2010, NEUROPSYCHOLOGIA, V48, P3179, DOI 10.1016/j.neuropsychologia.2010.06.011; Lalanne J, 2015, NEUROPSYCHOL REHABIL, V25, P254, DOI 10.1080/09602011.2014.949276; Lalanne J, 2013, CURR ALZHEIMER RES, V10, P1107, DOI 10.2174/15672050113106660175; Lalova M, 2013, COMPR PSYCHIAT, V54, P369, DOI 10.1016/j.comppsych.2012.10.005; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P3187, DOI 10.1016/j.neuropsychologia.2010.06.037; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Martinelli P, 2013, NEUROPSYCHOLOGY, V27, P69, DOI 10.1037/a0030453; McPartland T., 1954, AM SOCIOLOGICAL Q, V5, P61; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS N, 1990, PERCEPT PSYCHOPHYS, V47, P291, DOI 10.3758/BF03205003; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Picard L, 2013, CORTEX, V49, P1463, DOI 10.1016/j.cortex.2012.10.003; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Prebble SC, 2013, PSYCHOL BULL, V139, P815, DOI 10.1037/a0030146; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Quinette P, 2003, BRAIN, V126, P1917, DOI 10.1093/brain/awg201; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Raven J.C., MANUAL RAVENS PROGR; Rosenbaum RS, 2004, NEUROPSYCHOLOGIA, V42, P1619, DOI 10.1016/j.neuropsychologia.2004.04.010; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schacter DL, 2007, BEHAV BRAIN SCI, V30, P331, DOI 10.1017/S0140525X07002178; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; TEASDALE G, 1974, LANCET, V2, P81; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Viard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111046; Viard A, 2012, BRAIN COGNITION, V80, P111, DOI 10.1016/j.bandc.2012.05.004; Viard A, 2011, BRAIN COGNITION, V75, P1, DOI 10.1016/j.bandc.2010.10.009; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilson BA, 1996, BEHAV ASSESSMENT DYS; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	99	16	16	0	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAY	2015	71						133	145		10.1016/j.neuropsychologia.2015.03.014			13	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	CI8PR	WOS:000355034700015	25795040				2021-06-18	
J	Gajavelli, S; Kentaro, S; Diaz, J; Yokobori, S; Spurlock, M; Diaz, D; Jackson, C; Wick, A; Zhao, WZ; Leung, LY; Shear, D; Tortella, F; Bullock, MR				Gajavelli, Shyam; Kentaro, Shimoda; Diaz, Julio; Yokobori, Shoji; Spurlock, Markus; Diaz, Daniel; Jackson, Clayton; Wick, Alexandra; Zhao, Weizhao; Leung, Lai Y.; Shear, Deborah; Tortella, Frank; Bullock, M. Ross			Glucose and oxygen metabolism after penetrating ballistic-like brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						2-deoxy glucose; cerebral metabolism; Fluorojade B; glucose; neurodegeneration; oxygen	ISCHEMIC PENUMBRA; GUNSHOT WOUNDS; UNITED-STATES; RAT MODEL; ACTIVATION; HEMORRHAGE; EXPRESSION; BIOMARKERS; SEVERITY	Traumatic brain injury (TBI) is a major cause of death and disability in all age groups. Among TBI, penetrating traumatic brain injuries (PTBI) have the worst prognosis and represent the leading cause of TBI-related morbidity and death. However, there are no specific drugs/interventions due to unclear pathophysiology. To gain insights we looked at cerebral metabolism in a PTBI rat model: penetrating ballistic-like brain injury (PBBI). Early after injury, regional cerebral oxygen tension and consumption significantly decreased in the ipsilateral cortex in the PBBI group compared with the control group. At the same time point, glucose uptake was significantly reduced globally in the PBBI group compared with the control group. Examination of Fluorojade B-stained brain sections at 24 hours after PBBI revealed an incomplete overlap of metabolic impairment and neurodegeneration. As expected, the injury core had the most severe metabolic impairment and highest neurodegeneration. However, in the peri-lesional area, despite similar metabolic impairment, there was lesser neurodegeneration. Given our findings, the data suggest the presence of two distinct zones of primary injury, of which only one recovers. We anticipate the peri-lesional area encompassing the PBBI ischemic penumbra, could be salvaged by acute therapies.	[Gajavelli, Shyam; Kentaro, Shimoda; Diaz, Julio; Spurlock, Markus; Diaz, Daniel; Jackson, Clayton; Wick, Alexandra; Zhao, Weizhao; Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Leung, Lai Y.; Shear, Deborah; Tortella, Frank] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD USA	Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	RBullock@med.miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973	Department of DefenseUnited States Department of Defense [PT074521W81XWH-08-1-0419]	This work was supported by Department of Defense Grant #PT074521W81XWH-08-1-0419 to RB.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BACK T, 1995, J CEREBR BLOOD F MET, V15, P566, DOI 10.1038/jcbfm.1995.70; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; De Fazio M, 2011, NEUROCRIT CARE, V14, P91, DOI 10.1007/s12028-010-9494-3; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Heiss WD, 2011, CEREBROVASC DIS, V32, P307, DOI 10.1159/000330462; Henry Boret, 2012, J Emerg Trauma Shock, V5, P103, DOI 10.4103/0974-2700.93101; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kalesan B, 2014, AM J EPIDEMIOL, V179, P303, DOI 10.1093/aje/kwt255; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tsukada H, 2014, J CEREBR BLOOD F MET, V34, P708, DOI 10.1038/jcbfm.2014.5; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yao CP, 2011, J NEUROTRAUM, V28, P1237, DOI 10.1089/neu.2010.1678; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; ZHAO WZ, 1995, J CEREBR BLOOD F MET, V15, P552, DOI 10.1038/jcbfm.1995.69; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	40	16	17	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2015	35	5					773	780		10.1038/jcbfm.2014.243			8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CH1GK	WOS:000353769100012	25669903	Green Published, Other Gold			2021-06-18	
J	Legarreta, M; Graham, J; North, L; Bueler, CE; McGlade, E; Yurgelun-Todd, D				Legarreta, Margaret; Graham, Jessica; North, Lindsey; Bueler, C. Elliott; McGlade, Erin; Yurgelun-Todd, Deborah			DSM-5 Posttraumatic Stress Disorder Symptoms Associated With Suicide Behaviors in Veterans	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						suicide; PTSD; DSM-5; trauma; veterans	TRAUMATIC BRAIN-INJURY; AFGHANISTAN WAR VETERANS; RATING-SCALE; THERAPY BCBT; US VETERANS; RISK-FACTOR; IDEATION; PTSD; IRAQ; DEPRESSION	A connection between suicidality and posttraumatic stress disorder (PTSD) has been consistently demonstrated; however, the underlying relationship between suicidality and PTSD remains unclear. The aim of this study was to examine patterns of DSM-5 PTSD symptom endorsement that differentiated veteran participants with and without a history of suicide behaviors. We enrolled 95 veterans, 32 of whom reported no suicide ideation (SI) or suicide attempts (SA). The 63 remaining participants reported a history of SI, with 28 of the 63 also reporting a historical SA. Participants completed a standardized diagnostic interview (Structured Clinical Interview for DSM-IV-TR; First, Spitzer, Gibbon, & Williams, 2002), structured interview of suicidal behaviors (Columbia-Suicide Severity Rating Scale; Posner et al., 2011), and selected clinical measures. Veterans who reported SI and/or SA were more likely to meet criteria for PTSD on DSM-5 than were veterans who reported neither SI nor SA. Participants who reported SA were more likely to meet criteria for clusters C and D. Finally, at the symptom level, those who reported SI were more likely to report experiencing feelings of alienation. Those who reported a SA were more likely to report avoidance of thoughts and feelings, inability to recall an important aspect of their trauma, persistent negative beliefs, diminished interest, and feelings of alienation. These findings suggest that targeting specific symptoms of PTSD may aid in treatment of suicidal thoughts and behaviors associated with PTSD.	[Legarreta, Margaret; North, Lindsey] Univ Utah, VA Salt Lake City Hlth Care Syst, Rocky Mt Network Mental Illness Res Educ & Clin C, MIRECC,VISN 19,Sch Med, Salt Lake City, UT 84112 USA; [Legarreta, Margaret; North, Lindsey] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Graham, Jessica] VA Salt Lake City Hlth Care Syst, Rocky Mt Network Mental Illness Res Educ & Clin C, MIRECC, VISN 19, Salt Lake City, UT USA; [Bueler, C. Elliott; Yurgelun-Todd, Deborah] Univ Utah, Sch Med, Inst Brain, Salt Lake City, UT 84112 USA; [Yurgelun-Todd, Deborah] Univ Utah, VA Salt Lake City Hlth Care Syst, Rocky Mt Network Mental Illness Res Educ & Clin C, MIRECC,VISN 19,Sch Med,Dept Psychiat, Salt Lake City, UT 84112 USA	Legarreta, M (corresponding author), 500 Foothill Dr,Mail Code 116M, Salt Lake City, UT 84148 USA.	margaret.legarreta@va.gov	McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984	Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Medical Research Service of the Veterans Affairs Salt Lake City Health Care System; Department of Veterans Affairs Rocky Mountain Network Mental Illness Research, Education, and Clinical Center; Veterans Health Administration Merit Review Grant [5I01CX000253-02]	This research is supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Veterans Affairs Salt Lake City Health Care System, the Department of Veterans Affairs Rocky Mountain Network Mental Illness Research, Education, and Clinical Center, and Veterans Health Administration Merit Review Grant 5I01CX000253-02.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Briere J., 1995, TRAUMA SYMPTOM INVEN; Bryan CJ, 2012, PROF PSYCHOL-RES PR, V43, P130, DOI 10.1037/a0026307; Calabrese JR, 2011, J CLIN PSYCHIAT, V72, P1072, DOI 10.4088/JCP.11m06956; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; First MB., 2002, STRUCTURED CLIN INTE; Gradus JL, 2013, DEPRESS ANXIETY, V30, P1046, DOI 10.1002/da.22117; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; Iannuzzo RW, 2006, PSYCHIAT RES, V145, P21, DOI 10.1016/j.psychres.2005.10.009; Ilgen MA, 2013, JAMA PSYCHIAT, V70, P692, DOI 10.1001/jamapsychiatry.2013.908; Jakupcak M, 2011, J NERV MENT DIS, V199, P272, DOI 10.1097/NMD.0b013e3182124604; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; McCall WV, 2011, SLEEP, V34, P1149, DOI 10.5665/SLEEP.1222; Nye EC, 2007, MIL MED, V172, P1144; Oquendo MA, 2009, CRISIS, V30, P171, DOI 10.1027/0227-5910.30.4.171; Panagioti M, 2013, PSYCHIAT RES, V209, P55, DOI 10.1016/j.psychres.2013.02.018; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Rudd MD, 2012, MIL PSYCHOL, V24, P592, DOI 10.1080/08995605.2012.736325; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Tarrier N, 2004, SOC PSYCH PSYCH EPID, V39, P655, DOI 10.1007/s00127-004-0799-4; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Wilcox HC, 2009, ARCH GEN PSYCHIAT, V66, P305, DOI 10.1001/archgenpsychiatry.2008.557; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	34	16	16	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	MAY	2015	7	3					277	285		10.1037/tra0000026			9	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CH8YS	WOS:000354323400010	25793399	Bronze			2021-06-18	
J	Losoi, H; Waljas, M; Turunen, S; Brander, A; Helminen, M; Luoto, TM; Rosti-Otajarvi, E; Julkunen, J; Ohman, J				Losoi, Heidi; Waljas, Minna; Turunen, Senni; Brander, Antti; Helminen, Mika; Luoto, Teemu M.; Rosti-Otajarvi, Eija; Julkunen, Juhani; Ohman, Juha			Resilience Is Associated With Fatigue After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depressive symptoms; fatigue; head injury; insomnia; pain; resilience; traumatic brain injury	SLEEP DISTURBANCE; CHRONIC PAIN; SEVERITY; RELIABILITY; GUIDELINES; RECOVERY; SCALE	Objective: To examine resilience as a predictor of change in self-reported fatigue after mild traumatic brain injury (MTBI). Participants: A consecutive series of 67 patients with MTBI and 34 orthopedic controls. Design: Prospective longitudinal study. Main Measures: Resilience Scale, Beck Depression Inventory-Second Edition, and Pain subscale from Ruff Neurobehavioral Inventory 1 month after injury and Barrow Neurological Institute Fatigue Scale 1 and 6 months after injury. Results: Insomnia, pain, and depressive symptoms were significantly correlated with fatigue, but even when these variables were controlled for, resilience significantly predicted the change in fatigue from 1 to 6 months after MTBI. In patients with MTBI, the correlation between resilience and fatigue strengthened during follow-up. In controls, significant associations between resilience and fatigue were not found. Conclusion: Resilience is a significant predictor of decrease in self-reported fatigue following MTBI. Resilience seems to be a relevant factor to consider in the management of fatigue after MTBI along with the previously established associated factors (insomnia, pain, and depressive symptoms).	[Losoi, Heidi; Waljas, Minna; Turunen, Senni; Luoto, Teemu M.; Rosti-Otajarvi, Eija; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Brander, Antti] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, FI-33521 Tampere, Finland; [Losoi, Heidi; Julkunen, Juhani] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Helminen, Mika] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Helminen, Mika] Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland	Losoi, H (corresponding author), Tampere Univ Hosp, POB 2000, FI-33521 Tampere, Finland.	heidi.losoi@pshp.fi	Helminen, Mika T/I-3900-2016; Luoto, Teemu/W-6468-2018	Helminen, Mika T/0000-0001-5695-2084; Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367			Abiola Tajudeen, 2011, BMC Res Notes, V4, P509, DOI 10.1186/1756-0500-4-509; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Beck AT., 1996, BECK DEPRESSION INVE, V2; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Earvolino-Ramirez M, 2007, NURS FORUM, V42, P73, DOI 10.1111/j.1744-6198.2007.00070.x; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Heilemann MarySue V, 2003, J Nurs Meas, V11, P61, DOI 10.1891/106137403780954976; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Humphreys Janice, 2003, Issues Ment Health Nurs, V24, P137, DOI 10.1080/01612840305293; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Losoi H., 2013, PSYCHOL COMMUN HLTH, V2, P1, DOI [10.5964/pch.v2i1.40, DOI 10.5964/PCH.V2I1.40, 10.23668/psycharchives.2244, DOI 10.23668/PSYCHARCHIVES.2244]; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Maestas KL, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0b013e31828654b4; Mak WWS, 2011, J COUNS PSYCHOL, V58, P610, DOI 10.1037/a0025195; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Nishi Daisuke, 2010, BMC Res Notes, V3, P310, DOI 10.1186/1756-0500-3-310; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Robottom BJ, 2012, PARKINSONISM RELAT D, V18, P174, DOI 10.1016/j.parkreldis.2011.09.021; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Wagnild G, 2009, RESILIENCE SCALE USE; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild Gail, 2003, J Gerontol Nurs, V29, P42; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	47	16	17	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E24	E32		10.1097/HTR.0000000000000055			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100003	24842587				2021-06-18	
J	Love, S; Solomon, GS				Love, Shawn; Solomon, Gary S.			Talking With Parents of High School Football Players About Chronic Traumatic Encephalopathy A Concise Summary	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						chronic traumatic encephalopathy; concussion; traumatic brain injury; sports; football	LEAGUE PLAYERS; ALZHEIMERS-DISEASE; INJURY; DEPRESSION; SPORT; RISK; TAU; CONCUSSION; MORTALITY; SUICIDE	Over the past decade, athletic-related chronic traumatic encephalopathy (CTE) has garnered a great deal of attention in the popular press and, more recently, in the scientific press. With increasing frequency, sports medicine practitioners and providers are faced with questions from the parents of high school football players about CTE and the risk posed to children who participate in this or other contact or collision sports. The purpose of this review was to summarize the research on CTE in an attempt to provide some evidence-based answers to frequently asked questions in clinics from parents. Addressed are (1) the definitions of CTE and its symptoms, (2) the evidence for CTE in football, (3) abnormal tau protein, (4) the use of neuroimaging in CTE diagnosis, (5) risk for CTE, (6) CTE diagnosis in youth, (7) CTE and its relationship to suicide, and (8) contact and collision sports as a risk factor for permanent brain injury or death.	[Love, Shawn; Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Solomon, GS (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Neurosurg Clin, 1500 21st Ave South,Suite 1506, Nashville, TN 37232 USA.	gary.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019; Meijer, Anna/K-5118-2016		Nashville Predators; Tennessee Titans	One or more of the authors has declared the following potential conflict of interest or source of funding: G.S.S. receives consulting fees for clinical services from the Nashville Predators and the Tennessee Titans, receives royalties from book sales, and is a member of the Professional Advisory Board of ImPACT, for which he receives expense reimbursement for meeting attendance.	Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Braak H, 2012, ALZHEIMERS DEMENT, V8, P227, DOI 10.1016/j.jalz.2012.01.011; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Irwin Broh Research, 2013, SPORTS PART US, V2013; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Lavretsky H, 2009, AM J GERIAT PSYCHIAT, V17, P493, DOI 10.1097/JGP.0b013e3181953b82; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McKee A, 2012, BRAIN, V135, P1; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Federation of State High School Associations, PART STAT; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rockett IR, 2012, AM J PUBLIC HEALTH, V102, P84; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Small GW, 2012, ARCH NEUROL-CHICAGO, V69, P215, DOI 10.1001/archneurol.2011.559; Weir D. R., 2009, STUDY RETIRED NFL PL	32	16	16	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2015	43	5					1260	1264		10.1177/0363546514535187			5	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CH4CV	WOS:000353980000036	24907288				2021-06-18	
J	Neumann, D; Malec, JF; Hammond, FM				Neumann, Dawn; Malec, James F.; Hammond, Flora M.			The Association of Negative Attributions With Irritation and Anger After Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						irritation; anger; aggression; attribution styles; social cognition; traumatic brain injury	EPISODIC DISORDERS; AGGRESSION; BEHAVIOR; MANAGEMENT; VALIDITY; PERSONALITY; SURVIVORS; MARRIAGE; EMOTION; SYSTEM	Objectives: Study objectives were to examine associations of irritation and anger with negative attributions, and associations of negative attributions with trait aggression in participants with traumatic brain injury (TBI). Participants: Forty-eight participants with moderate to severe TBI participated in this study. Participants were primarily male (68.8%), and on average, approximately 5 years postinjury. Design: Prospective study using a quasi-experimental design. Main measures: Participants were presented with 21 vignettes that hypothetically led to negative consequences for the participant. Stories portrayed characters' actions as benign, ambiguous, or hostile. After each vignette, participants rated how irritated and angry they would be, and how intentional, hostile, and blameworthy they perceived the characters' actions. Participants' trait aggression was evaluated with the aggression questionnaire. Results: Irritation and anger ratings were strongly correlated with intent, hostility, and blame ratings of the character (p<.001). Trait aggression was significantly associated with attributions of intent, hostility, and blame (p<.001). Conclusion: These preliminary findings suggest that irritation and anger after TBI may be linked to the negative attributions they make about others' behaviors. Findings further indicate a relationship between negative attributions and trait aggression. Thus, individuals with TBI who have higher trait aggression may have a tendency to make more negative attributions about others' behaviors, and in turn, have stronger feelings of irritation and anger as a response. Future studies with healthy controls and larger sample sizes are needed to build upon this clinically relevant topic.	[Neumann, Dawn; Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, Indianapolis, IN 46254 USA	Neumann, D (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu			National Institute on Disability and Rehabilitation Research (NIDRR) Switzer Research Fellowships Program Priority (CFDA) [84.133F-1]; Indiana Spinal Cord and Brain Injury Research Fund	This research was funded by the National Institute on Disability and Rehabilitation Research (NIDRR) Switzer Research Fellowships Program Priority (CFDA No. 84.133F-1) and the Indiana Spinal Cord and Brain Injury Research Fund. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated. The authors thank James Epps, PhD for permission to use his hypothetical scenarios, and Lyn Turkstra, PhD for her assistance in modifying the hypothetical scenarios to improve readability for participants with brain injury.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; An SK, 2010, SCHIZOPHR RES, V118, P54, DOI 10.1016/j.schres.2010.01.025; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bailey CA, 2008, J YOUTH ADOLESCENCE, V37, P713, DOI 10.1007/s10964-007-9211-5; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Brookshire RH, 1993, DISCOURSE COMPREHENS; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Combs Dennis R, 2007, Cogn Neuropsychiatry, V12, P128, DOI 10.1080/13546800600787854; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; EPPS J, 1995, COGNITIVE THER RES, V19, P159, DOI 10.1007/BF02229692; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FINCHAM FD, 1992, J PERS SOC PSYCHOL, V62, P457, DOI 10.1037/0022-3514.62.3.457; Greve KW, 2001, BRAIN INJURY, V15, P255; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Holtzworth-Munroe A, 2001, BEHAV THER, V31, P603; Holtzworth-Munroe A, 1996, Violence Vict, V11, P319; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kassinove H, 1995, Issues Compr Pediatr Nurs, V18, P173, DOI 10.3109/01460869509087270; KELLEY HH, 1980, ANNU REV PSYCHOL, V31, P457, DOI 10.1146/annurev.ps.31.020180.002325; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Palmer EJ, 2005, AGGRESSIVE BEHAV, V31, P56, DOI 10.1002/ab.20072; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Sanford K, 2005, J FAM PSYCHOL, V19, P180, DOI 10.1037/0893-3200.19.2.180; Scherer K., 2001, APPRAISAL PROCESSES, V92, P120, DOI DOI 10.1016/S0166-4115(08)62387-0; Smith CA, 2004, EMOTION, V4, P133, DOI 10.1037/1528-3542.4.2.133; Spielberger C.D., 1970, STATE TRAIT ANXIETY; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Vitale JE, 2005, AGGRESSIVE BEHAV, V31, P99, DOI 10.1002/ab.20050; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1080/09602010244000444, 10.1016/S0960-9822(02)01374-X]; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181	44	16	16	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2015	60	2					155	161		10.1037/rep0000036			7	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	CL5CG	WOS:000356976800007	26120741	Bronze			2021-06-18	
J	Parker, EM; Gilchrist, J; Schuster, D; Lee, R; Sarmiento, K				Parker, Erin M.; Gilchrist, Julie; Schuster, Dan; Lee, Robin; Sarmiento, Kelly			Reach and Knowledge Change Among Coaches and Other Participants of the Online Course: "Concussion in Sports: What You Need to Know"	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; brain concussion; coach; Heads Up; sports; TBI (traumatic brain injury); training programs	TRAUMATIC BRAIN-INJURIES; HIGH-SCHOOL; RECREATION ACTIVITIES; UNITED-STATES; RECOVERY; CHILDREN; HEADS	Objectives: To describe the reach of the Heads Up "Concussion in Sports: What You Need to Know," online course and to assess knowledge change. Setting: Online. Participants: Individuals who have taken the free online course since its inception in May 2010 to July 2013. Design: Descriptive, uncontrolled, before and after study design. Main Measures: Reach is measured by the number of unique participants and the number of times the course was completed by state and sport coached and the rate of participation per 100 000 population by state. Knowledge change is measured by the distribution and mean of pre- and posttest scores by sex, primary role (eg, coach, student, and parent), and sport coached. Results: Between May 2010 and July 2013, the online concussion course was completed 819 223 times, reaching 666 026 unique participants, including residents from all US states and the District of Columbia. The distribution of overall scores improved from pre- to posttests, with 21% answering all questions correctly on the pretest and 60% answering all questions correctly on the posttest. Conclusion: Online training can be effective in reaching large audiences and improving knowledge about emerging health and safety issues such as concussion awareness.	[Parker, Erin M.; Gilchrist, Julie; Lee, Robin; Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA; [Schuster, Dan] Natl Federat State High Sch Associat, Indianapolis, IN USA	Parker, EM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Hwy NE,MS F-62, Atlanta, GA 30341 USA.	eparker@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Centers for Disease Control and Prevention, 10 YEAR ANN VIEWB; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Faure CE, 2011, SPORT J, V37, P112; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hennekens C. H, 1987, EPIDEMIOLOGY MED, P243; Institute of Medicine (IOM) & National Research Council (NRC), 2013, SPORTS REL CONC YOUT; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Washington Interscholastic Activities Association, WIAA CONC MAN TRAIN	19	16	16	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					198	206		10.1097/HTR.0000000000000097			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100132	25955706	Green Accepted			2021-06-18	
J	Wu, SC; Chen, WTL; Lin, HH; Fu, CY; Wang, YC; Lo, HC; Cheng, HT; Tzeng, CW				Wu, Shih-Chi; Chen, William Tzu-Liang; Lin, Hui-Han; Fu, Chih-Yuan; Wang, Yu-Chun; Lo, Hung-Chieh; Cheng, Han-Tsung; Tzeng, Chia-Wei			Use of extracorporeal membrane oxygenation in severe traumatic lung injury with respiratory failure	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							RENAL REPLACEMENT THERAPY; LIFE-SUPPORT; DISTRESS-SYNDROME; ECMO; ARDS; INFLAMMATION; DEFINITION; EXPERIENCE; MODEL; SHOCK	Objectives: The use of extracorporeal membrane oxygenation (ECMO) in managing acute respiratory distress syndrome had been accepted. Severe lung injury with respiratory failure is often encountered in trauma patients. We report our experience with the use of ECMO in severe traumatic lung injury. Methods: Patients with severe traumatic lung injury that met the following criteria were candidates for ECMO: (1) severe hypoxemia, PaO2/fraction of inspired oxygen (1.0) less than 60, and positive end-expiratory pressure greater than 10 cm H2O in spite of vigorous ventilation strategy; (2) irreversible CO2 retention with unstable hemodynamics; and (3) an initial arterial PaO2/fraction of inspired oxygen (1.0) less than 60, where the pulmonary condition and hemodynamics rapidly deteriorated despite vigorous mechanical ventilation strategy. Results: Over 60 months, a total of 19 patients with severe traumatic lung injury who received ECMO management were retrospectively reviewed. The median age was 38 years (25-58 years), the median injury severity score was 29 (25-34), the median admission Acute Physiology and Chronic Health Evaluation II (APACHE II) score was 25 (21-36), and the median blood transfusion volume was 5500 mL (3500-13 000). There were 9 venovenous and 10 venoarterial types. The survival rate was 68.4% (13/19). The survivors were younger (30 vs 53 years; 21-39 vs 48-63). There were 6 mortalities (3 pneumonia, 2 coagulopathy, and 1 cardiac rupture with cardiac tamponade). There were 5 of 19 patients with pre-ECMO traumatic brain hemorrhage (3 survived and 2 mortalities). A total of 16 patients received heparinization with 5 mortalities. Conclusions: The use of ECMO may offer an additional treatment modality in severe traumatic lung injury with respiratory failure that is unresponsive to optimal conventional ventilator support. Timely ECMO intervention is of value. (C) 2015 Elsevier Inc. All rights reserved.	[Wu, Shih-Chi; Wang, Yu-Chun; Lo, Hung-Chieh; Cheng, Han-Tsung; Tzeng, Chia-Wei] China Med Univ Hosp, Trauma & Emergency Ctr, Taichung 404, Taiwan; [Wu, Shih-Chi; Chen, William Tzu-Liang; Wang, Yu-Chun; Lo, Hung-Chieh] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, William Tzu-Liang] China Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung 404, Taiwan; [Lin, Hui-Han] China Med Univ Hosp, Dept Cardiovasc Surg, Taichung 404, Taiwan; [Fu, Chih-Yuan] Chang Gung Mem Hosp, Dept Trauma & Emergency Surg, Linkou, Taiwan	Wu, SC (corresponding author), China Med Univ Hosp, Trauma & Emergency Ctr, 2 Yuh Der Rd, Taichung 404, Taiwan.	rw114@mail.cmuh.org.tw; wtchen@mail.cmuh.org.tw; d10760@mail.cmuh.org.tw; drfu5564@yahoo.com.tw; traumawang@yahoo.com.tw; carfishcat@yahoo.com.tw; howardcheng324@gmail.com; D11814@mail.cmuh.org.tw	Figlerowicz, Marek/B-9550-2015; Urbanowicz, Anna/C-9550-2016	Urbanowicz, Anna/0000-0002-6854-7737			Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Biderman P, 2013, J TRAUMA ACUTE CARE, V75, P907, DOI 10.1097/TA.0b013e3182a8334f; BOUMAN C, 2003, AC DIAL QUAL IN 2 IN; Brower RG, 2004, NEW ENGL J MED, V351, P327; Burns KEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014623; Checkley W, 2011, JAMA-J AM MED ASSOC, V306, P1703, DOI 10.1001/jama.2011.1504; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Field D, 1996, LANCET, V348, P75; Huang YK, 2009, RESUSCITATION, V80, P535, DOI 10.1016/j.resuscitation.2009.02.016; Keel M, 2007, CURR OPIN CRIT CARE, V13, P674, DOI 10.1097/MCC.0b013e3282f1fe71; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lewandowski K, 2000, CRIT CARE, V4, P156, DOI 10.1186/cc689; Liao Chien-Hung, 2008, J Trauma, V64, pE15, DOI 10.1097/01.ta.0000196342.61425.7e; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2011, ANAESTHESIST, V60, P647, DOI 10.1007/s00101-011-1872-5; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Ried M, 2013, CRIT CARE, V17, DOI 10.1186/cc12782; Rossaint R, 2006, SHOCK, V26, P322, DOI 10.1097/01.shk.0000225403.15722.e9; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shen JH, 2013, INFLAMMATION, V36, P1186, DOI 10.1007/s10753-013-9654-7; Shi JL, 2014, ARTIF ORGANS, V38, P215, DOI 10.1111/aor.12154; VASILYEV S, 1995, CHEST, V107, P1083, DOI 10.1378/chest.107.4.1083; Vecsei V, 2005, EUR J TRAUMA, V31, P239, DOI DOI 10.1007/s00068-005-2033-9; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Wolf MJ, 2013, ANN THORAC SURG, V96, P917, DOI 10.1016/j.athoracsur.2013.05.056; Yuan KC, 2008, J TRAUMA, V65, P1151, DOI 10.1097/01.ta.0000235492.09223.83	33	16	17	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2015	33	5					658	662		10.1016/j.ajem.2015.02.007			5	Emergency Medicine	Emergency Medicine	CH8MX	WOS:000354291600011	25722287				2021-06-18	
J	Kenborg, L; Rugbjerg, K; Lee, PC; Ravnskjaer, L; Christensen, J; Ritz, B; Lassen, CF				Kenborg, Line; Rugbjerg, Kathrine; Lee, Pei-Chen; Ravnskjaer, Line; Christensen, Jane; Ritz, Beate; Lassen, Christina F.			Head injury and risk for Parkinson disease Results from a Danish case-control study	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; METAANALYSIS; SMOKING; HUMANS	Objective:To examine the association between head injuries throughout life and the risk for Parkinson disease (PD) in an interview-based case-control study.Methods:We identified 1,705 patients diagnosed with PD at 10 neurologic centers in Denmark in 1996-2009 and verified their diagnoses in medical records. Patients were matched to 1,785 controls randomly selected from the Danish Central Population Register on sex and year of birth. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression.Results:We observed no association between any head injury before first cardinal symptom and PD (OR 1.02; 95% CI 0.88, 1.19). Examination of number of head injuries (1: OR 1.02; 95% CI 0.87, 1.20; 2: OR 1.03; 95% CI 0.72, 1.47) or hospitalization for a head injury (OR 0.89; 95% CI 0.70, 1.12) did not show an association with PD. For 954 study subjects with at least one head injury, there was no evidence of an association between loss of consciousness (OR 0.89; 95% CI 0.67, 1.17), duration of loss of consciousness (1 minute: OR 0.93; 95% CI 0.58, 1.49; 1-5 minutes: OR 0.74; 95% CI 0.51, 1.08; 5 minutes: OR 0.81; 95% CI 0.53, 1.24), or amnesia (OR 1.31; 95% CI 0.88, 1.95) and risk for PD. Application of a lag time of 10 years between head injury and first cardinal symptom resulted in similar risk estimates.Conclusions:The results do not support the hypothesis that head injury increases the risk for PD.	[Kenborg, Line; Rugbjerg, Kathrine; Ravnskjaer, Line; Christensen, Jane; Lassen, Christina F.] Danish Canc Soc, Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Lee, Pei-Chen; Ritz, Beate] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Ritz, Beate] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Lee, Pei-Chen] Natl Taipei Univ Nursing Hlth Sci, Coll Healthcare Adm & Management, Dept Hlth Care Management, Taipei, Taiwan; [Lassen, Christina F.] Bispebjerg Hosp, Dept Occupat & Environm Med, DK-2400 Copenhagen, Denmark	Kenborg, L (corresponding author), Danish Canc Soc, Danish Canc Soc Res Ctr, Copenhagen, Denmark.	kenborg@cancer.dk	Kenborg, Line/T-4122-2018; Ritz, Beate R/E-3043-2015; Rugbjerg, Kathrine/L-6531-2019	Kenborg, Line/0000-0002-3584-6570; Rugbjerg, Kathrine/0000-0001-7854-1075; , Pei-Chen/0000-0001-7813-0823	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01ES013717]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES013717] Funding Source: NIH RePORTER	Supported by grant R01ES013717 from the NIH.	BHARUCHA NE, 1986, NEUROLOGY, V36, P284, DOI 10.1212/WNL.36.2.284; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Dong JQ, 2003, BIOMED ENVIRON SCI, V16, P173; Fang F, 2012, MOVEMENT DISORD, V27, P1632, DOI 10.1002/mds.25143; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Lai BCL, 2002, PARKINSONISM RELAT D, V8, P297, DOI 10.1016/S1353-8020(01)00054-2; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MORANO A, 1994, ACTA NEUROL SCAND, V89, P164; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; *R FDN STAT COMP, 2001, R LANG ENV STAT COMP; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Spangenberg S, 2009, PARKINSONISM RELAT D, V15, P12, DOI 10.1016/j.parkreldis.2008.02.004; Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wright JM, 2005, ARCH ENVIRON HEALTH, V60, P32, DOI 10.3200/AEOH.60.1.32-38	25	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 17	2015	84	11					1098	1103		10.1212/WNL.0000000000001362			6	Clinical Neurology	Neurosciences & Neurology	CD9YU	WOS:000351458600011	25681453	Green Published			2021-06-18	
J	Evald, L				Evald, Lars			Prospective memory rehabilitation using smartphones in patients with TBI: What do participants report?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Smartphones; Assistive technology; Memory disorders; Rehabilitation; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; PEOPLE; AIDS	Use of assistive devices has been shown to be beneficial as a compensatory memory strategy among brain injury survivors, but little is known about possible advantages and disadvantages of the technology. As part of an intervention study participants were interviewed about their experiences with the use of low-cost, off-the-shelf, unmodified smartphones combined with Internet calendars as a compensatory memory strategy. Thirteen community-dwelling patients with traumatic brain injury (TBI) received a 6-week group-based instruction in the systematic use of a smartphone as a memory compensatory aid followed by a brief structured open-ended interview regarding satisfaction with and advantages and disadvantages of the compensatory strategy. Ten of 13 participants continued to use a smartphone as their primary compensatory strategy. Audible and visual reminders were the most frequently mentioned advantages of the smartphone, and, second, the capability as an all-in-one memory device. In contrast, battery life was the most often mentioned disadvantage, followed by concerns about loss or failure of the device. Use of a smartphone seems to be a satisfactory compensatory memory strategy to many patients with TBI and smartphones come with features that are advantageous to other compensatory strategies. However, some benefits come hand-in-hand with drawbacks, such as the feeling of dependency. These aspects should be taken into account when choosing assistive technology as a memory compensatory strategy.	[Evald, Lars] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Evald, Lars] Aarhus Univ, MINDLAB, CFIN, CNRU, Aarhus, Denmark; [Evald, Lars] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark	Evald, L (corresponding author), Hammel Neurorehabil & Res Ctr, Voldbyvej 15, DK-8450 Hammel, Denmark.	lars.evald@rm.dk	Evald, Lars/Q-4384-2019	Evald, Lars/0000-0001-6255-2562			Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; De Joode EA, 2013, NEUROPSYCHOL REHABIL, V23, P133, DOI 10.1080/09602011.2012.726632; Evald L., 2014, PROSPECTIVE ME UNPUB; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Scherer MJ, 2014, DISABIL REHABIL-ASSI, V9, P1, DOI 10.3109/17483107.2013.870239; Scherer MJ, 2002, DISABIL REHABIL, V24, P1, DOI 10.1080/09638280110066262; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Sundhedsstyrelsen s, 2011, MED TEKNOLOGIVURDERI, V13; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Waldron B., 2012, IRISH J PSYCHOL, V33, DOI [https://doi.org/10.1080/03033910.2012.659044, DOI 10.1080/03033910.2012.659044]; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161	17	16	16	1	31	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 4	2015	25	2					283	297		10.1080/09602011.2014.970557			15	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	AZ6BY	WOS:000348304600006	25333304				2021-06-18	
J	Chitsabesan, P; Lennox, C; Williams, H; Tariq, O; Shaw, J				Chitsabesan, Prathiba; Lennox, Charlotte; Williams, Huw; Tariq, Omar; Shaw, Jenny			Traumatic Brain Injury in Juvenile Offenders: Findings From the Comprehensive Health Assessment Tool Study and the Development of a Specialist Linkworker Service	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mental health needs; neurodevelopmental disorders; self-harm; service provision; traumatic brain injury	CONCUSSION SYMPTOMS QUESTIONNAIRE; MENTAL-DISORDERS; YOUNG OFFENDERS; PREVALENCE; PREDICTORS; DETENTION; CHILDREN; CUSTODY; YOUTH; NEEDS	Background: Young people in contact with the youth juvenile justice system have well-documented vulnerabilities including high rates of mental health and neurodevelopmental disorders. Studies have suggested that they may also be at increased risk of traumatic brain injury (TBI). Objective: (1) To describe the profile of a cohort of juvenile offenders with TBI and associated comorbidity with other neurodevelopmental disorders, mental health needs, and offending behavior. (2) To describe the development of a specialist brain injury service for juvenile offenders with TBI within custody. Methods: Ninety-three male participants aged 15 to 18 years were consecutively admitted to a custodial secure facility. They were evaluated using a range of different neurocognitive and mental health measures including the Rivermead Post-Concussion Symptoms Questionnaire and the Comprehensive Health Assessment Tool. Results: Eight-two percent of those interviewed reported experiencing at least 1 TBI, and 44% reported ongoing neuropsychological symptoms. Eighteen percent of those sustaining a TBI reported moderate-severe postconcussion symptoms. Conclusions: There is a high prevalence of TBI in juvenile offenders in custody, with many experiencing multiple episodes. This study highlights the need for further research in this area. An example of a specialist brain injury linkworker service is described as one example of a model of service delivery for this group.	[Chitsabesan, Prathiba; Lennox, Charlotte; Tariq, Omar; Shaw, Jenny] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Mental Hlth & Risk, Manchester, Lancs, England; [Chitsabesan, Prathiba] Pennine Care NHS Fdn Trust, Manchester M33 6RG, Lancs, England; [Williams, Huw] Univ Exeter, Ctr Clin Neuropsychol Res, Exeter, Devon, England	Chitsabesan, P (corresponding author), Pennine Care NHS Fdn Trust, Stepping Hill Hosp, Child & Family Serv, Tree House, Manchester M33 6RG, Lancs, England.	pchitsabesan@yahoo.com		shaw, jennifer/0000-0003-2569-7687; Lennox, Charlotte/0000-0001-9014-9965	Department of Health (England); Barrow Cadbury Trust; Disabilities Trust Foundation	Evaluation of the comprehensive health assessment tool was funded through a research grant from the Department of Health (England) and evaluation of the specialist brain injury linkworker service by a research grant from the Barrow Cadbury Trust. The linkworker service is a 2-year project primarily funded by the Disabilities Trust Foundation. The authors acknowledge the contribution of Deborah Fortescue, Professor Michael Oddy, Kate French, and Tansy Warrilow from the Disabilities Trust Foundation in developing the specialist brain injury linkworker service described.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Centre for Mental Health, 2010, YOU JUST GET DO IT H; Chitsabesan P, 2006, BRIT J PSYCHIAT, V188, P534, DOI 10.1192/bjp.bp.105.010116; Chitsabesan P, 2014, J FORENSIC PSYCHI PS, V25, P1, DOI 10.1080/14789949.2014.882387; Chitsabesan P, 2007, J CHILD SERV, V2, P4, DOI 10.1108/17466660200700032; Coughlan AK, 1986, ADULT MEMORY INFORM; Coughlan AK., 2007, BIRT MEMORY INFORM P; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; FARRINGTON DP, 2002, OXFORD HDB CRIMINOLO, P657; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2008, J AM ACAD CHILD PSY, V47, P1010, DOI [10.1097/CHI.0b013e31817eeef3, 10.1097/CHI.ObO13e31817eecf3]; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Giola G, 2013, BEHAV RATING INVENTO; Golzari M, 2006, J ADOLESCENT HEALTH, V38, P776, DOI 10.1016/j.jadohealth.2005.06.008; Harrington R., 2005, MENTAL HLTH NEEDS EF; Hughes N., 2012, NOBODY MADE CONNECTI; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux D, 1998, BRAIN INJURY, V12, P667; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Keenan HT, 2008, BMJ-BRIT MED J, V337, P1208; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lader D, 2000, PSYCHIAT MORBIDITY Y; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meltzer H, 2002, MENTAL HLTH YOUNG PE; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Offender Health Research Network, 2013, COMPR HLTH ASS TOOL; Office of the Children's Commissioner, 2011, I THINK I MUST HAV B; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Putnins AL, 2005, INT J OFFENDER THER, V49, P143, DOI 10.1177/0306624X04269412; Royal College of Paediatrics and Child Health, 2013, HEALTHC STAND CHILDR; Ruchkin VV, 2003, J CHILD PSYCHOL PSYC, V44, P1058, DOI 10.1111/1469-7610.00190; Secord, 1989, TEST LANGUAGE COMPET; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; The Disabilities Foundation, PRIS LINKW SERV; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Vizard E, 2012, PARL SEM NEUR CHILDR; Wechsler D., 1991, WECHSLER INTELLIGENC; Williams H., 2012, REPAIRING SHATTERED; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	44	16	16	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					106	115		10.1097/HTR.0000000000000129			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300013	25734841				2021-06-18	
J	Ross, DE; Ochs, AL; DeSmit, ME; Seabaugh, JM; Havranek, MD				Ross, David E.; Ochs, Alfred L.; DeSmit, Megan E.; Seabaugh, Jan M.; Havranek, Michael D.		Alzheimer's Disease Neuroimaging	Man Versus Machine Part 2: Comparison of Radiologists' Interpretations and NeuroQuant Measures of Brain Asymmetry and Progressive Atrophy in Patients With Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							NEUROIMAGING INITIATIVE ADNI; MRI; VOLUMETRY	This study is an expanded version of an earlier study, which compared NeuroQuant measures of MRI brain volume with the radiologist's traditional approach in outpatients with mild or moderate traumatic brain injury. NeuroQuant volumetric analyses were compared with the radiologists' interpretations. NeuroQuant found significantly higher rates of atrophy (50.0%), abnormal asymmetry (83.3%), and progressive atrophy (70.0%) than the radiologists (12.5%, 0% and 0%, respectively). Overall, NeuroQuant wasmore sensitive for detecting at least one sign of atrophy, abnormal asymmetry, or progressive atrophy (95.8%) than the traditional radiologist's approach (12.5%).	[Ross, David E.; Ochs, Alfred L.; DeSmit, Megan E.; Seabaugh, Jan M.] Virginia Inst Neuropsychiat, Midlothian, VA 23114 USA; [Ross, David E.; Ochs, Alfred L.] Virginia Commonwealth Univ, Richmond, VA USA; [Havranek, Michael D.] Amicus Visual Solut, Richmond, VA USA	Ross, DE (corresponding author), Virginia Inst Neuropsychiat, Midlothian, VA 23114 USA.	DRoss@VaNeuropsychiatry.org		Ochs, Alfred/0000-0003-3932-876X	Virginia Institute of Neuropsychiatry; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG010129, K01 AG030514]; Dana Foundation; AbbottAbbott Laboratories; AstraZeneca ABAstraZeneca; Bayer Schering Pharma AGBayer AG; Bristol-Myers SquibbBristol-Myers Squibb; Eisai Global Clinical DevelopmentEisai Co Ltd; Elan Corporation; GenentechRoche HoldingGenentech; GE HealthcareGE Healthcare; GlaxoSmithKlineGlaxoSmithKline; Innogenetics; Johnson and JohnsonJohnson & JohnsonJohnson & Johnson USA; Eli Lilly and Co.Eli Lilly; Medpace, Inc.; Merck and Co., Inc.Merck & Company; Novartis AG; Pfizer IncPfizer; F. Hoffman-La Roche; Schering-PloughMerck & CompanySchering Plough Corporation; Synarc, Inc.; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG024904] Funding Source: NIH RePORTER	Supported internally by the Virginia Institute of Neuropsychiatry.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation.	Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.3233/BEN-2009-0226, 10.1155/2009/616581]; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miyahira Yoshinao, 2004, Seishin Shinkeigaku Zasshi, V106, P138; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Raz N, 2007, ANN NY ACAD SCI, V1097, P84, DOI 10.1196/annals.1379.018; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Talairach J., 1988, COPLANAR STEREOTAXIC; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007	14	16	16	0	2	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2015	27	2					147	152		10.1176/appi.neuropsych.13040088			6	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CJ1NM	WOS:000355250300111	25923853				2021-06-18	
J	Teng, SX; Katz, PS; Maxi, JK; Mayeux, JP; Gilpin, NW; Molina, PE				Teng, Sophie X.; Katz, Paige S.; Maxi, John K.; Mayeux, Jacques P.; Gilpin, Nicholas W.; Molina, Patricia E.			Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Alcohol; Neuroinflammation; Neurobehavior	MOBILITY GROUP BOX-1; INTERMITTENT ETHANOL EXPOSURE; FIBRILLARY ACIDIC PROTEIN; TOLL-LIKE RECEPTORS; OF-THE-LITERATURE; RECOGNITION MEMORY; DRUG-USE; MICROGLIAL ACTIVATION; PROFESSIONAL FOOTBALL; ALZHEIMERS-DISEASE	Traumatic brain injury (TBI) represents a leading cause of morbidity and mortality among young individuals. Alcohol abuse is a risk factor associated with increased TBI incidence. In addition, up to 26% of TBI patients engage in alcohol consumption after TBI. Limited preclinical studies have examined the impact of post-injury alcohol exposure on TBI recovery. The aim of this study was to determine the isolated and combined effects of TBI and alcohol on cognitive, behavioral, and physical recovery, as well as on associated neuroinflammatory changes. Male Sprague-Dawley rats (similar to 300 g) were subjected to a mild focal TBI by lateral fluid percussion (similar to 30 PSI, similar to 25 ms) under isoflurane anesthesia. On day 4 after TBI, animals were exposed to either sub-chronic intermittent alcohol vapor (95% ethanol 14 h on/10 h off; BAL similar to 200 mg/dL) or room air for 10 days. TBI induced neurological dysfunction reflected by an increased neurological severity score (NSS) showed progressive improvement in injured animals exposed to room air (TBI/air). In contrast, TBI animals exposed to alcohol vapor (TBI/alcohol) showed impaired NSS recovery throughout the 10-day period of alcohol exposure. Open-field exploration test revealed an increased anxiety-like behavior in TBI/alcohol group compared to TBI/air group. Additionally, alcohol-exposed animals showed decreased locomotion and impaired novel object recognition. Immunofluorescence showed enhanced reactive astrocytes, microglial activation, and HMGB1 expression localized to the injured cortex of TBI/alcohol as compared to TBI/air animals. The expression of neuroinflammatory markers showed significant positive correlation with NSS. These findings indicated a close relationship between accentuated neuroinflammation and impaired neurological recovery from post-TBI alcohol exposure. The clinical implications of long-term consequences in TBI patients exposed to alcohol during recovery warrant further investigation. (C) 2014 Elsevier Inc. All rights reserved.	[Molina, Patricia E.] Louisiana State Univ, Dept Physiol, Hlth Sci Ctr, New Orleans, LA 70112 USA; Louisiana State Univ, Alcohol & Drug Abuse Ctr Excellence, Hlth Sci Ctr, New Orleans, LA 70112 USA	Molina, PE (corresponding author), Louisiana State Univ, Dept Physiol, Alcohol & Drug Abuse Ctr Excellence, Hlth Sci Ctr, 1901 Perdido St Rm 7212, New Orleans, LA 70112 USA.	pmolin@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021; Gilpin, Nicholas/V-1266-2019	Molina, Patricia E./0000-0002-3598-384X; 	 [NIAAA-AA7577];  [AA018400];  [F30AA022838];  [LEQSF-EPS(2012)-PFUND-283]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K99AA018400, R00AA018400, T32AA007577, F30AA022838, R25AA021304] Funding Source: NIH RePORTER	This research was supported by grants NIAAA-AA7577, AA018400, F30AA022838, and LEQSF-EPS(2012)-PFUND-283.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Adams ZW, 2012, ADDICT BEHAV, V37, P848, DOI 10.1016/j.addbeh.2012.03.016; Alikunju S, 2011, BRAIN BEHAV IMMUN, V25, pS129, DOI 10.1016/j.bbi.2011.01.007; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asavarut Paladd, 2013, Acta Anaesthesiol Taiwan, V51, P28, DOI 10.1016/j.aat.2013.03.007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Baxter MG, 2010, BEHAV NEUROSCI, V124, P706, DOI 10.1037/a0021029; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Boyko M, 2011, BEHAV BRAIN RES, V223, P17, DOI 10.1016/j.bbr.2011.03.019; Briones TL, 2013, NEUROSCIENCE, V254, P324, DOI 10.1016/j.neuroscience.2013.09.031; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Clark RE, 2000, J NEUROSCI, V20, P8853; Crews FT, 2013, BIOL PSYCHIAT, V73, P602, DOI 10.1016/j.biopsych.2012.09.030; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Franke H, 1997, ALCOHOL, V14, P445, DOI 10.1016/S0741-8329(96)00209-1; FREUND G, 1969, ARCH NEUROL-CHICAGO, V21, P315, DOI 10.1001/archneur.1969.00480150105013; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gilpin NW, 2008, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0929s44, DOI 10.1002/0471142301.NS0929S44]; Gonca S, 2005, CELL BIOL INT, V29, P169, DOI 10.1016/j.cellbi.2004.11.020; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hayakawa Kazuhide, 2013, Acta Neurochir Suppl, V118, P31, DOI 10.1007/978-3-7091-1434-6_5; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karlsson S, 2008, INTENS CARE MED, V34, P1046, DOI 10.1007/s00134-008-1032-9; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Ling G.S, 2004, CURR PROTOC NEUROSCI, V2; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luan ZG, 2010, IMMUNOBIOLOGY, V215, P956, DOI 10.1016/j.imbio.2009.11.001; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; NAKASHIMA MN, 1995, CELL MOL NEUROBIOL, V15, P341, DOI 10.1007/BF02089944; Niranjan R, 2013, MOL NEUROBIOL, V48, P412, DOI 10.1007/s12035-013-8428-4; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Oscar-Berman M, 2012, NEUROPSYCHOL REV, V22, P154, DOI 10.1007/s11065-012-9198-x; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Riikonen J, 2002, ALCOHOL ALCOHOLISM, V37, P421, DOI 10.1093/alcalc/37.5.421; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Ruiz SM, 2013, ALCOHOL CLIN EXP RES, V37, P110, DOI 10.1111/j.1530-0277.2012.01862.x; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Whitaker AM, 2011, AM J PHYSIOL-REG I, V301, pR1529, DOI 10.1152/ajpregu.00035.2011; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang Qing-Wu, 2010, Front Biosci (Schol Ed), V2, P1081; Yang QW, 2010, J CEREBR BLOOD F MET, V30, P243, DOI 10.1038/jcbfm.2009.202; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	109	16	18	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2015	45						145	156		10.1016/j.bbi.2014.11.006			12	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	CC7BX	WOS:000350523800016	25489880	Green Accepted			2021-06-18	
J	Cartwright, C; Igbaseimokumo, U				Cartwright, Cathy; Igbaseimokumo, Usiakimi			Lumbar Puncture Opening Pressure Is Not a Reliable Measure of Intracranial Pressure in Children	JOURNAL OF CHILD NEUROLOGY			English	Article						lumbar puncture; Camino((R)) bolt; intracranial pressure	TRAUMATIC BRAIN-INJURY; HYPERTENSION; SIGNALS	There is very little data correlating lumbar puncture pressures to formal intracranial pressure monitoring despite the widespread use of both procedures. The hypothesis was that lumbar puncture is a single-point measurement and hence it may not be a reliable evaluation of intracranial pressure. The study was therefore carried out to compare lumbar puncture opening pressures with the Camino((R)) bolt intracranial pressure monitor in children. Twelve children with a mean age of 8.5 years who had both lumbar puncture and intracranial pressure monitoring were analyzed. The mean lumbar puncture opening pressure was 22.4 mm Hg versus a mean Camino bolt intracranial pressure of 7.8 mm Hg (P < .0001). Lumbar puncture therefore significantly overestimates the intracranial pressure in children. There were no complications from the intracranial pressure monitoring, and the procedure changed the treatment of all 12 children avoiding invasive operative procedures in most of the patients.	[Cartwright, Cathy; Igbaseimokumo, Usiakimi] Childrens Mercy Hosp, Div Neurosurg, Kansas City, MO 64108 USA	Igbaseimokumo, U (corresponding author), Childrens Mercy Hosp, Div Neurosurg, 2401 Gillham Rd, Kansas City, MO 64108 USA.	usiakimi@gmail.com					Baird LC, 2012, CHILD NERV SYST, V28, P411, DOI 10.1007/s00381-011-1615-6; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Eide PK, 2006, MED ENG PHYS, V28, P542, DOI 10.1016/j.medengphy.2005.09.003; Eide PK, 2005, PEDIATR NEUROSURG, V41, P122, DOI 10.1159/000085868; Eidlitz-Markus T, 2005, PEDIATR ANESTH, V15, P1078, DOI 10.1111/j.1460-9592.2005.01675.x; Ellis JA, 2012, J NEUROSURG-PEDIATR, V10, P14, DOI 10.3171/2012.3.PEDS11228; Horton JC, 2011, J NEURO-OPHTHALMOL, V31, P199, DOI 10.1097/WNO.0b013e31822b5aec; Hughes A, 2013, BMJ CASE REP, V2013; Inagaki T, 2007, CHILD NERV SYST, V23, P1455, DOI 10.1007/s00381-007-0436-0; Kapadia FN, 1996, BRIT J NEUROSURG, V10, P585; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Larsen G Y, 1999, Pediatr Rev, V20, P234, DOI 10.1542/pir.20-7-234; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Seruya M, 2011, J NEUROSURG-PEDIATR, V8, P40, DOI 10.3171/2011.4.PEDS1160; Tataryn Z, 2013, CHILD NERV SYST, V29, P2127, DOI 10.1007/s00381-013-2167-8; Warden KF, 2011, J NEURO-OPHTHALMOL, V31, P202, DOI 10.1097/WNO.0b013e3182183c8d; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x	20	16	16	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	FEB	2015	30	2					170	173		10.1177/0883073814533006			4	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CA9CY	WOS:000349219200004	24799366				2021-06-18	
J	Cull, JD; Sakai, LM; Sabir, I; Johnson, B; Tully, A; Nagy, K; Dennis, A; Starr, FL; Joseph, K; Wiley, D; Moore, HR; Oliphant, UJ; Bokhari, F				Cull, John David; Sakai, Lauren M.; Sabir, Imran; Johnson, Brent; Tully, Andrew; Nagy, Kimberly; Dennis, Andrew; Starr, Frederic L.; Joseph, Kimberly; Wiley, Dorion; Moore, Henry R., III; Oliphant, Uretz J.; Bokhari, Faran			Outcomes in Traumatic Brain Injury for Patients Presenting on Antiplatelet Therapy	AMERICAN SURGEON			English	Article							ELDERLY-PATIENTS; HEAD-INJURY; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; OLDER; ANTICOAGULATION; MANAGEMENT; MORTALITY; AGENTS; IMPACT	An increasing number of patients are presenting to trauma units with head injuries on antiplatelet therapy (APT). The influence of APT on these patients is poorly defined. This study examines the outcomes of patients on APT presenting to the hospital with blunt head trauma (BHT). Registries of two Level I trauma centers were reviewed for patients older than 40 years of age from January 2008 to December 2011 with BHT. Patients on APT were compared with control subjects. Primary outcome measures were in-hospital mortality, intracranial hemorrhage (ICH), and need for neurosurgical intervention (NI). Hospital length of stay (LOS) was a secondary outcome measure. Multivariate analysis was used and adjusted models included antiplatelet status, age, Injury Severity Score (ISS), and Glasgow coma scale (GCS). Patients meeting inclusion criteria and having complete data (n = 1547) were included in the analysis; 422 (27%) patients were taking APT. Rates of ICH, NI, and in-hospital mortality of patients with BHT in our study were 45.4, 3.1, and 5.8 per cent, respectively. Controlling for age, ISS, and GCS, there was no significant difference in ICH (odds ratio [OR], 0.84; 95% confidence interval [CI], 0.61 to 1.16), NI (OR, 1.26; 95% CI, 0.60 to 2.67), or mortality (OR, 1.79; 95% CI, 0.89 to 3.59) associated with APT. Subgroup analysis revealed that patients with ISS 20 or greater on APT had increased in-hospital mortality (OR, 2.34; 95% CI, 1.03 to 5.31). LOS greater than 14 days was more likely in the APT group than those in the non-APT group (OR, 1.85; 95% CI, 1.09 to 3.12). The effects of antiplatelet therapy in patients with BHT aged 40 years and older showed no difference in ICH, NI, and in-hospital mortality.	[Cull, John David; Sabir, Imran; Johnson, Brent; Tully, Andrew; Nagy, Kimberly; Dennis, Andrew; Starr, Frederic L.; Joseph, Kimberly; Wiley, Dorion; Bokhari, Faran] John H Stroger Hosp, Surg, Chicago, IL 60612 USA; [Sakai, Lauren M.; Moore, Henry R., III; Oliphant, Uretz J.] Carle Fdn Hosp, Dept Surg, Urbana, IL USA	Cull, JD (corresponding author), John H Stroger Hosp, Surg, 1969 W Ogden Ave, Chicago, IL 60612 USA.	jcull@cookcountyhhs.org					Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Dauerman HL, 2010, AM HEART J, V159, P508, DOI 10.1016/j.ahj.2010.01.010; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; HUYEN T, 2004, JAMA-J AM MED ASSOC, V292, P1867; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	17	16	16	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2015	81	2					128	132					5	Surgery	Surgery	CI6TK	WOS:000354894700023	25642873				2021-06-18	
J	Donnelly, J; Czosnyka, M; Sudhan, N; Varsos, GV; Nasr, N; Jalloh, I; Liu, XY; Dias, C; Sekhon, MS; Carpenter, KLH; Menon, DK; Hutchinson, PJ; Smielewski, P				Donnelly, Joseph; Czosnyka, Marek; Sudhan, Nazneen; Varsos, Georgios V.; Nasr, Nathalie; Jalloh, Ibrahim; Liu, Xiuyun; Dias, Celeste; Sekhon, Mypinder S.; Carpenter, Keri L. H.; Menon, David K.; Hutchinson, Peter J.; Smielewski, Peter			Increased Blood Glucose is Related to Disturbed Cerebrovascular Pressure Reactivity After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Glucose; Cerebral haemodynamics; Pressure reactivity; Vascular function; ICP; Traumatic brain injury	HEAD-INJURY; CEREBRAL METABOLISM; HYPERGLYCEMIA; FLOW; ISCHEMIA; TRIAL	Increased blood glucose and impaired pressure reactivity (PRx) after traumatic brain injury (TBI) are both known to correlate with unfavorable patient outcome. However, the relationship between these two variables is unknown. To test the hypothesis that increased blood glucose leads to increased PRx, we retrospectively analyzed data from 86 traumatic brain injured patients admitted to the Neurocritical Care Unit. Data analyzed included arterial glucose concentration, intracranial pressure (ICP), cerebral perfusion pressure (CPP) and end-tidal CO2. PRx was calculated as the moving correlation coefficient between averaged (10 seconds) arterial blood pressure and ICP. One arterial glucose concentration and one time-aligned PRx value were obtained for each patient, during each day until the fifth day after ictus. Mean arterial glucose concentrations during the first 5 days since ictus were positively correlated with mean PRx (Pearson correlation coefficient = 0.25, p = 0.02). The correlation was strongest on the first day after injury (Pearson correlation coefficient = 0.47, p = 0.008). Our preliminary findings indicate that increased blood glucose may impair cerebrovascular reactivity, potentially contributing to a mechanistic link between increased blood glucose and poorer outcome after TBI.	[Donnelly, Joseph; Czosnyka, Marek; Varsos, Georgios V.; Nasr, Nathalie; Jalloh, Ibrahim; Liu, Xiuyun; Carpenter, Keri L. H.; Hutchinson, Peter J.; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Sudhan, Nazneen; Sekhon, Mypinder S.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Dept Anaesthesia, Cambridge CB2 0QQ, England; [Nasr, Nathalie] Univ Toulouse 3, Hop Rangueil, Serv Neurol Vasc, INSERM,U1048,Team Toulouse 11 I2MC, F-31062 Toulouse, France; [Dias, Celeste] Hosp Sao Joao, Dept Intens Care, Neurocrit Care Unit, Oporto, Portugal; [Sekhon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada	Donnelly, J (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus,Box 167, Cambridge CB2 0QQ, England.	jd634@cam.ac.uk	Dias, Celeste/AAD-8711-2019; NASR, NATHALIE/K-3521-2019; Donnelly, Joseph/N-6803-2019; Dias, Celeste/AAV-3820-2020; Liu, Xiuyun/V-4427-2017; Donnelly, Joseph/E-9235-2018; Dias, Celeste/L-9901-2014	Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; Liu, Xiuyun/0000-0001-9540-4865; Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; czosnyka, marek/0000-0003-2446-8006; Smielewski, Peter/0000-0001-5096-3938; Carpenter, Keri/0000-0001-8236-7727; Hutchinson, Peter/0000-0002-2796-1835	Woolf Fisher scholarship; A. G. Leventis Foundation Scholarship; St Edmund's College, Cambridge; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Biomedical Research Centre, Cambridge (Brain Injury and Repair Theme); NIHR Biomedical Research Centre in Cambridge, UK; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000183B, G0600986, G9439390, G0001237, G0001354B, G1002277, G0001354] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, NF-SI-0508-10327, NF-SI-0512-10090] Funding Source: researchfish	We express our thanks to the whole NCCU team, the patients, and their families. JD is supported by a Woolf Fisher scholarship. GVV is supported by an A. G. Leventis Foundation Scholarship and a Charter Studentship from St Edmund's College, Cambridge. PJH is supported by an NIHR Research Professorship, the NIHR Cambridge Biomedical Research Centre and has been appointed as the Surgical Specialty Lead for Neurosurgery, Royal College of Surgeons of England Clinical Research Initiative. KLHC is supported by the NIHR Biomedical Research Centre, Cambridge (Brain Injury and Repair Theme). MC is supported by NIHR Biomedical Research Centre in Cambridge, UK.	Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1997, NEUROSURGERY, V41, P17; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; DUCKROW RB, 1985, ANN NEUROL, V17, P267, DOI 10.1002/ana.410170308; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Kawai N, 1997, STROKE, V28, P149, DOI 10.1161/01.STR.28.1.149; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LASSEN NA, 1964, CIRC RES, V15, P201; Lott MEJ, 2007, AM J PHYSIOL-HEART C, V292, pH304, DOI 10.1152/ajpheart.00940.2005; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; PENTELENYI T, 1977, INJURY, V8, P264, DOI 10.1016/0020-1383(77)90099-7; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Title LM, 2000, J AM COLL CARDIOL, V36, P2185, DOI 10.1016/S0735-1097(00)00980-3; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Ward ME, 2002, ANESTHESIOLOGY, V97, P471, DOI 10.1097/00000542-200208000-00026; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YIP PK, 1991, NEUROLOGY, V41, P899, DOI 10.1212/WNL.41.6.899; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	25	16	17	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					20	25		10.1007/s12028-014-0042-4			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300004	25124103	Green Accepted			2021-06-18	
J	Gibson, TJ; Whitehead, C; Taylor, R; Sykes, O; Chancellor, NM; Limon, G				Gibson, Troy J.; Whitehead, Claire; Taylor, Rebecca; Sykes, Olivia; Chancellor, Natalie M.; Limon, Georgina			Pathophysiology of penetrating captive bolt stunning in Alpacas (Vicugna pacos)	MEAT SCIENCE			English	Article						Alpaca; Behaviour; Captive bolt; Stunning; Slaughter	HALOTHANE-ANESTHETIZED CALVES; BRAIN-FUNCTION; ELECTROENCEPHALOGRAPHIC RESPONSES; CONCUSSIVE METHODS; CATTLE SHOT; SLAUGHTER; SHEEP; FEASIBILITY; LIVESTOCK; POSITION	The aim of this study was to examine the behavioural and cranial/spinal responses of alpacas culled by captive bolt shooting and the resulting pathophysiology of captive bolt injury. Ninety-six alpacas were shot (103 shots) in a range of locations with a penetrating captive bolt gun (CBG). Ten (9.8%) alpacas were incompletely concussed following the first shot. No animals required more than two shots. Incorrectly placed shots accounted for all of the animals that displayed signs of sensibility. Damage to the thalamus, hypothalamus, midbrain, medulla, cerebellum, parietal and occipital lobes were significantly associated with decreasing odds of incomplete concussion. In conclusion, the study confirmed that CBG stunning can induce insensibility in alpacas and suggests that the top of the head (crown) position maximises damage to structures of the thalamus and brainstem. (C) 2014 The Authors. Published by Elsevier Ltd.	[Gibson, Troy J.; Taylor, Rebecca; Sykes, Olivia; Chancellor, Natalie M.; Limon, Georgina] Royal Vet Coll, Hatfield AL9 7TA, Herts, England; [Whitehead, Claire] Camelid Vet Serv, Reading RG8 7NU, Berks, England	Gibson, TJ (corresponding author), Royal Vet Coll, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	tgibson@rvc.ac.uk	Gibson, Troy/AAA-8687-2019	Gibson, Troy/0000-0002-1242-2695	Humane Slaughter Association Dorothy Sidley Memorial Award	The authors would like to thank Dr. NG Gregory for helpful discussion and comments on the early draft of the manuscript. This study was partly supported by a Humane Slaughter Association Dorothy Sidley Memorial Award.	Atkinson S, 2013, ANIM WELFARE, V22, P473, DOI 10.7120/09627286.22.4.473; BLACKMORE DK, 1982, MEAT SCI, V7, P19, DOI 10.1016/0309-1740(82)90094-8; BLACKMORE DK, 1979, VET REC, V105, P372, DOI 10.1136/vr.105.16.372; BLACKMORE DK, 1984, RES VET SCI, V37, P223, DOI 10.1016/S0034-5288(18)31909-X; Bonaci CG, 2011, MANAGEMENT OF TECHNOLOGICAL CHANGES, BOOK 2, P477; Cardellino R.C., 2009, P ADV ANIMAL BREEDIN, V18, P366; DALY CC, 1986, RES VET SCI, V41, P349, DOI 10.1016/S0034-5288(18)30628-3; DALY CC, 1989, RES VET SCI, V46, P406, DOI 10.1016/S0034-5288(18)31189-5; DALY CC, 1986, RES VET SCI, V41, P353, DOI 10.1016/S0034-5288(18)30629-5; DALY CC, 1987, BRIT VET J, V143, P574, DOI 10.1016/0007-1935(87)90049-2; Dembo J.A, 1894, JEWISH METHOD SLAUGH; Finnie JW, 2002, AUST VET J, V80, P67, DOI 10.1111/j.1751-0813.2002.tb12840.x; FRICKER C, 1981, FLEISCHWIRTSCHAFT, V61, P124; Fries R, 2012, ANIMAL, V6, P1124, DOI 10.1017/S1751731111002667; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2009, NEW ZEAL VET J, V57, P96, DOI 10.1080/00480169.2009.36885; Gibson TJ, 2009, NEW ZEAL VET J, V57, P90, DOI 10.1080/00480169.2009.36884; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Grandin T, 1998, APPL ANIM BEHAV SCI, V56, P121, DOI 10.1016/S0168-1591(97)00102-0; Grandin T, 2002, J AM VET MED ASSOC, V221, P1258, DOI 10.2460/javma.2002.221.1258; GRANDIN T, 1980, INT J STUD ANIM PROB, V1, P242; GRANDIN T, 1994, J AM VET MED ASSOC, V204, P1354; Gregory N., 2000, Journal of Applied Animal Welfare Science, V3, P215, DOI 10.1207/S15327604JAWS0303_3; Gregory N. G., 1990, Veterinary History, V6, P73; Gregory N. G., 2007, Animal welfare and meat production, P191, DOI 10.1079/9781845932152.0191; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Jabbar A., 2013, PARASITES VECTORS, V6; LAMBOOY E, 1981, VET REC, V109, P359, DOI 10.1136/vr.109.16.359; Limon G, 2012, ANIM WELFARE, V21, P3, DOI 10.7120/096272812X13353700593248; Limon G, 2010, MEAT SCI, V84, P352, DOI 10.1016/j.meatsci.2009.09.001; Limon G, 2009, MEAT SCI, V82, P405, DOI 10.1016/j.meatsci.2009.01.022; Svendsen O, 2008, VET REC, V162, P90, DOI 10.1136/vr.162.3.90; von Wenzlawowicz M, 2012, ANIM WELFARE, V21, P51, DOI 10.7120/096272812X13353700593527; Whitehead C, 2013, IN PRACTICE, V35, P317, DOI 10.1136/inp.f3641	34	16	17	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	FEB	2015	100						227	231		10.1016/j.meatsci.2014.10.022			5	Food Science & Technology	Food Science & Technology	AY7WC	WOS:000347765700032	25460130	Other Gold, Green Accepted			2021-06-18	
J	McMillan, TM; Laurie, M; Oddy, M; Menzies, M; Stewart, E; Wainman-Lefley, J				McMillan, Thomas M.; Laurie, Marie; Oddy, Michael; Menzies, Mark; Stewart, Elaine; Wainman-Lefley, Jessica			Head Injury and Mortality in the Homeless	JOURNAL OF NEUROTRAUMA			English	Article						mortality; head injuries; lifestyle; craniocerebral trauma; traumatic brain injury; homeless; death; brain injuries	TRAUMATIC BRAIN-INJURY; PREVALENCE; COHORT; ADULTS; HOSTEL; PEOPLE; CITY; MEN	Risk factors for head injury are also risk factors for becoming homeless but there is little research on this vulnerable group, who can be neglected by health services that specialize in acquired brain injury. This study investigates the prevalence of admissions to hospital with a head injury in the homeless and associations with later mortality. It compares homeless people with and without a record of hospitalized head injury (HHI) and the Glasgow population. Data were obtained from a U.K. National Health Service strategy to enhance care of the homeless. This included development and production of local registers of homeless people. In Glasgow, the initiative took place over a seven-year period (2004-2010) and comprised 40 general practitioner (family practice) services in the locality of 55 homeless hostels. The register was linked to hospital admissions with head injury recorded in Scottish Medical Records and to the General Register of Scotland, which records deaths. A total of 1590 homeless people was registered in general practitioner (family doctor) returns. The prevalence of admission to hospital with head injury in the homeless over a 30-year period (13.5%) was 5.4 times higher than in the Glasgow population. In the homeless with HHI, 33.6% died in the seven-year census period, compared with 13.9% in the homeless with no hospitalized HI (NHHI). The standardized mortality ratio for HHI (4.51) was more than twice that for NHHI (2.08). The standardized mortality ratio for HHI aged 15-34 (17.54) was particularly high. These findings suggest that HHI is common in the homeless relative to the general population and is a risk factor for late mortality in the homeless population.	[McMillan, Thomas M.; Stewart, Elaine; Wainman-Lefley, Jessica] Univ Glasgow, Coll Med, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland; [Laurie, Marie] Natl Hlth Serv Greater Glasgow & Clyde, Dept Publ Hlth, Glasgow, Lanark, Scotland; [Menzies, Mark] Natl Hlth Serv Greater Glasgow & Clyde, Dept Informat Serv, Glasgow, Lanark, Scotland; [Oddy, Michael] Disabil Trust Fdn, Burgess Hill, England	McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk			Disabilities Trust; Chief Scientist Office [CZG/2/397] Funding Source: researchfish	This study was part funded by The Disabilities Trust. No competing financial conflicts exist.	American Psychological Association, 2010, HELP PEOPL HOM ROL P; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Faul M., 2010, TRAUMATIC BRAIN US E; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang S. W., 2009, BMJ-BRIT MED J, V339, P1, DOI DOI 10.1136/bmj.b2651; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Masel De Witt D. S., 2010, J NEUROTRAUM, V27, P1529; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan T. M., 2014, J NEUROL NEUROSURG P; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; Nordentoft M., 2003, BMJ-BRIT MED J, V327, P1; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Roworth M. A., 1988, COMMUNITY MED, V4, P327; *SCOTT EX, 2006, SCOTT IND MULT DEPR; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; SUSSER E, 1993, EPIDEMIOL REV, V15, P546, DOI 10.1093/oxfordjournals.epirev.a036133; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631	22	16	16	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2015	32	2					116	119		10.1089/neu.2014.3387			4	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AY6QM	WOS:000347690700006	25010750				2021-06-18	
J	Vera-Estay, E; Dooley, JJ; Beauchamp, MH				Vera-Estay, E.; Dooley, J. J.; Beauchamp, M. H.			Cognitive underpinnings of moral reasoning in adolescence: The contribution of executive functions	JOURNAL OF MORAL EDUCATION			English	Article						social cognition; adolescence; executive functions; moral reasoning	TRAUMATIC BRAIN-INJURY; JUDGMENT; BEHAVIOR; COMPETENCE; RESILIENCY; SYMPATHY; EMOTION; HOT	Adolescence is a developmental period characterized by intense changes, which impact the interaction between individuals and their environments. Moral reasoning (MR) is an important skill during adolescence because it guides social decisions between right and wrong. Identifying the cognitive underpinnings of MR is essential to understanding the development of this function. The aim of this study was to explore predictors of MR in typically developing adolescents (n = 92, 33 males, M = 16.3 years, SD = 2.2 years) and the specific contribution of higher order cognitive processing using an innovative visual MR assessment tool and measures of executive functioning and intelligence. MR maturity was correlated with four executive functions (cognitive flexibility, feedback utilization, conceptual reasoning, verbal fluency) and was predicted by four variables: age, intelligence, nonverbal flexibility and verbal fluency. Overall, these results contribute to a better understanding of MR during adolescence and highlight the importance of using innovative tools to measure social cognition.	[Vera-Estay, E.; Beauchamp, M. H.] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Vera-Estay, E.; Beauchamp, M. H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Dooley, J. J.] Cuyahoga Cty Court Psychiat Clin Justice Ctr, Cleveland, OH USA	Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC); Government of Chile (CONICYT)	This study was funded by the Social Sciences and Humanities Research Council of Canada (Miriam Beauchamp) and a scholarship to Evelyn Vera-Estay from the Government of Chile (CONICYT). The funding body was not involved in the study design, collection, analysis or interpretation of data or in the writing of the manuscript and the decision to submit the article for publication.	Adams G. R., 2008, BLACKWELL HDB ADOLES, V8, DOI [10.1002/9780470756607, DOI 10.1002/9780470756607]; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson PJ, 2010, STUD NEUROPSYCHOL NE, P3; Anderson SW, 1999, NAT NEUROSCI, V2, P1032; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Beauchamp M, 2012, ADM CODING MANUAL SO; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Blakemore SJ, 2008, Q J EXP PSYCHOL, V61, P40, DOI 10.1080/17470210701508715; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colby A., 1987, MEASUREMENT MORAL JU, V1; Cottone J, 2007, J SCI STUD RELIG, V46, P37, DOI 10.1111/j.1468-5906.2007.00339.x; Couper E, 2002, BRAIN IMPAIR, V3, P105, DOI DOI 10.1375/BRIM.3.2.105; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Derryberry WP, 2005, J ADV ACAD, V17, P6, DOI 10.4219/jsge-2005-392; Derryberry WP, 2007, J MORAL EDUC, V36, P475, DOI 10.1080/03057240701688036; Derryberry WP, 2008, GIFTED CHILD QUART, V52, P340, DOI 10.1177/0016986208321806; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Eisenberg N, 2004, CHILD DEV, V75, P25, DOI 10.1111/j.1467-8624.2004.00652.x; Eisenberg N, 2002, J PERS SOC PSYCHOL, V82, P993, DOI 10.1037//0022-3514.82.6.993; Eisenberg N, 2001, CHILD DEV, V72, P518, DOI 10.1111/1467-8624.00294; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; GFELLNER BM, 1986, J YOUTH ADOLESCENCE, V15, P147, DOI 10.1007/BF02141735; Gibbs J.C., 2010, MORAL DEV REALITY TH; GIBBS JC, 1982, CHILD DEV, V53, P895, DOI 10.2307/1129126; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hala S., 2010, SELF SOCIAL REGULATI, P293; Kalinian H, 2003, ARCH CLIN NEUROPSYCH, V18, P760; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Kohlberg L., 1983, MORAL STAGES CURRENT; Labelle-Chiasson V., 2012, J INT NEUROPSYCH SOC, V18, P206; Lahat A, 2013, CHILD DEV, V84, P955, DOI 10.1111/cdev.12001; Lahat A, 2012, HUM DEV, V55, P26, DOI 10.1159/000335525; Langdon PE, 2010, DEV REV, V30, P273, DOI 10.1016/j.dr.2010.01.001; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; Malti T, 2010, NEW DIR CHILD ADOLES, V129, P1, DOI 10.1002/cd.272; Malti T, 2009, CHILD DEV, V80, P442, DOI 10.1111/j.1467-8624.2009.01271.x; Martel MM, 2007, DEV PSYCHOPATHOL, V19, P541, DOI 10.1017/S0954579407070265; Miller M, 2010, J ABNORM CHILD PSYCH, V38, P315, DOI 10.1007/s10802-009-9369-2; Moll H., 2007, PHILOS T R SOC B, V362, P10; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; NARVAEZ D, 1993, J EDUC GIFTED, V16, P268, DOI 10.1177/016235329301600304; Narvaez D, 2010, NEW DIR CHILD ADOLES, V129, P77, DOI 10.1002/cd.276; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Piaget J., 1932, MORAL JUDGEMENT CHIL; Poulshock J. W., 2006, THESIS U EDINBURGH E; Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008; Rest JR., 1979, DEV JUDGING MORAL IS; Richardson CB, 2012, HUM DEV, V55, P4, DOI 10.1159/000335362; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Stams G. J., 2006, J ABNORMAL CHILD PSY, V34, P17; Steinberg L, 2009, AM PSYCHOL, V64, P583, DOI 10.1037/a0014763; Swedene JK, 2005, J MORAL EDUC, V34, P43, DOI 10.1080/03057240500049307; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tappan MB, 1997, DEV REV, V17, P78, DOI 10.1006/drev.1996.0422; Travis F, 2011, CONSCIOUS COGN, V20, P1256, DOI 10.1016/j.concog.2011.03.020; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Van Vugt E, 2011, INT J OFFENDER THER, V55, P1234, DOI 10.1177/0306624X11396441; Wain O, 2007, INT J NEUROSCI, V117, P135, DOI 10.1080/00207450500534068; Wechsler D., 2011, WECHLSER ABBREVIATED	73	16	16	2	36	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0305-7240	1465-3877		J MORAL EDUC	J. Moral Educ.	JAN 2	2015	44	1					17	33		10.1080/03057240.2014.986077			17	Education & Educational Research	Education & Educational Research	CD5XF	WOS:000351161400002					2021-06-18	
J	Chen, ST; Chang, CJ; Su, WC; Chang, LW; Chu, IH; Lin, MS				Chen, Shuo-Tsung; Chang, Cheng-Jen; Su, Wei-Chin; Chang, Lin-Wan; Chu, I-Hsuan; Lin, Muh-Shi			3-D titanium mesh reconstruction of defective skull after frontal craniectomy in traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Frontal intracranial haemorrhage; Head injury; Decompressive craniectomy; Three-dimensional titanium mesh; Reconstruction; Cosmesis; Quality of life	DECOMPRESSIVE CRANIECTOMY; CRANIOPLASTY; TECHNOLOGIES; FRACTURE; CHILDREN	Introduction: Decompressive craniectomy (DC) is a treatment strategy used to reduce intracranial pressure in patients with traumatic brain injuries. However, this procedure has a number of shortcomings, such as excessive sinking of the skin flap, which can lead to cerebral compromise and negatively affect the appearance of the patient. The reconstruction of skull defects has been proposed as a means to overcome these disadvantages. Few previous studies have reported the reconstruction of frontal skull defects using titanium mesh. The aim of this study was to provide a comprehensive review of aesthetic and surgical outcomes associated with this procedure and to list the complications encountered during the repair of frontal skull defects using three-dimensional (3-D) titanium mesh. Methods: A retrospective review was conducted using records from seven adult patients (32-60 years of age) who received titanium mesh implants at a university hospital in Taiwan between January 2011 and June 2012. Aesthetic outcomes, the function of cranial nerves V and VII, and complications (hardware extrusions, meningitis, osteomyelitis, brain abscess, and pneumocephalus) were evaluated. Results: An algorithm capable of accounting for bifrontal skull defects and median bone ridges was developed to improve computer-assisted design/manufacturing (CAD/CAM) of one-piece 3-D titanium mesh implants, thereby making it possible to repair bifrontal skull defects in a single operation. Following this procedure, aesthetic and functional outcomes were excellent and the implants in all patients appeared stable. However, extended healing times in two of the patients resulted in subclinical infections, which were resolved by administering antibiotics over a period of 2 weeks. No patients suffered trigeminal or facial dysfunction. Conclusions: Our findings support the use of 3-D titanium mesh in frontal skull reconstruction. Few complications were encountered, the contours of the forehead were faithfully rendered, and the cosmetic appearance of patients was excellent. For patients with bifrontal skull defects, the use of one-piece implants in a single operation provides numerous advantages over conventional staged surgeries. This application helps to reduce operating time, which is particularly beneficial for elderly patients and those requiring bifrontal cranioplasties. (C) 2014 Elsevier Ltd. All rights reserved.	[Chen, Shuo-Tsung] Tunghai Univ, Dept Math, Taichung 40704, Taiwan; [Chang, Cheng-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast Surg, Taoyuan, Taiwan; [Lin, Muh-Shi] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan; [Su, Wei-Chin; Chang, Lin-Wan; Chu, I-Hsuan; Lin, Muh-Shi] Taipei City Hosp, Zhong Xiao Branch, Dept Neurosurg, Taipei, Taiwan; [Lin, Muh-Shi] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan	Lin, MS (corresponding author), Dept Neurosurg, 87 Tongde Rd, Taipei 115, Taiwan.	neurosurgery2005@yahoo.com.tw	LLM, 林牧熹 醫學博士 法學碩士 Muh-Shi Lin MD PhD/U-7004-2019	LLM, 林牧熹 醫學博士 法學碩士 Muh-Shi Lin MD PhD/0000-0002-9798-8160			Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Di SM, 2013, ADV ORTHOP, V2013; Galantucci L. M., 2006, Journal of Medical Engineering & Technology, V30, P102, DOI 10.1080/03091900500131714; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Huang X, 2010, INT J MED SCI, V7, P385; Hung KS, 2004, J CLIN NEUROSCI, V11, P849, DOI 10.1016/j.jocn.2003.06.009; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Ju DT, 2008, ACTA NEUROCHIR SUPPL, V101, P169; KAISER A, 1993, EUR J PEDIATR SURG, V3, P236, DOI 10.1055/s-2008-1063551; Kung WM, 2012, BRAIN INJURY, V26, P1737, DOI 10.3109/02699052.2012.698361; Kung WM, 2012, J NEUROTRAUM, V29, P2030, DOI 10.1089/neu.2011.2220; Lakhani RS, 2001, ARCH OTOLARYNGOL, V127, P665, DOI 10.1001/archotol.127.6.665; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Margules A, 2010, JHN J, V5, P9; Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Scholz M, 2007, J CRANIO MAXILL SURG, V35, P388, DOI 10.1016/j.jcms.2007.06.006; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351	25	16	17	2	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					80	85		10.1016/j.injury.2014.09.019			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600016	25452005				2021-06-18	
J	Conder, R; Conder, AA				Conder, Robert; Conder, Alanna Adler			Neuropsychological and psychological rehabilitation interventions in refractory sport-related post-concussive syndrome	BRAIN INJURY			English	Article						Biofeedback; biopsychosocial; cognitive behavioural therapy; mild traumatic brain injury; neurofeedback; sport concussion	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; OF-THE-LITERATURE; HIGH-SCHOOL; COGNITIVE REHABILITATION; NEUROCOGNITIVE PERFORMANCE; CLINICAL MANAGEMENT; EARLY-CHILDHOOD; SEX-DIFFERENCES; SYMPTOMS	Background: The neuropsychological, physical, vestibular and oculomotor sequelae of sports-related concussion are extremely well documented. However, there is a paucity of interventions for these symptoms in refractory sports-related concussions. Aim: The intent of this article is to review the known and emerging neuropsychological and psychological rehabilitation interventions for reducing morbidity in refractory sports-related concussions (SRCs). Methods: The authors openly acknowledge the limited amount of empirical data available for review, as did the Zurich consensus papers, but posit a mindful and ethical approach towards rehabilitation interventions in the absence of evidence-based guidelines. Further, rehabilitation interventions proven useful with similar injuries or illnesses, particularly non-sports-related mild TBI, will be reviewed for applicability. Such interventions include Cognitive-Behavioural psychotherapy, biofeedback, cranial electrical stimulation, neurofeedback and cognitive rehabilitation. Results and conclusions: Modified approaches for rehabilitation with young children within family and school systems are provided. Recommendations for further research are offered.	[Conder, Robert; Conder, Alanna Adler] Carolina Neuropsychol Serv, Raleigh, NC 27607 USA	Conder, R (corresponding author), Carolina Neuropsychol Serv, 1540 Sunday Dr, Raleigh, NC 27607 USA.	bconder10@gmail.com	Meijer, Anna/K-5118-2016				Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; ANDERSEN MB, 1988, J SPORT EXERCISE PSY, V10, P294, DOI 10.1123/jsep.10.3.294; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Andraisik F, 2003, BIOFEEDBACK PRACTITI, P687; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Beauchamp M. R., 2012, OXFORD HDB SPORT PER, P273, DOI DOI 10.1093/OXFORDHB/9780199731763.013.0014; Beauchamp MK, 2012, J CLIN SPORT PSYCHOL, V6, P67, DOI 10.1123/jcsp.6.1.67; Beck A., 2000, MANUAL BECK DEPRESSI; Beck AT., 1996, BECK DEPRESSION INVE, V2; Beck J.S., 2011, COGNITIVE BEHAV THER; Bender M. C., 2003, WILL TRAUM BRAIN INJ; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bracken B. A., 2005, CLIN ASSESSMENT ATTE; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brooks J, 2006, SPORTS MEUROPSYCHOLO, P131; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown RP, 2009, ANN NY ACAD SCI, V31, P11; Burns David, 2008, FEELING GOOD NEW MOO; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Conder AA, 2011, 61 C EXC CHILDR GREE; Conder R, 1988, Brain Inj, V2, P365, DOI 10.3109/02699058809150909; Conder R., 1992, NEUROREHABILITATIVE, P7; Conder RL, 2012, 1 ANN M NHL NEUR CON; Conder RL, 2015, APPL NEUROPSYCH-CHIL, V4, P141, DOI 10.1080/21622965.2013.816849; Couch CM, 2011, ARCH CLIN NEUROPSYCH, V26, P349, DOI 10.1093/arclin/acr028; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; COWINGS PS, 1982, AVIAT SPACE ENVIR MD, V53, P570; Defence Centres of Excellence for Psychological Health and Traumatic Brain Injury US, 2012, ASS MAN DIZZ ASS MIL; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Dunkley C, 2011, EPILEPSY RES, V93, P96, DOI 10.1016/j.eplepsyres.2010.11.002; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Elliot AJ, 2011, PSYCHOPHYSIOLOGY, V48, P1340, DOI 10.1111/j.1469-8986.2011.01216.x; Engel G, 1997, SCIENCE, V196, P129; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Ewing M. E., 2002, CHILDREN YOUTH SPORT, P39; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Feltz DL, 1984, COGNITIVE SPORT PSYC, P114; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gass JJ, 2013, APPL PSYCHOPHYS BIOF, V38, P67; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia G, 2006, HEADS UP IN SPORTS; Gioia GA, 2012, PEDIAT ADOLESCENT CO, P687; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman B, 2013, NEUROLOGY, V80, P265; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey D. J., 2011, TXB TRAUMATIC BRAIN, P453; Heil J., 2012, OXFORD HDB SPORT PER; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Hermann C, 2002, APPL PSYCHOPHYS BIOF, V27, P143, DOI 10.1023/A:1016295727345; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hunt CA, 2013, SPORT EXERC PERFORM, V2, P220, DOI 10.1037/a0031957; Ievleva L., 1991, SPORT PSYCHOL, V5, P25, DOI DOI 10.1123/TSP.5.1.25; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jacobson E, 1938, PROGR RELAXATION; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennerly R, 2004, J NEUROTHERAPY, V8, P112; Kirk J. W., 2012, MILD TRAUMATIC BRAIN, P321; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kirsch DL, 2008, PAIN MANAGEMENT  JUL, P70; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kreutzer JS, 1989, COGNITIVE REHABILITA, V7, P30; Lagos L., 2012, BIOFEEDBACK, V40, P150, DOI [10.5298/1081-5937-40.4.05, DOI 10.5298/1081-5937-40.4.05]; Lagos L., 2013, BIOFEEDBACK, V41, P136, DOI [10.5298/1081-5937-41.3.02, DOI 10.5298/1081-5937-41.3.02]; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LeUnes A., 2008, SPORTS PSYCHOL; Linden M, 2013, P 2013 INT SOC NEUR; Linden W., 2007, PRINCIPLES PRACTICE, P151; Lovell MR, 2004, STUD NEUROPSYCHOL DE, P221; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Meyers MC, 2001, INT J SPORT PSYCHOL, V32, P29; Mihovich EG, 2009, P AM PSYCH ASS; National Collegiate Athletic Association [Internet], 2012, NCAA STUD PART HITS; Nestoriuc Y, 2008, APPL PSYCHOPHYS BIOF, V33, P125, DOI 10.1007/s10484-008-9060-3; Norris P. A., 2003, BIOFEEDBACK PRACTITI, P175; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rieck T, 2013, MED SCI SPORT EXER, V45, P1083, DOI 10.1249/MSS.0b013e3182831db1; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Russell-Chapin L, 2013, J NEUROTHERAPY, V17, P35, DOI DOI 10.1080/10874208.2013.759017; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, P265; Schwartz MS, 2003, BIOFEEDBACK PRACTITI; Shah AJ, 2011, PSYCHOSOM MED, V73, P475, DOI 10.1097/PSY.0b013e3182227d6a; Sherman R. A., 2012, PAIN ASSESSMENT INTE; Sime W., 2003, BIOFEEDBACK PRACTITI, P560; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; SMITH RE, 1995, J SPORT EXERCISE PSY, V17, P379, DOI 10.1123/jsep.17.4.379; Strack BW, 2011, BIOFEEDBACK NEUROFEE, P145; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Tatrow K, 2003, APPL PSYCHOPHYS BIOF, V28, P267, DOI 10.1023/A:1027326808356; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TAYLOR J, 1992, PROF PSYCHOL-RES PR, V23, P318, DOI 10.1037/0735-7028.23.4.318; Thatcher RW, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P241, DOI 10.1007/0-387-32565-4_11; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tinius T. P., 2000, J NEUROTHERAPY, V4, P27, DOI [10.1300/J184v04n02_05, DOI 10.1300/J184V04N02_05]; Trzepacz P. T., 1993, PSYCHIAT MENTAL STAT; Weiss M.R., 2012, OXFORD HDB SPORT PER, P448, DOI DOI 10.1093/OXFORDHB/9780199731763.013.0024; Werthner P, 2013, NEUROCONNECTIONS, V2, P32; Wilson P. E., 2012, MILD TRAUMATIC BRAIN, P303; Wilson V. E., 2011, BIOFEEDBACK NEUROFEE, P107; Wilson VE, 2011, BIOFEEDBACK NEUROFEE, P145; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Yucha C., 2008, EVIDENCE BASED PRACT; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	134	16	16	0	36	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	2					249	262		10.3109/02699052.2014.965209			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AZ4OI	WOS:000348201500014	25291459				2021-06-18	
S	Fife, TD; Kalra, D		Braaten, D		Fife, Terry D.; Kalra, Deepak			Persistent vertigo and dizziness after mild traumatic brain injury	DIZZINESS AND BALANCE DISORDERS	Annals of the New York Academy of Sciences		English	Article; Book Chapter						postconcussion syndrome; postconcussion dizziness; vertigo; mild traumatic brain injury; diffuse axonal injury; traumatic vestibulopathy; traumatic vestibular migraine	MINOR HEAD-INJURY; SPORTS-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; POSTTRAUMATIC MIGRAINE; DIAGNOSTIC-CRITERIA; VESTIBULAR NEURITIS; CLINICAL-FEATURES; TEMPORAL WINDOW; SYMPTOMS; VULNERABILITY	Vertigo, dizziness, and disequilibrium are common symptoms following concussion or mild traumatic brain injury (mTBI). Dizziness and vertigo may be the result of trauma to the peripheral vestibular system or the central nervous system, or, in some cases, may be due to anxiety, depression, or posttraumatic stress disorder; these mechanisms are not mutually exclusive. While most peripheral vestibular disorders can be identified by testing and examination, those without inner-ear causes that have persisting complaints of dizziness and motion sickness are more difficult to understand and to manage. Some of these patients exhibit features compatible with vestibular migraine and may be treated successfully with migraine-preventative medications. This paper reviews the nonotogenic causes of persisting dizziness, the possible mechanisms, and the pathophysiology, as a framework for patient management and for future research.	[Fife, Terry D.; Kalra, Deepak] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Fife, Terry D.] Univ Arizona, Coll Med, Dept Neurol, Phoenix, AZ USA	Fife, TD (corresponding author), Barrow Neurol Inst, 240 W Thomas Rd,Suite 301, Phoenix, AZ 85013 USA.	tfife@email.arizona.edu	Fife, Terry/M-1135-2019				Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Balaban CD, 2011, J VESTIBUL RES-EQUIL, V21, P315, DOI 10.3233/VES-2011-0428; Best C, 2006, J NEUROL NEUROSUR PS, V77, P658, DOI 10.1136/jnnp.2005.072934; Bisdorff Alexandre R, 2011, Ther Adv Neurol Disord, V4, P183, DOI 10.1177/1756285611401647; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; CDC, 2003, REP C MILD TRAUM BRA; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Curthoys IS, 2013, SEMIN NEUROL, V33, P231, DOI 10.1055/s-0033-1354595; Donaldson CJ, 2010, OTOLARYNG HEAD NECK, V143, P820, DOI 10.1016/j.otohns.2010.09.024; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fotuhi M, 2009, J NEUROL, V256, P711, DOI 10.1007/s00415-009-5050-5; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jeong SH, 2013, SEMIN NEUROL, V33, P185, DOI 10.1055/s-0033-1354598; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Loder E, 2012, HEADACHE, V52, P930, DOI 10.1111/j.1526-4610.2012.02185.x; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Manzari L, 2012, EUR ARCH OTO-RHINO-L, V269, P2441, DOI 10.1007/s00405-012-2127-z; Margulies S, 2000, J CLIN NEUROSCI, V7, P495, DOI 10.1054/jocn.1999.0773; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Monstad P, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-45; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; Pelosi S, 2013, AM J OTOLARYNG, V34, P490, DOI 10.1016/j.amjoto.2013.04.008; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Ruckenstein MJ, 2009, OTOLARYNG CLIN N AM, V42, P71, DOI 10.1016/j.otc.2008.09.011; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schonfeld U, 2010, ACTA OTO-LARYNGOL, V130, P702, DOI 10.3109/00016480903397686; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smitherman TA, 2013, HEADACHE, V53, P775, DOI 10.1111/head.12063; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Staab JP, 2003, LARYNGOSCOPE, V113, P1714, DOI 10.1097/00005537-200310000-00010; Stolte B., 2014, CEPHALALGIA; Tarlaci S, 2009, CLIN NEUROPHARMACOL, V32, P254, DOI 10.1097/WNF.0b013e3181a8c84f; Todd NPM, 2008, NEUROSCI LETT, V444, P36, DOI 10.1016/j.neulet.2008.08.011; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	67	16	18	0	17	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.		2015	1343						97	105		10.1111/nyas.12678			9	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	BC5NT	WOS:000353404000011	25728715				2021-06-18	
J	Giese, H; Sauvigny, T; Sakowitz, OW; Bierschneider, M; Guresir, E; Henker, C; Hohne, J; Lindner, D; Mielke, D; Pannewitz, R; Rohde, V; Scholz, M; Schuss, P; Regelsberger, J				Giese, Henrik; Sauvigny, Thomas; Sakowitz, Oliver W.; Bierschneider, Michael; Gueresir, Erdem; Henker, Christian; Hoehne, Julius; Lindner, Dirk; Mielke, Dorothee; Pannewitz, Robert; Rohde, Veit; Scholz, Martin; Schuss, Patrick; Regelsberger, Jan			German Cranial Reconstruction Registry (GCRR): protocol for a prospective, multicentre, open registry	BMJ OPEN			English	Article							MIDDLE-CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; EDEMA TRIAL HAMLET; DECOMPRESSIVE CRANIECTOMY; MALIGNANT INFARCTION; TERRITORY INFARCTION; HEMICRANIECTOMY; CRANIOPLASTY; SURGERY; EFFICACY	Introduction: Owing to increasing numbers of decompressive craniectomies in patients with malignant middle cerebral artery infarction, cranioplastic surgery becomes more relevant. However, the current literature mainly consists of retrospective single-centre (evidence class III) studies. This leads to a wide variability of technical approaches and clinical outcomes. To improve our knowledge about the key elements of cranioplasty, which may help optimising clinical treatment and long-term outcome, a prospective multicentre registry across Germany, Austria and Switzerland will be established. Methods: All patients undergoing cranioplastic surgery in participating centres will be invited to join the registry. Technical methods, materials, medical history, adverse events and clinical outcome measures, including modified Rankin scale and EQ-5D, will be assessed at several time points. Patients will be accessible to inclusion either at initial decompressive surgery or when cranioplasty is planned. Scheduled monitoring will be carried out at time of inclusion and subsequently at time of discharge, if any readmission is necessary, and at follow-up presentation. Cosmetic results and patient satisfaction will also be assessed. Collected data will be managed and statistically analysed by an independent biometric institute. The primary endpoint will be mortality, need for operative revision and neurological status at 3 months following cranioplasty. Ethics and dissemination: Ethics approval was obtained at all participating centres. The registry will provide reliable prospective evidence on surgical techniques, used materials, adverse events and functional outcome, to optimise patient treatment. We expect this study to give new insights in the treatment of skull defects and to provide a basis for future evidence-based therapy regarding cranioplastic surgery.	[Giese, Henrik] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Sauvigny, Thomas; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurol Surg, Hamburg, Germany; [Sakowitz, Oliver W.] Heidelberg Univ, Klinikum Ludwigsburg, Dept Neurosurg, Ludwigsburg, Germany; [Bierschneider, Michael] Trauma Ctr Murnau, Dept Neurosurg, Murnau, Germany; [Gueresir, Erdem; Schuss, Patrick] Univ Hosp Bonn, Dept Neurosurg, Bonn, Germany; [Henker, Christian] Univ Hosp Rostock, Dept Neurosurg, Rostock, Germany; [Hoehne, Julius] Univ Hosp Regensburg, Dept Neurosurg, Regensburg, Germany; [Lindner, Dirk] Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany; [Mielke, Dorothee; Rohde, Veit] Univ Med Ctr Gottingen, Dept Neurosurg, Gottingen, Germany; [Pannewitz, Robert] Univ Dusseldorf, Dept Neurosurg, Dusseldorf, Germany; [Scholz, Martin] Duisburg Med Ctr, Dept Neurosurg, Duisburg, Germany	Giese, H (corresponding author), Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany.	henrik.giese@med.uni-heidelberg.de	guresir, erdem/AAL-4484-2020; Schuss, Patrick/ABC-6469-2020; Hoehne, Julius/M-4210-2019; Hohne, Julius/J-6159-2015	guresir, erdem/0000-0002-6624-6885; Schuss, Patrick/0000-0002-5806-2576; Hoehne, Julius/0000-0002-8238-2211; Hohne, Julius/0000-0002-8238-2211; Henker, Christian/0000-0002-7591-3192; Guresir, Erdem/0000-0001-8319-0847	IMBI	The cost of maintaining the GCRR will be met by a consortium of cranioplasty suppliers/companies supporting the registry. Currently, funding is still in process. Contracts have been sent to the companies for verification. As soon as funding is available, the companies will be mentioned by name as well as the amount of payment, on the GCRR website (http://www.GCRR.zz.mu). Funding will be primarily used for data management and analysis, which are made by the IMBI and a study nurse. It is to be emphasised that the registry is initiated as an independent scientific effort investigating the surgical procedure of DC and CP.	Adeoye O, 2011, J STROKE CEREBROVASC, V20, P251, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.006; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; BILLER J, 1991, ANGIOLOGY, V42, P224, DOI 10.1177/000331979104200307; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hg LKY, 1970, STROKE, V1, P158, DOI 10.1161/01.STR.1.3.158; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kolias AG, 2014, BRIT J NEUROSURG, V28, P310, DOI 10.3109/02688697.2013.859657; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Neugebauer H, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-115; O'Kane MC, 1997, EUR J PEDIATR SURG, V7, P56; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Richards HK, 2009, J NEUROSURG-PEDIATR, V4, P389, DOI 10.3171/2009.4.PEDS09210; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Zweckberger K, 2014, CEREBROVASC DIS, V38, P313, DOI 10.1159/000365864	33	16	16	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	9							e009273	10.1136/bmjopen-2015-009273			5	Medicine, General & Internal	General & Internal Medicine	CU4FZ	WOS:000363484000093	26423857	DOAJ Gold, Green Published			2021-06-18	
J	Hannon, MJ; Behan, LA; O'Brien, MM; Tormey, W; Javadpour, M; Sherlock, M; Thompson, CJ				Hannon, M. J.; Behan, L. A.; O'Brien, M. M.; Tormey, W.; Javadpour, M.; Sherlock, M.; Thompson, C. J.			Chronic hypopituitarism is uncommon in survivors of aneurysmal subarachnoid haemorrhage	CLINICAL ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY FUNCTION; DIABETES-INSIPIDUS; ACUTE-PHASE; NEUROENDOCRINE DYSFUNCTION; GLUCOCORTICOID DEFICIENCY; CLINICAL INSIGHTS; HIGH-RISK; PREVALENCE; HYPONATREMIA	ObjectiveThe incidence of hypopituitarism after aneurysmal subarachnoid haemorrhage (SAH) is unclear from the conflicting reports in the literature. As routine neuroendocrine screening for hypopituitarism for all patients would be costly and logistically difficult, there is a need for precise data on the frequency of hypopituitarism and on factors which might predict the later development of pituitary dysfunction. We aimed to: (i) Establish the incidence of long-term hypopituitarism in patients with aneurysmal SAH. (ii) Determine whether data from patients' acute admission with SAH could predict the occurrence of long-term hypopituitarism. DesignOne hundred patients were studied prospectively from the time of presentation with acute SAH. Plasma cortisol, plasma sodium and a variety of clinical and haemodynamic parameters were sequentially measured for the first 12days of their acute admission. Forty-one patients then underwent dynamic pituitary testing at median 15months following SAH (range 7-30months), with insulin tolerance test (ITT) or, if contraindicated, a glucagon stimulation test (GST) plus short synacthen test (SST). If symptoms of cranial diabetes insipidus (CDI) were present, a water deprivation test was also performed. ResultsForty-one patients attended for follow-up dynamic pituitary testing. Although 14 of 100 had acute glucocorticoid deficiency immediately following SAH, only two of 41 had long-term adrenocorticotrophic hormone (ACTH) deficiency and four of 41 had growth hormone (GH) deficiency. None were hypothyroid or gonadotrophin deficient. None had chronic CDI or hyponatraemia. There was no association between acute glucocorticoid deficiency, acute CDI or acute hyponatraemia and long-term pituitary dysfunction. ConclusionBoth anterior and posterior hypopituitarism are very uncommon following SAH and are not predicted by acute clinical, haemodynamic or endocrinological parameters. Routine neuroendocrine screening is not justified in SAH patients.	[Hannon, M. J.; Behan, L. A.; O'Brien, M. M.; Sherlock, M.; Thompson, C. J.] Beaumont Hosp, Acad Dept Endocrinol, RCSI Med Sch, Dublin 9, Ireland; [Tormey, W.] Beaumont Hosp, Acad Dept Chem Pathol, RCSI Med Sch, Dublin 9, Ireland; [Javadpour, M.] Beaumont Hosp, Natl Neurosurg Ctr, RCSI Med Sch, Dublin 9, Ireland; [Sherlock, M.] Adelaide & Meath Hosp, Trinity Coll Dublin, Dept Endocrinol, Sch Med, Dublin, Ireland	Hannon, MJ (corresponding author), Beaumont Hosp, Acad Dept Endocrinol, Beaumont Rd, Dublin 9, Ireland.	markjhannon2002@yahoo.co.uk	Javadpour, Mohsen/AAX-4657-2020	Javadpour, Mohsen/0000-0001-9836-1741	Novo NordiskNovo Nordisk	Funded by an unrestricted educational grant from Novo Nordisk.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Crowley RK, 2007, CLIN ENDOCRINOL, V66, P475, DOI 10.1111/j.1365-2265.2007.02754.x; Davies MJ, 1996, J ROY SOC MED, V89, pP159; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Finucane FM, 2008, CLIN ENDOCRINOL, V69, P603, DOI 10.1111/j.1365-2265.2008.03240.x; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; MCIVER B, 1991, BRIT MED J, V303, P1465, DOI 10.1136/bmj.303.6815.1465; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Prabhakar VKB, 2006, POSTGRAD MED J, V82, P259, DOI 10.1136/pgmj.2005.039768; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; SPIRO SG, 1971, BRIT MED J, V3, P411, DOI 10.1136/bmj.3.5771.411; TAKAKU A, 1979, SURG NEUROL, V11, P349; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476	31	16	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	JAN	2015	82	1					115	121		10.1111/cen.12533			7	Endocrinology & Metabolism	Endocrinology & Metabolism	AX2QC	WOS:000346788000017	24965315				2021-06-18	
J	Hendricks, DJ; Sampson, E; Rumrill, P; Leopold, A; Elias, E; Jacobs, K; Nardone, A; Scherer, M; Stauffer, C				Hendricks, Deborah J.; Sampson, Elaine; Rumrill, Phillip; Leopold, Anne; Elias, Eileen; Jacobs, Karen; Nardone, Amanda; Scherer, Marcia; Stauffer, Callista			Activities and interim outcomes of a multi-site development project to promote cognitive support technology use and employment success among postsecondary students with traumatic brain injuries	NEUROREHABILITATION			English	Article						Cognitive support technology; traumatic brain injury	AFGHANISTAN; COMPUTER; PEOPLE; IRAQ	BACKGROUND: This article describes the activities and interim outcomes of a multi-site development project called Project Career, designed to promote cognitive support technology (CST) use and employment success for college and university students with traumatic brain injuries (TBIs). OBJECTIVES: To obtain early intervention results from participants in Project Career's first 18 months of operation. METHODS: Fifty-six students with TBI have participated to date across three implementation sites in Massachusetts, Ohio, and West Virginia, with 25 of these participants being military veterans. Descriptive analyses provide information regarding the participants, the barriers they face due to their TBI in obtaining a post-secondary education, and the impact services provided by Project Career have had to date in ameliorating those difficulties. Inferential statistical analyses provide preliminary results regarding program effectiveness. RESULTS: Preliminary results indicate the program is encouraging students to use CST strategies in the form of iPads and cognitive enhancement applications (also known as 'apps'). Significant results indicate participants are more positive, independent, and social; participants have a more positive attitude toward technology after six months in the program; and participants reported significantly improved experiences with technology during their first six months in the program. CONCLUSION: Participating students are actively preparing for their careers after graduation through a wide range of intensive vocational supports provided by project staff members.	[Hendricks, Deborah J.; Sampson, Elaine] W Virginia Univ, Morgantown, WV 26506 USA; [Rumrill, Phillip; Stauffer, Callista] Kent State Univ, Kent, OH 44242 USA; [Leopold, Anne; Elias, Eileen] JBS Int Inc, North Bethesda, MD USA; [Jacobs, Karen; Nardone, Amanda] Boston Univ, Boston, MA 02215 USA; [Scherer, Marcia] Univ Rochester, Rochester, NY USA	Hendricks, DJ (corresponding author), W Virginia Univ, POB 6080, Morgantown, WV 26506 USA.	hendricks@jan.wvu.edu		Jacobs, Karen/0000-0002-4718-990X; Scherer, Marcia/0000-0001-8374-6526	United States Department of Education, NIDRRUS Department of Education [H133A130066]	The contents of this article were developed under a grant from the United States Department of Education, NIDRR grant #H133A130066. However, those contents do not necessarily represent the policy of the Department of Education, and readers should not assume endorsement by the Federal Government.	Basso A., 2006, NEUROL DISORD PUBLIC, P164; Betz N. E., 2001, MANUAL CAREER DECISI; Bureau of Labor Statistics, 2011, USDL121125 BUR LAB S; CARROLL JM, 1993, INTERACT COMPUT, V5, P3, DOI 10.1016/0953-5438(93)90022-L; Centers for Disease Control and Prevention (CDC), 2014, RAT TBI REL EM DEP V; Crites J. O., 2011, CAREER MATURITY INVE; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Garber B., 2015, TRAUMATIC BRAIN INJU; Gilchrist J., 2011, NONFATAL TRAUMATIC B; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; ROESSLER RT, 2006, CASE MANAGEMENT REHA; Rumrill P., J OCCUPATIONAL REHAB; Sauer A. L., 2010, DISABILITY REHABILIT, V5, P1; Scherer M., 2012, ASSISTIVE TECHNOLOGI; Scherer MJ, 2005, MATCHING PERSON TECH; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; United States Army, 2015, US NATO PARTN MEET D; US Department of Education National Center for Education Statistics, 2014, 2014083 NCES US DEP; Wagner M., 2005, HIGH SCH 1 LOOK POST; Wehman P., 2013, LIFE CLASSROOM; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029; Wehmeyer M. L., 2003, INT REV RES MENTAL R; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006	28	16	16	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	3					449	458		10.3233/NRE-151273			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY3QH	WOS:000366324100010	26484525				2021-06-18	
J	Lu, LY; Cao, HL; Wei, XE; Li, YH; Li, WB				Lu, Liyan; Cao, Heli; Wei, Xiaoer; Li, Yuehua; Li, Wenbin			Iron Deposition Is Positively Related to Cognitive Impairment in Patients with Chronic Mild Traumatic Brain Injury: Assessment with Susceptibility Weighted Imaging	BIOMED RESEARCH INTERNATIONAL			English	Article							PARKINSONS-DISEASE; IMMATURE RAT; STRESS; MATTER; PHASE; MRI; ABNORMALITIES; PERFORMANCE; NETWORK	Background. This study aimed to evaluate the usability of SWI in assessment of brain iron to detect cognitive dysfunction in patients with chronic mild traumatic brain injury (mTBI). Methods. 39 patients with mTBI and 37 normal controls were given the Mini-Mental State Examination (MMSE) and underwent SWI scanning at least 6 months after injury. Angle radian values were calculated with phase images. The angle radian values were compared between groups using analysis of covariance, and their association with MMSE scores was analyzed using Spearman correlations. Results. Significantly higher angle radian values (p < 0.05) were found in the head of the caudate nucleus, the lenticular nucleus, the hippocampus, the thalamus, the right substantia nigra, the red nucleus, and the splenium of the corpus callosum (SCC) in the mTBI group, compared to the control group. MMSE scores were negatively correlated with angle radian values in the right substantia nigra (r = -0.685, p < 0.001). Conclusions. Patients with chronic mTBI might have abnormally high accumulations of iron, and their MMSE scores are negatively associated with angle radian values in the right substantia nigra, suggesting a role of SWI in the assessment of cognitive impairments of these patients.	[Lu, Liyan; Wei, Xiaoer; Li, Yuehua; Li, Wenbin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China; [Cao, Heli] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China	Li, WB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sh163.net			National Natural Scientific Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271540, 81301213]; Science and Technology Commission of Shanghai Municipality Grant (STCSM)Science & Technology Commission of Shanghai Municipality (STCSM) [08411951200]	This study is supported by the National Natural Scientific Foundation of China (NSFC; no. 81271540 and no. 81301213) and the Science and Technology Commission of Shanghai Municipality Grant (STCSM; no. 08411951200).	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster ER, 2008, BRAIN COGNITION, V67, P1, DOI 10.1016/j.bandc.2007.10.002; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu J., 2015, J NEUROTRAUMA; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Lu LY, 2014, NEUROL INDIA, V62, P487, DOI 10.4103/0028-3886.144434; Lull N, 2010, NEUROLOGIA, V25, P174; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Rossi M, 2010, INVEST RADIOL, V45, P795, DOI 10.1097/RLI.0b013e3181ec9c96; Rossi ME, 2014, ACAD RADIOL, V21, P64, DOI 10.1016/j.acra.2013.09.018; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shen W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140739; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tuite Paul J, 2013, J Alzheimers Dis Parkinsonism, VSuppl 1, P001; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050706; Wu SF, 2014, EUR REV MED PHARMACO, V18, P2605; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhang ZQ, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0117-3	49	16	17	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								470676	10.1155/2015/470676			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	DA2JZ	WOS:000367622400001	26798636	DOAJ Gold, Green Published			2021-06-18	
J	Ma, YX; Nie, H; Chen, HY; Li, JF; Hong, YY; Wang, B; Wang, CX; Zhang, J; Cao, W; Zhang, MC; Xu, YN; Ding, XT; Yin, SK; Qu, XK; Ying, WH				Ma, Yingxin; Nie, Hui; Chen, Heyu; Li, Jiefu; Hong, Yunyi; Wang, Ban; Wang, Caixia; Zhang, Jie; Cao, Wei; Zhang, Mingchao; Xu, Yongning; Ding, Xianting; Yin, Shan Kai; Qu, Xinkai; Ying, Weihai			NAD(+)/NADH Metabolism and NAD(+)-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications	CURRENT MEDICINAL CHEMISTRY			English	Article						CD38; cell death; ischemic brain injury; NAD(+); poly(ADP-ribose) polymerase; sirtuins	CYCLIC ADP-RIBOSE; NF-KAPPA-B; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASE; INDUCED APOPTOSIS; CEREBRAL-ISCHEMIA; NEURONAL SURVIVAL; CD38; ACTIVATION; NADH	NAD(+) and NADH play crucial roles in a variety of biological processes including energy metabolism, mitochondrial functions, and gene expression. Multiple studies have indicated that NAD(+) administration can profoundly decrease oxidative cell death as well as ischemic and traumatic brain injury, suggesting NAD(+) metabolism as a promising therapeutic target for cerebral ischemia and head injury. Cumulating evidence has suggested that NAD(+) can produce its protective effects by multiple mechanisms, including preventing mitochondrial alterations, enhancing energy metabolism, preventing virtually all forms of cell death including apoptosis, necrosis and autophagy, inhibiting inflammation, directly increasing antioxidation capacity of cells and tissues, and activating SIRT1. Increasing evidence has also suggested that NADH metabolism is a potential therapeutic target for treating several neurological disorders. A number of studies have further indicated that multiple NAD(+)-dependent enzymes such as sirtuins, polymerase(ADP-ribose) polymerases (PARPs) and CD38 mediate cell death and multiple biological processes. In this article, an overview of the recent findings regarding the roles of NAD(+)/NADH and NAD(+)-dependent enzymes in cell death and ischemic brain injury is provided. These findings have collectively indicated that NAD(+)/NADH and NAD(+)-dependent enzymes play fundamental roles in oxidative stress-induced cell death and ischemic brain injury, which may become promising therapeutic targets for brain ischemia and multiple other neurological disorders.	[Ying, Weihai] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Ma, Yingxin; Nie, Hui; Chen, Heyu; Hong, Yunyi; Wang, Ban; Wang, Caixia; Zhang, Jie; Cao, Wei; Ding, Xianting; Ying, Weihai] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Ma, Yingxin; Nie, Hui; Chen, Heyu; Hong, Yunyi; Wang, Ban; Wang, Caixia; Zhang, Jie; Cao, Wei; Ding, Xianting; Ying, Weihai] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Li, Jiefu; Zhang, Mingchao; Xu, Yongning] Shanghai Jiao Tong Univ, Zhiyuan Coll, Shanghai 200030, Peoples R China; [Yin, Shan Kai] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Otorhinolaryngol, Shanghai 200030, Peoples R China; [Qu, Xinkai] Shanghai Jiao Tong Univ, Chest Hosp, Dept Cardiol, Shanghai 200030, Peoples R China	Ying, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Hua Shan Rd, Shanghai 200032, Peoples R China.	weihaiy@sjtu.edu.cn	; /M-8065-2017	Hong, Yunyi/0000-0002-2921-6417; /0000-0002-0062-4652	Chinese National Science FoundationNational Natural Science Foundation of China (NSFC) [81171098, 81271305]; Shanghai Jiao Tong University Grants for Interdisciplinary Research on Medicine and Engineering	This study was supported by Chinese National Science Foundation Grants #81171098 and #81271305 (to W. Y.), and Shanghai Jiao Tong University Grants for Interdisciplinary Research on Medicine and Engineering (to W. Y.).	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066; Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Banerjee S, 2008, J NEUROIMMUNE PHARM, V3, P154, DOI 10.1007/s11481-008-9105-7; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Boulares AH, 2002, CANCER RES, V62, P4439; Boulares AH, 2002, J BIOL CHEM, V277, P372, DOI 10.1074/jbc.M107738200; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Bruzzone S, 2004, J NEUROCHEM, V89, P264, DOI 10.1111/j.1471-4159.2003.02326.x; Bruzzone S, 2001, FASEB J, V15, P10; Cai AL, 2006, EUR J NEUROSCI, V24, P2169, DOI 10.1111/j.1460-9568.2006.05110.x; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chen HY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/213234; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; Guarente L, 2000, GENE DEV, V14, P1021; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; He X, 2012, BIOCHEM BIOPH RES CO, V417, P468, DOI 10.1016/j.bbrc.2011.11.141; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hong Y S.J., 2010, FASEB J; Hong YY, 2014, NEUROSCI LETT, V560, P46, DOI 10.1016/j.neulet.2013.11.039; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Huang J.Y., 1804, BIOCH BIOPHYS ACTA, P1645; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Kim SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014731; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Li YX, 2013, NEUROSCI LETT, V544, P36, DOI 10.1016/j.neulet.2013.03.032; Love S, 1999, NEUROPATH APPL NEURO, V25, P98; Lu HF, 2007, BIOCHEM BIOPH RES CO, V362, P946, DOI 10.1016/j.bbrc.2007.08.095; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Ma YX, 2014, GLIA, V62, P943, DOI 10.1002/glia.22651; Ma YX, 2012, BIOCHEM BIOPH RES CO, V418, P714, DOI 10.1016/j.bbrc.2012.01.084; Ma Yingxin, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P21; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Matsuura S, 2011, BRAIN RES, V1410, P122, DOI 10.1016/j.brainres.2011.05.069; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; Narayan N., 2012, NATURE; Nie H, 2014, NEUROREPORT, V25, P838, DOI 10.1097/WNR.0000000000000192; Nie Hui, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P65; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pardo Beatriz, 2013, Front Endocrinol (Lausanne), V4, P149, DOI 10.3389/fendo.2013.00149; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Pellegrini L, 2012, CELL DEATH DIFFER, V19, P1815, DOI 10.1038/cdd.2012.62; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pillai JB, 2006, AM J PHYSIOL-HEART C, V291, pH1545, DOI 10.1152/ajpheart.01124.2005; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Sheng C., 2014, IEEE T PATTERN ANAL, P1; Sheng Caibin, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P1; Shimizu T, 2013, J CEREBR BLOOD F MET, V33, P1549, DOI 10.1038/jcbfm.2013.105; Siegel CS, 2013, NEUROSCIENCE, V237, P223, DOI 10.1016/j.neuroscience.2013.01.068; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Stryer L., 1995, BIOCHEMISTRY-US; Sundaresan NR, 2011, J MOL CELL CARDIOL, V51, P614, DOI 10.1016/j.yjmcc.2011.01.008; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Teng F, 2013, EXP NEUROL, V248, P416, DOI 10.1016/j.expneurol.2013.07.007; Thornburg JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2154; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Van Meter M, 2011, CELL CYCLE, V10, P3153, DOI 10.4161/cc.10.18.17435; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang B, 2014, CHEM-BIOL INTERACT, V212, P65, DOI 10.1016/j.cbi.2014.01.013; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Xia WL, 2010, CLIN EXP PHARMACOL P, V37, P253, DOI 10.1111/j.1440-1681.2009.05279.x; Xia WL, 2009, CURR PHARM DESIGN, V15, P12, DOI 10.2174/138161209787185832; Xiong J, 2013, CELL PHYSIOL BIOCHEM, V31, P44, DOI 10.1159/000343348; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Ying W, 2010, CURR MED CHEM, V17, P2152, DOI 10.2174/092986710791299911; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; YUAN M, EXP NEUROL; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012; Zheng CB, 2012, NEUROSCI LETT, V512, P67, DOI 10.1016/j.neulet.2012.01.007; Zhu KQ, 2005, NEUROREPORT, V16, P1209, DOI 10.1097/00001756-200508010-00015	107	16	17	1	34	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2015	22	10					1239	1247		10.2174/0929867322666150209154420			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CD5WW	WOS:000351160400008	25666794				2021-06-18	
J	Mackenzie, B; Vivier, P; Reinert, S; Machan, J; Kelley, C; Jacobs, E				Mackenzie, Bonnie; Vivier, Patrick; Reinert, Steven; Machan, Jason; Kelley, Caroline; Jacobs, Elizabeth			Impact of a State Concussion Law on Pediatric Emergency Department Visits	PEDIATRIC EMERGENCY CARE			English	Article							TRAUMATIC BRAIN-INJURY; AMERICAN MEDICAL SOCIETY; SPORT-RELATED CONCUSSION; BOOSTER SEAT USE; HELMET-USE LAWS; UNITED-STATES; HEAD-INJURY; HIGH-SCHOOL; CHILDREN	Objective: Many states have passed concussion laws that mandate that players undergo medical clearance before returning to play. Few data have been collected on the impact of such laws on emergency department (ED) visits. This study measures the impact of Rhode Island concussion legislation on sports-related concussion visits to a pediatric ED. Methods: International Classification of Diseases, Ninth Revision, Clinical Modification codes with injury mechanism-associated E-codes were extracted from hospital databases from 2004 to 2011 for both sports-related concussions and sports-related ankle ligamentous injuries (comparison group). Visit rates for sports-related concussions were compared before and after the passage of the state concussion law. Secondary outcome measures included rates of head imaging per ED visit for concussion before and after passage of the law. Times series analysis was used to analyze season-to-season count and rate changes. Results: Overall rate of sports-related concussion visits more than doubled (2.2-fold increase; 95% confidence interval, 1.3-3.6; adjusted P = 0.01) during the fall sports season following the implementation of legislation (2010) relative to the previous year (3.6% vs 1.4%). Rates of sports-related ankle sprain visits tended to increase during the fall sports season but did not achieve statistical significance. Rates of computed tomography scan imaging of the head did not change over time. Conclusions: The data from this study revealed an increase in pediatric ED visits for sports-related concussions, without a corresponding increase in head imaging, suggesting that the passage of a state concussion law has led to increased vigilance in evaluation of sports-related concussions, without an increase in diagnostic computed tomography scans.	[Mackenzie, Bonnie; Vivier, Patrick; Jacobs, Elizabeth] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Vivier, Patrick] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Reinert, Steven] Brown Univ, Lifespan Informat Serv, Providence, RI 02912 USA; [Machan, Jason] Brown Univ, Dept Orthoped & Surg, Providence, RI 02912 USA; [Machan, Jason; Kelley, Caroline] Brown Univ, Providence, RI 02912 USA	Mackenzie, B (corresponding author), Rhode Isl Hosp, Dept Emergency Med, 593 Eddy St,Claverick 2, Providence, RI 02903 USA.	bonnie.mackenzie@mac.com	Machan, Jason T/D-3897-2013	Machan, Jason T/0000-0003-2048-4914; Geiger, Caroline/0000-0001-8616-8450	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104937] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM104937] Funding Source: Medline		Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Aldana PR, 2011, AAP NEWS, pE110620; [Anonymous], 2011, 2011 RHOD ISL KIDS C; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; CHERRY DK, 2002, ADV DATA, V328, P1; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gunn VL, 2007, PEDIATRICS, V119, pE131, DOI 10.1542/peds.2006-1876; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; SOSIN DM, 1992, JAMA-J AM MED ASSOC, V267, P1649, DOI 10.1001/jama.267.12.1649; Sun KN, 2010, PEDIATRICS, V126, P484, DOI 10.1542/peds.2010-0249; Swenson DM, 2013, CLIN J SPORT MED; Wei HG, 2000, ACAD EMERG MED, V7, P710, DOI 10.1111/j.1553-2712.2000.tb02052.x; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; 2000, PEDIATRICS, V106, P154	27	16	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2015	31	1					25	30		10.1097/PEC.0000000000000325			6	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	AY2NK	WOS:000347426700006	25526017				2021-06-18	
J	Shamloo, A; Heibatollahi, M; Mofrad, MRK				Shamloo, Amir; Heibatollahi, Motahare; Mofrad, Mohammad R. K.			Directional migration and differentiation of neural stem cells within three-dimensional microenvironments	INTEGRATIVE BIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EXTRACELLULAR-MATRIX; MICROFLUIDIC DEVICE; PRECURSOR CELLS; GROWTH-FACTOR; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; CHEMOTAXIS; NEURONS; REPAIR	A Harnessing neural stem cells to repair neuronal damage is a promising potential treatment for neuronal diseases. To enable future therapeutic efficacy, the survival, proliferation, migration and differentiation of neural stem/progenitor cells (NPCs) should be accurately studied and optimized in in vitro platforms before transplanting these cells into the body for treatment purposes. Such studies can determine the appropriate quantities of the biochemical and biomechanical factors needed to control and optimize NPC behavior in vivo. In this study, NPCs were cultured within a microfluidic device while being encapsulated within the collagen matrix. The migration and differentiation of NPCs were studied in response to varying concentrations of nerve growth factor (NGF) and within varying densities of collagen matrices. It was shown that the migration and differentiation of NPCs can be significantly improved by providing the appropriate range of NGF concentrations while encapsulating the cells within the collagen matrix of optimal density. In particular, it was observed that within collagen matrices of intermediate density (0.9 mg ml(-1)), NPCs have a higher ability to migrate farther and in a collective manner while their differentiation into neurons is significantly higher and the cells can form protrusions and connections with their neighboring cells. Within collagen matrices with higher densities (1.8 mg ml (-1)), the cells did not migrate significantly as compared to the ones within lower matrix densities; within the matrices with lower collagen densities (0.45 mg ml(-1)) most of the cells migrated in an individual manner. However, no significant differentiation into neurons was observed for these two cases. It was also found that depending on the collagen matrix density, a minimum concentration of NGF caused a collective migration of NPCs, and a minimum concentration gradient of this factor stimulated the directional navigation of the cells. The results of this study can be implemented in designing platforms appropriate for regeneration of damaged neuronal systems.	[Shamloo, Amir; Heibatollahi, Motahare; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Shamloo, Amir; Heibatollahi, Motahare; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Shamloo, Amir] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Mofrad, Mohammad R. K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859; , amir/0000-0002-0131-0567	National Science Foundation CAREER awardNational Science Foundation (NSF) [CBET-0955291]; Siebel Stem Cell Institute	Financial support through a National Science Foundation CAREER award CBET-0955291 (M.R.K.M.) and a Siebel Stem Cell Institute post-doctoral fellowship (A.S.) is gratefully acknowledged. The authors would also like to thank the UC Berkeley Stem Cell Center and QB3 Shared Stem Cell Facilities for their assistance throughout this project. Fruitful discussions with Dr David Schaffer and the members of the Molecular Cell Biomechanics Laboratory are highly appreciated.	Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11; Gordon RJ, 2012, EXP NEUROL, V233, P587, DOI 10.1016/j.expneurol.2011.11.029; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Han S, 2012, LAB CHIP, V12, P2305, DOI 10.1039/c2lc21285d; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Jahed Z, 2014, INT REV CEL MOL BIO, V310, P171, DOI 10.1016/B978-0-12-800180-6.00005-0; Jamali Y, 2013, J COMPUT PHYS, V244, P264, DOI 10.1016/j.jcp.2012.09.010; Kamm R.D., 2014, CELLULAR MECHANOTRAN; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kolahi KS, 2010, WIRES SYST BIOL MED, V2, P625, DOI 10.1002/wsbm.79; Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042; Kuhn HG, 2001, EUR ARCH PSY CLIN N, V251, P152, DOI 10.1007/s004060170035; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; McKeown SJ, 2013, DEV BIOL, V373, P244, DOI 10.1016/j.ydbio.2012.10.028; McLennan R, 2010, DEV BIOL, V339, P114, DOI 10.1016/j.ydbio.2009.12.022; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Namba T, 2011, J NEUROCHEM, V118, P34, DOI 10.1111/j.1471-4159.2011.07282.x; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Rajan P, 2006, METHOD ENZYMOL, V419, P23, DOI 10.1016/S0076-6879(06)19002-3; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shamloo A, 2012, TISSUE ENG PT A, V18, P320, DOI [10.1089/ten.tea.2011.0323, 10.1089/ten.TEA.2011.0323]; Shamloo A, 2013, INTEGR BIOL-UK, V5, P1076, DOI 10.1039/c3ib40025e; Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Sherafat MA, 2012, J MOL NEUROSCI, V48, P144, DOI 10.1007/s12031-012-9791-8; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Theveneau Eric, 2010, Small GTPases, V1, P113, DOI 10.4161/sgtp.1.2.13673; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Xu H, 2013, SMALL, V9, P585, DOI 10.1002/smll.201202208; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9; Zhu WS, 2011, DRUG DELIV, V18, P338, DOI 10.3109/10717544.2011.557785	60	16	17	1	37	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1757-9694	1757-9708		INTEGR BIOL-UK	Integr. Biol.		2015	7	3					335	344		10.1039/c4ib00144c			10	Cell Biology	Cell Biology	CD5OA	WOS:000351136500006	25633746				2021-06-18	
J	Kjeldgaard, D; Forchhammer, HB; Teasdale, TW; Jensen, RH				Kjeldgaard, Dorte; Forchhammer, Hysse B.; Teasdale, Thomas W.; Jensen, Rigmor H.			Cognitive behavioural treatment for the chronic post-traumatic headache patient: a randomized controlled trial	JOURNAL OF HEADACHE AND PAIN			English	Article						Chronic post-traumatic headache; Treatment; Cognitive therapy; Brain concussion; RCT	CLINICAL-TRIALS; INJURY; CONCUSSION; EFFICACY; THERAPY	Background: Chronic post-traumatic headache (CPTH) after mild head injury can be difficult to manage. Research is scarce and successful interventions are lacking. To evaluate the effect of a group-based Cognitive Behavioural Therapy (CBT) intervention in relation to headache, pain perception, psychological symptoms and quality of life in patients with CPTH. Methods: Ninety patients with CPTH according to ICHD-2 criteria were enrolled from the Danish Headache Center into a randomized, controlled trial. Patients were randomly assigned to either a waiting list group or to a nine-week CBT group intervention. At baseline and after 26 weeks all patients completed the Rivermead Post Concussion Symptoms Questionnaire, SF-36, SCL-90-R and a headache diary. Results: The CBT had no effect on headache and pressure pain thresholds and only a minor impact on the CPTH patients' quality of life, psychological distress, and the overall experience of symptoms. The waiting-list group experienced no change in headache but, opposed to the treatment group, a significant decrease in somatic and cognitive symptoms indicating a spontaneous remission over time. Conclusions: Our primarily negative findings confirm that management of patients with CPTH still remains a considerable challenge. Psychological group therapy with CBT might be effective in an earlier stage of CPTH and in less severely affected patients but our findings strongly underline the need for randomized controlled studies to test the efficacy of psychological therapy.	[Kjeldgaard, Dorte] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, Copenhagen, Denmark; [Forchhammer, Hysse B.] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Copenhagen, Denmark; [Teasdale, Thomas W.] Univ Copenhagen, Fac Social Sci, Dept Psychol, Copenhagen, Denmark; [Jensen, Rigmor H.] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Copenhagen, Denmark	Jensen, RH (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, Nordre Ringvej 69, DK-2600 Glostrup, Copenhagen, Denmark.	rigmor.jensen@regionh.dk			LundbeckLundbeck Corporation [R67-A6507]; Danish "Helsefonden" [2099B033]; AllerganAbbVieAllergan; PfizerPfizer	The research received grants from Lundbeck (R67-A6507) and the Danish "Helsefonden" (2099B033).; DK received honoraria and travel funding from Allergan and Pfizer. HBF, TWT and RHJ have not received any funding relating to this study. RHJ is a board member of EHMTIC, EHF, LTB, ATI, Linde Gas and Neurocore.	Aaseth K, 2008, CEPHALALGIA, V28, P705, DOI 10.1111/j.1468-2982.2008.01577.x; Altman D, 1991, PRACTICAL STAT MED R; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Beck J.S., 2011, COGNITIVE BEHAV THER; Bendtsen L, 1996, ARCH NEUROL-CHICAGO, V53, P373, DOI 10.1001/archneur.1996.00550040113021; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P991, DOI 10.1016/S0895-4356(98)00091-2; Blanchard E. B., 1985, MANAGEMENT CHRONIC H; de Groot FM, 2011, J MANIP PHYSIOL THER, V34, P297, DOI 10.1016/j.jmpt.2011.04.007; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Ferguson RJ, 1996, COGNITIVE BEHAV TREA, P615; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Ham LP, 1996, BIOFEEDBACK SELF-REG, V21, P93, DOI 10.1007/BF02284689; Hickling EJ, 1992, HEADACHE Q-CURR TREA, V3, P285; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jensen R, 2011, CEPHALALGIA, V31, P1549, DOI 10.1177/0333102411424212; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kjeldgaard D, 2014, THESIS U COPENHAGEN; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; MEDINA JL, 1992, HEADACHE, V32, P180, DOI 10.1111/j.1526-4610.1992.hed3204180.x; Munksgaard SB, 2012, HEADACHE, V52, P1120, DOI 10.1111/j.1526-4610.2012.02191.x; Nash JM, 2004, PAIN MED, V5, P178, DOI 10.1111/j.1526-4637.2004.04031.x; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Penzien DB, 2005, HEADACHE, V45, pS110, DOI 10.1111/j.1526-4610.2005.4502004.x; RUSSELL MB, 1992, CEPHALALGIA, V12, P369, DOI 10.1111/j.1468-2982.1992.00369.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stetter F, 2002, APPL PSYCHOPHYS BIOF, V27, P45, DOI 10.1023/A:1014576505223; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tatrow K, 2003, APPL PSYCHOPHYS BIOF, V28, P267, DOI 10.1023/A:1027326808356; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Zasler ND, 2011, J HEAD TRAUMA REHAB, V26, P397, DOI 10.1097/HTR.0b013e31822721f8; Zeeberg P, 2005, CEPHALALGIA, V25, P1159, DOI 10.1111/j.1468-2982.2005.00980.x	40	16	16	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC 2	2014	15								81	10.1186/1129-2377-15-81			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AW4WA	WOS:000346277100001	25441170	DOAJ Gold, Green Published			2021-06-18	
J	Shi, HY; Hwang, SL; Lee, IC; Chen, IT; Lee, KT; Lin, CL				Shi, Hon-Yi; Hwang, Shiuh-Lin; Lee, I-Chen; Chen, I-Te; Lee, King-Teh; Lin, Chih-Lung			Trends and outcome predictors after traumatic brain injury surgery: a nationwide population-based study in Taiwan	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; trends; predictors; hospital resource utilization; mortality rate	UNITED-STATES; MORTALITY; SURVIVAL; CENTERS; IMPACT; COSTS	Object. The authors sought to analyze trends in hospital resource utilization and mortality rates in a population of patients who had received traumatic brain injury (TBI) surgery. Methods. This nationwide population-based cohort study retrospectively analyzed 18,286 patients who had received surgical treatment for TBI between 1998 and 2010. The multiple linear regression model and Cox proportional hazards model were used for multivariate assessment of outcome predictors. Results. The prevalence rate of surgical treatment for patients with TBI gradually but significantly (p < 0.001) increased by 47.6% from 5.0 per 100,000 persons in 1998 to 7.4 per 100,000 persons in 2010. Age, sex, Deyo-Charlson comorbidity index score, hospital volume, and surgeon volume were significantly associated with TBI surgery outcomes (p < 0.05). Over the 12-year period analyzed, the estimated mean hospital treatment cost increased 19.06%, whereas the in-hospital mortality rate decreased 10.9%. The estimated mean time of overall survival after TBI surgery (+/- SD) was 83.0 +/- 4.2 months, and the overall in-hospital and 1-, 3-, and 5-year survival rates were 74.5%, 67.3%, 61.1%, and 57.8%, respectively. Conclusions. These data reveal an increased prevalence of TBI, especially in older patients, and an increased hospital treatment cost but a decreased in-hospital mortality rate. Health care providers and patients should recognize that attributes of the patient and of the hospital may affect hospital resource utilization and the mortality rate. These results are relevant not only to other countries with similar population sizes but also to countries with larger populations.	[Shi, Hon-Yi; Lee, I-Chen; Chen, I-Te; Lee, King-Teh] Kaohsiung Med Univ, Coll Med, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Hwang, Shiuh-Lin; Lin, Chih-Lung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Hwang, Shiuh-Lin; Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 80708, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Div Hepatobiliary Surg, Dept Surg, Kaohsiung 80708, Taiwan	Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, 100 Shih Chun 1st Rd, Kaohsiung 80708, Taiwan.	hshi@kmu.edu.tw					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Leitgeb J, 2012, J TRAUMA ACUTE CARE, V72, P1263, DOI 10.1097/TA.0b013e318248ed83; Lin JW, 2008, ACT NEUR S, V101, P113; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Soll-Johanning H, 2004, DAN MED BULL, V51, P207; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7	30	16	18	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1323	1330		10.3171/2014.8.JNS131526			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700004	25280095				2021-06-18	
J	Tu, TW; Turtzo, LC; Williams, RA; Lescher, JD; Dean, DD; Frank, JA				Tu, Tsang-Wei; Turtzo, L. Christine; Williams, Rashida A.; Lescher, Jacob D.; Dean, Dana D.; Frank, Joseph A.			Imaging of Spontaneous Ventriculomegaly and Vascular Malformations in Wistar Rats: Implications for Preclinical Research	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Arteriovenous malformation; Diffusion tensor MRI; Hydrocephalus; MR angiography; Ventriculomegaly; Wistar rats	WHITE-MATTER INTEGRITY; BLOOD-FLOW; CONGENITAL HYDROCEPHALUS; SPINAL-CORD; INTRACRANIAL-PRESSURE; REACTIVE ASTROCYTOSIS; OPTIC-NERVE; DIFFUSION; INJURY; AXON	Wistar rats are widely used in biomedical research and commonly serve as a model organism in neuroscience studies. In most cases when noninvasive imaging is not used, studies assume a consistent baseline condition in rats that lack visible differences. While performing a series of traumatic brain injury studies, we discovered mild spontaneous ventriculomegaly in 70 (43.2%) of 162 Wistar rats that had been obtained from 2 different vendors. Advanced magnetic resonance (MR) imaging techniques, including MR angiography and diffusion tensor imaging, were used to evaluate the rats. Multiple neuropathologic abnormalities, including presumed arteriovenous malformations, aneurysms, cysts, white matter lesions, and astrogliosis were found in association with ventriculomegaly. Postmortem microcomputed tomography and immunohistochemical staining confirmed the presence of aneurysms and arteriovenous malformations. Diffusion tensor imaging showed significant decreases in fractional anisotropy and increases in mean diffusivity, axial diffusivity, and radial diffusivity in multiple white matter tracts (p < 0.05). These results could impact the interpretation, for example, of a pseudo-increase of axon integrity and a pseudo-decrease of myelin integrity, based on characteristics intrinsic to rats with ventriculomegaly. We suggest the use of baseline imaging to prevent the inadvertent introduction of a high degree of variability in preclinical studies of neurologic disease or injury in Wistar rats.	[Tu, Tsang-Wei; Turtzo, L. Christine; Williams, Rashida A.; Lescher, Jacob D.; Frank, Joseph A.] NIH, Frank Lab, Ctr Clin, Bethesda, MD 20892 USA; [Dean, Dana D.] Baylor Univ, Dept Environm Sci, Waco, TX 76798 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	Tu, TW (corresponding author), NIH, Ctr Clin, Bldg 10,Room B1N256,10 Ctr Dr MSC 1074, Bethesda, MD 20892 USA.	tut@cc.nih.gov	Frank, Joseph/W-2021-2019		Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award) [300604-8.01-60855, 305500-8.01-60855]; Intramural Research Programs of the Clinical Center; National Institute of Biomedical Imaging and Bioengineering at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award 300604-8.01-60855 and 305500-8.01-60855) and from the Intramural Research Programs of the Clinical Center and of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health.	Alperin N, 2005, ACT NEUR S, V95, P177; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; Brodbelt A, 2007, BRIT J NEUROSURG, V21, P510, DOI 10.1080/02688690701447420; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Couzin-Frankel J, 2013, SCIENCE, V342, P922, DOI 10.1126/science.342.6161.922; Del Bigio MR, 2001, NEUROSURG CLIN N AM, V12, P639, DOI 10.1016/S1042-3680(18)30022-6; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; Diringer MN, 1998, STROKE, V29, P1352, DOI 10.1161/01.STR.29.7.1352; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; FRANKLIN JB, 1964, J MORPHOL, V115, P273, DOI 10.1002/jmor.1051150210; Fukumitsu H, 2000, CHILD NERV SYST, V16, P516, DOI 10.1007/s003810000305; GRUBB RL, 1975, J NEUROSURG, V43, P385, DOI 10.3171/jns.1975.43.4.0385; ITAKURA T, 1989, ACTA NEUROCHIR, V96, P154, DOI 10.1007/BF01456176; Jain-Ghai S, 2014, PEDIATRICS, V133, pE1092, DOI 10.1542/peds.2013-1230; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Jones Hazel C, 2005, Cerebrospinal Fluid Res, V2, P2, DOI 10.1186/1743-8454-2-2; JONES HC, 1988, NEUROPATH APPL NEURO, V14, P263, DOI 10.1111/j.1365-2990.1988.tb00887.x; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; KOHN DF, 1977, INFECT IMMUN, V16, P680, DOI 10.1128/IAI.16.2.680-689.1977; KOHN DF, 1981, ACTA NEUROPATHOL, V54, P211, DOI 10.1007/BF00687744; KOTO M, 1987, EXP ANIM TOKYO, V36, P157, DOI 10.1538/expanim1978.36.2_157; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levy ML, 2004, J NEUROSURG, V101, P25, DOI 10.3171/ped.2004.101.2.0025; McAllister James P 2nd, 2010, Cerebrospinal Fluid Res, V7, P7, DOI 10.1186/1743-8454-7-7; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Miyan JA, 2001, EXPTL BIOL REV, P91; Mulla MSA, 2012, SCAND J LAB ANIM SCI, V39, P65; MYERS RR, 1982, J NEUROPATH EXP NEUR, V41, P391, DOI 10.1097/00005072-198207000-00002; Ohmiya M, 2001, J NEUROSCI RES, V65, P228, DOI 10.1002/jnr.1146; Otsubo Yutaka, 1997, Neurologia Medico-Chirurgica, V37, P669, DOI 10.2176/nmc.37.669; Pierpaoli C, 2010, P ISMRM 18 ANN M, P1597; Sabharwal Paramveer, 2013, J Pediatr Neurosci, V8, P126, DOI 10.4103/1817-1745.117843; SASAKI S, 1983, NEUROSURGERY, V13, P548, DOI 10.1227/00006123-198311000-00011; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; SHIMIZU A, 1992, CHILD NERV SYST, V8, P25, DOI 10.1007/BF00316558; Sival DA, 2011, BRAIN PATHOL, V21, P163, DOI 10.1111/j.1750-3639.2010.00432.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tu T., 2013, J NEUROSCI NEUROENG, V2, P415; Tu TW, 2014, MAGN RESON IMAGING, V32, P1335, DOI 10.1016/j.mri.2014.07.004; Tu TW, 2013, NMR BIOMED, V26, P1484, DOI 10.1002/nbm.2981; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; VANEDEN CG, 1986, LAB ANIM, V20, P257, DOI 10.1258/002367786780865548; Walker EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2958; Wang R, 2007, P INT SOC MAG RESON, V15, P3720; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; YOSHIDA Y, 1990, Neurologia Medico-Chirurgica, V30, P445, DOI 10.2176/nmc.30.445; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5	53	16	16	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2014	73	12					1152	1165		10.1097/NEN.0000000000000140			14	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AU0DQ	WOS:000345294200007	25383642	Bronze, Green Accepted			2021-06-18	
J	Volman, V; Ng, LJ				Volman, Vladislav; Ng, Laurel J.			Primary paranode demyelination modulates slowly developing axonal depolarization in a model of axonal injury	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Traumatic axonal injury; Demyelination; Trauma; Potassium regulation; Computational neuroscience	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD AXONS; MYELINATED AXONS; ACTION-POTENTIALS; WHITE-MATTER; EXCITABILITY PROPERTIES; POTASSIUM CHANNELS; HUMAN MOTOR	Neurological sequelae of mild traumatic brain injury are associated with the damage to white matter myelinated axons. In vitro models of axonal injury suggest that the progression to pathological ruin is initiated by the mechanical damage to tetrodotoxin-sensitive voltage-gated sodium channels that breaches the ion balance through alteration in kinetic properties of these channels. In myelinated axons, sodium channels are concentrated at nodes of Ranvier, making these sites vulnerable to mechanical injury. Nodal damage can also be inflicted by injury-induced partial demyelination of paranode/juxtaparanode compartments that flank the nodes and contain high density of voltage-gated potassium channels. Demyelination-induced potassium deregulation can further aggravate axonal damage; however, the role of paranode/juxtaparanode demyelination in immediate impairment of axonal function, and its contribution to the development of axonal depolarization remain elusive. A biophysically realistic computational model of myelinated axon that incorporates ion exchange mechanisms and nodal/paranodal/juxtaparanodal organization was developed and used to study the impact of injury-induced demyelination on axonal signal transmission. Injured axons showed alterations in signal propagation that were consistent with the experimental findings and with the notion of reduced axonal excitability immediately post trauma. Injury-induced demyelination strongly modulated the rate of axonal depolarization, suggesting that trauma-induced damage to paranode myelin can affect axonal transition to degradation. Results of these studies clarify the contribution of paranode demyelination to immediate post trauma alterations in axonal function and suggest that partial paranode demyelination should be considered as another "injury parameter" that is likely to determine the stability of axonal function.	[Volman, Vladislav; Ng, Laurel J.] L 3 Appl Technol Simulat Engn & Testing, San Diego, CA 92121 USA; [Volman, Vladislav] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Volman, Vladislav] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA	Volman, V (corresponding author), L 3 Appl Technol Simulat Engn & Testing, 10770 Wateridge Circle,Suite 200, San Diego, CA 92121 USA.	Vladislav.Volman@L-3com.com			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-D-0011]; Direct For Mathematical & Physical ScienNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1308264] Funding Source: National Science Foundation	This work was sponsored by the US Army Medical Research and Materiel Command under contract W81XWH-11-D-0011. This document is cleared for all audiences for OPSEC purposes. Cleared 09/18/2013. The opinions or assertions contained herein are private views of the authors, and are not to be construed as official or as reflecting views of the Department of the Army or the Department of Defense. PAO REVIEWED. The authors declare no competing financial interests.	Bhat MA, 2003, CURR OPIN NEUROBIOL, V13, P552, DOI 10.1016/j.conb.2003.09.004; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Coggan JS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065002; Coggan JS, 2010, P NATL ACAD SCI USA, V107, P20602, DOI 10.1073/pnas.1013798107; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gow A, 2008, NEURON GLIA BIOL, V4, P307, DOI 10.1017/S1740925X09990391; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hille B., 2001, IONS CHANNELS EXCITA; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huff TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017176; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Janigro D, 1997, J NEUROSCI, V17, P2813; Kager H, 2000, J NEUROPHYSIOL, V84, P495; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lauger P., 1991, ELECTROGENIC ION PUM; Lopreore CL, 2008, BIOPHYS J, V95, P2624, DOI 10.1529/biophysj.108.132167; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; MORAN O, 1983, NATURE, V304, P344, DOI 10.1038/304344a0; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Southwood C, 2004, J NEUROSCI, V24, P11215, DOI 10.1523/JNEUROSCI.3479-04.2004; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Steffensen I, 1997, BRAIN RES, V776, P1, DOI 10.1016/S0006-8993(97)00868-8; STEPHANOVA DI, 1995, BIOL CYBERN, V73, P275, DOI 10.1007/s004220050183; Stephanova DI, 2000, BIOL CYBERN, V83, P161, DOI 10.1007/s004220000151; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P2334, DOI 10.1016/j.clinph.2005.07.013; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P1159, DOI 10.1016/j.clinph.2005.01.005; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P1153, DOI 10.1016/j.clinph.2004.12.011; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Stephanova D, 2008, EUR BIOPHYS J BIOPHY, V37, P183, DOI 10.1007/s00249-007-0215-6; Stys PK, 1996, ANN NY ACAD SCI, V779, P366, DOI 10.1111/j.1749-6632.1996.tb44808.x; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; Vabnick I, 1998, J NEUROBIOL, V37, P80, DOI 10.1002/(SICI)1097-4695(199810)37:1<80::AID-NEU7>3.3.CO;2-U; Volman V, 2012, FRONT COMPUT NEUROSC, V6, P1; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zeng SY, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061916	70	16	16	0	9	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	DEC	2014	37	3					439	457		10.1007/s10827-014-0515-7			19	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	AT2LZ	WOS:000344767600004	24986633				2021-06-18	
J	Jagnoor, J; Cameron, ID				Jagnoor, Jagnoor; Cameron, Ian D.			Traumatic brain injury - support for injured people and their carers	AUSTRALIAN FAMILY PHYSICIAN			English	Article						brain injuries; traumatic; rehabilitation; general practice		Background Traumatic brain injury (TBI) is a major cause of lifelong disability and death worldwide, but is considered a 'silent epidemic' as society is largely unaware of the magnitude of the problem. TBI is a complex injury with a broad spectrum of symptoms and disabilities. Patients with a TBI may have a range of physical, mental, cognitive and social problems. Objective This article provides a summary of the available evidence for assessing TBI and managing the common mental health, physical and cognitive/behavioural issues associated with TBI. Discussion Translational and clinical research has revealed that TBI can no longer be regarded as a single clinical entity with a defined outcome. Each type of injury can lead to a distinct clinical condition that requires careful assessment and appropriate management to reduce long-term disability. In this article we discuss some of the more common health issues related to TBI.	[Jagnoor, Jagnoor; Cameron, Ian D.] Univ Sydney, Royal N Shore Hosp, Rehabil Studies Unit, Kolling Inst, St Leonards, NSW 2065, Australia	Jagnoor, J (corresponding author), Univ Sydney, Royal N Shore Hosp, Rehabil Studies Unit, Kolling Inst, St Leonards, NSW 2065, Australia.	jagnoor.jagnoor@sydney.edu.au					Ankri J, 2005, INT J GERIATR PSYCH, V20, P254, DOI 10.1002/gps.1275; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; NSW Government, CAR SUPP PATHW PEOPL; Pirkis Jane, 2005, Aust New Zealand Health Policy, V2, P8, DOI 10.1186/1743-8462-2-8; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2012, TRAUMATIC BRAIN INJU; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; TEASDALE G, 1974, LANCET, V2, P81; TREVENA L, 2004, CLIN PRACTICE GUIDEL; UZZELL BP, 1996, RECOVERY TRAUMATIC B	29	16	17	0	4	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	NOV	2014	43	11					758	763					6	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	V41WU	WOS:000209577100018	25393460				2021-06-18	
J	Kretschmer, A; Altgassen, M; Rendell, PG; Bolte, S				Kretschmer, Anett; Altgassen, Mareike; Rendell, Peter G.; Bolte, Sven			Prospective memory in adults with high-functioning autism spectrum disorders: Exploring effects of implementation intentions and retrospective memory load	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Asperger syndrome; Executive function; Memory for intentions; Implementation intentions; Cognition; Planning abilities; Retrospective memory load	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; EMOTIONAL VALENCE; OLDER-ADULTS; VIRTUAL WEEK; FREE-RECALL; PERFORMANCE; DEFICITS; CHILDREN; TIME	This study examined, for the first time, the impact of implementation intentions on Prospective memory (PM) performance in adults with autism spectrum disorders (ASD) and further explored the role of retrospective memory for PM in ASD. PM was assessed with Virtual Week, a computerized game simulating upcoming everyday-life tasks. Twenty-seven adults with ASD and 27 age- and ability-matched controls were included. Half of the participants were, instructed to form implementation intentions (i.e., encoding PM tasks in form of if-then statements), while the rest received simple PM instructions. Results provide first tentative evidence for beneficial effects of implementation intentions and PM tasks with low demands on retrospective memory for adults with ASD's PM. Overall, results point to the importance of planning and retrospective memory for successful prospective remembering in ASD. (C) 2014 Elsevier Ltd. All rights reserved.	[Kretschmer, Anett; Altgassen, Mareike] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Altgassen, Mareike] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Rendell, Peter G.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Bolte, Sven] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Neuropsychiat Unit, Ctr Neurodev Disorders KIND, Stockholm, Sweden; [Bolte, Sven] Stockholm Cty Council, Div Child & Adolescent Psychiat, Stockholm, Sweden	Kretschmer, A (corresponding author), Tech Univ Dresden, Dept Psychol, Zellescher Weg 17, D-01062 Dresden, Germany.	anett.kretschmer@tu-dresden.de	Altgassen, Mareike/AAN-1767-2020; Kretschmer-Trendowicz, Anett/L-9513-2016; Bolte, Sven/AAH-8675-2019; Altgassen, Mareike/J-3048-2012; Rendell, Peter/E-7539-2010	Altgassen, Mareike/0000-0002-2644-8298; Bolte, Sven/0000-0002-4579-4970; Rendell, Peter/0000-0002-4829-4322			Aarts H, 1999, EUR J SOC PSYCHOL, V29, P971, DOI 10.1002/(SICI)1099-0992(199912)29:8<971::AID-EJSP963>3.0.CO;2-A; Achenbach T. M., 2003, ADULT SELF REPORT; Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; Altgassen M, 2012, J AUTISM DEV DISORD, V42, P2141, DOI 10.1007/s10803-012-1466-3; Altgassen M, 2010, J NEURODEV DISORD, V2, P2, DOI 10.1007/s11689-009-9030-y; Altgassen M, 2009, BRAIN IMPAIR, V10, P52, DOI 10.1375/brim.10.1.52; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bastin C., 2002, CURRENT PSYCHOL LETT, V7, P105; Bebko J. M., 2000, AUTISM, V4, P299, DOI DOI 10.1177/1362361300004003006; Bennetto L, 1996, CHILD DEV, V67, P1816, DOI 10.1111/j.1467-8624.1996.tb01830.x; Bishop S.L., 2001, AUTISM DIAGNOSTIC OB; Boucher J, 2012, PSYCHOL BULL, V138, P458, DOI 10.1037/a0026869; Bowler DM, 2000, J ABNORM PSYCHOL, V109, P663, DOI 10.1037//0021-843X.109.4.663; Brandimonte M., 1996, PROSPECTIVE MEMORY T; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Breneiser J. E, 2009, N AM J PSYCHOL, V11, P401; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; Dunn L. M., 2007, PEABODY PICTURE VOCA, V4; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 2003, J EXP PSYCHOL-APPL, V9, P147, DOI 10.1037/1076-898X.9.3.147; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Foster ER, 2013, NEUROPSYCHOLOGY, V27, P170, DOI 10.1037/a0031946; Gaigg SB, 2008, NEUROPSYCHOLOGIA, V46, P983, DOI 10.1016/j.neuropsychologia.2007.11.011; Gollwitzer P.M., 1993, EUR REV SOC PSYCHOL, VVol. 4, P141, DOI DOI 10.1080/14792779343000059; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Henry J. D., 2014, J EXPT CHILD PSYCHOL; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Jones CRG, 2011, J AUTISM DEV DISORD, V41, P455, DOI 10.1007/s10803-010-1067-y; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2004, MEMORY, V12, P553, DOI 10.1080/09658210344000099; Kliegel M., 2008, PROSPECTIVE MEMORY C, P283; Kliegel M, 2002, PSYCHOL BEITR, V44, P303, DOI DOI 10.1037/0012-1649.44.2.612; Leitz JR, 2009, PSYCHOPHARMACOLOGY, V205, P379, DOI 10.1007/s00213-009-1546-z; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mackinlay R, 2006, BRAIN COGNITION, V61, P14, DOI 10.1016/j.bandc.2005.12.006; Mantyla T, 1997, AGING NEUROPSYCHOL C, V4, P81, DOI 10.1080/13825589708256638; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McFarland CP, 2011, AGING NEUROPSYCHOL C, V18, P633, DOI 10.1080/13825585.2011.613449; Meeks JT, 2010, PSYCHOL RES-PSYCH FO, V74, P82, DOI 10.1007/s00426-008-0223-x; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; OZONOFF S, 1994, DEV PSYCHOPATHOL, V6, P415, DOI 10.1017/S0954579400006027; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Paraskevaides T, 2010, PSYCHOPHARMACOLOGY, V208, P301, DOI 10.1007/s00213-009-1731-0; Pereira A, 2012, AGING NEUROPSYCHOL C, V19, P549, DOI 10.1080/13825585.2011.638977; PRIOR M, 1990, J AUTISM DEV DISORD, V20, P581, DOI 10.1007/BF02216063; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Raven J.C., 2008, STANDARD PROGR MATRI; Rendell PG, 2012, J CLIN EXP NEUROPSYC, V34, P738, DOI 10.1080/13803395.2012.670388; Rendell PG, 2011, COGNITION EMOTION, V25, P916, DOI 10.1080/02699931.2010.508610; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Rummel J, 2012, MEMORY, V20, P803, DOI 10.1080/09658211.2012.707214; Schnitzspahn K. M., 2014, FUTURE THINKIN UNPUB; Schnitzspahn KM, 2009, EUR J AGEING, V6, P147, DOI 10.1007/s10433-009-0116-x; SCHOPLER E, 1984, EFFECTS AUTISM FAMIL, P65; Smith BJ, 2007, J AUTISM DEV DISORD, V37, P445, DOI 10.1007/s10803-006-0180-4; TERRY WS, 1988, PSYCHOL REP, V62, P299, DOI 10.2466/pr0.1988.62.1.299; Trawley SL, 2014, J COGN PSYCHOL, V26, P39, DOI 10.1080/20445911.2013.852199; Webb TL, 2003, J EXP SOC PSYCHOL, V39, P279, DOI 10.1016/S0022-1031(02)00527-9; WILLIAMS D, 2013, CHEM IND-LONDON, V77, P43, DOI DOI 10.L007/S10803-012-1703-9; Williams DM, 2014, NEUROPSYCHOLOGY, V28, P30, DOI 10.1037/neu0000008; Zimmermann TD, 2010, APPL COGNITIVE PSYCH, V24, P645, DOI 10.1002/acp.1576; Zinke K, 2010, CHILD NEUROPSYCHOL, V16, P229, DOI 10.1080/09297040903559648	72	16	16	4	32	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	NOV	2014	35	11					3108	3118		10.1016/j.ridd.2014.07.052			11	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	AO7PY	WOS:000341546300050	25151603				2021-06-18	
J	Smedema, SM				Smedema, Susan Miller			Core Self-Evaluations and Well-Being in Persons With Disabilities	REHABILITATION PSYCHOLOGY			English	Article						core self-evaluation; subjective well-being; persons with disabilities	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; POSITIVE PSYCHOLOGY; JOB-SATISFACTION; SOCIAL SUPPORT; EFFICACY; PEOPLE; ESTEEM; HEALTH; NEUROTICISM	Purpose: The purpose of this article is to introduce the concept of core self-evaluations (CSE), which is conceptualized as the overall, fundamental perception that individuals have about their worth and capability as people (Judge, Locke, Durham, & Kluger, 1998). CSE is a higher order variable that is reflective of the self-concept and comprises personality traits including self-esteem, generalized self-efficacy, locus of control, and emotional stability. Method: In this article, the theoretical background of the CSE construct is reviewed, the existing literature on CSE in the general population is summarized, and future directions for the use of CSE in rehabilitation psychology research and clinical settings is proposed. Implications: CSE has great potential as a global positive contributor of well-being in persons with disabilities, and research addressing its relationship with outcomes such as well-being and its clinical applications has great promise to augment rehabilitation psychology practice in the future.	[Smedema, Susan Miller] Univ Wisconsin, Madison, WI 53706 USA	Smedema, SM (corresponding author), Univ Wisconsin, Dept Rehabil Psychol & Special Educ, 1000 Bascom Mall,Room 419, Madison, WI 53706 USA.	ssmedema@wisc.edu					BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI; Barone D., 1997, SOCIAL COGNITIVE PSY, DOI DOI 10.1007/978-1-4615-5843-9; Berry JW, 2007, J PERS ASSESS, V89, P292, DOI 10.1080/00223890701629813; BOLGER N, 1991, J PERS, V59, P355, DOI 10.1111/j.1467-6494.1991.tb00253.x; Burns R.B., 1979, SELF CONCEPT THEORY; Chan F, 2009, REHABIL COUNS BULL, V52, P114, DOI 10.1177/0034355208323947; Chang CH, 2012, J MANAGE, V38, P81, DOI 10.1177/0149206311419661; Chronister J, 2013, J COMMUNITY PSYCHOL, V41, P582, DOI 10.1002/jcop.21558; Coopersmith S., 1967, ANTECEDENTS SELF EST; COSTA PT, 1988, J PERS SOC PSYCHOL, V55, P258, DOI 10.1037/0022-3514.55.2.258; Csikszentmihalyi M., 2000, BOREDOM ANXIETY; Devereux PG, 2005, QUAL HEALTH RES, V15, P1360, DOI 10.1177/1049732305282200; Diener E., 2005, HDB POSITIVE PSYCHOL, P63; Dunn DS, 2005, REHABIL PSYCHOL, V50, P305, DOI 10.1037/0090-5550.50.3.305; Endermann M, 2009, SEIZURE-EUR J EPILEP, V18, P167, DOI 10.1016/j.seizure.2008.08.013; Eysenck H. J, 1975, MANUAL EYSENCK PERSO; Eysenck H. J., 1990, HDB PERSONALITY THEO, P244; Ferris DL, 2011, PERS PSYCHOL, V64, P137, DOI 10.1111/j.1744-6570.2010.01204.x; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; Gomez V, 2012, J RES PERS, V46, P317, DOI 10.1016/j.jrp.2012.03.001; Hampton NZ, 2004, REHABIL COUNS BULL, V48, P31, DOI 10.1177/00343552040480010401; Hampton NZ, 2000, REHABIL COUNS BULL, V43, P66; HEINEMANN AW, 1982, REHABIL COUNS BULL, V25, P197; HEPPNER PP, 2005, HDB POSITIVE PSYCHOL, P288; James W, 1890, PRINCIPLES PSYCHOL, DOI [10.1037/11059-000, DOI 10.1037/11059-000]; Johnson RE, 2011, J APPL PSYCHOL, V96, P744, DOI 10.1037/a0021504; Judge TA, 1997, RES ORGAN BEHAV, V19, P151; Judge TA, 2005, J APPL PSYCHOL, V90, P257, DOI 10.1037/0021-9010.90.2.257; Judge TA, 1998, J APPL PSYCHOL, V83, P17, DOI 10.1037/0021-9010.83.1.17; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Judge TA, 2000, J APPL PSYCHOL, V85, P237, DOI 10.1037//0021-9010.85.2.237; Kammeyer-Mueller JD, 2009, J APPL PSYCHOL, V94, P177, DOI 10.1037/a0013214; Krause JS, 1998, REHABIL COUNS BULL, V41, P162; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Levenson H., 1981, RES LOCUS CONTROL CO, V1, P15, DOI DOI 10.1016/B978-0-12-443201-7.50006-3; Li L, 1998, J SOC PSYCHOL, V138, P13, DOI 10.1080/00224549809600349; Linkowski D. C., 1974, REHABILITATION COUNS, V17, P28; Livneh H, 2005, J COUNS DEV, V83, P12, DOI 10.1002/j.1556-6678.2005.tb00575.x; LIVNEH H, 2000, J APPL REHABILITATIO, V31, P3; Livneh H., 1997, PSYCHOSOCIAL ADAPTAT; Maddux JE., 1995, SELF EFFICACY ADAPTA, P143, DOI [10.1007/978-1-4419-6868-5_5, DOI 10.1007/978-1-4419-6868-5_5]; Maddux JE., 2005, HDB POSITIVE PSYCHOL, P277; MARINI I, 1995, REHABIL COUNS BULL, V38, P198; MARSHAK LE, 1993, COUNSELING PERSONS P; Martz E., 2000, J APPL REHABILITATIO, V31, P14; MEHNERT T, 1990, REHABIL PSYCHOL, V35, P3, DOI 10.1037/h0079046; Miller SM, 2009, DISABIL REHABIL, V31, P988, DOI 10.1080/09638280802378025; Nosek MA, 2003, SOC SCI MED, V56, P1737, DOI 10.1016/S0277-9536(02)00169-7; Nosek MA, 2001, J REHABIL, V67, P20; Packer E., 1985, OBJECTIVIST FORUM, V6, P1; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Post MWM, 1997, SPINAL CORD, V35, P109, DOI 10.1038/sj.sc.3100362; Reich J. W., 1997, HDB HLTH BEHAV RES, P93; Roessler R. T., 1978, PSYCHOSOCIAL ADJUSTM; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1126/science.148.3671.804; ROTTER JB, 1966, PSYCHOL MONOGRAPHS, V80; Schwarzer R, 1995, MEASURES HLTH PSYCHO, P35; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; SHADISH WR, 1981, J CONSULT CLIN PSYCH, V49, P297, DOI 10.1037/0022-006X.49.2.297; Shnek ZM, 1997, ANN BEHAV MED, V19, P287, DOI 10.1007/BF02892293; Smedema SM, 2010, REHABIL COUNS BULL, V53, P131, DOI 10.1177/0034355209358272; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Tsaousis I, 2007, PERS INDIV DIFFER, V42, P1441, DOI 10.1016/j.paid.2006.10.025; Turner K. D., 1990, J REHABIL, V46, P19; Wells L. E., 1976, SELF ESTEEM ITS CONC; Williams S. L., 1995, SELF EFFICACY ADAPTA, P69; World Health Organization, 2001, INT CLASS FUNCT DIS; Wright B.A., 1983, PHYS DISABILITY PSYC, V2nd edition; Wright B. A., 1960, PHYS DISABILITY PSYC; ZUROFF DC, 1980, J PERS SOC PSYCHOL, V39, P130, DOI 10.1037/0022-3514.39.1.130	73	16	16	0	35	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2014	59	4					407	414		10.1037/rep0000013			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	AT8BQ	WOS:000345159200005	25383725				2021-06-18	
J	Kramer, CL; Rabinstein, AA; Wijdicks, EFM; Hocker, SE				Kramer, Christopher L.; Rabinstein, Alejandro A.; Wijdicks, Eelco F. M.; Hocker, Sara E.			Neurologist Versus Machine: Is the Pupillometer Better than the Naked Eye in Detecting Pupillary Reactivity	NEUROCRITICAL CARE			English	Article						Pupillometer; Neurological examination; Brain death; Uncal herniation; Neurocritical care; Pupillary reactivity	QUALITY STANDARDS SUBCOMMITTEE; AMERICAN ACADEMY; SCALE; COMA	A 62-year-old man with severe traumatic brain injury developed postsurgical anisocoria in which there was a discrepancy between pupillometer and manual testing. Case report. The patient's larger pupil was read as unreactive by the pupillometer but constricted 1 mm over 7-9 s of continuous light stimulation. While pupillometry assessment is a valuable adjunct to the manual pupillary assessment, this case demonstrates that nonreactive pupils read on the pupillometer should be confirmed with the manual examination because it can miss very slowly reacting pupils.	[Kramer, Christopher L.; Rabinstein, Alejandro A.; Wijdicks, Eelco F. M.; Hocker, Sara E.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA	Kramer, CL (corresponding author), Mayo Clin, Dept Neurol, Mary Brigh 8-D,200 First St SW, Rochester, MN 55905 USA.	kramer.christopher1@mayo.edu; Rabinstein.Alejandro@mayo.edu; wijde@mayo.edu; Hocker.Sara@mayo.edu					Bushnell CD, 1999, NEUROLOGY, V52, P1374, DOI 10.1212/WNL.52.7.1374; Clark A, 2006, EMERG MED J, V23, P440, DOI 10.1136/emj.2005.030247; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; VANDENBERGE JH, 1979, J NEUROL NEUROSUR PS, V42, P1163, DOI 10.1136/jnnp.42.12.1163; Walters BC, 2000, BRAIN TRAUMA FDN GUI, P186; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wilson S F, 1988, J Neurosci Nurs, V20, P189	12	16	16	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					309	311		10.1007/s12028-014-9988-5			3	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900019	24865269				2021-06-18	
J	Kreitzer, N; Lyons, MS; Hart, K; Lindsell, CJ; Chung, S; Yick, A; Bonomo, J				Kreitzer, Natalie; Lyons, Michael S.; Hart, Kim; Lindsell, Cristopher J.; Chung, Sora; Yick, Andrew; Bonomo, Jordan			Repeat Neuroimaging of Mild Traumatic Brain-injured Patients With Acute Traumatic Intracranial Hemorrhage: Clinical Outcomes and Radiographic Features	ACADEMIC EMERGENCY MEDICINE			English	Article							CRANIAL COMPUTED-TOMOGRAPHY; SUBARACHNOID HEMORRHAGE; PREDICTORS; EVOLUTION	ObjectivesEmergency department (ED) management of mild traumatic brain injury (TBI) patients with any form of traumatic intracranial hemorrhage (ICH) is variable. Since 2000, our center's standard practice has been to obtain a repeat head computed tomography (CT) at least 6 hours after initial imaging. Patients are eligible for discharge if clinical and CT findings are stable. Whether this practice is safe is unknown. This study characterized clinical outcomes in mild TBI patients with acute traumatic ICH seen on initial ED neuroimaging. MethodsThis retrospective cohort study included patients presenting to the ED with blunt mild TBI with Glasgow Coma Scale (GCS) scores of 14 or 15 and stable vital signs, during the period from January 2001 to January 2010. Patients with any ICH on initial head CT and repeat head CT within 24 hours were eligible. Cases were excluded for initial GCS < 14, injury > 24 hours old, pregnancy, concomitant nonminor injuries, and coagulopathy. A single investigator abstracted data from records using a standardized case report form and data dictionary. Primary endpoints included death, neurosurgical procedures, and for discharged patients, return to the ED within 7 days. Differences in proportions were computed with 95% confidence intervals (CIs). ResultsOf 1,011 patients who presented to the ED and had two head CTs within 24 hours, 323 (32%) met inclusion criteria. The median time between CT scans was 6 hours (interquartile range = 5 to 7 hours). A total of 153 (47%) patients had subarachnoid hemorrhage, 132 (41%) patients had subdural hemorrhage, 11 (3%) patients had epidural hemorrhage, 78 (24%) patients had cerebral contusions, and 59 (18%) patients had intraparenchymal hemorrhage. Four of 323 (1.2%, 95% CI = 0.3% to 3.2%) patients died within 2 weeks of injury. Three of the patients who died had been admitted from the ED on their initial visits, and one had been discharged home. There were 206 patients (64%) discharged from the ED, 28 (13.6%) of whom returned to the ED within 1 week. Of the 92 who were hospitalized, three (0.9%, 95% CI = 0.2% to 2.7%) required neurosurgical intervention. ConclusionDischarge after a repeat head CT and brief period of observation in the ED allowed early discharge of a cohort of mild TBI patients with traumatic ICH without delayed adverse outcomes. Whether this justifies the cost and radiation exposure involved with this pattern of practice requires further study. Resumen ObjetivosEl manejo de los pacientes con traumatismo craneoencefalico leve (TCEL) en el servicio de urgencias (SU) con cualquier forma de hemorragia intracraneal traumatica (HICT) es variable. Desde el ano 2000, la practica habitual de nuestro centro ha sido obtener una nueva tomografia computarizada (TC) craneal al menos seis horas tras la prueba de imagen inicial. Los pacientes son candidatos para el alta si los hallazgos clinicos y de la TC son estables. No se sabe si esta practica es segura. Este estudio determino los resultados clinicos en los pacientes con TCEL con HICT aguda diagnosticada en la prueba de imagen inicial del SU. MetodologiaEstudio de cohorte retrospectivo que incluyo a los pacientes que acudieron al SU con TCEL cerrado con una puntuacion de 14 o 15 en la Escala del Coma de Glasgow (ECG) y estabilidad hemodinamica durante el periodo de enero de 2001 a enero de 2010. Se incluyeron los pacientes con cualquier HICT en la TC craneal inicial y un TC craneal repetido en las primeras 24 horas. Se excluyeron casos con puntuacion inicial en la ECG <14, traumatismo hacia mas de 24 horas, embarazo, lesiones no leves concomitantes y coagulopatia. Un unico investigador recogio los datos de las historias clinicas usando un formulario estandarizado del informe del caso y un diccionario de datos. Los resultados principales incluyeron muerte, procedimientos neuroquirurgicos y, para los pacientes dados de alta, revisita al SU en los primeros siete dias. Se calcularon las diferencias en las proporciones con sus intervalos de confianza (IC) del 95%. ResultadosDe los 1.011 paciente que acudieron al SU y tuvieron dos TC craneales en las primeras 24 horas, 323 (32%) cumplieron los criterios de inclusion. La mediana de tiempo entre los TC fue de 6 horas (rango intercuartilico [RIC] de 2 horas). Los hallazgos del TC inicial fueron: hematoma epidural, contusion cerebral, hematoma subdural, hemorragia intraparenquimatosa, hemorragia subaracnoidea o su combinacion. Ciento cincuenta y tres (47%) pacientes tuvieron hemorragia subaracnoidea, 132 (41%) hematoma subdural, 11 (3%) hematoma epidural, 78 (24%) contusion cerebral y 59 (18%) hemorragia intraparenquimatosa. Cuatro de 323 (1,2%, IC 95% = 0,3% a 3,2%) pacientes fallecieron en las primeras 2 semanas del traumatismo. Tres de los pacientes que murieron se habian ingresado desde el SU en la visita inicial y uno habia sido dado de alta al domicilio. Hubo 206 pacientes (64%) dados de alta desde el SU, 28 (1,6%) de los cuales revisitaron el SU en la primera semana. De los 92 que se ingresaron, 3 (0,9%, IC 95% = 0,2% a 2,7%) requirieron una intervencion neuroquirurgica. ConclusionesEl alta tras un TC craneal repetido y un breve periodo de observacion en el SU permitio altas precoces en una cohorte de pacientes con TCEL con HICT sin resultados adversos diferidos. Se requieren futuros estudios si esta forma de actuar justifica los costes y la exposicion a la radiacion.ACADEMIC EMERGENCY MEDICINE 2014; 21: 1084-1091 (C) 2014 by the Society for Academic Emergency Medicine	[Kreitzer, Natalie; Lyons, Michael S.; Hart, Kim; Lindsell, Cristopher J.; Chung, Sora; Yick, Andrew; Bonomo, Jordan] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA	Kreitzer, N (corresponding author), Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA.	kreitzne@ucmail.uc.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR026314, 5UL1RR026314-03] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS047996] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996] Funding Source: NIH RePORTER		Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Bugaev N, 2013, J TRAUMA ACUTE CARE, V74, P1151, DOI 10.1097/TA.0b013e3182827191; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; Leiner Tim, 2013, Ned Tijdschr Geneeskd, V157, pA6711; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; REINUS WR, 1993, ANN EMERG MED, V22, P1148, DOI 10.1016/S0196-0644(05)80981-3; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Valadka A. B., 2004, TRAUMA, P385; Verma RK, 2013, EUR J RADIOL, V82, P1539, DOI 10.1016/j.ejrad.2013.03.021; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	22	16	16	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	OCT	2014	21	10					1084	1091		10.1111/acem.12479			8	Emergency Medicine	Emergency Medicine	AR8KA	WOS:000343822800002	25308130	Green Accepted			2021-06-18	
J	Ma, L; Roberts, JS; Pihoker, C; Richards, TL; Shaw, DWW; Marro, KI; Vavilala, MS				Ma, Li; Roberts, Joan S.; Pihoker, Catherine; Richards, Todd L.; Shaw, Dennis W. W.; Marro, Ken I.; Vavilala, Monica S.			Transcranial Doppler-Based Assessment of Cerebral Autoregulation in Critically Ill Children During Diabetic Ketoacidosis Treatment	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cerebral autoregulation; cerebral blood flow; cerebral edema; cerebral perfusion; diabetic ketoacidosis	CAUSE-SPECIFIC MORTALITY; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW VELOCITY; GENDER-DIFFERENCES; EDEMA; HYPEREMIA; ANTERIOR	Objectives: Impaired cerebral autoregulation may be associated with poor outcome in diabetic ketoacidosis. We examined change in cerebral autoregulation during diabetic ketoacidosis treatment. Design: Prospective observational cohort study. Setting: Tertiary care children's hospital. Patients/Subjects: Children admitted to the ICU with diabetic ketoacidosis (venous pH < 7.3, glucose > 300 mg/dL, Hco(3) < 15 mEq/L, and ketonuria) constituted cases, and children with type I diabetes without diabetic ketoacidosis constituted controls. Interventions: None. Measurements and Main Results: Between 2005 and 2009, 32 cases and 50 controls were enrolled. Transcranial Doppler ultrasonography was used to measure middle cerebral artery flow velocities, and cerebral autoregulation testing was achieved via tilt-table testing. Cases underwent two and controls underwent one cerebral autoregulation test. Cerebral autoregulation was quantified by the autoregulatory index (autoregulatory index < 0.4 = impaired and autoregulatory index 0.4-1.0 = intact autoregulation). The first autoregulation test was obtained early (time 1, 12-24 hr; median [interquartile range], 8 hr [5-18 hr]) during diabetic ketoacidosis treatment, and a second autoregulation test was obtained during recovery (time 2, 36-72 hr; median [-interquartile range], 46 hr [40-59 hr]) from time 0 (defined as time of insulin start). Cases had lower autoregulatory index at time 1 than time 2 (p < 0.001) as well lower autoregulatory index than control subjects (p < 0.001). Cerebral autoregulation was impaired in 40% (n = 13) of cases at time 1 and in 6% (n = 2) of cases at time 2. Five cases (17%) showed persistent impairment of cerebral autoregulation between times 1 and 2 of treatment. All control subjects had intact cerebral autoregulation. Conclusions: Impaired cerebral autoregulation was common early during diabetic ketoacidosis treatment. Although the majority improved during diabetic ketoacidosis treatment, 17% of subjects had impairment between 36 and 72 hours after start of insulin therapy. The observed impaired cerebral autoregulation appears specific to the diabetic ketoacidosis process in patients with type I diabetes.	[Ma, Li; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Roberts, Joan S.; Pihoker, Catherine; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Roberts, Joan S.; Pihoker, Catherine; Shaw, Dennis W. W.] Seattle Childrens Hosp, Seattle, WA USA; [Richards, Todd L.; Marro, Ken I.; Vavilala, Monica S.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA	Vavilala, MS (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	vavilala@uw.edu			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD049832-02]; Department of Anesthesiology and Pain Medicine, University of WashingtonUniversity of Washington; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); JDRFJuvenile Diabetes Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD049832] Funding Source: NIH RePORTER	Supported, in part, by National Institute of Child Health and Human Development (R21HD049832-02) and Department of Anesthesiology and Pain Medicine, University of Washington.; Dr. Vavilala received support for article research from the National Institutes of Health (NIH). Her institution received grant support from the NIH. Dr. Roberts is employed by LUMG. Dr. Pihoker's institution received funding from CDC, NIDDK, and JDRF for diabetes grants. Dr. Richards consults for a company to review scientific grants, receives royalties from a book on brain and learning, received support for travel from a NIH grant, and received support for article research from the NIH. Dr. Richards and his institution have a patent on DTI imaging. His institution received grant support from the NIH grants and contract and is employed by the University of Washington. Dr. Marro received support for article research from the NIH. His institution received grant support from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Aoi MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046794; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Deeter KH, 2011, PEDIATR DIABETES, V12, P295, DOI 10.1111/j.1399-5448.2010.00695.x; Dillon ES, 1936, AM J MED SCI, V192, P360, DOI 10.1097/00000441-193609000-00007; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Glaser NS, 2013, J PEDIATR-US, V163, P1111, DOI 10.1016/j.jpeds.2013.06.008; HOFFMAN WH, 1995, J CLIN ULTRASOUND, V23, P517, DOI 10.1002/jcu.1870230903; Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x; Levin DL, 2008, PEDIATR CRIT CARE ME, V9, P320, DOI 10.1097/PCC.0b013e31816c7082; ORCHARD TJ, 1991, DIABETES CARE, V14, P55; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Roberts JS, 2006, CRIT CARE MED, V34, P2217, DOI 10.1097/01.CCM.0000227182.51591.21; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2011, PEDIATR CRIT CARE ME, V12, pE344, DOI 10.1097/PCC.0b013e3182196c9c; Vavilala MS, 2010, PEDIATR CRIT CARE ME, V11, P332, DOI 10.1097/PCC.0b013e3181c013f4; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Yuen N, 2008, DIABETES, V57, P2588, DOI 10.2337/db07-1410	25	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2014	15	8					742	749		10.1097/PCC.0000000000000197			8	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	AQ8CD	WOS:000343049200012	25072475				2021-06-18	
J	Margetis, K; Korfias, SI; Gatzonis, S; Boutos, N; Stranjalis, G; Boviatsis, E; Sakas, DE				Margetis, Konstantinos; Korfias, Stefanos I.; Gatzonis, Stylianos; Boutos, Nick; Stranjalis, George; Boviatsis, Efstathios; Sakas, Damianos E.			Intrathecal Baclofen Associated With Improvement of Consciousness Disorders in Spasticity Patients	NEUROMODULATION			English	Article						Baclofen; consciousness disorders; GABA-B; infusion pump; intrathecal drug delivery; MeSH; persistent vegetative state; receptors; therapy	THALAMIC RETICULAR NUCLEUS; TRAUMATIC BRAIN-INJURY; GABA(B) RECEPTORS; VEGETATIVE STATE; SELECTIVE LOSS; BASAL GANGLIA; RECOVERY; NEURONS; INHIBITION; HYPOCRETIN	ObjectiveIntrathecal baclofen (ITB) pump is a therapeutic option for persistent vegetative state and minimal conscious state patients that have associated spasticity. We investigated whether this treatment modality can affect their level of consciousness. MethodIn this prospective, open label, observational study, we implanted ITB pumps for the treatment of spasticity in eight patients with disorders of consciousness (vegetative state and minimally conscious state) and we followed them with the Coma Recovery Scale-Revised, the Eastern Cooperative Oncology Group (ECOG) performance scale, and the Modified Ashworth spasticity scale. Baclofen dose and complications also were noted. ResultsThe offending pathologies were traumatic brain injury in six, anoxia due to cardiac arrest in one, acute obstructive hydrocephalus in one. Two of the patients showed a marked, persistent improvement that fulfilled the criteria of emergence from minimally conscious state. Two of patients had their ITB pumps prematurely removed because of complications. The ECOG score was 4 for all patients and did not change during the study. ConclusionITB might be associated with a significant improvement in the disorder of consciousness of two patients from a total of six that had a chronic ITB treatment.	[Margetis, Konstantinos; Korfias, Stefanos I.; Gatzonis, Stylianos; Boutos, Nick; Stranjalis, George; Boviatsis, Efstathios; Sakas, Damianos E.] Univ Athens, Dept Neurosurg 1, Athens 10676, Greece	Margetis, K (corresponding author), Univ Athens, Dept Neurosurg, Evangelismos Hosp, Ipsilantou 45, Athens 10676, Greece.	konstantinmarg@yahoo.com	Margetis, Konstantinos/M-1104-2019				Ambardekar AV, 1999, NEUROSCIENCE, V93, P1339, DOI 10.1016/S0306-4522(99)00282-1; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bowery NG, 2010, ADV PHARMACOL, V58, P1, DOI 10.1016/S1054-3589(10)58001-3; BOWERY NG, 1987, NEUROSCIENCE, V20, P365, DOI 10.1016/0306-4522(87)90098-4; Bowery NG, 1999, NEUROPHARMACOLOGY, V38, P1675, DOI 10.1016/S0028-3908(99)00130-6; BOWERY NG, 1992, ARZNEIMITTELFORSCH, V42-1, P215; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Ferrarelli F, 2011, SCHIZOPHRENIA BULL, V37, P306, DOI 10.1093/schbul/sbq142; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Kawecki Zdzislaw, 2007, Przegl Lek, V64 Suppl 2, P13; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Margetis K, 2014, J CLIN PSYCHOPHARM, V34, P171, DOI 10.1097/JCP.0b013e3182a59232; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; McAlonan K, 2000, J NEUROSCI, V20, P8897; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Montero VM, 1999, NEUROSCIENCE, V91, P805, DOI 10.1016/S0306-4522(98)00632-0; Montero VM, 1997, NEUROSCIENCE, V76, P1069, DOI 10.1016/S0306-4522(96)00417-4; Montero VM, 2000, BRAIN RES, V864, P95, DOI 10.1016/S0006-8993(00)02182-X; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Oyama H, 2010, NEUROL MED-CHIR, V50, P386, DOI 10.2176/nmc.50.386; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pistoia F, 2013, BRAIN INJURY, V27, P1330, DOI 10.3109/02699052.2013.809554; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Posner J., 2007, PLUM POSNERS DIAGNOS, V4; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stevens DR, 1999, EUR J NEUROSCI, V11, P1148, DOI 10.1046/j.1460-9568.1999.00519.x; Taira T, 2007, ACTA NEUROCHIR SUPPL, V97, P227; Taira T, 2003, ACT NEUR S, V87, P37; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Ulrich D, 1996, P NATL ACAD SCI USA, V93, P13245, DOI 10.1073/pnas.93.23.13245; Ulrich D, 1996, J PHYSIOL-LONDON, V493, P845, DOI 10.1113/jphysiol.1996.sp021427; Ulrich D, 2007, J NEUROPHYSIOL, V98, P3791, DOI 10.1152/jn.00756.2007; Weese GD, 1999, J NEUROSCI, V19, P10135; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Xie XM, 2006, J PHYSIOL-LONDON, V574, P399, DOI 10.1113/jphysiol.2006.108266	50	16	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	OCT	2014	17	7					699	704		10.1111/ner.12147			6	Medicine, Research & Experimental; Clinical Neurology	Research & Experimental Medicine; Neurosciences & Neurology	AU3KT	WOS:000345512700017	24350688				2021-06-18	
J	Scher, AI; Ross, GW; Sigurdsson, S; Garcia, M; Gudmundsson, LS; Sveinbojrnsdottir, S; Wagner, AK; Gudnason, V; Launer, LJ				Scher, Ann I.; Ross, G. Webster; Sigurdsson, Sigurdur; Garcia, Melissa; Gudmundsson, Larus S.; Sveinboejrnsdottir, Sigurlaug; Wagner, Amy K.; Gudnason, Vilmundur; Launer, Lenore J.			Midlife migraine and late-life parkinsonism AGES-Reykjavik Study	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; RESTLESS LEGS SYNDROME; CHRONIC DAILY HEADACHE; DISEASE; IRON; DOPAMINE; RISK; DYSFUNCTION; PREVALENCE; FEATURES	Objective: In the present study, we tested the hypothesis that having migraine in middle age is related to late-life parkinsonism and a related disorder, restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED). Methods: The AGES-Reykjavik cohort (born 1907-1935) has been followed since 1967. Headaches were classified based on symptoms assessed in middle age. From 2002 to 2006, 5,764 participants were reexamined to assess symptoms of parkinsonism, diagnosis of Parkinson disease (PD), family history of PD, and RLS/WED. Results: Subjects with midlife migraine, particularly migraine with aura (MA), were in later life more likely than others to report parkinsonian symptoms (odds ratio [OR] MA = 3.6 [95% CI 2.7-4.8]) and diagnosed PD (ORMA = 2.5 [95% CI 1.2-5.2]). Women with MA were more likely than others to have a parent (ORMA = 2.26 [95% CI 1.3-4.0]) or sibling (ORMA = 1.78 [95% CI 1.1-2.9]) with PD. Late-life RLS/WED was increased for headache generally. Associations were independent of cardiovascular disease and MRI-evident presumed ischemic lesions. Conclusions: These findings suggest there may be a common vulnerability to, or consequences of, migraine and multiple indicators of parkinsonism. Additional genetic and longitudinal observational studies are needed to identify candidate pathways that may account for the comorbid constellation of symptoms.	[Scher, Ann I.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Scher, Ann I.; Garcia, Melissa; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Ross, G. Webster] Vet Affairs Pacific Islands Hlth Care Syst, Honolulu, HI USA; [Ross, G. Webster] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Sigurdsson, Sigurdur; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gudmundsson, Larus S.] Univ Iceland, Sch Hlth Sci, Reykjavik, Iceland; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Sveinboejrnsdottir, Sigurlaug] Broomfield Hosp, Dept Neurol, Chelmsford, Essex, England; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA	Scher, AI (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	ascher@usuhs.mil	Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019	Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Scher, Ann/0000-0003-4599-9834; Gudmundsson, Larus S/0000-0003-4660-1111	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [N01-AG-12100]; National Institute on Aging Intramural Program, Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [N01AG012100] Funding Source: NIH RePORTER	The AGES-Reykjavik Study was supported by NIH N01-AG-12100, the National Institute on Aging Intramural Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The views expressed in this work are those of the authors and do not necessarily reflect the official policy or position of the Department of Defense or the US Government.	Allen RP, 2001, NEUROLOGY, V56, P263, DOI 10.1212/WNL.56.2.263; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barbanti P, 2002, CEPHALALGIA, V22, P2, DOI 10.1046/j.1468-2982.2002.00313.x; Barbanti P, 2000, CEPHALALGIA, V20, P720, DOI 10.1046/j.1468-2982.2000.00123.x; Barbanti P, 2013, NEUROL SCI, V34, pS67, DOI 10.1007/s10072-013-1415-8; Bashir A, 2013, NEUROLOGY, V81, P1260, DOI 10.1212/WNL.0b013e3182a6cb32; Bigal ME, 2006, NEUROLOGY, V67, P246, DOI 10.1212/01.wnl.0000225186.76323.69; Charbit AR, 2010, CURR OPIN NEUROL, V23, P275, DOI 10.1097/WCO.0b013e3283378d5c; Colosimo C, 2010, J NEUROL, V257, P5, DOI 10.1007/s00415-009-5255-7; Connor JR, 2003, NEUROLOGY, V61, P304, DOI 10.1212/01.WNL.0000078887.16593.12; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; d'Onofrio F, 2012, NEUROL SCI, V33, pS55, DOI 10.1007/s10072-012-1042-9; Dahodwala N, 2012, PARKINSONISM RELAT D, V18, P216, DOI 10.1016/j.parkreldis.2011.09.003; de Laat KF, 2012, STROKE, V43, P2574, DOI 10.1161/STROKEAHA.112.657130; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Desseilles M, 2008, SLEEP, V31, P777, DOI 10.1093/sleep/31.6.777; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Granziera C, 2014, HUM BRAIN MAPP, V35, P1461, DOI 10.1002/hbm.22266; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kruit MC, 2009, CEPHALALGIA, V29, P351, DOI 10.1111/j.1468-2982.2008.01723.x; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2012, CEPHALALGIA, V32, P382, DOI 10.1177/0333102412439355; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SIGURDSSON E, 1995, ANN INTERN MED, V122, P96, DOI 10.7326/0003-4819-122-2-199501150-00003; Silber MH, 2013, MAYO CLIN PROC, V88, P977, DOI 10.1016/j.mayocp.2013.06.016; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; Tanner CM, 1996, ANN EPIDEMIOL, V6, P438, DOI 10.1016/S1047-2797(96)00066-X; Tepper SJ, 2012, HEADACHE, V52, P236, DOI 10.1111/j.1526-4610.2011.02056.x; VANHILTEN JJ, 1992, CLIN NEUROL NEUROSUR, V94, pS168; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x; Winter AC, 2013, CEPHALALGIA, V33, P130, DOI 10.1177/0333102412466965	40	16	16	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 30	2014	83	14					1246	1252		10.1212/wnl.0000000000000840			7	Clinical Neurology	Neurosciences & Neurology	AT3UN	WOS:000344860700010	25230997	Green Published			2021-06-18	
J	Moore, H; Gillespie, A				Moore, Helen; Gillespie, Alex			The caregiving bind: Concealing the demands of informal care can undermine the caregiving identity	SOCIAL SCIENCE & MEDICINE			English	Article						UK; Informal care; Acquired brain injury; Disagreement; Misunderstanding; Identity	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; HEALTH; STRESS; PARENT; CANCER; PERSPECTIVES; EXPERIENCES; DISABILITY; DEPRESSION	Disagreements and misunderstandings between informal caregivers and care-receivers have been widely reported, but the causes are unclear. The present article compares the views of people with acquired brain injury and their main informal caregivers (28 dyads, n = 56). First, we report a quantitative analysis finding that the majority of disagreements were about caregivers' identity. Caregivers saw themselves as less confident, less intelligent, more embarrassed, more independent and more overprotective than care-receivers rated them to be. Caregivers understood the care-receivers' ratings but disagreed with them' Second, we report a qualitative analysis focussing on how caregivers felt themselves to be perceived by significant others. Caregivers felt that the care-receiver, family members, the general public, health services and even friends often have negative views of them. The 'caregiving bind' is proposed as a cause of caregivers' negative identity. It arises when caregivers try to protect the care-receiver's identity by concealing the extent of informal care provision, with the unintended consequence of undermining the prospects of the caregiver receiving positive social recognition for the challenging work of caregiving. The caregiving bind has implications for therapy and points to the potential of friends and health services to provide caregivers with positive social recognition. (C) 2014 The Authors. Published by Elsevier Ltd.	[Moore, Helen] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Gillespie, Alex] London Sch Econ, Dept Social Psychol, London WC2A 2AE, England	Moore, H (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	helenmooreuk@yahoo.co.uk; a.t.gillespie@lse.ac.uk					Ashworth Mark, 2010, Qual Prim Care, V18, P127; Badr H, 2007, PSYCHOL HEALTH, V22, P211, DOI 10.1080/14768320600843077; Bar-Tal Y, 2005, SOC SCI MED, V60, P1459, DOI 10.1016/j.socscimed.2004.08.003; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Bowen C., 2010, RELATIONAL APPROACH; Brain Injury Association of America, 2011, BRAIN INJ BRAIN INJ; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Braun M, 2009, AGING MENT HEALTH, V13, P426, DOI 10.1080/13607860902879441; Brittain KR, 2007, SOC SCI MED, V65, P1274, DOI 10.1016/j.socscimed.2007.04.002; Buckner L., 2011, VALUING CARERS 2011; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Croteau C, 2006, APHASIOLOGY, V20, P327, DOI 10.1080/02687030500475051; Emslie C, 2009, SOC SCI MED, V68, P1169, DOI 10.1016/j.socscimed.2009.01.004; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Farmer J.E., 1996, RECOVERY TRAUMATIC B; FLEURIDAS C, 1986, J MARITAL FAM THER, V12, P113, DOI 10.1111/j.1752-0606.1986.tb01629.x; Gaber TAZK, 2008, BRAIN INJURY, V22, P589, DOI 10.1080/02699050802132461; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gillespie A, 2010, APHASIOLOGY, V24, P1559, DOI 10.1080/02687038.2010.500810; Gillespie A, 2010, J THEOR SOC BEHAV, V40, P19, DOI 10.1111/j.1468-5914.2009.00419.x; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Goffman E., 1963, STIGMA NOTES MANAGEM; Goffman E., 1959, PRESENTATION SELF EV; Gosling J, 1999, BRAIN INJURY, V13, P785; Greenwood N, 2009, INT J NURS STUD, V46, P1122, DOI 10.1016/j.ijnurstu.2009.02.011; HARPER S, 1990, INT J AGING HUM DEV, V30, P241, DOI 10.2190/9BLE-FED4-BRAC-RPX3; Hengst JA, 2008, INT J LANG COMM DIS, V43, P58, DOI 10.1080/13682820701698093; Honneth Axel, 1996, STRUGGLE RECOGNITION; Horowitz A, 2004, GERONTOLOGIST, V44, P532, DOI 10.1093/geront/44.4.532; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; HSCIC, 2010, SURV CAR HOUS ENGL 2; James W., 1890, PRINCIPLES PSYCHOL; Johansson NO, 2005, SCAND J PSYCHOL, V46, P349, DOI 10.1111/j.1467-9450.2005.00465.x; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Jones L, 2013, CLIN REHABIL, V27, P272, DOI 10.1177/0269215512455532; KREFTING L, 1990, SOC SCI MED, V30, P859, DOI 10.1016/0277-9536(90)90213-C; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Laing R.D., 1966, INTERPERSONAL PERCEP; Locock L, 2010, SOC SCI MED, V71, P1498, DOI 10.1016/j.socscimed.2010.06.043; MacIntosh R, 2012, SOC SCI MED, V74, P332, DOI 10.1016/j.socscimed.2011.03.014; Maslow A., 1954, MOTIVATION PERSONALI; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Mead George Herbert, 1934, MIND SELF SOC STANDP; MURPHY J, 2000, BRIT J THERAPY REHAB, V7, P454, DOI DOI 10.12968/BJTR.2000.7.11.13835; Newsom JT, 1998, HEALTH PSYCHOL, V17, P172, DOI 10.1037/0278-6133.17.2.172; Noble LM, 2004, CURR OPIN PSYCHIATR, V17, P289, DOI 10.1097/01.yco.0000133832.42167.76; Perrin PB, 2013, PM&R, V5, P839, DOI 10.1016/j.pmrj.2013.05.018; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Pot AM, 1998, PATIENT EDUC COUNS, V34, P43, DOI 10.1016/S0738-3991(98)00048-2; Power A, 2008, SOC SCI MED, V67, P834, DOI 10.1016/j.socscimed.2008.05.023; Reader TW, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-156; RIDLEY B, 1989, SOC SCI MED, V29, P555, DOI 10.1016/0277-9536(89)90201-3; Robinson L, 2007, HEALTH RISK SOC, V9, P389, DOI 10.1080/13698570701612774; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; SEMPLE SJ, 1992, GERONTOLOGIST, V32, P648, DOI 10.1093/geront/32.5.648; Sillars A, 2005, HUM COMMUN RES, V31, P102, DOI 10.1093/hcr/31.1.102; Simon C, 2009, SOC SCI MED, V69, P404, DOI 10.1016/j.socscimed.2009.04.007; SKAFF MM, 1992, GERONTOLOGIST, V32, P656, DOI 10.1093/geront/32.5.656; Thomas C, 2002, SOC SCI MED, V54, P529, DOI 10.1016/S0277-9536(01)00048-X; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Turner HA, 1997, AM J COMMUN PSYCHOL, V25, P35, DOI 10.1023/A:1024693707990; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Walsh F., 2006, STRENGTHENING FAMILY; Walsh RS, 2014, HEALTH PSYCHOL REV, V8, P458, DOI 10.1080/17437199.2012.733914; Walters K, 2000, AGE AGEING, V29, P505, DOI 10.1093/ageing/29.6.505; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Yeates G.N., 2013, HDB REAL NEUROPSYCHO, P271; Yeates G, 2007, NEUROPSYCHOL REHABIL, V17, P151, DOI 10.1080/09602010600696423; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	73	16	16	0	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	SEP	2014	116						102	109		10.1016/j.socscimed.2014.06.038			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	AN6HN	WOS:000340695700012	24996218	Other Gold, Green Accepted			2021-06-18	
J	Quatman-Yates, C; Hugentobler, J; Ammon, R; Mwase, N; Kurowski, B; Myer, GD				Quatman-Yates, Catherine; Hugentobler, Jason; Ammon, Robin; Mwase, Najima; Kurowski, Brad; Myer, Gregory D.			The Utility of the Balance Error Scoring System for Mild Brain Injury Assessments in Children and Adolescents	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; balance; postural control; Balance Error Scoring System (BESS); children and adolescents	SPORT-RELATED CONCUSSION; 4TH INTERNATIONAL-CONFERENCE; COLLEGIATE FOOTBALL PLAYERS; POSTURAL CONTROL; RECURRENT CONCUSSION; CEREBRAL CONCUSSION; CONSENSUS STATEMENT; HIGH-SCHOOL; RECOVERY; KNEE	The Balance Error Scoring System (BESS) is widely recognized as an acceptable assessment of postural control for adult patients following a mild traumatic brain injury (mTBI) or concussion. However, the measurement properties of the BESS as a post-mTBI assessment test for younger patients are not well understood. The purpose of this study was to evaluate the utility of the BESS as a post-mTBI assessment test for children and adolescents aged 8 to 18 years through 2 investigations: (1) a retrospective medical records review of the relationship among age, BESS scores, and other common post-mTBI assessment tests; and (2) a prospective study comparing BESS scores for a cohort of children with a recent mTBI and BESS scores for a cohort of matched healthy peers. Age was found to be significantly correlated with several of the BESS measures and the total BESS score (P < 0.05). Significant differences were observed between the injured and healthy cohorts for 3 of the BESS measures and the total BESS score. However, the observed differences were not likely to be clinically meaningful. Cumulatively, evidence from the literature and the results of these studies indicate that the BESS may be limited for producing accurate assessments of younger athletes' post-mTBI postural control abilities. Future research recommendations include testing of modified versions of the BESS or other alternatives for post-mTBI postural control assessments with younger individuals.	[Quatman-Yates, Catherine; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine; Hugentobler, Jason] Cincinnati Childrens Hosp Med Ctr, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA; [Ammon, Robin] Univ S Dakota, Sport Management Program Coordinator, Vermillion, SD 57069 USA; [Mwase, Najima] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Phys Med & Rehabil, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat & Orthopaed Surg, Cincinnati, OH USA	Quatman-Yates, C (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Catherine.quatman@cchmc.org	Quatman-Yates, Catherine/AAK-4507-2021; Quatman-Yates, Catherine/U-9580-2019; Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	NIH-K23United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K23HD074683-01A1]; Cincinnati Children's Hospital Research in Patient Services PS2 Award; University Research Council Post-Doctoral Fellowship Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER	The authors acknowledge the following: NIH-K23: 1K23HD074683-01A1, Cincinnati Children's Hospital Research in Patient Services PS2 Award, University Research Council Post-Doctoral Fellowship Grant.	Andrish J T, 2001, Am J Orthop (Belle Mead NJ), V30, P103; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Concussion in Sports Group, 2013, BRIT J SPORT MED, V47, P263; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Ford KR, 2008, BRIT J SPORT MED, V42, P561, DOI 10.1136/bjsm.2007.044883; Ford KR, 2010, MED SCI SPORT EXER, V42, P1923, DOI 10.1249/MSS.0b013e3181dc99b1; Ford KR, 2010, AM J SPORT MED, V38, P1829, DOI 10.1177/0363546510367425; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Gribble PA, 2004, J ELECTROMYOGR KINES, V14, P641, DOI 10.1016/j.jelekin.2004.05.001; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haddad JM, 2008, EXP BRAIN RES, V190, P431, DOI 10.1007/s00221-008-1483-9; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hewett TE, 2004, J BONE JOINT SURG AM, V86A, P1601, DOI 10.2106/00004623-200408000-00001; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Lee SP, 2014, GAIT POSTURE, V39, P933, DOI 10.1016/j.gaitpost.2013.12.004; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Olson B., 2012, ATHLETIC TRAIN SPORT, V4, P141; Quatman-Yates CC, 2013, PEDIATR PHYS THER, V25, P271, DOI 10.1097/PEP.0b013e31828e1e9d; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sheehan DP, 2011, MEAS PHYS EDUC EXERC, V15, P234, DOI 10.1080/1091367X.2011.568368; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Sport Concussion Assessment Tool 3rd edition (SCAT3), 2013, BRIT J SPORT MED, V47, P259; Takacs J, 2012, J BIOMECH, V45, P2791, DOI 10.1016/j.jbiomech.2012.08.041; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; WOOLLACOTT MH, 1990, PHYS THER, V70, P799, DOI 10.1093/ptj/70.12.799	51	16	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	SEP	2014	42	3					32	38		10.3810/psm.2014.09.2073			7	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	AR2FQ	WOS:000343399400004	25295764	Green Accepted			2021-06-18	
J	Reed, N; Murphy, J; Dick, T; Mah, K; Paniccia, M; Verweel, L; Dobney, D; Keightley, M				Reed, Nick; Murphy, James; Dick, Talia; Mah, Katie; Paniccia, Melissa; Verweel, Lee; Dobney, Danielle; Keightley, Michelle			A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 91; concussion; children; youth; athletes; assessment; management; rehabilitation	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; ICE HOCKEY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; CHILDREN; REHABILITATION; DYSFUNCTION; MANAGEMENT; ZURICH	Concussion is one of the most commonly reported injuries amongst children and youth involved in sport participation. Following a concussion, youth can experience a range of short and long term neurobehavioral symptoms (somatic, cognitive and emotional/behavioral) that can have a significant impact on one's participation in daily activities and pursuits of interest (e. g., school, sports, work, family/social life, etc.). Despite this, there remains a paucity in clinically driven research aimed specifically at exploring concussion within the youth sport population, and more specifically, multi-modal approaches to measuring recovery. This article provides an overview of a novel and multi-modal approach to measuring recovery amongst youth athletes following concussion. The presented approach involves the use of both pre-injury/baseline testing and postinjury/follow-up testing to assess performance across a wide variety of domains (post-concussion symptoms, cognition, balance, strength, agility/motor skills and resting state heart rate variability). The goal of this research is to gain a more objective and accurate understanding of recovery following concussion in youth athletes (ages 10-18 years). Findings from this research can help to inform the development and use of improved approaches to concussion management and rehabilitation specific to the youth sport community.	[Reed, Nick; Murphy, James; Dick, Talia; Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Reed, Nick; Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada; [Reed, Nick; Mah, Katie; Paniccia, Melissa; Verweel, Lee; Dobney, Danielle; Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada	Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	NReed@hollandbloorview.ca	Meijer, Anna/K-5118-2016		Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	We would like to thank the Canadian Institutes of Health Research (CIHR) who have provided funding for this research. Further, we would like to acknowledge Dr. Tim Taha and Dr. Scott Thomas from the University of Toronto for their assistance with the development of our protocol for the collection of resting state heart rate variability data.	Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Keightley M, 2013, INT J SPORTS MED, V34, P756, DOI 10.1055/s-0032-1327574; Khan F., MED J AUSTR, V178, P290; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Korpelainen JT, 1996, ACTA NEUROL SCAND, V94, P337, DOI 10.1111/j.1600-0404.1996.tb07076.x; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Reed N, 2012, BRAIN INJURY, V26, P766; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	22	16	16	1	14	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	SEP	2014		91							e51892	10.3791/51892			9	Multidisciplinary Sciences	Science & Technology - Other Topics	CB0FM	WOS:000349301100056	25285728	Green Published			2021-06-18	
J	Siegmund, GP; Guskiewicz, KM; Marshall, SW; DeMarco, AL; Bonin, SJ				Siegmund, Gunter P.; Guskiewicz, Kevin M.; Marshall, Stephen W.; DeMarco, Alyssa L.; Bonin, Stephanie J.			A Headform for Testing Helmet and Mouthguard Sensors that Measure Head Impact Severity in Football Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Brain injury; Validation; Repeatability	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; ACCELERATION; CONCUSSION; KINEMATICS; SYSTEM	A headform is needed to validate and compare helmet- and mouthguard-based sensors that measure the severity and direction of football head impacts. Our goal was to quantify the dynamic response of a mandibular load-sensing headform (MLSH) and to compare its performance and repeatability to an unmodified Hybrid III headform. Linear impactors in two independent laboratories were used to strike each headform at six locations at 5.5 m/s and at two locations at 3.6 and 7.4 m/s. Impact severity was quantified using peak linear acceleration (PLA) and peak angular acceleration (PAA), and direction was quantified using the azimuth and elevation of the PLA. Repeatability was quantified using coefficients of variation (COV) and standard deviations (SD). Across all impacts, PLA was 1.6 +/- A 1.8 g higher in the MLSH than in the Hybrid III (p = 0.002), but there were no differences in PAA (p = 0.25), azimuth (p = 0.43) and elevation (p = 0.11). Both headforms exhibited excellent or acceptable repeatability for PLA (HIII:COV = 2.1 +/- A 0.8%, MLSH:COV = 2.0 +/- A 1.2%, p = 0.98), but site-specific repeatability ranging from excellent to poor for PAA (HIII:COV = 7.2 +/- A 4.0%, MLSH:COV = 8.3 +/- A 5.8%, p = 0.58). Direction SD were generally < 1A degrees and did not vary between headforms. Overall, both headforms are similarly suitable for validating PLA in sensors that measure head impact severity in football players, however their utility for validating sensor PAA values varies with impact location.	[Siegmund, Gunter P.; DeMarco, Alyssa L.] MEA Forens Engineers & Scientists, Richmond, BC V7A 4S5, Canada; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Bonin, Stephanie J.] MEA Forens Engineers & Scientists, Laguna Hills, CA USA	Siegmund, GP (corresponding author), MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada.	gunter.siegmund@meaforensic.com	Siegmund, Gunter P/B-7003-2013	Siegmund, Gunter/0000-0003-2387-941X; DeMarco, Alyssa/0000-0002-3106-386X; Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233	National Football League (NFL); National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49-CE001495]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001495] Funding Source: NIH RePORTER	This study was funded by the National Football League (NFL). Author KMG approved the protocol and publication of these results on behalf of the NFL. The authors wish to acknowledge Chris Withnall and Michael Wonnacott of Biokinetics and Associates, and Dave Halstead and Elizabeth McCalley of Southern Impact Research Center (SIRC) for their assistance in refining the protocol and acquiring the data. SWM is partly supported by a grant R49-CE001495 from the National Center for Injury Prevention and Control. Author GPS owns shares in a forensic consulting company that may benefit from being associated with this study. Author KMG is a member of the NFL's Head, Neck and Spine Committee and Chair of the Subcommittee on Equipment and Playing Rules. The remaining authors declare no conflict of interest. Biokinetics and Associates Ltd. is the manufacturer of the MLSH headform and half of the data presented here was gathered in their lab. All tests at Biokinetics and Associates Ltd. were conducted under the supervision of author GPS, and they had no hand in post-processing these data.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; [Anonymous], 2013, 1583012013E ISO; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bortenschlager K., 2009, P 21 ESV C STUTTG GE; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Craig MJ, 2009, SAE INT J PASSEN CAR, V2, P587, DOI 10.4271/2009-01-0388; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Higgins M, 2007, J ATHL TRAINING, V42, P5; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kaleps I., 1988, HYBRID 3 GEOMETRICAL; Knox T, 2009, SAE INT J PASSENG CA, V1, P652; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Olvey SE, 2004, NEUROSURGERY, V54, P672, DOI 10.1227/01.NEU.0000108782.68099.29; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Wonnacott M., 2010, 2010010136 SAE	26	16	16	0	31	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2014	42	9					1834	1845		10.1007/s10439-014-1052-2			12	Engineering, Biomedical	Engineering	AN2DN	WOS:000340394100004	24920257				2021-06-18	
J	Weaver, SM; Portelli, JN; Chau, A; Cristofori, I; Moretti, L; Grafman, J				Weaver, Starla M.; Portelli, Jaclyn N.; Chau, Aileen; Cristofori, Irene; Moretti, Laura; Grafman, Jordan			Genetic polymorphisms and traumatic brain injury: the contribution of individual differences to recovery	BRAIN IMAGING AND BEHAVIOR			English	Article						Genetic polymorphisms; Traumatic brain injury; Polymorphisms	APOLIPOPROTEIN-E GENOTYPE; O-METHYLTRANSFERASE GENE; COMT VAL(108/158) MET; ANGER-RELATED TRAITS; WORKING-MEMORY; DECISION-MAKING; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; MONOAMINE-OXIDASE; RECEPTOR GENE	Recovery after Traumatic Brain Injury (TBI) is variable, even for patients with similar severity of brain injury. Recent research has highlighted the contribution that genetic predisposition plays in determining TBI outcome. This review considers the potential for genetic polymorphisms to influence recovery of cognitive and social processes following TBI. Limitations and considerations that researchers should make when assessing the potential impact of polymorphisms on TBI outcome are also discussed. Understanding the genetic factors that support neuroplasticity will contribute to an understanding of the variation in outcome following injury and help to identify potential targets for rehabilitation.	[Weaver, Starla M.; Portelli, Jaclyn N.; Chau, Aileen; Cristofori, Irene; Moretti, Laura; Grafman, Jordan] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ 07052 USA	Weaver, SM (corresponding author), Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	sweaver@kesslerfoundation.org; jgrafman@ric.org		Weaver, Starla/0000-0002-9559-8337; Grafman, Jordan H./0000-0001-8645-4457; Cristofori, Irene/0000-0003-2339-1457	Kessler Foundation	The preparation of this article was supported by funding from the Kessler Foundation. Portions of this manuscript were previously published (Weaver, Chau, Portelli & Grafman, in press).	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Awh E, 2008, NAT NEUROSCI, V11, P5, DOI 10.1038/nn0108-5; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Beste C, 2011, NEUROPSYCHOLOGIA, V49, P2664, DOI 10.1016/j.neuropsychologia.2011.05.014; Beste C, 2010, NEUROIMAGE, V50, P764, DOI 10.1016/j.neuroimage.2009.11.067; Bevilacqua L, 2011, TRENDS COGN SCI, V15, P401, DOI 10.1016/j.tics.2011.07.009; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blair KS, 2008, PSYCHOPHARMACOLOGY, V196, P29, DOI 10.1007/s00213-007-0920-y; Borg J, 2009, INT J NEUROPSYCHOPH, V12, P783, DOI 10.1017/S1461145708009759; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Caldu X, 2007, NEUROIMAGE, V37, P1437, DOI 10.1016/j.neuroimage.2007.06.021; Camara E, 2010, CEREB CORTEX, V20, P1985, DOI 10.1093/cercor/bhp263; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Cerasa A, 2008, BRAIN RES, V1201, P114, DOI 10.1016/j.brainres.2008.01.048; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Clark L, 2005, PSYCHOPHARMACOLOGY, V182, P570, DOI 10.1007/s00213-005-0104-6; Congdon E, 2009, BIOL PSYCHOL, V81, P144, DOI 10.1016/j.biopsycho.2009.03.005; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Conley YP, 2011, PM&R, V3, pS52, DOI 10.1016/j.pmrj.2011.04.004; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Dardiotis E., 2010, NEUROSURGERY FOCUS, V28, P1; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Enge S, 2011, NEUROPSYCHOLOGIA, V49, P3776, DOI 10.1016/j.neuropsychologia.2011.09.038; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Erickson KI, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.011.2008; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; FISKE ST, 1993, ANNU REV PSYCHOL, V44, P155, DOI 10.1146/annurev.psych.44.1.155; Furman DJ, 2011, SOC COGN AFFECT NEUR, V6, P270, DOI 10.1093/scan/nsq029; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; Giegling I, 2006, J AFFECT DISORDERS, V96, P75, DOI 10.1016/j.jad.2006.05.016; Goel V, 2007, CEREB CORTEX, V17, P2245, DOI 10.1093/cercor/bhl132; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Gong PY, 2011, CAN J NEUROL SCI, V38, P303, DOI 10.1017/S0317167100011513; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.8.1120-1122; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hamidovic A, 2009, EXP CLIN PSYCHOPHARM, V17, P374, DOI 10.1037/a0017840; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lane HY, 2008, J PSYCHIATR NEUROSCI, V33, P47; Lee BK, 2011, ARCH GEN PSYCHIAT, V68, P314, DOI 10.1001/archgenpsychiatry.2011.6; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Mani TM, 2007, NEUROCASE, V13, P229, DOI 10.1080/13554790701594862; Manuck SB, 1999, BIOL PSYCHIAT, V45, P603, DOI 10.1016/S0006-3223(98)00375-8; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Missitzi J, 2011, J PHYSIOL-LONDON, V589, P297, DOI 10.1113/jphysiol.2010.200600; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nomura M, 2006, PSYCHOPHARMACOLOGY, V187, P30, DOI 10.1007/s00213-006-0398-z; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ptak R, 2004, NEUROCASE, V10, P52, DOI 10.1080/13554790490960495; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Ready RE, 2011, AM J ALZHEIMERS DIS, V26, P463, DOI 10.1177/1533317511421921; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Reuter M, 2005, BEHAV BRAIN RES, V164, P93, DOI 10.1016/j.bbr.2005.06.002; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Roiser JP, 2009, J NEUROSCI, V29, P5985, DOI 10.1523/JNEUROSCI.0407-09.2009; Rujescu D, 2002, MOL PSYCHIATR, V7, P1023, DOI 10.1038/sj.mp.4001128; Ryan L, 2011, NEUROIMAGE, V54, P1565, DOI 10.1016/j.neuroimage.2010.08.052; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, PSYCHIAT CLIN NEUROS, V60, P70, DOI 10.1111/j.1440-1819.2006.01462.x; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sanchez MM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.47; Sanfey AG, 2003, NEUROPSYCHOLOGIA, V41, P1218, DOI 10.1016/S0028-3932(03)00039-3; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Siegel JA, 2012, NEUROBIOL AGING, V33, P345, DOI 10.1016/j.neurobiolaging.2010.03.002; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; Soliman A, 2011, PSYCHOL MED, V41, P1051, DOI 10.1017/S0033291710001601; Solis-Ortiz S, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-67; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Swan GE, 2005, J GERIATR PSYCH NEUR, V18, P196, DOI 10.1177/0891988705281864; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Watson KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004156; Wetter SR, 2005, J CLIN EXP NEUROPSYC, V27, P943, DOI 10.1080/13803390490919001; Wilkosc M, 2010, ACTA NEUROBIOL EXP, V70, P86; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Wishart HA, 2011, J INT NEUROPSYCH SOC, V17, P174, DOI 10.1017/S1355617710001402; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	123	16	16	0	16	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		420	434		10.1007/s11682-012-9197-9			15	Neuroimaging	Neurosciences & Neurology	AP9ZR	WOS:000342441400011	22878895				2021-06-18	
J	Dias, C; Maia, I; Cerejo, A; Varsos, G; Smielewski, P; Paiva, JA; Czosnyka, M				Dias, Celeste; Maia, Isabel; Cerejo, Antonio; Varsos, Georgios; Smielewski, Peter; Paiva, Jose-Artur; Czosnyka, Marek			Pressures, Flow, and Brain Oxygenation During Plateau Waves of Intracranial Pressure	NEUROCRITICAL CARE			English	Article						Multimodal brain monitoring; Intracranial pressure; Plateau waves; Cerebral perfusion pressure; Cerebrovascular reactivity; Head injury	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURED PATIENTS; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; TISSUE OXYGEN; REACTIVITY; MODEL; VOLUME	Plateau waves are common in traumatic brain injury. They constitute abrupt increases of intracranial pressure (ICP) above 40 mmHg associated with a decrease in cerebral perfusion pressure (CPP). The aim of this study was to describe plateau waves characteristics with multimodal brain monitoring in head injured patients admitted in neurocritical care. Prospective observational study in 18 multiple trauma patients with head injury admitted to Neurocritical Care Unit of Hospital Sao Joao in Porto. Multimodal systemic and brain monitoring of primary variables [heart rate, arterial blood pressure, ICP, CPP, pulse amplitude, end tidal CO2, brain temperature, brain tissue oxygenation pressure, cerebral oximetry (CO) with transcutaneous near-infrared spectroscopy and cerebral blood flow (CBF)] and secondary variables related to cerebral compensatory reserve and cerebrovascular reactivity were supported by dedicated software ICM+ (www.neurosurg.cam.ac.uk/icmplus). The compiled data were analyzed in patients who developed plateau waves. In this study we identified 59 plateau waves that occurred in 44 % of the patients (8/18). During plateau waves CBF, cerebrovascular resistance, CO, and brain tissue oxygenation decreased. The duration and magnitude of plateau waves were greater in patients with working cerebrovascular reactivity. After the end of plateau wave, a hyperemic response was recorded in 64 % of cases with increase in CBF and brain oxygenation. The magnitude of hyperemia was associated with better autoregulation status and low oxygenation levels at baseline. Multimodal brain monitoring facilitates identification and understanding of intrinsic vascular brain phenomenon, such as plateau waves, and may help the adequate management of acute head injury at bed side.	[Dias, Celeste; Maia, Isabel; Paiva, Jose-Artur] Hosp Sao Joao, Neurocrit Care Unit, Dept Intens Care, Oporto, Portugal; [Cerejo, Antonio] Hosp Sao Joao, Dept Neurosurg, Oporto, Portugal; [Varsos, Georgios; Smielewski, Peter; Czosnyka, Marek] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England	Dias, C (corresponding author), Hosp Sao Joao, Neurocrit Care Unit, Dept Intens Care, Oporto, Portugal.	mceleste.dias@gmail.com	Dias, Celeste/AAD-8711-2019; Dias, Celeste/L-9901-2014; Dias, Celeste/AAV-3820-2020; Paiva, Jose-Artur/AAO-9730-2021	Dias, Celeste/0000-0003-0340-9808; Dias, Celeste/0000-0003-0340-9808; Smielewski, Peter/0000-0001-5096-3938	National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237] Funding Source: Medline		Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Brain Trauma Foundation American Association of Neurological Surgeons, 2007, J NEUROTRAUM, V24, P59; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Citerio G, 2004, INTENS CARE MED, V30, P1882, DOI 10.1007/s00134-004-2377-3; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; HAYASHI M, 1984, J NEUROSURG, V61, P30, DOI 10.3171/jns.1984.61.1.0030; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; JANNY P, 1950, THESIS PARIS; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MATSUDA M, 1979, J NEUROSURG, V50, P483, DOI 10.3171/jns.1979.50.4.0483; Radolovich DK, 2010, ANESTH ANALG, V110, P165, DOI 10.1213/ANE.0b013e3181c0722f; RENIER D, 1982, J NEUROSURG, V57, P370, DOI 10.3171/jns.1982.57.3.0370; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Smielewski P, 2005, ACT NEUR S, V95, P43; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; Varsos GV, 2013, J CEREBR BLOOD F MET, V33, P235, DOI 10.1038/jcbfm.2012.161	24	16	16	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2014	21	1					124	132		10.1007/s12028-013-9918-y			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AL7XP	WOS:000339350500019	24072460				2021-06-18	
J	Dziewas, R; Glahn, J; Helfer, C; Ickenstein, G; Keller, J; Lapa, S; Ledl, C; Lindner-Pfleghar, B; Nabavi, D; Prosiegel, M; Riecker, A; Stanschus, S; Warnecke, T; Busse, O				Dziewas, R.; Glahn, J.; Helfer, C.; Ickenstein, G.; Keller, J.; Lapa, S.; Ledl, C.; Lindner-Pfleghar, B.; Nabavi, D.; Prosiegel, M.; Riecker, A.; Stanschus, S.; Warnecke, T.; Busse, O.			FEES for neurogenic dysphagia. Training curriculum of the German Society of Neurology and the German Stroke Society	NERVENARZT			German	Article						Nervous system diseases; Muscular diseases; Stroke; Teaching; Clinical competence	FIBEROPTIC ENDOSCOPIC EVALUATION; TRAUMATIC BRAIN-INJURY; SWALLOWING DISORDERS; LATERAL-SCLEROSIS; ASPIRATION; SAFETY; VIDEOFLUOROSCOPY; RECOMMENDATIONS; COMPLICATIONS; DIAGNOSIS	Neurogenic dysphagia is one of the most frequent and prognostically relevant neurological deficits in a variety of disorders, such as stroke, parkinsonism and advanced neuromuscular diseases. Flexible endoscopic evaluation of swallowing (FEES) is now probably the most frequently used tool for objective dysphagia assessment in Germany. It allows evaluation of the efficacy and safety of swallowing, determination of appropriate feeding strategies and assessment of the efficacy of different swallowing manoeuvres. The literature furthermore indicates that FEES is a safe and well-tolerated procedure. In spite of the huge demand for qualified dysphagia diagnostics in neurology, a systematic FEES education has yet not been established. The structured training curriculum presented in this article aims to close this gap and intends to enforce a robust and qualified FEES service. As management of neurogenic dysphagia is not confined to neurologists, this educational program is applicable to other clinicians and speech language therapists with expertise in dysphagia as well.	[Dziewas, R.; Warnecke, T.] Univ Klinikum Munster, Klin Allgemeine Neurol, D-48129 Munster, Germany; [Glahn, J.] Johannes Wesling Klinikum, Neurol Klin, Minden, Germany; [Helfer, C.] Vivantes Klinikum Neukolln, Kliniken HNO & Neurol, Berlin, Germany; [Ickenstein, G.] HELIOS Klinikum Aue, Neurol Klin, Dusseldorf, Germany; [Ickenstein, G.] HELIOS Klinikum Aue, Stroke Unit, Dusseldorf, Germany; [Keller, J.] St Martinus Krankenhaus, Klin Akut Geriatrie, Dusseldorf, Germany; [Lapa, S.] Univ Klinikum Frankfurt aM, ZNN, Neurol Klin, Ulm, Germany; [Ledl, C.] Schon Klin Bad Aibling, Ulm, Germany; [Lindner-Pfleghar, B.; Riecker, A.] Univ Ulm, Neurol Klin, D-89069 Ulm, Germany; [Lindner-Pfleghar, B.; Riecker, A.] Rehabil Klinikum Ulm RKU, Ulm, Germany; [Nabavi, D.] Vivantes Klinikum Neukolln, Neurol Klin, Berlin, Germany; [Prosiegel, M.] Deutsch Interdisziplinare Gesell Dysphagie, Munich, Germany; [Stanschus, S.] Kreiskliniken Reutlingen, Abt Logopadie, Berlin, Germany; [Stanschus, S.] Kreiskliniken Reutlingen, Schluckzentrum, Berlin, Germany; [Busse, O.] Geschaftsstelle DSG & DGN, Berlin, Germany	Dziewas, R (corresponding author), Univ Klinikum Munster, Klin Allgemeine Neurol, Albert Schweitzer Campus 1, D-48129 Munster, Germany.	Rainer.Dziewas@ukmuenster.de	Dziewas, Rainer/AAX-9505-2020	Dziewas, Rainer/0000-0003-1592-8461			*AM SPEECH LANG HE, 2005, ROL SPEECH  LANG PAT; American Speech-Language Hearing Association, 2002, KNOWL SKILLS SPEECH; Aviv JE, 2000, DYSPHAGIA, V15, P39, DOI 10.1007/s004559910008; Aviv JE., 2001, ENDOSCOPIC EVALUATIO, P235; Carnaby-Mann G, 2008, PHYS MED REH CLIN N, V19, P747, DOI 10.1016/j.pmr.2008.05.008; Cohen MA, 2003, LARYNGOSCOPE, V113, P21, DOI 10.1097/00005537-200301000-00004; DEUTSCHMANN MW, 2012, HEAD NECK-J SCI SPEC, V35, P974; Dziewas R, 2013, NERVENARZT, V84, P705, DOI 10.1007/s00115-013-3791-y; Dziewas R, 2003, J NEUROL NEUROSUR PS, V74, P1429, DOI 10.1136/jnnp.74.10.1429; Dziewas R, 2008, CEREBROVASC DIS, V26, P41, DOI 10.1159/000135652; GROB D, 1987, ANN NY ACAD SCI, V505, P472; Hafner G, 2008, EUR ARCH OTO-RHINO-L, V265, P441, DOI 10.1007/s00405-007-0507-6; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; HORNER J, 1994, ALZ DIS ASSOC DIS, V8, P177; Kelly AM, 2006, CLIN OTOLARYNGOL, V31, P425, DOI 10.1111/j.1749-4486.2006.01292.x; Kelly AM, 2007, FIBREOPTIC ENDOSCOPI; Kelly AM, 2007, LARYNGOSCOPE, V117, P1723, DOI 10.1097/MLG.0b013e318123ee6a; Kuhnlein P, 2008, NAT CLIN PRACT NEURO, V4, P366, DOI 10.1038/ncpneuro0853; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; Langmore SE, 2001, ENDOSCOPIC EVALUATIO; Langmore SE, 2007, ARCH NEUROL-CHICAGO, V64, P58, DOI 10.1001/archneur.64.1.58; Langmore Susan E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P485, DOI 10.1097/00020840-200312000-00014; Leder SB, 2004, DYSPHAGIA, V19, P177, DOI 10.1007/s00455-004-0009-2; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Leder SB, 1998, DYSPHAGIA, V13, P19, DOI 10.1007/PL00009544; Leder SB, 1997, DYSPHAGIA, V12, P52; Macht M, 2011, CRIT CARE, V15, DOI 10.1186/cc10472; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; McCullough GH, 2005, J SPEECH LANG HEAR R, V48, P1280, DOI 10.1044/1092-4388(2005/089); Miller N, 2006, AGE AGEING, V35, P614, DOI 10.1093/ageing/afl105; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; Mulcahy KP, 2012, DYSPHAGIA, V27, P64, DOI 10.1007/s00455-011-9338-0; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; O'Donoghue S, 1999, FOLIA PHONIATR LOGO, V51, P158, DOI 10.1159/000021494; Prosiegel M, 2012, NERVENARZT, V83, P1590, DOI 10.1007/s00115-012-3679-2; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Suntrup S, 2012, NERVENARZT, V83, P1619, DOI 10.1007/s00115-012-3611-9; Suntrup S, 2012, J NEUROL, V259, P93, DOI 10.1007/s00415-011-6129-3; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; Warnecke T, 2009, KLIN NEUROPHYSIOL, V40, P194, DOI 10.1055/s-0029-1220750; Warnecke T, 2010, MOVEMENT DISORD, V25, P1239, DOI 10.1002/mds.23060; Warnecke T, 2009, NEUROMUSCULAR DISORD, V19, P704, DOI 10.1016/j.nmd.2009.06.371; Warnecke T, 2009, STROKE, V40, P482, DOI 10.1161/STROKEAHA.108.520775; Willging J Paul, 2005, Curr Gastroenterol Rep, V7, P240, DOI 10.1007/s11894-005-0041-x; Wu CH, 1997, LARYNGOSCOPE, V107, P396	46	16	16	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	AUG	2014	85	8					1006	+		10.1007/s00115-014-4114-7			9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AN2EH	WOS:000340396300013	25060752				2021-06-18	
J	Jin, G; Liu, BL; You, ZR; Bambakidis, T; Dekker, SE; Maxwell, J; Halaweish, I; Linzel, D; Alam, HB				Jin, Guang; Liu, Baoling; You, Zerong; Bambakidis, Ted; Dekker, Simone E.; Maxwell, Jake; Halaweish, Ihab; Linzel, Durk; Alam, Hasan B.			Development of a novel neuroprotective strategy: Combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells	SURGERY			English	Article							HISTONE DEACETYLASE INHIBITION; INDUCED NEURONAL APOPTOSIS; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; HEMORRHAGIC-SHOCK; ISCHEMIC DAMAGE; CARDIAC-ARREST; PROTEIN; STROKE; DEATH	Background. Therapeutic hypothermia and histone deacetylase inhibitors, such as valproic acid (VPA),.independently have been shown to have neuroprotective properties in models of cerebral ischemic and traumatic brain injury. However, the depth of hypothermia and the dose of VPA needed to achieve the desired result are logistically challenging. It remains unknown whether these two promising strategies can be combined to yield synergistic results. We designed an experiment to answer this question by subjecting hippocampal-derived HT22 cells to severe hypoxia in vitro. Methods. Mouse hippocampal HT22 cells were exposed to 200 AM cobalt chloride (CoCl2), which created hypoxic conditions in vitro. Cells were incubated for 6 or 30 hours under the following conditions: (1) Dulbecco's Modified Eagle Medium; (2) 200 mu M CoCl2; (3) 200 mu M CoCl2 plus 1 mmol/L VPA; (4) 200 AM CoCl2 plus 32 degrees C hypothermia; and (5) 200 mu M CoCl2 plus both 1 mmol/L VPA and 32 C hypothermia. Cellular viability was evaluated by (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) and lactate dehydrogenase release assays at 30 hours after treatment. Levels of acetylated histone H3, hypoxia-inducible factor-1 alpha, phospho-GSK-3 beta, beta-catenin, and high-mobility group box-1 were measured by Western blotting. Results. High levels of acetylated histone H3 were detected in the VPA-treated cells. The release of lactate dehydrogenase was greatly suppressed after the combined hypothermia + VPA treatment (0.269 +/- 0.003) versus VPA (0.836 +/- 0.026) or hypothermia (0.451 +/- 0.005) treatments alone (n = 3, P = .0001). (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay showed that the number of viable cells was increased by 17.6 % when VPA and hypothermia were used in combination (n = 5, P = .0001). Hypoxia-inducible factor-la and phospho-GSK-3 beta expression were synergistically affected by the combination treatment, whereas high-mobility group box-1 was increased by VPA treatment, and inhibited by the hypothermia. Conclusion. This is the first study to demonstrate that the neuroprotective effects of VPA and hypothermia are synergistic. This novel approach can be used to develop more effective therapies for the prevention of neuronal death.	[Jin, Guang; Liu, Baoling; Bambakidis, Ted; Dekker, Simone E.; Maxwell, Jake; Halaweish, Ihab; Linzel, Durk; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [You, Zerong] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA USA	Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 GM084127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM084127] Funding Source: NIH RePORTER	Supported in part by a grant from the National Institutes of Health (RO1 GM084127) to H.B.A.	Alam HB, 2012, BRIT J SURG, V99, P29, DOI 10.1002/bjs.7756; Alam HB, 2012, J TRAUMA ACUTE CARE, V73, P809, DOI 10.1097/TA.0b013e318265d1b8; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Alam HB, 2005, J SURG RES, V126, P172, DOI 10.1016/j.jss.2005.01.019; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Caltana L, 2009, NEUROTOX RES, V15, P348, DOI 10.1007/s12640-009-9038-9; Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129; Chen WQ, 2008, ACTA NEUROCHIR SUPPL, V102, P395, DOI 10.1007/978-3-211-85578-2_77; Chhunchha B, 2013, AM J PHYSIOL-CELL PH, V304, pC636, DOI 10.1152/ajpcell.00345.2012; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Kallmunzer B, 2011, CEREBROVASC DIS, V31, P532, DOI 10.1159/000324621; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim SH, 2007, ONCOL REP, V17, P647; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Li YQ, 2008, J TRAUMA, V64, P863, DOI 10.1097/TA.0b013e318166b822; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Lyden PD, 2006, INT J STROKE, V1, P9, DOI 10.1111/j.1747-4949.2005.00011.x; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; Song ZC, 2012, CELL PROLIFERAT, V45, P239, DOI 10.1111/j.1365-2184.2012.00810.x; Sugiura S, 2011, SHOCK, V36, P494, DOI 10.1097/SHK.0b013e31822f7e58; Tanaka T, 2010, AM J PHYSIOL-REG I, V298, pR661, DOI 10.1152/ajpregu.00732.2009; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; West MA, 2008, J TRAUMA, V64, P870; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	39	16	17	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2014	156	2					221	228		10.1016/j.surg.2014.03.038			8	Surgery	Surgery	AL9LV	WOS:000339463700003	24950983	Green Accepted			2021-06-18	
J	Karver, CL; Kurowski, B; Semple, EA; Stancin, T; Taylor, HG; Yeates, KO; Walz, NC; Wade, SL				Karver, Christine L.; Kurowski, Brad; Semple, Erin A.; Stancin, Terry; Taylor, H. Gerry; Yeates, Keith O.; Walz, Nicolay C.; Wade, Shari L.			Utilization of Behavioral Therapy Services Long-Term After Traumatic Brain Injury in Young Children	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Behavior therapy; Rehabilitation	UNITED-STATES; CHILDHOOD; OUTCOMES; AGE; SYMPTOMATOLOGY; ADOLESCENTS; ADAPTATION; PREDICTORS; CAREGIVER; ATTENTION	Objective: To examine associations of clinical need, defined by elevated parent ratings of child behavior problems and utilization of behavioral health services in young children with traumatic brain injury (TBI) and an orthopedic injury (OI) comparison group. Design: Parents completed outcome measures 18 months after injury and at an extended follow-up conducted an average of 38 months postinjury. Setting: Children's hospitals and a general hospital. Participants: Participants included parents of 3 groups of children injured between 3 and 7 years of age (N=139): 47 children with complicated mild to moderate TBI, 18 with severe TBI, and 74 with OI. Interventions: Not applicable. Main Outcome Measures: Parents completed ratings of child behavior, mental health symptomology, and family functioning at both visits; at the extended follow-up, they reported utilization of behavior therapy or counseling services since the 18-month follow-up visit. Results: Children with TBI had more behavior problems than those with OI. Although clinical need at both follow-ups was associated with greater service utilization at the extended follow-up, all groups had unmet needs as defined by a clinical need in the absence of services. Lower socioeconomic status was associated with higher rates of unmet need across groups. Conclusions: The results document unmet long-term behavioral health needs after both TBI and OI in children and underscore the importance of monitoring and treatment of postinjury behavior problems. (C) 2014 by the American Congress of Rehabilitation Medicine	[Karver, Christine L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Karver, Christine L.; Kurowski, Brad; Wade, Shari L.] Cincinnati Childrens Hosp, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Semple, Erin A.] Univ Toledo, Coll Med, Toledo, OH 43606 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Univ Hosp, Cleveland, OH 44106 USA; [Yeates, Keith O.] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Walz, Nicolay C.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA	Karver, CL (corresponding author), Univ Cincinnati, Dept Psychol, Edwards Ctr 1, ML 0376, Cincinnati, OH 45221 USA.	karvercl@mail.uc.edu	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729, K02 HD44099]; United States Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services, National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04, K12 HD001097-16]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683, K12HD001097, R01HD042729] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02HD044099] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	Supported in part by the National Institute of Child Health and Human Development (grant nos. R01 HD42729 K02 HD44099), United States Public Health Service National Institutes of Health (grant no. M01 RR 08084), State of Ohio Emergency Medical Services trauma research grants, National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (grant nos. 8 UL1 TR000077-04 and K12 HD001097-16).	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Jensen PS, 2011, PEDIATRICS, V128, P970, DOI 10.1542/peds.2009-0367; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kazdin AE, 1997, J CONSULT CLIN PSYCH, V65, P453, DOI 10.1037/0022-006X.65.3.453; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Snell-Johns J, 2004, J FAM PSYCHOL, V18, P19, DOI 10.1037/0893-3200.18.1.19; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Verger K, 2000, BRAIN INJURY, V14, P495; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	40	16	16	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2014	95	8					1556	1563		10.1016/j.apmr.2014.03.030			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AM2ND	WOS:000339687200020	24755047	Green Accepted			2021-06-18	
J	Lange, RT; Shewchuk, JR; Rauscher, A; Jarrett, M; Heran, MKS; Brubacher, JR; Iverson, GL				Lange, Rael T.; Shewchuk, Jason R.; Rauscher, Alexander; Jarrett, Michael; Heran, Manraj K. S.; Brubacher, Jeffrey R.; Iverson, Grant L.			A Prospective Study of the Influence of Acute Alcohol Intoxication Versus Chronic Alcohol Consumption on Outcome Following Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Alcohol intoxication; Traumatic brain injury; Concurrent; Diffusion tensor imaging; Lifetime alcohol abuse	SERUM ETHANOL LEVELS; SUBSTANCE-ABUSE; WHITE-MATTER; HEAD-INJURY; POLYSUBSTANCE ABUSE; CORPUS-CALLOSUM; LEVEL; DISRUPTION; RECOVERY; ROBUST	The purpose of the study was to disentangle the relative contributions of day-of-injury alcohol intoxication and pre-injury alcohol misuse on outcome from TBI. Participants were 142 patients enrolled from a Level 1 Trauma Center (in Vancouver, Canada) following a traumatic brain injury (TBI; 43 uncomplicated mild TBI and 63 complicated mild-severe TBI) or orthopedic injury [36 trauma controls (TC)]. At 6-8 weeks post-injury, diffusion tensor imaging (DTI) of the whole brain was undertaken using a Phillips 3T scanner. Participants also completed neuropsychological testing, an evaluation of lifetime alcohol consumption (LAC), and had blood alcohol levels (BALs) taken at the time of injury. Participants in the uncomplicated mild TBI and complicated mild-severe TBI groups had higher scores on measures of depression and postconcussion symptoms (d = 0.45-0.83), but not anxiety, compared with the TC group. The complicated mild-severe TBI group had more areas of abnormal white matter on DTI measures (all p < .05; d = 0.54-0.61) than the TC group. There were no difference between groups on all neurocognitive measures. Using hierarchical regression analyses and generalized linear modeling, LAC and BAL did provide a unique contribution toward the prediction of attention and executive functioning abilities; however, the variance accounted for was small. LAC and BAL did not provide a unique and meaningful contribution toward the prediction of self-reported symptoms, DTI measures, or the majority of neurocognitive measures. In this study, BAL and LAC were not predictive of mental health symptoms, postconcussion symptoms, cognition, or white-matter changes at 6-8 weeks following TBI.	[Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Lange, Rael T.; Shewchuk, Jason R.; Rauscher, Alexander; Jarrett, Michael; Heran, Manraj K. S.; Brubacher, Jeffrey R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Shewchuk, Jason R.; Heran, Manraj K. S.; Brubacher, Jeffrey R.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Rauscher, Alexander; Jarrett, Michael] UBC MRI Res Ctr, Vancouver, BC, Canada; [Rauscher, Alexander] UBC Brain Res Ctr, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Univ, Sch Med, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA	Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 8,Room 2264,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rael.t.lange@us.army.mil		Rauscher, Alexander/0000-0002-1961-8252; Brubacher, Jeffrey/0000-0002-4866-4231; Iverson, Grant/0000-0001-7348-9570	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200903MOP-200377-BSB-CAAA-161276]; Alcohol Beverage Medical Research Foundation	This work was primarily supported by the Canadian Institutes of Health Research (200903MOP-200377-BSB-CAAA-161276 to RL, GI, JB, and MH); and in part by the Alcohol Beverage Medical Research Foundation (to RL, GI, JB, and MH).	Akshoomoff N A, 1989, Arch Clin Neuropsychol, V4, P275, DOI 10.1016/0887-6177(89)90018-8; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Altura BM, 1999, ALCOHOL, V19, P119, DOI 10.1016/S0741-8329(99)00025-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R., 2007, NONLINEAR REGISTRATI; Barba M, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-23; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Beatty M. E., 1994, DRUG ALCOHOL DEPEN, V37, P247; Beck A.T., 1993; Beck AT., 1996, BECK DEPRESSION INVE, V2; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; BRANDT J, 1983, ARCH GEN PSYCHIAT, V40, P435; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Canadian Institute for Health Information, 2002, ONT TRAUM REG B ALC; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CHARNESS ME, 1993, ALCOHOL CLIN EXP RES, V17, P2, DOI 10.1111/j.1530-0277.1993.tb00718.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cowie S. E., 2005, CAN TRAUM SCI M WHIS; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Dikmen S. S., 1993, NEUROPSYCHOLOGIA, V7, P296, DOI DOI 10.1037/0894-4105.7.3.296; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; Errico A. L., 1991, PSYCHOL ASSESSMENT, V3, P693; ERRICO AL, 1990, PSYCHOL ASSESSMENT, V2, P45, DOI DOI 10.1037/1040-3590.2.1.45; Fan AZ, 2006, EUR J EPIDEMIOL, V21, P129, DOI 10.1007/s10654-005-5457-y; Fein G, 1998, ALCOHOL CLIN EXP RES, V22, p196S, DOI 10.1111/j.1530-0277.1998.tb04000.x; Freudenheim JL, 2003, J NUTR, V133, P3619; GORDON SM, 1988, J SUBST ABUSE TREAT, V5, P99, DOI 10.1016/0740-5472(88)90019-0; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Gururaj G., 2004, J INDIAN MED ASSOC, V102, P163; HARPER CG, 1985, BRIT MED J, V290, P501, DOI 10.1136/bmj.290.6467.501; Hayashi PH, 2004, AM J GASTROENTEROL, V99, P76, DOI 10.1046/j.1572-0241.2003.04013.x; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JENSEN GB, 1993, LANCET, V342, P1201; JERNIGAN T, 1992, IMAGING ALCOHOL RES, P121; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KRAMER JH, 1989, ALCOHOL CLIN EXP RES, V13, P240, DOI 10.1111/j.1530-0277.1989.tb00320.x; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kreutzer J. S., 1990, COGNITIVE REHABILITA, V8, P14; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Ma XY, 2005, ALCOHOL CLIN EXP RES, V29, P1214, DOI 10.1097/01.ALC.0000171934.22755.6D; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; McCann SE, 1999, AM J EPIDEMIOL, V150, P334, DOI 10.1093/oxfordjournals.aje.a010012; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; Miller Norman S., 1994, P471; MUURONEN A, 1989, ALCOHOL CLIN EXP RES, V13, P137, DOI 10.1111/j.1530-0277.1989.tb00298.x; National Institute on Alcoholism and Alcohol Abuse, 2005, HELP PAT WHO DRINK T; Nixon SJ, 1999, PSYCHOL SCI, V10, P181, DOI 10.1111/1467-9280.00130; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Paraherakis A, 2001, SUBST USE MISUSE, V36, P257, DOI 10.1081/JA-100102625; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; PARSONS OA, 1993, NEUROL CLIN, V11, P205; PARSONS OA, 1990, ALCOHOL CLIN EXP RES, V14, P746, DOI 10.1111/j.1530-0277.1990.tb01239.x; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pfefferbaum A, 2005, NEUROPSYCHOPHARMACOL, V30, P423, DOI 10.1038/sj.npp.1300623; Pfefferbaum A, 2002, ALCOHOL CLIN EXP RES, V26, P1031, DOI 10.1097/01.ALC.0000021146.01778.55; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Psychological Corporation, 2001, WECHSL TEST AD READ; Reynolds C. R., 2003, REYNOLDS INTELLECTUA; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rosenbloom M, 2003, ALCOHOL RES HEALTH, V27, P146; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Ruff R. M., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI DOI 10.1097/00001199-199009000-00006; Russell M, 1998, DRUG ALCOHOL REV, V17, P377, DOI 10.1080/09595239800187221; Russell M, 2001, SUBST USE MISUSE, V36, P1417, DOI 10.1081/JA-100106958; Russell M, 1997, AM J EPIDEMIOL, V146, P975; SACHS H, 1987, ARCH NEUROL-CHICAGO, V44, P1242, DOI 10.1001/archneur.1987.00520240024007; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schunemann Holger J, 2002, Sleep Breath, V6, P161, DOI 10.1055/s-2002-36527; Schunemann Holger J, 2002, BMC Pulm Med, V2, P3, DOI 10.1186/1471-2466-2-3; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stranges S, 2004, HEPATOLOGY, V39, P754, DOI 10.1002/hep.20149; Sullivan EV, 1996, ALCOHOL CLIN EXP RES, V20, P348, DOI 10.1111/j.1530-0277.1996.tb01651.x; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Tate PS, 1999, BRAIN INJURY, V13, P767; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; Tombaugh TN, 1996, TEST MEMORY MALINGER; Turner AP, 2006, REHABIL PSYCHOL, V51, P78, DOI 10.1037/0090-5550.51.1.78; Van Zijl PCM, 2004, MRI ATLAS HUMAN WHIT; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; White T., 2003, NEUROPSYCHOLOGICAL A; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916	123	16	16	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2014	29	5					478	495		10.1093/arclin/acu027			18	Psychology, Clinical; Psychology	Psychology	AM6AZ	WOS:000339944200008	24964748				2021-06-18	
J	Liao, GP; Olson, SD; Kota, DJ; Hetz, RA; Smith, P; Bedi, S; Cox, CS				Liao, George P.; Olson, Scott D.; Kota, Daniel J.; Hetz, Robert A.; Smith, Philippa; Bedi, Supinder; Cox, Charles S., Jr.			Far-red tracer analysis of traumatic cerebrovascular permeability	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Blood brain barrier; Fluorescence; Edema; Permeability	CONTROLLED CORTICAL IMPACT; BRAIN-INJURY; CELL THERAPY; BARRIER; CONTUSION; MODEL	Background: Blood brain barrier (BBB) compromise is a key pathophysiological component of secondary traumatic brain injury characterized by edema and neuroinflammation in a previously immune-privileged environment. Current assays for BBB permeability are limited by working size, harsh extraction processes, suboptimal detection via absorbance, and wide excitation fluorescence spectra. In this study, we evaluate the feasibility of AlexaFluor 680, a farred dye bioconjugated to dextran, as an alternative assay to improve resolution and sensitivity. Methods: Alexa Fluor was introduced intravenously on the day of sacrifice to three groups: sham, controlled cortical impact (CCI), and CCI treated with a cell based therapy known to reduce BBB permeability. The brains were sectioned coronally and imaged using an infrared laser scanner to generate intensity plot profiles as well as signal threshold images to distinguish regions with varying degrees of permeability. Results: Linear plot profile analysis demonstrated greater signal intensity from CCI than treated rats at corresponding injury depths. Threshold analysis identified rims of signal at low + narrow threshold ranges. The integrated signals from a treatment group known to preserve the BBB were significantly less than the groups with CCI injury alone. There was no significant difference at high + wide signal intensity threshold ranges. Conclusions: Alexa Fluor 680 infrared photodetection and image analysis can aid in detecting differential degrees of BBB permeability after traumatic brain injury and maybe particularly useful in demonstrating BBB preservation of at-risk regions in response to therapeutic agents. (C) 2014 Elsevier Inc. All rights reserved.	[Liao, George P.; Olson, Scott D.; Kota, Daniel J.; Hetz, Robert A.; Smith, Philippa; Bedi, Supinder; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA	Liao, GP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, 6431 Fannin,MSB 5-230, Houston, TX 77030 USA.	George.P.Liao@uth.tmc.edu		Olson, Scott/0000-0001-8032-3755	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44NS077511] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008792] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44 NS077511] Funding Source: Medline		Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Imer M, 2009, NEUROL RES, V31, P977, DOI 10.1179/174313209X385617; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Nuriya M, 2013, CEREB CORTEX, V23, P2118, DOI 10.1093/cercor/bhs198; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510	21	16	16	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2014	190	2					628	633		10.1016/j.jss.2014.05.011			6	Surgery	Surgery	AM4DD	WOS:000339801800037	24906578	Green Accepted			2021-06-18	
J	Schintu, S; Hadj-Bouziane, F; Dal Monte, O; Knutson, KM; Pardini, M; Wassermann, EM; Grafman, J; Krueger, F				Schintu, Selene; Hadj-Bouziane, Fadila; Dal Monte, Olga; Knutson, Kristine M.; Pardini, Matteo; Wassermann, Eric M.; Grafman, Jordan; Krueger, Frank			Object and space perception - Is it a matter of hemisphere?	CORTEX			English	Article						Dorsal stream; Ventral stream; Lateralization; VLSM; Insula	BRAIN-LESIONS; FUNCTIONAL NEUROANATOMY; NEURAL FRAMEWORK; VISUAL OBJECT; RECOGNITION; ATTENTION; NETWORK; ANATOMY; NEGLECT; RTMS	In the 1980s, following Newcombe's observations, Ungerleider and Mishkin put forward the functional subdivision of the visual system into a ventral stream dedicated to object perception and a dorsal stream dedicated to space perception. Ten years after this discovery, the perception-action model re-defined the dorsal stream as responsible for nonconscious visual guidance, and most recently a tripartition has been suggested to account for a variety of visuospatial functions. Here, we investigated the neural underpinnings of object and space perception by combining the administration of the Visual Object Space Perception (VOSP) battery with a voxel-based lesion symptom mapping (VLSM) approach in a large sample of patients with penetrating traumatic brain injury (pTBI). First, our results provided new support for the complementary role of both hemispheres in object recognition. The right lateral occipital complex was found to be critical in early perceptual discrimination, whereas more anterior temporal and frontal regions in the left hemisphere were found to be critical in more complex forms of object discrimination and recognition. Second, our findings confirmed that space perception depended on the integrity of the right inferior parietal lobule (IPL) and revealed that a network linking the right IPL with the right premotor cortex was critical for the perception of spatial relationships in both 2D and 3D representations. Taken together, our results supported the functional subdivision of the visual system and shed new light on the specific processes involved along both the dorsal and the ventral streams. (C) 2014 Elsevier Ltd. All rights reserved.	[Schintu, Selene; Hadj-Bouziane, Fadila] CNRS, INSERM, Lyon Neurosci Res Ctr, ImpAct Team,UMR5292,U1028, Lyon, France; [Schintu, Selene; Hadj-Bouziane, Fadila] Univ UCBL Lyon 1, Lyon, France; [Dal Monte, Olga] Univ Turin, Dept Neuropsychol, Turin, Italy; [Knutson, Kristine M.; Wassermann, Eric M.] Natl Inst Neurol Disorders & Stroke, Behav Neurol Unit, Natl Inst Hlth, Bethesda, MD USA; [Pardini, Matteo] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet, Genoa, Italy; [Grafman, Jordan] Inst Chicago, Cognit Neurosci Lab Rehabil, Chicago, IL USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Schintu, S (corresponding author), CRNL, ImpAct Team, 16 Ave Doyen Lepine, F-69676 Bron, France.	selene.schintu@gmail.com; fkrueger@gmu.edu	Dal Monte, Olga/P-3759-2018; Pardini, Matteo/F-8414-2010; Hadj-Bouziane, Fadila/AAC-7147-2020; Wassermann, Eric M./AAC-9064-2020; Hadj-Bouziane, Fadila/A-1180-2013; Schintu, Selene/ABF-7032-2020; Hadj-Bouziane, Fadila/F-6309-2016	Dal Monte, Olga/0000-0002-7823-4769; Pardini, Matteo/0000-0002-4740-1982; Wassermann, Eric M./0000-0003-0628-0210; Schintu, Selene/0000-0002-6362-3905; Hadj-Bouziane, Fadila/0000-0002-5415-7949; Knutson, Kristine/0000-0003-4626-4514	U.S. National Institute of Neurological Disorders and Stroke intramural research programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); States Army Medical Research and Material Command; Henry M. Jackson Foundation [DAMD17-01-1-0675]; NEURODIS Foundation	The work was supported by the U.S. National Institute of Neurological Disorders and Stroke intramural research program, and a project grant from the United States Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study, Grant DAMD17-01-1-0675). Selene Schintu was supported with funding from the Henry M. Jackson Foundation, and Fadila Hadj-Bouziane by the NEURODIS Foundation. The authors are grateful to all the Vietnam veterans who participated in this study and the National Naval Medical Center for their support and provision of facilities, as well as V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for their invaluable help with the testing of participants and organization of this study. Note that the views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, nor the U.S. Government. For further information about the Vietnam Head Injury Study, contact J. G. at jgrafman@northwestern.edu. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Acres K, 2009, NEUROPSYCHOLOGIA, V47, P1836, DOI 10.1016/j.neuropsychologia.2009.02.024; Baldo JV, 2013, CORTEX, V49, P658, DOI 10.1016/j.cortex.2012.03.001; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Bartolomeo P, 2012, FRONTIERS HUMAN NEUR, V6; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bonello PJ, 1997, CLIN NEUROPSYCHOL, V11, P436, DOI 10.1080/13854049708400475; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brighina F, 2002, NEUROREPORT, V13, P2571, DOI 10.1097/00001756-200212200-00038; Clower DM, 2005, CEREB CORTEX, V15, P913, DOI 10.1093/cercor/bhh190; Clower DM, 2001, J NEUROSCI, V21, P6283; CORBETTA M, 1993, J NEUROSCI, V13, P1202; De Renzi E, 2000, SEMIN NEUROL, V20, P479, DOI 10.1055/s-2000-13181; De Renzi E., 1982, DISORDERS SPACE EXPL; DERENZI E, 1969, NEUROLOGY, V19, P634; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Fattori P, 2009, J NEUROSCI, V29, P1928, DOI 10.1523/JNEUROSCI.4998-08.2009; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; KAPLAN E, 1976, BOSTON NAMING TEST; Karnath HO, 2009, J NEUROSCI, V29, P5854, DOI 10.1523/JNEUROSCI.5192-08.2009; Kinsbourne M., 1987, ADV PSYCHOL NEUROPHY, V45, P69, DOI [10.1016/S0166-4115(08)61709-4, DOI 10.1016/S0166-4115(08)61709-4]; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Konen CS, 2011, NEURON, V71, P49, DOI 10.1016/j.neuron.2011.05.030; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Martens U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047009; McCarthy R. A., 1990, COGNITIVE NEUROPSYCH, Vx; McNeil M. M., 1994, REVISED TOKEN TEST; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Milner A.D., 2006, VISUAL BRAIN ACTION, V2nd; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; NEWCOMBE F, 1971, J NEUROL NEUROSUR PS, V34, P329, DOI 10.1136/jnnp.34.3.329; Newcombe F., 1969, MISSILE WOUNDS BRAIN; Ploran EJ, 2007, J NEUROSCI, V27, P11912, DOI 10.1523/JNEUROSCI.3522-07.2007; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rounis E, 2007, J COGNITIVE NEUROSCI, V19, P513, DOI 10.1162/jocn.2007.19.3.513; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Stewart L, 2001, NEUROPSYCHOLOGIA, V39, P1, DOI 10.1016/S0028-3932(00)00084-1; TAYLOR A M, 1973, Cortex, V9, P82; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L. G., 1982, 2 CORTICAL VISUAL SY; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; United States Department of Defense, 1960, ARM FORC QUAL TEST A; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Warrington E. K., 1991, VISUAL OBJECT SPACE, V4; WARRINGTON EK, 1978, PERCEPTION, V7, P695, DOI 10.1068/p070695; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Xu J, 2009, P NATL ACAD SCI USA, V106, P20664, DOI 10.1073/pnas.0909197106; Zachariou V., 2013, J COGNITIVE NEUROSCI, P1; Zelkowicz BJ, 1998, J INT NEUROPSYCH SOC, V4, P160, DOI 10.1017/S135561779800160X	77	16	16	1	40	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	AUG	2014	57						244	253		10.1016/j.cortex.2014.04.009			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	AN1BK	WOS:000340317500018	24929474				2021-06-18	
J	Schober, ME; Requena, DF; Davis, LJ; Metzger, RR; Bennett, KS; Morita, D; Niedzwecki, C; Yang, ZH; Wang, KKW				Schober, Michelle E.; Requena, Daniela F.; Davis, Lizeth J.; Metzger, Ryan R.; Bennett, Kimberly S.; Morita, Denise; Niedzwecki, Christian; Yang, Zhihui; Wang, Kevin K. W.			Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury	BRAIN RESEARCH			English	Article						Controlled cortical impact; Apoptosis; Excitotmdcity; Cell death; Developmental	CONTROLLED CORTICAL IMPACT; CEREBROSPINAL-FLUID; APOPTOTIC NEURODEGENERATION; CALPAIN; DEGRADATION; CHILDREN; NEURONS; AGE; VULNERABILITY; ACCUMULATION	After traumatic brain injury (TBI), proteolysis of Alpha II Spectrin by Calpain 1 produces 145 Spectrin breakdown products (SBDPs) while proteolysis by Caspase 3 produces 120 SBDPs. 145 and 120 SBDP immunoblotting reflects the relative importance of caspase-dependent apoptosis or calpain-dependent excitotoxic/necrotoxic cell death in brain regions over time. In the adult rat, controlled cortical impact (CCI) increased 120 SBDPs in the first hours, lasting a few days, and increased 145 SBDPs within the first few days lasting up to 14 days after injury. Little is known about SBDPs in the immature brain after TBI. Since development affects susceptibility to apoptosis after TBI, we hypothesized that CCI would increase 145 and 120 SBDPs in the immature rat brain relative to SHAM during the first 3 and 5 days, respectively. SBDPs were measured in hippocampi and cortices at post injury days (PID) 1, 2, 3, 5, 7 and 14 after CCI or SHAM surgery in the 17 day old Sprague Dawley rat. 145 SBDPs increased in both brain tissues ipsilateral to injury during the first 3 days, while changes in contralateral tissues were limited to PID2 cortex. 145 SBDPs elevations were more marked and enduring in hippocampus than in cortex. Against expectations, 120 SBDPs only increased in PID1 hippocampus and PID2 cortex. 145 SBDPs elevations occurred early after CCI, similar to previous studies in the adult rat, but resolved more quickly. The minimal changes in 120 SBDPs suggest that calpain-dependent, but not caspase-dependent, cell death predominates in the 17 day old rat after CCI. (C) 2014 Elsevier B.V. All rights reserved.	[Requena, Daniela F.; Davis, Lizeth J.] Univ Utah, Div Neonatol, Dept Pediat, Salt Lake City, UT 84132 USA; [Schober, Michelle E.; Bennett, Kimberly S.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT 84132 USA; [Metzger, Ryan R.] Univ Utah, Dept Surg, Salt Lake City, UT 84132 USA; [Morita, Denise] Univ Utah, Dept Pediat, Div Neurol, Salt Lake City, UT 84132 USA; [Niedzwecki, Christian] Univ Utah, Dept Pediat, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA; [Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarker Res, Dept Pediat, Gainesville, FL 32611 USA	Schober, ME (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT 84132 USA.	michelle.schober@hsc.utah.edu		Wang, Kevin/0000-0002-9343-6473	PCMC Foundation Integrative [PCMCF-ISA-KS01-2011-01]; CHRCDA [NIH K12HD001410]; Divisions of Neonatology and Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City UT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001410] Funding Source: NIH RePORTER	Funding for this study was provided by the PCMC Foundation Integrative Grant PCMCF-ISA-KS01-2011-01, the CHRCDA (NIH K12HD001410) and from the Divisions of Neonatology and Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City UT.	Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cardali S, 2006, J Neurosurg Sci, V50, P25; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Polster BM, 2003, CELL DEATH DIFFER, V10, P365, DOI 10.1038/sj.cdd.4401158; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saransaari P, 2003, AMINO ACIDS, V24, P213, DOI 10.1007/s00726-002-0310-z; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	54	16	16	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 29	2014	1574						105	112		10.1016/j.brainres.2014.05.046			8	Neurosciences	Neurosciences & Neurology	AM6ZM	WOS:000340014500012	24929209	Green Accepted			2021-06-18	
J	Filippidis, AS; Liang, XY; Wang, WL; Parveen, S; Baumgarten, CM; Marmarou, CR				Filippidis, Aristotelis S.; Liang, Xiuyin; Wang, Weili; Parveen, Shanaaz; Baumgarten, Clive M.; Marmarou, Christina R.			Real-Time Monitoring of Changes in Brain Extracellular Sodium and Potassium Concentrations and Intracranial Pressure after Selective Vasopressin-1a Receptor Inhibition following Focal Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						AQP4; cations; TBI; V1a receptor; vasopressin	CEREBRAL-ARTERY OCCLUSION; PHORBOL-MYRISTATE ACETATE; ATRIAL-NATRIURETIC-PEPTIDE; KINASE-C ACTIVATOR; ARGININE-VASOPRESSIN; AQP4 EXPRESSION; SPREADING DEPOLARIZATIONS; ANTAGONIST SR49059; WATER TRANSPORT; EDEMA FORMATION	Brain swelling and increased intracranial pressure (ICP) following traumatic brain injury (TBI) contribute to poor outcome. Vasopressin-1a receptors (V1aR) and aquaporin-4 (AQP4) regulate water transport and brain edema formation, perhaps in part by modulating cation fluxes. After focal TBI, V1aR inhibitors diminish V1aR and AQP4, reduce astrocytic swelling and brain edema. We determined whether V1aR inhibition with SR49059 after lateral controlled-cortical-impact (CCI) injury affects extracellular Na+ and K+ concentrations ([Na+](e); [K+](e)). Ion-selective Na+ and K+ electrodes (ISE) and an ICP probe were implanted in rat parietal cortex, and [Na+](e), [K+](e), and physiological parameters were monitored for 5 h post-CCI. Sham-vehicle-ISE, CCI-vehicle-ISE and CCI-SR49059-ISE groups were studied, and SR49059 was administered 5 min to 5 h post-injury. We found a significant injury-induced decrease in [Na+](e) to 80.1 +/- 15 and 87.9 +/- 7.9 mM and increase in [K+](e) to 20.9 +/- 3.8 and 13.4 +/- 3.4 mM at 5 min post-CCI in CCI-vehicle-ISE and CCI-SR49059-ISE groups, respectively (p < 0.001 vs. baseline; ns between groups). Importantly, [Na+](e) in CCI-SR49059-ISE was reduced 5-20 min post-injury and increased to baseline at 25 min, whereas recovery in CCI-vehicle-ISE required more than 1 hr, suggesting SR49059 accelerated [Na+](e) recovery. In contrast, [K+](e) recovery took 45 min in both groups. Further, ICP was lower in the CCI-SR49059-ISE group. Thus, selective V1aR inhibition allowed faster [Na+](e) recovery and reduced ICP. By augmenting the [Na+](e) recovery rate, SR49059 may reduce trauma-induced ionic imbalance, blunting cellular water influx and edema after TBI. These findings suggest SR49059 and V1aR inhibitors are potential tools for treating cellular edema post-TBI.	[Filippidis, Aristotelis S.; Liang, Xiuyin; Wang, Weili; Parveen, Shanaaz; Marmarou, Christina R.] Virginia Commonwealth Univ, Dept Neurosurg, Med Coll Virginia, Richmond, VA 23298 USA; [Baumgarten, Clive M.; Marmarou, Christina R.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia, Richmond, VA 23298 USA; [Baumgarten, Clive M.] Virginia Commonwealth Univ, Dept Internal Med, Med Coll Virginia, Richmond, VA 23298 USA	Marmarou, CR (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, 1101 East Marshall St,POB 980631, Richmond, VA 23298 USA.	crmarmar@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS019235, 5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R01NS019235] Funding Source: NIH RePORTER	This work was supported by NIH grant 5R01NS019235. Microscopy was performed at the VCU-Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, by NIH Core grant 5P30NS047463. SR49059 was a generous gift from Sanofi-Aventis Recherche Exploratoire, Montpellier, France.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amorini AM, 2003, ACT NEUR S, V86, P261; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Cserr H., 1991, ADV COMP ENV PHYSL, P61; CSERR HF, 1991, J PHYSIOL-LONDON, V442, P277, DOI 10.1113/jphysiol.1991.sp018793; CSERR HF, 1992, PROG BRAIN RES, V91, P3; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; DOCZI T, 1982, NEUROSURGERY, V11, P402; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Fazzina G, 2010, J NEUROTRAUM, V27, P453, DOI 10.1089/neu.2008.0782; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P258; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; LANDGRAF R, 1992, PROG BRAIN RES, V91, P29; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LATZKOVITS L, 1993, AM J PHYSIOL, V264, pC603; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Lu H, 2013, CHINESE MED J-PEKING, V126, P4316, DOI 10.3760/cma.j.issn.0366-6999.20131139; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P191, DOI 10.1007/978-3-7091-0693-8_32; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marmarou CR, 2012, J NEUROTRAUM, V29, pA121; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Okuno K, 2008, ACTA NEUROCHIR SUPPL, V102, P431, DOI 10.1007/978-3-211-85578-2_84; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Reinert M, 2000, Neurosurg Focus, V8, pe10; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Richter F, 2008, J CEREBR BLOOD F MET, V28, P984, DOI 10.1038/sj.jcbfm.9600594; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Stiefel MF, 2002, J NEUROSURG, V97, P97, DOI 10.3171/jns.2002.97.1.0097; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Vajda Z, 2001, NEUROSURGERY, V49, P697, DOI 10.1097/00006123-200109000-00031; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	67	16	16	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1258	1267		10.1089/neu.2013.3063			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000003	24635833	Green Published			2021-06-18	
J	Sykora, M; Steinmacher, S; Steiner, T; Poli, S; Diedler, J				Sykora, Marek; Steinmacher, Sahra; Steiner, Thorsten; Poli, Sven; Diedler, Jennifer			Association of intracranial pressure with outcome in comatose patients with intracerebral hemorrhage	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Intracerebral hemorrhage; Outcome; Intracranial pressure; Cerebral perfusion pressure; ICP; CPP	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; ABC/2 ESTIMATION TECHNIQUE; REACTIVITY; HEMATOMAS	Background: Therapeutic targets for intracranial pressure (ICP) in patients with severe intracerebral hemorrhage (ICH) are approximated from data of traumatic brain injury. However, specific data for ICH are lacking. Here, we aimed to investigate the association between ICP, mortality and functional outcome following severe ICH. Methods: We analyzed consecutive comatose patients with ICH in whom ICP monitoring was applied. Outcome at 3 months was assessed using the modified Rankin scale (mRS). Multivariate logistic regression including pre-defined predictors was used in order to identify the effects of ICP on outcome. Results: 121 patients with ICH and ICP monitoring were analyzed. Mean ICP (OR 12, Cl 1.08-1.45,p = 0.003), ICP variability (OR 13, Cl 1.03-1.73, p = 0.03) and relative frequency of ICP values >20 mm Hg (OR 1.1, CI 1.02-1.15, p = 0.008) were independently associated with mortality at 3 months. Relative frequency of ICP values > 20 mm Hg (OR 1.1, CI 1.001-1.3, p = 0.04) was associated also with poor functional outcome at 3 months. Conclusions: Our data suggest that in the context of other predictors as age, admission clinical status, hemorrhage volume and intraventricular hemorrhage, average ICP, ICP variability and the frequency of ICP values >20 mm Hg are independently associated with mortality and poor outcome after ICH. Further studies and prospective validations of ICP thresholds for ICH patients are highly warranted. (C) 2014 Elsevier B.V. All rights reserved.	[Sykora, Marek; Steinmacher, Sahra; Poli, Sven; Diedler, Jennifer] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Steiner, Thorsten] Klinikum Frankfurt Hochst, Dept Neurol, Frankfurt, Germany; [Poli, Sven; Diedler, Jennifer] Univ Tubingen, Dept Neurol, Tubingen, Germany; [Diedler, Jennifer] Univ Tubingen, Dept Neurosurg, Tubingen, Germany	Sykora, M (corresponding author), Heidelberg Univ, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	marek.sykora@med.uni-heidelberg.de	Steiner, Thorsten/A-7391-2014; Steiner, Thorsten/L-2868-2018	Steiner, Thorsten/0000-0002-5080-8222			Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Fernandes HM, 2000, ACT NEUR S, V76, P463; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Hamani C, 2003, ARQ NEURO-PSIQUIAT, V61, P376, DOI 10.1590/S0004-282X2003000300010; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nikaina I, 2012, J CRIT CARE, V27, P83, DOI 10.1016/j.jcrc.2011.04.004; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Tian Y, 2013, J NEUROL SCI, V330, P38, DOI 10.1016/j.jns.2013.04.001; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	17	16	20	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUL 15	2014	342	1-2					141	145		10.1016/j.jns.2014.05.012			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AK4SN	WOS:000338414500022	24857761				2021-06-18	
J	Bosch, M; McKenzie, JE; Mortimer, D; Tavender, EJ; Francis, JJ; Brennan, SE; Knott, JC; Ponsford, JL; Pearce, A; O'Connor, DA; Grimshaw, JM; Rosenfeld, JV; Gruen, RL; Green, SE				Bosch, Marije; McKenzie, Joanne E.; Mortimer, Duncan; Tavender, Emma J.; Francis, Jill J.; Brennan, Sue E.; Knott, Jonathan C.; Ponsford, Jennie L.; Pearce, Andrew; O'Connor, Denise A.; Grimshaw, Jeremy M.; Rosenfeld, Jeffrey V.; Gruen, Russell L.; Green, Sally E.		NET Program	Implementing evidence-based recommended practices for the management of patients with mild traumatic brain injuries in Australian emergency care departments: study protocol for a cluster randomised controlled trial	TRIALS			English	Article						Mild traumatic brain injury; Cluster trial; Emergency department	MINOR HEAD-INJURY; GENERALIZED ESTIMATING EQUATIONS; NEW-ORLEANS CRITERIA; GLASGOW COMA SCALE; WESTMEAD PTA SCALE; COMPUTED-TOMOGRAPHY; QUALITY IMPROVEMENT; ORGANIZATIONAL READINESS; POSTTRAUMATIC AMNESIA; COGNITIVE IMPAIRMENT	Background: Mild head injuries commonly present to emergency departments. The challenges facing clinicians in emergency departments include identifying which patients have traumatic brain injury, and which patients can safely be sent home. Traumatic brain injuries may exist with subtle symptoms or signs, but can still lead to adverse outcomes. Despite the existence of several high quality clinical practice guidelines, internationally and in Australia, research shows inconsistent implementation of these recommendations. The aim of this trial is to test the effectiveness of a targeted, theory- and evidence-informed implementation intervention to increase the uptake of three key clinical recommendations regarding the emergency department management of adult patients (18 years of age or older) who present following mild head injuries (concussion), compared with passive dissemination of these recommendations. The primary objective is to establish whether the intervention is effective in increasing the percentage of patients for which appropriate post-traumatic amnesia screening is performed. Methods/design: The design of this study is a cluster randomised trial. We aim to include 34 Australian 24-hour emergency departments, which will be randomised to an intervention or control group. Control group departments will receive a copy of the most recent Australian evidence-based clinical practice guideline on the acute management of patients with mild head injuries. The intervention group will receive an implementation intervention based on an analysis of influencing factors, which include local stakeholder meetings, identification of nursing and medical opinion leaders in each site, a train-the-trainer day and standardised education and interactive workshops delivered by the opinion leaders during a 3 month period of time. Clinical practice outcomes will be collected retrospectively from medical records by independent chart auditors over the 2 month period following intervention delivery (patient level outcomes). In consenting hospitals, eligible patients will be recruited for a follow-up telephone interview conducted by trained researchers. A cost-effectiveness analysis and process evaluation using mixed-methods will be conducted. Sample size calculations are based on including 30 patients on average per department. Outcome assessors will be blinded to group allocation.	[Bosch, Marije; Tavender, Emma J.; Rosenfeld, Jeffrey V.; Gruen, Russell L.] Monash Univ, Dept Surg, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Bosch, Marije; Tavender, Emma J.; Ponsford, Jennie L.; Rosenfeld, Jeffrey V.; Gruen, Russell L.] Alfred & Monash Univ, Natl Trauma Res Inst, Melbourne, Vic, Australia; [McKenzie, Joanne E.; Brennan, Sue E.; O'Connor, Denise A.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Mortimer, Duncan] Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia; [Francis, Jill J.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Knott, Jonathan C.] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Knott, Jonathan C.] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Pearce, Andrew] MedSTAR Emergency Med Retrieval Serv, Adelaide, SA, Australia; [Pearce, Andrew] Royal Adelaide Hosp, Emergency Dept, Adelaide, SA 5000, Australia; [Grimshaw, Jeremy M.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Gruen, Russell L.] Alfred Hosp, Dept Trauma, Melbourne, Vic, Australia	Bosch, M (corresponding author), Monash Univ, Dept Surg, Cent Clin Sch, Melbourne, Vic 3004, Australia.	marije.bosch@monash.edu	MUNOZ, ROSA ANA/H-3964-2018; Harris, Claire/J-1899-2019; Cooper, D. James/G-7961-2013; Morley, Peter/G-5280-2017; McDonald, Steve/AAE-1613-2020; O'Connor, Denise/ABC-6655-2020; McKenzie, Joanne E/I-2925-2014	MUNOZ, ROSA ANA/0000-0002-7504-2163; Harris, Claire/0000-0002-5367-8144; Cooper, D. James/0000-0002-5872-9051; Morley, Peter/0000-0003-2653-090X; McDonald, Steve/0000-0003-2832-5205; O'Connor, Denise/0000-0002-6836-122X; McKenzie, Joanne E/0000-0003-3534-1641; Green, Sally Elizabeth/0000-0002-9564-9050; Mortimer, Duncan Stuart/0000-0002-7211-6454; Fitzgerald, Mark/0000-0003-0183-7761; Meares, Susanne/0000-0002-3859-9974; Francis, Jill/0000-0001-5784-8895; Brennan, Sue/0000-0003-1789-8809; Kaye, Andrew Henry/0000-0001-5049-8861; Morokoff, Andrew/0000-0002-5159-3438; Cameron, Peter/0000-0002-1443-557X; Tavender, Emma/0000-0002-7230-712X	Victorian Transport Accident Commission (TAC), Australia; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian NHMRC Public Health FellowshipNational Health and Medical Research Council of Australia [606726]	This protocol is part of a 5-year grant (the Neurotrauma Evidence Translation (NET) Program), funded by the Victorian Transport Accident Commission (TAC), Australia. The TAC has had no involvement in the study design, preparation of the manuscript, or the decision to submit the manuscript for publication. RLG is supported by a Practitioner Fellowship from the Australian National Health and Medical Research Council. DAO is supported by an Australian NHMRC Public Health Fellowship (606726). JMG holds a Canada Research Chair in Health Knowledge and Transfer.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson NR, 1998, J ORGAN BEHAV, V19, P235, DOI 10.1002/(SICI)1099-1379(199805)19:3<235::AID-JOB837>3.0.CO;2-C; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Australasian Society for Emergency Medicine (ASEM), 2009, DIR EM DEP AUSTR NZ; Baker DP, 2006, HEALTH SERV RES, V41, P1576, DOI 10.1111/j.1475-6773.2006.00566.x; Bay E, 2011, ADV EMERG NURS J, V33, P181, DOI 10.1097/TME.0b013e318217c958; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Berger VW, 2010, CONTEMP CLIN TRIALS, V31, P406, DOI 10.1016/j.cct.2010.05.001; Bosch M, 2013, J EVAL CLIN PRACT, V19, P763, DOI 10.1111/j.1365-2753.2012.01835.x; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brazier J, 2008, PRO NEWSLETTER, V40, P14, DOI [10.4135/9781412971980.n298, DOI 10.4135/9781412971980.N298]; Brown R, 2009, INT J EMERG MED, V2, P161, DOI 10.1007/s12245-009-0124-9; Campbell A, 2005, CLIN GOVT INT J, V10, P2, DOI DOI 10.1108/14777270510579305; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Carlin JB, 1999, STAT MED, V18, P2655, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2655::AID-SIM202>3.3.CO;2-R; Compton S, 2007, ACAD EMERG MED, V14, P991, DOI 10.1197/j.aem.2007.06.031; Copas AJ, 2010, J APPL STAT, V37, P911, DOI 10.1080/02664760902939604; Dillman D.A., 2011, MAIL INTERNET SURVEY; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Fitzmaurice GM, 2004, APPL LONGITUDINAL AN, P353; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125, 10.1002/14651858.CD000125.pub4]; Frambach RT, 2002, J BUS RES, V55, P163, DOI 10.1016/S0148-2963(00)00152-1; Francis JJ, 2010, PSYCHOL HEALTH, V25; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gallo A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-116; Glynn RJ, 2007, MED CARE, V45, pS38, DOI 10.1097/MLR.0b013e318070c0a0; Goh S., 1997, EUROPEAN MANAGEMENT, V15, P575, DOI DOI 10.1016/S0263-2373(97)00036-4; Green SE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-74; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grimshaw JM, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-38; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P788, DOI 10.1136/jech.2003.014415; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Health Services Research Unit, DAT ICCS; Helfrich CD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-38; Hemming K, 2013, STATA J, V13, P114, DOI 10.1177/1536867X1301300109; Heng K. W. J., 2007, SMJ Singapore Medical Journal, V48, P1107; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hrisos S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-37; Hulscher MEJL, 2003, QUAL SAF HEALTH CARE, V12, P40, DOI 10.1136/qhc.12.1.40; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnston, 2004, CONSTRUCTING QUESTIO; Kerr J, 2007, EMERG MED J, V24, P330, DOI 10.1136/emj.2006.044230; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kissane DW, 2006, AM J PSYCHIAT, V163, P1208, DOI 10.1176/appi.ajp.163.7.1208; Kivimaki M, 1999, J OCCUP ORGAN PSYCH, V72, P241, DOI 10.1348/096317999166644; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McDonald AM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-74; McRae AD, 2011, TRIALS, V12, DOI [10.1186/1745-6215-12-183, 10.1186/1745-6215-12-202]; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Miller L, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-7; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Norman R, 2013, AUST NZ J PUBL HEAL, V37, P17, DOI 10.1111/1753-6405.12005; NSW Institute of Trauma and Injury Management, 2011, IN MAN CLOS HEAD INJ; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Pare G, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-15; Peachey T, 2011, EMERG MED J, V28, P707, DOI 10.1136/emj.2010.093872; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Scott SD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-65; SENN SJ, 1989, STAT MED, V8, P467, DOI 10.1002/sim.4780080410; Sharpe S, 2012, J PAEDIATR CHILD H, V48, P170, DOI 10.1111/j.1440-1754.2011.02068.x; Sheehan A, 2012, EMERG MED J, V29, P899, DOI 10.1136/emermed-2011-200155; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; StataCorp, 2011, STAT STAT SOFTW REL; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI [10.1111/j.1525-1497.2006.00355.x, 10.1007/s11606-006-0267-9]; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taljaard M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2496; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; TEASDALE G, 1974, LANCET, V2, P81; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Treweek S., 2011, TRIALS S1, V12, pA110; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub4, 10.1002/14651858.MR000013.pub5]; Ukoumunne OC, 1999, HEALTH TECHNOL ASSES, V3, P3, DOI DOI 10.3310/hta3050; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; von Wild KRH, 2008, ACT NEUR S, V101, P55; Walker AE, 2000, J EVAL CLIN PRACT, V6, P185, DOI 10.1046/j.1365-2753.2000.00235.x; Walshe K, 2007, INT J QUAL HEALTH C, V19, P57, DOI 10.1093/intqhc/mzm004; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	116	16	16	0	24	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 11	2014	15								281	10.1186/1745-6215-15-281			20	Medicine, Research & Experimental	Research & Experimental Medicine	AL7ZD	WOS:000339355100001	25012235	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Di Battista, A; Godfrey, C; Soo, C; Catroppa, C; Anderson, V				Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki			Depression and Health Related Quality of Life in Adolescent Survivors of a Traumatic Brain Injury: A Pilot Study	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; ANXIETY DISORDERS; SYMPTOMS; RELIABILITY; PREVALENCE; PREDICTORS; CHILDHOOD; SEVERITY; VALIDITY; IMPACT	Traumatic brain injury is (TBI) a leading cause of morbidity and mortality in youth. Adult survivors of a severe pediatric TBI are vulnerable to global impairments, including greater employment difficulties, poor quality of life (HRQoL) and increased risk of mental health problems. When estimating the health related quality of life in adolescents, the presence of anxiety and depression and the quality of social relationships are important considerations, because adolescents are entrenched in social development during this phase of maturation. The influence of anxiety, depression and loneliness on health related quality of life in adolescent survivors of TBI has not been documented. This pilot study aimed to identify and measure the relationship between anxiety, depression and loneliness and perceived health related quality of life in adolescent survivors of a TBI. Method: mixed method/cohort pilot study (11 adolescents, mild to severe TBI; 9 parents), using self-report and proxy-report measures of anxiety, depression, health related quality of life, loneliness and clinical psychiatric interviews (adolescent only). Results: Self-reported depression was significantly correlated with self-reported HRQoL (rs [11] = 20.88, p<0.001). Age at injury was significantly correlated with self-reported HRQoL (rs [11] = -0.68, p = 0.02). Self-reported depression predicted self-reported HRQoL (R-2 = 0.79, F [1,10] = 33.48, p<0.001), but age at injury did not (R-2 = 0.19, F [1,10] = 2.09, p = 0.18). Conclusions: Our results suggest that depression is a predictor of health related quality of life in youth post-TBI. The possibility of using targeted assessment and therapy for depression post-TBI to improve health related quality of life should be explored.	[Di Battista, Ashley; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia; [Di Battista, Ashley] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Di Battista, A (corresponding author), Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia.	ashley.dibattista@sickkids.ca			Victorian Government; Victorian Neurotrauma Initiative; Australian National Health & Medical Research CouncilNational Health and Medical Research Council of Australia; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research (CIHR), CanadaCanadian Institutes of Health Research (CIHR); Victorian Government, Australia	Funding provided by Victorian Government Operational Infrastructure Scheme, Victorian Neurotrauma Initiative - fellowship to CS, Australian National Health & Medical Research Council - fellowships to VA and CC and Canadian Institutes of Health Research - Doctoral Research Award to AD. This research was supported in part by grants from the Canadian Institutes of Health Research (CIHR) Doctoral Research Award (DRA), Canada - awarded to ADB, and the Victorian Government Operations Infrastructure Funding, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Anderson VA, 2010, J NEUROTRAUM, V27, P1; Avenevoli S, 2001, BIOL PSYCHIAT, V49, P1071, DOI 10.1016/S0006-3223(01)01142-8; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bloom D, 1997, J INT NEUROPSYCH SOC, V5, P127; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Eapen V, 2012, CURR OPIN PSYCHIATR, V25, P7, DOI 10.1097/YCO.0b013e32834de3bd; First M., 1997, USERS GUIDE STRUCTUR; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1111/1469-7610.00629; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HODGES K, 1993, J CHILD PSYCHOL PSYC, V34, P49, DOI 10.1111/j.1469-7610.1993.tb00967.x; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Hoza B, 2000, J CLIN CHILD PSYCHOL, V29, P119, DOI 10.1207/S15374424jccp2901_12; Irons C, 2005, J ADOLESCENCE, V28, P325, DOI 10.1016/j.adolescence.2004.07.004; Juvonen J., 2001, PEER HARASSMENT SCH; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kazadin AE, 1983, J AM ACAD CHILD ADOL, V22, P157; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kovacs M., 1992, CHILDRENS DEPRESSION; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCarthy ML, 2006, ARCH PHYS MED REHAB, V160, P253; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Saro J, 2013, BEST PRACTICES USING; SCHMIDT N, 1983, J PERS SOC PSYCHOL, V44, P1038, DOI 10.1037/0022-3514.44.5.1038; Spielberger CD, 1989, STATE TRAIT ANXIETY; Statistics ABo, 2008, STAT ABO ED UPD 17 J; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Ware JE, 1994, SF 36 PHYSL MENTAL H; Wechsler D, 1999, CORPORATION TP	42	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101842	10.1371/journal.pone.0101842			10	Multidisciplinary Sciences	Science & Technology - Other Topics	AK9RG	WOS:000338763800045	25010719	DOAJ Gold, Green Published			2021-06-18	
J	Liu, YQ; Liu, ZW; Li, XM; Luo, BW; Xiong, J; Gan, WT; Jiang, M; Zhang, ZY; Schluesener, HJ; Zhang, ZR				Liu, Yuqi; Liu, Zongwei; Li, Xiaoming; Luo, Bangwei; Xiong, Jian; Gan, Woting; Jiang, Man; Zhang, Zhiyuan; Schluesener, Hermann J.; Zhang, Zhiren			Accumulation of connective tissue growth factor(+) cells during the early phase of rat traumatic brain injury	DIAGNOSTIC PATHOLOGY			English	Article						Connective tissue growth factor; Astrocytes; Weight-drop model; Traumatic brain injury	EXPRESSION; SCLEROSIS; DISEASE; LESIONS	Background: Glial scar formation is a common histopathological feature of traumatic brain injury (TBI). Astrogliosis and expression of transforming growth factor beta (TGF-beta) are key components of scar formation and blood-brain barrier modulation. Connective tissue growth factor (CTGF) is considered a cytokine mediating the effects of TGF-beta. Methods: Here, we studied the CTGF expression in an open-skull weight-drop-induced TBI, with a focus on the early phase, most amenable to therapy. Results: In normal rat brains of our study, CTGF(+) cells were rarely observed. Significant parenchymal accumulation of CTGF(+) non-neuron cells was observed 72 h post-TBI and increased continuously during the investigating time. We also observed that the accumulated CTGF(+) non-neuron cells were mainly distributed in the perilesional areas and showed activated astrocyte phenotypes with typical stellate morphologic characteristics. Conclusion: Our observations demonstrated the time-dependent and lesion-associated accumulation of cellular CTGF expression in TBI, suggesting a pathological role of CTGF in TBI.	[Liu, Yuqi; Liu, Zongwei; Li, Xiaoming; Luo, Bangwei; Xiong, Jian; Gan, Woting; Jiang, Man; Zhang, Zhiren] Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China; [Zhang, Zhiyuan; Schluesener, Hermann J.] Univ Tubingen, Inst Brain Res, Tubingen, Germany	Zhang, ZR (corresponding author), Third Mil Med Univ, Inst Immunol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China.	zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835	National Science and Technology Major Projects of New Drugs [2012ZX09103301-035]; SRF for ROCSScientific Research Foundation for the Returned Overseas Chinese Scholars; SRF for SEM	This investigation was supported by the National Science and Technology Major Projects of New Drugs (2012ZX09103301-035) and the SRF for ROCS, SEM.	Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hertel M, 2000, EUR J NEUROSCI, V12, P376, DOI 10.1046/j.1460-9568.2000.00930.x; Hobbenaghi R, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-123; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Liu YQ, 2013, NEUROREPORT, V24, P281, DOI 10.1097/WNR.0b013e32835f2810; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Oemar BS, 1997, CIRCULATION, V95, P831; Rongchao Sun, 2012, Diagn Pathol, V7, P54, DOI 10.1186/1746-1596-7-54; Schwab JM, 2000, NEUROPATH APPL NEURO, V26, P434, DOI 10.1046/j.1365-2990.2000.00271.x; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spliet WGM, 2003, ACTA NEUROPATHOL, V106, P449, DOI 10.1007/s00401-003-0741-y; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Ueberham U, 2003, NEUROSCIENCE, V116, P1, DOI 10.1016/S0306-4522(02)00670-X; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	17	16	16	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1746-1596			DIAGN PATHOL	Diagn. Pathol.	JUL 10	2014	9								141	10.1186/1746-1596-9-141			5	Pathology	Pathology	AL7AG	WOS:000339284600001	25012526	DOAJ Gold, Green Published			2021-06-18	
J	Kinsella, GJ; Olver, J; Ong, B; Gruen, R; Hammersley, E				Kinsella, Glynda J.; Olver, John; Ong, Ben; Gruen, Russell; Hammersley, Eleanor			Mild Traumatic Brain Injury in Older Adults: Early Cognitive Outcome	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic injury; Mild head injury; Older age; Orthopedic injury; Prospective memory; Cognition; Neuropsychological outcome	PROSPECTIVE MEMORY; FALLS; AGE; IMPAIRMENT; PREDICTION; RETRIEVAL; MORTALITY; CHILDREN; MODERATE; COSTS	Severe traumatic brain injury (TBI) in older age is associated with high rates of mortality. However, little is known about outcome following mild TBI (mTBI) in older age. We report on a prospective cohort study investigating 3 month outcome in older age patients admitted to hospital-based trauma services. First, 50 mTBI older age patients and 58 orthopedic controls were compared to 123 community control participants to evaluate predisposition and general trauma effects on cognition. Specific brain injury effects were subsequently evaluated by comparing the orthopedic control and mTBI groups. Both trauma groups had significantly lower performances than the community group on prospective memory (d = 0.82 to 1.18), attention set-shifting (d = -0.61 to -0.69), and physical quality of life measures (d = 0.67 to 0.84). However, there was only a small to moderate but non-significant difference in the orthopedic control and mTBI group performances on the most demanding task of prospective memory (d = 0.37). These findings indicate that, at 3 months following mTBI, older adults are at risk of poor cognitive performance but this is substantially accounted for by predisposition to injury or general multi-system trauma.	[Kinsella, Glynda J.; Ong, Ben; Hammersley, Eleanor] La Trobe Univ, Melbourne, Vic 3086, Australia; [Kinsella, Glynda J.] Caulfield Hosp, Dept Psychol, Melbourne, Vic, Australia; [Olver, John] Epworth Healthcare, Rehabil & Psychiat, Melbourne, Vic, Australia; [Olver, John; Gruen, Russell] Monash Univ, Fac Med, Melbourne, Vic 3004, Australia; [Gruen, Russell] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Gruen, Russell] Alfred Hosp, Dept Surg, Melbourne, Vic, Australia	Kinsella, GJ (corresponding author), La Trobe Univ, Melbourne, Vic 3086, Australia.	g.kinsella@latrobe.edu.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934; Olver, John/0000-0001-7069-1191	Victorian Neurotrauma Initiative [DP 042]; Transport Accident Commission	The authors acknowledge the contribution to the research by Dr. Evrim March, Samuel Parsons, Dr. Bethan Potter, and Dr. Sarah Price; and the enthusiastic involvement of the participants in the assessment process. Conflicts of Interest: There are no conflicts of interest. Funding statement: This project was supported by a research grant from the Victorian Neurotrauma Initiative (GJK, J.O., B.O., grant number DP 042), and the Transport Accident Commission.	AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Albert MS, 2001, J INT NEUROPSYCH SOC, V7, P631, DOI 10.1017/S1355617701755105; [Anonymous], 2012, AG 21 CENT CEL CHALL; Australian Bureau of Statistics, 2009, AUSTR NZ CLASS OCC A; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bradley C, 2013, INJURY RES STAT SERI, V70; Brandt J., 2001, HOPKINS VERBAL LEARN; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Gallo J.J., 2006, HDB GERIATRIC ASSESS, P193; Gennarelli T.A., 2008, ABBREVIATED INJURY S; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Harrison J, 2008, INJURY RES STAT SERI, V45; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kinsella GJ, 2009, J NEUROL NEUROSUR PS, V80, P730, DOI 10.1136/jnnp.2008.148346; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCrae M. A., 2008, MILD TRAUMATIC BRAIN; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Ware J., 2002, SCORE VERSION 2 SF 1; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	58	16	16	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2014	20	6					663	671		10.1017/S1355617714000447			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	AL7PH	WOS:000339326300010	24834461				2021-06-18	
J	Schoonman, GG; Bakker, DP; Jellema, K				Schoonman, G. G.; Bakker, D. P.; Jellema, K.			Low risk of late intracranial complications in mild traumatic brain injury patients using oral anticoagulation after an initial normal brain computed tomography scan: education instead of hospitalization	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						brain; human; injury; intracranial; oral anticoagulation; trauma	HEAD-INJURY; ADMISSION	Background and purpose Mild traumatic brain injury (mTBI) is a common neurological disorder. Whether oral anticoagulation (OAC) use is a risk factor for secondary deterioration in mTBI patients after a normal computed tomography (CT) scan is unclear. Therefore data were retrospectively collected on patients with mTBI who used OAC to determine the incidence of secondary clinical deterioration after an initial normal head CT scan. Methods This was a retrospective single-centre patient record study. All patients with an mTBI who presented at the emergency department between January 2007 and October 2011 were selected. Inclusion criteria were mTBI and at least 1week of OAC use resulting in an international normalized radio >1.1. CT scans were re-evaluated for this study. Results A total of 211 mTBI patients using OAC and with an initial CT scan without abnormalities were included in the analysis. In five patients a secondary deterioration was found. One patient developed a subdural hematoma after 15h of clinical observation. The other four patients became symptomatic between 2 and 28days after trauma. Conclusions A low risk of secondary deterioration within 24h in mTBI patients taking OAC with a normal first head CT scan was found. Our study does not support the recommendation of the current guidelines that these patients should be clinically observed for at least 24h. The fact that in our series the majority of secondary deteriorations occurred between 2 and 28days after trauma underscores the importance of patient instructions upon discharge from the hospital.	[Schoonman, G. G.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Schoonman, G. G.; Bakker, D. P.; Jellema, K.] Med Ctr Haaglanden, Dept Neurol, NL-2512 VA The Hague, Netherlands	Jellema, K (corresponding author), Med Ctr Haaglanden, Dept Neurol, Lijnbaan 32, NL-2512 VA The Hague, Netherlands.	k.jellema@mchaaglanden.nl					af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; de Boussard CN, 2006, J TRAUMA, V61, P577, DOI 10.1097/01.ta.0000224901.67930.ce; Engelen Marc, 2009, Cases J, V2, P7587, DOI 10.4076/1757-1626-2-7587; Erly WK, 2003, AM J ROENTGENOL, V180, P1727, DOI 10.2214/ajr.180.6.1801727; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; McCarthy DM, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/306859; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Parmar K. A., 2006, SMJ Singapore Medical Journal, V47, P676; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Reed D, INITIAL MANAGEMENT C; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	16	16	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JUL	2014	21	7					1021	1025		10.1111/ene.12429			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AJ4CE	WOS:000337616900014	24684394				2021-06-18	
J	Zhang, Y; Zhu, Y; Su, WQ; Zhou, ZF; Jin, Y; Wang, XJ				Zhang, Yu; Zhu, Yuan; Su, Wenqiang; Zhou, Zhifei; Jin, Yan; Wang, Xiaojing			A retrospective study of pediatric traumatic dental injuries in Xi'an, China	DENTAL TRAUMATOLOGY			English	Article						pediatric dentistry; traumatic dental injuries; primary and permanent teeth; children	QUALITY-OF-LIFE; PERMANENT TEETH; PREVALENCE; CHILDREN; UNIVERSITY; ADOLESCENTS; TURKEY; IMPACT	Background/AimPediatric traumatic dental injury is an important public health problem because of its high prevalence, severe physical or psychological impacts, and high prevention and treatment costs. This study aimed to determine the distributive features of pediatric traumatic dental injury in a university dental hospital in Xi'an, China. Materials and methodsChildren (aged 1 to 15years) visiting the hospital from February 2011 to May 2012 as a result of dental trauma were investigated. Trauma-related information was recorded and analyzed. ResultsMost of the traumas occurred in children aged 7 to 12years and affected the maxillary incisors. Of all the children involved, 17.2% had overjet. Concussion, enamel-dentin-pulp fracture, avulsion, and lateral luxation occurred more in the primary dentition (20.9%, 16.5%, 14.3%, and 13.2%, respectively). However, most traumas to the permanent dentition were enamel-dentin-pulp fractures and enamel-dentin fractures (33.7% and 29.1%, respectively). Most traumas were luxations (n=156) in the 1- to 6-year-old group, while fractures were more common in the 7- to 12- and >13-year-old groups (n=549, 84; P<0.001). In total, 357 urban children had access to immediate medical care, whereas only 12 rural children were able to access a clinic within 24h after injury (P<0.001). ConclusionBased on the information presented in this survey, the government should focus on medical development in rural settings and should attempt to balance the distribution of medical resources between urban and rural areas. Educational and preventive programs should also be promoted to enhance the guardians' awareness regarding pediatric traumatic dental injuries.	[Zhang, Yu; Zhu, Yuan; Su, Wenqiang; Zhou, Zhifei; Wang, Xiaojing] Fourth Mil Med Univ, Dept Pediat Dent, Sch Stomatol, Xian 710032, Shanxi, Peoples R China; [Jin, Yan] Fourth Mil Med Univ, Dept Oral Histol & Pathol, Res & Dev Ctr Tissue Engn, Sch Stomatol, Xian 710032, Shanxi, Peoples R China	Jin, Y (corresponding author), Fourth Mil Med Univ, Dept Oral Histol & Pathol, Res & Dev Ctr Tissue Engn, Sch Stomatol, Xian 710032, Shanxi, Peoples R China.	yanjin@fmmu.edu.cn; wxjing@fmmu.edu.cn	Jin, Yan/I-4204-2013		Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81170964]	This study was supported by grants from the Nature Science Foundation of China (81170964). The authors thank the parents and the children who participated in this survey. We also appreciate the collaboration with Dr. Li'an Wu, Lintian Yuan, Jun Fang, Xin Ge, Fen Liu, Jingtao Chen, and Ling Tan during the process of collecting these clinical cases.	Al-Jundi SH, 2002, DENT TRAUMATOL, V18, P181, DOI 10.1034/j.1600-9657.2002.02081.x; Andreasen FM, 2007, TXB COLOR ATLAS TRAU; Beltrao EM, 2007, EUR ARCH PAEDIATR DE, V8, P141, DOI 10.1007/BF03262583; Cardoso M, 2002, DENT TRAUMATOL, V18, P129, DOI 10.1034/j.1600-9657.2002.00030.x; Cortes MID, 2002, COMMUNITY DENT ORAL, V30, P193; Cortes MIS, 2001, DENT TRAUMATOL, V17, P22, DOI 10.1034/j.1600-9657.2001.170105.x; Bonini GADC, 2009, DENT TRAUMATOL, V25, P594, DOI 10.1111/j.1600-9657.2009.00826.x; Ekanayake L, 2008, DENT TRAUMATOL, V24, P471, DOI 10.1111/j.1600-9657.2008.00611.x; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Gong Y, 2011, DENT TRAUMATOL, V27, P203, DOI 10.1111/j.1600-9657.2010.00938.x; Granville-Garcia AF, 2006, DENT TRAUMATOL, V22, P318, DOI 10.1111/j.1600-9657.2005.00390.x; Jokic NI, 2009, DENT TRAUMATOL, V25, P84, DOI 10.1111/j.1600-9657.2008.00711.x; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-4469.2003.00203.x; Malikaew P, 2006, COMMUNITY DENT HLTH, V23, P222; Nicolau B, 2001, DENT TRAUMATOL, V17, P213; Oulis CJ, 1996, ENDOD DENT TRAUMATOL, V12, P60; Petersson EE, 1997, SWED DENT J, V21, P55; Piovesan C, 2012, BRAZ ORAL RES, V26, P464, DOI 10.1590/S1806-83242012000500014; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; Ramos-Jorge ML, 2008, DENT TRAUMATOL, V24, P159, DOI 10.1111/j.1600-9657.2007.00533.x; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Robson F, 2009, DENT TRAUMATOL, V25, P118, DOI 10.1111/j.1600-9657.2008.00725.x; Sandalli N, 2005, DENT TRAUMATOL, V21, P188, DOI 10.1111/j.1600-9657.2005.00309.x; Saroglu I, 2002, DENT TRAUMATOL, V18, P299, DOI 10.1034/j.1600-9657.2002.00093.x; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; Soriano EP, 2007, DENT TRAUMATOL, V23, P232, DOI 10.1111/j.1600-9657.2005.00426.x; Wong FSL, 2004, DENT TRAUMATOL, V20, P327, DOI 10.1111/j.1600-9657.2004.00263.x; Zhang X, 2011, DENT TRAUMATOL, V27, P379, DOI 10.1111/j.1600-9657.2011.01024.x	28	16	19	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2014	30	3					211	215		10.1111/edt.12075			5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AG5OT	WOS:000335469000008	24118923				2021-06-18	
J	Del Rossi, G; Malaguti, A; Del Rossi, S				Del Rossi, Gianluca; Malaguti, Alfonso; Del Rossi, Samanta			Practice Effects Associated With Repeated Assessment of a Clinical Test of Reaction Time	JOURNAL OF ATHLETIC TRAINING			English	Article						yardstick test; concussion-assessment battery; head injuries	PERFORMANCE; CONCUSSION; ALCOHOL; TASK	Context: Researchers have confirmed that the ruler-drop test could be included as part of a multifaceted concussion-assessment battery and potentially as a way to track recovery from head injury. However, it is unclear if this clinical test of reaction time would be characterized by inconsistent performance because of practice effects. Objective: To determine if the ruler-drop test is susceptible to practice effects after serial administration. Design: Descriptive laboratory study. Setting: Sports medicine research laboratory. Patients or Other Participants: Forty-three persons (age = 21.8 +/- 2.6 years). Intervention(s): Ten sessions were completed over 5 weeks. Participants completed 10 trials of the ruler-drop test during each session. Main Outcome Measure(s): The mean reaction times calculated for all participants from each test session were analyzed to determine if there was any meaningful change (ie, improvement) in reaction time over the course of the investigation. Results: Simple reaction time improved (ie, decreased) after repeated administration of the ruler-drop test, and the most pronounced improvement occurred between the first 2 test sessions. Between the first and second test sessions, reaction time decreased by almost 7 milliseconds, and there was an overall improvement of almost 13 milliseconds between the first and tenth sessions. Although the pairwise comparisons between the first and second and the first and third sessions were not significant, the change in mean reaction time between the first session and most of the other sessions was significant. We noted no differences when successive sessions were compared. Conclusions: To prevent practice-related improvements in reaction time, practitioners should allow at least 1 practice session before recording baseline results on the ruler-drop test.	[Del Rossi, Gianluca; Malaguti, Alfonso; Del Rossi, Samanta] Univ S Florida, Tampa, FL 33612 USA	Del Rossi, G (corresponding author), Univ S Florida, 13220 USF Laurel Dr,MDF 5117,Mail Code MDC 106, Tampa, FL 33612 USA.	gdelross@health.usf.edu	Del Rossi, Gianluca/AAR-5000-2020				Abernethy B, 2005, BIOPHYSICAL FDN HUMA, P227; Cote KA, 2009, J SLEEP RES, V18, P291, DOI 10.1111/j.1365-2869.2008.00733.x; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Hernandez OH, 2007, J STUD ALCOHOL DRUGS, V68, P276, DOI 10.15288/jsad.2007.68.276; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jauch-Chara K, 2010, PSYCHONEUROENDOCRINO, V35, P624, DOI 10.1016/j.psyneuen.2009.09.018; MAYLOR EA, 1992, Q J EXP PSYCHOL-A, V44, P119, DOI 10.1080/14640749208401286; Udermann BE, 2004, PERCEPT MOTOR SKILL, V98, P409; Van Den Berg J, 2006, PERCEPT MOTOR SKILL, V102, P589, DOI 10.2466/PMS.102.2.589-599; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	16	16	16	0	14	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2014	49	3					356	359		10.4085/1062-6059-49.2.04			4	Sport Sciences	Sport Sciences	AQ4LJ	WOS:000342768200010	24673236	Green Published			2021-06-18	
J	Simpson, GK; Sabaz, M; Daher, M; Gordon, R; Strettles, B				Simpson, Grahame K.; Sabaz, Mark; Daher, Maysaa; Gordon, Robert; Strettles, Barbara			Challenging Behaviours, Co-morbidities, Service Utilisation and Service Access among Community-dwelling Adults with Severe Traumatic Brain Injury: A Multicentre Study	BRAIN IMPAIRMENT			English	Article						challenging behaviours; traumatic brain injury; service utilisation; needs; mental health; drug and alcohol abuse	OUTCOME MEASURE; HEALTH-CARE; AGGRESSION; PREVALENCE; PEOPLE; NEEDS; REHABILITATION; INTERVENTIONS; DISORDERS; SCALE	Objective: To examine patterns, predictors and unmet needs of service utilisation and access to mental health and/or drug and alcohol services among community-dwelling adults with severe traumatic brain injury, and compare those who displayed challenging behaviours with those not displaying challenging behaviour. Design: Retrospective multicentre study. Subjects: All active clients (n = 507) of the New South Wales (NSW) Brain Injury Rehabilitation Program (BIRP) community rehabilitation teams. Methods: Clinician-rated data were collected on client challenging behaviours, mental health and functional status, service utilisation and unmet needs. Betweengroups analyses (challenging behaviour versus no challenging behaviours) were conducted to examine patterns of service utilisation and unmet needs. Predictors for service utilisation were tested by multiple linear regression. Results: Challenging behaviours were associated with higher use of BIRP and non-BIRP services and greater levels of unmet needs. Challenging behaviour was an independent predictor of higher levels of service utilisation, in conjunction, with pre-and post-injury mental health and drug and alcohol co-morbidities and geographic location. Only 15.3% of the 111 clients with challenging behaviours and co-morbid drug and alcohol problems accessed a drug and alcohol service, while another 32.4% had unmet needs for such services. Conclusion: Challenging behaviours make an independent contribution to increased levels of service utilisation after severe traumatic brain injury.	[Simpson, Grahame K.; Sabaz, Mark] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Sch Med, Sydney, NSW 2006, Australia; [Simpson, Grahame K.; Daher, Maysaa; Strettles, Barbara] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Gordon, Robert] Univ Wollongong, Australian Hlth Serv Res Inst, Wollongong, NSW 2522, Australia; [Strettles, Barbara] Agcy Clin Innovat, Sydney, NSW, Australia	Simpson, GK (corresponding author), Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia.	grahame.simpson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060	New South Wales Agency for Clinical Innovation (ACI)	The New South Wales Agency for Clinical Innovation (ACI) funded the project. Dr Mark Sabaz was employed by ACI while undertaking the project. Thanks to Dr Jeff Rogers, Inika Gillis, the project steering committee and the participating BIRP clinicians.	Agency for Healthcare Research and Quality, 2011, TRAUM BRAIN INJ DEPR; Alderman N, 2007, BRAIN INJURY, V21, P891, DOI 10.1080/02699050701543560; Alderman N, 2013, BRAIN IMPAIR, V14, P5, DOI 10.1017/BrImp.2013.7; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Belanger HG, 2008, ARCH PHYS MED REHAB, V89, P244, DOI 10.1016/j.apmr.2007.08.145; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Coetzer R., 2001, PSYCHIAT B, V25, P421, DOI DOI 10.1192/pb.25.11.421; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Feinstein A, 2002, NEUROLOGY, V59, P674, DOI 10.1212/WNL.59.5.674; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleminger S, 2005, PSYCHIATR BULL, V29, P53, DOI 10.1192/pb.29.2.53; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Jackson H, 2001, NEUROREHABILITATION, V16, P27; James AIW, 2013, BRAIN INJURY, V27, P1162, DOI 10.3109/02699052.2013.804200; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kelly G, 2008, BRAIN IMPAIR, V9, P293, DOI 10.1375/brim.9.3.293; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; National Trauma Research Institute, 2012, DEV RES PROGR ADDR B; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prang KH, 2012, BRAIN INJURY, V26, P441; Price Waterhouse Coopers, 2012, JOIN AG ABI CHALL BE; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sabaz M., 2010, NSW BRAIN INJURY REH; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Simpson G., 2002, AUSTR SOCIAL WORK, V55, P24, DOI DOI 10.1080/03124070208411669; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Sloan S., 2004, BRAIN IMPAIR, V5, P12, DOI DOI 10.1375/BRIM.5.1.12.35399; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood RL, 2001, NEUROBEHAVIOURAL DIS; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Ylvisaker M., 1998, COLLABORATIVE BRAIN	51	16	16	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2014	15	1					28	42		10.1017/BrImp.2014.7			15	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AI9NO	WOS:000337259500004					2021-06-18	
J	Sun, LQ; Gao, JL; Zhao, MM; Jing, XB; Cui, Y; Xu, XY; Wang, KJ; Zhang, WQ; Cui, JZ				Sun, Liqian; Gao, Junling; Zhao, Manman; Jing, Xiaobin; Cui, Ying; Xu, Xiaoyu; Wang, Kaijie; Zhang, Wenqian; Cui, Jianzhong			The effects of BMSCs transplantation on autophagy by CX43 in the hippocampus following traumatic brain injury in rats	NEUROLOGICAL SCIENCES			English	Article						Autophagy; BMSCs; CX43; Hippocampus; Traumatic brain injury	MARROW STROMAL CELLS; COMBINATION THERAPY; MODEL	Traumatic brain injury (TBI) can initiate a series of complicated pathological events, and induce various types of neuronal cell death including autophagy and apoptosis. Currently, the treatment of TBI is one of the main challenges in neurobiology. In this regard, the administration of bone marrow stromal cells (BMSCs) represents a novel treatment modality for TBI. However, the protective mechanism of BMSCs was unknown in the TBI. The aim of the present study was to assess the effects of BMSCs on connexin 43(CX43) and autophagy in the hippocampus following TBI in rats. A rat model of TBI was created using a modified weight-drop device. Double-membrane structures in the process of autophagy formation were frequently observed in injured brain by electron microscopy. The levels of autophagic pathway associated proteins and CX43 were also detected by western blot analysis. Specifically, immunoblotting results showed that BMSCs treatment after TBI could down-regulate light chain 3 (LC3), Beclin-1 and CX43 expression in the hippocampus. Taken together, our results demonstrated that BMSCs were able to significantly suppress TBI-induced autophagy activity, and the potential mechanism by regulating CX43 levels.	[Sun, Liqian; Cui, Ying; Xu, Xiaoyu; Wang, Kaijie; Zhang, Wenqian; Cui, Jianzhong] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Peoples R China; [Gao, Junling; Zhao, Manman] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Peoples R China; [Jing, Xiaobin] Tangshan Ophthalmol Hosp, Dept Ophthalmol, Tangshan 063000, Peoples R China	Sun, LQ (corresponding author), Tangshan Gongren Hosp, Dept Neurosurg, 27 Wen Hua Rd, Tangshan 063000, Peoples R China.	slq20000@126.com			Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401071]	The present study was supported by a grant from the Natural Science Foundation of Hebei Province (No. H2012401071).	Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Kuroda S, 2011, J STEM CELLS REGEN, V7, P2; Lai Y, 2007, J CEREB BLOOD FLOW M, V28, P540; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Wang T, 2013, NEUROSCIENCE, V231, P70, DOI 10.1016/j.neuroscience.2012.11.019; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y	15	16	16	1	10	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2014	35	5					677	682		10.1007/s10072-013-1575-6			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AI4BJ	WOS:000336810100005	24221859				2021-06-18	
J	Gonzalez, CLR; Mills, KJ; Genee, I; Li, FF; Piquette, N; Rosen, N; Gibb, R				Gonzalez, Claudia L. R.; Mills, Kelly J.; Genee, Inge; Li, Fangfang; Piquette, Noella; Rosen, Nicole; Gibb, Robbin			Getting the right grasp on executive function	FRONTIERS IN PSYCHOLOGY			English	Article						grasping movements; left hemisphere; space use; development; frontal lobe; handedness; assessment; intervention	DEVELOPMENTAL COORDINATION DISORDER; FINE MOTOR-SKILLS; BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; HAND-USE; HEMISPHERIC-SPECIALIZATION; GENERAL INTELLIGENCE; PREFRONTAL CORTEX; ACADEMIC ABILITY; CHILDREN	Executive Function (EF) refers to important socio-emotional and cognitive skills that are known to be highly correlated with both academic and life success. EF is a blanket term that is considered to include self-regulation, working memory, and planning. Recent studies have shown a relationship between EF and motor control. The emergence of motor control coincides with that of EF, hence understanding the relationship between these two domains could have significant implications for early detection and remediation of later EF deficits. The purpose of the current study was to investigate this relationship in young children. This study incorporated the Behavioral Rating Inventory of Executive Function (BRIEF) and two motor assessments with a focus on precision grasping to test this hypothesis. The BRIEF is comprised of two indices of EF: (1) the Behavioral Regulation Index (BRI) containing three subscales: Inhibit, Shift, and Emotional Control; (2) the Metacognition Index (MI) containing five subscales: Initiate, Working Memory, Plan/Organize, Organization of Materials, and Monitor. A global executive composite (GEC) is derived from the two indices. In this study, right-handed children aged 5-6 and 9-10 were asked to: grasp-to-construct (Lego (R) models); and grasp-to-place (wooden blocks), while their parents completed the BRIEF questionnaire. Analysis of results indicated significant correlations between the strength of right hand preference for grasping and numerous elements of the BRIEF including the BRI, MI, and GEC. Specifically, the more the right hand was used for grasping the better the EF ratings. In addition, patterns of space-use correlated with the GEC in several subscales of the BRIEF Finally and remarkably, the results also showed a reciprocal relationship between hand and space use for grasping and EF These findings are discussed with respect to: (1) the developmental overlap of motor and executive functions; (2) detection of EF deficits through tasks that measure lateralization of hand and space use; and (3) the possibility of using motor interventions to remediate EF deficits.	[Gonzalez, Claudia L. R.; Mills, Kelly J.] Univ Lethbridge, Brain Act Lab, Dept Kinesiol, Lethbridge, AB T1K 3M4, Canada; [Genee, Inge; Rosen, Nicole] Univ Lethbridge, Dept Modern Languages, Lethbridge, AB T1K 3M4, Canada; [Li, Fangfang] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada; [Piquette, Noella] Univ Lethbridge, Dept Educ, Lethbridge, AB T1K 3M4, Canada; [Gibb, Robbin] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	Gonzalez, CLR (corresponding author), Univ Lethbridge, Brain Act Lab, Dept Kinesiol, Lethbridge, AB T1K 3M4, Canada.	claudia.gonzalez@uleth.ca	VARRECCHIA, TIWANA/AAJ-8712-2021	Li, Fangfang/0000-0001-7047-6918			Abe M, 2009, BEHAV BRAIN RES, V198, P13, DOI 10.1016/j.bbr.2008.10.046; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Butcher PR, 2009, J CHILD PSYCHOL PSYC, V50, P920, DOI 10.1111/j.1469-7610.2009.02066.x; Cameron CE, 2012, CHILD DEV, V83, P1229, DOI 10.1111/j.1467-8624.2012.01768.x; Carlson AG, 2013, J GENET PSYCHOL, V174, P514, DOI 10.1080/00221325.2012.717122; Chaddock L, 2011, J INT NEUROPSYCH SOC, V17, P975, DOI 10.1017/S1355617711000567; Cheyne CP, 2010, LATERALITY, V15, P451, DOI 10.1080/13576500902976956; Crow TJ, 1998, NEUROPSYCHOLOGIA, V36, P1275, DOI 10.1016/S0028-3932(98)00039-6; Davis EE, 2011, BRIT J PSYCHOL, V102, P569, DOI 10.1111/j.2044-8295.2011.02018.x; de Bruin N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00004; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Diamond A, 2007, DEVELOPMENTAL SCI, V10, P152, DOI 10.1111/j.1467-7687.2007.00578.x; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Donders J, 2002, CHILD NEUROPSYCHOL, V8, P229, DOI 10.1076/chin.8.4.229.13508; Dubois J, 2009, CEREB CORTEX, V19, P414, DOI 10.1093/cercor/bhn097; ELIASON MJ, 1986, J DEV BEHAV PEDIATR, V7, P175; Eliasson AC, 2004, DEV MED CHILD NEUROL, V46, P19, DOI 10.1017/S0012162204000040; Fuentes CT, 2009, NEUROLOGY, V73, P1532, DOI 10.1212/WNL.0b013e3181c0d48c; Gallivan JP, 2011, NEUROPSYCHOLOGIA, V49, P3710, DOI 10.1016/j.neuropsychologia.2011.09.027; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Gonzalez CLR, 2009, NEUROPSYCHOLOGIA, V47, P3182, DOI 10.1016/j.neuropsychologia.2009.07.019; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Herve PY, 2013, TRENDS COGN SCI, V17, P69, DOI 10.1016/j.tics.2012.12.004; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Iverson JM, 2010, J CHILD LANG, V37, P229, DOI 10.1017/S0305000909990432; Jabusch HC, 2009, HUM MOVEMENT SCI, V28, P74, DOI 10.1016/j.humov.2008.08.001; Jacquet AY, 2012, DEV PSYCHOBIOL, V54, P36, DOI 10.1002/dev.20572; Johnson LJ, 1995, J EARLY INTERVENTION, V19, P315, DOI 10.1177/105381519501900406; Jongbloed-Pereboom M, 2013, J EXP CHILD PSYCHOL, V114, P295, DOI 10.1016/j.jecp.2012.08.008; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; Kirby A, 2008, DYSLEXIA, V14, P197, DOI 10.1002/dys.367; Kolb B., 2009, FUNDAMENTALS HUMAN N; Lalonde G, 2013, J NEUROSCI METH, V219, P76, DOI 10.1016/j.jneumeth.2013.07.005; Lin W, 2008, AM J NEURORADIOL, V29, P1883, DOI 10.3174/ajnr.A1256; Luo Z, 2007, BRIT J DEV PSYCHOL, V25, P595, DOI 10.1348/026151007X185329; Masten AS, 2012, EDUC RESEARCHER, V41, P363, DOI [10.3102/0013189X12467366, 10.3102/0013189X12459883]; Mayringer H, 2002, NEUROPSYCHOLOGIA, V40, P701, DOI 10.1016/S0028-3932(01)00191-9; Michel GF, 2006, DEV PSYCHOBIOL, V48, P436, DOI 10.1002/dev.20161; Momennejad I, 2013, J NEUROSCI, V33, P17342, DOI 10.1523/JNEUROSCI.0492-13.2013; Moriguchi Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00867; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Pennequin V, 2010, BRAIN COGNITION, V74, P107, DOI 10.1016/j.bandc.2010.07.003; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Racine MB, 2008, J CHILD NEUROL, V23, P399, DOI 10.1177/0883073807309244; Ratnarajah N, 2013, NEUROIMAGE, V75, P187, DOI 10.1016/j.neuroimage.2013.02.052; Roebers CM, 2009, DEVELOPMENTAL SCI, V12, P175, DOI 10.1111/j.1467-7687.2008.00755.x; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Rosenblum S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00357; ROTH M, 1993, EXCEPT CHILDREN, V59, P348, DOI 10.1177/001440299305900407; Sacrey LAR, 2013, DEV PSYCHOBIOL, V55, P902, DOI 10.1002/dev.21083; Sacrey LAR, 2012, INFANT BEHAV DEV, V35, P543, DOI 10.1016/j.infbeh.2012.05.006; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Stone KD, 2014, EXP BRAIN RES, V232, P385, DOI 10.1007/s00221-013-3746-3; Stone KD, 2013, EXP BRAIN RES, V224, P455, DOI 10.1007/s00221-012-3325-z; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sugden D, 2008, INT J DISABIL DEV ED, V55, P173, DOI 10.1080/10349120802033691; Thibaut JP, 2010, J EXP CHILD PSYCHOL, V105, P116, DOI 10.1016/j.jecp.2009.10.003; van der Meulen M, 2014, HUM BRAIN MAPP, V35, P455, DOI 10.1002/hbm.22192; van Swieten LM, 2010, J EXP PSYCHOL HUMAN, V36, P493, DOI 10.1037/a0017177; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; WOLFF PH, 1985, DEV MED CHILD NEUROL, V27, P344	71	16	16	0	80	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	APR 7	2014	5									10.3389/fpsyg.2014.00285			11	Psychology, Multidisciplinary	Psychology	AE1VK	WOS:000333758800001	24778624	DOAJ Gold, Green Published			2021-06-18	
J	Nishijima, DK; Sena, M; Galante, JM; Shahlaie, K; London, J; Melnikow, J; Holmes, JF				Nishijima, Daniel K.; Sena, Matthew; Galante, Joseph M.; Shahlaie, Kiarash; London, Jason; Melnikow, Joy; Holmes, James F.			Derivation of a Clinical Decision Instrument to Identify Adult Patients With Mild Traumatic Intracranial Hemorrhage at Low Risk for Requiring ICU Admission	ANNALS OF EMERGENCY MEDICINE			English	Article							INTENSIVE-CARE-UNIT; INJURY SEVERITY SCORE; BRAIN-INJURY; HEAD-INJURY; TREE ANALYSIS; UTILITY; TOMOGRAPHY; IMPACT	Study objective: The objective of this study is to derive a clinical decision instrument with a sensitivity of at least 95% (with upper and lower bounds of the 95% confidence intervals [CIs] within a 5% range) to identify adult emergency department patients with mild traumatic intracranial hemorrhage who are at low risk for requiring critical care resources during hospitalization and thus may not need admission to the ICU. Methods: This was a prospective, observational study of adult patients with mild traumatic intracranial hemorrhage (initial Glasgow Coma Scale [GCS] score 13 to 15, with traumatic intracranial hemorrhage) presenting to a Level I trauma center from July 2009 to February 2013. The need for ICU admission was defined as the presence of an acute critical care intervention (intubation, neurosurgical intervention, blood product transfusion, vasopressor or inotrope administration, invasive monitoring for hemodynamic instability, urgent treatment for arrhythmia or cardiopulmonary resuscitation, and therapeutic angiography). We derived the clinical decision instrument with binary recursive partitioning (with a misclassification cost of 20 to 1). The accuracy of the decision instrument was compared with the treating physician's (emergency medicine faculty) clinical impression. Results: A total of 600 patients with mild traumatic intracranial hemorrhage were enrolled; 116 patients (19%) had a critical care intervention. The derived instrument consisted of 4 predictor variables: admission GCS score less than 15, nonisolated head injury, aged 65 years or older, and evidence of swelling or shift on initial cranial computed tomography scan. The decision instrument identified 114 of 116 patients requiring an acute critical care intervention (sensitivity 98.3%; 95% Cl 93.9% to 99.5%) if at least 1 variable was present and 192 of 484 patients who did not have an acute critical care intervention (specificity 39.7%; 95% Cl 35.4% to 44.1%) if no variables were present. Physician clinical impression was slightly less sensitive (90.1%; 95% Cl 83.1% to 94.4%) but overall similar to the clinical decision instrument. Conclusion: We derived a clinical decision instrument that identifies a subset of patients with mild traumatic intracranial hemorrhage who are at low risk for acute critical care intervention and thus may not require ICU admission. Physician clinical impression had test characteristics similar to those of the decision instrument. Because the results are based on single-center data without a validation cohort, external validation is required.	[Nishijima, Daniel K.; Holmes, James F.] UC Davis Sch Med, Dept Emergency Med, Sacramento, CA 95616 USA; [Galante, Joseph M.] UC Davis Sch Med, Div Trauma Surg, Sacramento, CA USA; [Shahlaie, Kiarash] UC Davis Sch Med, Dept Neurol Surg, Sacramento, CA USA; [Melnikow, Joy] UC Davis Sch Med, Ctr Healthcare Policy & Res, Sacramento, CA USA; [Melnikow, Joy] UC Davis Sch Med, Dept Family & Community Med, Sacramento, CA USA; [Sena, Matthew; London, Jason] Kaiser Permanente South Sacramento, Div Trauma Surg, Sacramento, CA USA	Nishijima, DK (corresponding author), UC Davis Sch Med, Dept Emergency Med, Sacramento, CA 95616 USA.	daniel.nishijima@ucdmc.ucdavis.edu			National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist and provided the following details: Dr. Nishijima was supported through a Mentored Clinical Research Training Program Award (grant UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 1999, CRIT CARE MED, V27, P633; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brieman L., 1984, CLASSIFICATION REGRE; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Escher M, 2006, BMJ-BRIT MED J, V329, P425; Frost SA, 2009, RESUSCITATION, V80, P224, DOI 10.1016/j.resuscitation.2008.10.030; Goldhill DR, CRIT CARE MED; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Hillman KM, 2002, INTENS CARE MED, V28, P1629, DOI 10.1007/s00134-002-1496-y; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; Huynh T, 2006, AM SURGEON, V72, P1162; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; SAX FL, 1987, CRIT CARE MED, V15, P510, DOI 10.1097/00003246-198705000-00012; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Truog RD, 2006, CRIT CARE MED, V34, P958, DOI 10.1097/01.CCM.0000206116.10417.D9; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	37	16	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	APR	2014	63	4					448	456		10.1016/j.annemergmed.2013.11.003			9	Emergency Medicine	Emergency Medicine	AF3XZ	WOS:000334647300016	24314900	Green Accepted			2021-06-18	
J	Rajandram, RK; Omar, SNS; Rashdi, MFN; Jabar, MNA				Rajandram, Rama Krsna; Omar, Syed Nabil Syed; Rashdi, Muhd Fazly Nizam; Jabar, Mohd Nazimi Abdul			Maxillofacial injuries and traumatic brain injury - a pilot study	DENTAL TRAUMATOLOGY			English	Article						facial trauma; traumatic brain injury; facial bone fracture; maxillofacial trauma; motor vehicle accident	CLOSED-HEAD INJURIES; FACIAL FRACTURES; MALAYSIA; IMPACT	Background Maxillofacial injuries comprising hard tissue as well as soft tissue injuries can be associated with traumatic brain injuries due to the impact of forces transmitted through the head and neck. To date, the role of maxillofacial injury on brain injury has not been properly documented with some saying it has a protective function on the brain while others opposing this idea. Aim This cross-sectional retrospective study evaluated all patients with maxillofacial injuries. The aim of the study was to analyze the occurrence and relationship of maxillofacial injuries with traumatic brain injuries. Material and Methods We retrospectively studied the hospital charts of all trauma patients seen at the accident and emergency department of UKM Medical Centre from November 2010 until November 2011. A detail analysis was then carried out on all patients who satisfied the inclusion and exclusion criteria. Results A total of 11294 patients were classified as trauma patients in which 176 patients had facial fractures and 292 did not have facial fractures. Middle face fractures was the most common pattern of facial fracture seen. Traumatic brain injury was present in 36.7% of maxillofacial cases. A significant association was found between facial fractures and traumatic brain injury (P<0.05). Patient with facial fractures had a 1.5 increased risk of having a traumatic brain injury (95% CI 1.197-1.909). Conclusion Patients with maxillofacial injuries with or without facial fractures are at risk of acute or delayed traumatic brain injury. All patients should always have proper radiological investigations together with a proper observation and follow-up schedule.	[Rajandram, Rama Krsna; Omar, Syed Nabil Syed; Rashdi, Muhd Fazly Nizam; Jabar, Mohd Nazimi Abdul] Natl Univ Malaysia, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia	Rajandram, RK (corresponding author), Natl Univ Malaysia, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia.	decruze79@yahoo.com	Nabil, Syed/S-6602-2019; Rajandram, Rama/C-6674-2017; Jabar, Nazimi Abdul/M-6175-2014	Nabil, Syed/0000-0001-6709-357X; Rajandram, Rama/0000-0001-7343-0800; Jabar, Nazimi Abdul/0000-0003-3761-1342	National University of Malaysia Young Reseachers Grant [UKM-GGPM-TKP-023-2011]	This paper is supported by the National University of Malaysia Young Reseachers Grant (UKM-GGPM-TKP-023-2011).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Allareddy V, 2011, J ORAL MAXIL SURG, V69, P2613, DOI 10.1016/j.joms.2011.02.057; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Grant AL, 2012, J CRANIOFAC SURG, V23, P1324, DOI 10.1097/SCS.0b013e31825e60ae; Hashim H, 2011, DENT TRAUMATOL, V27, P19, DOI 10.1111/j.1600-9657.2010.00958.x; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Langlois JA, 1996, J HEAD TRAUMA REHAB, V2005, P196; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Naveen Shankar A, 2011, J CRANIOMAXILLOFAC S, V40, P675; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Ramli R, 2011, DENT TRAUMATOL, V27, P122, DOI 10.1111/j.1600-9657.2010.00968.x; Simoni Payman, 2003, Arch Facial Plast Surg, V5, P113; Thoren H, 2010, J ORAL MAXIL SURG, V68, P805, DOI 10.1016/j.joms.2009.09.057; Tsang KK, 2011, BR J ORAL MAXILLOFAC, V50, P298	18	16	18	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2014	30	2					128	132		10.1111/edt.12052			5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AC0KO	WOS:000332183400008	23782407				2021-06-18	
J	Petrasek, T; Prokopova, I; Sladek, M; Weissova, K; Vojtechova, I; Bahnik, S; Zemanova, A; Schonig, K; Berger, S; Tews, B; Bartsch, D; Schwab, ME; Sumova, A; Stuchlik, A				Petrasek, Tomas; Prokopova, Iva; Sladek, Martin; Weissova, Kamila; Vojtechova, Iveta; Bahnik, Stepan; Zemanova, Anna; Schoenig, Kai; Berger, Stefan; Tews, Bjoern; Bartsch, Dusan; Schwab, Martin E.; Sumova, Alena; Stuchlik, Ales			Nogo-A-deficient transgenic rats show deficits in higher cognitive functions, decreased anxiety, and altered circadian activity patterns	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						Nogo-A; AAPA; Carousel maze; passive avoidance; neophobia; anhedonia; circadian rhythmicity	NEURITE OUTGROWTH INHIBITOR; TRAUMATIC BRAIN-INJURY; PLACE AVOIDANCE TASK; DOWN-REGULATION; SYNAPTIC PLASTICITY; GENETIC DELETION; CAROUSEL MAZE; RECEPTOR 1; SCHIZOPHRENIA; ASSOCIATION	Decreased levels of Nogo-A-dependent signaling have been shown to affect behavior and cognitive functions. In Nogo-A knockout and knockdown laboratory rodents, behavioral alterations were observed, possibly corresponding with human neuropsychiatric diseases of neurodevelopmental origin, particularly schizophrenia. This study offers further insight into behavioral manifestations of Nogo-A knockdown in laboratory rats, focusing on spatial and non-spatial cognition, anxiety levels, circadian rhythmicity, and activity patterns. Demonstrated is an impairment of cognitive functions and behavioral flexibility in a spatial active avoidance task, while non-spatial memory in a step-through avoidance task was spared. No signs of anhedonia, typical for schizophrenic patients, were observed in the animals. Some measures indicated lower anxiety levels in the Nogo-A-deficient group. Circadian rhythmicity in locomotor activity was preserved in the Nogo-A knockout rats and their circadian period (tau) did not differ from controls. However, daily activity patterns were slightly altered in the knockdown animals. We conclude that a reduction of Nogo-A levels induces changes in CNS development, manifested as subtle alterations in cognitive functions, emotionality, and activity patterns.	[Petrasek, Tomas; Prokopova, Iva; Vojtechova, Iveta; Zemanova, Anna; Stuchlik, Ales] Acad Sci Czech Republ, Inst Physiol, Dept Neurophysiol Memory, Prague 14220 4, Czech Republic; [Petrasek, Tomas] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Sladek, Martin; Weissova, Kamila; Sumova, Alena] Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Prague 14220 4, Czech Republic; [Bahnik, Stepan] Univ Wurzburg, Dept Psychol 2, D-97070 Wurzburg, Germany; [Schoenig, Kai; Berger, Stefan; Bartsch, Dusan] Cent Inst Mental Hlth, Dept Mol Biol, Mannheim, Germany; [Tews, Bjoern; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Tews, Bjoern; Schwab, Martin E.] Swiss Fed Inst Technol Zurich, Dept Biol, Zurich, Switzerland; [Tews, Bjoern] German Canc Res Ctr, Div Mol Mech Tumor Invas, Heidelberg, Germany	Petrasek, T (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Neurophysiol Memory, Videnska 1083, Prague 14220 4, Czech Republic.	disworlds@gmail.com; stuchlik@biomed.cas.cz	Sladek, Martin/C-3383-2012; Weissova, Kamila/X-1856-2018; Stuchlik, Ales/V-8543-2019; Schwab, Martin E/B-6818-2016; Sumova, Alena/C-3390-2012; Petrasek, Tomas/G-3977-2014; Vojtechova, Iveta/R-8878-2017	Sladek, Martin/0000-0002-9744-9386; Weissova, Kamila/0000-0002-3023-4751; Stuchlik, Ales/0000-0002-5394-6305; Sumova, Alena/0000-0003-4126-5470; Petrasek, Tomas/0000-0002-3793-8364; Vojtechova, Iveta/0000-0001-7029-7936; Bahnik, Stepan/0000-0002-0579-6808; Miskova, Iva/0000-0001-6601-418X	GAUK [365911]; GACRGrant Agency of the Czech Republic [14-03627S]; IGA MZ CR [NT13386]; AVCR [M200111204]; German Ministry for Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01GQ1003B]; National Bernstein Network for Computational Neuroscience [HEALTH-F2-2007-201714 DEVANX]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG-RTG 1253/2];  [31-122527/1]	This work was funded mainly by GAUK grant 365911 (awarded to Tomas Petrasek) and GACR 14-03627S (awarded to Ales Stuchlik). Additional support came from IGA MZ CR NT13386 and AVCR M200111204 awarded to Ales Stuchlik. Support for foreign partners was provided by grants from the German Ministry for Education and Research (BMBF, 01GQ1003B), National Bernstein Network for Computational Neuroscience, HEALTH-F2-2007-201714 DEVANX (awarded to Dusan Bartsch), and the Grant No. 31-122527/1 (awarded to Martin E. Schwab). The work of Stepan Bahnik was partly supported by the Deutsche Forschungsgemeinschaft (DFG-RTG 1253/2).	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Bahnik S, 2013, CAROUSEL MAZE MANAGE; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bubenikova-Valesova V, 2008, NEUROSCI BIOBEHAV R, V32, P1014, DOI 10.1016/j.neubiorev.2008.03.012; Bubenikova-Valesova V, 2008, P NATL ACAD SCI USA, V105, P1061, DOI 10.1073/pnas.0711273105; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; Carr ZJ, 2011, J NEUROSURG ANESTH, V23, P138, DOI 10.1097/ANA.0b013e3182049f19; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hsu R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001234; Huber AB, 2002, J NEUROSCI, V22, P3553; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; Jitoku D, 2011, AM J MED GENET B, V156B, P581, DOI 10.1002/ajmg.b.31199; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kristofikova Z, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00090; Le Pen G, 2002, PSYCHOPHARMACOLOGY, V161, P434, DOI 10.1007/s00213-002-1092-4; Lecourtier L, 2012, NEUROSCIENCE, V207, P110, DOI 10.1016/j.neuroscience.2012.01.040; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Lobellova V, 2013, BEHAV BRAIN RES, V246, P55, DOI 10.1016/j.bbr.2013.03.006; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Masliah E, 2010, NEUROSCIENCE, V169, P488, DOI 10.1016/j.neuroscience.2010.04.045; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI [10.1177/0748730403018003006, 10.1177/0748730403253370]; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; Pelizza Lorenzo, 2009, Ann Gen Psychiatry, V8, P22, DOI 10.1186/1744-859X-8-22; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Petrasek T, 2014, NEUROBIOL LEARN MEM, V107, P42, DOI 10.1016/j.nlm.2013.10.015; Phillips WA, 2003, BEHAV BRAIN SCI, V26, P65, DOI 10.1017/S0140525X03000025; Prokopova I, 2012, PHARMACOL BIOCHEM BE, V102, P151, DOI 10.1016/j.pbb.2012.04.003; R Core Team, 2013, R LANG ENV STAT COMP; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; Stuchlik A, 2004, NEUROSCI LETT, V366, P162, DOI 10.1016/j.neulet.2004.05.037; Stuchlik A, 2007, BEHAV BRAIN RES, V178, P47, DOI 10.1016/j.bbr.2006.11.046; Swerdlow NR, 2012, DEV NEUROSCI-BASEL, V34, P240, DOI 10.1159/000336841; Tan EC, 2005, MOL BRAIN RES, V139, P212, DOI 10.1016/j.molbrainres.2005.05.010; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Tews B, 2013, P NATL ACAD SCI USA, V110, P6583, DOI 10.1073/pnas.1217665110; Vales K, 2006, NEUROSCI RES, V55, P383, DOI 10.1016/j.neures.2006.04.007; VanGuilder HD, 2012, J NEUROCHEM, V121, P77, DOI 10.1111/j.1471-4159.2012.07671.x; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Voineskos AN, 2009, J NEUROSCI, V29, P5045, DOI 10.1523/JNEUROSCI.0477-09.2009; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Willi R, 2009, GENES BRAIN BEHAV, V8, P181, DOI 10.1111/j.1601-183X.2008.00460.x; Willi R, 2013, NEUROBIOL DIS, V54, P150, DOI 10.1016/j.nbd.2013.01.011; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010	64	16	16	1	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAR 18	2014	8								90	10.3389/fnbeh.2014.00090			15	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AD0NH	WOS:000332930600001	24672453	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Mayr, U; LaRoux, C; Rolheiser, T; Osternig, L; Chou, LS; van Donkelaar, P				Mayr, Ulrich; LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan; van Donkelaar, Paul			Executive Dysfunction Assessed with a Task-Switching Task following Concussion	PLOS ONE			English	Article							INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; ATTENTION; DEFICITS	Concussion frequently results in executive function deficits that can be specifically probed using task-switching tasks. The current study examined in detail the influence of concussion on task switching performance using both spatial and numerical stimuli. Individuals with concussion (n = 16) were tested within 48 hours of injury and 7, 14, and 28 days later. Healthy sex-, age-, height-, weight- and activity-matched controls (n = 16) were also tested at the same intervals. Switch costs were significantly greater in the participants with concussion than in the controls for both types of stimuli. By contrast, the global costs on non-switching trials were unaffected by concussion. We conclude that concussion has pronounced negative effects on the ability to switch task sets that generalize across task combinations (spatial or numerical) and that persist across at least a month after injury.	[Mayr, Ulrich] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada	van Donkelaar, P (corresponding author), Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.	paul.vandonkelaar@ubc.ca			VAUS Department of Veterans Affairs [A4842C8, A4843C]; University of Oregon; Peace Health Oregon Region; DoD-TATRCUnited States Department of Defense [W81XWH-11-1-0717]	This work was supported by VA (A4842C8, A4843C), University of Oregon, Peace Health Oregon Region, DoD-TATRC (W81XWH-11-1-0717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agel J, 2007, J ATHL TRAINING, V42, P249; Arrington CM, 2005, J EXP PSYCHOL LEARN, V31, P683, DOI 10.1037/0278-7393.31.4.683; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dick R, 2007, J ATHL TRAINING, V42, P221; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Mayr U, 2006, PSYCHOL SCI, V17, P774, DOI 10.1111/j.1467-9280.2006.01781.x; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Schmitter-Edgecombe M, 2006, NEUROPSYCHOLOGY, V20, P675, DOI 10.1037/0894-4105.20.6.675; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	17	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91379	10.1371/journal.pone.0091379			5	Multidisciplinary Sciences	Science & Technology - Other Topics	AC9GM	WOS:000332842400082	24618717	DOAJ Gold, Green Published			2021-06-18	
J	Hosseini, H; Moosavi-Nejad, S; Akiyama, H; Menezes, V				Hosseini, H.; Moosavi-Nejad, S.; Akiyama, H.; Menezes, V.			Shock wave interaction with interfaces between materials having different acoustic impedances	APPLIED PHYSICS LETTERS			English	Article							THERAPY; INCREASE; BRAIN	We experimentally examined interaction of blast waves with water-air/air-water interfaces through high-speed-real-time visualization and measurement of pressure across the waves. The underwater shock wave, which was expected to reflect totally at the water-air interface, was observed transmitting a shock front to air. Transmission of a blast wave from air to water was also visualized and evaluated. Underwater shock waves are used in several medical/biological procedures, where such unforeseen transmissions can result in detriments. The details provide a guideline to evaluate blast wave transmissions, which can induce tissue and brain injuries. The results explain mechanisms behind blast-induced traumatic brain injury. (C) 2014 AIP Publishing LLC.	[Hosseini, H.; Moosavi-Nejad, S.; Akiyama, H.] Kumamoto Univ, Inst Pulsed Power Sci, Bioelect Dept, Kumamoto 8608555, Japan; [Moosavi-Nejad, S.] Fukuoka Univ, Fac Med, Dept Anat, Fukuoka 8140180, Japan; [Menezes, V.] Indian Inst Technol, Dept Aerosp Engn, Bombay 400076, Maharashtra, India	Hosseini, H (corresponding author), Kumamoto Univ, Inst Pulsed Power Sci, Bioelect Dept, Kumamoto 8608555, Japan.	hosseini@kumamoto-u.ac.jp		Akiyama, Hidenori/0000-0002-9675-1209	Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24540539]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25289076, 24540539] Funding Source: KAKEN	This work was supported in part by Grant-in-Aid for Scientific Research No. 24540539 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baker WE., 1973, EXPLOSIONS AIR; Catalano MG, 2007, THYROID, V17, P91, DOI 10.1089/thy.2006.0142; CHAUSSY C, 1980, LANCET, V2, P1265; Chen H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.034301; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Christensen D.A., 1988, ULTRASONIC BIOINSTRU; Cole R. H., 1965, UNDERWATER EXPLOSION, P55; Haake M, 2003, BRIT MED J, V327, P75, DOI 10.1136/bmj.327.7406.75; Hosseini SHR, 2006, MINIM INVASIV THER, V15, P230, DOI 10.1080/13645700600836315; Hosseini SHR, 2005, J FLUID MECH, V530, P223, DOI 10.1017/S0022112005003587; Ito K, 2011, AM J CARDIOVASC DRUG, V11, P295, DOI 10.2165/11592760-000000000-00000; Ivings MJ, 1998, INT J NUMER METH FL, V28, P395, DOI 10.1002/(SICI)1097-0363(19980915)28:3<395::AID-FLD718>3.0.CO;2-S; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kuo YR, 2007, J SURG RES, V143, P385, DOI 10.1016/j.jss.2006.12.552; Menezes V, 2008, SHOCK WAVES, V18, P393, DOI 10.1007/s00193-008-0163-9; Menezes V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050823; Menezes V, 2009, J APPL PHYS, V106, DOI 10.1063/1.3245320; Moosavi-Nejad SF, 2006, CANCER SCI, V97, P296, DOI 10.1111/j.1349-7006.2006.00172.x; Nagayama K, 2002, J APPL PHYS, V91, P476, DOI 10.1063/1.1421630; Nakada M, 2008, JPN J APPL PHYS, V47, P1522, DOI 10.1143/JJAP.47.1522; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Saito T, 2003, SHOCK WAVES, V13, P139, DOI 10.1007/s00193-003-0201-6; Schimizze B, 2013, APPL ACOUST, V74, P1, DOI 10.1016/j.apacoust.2012.05.011; Speed CA, 2004, J BONE JOINT SURG BR, V86B, P165, DOI 10.1302/0301-620X.86B2.14253; Takiya T., 2012, ADV STUD THEOR PHYS, V6, P233; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	26	16	16	1	32	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	MAR 10	2014	104	10							103701	10.1063/1.4867883			5	Physics, Applied	Physics	AD2RM	WOS:000333082800085					2021-06-18	
J	Bressan, S; Daverio, M; Martinolli, F; Dona, D; Mario, F; Steiner, IP; Da Dalt, L				Bressan, Silvia; Daverio, Marco; Martinolli, Francesco; Dona, Daniele; Mario, Federica; Steiner, Ivan P.; Da Dalt, Liviana			The use of handheld near-infrared device (Infrascanner) for detecting intracranial haemorrhages in children with minor head injury	CHILDS NERVOUS SYSTEM			English	Article						Minor head injury; Near-infrared spectroscopy; CTscan; Children	COMPUTED-TOMOGRAPHY; ADVERSE EVENTS; DECISION RULE; SPECTROSCOPY; CHILDHOOD; SEDATION; ADULTS; SCANS; RISK; CT	A handheld device using near-infrared technology (Infrascanner) has shown good accuracy for detection of traumatic intracranial haemorrhages in adults. This study aims to determine the feasibility of use of Infrascanner in children with minor head injury (MHI) in the Emergency Department (ED). Secondary aim was to assess its potential usefulness to reduce CT scan rate. Prospective pilot study conducted in two paediatric EDs, including children at high or intermediate risk for clinically important traumatic brain injury (ciTBI) according to the adapted PECARN rule in use. Completion of Infrascanner measurements and time to completion were recorded. Decision on CT scan and CT scan reporting were performed independently and blinded to Infrascanner results. Completion of the Infrascanner measurement was successfully achieved in 103 (94 %) of 110 patients enrolled, after a mean of 4.4 +/- 2.9 min. A CT scan was performed in 18 (17.5 %) children. Only one had an intracranial haemorrhage that was correctly identified by the Infrascanner. The exploratory analysis showed a specificity of 93 % (95 % CI, 86.5-96.6) and a negative predictive value of 100 % (95 % CI, 81.6-100) for ciTBI. The use of Infrascanner would have led to avoid ten CT scan, reducing the CT scan rate by 58.8 %. Infrascanner seems an easy-to-use tool for children presenting to the ED following a MHI, given the high completion rate and short time to completion. Our preliminary results suggest that Infrascanner is worthy of further investigation as a potential tool to decrease the CT scan rate in children with MHI.	[Bressan, Silvia; Daverio, Marco; Martinolli, Francesco; Dona, Daniele; Mario, Federica; Da Dalt, Liviana] Univ Padua, Dept Womans & Childs Hlth, I-35128 Padua, Italy; [Daverio, Marco; Martinolli, Francesco; Da Dalt, Liviana] Osped Ca Foncello, Pediat Unit, Treviso, Italy; [Steiner, Ivan P.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Bressan, Silvia] Univ Padua, Div Pediat Emergency Med, Dept Womans & Childs Hlth, I-35128 Padua, Italy	Bressan, S (corresponding author), Univ Padua, Div Pediat Emergency Med, Dept Womans & Childs Hlth, Via Giustiniani 3, I-35128 Padua, Italy.	silviabress@gmail.com	Daverio, Marco/AAB-1646-2019; Dona, Daniele/W-7088-2019	Daverio, Marco/0000-0002-3127-8836; Dona, Daniele/0000-0001-7105-2105			Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Coskun F, 2010, SCI RES ESSAYS, V5, P1911; Cravero JP, 2006, PEDIATRICS, V118, P1087, DOI 10.1542/peds.2006-0313; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Francis SV, 2005, J CLIN NEUROSCI, V12, P291, DOI 10.1016/j.jocn.2004.06.009; Ghalenoui H, 2008, PREHOSP DISASTER MED, V23, P558, DOI 10.1017/S1049023X00006415; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kessel B, 2007, INJURY, V38, P1065, DOI 10.1016/j.injury.2007.05.009; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Malviya S, 2000, BRIT J ANAESTH, V84, P743; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0	26	16	17	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2014	30	3					477	484		10.1007/s00381-013-2314-2			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AC2HA	WOS:000332319200013	24469947				2021-06-18	
J	Fleming, J; Nalder, E; Alves-Stein, S; Cornwell, P				Fleming, Jennifer; Nalder, Emily; Alves-Stein, Serena; Cornwell, Petrea			The Effect of Environmental Barriers on Community Integration for Individuals With Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						environmental factors; participation; rehabilitation; traumatic brain injury	REHABILITATION; OUTCOMES; PEOPLE; ADULTS; PERSPECTIVES; PRODUCTIVITY; OUTPATIENT; PREDICTION; SCALE; HOME	Objective: To describe environmental barriers endorsed by individuals with traumatic brain injury during the first 6 months after discharge and determine their effect on community integration. Design: Prospective longitudinal study with data collected at predischarge and at 1, 3, and 6 months postdischarge. Participants: One hundred thirty-five individuals with a diagnosis of traumatic brain injury discharged from a large metropolitan hospital to a home/community environment. Measures: Sydney Psychosocial Reintegration Scale; Craig Hospital Inventory of Environmental Factors; and Mayo-Portland Adaptability Inventory-4. Results: Multiple regression analyses indicated that environmental barriers arising during the transition from hospital to home had a negative association with community integration outcomes. Physical barriers were most commonly endorsed, but attitudinal barriers were significantly correlated with relationship changes. Conclusion: Environmental barriers should be addressed in rehabilitation and considered in policy development for people with traumatic brain injury. Future research on the measurement of environmental barriers is recommended.	[Fleming, Jennifer; Nalder, Emily; Alves-Stein, Serena] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Queensland Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Cornwell, Petrea] Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Griffith Hlth Inst, Behav Basis Hlth Program, Brisbane, Qld 4111, Australia	Fleming, J (corresponding author), Queensland Hlth, Ctr Functioning & Hlth Res, POB 6053, Brisbane, Qld 4102, Australia.	j.fleming@uq.edu.au	Cornwell, Petrea/AAE-5547-2019	Alves-Stein, Serena/0000-0002-3457-4438	Australian Research CouncilAustralian Research Council [LP0776294]; Department of Communities (Disability Services); Acquired Brain Injury Outreach Service	This project is supported by an Australian Research Council Linkage grant (LP0776294) and partner organizations, Department of Communities (Disability Services) and Acquired Brain Injury Outreach Service.	Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Conneeley A. L., 2002, BRIT J OCCUPATIONAL, V65, P356; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gentleman D, 2001, TRAUMA, V3, P193; Guscia R, 2006, J POLICY PRACT INTEL, V3, P173, DOI DOI 10.1111/J.1741-1130.2006.00077.X; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Marrosszeky N, 1998, PTA PROTOCOL GUIDELI; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; StataCorp, 2009, STAT STAT SOFTW REL; Tabachnick BG, 2007, USING MULTIVARIATE S; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 2003, 26 ANN BRAIN IMP C S; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 2011, TBI EXPRESS SOCIAL C; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2001, INT CLASS FUNCT DIS; Ylvisaker M, 2009, DEV NEUROREHABIL, V12, P370, DOI 10.3109/17518420903087533	37	16	16	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					125	135		10.1097/HTR.0b013e318286545d			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600006	23474885				2021-06-18	
J	Fujii, DE; Ahmed, L				Fujii, Daryl E.; Ahmed, Iqbal			Psychotic Disorder Caused by Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Psychosis; Mental disorder; Brain; Trauma	PSYCHIATRIC-DISORDERS; NEGATIVE SYMPTOMS; HEAD-INJURY; SCHIZOPHRENIA; RISK; PREVALENCE; EPILEPSY; HALLUCINATIONS; NEUROCOGNITION; OUTPATIENTS	Psychosis is a rare and severe sequela of traumatic brain injury (TBI). This article assists clinicians in differential diagnosis by providing literature-based guidance with regard to use of the Diagnostic and Statistical Manual for Mental Disorders 5 criteria for this condition. This article also describes potential relationships between TBI and the development of a psychosis within the conceptualization of psychosis as a neurobehavioral syndrome.	[Fujii, Daryl E.] Community Living Ctr, Vet Affairs Pacific Isl Hlth Care Serv, Honolulu, HI 96819 USA; [Ahmed, Iqbal] Univ Hawaii, Tripler Army Med Ctr, Dept Psychiat, Honolulu, HI 96859 USA; [Ahmed, Iqbal] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Fujii, DE (corresponding author), Community Living Ctr, Vet Affairs Pacific Isl Hlth Care Serv, 459 Patterson Rd, Honolulu, HI 96819 USA.	dfujii07@gmail.com					ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Ahmed AO, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0345-0; Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Arfken C, 2008, SCHIZOPHR RES, V102, P21; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI 10.1089/neu.2008-0849; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; CAZZULLO CL, 1989, PSYCHIAT RES, V29, P257, DOI 10.1016/0165-1781(89)90055-3; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Coronado VG, 2006, JAMA-J AM MED ASSOC, V295, P1764; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Dixon LB, 2010, SCHIZOPHRENIA BULL, V36, P48, DOI 10.1093/schbul/sbp115; Elliott B, 2009, EPILEPSY RES, V85, P172, DOI 10.1016/j.eplepsyres.2009.03.017; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Fujii DE, 2007, SPECTRUM OF PSYCHOTIC DISORDERS: NEUROBIOLOGY, ETIOLOGY, AND PATHOGENESIS, P3, DOI 10.1017/CBO9780511543784.002; Fujii DE, 2007, SPECTRUM OF PSYCHOTIC DISORDERS: NEUROBIOLOGY, ETIOLOGY, AND PATHOGENESIS, P535, DOI 10.1017/CBO9780511543784.028; Fujii DE, 2004, SCHIZOPHR RES, V69, P67, DOI 10.1016/S0920-9964(03)00122-1; Fujii DE, 2003, SCHIZOPHR RES, V59, P219, DOI 10.1016/S0920-9964(01)00328-0; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hwu HG, 2002, SCHIZOPHR RES, V56, P105, DOI 10.1016/S0920-9964(01)00251-1; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; Knobel A, 2008, EUR ARCH PSY CLIN N, V258, P76, DOI 10.1007/s00406-008-5008-0; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Makinen J, 2008, NORD J PSYCHIAT, V62, P334, DOI 10.1080/08039480801959307; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; NASRALLAH HA, 1983, J CLIN PSYCHIAT, V44, P407; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Pearlson GD, 1999, BIOL PSYCHIAT, V46, P627, DOI 10.1016/S0006-3223(99)00071-2; Ritchie E C, 1989, J Neuropsychiatry Clin Neurosci, V1, P449; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith MJ, 2009, COMPR PSYCHIAT, V50, P245, DOI 10.1016/j.comppsych.2008.07.009; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; VITA A, 1991, AM J PSYCHIAT, V148, P1577; VITA A, 1988, SCHIZOPHR RES, V1, P329, DOI 10.1016/0920-9964(88)90046-1; White C, 2009, PSYCHOL MED, V39, P1447, DOI 10.1017/S003329170800514X; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353	54	16	18	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					113	+		10.1016/j.psc.2013.11.006			13	Psychiatry	Psychiatry	AD8UM	WOS:000333541200009	24529427				2021-06-18	
J	MacNeill, H; Telner, D; Sparaggis-Agaliotis, A; Hanna, E				MacNeill, Heather; Telner, Deanna; Sparaggis-Agaliotis, Alexandra; Hanna, Elizabeth			All for One and One for All: Understanding Health Professionals' Experience in Individual Versus Collaborative Online Learning	JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS			English	Article						online; computer-based education; interprofessional education; collaboration; innovative educational interventions; problem-based; case-based learning; small group; team learning; computer-supported collaborative learning (CSCL); synchronous online learning	EDUCATION	Introduction Computer-supported collaborative learning (CSCL) may facilitate continuing interprofessional education while overcoming barriers of time and place for busy health care professionals. The purpose of this study was to understand the experiences, advantages, and challenges of group versus individual online learning. Methods Fifteen multidisciplinary health professionals participated in a 12-week online course on either diabetes or traumatic brain injury. This consisted of background e-modules and a longitudinal build-a-case exercise, done either individually or as a group. Focus group sessions exploring participants' experiences after course completion and at 4 months were conducted, transcribed, and analyzed for recurring themes. Participant reflection homework and video-recorded group sessions were used for triangulation of results. Results Individual learners appreciated the flexibility and control, but experienced decreased motivation. Group learners appreciated the immediate feedback from their co-learners and felt social pressure to come to the weekly sessions prepared but expressed challenges in determining group goal-setting for the session. Both groups felt they learned about interprofessional roles; however, group learners described a richer learning experience and understanding of interprofessional roles through the online collaboration exercise. The intense resources necessary for interprofessional CSCL, including time, faculty development, and technological issues, are described. Discussion CSCL is a valuable educational strategy in online learning. While individual online learning may be better suited for short and simple educational interventions such as knowledge acquisition, CSCL seems to allow for richer and deeper learning in complex and interprofessional educational experiences. However, strategies, resources, and faculty development required to enhance CSCL need to be addressed carefully.	[MacNeill, Heather] Bridgepoint Act Healthcare, Med Educ & COIL, Toronto, ON M4M 2B5, Canada; [MacNeill, Heather] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Telner, Deanna] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Sparaggis-Agaliotis, Alexandra; Hanna, Elizabeth] Bridgepoint Act Healthcare, Toronto, ON M4M 2B5, Canada; [Hanna, Elizabeth] Univ Toronto, Dept Speech Language Pathol, Fac Med, Toronto, ON M5S 1A1, Canada	MacNeill, H (corresponding author), Bridgepoint Act Healthcare, 14 St Matthews Rd, Toronto, ON M4M 2B5, Canada.	hmacneill@bridgepointhealth.ca		MacNeill, Heather/0000-0001-9842-3578	Medical Education Research Grant (MERG) from the Royal College of Physicians and Surgeons of Canada (RCPSC); HSBC Bank of Canada	The authors report that this study was funded by a Medical Education Research Grant (MERG) from the Royal College of Physicians and Surgeons of Canada (RCPSC). The COIL project was funded by a nonrestrictive educational grant from HSBC Bank of Canada.	Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Cook DA, 2010, MED EDUC, V44, P765, DOI 10.1111/j.1365-2923.2010.03723.x; Delva D, 2008, J INTERPROF CARE, V22, P598, DOI 10.1080/13561820802201819; Garrison D. Randy, 2007, Internet and Higher Education, V10, P157, DOI 10.1016/j.iheduc.2007.04.001; Garrison DR, INTERNET HIGH ED, V2, P87; Gokhale A.A., 1995, J TECHNOLOGY ED, V7, P22, DOI [10.21061/jte.v7i1.a.2., DOI 10.21061/JTE.V7I1.A.2]; Guan JF, 2008, J CONTIN EDUC HEALTH, V28, P172, DOI 10.1002/chp.174; Hanna E, 2013, J INTERPROF CARE, V27, P298, DOI 10.3109/13561820.2012.723071; Harasim L.M., 1995, LEARNING NETWORKS FI; Hung D. W. L., 2001, Educational Media International, V38, P3, DOI 10.1080/09523980121818; JOYES G, 2005, INT J TEACH LEARN HI, V17, P33; Kirschner F, 2009, COMPUT HUM BEHAV, V25, P306, DOI 10.1016/j.chb.2008.12.008; Kourdioukova EV, 2011, EUR J RADIOL, V78, P353, DOI 10.1016/j.ejrad.2010.08.041; Luke R, 2009, J CONTIN EDUC HEALTH, V29, P161, DOI 10.1002/chp.20030; MacNeill H, 2010, INTERPROFESSIONAL E, P75; Mazmanian PE, 2002, JAMA-J AM MED ASSOC, V288, P1057, DOI 10.1001/jama.288.9.1057; Meads G, 2005, CASE FOR INTERPROFESSIONAL COLLABORATION: IN HEALTH AND SOCIAL CARE, P1, DOI 10.1002/9780470776308; Means B, 2010, EVALUATION EVIDENCE; Morgan RL, 2000, J INSTRUCTIONAL PSYC, V27, P53; Morse JM., 1995, QUALITATIVE RES METH, V2; Oncu S, 2008, COMPUT EDUC, V57, P1098; Palloff R., 2005, COLLABORATING ONLINE; Palloff RM, 2005, COLLABORATING ONLINE, p[3, 57]; Resta P, 2007, EDUC PSYCHOL REV, V19, P65, DOI 10.1007/s10648-007-9042-7; Roberts TS, 2007, EDUC TECHNOL SOC, V10, P257; Ryan David Patrick, 2004, J Contin Educ Health Prof, V24, P112, DOI 10.1002/chp.1340240208; Sargeant Joan, 2004, J Contin Educ Health Prof, V24, P227, DOI 10.1002/chp.1340240406; Sloffer S. J., 1999, 899 CRLT IND U; Stahl G, 2006, CAMB HANDB PSYCHOL, P409; Swan K., 2008, E MENTOR, V2; Triola MM, 2012, MED TEACH, V34, pE15, DOI 10.3109/0142159X.2012.638010; Valcke M, 2009, INTERNET HIGH EDUC, V12, P165, DOI 10.1016/j.iheduc.2009.08.003	32	16	16	0	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-1912	1554-558X		J CONTIN EDUC HEALTH	J. Contin. Educ. Health Prof.	SPR	2014	34	2					102	111		10.1002/chp.21226			10	Education, Scientific Disciplines; Health Care Sciences & Services	Education & Educational Research; Health Care Sciences & Services	AJ4DV	WOS:000337622500003	24939352				2021-06-18	
J	Murnane, O; Mabrey, H; Pearson, A; Byrd, S; Akin, F				Murnane, Owen; Mabrey, Heather; Pearson, Amber; Byrd, Stephanie; Akin, Faith			Normative Data and Test-Retest Reliability of the SYNAPSYS Video Head Impulse Test	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						Head impulse test; semicircular canal; vestibulo-ocular reflex; video head impulse test	HORIZONTAL VESTIBULOOCULAR REFLEX; SEMICIRCULAR-CANAL FUNCTION; VESTIBULAR DYSFUNCTION; RESTING DISCHARGE; SQUIRREL-MONKEY; OCULOGRAPHY; NEURECTOMY; DEFICITS; NEURONS	Background: The observation or measurement of eye movement can aid in the detection and localization of vestibular pathology due to the relationship between the function of the vestibular sensory receptors in the inner ear and the eye movements produced by the vestibulo-ocular reflex (VOR). The majority of bedside and laboratory tests of vestibular function involve the observation or measurement of horizontal eye movements (i.e., horizontal VOR) produced by stimuli that activate the horizontal semicircular canals (SCCs) and the superior vestibular nerve. The video head impulse test (vHIT) is a new clinical test of dynamic SCC function that uses a high-speed digital video camera to record head and eye movement during and immediately after passive head rotations. The SYNAPSYS Inc. vHIT device measures the "canal deficit" (deviation in gaze) during passive head impulses in the horizontal and diagonal (vertical) planes. There is, however, a paucity of data that has been reported using this device. Purpose: The purpose of this study was to obtain normative data and assess the test-retest reliability of the SYNAPSYS vHIT (version 2.0). Research Design: A prospective repeated measures design was utilized. Study Sample: Thirty young adults with normal hearing, normal caloric test results, and a negative history of vestibular disorder, neurological disease, open or closed head injury, or cervical spine injury participated in the study. Data Collection and Analysis: A single examiner manually rotated each participant's head in the horizontal and diagonal planes in two directions (left and right in the horizontal plane; downward and upward in each diagonal plane) resulting in the stimulation of each of the six SCCs. Each participant returned for repeat testing to assess test-retest reliability. The effects of ear, session, and semicircular canal (horizontal, anterior, posterior) on the magnitude of canal deficit during the vHIT were assessed using repeated measures analysis of variance. Results: The mean canal deficit of the horizontal canals (8.3%) was significantly lower than the mean canal deficit of the anterior canals (16.5%) and the posterior canals (15.2%); there was no significant difference between the mean canal deficits of the anterior and posterior canals. The main effects of session and ear on canal deficit were not,significant, and there were no significant interaction effects. There was no significant difference between the mean canal deficit for session 1 and session 2 for the horizontal, anterior, and posterior canals. The 95th percentiles for canal deficit were 19, 26, and 22% for the horizontal, anterior, and posterior SCCs, respectively. Conclusions: Testing of all six SCCs was completed in most participants in similar to 10 min and was well-tolerated. The vHIT has some important advantages relative to more established laboratory tests of horizontal SCC function including the ability to assess the vertical SCCs, lower cost, shorter test time, greater portability, minimal space requirements, and increased patient comfort. Additional data, however, should be obtained from older participants with normal vestibular function and from patients with vestibular disorders. Within-subject comparisons between the results of the vHIT and the caloric and rotary chair tests will be important in determining the role of the vHIT in the vestibular test battery.	[Murnane, Owen; Pearson, Amber; Byrd, Stephanie; Akin, Faith] VA Med Ctr, Vestibular Balance Res Lab, Mountain Home, TN 37604 USA; [Murnane, Owen; Mabrey, Heather; Akin, Faith] E Tennessee State Univ, Dept Audiol & Speech Language Pathol, Johnson City, TN 37614 USA	Murnane, O (corresponding author), VA Med Ctr, Audiol 126, Mountain Home, TN 37604 USA.	owen.murnane@va.gov			Auditory and Vestibular Dysfunction Research Enhancement Award Program - Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, DC	This work was supported by the Auditory and Vestibular Dysfunction Research Enhancement Award Program sponsored by the Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, DC.	BALOH RW, 1977, ACTA OTO-LARYNGOL, V83, P475, DOI 10.3109/00016487709128874; Barin K, 2008, BALANCE FUNCTION ASS, P229; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; Bartolomeo M, 2014, EUR ARCH OTO-RHINO-L, V271, P681, DOI 10.1007/s00405-013-2451-y; Beynon GJ, 1998, CLIN OTOLARYNGOL, V23, P117; Blodow A, 2013, AURIS NASUS LARYNX, V40, P348, DOI 10.1016/j.anl.2012.11.002; BOHMER A, 1985, BRAIN RES, V326, P291, DOI 10.1016/0006-8993(85)90038-1; Cremer PD, 1998, BRAIN, V121, P699, DOI 10.1093/brain/121.4.699; ESTES MS, 1975, J NEUROPHYSIOL, V38, P1232; Ewald E, 1892, PHYSL UNTERSUCHUNGEN; FOSTER CA, 1994, LARYNGOSCOPE, V104, P473; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HALMAGYI GM, 1990, EXP BRAIN RES, V81, P479, DOI 10.1007/BF02423496; HAMID MA, 1991, OTOLARYNG HEAD NECK, V105, P40, DOI 10.1177/019459989110500106; HAMID MA, 1987, VESTIBULAR SYSTEM NE, P115; Harvey SA, 1996, LARYNGOSCOPE, V106, P6, DOI 10.1097/00005537-199601000-00002; Harvey SA, 1997, AM J OTOL, V18, P207; Herdman SJ, 1998, AM J OTOL, V19, P790; Kessler P, 2008, ACTA OTO-LARYNGOL, V128, P29, DOI 10.1080/00016480701299642; Kirkwood B. R., 2003, ESSENTIALS MED STAT; Lehnen N, 2004, NEUROLOGY, V62, P2294, DOI 10.1212/WNL.62.12.2294; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mahringer A, 2014, EUR ARCH OTO-RHINO-L, V271, P463, DOI 10.1007/s00405-013-2376-5; McCaslin DL, EAR HEAR IN PRESS; Minor LB, 1999, J NEUROPHYSIOL, V82, P1254; Murnane OD, 2009, EAR HEARING, V30, P313, DOI 10.1097/AUD.0b013e31819c3ec7; Perez N, 2003, OTOL NEUROTOL, V24, P913, DOI 10.1097/00129492-200311000-00016; Perez-Fernandez N, 2012, ACTA OTORRINOLAR ESP, V63, P429, DOI 10.1016/j.otorri.2012.04.010; Prepageran N, 2005, ACTA OTO-LARYNGOL, V125, P48, DOI 10.1080/00016480410017981; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Ulmer E, 2005, Ann Otolaryngol Chir Cervicofac, V122, P84, DOI 10.1016/S0003-438X(05)82329-1; Ulmer E, 2011, EUR ANN OTORHINOLARY, V128, P278, DOI 10.1016/j.anorl.2011.05.005; Weber KP, 2009, ANN NY ACAD SCI, V1164, P486, DOI 10.1111/j.1749-6632.2008.03730.x; Weber KP, 2008, NEUROLOGY, V70, P454	36	16	16	0	13	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	MAR	2014	25	3			SI		244	252		10.3766/jaaa.25.3.3			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Audiology & Speech-Language Pathology; Otorhinolaryngology	AL5CL	WOS:000339151000003	25032968				2021-06-18	
J	Auble, BA; Bollepalli, S; Makoroff, K; Weis, T; Khoury, J; Colliers, T; Rose, SR				Auble, Bethany A.; Bollepalli, Sureka; Makoroff, Kathi; Weis, Tammy; Khoury, Jane; Colliers, Tracy; Rose, Susan R.			Hypopituitarism in Pediatric Survivors of Inflicted Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						pituitary; prolactin; shaken baby syndrome; short stature; traumatic brain injury	PITUITARY-FUNCTION; CHILDREN; DYSFUNCTION; CHILDHOOD; PHASE	Endocrine dysfunction is common after accidental traumatic brain injury (TBI). Prevalence of endocrine dysfunction after inflicted traumatic brain injury (iTBI) is not known. The aim of this study was to examine endocrinopathy in children after moderate-to-severe iTBI. Children with previous iTBI (n=14) were evaluated for growth/endocrine dysfunction, including anthropometric measurements and hormonal evaluation (nocturnal growth hormone [GH], thyrotropin surge, morning and low-dose adrenocorticotropin stimulated cortisol, insulin-like growth factor 1, IGF-binding protein 3, free thyroxine, prolactin [PRL], and serum/urine osmolality). Analysis used Fisher's exact test and Wilcoxon's rank-sum test, as appropriate. Eighty-six percent of subjects had endocrine dysfunction with at least one abnormality, whereas 50% had two or more abnormalities, significantly increased compared to an estimated 2.5% with endocrine abnormality in the general population (p<0.001). Elevated prolactin was common (64%), followed by abnormal thyroid function (33%), short stature (29%), and low GH peak (17%). High prolactin was common in subjects with other endocrine abnormalities. Two were treated with thyroid hormone and 2 may require GH therapy. In conclusion, children with a history of iTBI show high risk for endocrine dysfunction, including elevated PRL and growth abnormalities. This effect of iTBI has not been well described in the literature. Larger, multi-center, prospective studies would provide more data to determine the extent of endocrine dysfunction in iTBI. We recommend that any child with a history of iTBI be followed closely for growth velocity and pubertal changes. If growth velocity is slow, PRL level and a full endocrine evaluation should be performed.	[Auble, Bethany A.; Bollepalli, Sureka; Weis, Tammy; Rose, Susan R.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Endocrinol, Cincinnati, OH 45229 USA; [Makoroff, Kathi; Colliers, Tracy] Cincinnati Childrens Hosp Med Ctr, Ctr Safe & Hlth Children, Cincinnati, OH 45229 USA; [Khoury, Jane] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; Univ Cincinnati, Sch Med, Cincinnati, OH USA	Auble, BA (corresponding author), Med Coll Wisconsin, Childrens Hosp Wisconsin, MS C520,9000 West Wisconsin Ave,POB 1997, Milwaukee, WI 53201 USA.	bethanyauble@gmail.com	Khoury, Jane/O-2068-2015		Pfizer Global PharmaceuticalsPfizer; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [8 UL1 TR000077-04]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	Partial support for this work was received from a grant from Pfizer Global Pharmaceuticals for investigator-initiated research, as well as from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (NIH; through grant no. 8 UL1 TR000077-04). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; *ASS ADV AUT MED, 2001, ABBR INJ SCAL 1990 R; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; DONS RF, 1998, ENDOCRINE METABOLIC, P8; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Kappy MS, 2010, PEDIAT PRACTICE ENDO; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; ROSE SR, 1995, PEDIATR RES, V38, P967, DOI 10.1203/00006450-199512000-00023; Rose SR, 1999, J PEDIATR ENDOCR MET, V12, P167; ROSE SR, 1989, J CLIN ENDOCR METAB, V68, P1086, DOI 10.1210/jcem-68-6-1086; Rose SR, 1999, HORM RES, V52, P73, DOI 10.1159/000023438; Rose SR, 2010, J PEDIATR-US, V157, P662, DOI 10.1016/j.jpeds.2010.04.047; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476	18	16	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					321	326		10.1089/neu.2013.2916			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600004	24028400	Green Published			2021-06-18	
J	Head, J; Helton, WS				Head, James; Helton, William S.			Practice does not make perfect in a modified sustained attention to response task	EXPERIMENTAL BRAIN RESEARCH			English	Article						Attention; Response inhibition; Speed-accuracy trade-offs; Sustained attention; Vigilance	TRAUMATIC BRAIN-INJURY; REPEATED SESSIONS; SIGNAL; MIND; PERFORMANCE; VARIABILITY; SENSITIVITY; ENGAGEMENT; EXPERIENCE; DECREMENT	In the current investigation, we examined the changes in performance, task-related thoughts (TRT), and task-unrelated thoughts (TUT) over four sessions of a modified sustained attention to response task (SART). Eighteen participants completed a clockwise manual selection SART (Head and Helton in Conscious Cogn 22:913-919, 2013) and a conscious thought questionnaire once a week for four weeks. Response times and errors of commission oscillated over sessions in line with a motor strategy interpretation of the SART. As participants became faster in the task, they made more commission errors. The conscious thought questionnaire failed to show a relationship between errors of commission and TRT and TUT on the SART at either a between-subject or within-subject level of analysis. Commission errors in the SART may be better measures of executive motor control and response strategy than perceptual decoupling.	[Head, James; Helton, William S.] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand	Helton, WS (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 1, New Zealand.	deak.helton@canterbury.ac.nz					BAKAN P, 1955, J EXP PSYCHOL, V50, P387, DOI 10.1037/h0044041; Beilock SL, 2004, PSYCHON B REV, V11, P373, DOI 10.3758/BF03196585; BINFORD JR, 1966, J EXP PSYCHOL, V72, P339, DOI 10.1037/h0023633; COLE TB, 1988, AM J PUBLIC HEALTH, V78, P1585, DOI 10.2105/AJPH.78.12.1585; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Green AL, 2011, EXP BRAIN RES, V215, P307, DOI 10.1007/s00221-011-2898-2; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Hancock PA, 2013, AM PSYCHOL, V68, P97, DOI 10.1037/a0030214; He JB, 2011, HUM FACTORS, V53, P13, DOI 10.1177/0018720810391530; Head J, 2013, CONSCIOUS COGN, V22, P913, DOI 10.1016/j.concog.2013.06.003; Head J, 2012, CONSCIOUS COGN, V21, P1617, DOI 10.1016/j.concog.2012.08.009; Head J, 2012, EXP BRAIN RES, V216, P103, DOI 10.1007/s00221-011-2914-6; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; Helton WS, 2014, HUM FACTORS, V56, P322, DOI 10.1177/0018720813490727; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Helton WS, 2011, EXP BRAIN RES, V209, P401, DOI 10.1007/s00221-011-2563-9; Helton WS, 2011, PSYCHOL RES-PSYCH FO, V75, P384, DOI 10.1007/s00426-010-0316-1; Helton WS, 2009, CONSCIOUS COGN, V18, P600, DOI 10.1016/j.concog.2009.06.002; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Helton WS, 2005, BRIT J PSYCHOL, V96, P249, DOI 10.1348/000712605X38369; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; Maxwell S. E., 2004, DESIGNING EXPT ANAL; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McVay JC, 2012, J EXP PSYCHOL GEN, V141, P302, DOI 10.1037/a0025250; Ossowski U, 2011, CONSCIOUS COGN, V20, P1649, DOI 10.1016/j.concog.2011.08.015; Peebles D, 2004, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON COGNITIVE MODELING, P231; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Seli P, 2013, BEHAV RES METHODS, V45, P355, DOI 10.3758/s13428-012-0266-1; Seli P, 2012, CONSCIOUS COGN, V21, P277, DOI 10.1016/j.concog.2011.09.017; Shaw TH, 2013, BRAIN COGNITION, V82, P265, DOI 10.1016/j.bandc.2013.05.003; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2003, CONSCIOUS COGN, V12, P169, DOI 10.1016/S1053-8100(02)00003-X; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2013, CAN J EXP PSYCHOL, V67, P32, DOI 10.1037/a0030760; Stevenson H, 2011, BRAIN COGNITION, V77, P215, DOI 10.1016/j.bandc.2011.08.007; THURMOND JB, 1970, PERCEPT PSYCHOPHYS, V7, P100, DOI 10.3758/BF03210142; WIENER EL, 1964, PERCEPT MOTOR SKILL, V18, P104, DOI 10.2466/pms.1964.18.1.104; Wilson K.M., 2013, P HUM FACT ERG SOC A, V57, P1244; Yanko MR, 2013, ACCIDENT ANAL PREV, V57, P80, DOI 10.1016/j.aap.2013.04.003; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	44	16	16	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	FEB	2014	232	2					565	573		10.1007/s00221-013-3765-0			9	Neurosciences	Neurosciences & Neurology	AA0GG	WOS:000330773000020	24247591				2021-06-18	
J	Huang, EYK; Tsui, PF; Kuo, TT; Tsai, JJ; Chou, YC; Ma, HI; Chiang, YH; Chen, YH				Huang, Eagle Yi-Kung; Tsui, Pi-Fen; Kuo, Tung-Tai; Tsai, Jing-Jr; Chou, Yu-Ching; Ma, Hsin-I; Chiang, Yung-Hsiao; Chen, Yuan-Hao			Amantadine Ameliorates Dopamine-Releasing Deficits and Behavioral Deficits in Rats after Fluid Percussion Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; PLACEBO-CONTROLLED TRIAL; WATER MAZE PERFORMANCE; OXIDATIVE STRESS; BASAL GANGLIA; HEAD-INJURY; STRIATUM; METHYLPHENIDATE; TRANSPORTER	Aims: To investigate the role of dopamine in cognitive and motor learning skill deficits after a traumatic brain injury (TBI), we investigated dopamine release and behavioral changes at a series of time points after fluid percussion injury, and explored the potential of amantadine hydrochloride as a chronic treatment to provide behavioral recovery. Materials and Methods: In this study, we sequentially investigated dopamine release at the striatum and behavioral changes at 1, 2, 4, 6, and 8 weeks after fluid percussion injury. Rats subjected to 6-Pa cerebral cortical fluid percussion injury were treated by using subcutaneous infusion pumps filled with either saline (sham group) or amantadine hydrochloride, with a releasing rate of 3.6mg/kg/hour for 8 weeks. The dopamine-releasing conditions and metabolism were analyzed sequentially by fast scan cyclic voltammetry (FSCV) and high-pressure liquid chromatography (HPLC). Novel object recognition (NOR) and fixed-speed rotarod (FSRR) behavioral tests were used to determine treatment effects on cognitive and motor deficits after injury. Results: Sequential dopamine-release deficits were revealed in 6-Pa-fluid-percussion cerebral cortical injured animals. The reuptake rate (tau value) of dopamine in injured animals was prolonged, but the tau value became close to the value for the control group after amantadine therapy. Cognitive and motor learning impairments were shown evidenced by the NOR and FSRR behavioral tests after injury. Chronic amantadine therapy reversed dopamine-release deficits, and behavioral impairment after fluid percussion injuries were ameliorated in the rats treated by using amantadine-pumping infusion. Conclusion: Chronic treatment with amantadine hydrochloride can ameliorate dopamine-release deficits as well as cognitive and motor deficits caused by cerebral fluid-percussion injury.	[Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Tsai, Jing-Jr; Ma, Hsin-I; Chen, Yuan-Hao] Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei Med Univ Hosp, PhD Program Neural Regenerat Med, Dept Neurosurg,Grad Inst Neural Regenerat Med, Taipei, Taiwan	Chen, YH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan.	nova.chenyuanhao@gmail.com	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2314-B-016-008]; Tri-Service General Hospital of Taiwan [TSGH-C101-084, TSGH-C100-033]	This work was supported by the National Science Council of Taiwan under grant NSC 101-2314-B-016-008, and by Medical Research Project grants TSGH-C101-084, and TSGH-C100-033 from the Tri-Service General Hospital of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Berman SB, 1996, J NEUROCHEM, V67, P593; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; CHAPMAN AG, 1989, NEUROSCI LETT, V107, P256, DOI 10.1016/0304-3940(89)90827-6; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; FILLOUX F, 1991, SYNAPSE, V8, P281, DOI 10.1002/syn.890080406; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEIKKILA RE, 1972, EUR J PHARMACOL, V20, P156, DOI 10.1016/0014-2999(72)90144-6; Huang EYK, 2003, N-S ARCH PHARMACOL, V368, P386, DOI 10.1007/s00210-003-0803-7; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MIZOGUCHI K, 1994, BRAIN RES, V662, P255, DOI 10.1016/0006-8993(94)90821-4; OLNEY JW, 1990, EXP NEUROL, V108, P269, DOI 10.1016/0014-4886(90)90134-E; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.0.CO;2-K; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Takahashi T, 1996, BRAIN RES BULL, V41, P363, DOI 10.1016/S0361-9230(96)00211-0; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang T, 2013, J NEUROTRAUMA; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	63	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86354	10.1371/journal.pone.0086354			14	Multidisciplinary Sciences	Science & Technology - Other Topics	302PJ	WOS:000330617100013	24497943	DOAJ Gold, Green Published			2021-06-18	
J	Andersen, J; Kot, N; Ennis, N; Colantonio, A; Ouchterlony, D; Cusimano, MD; Topolovec-Vranic, J				Andersen, Jackie; Kot, Nadine; Ennis, Naomi; Colantonio, Angela; Ouchterlony, Donna; Cusimano, Michael D.; Topolovec-Vranic, Jane			Traumatic brain injury and cognitive impairment in men who are homeless	DISABILITY AND REHABILITATION			English	Article						Cognitive symptoms; homeless persons; men; traumatic brain injury	RELIABILITY; VALIDITY; SAMPLE; HEALTH; DEFICITS; BATTERY; HOSTEL; MEMORY; ADULTS; RBANS	Purpose: To examine cognitive performance among a sample of men in a residential unit of an urban homeless shelter and to compare cognitive performance between those with and without a history of traumatic brain injury (TBI). Methods: An exploratory, quantitative study of participants recruited through convenience sampling. Participants were screened for TBI using the Brain Injury Screening Questionnaire, and cognitive function using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Data were analyzed to examine associations between TBI status and cognitive performance. Results: Thirty-four participants were recruited for the study: n = 12 with a positive and n = 22 with a negative screen for TBI. Both groups performed below norms in all cognitive domains measured by the RBANS. Those with a positive screen for TBI performed significantly worse on attention tasks than those with a negative screen for TBI (p = 0.026). RBANS scores were not associated with either mental health or substance abuse status. Conclusions: A history of TBI was associated with generally poorer cognitive performance in the study sample. An improved awareness of TBI and cognitive dysfunction among service providers and routine TBI screening could improve treatment and service delivery for this population.	[Andersen, Jackie; Kot, Nadine; Colantonio, Angela; Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Ennis, Naomi; Ouchterlony, Donna; Cusimano, Michael D.; Topolovec-Vranic, Jane] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Ouchterlony, Donna] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.; Topolovec-Vranic, Jane] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Topolovec-Vranic, J (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St,Bond 3-012, Toronto, ON M5B 1W8, Canada.	topolovec-vranicj@smh.ca	Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Colantonio, Angela/0000-0003-2094-4765; Cusimano, Michael/0000-0002-9989-0650	St. Michael's Hospital Head Injury Clinic; Canadian Institutes of Health Research (CIHR) Traumatic Brain Injury and Violence Research TeamCanadian Institutes of Health Research (CIHR) [TIR-103946]; CIHR Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Saunderson Family Chair in Acquired Brain Injury Research, Toronto Rehabilitation Institute	The authors report no declarations of interest. Funding for this project was provided by the St. Michael's Hospital Head Injury Clinic, and the Canadian Institutes of Health Research (CIHR) Traumatic Brain Injury and Violence Research Team (# TIR-103946). Support for Dr Colantonio was obtained from the CIHR Chair in Gender, Work and Health (#CGW-126580) and the Saunderson Family Chair in Acquired Brain Injury Research, Toronto Rehabilitation Institute.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Cantor JB, 2006, J HEAD TRAUMA REHAB, V21, P424, DOI 10.1097/00001199-200609000-00039; CDC, 2003, REP C MILD TRAUM BRA; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; COHEN CI, 1988, J GERONTOL, V43, pS121, DOI 10.1093/geronj/43.4.S121; COHEN CI, 1988, GERONTOLOGIST, V28, P58, DOI 10.1093/geront/28.1.58; COHEN CI, 1988, J AM GERIATR SOC, V36, P492, DOI 10.1111/j.1532-5415.1988.tb04018.x; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cowan Nelson, 1995, ATTENTION MEMORY INT; Department for Children Schools and Families, 2008, TRANSF SOC CAR, P1; Der G, 2010, AGING NEUROPSYCHOL C, V17, P55, DOI 10.1080/13825580903009071; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Eslinger PJ, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P990; Faul M, TRAUMATIC BRAIN INJU; Fichter MM, 1996, EUR ARCH PSY CLIN N, V246, P185, DOI 10.1007/BF02188952; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Gillen G, 2009, COGNITIVE PERCEPTUAL; Gonzalez EA, 2001, J NERV MENT DIS, V189, P176, DOI 10.1097/00005053-200103000-00006; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gordon WA, 2010, BRAIN INJURY SCREENI; GRIEVE J, 2000, NEUROPSYCHOLOGY OCCU; Health Care for the Homeless Clinicians' Network, 2003, HEAL HANDS, V7, P1; Highley JL, 2008, NASHVILLE HLTH CARE; Hodges JR, 2012, COGNITIVE ASSESSMENT; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Lafferty B, 2010, JNP-J NURSE PRACT, V6, P358; Lehmkul D, 1988, TIRR SYMPTOM CHECKLI; LEVIN HS, 1982, NEUROBEHAVIOURAL CON; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI [10.1097/00001199-198709000-00009, DOI 10.1097/00001199-198709000-00009]; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Picard M, 1991, HELPS BRIEF SCREENIN; Randolph C, 1998, REPEATABLE BATTERY A; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Seidman LJ, 2003, PSYCHIAT SERV, V54, P905, DOI 10.1176/appi.ps.54.6.905; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wald M. M., 2008, BRAIN INJURY PROFESS, V5, P22	48	16	16	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	26					2210	2215		10.3109/09638288.2014.895870			6	Rehabilitation	Rehabilitation	AW4MS	WOS:000346255900003	24621413				2021-06-18	
J	Atmaca, N; Yildirim, E; Guner, B; Kabakci, R; Bilmen, FS				Atmaca, Nurgul; Yildirim, Ebru; Guner, Bayram; Kabakci, Ruhi; Bilmen, Fatih Sultan			Effect of Resveratrol on Hematological and Biochemical Alterations in Rats Exposed to Fluoride	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; SODIUM-FLUORIDE; INDUCED NEPHROTOXICITY; INDUCED HEPATOTOXICITY; OXIDATIVE STRESS; VITAMIN-E; FLUOROSIS; TOXICITY; PARAMETERS; PROTECTS	We investigated the protective effects of resveratrol on hematological and biochemical changes induced by fluoride in rats. A total of 28 rats were divided into 4 groups: control, resveratrol, fluoride, and fluoride/resveratrol (n = 7 each), for a total of 21 days of treatment. Blood samples were taken and hematological and biochemical parameters were measured. Compared to the control group, the fluoride-treated group showed significant differences in several hematological parameters, including decreases in WBC, RBC, and PLT counts and neutrophil ratio. The group that received resveratrol alone showed a decrease in WBC count compared to the control group. Furthermore, in comparison to the control group, the fluoride group showed significantly increased ALT enzyme activity and decreased inorganic phosphorus level. The hematological and biochemical parameters in the fluoride + resveratrol treated group were similar to control group. In the fluoride + resveratrol group, resveratrol restored the changes observed following fluoride treatment, including decreased counts of WBC, RBC, and PLT, decreased neutrophil ratio and inorganic phosphorus levels, and elevated ALT enzyme activity. The present study showed that fluoride caused adverse effects in rats and that resveratrol reduced hematological and biochemical alterations produced by fluoride exposure.	[Atmaca, Nurgul; Kabakci, Ruhi; Bilmen, Fatih Sultan] Kirikkale Univ, Fac Vet Med, Dept Physiol, TR-71451 Kirikkale, Turkey; [Yildirim, Ebru] Kirikkale Univ, Fac Vet Med, Dept Pharmacol Toxicol, TR-71451 Kirikkale, Turkey; [Guner, Bayram] Kirikkale Univ, Fac Vet Med, Dept Biochem, TR-71451 Kirikkale, Turkey	Atmaca, N (corresponding author), Kirikkale Univ, Fac Vet Med, Dept Physiol, TR-71451 Kirikkale, Turkey.	nurgulzengin@yahoo.com	KABAKCI, Ruhi/AAG-9512-2019	KABAKCI, Ruhi/0000-0001-9131-0933			Agha FE, 2012, LIFE SCI J, V9, P1260; ANDERSON RE, 1984, IN VITRO CELL DEV B, V20, P847, DOI 10.1007/BF02619630; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bandyopadhyay B., 2012, INT J RES CHEM ENV, V2, P160; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Bharti VK, 2009, BIOL TRACE ELEM RES, V130, P131, DOI 10.1007/s12011-009-8320-2; Bouaziz H, 2006, PESTIC BIOCHEM PHYS, V86, P124, DOI 10.1016/j.pestbp.2006.02.004; Campbell T. W., 2012, Veterinary hematology and clinical chemistry, P225; CARLSON CH, 1960, P SOC EXP BIOL MED, V104, P235; Cetin N., 2004, EU J HLTH SCI, V13, P46; Dalaklioglu S, 2013, HUM EXP TOXICOL, V32, P662, DOI 10.1177/0960327112468178; Dissanayake C. B., 1991, International Journal of Environmental Studies, V38, P137, DOI 10.1080/00207239108710658; Do Amaral CL, 2008, ARCH TOXICOL, V82, P363, DOI 10.1007/s00204-007-0262-x; Donnelly LE, 2004, AM J PHYSIOL-LUNG C, V287, pL774, DOI 10.1152/ajplung.00110.2004; Eraslan G, 2007, PESTIC BIOCHEM PHYS, V88, P273, DOI 10.1016/j.pestbp.2007.01.002; Eren E, 2005, TOXICOL IND HEALTH, V21, P255, DOI 10.1191/0748233705th236oa; Ersoy IH, 2010, BIOL TRACE ELEM RES, V138, P22, DOI 10.1007/s12011-009-8595-3; Hismiogullari SE, 2013, KAFKAS UNIV VET FAK, V19, pA1, DOI 10.9775/kvfd.2012.6989; Juan ME, 2002, J NUTR, V132, P257; Kanbur M, 2009, FOOD CHEM TOXICOL, V47, P1184, DOI 10.1016/j.fct.2009.02.008; Karadeniz A, 2008, FLUORIDE, V41, P67; KARRAM MH, 1992, FLUORIDE, V25, P23; Khan AM, 2013, FLUORIDE, V46, P34; Khandare AL, 2000, FLUORIDE, V33, P33; Machalinska A, 2002, FLUORIDE, V35, P81; Machalinski B, 2000, FLUORIDE, V33, P168; Mittal M, 2007, DRUG CHEM TOXICOL, V30, P263, DOI 10.1080/01480540701380075; MOHIUDDIN SM, 1989, INDIAN VET J, V66, P1089; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; Naresh K., 2011, J ADV RES BIOL SCI, V3, P58; Paul V, 1998, ENVIRON TOXICOL PHAR, V6, P187, DOI 10.1016/S1382-6689(98)00033-7; PILLAI KS, 1988, TOXICOL LETT, V44, P21, DOI 10.1016/0378-4274(88)90125-7; Priya CAYB, 1997, FLUORIDE, V30, P51; Rao A. V. B., 2010, AM EUR J TOXICOL SCI, V2, P93; Ravichandran B, 2012, TOXICOL ENVIRON CHEM, V94, P2052, DOI 10.1080/02772248.2012.723485; Shashi A, 2001, FLUORIDE, V34, P34; Silan C, 2007, BIOL PHARM BULL, V30, P79, DOI 10.1248/bpb.30.79; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Susheela AK, 1999, CURR SCI INDIA, V77, P1250; Susheela AK, 2001, FLUOR RES RURAL DEV, V34, P181; Tatlidede E, 2009, FREE RADICAL RES, V43, P195, DOI 10.1080/10715760802673008; Trivedi MH, 2012, FLUORIDE, V45, P13; Tunali-Akbay T, 2010, J PHARM PHARM SCI, V13, P303, DOI 10.18433/J30K5Q; [王五一 Wang Wuyi], 2002, [土壤与环境, Soil and environmental sciences], V11, P383; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; Xiong XZ, 2007, ENVIRON RES, V103, P112, DOI 10.1016/j.envres.2006.05.008; ZEIGER E, 1993, ENVIRON MOL MUTAGEN, V21, P309, DOI 10.1002/em.2850210402	49	16	17	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								698628	10.1155/2014/698628			5	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AJ2NI	WOS:000337492600001	24995323	DOAJ Gold, Green Published			2021-06-18	
J	Block, C; Fabrizio, K; Bagley, B; Hannah, J; Camp, S; Mindingall, N; Labbe, D; Lokken, K				Block, Cady; Fabrizio, Katherine; Bagley, Beau; Hannah, Joanna; Camp, Susan; Mindingall, Nazaren; Labbe, Don; Lokken, Kristine			Assessment of Veteran and Caregiver Knowledge About Mild Traumatic Brain Injury in a VA Medical Center	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attitudes; knowledge; practice; health knowledge; veterans; military personnel; brain injuries	POSTCONCUSSION SYNDROME; INFORMATIONAL CASCADES; WAR VETERANS; MISCONCEPTIONS; CONCUSSION; IRAQ; AFGHANISTAN; SURVIVORS; TERMINOLOGY; DEPLOYMENT	Objective: To examine the accuracy of knowledge about mild traumatic brain injury (TBI) of veterans and their friends/family members. Setting: VA Medical Center. Participants: One hundred veterans and 50 of their friends/family members. Design: Cross-sectional survey. Main Measures: A 60-item questionnaire was created by drawing both from the Neurobehavioral Symptom Inventory and from a brain injury knowledge survey developed for use with the general public. Results: Both groups were equally able to identify true mild TBI items, but both also endorsed numerous items not typical of a mild injury. Self-reported prior TBI and receipt of TBI education were unrelated to the level of knowledge. For both groups, knowing another individual with TBI was unrelated to other aspects of mild TBI knowledge. Only 1 in 5 veterans endorsed receiving brain injury education while in the military. Conclusion: Results of this study may assist in the development of targeted TBI educational interventions for veterans and their friends/family members within the Veterans Affairs system. Ultimately, increased knowledge about mild TBI improves the likelihood that veterans receive care congruent with their needs and may potentially improve outcomes for those with mild TBI.	[Block, Cady; Fabrizio, Katherine; Labbe, Don] Univ Alabama Birmingham, Div Med Clin Psychol, Dept Psychol, Birmingham, AL 35294 USA; [Bagley, Beau; Hannah, Joanna; Camp, Susan; Mindingall, Nazaren; Lokken, Kristine] Birmingham Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Birmingham, AL USA	Block, C (corresponding author), Univ Alabama Birmingham, Div Med Clin Psychol, CH 201,1530 3rd Ave S, Birmingham, AL 35294 USA.	cblock@uab.edu	Block, Cady/I-3078-2014	Block, Cady/0000-0001-7168-6116			Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; [Anonymous], 2010, SOCIAL LIFE HLTH INF; Baxendale S, 2004, BMJ-BRIT MED J, V329, P1480, DOI 10.1136/bmj.329.7480.1480; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Binder LM, 1999, ARCH CLIN NEUROPSYCH, V14, P531, DOI 10.1016/S0887-6177(98)00047-X; Bush NE, 2012, TELEMED E-HEALTH, V18, P253, DOI 10.1089/tmj.2011.0131; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Deidan C, 2002, STUD NEUROPSYCHOL DE, P281; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Jackson H, 2001, NEUROREHABILITATION, V16, P27; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; Linden MA, 2010, BRAIN INJURY, V24, P642, DOI 10.3109/02699051003601689; Linden MA, 2005, BRAIN INJURY, V19, P1011, DOI 10.1080/02699050500110314; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; McCrea M, 2008, MILD TRAUMATIC BRAIN; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MORROW KA, 1992, J COUNS DEV, V70, P571, DOI 10.1002/j.1556-6676.1992.tb01663.x; O'Jile J. R., 1997, INT J REHABILITATION, V3, P61, DOI DOI 10.1007/BF02766798; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; *RAND CTR MIL HLTH, 2008, INV WOUNDS MENT HLTH; Risher P, 2000, PUBLIC PERCEPTIONS B; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; U.S. Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; US Centers for Disease Control and Prevention, 2012, TRAUMATIC BRAIN INJU; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P	48	16	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					76	88		10.1097/HTR.0b013e3182886d78			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400013	23524877				2021-06-18	
J	Cernak, I; Wing, ID; Davidsson, J; Plantman, S				Cernak, Ibolja; Wing, Ian D.; Davidsson, Johan; Plantman, Stefan			A novel mouse model of penetrating brain injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; models of injury; penetrating ballistic-like brain injury; animal studies; gliosis; neurodegeneration; histology	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN; REACTIVE ASTROCYTES; RAT MODEL; ADULT; REGENERATION; MECHANISMS; DEFICITS; BLAST; MOTOR	Penetrating traumatic brain injury (pTBI) has been difficult to model in small laboratory animals, such as rats or mice. Previously, we have established a non-fatal, rat model for pTBI using a modified air-rifle that accelerates a pellet, which hits a small probe that then penetrates the experimental animal's brain. Knockout and transgenic strains of mice offer attractive tools to study biological reactions induced by TBI. Hence, in the present study, we adapted and modified our model to be used with mice. The technical characterization of the impact device included depth and speed of impact, as well as dimensions of the temporary cavity formed in a brain surrogate material after impact. Biologically, we have focused on three distinct levels of severity (mild, moderate, and severe), and characterized the acute phase response to injury in terms of tissue destruction, neural degeneration, and gliosis. Functional outcome was assessed by measuring bodyweight and motor performance on rotarod. The results showed that this model is capable of reproducing major morphological and neurological changes of pTBI; as such, we recommend its utilization in research studies aiming to unravel the biological events underlying injury and regeneration after pTBI.	[Cernak, Ibolja] Univ Alberta, Mil & Vet Clin Rehabil Res, Edmonton, AB, Canada; [Wing, Ian D.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Davidsson, Johan] Chalmers Univ Technol, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Plantman, Stefan] Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden	Plantman, S (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	stefan.plantman@ki.se	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514; Ibolja, Cernak/0000-0003-3214-698X	Karolinska InstitutetKarolinska Institutet; Swedish Brain Foundation; Johns Hopkins University Applied Physics Laboratory (Laurel, Maryland, USA)	This work was supported by Karolinska Institutet, the Swedish Brain Foundation, and the Johns Hopkins University Applied Physics Laboratory (Laurel, Maryland, USA) Internal Research and Development (IRAD) funds. The sponsors did not influence the study design, data collection, analysis and interpretation of data, or the report content.	Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asher RA, 2000, J NEUROSCI, V20, P2427; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Cernak I, 2010, MED DATA REV, V2, P297; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Davalos A, 2000, NEUROLOGY, V54, P1568, DOI 10.1212/WNL.54.8.1568; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; FAWCETT J, 1994, J NEUROL, V242, pS25, DOI 10.1007/BF00939237; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Ishikawa E, 2000, NEUROL MED-CHIR, V40, P458, DOI 10.2176/nmc.40.458; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; Luria A.R., 1987, MAN SHATTERED WORLD; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Solmaz I, 2009, TURK NEUROSURG, V19, P216; SQUIRE LR, 1989, EXP NEUROL, V105, P23, DOI 10.1016/0014-4886(89)90168-4; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tan YH, 1998, J ORAL MAXIL SURG, V56, P345, DOI 10.1016/S0278-2391(98)90113-6; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1602/neurorx.1.1.71; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	62	16	16	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								209	10.3389/fneur.2014.00209			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QW	WOS:000209629300196	25374559	DOAJ Gold, Green Published			2021-06-18	
J	LeBlanc, J; de Guise, E; Champoux, MC; Couturier, C; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M				LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Early conversational discourse abilities following traumatic brain injury: An acute predictive study	BRAIN INJURY			English	Article						Acute care; conversational discourse; outcome; Protocole Montreal d'evaluation de la communication; traumatic brain injury	SOCIAL COMMUNICATION-SKILLS; CLOSED-HEAD-INJURY; COGNITIVE RESERVE; REHABILITATION; INTEGRATION; OUTCOMES; ADULTS; SCALE; MILD; DISABILITY	Primary objective: To date, little information is available regarding communication and conversational discourse proficiency post-traumatic brain injury (TBI) in the acute care phase. The main goal of this study was to examine how conversational discourse impairment following TBI predicts early outcome. Factors which influence conversational discourse performance were also explored. Methods: The conversational discourse checklist of the Protocole Montreal d'evaluation de la communication (D-MEC) was administered in an acute tertiary care trauma centre to 195 adults within 3 weeks post-TBI. Outcome was measured with the Disability Rating Scale (DRS), the extended Glasgow Outcome Scale (GOS-E) and included discharge destinations from acute care. Main outcomes and results: Linear regression results showed that the D-MEC total score, age and initial GCS score accounted for 50% of the variation of the DRS scores. The DRS score was lower, signifying better outcome, when the total D-MEC score was higher, the subject was younger and when the initial GCS score was higher. Moreover, D-MEC performance significantly predicted the moderate and severe disability categories of the GOS-E and the probability of requiring rehabilitation (p < 0.05). Conclusion: These results provide additional information to guide healthcare professionals in predicting overall outcome acutely post-TBI.	[LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Dept Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada	LeBlanc, J (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca					Blake ML, 2006, AM J SPEECH-LANG PAT, V15, P255; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bruin J., 2006, Newtest: Command to compute new test; CANNITO M P, 1988, Seminars in Speech and Language, V9, P117, DOI 10.1055/s-0028-1082459; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coelho C. A., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cote H., 2004, REEDUCATION ORTHOPHO, V219, P107; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico JS, 1985, COMMUNICATION SKILLS, P165; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Field SJ, 2000, BRAIN LANG, V74, P213, DOI 10.1006/brln.2000.2335; Fonseca RP, 2008, SPAN J PSYCHOL, V11, P678, DOI 10.1017/S1138741600004686; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GLOSSER G, 1992, J GERONTOL, V47, pP266, DOI 10.1093/geronj/47.4.P266; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hagen C, 1981, TOP LANG DIS, V1, P73; Hagen C., 1979, LEVELS COGNITIVE FUN; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Heaton R. K, 1981, WISCONSIN CARD SORTI; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joanette Y., 2004, PROTOCOLE MONTREAL E; Kemper S, 2001, PSYCHOL AGING, V16, P600, DOI 10.1037//0882-7974.16.4.600; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18]; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; LIVINGSTON M, 1988, J HEAD TRAUMA REHAB, V3, P6, DOI DOI 10.1097/00001199-198812000-00004; McDonald S, 1999, COMMUNICATION DISORD; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2000, BRAIN INJURY, V14, P987; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shadden B B, 1997, Semin Speech Lang, V18, P143; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith A., 1982, SYMBOL DIGIT MODALIT; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Tompkins CA, 2012, ARCH PHYS MED REHAB, V93, pS61, DOI 10.1016/j.apmr.2011.10.015; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wechsler D., 1981, WECHSLER INTELLIGENC, V3rd; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200	69	16	19	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					951	958		10.3109/02699052.2014.888760			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600009	24826957				2021-06-18	
J	Pfortmueller, CA; Kunz, M; Lindner, G; Zisakis, A; Puig, S; Exadaktylos, AK				Pfortmueller, Carmen A.; Kunz, Mirco; Lindner, Gregor; Zisakis, Athanasios; Puig, Stefan; Exadaktylos, Aristomenis K.			Fall-Related Emergency Department Admission: Fall Environment and Settings and Related Injury Patterns in 6357 Patients with Special Emphasis on the Elderly	SCIENTIFIC WORLD JOURNAL			English	Article							PREVENTION; HOSPITALIZATIONS; FRACTURES; ADULTS; COST; HOME; AGE	Principals. Throughout the world, falls are a major public health problem and a socioeconomic burden. Nevertheless there is little knowledge about how the injury types may be related to the aetiology and setting of the fall, especially in the elderly. We have therefore analysed all patients presenting with a fall to our Emergency Department (ED) over the past five years. Methods. Our retrospective data analysis comprised adult patients admitted to our Emergency Department between January 1, 2006, and December 31, 2010, in relation to a fall. Results. Of a total of 6357 patients 78% (n = 4957) patients were younger than 75 years. The main setting for falls was patients home (n = 2239, 35.3%). In contrast to the younger patients, the older population was predominantly female (56.3% versus 38.6%; P < 0.0001). Older patients were more likely to fall at home and suffer from medical conditions (all P < 0.0001). Injuries to the head (P < 0.0001) and to the lower extremity (P < 0.019) occurred predominantly in the older population. Age was the sole predictor for recurrent falls (OR 1.2, P < 0.0001). Conclusion. Falls at home are the main class of falls for all age groups, particularly in the elderly. Fall prevention strategies must therefore target activities of daily living. Even though falls related to sports mostly take place in the younger cohort, a significant percentage of elderly patients present with falls related to sporting activity. Falls due to medical conditions were most likely to result in mild traumatic brain injury.	[Pfortmueller, Carmen A.; Lindner, Gregor] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Lindner, Gregor; Zisakis, Athanasios; Puig, Stefan; Exadaktylos, Aristomenis K.] Univ Bern, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Lindner, Gregor; Zisakis, Athanasios; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Kunz, Mirco] Cantonal Hosp Winterthur, Div Anesthesiol, CH-8400 Winterthur, Switzerland; [Puig, Stefan] Univ Hosp Bern, Univ Inst Diagnost Intervent & Pediat Radiol, CH-3010 Bern, Switzerland	Pfortmueller, CA (corresponding author), Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland.	cpfortmueller@gmail.com	Lindner, Gregor/AAR-6761-2020	Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Annweiler C, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-50; [Anonymous], 2011, PROVIDER S SAI; Barnett A, 2003, AGE AGEING, V32, P407, DOI 10.1093/ageing/32.4.407; Caterino JM, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-19; Demetriades D, 2005, J TRAUMA, V58, P342, DOI 10.1097/01.TA.0000135161.44100.D8; Frick KD, 2010, J AM GERIATR SOC, V58, P136, DOI 10.1111/j.1532-5415.2009.02575.x; Heinrich S, 2010, OSTEOPOROSIS INT, V21, P891, DOI 10.1007/s00198-009-1100-1; KALLINEN M, 1995, SPORTS MED, V20, P41, DOI 10.2165/00007256-199520010-00004; Kool B, 2007, INJURY, V38, P570, DOI 10.1016/j.injury.2006.10.014; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; Mitchell R, 2010, AUSTRALAS J AGEING, V29, P117, DOI 10.1111/j.1741-6612.2010.00413.x; Moore M, 2010, J AM GERIATR SOC, V58, P357, DOI 10.1111/j.1532-5415.2009.02683.x; O'Connor Patricia, 2006, Healthc Q, V9 Spec No, P43; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Sartini M, 2010, EUR J PUBLIC HEALTH, V20, P604, DOI 10.1093/eurpub/ckp165; Sherrington C, 2004, J Sci Med Sport, V7, P43, DOI 10.1016/S1440-2440(04)80277-9; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Thomas S, 2010, AGE AGEING, V39, P681, DOI 10.1093/ageing/afq102; Ullah S, 2010, OSTEOPOROSIS INT, V21, P2125, DOI 10.1007/s00198-010-1189-2; Wareham K, 2003, INJURY, V34, P219, DOI 10.1016/S0020-1383(02)00212-7; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Zelle BA, 2005, INJURY, V36, P169, DOI 10.1016/j.injury.2004.06.004	24	16	16	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1537-744X			SCI WORLD J	Sci. World J.		2014									256519	10.1155/2014/256519			6	Multidisciplinary Sciences	Science & Technology - Other Topics	AC9QJ	WOS:000332869000001	24723797	DOAJ Gold, Green Published			2021-06-18	
J	Quinn, AC; Bhargava, D; Al-Tamimi, YZ; Clark, MJ; Ross, SA; Tennant, A				Quinn, Audrey C.; Bhargava, Deepti; Al-Tamimi, Yahia Z.; Clark, Matthew J.; Ross, Stuart A.; Tennant, Alan			Self-perceived health status following aneurysmal subarachnoid haemorrhage: a cohort study	BMJ OPEN			English	Article						Stroke Medicine	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRACRANIAL ANEURYSMS; OUTCOME MEASURES; POPULATION; MODEL; TRIAL; MOOD; QUESTIONNAIRE	Objective The objective of the study was to assess the long-term self-reported health status and quality of life (QoL) of patients following an aneurysmal subarachnoid haemorrhage (ASAH) using a self-completed questionnaire booklet. Design A two-cohort study. Setting A regional tertiary neurosurgical centre. Participants 2 cohorts of patients with ASAH treated between 1998 and 2008 and followed up at approximately 1year. Interventions Routine care. Primary and secondary outcomes A range of standardised scales included: AKC Short Sentences Test, the Barthel Index, the Self-Report Dysexecutive Questionnaire, the Everyday Memory Questionnaire, Stroke Symptom Checklist, Wimbledon Self-Report Scale, Modified Rankin Score (MRS) and a new Stroke-QoL. The data from summated scales were fit to the Rasch measurement model to validate the summed score. Results 214 patients (48%) returned the questionnaires; the majority (76%) had a World Federation of Neurosurgeons grade of 1 or 2. The most frequent aneurysm type was that of the anterior communicating artery (28%) with approximately 90% of aneurysms of the anterior circulation. Of those previously in full or part-time employment, 48.9% were unemployed at follow-up. All summated scales satisfied the Rasch measurement model requirements, such that their summed scores were a sufficient statistic. Given this, one-third of patients were noted to have a significant mood disorder and 25% had significant dysexecutive function. Patients with an MRS of 3, 4 or 5 had significantly worse scores on most outcome measures, but a significant minority of those with a score of zero had failed to return to work and displayed significant mood disorder. Conclusions A range of self-reported cognitive and physical deficits have been highlighted in a cohort of patients with ASAH. While the MRS has been shown to provide a reasonable indication of outcome, in routine clinical follow-up it requires supplementation by instruments assessing dysexecutive function, memory and mood.	[Quinn, Audrey C.; Clark, Matthew J.] Leeds Gen Infirm, Dept Anaesthesia, Leeds, W Yorkshire, England; [Bhargava, Deepti] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Al-Tamimi, Yahia Z.] Hope Hosp, Dept Neurosurg, Manchester, Lancs, England; [Ross, Stuart A.] Leeds Gen Infirm, Dept Neurosurg, Leeds, W Yorkshire, England; [Tennant, Alan] Univ Leeds, LIRMM, Fac Med & Hlth, Leeds, W Yorkshire, England	Quinn, AC (corresponding author), Leeds Gen Infirm, Dept Anaesthesia, Leeds, W Yorkshire, England.	a.c.quinn@leeds.ac.uk		Tennant, Alan/0000-0002-0728-2130			Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Andrich D., 2009, RUMM 2030; Barker S, 2007, CLIN REHABIL, V22, P667; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; Bent N, 2002, LANCET, V360, P1280, DOI 10.1016/S0140-6736(02)11316-X; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Bowen A, 1999, BRAIN INJURY, V13, P547; Christiensen KB, 2013, RASCH MODELS HLTH; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fertl E, 1999, ACTA NEUROCHIR, V141, P571, DOI 10.1007/s007010050345; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Gomertz P, 1994, CLIN REHABIL, V8, P233; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hellawell DJ, 1999, CLIN REHABIL, V13, P333, DOI 10.1191/026921599669500092; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hutter B.O., 1993, NEUROSURGERY, V33, P1005; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kapapa T, 2012, WORLD NEUROSURG; Kim DH, 2005, STROKE, V36, P792, DOI 10.1161/01.STR.0000157594.58180.97; Krajewski K, 2014, NEUROSURG REV, V37, P55, DOI 10.1007/s10143-013-0489-3; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Kreiter KT, 2013, J NEUROL SCI, V335, P64, DOI 10.1016/j.jns.2013.08.024; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; LONGSTRETH WT, 1993, NEUROLOGY, V43, P712, DOI 10.1212/WNL.43.4.712; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; McKenna SP, 2004, VALUE HEALTH, V7, pS1, DOI 10.1111/j.1524-4733.2004.7s101.x; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Pedrero-Perez EJ, 2011, REV NEUROLOGIA, V52, P394, DOI 10.33588/rn.5207.2010731; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Stienen MN, 2013, ACTA NEUROCHIR, V155, P2045, DOI 10.1007/s00701-013-1823-9; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Sunderland A., 1983, J VERB LEARN VERB BE, V22, P727, DOI [10.1016/S0022-5371(83)90229-3, DOI 10.1093/BRAIN/AWU207]; TENNANT A, 1995, ANN RHEUM DIS, V54, P439, DOI 10.1136/ard.54.6.439; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Vetkas A, 2013, ACTA NEUROCHIR, V155, P1107, DOI 10.1007/s00701-013-1683-3; Visser-Meily JMA, 2013, CEREBROVASC DIS, V36, P126, DOI 10.1159/000353642; WAINER H, 1987, J EDUC MEAS, V24, P185, DOI 10.1111/j.1745-3984.1987.tb00274.x; Wilburn J, 2013, J HAND SURG-AM, V38A, P1209, DOI 10.1016/j.jhsa.2013.03.036; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 2001, INT CLASS FUNCT DIS	51	16	16	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2014	4	4							e003932	10.1136/bmjopen-2013-003932			8	Medicine, General & Internal	General & Internal Medicine	AH0SL	WOS:000335830500003	24699459	DOAJ Gold, Green Published			2021-06-18	
J	Sang, G; Du, JM; Chen, YY; Chen, YB; Chen, JX; Chen, YC				Sang, Gao; Du, Jian-Min; Chen, Yong-Yi; Chen, Yang-Bo; Chen, Jun-Xian; Chen, Yong-Can			Plasma copeptin levels are associated with prognosis of severe acute pancreatitis	PEPTIDES			English	Article						Copeptin; Severe acute pancreatitis; Prognosis; Biomarker	TRAUMATIC BRAIN-INJURY; ORGAN FAILURE; MARKER; VASOPRESSIN; PRECURSOR; MORTALITY; NECROSIS; SCORE	Copeptin reflects the individual stress level, and is correlated with outcomes of critical illness. This study was designed to evaluate its relationship with disease severity, local complications, organ failure and mortality of severe acute pancreatitis (SAP). Seventy-eight SAP patients and 78 sex- and age-matched healthy individuals were recruited. Plasma samples were obtained on admission from SAP patients and at study entry from healthy individuals. Copeptin concentration was determined using enzyme-linked immunosorbent assay. Plasma copeptin level was obviously higher in patients than in healthy individuals, was identified as an independent predictor of local complications, organ failure and in-hospital mortality, was highly associated with traditional predictors of disease severity and mortality including the Acute Physiology and Chronic Health Care Evaluation II score, Ranson score, multiple organ dysfunction score, sequential organ failure assessment score, and predicted local complications, organ failure, and in-hospital mortality of SAP patients with high areas under receiver operating characteristic curve. Furthermore, its predictive value was similar to the traditional predictors'. However, it could not improve these traditional predictors' predictive values. Therefore, increased plasma copeptin level is associated with disease severity and identified as a novel prognostic marker of local complications, organ failure and mortality after SAP. (C) 2013 Elsevier Inc. All rights reserved.	[Sang, Gao] Chinese Med Univ, Tongde Hosp Zhejiang, Dept Paediat, Hangzhou 310012, Zhejiang, Peoples R China; [Du, Jian-Min] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Paediat, Hangzhou 310006, Zhejiang, Peoples R China; [Chen, Yong-Yi] Chinese Med Univ, Tongde Hosp Zhejiang, Dept Tradit Chinese Internal Med, Hangzhou 310012, Zhejiang, Peoples R China; [Chen, Yang-Bo] Chinese Med Univ, Tongde Hosp Zhejiang, Intens Care Unit, Hangzhou 310012, Zhejiang, Peoples R China; [Chen, Jun-Xian; Chen, Yong-Can] Chinese Med Univ, Tongde Hosp Zhejiang, Dept Gastroenterol, Hangzhou 310012, Zhejiang, Peoples R China	Chen, YY (corresponding author), Chinese Med Univ, Tongde Hosp Zhejiang, Dept Tradit Chinese Internal Med, Hangzhou 310012, Zhejiang, Peoples R China.	gstongde@63.com					Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Barat C, 2004, BIOCHEMISTRY-US, V43, P8191, DOI 10.1021/bi0400094; De Marchis GM, 2013, NEUROLOGY, V80, P1278, DOI 10.1212/WNL.0b013e3182887944; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Hoque R, 2012, PANCREAS, V41, P353, DOI 10.1097/MPA.0b013e3182321500; Isman FK, 2013, AM J EMERG MED, V31, P690, DOI 10.1016/j.ajem.2012.12.016; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Katan M, 2008, CRIT CARE, V12, DOI 10.1186/cc6799; Kolditz M, 2012, RESP MED, V106, P1320, DOI 10.1016/j.rmed.2012.06.008; Lin C, 2013, PEPTIDES, V42, P43, DOI 10.1016/j.peptides.2013.01.015; Malangoni MA, 2005, AM J SURG, V189, P273, DOI 10.1016/j.amjsurg.2004.11.013; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Petrov MS, 2010, GASTROENTEROLOGY, V139, P813, DOI 10.1053/j.gastro.2010.06.010; Rahman SH, 2007, ANN SURG, V245, P282, DOI 10.1097/01.sla.0000245471.33987.4b; RANSON JHC, 1977, J SURG RES, V22, P79, DOI 10.1016/0022-4804(77)90045-2; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Singh RG, 2002, INT J CLIN PRACT, V56, P777; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Haehling S, 2012, CLIN CHEM, V58, P307, DOI 10.1373/clinchem.2011.173658	22	16	17	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JAN	2014	51						4	8		10.1016/j.peptides.2013.10.019			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	282XO	WOS:000329208100002	24184419				2021-06-18	
S	Stemper, BD; Pintar, FA		Niranjan, A; Lunsford, LD		Stemper, Brian D.; Pintar, Frank A.			Biomechanics of Concussion	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							CHRONIC TRAUMATIC ENCEPHALOPATHY; POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; DIFFUSE AXONAL INJURY; BRAIN-INJURY; INTRACRANIAL-PRESSURE; RECURRENT CONCUSSION; COGNITIVE IMPAIRMENT; ANIMAL-MODEL; HEAD-INJURY	This report provides an overview of the biomechanics associated with mild traumatic brain injury (TBI), also known as concussion. Specifically, the role of angular acceleration in modulating concussion onset and severity is highlighted. Studies conducted and published from the 1960s to the 1980s provided initial estimates for TBI tolerance due to high rate head rotation. However, injury levels in those studies were more severe than what is considered to be concussion in the contemporary environment. Therefore, this issue deserves additional attention to provide quantitative estimates for concussive tolerance due to head rotational acceleration focusing on the types of clinical outcomes described today. Likewise, concussion in military personnel has notably increased in current conflicts due to the incorporation of improvised explosive devices and roadside bombs. Clinical evidence indicates that outcomes from concussion due to blast may be quite different from those due to head rotational acceleration. This report also provides an overview of blast concussion mechanisms and highlights some of the recent preclinical work in this area. As with head rotational acceleration, blast tolerance is necessary to understand the scope of this problem, better protect these personnel, and provide more informed return-to-duty guidelines for service members. (C) 2014 S. Karger AG, Basel	[Stemper, Brian D.; Pintar, Frank A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Pintar, Frank A.] VA Med Ctr, Milwaukee, WI USA	Stemper, BD (corresponding author), Zablocki VA Med Ctr, Dept Neurosurg, Neurosci Res Labs 151, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	bstemper@mcw.edu	Stemper, Brian/AAX-7611-2020				ABEL JM, 1978, 22 STAPP CAR CRASH C; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; [Anonymous], 1969, J AMER MED ASSOC, V210, P2272; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bazarian JJ, 2004, ANN EMERG MED, V44, P142, DOI 10.1016/j.annemergmed.2004.03.029; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Fijalkowski RJ, 2007, P INT IRCOBI C BIOM, P161; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Gennarelli T.A., 1990, 34 ANN P ASS ADV AUT; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 2003, 47 ANN P ASS ADV AUT; Gennarelli TA, 1971, 15 STAPP CAR CRASH C; Gennarelli TA, 1987, 31 STAPP CAR CRASH C; GENNARELLI TA, 1972, 16 STAPP CAR CRASH C; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HIGGINS LS, 1967, 11 STAPP CAR CRASH C; Hirsch AE, 1970, 14 STAPP CAR CRASH C; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbourn AHS, 1943, LANCET, V2, P438; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Lamy Michael, 2011, Ann Adv Automot Med, V55, P125; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MORTIMER JA, 1985, MINN MED, V68, P299; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Ommaya AK, 1967, 11 STAPP CAR CRASH C; Ommaya AK, 1970, COMP TOLERANCES CERE; Ommaya AK, 1966, 10 STAPP CAR CRASH C; Ono K, 1980, 24 STAPP CAR CRASH C; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabharwal R K, 1987, J Assoc Physicians India, V35, P571; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Shah AS, 2011, ASME 2011 INT MECH E; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Talavage TM, 2013, J NEUROTRAUMA; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; Versace J, 1971, 15 STAPP CAR CRASH C; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	71	16	17	0	21	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						14	27		10.1159/000358748	10.1159/isbn.978-3-318-02649-8		14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000003	24923389				2021-06-18	
J	Tramontana, MG; Cowan, RL; Zald, D; Prokop, JW; Guillamondegui, O				Tramontana, Michael G.; Cowan, Ronald L.; Zald, David; Prokop, Jonathan W.; Guillamondegui, Oscar			Traumatic brain injury-related attention deficits: Treatment outcomes with lisdexamfetamine dimesylate (Vyvanse)	BRAIN INJURY			English	Article						Attention-deficit/hyperactivity disorder; head injury; neuropsychological effects; stimulant medication treatment	DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; EFFICACY; CHILDREN; METHYLPHENIDATE; PLACEBO; ADOLESCENTS; SAFETY; PREDICTORS; ADULTS	Background and objectives: Attention deficits are often among the most persistent and debilitating impairments resulting from traumatic brain injury (TBI). This study examined the effects of lisdexamfetamine dimesylate (Vyvanse) in treating attention deficits due to moderate-to-severe TBI. It was the first study of lisdexamfetamine dimesylate with this population and, in fact, was the first controlled trial in this area examining a stimulant medication option other than methylphenidate. Methods: This was a 12-week, randomized, double-blind, placebo-controlled, cross-over trial. A total of 22 rigorously selected cases were enrolled, 13 of whom completed the trial. They were 16-42 years of age and had newly acquired attention deficits persisting for 6-34 months post-injury. They were assessed on a broad range of neuropsychological and behavioural measures at baseline, 6-weeks and at 12-weeks. Results and conclusions: Positive treatment effects were found involving selective measures of sustained attention, working memory, response speed stability and endurance and in aspects of executive functioning. No major problems with safety or tolerability were observed. Some moderating treatment effects were found from a broad range of pre-treatment subject characteristics and injury variables examined. Avenues for further research and treatment applications in this area are discussed.	[Tramontana, Michael G.; Cowan, Ronald L.; Zald, David; Prokop, Jonathan W.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA; [Zald, David] Vanderbilt Univ, Med Ctr, Dept Psychol, Nashville, TN USA; [Guillamondegui, Oscar] Vanderbilt Univ, Med Ctr, Dept Surg Trauma, Nashville, TN USA	Tramontana, MG (corresponding author), Village Vanderbilt, Suite 2200,1500 21st Ave South, Nashville, TN 37212 USA.	michael.tramontana@vanderbilt.edu			Shire Pharmaceuticals [IST-ALB-000236]	This study was based on an Investigator Sponsored Trial funded by Shire Pharmaceuticals (IST-ALB-000236), Michael G. Tramontana, PhD, Principal Investigator.	Adler LA, 2008, J CLIN PSYCHIAT, V69, P1364, DOI 10.4088/JCP.v69n0903; Bales James W, 2010, Open Drug Discov J, V2, P119; Barkley R.A, 2006, ATTENTION DEFICIT HY; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Biederman J, 2007, CLIN THER, V29, P450, DOI 10.1016/S0149-2918(07)80083-X; Brams M, 2012, J CLIN PSYCHIAT, V73, P977, DOI 10.4088/JCP.11m07430; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Coghill D, 2013, EUR NEUROPSYCHOPHARM, V23, P1208, DOI 10.1016/j.euroneuro.2012.11.012; Findling RL, 2011, J AM ACAD CHILD PSY, V50, P395, DOI 10.1016/j.jaac.2011.01.007; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Overtoom CCE, 2003, BEHAV BRAIN RES, V145, P7, DOI 10.1016/S0166-4328(03)00097-4; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Wigal SB, 2009, CHILD ADOLESCENT PSY, V3, P1; Wigal T, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-34; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	29	16	17	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1461	1472		10.3109/02699052.2014.930179			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200016	24988121				2021-06-18	
J	Truong, JQ; Ciuffreda, KJ; Han, MHE; Suchoff, IB				Truong, James Q.; Ciuffreda, Kenneth J.; Han, M. H. Esther; Suchoff, Irwin B.			Photosensitivity in mild traumatic brain injury (mTBI): A retrospective analysis	BRAIN INJURY			English	Article						Contact lenses; neural adaptation; photophobia; photosensitivity; tinted lenses; traumatic brain injury; visual discomfort	DARK-ADAPTATION; VISUAL SYSTEM; EPIDEMIOLOGY; PHOTOPHOBIA; LIGHT	Primary objective: To determine whether photosensitivity (PS) changes over time and, if so, what factors may be related to the change; furthermore, to determine whether tint density changes over time, all in mild traumatic brain injury (mTBI). Design and methods: A retrospective analysis of 62 patient records (aged 18-40 years) with mTBI and PS was conducted. All charts were obtained from the SUNY/College of Optometry clinics from 2004-2011. Results: Fifty per cent demonstrated reduced PS over time, with most occurring after year 1 post-injury (40%). Promotion of PS reduction appears to be associated with the lack of spectacle tint usage (p = 0.01) and the use of contact lenses (p = 0.03). Inhibition of PS reduction appears to be associated with tinted lenses (p = 0.06), hyperacusis (p = 0.03), dry eye (p = 0.04), migraines (p = 0.03) and loss of consciousness at the time of injury (p = 0.05). Concerning tint density changes over time, 71% (p = 0.002) maintained the same degree over time, while 27% (p = 0.002) reduced and 2% waxed and waned. Conclusion: Neural adaptation to PS appears to be a long-term process. Tint usage may act to inhibit this adaptive process, while the use of contact lenses may act to promote it. These findings may provide guidance in the clinical management of photosensitivity in the mTBI population.	[Truong, James Q.; Ciuffreda, Kenneth J.; Han, M. H. Esther; Suchoff, Irwin B.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA	Truong, JQ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	james.q.truong@gmail.com					Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; CLARK W. E. LeGROS, 1949, DOCUMENTA OPHTHALMOL, V3, P57; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; DOWLING JE, 1967, SCIENCE, V155, P273, DOI 10.1126/science.155.3760.273; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; GALLIN PF, 1995, AM J OPHTHALMOL, V119, P202, DOI 10.1016/S0002-9394(14)73874-7; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; HAY JC, 1963, SCIENCE, V141, P167, DOI 10.1126/science.141.3576.167; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Kapoor N, 2009, MED MANAGEMENT ADULT, P407; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KOHLER I, 1962, SCI AM, V206, P62, DOI 10.1038/scientificamerican0562-62; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; MCCOLLOUGH C, 1965, AM J PSYCHOL, V78, P362, DOI 10.2307/1420571; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; REEVES A, 2004, VISUAL NEUROSCIENCES, P851; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Suchoff IB, 2001, VISUAL VESTIBULAR CO; VIRSU V, 1977, EXP BRAIN RES, V27, P35; Walline Jeffrey J, 2007, Eye Contact Lens, V33, P317, DOI 10.1097/ICL.0b013e31804f80fb	28	16	16	1	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1283	1287		10.3109/02699052.2014.915989			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900008	24945993				2021-06-18	
J	Vanderploeg, RD; Donnell, AJ; Belanger, HG; Curtiss, G				Vanderploeg, Rodney D.; Donnell, Alison J.; Belanger, Heather G.; Curtiss, Glenn			Consolidation deficits in traumatic brain injury: The core and residual verbal memory defect	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Memory; Neuropsychological tests; Closed head injury; Longitudinal studies; Veterans health	CLOSED-HEAD-INJURY; LEARNING TEST; COGNITIVE SEQUELAE; FOLLOW-UP; RECOVERY; MODERATE; PERFORMANCE; RETRIEVAL; TBI; ORGANIZATION	While memory deficits are consistently found to be a salient problem in individuals with moderate to severe traumatic brain injury (TBI), the specific memory processes (i.e., encoding, consolidation, and retrieval) underlying the verbal memory deficit are disputed in the literature. The current study evaluated the recovery of these verbal memory processes over time. A TBI patient group evaluated acutely after the injury (baseline) and again at 6 months and 1 year post injury was compared to a demographically similar control group evaluated only once. The current results replicated previous findings in support of an impaired consolidation hypothesis as the primary deficit underlying memory impairment in TBI. These deficits are reflected in relatively more rapid forgetting through 1 year post injury and relatively less proactive interference up to 6 months post injury.	[Vanderploeg, Rodney D.; Donnell, Alison J.; Belanger, Heather G.; Curtiss, Glenn] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley Vet Hosp, HSR&D RR&D Ctr Excellence Maximizing Rehabil Outc, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Curtiss, Glenn] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.; Donnell, Alison J.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA	Vanderploeg, RD (corresponding author), James A Haley Vet Hosp Psychol Serv 116B, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Rodney.vanderploeg@va.gov	Curtiss, Glenn/ABB-5566-2020		Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Health Administration (VHA)US Department of Veterans Affairs; Defense and Veterans Brain Injury Center (DVBIC) through the U.S. Army Medical Research and Materiel Command [W81XWH-09-C-0026]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration (VHA), and the Defense and Veterans Brain Injury Center (DVBIC) through the U.S. Army Medical Research and Materiel Command under Contract No. W81XWH-09-C-0026. Further support was provided by the James A. Haley Veterans' Hospital.	Atkinson R.C., 1968, PSYCHOL LEARNING MOT; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Baddeley AD, 2000, OXFORD HDB MEMORY, P77; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Broadbent DE, 1958, PERCEPTION COMMUNICA; Brown S.C., 2000, OXFORD HDB MEMORY, P93, DOI DOI 10.1016/J.ADOLESCENCE.2017.05.018; BUTTERS N, 1995, ANNU REV PSYCHOL, V46, P493; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Centers for Disease Control Vietnam Experience Study, 1988, JAMA-J AM MED ASSOC, V18, P2701; Centers for Disease Control Vietnam Experience Study, 1988, JAMA-J AM MED ASSOC, V18, P2708; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deluca J., 2004, COMPREHENSIVE HDB PS, P217; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; Hart R. P., 1994, NEUROPSYCHOLOGY, V8, P325, DOI [10.1037/0894-4105.8.3.325, DOI 10.1037/0894-4105.8.3.325]; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; JOHNSON MK, 1992, J COGNITIVE NEUROSCI, V4, P268, DOI 10.1162/jocn.1992.4.3.268; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kreutzer JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2000, BRAIN INJURY, V14, P987; NOVACK TA, 1995, CLIN NEUROPSYCHOL, V9, P38; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Paolo AM, 1997, NEUROPSYCHOLOGY, V11, P613, DOI 10.1037/0894-4105.11.4.613; Postman L., 1971, EXPT PSYCHOL, P1019; Ruff R. M., 1991, J NEUROSURG, V75, P550; Squire L. R., 1983, MEMORY CONSOLIDATION, P185; SQUIRE LR, 1987, MEMORY BRAIN; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wills P, 2000, BRAIN INJURY, V14, P693; Wilson B. A., 1994, MEMORY, V2, P149; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Wright MJ, 2009, J CLIN EXP NEUROPSYC, V31, P790, DOI 10.1080/13803390802508918	56	16	16	3	8	TAYLOR & FRANCIS INC	PHILADELPHIA	520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2014	36	1					58	73		10.1080/13803395.2013.864600			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AI4KT	WOS:000336834800005	24303929				2021-06-18	
J	Wan, CH; Chen, J; Hu, BY; Zou, HF; Li, AH; Guo, AH; Jiang, JK				Wan, Chunhua; Chen, Jian; Hu, Baoying; Zou, Huifei; Li, Aihong; Guo, Aihang; Jiang, Junkang			Downregulation of UBE2Q1 Is Associated With Neuronal Apoptosis in Rat Brain Cortex Following Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						UBE2Q1; traumatic brain injury; neuronal apoptosis; p53; rat	NEURITE OUTGROWTH; OXIDATIVE STRESS; CEREBRAL-CORTEX; ADULT BRAIN; CELL-DEATH; ACTIVATION; EXPRESSION; P53; UBIQUITIN; HIPPOCAMPUS	Aberrant functionality of the ubiquitin proteasome system (UPS) has been implicated in the pathology of various neurological disorders. Although it has been reported that the expressions of various UPS components were altered significantly following traumatic brain injury (TBI), detailed information on the subject remains largely unclear. In the study, using microarray assay, we identified a gene encoding ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) that was significantly downregulated during TBI. Western blot and immunohistochemical analyses verified the reduced expression of UBE2Q1 in ipsilateral brain cortex adjacent to the lesion site compared with the contralateral and sham-operated ones. Double-immunofluorescence staining indicated that UBE2Q1 was expressed mainly in the nucleus of neurons, with a minority in astrocytes in normal cortex. In addition, we observed a remarkable reduction in the number of UBE2Q1-positive neurons following brain trauma. Furthermore, we showed that TBI resulted in a significant increase in the levels of p53, bax, p21 and active caspase 3 in brain cortex, which was correlated with decreased expression of UBE2Q1. We also found that knockdown of UBE2Q1 apparently increased the level of p53, whereas overexpressing UBE2Q1 attenuated cellular p53 level in PC12 neuronal cells. Accordingly, interference with UBE2Q1 augmented H2O2-induced apoptosis of PC12 cells. Taken together, our findings indicate that UBE2Q1 might play an important role in the neuropathological process of TBI through modulating p53 signaling. (c) 2013 Wiley Periodicals, Inc.	[Wan, Chunhua; Jiang, Junkang] Nantong Univ, Sch Publ Hlth, Nantong 226001, Peoples R China; [Chen, Jian; Zou, Huifei; Li, Aihong; Guo, Aihang] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Jiangsu, Peoples R China; [Hu, Baoying] Nantong Univ, Coll Med, Nantong, Peoples R China	Jiang, JK (corresponding author), Nantong Univ, Sch Publ Hlth, 9 Seyuan St, Nantong 226001, Peoples R China.	jiang_junkang@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300720, 81371367]	Contract grant sponsor: National Natural Science Foundation of China, Contract grant numbers: 81300720 (to C. W.); 81371367 (to J.C.).	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Cregan SP, 1999, J NEUROSCI, V19, P7860; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Klimaschewski L, 2003, NEWS PHYSIOL SCI, V18, P29, DOI 10.1152/nips.01408.2002; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Lee BK, 2012, J NEUROSCI RES, V90, P860, DOI 10.1002/jnr.22818; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Liu YH, 2012, MOL BIOL CELL, V23, P4506, DOI 10.1091/mbc.E12-05-0362; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakamura T, 2008, MOL CELL ENDOCRINOL, V281, P47, DOI 10.1016/j.mce.2007.10.007; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Povlishock J T, 1992, Hum Cell, V5, P345; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saha MN, 2010, CANCER BIOL THER, V10, P567, DOI 10.4161/cbt.10.6.12535; Saito A, 2005, J CEREBR BLOOD F MET, V25, P267, DOI 10.1038/sj.jcbfm.9600028; Seghatoleslam A, 2012, MOL BIOL REP, V39, P5135, DOI 10.1007/s11033-011-1309-x; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Tao T, 2012, MOL BIOL CELL, V23, P2635, DOI 10.1091/mbc.E11-09-0805; Wan C, 2013, J MOL NEURO IN PRESS; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Zhuang Z, 2013, J NEUROSCI RES, V91, P1599, DOI [10.1002/jnr.23186, 10.1002/jnr.23281]	40	16	17	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2014	92	1					1	12		10.1002/jnr.23305			12	Neurosciences	Neurosciences & Neurology	254LK	WOS:000327167000001	24166684				2021-06-18	
J	Xing, GQ; Ren, M; Verma, A				Xing, Guoqiang; Ren, Ming; Verma, Ajay			Divergent temporal expression of hyaluronan metabolizing enzymes and receptors with craniotomy vs. controlled-cortical impact injury in rat brain: a pilot study	FRONTIERS IN NEUROLOGY			English	Article						TBI; secondary injury factors; hyaluronic acid; receptor; synthesis; degradation; hyaluronidase; rat brain		Traumatic brain injury (TBI) triggers many secondary changes in tissue biology, which ultimately determine the extent of injury and clinical outcome. Hyaluronan [hyaluronic acid (HA)] is a protective cementing gel present in the intercellular spaces whose degradation has been reported as a causative factor in tissue damage. Yet little is known about the expression and activities of genes involved in HA catabolism after TBI. Young adult male Sprague-Dawley rats were assigned to three groups: naive control, craniotomy, and controlled-cortical impact-induced TBI (CCI-TBI). Four animals per group were sacrificed at 4 h, 1, 3, and 7 days post-CCI. The mRNA expression of hyaluronan synthases (HAS1-3), hyaluronidases (enzymes for HA degradation, HYAL 1-4, and PH20), and CD44 and RHAMM (membrane receptors for HA signaling and removal) were determined using real-time PCR. Compared to the naive controls, expression of HAS1 and HAS2 mRNA, but not HAS3 mRNA increased significantly following craniotomy alone and following CCI with differential kinetics. Expression of HAS2 mRNA increased significantly in the ipsilateral brain at 1 and 3 days post-CCI. HYAL1 mRNA expression also increased significantly in the craniotomy group and in the contralateral CCI at 1 and 3 days post-CCI. CD44 mRNA expression increased significantly in the ipsilateral CCI at 4 h, 1, 3, and 7 days post-CCI (up to 25-fold increase). These data suggest a dynamic regulation and role for HA metabolism in secondary responses to TBI.	[Xing, Guoqiang; Ren, Ming; Verma, Ajay] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA	Xing, GQ (corresponding author), Johns Hopkins Univ, MCC, Lotus Biotech Com, 9601 Med Ctr Dr,Suite 227, Rockville, MD 20850 USA.	gxing99@yahoo.com	Xing, Guoqiang/ABA-8450-2020		Lotus Biotech.com; GEMI Fund; Henry Jackson Foundation DBSCIP	This work was supported in part by, Lotus Biotech.com, GEMI Fund and Henry Jackson Foundation DBSCIP. Daniel Xing proofread the manuscript.	Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Al Qteishat A, 2006, NEUROREPORT, V17, P1111, DOI 10.1097/01.wnr.0000227986.69680.20; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Andhare RA, 2009, OSTEOARTHR CARTILAGE, V17, P906, DOI 10.1016/j.joca.2008.12.007; Ariyoshi W, 2012, ARTHRITIS RHEUM-US, V64, P187, DOI 10.1002/art.33329; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Aya KL, 2014, WOUND REPAIR REGEN, V22, P579, DOI 10.1111/wrr.12214; BERG S, 1988, SCAND J CLIN LAB INV, V48, P727, DOI 10.3109/00365518809088752; Bertrand P, 2005, INT J CANCER, V113, P207, DOI 10.1002/ijc.20562; Bifone A, 2010, MAGN RESON IMAGING, V28, P1200, DOI 10.1016/j.mri.2010.07.001; Bugiani M, 2013, BRAIN, V136, P209, DOI 10.1093/brain/aws320; Cabrera PV, 2000, MEDICINA-BUENOS AIRE, V60, P940; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campo GM, 2012, J CELL BIOCHEM, V113, P1852, DOI 10.1002/jcb.24054; Casalino-Matsuda SM, 2009, AM J RESP CELL MOL, V40, P277, DOI 10.1165/rcmb.2008-0073OC; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cortivo R, 1996, SEMIN ARTHRITIS RHEU, V26, P492, DOI 10.1016/S0049-0172(96)80030-8; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Ekici S, 2004, INT J CANCER, V112, P121, DOI 10.1002/ijc.20368; Fang XJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-290; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Flugge LA, 1999, CHEM BIOL, V6, pR157, DOI 10.1016/S1074-5521(99)80043-X; Forteza RM, 2012, J BIOL CHEM, V287, P42288, DOI 10.1074/jbc.M112.387795; Fox JW, 2013, TOXICON, V62, P75, DOI 10.1016/j.toxicon.2012.09.009; Fukuda K, 2001, OSTEOARTHR CARTILAGE, V9, P390, DOI 10.1053/joca.2000.0400; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; GROOTVELD M, 1991, BIOCHEM J, V273, P459, DOI 10.1042/bj2730459; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; Horton MR, 1999, CHEST, V116, p17S, DOI 10.1378/chest.116.suppl_1.17S; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Jong A, 2012, J BIOL CHEM, V287, P15298, DOI 10.1074/jbc.M112.353375; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kashima Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058760; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Knepper PA, 2005, INVEST OPHTH VIS SCI, V46, P2829, DOI 10.1167/iovs.04-1472; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; KONTTINEN YT, 1990, CLIN CHIM ACTA, V193, P39, DOI 10.1016/0009-8981(90)90005-D; Krasinski R, 2009, POSTEP HIG MED DOSW, V63, P205; Krasinski Rafal, 2007, Postepy Hig Med Dosw (Online), V61, P683; LAURENT UBG, 1992, MATRIX, V12, P130, DOI 10.1016/S0934-8832(11)80054-5; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Li JM, 2013, ENVIRON MOL MUTAGEN, V54, P429, DOI 10.1002/em.21794; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014; Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048; McKallip RJ, 2013, TOXINS, V5, P1814, DOI 10.3390/toxins5101814; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Miki Y, 2010, INFLAMM RES, V59, P471, DOI 10.1007/s00011-009-0147-y; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MORALES TI, 1988, J BIOL CHEM, V263, P3632; Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5; Moseley R, 2002, BIOMATERIALS, V23, P2255, DOI 10.1016/S0142-9612(01)00360-X; NAGY JI, 1995, J NEUROSCI, V15, P241; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Nishida Y, 2005, EXP CELL RES, V307, P194, DOI 10.1016/j.yexcr.2005.03.026; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; Nishida Y, 2014, J BIOL CHEM, V289, P18121, DOI 10.1074/jbc.A114.021893; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Piao JH, 2013, GLIA, V61, P361, DOI 10.1002/glia.22438; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Recklies AD, 2001, BIOCHEM J, V354, P17, DOI 10.1042/0264-6021:3540017; SAARI H, 1991, ANN RHEUM DIS, V50, P389, DOI 10.1136/ard.50.6.389; Schaller B, 2004, BRAIN RES PROTOC, V12, P125, DOI 10.1016/j.brainresprot.2003.09.003; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schmidt EP, 2014, J BIOL CHEM, V289, P8194, DOI 10.1074/jbc.M113.539452; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sokoloff L, 2008, COGN NEURODYNAMICS, V2, P1, DOI 10.1007/s11571-007-9033-x; Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410; Temiz A, 2010, OTOLARYNG HEAD NECK, V143, P772, DOI 10.1016/j.otohns.2010.07.007; Trabucchi E, 2002, INT J TISSUE REACT, V24, P65; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; TURLEY EA, 1994, GLIA, V12, P68, DOI 10.1002/glia.440120109; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Wakao N, 2011, NEUROSCI LETT, V488, P299, DOI 10.1016/j.neulet.2010.11.051; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Xing GQ, 2012, EXP NEUROL, V234, P31, DOI 10.1016/j.expneurol.2011.12.007; Yamazaki Kenji, 2003, Pathophysiology, V9, P215, DOI 10.1016/S0928-4680(03)00024-5; Yu HM, 2011, MOL CELL BIOCHEM, V352, P65, DOI 10.1007/s11010-011-0740-6; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	108	16	16	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								173	10.3389/fneur.2014.00173			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QW	WOS:000209629300162	25309501	DOAJ Gold, Green Published			2021-06-18	
J	Fernandes, FAO; de Sousa, RJA				Fernandes, Fabio A. O.; Alves de Sousa, R. J.			Finite element analysis of helmeted oblique impacts and head injury evaluation with a commercial road helmet	STRUCTURAL ENGINEERING AND MECHANICS			English	Article						biomechanics; finite element method; head injury; motorcycle helmet; oblique impact	ENERGY-ABSORPTION; TOLERANCE; CRITERION; FOAMS	In this work, the safety performance of a commercial motorcycle helmet already placed on the market is assessed. The assessed motorcycle helmet is currently homologated by several relevant motorcycle standards. Impacts including translational and rotational motions are accurately simulated through a finite element numerical framework. The developed model was validated against experimental results: firstly, a validation concerning the constitutive model for the expanded polystyrene, the material responsible for energy absorption during impact; secondly, a validation regarding the acceleration measured at the headform's centre of gravity during the linear impacts defined in the ECE R22.05 standard. Both were successfully validated. After model validation, an oblique impact was simulated and the results were compared against head injury thresholds in order to predict the resultant head injuries. From this comparison, it was concluded that brain injuries such as concussion and diffuse axonal injury may occur even with a helmet certified by the majority of the motorcycle helmet standards. Unfortunately, these standards currently do not contemplate rotational components of acceleration. Conclusion points out to a strong recommendation on the necessity of including rotational motion in forthcoming motorcycle helmet standards and improving the current test procedures and head injury criteria used by the standards, to improve the safety between the motorcyclists.	[Fernandes, Fabio A. O.; Alves de Sousa, R. J.] Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, P-3810193 Aveiro, Portugal	de Sousa, RJA (corresponding author), Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Campus Santiago, P-3810193 Aveiro, Portugal.	fabiofernandes@ua.pt; rsousa@ua.pt	Fernandes, Fabio A.O./H-2680-2012; de Sousa, Ricardo Alves/E-4405-2010	Fernandes, Fabio A.O./0000-0001-9751-8807; de Sousa, Ricardo Alves/0000-0002-5848-6424	Portuguese Foundation for Science and Technology (FCT)Portuguese Foundation for Science and Technology [PTDC/EME-TME/109856/2009]; COMPETE Program; CMS helmets, Portugal;  [SFRH/BD/91292/2012]	The authors are grateful to the Portuguese Foundation for Science and Technology (FCT) who financially supported this work, through grant PTDC/EME-TME/109856/2009, COMPETE Program and the scholarship SFRH/BD/91292/2012, and also to CMS helmets, Portugal.	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aare Magnus, 2003, Inj Control Saf Promot, V10, P131, DOI 10.1076/icsp.10.3.131.14556; ABNT (AssociacAo Brasileira de Normas Tecnicas), 2001, 74712001 ABNT NBR; Advani SH, 1982, HUMAN BODY DYNAMICS; Alves de Sousa R.J., 2012, SIMUL-T SOC MOD SIM, V88, P579; [Anonymous], 2001, COST327; [Anonymous], 2010, AB 6 10 DOC; [Anonymous], 2008, CATIA V5; ANSR Autoridade Nacional Seguranca Rodoviaria, 2011, OBS SEG ROD SIN ROD; ANSR Autoridade Nacional Seguranca Rodoviaria, 2010, OBS SEG ROD SIN ROD; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Coelho RM, 2013, MATER DESIGN, V43, P384, DOI 10.1016/j.matdes.2012.07.020; Davidsson J., 2009, P IRCOBI C YORK SEPT; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; ERSO European Road Safety Observatory, 2012, ANN STAT REP BAS DAT; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; Fernandes F.A.O., 2013, P IRCOBI C GOTH SEPT; Fijalkowski R.J., 2006, P IRCOBI C MADR SEPT; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli TA, 2003, ANN P ASS ADV AUTOMO, P624; King A., 2003, P IRCOBI C LISB SEP; Kleiven S., 2003, P RTO SEPC M NATO KO; Kleiven S., 2007, BIOMECHANICS NEURONI; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; LOWENHIELM P, 1974, Z RECHTSMED, V75, P131, DOI 10.1007/BF02114709; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mellor A., 2005, P 19 INT TECHN C ENH; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Morrison III B., 2003, P 47 STAPP CAR CRASH; Newman J., 2000, P IRCOBI C MONTP SEP; Newman J., 2005, P IRCOBI C PRAG SEPT; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J.A., 1986, P IRCOBI C ZUR SEPT; Ommaya A.K., 1985, BIOMECHANICS HEAT IN; Ommaya AK, 1967, P 11 STAPP CAR CRASH, P670906; Otte D., 1999, CONTRIBUTION FINAL D; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Shreiber D. I., 1997, P 41 STAPP CAR CRASH; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P422, DOI 10.1016/S0924-0136(02)00047-X; Thibault L.E., 1990, P IRCOBI C SEPT; Thomson R., 2001, P IRCOBI C ISL MAN S; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Vallee H., 1984, P IRCOBI C DELFT SEP; World Health Organization, 2009, GLOB STAT REP ROAD S; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	48	16	16	0	32	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	1225-4568	1598-6217		STRUCT ENG MECH	Struct. Eng. Mech.	DEC 10	2013	48	5					661	679		10.12989/sem.2013.48.5.661			19	Engineering, Civil; Engineering, Mechanical	Engineering	269YK	WOS:000328280600004					2021-06-18	
J	Ren, CH; Zoltewicz, S; Guingab-Cagmat, J; Anagli, J; Gao, MQ; Hafeez, A; Li, N; Cao, JQ; Geng, XK; Kobeissy, F; Mondello, S; Larner, SF; Hayes, RL; Ji, XM; Ding, YC				Ren, Changhong; Zoltewicz, Susie; Guingab-Cagmat, Joy; Anagli, John; Gao, Mingqing; Hafeez, Adam; Li, Ning; Cao, Jinqiang; Geng, Xiaokun; Kobeissy, Firas; Mondello, Stefania; Larner, Stephen F.; Hayes, Ronald L.; Ji, Xunming; Ding, Yuchuan			Different expression of ubiquitin C-terminal hydrolase-L1 and alpha II-spectrin in ischemic and hemorrhagic stroke: Potential biomarkers in diagnosis	BRAIN RESEARCH			English	Article						Stroke; Biomarker; Ischemia; Hemorrhagia; Ubiquitin C-terminal hydrolase-L1; alpha II-Spectrin	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; FIBRILLARY ACIDIC PROTEIN; INTRACEREBRAL HEMORRHAGE; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; MARKERS; RATS; NEURODEGENERATION; IDENTIFICATION	The two primary categories of stroke, ischemic and hemorrhagic, both have fundamentally different mechanisms and thus different treatment options. These two stroke categories were applied to rat models to identify potential biomarkers that can distinguish between them. Ischemic stroke was induced by middle cerebral artery occlusion (MCAO) without reperfusion while hemorrhagic stroke was induced by injecting collagenase IV into the striatum. Brain hemispheres and biofluids were collected at two time points: 3 and 6 h after stroke. Known molecules were tested on the rat samples via quantitative immunoblotting (injured brain, CSF) and Banyan's proprietary ELISA assays (CSF, serum). The injured brain quantitative analyses revealed that ell-spectrin breakdown products (SBDP150, SBDP145) were strongly increased after 6 h ischemia. In CSF, SBDP145 and ubiquitin C-terminal hydrolase-L1 (UCH-L1) levels were elevated after 6 h ischemic stroke detected by Western blot and ELISA. In serum UCH-L1 levels were increased after 3 and 6 h of ischemia detected by ELISA. However, levels of those proteins in hemorrhagic stroke remain normal. In summary, in both the brain and the biofluids, SBDPs and UCH-L1 were elevated after ischemic but not hemorrhagic stroke. These molecules behaved differently in the two stroke models and thus may be capable of being differentiated. (C) 2013 Elsevier B.V. All rights reserved.	[Ren, Changhong; Gao, Mingqing; Li, Ning; Cao, Jinqiang; Geng, Xiaokun; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Inst Hypoxia Med, Beijing 100053, Peoples R China; [Zoltewicz, Susie; Guingab-Cagmat, Joy; Anagli, John; Mondello, Stefania; Larner, Stephen F.; Hayes, Ronald L.] Banyan Biomarkers Inc, Banyan Labs, Alachua, FL USA; [Ren, Changhong; Zoltewicz, Susie; Guingab-Cagmat, Joy; Anagli, John; Li, Ning; Larner, Stephen F.; Hayes, Ronald L.; Ji, Xunming; Ding, Yuchuan] Xuanwu Banyan Biomarker Res & Assay Ctr, Beijing 100053, Peoples R China; [Hafeez, Adam; Ding, Yuchuan] Wayne State Univ Sch Med, Dept Neurosurg, Detroit, MI USA; [Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China; [Kobeissy, Firas] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA	Ji, XM (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Chang Chun Rd 45, Beijing 100053, Peoples R China.	jixm@ccmu.edu.cn	Ji, Xunming/AAN-3370-2021; Kobeissy, Firas/E-7042-2017; Mondello, Stefania/A-1813-2012	Kobeissy, Firas/0000-0002-5008-6944; Mondello, Stefania/0000-0002-8587-3614	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171241]; Program of Excellent Talents of Beijing [2011D005018000007]	This work is supported by the Program of National Natural Science Foundation of China (81171241) and the Program of Excellent Talents of Beijing (2011D005018000007).	Allard L, 2004, PROTEOMICS, V4, P2242, DOI 10.1002/pmic.200300809; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Cuadrado E, 2010, J NEUROPATH EXP NEUR, V69, P1105, DOI 10.1097/NEN.0b013e3181f8c539; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Ding YC, 2002, STROKE, V33, P2492, DOI 10.1161/01.STR.0000028237.15541.CC; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2009, NEUROLOGY, V73, P393, DOI 10.1212/WNL.0b013e3181b05ef9; Gardali S., 2006, J NEUROSURG SCI, V50, P25; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kent DM, 2003, STROKE, V34, P464, DOI 10.1161/01.STR.0000051506.43212.8B; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MATIASGUIU J, 1986, ACTA NEUROL SCAND, V73, P461, DOI 10.1111/j.1600-0404.1986.tb04585.x; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Takahashi M, 1999, CLIN CHEM, V45, P1307; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Whiteley W, 2011, J ROY COLL PHYS EDIN, V41, P152, DOI 10.4997/JRCPE.2011.207; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; WILKINSON KD, 1992, BIOCHEM SOC T, V20, P631, DOI 10.1042/bst0200631; Wilkinson KD, 1997, FASEB J, V11, P1245	33	16	17	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 2	2013	1540						84	91		10.1016/j.brainres.2013.09.051			8	Neurosciences	Neurosciences & Neurology	264WI	WOS:000327911300008	24140110				2021-06-18	
J	Casano-Sancho, P; Suarez, L; Ibanez, L; Garcia-Fructuoso, G; Medina, J; Febrer, A				Casano-Sancho, Paula; Suarez, Larisa; Ibanez, Lourdes; Garcia-Fructuoso, Gemma; Medina, Julita; Febrer, Anna			Pituitary dysfunction after traumatic brain injury in children: is there a need for ongoing endocrine assessment?	CLINICAL ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; LONG-TERM; HYPOPITUITARISM; ADOLESCENTS; CHILDHOOD; PREVALENCE; DIAGNOSIS; SURVIVORS; THERAPY	Background Hypopituitarism has been widely described in adults after traumatic brain injury (TBI); however, the available data in paediatric populations are scarce. Here, we report the results of a prospective, long-term study in children, adolescents and young adults. Study group Thirty-seven children (age, 2 months to 19.9 years) of 51 eligible patients were followed for 1 year. Clinical and baseline endocrine variables were assessed in all 3 and 12 months after TBI; children >= 6 years underwent two stimulation tests (glucagon stimulation and megatest). Results In the group >= 6 years, 11 of 23 patients (47.8%) had a subnormal GH peak 3 months after TBI that persisted in 8 of 23 patients (34%) after 1 year. The GH response showed no correlation with injury severity (GCS, Marshall classification). Growth velocity was normal in all patients, except for one. Body mass index (BMI) SDS increased significantly in the group with low GH response. A suboptimal cortisol was observed in 10 of 23 subjects, which normalized in all but three, 1 year thereafter. All patients but one showed a pubertal response to GnRH testing. No clinical or hormonal abnormalities were detectable in children <6years. Conclusion Our results recommend to prospectively follow children after TBI: firstly, because the impairment of pituitary function cannot be predicted, and secondly, to avoid the potential consequences of pituitary dysfunction. Prospective clinical trials are needed before recommending a systematic screening after TBI and/or GH therapy either in postpubertal children or in prepubertal children who grow normally.	[Casano-Sancho, Paula; Ibanez, Lourdes; Garcia-Fructuoso, Gemma; Medina, Julita; Febrer, Anna] Hosp St Joan de Deu, Barcelona, Spain; [Casano-Sancho, Paula; Ibanez, Lourdes] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain	Casano-Sancho, P (corresponding author), St Joan de Deu Hosp, Pediat Endocrinol Unit, Barcelona, Spain.	pcasano@hsjdbcn.org	Ibanez, Lourdes/F-8316-2014; Ibanez, Lourdes/F-8316-2014	Ibanez, Lourdes/0000-0003-4595-7191; Ibanez, Lourdes/0000-0002-5058-1603			Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bellone S., 2012, PITUITARY; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; IBANEZ L, 1994, J CLIN ENDOCR METAB, V78, P30, DOI 10.1210/jc.78.1.30; Ibanez L, 2009, J CLIN ENDOCR METAB, V94, P1049, DOI 10.1210/jc.2008-2176; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.1007/BF03350340, 10.3275/7045]; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Phillip M, 2002, J PEDIATR ENDOCR MET, V15, P1267; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Rosenfeld RG, 1997, J CLIN ENDOCR METAB, V82, P349, DOI 10.1210/jc.82.2.349; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; YUEN KC, 2011, ENDOCRINE, V40, P130	29	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	DEC	2013	79	6					853	858		10.1111/cen.12237			6	Endocrinology & Metabolism	Endocrinology & Metabolism	247SM	WOS:000326640500016	23650946				2021-06-18	
J	Hwabejire, JO; Imam, AM; Jin, G; Liu, BL; Li, YQ; Sillesen, M; Jepsen, CH; Lu, J; deMoya, MA; Alam, HB				Hwabejire, John O.; Imam, Ayesha M.; Jin, Guang; Liu, Baoling; Li, Yongqing; Sillesen, Martin; Jepsen, Cecilie H.; Lu, Jennifer; deMoya, Marc A.; Alam, Hasan B.			Differential effects of fresh frozen plasma and normal saline on secondary brain damage in a large animal model of polytrauma, hemorrhage and traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	43rd Annual Meeting of the Western-Trauma-Association	MAR 03-08, 2013	Snowmass, CO	Western Trauma Assoc		Brain; trauma; hemorrhage; metabolism; swine	HYPOTENSION; HYPOXIA	BACKGROUND: We have previously shown that the extent of traumatic brain injury (TBI) in large animal models can be reduced with early infusion of fresh frozen plasma (FFP), but the precise mechanisms remain unclear. In this study, we investigated whether resuscitation with FFP or normal saline differed in their effects on cerebral metabolism and excitotoxic secondary brain injury in a model of polytrauma, TBI, and hemorrhagic shock. METHODS: Yorkshire swine (n = 10) underwent Grade III liver injury, rib fracture, standardized TBI, and volume-controlled hemorrhage, (40% +/- 5%) and were randomly resuscitated with either FFP or normal saline. Hemodynamic parameters and brain oxygenation were continuously monitored, while microdialysis was used to measure the brain concentrations of pyruvate, lactate, glutamate, and glycerol at baseline; 1 hour and 2 hours after shock; immediate postresuscitation (PR); as well as 2, 4, and 6 hours PR. Cells from the injured hemisphere were separated into mitochondrial and cytosolic fractions and analyzed for activity of the pyruvate dehydrogenase complex (PDH). RESULTS: There were no baseline differences in cerebral perfusion pressure, brain oxygenation, as well as concentrations of pyruvate, lactate, glutamate, and glycerol between the groups. At 2 hours and 4 hours PR, the FFP group had significantly higher cerebral perfusion pressures (52 [5] mm Hg vs. 43 [2] mm Hg, p = 0.016; and 50 [7] mm Hg vs. 37 [1] mm Hg, p = 0.008, respectively). There was a sustained and significant (p < 0.05) drop in the glutamate and glycerol levels in the FFP group, implying a decrease in excitotoxicity and brain damage, respectively. Mitochondrial PDH activity was significantly higher (2,666.2 [638.2] adjusted volume INT x mm(2) vs. 1,293.4 [88.8] adjusted volume INT x mm(2), p = 0.008), and cytosolic PDH activity was correspondingly lower (671.4 [209.2] adjusted volume INT x mm(2) vs. 3070.7 [484.3] adjusted volume INT x mm(2), p < 0.001) in the FFP group, suggesting an attenuation of mitochondrial dysfunction and permeability. CONCLUSION: In this model of TBI, polytrauma, and hemorrhage, FFP resuscitation confers neuroprotection by improving cerebral perfusion, diminishing glutamate-mediated excitotoxic secondary brain injury and reducing mitochondrial dysfunction. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Hwabejire, John O.; Imam, Ayesha M.; Jin, Guang; Liu, Baoling; Li, Yongqing; Sillesen, Martin; Jepsen, Cecilie H.; Lu, Jennifer; deMoya, Marc A.; Alam, Hasan B.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; [Jin, Guang; Liu, Baoling; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA	Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475			Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeGraba TJ, 2000, NEUROL CLIN, V18, P475, DOI 10.1016/S0733-8619(05)70203-6; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Olson DA, 2013, HEAD INJURY E MED; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	18	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2013	75	6					968	974		10.1097/TA.0b013e31829a021a			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	300IR	WOS:000330458100008	24256668				2021-06-18	
J	Pretz, CR; Malec, JF; Hammond, FM				Pretz, Christopher R.; Malec, James F.; Hammond, Flora M.			Longitudinal Description of the Disability Rating Scale for Individuals in the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems National Database	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Disability Rating Scale; Longitudinal studies; Rehabilitation; Rehabilitation outcome; Traumatic brain injuries	FUNCTIONAL INDEPENDENCE MEASURE; OUTCOME MEASURES; MULTICENTER; COMMUNITY; MODERATE; COHORT	Objective: To develop a detailed understanding of temporal change (ie, estimated trajectories) at the individual level as measured by the Disability Rating Scale (DRS). Design: Individual growth curve (IGC) analysis of retrospective data obtained from the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury (TBI) Model Systems National Database. Setting: Multicenter longitudinal database study. Participants: Individuals with TBI (N=8816) participating in the TBI Model Systems National Database project. Interventions: Not applicable. Main Outcome Measure: DRS. Results: The negative exponential consisting of 3 growth parameters (pseudointercept, asymptote, rate) was successfully used to predict trajectory of recovery on the DRS qualified by the following covariates: race, sex, level of education and age at admission, rehabilitation length of stay, and cognitive and motor FIM scores at rehabilitation admission. Based on these results, an interactive tool was developed to allow prediction of the trajectory of recovery for individuals and subgroups with specified characteristics on the selected covariates. Conclusions: With the use of IGC analysis, the longitudinal trajectory of recovery on the DRS for individuals sharing common characteristics and traits can be described. This methodology allows researchers and clinicians to predict numerous individual-level trajectories through use of a web-based computer automated interactive tool. Archives of Physical Medicine and Rehabilitation 2013;94:2478-85 (C) 2013 by the American Congress of Rehabilitation Medicine	[Pretz, Christopher R.] Craig Hosp, Englewood, CO 80132 USA; [Pretz, Christopher R.] Traumat Brain Injury Natl Stat & Data Ctr, Englewood, CO 80132 USA; [Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Malec, James F.; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA	Pretz, CR (corresponding author), Craig Hosp, 3425 South Clarkson St, Englewood, CO 80132 USA.	cpretz@craighospital.org			National Institute on Disability and Rehabilitation Research (NIDRR) Traumatic Brain Injury Model Systems National Data and Statistical Center [H133A110006]; NIDRR Rehabilitation Research Training Center on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; NIDRR Traumatic Brain Injury Model Systems grant at the Indiana University School of Medicine [H133120035]	Supported by the National Institute on Disability and Rehabilitation Research (NIDRR) Traumatic Brain Injury Model Systems National Data and Statistical Center (grant no. H133A110006), the NIDRR Rehabilitation Research Training Center on Improving Measurement of Medical Rehabilitation Outcomes (grant no. H133B090024), and the NIDRR Traumatic Brain Injury Model Systems grant at the Indiana University School of Medicine (grant no. H133120035).	Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Johnston MV, 2006, AM J PHYS MED REHAB, V85, P292, DOI 10.1097/01.phm.0000202079.58567.3b; Kothari S, 2012, BRAIN INJURY MED PRI; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570	22	16	16	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2013	94	12					2478	2485		10.1016/j.apmr.2013.06.019			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	264UD	WOS:000327905600022	23827348				2021-06-18	
J	Xiang, J; Shi, JX; Wheeler, KK; Yeates, KO; Taylor, HG; Smith, GA				Xiang, Joe; Shi, Junxin; Wheeler, Krista Kurz; Yeates, Keith Owen; Taylor, H. Gerry; Smith, Gary A.			Paediatric patients with abusive head trauma treated in US Emergency Departments, 2006-2009	BRAIN INJURY			English	Article						Abuse; children; emergency department; head trauma; traumatic brain injury	BRAIN-INJURY; CHILD-ABUSE; INFANTS	Objective: To study characteristics and outcomes of paediatric patients with abusive head trauma (AHT) treated in emergency departments. Methods: Nationwide Emergency Department Sample (NEDS) data were analysed. The CDC recommended AHT definition was used to classify children <= 4 years with head trauma into AHT and non-AHT groups. Outcomes were compared between patients with AHT and patients with non-AHT. Logistic models were fitted to identify risk factors. Results: An estimated 10 773 paediatric patients with AHT were treated in EDs in 2006-2009. The average annual rate was 12.83 per 100 000 for children <= 4 years. Children < 1 year of age accounted for most AHT cases (60.6%) and males had a significantly higher AHT rate than females. Medicaid was the primary payer for 66.1% of AHT injuries and 40.3% of non-AHT injuries. The case mortality rate was 53.9 (95% CI = 41.0-66.7) per 1000 patients with AHT compared with 1.6 (95% CI = 1.4-1.9) per 1000 patients with non-AHT. Conclusions: Child caregivers should be educated about the serious consequences of AHT and proper techniques for caring for infants. Unbiased and accurate documentation of AHT by physicians and medical coders is crucial for monitoring AHT injuries.	[Xiang, Joe; Shi, Junxin; Wheeler, Krista Kurz; Yeates, Keith Owen; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Xiang, Joe; Taylor, H. Gerry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yeates, Keith Owen; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Wheeler, Krista/0000-0003-3728-8928			Agency for Healthcare Research and Quality, 2011, OV NAT EM DEP SAMPL; Baker SP, 1992, THE INJURY FACT BOOK; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Barth RP, 2009, FUTURE CHILD, V19, P95, DOI 10.1353/foc.0.0031; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; Hooft A, 2013, J PEDIATR-US, V162, P80, DOI 10.1016/j.jpeds.2012.06.037; Huang MI, 2011, J NEUROSURG-PEDIATR, V8, P171, DOI 10.3171/2011.5.PEDS1139; Jenny C, 2013, JAMA-J AM MED ASSOC, V281, P621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Libby AM, 2003, PEDIATRICS, V112, P58, DOI 10.1542/peds.112.1.58; McKenzie K, 2009, INJURY PREV, V15, P60, DOI 10.1136/ip.2008.019935; National Center for Injury Prevention and Control, 2012, PREV SHAK BAB SYNDR; Oluigbo CO, 2012, J NEUROSURG-PEDIATR, V9, P125, DOI 10.3171/2011.11.PEDS09449; Parks S, 2012, INJURY PREVENTION, V18; Parks S, 2012, PEDIAT ABUSE HEAD TR; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Prasad MR, 2005, ARCH DIS CHILD, V90, P82, DOI 10.1136/adc.2003.045583; Runyan DK, 2008, AM J PREV MED, V34, pS163, DOI 10.1016/j.amepre.2008.01.010; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; U.S. Census Bureau, 2010, TABL 1 ANN EST RES P; Wright RJ, 1999, PEDIATR EMERG CARE, V15, P376, DOI 10.1097/00006565-199912000-00002	32	16	16	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1555	1561		10.3109/02699052.2013.831126			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400009	24102484				2021-06-18	
J	Barz, H; Schreiber, A; Barz, U				Barz, Helmut; Schreiber, Almut; Barz, Ulrich			Impulses and pressure waves cause excitement and conduction in the nervous system	MEDICAL HYPOTHESES			English	Article							MECHANISM	It is general accepted, that nerval excitement and conduction is caused by voltage changes. However, the influx of fluid into an elastical tube releases impulses or pressure waves. Therefore an influx of ion currents, respectively fluid motions into the elastic neuronal cells and fibres also induce impulses. This motion of charge carriers are measured by voltage devices as oscillations or action potentials, but the voltage changes may be an epiphenomenon of the (mechanical) impulses. Impulse waves can have a high speed. As stiffer or inelastic a tube wall, the greater is the speed of the impulse. Myelin sheaths cause a significant stiffening of the nerve fibre wall and myelinated fibres have a conduction velocity up to 120 m/s. The influx of fluid at the nodes of Ranvier intensifies periodically the impulse wave in the nerve fibres. The authors suggest that also the muscle end-plate acts as a conductor of axonal impulses to the inner of the muscle fibres and that the exocytosis of acetylcholine into the synaptic cleft may be an amplifier of the axonal impulse. It is discussed that intracellular actin filaments may also influence motions at the neuronal membrane. Many sensory nerve cells are excited due to exogenous or endogenous mechanical impulses. It may plausible that such impulses are conducted directly to the sensory nerve cell bodies in the dorsal root ganglia without the transformation in electric energy. Excitation conduction happens without noteworthy energy consumption because the flow of ion currents through the membranes takes place equivalent to the concentration gradient. Impulse waves cause short extensions of the lipid membranes of the cell- and fibres walls and therefore they can induce opening and closing of the included ion channels. This mechanism acts to "voltage gated" and "ligand-gated" channels likewise. The concept of neuronal impulses can be helpful to the understanding of other points of neurophysiology or neuronal diseases. This includes e.g., the brain concussion and pathohistological findings in Alzheimer dementia. To verify the concept of (mechanical) impulses in the nervous system it is necessary to carry out biophysical or mechanical investigations in very small dimensions and the authors hope to give for this a sufficient stimulus. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.	[Barz, Helmut] Dietrich Bonhoeffer Hosp, Dept Neuropathol, D-17022 Neubrandenburg, Germany; [Schreiber, Almut] Inst Arbeits & Sozialhyg, D-01069 Dresden, Saxony, Germany; [Barz, Ulrich] Univ Halle Wittenberg, D-06108 Halle, Saxony Anhalt, Germany	Barz, H (corresponding author), Holunderweg 17, D-18209 Bad Doberan, Germany.	HelmutBarz@gmx.de; almut.schreiber@fit-for-work.eu; UlrichBarz@yahoo.de					Adams JH, 1992, GREENFIELDS NEUROPAT, P106; Bamburg J. R., 1991, NEURONAL CYTOSKELETO, P121; Barz H, 1992, Acta Histochem Suppl, V42, P77; Barz H., 1992, ZEREBRALEN DURCHBLUT, VII, P554; Berg JM, 2013, BIOCHIMIE, P374; Beyder A, 2010, J PHYSL, V24, P4569; Cole KS, 1939, J GEN PHYSIOL, V22, P649, DOI 10.1085/jgp.22.5.649; Corry B, 2006, BIOPHYS J, V90, P799, DOI 10.1529/biophysj.105.067868; Dudel J., 1996, NEUROWISSENSCHAFT MO, P87; Dudel J., 1996, NEUROWISSENSCHAFTEN, P115; FIFKOVA E, 1985, CELL MOL NEUROBIOL, V5, P47, DOI 10.1007/BF00711085; Forbes M., 2012, CELL PHYSL SOURCE BO, P67; Freedman JC, 2012, CELL PHYSL SOURCE BO, P3; French AS, 2012, CELL PHYSL SOURCE BO, P633; Gekle M, 2010, TASCHENLEHRBUCH PHYS, P191; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graeber MB, 2002, GREENFIELDS NEUROPAT, VI, P123; Guckenheimer J, 2002, SIAM J APPL DYN SYST, V1, P105, DOI 10.1137/S1111111101394040; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kandel ER, 1995, ESSENTIALS NEURAL SC, P197; Koester J, 1995, ESSENTIALS NEURAL SC, P115; Lambert S., 2012, CELL PHYSL SOURCE BO, P475; Mirra S. S., 2002, GREENFIELDS NEUROPAT, V2, P195; Morris C. E, 2012, CELL PHYSL SOURCE BO, P493; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Rudel R, 1996, NEUROWISSENSCHAFT MO, P145; Sperelakis N, 2012, CELL PHYSL SOURCE BO, P325; Suszkiw J B., 2012, CELL PHYSL SOURCE BO, P563; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010	30	16	17	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	NOV	2013	81	5					768	772		10.1016/j.mehy.2013.07.049			5	Medicine, Research & Experimental	Research & Experimental Medicine	257DI	WOS:000327363400006	23953966	Other Gold			2021-06-18	
J	Keenan, HT; Murphy, NA; Staheli, R; Savitz, LA				Keenan, Heather T.; Murphy, Nancy A.; Staheli, Russ; Savitz, Lucy A.			Healthcare Utilization in the First Year After Pediatric Traumatic Brain Injury in an Insured Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; health services; pediatric; screening; traumatic brain injury	CHILDREN; SERVICES; ADOLESCENTS; TRENDS; FAMILY; TBI; PERFORMANCE; CHILDHOOD; DEATHS; MATRIX	Objective: To compare the healthcare use by children with and without a traumatic brain injury (TBI) in the year following injury to understand whether children access primary care. Participants: Children 0 to 15 years with a TBI (N = 545) and (N = 2310) uninjured age and sex-matched comparisons. Setting: A full benefits healthcare plan from 2000 to 2007. Main Measures: Mean annual healthcare utilization. Results: Children with TBI had higher mean annual outpatient visits (4.2 vs 3.5, P =.001), but similar mean annual general pediatric visits (2.7 vs 2.8, P =.3) than comparison children. More cases than comparisons attended a general pediatric visit (80.0% vs 73.3%, risk ratio = 1.1, 95% CI: 1.0-1.1). However, approximately 50% of children older than 7 years who had an intracranial injury did not attend a general pediatric visit and those were slightly more likely to receive specialty care (adjusted risk ratio = 1.1, 95% CI: 1.0-1.2). These children did not appear to be substituting specialty for primary care. Conclusions: Children with a full benefits insurance plan do not access primary care routinely after TBI. These findings present a challenge for designing a system to screen children after TBI.	[Keenan, Heather T.; Murphy, Nancy A.] Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; [Staheli, Russ; Savitz, Lucy A.] Intermt Healthcare, Salt Lake City, UT USA	Keenan, HT (corresponding author), Univ Utah, Dept Pediat, POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; [Anonymous], 1999, JAMA, V282, P974; Attar Mohammad A, 2005, J Perinatol, V25, P36, DOI 10.1038/sj.jp.7211203; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Hooper S R, 2001, N C Med J, V62, P350; Irwin CE, 2009, PEDIATRICS, V123, pE565, DOI 10.1542/peds.2008-2601; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Medical home initiatives for children with special needs project advisory committee. American Academy of Pediatrics, 2002, PEDIATRICS 1, V110, P184; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Statistics NCfH, 2001, ICD 9 CM INT CLASS D; Strickland BB, 2011, PEDIATRICS, V127, P604, DOI 10.1542/peds.2009-3555; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	32	16	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					426	432		10.1097/HTR.0b013e31825935b8			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200006	22691966				2021-06-18	
J	Logan, BW; Goldman, S; Zola, M; Mackey, A				Logan, Bret W.; Goldman, Sarah; Zola, Marc; Mackey, Angela			Concussive Brain Injury in the Military: September 2001 to the Present	BEHAVIORAL SCIENCES & THE LAW			English	Article							SYMPTOMS	Since the terrorist attacks of September 11, 2001, 1,348,405 citizens have been deployed to combat in Operation Iraqi Freedom (OIF), Operation New Dawn in Iraq, and Operation Enduring Freedom in Afghanistan (OEF). During this same period 266,810 (20%) of these individuals have been diagnosed with a traumatic brain injury (TBI). The majority of these were Army soldiers, with 155,282 (58%) receiving the diagnosis. Mild TBI comprised 82% of the total, with the remainder being moderate to severe. Over this same period the Department of Defense (DoD) has invested $374.9 million to enhance access and quality of care services, including 57 TBI treatment centers in the combat theater and throughout the U.S. The Army's medical research division, the Medical Research and Material Command (MRMC), has invested an additional $700 million to TBI research during this time. The effort has faced a number of challenges, including limited human subject basic and translational research, limited epidemiological data on combat-related injuries, limited capacity and standards for data acquisition, and a lack of standardized evidenced-based protocols for treatment. All these areas have undergone significant growth and development, leading to the comprehensive system of care present today. A further challenge in this patient population has been the clinical co-morbidity of TBI, post-traumatic stress disorder, and chronic pain syndrome. The Army and the DoD have created treatment programs that are interdisciplinary in clinical approach, targeting particular neuropsychological domains of dysfunction rather than diagnostic category or etiology of injury. This article presents the history of this effort, the challenges to accurate and adequate diagnosis and care that remain, and the future of brain injury clinical and research efforts in the military. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Logan, Bret W.] Intrepid Spirit III NICOE Satellite Ft Campbell, Ft Campbell, KY 42223 USA; [Zola, Marc] NICOE Satellite, Intrepid Spirit 3, Rehabil Serv, Ft Campbell, KY USA; [Mackey, Angela] NICOE Satellite, Intrepid Spirit 3, Ft Campbell, KY USA	Logan, BW (corresponding author), Intrepid Spirit III NICOE Satellite Ft Campbell, 650 Joel Dr,BLDG 2543, Ft Campbell, KY 42223 USA.	Bret.W.Logan.civ@mail.mil					[Anonymous], 2012, CONCUSSION MANAGEMEN; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Defense Manpower Data Center, 2013, US CAS STAT OIF OND; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Office of the Surgeon General U. A., 2013, TBI TALK POINTS 2013; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Vanderploeg R. D., 2013, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0b013e318281966e.	12	16	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		803	813		10.1002/bsl.2092			11	Psychology, Applied; Law	Psychology; Government & Law	262KI	WOS:000327733400009	24130079				2021-06-18	
J	Miller, T; Bhattacharya, S; Zamula, W; Lezotte, D; Kowalske, K; Herndon, D; Fauerbach, J; Engrav, L				Miller, Ted; Bhattacharya, Soma; Zamula, William; Lezotte, Dennis; Kowalske, Karen; Herndon, David; Fauerbach, James; Engrav, Loren			Quality-of-life loss of people admitted to burn centers, United States	QUALITY OF LIFE RESEARCH			English	Article						Burn; QALY; Systematic review of scorings; SF-12; EQ-5d	NATIONALLY REPRESENTATIVE SAMPLE; GENERAL-POPULATION; HEALTH-STATUS; EQ-5D INDEX; US SAMPLE; SF-12; VALIDITY; QUESTIONNAIRE; HETEROGENEITY; UTILITIES	To estimate quality-of-life loss per serious burn survivor in a large U.S. cohort. Longitudinal functional assessments of all 1,587 people receiving primary treatment in 5 burn centers between 2000 and 2009 included pre-burn (retrospective), at time of discharge, and 6, 12, and 24 months post-injury. We assessed adults with RAND Short Form (SF) 12 and children with SF-10 or Child Health Questionnaire, the child surveys scored using standard norms-based scoring. A literature review identified 20 quality-adjusted life year utility scorings for SF-12 and 27 scorings for EQ-5d response distributions predicted from SF-12 scores. We computed composite scores for each patient and time period by applying 32 scorings that met quality/non-duplication criteria. Mean quality-of-life scores were 0.805 4 weeks pre-burn, 0.562 at discharge, rebounded through 1 year, and stabilized at 0.735 (0.750 for TBSA burned below 25 %, 0.722 for TBSA burned of 25-50 %, and 0.695 for larger burns). As a percentage of initial levels, burns reduced short-term quality of life by 30 %. Long-term loss averaged 11 %, ranging from 9 % for TBSA burned below 25-13 % for TBSA burned above 50 %. Children recovered faster and more fully. Burns cause substantial losses in quality of life, with long-term losses comparable to traumatic brain injury.	[Miller, Ted; Bhattacharya, Soma] Pacific Inst Res & Evaluat, Calverton, MD USA; [Zamula, William] US Consumer Prod Safety Commiss, Bethesda, MD USA; [Lezotte, Dennis] Univ Colorado, Hlth Sci Ctr, Lakeland, CO USA; [Kowalske, Karen] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Herndon, David] Univ Texas Med Branch, Galveston, TX 77555 USA; [Herndon, David] Shriners Hosp Crippled Children, Galveston, TX USA; [Fauerbach, James] Johns Hopkins Univ, Baltimore, MD USA; [Engrav, Loren] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	Miller, T (corresponding author), Pacific Inst Res & Evaluat, Calverton, MD USA.	miller@pire.org	Herndon, David/AAC-3354-2020	Miller, Ted/0000-0002-0958-2639	U.S. Consumer Product Safety Commission (CPSC); U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; BMS Centers; BMS National Data and Statistical Center	This study was funded by a contract with the U.S. Consumer Product Safety Commission (CPSC). This journal article was prepared in part by CPSC staff but has not been reviewed or approved by, and may not necessarily reflect the views of, the Commission. The deidentified data used for this study were obtained from the Burn Model Systems Centers Database which is supported by the U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) in collaboration with the BMS Centers and the BMS National Data and Statistical Center. However, these contents may not reflect the opinions or views of the BMS Centers, NIDRR, or the U.S. Department of Education.	Sanchez JLA, 2007, ARCH SURG-CHICAGO, V142, P50, DOI 10.1001/archsurg.142.1.50; [Anonymous], 2008, CHILD HLTH QUEST SCO; Badia X, 1998, QUAL LIFE RES, V7, P311, DOI 10.1023/A:1024933913698; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Bult JR, 1996, MED DECIS MAKING, V16, P226, DOI 10.1177/0272989X9601600306; Bult JR, 1998, MED CARE, V36, P523, DOI 10.1097/00005650-199804000-00008; Cleemput I, 2004, VALUE HEALTH, V7, P499, DOI 10.1111/j.1524-4733.2004.74013.x; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF., 1997, METHODS EC EVALUATIO, V2nd; Econsys, 2008, STUD COMP PAYM SERV, VIII; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Farivar Sepideh S, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P515, DOI 10.1586/14737167.4.5.515; Franks P, 2004, MED DECIS MAKING, V24, P247, DOI 10.1177/0272989X04265477; Franks P, 2003, MED CARE, V41, P1277, DOI 10.1097/01.MLR.0000093480.58308.D8; Fryback DG, 1997, MED DECIS MAKING, V17, P1, DOI 10.1177/0272989X9701700101; Gray AM, 2006, MED DECIS MAKING, V26, P18, DOI 10.1177/0272989X05284108; Greene W. H., 2008, ECONOMETRIC ANAL, V6th; Grenier W., 2003, EUR J HEALTH ECON, V4, P222; Hakim Z, 1999, HEALTH ECON, V8, P103; Jelsma J, 2003, POPUL HEALTH METR, V1, P11, DOI [DOI 10.1186/1478-7954-1-11, 10.1186/1478-7954-1-11]; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lawrence WF, 2004, MED DECIS MAKING, V24, P160, DOI 10.1177/0272989X04264015; Lundberg L, 1999, MED DECIS MAKING, V19, P128, DOI 10.1177/0272989X9901900203; MCHORNEY CA, 1992, MED CARE S, V30, P253; Mortimer D, 2008, MED DECIS MAKING, V28, P66, DOI 10.1177/0272989X07309642; Nichol MB, 2001, MED DECIS MAKING, V21, P105, DOI 10.1177/02729890122062352; Oster C, 2009, BURNS, V35, P723, DOI 10.1016/j.burns.2008.11.007; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Schofield M J, 1998, J Health Psychol, V3, P259, DOI 10.1177/135910539800300209; Sengupta N, 2004, MED CARE, V42, P927, DOI 10.1097/01.mlr.0000135812.52570.42; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Shmueli A, 2004, MED DECIS MAKING, V24, P61, DOI 10.1177/0272989X03261562; Shmueli A, 1999, MED DECIS MAKING, V19, P122, DOI 10.1177/0272989X9901900202; Stratmann-Schoene D, 2006, HEALTH ECON, V15, P553, DOI 10.1002/hec.1082; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; The EuroQol Group, 2007, EQ 5D VALUE SETS INV; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Turner-Bowker D. M., 2003, SF 10 CHILDREN USERS; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Ware J., 2002, SCORE VERSION 2 SF 1; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Wittrup-Jensen K. U., 2008, ESTIMATION PREFERENC	43	16	16	0	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	NOV	2013	22	9					2293	2305		10.1007/s11136-012-0321-5			13	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	268ZB	WOS:000328208300004	23224665				2021-06-18	
J	Siman-Tov, M; Radomislensky, I; Peleg, K				Siman-Tov, Maya; Radomislensky, Irina; Peleg, Kobi		ITG	Reduction in trauma mortality in Israel during the last decade (2000-2010): The impact of changes in the trauma system	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Survival; Mortality trend; Inpatient death	INJURED PATIENTS; SURVIVAL; STATE; EPIDEMIOLOGY; VOLUME; CARE	Hypothesis: Following the introduction of changes to the trauma system there would be a period of time during which the impact on mortality would be minimal. A decrease in mortality rates would be noted as the TS matured and would continue over time. Design: A retrospective cohort study of all severely injured patients (injury severity score >= 16) recorded in the Israeli National Trauma Registry at six level I trauma centres in Israel from 2000 to 2010. Inpatient death rates were examined overall and by sub groups. Setting: The National Trauma Registry contains hospitalized patients, transfer patients to or from other hospitals and those who died in the emergency department. It excludes patients who were dead on arrival, discharged following treatment in the emergency department, and patients whose injuries by definition are not classified as trauma. Main outcome measures: In-hospital mortality Results: Data included 23,143 severe trauma patients available for analysis. Inpatient mortality rates decreased significantly from 16% in 2000 to 11% in 2010. The odds ratio for mortality in 2010 vs. 2000, adjusted for year, age, sex, mechanism of injury, traumatic brain injury, penetrating injury, and severity of injury (ISS >= 25), was 0.53, confirming a downward trend. Conclusions: A steady significant reduction in the inpatient mortality rate for severe trauma patients hospitalized at all level I trauma centres in Israel between 2000 and 2010 was observed. Although a single factor that explains the reduction was not identified, evidently the establishment of the trauma system brought about a significant decrease in hospital mortality. Integrated cooperation between components of the national trauma system in Israel over the years may explain the reduction. (c) 2012 Elsevier Ltd. All rights reserved.	[Siman-Tov, Maya; Radomislensky, Irina; Peleg, Kobi] Gertner Inst Epidemiol & Hlth Policy Res, Israel Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel; [Peleg, Kobi] Tel Aviv Univ, Sch Publ Hlth, Dept Disaster Management, IL-69978 Tel Aviv, Israel	Peleg, K (corresponding author), Chaim Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Israel Natl Ctr Trauma & Emergency Med Res, IL-52621 Tel Hashomer, Israel.	kobip@gertner.health.gov.il					Abernathy JH, 2002, AM SURGEON, V68, P182; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Barquist E, 2000, J TRAUMA, V49, P63, DOI 10.1097/00005373-200007000-00009; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Cooper A, 2000, J TRAUMA, V48, P16, DOI 10.1097/00005373-200001000-00004; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; DEMETRIADES D, 1995, ARCH SURG-CHICAGO, V130, P216; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Heruti R J, 1997, Harefuah, V133, P155; Israel Ministry of Health, 1992, REV COMM REP TRAUM C; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Liberman M, 2005, SURGERY, V137, P647, DOI 10.1016/j.surg.2005.03.011; MacKenzie EJ, 1999, J TRAUMA, V47, pS34, DOI 10.1097/00005373-199909001-00008; Mann NC, 2001, J TRAUMA, V50, P1111, DOI 10.1097/00005373-200106000-00022; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; Melton SM, 2003, J TRAUMA, V54, P273, DOI 10.1097/01.TA.0000038506.54819.11; Michaelson Moshe, 1997, Harefuah, V133, P656; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; O'Keefe GE, 1999, ANN SURG, V229, P409, DOI 10.1097/00000658-199903000-00015; Peleg K, 2004, ARCH SURG-CHICAGO, V139, P1231, DOI 10.1001/archsurg.139.11.1231; Rogers FB, 2001, J TRAUMA, V50, P409, DOI 10.1097/00005373-200103000-00003; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; Shafi S, 2006, J TRAUMA, V61, P1374, DOI 10.1097/01.ta.0000246698.07125.c0; SMITH RF, 1990, J TRAUMA, V30, P1066, DOI 10.1097/00005373-199009000-00002; World Health Organization, 2010, VIOL INJ FACTS	28	16	17	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2013	44	11					1448	1452		10.1016/j.injury.2012.08.054			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	227ZT	WOS:000325155000012	23021368				2021-06-18	
J	Szabo, AJ; Alosco, ML; Fedor, A; Gunstad, J				Szabo, Ashley J.; Alosco, Michael L.; Fedor, Andrew; Gunstad, John			Invalid Performance and the ImPACT in National Collegiate Athletic Association Division I Football Players	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; neuropsychological tests; malingering	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; VALIDITY; SCORES; RISK	Context: Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a computerized cognitive test battery commonly used for concussion evaluation. An important aspect of these procedures is baseline testing, but researchers have suggested that many users do not use validity indices to ensure adequate effort during testing. No one has examined the prevalence of invalid performance for college football players. Objective: To examine the prevalence of invalid scores on ImPACT testing. Design: Cross-sectional study. Setting: National Collegiate Athletic Association Division I university. Patients or Other Participants: A total of 159 athletes (age = 20.3 +/- 1.41 years; range = 17.8-23.7 years) from a Division I collegiate football team participated. Intervention(s): An informational intervention regarding the importance of concussion testing to promote safety was administered before testing for the most recent season. Main Outcome Measure(s): We examined preseason ImPACT testing data across a 3-year period (total assessments = 269). Based on invalid and sandbagging indices denoted by the ImPACT manual, protocols were examined to indicate how many invalid indices each athlete had. Results: A total of 27.9% (n = 75) of assessments were suggestive of invalid scores, with 4.1% (n = 11) suggesting invalid responding only, 17.5% (n = 47) indicating "sandbagging" only, and 6.3% (n = 17) showing both invalid and sandbagging responding. The informational intervention did not reduce the prevalence of invalid responding. Conclusions: These findings highlight the need for further information about the ImPACT validity indices and whether they truly reflect poor effort. Future work is needed to identify practices to reliably target and reduce invalid responding.	[Szabo, Ashley J.; Alosco, Michael L.; Fedor, Andrew; Gunstad, John] Kent State Univ, Dept Psychol, Kent, OH 44242 USA	Gunstad, J (corresponding author), Kent State Univ, Dept Psychol, 221 Kent Hall, Kent, OH 44242 USA.	jgunstad@kent.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK075119, HL089311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL089311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK075119, R56DK075119] Funding Source: NIH RePORTER	Indirect funding for this project was provided by grants DK075119 and HL089311 from the National Institutes of Health.	Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; BARTH JT, 2006, SPORTS NEUROPSYCHOLO, P3; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brown CN, 2007, J ATHL TRAINING, V42, P515; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Freeman JR, 2005, TXB TRAUMATIC BRAIN, P453; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Groth-Marnat G., 2003, HDB PSYCHOL ASSESSME, P66; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lezak M., 2004, NEUROPSYCHOLOGICAL A, P100; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, IMPACT VERSION 6 0 C; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Ratliff-Crain J, 1999, PSYCHOL HEALTH, V14, P625, DOI 10.1080/08870449908410754; Rimal RN, 2010, J APPL SOC PSYCHOL, V40, P287, DOI 10.1111/j.1559-1816.2009.00574.x; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008	27	16	16	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2013	48	6					851	855		10.4085/1062-6050-48.6.20			5	Sport Sciences	Sport Sciences	268AW	WOS:000328141200016	24151810	Green Published			2021-06-18	
J	Szmydynger-Chodobska, J; Gandy, JR; Varone, A; Shan, RZ; Chodobski, A				Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam			Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury	PLOS ONE			English	Article							CHOROID-PLEXUS; VASOPRESSIN V-1A; V-2 RECEPTORS; EXPRESSION; DAMAGE; MICE; INFILTRATION; TISSUE; CELLS; RATS	Several lines of evidence indicate that the blood-cerebrospinal fluid barrier (BCSFB), which primarily resides in the choroid plexus (CP), plays a significant pathophysiological role not only in neuroinflammatory diseases, such as multiple sclerosis, but also in traumatic brain injury (TBI). Here we investigated how arginine vasopressin (AVP) regulates function of the BCSFB in the context of post-traumatic neuroinflammation. It has previously been shown that AVP exacerbates various forms of brain injury, but the mechanisms underlying this AVP action are poorly understood. Type 1A AVP receptor is highly expressed on the CP epithelium and the CP synthesizes AVP. Using the controlled cortical impact model of TBI, we demonstrated decreased post-traumatic production of proinflammatory mediators by the CP and reduced influx of inflammatory cells across the BCSFB in AVP-deficient Brattleboro rats when compared with Long-Evans rats, a parental strain for Brattleboro rats. Arginine vasopressin was also found to play an important role in post-traumatic activation of c-Jun Nterminal kinase (JNK) in the CP. In the CP epithelial cell cultures, AVP augmented the tumor necrosis factor-alpha- and interleukin-1 beta-dependent increase in synthesis of proinflammatory mediators, including neutrophil chemoattractants, an action largely dependent on the JNK signaling pathway. Under in vivo conditions, a selective JNK inhibitor decreased the post-traumatic production of neutrophil chemoattractants by the CP and reduced the influx of neutrophils across the BCSFB. These results provide evidence for the synergistic interactions between proinflammatory cytokines and AVP, a ligand for G protein-coupled receptors, and support a pathophysiological role of AVP in post-traumatic neuroinflammation.	[Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam] Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA	Szmydynger-Chodobska, J (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS49479]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	This work was supported by grant NS49479 from the NIH (to AC) and by funds from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; Armstead WM, 2001, STROKE, V32, P1408, DOI 10.1161/01.STR.32.6.1408; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Chodobski A, 2013, VASCULAR ME IN PRESS; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; NAKAGAWA H, 1994, BIOCHEM J, V301, P545, DOI 10.1042/bj3010545; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska Joanna, 2007, Cerebrospinal Fluid Res, V4, P11, DOI 10.1186/1743-8454-4-11; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Wang YF, 2006, J NEUROCHEM, V98, P1046, DOI 10.1111/j.1471-4159.2006.03950.x; Xu Miao, 2007, Chin J Traumatol, V10, P90; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79328	10.1371/journal.pone.0079328			9	Multidisciplinary Sciences	Science & Technology - Other Topics	245XZ	WOS:000326499300075	24223928	DOAJ Gold, Green Published			2021-06-18	
J	Tu, TW; Kim, JH; Yin, FQ; Jakeman, LB; Song, SK				Tu, Tsang-Wei; Kim, Joong H.; Yin, Feng Qin; Jakeman, Lyn B.; Song, Sheng-Kwei			The impact of myelination on axon sparing and locomotor function recovery in spinal cord injury assessed using diffusion tensor imaging	NMR IN BIOMEDICINE			English	Article						diffusion tensor imaging; myelin; dysmyelination; white matter; spinal cord injury	WHITE-MATTER CHANGES; TRAUMATIC BRAIN-INJURY; IN-VIVO; MOUSE MODEL; MULTIPLE-SCLEROSIS; WALLERIAN DEGENERATION; CONTUSION INJURY; SHIVERER MICE; DEMYELINATION; GLYCOPROTEIN	The dysmyelinated axons of shiverer mice exhibit impaired conduction characteristics, similar to early postnatal axons before myelination, whereas the patterns of neuronal activity and connectivity are relatively comparable with those of wild-type myelinated axons. This unique dysmyelination pattern is exploited in the present study to determine the role of compact myelin in the loss and recovery of function following traumatic spinal cord injury (SCI). We applied in vivo diffusion tensor imaging (DTI) and post-mortem immunohistochemistry analysis to examine changes in myelin and axonal integrity, and evaluated these changes in concert with the analysis of locomotor function from 1 to 4 weeks following a mid-thoracic contusion injury in homozygous shiverer and heterozygous littermate mice. The DTI biomarkers, axial and radial diffusivities, are noninvasive indicators of axon and myelin integrity in response to SCI of both myelinated and dysmyelinated spinal cord. We show that myelin is critical for normal hind limb function in open field locomotion. However, when the functional outcome is limited during chronic SCI, the extent of recovery is associated with residual axonal integrity and independent of the extent of intact myelin at the lesion epicenter. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Tu, Tsang-Wei] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA; [Kim, Joong H.; Song, Sheng-Kwei] Washington Univ, Dept Radiol, St Louis, MO 63110 USA; [Yin, Feng Qin; Jakeman, Lyn B.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Yin, Feng Qin; Jakeman, Lyn B.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA	Song, SK (corresponding author), Washington Univ, Sch Med, Dept Radiol, 4525 Scott Ave, St Louis, MO 63110 USA.	ssong@wustl.edu		Jakeman, Lyn/0000-0002-1760-8819	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS047592, R01 NS054194, P01 NS059560]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047592, P01NS059560, R01NS054194] Funding Source: NIH RePORTER	This study was supported in part by National Institute of Health R01 NS047592, R01 NS054194, and P01 NS059560.	Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Andrews H, 2006, J NEUROSCI RES, V83, P1533, DOI 10.1002/jnr.20842; Bando Y, 2008, EUR J NEUROSCI, V28, P1731, DOI 10.1111/j.1460-9568.2008.06474.x; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Biddle F, 1973, MOUSE NEWS LETT, V48; Bilgen M, 2000, MAGN RESON MED, V43, P594; Blight A, 1988, J Am Paraplegia Soc, V11, P26; Brady ST, 1999, J NEUROSCI, V19, P7278, DOI 10.1523/JNEUROSCI.19-17-07278.1999; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; Clark CA, 2000, MAGN RESON MED, V43, P133; Cohen-Adad J, 2011, NEUROIMAGE, V57, P1068, DOI 10.1016/j.neuroimage.2011.04.068; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Drobyshevsky A, 2007, DEV NEUROSCI-BASEL, V29, P289, DOI 10.1159/000105470; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Ellingson BM, 2008, ANN BIOMED ENG, V36, P224, DOI 10.1007/s10439-007-9415-6; Ellingson BM, 2010, MAGN RESON IMAGING, V28, P1353, DOI 10.1016/j.mri.2010.06.006; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Gulani V, 2001, MAGNET RESON MED, V45, P191, DOI 10.1002/1522-2594(200102)45:2<191::AID-MRM1025>3.0.CO;2-9; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Huppi PS, 1998, PEDIATR RES, V44, P584; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Kim JH, 2009, J NEUROTRAUM, V26, P1395, DOI [10.1089/neu.2008.0728, 10.1089/neu.2008-0728]; Kirkpatrick LL, 2001, J NEUROSCI, V21, P2288; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Ludeman NA, 2008, NEUROLOGY, V71, P1676, DOI 10.1212/01.wnl.0000304084.59964.e2; Ma MH, 2004, J COMP NEUROL, V474, P469, DOI 10.1002/cne.20149; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; McGavern DB, 2000, BRAIN, V123, P519, DOI 10.1093/brain/123.3.519; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Mohamed FB, 2011, AM J NEURORADIOL, V32, P339, DOI 10.3174/ajnr.A2334; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Nevo U, 2001, MAGN RESON MED, V45, P1, DOI 10.1002/1522-2594(200101)45:1<1::AID-MRM1001>3.0.CO;2-I; NOMURA Y, 1994, AM J NEURORADIOL, V15, P231; OKA A, 1993, J NEUROSCI, V13, P1441; ONO J, 1995, BRAIN RES, V671, P141, DOI 10.1016/0006-8993(94)01335-F; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Pitt D, 2003, NEUROLOGY, V61, P1113, DOI 10.1212/01.WNL.0000090564.88719.37; Pitt D, 2010, BRAIN RES, V1309, P146, DOI 10.1016/j.brainres.2009.10.066; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwartz ED, 2005, NEUROREPORT, V16, P73, DOI 10.1097/00001756-200501190-00017; Schwartz ED, 2003, EXP NEUROL, V184, P570, DOI 10.1016/S0014-4886(03)00295-4; Sinha K, 2006, J NEUROPHYSIOL, V95, P1683, DOI 10.1152/jn.00899.2005; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	91	16	17	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	NOV	2013	26	11					1484	1495		10.1002/nbm.2981			12	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	283DK	WOS:000329225200016	23775778	Green Accepted			2021-06-18	
J	Shahaduzzaman, M; Acosta, S; Bickford, PC; Borlongan, CV				Shahaduzzaman, Md; Acosta, Sandra; Bickford, Paula C.; Borlongan, Cesar V.			alpha-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury	MEDICAL HYPOTHESES			English	Article							REPEAT KINASE 2; HEAD-INJURY; OXIDATIVE STRESS; ANIMAL-MODELS; PROGRESSION; LRRK2; DJ-1; ACTIVATION; MECHANISMS; MICROGLIA	Parkinson's disease (PD) affects more than 1% of population over 65 and it is characterized by gradual loss of nigrostriatal dopaminergic neurons and wide spread accumulation of alpha-synuclein. Collectively 30% of familial and 3-5% of sporadic form of PD are associated with genetic mutation. Compelling evidence implicates that in addition to inherited factors, acquired co-morbidities contribute to PD pathology. Here, we hypothesize that traumatic brain injury (TBI) exacerbates nigrostriatal dopaminergic degeneration by modulating PD-associated genes including alpha-synuclein, DJ-1. LRRK2, among others. Thus this article will present speculative arguments of a genetic component contributing to this TBI and PD pathological overlap. Published by Elsevier Ltd.	[Shahaduzzaman, Md; Acosta, Sandra; Bickford, Paula C.; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; [Bickford, Paula C.] James A Haley Vet Affairs Hosp, Tampa, FL USA; [Bickford, Paula C.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA	Shahaduzzaman, M (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.	mshahad@health.usf.edu	Bickford, Paula C/J-5970-2012; Borlongan, Cesar/I-5696-2012	Bickford, Paula C/0000-0001-9657-7725; Borlongan, Cesar/0000-0002-2966-9782			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Billia F, 2013, P NATL ACAD SCI USA, V110, P6085, DOI 10.1073/pnas.1303444110; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005482; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Cuny GD, 2009, CURR PHARM DESIGN, V15, P3919, DOI 10.2174/138161209789649330; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gao HM, 2011, ENVIRON HEALTH PERSP, V119, P807, DOI 10.1289/ehp.1003013; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Greggio E, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-6; Guerreiro PS, 2013, J MOL MED, V91, P513, DOI 10.1007/s00109-012-0984-y; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jeong HJ, 2012, EXP MOL MED, V44, P586, DOI 10.3858/emm.2012.44.10.067; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kuldip Dave D., 2012, MJFF ANIMAL MODELS 2; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Li TX, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/942412; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu GX, 2012, FUTUR NEUROL, V7, P145, DOI 10.2217/FNL.12.2; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Malpass K, 2013, NAT REV NEUROL, V9, P179, DOI [10.1038/nrneurol.2013.35, 10.1038/nrneurol.2012.35, 10.1038/nrneurol.2013.55, 10.1038/nrneurol.2013.64, 10.1038/nrneurol.2013.158, 10.1038/nrneurol.2012.245, 10.1038/nrneurol.2013.77, 10.1038/nrneurol.2013.138, 10.1038/nrneurol.2013.119]; Markopoulou K, 2013, NEUROLOGY, V80; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Moore DJ, 2008, CURR NEUROL NEUROSCI, V8, P288, DOI 10.1007/s11910-008-0045-7; Mukhida K, 2005, MED HYPOTHESES, V64, P1120, DOI 10.1016/j.mehy.2004.12.020; Pabon MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045256; Protter D, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/829207; [乔森(综述) Qiao Sen], 2012, [浙江大学学报. 医学版, Journal of Zhejiang University. Medical Sciences], V41, P210; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Ramsey CP, 2010, HUM MOL GENET, V19, P1425, DOI 10.1093/hmg/ddq017; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Rousseaux MWC, 2012, P NATL ACAD SCI USA, V109, P15918, DOI 10.1073/pnas.1205102109; Rugbjerg K, 2008, BMJ-BRIT MED J, V337, pa2494, DOI [10.1136/bmj.a2494, DOI 10.1136/BMJ.A2494]; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Siebert H, 2010, J NEUROCHEM, V114, P1007, DOI 10.1111/j.1471-4159.2010.06832.x; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spangenberg S, 2009, PARKINSONISM RELAT D, V15, P12, DOI 10.1016/j.parkreldis.2008.02.004; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tufekci KU, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/487450; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Wan OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038545; Wilms H, 2009, INT J IMMUNOPATH PH, V22, P897, DOI 10.1177/039463200902200405; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamaguchi H, 2007, MOL NEUROBIOL, V2; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	64	16	16	0	17	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2013	81	4					675	680		10.1016/j.mehy.2013.07.025			6	Medicine, Research & Experimental	Research & Experimental Medicine	243ZO	WOS:000326357100033	23920272				2021-06-18	
J	Walder, B; Robin, X; Rebetez, MML; Copin, JC; Gasche, Y; Sanchez, JC; Turck, N				Walder, Bernhard; Robin, Xavier; Rebetez, Marie My Lien; Copin, Jean-Christophe; Gasche, Yvan; Sanchez, Jean-Charles; Turck, Natacha			The Prognostic Significance of the Serum Biomarker Heart-Fatty Acidic Binding Protein in Comparison with S100b in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood biomarkers; outcome prediction; traumatic brain injury	TROPONIN-T; EPIDEMIOLOGY; MORTALITY; PROFILES; MODELS; MARKER; SCALE; INDEX	The outcome after severe traumatic brain injury (TBI) is largely unfavorable, with approximately two thirds of patients suffering from severe disabilities or dying during the first 6 months. Existing predictive models displayed only limited utility for outcome prediction in individual patients. Time courses of heart-fatty acidic binding protein (H-FABP) and their association with outcome were investigated and compared with S100b. Forty-nine consecutive patients with severe TBI (sTBI; Head component of the Abbreviated Injury Scale [HAIS] >3) with mono and multiple trauma were enrolled in this study. Enzyme-linked immunosorbent assay measured blood concentrations of H-FABP and S100b at 6, 12, 24, and 48h after TBI. Outcome measures were conscious state at 14 days (Glasgow Coma Scale), disability (Glasgow Outcome Scale Extended; GOSE), and mortality at 3 months. Univariate logistic regression analysis and receiver operating characteristic curves analysis were carried out. Maximal H-FABP and S100b concentrations were observed at 6h after TBI (34.4 +/- 34.0 and 0.64 +/- 0.99ng/mL, respectively). Patients with multi-trauma had significantly higher H-FABP concentrations at 24 and 48h (22.6 +/- 25.6 and 12.4 +/- 18.2ng/mL, respectively), compared to patients with mono trauma (6.9 +/- 5.1 and 3.7 +/- 4.2ng/mL, respectively). In the first 48h, H-FABP and S100b were inversely correlated with the GOSE at 3 months; H-FABP at 48h predicted mortality with 75% sensitivity and 93% specificity. Early blood levels of H-FABP after sTBI have prognostic significance for survival and disability.	[Walder, Bernhard; Rebetez, Marie My Lien] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Robin, Xavier; Sanchez, Jean-Charles; Turck, Natacha] Univ Geneva, Dept Human Prot Sci, Translat Biomarker Grp, CH-1211 Geneva, Switzerland; [Copin, Jean-Christophe; Gasche, Yvan] Univ Geneva, Geneva Neurosci Ctr, CH-1211 Geneva, Switzerland; [Copin, Jean-Christophe; Gasche, Yvan] Univ Hosp Geneva, Dept Intens Care, Geneva, Switzerland; [Copin, Jean-Christophe] Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland	Turck, N (corresponding author), Univ Geneva, Ctr Med Univ, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	natacha.turck@unige.ch	Robin, Xavier/A-1680-2009	Robin, Xavier/0000-0002-6813-3200			Alhadi HA, 2004, QJM-INT J MED, V97, P187, DOI 10.1093/qjmed/hch037; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Dinh W, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-41; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Garcia-Valdecasas S, 2011, ACTA CARDIOL, V66, P315, DOI 10.1080/AC.66.3.2114131; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Inoue K, 2011, CIRC J, V75, P2813, DOI 10.1253/circj.CJ-11-0598; Kleindienst A, 2010, CARDIOVASC PSYCHIAT, V2010; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Lin ZX, 2011, CLIN CHIM ACTA, V412, P1678, DOI 10.1016/j.cca.2011.05.031; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McCann CJ, 2009, AM J CARDIOL, V103, P22, DOI 10.1016/j.amjcard.2008.08.026; McKeating EG, 1998, ACT NEUR S, V71, P200; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muehlschlegel JD, 2010, ANESTH ANALG, V111, P1101, DOI 10.1213/ANE.0b013e3181dd9516; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Okamoto F, 2000, CLIN CHEM LAB MED, V38, P231, DOI 10.1515/CCLM.2000.034; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Sofijanova A, 2012, Prilozi, V33, P147; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Zanier ER, 2008, ACTA NEUROCHIR SUPPL, V102, P339, DOI 10.1007/978-3-211-85578-2_65; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	42	16	18	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1631	1637		10.1089/neu.2012.2791			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800003	23590685				2021-06-18	
J	Blum, K; Olive, MF; Wang, KKW; Febo, M; Borsten, J; Giordano, J; Hauser, M; Gold, MS				Blum, Kenneth; Olive, M. Foster; Wang, Kevin K. W.; Febo, Marcelo; Borsten, Joan; Giordano, John; Hauser, Mary; Gold, Mark S.			Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; METHAMPHETAMINE EXPOSURE; SYNTHETIC CATHINONES; MEPHEDRONE; ABUSE; 4-METHYLMETHCATHINONE; PHARMACOLOGY; ACTIVATION; DOPAMINE; ECSTASY	Consensus in the most recent literature indicates that psychoactive "bath salts" is a relatively new drug-combination that was added to Schedule I classification in October 2011. Common ingredients include the cathinone analogs: mephedrone and methylenedioxypyrovalerone (MDPV). The mechanism of action of these synthetic cathinone analogs has not yet been well studied. We propose an intensive systematic investigation to determine the potential for cathinones to produce neurotoxic effects in various brain regions. In spite of a lack of evidence, for neurotoxicity there are number of horrific cases now on record that suggest intensification of research is needed. For example, a suicide by hanging had high 3,4-MDPV concentration while a driver under the influence had the highest reported methylone (MEPH) concentration. More interestingly, there have been consistent case reports indicating delayed responses, including: severe agitation with possible psychosis, suicidal ideation, rhabdomyolysis, hypertension, tachycardia, and death. In animal studies, amphetamine (AMPH), methamphetamine (METH) and cocaine release dopamine (DA), similarly to the action of cathinone and particular cathinone analogues. Two components of bath salts, MEPH and MDPV produce opposite effects at human dopamine transporter (hDAT) comparable to METH and cocaine, respectively. Moreover, it has already been found by others that MEPH is almost as potent as METH; and MDPV is much more potent than cocaine with longer lasting effects. It has been conjectured correctly that bath salts containing MDPV and MEPH (or a similar drug) might be expected both, to initially release DA and subsequently prevent its reuptake via hDAT. The null hypothesis, that cathinones do not cause neurotoxicity to dopamine nerve endings of the striatum, seems parsimonious and requires intensive investigation. Our hypothesis is that when consumed by humans, cathinones may induce neurotoxic pathways involving the neuro-glial-microglia and/or specific inflammation, that may help explain the clinically observed delayed response. We intend to explore this hypothesis utilizing a novel proteomic and biomarker technique developed by scientists at the McKnight Brain Institute, University of Florida as well as magnetic-resonance imaging across pre-frontal orbital cortex-cingulate gyrus and mesolimbic pathways of the brain of rodents. (C) 2013 Elsevier Ltd. All rights reserved.	[Blum, Kenneth; Wang, Kevin K. W.; Febo, Marcelo; Gold, Mark S.] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA; [Blum, Kenneth; Wang, Kevin K. W.; Febo, Marcelo; Gold, Mark S.] Univ Florida, McKnight Brain Inst, Coll Med, Gainesville, FL 32611 USA; [Olive, M. Foster] Arizona State Univ, Dept Psychol, Behav Neurosci Program, Tempe, AZ 85287 USA; [Blum, Kenneth; Borsten, Joan] Malibu Beach Recovery Ctr, Dept Addict Res & Therapy, Malibu Beach, CA USA; [Blum, Kenneth; Giordano, John] G&G Holist Hlth Care Serv LLC, Dept Holist Res, North Miami Beach, FL USA; [Blum, Kenneth; Hauser, Mary] Domin Diagnost Inc, North Kingstown, RI USA; [Blum, Kenneth] Path Fdn NY, Dept Clin Neurol, New York, NY USA; [Blum, Kenneth] Univ Vermont, Coll Med, Dept Psychiat, Burlington, VT USA; [Blum, Kenneth] Univ Vermont, Coll Med, Global Serv Unit, Burlington, VT USA; [Blum, Kenneth] Univ Vermont, Coll Med, Ctr Clin & Translat Sci, Burlington, VT USA; [Blum, Kenneth] IIOAB, Ctr Genom & Appl Gene Technol, Purbe Medinpur, W Bengal, India	Blum, K (corresponding author), McKnight Brain Inst, POB 100256, Gainesville, FL 32610 USA.	drd2gene@ufl.edu	Febo, Marcelo/G-5718-2011; Febo, Marcelo/X-6769-2019	Febo, Marcelo/0000-0001-8981-4163; Olive, Foster/0000-0002-2517-0351; Wang, Kevin/0000-0002-9343-6473	PATH Foundation NY, New York though Life-Extension foundation; LifeGen, Inc. Lederoch, Pennsylvania; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA019946, DA025606]; University of Florida, College of Medicine faculty fund; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA025606, R01DA019946] Funding Source: NIH RePORTER	The authors are grateful the staff of Malibu Beach Recovery Center, Malibu Beach, California. The authors are grateful for the expert editorial comments of Margaret A. Madigan. The authors acknowledge the financial support of PATH Foundation NY, New York though a grant from Life-Extension foundation to Kenneth Blum and Eric R. Braverman, and LifeGen, Inc. Lederoch, Pennsylvania. Febo Marcelo is the recipient of NIH Grant # R01DA019946; M. Foster Olive is the recipient of NIH Grant # DA025606; Kevin Wang has received a grant from the University of Florida, College of Medicine faculty fund.	Angoa-Perez M, 2012, J NEUROCHEM, V120, P1097, DOI 10.1111/j.1471-4159.2011.07632.x; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Benzie Fred, 2011, Morbidity and Mortality Weekly Report, V60, P624; Coppola M, 2012, TOXICOL LETT, V208, P12, DOI 10.1016/j.toxlet.2011.10.002; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Hadlock GC, 2011, J PHARMACOL EXP THER, V339, P530, DOI 10.1124/jpet.111.184119; Karila Laurent, 2012, Rev Prat, V62, P664; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; Kobeissy FH, 2008, J PROTEOME RES, V7, P1971, DOI 10.1021/pr800029h; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2009, METHODS MOL BIOL, V566, P217, DOI 10.1007/978-1-59745-562-6_15; Krimer LS, 1998, NAT NEUROSCI, V1, P286; Lisek R, 2012, DRUG ALCOHOL DEPEN, V126, P257, DOI 10.1016/j.drugalcdep.2012.04.021; Meyer MR, 2012, J MASS SPECTROM, V47, P253, DOI 10.1002/jms.2960; Murray BL, 2012, J MED TOXICOL, V8, P69, DOI 10.1007/s13181-011-0196-9; Penders TM, 2012, GEN HOSP PSYCHIAT, V34, P647, DOI 10.1016/j.genhosppsych.2012.06.005; Prosser JM, 2012, J MED TOXICOL, V8, P33, DOI 10.1007/s13181-011-0193-z; Ramoz L, 2012, NEUROSCIENCE, V208, P79, DOI 10.1016/j.neuroscience.2012.01.019; Robinson JE, 2012, BEHAV BRAIN RES, V234, P76, DOI 10.1016/j.bbr.2012.06.012; Ross EA, 2012, AM J MED, V125, P854, DOI 10.1016/j.amjmed.2012.02.019; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Spiller HA, 2011, CLIN TOXICOL, V49, P499, DOI 10.3109/15563650.2011.590812; Thornton SL, 2012, J MED TOXICOL, V8, P310, DOI 10.1007/s13181-012-0232-4; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; Watterson LB, 2012, J ADDICT RES THER, V3, P101; Watterson LR, 2012, ADDICT BIOL, DOI DOI 10.1111/11369-1600.2012.00474.X.[EPUB; Wieland DM, 2012, J PSYCHOSOC NURS MEN, V50, P17, DOI 10.3928/02793695-20120120-01	29	16	16	0	32	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	SEP	2013	81	3					450	455		10.1016/j.mehy.2013.06.007			6	Medicine, Research & Experimental	Research & Experimental Medicine	210ZR	WOS:000323874400021	23845561				2021-06-18	
J	Newsome, MR; Scheibel, RS; Mayer, AR; Chu, ZLD; Wilde, EA; Hanten, G; Steinberg, JL; Lin, XD; Li, XQ; Merkley, TL; Hunter, JV; Vasquez, AC; Cook, L; Lu, HZ; Vinton, K; Levin, HS				Newsome, Mary R.; Scheibel, Randall S.; Mayer, Andrew R.; Chu, Zili D.; Wilde, Elisabeth A.; Hanten, Gerri; Steinberg, Joel L.; Lin, Xiaodi; Li, Xiaoqi; Merkley, Tricia L.; Hunter, Jill V.; Vasquez, Ana C.; Cook, Lori; Lu, Hanzhang; Vinton, Kami; Levin, Harvey S.			How Functional Connectivity between Emotion Regulation Structures Can Be Disrupted: Preliminary Evidence from Adolescents with Moderate to Severe Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Resting state; fMRI; Adolescents; Empathy; TBI; Anterior cingulate	GENERALIZED ANXIETY DISORDER; DEFAULT MODE; HEAD-INJURY; CORTICAL THICKNESS; NEURAL SYSTEMS; VISUAL-CORTEX; GLOBAL SIGNAL; AMYGDALA; NETWORK; ACTIVATION	Outcome of moderate to severe traumatic brain injury (TBI) includes impaired emotion regulation. Emotion regulation has been associated with amygdala and rostral anterior cingulate (rACC). However, functional connectivity between the two structures after injury has not been reported. A preliminary examination of functional connectivity of rACC and right amygdala was conducted in adolescents 2 to 3 years after moderate to severe TBI and in typically developing (TD) control adolescents, with the hypothesis that the TBI adolescents would demonstrate altered functional connectivity in the two regions. Functional connectivity was determined by correlating fluctuations in the blood oxygen level dependent (BOLD) signal of the rACC and right amygdala with that of other brain regions. In the TBI adolescents, the rACC was found to be significantly less functionally connected to medial prefrontal cortices and to right temporal regions near the amygdala (height threshold T = 2.5, cluster level p < .05, FDR corrected), while the right amygdala showed a trend in reduced functional connectivity with the rACC (height threshold T = 2.5, cluster level p = .06, FDR corrected). Data suggest disrupted functional connectivity in emotion regulation regions. Limitations include small sample sizes. Studies with larger sample sizes are necessary to characterize the persistent neural damage resulting from moderate to severe TBI during development.	[Newsome, Mary R.; Scheibel, Randall S.; Wilde, Elisabeth A.; Hanten, Gerri; Lin, Xiaodi; Li, Xiaoqi; Merkley, Tricia L.; Vasquez, Ana C.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Chu, Zili D.; Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Chu, Zili D.; Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Steinberg, Joel L.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Merkley, Tricia L.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Cook, Lori; Vinton, Kami] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Lu, Hanzhang] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Newsome, MR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Ste 12-59, Houston, TX 77030 USA.	mnewsome@bcm.edu	Merkley, Tricia/AAN-2989-2020	Merkley, Tricia/0000-0002-0897-8391	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS21889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by NINDS grant R01-NS21889 "Neurobehavioral outcome of head injury in children," Harvey S. Levin, PI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. There are no potential conflicts of interest, including financial, between any of the authors and the work presented in this manuscript. We are grateful to the youth and their families for taking part in the research, to the South Central Mental Illness Research, Education, and Clinical Center (MIRECC) for providing facilities that allowed analyses of the fMRI data, to the Editor, Associate Editor, and to three anonymous reviewers who provided valuable feedback. Zachary Dorsey and Isaiah Tate aided in the preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Ansari AHJ, 2011, IEEE ENG MED BIO, P5056, DOI 10.1109/IEMBS.2011.6091252; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Corbetta M, 2012, DEV PSYCHOBIOL, V54, P239, DOI 10.1002/dev.20507; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Dyck M, 2011, NEUROIMAGE, V54, P2503, DOI 10.1016/j.neuroimage.2010.10.013; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Glascher J, 2003, J NEUROSCI, V23, P10274; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Hatfield E., 1993, CURR DIRECT PSYCHOL, V2, P96, DOI [10.1111/1467-8721.ep10770953., 10.1111/1467-8721.ep10770953, DOI 10.1111/1467-8721.EP10770953]; Hinvest NS, 2011, NEUROPSYCHOLOGIA, V49, P2311, DOI 10.1016/j.neuropsychologia.2011.02.023; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Scheibel RS, 2011, SOC NEUROSCI-UK, V6, P582, DOI 10.1080/17470919.2011.588844; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schreiber LRN, 2012, J PSYCHIATR RES, V46, P651, DOI 10.1016/j.jpsychires.2012.02.005; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Szabo CA, 2001, AM J NEURORADIOL, V22, P1342; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Xia Jun, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P500	72	16	17	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2013	19	8					911	924		10.1017/S1355617713000817			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	209AQ	WOS:000323725800008	23981357				2021-06-18	
J	Unal, A; Bulbul, F; Alpak, G; Virit, O; Copoglu, US; Savas, HA				Unal, Ahmet; Bulbul, Feridun; Alpak, Gokay; Virit, Osman; Copoglu, U. Sertan; Savas, Haluk A.			Effective Treatment of Catatonia by Combination of Benzodiazepine and Electroconvulsive Therapy	JOURNAL OF ECT			English	Article						catatonia; ECT; benzodiazepine	LORAZEPAM; ECT	Objective: Catatonia, a motor dysregulation syndrome, can emerge in numerous psychiatric disorders, mainly in schizophrenia and mood disorders, and metabolic and endocrine disorders such as infections, toxic states, epilepsy, and traumatic brain injury. In our study, we aimed to investigate demographic, clinical, and treatment-related characteristics of catatonic patients managed in our inpatient clinic. Methods: The medical records of 57 patients diagnosed to have catatonia according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, criteria who were admitted to the inpatient psychiatry clinic of the Gaziantep University School of Medicine between 1 January, 2003, and 31 December, 2011, were retrospectively reviewed. Results: In patients with catatonia, mood disorders (63.2%) were found to be the most common underlying or primary disease, whereas mutism (47.4%) was found to be the most common catatonic symptom. There was a comorbid medical condition in 9 patients (15.8%). Patients underwent an average of 9.00 electroconvulsive therapy (ECT) sessions. Among 57 patients with catatonia, catatonic symptoms were resolved in 57 patients (100%) by benzodiazepine and ECT. Conclusions: In our study, full recovery was achieved in catatonia by benzodiazepine plus ECT combination. As a result, we recommend combined ECT and benzodiazepine for catatonia.	[Unal, Ahmet; Bulbul, Feridun; Alpak, Gokay; Virit, Osman; Savas, Haluk A.] Gaziantep Univ, Fac Med, Dept Psychiat, TR-27310 Sahinbey, Gaziantep, Turkey; [Copoglu, U. Sertan] Sanliurfa Ceylanpinar State Hosp, Dept Psychiat, Sanliurfa, Turkey	Unal, A (corresponding author), Gaziantep Univ, Fac Med, Dept Psychiat, TR-27310 Sahinbey, Gaziantep, Turkey.	drahmetunal@hotmail.com	Unal, Ahmet/ABH-9455-2020	Unal, Ahmet/0000-0002-8612-528X			American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Bush G, 1996, ACTA PSYCHIAT SCAND, V93, P137, DOI 10.1111/j.1600-0447.1996.tb09815.x; Cabo-Rodriguez B, 2011, EUR PSYCHIAT, V26, P1211; Chalasani P, 2005, PSYCHOL MED, V35, P1667, DOI 10.1017/S0033291705005453; Chalasani Padmaja, 2011, Indian J Psychiatry, V53, P49, DOI 10.4103/0019-5545.75564; Clark T, 1999, HOSP MED, V60, P740, DOI 10.12968/hosp.1999.60.10.1219; DEVANAND DP, 1995, CONVULSIVE THER, V11, P3; Dutt Alakananda, 2011, Indian J Psychiatry, V53, P36, DOI 10.4103/0019-5545.75559; Fink M, 2012, ACTA PSYCHIAT SCAND, V125, P11, DOI 10.1111/j.1600-0447.2011.01771.x; FRANCIS A, 1992, AM J PSYCHIAT, V149, P581; Francis A, 1997, COMPR PSYCHIAT, V38, P56, DOI 10.1016/S0010-440X(97)90054-7; Francis A, 2010, CURR PSYCHIAT REP, V12, P180, DOI 10.1007/s11920-010-0113-y; Hatta K, 2007, J ECT, V23, P233, DOI 10.1097/yct.0b013e3181587949; Huang TL, 2005, PSYCHIAT CLIN NEUROS, V59, P52, DOI 10.1111/j.1440-1819.2005.01331.x; Hung YY, 2006, CLIN NEUROPHARMACOL, V29, P144, DOI 10.1097/01.WNF.0000221908.56361.C7; Makhinson M, 2012, J ECT, V28, pE35, DOI 10.1097/YCT.0b013e318254c2ea; McKeown NJ, 2010, WEST J EMERG MED, V11, P186; Penland H. R., 2006, ANN GEN PSYCHIATR, V5, P1; Pfuhlmann B, 2001, EUR ARCH PSY CLIN N, V2511, P14; PHILBRICK KL, 1994, J NEUROPSYCH CLIN N, V6, P1; Raveendranathan D, 2012, EUR ARCH PSY CLIN N, V262, P425, DOI 10.1007/s00406-011-0285-4; Reisner AD, 2003, NEUROPSYCHOL REV, V13, P199, DOI 10.1023/B:NERV.0000009484.76564.58; ROHLAND BM, 1993, J AFFECT DISORDERS, V29, P255, DOI 10.1016/0165-0327(93)90015-C; ROSEBUSH PI, 1991, J CLIN PSYCHIAT, V52, P187; Seethalakshmi R, 2008, ANN CLIN PSYCHIATRY, V20, P5, DOI 10.1080/10401230701844786; Sienaert P, 2011, J AFFECT DISORDERS, V135, P1, DOI 10.1016/j.jad.2011.02.012; Taylor MA, 2003, AM J PSYCHIAT, V160, P1233, DOI 10.1176/appi.ajp.160.7.1233; Tibrewal P, 2010, PROG NEURO-PSYCHOPH, V34, P1520, DOI 10.1016/j.pnpbp.2010.08.017; Tuerlings JHAM, 2010, GEN HOSP PSYCHIAT, V32, P631, DOI 10.1016/j.genhosppsych.2010.08.007; Van Den Eede F, 2005, EUR PSYCHIAT, V20, P422, DOI 10.1016/j.eurpsy.2005.03.012; van Waarde JA, 2010, J ECT, V26, P248, DOI 10.1097/YCT.0b013e3181c18a13; Virit O, 2009, KLIN PSIKIYATRI, V12, P51; Weder ND, 2008, ANN CLIN PSYCHIATRY, V20, P97, DOI 10.1080/10401230802017092	33	16	16	4	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1095-0680	1533-4112		J ECT	J. ECT	SEP	2013	29	3					206	209		10.1097/YCT.0b013e3182887a1a			4	Behavioral Sciences; Psychiatry	Behavioral Sciences; Psychiatry	298YX	WOS:000330362100020	23965606				2021-06-18	
J	Williams, C; Wood, RL				Williams, Claire; Wood, Rodger Ll			The Impact of Alexithymia on Relationship Quality and Satisfaction Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affective symptoms; alexithymia; brain injuries; emotions; family relations; marital status; traumatic brain injury	CLOSED-HEAD-INJURY; DYADIC ADJUSTMENT; MARITAL SATISFACTION; SCALE; RECOGNITION; INDIVIDUALS; PERSONALITY; STABILITY; AWARENESS; DISTRESS	Objectives: To explore relationship quality and satisfaction in couples following traumatic brain injury (TBI), obtaining the perspective of both patients with TBI and their noninjured partner; to examine the impact of alexithymia on ratings of relationship quality and satisfaction following TBI. Participants: A total of 47 patients with TBI and their noninjured partners. Measures: Twenty-item Toronto Alexithymia Scale; Index of Marital Satisfaction; and Dyadic Adjustment Scale. Results: Significant differences emerged between patients with TBI and their noninjured partners on measures of relationship quality and satisfaction, with patients reporting significantly fewer relationship problems and greater levels of overall relationship satisfaction. In contrast, the noninjured partners of patients with TBI and acquired alexithymia reported significantly lower ratings of overall relationship quality, adjustment, consensus, and cohesion. Conclusion: The presence of alexithymia in persons with TBI is an important factor affecting relationship quality and satisfaction. Future research should continue to explore the impact of emotional deficit disorders following TBI on the quality of relationships following injury and, in turn, the risk of relationship breakdown.	[Williams, Claire; Wood, Rodger Ll] Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales	Williams, C (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales.	claire.williams@swansea.ac.uk		Williams, Claire/0000-0002-0791-744X			AIDA Y, 1991, SEX ROLES, V24, P43, DOI 10.1007/BF00288702; Allerdings MD, 2001, BRAIN COGNITION, V47, P304; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; BOND MR, 1984, CLOSED HEAD INJURY P, P148; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burba B, 2006, CAN J PSYCHIAT, V51, P468, DOI 10.1177/070674370605100709; Burleson BR, 1997, J MARRIAGE FAM, V59, P884, DOI 10.2307/353790; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Carey MP, 1993, PSYCHOL ASSESSMENT, V5, P238, DOI DOI 10.1037/1040-3590.5.2.238; Cohen J, 1998, STAT POWER ANAL BEHA; CRANE DR, 1991, AM J FAM THER, V19, P60, DOI 10.1080/01926189108250835; FISCHER J, 1994, MEASURES CLIN PRACTI; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hudson W.W., 1982, CLIN MEASUREMENT PAC; Humphreys TP, 2009, PERS INDIV DIFFER, V46, P43, DOI 10.1016/j.paid.2008.09.002; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; KURDEK LA, 1985, J HOMOSEXUAL, V12, P85; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lewis F M, 1995, Oncol Nurs Forum, V22, P943; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Luminet O, 2001, PSYCHOTHER PSYCHOSOM, V70, P254, DOI 10.1159/000056263; Lumley MA, 1996, J PSYCHOSOM RES, V41, P505, DOI 10.1016/S0022-3999(96)00222-X; Mallinckrodt B, 2005, J COUNS PSYCHOL, V52, P358, DOI 10.1037/0022-0167.52.3.358; MANN LS, 1994, PSYCHOL REP, V74, P563, DOI 10.2466/pr0.1994.74.2.563; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meeks BS, 1998, J SOC PERS RELAT, V15, P755, DOI 10.1177/0265407598156003; Norman GR, 1993, PDQ STAT; Northouse L, 2001, J BEHAV MED, V24, P115, DOI 10.1023/A:1010772913717; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Oddy M, 2001, SEX RELATSH THER, V16, P247, DOI [10.1080/14681990125256, DOI 10.1080/14681990125256]; Office for National Statistics, DIV ENGL WAL AG MARR; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; Parker JDA, 2001, PERS INDIV DIFFER, V30, P107, DOI 10.1016/S0191-8869(00)00014-3; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; Peters LC, 2002, BRAIN INJURY, V6, P461; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Ridout N, 2010, EAT BEHAV, V11, P1, DOI 10.1016/j.eatbeh.2009.07.008; ROLLINS BC, 1974, J MARRIAGE FAM, V36, P271, DOI 10.2307/351153; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; SPANIER GB, 1982, J MARRIAGE FAM, V44, P731, DOI 10.2307/351593; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Taylor G. J., 1997, DISORDERS AFFECT REG; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; TEASDALE G, 1974, LANCET, V2, P81; Vanheule S, 2007, PSYCHOPATHOLOGY, V40, P14, DOI 10.1159/000096385; Vanheule S, 2007, J CLIN PSYCHOL, V63, P109, DOI 10.1002/jclp.20324; WALKER JG, 1992, J PEDIATR PSYCHOL, V17, P345, DOI 10.1093/jpepsy/17.3.345; Weinryb RM, 1996, PERS INDIV DIFFER, V20, P13, DOI 10.1016/0191-8869(95)00137-U; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams KR, 2001, BRAIN INJURY, V15, P349, DOI 10.1080/026990501750111319; Wood RL, 2005, PSYCHOLOGIST, V18, P138; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518	74	16	16	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					E21	E30		10.1097/HTR.0b013e318267b0ab			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600003	23076095				2021-06-18	
J	Zou, S; Chisholm, R; Tauskela, JS; Mealing, GA; Johnston, LJ; Morris, CE				Zou, Shan; Chisholm, Roderick; Tauskela, Joseph S.; Mealing, Geoff A.; Johnston, Linda J.; Morris, Catherine E.			Force Spectroscopy Measurements Show That Cortical Neurons Exposed to Excitotoxic Agonists Stiffen before Showing Evidence of Bleb Damage	PLOS ONE			English	Article							GATED CHANNEL ACTIVITY; ANOXIC DEPOLARIZATION; MECHANICAL-PROPERTIES; MEMBRANE TENSION; SODIUM-CHANNELS; CA1 NEURONS; CALCIUM; NA+; CYTOSKELETON; INJURY	In ischemic and traumatic brain injury, hyperactivated glutamate (N-methyl-D-aspartic acid, NMDA) and sodium (Nav) channels trigger excitotoxic neuron death. Na+, Ca++ and H2O influx into affected neurons elicits swelling (increased cell volume) and pathological blebbing (disassociation of the plasma membrane's bilayer from its spectrin-actomyosin matrix). Though usually conflated in injured tissue, cell swelling and blebbing are distinct processes. Around an injury core, salvageable neurons could be mildly swollen without yet having suffered the bleb-type membrane damage that, by rendering channels leaky and pumps dysfunctional, exacerbates the excitotoxic positive feedback spiral. Recognizing when neuronal inflation signifies non-lethal osmotic swelling versus blebbing should further efforts to salvage injury-penumbra neurons. To assess whether the mechanical properties of osmotically-swollen versus excitotoxically-blebbing neurons might be cytomechanically distinguishable, we measured cortical neuron elasticity (gauged via atomic force microscopy (AFM)-based force spectroscopy) upon brief exposure to hypotonicity or to excitotoxic agonists (glutamate and Nav channel activators, NMDA and veratridine). Though unperturbed by solution exchange per se, elasticity increased abruptly with hypotonicity, with NMDA and with veratridine. Neurons then invariably softened towards or below the pre-treatment level, sometimes starting before the washout. The initial channel-mediated stiffening bespeaks an abrupt elevation of hydrostatic pressure linked to NMDA or Nav channel-mediated ion/H2O fluxes, together with increased [Ca++](int)-mediated submembrane actomyosin contractility. The subsequent softening to below-control levels is consistent with the onset of a lethal level of bleb damage. These findings indicate that dissection/identification of molecular events during the excitotoxic transition from stiff/swollen to soft/blebbing is warranted and should be feasible.	[Zou, Shan; Chisholm, Roderick; Tauskela, Joseph S.; Mealing, Geoff A.; Johnston, Linda J.] Natl Res Council Canada, Ottawa, ON, Canada; [Morris, Catherine E.] Ottawa Hosp Res Inst, Ottawa, ON, Canada	Johnston, LJ (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	Linda.Johnston@nrc-cnrc.gc.ca	Zou, Shan/AAD-5515-2020	Zou, Shan/0000-0002-2480-6821; Morris, Catherine/0000-0002-7401-6545	National Research Council Canada	This work was funded by the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Boal D, 2002, MECH CELL; Bobryshev YV, 2013, PATHOBIOLOGY, V80, P24, DOI 10.1159/000339430; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; Calabrese B, 2002, BIOPHYS J, V83, P2560, DOI 10.1016/S0006-3495(02)75267-3; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chorzalska A, 2010, CELL MOL BIOL LETT, V15, P406, DOI 10.2478/s11658-010-0012-6; Dai JW, 1998, J NEUROSCI, V18, P6681; Devaux JJ, 2010, J PHYSIOL-LONDON, V588, P4719, DOI 10.1113/jphysiol.2010.196022; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Hains BC, 2004, EXP NEUROL, V188, P365, DOI 10.1016/j.expneurol.2004.04.001; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156; Ikeda J, 1996, J NEUROSCI RES, V43, P613; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Irmscher M, 2012, BIOPHYS J, V102, P698, DOI 10.1016/j.bpj.2011.12.054; Ishmael JE, 2007, BRAIN RES, V1143, P46, DOI 10.1016/j.brainres.2007.01.061; Johnson J K, 1985, CONTACT MECH; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Kelly CV, 2009, J BIOL PHYS, V35, P279, DOI 10.1007/s10867-009-9167-7; Koenig X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020300; LANGTON PD, 1993, J PHYSIOL-LONDON, V471, P1; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liu XX, 2008, J MEMBRANE BIOL, V226, P17, DOI 10.1007/s00232-008-9135-3; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Markin VS, 1999, BIOPHYS J, V76, P2852, DOI 10.1016/S0006-3495(99)77439-4; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Mere J, 2005, BIOCHEM J, V386, P47, DOI 10.1042/BJ20041054; MILTON RL, 1990, J NEUROSCI, V10, P885; Morris C.E., 2011, CELL PHYSL SOURCE BO, P493; Morris CE, 2012, PROG BIOPHYS MOL BIO, V110, P245, DOI 10.1016/j.pbiomolbio.2012.07.003; Morris CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00019; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P915, DOI 10.1097/00004647-199609000-00015; Okuyama K, 2000, EUR J PHARMACOL, V398, P209, DOI 10.1016/S0014-2999(00)00305-8; Rasband MN, 2013, CURR BIOL, V23, pR197, DOI 10.1016/j.cub.2013.01.050; Sakaguchi T, 1999, NEUROSCI LETT, V274, P135, DOI 10.1016/S0304-3940(99)00702-8; Sanchez D, 2008, BIOPHYS J, V95, P3017, DOI 10.1529/biophysj.108.129551; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; SMALL DL, 1994, AM J PHYSIOL, V267, pC598; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Spagnoli C, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031916; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steltenkamp S, 2006, SMALL, V2, P1016, DOI 10.1002/smll.200600018; Sun GC, 2006, ACTA PHARMACOL SIN, V27, P1537, DOI 10.1111/j.1745-7254.2006.00452.x; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Takahashi M, 1996, BRAIN RES, V735, P1, DOI 10.1016/S0006-8993(96)00536-7; Tauskela JS, 2012, J NEUROCHEM, V122, P470, DOI 10.1111/j.1471-4159.2012.07791.x; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Tauskela JS, 2003, AM J PHYSIOL-CELL PH, V285, pC899, DOI 10.1152/ajpcell.00110.2003; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; WAN X, 1995, J MEMBRANE BIOL, V145, P21; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Wilson JR, 2014, WORLD NEUROSURG, V81, P825, DOI 10.1016/j.wneu.2013.01.001; Wu BJ, 2001, J EXP BIOL, V204, P4271; Xiang K, 2012, EPILEPSY RES, V99, P293, DOI 10.1016/j.eplepsyres.2011.12.011; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yilmaz C, 2009, TURK NEUROSURG, V19, P367; Zhang J, 2012, BRAIN RES, V1471, P129, DOI 10.1016/j.brainres.2012.06.031; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P117, DOI 10.1111/j.1469-7793.2000.t01-1-00117.x	82	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73499	10.1371/journal.pone.0073499			13	Multidisciplinary Sciences	Science & Technology - Other Topics	211BX	WOS:000323880200083	24023686	DOAJ Gold, Green Published			2021-06-18	
J	Espinosa-Garcia, C; Vigueras-Villasenor, RM; Rojas-Castaneda, JC; Aguilar-Hernandez, A; Monfil, T; Cervantes, M; Morali, G				Espinosa-Garcia, Claudia; Maria Vigueras-Villasenor, Rosa; Cesar Rojas-Castaneda, Julio; Aguilar-Hernandez, Alejandra; Monfil, Tomas; Cervantes, Miguel; Morali, Gabriela			Post-ischemic administration of progesterone reduces caspase-3 activation and DNA fragmentation in the hippocampus following global cerebral ischemia	NEUROSCIENCE LETTERS			English	Article						Global cerebral ischemia; Progesterone; Neuroprotection; Caspase-3; DNA fragmentation	DELAYED NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; NEUROPROTECTIVE FACTOR; FOREBRAIN ISCHEMIA; CYTOCHROME-C; CA1 NEURONS; CELL-DEATH; RATS; DAMAGE; MODEL	Delayed death of hippocampal CA1 pyramidal neurons following global cerebral ischemia/reperfusion may be mediated, in part, by caspase-3 activation resulting in DNA fragmentation. Progesterone (P-4) is known to exert neuroprotective effects in several models of brain injury. This study was designed to assess the effect of P-4 on caspase-3 levels and activation, and DNA fragmentation in the hippocampus following global cerebral ischemia/reperfusion. Adult male Sprague-Dawley rats were subjected to global ischemia by the four-vessel occlusion model. P-4 (8 mg/kg), or its vehicle were administered i.v. at 15 min, 2, 6, 24, 48 and 70 h of reperfusion. Remaining pyramidal neurons were assesed by the Nissl staining technique, caspase-3 levels and activation by immunohistochemistiy and an in situ activity assay, and DNA fragmentation by the TUNEL method. Post-ischemic progesterone treatment significantly reduced the ischemia/reperfusion-induced increase in caspase-3 levels and activation at 72 h, and DNA fragmentation and CA1 neuronal loss at 7 days. Present results suggest the reduction of caspase-3 levels/activation, and DNA fragmentation, as a part of the neuroprotective effects of progesterone against global cerebral ischemia/reperfusion injury. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Espinosa-Garcia, Claudia; Aguilar-Hernandez, Alejandra; Monfil, Tomas; Morali, Gabriela] CMN Siglo XXI, Unidad Invest Med Farmacol, Mexico City, DF, Mexico; [Maria Vigueras-Villasenor, Rosa; Cesar Rojas-Castaneda, Julio] Inst Nacl Pediat Mexico, Subdirecc Med Expt, Mexico City, DF, Mexico; [Cervantes, Miguel] UMSNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico	Morali, G (corresponding author), IMSS, Ctr Medico Nacl Siglo XXI, Unidad Invest Med Farmacol, Eugenia 626 Girasol 302, Mexico City 03100, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Espinosa-Garcia, Claudia/0000-0002-9909-9092	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/G11-2/1029, 2010020]; Secretaria de Educacion Publica [PROMEP/103.5/0914106]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [229241]	This paper constitutes a partial fulfillment of the requirements for the Ph.D. of CEG at the PDCB, UNAM. This study was partially supported by Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G11-2/1029, and CEG fellowship 2010020); Secretaria de Educacion Publica (PROMEP/103.5/0914106); and CONACYT (CEG fellowship 229241). Authors thank Mr. Pedro Medina and Ms. Patricia Quintanar for their skillful technical assistance.	Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen J, 1998, J NEUROSCI, V18, P4914; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gillardon F, 1997, MOL BRAIN RES, V50, P16, DOI 10.1016/S0169-328X(97)00162-9; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Karanjia N, 2011, CURR TREAT OPTION NE, V13, P191, DOI 10.1007/s11940-011-0112-2; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Morali G, 2012, RESTOR NEUROL NEUROS, V30, P1, DOI 10.3233/RNN-2011-0605; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Petito CK, 1997, J CEREBR BLOOD F MET, V17, P967, DOI 10.1097/00004647-199709000-00006; PULSINELLI WA, 1988, STROKE, V19, P913, DOI 10.1161/01.STR.19.7.913; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rami A, 2003, NEUROCHEM INT, V43, P211, DOI 10.1016/S0197-0186(03)00002-0; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Tanaka H, 2004, J NEUROSCI, V24, P2750, DOI 10.1523/JNEUROSCI.5475-03.2004; Teschendorf P, 2008, NEUROSCI LETT, V448, P194, DOI 10.1016/j.neulet.2008.10.030; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhan RZ, 2001, J CEREBR BLOOD F MET, V21, P529, DOI 10.1097/00004647-200105000-00007	31	16	17	1	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	AUG 29	2013	550						98	103		10.1016/j.neulet.2013.06.023			6	Neurosciences	Neurosciences & Neurology	210RE	WOS:000323851400019	23810799				2021-06-18	
J	Hemley, SJ; Bilston, LE; Cheng, S; Chan, JN; Stoodley, MA				Hemley, Sarah J.; Bilston, Lynne E.; Cheng, Shaokoon; Chan, Jing Ning; Stoodley, Marcus A.			Aquaporin-4 Expression in Post-Traumatic Syringomyelia	JOURNAL OF NEUROTRAUMA			English	Article						aquaporin-4; post-traumatic syringomyelia; spinal cord injury	SPINAL-CORD-INJURY; CEREBROSPINAL-FLUID FLOW; SUBARACHNOID SPACE; WATER CHANNEL; BRAIN EDEMA; ANIMAL-MODEL; MICE; RAT; ARACHNOIDITIS; ISOFORMS	Aquaporin-4 (AQP4) is an astroglial water channel protein that plays an important role in the transmembrane movement of water within the central nervous system. AQP4 has been implicated in numerous pathological conditions involving abnormal fluid accumulation, including spinal cord edema following traumatic injury. AQP4 has not been studied in post-traumatic syringomyelia, a condition that cannot be completely explained by current theories of cerebrospinal fluid dynamics. Alterations of AQP4 expression or function may contribute to the fluid imbalance leading to syrinx formation or enlargement. The aim of this study was to examine AQP4 expression levels and distribution in an animal model of posttraumatic syringomyelia. Immunofluorescence and western blotting were used to assess AQP4 and glial fibrillary acidic protein (GFAP) expression in an excitotoxic amino acid/arachnoiditis model of post-traumatic syringomyelia in Sprague-Dawley rats. At all time-points, GFAP-positive astrocytes were observed in tissue surrounding syrinx cavities, although western blot analysis demonstrated an overall decrease in GFAP expression, except at the latest stage investigated. AQP4 expression was significantly higher at the level of syrinx at three and six weeks following the initial syrinx induction surgery. Significant increases in AQP4 expression also were observed in the upper cervical cord, rostral to the syrinx except in the acute stage of the condition at the three-day time-point. Immunostaining showed that AQP4 was expressed around all syrinx cavities, most notably adjacent to a mature syrinx (six- and 12-week time-point). This suggests a relationship between AQP4 and fluid accumulation in post-traumatic syringomyelia. However, whether this is a causal relationship or occurs in response to an increase in fluid needs to be established.	[Hemley, Sarah J.; Stoodley, Marcus A.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Bilston, Lynne E.] Neurosci Res Australia, Sydney, NSW, Australia; [Bilston, Lynne E.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Cheng, Shaokoon] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Chan, Jing Ning] Gosford Hosp, Sydney, NSW, Australia	Hemley, SJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, Level 1,2 Technol Pl, Sydney, NSW 2109, Australia.	sarah.hemley@mq.edu.au	Bilston, Lynne E/C-9665-2011	Bilston, Lynne E/0000-0001-8250-9019; hemley, sarah/0000-0003-3064-861X; Cheng, Shaokoon/0000-0002-2057-4605; Stoodley, Marcus/0000-0002-4207-8493	Column of Hope Research Grant; National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia [604008]; Brain Foundation of Australia; NHMRC of AustraliaNational Health and Medical Research Council of Australia; NHMRCNational Health and Medical Research Council of Australia	This work was funded by a Column of Hope Research Grant, the National Health and Medical Research Council (NHMRC) of Australia (Project No. 604008) and the Brain Foundation of Australia.; Dr Hemley was supported by a scholarship from the NHMRC of Australia.; Professor Bilston is supported by an NHMRC senior research fellowship.	Attenello FJ, 2008, NEUROSURGERY, V62, P1307, DOI 10.1227/01.neu.0000333302.72307.3b; Batzdorf U, 1998, J NEUROSURG, V89, P382, DOI 10.3171/jns.1998.89.3.0382; Bilston LE, 2010, J NEUROSURG, V112, P808, DOI 10.3171/2009.5.JNS08945; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Brodbelt AR, 2003, SPINE, V28, pE413, DOI 10.1097/01.BRS.0000092346.83686.B9; Brodbelt AR, 2003, EUR SPINE J, V12, P300, DOI 10.1007/s00586-002-0492-9; Calamita G, 2001, BIOL REPROD, V64, P1660, DOI 10.1095/biolreprod64.6.1660; Cheng S, 2012, J BIOMECH, V45, P1186, DOI 10.1016/j.jbiomech.2012.01.050; CURTIS KA, 1995, PARAPLEGIA, V33, P290, DOI 10.1038/sc.1995.65; Cutler CP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00021; Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5; HALL P, 1980, J NEUROSURG, V52, P812, DOI 10.3171/jns.1980.52.6.0812; Hemley SJ, 2009, J NEUROSURG-SPINE, V11, P696, DOI 10.3171/2009.6.SPINE08564; Hirt B, 2011, NEUROSCIENCE, V189, P79, DOI 10.1016/j.neuroscience.2011.05.037; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Klekamp J, 2002, J NEUROSURG, V97, P317, DOI 10.3171/spi.2002.97.3.0317; Klekamp J, 1997, J NEUROSURG, V86, P233, DOI 10.3171/jns.1997.86.2.0233; Klekamp J, 2002, ACTA NEUROCHIR, V144, P649, DOI 10.1007/s00701-002-0944-3; Klekamp J, 2001, NEUROSURGERY, V48, P174, DOI 10.1097/00006123-200101000-00031; Koyanagi I, 2005, SURG NEUROL, V63, P350, DOI 10.1016/j.surneu.2004.05.038; LASFARGUES JE, 1995, PARAPLEGIA, V33, P62, DOI 10.1038/sc.1995.16; Lignot JH, 2002, J EXP BIOL, V205, P2653; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mao L, 2011, BRAIN INJURY, V25, P300, DOI 10.3109/02699052.2010.542432; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rossi A, 2011, GLIA, V59, P1056, DOI 10.1002/glia.21177; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saito F, 2008, J TRAUMA, V64, P53, DOI 10.1097/TA.0b013e31815b847d; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Solenov EI, 2002, J NEUROSCI METH, V113, P85, DOI 10.1016/S0165-0270(01)00481-2; Sorbo JG, 2012, J NEUROSCI METH, V211, P31, DOI 10.1016/j.jneumeth.2012.07.021; Stoodley MA, 1997, J NEUROSURG, V86, P686, DOI 10.3171/jns.1997.86.4.0686; Stoodley MA, 1996, BRAIN RES, V707, P155, DOI 10.1016/0006-8993(95)01228-1; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Terris J, 1995, AM J PHYSIOL-RENAL, V269, pF775; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Yang LQ, 2001, SPINE, V26, P1842, DOI 10.1097/00007632-200109010-00004; Yeo SI, 2011, ANAT CELL BIOL, V44, P50, DOI 10.5115/acb.2011.44.1.50; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	48	16	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1457	1467		10.1089/neu.2012.2614			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500010	23441695	Green Published			2021-06-18	
J	Majdan, M; Mauritz, W; Wilbacher, I; Janciak, I; Brazinova, A; Rusnak, M; Leitgeb, J				Majdan, Marek; Mauritz, Walter; Wilbacher, Ingrid; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes			Traumatic brain injuries caused by traffic accidents in five European countries: outcome and public health consequences	EUROPEAN JOURNAL OF PUBLIC HEALTH			English	Article							ADMISSION CHARACTERISTICS; PRACTICAL SCALE; ROAD-USER; HOSPITALIZATION; VALIDATION; SEVERITY; PROFILES; IMPACT; TABLES; COMA	Background: Road traffic accidents (RTAs) have been identified by public health organizations as being of major global concern. Traumatic brain injuries (TBIs) are among the most severe injuries and are in a large part caused by RTA. The objective of this article is to analyse the severity and outcome of TBI caused by RTA in different types of road users in five European countries. Methods: The demographic, severity and outcome measures of 683 individuals with RTA-related TBI from Austria, Slovakia, Bosnia, Croatia and Macedonia were analysed. Five types of road users (car drivers, car passengers, motorcyclists, bicyclists and pedestrians) were compared using univariate and multivariate statistical methods. Short-term outcome [intensive care unit (ICU) survival] and last available long-term outcome of patients were analysed. Results: In our data set, 44% of TBI were traffic related. The median age of patients was 32.5 years, being the lowest (25 years) in car passengers. The most severe and extensive injuries were reported in pedestrians. Pedestrians had the lowest rate of ICU survival (60%) and favourable long-term outcome (46%). Drivers had the highest ICU survival (73%) and car passengers had the best long-term outcome (59% favourable). No differences in the outcome were found between countries with different economy levels. Conclusion: TBI are significantly associated with RTA and thus, tackling them together could be more effective. The population at highest risk of RTA-related TBI are young males (in our sample median age: 32.5 years). Pedestrians have the most severe TBI with the worst outcome. Both groups should be a priority for public health action.	[Majdan, Marek; Brazinova, Alexandra; Rusnak, Martin] Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Trnava 91843, Slovakia; [Majdan, Marek; Mauritz, Walter; Wilbacher, Ingrid; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin] INRO, Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, Vienna, Austria	Majdan, M (corresponding author), Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Rusnak, Martin/K-9349-2016; Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Rusnak, Martin/0000-0003-3321-1042; Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board (AUVA) [FK 33/2003]; 'Jubilee Fund' of the Austrian National Bank [8987]; European UnionEuropean Commission; Austrian National Bank (Jubilee Fund); Austrian Worker's Compensation Board; Ala and Ralph Isham	Funding for our work was received from European Union (Project 'Research-Treat- BI'; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; Contract number: ICA2-CT-2002-100); Austrian Worker's Compensation Board (AUVA; Contract number FK 33/2003); the 'Jubilee Fund' of the Austrian National Bank (Project number 8987); the International Neurotrauma Research Organisation is supported by an annual grant from Mrs Ala Auersperg-Isham and Mr Ralph Isham, and donations from various sources. Grants from European Union, Austrian National Bank (Jubilee Fund), Austrian Worker's Compensation Board, Ala and Ralph Isham and other private sponsors. Conflicts of interest:	*AAAM, 1990, ABBR INJ SCAL 1990 R; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Campbell MJ., 2002, STAT SQUARE ONE, V9; COLLINS BA, 1993, NEW ZEAL MED J, V106, P514; Harruff RC, 1998, ACCIDENT ANAL PREV, V30, P11, DOI 10.1016/S0001-4575(97)00057-2; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; JENNETT B, 1975, LANCET, V1, P480; LANGLEY J, 1994, ACCIDENT ANAL PREV, V26, P549, DOI 10.1016/0001-4575(94)90046-9; Lydersen S, 2007, STAT MED, V26, P4328, DOI 10.1002/sim.2839; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Margie Peden R.S., 2004, WORLD REPORT ROAD TR; Markogiannakis H, 2006, EMERG MED J, V23, P27, DOI 10.1136/emj.2004.022392; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Mauritz W, 2011, EUR J TRAUMA EMERG S, V37, P387, DOI 10.1007/s00068-010-0053-6; Mayou R, 2003, INJURY, V34, P197, DOI 10.1016/S0020-1383(02)00285-1; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Mohan D, 2003, B WORLD HEALTH ORGAN, V81, P684; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Santamarina-Rubio E, 2007, ACCIDENT ANAL PREV, V39, P1, DOI 10.1016/j.aap.2006.06.019; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Team R. D. C, 2011, R LANG ENV STAT COMP; TEASDALE G, 1974, LANCET, V2, P81; Wong E, 2002, J EMERG MED, V22, P139, DOI 10.1016/S0736-4679(01)00455-3; World Bank, 2011, WE CLASS COUNTR; World Health Organization, 2009, GLOB STAT REP ROAD S	32	16	17	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1101-1262			EUR J PUBLIC HEALTH	Eur. J. Public Health	AUG	2013	23	4					682	687		10.1093/eurpub/cks074			6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	190KH	WOS:000322338200028	22689382				2021-06-18	
J	Salas, CE; Gross, JJ; Rafal, RD; Vinas-Guasch, N; Turnbull, OH				Salas, Christian E.; Gross, James J.; Rafal, Robert D.; Vinas-Guasch, Nestor; Turnbull, Oliver H.			Concrete behaviour and reappraisal deficits after a left frontal stroke: A case study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Concrete behaviour; Reappraisal; Emotion regulation; Abstraction; Rehabilitation	TRAUMATIC BRAIN-INJURY; EMOTION REGULATION; PREFRONTAL CORTEX; COGNITIVE CONTROL; EXECUTIVE FUNCTIONS; ASSESSMENT BATTERY; HOSPITAL ANXIETY; SELF-REGULATION; VERBAL FLUENCY; EVERYDAY LIFE	Concrete behaviour, the inability to disengage from immediate experience in order to manipulate ideas and thoughts, has long been understood to be a common problem after frontal lobe lesions. However, there has been little consideration of the impact that concreteness may have on emotional functioning, specifically in the use of thinking to manipulate emotional responses. One widely studied emotion regulation strategy is reappraisal, which depends on several frontal lobe related cognitive control processes. While there have been numerous neuroimaging findings on reappraisal, no study has used brain injured patients to investigate this issue. The present case study is the first to describe the capacity to generate reappraisals in a patient (Mrs M), whose behaviour became concrete after a left prefrontal stroke. Using a picture-based reappraisal paradigm, her performance was compared to non-concrete brain-lesioned patients, and neurologically healthy controls. Although Mrs M showed relatively preserved overall cognitive function, she was completely unable to spontaneously generate reappraisals. In striking contrast, once external support was offered, in the form of prompts, her capacity to reappraise dramatically improved. The results are analysed in terms of three neuropsychological capacities - all compromised in Mrs M - previously proposed as reappraisal components: response inhibition, abstraction, and verbal fluency. A number of implications for rehabilitation are discussed, including how the use of prompting may facilitate reappraisal capacity.	[Salas, Christian E.; Rafal, Robert D.; Vinas-Guasch, Nestor; Turnbull, Oliver H.] Bangor Univ, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales; [Gross, James J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Salas, Christian E.] Inst Psiquiatr JH Barak, Unidad Psicoterapia Dinam, Santiago, Chile	Salas, CE (corresponding author), Bangor Univ, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales.	pspa35@bangor.ac.uk	Gross, James/AAM-4104-2020	Vinas-Guasch, Nestor/0000-0002-8661-0103	Government of Chile; Institute for the Study of Affective Neuroscience	This article was supported by a PhD studentship awarded by the Government of Chile to Christian Salas, and by the Institute for the Study of Affective Neuroscience. We appreciate the support and encouragement received by Fergus Gracey while writing this article. We are also grateful of Becca Henderson for helping us to recruit the participants of the study.	Abreau B. C., 2009, LIFE BALANCE MULTIDI, P223; Alexander MP, 2007, NEUROLOGY, V68, P1515, DOI 10.1212/01.wnl.0000261482.99569.fb; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barrash J., 2011, J CLIN EXPT NEUROPSY, V33, P1; Barrash J, 1997, IOWA SCALES PERSONAL; Beer JS., 2007, HDB EMOTION REGULATI, P69; Beldarrain MG, 2005, COGNITIVE BRAIN RES, V24, P723, DOI 10.1016/j.cogbrainres.2005.03.013; Bowen C., 2010, RELATIONAL APPROACH; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Carthy T, 2010, BEHAV RES THER, V48, P384, DOI 10.1016/j.brat.2009.12.013; Cattran CJ, 2011, BRAIN INJURY, V25, P1035, DOI 10.3109/02699052.2011.607787; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Demanet J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00336; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DREWE E A, 1975, Cortex, V11, P8; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Goel V, 2010, WIRES COGN SCI, V1, P613, DOI 10.1002/wcs.71; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goldstein K, 1936, J NEUROL PSYCHOPATHO, V17, P27; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Goldstein K, 1941, PSYCHOL MONOGR, V53, P1; Goldstein K, 1936, PSYCHIAT QUART, V10, P586, DOI 10.1007/BF01563142; Green MJ, 2006, ACTA NEUROPSYCHIATR, V18, P144, DOI 10.1111/j.1601-5215.2006.00149.x; Gross J. J., 1998, REV GEN PSYCHOL VOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Gross J.J., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gross J.J., 2007, HDB EMOTION REGULATI; Gross JJ, 2011, EMOT REV, V3, P8, DOI 10.1177/1754073910380974; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Guedj E, 2008, J NEUROL SCI, V273, P84, DOI 10.1016/j.jns.2008.06.035; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Gyurak A, 2009, COGN AFFECT BEHAV NE, V9, P144, DOI 10.3758/CABN.9.2.144; Hanfmann E, 1944, PSYCHOL MONOGR, V57, P1; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Cunha PJ, 2010, ADDICT BEHAV, V35, P875, DOI 10.1016/j.addbeh.2010.05.005; Jones SR, 2009, PRIVATE SPEECH, EXECUTIVE FUNCTIONING, AND THE DEVELOPMENT OF VERBAL SELF-REGULATION, P69; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Joormann J., 2005, COGNITIVE LIMITATION, P275, DOI [10.1017/CBO9780511720413.012, DOI 10.1017/CB09780511720413.012]; JUDD T, 1999, NEUROPSYCHOTHERAPY C; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Klonoff PS, 2010, PSYCHOTHERAPY BRAIN; Lang P. J, 2008, A8 U FLOR; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Lieberman MD, 2011, EMOTION, V11, P468, DOI 10.1037/a0023503; Luria A. R., 1966, HIGHER CORTICAL FUNC; Luria A. R., 1960, PERSPECTIVES PERSONA, V139-149; Luria A. R., 1963, RESTORATION FUNCTION; LURIA AR, 1959, WORD, V15, P341, DOI 10.1080/00437956.1959.11659703; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; McDonald S., 2010, J CLIN EXPT NEUROPSY, P1; McRae K, 2012, EMOTION, V12, P250, DOI 10.1037/a0026351; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; McRae K, 2012, SOC COGN AFFECT NEUR, V7, P253, DOI 10.1093/scan/nsq103; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Mesulam M., 2000, PRINCIPLES BEHAV COG; Mesulam M.-M., 2002, PRINCIPLES FRONTAL L, P8, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0002; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Morin Alain, 2012, Open Neuroimag J, V6, P78, DOI 10.2174/1874440001206010078; Muller U, 2009, PRIVATE SPEECH, EXECUTIVE FUNCTIONING, AND THE DEVELOPMENT OF VERBAL SELF-REGULATION, P53; Niven K, 2009, EMOTION, V9, P498, DOI 10.1037/a0015962; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ochsner KN, 2007, HDB EMOTION REGULATI, P87; Oei NYL, 2012, SOC COGN AFFECT NEUR, V7, P403, DOI 10.1093/scan/nsr024; Ogden J. A., 1996, FRACTURED MINDS CASE; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Prigatano G. P., 1990, CLIN NEUROPSYCHOL, V4, P163, DOI [10.1080/13854049008401509, DOI 10.1080/13854049008401509]; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Ray RD, 2010, EMOTION, V10, P587, DOI 10.1037/a0019015; Rees SA, 2011, INT J INCLUSIVE EDUC, V15, P925, DOI 10.1080/13603110903464361; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rime B., 2007, HDB EMOTION REGULATI, P466; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; Robinson G, 2010, NEUROPSYCHOLOGIA, V48, P1652, DOI 10.1016/j.neuropsychologia.2010.02.010; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; ROVNER BW, 1987, HOSP PRACT, V22, P99; Salas C. E., 2011, EMOTION, DOI [10.1037/a002581, DOI 10.1037/A002581]; Salas C.E., 2012, NEUROPSYCHOANALYSIS, V14, P77, DOI DOI 10.1080/15294145.2012.10773691; Salas C. E., OPENING NEW IN PRESS; Salas C.E., 2013, NEURODISABILITY PSYC, V1, P1; Sarazin M, 1998, NEUROLOGY, V51, P142, DOI 10.1212/WNL.51.1.142; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; SCHERER KR, 1986, MOTIV EMOTION, V10, P295, DOI 10.1007/BF00992106; Scherer KR, 2004, SOC SCI INFORM, V43, P499, DOI 10.1177/0539018404047701; Schiltz C, 2006, CEREB CORTEX, V16, P574, DOI 10.1093/cercor/bhj005; Schmeichel BJ, 2008, J PERS SOC PSYCHOL, V95, P1526, DOI 10.1037/a0013345; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; Shallice T., 2008, CORTEX, P1; Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; STERN RA, 1994, CLIN NEUROPSYCHOL, V8, P309, DOI 10.1080/13854049408404137; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Urry HL, 2010, EMOTION, V10, P125, DOI 10.1037/a0017434; Vanderhasselt M. A., 2012, BIOL PSYCHOL, P1; Vygotsky L., 1986, V4th ed.; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Whitmer AJ, 2007, PSYCHOL SCI, V18, P546, DOI 10.1111/j.1467-9280.2007.01936.x; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Winsler A, 2009, PRIVATE SPEECH, EXECUTIVE FUNCTIONING, AND THE DEVELOPMENT OF VERBAL SELF-REGULATION, P3; Ylvisaker M, 2000, BRAIN IMPAIR, V1, P12, DOI DOI 10.1375/BRIM.1.1.12; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	121	16	16	1	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 1	2013	23	4					467	500		10.1080/09602011.2013.784709			34	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	187WG	WOS:000322151600001	23551078				2021-06-18	
J	Tisdall, MM; Rejdak, K; Kitchen, ND; Smith, M; Petzold, A				Tisdall, Martin M.; Rejdak, Konrad; Kitchen, Neil D.; Smith, Martin; Petzold, Axel			The Prognostic Value of Brain Extracellular Fluid Nitric Oxide Metabolites After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Microdialysis; Nitric oxide; Neurocritical care; Neuromonitoring	SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; MICRODIALYSIS; NITRATE	Nitric oxide (NO) is a compound with both protective and damaging effects on neurons. Quantification of NO metabolites in humans is limited by sample contamination with blood. In vivo cerebral microdialysis may offer an alternative approach as sampling of extracellular fluid (ECF) adjacent to neurons becomes possible. We investigate the prognostic value of brain ECF NO metabolites in patients with traumatic brain injury (TBI). A prospective case cohort of 195 ECF samples collected from 11 cases over 4 days following TBI was collected. Nitrate and nitrite concentrations ([NO (x) ]) were quantified using a vanadium-based colorimetric assay. Early ECF [NO (x) ] (< 48 h post TBI) were significantly higher in non-survivors (median 59.2 mu mol/l, n = 7) compared to survivors (23.3 mu mol/l, n = 4) (P = 0.04). Late (48-96 h) ECF [NO (x) ] remained higher in non-survivors (47.9 mu mol/l) compared to survivors (23.0 mu mol/l) but this was not significant (P = 0.29). Receiver operator characteristic analysis shows an optimized cutoff level for ECF [NO (x) ] of 26.5 mu mol/l measured < 48 h post TBI for predicting non-survival (sensitivity 100%, specificity 75%). Early ECF NO (x) concentrations are of prognostic value after TBI. ECF NO (x) may be a useful biomarker for treatment trials targeted at nitric oxide metabolism.	[Tisdall, Martin M.; Smith, Martin; Petzold, Axel] Natl Hosp Neurol & Neurosurg, Dept Neuroanaesthesia, London WC1N 3BG, England; [Tisdall, Martin M.; Smith, Martin; Petzold, Axel] Natl Hosp Neurol & Neurosurg, Dept Neurocrit Care, London WC1N 3BG, England; [Tisdall, Martin M.; Kitchen, Neil D.] Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, London WC1N 3BG, England; [Rejdak, Konrad] Med Univ Lublin, Dept Neurol, Lublin, Poland; [Petzold, Axel] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands	Tisdall, MM (corresponding author), Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England.	martin.tisdall@uclh.nhs.uk	Smith, Martin/B-2616-2009; Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749; Tisdall, Martin/0000-0001-8880-8386; Rejdak, Konrad/0000-0002-7019-6681	Wellcome Clinical Research Training Fellowship Grant [075608]; Department of Health's National Institute for Health Research Centres via the UCLH/UCL Comprehensive Biomedical Research Centre; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701458] Funding Source: researchfish	MT is supported by a Wellcome Clinical Research Training Fellowship Grant, Grant No 075608. MS is partially funded by the Department of Health's National Institute for Health Research Centres funding scheme via the UCLH/UCL Comprehensive Biomedical Research Centre.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hlatky R, 2002, ACT NEUR S, V81, P331; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Rejdak K, 2004, J NEUROL SCI, V219, P71, DOI 10.1016/j.jns.2003.12.011; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4	11	16	16	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2013	19	1					65	68		10.1007/s12028-011-9633-5			4	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	187SP	WOS:000322140000010	22002154				2021-06-18	
J	Du, JM; Sang, G; Jiang, CM; He, XJ; Han, Y				Du, Jian-Min; Sang, Gao; Jiang, Chun-Ming; He, Xiao-Jun; Han, Yong			Relationship between plasma copeptin levels and complications of community-acquired pneumonia in preschool children	PEPTIDES			English	Article						Copeptin; Children; Community-acquired pneumonia; Complication; Pleural effusion; Biomarker	CORTICOTROPIN-RELEASING HORMONE; ACUTE RESPIRATORY-INFECTIONS; TRAUMATIC BRAIN-INJURY; REGULATORY MECHANISMS; EMERGENCY-DEPARTMENT; VASOPRESSIN; PEPTIDE; RISK; PRECURSOR; BIOMARKER	High plasma copeptin level has been associated with clinical outcomes after acute illness. The present study was undertaken to investigate the plasma copeptin concentrations in preschool children with community-acquired pneumonia (CAP) and to analyze the correlations of copeptin with CAP-related complications and pleural effusion. Plasma copeptin concentrations of 100 healthy children and 165 preschool children with CAP were measured. 35 children (21.2%) presented with complicated CAP and 28 children (17.0%) presented with pleural effusion. The admission copeptin levels were significantly increased in all patients (49.7 +/- 21.4 pmol/L), children with complicated CAP (73.0 +/- 16.9 pmol/L), those with uncomplicated CAP (43.4 +/- 17.8 pmol/L), those with pleural effusion (70.9 +/- 17.4 pmol/L) and those without pleural effusion (45.3 +/- 19.5 pmol/L) compared with healthy control individuals (9.0 +/- 2.7 pmol/L, all P < 0.001). Multivariate logistic regression analysis showed that plasma copeptin levels were independently related to CAP-related complications (odds ratio 1.214, 95% confidence interval 1.104-1.872, P < 0.001) and pleural effusion (odds ratio 1.226, 95% confidence interval 1.109-1.917, P < 0.001). A receiver operating characteristic curve analysis showed plasma copeptin level better predicted CAP-related complications (area under curve 0.876, 95% confidence interval 0.815-0.922) and pleural effusion (area under curve 0.831, 95% confidence interval 0.765-0.885). Thus, plasma copeptin level may represent a novel biomarker for predicting CAP-related complications in preschool children. (c) 2013 Elsevier Inc. All rights reserved.	[Du, Jian-Min; Jiang, Chun-Ming; He, Xiao-Jun; Han, Yong] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Paediat, Hangzhou 310006, Zhejiang, Peoples R China; [Sang, Gao] Tongde Hosp Zhejiang Prov, Dept Paediat, Hangzhou 310012, Zhejiang, Peoples R China	Jiang, CM (corresponding author), Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Paediat, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	hanrdxcb@163.com					Asfar P, 2006, CRIT CARE CLIN, V22, P131, DOI 10.1016/j.ccc.2005.08.007; Christ-Crain Mirjam, 2008, Expert Rev Respir Med, V2, P565, DOI 10.1586/17476348.2.5.565; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Francois P, 2010, ACTA PAEDIATR, V99, P861, DOI 10.1111/j.1651-2227.2010.01734.x; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Itoi K, 1998, ENDOCR J, V45, P13, DOI 10.1507/endocrj.45.13; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Katan M, 2010, SWISS MED WKLY, V140, P11, DOI 10.4414/smw.2010.13101; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kolditz M, 2012, RESP MED, V106, P1320, DOI 10.1016/j.rmed.2012.06.008; Kunyoshi V, 2006, PEDIATR SURG INT, V22, P186, DOI 10.1007/s00383-005-1620-5; Masia M, 2007, CLIN CHEM, V53, P2193, DOI 10.1373/clinchem.2007.085688; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; Mulholland K, 2003, PEDIATR PULM, V36, P469, DOI 10.1002/ppul.10344; Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Pinto KDBPC, 2004, REV PANAM SALUD PUBL, V15, P104, DOI 10.1590/S1020-49892004000200005; Purhonen AK, 2012, PEPTIDES, V36, P129, DOI 10.1016/j.peptides.2012.05.001; Seligman R, 2008, CRIT CARE, V12, DOI 10.1186/cc6780; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575	25	16	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781			PEPTIDES	Peptides	JUL	2013	45						61	65		10.1016/j.peptides.2013.04.015			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	170KW	WOS:000320850300009	23659862				2021-06-18	
J	Khaksari, M; Mahmmodi, R; Shahrokhi, N; Shabani, M; Joukar, S; Aqapour, M				Khaksari, Mohammad; Mahmmodi, Reza; Shahrokhi, Nader; Shabani, Mohammad; Joukar, Siavash; Aqapour, Mobin			The Effects of Shilajit on Brain Edema, Intracranial Pressure and Neurologic Outcomes following the Traumatic Brain Injury in Rat	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Brain edema; Intracranial pressure; Rat; Shilajit; Trauma	MICROGLIAL ACTIVATION; METALLOPROTEINASES; INHIBITORS; BARRIER	Objective(s): Brain edema is one of the most serious causes of death within the first few days after trauma brain injury (TBI). In this study we have investigated the role of Shilajit on brain edema, blood-brain barrier (BBB) permeability, intracranial pressure (ICP) and neurologic outcomes following brain trauma. Materials and Methods: Diffuse traumatic brain trauma was induced in rats by drop of a 250 g weight from a 2 m high (Marmarou's methods). Animals were randomly divided into 5 groups including sham, TBI, TBI-vehicle, TBI-Shi150 group and TBI-Shi250 group. Rats were undergone intraperitoneal injection of Shilajit and vehicle at 1, 24, 48 and 72 hr after trauma. Brain water content, BBB permeability, ICP and neurologic outcomes were finally measured. Results: Brain water and Evans blue dye contents showed significant decrease in Shilajit-treated groups compared to the TBI-vehicle and TBI groups. Intracranial pressure at 24, 48 and 72 hr after trauma had significant reduction in Shilajit-treated groups as compared to TBI-vehicle and TBI groups (P<0.001). The rate of neurologic outcomes improvement at 4, 24, 48 and 72 hr after trauma showed significant increase in Shilajit-treated groups in comparison to theTBI-vehicle and TBI groups (P<0.001). Conclusion: The present results indicated that Shilajit may cause in improvement of neurologic outcomes through decreasing brain edema, disrupting of BBB, and ICP after the TBI.	[Khaksari, Mohammad; Joukar, Siavash] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran; [Mahmmodi, Reza] Jiroft Educ, Jiroft, Iran; [Shahrokhi, Nader; Shabani, Mohammad] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran; [Aqapour, Mobin] Mobin Kahroba Kimia Co, Kerman, Iran	Shahrokhi, N (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran.	nshahrokhi@kmu.ac.ir	Shahrokhi, Nader/AAV-3747-2020; Haddad, Mohammad Khaksari/AAB-9025-2019	Shahrokhi, Nader/0000-0002-0149-7819; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Shabani, Mohammad/0000-0002-2082-5849; Joukar, Siyavash/0000-0002-9937-6985	Neuroscience Research Center of Kerman University of Medical Sciences, Kerman, Iran	The present study was financially supported by the Neuroscience Research Center of Kerman University of Medical Sciences, Kerman, Iran.	Agarwal SP, 2007, PHYTOTHER RES, V21, P401, DOI 10.1002/ptr.2100; Aiello A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen072; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; [Anonymous], 1991, B D MATERIA MED AYUR; [Anonymous], 1992, PHYTOTHER RES, V6, P163; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BHATTACHARYA SK, 1995, PHYTOTHER RES, V9, P56, DOI 10.1002/ptr.2650090113; BHATTACHARYA SK, 1992, PHYTOTHER RES, V6, P163, DOI 10.1002/ptr.2650060315; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Domowicz MS, 2011, BRAIN RES, V1389, P35, DOI 10.1016/j.brainres.2011.03.006; Education MoHaM, 2001, DEV COORD STAT YB MO; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Garedew A, 2004, THERMOCHIM ACTA, V417, P301, DOI 10.1016/j.tca.2003.09.034; GHOSAL S, 1993, PHYTOTHER RES, V7, P29, DOI 10.1002/ptr.2650070109; GHOSAL S, 1989, PHYTOTHER RES, V3, P249, DOI 10.1002/ptr.2650030606; GHOSAL S, 1990, PURE APPL CHEM, V62, P1285, DOI 10.1351/pac199062071285; Ghosal S., 1988, PHYTOTHER RES, V2, P187, DOI DOI 10.1002/PTR.2650020408; GOEL RK, 1990, J ETHNOPHARMACOL, V29, P95, DOI 10.1016/0378-8741(90)90102-Y; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; KEL'GINBAEV N S, 1973, Eksperimental'naya Khirurgiya i Anesteziologiya, V18, P31; Keshavarzi Z, 2012, IRAN J BASIC MED SCI, V15, P1102; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI 10.1139/y10-103; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Lee H, 2005, J NUTR, V135, P544; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meena Harsahay, 2010, Int J Ayurveda Res, V1, P37, DOI 10.4103/0974-7788.59942; MILDE LN, 1985, ANESTHESIOLOGY, V63, P371, DOI 10.1097/00000542-198510000-00005; Mohd Aamir Mirza MNA, 2010, INT J CURRENT PHARM, V1, P2; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sarkaki AR, 2011, J NEUROTRAUM, V18; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SHAKUROV A Sh, 1965, Ortop Travmatol Protez, V26, P24; Spassov V, 1994, EUR NEUROPSYCHOPHARM, V4, P396; Takasugi Y, 2005, EXP ANIM TOKYO, V54, P193, DOI 10.1538/expanim.54.193; Thawatchai Phaechamud JC, 2008, SILPAKORN U SIENCE T, V2, P7; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Yin H, 2011, KOREAN J PHYSIOL PHA, V15, P285, DOI 10.4196/kjpp.2011.15.5.285	50	16	17	0	4	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JUL	2013	16	7					858	864					7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	298LL	WOS:000330325300008	23997917	DOAJ Gold			2021-06-18	
J	Zakzanis, KK; McDonald, K; Troyer, AK				Zakzanis, Konstantine K.; McDonald, Krysta; Troyer, Angela K.			Component analysis of verbal fluency scores in severe traumatic brain injury	BRAIN INJURY			English	Article						Component analysis scores; neuropsychology; severe traumatic brain injury; verbal fluency	LONGITUDINAL ANALYSIS; FOLLOW-UP; MODERATE; PERFORMANCE; MEMORY; TBI; REHABILITATION; IMPAIRMENTS; RETURN	Primary objective: This study set out to examine the sensitivity of verbal fluency component scores in severe traumatic brain injury (TBI). Research design: A retrospective cross-sectional design was used, with control participants chosen at random from the community and TBI patients from litigation cases. Methods and procedures: Fifty-four healthy controls and 28 patients who had incurred a severe TBI were included in the study. The Controlled Oral Word Association test was rescored to include clustering and switching scores for phonemic and semantic fluency separately. The scores were compared between controls and TBI patients using independent samples t-tests. Main outcomes and results: The findings demonstrate that component scores for semantic fluency yielded the largest effect sizes overall (d = 1.32 and d = 1.53), but not phonemic fluency. Total words generated in phonemic fluency yielded the largest effect size, although still modest (d = 0.62). Conclusions: While verbal fluency may be a useful test tool to elicit evidence of neuropsychological impairment after TBI, these findings are consistent with previous research demonstrating that component scores are more sensitive indices. There is potential clinical utility in using component scores for examining the specific severity of verbal fluency impairment in TBI and guiding rehabilitation efforts.	[Zakzanis, Konstantine K.; McDonald, Krysta] Univ Toronto Scarborough, Dept Psychol, Toronto, ON M1C 1A4, Canada; [Troyer, Angela K.] Univ Toronto, Baycrest Neuropsychol & Cognit Hlth Program, Toronto, ON, Canada; [Troyer, Angela K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca		Troyer, Angela K./0000-0001-5660-4127			Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; ESTES WK, 1974, AM PSYCHOL, V29, P740, DOI 10.1037/h0037458; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Ho AK, 2002, NEUROPSYCHOLOGIA, V40, P1277, DOI 10.1016/S0028-3932(01)00217-2; Jurado MA, 2000, BRAIN INJURY, V14, P789; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V4th ed, P1016; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Moore DJ, 2006, SCHIZOPHR RES, V87, P254, DOI 10.1016/j.schres.2006.06.005; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rich JB, 1999, NEUROPSYCHOLOGY, V13, P525, DOI 10.1037/0894-4105.13.4.525; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Slick D., 1997, VSVT VICTORIA SYMPTO; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tombaugh TN, 1996, TEST MEMORY MALINGER; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P419, DOI 10.1076/jcen.20.3.419.821; Zakzanis KK, 2000, NEUROPSY NEUROPSY BE, V13, P239; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	49	16	16	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					903	908		10.3109/02699052.2013.775505			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200018	23758471				2021-06-18	
J	Bodanapally, UK; Kathirkamanathan, S; Geraymovych, E; Mirvis, SE; Choi, AY; McMillan, AB; Zhuo, JC; Shin, RK				Bodanapally, Uttam K.; Kathirkamanathan, Shanmuganathan; Geraymovych, Elena; Mirvis, Stuart E.; Choi, Andrew Y.; McMillan, Alan B.; Zhuo, Jiachen; Shin, Robert K.			Diagnosis of Traumatic Optic Neuropathy: Application of Diffusion Tensor Magnetic Resonance Imaging	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							INJURY	Background: Using diffusion tensor imaging, we evaluated the directional diffusivities of the optic nerve in patients with traumatic optic neuropathy (TON). Methods: Our study consisted of 12 patients with unilateral TON, 6 patients with severe traumatic brain injury (comparison group A), and 6 patients with normal conventional brain magnetic resonance imaging (comparison group B). The contralateral optic nerve in patients with TON also was evaluated (comparison group C). Two trauma radiologists, blinded to the clinical diagnosis, independently obtained the directional diffusivities. The intraorbital optic nerve was divided into anterior and posterior segments to evaluate intersegmental differences in directional diffusivities. Results: The mean axial diffusivity (AD) in both optic nerve segments and the mean diffusivity (ADC) in the posterior segment on the affected side were significantly lower and differentiated subjects with TON from those in comparison groups A and B. Area under the receiver operating characteristic curve was 0.762, 0.746, and 0.737 for posterior AD, anterior AD, and posterior ADC, respectively. The mean AD, mean diffusivity, and radial diffusivity were lower in the affected nerves in comparison to the contralateral nerve (comparison group C), but the values did not reach statistical significance. Conclusion: Decreased AD and mean diffusivity in the posterior segment of the optic nerve may serve as a bio-marker of axonal damage in patients with TON and merits further investigation as a predictor of initial visual acuity and potential visual recovery. (C) 2013 by North American Neuro-Ophthalmology Society	[Bodanapally, Uttam K.; Kathirkamanathan, Shanmuganathan; Mirvis, Stuart E.; Choi, Andrew Y.; McMillan, Alan B.; Zhuo, Jiachen] Univ Maryland, Med Ctr, Dept Radiol, Baltimore, MD 21201 USA; [Geraymovych, Elena; Shin, Robert K.] Univ Maryland, Med Ctr, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA; [Choi, Andrew Y.] Air Force Sch Aerosp Med, Dept Radiol, Wright Patterson AFB, OH USA	Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu					Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Cockerham KP, 2003, OPHTHALMIC CARE COMB, P395; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; HOSMER DW, 2000, WILEY PS TX, P1; Hoyt CS, 2007, EYE, V21, P1285, DOI 10.1038/sj.eye.6702849; Lee V, 2010, EYE, V24, P240, DOI 10.1038/eye.2009.79; Levin LA, 2007, CAN J OPHTHALMOL, V42, P403, DOI 10.3129/i07-046; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; NAU HE, 1987, ACTA NEUROCHIR, V89, P16, DOI 10.1007/BF01406662; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Steinsapir K, 2005, COMPR OPHTHALMOL UPD, V6, P11; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; WALSH FRANK B., 1966, INVEST OPHTHALMOL, V5, P433; Yang QT, 2011, ORL-J OTO-RHIN-LARYN, V73, P301, DOI 10.1159/000330723	15	16	17	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	JUN	2013	33	2					128	133		10.1097/WNO.0b013e3182842553			6	Clinical Neurology; Ophthalmology	Neurosciences & Neurology; Ophthalmology	299FT	WOS:000330382000009	23528798				2021-06-18	
J	Cao, Y; Selassie, AW; Krause, JS				Cao, Yue; Selassie, Anbesaw W.; Krause, James S.			Risk of Death After Hospital Discharge With Traumatic Spinal Cord Injury: A Population-Based Analysis, 1998-2009	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Mortality; Rehabilitation; Risk; Spinal cord injuries	VENOUS THROMBOEMBOLISM; CARE SERVICES; MORTALITY; SURVIVAL; TRENDS; PEOPLE; ACCESS; BRAIN	Objective: To investigate risk factors associated with mortality among people with traumatic spinal cord injury (TSCI) after discharge from acute care hospitals in South Carolina and to compare their mortality experiences with the general population. Design: Retrospective cohort study. Setting: Sixty-two acute care, nonfederal hospitals. Participants: Persons (N=2685) with TSCI. Interventions: Not applicable. Main Outcome Measures: Death after TSCI from all causes within 4288 days of observation after discharge from acute care facilities. Results: The crude annual mortality rate during the period was 33 per 1000 person-years. Number of comorbidities, admission into trauma centers, advancing age, type of insurance, injury level and completeness, and being a man were significantly associated (P<.05) with the risk of death after discharge from acute care facilities. The overall mortality rate of our cohort is 3.6 times (95% confidence interval, 3.3-3.9) higher than the general population. Conclusions: The causes of postdischarge deaths are multifactorial, and more emphasis should be placed on managing and monitoring chronic diseases throughout the recovery process to improve the survivorship of people with TSCI. (C) 2013 by the American Congress of Rehabilitation Medicine	[Cao, Yue; Krause, James S.] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Selassie, Anbesaw W.] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA	Cao, Y (corresponding author), Dept Hlth Sci & Res, 77 President St,Room 207,MSC 700, Charleston, SC 29425 USA.	caoyu@musc.edu			Department of Education, National Institute on Disability and Rehabilitation Research [H133B090005]; South Carolina Spinal Cord Injury Research Fund [SCIRF 11-006, SCIRF 11-004]	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant no. H133B090005) and the South Carolina Spinal Cord Injury Research Fund (grant nos. SCIRF 11-006 and SCIRF 11-004).	Ahoniemi E, 2008, SPINAL CORD, V46, P781, DOI 10.1038/sc.2008.53; Alander DH, 1997, SPINE, V22, P1189, DOI 10.1097/00007632-199706010-00003; Allison P., 2010, SURVIVAL ANAL USING; Banja J D, 2001, J Spinal Cord Med, V24, P230; BIERINGSORENSEN F, 1990, PARAPLEGIA, V28, P105, DOI 10.1038/sc.1990.13; BURSTIN HR, 1993, JAMA-J AM MED ASSOC, V270, P845, DOI 10.1001/jama.270.7.845; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; Bushnik T, 2002, TOPICS SPINAL CORD I, V7, P17; CDC National Center for Health Statistics, 2012, UND CAUS DEATH 1999; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Chen Y., 2010, ESSENTIALS SPINAL CO; Claridge JA, 2006, J TRAUMA, V60, P178, DOI 10.1097/01.ta.0000198804.74514.0c; DeVivo MJ, 2010, SPINAL CORD MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P78; DeVivo MJ, 2011, ARCH PHYS MED REHAB, V92, P332, DOI 10.1016/j.apmr.2010.08.031; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; DEVIVO MJ, 1987, ARCH NEUROL-CHICAGO, V44, P872, DOI 10.1001/archneur.1987.00520200074023; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P156; Dixon L, 2001, PSYCHIAT SERV, V52, P786, DOI 10.1176/appi.ps.52.6.786; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; GARCIARENESES J, 1991, PARAPLEGIA, V29, P180, DOI 10.1038/sc.1991.26; Georgiou C, 2009, WORLD J SURG, V33, P1087, DOI 10.1007/s00268-009-9923-7; Giskes K, 2009, J EPIDEMIOL COMMUN H, V63, P113, DOI 10.1136/jech.2008.078352; Gittler J, 2008, RES GERONTOL NURS, V1, P264, DOI 10.3928/19404921-20081001-08; Golob JF, 2008, J TRAUMA, V64, P311, DOI 10.1097/TA.0b013e3181627625; GRIFFIN MR, 1985, J CHRON DIS, V38, P643, DOI 10.1016/0021-9681(85)90018-9; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Hagglund K J, 1999, Mo Med, V96, P447; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1507, DOI 10.1016/S0003-9993(99)90265-4; Jones T, 2005, ARCH PHYS MED REHAB, V86, P2240, DOI 10.1016/j.apmr.2005.07.286; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; KARAMEHMETOGLU SS, 1995, PARAPLEGIA, V33, P469, DOI 10.1038/sc.1995.102; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; KIWERSKI J, 1981, PARAPLEGIA, V19, P347, DOI 10.1038/sc.1981.66; Kochanek, 2012, NATL VITAL STAT REPO, V60; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Krause JS, 2009, SPINAL CORD, V47, P592, DOI 10.1038/sc.2009.15; Krause JS, 2008, ARCH PHYS MED REHAB, V89, P1482, DOI 10.1016/j.apmr.2007.11.062; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P339, DOI 10.1016/j.apmr.2010.09.032; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P95, DOI 10.1016/j.apmr.2008.07.012; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P628, DOI 10.1016/j.apmr.2008.10.014; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Moore L, 2008, ANN EMERG MED, V52, P356, DOI 10.1016/j.annemergmed.2007.09.007; National Spinal Cord Injury Statistical Center, 2010, J Spinal Cord Med, V33, P439; NSCISC, 2011, SPIN CORD INJ FACTS; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P48, DOI 10.1016/j.apmr.2004.07.346; Saunders LL, 2009, J TRAUMA, V66, P184, DOI 10.1097/TA.0b013e31815644e5; Segrin C, 2007, PERS INDIV DIFFER, V43, P637, DOI 10.1016/j.paid.2007.01.017; Selassie AW, 2013, SPINAL CORD, V51, P48, DOI 10.1038/sc.2012.88; Selassie AW, 2011, ARCH PHYS MED REHAB, V92, P1534, DOI 10.1016/j.apmr.2011.04.018; Shigaki CL, 2002, REHABIL PSYCHOL, V47, P204, DOI 10.1037//0090-5550.47.2.204; Shoko T, 2010, J AM COLL SURGEONS, V211, P338, DOI 10.1016/j.jamcollsurg.2010.04.010; Smedley BD, 2003, UNEQUAL TREATMENT CO; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; STRAUSS DJ, 2000, J INSURANCE MED, V32, P11; Surkin J, 2000, SPINE, V25, P716, DOI 10.1097/00007632-200003150-00011; Suzuki R, 2007, REHABIL PSYCHOL, V52, P338, DOI 10.1037/0090-5550.52.3.338; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; The Henry Kaiser Foundation, 2008, EX SOURC COV MED BEN; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ., 1995, GUIDELINES SURVEILLA; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; Warren S, 1995, Alaska Med, V37, P11; WOODRUFF BA, 1994, AM J PREV MED, V10, P10	69	16	16	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2013	94	6					1054	1061		10.1016/j.apmr.2013.01.022			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	158FH	WOS:000319954400007	23391523				2021-06-18	
J	Danaila, L; Popescu, I; Pais, V; Riga, D; Riga, S; Pais, E				Danaila, L.; Popescu, I.; Pais, V.; Riga, D.; Riga, S.; Pais, E.			Apoptosis, Paraptosis, Necrosis, and Cell Regeneration in Posttraumatic Cerebral Arteries	CHIRURGIA			English	Article						posttraumatic cerebral arteries; apoptosis; paraptosis; necrosis; cell regeneration; ultrastructure	BRAIN-INJURY; DEATH; PATHOPHYSIOLOGY; MECHANISMS; ISCHEMIA	This study is to understand the nature and functional significance of the activated cell death programs and rehabilitation signs during late vascular changes after brain injury. We used light and transmission electron microscopy to describe changes of cells within the vascular endothelium and tunica media of the cortical arteries four weeks after craniocerebral traumatism. Within tunica media of the posttraumatic damaged artery, apoptotic and paraptotic phenotypes were identified as well as some early ultrastructural signs of smooth muscle cells regeneration, these cell highlighting a remarkable degree of plasticity. Surprisingly, some endothelial cells showed an extensive rough endoplasmic reticulum development, whereas other endothelial cells showed typical necrosis. In conclusion, two groups of suicidal cells - apoptotic and paraptotic cells - were encountered in the same lesional vascular wall after neurotrauma, showing also signs of cell regeneration. The pathophysiologic significance of the coexisting double cell death programs and cell regeneration seems to be in relation with late cell survival, after arterial damage when some cells disappear and other cells try to survive undergoing reversible injury.	[Danaila, L.; Pais, V.] Natl Inst Neurol & Neurovasc Dis, Dept Neurosurg, Bucharest, Romania; [Popescu, I.] Fundeni Clin Inst, Dept Gen Surg & Liver Transplantat Dan Setlacec, Bucharest, Romania; [Riga, D.; Riga, S.] Al Obregia Clin Hosp Psychiat, Dept Stress Res & Prophylaxis, Bucharest, Romania; [Pais, E.] Spectral Mol Imaging Inc, Los Angeles, CA USA	Danaila, L (corresponding author), Natl Inst Neurol & Neurovasc Dis, Dept Neurosurg, Bucharest, Romania.	leondanaila@neuroch.info	Pais, Emil Sebastian/H-7155-2013; POPESCU, IRINEL/B-3048-2008; Riga, Dan/AAL-5762-2021	Pais, Emil Sebastian/0000-0002-0245-671X; 			Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bredesen DE, 2004, AGING CELL, V3, P255, DOI 10.1111/j.1474-9728.2004.00121.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Crisby M, 1997, ATHEROSCLEROSIS, V130, P17, DOI 10.1016/S0021-9150(96)06037-6; Danaila L, 2005, PROGRAMMED CELL DEAT; Danaila L, 2008, PROGRAMMED CELL DEAT; Diederich M, 2003, ANN NEW YORK ACAD SC, V1010; Fujikawa DG, 2002, TRENDS PHARMACOL SCI, V23, P309, DOI 10.1016/S0165-6147(02)02042-4; Geng YJ, 2001, CELL RES, V11, P253, DOI 10.1038/sj.cr.7290094; Gremmels H, 2011, ANTIOXID REDOX SIGN, V15, P1029, DOI 10.1089/ars.2010.3594; Grimes R, 2011, J BONE MINER RES, V26, P2597, DOI 10.1002/jbmr.486; LI Y, 1995, AM J PATHOL, V146, P1045; Lizard G, 1999, ARTERIOSCL THROM VAS, V19, P1190, DOI 10.1161/01.ATV.19.5.1190; Mayr M, 2001, EXP GERONTOL, V36, P969, DOI 10.1016/S0531-5565(01)00090-0; Pais V, 2011, ULTRASTRUCTURE DYING; Pais V, 2009, PROGRAMMED CELL DEAT; Pais V, 2012, ULTRASTRUCT PATHOL, V36, P166, DOI 10.3109/01913123.2012.655856; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Riga D, 2009, 13 IABG INT ASS BIOM; Riga D., 2007, ANTIAGING MED LONGEV, P199; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	23	16	16	0	15	EDITURA CELSIUS	BUCHAREST	STR LITOVOI VOIEVOD NR 1, BL OD7A, SC A, AP 20, SECTOR 2, BUCHAREST, 00000, ROMANIA	1221-9118			CHIRURGIA-BUCHAREST	Chirurgia	MAY-JUN	2013	108	3					319	324					6	Surgery	Surgery	168GY	WOS:000320694900005	23790779				2021-06-18	
J	Ewing-Cobbs, L; Prasad, MR; Mendez, D; Barnes, MA; Swank, P				Ewing-Cobbs, Linda; Prasad, Mary R.; Mendez, Donna; Barnes, Marcia A.; Swank, Paul			Social Interaction in Young Children with Inflicted and Accidental Traumatic Brain Injury: Relations with Family Resources and Social Outcomes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Joint attention; Gaze; Developmental outcome; Social cognition; High risk; Child abuse; Communication; Adaptive behavior; Cognition; Infants	INFANT JOINT ATTENTION; VISUAL-ATTENTION; SKILLS; COMPETENCE; ADOLESCENTS; COGNITION; MODERATE; AUTISM	Core social interaction behaviors were examined in young children 0-36 months of age who were hospitalized for accidental (n = 61) or inflicted (n = 64) traumatic brain injury (TBI) in comparison to typically developing children (n = 60). Responding to and initiating gaze and joint attention (JA) were evaluated during a semi-structured sequence of social interactions between the child and an examiner at 2 and 12 months after injury. The accidental TBI group established gaze less often and had an initial deficit initiating JA that resolved by the follow-up. Contrary to expectation, children with inflicted TBI did not have lower rates of social engagement than other groups. Responding to JA was more strongly related than initiating JA to measures of injury severity and to later cognitive and social outcomes. Compared to complicated-mild/moderate TBI, severe TBI in young children was associated with less responsiveness in social interactions and less favorable caregiver ratings of communication and social behavior. JA response, family resources, and group interacted to predict outcomes. Children with inflicted TBI who were less socially responsive and had lower levels of family resources had the least favorable outcomes. Low social responsiveness after TBI may be an early marker for later cognitive and adaptive behavior difficulties.	[Ewing-Cobbs, Linda; Prasad, Mary R.; Barnes, Marcia A.; Swank, Paul] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX USA; [Ewing-Cobbs, Linda; Prasad, Mary R.; Barnes, Marcia A.; Swank, Paul] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX USA; [Mendez, Donna] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA	Ewing-Cobbs, L (corresponding author), Childrens Learning Inst, Dept Pediat, 7000 Fannin,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS029462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462] Funding Source: NIH RePORTER	This publication was supported by Grant Number R01 NS029462 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The participation of the children and families, as well as the assistance of the Texas Department of Protective and Regulatory Services, is gratefully acknowledged. The authors report no financial or other conflict of interest.	Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Bayley N., 2006, BAYLEY SCALES INFANT; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bernard K, 2010, ARCH PEDIAT ADOL MED, V164, P438, DOI 10.1001/archpediatrics.2010.54; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Carpenter M, 2002, J AUTISM DEV DISORD, V32, P91, DOI 10.1023/A:1014836521114; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Charman T, 2000, COGNITIVE DEV, V15, P481, DOI 10.1016/S0885-2014(01)00037-5; D'Entremont B, 2007, CHILD DEV, V78, P723, DOI 10.1111/j.1467-8624.2007.01026.x; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Dunham P.J., 1995, JOINT ATTENTION ITS, P29; DUNST CJ, 1987, CHILD CARE HLTH DEV, V13, P111, DOI 10.1111/j.1365-2214.1987.tb00528.x; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hirotani M, 2009, NEUROREPORT, V20, P600, DOI 10.1097/WNR.0b013e32832a0a7c; Hoehl S, 2009, CHILD DEV, V80, P968, DOI 10.1111/j.1467-8624.2009.01311.x; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Landry SH, 2004, DEV NEUROPSYCHOL, V26, P707, DOI 10.1207/s15326942dn2603_4; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; LEUNG EHL, 1981, DEV PSYCHOL, V17, P215, DOI 10.1037/0012-1649.17.2.215; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Mundy P, 2010, NEURAL NETWORKS, V23, P985, DOI 10.1016/j.neunet.2010.08.009; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; SCAIFE M, 1975, NATURE, V253, P265, DOI 10.1038/253265a0; Sheinkopf SI, 2004, DEV PSYCHOPATHOL, V16, P273, DOI 10.1017/S0954579404044517; Sparrow S., 1984, VINELAND ADAPTIVE BE; St James-Roberts I, 1979, Adv Child Dev Behav, V14, P253, DOI 10.1016/S0065-2407(08)60116-0; TEASDALE G, 1974, LANCET, V2, P81; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Van Hecke AV, 2007, CHILD DEV, V78, P53; Van Hecke AV, 2012, INFANT BEHAV DEV, V35, P303, DOI 10.1016/j.infbeh.2011.12.001; Vygotsky L.S., 1978, MIND SOC; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	52	16	16	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2013	19	5					497	507		10.1017/S1355617713000210			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	136OB	WOS:000318370100002	23507345	Green Accepted			2021-06-18	
J	Hibino, S; Mase, M; Shirataki, T; Nagano, Y; Fukagawa, K; Abe, A; Nishide, Y; Aizawa, A; Iida, A; Ogawa, T; Abe, J; Hatta, T; Yamada, K; Kabasawa, H				Hibino, Shin; Mase, Mitsuhito; Shirataki, Tatsuaki; Nagano, Yuri; Fukagawa, Kazutoshi; Abe, Akiko; Nishide, Yukiko; Aizawa, Ayumi; Iida, Akihiko; Ogawa, Tetsuo; Abe, Junko; Hatta, Takeshi; Yamada, Kazuo; Kabasawa, Hidehiro			Oxyhemoglobin Changes During Cognitive Rehabilitation After Traumatic Brain Injury Using Near Infrared Spectroscopy	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic brain injury; cognitive impairment; rehabilitation; near infrared spectroscopy	ANTERIOR PREFRONTAL CORTEX; WORKING-MEMORY; CHILDREN	To investigate cerebral reactions to cognitive rehabilitation tasks, oxyhemoglobin changes were compared in 9 patients with cognitive impairments after traumatic brain injury (TBI) and 47 healthy controls using functional near infrared spectroscopy (fNIRS) during nine cognitive rehabilitation tasks employed at Nagoya City Rehabilitation Center. Forty-seven measurement channels were placed on the frontal to temporal cortices, and organized into seven channel regions. Oxyhemoglobin changes were normalized based on the mean oxyhemoglobin value at the resting state, and integrated throughout a task. Statistical analyses of the differences between the TBI patients and controls were performed with the two-sided Mann-Whitney U test. Oxyhemoglobin changes were high for both controls and TBI patients in the lateral frontal regions. Oxyhemoglobin changes in TBI patients tended to be higher than controls in the medial frontal regions for most training tasks, and significant differences (p < 0.05) were seen for two tasks in the medial frontal regions. Different regions were activated during the tasks in TBI patients compared to controls. fNIRS measurement is useful in the evaluation of changes of neuronal activities during rehabilitation tasks in TBI patients.	[Hibino, Shin; Shirataki, Tatsuaki; Nagano, Yuri; Fukagawa, Kazutoshi; Abe, Akiko; Nishide, Yukiko; Aizawa, Ayumi; Iida, Akihiko; Ogawa, Tetsuo; Kabasawa, Hidehiro] Nagoya City Rehabil Ctr, Nagoya, Aichi, Japan; [Mase, Mitsuhito; Yamada, Kazuo] Nagoya City Univ, Grad Sch Med Sci, Dept Neurosurg, Nagoya, Aichi 4678601, Japan; [Abe, Junko] Gifu Univ Med Sci, Dept Nursing, Gifu, Japan; [Hatta, Takeshi] Kansai Univ Welf Sci, Fac Hlth Sci Welf, Osaka, Japan	Mase, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mitmase@med.nagoya-cu.ac.jp			General Insurance Association of Japan	This research was supported by grants from the General Insurance Association of Japan.	Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Malia KB, 1977, BRAINWAVE R INFORM 1; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Meyers JE, 1996, REY COMPLEX FIGURE T; Reynolds JR, 2006, CEREB CORTEX, V16, P519, DOI 10.1093/cercor/bhi131; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Simons JS, 2005, NEUROPSYCHOLOGIA, V43, P1774, DOI 10.1016/j.neuropsychologia.2005.02.004; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	20	16	17	0	5	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2013	53	5					299	303		10.2176/nmc.53.299			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	149GY	WOS:000319308200004	23708220	Bronze			2021-06-18	
J	Korley, FK; Morton, MJ; Hill, PM; Mundangepfupfu, T; Zhou, TT; Mohareb, AM; Rothman, RE				Korley, Frederick K.; Morton, Melinda J.; Hill, Peter M.; Mundangepfupfu, Tichaendepi; Zhou, Tingting; Mohareb, Amir M.; Rothman, Richard E.			Agreement Between Routine Emergency Department Care and Clinical Decision Support Recommended Care in Patients Evaluated for Mild Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							CT HEAD RULE; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY	Objectives Emergency department (ED) computed tomography (CT) use has increased significantly during the past decade. It has been suggested that adherence to clinical decision support (CDS) may result in a safe decrease in CT ordering. In this study, the authors quantified the percentage agreement between routine and CDS-recommended care and the anticipated consequence of strict adherence to CDS on CT use in mild traumatic brain injury (mTBI). Methods This was a prospective observational study of patients with mTBI who presented to an urban academic ED of a tertiary care hospital. Patients 18years or older, presenting within 24hours of nonpenetrating trauma to the head, from August 2010 to July 2011, were eligible for enrollment. Structured data forms were completed by trained research assistants (RAs). The primary outcome was the percentage agreement between routine head CT use and CDS-recommended head CT use. CDS examined were: the 2008 American College of Emergency Physicians [ACEP] neuroimaging, the New Orleans rule, and the Canadian head CT rule. Differences between outcome groups were assessed using the chi-square test for categorical variables and the Kruskal-Wallis rank test for continuous variables. The percentage agreement between routine practice and CDS-recommended practice was calculated. Results Of the 169 patients enrolled, 130 (76.9%) received head CT scans, and five of the 130 (3.8%) had acute traumatic intracranial findings. For all subjects, agreement between routine practice and CDS-recommended practice was 77.5, 65.7, and 78.1%, for the ACEP, Canadian, and New Orleans CDS, respectively. Strict adherence to the 2008 ACEP neuroimaging CDS would result in no statistically significant difference in head CT use (routine care, 76.9%; CDS-recommended, 82.8%; p=0.17). Strict adherence to the New Orleans CDS would result in an increase in head CT use (routine care, 76.9%; CDS-recommended, 94.1%; p<0.01). Strict adherence to the Canadian CDS would result in a decrease in head CT use (routine care, 76.9%; CDS-recommended, 56.8%; p<0.01). Conclusions There is a 60% to 80% agreement between routine and CDS-recommended head CT use. Of the three CDS systems examined, the only one that may result in a reduction in head CT use if strictly followed was the Canadian head CT CDS. Further studies are needed to examine reasons for the less than optimal agreement between routine care and care recommended by the Canadian head CT CDS. (C) 2013 by the Society for Academic Emergency Medicine	[Korley, Frederick K.; Morton, Melinda J.; Hill, Peter M.; Rothman, Richard E.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Mundangepfupfu, Tichaendepi] Lincoln Med & Mental Hlth Ctr, Bronx, NY 10451 USA; [Zhou, Tingting; Mohareb, Amir M.] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	Korley, FK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	fkorley1@jhmi.edu		Rothman, Richard/0000-0002-1017-9505; Hamer, Melinda/0000-0002-6736-1738			Brehaut JC, 2010, MED DECIS MAKING, V30, P398, DOI 10.1177/0272989X09344747; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; Godbout BJ, 2011, EMERG RADIOL, V18, P381, DOI 10.1007/s10140-011-0966-3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; *I MED, 2001, CROSS QUAL CHASM NEW; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pathman DE, 1996, MED CARE, V34, P873, DOI 10.1097/00005650-199609000-00002; Raja AS, 2011, ARCH INTERN MED, V171, P260, DOI 10.1001/archinternmed.2010.520; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	21	16	16	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2013	20	5					463	469		10.1111/acem.12136			7	Emergency Medicine	Emergency Medicine	144GO	WOS:000318927900006	23672360	Bronze			2021-06-18	
J	Liu, CX; Wu, WJ; Zhang, B; Xiang, J; Zou, J				Liu, Chunxing; Wu, Wenjie; Zhang, Bin; Xiang, Jie; Zou, Jian			Temporospatial expression and cellular localization of glutamine synthetase following traumatic spinal cord injury in adult rats	MOLECULAR MEDICINE REPORTS			English	Article						glutamine synthetase; spinal cord injury; glutamate; glial cells	EXCITATORY AMINO-ACID; TUMOR-NECROSIS-FACTOR; NEURAL STEM-CELLS; CEREBRAL-CORTEX; ASTROCYTES; MICROGLIA; BRAIN; DIFFERENTIATION; INVOLVEMENT; RECEPTORS	Glutamine synthetase (GS) is an enzyme involved in an endogenous mechanism of protection against glutamate neurotoxicity and is important in the regulation of astrocyte migration. To date, limited information is available concerning the expression of GS in normal spinal cords and following injury. In the present study, GS expression was identified in astrocytes, oligodendrocytes and microglia in normal rat spinal cords. Following traumatic spinal cord injury (SCI), the glutamate concentration increased rapidly at 1 h and returned to baseline rapidly. However, the GS activity and protein levels were found to decrease at 4 h and then increase gradually from day 3 following SCI. The quantification of astrocytes, oligodendrocytes and activated microglia/macrophages, as well as immunohistochemistry staining of day 7 post-injured spinal cords, indicated that the astrocytes and microglia/macrophages contributed to the increase in GS. Collectively, the results provided evidence for the temporospatial expression and location of GS following SCI and suggested that the changes in GS levels may contribute to glutamate neurotoxicity and glial cell response following SCI.	[Liu, Chunxing] Huadong Sanitarium, Dept Clin Testing, Wuxi 214065, Jiangsu, Peoples R China; [Wu, Wenjie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200127, Peoples R China; [Zhang, Bin; Zou, Jian] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Clin Lab Sci, Wuxi 214023, Peoples R China; [Zhang, Bin; Xiang, Jie; Zou, Jian] Wuxi Clin Sci Res Inst, Wuxi 214023, Jiangsu, Peoples R China	Zou, J (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Clin Lab Sci, 299 Qingyang Rd, Wuxi 214023, Peoples R China.	zoujan@gmail.com	Zou, Jian/V-9067-2019		Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000527]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2010159]; Science and Technology Development Program of Huadong Sanitarium [201001]	The current study was supported by grants from the Natural Science Foundation of China (no. 81000527), the Natural Science Foundation of Jiangsu Province (no. BK2010159) and the Science and Technology Development Program of Huadong Sanitarium (no. 201001). The authors would like to thank BiomedWorld Bioscience Ltd., Co., for their editing of the manuscript.	Baldwin SA, 1998, J NEUROTRAUM, V15, P1015, DOI 10.1089/neu.1998.15.1015; Benton RL, 2000, NEUROSCI LETT, V291, P1, DOI 10.1016/S0304-3940(00)01362-8; CALDANI M, 1982, EXPERIENTIA, V38, P1199, DOI 10.1007/BF01959739; Chretien F, 2002, NEUROPATH APPL NEURO, V28, P410, DOI 10.1046/j.1365-2990.2002.00426.x; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Egnaczyk GF, 2003, PROTEOMICS, V3, P689, DOI 10.1002/pmic.200300407; Eid T, 2012, NEUROCHEM RES, V37, P2339, DOI 10.1007/s11064-012-0766-5; Hu JG, 2004, J NEUROSCI RES, V78, P637, DOI 10.1002/jnr.20317; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Levy HL, 2005, NEW ENGL J MED, V353, P1968, DOI 10.1056/NEJMe058227; Lu HZ, 2008, BRAIN BEHAV IMMUN, V22, P1217, DOI 10.1016/j.bbi.2008.06.006; Lu HZ, 2010, DIFFERENTIATION, V80, P228, DOI 10.1016/j.diff.2010.09.179; Mills CD, 2001, J NEUROCHEM, V79, P835, DOI 10.1046/j.1471-4159.2001.00630.x; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; POLITIS MJ, 1985, BRAIN RES, V359, P183, DOI 10.1016/0006-8993(85)91427-1; Romero-Aleman MM, 2004, EXP NEUROL, V188, P74, DOI 10.1016/j.expneurol.2004.03.014; Saitoh F, 2010, J NEUROSCI, V30, P1204, DOI 10.1523/JNEUROSCI.3591-09.2010; Shaked I, 2002, J NEUROCHEM, V83, P574, DOI 10.1046/j.1471-4159.2002.01168.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Wang XF, 2006, ACTA NEUROPATHOL, V111, P220, DOI 10.1007/s00401-005-0016-x; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Xu B, 2012, TOXICOLOGY, V300, P112, DOI 10.1016/j.tox.2012.06.006; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3; Zou J, 2011, NEUROCHEM INT, V58, P404, DOI 10.1016/j.neuint.2010.12.018; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	27	16	17	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997			MOL MED REP	Mol. Med. Rep.	MAY	2013	7	5					1431	1436		10.3892/mmr.2013.1383			6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	136TF	WOS:000318385600012	23525248	Bronze			2021-06-18	
J	Sanganahalli, BG; Herman, P; Hyder, F; Kannurpatti, SS				Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed; Kannurpatti, Sridhar S.			Mitochondrial Functional State Impacts Spontaneous Neocortical Activity and Resting State fMRI	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; BOLD SIGNAL FLUCTUATIONS; NEURONAL-ACTIVITY; DEFAULT NETWORK; IN-VIVO; INTERHEMISPHERIC SYNCHRONY; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; SLOW OSCILLATIONS; CALCIUM-UPTAKE	Mitochondrial Ca2+ uptake, central to neural metabolism and function, is diminished in aging whereas enhanced after acute/sub-acute traumatic brain injury. To develop relevant translational models for these neuropathologies, we determined the impact of perturbed mitochondrial Ca2+ uptake capacities on intrinsic brain activity using clinically relevant markers. From a multi-compartment estimate of probable baseline Ca2+ ranges in the brain, we hypothesized that reduced or enhanced mitochondrial Ca2+ uptake capacity would decrease or increase spontaneous neuronal activity respectively. As resting state fMRI-BOLD fluctuations and stimulus-evoked BOLD responses have similar physiological origins [ 1] and stimulus-evoked neuronal and hemodynamic responses are modulated by mitochondrial Ca2+ uptake capacity [2,3] respectively, we tested our hypothesis by measuring hemodynamic fluctuations and spontaneous neuronal activities during normal and altered mitochondrial functional states. Mitochondrial Ca2+ uptake capacity was perturbed by pharmacologically inhibiting or enhancing the mitochondrial Ca2+ uniporter (mCU) activity. Neuronal electrical activity and cerebral blood flow (CBF) fluctuations were measured simultaneously and integrated with fMRI-BOLD fluctuations at 11.7T. mCU inhibition reduced spontaneous neuronal activity and the resting state functional connectivity (RSFC), whereas mCU enhancement increased spontaneous neuronal activity but reduced RSFC. We conclude that increased or decreased mitochondrial Ca2+ uptake capacities lead to diminished resting state modes of brain functional connectivity.	[Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Magnet Resonance Res Ctr, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA; [Kannurpatti, Sridhar S.] UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA	Kannurpatti, SS (corresponding author), UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	kannursr@umdnj.edu	Sanganahalli, Basavaraju G/C-3296-2008; Hyder, Fahmeed/A-2644-2015	Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Herman, Peter/0000-0003-2218-9652	American Heart AssociationAmerican Heart Association [0930132N]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30NS052519]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH067528] Funding Source: NIH RePORTER	This work was supported by grants from the American Heart Association 0930132N (SK) and National Institute of Health P30NS052519 (FH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bardutzky J, 2005, J CEREBR BLOOD F MET, V25, P968, DOI 10.1038/sj.jcbfm.9600095; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Busche MA, 2012, P NATL ACAD SCI US; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; Hyder F, 2010, P NATL ACAD SCI USA, V107, P10773, DOI 10.1073/pnas.1005135107; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Kannurpatti SS BB, 2003, MAP REVERSIBLE MODUL, P1856; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kreiner L, 2006, J BIOL CHEM, V281, P4691, DOI 10.1074/jbc.M511971200; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESLIE SW, 1985, BRAIN RES, V329, P177, DOI 10.1016/0006-8993(85)90523-2; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Luu P, 2001, J CLIN NEUROPHYSIOL, V18, P302, DOI 10.1097/00004691-200107000-00002; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nemoto EM, 2005, ADV EXP MED BIOL, V566, P83; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; PAXINOS G, 1996, RAT BRAIN STEREOTAXI; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sanganahalli BG, 2009, J NEUROSCI, V29, P1707, DOI 10.1523/JNEUROSCI.5549-08.2009; Sanganahalli BG, 2013, J CEREBRAL IN PRESS; Sarnat HB, 2011, CAN J NEUROL SCI, V38, P909, DOI 10.1017/S0317167100012518; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Simpson PB, 2000, J BIOENERG BIOMEMBR, V32, P5, DOI 10.1023/A:1005552126516; Simpson PB, 1998, BRAIN RES REV, V26, P72, DOI 10.1016/S0165-0173(97)00056-8; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Tsytsarev V, 2012, J NEUROSCI METH, V203, P136, DOI 10.1016/j.jneumeth.2011.09.005; Ueki M, 1992, ACTA ANAESTH SCAND, V36, P5; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Vern BA, 1997, BRAIN RES, V775, P233, DOI 10.1016/S0006-8993(97)01028-7; Vern BA, 1998, ADV EXP MED BIOL, V454, P561; VITORICA J, 1986, BRAIN RES, V378, P36, DOI 10.1016/0006-8993(86)90284-2; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	72	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63317	10.1371/journal.pone.0063317			11	Multidisciplinary Sciences	Science & Technology - Other Topics	147KY	WOS:000319167000106	23650561	DOAJ Gold, Green Published			2021-06-18	
J	Riegler, LJ; Neils-Strunjas, J; Boyce, S; Wade, SL; Scheifele, PM				Riegler, Lindsay James; Neils-Strunjas, Jean; Boyce, Suzanne; Wade, Shari L.; Scheifele, Peter M.			Cognitive intervention results in web-based videophone treatment adherence and improved cognitive scores	MEDICAL SCIENCE MONITOR			English	Article						rehabilitation; traumatic brain injury; veterans; telehealth; cognitive	TELEHEALTH DELIVERY; REHABILITATION; PROGRAM; OUTCOMES; ADULTS	Background: We report findings from an intervention study using telehealth modalities to determine whether provision of telehealth services can improve access to care and increase adherence to cognitive therapy in veterans with mild traumatic brain injury (TBI) while matching traditional care in terms of outcomes. Material/Methods: Veterans who were initially non-adherent to clinic-based cognitive therapy were offered a newly developed treatment. The control participants were selected from patient records of veterans who had completed cognitive treatment and matched to MOPS-VI participants on the basis of age, marital or relationship status, and composite memory index score. Baseline and post-treatment cognitive functioning as assessed by the Test of Memory and Learning 2nd Edition (TOMAL-2) was obtained for all participants. The MOPS-VI modules were designed to increase understanding of TBI and elicit problem-solving skills for attention and memory impairment. Results: Sixty-seven percent of veterans (who were assigned to the MOPS-VI treatment group because they were initially non-adherent with the clinic-based treatment) completed the MOPS-VI telemedicine treatment. Results of a two-way analysis of Variance (ANOVA) comparing baseline and follow-up scores on the TOMAL-2 in the MOPS-VI and control groups revealed there was a significant pre-post assessment effect, indicating that participant's memory and learning improved after treatment for both MOPS-VI and standard treatment groups. There was no significant difference between clinic-based treatment and MOPS-VI therapy. Conclusions: Preliminary evidence supports the efficacy of the treatment, defined as increased compliance in completing the treatment program, and improvements in standardized memory and learning test results comparable to those following clinic-based treatment.	[Riegler, Lindsay James; Neils-Strunjas, Jean; Boyce, Suzanne; Scheifele, Peter M.] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA; [Riegler, Lindsay James] Cincinnati Vet Med Ctr, Cincinnati, OH USA; [Neils-Strunjas, Jean] Armstrong Atlantic State Univ, Dept Rehabil Sci, Commun Sci & Disorders Program, Savannah, GA USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Riegler, LJ (corresponding author), Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA.	jamesls@mail.us.edu		Boyce, Suzanne/0000-0003-2105-2486	Veterans AdministrationUS Department of Veterans Affairs	Support for this study was provided by grants from the Veterans Administration	Adams W, AS KAUFMAN NL KAUFMA; Barak A, 2009, ANN BEHAV MED, V38, P4, DOI 10.1007/s12160-009-9130-7; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Darkins A, 2006, TELEMEDICINE STANDAR; Department of Defense, TRAUM BRAIN INJ CAR; Dunn L. M., 1997, PPVT 3 PEABODY PICTU; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Godleski L, 2008, BEHAV SCI LAW, V26, P271, DOI 10.1002/bsl.811; Lewis C, 2008, AM J SPEECH-LANG PAT, V17, P139, DOI 10.1044/1058-0360(2008/014); O'Brian S, 2008, J SPEECH LANG HEAR R, V51, P184, DOI 10.1044/1092-4388(2008/014); Reynolds C. R., 2007, TEST MEMORY LEARNING; Rose VL, 1999, AM FAM PHYSICIAN, V59, P1051; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; *SPSS INC, 1998, SPSS BAS 8 0 WIND US; Tindall LR, 2008, TELEMED J E-HEALTH, V14, P1070, DOI 10.1089/tmj.2008.0040	18	16	16	0	7	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	APR 15	2013	19						269	275		10.12659/MSM.883885			7	Medicine, Research & Experimental	Research & Experimental Medicine	159OM	WOS:000320055100001	23584165	Green Published			2021-06-18	
J	Bruins, B; Kilbaugh, TJ; Margulies, SS; Friess, SH				Bruins, Benjamin; Kilbaugh, Todd J.; Margulies, Susan S.; Friess, Stuart H.			The Anesthetic Effects on Vasopressor Modulation of Cerebral Blood Flow in an Immature Swine Model	ANESTHESIA AND ANALGESIA			English	Article							TRAUMATIC BRAIN-INJURY; ISOFLURANE ANESTHESIA; OXYGEN-CONSUMPTION; NITROUS-OXIDE; MIDAZOLAM; AUTOREGULATION; PROPOFOL; VELOCITY; METABOLISM; PERFUSION	BACKGROUND: The effect of various sedatives and anesthetics on vasopressor modulation of cerebral blood flow (CBF) in children is unclear. In adults, isoflurane has been described to decrease CBF to a lesser extent than fentanyl and midazolam. Most large-animal models of neurocritical care use inhaled anesthetics for anesthesia. Investigations involving modulations. CBF would have improved translatability within a model that more closely approximates the current practice in the pediatric intensive care unit. METHODS: Fifteen 4-week-old piglets were given 1 of 2 anesthetic protocols: total IV anesthesia (TIVA) (midazolam 1 mg/kg/h and fentanyl 100 mu g/kg/h, n = 8) or ISO (isoflurane 1.5%-2% and fentanyl 100 mu g/kg/h, n = 7). Mean arterial blood pressure, intracranial pressure (ICP), CBF, and brain tissue oxygen tension were measured continuously as piglets were exposed to escalating doses of arginine vasopressin, norepinephrine (NE), and phenylephrine (PE). RESULTS: Baseline CBF was similar in the 2 groups (ISO 38 +/- 10 vs TIVA 35 +/- 26 mL/100 g/min) despite lower baseline cerebral perfusion pressure in the ISO group (45 +/- 11 vs 71 +/- 11 mm Hg; P < 0.0005). Piglets in the ISO group displayed increases in ICP with PE and NE (11 +/- 4 vs 16 +/- 4 mm Hg, and 11 +/- 8 vs 18 +/- 5 mm Fig; P < 0.05), but in the TIVA group, only exposure to PE resulted in increases in ICP when comparing maximal dose values with baseline data (11 +/- 4 vs 15 +/- 5 mm Hg; P < 0.05). Normalized CBF displayed statistically significant increases regarding anesthetic group and vasopressor dose when piglets were exposed to NE and PE (P < 0.05), suggesting an impairment of autoregulation within ISO, but not TIVA. CONCLUSION: The vasopressor effect on CBF was limited when using a narcotic-benzodiazepine based anesthetic protocol compared with volatile anesthetics, consistent with a preservation of autoregulation. Selection of anesthetic drugs is critical to investigate mechanisms of cerebrovascular hemodynamics, and in translating critical care investigations between the laboratory and bedside. (Anesth Analg 2013;116:838-44)	[Bruins, Benjamin; Kilbaugh, Todd J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Friess, Stuart H.] Washington Univ, Dept Pediat, St Louis Sch Med, St Louis, MO 63110 USA	Friess, SH (corresponding author), Washington Univ, Dept Pediat, St Louis Sch Med, Campus Box 8028,5th Floor MPRB,660 S Euclid Ave, St Louis, MO 63110 USA.	Friess_S@kids.wustl.edu		Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08NS064051, U01NS069545, R01NS39679]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS064051, R01NS039679, U01NS069545] Funding Source: NIH RePORTER	Supported by NIH grants K08NS064051, U01NS069545, and R01NS39679.	Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; CHENG MA, 1993, J NEUROSURG ANESTH, V5, P232; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHI OZ, 1992, ANESTHESIOLOGY, V76, P426, DOI 10.1097/00000542-199203000-00016; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; CUCCHIARA RF, 1974, ANESTHESIOLOGY, V40, P571, DOI 10.1097/00000542-197406000-00011; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; FORSTER A, 1982, ANESTHESIOLOGY, V56, P453, DOI 10.1097/00000542-198206000-00009; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; GELMAN S, 1984, ANESTH ANALG, V63, P557; HOFFMAN WE, 1986, ANESTH ANALG, V65, P729; KNUDSEN L, 1990, ANAESTHESIA, V45, P1016, DOI 10.1111/j.1365-2044.1990.tb14877.x; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Muller S, 2008, CRIT CARE, V12, DOI 10.1186/cc6794; Myburgh JA, 2002, ANAESTH INTENS CARE, V30, P725, DOI 10.1177/0310057X0203000602; Nachar RA, 2011, PEDIATR RES, V70, P473, DOI 10.1203/PDR.0b013e31822e178e; Nouira S, 2005, CRIT CARE MED, V33, P2339, DOI 10.1097/01.CCM.0000182801.48137.13; NUGENT M, 1982, ANESTHESIOLOGY, V56, P172, DOI 10.1097/00000542-198203000-00003; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Ogawa Y, 2010, ANESTH ANALG, V111, P1279, DOI 10.1213/ANE.0b013e3181f42fc0; OLSEN KS, 1992, BRIT J ANAESTH, V69, P263, DOI 10.1093/bja/69.3.263; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Rosengarten B, 2012, CRIT CARE, V16, DOI 10.1186/cc11310; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schramm P, 2012, CRIT CARE, V16, DOI 10.1186/cc11665; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Simon F, 2009, CRIT CARE, V13, DOI 10.1186/cc7959; Smith JH, 2005, ACTA ANAESTH SCAND, V49, P23, DOI 10.1111/j.1399-6576.2004.00535.x; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Swindle MM., 2007, SWINE LAB SURG ANEST; Todd MM, 1996, J NEUROSURG ANESTH, V8, P296, DOI 10.1097/00008506-199610000-00007; Tsuneyoshi I, 2001, CRIT CARE MED, V29, P487, DOI 10.1097/00003246-200103000-00004; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642; WOLFF J, 1990, ACTA ANAESTH SCAND, V34, P75, DOI 10.1111/j.1399-6576.1990.tb03189.x	42	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	APR	2013	116	4					838	844		10.1213/ANE.0b013e3182860fe7			7	Anesthesiology	Anesthesiology	113EA	WOS:000316648100014	23460561	Green Accepted			2021-06-18	
J	Nickele, CM; Kamps, TK; Medow, JE				Nickele, Christopher M.; Kamps, Timothy K.; Medow, Joshua E.			Safety of a DVT Chemoprophylaxis Protocol Following Traumatic Brain Injury: A Single Center Quality Improvement Initiative	NEUROCRITICAL CARE			English	Article						Clinical protocols; Craniocerebral trauma; Intracranial hemorrhages; Prevention and control; Quality improvement; Venous thrombosis	VENOUS THROMBOSIS PROPHYLAXIS; INTRACRANIAL HEMORRHAGIC INJURIES; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; ENOXAPARIN PROPHYLAXIS; COMPRESSION STOCKINGS; MAJOR TRAUMA; THROMBOEMBOLISM; PREVENTION; THROMBOPROPHYLAXIS	Venous thromboembolism (VTE) is a complication that affects approximately 30 % of moderate and severe traumatic brain injury (TBI) patients when pharmacologic prophylaxis is not used. Following TBI, specifically in the case of contusions, the safety and efficacy of pharmacologic thromboembolism prophylaxis (PTP) has been studied only in small sample sizes. In this study, we attempt to assess the safety and efficacy of a PTP protocol for TBI patients, as a quality improvement (QI) initiative, in the neuroscience intensive care unit (NSICU). Between January 1st and December 31st, 2009, consecutive patients discharged from the University of Wisconsin NSICU after > a 48 h minimum stay were evaluated as part of a QI project. A protocol for the initiation of PTP was designed and implemented for NSICU patients. The protocol did not vary based on type of intracranial injury. The rate of VTE was reported as was heparin-induced thrombocytopenia and PTP-related expansion of intracranial hemorrhage (IH) requiring reoperation. The number of patients receiving PTP and the timing of therapy were tracked. Patients were excluded for persistent coagulopathy, other organ system bleeding (such as the gastrointestinal tract), or pregnancy. Faculty could opt out of the protocol without reason. Using the same criteria, patients discharged during the preceding 6 months, from July 1st to December 31st, 2008, were evaluated as controls as the PTP protocol was not in effect during this time. During the control period, there were 48 head trauma admissions who met the inclusion criteria. In 22 patients (45.8 %), PTP was initiated at an average of 4.9 +/- A 5.4 days after admission. During the protocol period, there were 87 head trauma admissions taken from 1,143 total NSICU stays who met criteria. In 63 patients (72.4 %), the care team in the NSICU successfully initiated PTP, at an average of 3.4 +/- A 2.8 days after admission. All 87 trauma patients were analyzed, and the rate of clinically significant deep venous thrombosis (DVT) was 6.9 % (6 of 87). Three protocol patients (3.45 %) went to the operating room for surgery after the initiation of PTP; none of these patients had a measurable change in hemorrhage size on head CT. The change in percentage of patients receiving PTP was significantly increased by the protocol (p < 0.0001); while the average days to first PTP dose trended down with institution of the protocol, this change was not statistically significant. A PTP protocol in the NSICU is useful in controlling the number of complications from DVT and pulmonary embolism while avoiding additional IH. This protocol, based on a published body of literature, allowed for VTE rates similar to published rates, while having no PTP-related hemorrhage expansion. The protocol significantly changed physician behavior, increasing the percentage of patients receiving PTP during their hospitalization; whether long-term patient outcomes are affected is a potential goal for future study.	[Nickele, Christopher M.; Medow, Joshua E.] Univ Wisconsin Hosp & Clin, Dept Neurol Surg, Madison, WI 53792 USA; [Kamps, Timothy K.] Univ Wisconsin, Dept Qual Resources, Madison, WI USA	Medow, JE (corresponding author), Univ Wisconsin Hosp & Clin, Dept Neurol Surg, 600 Highland Ave,CSC K4-822, Madison, WI 53792 USA.	medow@neurosurgery.wisc.edu					Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Arnold JD, 2010, AM SURGEON, V76, P563; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; KUDSK KA, 1989, AM J SURG, V158, P515, DOI 10.1016/0002-9610(89)90182-7; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Scudday T, 2011, J AM COLL SURGEONS, V213, P53; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3	19	16	16	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2013	18	2					184	192		10.1007/s12028-012-9786-x			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	105PR	WOS:000316084700005	23099845				2021-06-18	
J	Fenerty, L; Thibault-Halman, G; Bruce, BS; Landry, J; Young, J; Walling, S; Clarke, DB				Fenerty, Lynne; Thibault-Halman, Ginette; Bruce, Beth S.; Landry, Jacob; Young, Julian; Walling, Simon; Clarke, David B.			Helmets for skiing and snowboarding: Who is using them and why	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Helmet; skiing; snowboarding; traumatic brain injury; epidemiology	HEAD-INJURIES; SKIERS; LEGISLATION; RISK; PREVALENCE; ATTITUDES; TRENDS; IMPACT; AREAS; WEAR	BACKGROUND: In Canada, winter sports injuries are responsible for significant health care burden, with estimates of $400 million in direct and indirect annual health care costs. For ski-related injuries, helmets have been shown to provide significant protection. Current common practice in Canada, including the Province of Nova Scotia, is to leave the decision of whether to wear a helmet to the individual. The purposes of this study were to document skiers' and snowboarders' use of helmets and to isolate factors associated with helmet use and nonuse. METHODS: A mixed methods approach was used to collect data during a 2-month period at the province's three ski hills. Naturalistic observations documented helmet use and falls, whereas interviews identified factors influencing helmet use or nonuse. RESULTS: Helmets were used by most skiers (74%) and snowboarders (72%); the use varied significantly between ski hills, ranging from 69% to 79%. Females were more likely to wear helmets compare with males (80% vs. 70%). The highest rates of use were found among 4-year-old to 12-year-old children, with helmet use declining as age increases. Qualitative data revealed that helmet users were most influenced by the protective benefits of helmets (77%), personal choice (46%), family (44%), and rules (44%), while non-helmet users cited personal choice (29%), comfort (26%), rules (14%), and cost (11%) as reasons for nonuse. CONCLUSION: More than 25% of skiers and snowboarders remain at increased risk of a serious brain injury by not wearing a helmet. Changes in regulations may be required to ensure widespread use of helmets on ski hills. (J Trauma Acute Care Surg. 2013;74: 895-900. Copyright (c) 2013 by Lippincott Williams & Wilkins)	[Fenerty, Lynne; Thibault-Halman, Ginette; Bruce, Beth S.; Landry, Jacob; Walling, Simon; Clarke, David B.] Dalhousie Univ, Div Neurosurg, Halifax, NS B3H 3A7, Canada; [Young, Julian] Govt Nova Scotia, Dept Hlth & Wellness, Halifax, NS, Canada	Clarke, DB (corresponding author), Dalhousie Univ, Div Neurosurg, Halifax Infirm, 1796 Summer St,Suite 3807, Halifax, NS B3H 3A7, Canada.	d.clarke@dal.ca			Nova Scotia Department of Health and Wellness; Dalhousie University Division of Neurosurgery	Funding for this project was provided by the Nova Scotia Department of Health and Wellness as well as Dalhousie University Division of Neurosurgery.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Andersen PA, 2004, INJURY PREV, V10, P358, DOI 10.1136/ip.2004.005967; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Cundy TP, 2010, J TRAUMA, V69, P1486, DOI 10.1097/TA.0b013e3181fee31c; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Forjuoh SN, 2002, ARCH PEDIAT ADOL MED, V156, P656, DOI 10.1001/archpedi.156.7.656; Greve MW, 2009, WILD ENVIRON MED, V20, P234, DOI 10.1580/08-WEME-OR-244R1.1; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hagel BE, 2010, AM J EPIDEMIOL, V171, P1134, DOI 10.1093/aje/kwq039; Josefson D, 1998, BRIT MED J, V316, P172; King WD, 2007, J TRAUMA, V63, pS25, DOI 10.1097/TA.0b013e31812f5e7a; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Miles M.B., 1994, QUALITATIVE DATA ANA; Moffat C, 2009, WEST J EMERG MED, V10, P257; Public Health Agency of Canada Health Surveillance and Epidemiology Division, 2003, INJ ASS IC SNOW SPOR; Ruedl G, 2012, INJURY PREV, V18, P182, DOI 10.1136/injuryprev-2011-040042; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Xiang H, 2004, INJURY PREV, V10, P99, DOI 10.1136/ip.2003.004655	26	16	16	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2013	74	3					895	900		10.1097/TA.0b013e31827e19ca			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	108UO	WOS:000316321900036	23425754				2021-06-18	
J	Lustenberger, T; Talving, P; Lam, L; Inaba, K; Bass, M; Plurad, D; Demetriades, D				Lustenberger, Thomas; Talving, Peep; Lam, Lydia; Inaba, Kenji; Bass, Margarita; Plurad, David; Demetriades, Demetrios			Effect of diabetes mellitus on outcome in patients with traumatic brain injury: A national trauma databank analysis	BRAIN INJURY			English	Article						Diabetes mellitus; head injury; traumatic brain injury; outcome; mortality	CRITICALLY-ILL PATIENTS; PREEXISTING CONDITIONS; HEAD-INJURY; HYPERGLYCEMIA; IMPACT; MORTALITY; APOPTOSIS; RATS	Background: Diabetes mellitus (DM) is associated with worsened outcomes following severe injury. However, clinical studies evaluating the effect of DM on outcomes in patients suffering traumatic brain injury (TBI) are currently lacking. Methods: This was a National Trauma Databank (NTDB) study over a 5-year period. Patients with DM were matched with victims of isolated TBI without DM in a 1: 2 ratio. Outcomes included mortality, hospital and surgical intensive care unit (SICU) length of stay, ventilator days and discharge disposition. Results: Of the 35 005 patients with isolated TBI, 636 (1.8%) cases had documented DM. After matching 1272 counterparts without DM, no differences with regards to demographic and injury characteristics were observed comparing the two groups. Overall mortality in the study population was 18.8% (n = 358), with a significantly increased in-hospital mortality in patients with vs without DM [22.6% vs 16.8%; OR (95% CI): 1.45 (1.14-1.83); p = 0.002]. Patients with DM were significantly less frequently discharged home compared to their counterparts without DM [38.9% vs 46.1%; OR (95% CI): 0.75 (0.60-0.93); p = 0.008]. Conclusion: Traumatic brain injury in conjunction with diabetes mellitus is associated with an almost 1.5-fold increased mortality while compared to patients with isolated TBI without diabetes mellitus. Prospective validation of these findings is warranted to determine the underlying aetiology.	[Lustenberger, Thomas; Talving, Peep; Lam, Lydia; Inaba, Kenji; Bass, Margarita; Plurad, David; Demetriades, Demetrios] Univ So Calif, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, Dept Surg,Med Ctr, Los Angeles, CA 90033 USA	Talving, P (corresponding author), Univ So Calif, Los Angeles Cty Gen Hosp LAC USC, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, 1200 North State St,C5L100, Los Angeles, CA 90033 USA.	peep.talving@surgery.usc.edu	Talving, Peep/G-8621-2015; INABA, KENJI/AAC-8532-2020; Talving, Peep/E-6015-2013	Talving, Peep/0000-0002-9741-2073; 			Ahmad R, 2007, ARCH SURG-CHICAGO, V142, P613, DOI 10.1001/archsurg.142.7.613; American College of Surgeons Committee on Trauma, 2007, US MAN NAT TRAUM DAT; Bochicchio GV, 2006, WORLD J SURG, V30, P114, DOI 10.1007/s00268-005-0203-x; Cole FJ, 2007, J TRAUMA, V63, P1358; Dubey A, 2000, Bull Hosp Jt Dis, V59, P94; Elangovan V, 2000, J NEUROTRAUM, V17, P1013, DOI 10.1089/neu.2000.17.1013; FIETSAM R, 1991, AM SURGEON, V57, P551; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Halkos ME, 2010, ANN THORAC SURG, V90, P124, DOI 10.1016/j.athoracsur.2010.03.111; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Li ZG, 2004, LIFE SCI, V76, P249, DOI 10.1016/j.lfs.2004.03.039; Lieberman D, 1996, DISABIL REHABIL, V18, P224, DOI 10.3109/09638289609166305; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Malmberg K, 1997, CARDIOVASC RES, V34, P248, DOI 10.1016/S0008-6363(96)00263-5; McCampbell B, 2002, J BURN CARE REHABIL, V23, P157, DOI 10.1097/00004630-200205000-00004; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; Rizk NN, 2005, BRAIN RES, V1053, P1, DOI 10.1016/j.brainres.2005.05.036; Thourani VH, 1999, ANN THORAC SURG, V67, P1045, DOI 10.1016/S0003-4975(99)00143-5; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	24	16	16	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2013	27	3					281	285		10.3109/02699052.2012.743178			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400004	23252407				2021-06-18	
J	Ornstein, TJ; Max, JE; Schachar, R; Dennis, M; Barnes, M; Ewing-Cobbs, L; Levin, HS				Ornstein, Tisha J.; Max, Jeffrey E.; Schachar, Russell; Dennis, Maureen; Barnes, Marcia; Ewing-Cobbs, Linda; Levin, Harvey S.			Response inhibition in children with and without ADHD after traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							ATTENTION-DEFICIT HYPERACTIVITY; CLOSED-HEAD-INJURY; DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC-DISORDERS; STOP TASK; TBI; CLASSIFICATION; NEUROSCIENCE; ADOLESCENTS; CHILDHOOD	Children with attention-deficit hyperactivity disorder (ADHD) and traumatic brain injury (TBI) show deficient response inhibition. ADHD itself is a common consequence of TBI, known as secondary ADHD (S-ADHD). Similarity in inhibitory control in children with TBI, S-ADHD, and ADHD would implicate impaired frontal-striatal systems; however, it is first necessary to delineate similarities and differences in inhibitory control in these conditions. We compared performance of children with ADHD and those with TBI without pre-injury ADHD on a stop signal, response inhibition task. Participants were 274 children aged 614 years. There were 92 children with ADHD, 103 children with TBI, and 79 typically developing children who served as controls. Among the TBI participants, injury severity ranged from mild to severe. Children with ADHD and TBI showed deficient inhibition. The deficit in children with ADHD was as great as or greater than that in children with TBI, regardless of degree of TBI severity or the presence of S-ADHD. The finding indicates that TBI results in deficient inhibition regardless of the development of S-ADHD.	[Ornstein, Tisha J.] Ryerson Univ, Dept Psychol, Toronto, ON M5B 2K3, Canada; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Schachar, Russell] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Barnes, Marcia] Univ Texas Med Sch, Dept Pediat, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr, Dept Pediat, Houston, TX USA; [Levin, Harvey S.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA	Ornstein, TJ (corresponding author), Ryerson Univ, Dept Psychol, Off 816 Jorgenson Hall,350 Victoria St, Toronto, ON M5B 2K3, Canada.	tjornste@psych.ryerson.ca		Schachar, Russell/0000-0002-2015-4395	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP44070]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08-MH01800]; National Institute of Health, NINDS division [NS-21889]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by grants from the Canadian Institutes of Health Research (No. MOP44070), the National Institute of Mental Health (No. K-08-MH01800), and the National Institute of Health, NINDS division (No. NS-21889).	Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Boyle MH, 1996, J AM ACAD CHILD PSY, V35, P1440, DOI 10.1097/00004583-199611000-00012; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; Castellanos FX, 1997, CHILD ADOL PSYCH CL, V6, P383, DOI 10.1016/S1056-4993(18)30310-9; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Crosbie J, 2001, AM J PSYCHIAT, V158, P1884, DOI 10.1176/appi.ajp.158.11.1884; Crosbie J, 2008, NEUROSCI BIOBEHAV R, V32, P40, DOI 10.1016/j.neubiorev.2007.05.002; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Ickowicz A, 2006, CAN J PSYCHIAT, V51, P325, DOI 10.1177/070674370605100508; Konrad KN, 2000, BRAIN INJURY, V14, P859; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; Logan Gordon D., 1994, P189; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, BRAIN INJURY, V11, P699; Nigg JT, 1999, J ABNORM CHILD PSYCH, V27, P393, DOI 10.1023/A:1021980002473; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Slaats-Willemse D, 2003, J AM ACAD CHILD PSY, V42, P1242, DOI 10.1097/00004583-200310000-00016; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	37	16	17	0	18	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2013	7	1					1	11		10.1111/j.1748-6653.2012.02027.x			11	Psychology; Psychology, Experimental	Psychology	103MN	WOS:000315921200001	23464806	Green Accepted			2021-06-18	
J	Takeuchi, S; Nawashiro, H; Wada, K; Takasato, Y; Masaoka, H; Hayakawa, T; Nagatani, K; Otani, N; Osada, H; Shima, K				Takeuchi, Satoru; Nawashiro, Hiroshi; Wada, Kojiro; Takasato, Yoshio; Masaoka, Hiroyuki; Hayakawa, Takanori; Nagatani, Kimihiro; Otani, Naoki; Osada, Hideo; Shima, Katsuji			Ventriculomegaly after decompressive craniectomy with hematoma evacuation for large hemispheric hypertensive intracerebral hemorrhage	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Decompressive craniectomy; Ventriculomegaly; Intracerebral hemorrhage; Hypertensive	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; QUALITY-OF-LIFE; MALIGNANT INFARCTION; RANDOMIZED-TRIAL; SURGICAL TRIAL; HEAD-INJURY; HEMICRANIECTOMY; HYDROCEPHALUS	Objective: The aim of the present study was to investigate factors associated with the development of ventriculomegaly suggestive of hydrocephalus (VSOH) after decompressive craniectomy with hematoma evacuation for hemispheric hypertensive intracerebral hemorrhage. Methods: This study focused on 21 patients who underwent decompressive craniectomy with hematoma evacuation for hemispheric hypertensive intracerebral hemorrhage. The patients' clinical and radiological findings were retrospectively reviewed. Results: Eleven patients were male and ten were female, with an age range from 22 to 75 years (mean, 56.6 years). The preoperative Glasgow Coma Scale score ranged from 3 to 13 (mean, 6.9). Hematoma volumes ranged from 33.4 to 98.1 ml (mean, 74.2 ml). Hematoma locations were the basal ganglia in 10 patients and the subcortex in 11 patients. The presence of intraventricular hemorrhage was significantly associated with the development of VSOH (P=0.023). The distance of the decompressive defect to the midline and the presence of meningitis showed a strong trend for association with VSOH (P=0.051, P=0.090, respectively). Conclusion: Careful attention should be paid to the occurrence of VSOH after decompressive craniectomy with hematoma evacuation in intracerebral hemorrhage patients with intraventricular extension, meningitis, and/or a short distance of the decompressive defect to the midline. (C) 2012 Elsevier B.V. All rights reserved.	[Takeuchi, Satoru; Nawashiro, Hiroshi; Wada, Kojiro; Nagatani, Kimihiro; Otani, Naoki; Osada, Hideo; Shima, Katsuji] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan; [Takasato, Yoshio; Masaoka, Hiroyuki; Hayakawa, Takanori] Natl Hosp Org Disaster Med Ctr, Dept Neurosurg, Tokyo, Japan	Takeuchi, S (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	s.takeuchi@room.ocn.ne.jp					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; ANDERSON CS, 1994, J NEUROL NEUROSUR PS, V57, P936, DOI 10.1136/jnnp.57.8.936; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; GIROUD M, 1991, J NEUROL NEUROSUR PS, V54, P595, DOI 10.1136/jnnp.54.7.595; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Ma L, 2010, J STROKE CEREBROVASC, V19, P294, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.002; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mendelow AD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-124; Mendelow AD, 2005, LANCET, V365, P387; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315; Murthy JMK, 2005, NEUROCRIT CARE, V2, P258, DOI 10.1385/NCC:2:3:258; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Ramnarayan R, 2009, J STROKE CEREBROVASC, V18, P1, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.001; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Staykov D, 2009, STROKE, V40, P3275, DOI 10.1161/STROKEAHA.109.551945; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	37	16	22	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2013	115	3					317	322		10.1016/j.clineuro.2012.05.026			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	095BJ	WOS:000315309200013	22727212				2021-06-18	
J	Green, JA; Pellegrini, DC; Vanderkolk, WE; Figueroa, BE; Eriksson, EA				Green, Joel A.; Pellegrini, Daniela C.; Vanderkolk, Wayne E.; Figueroa, Bryan E.; Eriksson, Evert A.			Goal Directed Brain Tissue Oxygen Monitoring Versus Conventional Management in Traumatic Brain Injury: An Analysis of In Hospital Recovery	NEUROCRITICAL CARE			English	Article						Trauma; pBtO2; Traumatic brain injury; Brain tissue oxygenation; Intracranial pressure; Intracranial monitor; Outcome	TENSION	Brain tissue oxygen monitoring (pBtO2) has been advocated in the treatment of patients with severe traumatic brain injuries (TBI); however, controversy exists regarding the improvements that pBtO2 monitoring provides. The objective of our study was to evaluate our experience and effect on mortality with goal directed pBtO2 monitoring for severe TBI compared to traditional ICP/CPP monitoring. All patients admitted with severe TBI (GCS < 8) to our Level 1 trauma center from June 2007 through June 2009 were retrospectively analyzed. All patients had ICP monitoring and pBtO2 monitors were placed based on the current practices of the attending neurosurgeon producing two temporally matched cohorts of patients with and without pBtO2 monitors. Exclusion criteria were age < 18 years and survival < 24 h. Goal-directed therapy was utilized in all patients to maintain ICP < 20 mmHg and CPP > 60 mmHg. Patients with pBtO2 monitors were managed to maintain a level > 20 mmHg. 74 patients were treated for severe TBI over the 2-year study period with 37 patients in each group. Both groups were similar in age, sex, and admission Glascow Coma Score(GCS).The pBtO2-monitored group did, however, have significantly lower injury severity score [26 (25-30) vs. 30 (26-36), p = 0.03] and AIS Chest [0 (0-0) vs. 2 (0-3), p = 0.02]. There was no survival difference found (64.9 vs. 54.1 %, p = 0.34). No difference with respect to discharge GCS or discharge Functional Independence Measure score was identified. Compared with ICP/CPP-directed therapy alone, the addition of pBtO2 monitoring did not provide a survival or functional status improvement at discharge. The true clinical benefit of pBtO2 monitoring will require further study.	[Green, Joel A.; Vanderkolk, Wayne E.] St Marys Hlth Care, Dept Trauma, Grand Rapids, MI USA; [Pellegrini, Daniela C.] Univ Wisconsin, Dept Internal Med, Madison, WI USA; [Figueroa, Bryan E.] Spectrum Hlth, Dept Neurosurg, Grand Rapids, MI USA; [Eriksson, Evert A.] Med Univ S Carolina, Dept Gen Surg, Charleston, SC 29425 USA	Eriksson, EA (corresponding author), Med Univ S Carolina, Dept Gen Surg, 96 Jonathan Lucas St,Suite 420, Charleston, SC 29425 USA.	joelgreenmd@gmail.com; pellegrd@gmail.com; waynshell@aol.com; bfigueroa@greatlakesneuro.com; evsurgery@gmail.com		Eriksson, Evert/0000-0002-4099-325X			Bardt TF, 1998, ACT NEUR S, V71, P153; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS3; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Eriksson EA, 2012, CLIN NEUROPHYSIOL, V123, P1255, DOI 10.1016/j.clinph.2011.08.035; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Martin MJ, 2005, J TRAUMA, V59, P860, DOI 10.1097/01.ta.0000187964.47703.e9; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3	19	16	18	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2013	18	1					20	25		10.1007/s12028-012-9797-7			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	086SY	WOS:000314708500004	23138547				2021-06-18	
J	Wood, RL; McHugh, L				Wood, Rodger Ll.; McHugh, Louise			Decision Making after Traumatic Brain Injury: A Temporal Discounting Paradigm	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; TBI; Impulsive behavior; Neuropsychological tests; Executive function; Decision making	VENTROMEDIAL PREFRONTAL CORTEX; BARRATT IMPULSIVENESS SCALE; WORKING-MEMORY; SELF-CONTROL; RISK-TAKING; BEHAVIOR; CHOICE; DELAY; INTELLIGENCE; AMYGDALA	A temporal discounting paradigm was used to examine decision making for hypothetical monetary reward following traumatic brain injury (TBI). A case-control design compared individuals following moderate or severe TBI with a healthy control group matched for age and gender. The impact of intelligence, impulsivity, and mood on temporal discounting performance was examined. A within-subjects design for the TBI group determined the influence of a range of neuropsychological tests on temporal discounting performance. Both patients and controls demonstrated temporal discounting. However, the TBI group discounted more than controls, suggesting that their decision making was more impulsive, consistent with ratings on the impulsiveness questionnaire. Discounting performance was independent of neuropsychological measures of intelligence, memory, and executive function. There was no relationship between temporal discounting and ratings of everyday executive function made by patients' relatives. Low mood did not account for discounting performance. The results of this study suggest that temporal discounting may be a useful neuropsychological paradigm to assess decision making linked to monetary reward following TBI. Performance was relatively independent of intelligence, memory and standard tests of executive ability and may therefore assist when assessing a patient's mental capacity to manage their financial affairs. (JINS, 2013, 19, 181-188)	[Wood, Rodger Ll.] Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales; [McHugh, Louise] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland	Wood, RL (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Brain Injury Res Grp, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk		McHugh, Louise/0000-0002-2526-4649			Ainslie G., 2001, BREAKDOWN WILL; Barratt E. S., 1994, VIOLENCE MENTAL DISO, P61; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; Christ SE, 2003, NEUROPSYCHOLOGY, V17, P171, DOI 10.1037/0894-4105.17.1.171; Cicerone K.D., 1997, ARCH CLIN NEUROPSYCH, V12, P175; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; GREEN L, 1993, BEHAV PHILOS, V21, P37; Greve KW, 2001, BRAIN INJURY, V15, P255; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Klapproth F, 2011, KRONOSCOPE, V11, P41, DOI 10.1163/156852411X595251; Marsh DM, 2002, PERS INDIV DIFFER, V33, P1291, DOI 10.1016/S0191-8869(02)00014-4; MCALLISTER TW, 2007, BRAIN INJURY MED PRI, P835; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MILLER LA, 1992, NEUROPSYCHOLOGIA, V30, P69, DOI 10.1016/0028-3932(92)90015-E; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Oddy M, 2008, J CLIN EXP NEUROPSYC, V30, P568, DOI 10.1080/13803390701555598; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfister HR, 2008, JUDGM DECIS MAK, V3, P5; Psychological Corporation, 2001, WECHSLER TEST ADULT; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Reed DD, 2011, J APPL BEHAV ANAL, V44, P1, DOI 10.1901/jaba.2011.44-1; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; Shallice, 1997, HAYLING BRIXTON TEST; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; TEASDALE G, 1974, LANCET, V2, P81; Walsh K. W., 1985, UNDERSTANDING BRAIN; Wechsler D, 1997, WAIS 3 ADM SCORING M; Willner P, 2010, AJIDD-AM J INTELLECT, V115, P157, DOI 10.1352/1944-7558-115.2.157; Wilson B.A., 1997, NEUROPSYCHOL REHABIL, V5, P662; Yuen KSL, 2003, J AFFECT DISORDERS, V75, P11, DOI 10.1016/S0165-0327(02)00022-8; Zeelenberg M, 2008, JUDGM DECIS MAK, V3, P18	42	16	16	0	21	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2013	19	2					181	188		10.1017/S135561771200118X			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	085WV	WOS:000314645900008	23298735				2021-06-18	
J	Yeiser, LA; Villasana, LE; Raber, J				Yeiser, Lauren A.; Villasana, Laura E.; Raber, Jacob			ApoE isoform modulates effects of cranial Fe-56 irradiation on spatial learning and memory in the water maze	BEHAVIOURAL BRAIN RESEARCH			English	Article						ApoE; Water maze; Open field; Irradiation; Hippocampal function	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E GENOTYPE; OBJECT RECOGNITION; ALZHEIMERS-DISEASE; MICE; SEX; ATHEROSCLEROSIS; RADIATION; AGE; SUSCEPTIBILITY	Apolipoprotein E, which plays an important role in lipid transport and metabolism and neuronal repair, might modulate the CNS risk following Fe-56 irradiation exposure during space missions. In this study, we investigated this risk by behavioral and cognitive testing male E2, E3, and E4 mice 3 months following cranial Fe-56 irradiation. In the open field, mice irradiated with 2 Gy showed higher activity levels than sham-irradiated mice or mice irradiated with 1 Gy. In addition, E2 mice showed higher activity and lower measures of anxiety than E3 and E4 mice in the open field and elevated zero maze. During hidden platform training, sham-irradiated mice showed most robust learning, 1 Gy irradiated mice reduced learning, and 2 Gy irradiated mice no improvement over the four sessions. In the water maze probe trials, sham-irradiated E2. E3, and E4 mice and E2 and E4 mice irradiated with 1 Gy showed spatial memory retention, but E3 mice irradiated with 1 Gy, and E2, E3, and E4 mice irradiated with 2 Gy did not. Thus, cranial Fe-56 irradiation increases activity levels in the open field and impairs spatial learning and memory in the water maze. E3 mice are more susceptible than E2 or E4 mice to impairments in spatial memory retention in the water maze, indicating that apoE isoform modulates the CNS risk following space missions. (C) 2012 Elsevier B.V. All rights reserved.	[Yeiser, Lauren A.; Villasana, Laura E.; Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Portland, OR 97201 USA	Raber, J (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, 3181 SW Sam Jackson Pkwy,Mail Code 1-470, Portland, OR 97239 USA.	raberj@ohsu.edu			 [NNJ05HE63G];  [NSCOR NNX10AD59G (NASA)]	This work was supported by NNJ05HE63G and NSCOR NNX10AD59G (NASA).	Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Berteau-Pavy F, 2007, NEUROSCIENCE, V147, P6, DOI 10.1016/j.neuroscience.2007.03.005; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cucinotta F., 2011, RISK ACUTE LATE CENT; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Haley GE, 2012, INT J RADIAT ONCOL, V84, P793, DOI 10.1016/j.ijrobp.2011.12.049; Haley GE, 2010, AGE, V32, P283, DOI 10.1007/s11357-010-9137-9; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Olsen R, 2012, GENES BRAIN BEHAV; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2011, RADIAT RES, V80, P567; Rabin B, 2008, EFFECTS EXPOSURE HEA; Rabin BM, 2009, ADV SPACE RES, V43, P1193, DOI 10.1016/j.asr.2009.01.015; ROSES AD, 1995, ARZNEIMITTEL-FORSCH, V45-1, P413; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Shukitt-Hale B, 2003, ADV SPACE RES-SERIES, V31, P119, DOI 10.1016/S0273-1177(02)00878-5; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Villasana L, 2010, RADIAT ENVIRON BIOPH, V49, P421, DOI 10.1007/s00411-010-0290-4; Villasana LE, 2011, INT J RADIAT ONCOL, V80, P567, DOI 10.1016/j.ijrobp.2010.12.034	29	16	16	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	JAN 15	2013	237						207	214		10.1016/j.bbr.2012.09.029			8	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	051IG	WOS:000312119200028	23018124				2021-06-18	
J	Bell, ED; Kunjir, RS; Monson, KL				Bell, E. David; Kunjir, Rahul S.; Monson, Kenneth L.			Biaxial and failure properties of passive rat middle cerebral arteries	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Rat cerebral arteries; Passive biaxial mechanical properties	MECHANICAL-PROPERTIES; BLOOD-VESSELS	Rodents are commonly used as test subjects in research on traumatic brain injury and stroke. However, study of rat cerebral vessel properties has largely been limited to pressure-diameter response within the physiological loading range. A more complete, multiaxial description is needed to guide experiments on rats and rat vessels and to appropriately translate findings to humans. Accordingly, we dissected twelve rat middle cerebral arteries (MCAs) and subjected them to combined inflation and axial stretch tests around physiological loading conditions while in a passive state. The MCAs were finally stretched axially to failure. Results showed that MCAs under physiological conditions were stiffer in the axial than circumferential direction by a mean (+/- standard deviation) factor of 1.72 (+/- 0.73), similar to previously reported behavior of human cerebral arteries. However, the stiffness for both directions was lower in rat MCA than in human cerebral arteries (p < 0.01). Failure stretch values were higher in rat MCA (1.35 +/- 0.08) than in human vessels (1.24 +/- 0.09) (p=0.003), but corresponding 1st Piola Kirchhoff stress values for rats (0.42 +/- 0.09 MPa) were considerably lower than those for humans (3.29 +/- 0.64 MPa) (p < .001). These differences between human and rat vessel properties should be considered in rat models of human cerebrovascular injury and disease. (C) 2012 Elsevier Ltd. All rights reserved.	[Bell, E. David; Monson, Kenneth L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Kunjir, Rahul S.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA	Monson, KL (corresponding author), Univ Utah, 50 S Cent Campus Dr,MEB 2132, Salt Lake City, UT 84112 USA.	ken.monson@mech.utah.edu	Bell, E David/K-7196-2013; Monson, Ken/L-4702-2019	Monson, Ken/0000-0002-8461-6034	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K25HD048643]; Department of DefenseUnited States Department of Defense [W81XWH-08-1-0295]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K25HD048643] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health (5K25HD048643) and the Department of Defense (W81XWH-08-1-0295).	Baek S, 2007, COMPUT METHOD APPL M, V196, P3070, DOI 10.1016/j.cma.2006.06.018; BUSBY DE, 1965, CAN J PHYSIOL PHARM, V43, P185, DOI 10.1139/y65-018; CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600; Coulson RJ, 2004, J BIOMECH ENG-T ASME, V126, P76, DOI 10.1115/1.1645525; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fung Y., 1993, BIOMECHANICS MECH PR; Gonzalez JM, 2005, EXP PHYSIOL, V90, P463, DOI 10.1113/expphysiol.2005.030056; HAJDU MA, 1994, AM J PHYSIOL, V266, pH1027; HAYASHI K, 1980, BIORHEOLOGY, V17, P211; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P340, DOI 10.1115/1.2891194; Humphrey JD, 2002, CARDIOVASCULAR SOLID; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Monson KL, 2008, ANN BIOMED ENG, V36, P2028, DOI 10.1007/s10439-008-9578-9; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SCOTT S, 1972, CAN J PHYSIOL PHARM, V50, P328, DOI 10.1139/y72-049; Society of Automotive Engineers (SAE), 1995, J2111 SAE; Steelman SM, 2010, J BIOMECH, V43, P2717, DOI 10.1016/j.jbiomech.2010.06.024; VANLOON P, 1977, BIORHEOLOGY, V14, P181; Wagner HP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003873; Wicker BK, 2008, COMPUT METHOD BIOMEC, V11, P539, DOI 10.1080/10255840801949793	25	16	16	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JAN 4	2013	46	1					91	96		10.1016/j.jbiomech.2012.10.015			6	Biophysics; Engineering, Biomedical	Biophysics; Engineering	080QJ	WOS:000314258000016	23141521	Green Accepted			2021-06-18	
J	Agirbasli, M; Undar, A				Agirbasli, Mehmet; Uendar, Akif			Monitoring Biomarkers After Pediatric Heart Surgery: A New Paradigm on the Horizon	ARTIFICIAL ORGANS			English	Article; Proceedings Paper	8th International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion	JUN 13-16, 2012	Istanbul, TURKEY			Pediatric heart surgery; Biomarkers; Cardiopulmonary bypass; Outcomes; Congenital heart disease	FIBRILLARY ACIDIC PROTEIN; ACUTE CORONARY SYNDROMES; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; PLASMA-PROTEIN; SERUM; MARKERS; DISEASE; FEASIBILITY	Until recently, risk scoring systems for adult patients consisted of only clinical criteria. Currently, we are experiencing an abundant surge of literature integrating a wide range of biomarker arrays to clinical criteria in assessing the risk in an adult. In fact, novel risk scoring systems such as Reynolds criteria have emerged by combining the validated biomarkers to the traditional risk factors. Novel biomarkers potentially improve clinical management of cardiovascular disease, but there are gaps in understanding their role during childhood. The reason might be related to relatively lower prevalence of cardiovascular disease in children compared to the adult population. One exceptional group is the children with congenital heart disease. Recent studies indicate that novel biomarkers can alert the clinician in a timely manner about neurological and myocardial injury and their inflammatory consequences. Current technologies enable us to measure several biomarkers using only a few microliters of plasma. The preliminary studies show that novel biomarkers in addition to the traditionally studied biomarkers can help the clinician to identify children at high risk following pediatric heart surgery. Future studies are needed to confirm the role of biomarkers in monitoring children after cardiopulmonary bypass.	[Agirbasli, Mehmet] Marmara Univ, Dept Cardiol, Istanbul, Turkey; [Uendar, Akif] Penn State Hershey Childrens Hosp, Penn State Hershey Coll Med, Penn State Hershey Pediat Cardiovasc Res Ctr, Dept Pediat,Penn State Milton S Hershey Med Ctr, Hershey, PA USA; [Uendar, Akif] Penn State Hershey Childrens Hosp, Penn State Hershey Coll Med, Penn State Milton S Hershey Med Ctr, Dept Surg & Bioengn, Hershey, PA USA	Undar, A (corresponding author), Penn State Hershey Coll Med, Dept Pediat, H085,500 Univ Dr,POB 850, Hershey, PA 17033 USA.	aundar@psu.edu	Wang, Shigang/B-1215-2013	Wang, Shigang/0000-0002-5229-3330			ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Adams JE, 1999, CLIN CHIM ACTA, V284, P127, DOI 10.1016/S0009-8981(99)00074-1; ADAMS JE, 1993, CIRCULATION, V88, P750, DOI 10.1161/01.CIR.88.2.750; Agirbasli M, 2005, INT J CLIN PRACT, V59, P102, DOI 10.1111/j.1742-1241.2005.00379.x; Agirbasli M, 2010, ARTIF ORGANS, V34, P987, DOI 10.1111/j.1525-1594.2010.01133.x; Akcevin A, 2010, ARTIF ORGANS, V34, P879, DOI 10.1111/j.1525-1594.2010.01159.x; Andropoulos DB, 2010, J THORAC CARDIOV SUR, V139, P543, DOI 10.1016/j.jtcvs.2009.08.022; Aran K, 2011, LAB CHIP, V11, P2858, DOI 10.1039/c1lc20080a; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; CHANDLER WL, 1990, BLOOD, V76, P930; Creighton DE, 2007, PEDIATRICS, V120, pE478, DOI 10.1542/peds.2006-3250; Domico M, 2011, PEDIATR CRIT CARE ME, V12, pS33, DOI 10.1097/PCC.0b013e318221178d; Furukawa T, 2012, PEDIATR CARDIOL, V33, P264, DOI 10.1007/s00246-011-0135-1; Hasegawa T, 2004, J THORAC CARDIOV SUR, V127, P1697, DOI 10.1016/j.jtcvs.2004.02.006; Jenkins Kathy J, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P180, DOI 10.1053/j.pcsu.2004.02.009; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V124, P97, DOI 10.1067/mtc.2002.122311; JONAS RA, 1993, ANN THORAC SURG, V56, P1467, DOI 10.1016/0003-4975(93)90732-W; Knottnerus ILH, 2010, STROKE, V41, P1617, DOI 10.1161/STROKEAHA.109.576223; Lardner D, 2004, PEDIATR ANESTH, V14, P495, DOI 10.1111/j.1460-9592.2004.01230.x; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Lund J, 2010, CLIN CHEM, V56, P1158, DOI 10.1373/clinchem.2009.136960; Maar SP, 2008, PEDIATR EMERG CARE, V24, P883, DOI 10.1097/PEC.0b013e31819112b7; Majnemer A, 2006, J PEDIATR-US, V148, P72, DOI 10.1016/j.jpeds.2005.08.036; Moller JH, 1998, PERS PED C, V6, P19; O'Connor RE, 2010, CIRCULATION, V122, pS787, DOI 10.1161/CIRCULATIONAHA.110.971028; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pinto N, 2011, CURR DRUG METAB, V12, P487, DOI 10.2174/138920011795495321; Ramaswamy V, 2009, PEDIATR NEUROL, V40, P215, DOI 10.1016/j.pediatrneurol.2008.09.026; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rizzo G, 2011, J MATERN-FETAL NEO M, V24, P253, DOI 10.3109/14767058.2010.482627; Sasso LA, 2010, MICROFLUID NANOFLUID, V9, P253, DOI 10.1007/s10404-009-0543-1; Savage WJ, 2011, AM J HEMATOL, V86, P427, DOI 10.1002/ajh.21995; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schmitt B, 1998, BRAIN DEV-JPN, V20, P536, DOI 10.1016/S0387-7604(98)00046-1; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Su XWW, 2010, ARTIF ORGANS, V34, pE91, DOI 10.1111/j.1525-1594.2009.00963.x; Umstead TM, 2012, ARTIF ORGANS, V36, pE1, DOI 10.1111/j.1525-1594.2011.01412.x; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Williams RG, 2006, J AM COLL CARDIOL, V47, P701, DOI 10.1016/j.jacc.2005.08.074	40	16	17	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	JAN	2013	37	1					10	15		10.1111/j.1525-1594.2012.01573.x			6	Engineering, Biomedical; Transplantation	Engineering; Transplantation	072XG	WOS:000313706400004	24329546				2021-06-18	
J	Brandner, S; Thaler, C; Lewczuk, P; Lelental, N; Buchfelder, M; Kleindienst, A				Brandner, Sebastian; Thaler, Christian; Lewczuk, Piotr; Lelental, Natalia; Buchfelder, Michael; Kleindienst, Andrea			Neuroprotein Dynamics in the Cerebrospinal Fluid: Intraindividual Concomitant Ventricular and Lumbar Measurements	EUROPEAN NEUROLOGY			English	Article						Biomarker; S100B; Neuron-specific enolase; beta-Trace; Neurotrauma; Neuroproteins; Cerebrospinal fluid; Ventricular drain	NEURON-SPECIFIC ENOLASE; BETA-TRACE PROTEIN; S-100 PROTEIN; S100B; SERUM; MARKER; CSF; RELEASE; DAMAGE; BLOOD	Objective:The measurement of neuromarker/neuroproteins in the cerebrospinal fluid (CSF) is gaining increased popularity. However, insufficient information is available on the rostrocaudal distribution of neuroproteins in the CSF to guarantee an appropriate interpretation of ventricular versus lumbar concentrations. Methods: In 10 patients treated with both an external ventricular and a lumbar CSF drain, we collected concomitant CSF samples. We measured CSF concentrations of the glial S100B protein, the neuron-specific enolase (Cobas e411 (R); Roche Diagnostics), the leptomeningeal beta-trace protein (BN Pro Spec (R); Dade Behring/Siemens), and the blood-derived albumin (Immage; Beckman Coulter). Statistical analysis was performed with a paired Wilcoxon signed ranks test. Results: In patients with a free CSF circulation without any recent neurosurgical procedure, S100B and neuron-specific enolase concentrations did not differ between the ventricular and lumbar CSF while beta-trace and albumin levels were significantly higher in the lumbar than in the ventricular CSF (p = 0.008 and p = 0.005). Following posterior fossa tumor surgery, all proteins accumulate in the lumbar CSF. Conclusion: For brain-derived proteins, we could not confirm a rostrocaudal CSF gradient while lepto-meningeal and blood-derived proteins accumulate in the lumbar CSF. We conclude that for the interpretation of protein CSF concentrations, the source of the sample is of crucial importance. Copyright (C) 2013 S. Karger AG, Basel	[Brandner, Sebastian; Thaler, Christian; Buchfelder, Michael; Kleindienst, Andrea] Univ Erlangen Nurnberg, Dept Neurosurg, DE-91054 Erlangen, Germany; [Lewczuk, Piotr; Lelental, Natalia] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, DE-91054 Erlangen, Germany	Kleindienst, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Schwabachanlage 6, DE-91054 Erlangen, Germany.	andrea.kleindienst@uk-erlangen.de	Kleindienst, Andrea/F-1674-2014; Brandner, Sebastian/J-4562-2014	Kleindienst, Andrea/0000-0003-4758-0324; Brandner, Sebastian/0000-0002-9821-0342	ZNS - Hannelore Kohl Stiftung	This work was supported by a grant of the ZNS - Hannelore Kohl Stiftung to A.K.	Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brandner S, 2013, J NEUROTRAUM, V30, P1205, DOI 10.1089/neu.2012.2621; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; JACOBI C, 1988, CLIN CHIM ACTA, V177, P49, DOI 10.1016/0009-8981(88)90306-3; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nygaard O, 1997, CLIN CHEM, V43, P541; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Reiber H, 2003, ACTA NEUROL SCAND, V108, P359, DOI 10.1034/j.1600-0404.2003.00173.x; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Staykov D, 2009, STROKE, V40, P3275, DOI 10.1161/STROKEAHA.109.551945; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; Tarnaris A, 2011, NEUROCHEM RES, V36, P528, DOI 10.1007/s11064-010-0374-1; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Woertgen C, 2004, NEUROSURG REV, V27, P178, DOI 10.1007/s10143-004-0341-x	25	16	16	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2013	70	3-4					189	194		10.1159/000352032			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	240ZF	WOS:000326135500015	23969528	Green Published			2021-06-18	
J	Goodrich, GL; Martinsen, GL; Flyg, HM; Kirby, J; Asch, SM; Brahm, KD; Brand, JM; Cajamarca, D; Cantrell, JL; Chong, T; Dziadul, JA; Hetrick, BJ; Huang, MA; Ihrig, C; Ingalla, SP; Meltzer, BR; Rakoczy, CM; Rone, A; Schwartz, E; Shea, JE				Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Asch, Steven M.; Brahm, Karen D.; Brand, John M.; Cajamarca, Diana; Cantrell, Jenette L.; Chong, Theresa; Dziadul, John A.; Hetrick, Barbara J.; Huang, Michael A.; Ihrig, Carolyn; Ingalla, Shanida P.; Meltzer, Bradley R.; Rakoczy, Chrystyna M.; Rone, Ashley; Schwartz, Elliot; Shea, Jane E.			Development of a mild traumatic brain injury-specific vision screening protocol: A Delphi study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						accommodation; binocular vision; consensus; convergence insufficiency; Delphi method; mild traumatic brain injury; oculomotor; optometrist; traumatic brain injury; visual symptoms	POST-CONCUSSION SYNDROME; CONVERGENCE INSUFFICIENCY; PHYSICAL-EXAMINATION; VISUAL FUNCTION; POLYTRAUMA; PREVALENCE; GUIDELINES; SYMPTOMS; VETERANS; HISTORY	Although traumatic brain injury (TBI) can happen to anyone at any time, the wars in Iraq and Afghanistan have brought it renewed attention. Fortunately, most cases of TBI from the recent conflicts are mild TBI (mTBI). Still, many physical, psychological, and social problems are associated with mTBI. Among the difficulties encountered are oculomotor and vision problems, many of which can impede daily activities such as reading. Therefore, correct diagnosis and treatment of these mTBI-related vision problems is an important part of patient recovery. Numerous eye care providers in the Department of Veterans Affairs, in military settings, and in civilian practices specialize and are proficient in examining patients who have a history of TBI. However, many do not have this level of experience working with and treating patients with mTBI. Recognizing this, we used a modified Delphi method to derive expert opinions from a panel of 16 optometrists concerning visual examination of the patient with mTBI. This process resulted in a clinical tool containing 17 history questions and 7 examination procedures. This tool provides a set of clinical guidelines that can be used as desired by any eye care provider either as a screening tool or adjunct to a full eye examination when seeing a patient with a history of mTBI. The 757 goal of this process was to provide optimal and uniform vision care for the patient with mTBI.	[Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Asch, Steven M.; Ingalla, Shanida P.] Dept Vet Affairs VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Brahm, Karen D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Brand, John M.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Cajamarca, Diana] West Palm Beach VA Med Ctr VAMC, W Palm Beach, FL USA; [Cantrell, Jenette L.] Bay Pines VA Healthcare Syst, Bay Pines, FL USA; [Chong, Theresa] VA Southern Nevada Healthcare Syst, North Las Vegas, NV USA; [Dziadul, John A.] Viera VA Outpatient Clin, Viera, FL USA; [Hetrick, Barbara J.] Jonathan M Wainwright Mem VAMC, Walla Walla, WA USA; [Huang, Michael A.] VA Mission Valley Clin, San Diego, CA USA; [Ihrig, Carolyn] VA Western New York Healthcare Syst, Buffalo, NY USA; [Meltzer, Bradley R.] Northport VAMC, Northport, NY USA; [Rakoczy, Chrystyna M.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Rone, Ashley] Lexington VAMC, Lexington, KY USA; [Schwartz, Elliot] VA New York Harbor Healthcare Syst, New York, NY USA; [Shea, Jane E.] VA St Louis Hlth Care Syst, St Louis, MO USA	Goodrich, GL (corresponding author), VA Palo Alto Hlth Care Syst, 795 Willow Rd,Bldg T-365, Menlo Pk, CA 94025 USA.	Gregorv.Goodrich@va.gov	Goodrich, Gregory L./AAF-7184-2019		VA Health Services Research & Development QUERI [RRP 11-008]	This material was based on work supported by a VA Health Services Research & Development QUERI (grant RRP 11-008).	[Anonymous], 2011, POL BLAST REL INJ QU; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borsting E, 1999, OPTOMETRY VISION SCI, V76, P221, DOI 10.1097/00006324-199904000-00025; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Campbell SM, 1999, MED CARE, V37, P964, DOI 10.1097/00005650-199909000-00012; Campbell SM, 2000, BRIT MED J, V321, P425, DOI 10.1136/bmj.321.7258.425; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Centers for Disease Control and Prevention, 2013, MAN PEOPL HAV TBI; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Cohen Y, 2010, OPTOMETRY, V81, P28, DOI 10.1016/j.optm.2008.10.019; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW NUMB TBI; Douglas RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1155, DOI 10.1001/archophthalmol.2009.232; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; GOSS DA, 1992, CURR OPIN OPHTHALMOL, V3, P78, DOI 10.1097/00055735-199202000-00011; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hokoda S C, 1985, J Am Optom Assoc, V56, P560; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kingston J, 2010, J VISUAL IMPAIR BLIN, V104, P603, DOI 10.1177/0145482X1010401006; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; MILHOLLAND AV, 1973, NEW ENGL J MED, V288, P1272, DOI 10.1056/NEJM197306142882405; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Murphy M K, 1998, Health Technol Assess, V2, pi; Myint J, 2010, EYE, V24, P1509, DOI 10.1038/eye.2010.62; PETERSON MC, 1992, WESTERN J MED, V156, P163; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rand Corporation, 2013, DELPH METH; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; SCHOENBAUM SC, 1976, NEW ENGL J MED, V295, P759, DOI 10.1056/NEJM197609302951405; Stelmack J, 2004, J REHABIL RES DEV, V41, P233, DOI 10.1682/JRRD.2004.02.0233; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tobacman JK, 2003, MED DECIS MAKING, V23, P122, DOI 10.1177/0272989X03251241; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; Wold JE, 2003, J CATARACT REFR SURG, V29, P1878, DOI 10.1016/S0886-3350(03)00667-9	51	16	16	0	20	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	6					757	768		10.1682/JRRD.2012.10.0184			12	Rehabilitation	Rehabilitation	217HJ	WOS:000324350200005	24203539	Bronze			2021-06-18	
J	Martini, RP; Deem, S; Treggiari, MM				Martini, Ross P.; Deem, Steven; Treggiari, Miriam M.			Targeting Brain Tissue Oxygenation in Traumatic Brain Injury	RESPIRATORY CARE			English	Article						oxygen; brain injury; trauma; brain; oxygenation	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; POSITRON-EMISSION-TOMOGRAPHY; INTRA-CRANICAL PRESSURE; ACUTE LUNG INJURY; INTRACRANIAL-PRESSURE; METABOLISM; HYPOXIA; HYPERTENSION; EXPERIENCE	The management of patients with traumatic brain injury has evolved in the last several years, due to the introduction of new, invasive monitoring devices. The ability to monitor parameters other than measurements related to pressures has generated substantial interest. Brain tissue oxygenation monitoring has been consistently shown to provide prognostic information, as indicated by poor prognosis associated with low brain tissue oxygen values. Furthermore, various physiologic manipulations, including increasing the P-aO2, have been associated with an increase in brain tissue oxygenation. Whether brain-oxygenation-guided therapy results in improvement in outcomes is debatable. Retrospective studies suggest benefit, while prospective studies have shown a higher intensity of therapeutic interventions with no outcome differences. Data from high quality randomized trials are necessary to determine if brain-oxygenation-guided therapy is beneficial. An oxygen challenge (transient increase in F-IO2 to 0.6 up to 1.0) to assess the responsiveness of the monitoring and ascertain the presence of technical malfunction is an accepted practice.	[Martini, Ross P.] Oregon Hlth & Sci Univ Hosp, Dept Anesthesiol & Perioperat Med, Portland, OR USA; [Deem, Steven; Treggiari, Miriam M.] Univ Washington, Harborview Med Ctr, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA	Treggiari, MM (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Anesthesiol & Pain Med, Box 359724, Seattle, WA 98104 USA.	treggmm@u.washington.edu		Martini, Ross/0000-0001-8811-6558			Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Bardt TF, 1998, ACT NEUR S, V71, P153; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gupta AK, 2002, J NEUROSURG, V96, P263, DOI 10.3171/jns.2002.96.2.0263; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hoffman WE, 1998, NEUROL RES, V20, pS81; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marmarou A, 1991, J NEUROSURG, V75, pS59; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Servadei F, 2002, ACT NEUR S, V81, P81; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	54	16	17	0	12	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	JAN	2013	58	1			SI		162	169		10.4187/respcare.01942			8	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	071PG	WOS:000313606100020	23271826	Bronze			2021-06-18	
J	Peruzzaro, ST; Gallagher, J; Dunkerson, J; Fluharty, S; Mudd, D; Hoane, MR; Smith, JS				Peruzzaro, Sarah T.; Gallagher, Jonathan; Dunkerson, Jacob; Fluharty, Sarah; Mudd, David; Hoane, Michael R.; Smith, Jeffrey S.			The impact of enriched environment and transplantation of murine cortical embryonic stem cells on recovery from controlled cortical contusion injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; recovery of function; CCI; embryonic stem cells; enriched environment	TRAUMATIC BRAIN-INJURY; FRONTAL-CORTEX LESIONS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; FUNCTIONAL RECOVERY; COGNITIVE DEFICITS; SENSORIMOTOR FUNCTION; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; FOCAL ISCHEMIA	Purpose: The effectiveness of embryonic stem cell (eSC) therapy has been explored in many models of neurological disease and several research groups have shown that eSC treatment leads to improved outcomes in pre-clinical models of traumatic brain injury (TBI). Though functional recovery occurs, few surviving eSCs appear to develop neuronal characteristics; instead the majority of the surviving eSC express glial phenotypes. Additionally, researchers have shown that enriching the post-surgical environment of the subject promotes functional recovery following TBI. The purpose of the current project was to determine if post-surgical environmental enrichment (EE) impacts the survival, migration, and integration of eSCs in a rodent model of TBI and if the presence of these cells lead to improved outcomes. Methods: In the current study, the medial frontal cortex (MFC) of rats was injured using a controlled cortical impact (CCI) device. Immediately following injury the rats were placed into either EE or standard environment (SE) housing and then seven days post-injury rats received either murine cortical eSC or media. Behavioral testing consisted of the Morris water maze (MWM), Barnes Maze (BM), and Rotarod tasks (RR). Results: On the MWM task, TBI/eSC/EE animals performed as well as the Sham/SE and Sham/EE groups. The TBI/eSC/SE, TBI/Media/EE, and TBI/Media/SE groups were impaired compared to the controls. By the end of training on the BM there were no differences between the Sham, TBI/Media/EE, and TBI/eSC/EE groups. On the RR task all animals placed in the EE performed equally well and significantly better than their SE housed counterparts. By the end of training on the RR task, the TBI/eSC/EE group performed as well as the sham counterparts, and though not significant they also surpassed the performance of the injured animals that received enrichment or eSC treatment alone. Conclusions: Combing therapeutic strategies with enriching the post-injury environment is likely to be an important addition to determining the efficacy of pre-clinical therapies.	[Peruzzaro, Sarah T.] Univ Portland, Portland, OR 97203 USA; [Gallagher, Jonathan; Dunkerson, Jacob; Fluharty, Sarah; Mudd, David; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA; [Hoane, Michael R.] So Illinois Univ, Restorat Neurosci Lab, Carbondale, IL 62901 USA	Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, Malcolm & Lois Field Endowed Chair Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Hoane, Michael/0000-0001-7779-2657; Smith, Jeffrey/0000-0001-5499-4475	Support of Mentors and their Students (SOMAS) program; M.J. Murdock Charitable Trust; Hewlett Packard	This work was supported by funding from the Support of Mentors and their Students (SOMAS) program, the M.J. Murdock Charitable Trust, and Hewlett Packard. The authors would also like to thank Russ Wood, Pam Ward, Kasey Moritz, Robert Underly, Cole Vonder Haar, Danielle Friend, and Kyle Fink for their technical assistance with the project.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobrossy MD, 2004, EUR J NEUROSCI, V19, P159, DOI 10.1111/j.1460-9568.2004.03105.x; Eaton MJ, 2008, BEHAV BRAIN RES, V194, P236, DOI 10.1016/j.bbr.2008.07.001; ERB DE, 1991, EXP BRAIN RES, V83, P253; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hicks AU, 2008, BRAIN RES, V1231, P103, DOI 10.1016/j.brainres.2008.07.041; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Johansson BB, 2004, RESTOR NEUROL NEUROS, V22, P163; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Kempermann G, 1999, HIPPOCAMPUS, V9, P321, DOI 10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kolb B, 1991, CEREB CORTEX, V1, P189, DOI 10.1093/cercor/1.2.189; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; Lu L, 2003, EXP NEUROL, V183, P600, DOI 10.1016/S0014-4886(03)00248-6; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nygren J, 2006, STROKE, V37, P2824, DOI 10.1161/01.STR.0000244769.39952.90; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Scaccianoce S, 2006, BEHAV BRAIN RES, V168, P323, DOI 10.1016/j.bbr.2005.04.024; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	60	16	17	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2013	31	4					431	450		10.3233/RNN-120299			20	Neurosciences	Neurosciences & Neurology	171NC	WOS:000320935100007	23531530				2021-06-18	
J	Saxton, ME; Younan, SS; Lah, S				Saxton, Melissa E.; Younan, Shameran Slewa; Lah, Suncica			Social behaviour following severe traumatic brain injury: Contribution of emotion perception deficits	NEUROREHABILITATION			English	Article						Brain injuries; emotions; social behaviour; rehabilitation	STRESS SCALES DASS; COMMUNICATION ABILITIES; PSYCHOMETRIC PROPERTIES; DEPRESSION; ANXIETY; VALIDITY; SKILLS; OUTCOMES; ADJUSTMENT; VERSION	OBJECTIVE: This theoretically driven study aimed to determine contribution of emotional perception impairments to social behaviour following traumatic brain injury (TBI). METHODS: Adults with severe TBI (n = 24) participated. Emotion perception predictors included: (i) appraisal: Montreal Set of Facial Displays of Emotion, The Adapted Story Task, (ii) affective state: Depression, Anxiety and Stress Scale (DASS-21), Interpersonal Reactivity Index (IRI) and (iii) regulation: Delis Kaplan Executive Function System -Colour Word Interference and Word Fluency. Social behavioural outcomes were (i) interpersonal: Key Behaviors Change Inventory (KBCI) - Interpersonal Difficulties and (ii) communication: KBCI - Communication Problems. RESULTS: Social behaviours correlated with affective state, but not appraisal or regulation. Simultaneous regression analyses revealed significant independent contributions of affective state: (i) the IRI Perspective Taking to the KBCI Interpersonal Difficulties and (ii) the DASS-21 (composite) and IRI Perspective Taking to the KBCI Communication Problems. The models explained 52% and 72% of the variance of the KBCI Interpersonal Difficulties and Communication Problems respectively. CONCLUSIONS: This study provides evidence that impairments in certain aspects of emotion perception: affective state [empathy (perspective taking) and mood], but not appraisal and regulation, contribute to social behaviour difficulties in patients with severe TBI, which has important implications for rehabilitation.	[Saxton, Melissa E.; Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Younan, Shameran Slewa] Univ Western Sydney, Sch Med, Sydney, NSW, Australia	Lah, S (corresponding author), Univ Sydney, Sch Psychol, Mungo Mac Callum Bldg A19, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au		Lah, Suncica/0000-0003-2282-4812			Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Barlow D., 2001, CLIN HDB PSYCHOL DIS, V3rd; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beaupre M. G., 2000, MONTREAL SET FACIAL; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; CHRISTOPHER FS, 1993, J MARRIAGE FAM, V55, P469, DOI 10.2307/352816; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davis M.H, 1980, J PERS SOC PSYCHOL, V10, P85; Delis D.C., 2001, EXAMINERS MANUAL; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Higgins E.T., 1992, J LANG SOC PSYCHOL, V11, P107, DOI [10.1177/0261927X92113001, DOI 10.1177/0261927X92113001]; Hodgson J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Kraus J. F., 2005, TXB TRAUMATIC BRAIN, P3; KRAUSS RM, 1991, SOC COGNITION, V9, P2, DOI 10.1521/soco.1991.9.1.2; Long E, 2008, BRAIN IMPAIR, V9, P274, DOI 10.1375/brim.9.3.274; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Maguire P, 2002, BRIT MED J, V325, P697, DOI 10.1136/bmj.325.7366.697; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; MILLER WR, 1975, PSYCHOL BULL, V82, P238, DOI 10.1037/h0076367; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; REDMOND MV, 1995, J RES PERS, V29, P35, DOI 10.1006/jrpe.1995.1003; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Sale P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, 10.1097/00001199-199109000-00004.]; Scattone D, 2007, PSYCHOL SCHOOLS, V44, P717, DOI 10.1002/pits.20260; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schutte NS, 2001, J SOC PSYCHOL, V141, P523, DOI 10.1080/00224540109600569; SHEAN GD, 1995, J NERV MENT DIS, V183, P485, DOI 10.1097/00005053-199507000-00011; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	56	16	16	3	24	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	2					263	271		10.3233/NRE-130954			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	228IO	WOS:000325179600011	23949062				2021-06-18	
J	Vazan, P; Golub, A; Bennett, AS				Vazan, Peter; Golub, Andrew; Bennett, Alex S.			Substance Use and Other Mental Health Disorders Among Veterans Returning to the Inner City: Prevalence, Correlates, and Rates of Unmet Treatment Need	SUBSTANCE USE & MISUSE			English	Article						veterans' reintegration; substance use and mental health disorders; prevalence estimates; unmet treatment need; respondent-driven sampling (RDS)	POSTTRAUMATIC-STRESS-DISORDER; DRUG-USERS; AFGHANISTAN VETERANS; SERVICE MEMBERS; ALCOHOL MISUSE; IRAQ; DEPLOYMENT; VA; PTSD; CARE	Estimates of substance use and other mental health disorders of veterans (N = 269) who returned to predominantly low-income minority New York City neighborhoods between 2009 and 2012 are presented. Although prevalences of posttraumatic stress disorder, traumatic brain injury, and depression clustered around 20%, the estimated prevalence rates of alcohol use disorder, drug use disorder, and substance use disorder were 28%, 18%, and 32%, respectively. Only about 40% of veterans with any diagnosed disorder received some form of treatment. For alcohol use disorder, the estimate of unmet treatment need was 84%, which is particularly worrisome given that excessive alcohol use was the greatest substance use problem.	[Vazan, Peter; Golub, Andrew; Bennett, Alex S.] Natl Dev & Res Inst Inc, New York, NY 10010 USA	Vazan, P (corresponding author), Natl Dev & Res Inst Inc, 71 West 23rd St,8th Floor, New York, NY 10010 USA.	vazan@ndri.org			National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA020178]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA020178] Funding Source: NIH RePORTER	This research was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (R01 AA020178). Points of view expressed in this paper do not necessarily represent the official position of the U.S. Government, NIAAA, or NDRI. The authors express their deep appreciation to the project interviewers *Mr. Gary Huggins (U. S. Marines, retired), Mr. Atiba Marson-Quinones (U. S. Navy Reserves), and Ms. Morgan Cooley (U. S. Army, retired)* and all of the veterans who participated in the study.	Abdul-Quader AS, 2006, AIDS BEHAV, V9, P403; Anderson GL, 2009, EDUC POLICY, V23, P267, DOI 10.1177/0895904808328514; Bass E., 2012, VETERANS HLTH ADM TR; Bennett A. S., 2013, SUBST USE MISUSE, V48; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bourgois, 2003, SEARCH RESPECT SELLI; Bray R.M., 2009, 2008 DEP DEFENSE SUR; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Finley Erin, 2011, FIELDS COMBAT UNDERS; Golub A., 2013, SUBST USE MISUSE, V48; Golub Andrew, 2007, Criminol Public Policy, V6, P131, DOI 10.1111/j.1745-9133.2007.00426.x; Golub A, 2013, MIL MED, V178, P107, DOI 10.7205/MILMED-D-12-00131; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heckathorn D., 2012, RESPONDENT DRIVEN SA; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hosmer D, 1989, APPL LOGISTIC REGRES; Iguchi MY, 2009, J URBAN HEALTH, V86, pS5, DOI 10.1007/s11524-009-9365-4; Institute of Medicine (IOM), 2009, COMB TOB US MIL VET; IOM, 2012, TREATM POSTTR STRESS; IOM (Institute of Medicine), 2012, SUBST US DIS US ARM; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jeffri J., 2003, RESPONDENT DRIVEN SA, V3, P48; Johnson CV, 2009, AM J PUBLIC HEALTH, V99, pS187, DOI 10.2105/AJPH.2007.127464; Karney B.R., 2008, INVISIBLE WOUNDS PRE; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kirby AC, 2008, ADDICT BEHAV, V33, P1448, DOI 10.1016/j.addbeh.2008.05.007; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lansky A, 2007, PUBLIC HEALTH REP, V122, P48, DOI 10.1177/00333549071220S108; Luchins DJ, 2008, ADM POLICY MENT HLTH, V35, P270, DOI 10.1007/s10488-008-0169-8; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Maust DT, 2011, PSYCHIAT SERV, V62, P310, DOI 10.1176/ps.62.3.pss6203_0310; Nelson JP, 2008, NICOTINE TOB RES, V10, P775, DOI 10.1080/14622200802027123; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rusch ML, 2009, J URBAN HEALTH, V86, P760, DOI 10.1007/s11524-009-9377-0; SAMHSA, 2012, TREATM EP DAT SET TE; SAMHSA, 2012, NSDUH SER H, VH-44; *SAMHSA, 2005, NSDUH REP SUBST US D; SAMHSA, 2010, 2009 NAT SURV DRUG U; Schell T.L., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720-1ccf.12, DOI 10.7249/MG720-1CCF.12]; Schell T.L., 2011, NEEDS ASSESSMENT NEW; Schiller J. S., 2012, VITAL HLTH STAT, V10, P10; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Shahmanesh M, 2009, AM J PUBLIC HEALTH, V99, P1239, DOI 10.2105/AJPH.2008.149930; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR, VI; Substance Abuse and Mental Health Services Administration [SAMHSA] Office of Applied Studies, 2008, NSDUH REP MAJ DEPR E; Tanielian T, 2008, INVISIBLE WOUNDS WAR; U.S. Army, 2010, ARM HLTH PROM RISK R; US Department of Defense, 2008, ENH POSTD HLTH ASS P; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; WAGNER TH, 2007, PSYCHOL SERVICES, V0004; Wang JC, 2007, ADDICT BEHAV, V32, P924, DOI 10.1016/j.addbeh.2006.06.031; Wattana W, 2007, DRUG ALCOHOL DEPEN, V90, P228, DOI 10.1016/j.drugalcdep.2007.03.013; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Yano EM, 2012, J GEN INTERN MED, V27, P331, DOI 10.1007/s11606-011-1904-5	65	16	16	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2013	48	10					880	893		10.3109/10826084.2013.796989			14	Substance Abuse; Psychiatry; Psychology	Substance Abuse; Psychiatry; Psychology	186ES	WOS:000322025400008	23869460	Green Accepted			2021-06-18	
J	Walker, WC; McDonald, SD; Ketchum, JM; Nichols, M; Cifu, DX				Walker, William C.; McDonald, Scott D.; Ketchum, Jessica M.; Nichols, Michelle; Cifu, David X.			Identification of Transient Altered Consciousness Induced by Military-Related Blast Exposure and Its Relation to Postconcussion Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; explosive blast; military injury; questionnaire	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; PSYCHOMETRIC PROPERTIES; PTSD CHECKLIST; RELIABILITY; VALIDITY; QUESTIONNAIRE; INTERVIEW	Background: The ongoing controversy whether mild traumatic brain injury (TBI) can cause chronic sequel is partly due to diagnostic limitations. Diagnosing mild TBI is particularly challenging when assessment is not immediate, and when informed, first responder documentation or witness corroboration is absent. In this common scenario, the diagnosis is made entirely on self-report of an initial period of alteration of consciousness (AOC) associated with a plausible injury mechanism. Yet, there is scant published empirical guidance on methods for accurately detecting historical AOC. Objectives: To assess the value that recalled AOC symptoms collected via questionnaire have in evaluating individuals exposed to blast during recent military deployment. More specifically, to analyze the concrete AOC items (those signifying unconsciousness and/or posttraumatic amnesia) for their (1) frequency and distribution of positive versus negative responses, (2) interitem agreement, and (3) relation to current neuropsychiatric symptoms including those consistent with postconcussion syndrome (PCS). Participants: Eighty-seven active duty or Veteran subjects who experienced acute effects from a blast within the past 2 years while deployed for Operations Enduring and Iraqi Freedom. Results: Twenty-nine participants (33.3%) responded positively to at least 1 of 3 concrete AOC items: gap in memory (17.2%), memory not continuous (13.8%), and/or told by observer they had loss of consciousness (20.7%). Alteration of consciousness items were associated with but nondiscriminate of current symptom distress on standardized measures of PCS (Rivermead Postconcussion Symptom Questionnaire), posttraumatic stress disorder (PTSD; PTSD Checklist), depression (Centers for Epidemiological Studies Depression Scale), and pain (Short Form McGill Pain Questionnaire). Conclusions: The positive association between subjects' questionnaire-based AOC item responses and current symptom complex measures suggests that mild TBI has a role in the development of chronic neuropsychiatric symptoms after blast exposure. The lack of symptom-complex discrimination, and the inconsistencies found in subjects' item responses suggest that a structured interview may improve postacute diagnostic specificity for mild TBI.	[Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, MCV Stn, Richmond, VA 23298 USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Psychol Humanities & Sci, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Walker, William C.; McDonald, Scott D.; Nichols, Michelle] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, William C.; Nichols, Michelle] Def & Vet Brain Injury Ctr, Rockville, MD USA; [Nichols, Michelle] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Cifu, David X.] Dept Vet Affairs, Off Rehabil Serv, Washington, DC USA	Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, MCV Stn, Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Ketchum, Jessica/AAE-8200-2020; Walker, William C/N-3162-2014; Nichols, Michelle/AAV-2740-2020	Cifu, David/0000-0003-1600-9387; Ketchum, Jessica/0000-0002-5566-3691; Nichols, Michelle/0000-0002-2078-9649	US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP) [W91ZSQ8118N6200001]	This study was supported by a grant from US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP) grant no. W91ZSQ8118N6200001; Epidemiological Study of Mild Traumatic Brain Injury Sequelae Caused by Blast Exposure during Operations Iraq Freedom and Enduring Freedom.	Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; First MB., 2002, STRUCTURED CLIN INTE; Flaherty S A, 1996, AANA J, V64, P133; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	35	16	16	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2013	28	1					68	76		10.1097/HTR.0b013e318255dfd0			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	070ZW	WOS:000313555400008	22647964				2021-06-18	
J	Xie, BW; Park, D; Van Beek, ER; Blankevoort, V; Orabi, Y; Que, I; Kaijzel, EL; Chan, A; Hogg, PJ; Lowik, CWGM				Xie, B-W; Park, D.; Van Beek, E. R.; Blankevoort, V.; Orabi, Y.; Que, I.; Kaijzel, E. L.; Chan, A.; Hogg, P. J.; Lowik, C. W. G. M.			Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator	CELL DEATH & DISEASE			English	Article						traumatic brain injury; cryolesion; apoptosis; necrosis; GSAO; optical imaging	IN-VIVO; APOPTOSIS; NECROSIS; EXPRESSION; TISSUES; MODEL; MICE	Traumatic brain injury is a major public health concern and is characterised by both apoptotic and necrotic cell death in the lesion. Anatomical imaging is usually used to assess traumatic brain injuries and there is a need for imaging modalities that provide complementary cellular information. We sought to non-invasively image cell death in a mouse model of traumatic brain injury using a near-infrared fluorescent conjugate of a synthetic heat shock protein-90 alkylator, 4-(N-(S-glutathionylacetyl) amino) phenylarsonous acid (GSAO). GSAO labels both apoptotic and necrotic cells coincident with loss of plasma membrane integrity. The optical GSAO specifically labelled apoptotic and necrotic cells in culture and did not accumulate in healthy organs or tissues in the living mouse body. The conjugate is a very effective imager of cell death in brain lesions. The optical GSAO was detected by fluorescence intensity and GSAO bound to dying/dead cells was detected from prolongation of the fluorescence lifetime. An optimal signal-to-background ratio was achieved as early as 3 h after injection of the probe and the signal intensity positively correlated with both lesion size and probe concentration. This optical GSAO offers a convenient and robust means to non-invasively image apoptotic and necrotic cell death in brain and other lesions. Cell Death and Disease (2013) 4, e473; doi:10.1038/cddis.2012.207; published online 24 January 2013	[Xie, B-W; Van Beek, E. R.; Blankevoort, V.; Orabi, Y.; Que, I.; Kaijzel, E. L.; Chan, A.; Lowik, C. W. G. M.] Leiden Univ, Dept Radiol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Park, D.; Hogg, P. J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Park, D.; Hogg, P. J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Bldg C25, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au		Hogg, Philip/0000-0001-6486-2863; Kaijzel, Eric/0000-0003-3118-9910; Chan, Alan/0000-0001-6949-9274	Dutch Centre for Translational Molecular Medicine, project [03O-202]; ENCITE project [201842]; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Cancer Council New South WalesCancer Council New South Wales	This study is supported by the Dutch Centre for Translational Molecular Medicine, project MUSIS (grant 03O-202), the ENCITE project 201842, the National Health and Medical Research Council of Australia and the Cancer Council New South Wales.	ADAMS E, 1990, INORG CHEM, V29, P1500, DOI 10.1021/ic00333a012; Akers WJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982535; Ardeshirpour Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031881; Beekman CAC, 2011, APPL RADIAT ISOTOPES, V69, P656, DOI 10.1016/j.apradiso.2010.12.012; Blankenberg FG, 2008, CANCER BIOL THER, V7, P1525, DOI 10.4161/cbt.7.10.6934; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Erten A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3509111; Faul M., 2010, TRAUMATIC BRAIN INJU, P1; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; Goiffon RJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3095800; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Hall DJ, 2012, J CEREBR BLOOD F MET, V32, P23, DOI 10.1038/jcbfm.2011.119; Hanshaw RG, 2005, BIOORGAN MED CHEM, V13, P5035, DOI 10.1016/j.bmc.2005.04.071; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Hotta N, 2005, MOL BRAIN RES, V133, P71, DOI 10.1016/j.molbrainres.2004.09.027; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lederle W, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-26; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MERYMAN HT, 1956, SCIENCE, V124, P515, DOI 10.1126/science.124.3221.515; Nardai G, 2000, ARCH BIOCHEM BIOPHYS, V384, P59, DOI 10.1006/abbi.2000.2075; Niu G, 2010, J NUCL MED, V51, P1659, DOI 10.2967/jnumed.110.078584; Park D, 2011, J AM CHEM SOC, V133, P2832, DOI 10.1021/ja110226y; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Smith BA, 2012, ACS CHEM NEUROSCI, V3, P530, DOI 10.1021/cn3000197; Steinbach JP, 1999, NEUROPATH APPL NEURO, V25, P468; Stoffel M, 2004, J NEUROTRAUM, V21, P733, DOI 10.1089/0897715041269678; Taruttis A, 2012, AM J ROENTGENOL, V199, P263, DOI 10.2214/AJR.11.8431; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Wen JY, 2007, TECHNOL CANCER RES T, V6, P635, DOI 10.1177/153303460700600607; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xie BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031875; Xiong CY, 2011, J MED CHEM, V54, P1825, DOI 10.1021/jm101477d; Zhao M, 2009, ANTI-CANCER AGENT ME, V9, P1018, DOI 10.2174/187152009789377691	35	16	16	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JAN	2013	4								e473	10.1038/cddis.2012.207			8	Cell Biology	Cell Biology	101IE	WOS:000315767600023	23348587	DOAJ Gold, Green Published			2021-06-18	
J	Echlin, PS; Skopelja, EN; Worsley, R; Dadachanji, SB; Lloyd-Smith, DR; Taunton, JA; Forwell, LA; Johnson, AM				Echlin, Paul S.; Skopelja, Elaine N.; Worsley, Rachel; Dadachanji, Shiroy B.; Lloyd-Smith, D. Rob; Taunton, Jack A.; Forwell, Lorie A.; Johnson, Andrew M.			A prospective study of physician-observed concussion during a varsity university ice hockey season: incidence and neuropsychological changes. Part 2 of 4	NEUROSURGICAL FOCUS			English	Article						concussion; ice hockey; incidence; neuropsychological testing; sex; Canada	SCHOOL FOOTBALL PLAYERS; CHRONIC TRAUMATIC ENCEPHALOPATHY; INJURY SURVEILLANCE SYSTEM; SPORT-RELATED CONCUSSION; BASE-LINE VALUES; RECURRENT CONCUSSION; PROFESSIONAL FOOTBALL; DESCRIPTIVE EPIDEMIOLOGY; INTERNATIONAL-CONFERENCE; BRAIN-FUNCTION	Object. The primary objective of this study was to measure the incidence of concussion according to a relative number of athlete exposures among 25 male and 20 female varsity ice hockey players. The secondary objective was to present neuropsychological test results between preseason and postseason play and at 72 hours, 2 weeks, and 2 months after concussion. Methods. Every player underwent baseline assessments using the Sport Concussion Assessment Tool-2 (SCAT2), Immediate Post-Concussion Assessment and Cognitive Test (ImPACT), and MRI. Each regular season and postseason game was observed by 2 independent observers (a physician and a nonphysician observer). Players with a diagnosed concussion were removed from the game, examined in the team physician's office using the SCAT2 and ImPACT, and sent to undergo MRI. Results. Eleven concussions occurred during the 55 physician-observed games (20%). The incidence of concussion, expressed as number of concussions per 1000 athlete exposures, was 10.70 for men and women combined in regular season play, 11.76 for men and women combined across both the regular season and playoff season, 7.50 for men and 14.93 for women in regular season play, and 8.47 for men across both the regular season and playoff season. One male player experienced repeat concussions. No concussions were reported during practice sessions, and 1 concussion was observed and diagnosed in an exhibition game. Neuropsychological testing suggested no statistically significant preseason/postseason differences between athletes who sustained a physician-diagnosed concussion and athletes who did not sustain a physician-diagnosed concussion on either the ImPACT or SCAT2. The athletes who sustained a physician-diagnosed concussion demonstrated few reliable changes postinjury. Conclusions. Although the incidence of game-related concussions per 1000 athlete exposures in this study was half the highest rate reported in the authors' previous research, it was 3 times higher than the incidence reported by other authors within the literature concerning men's collegiate ice hockey and 5 times higher than the highest rate previously reported for woman's collegiate ice hockey. Interestingly, the present results suggest a substantively higher incidence of concussion among women (14.93) than men (7.50). The reproducible and significantly higher incidence of concussion among both men and woman ice hockey players, when compared with nonphysician-observed games, suggests a significant underestimation of sports concussion in the scientific literature. (http://thejns.org/doi/abs/10.3171/2012.10.FOCUS12286)	[Echlin, Paul S.] Elliott Sports Med Clin, Burlington, ON L7N 2G3, Canada; [Skopelja, Elaine N.] Indiana Univ, Sch Med Lib, Indianapolis, IN 46204 USA; [Worsley, Rachel] Univ British Columbia, Sch Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Dadachanji, Shiroy B.; Taunton, Jack A.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Lloyd-Smith, D. Rob] Univ British Columbia, Dept Family Med, Vancouver, BC V5Z 1M9, Canada; [Forwell, Lorie A.] Univ Western Ontario, Fowler Kennedy Sport Med Clin, London, ON, Canada; [Forwell, Lorie A.] Univ Western Ontario, Sch Phys Therapy, London, ON, Canada; [Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada	Echlin, PS (corresponding author), Elliott Sports Med Clin, 1100 Walkers Line,Suite 2, Burlington, ON L7N 2G3, Canada.	psechlin@gmail.com	Johnson, Andrew M/B-2048-2012	Skopelja, Elaine/0000-0002-2847-8909; Johnson, Andrew M./0000-0002-7269-3016			Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cusimano M, 2002, CAN J NEUROL SCI S1, V29, pS25; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Keating P, ESPN MAGAZINE; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Lehman EJ, 2012, NEUROLOGY; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; O'Kane JW, 2011, CLIN J SPORT MED, V21, P486, DOI 10.1097/JSM.0b013e31822e89a8; Pinto M, 1999, CLIN J SPORT MED, V9, P70, DOI 10.1097/00042752-199904000-00005; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Shuttleworth-Edwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P479, DOI 10.1016/j.acn.2008.07.002; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	57	16	16	0	15	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2012	33	6							E2	10.3171/2012.10.FOCUS12286			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	048GI	WOS:000311898500003	23199425	Bronze			2021-06-18	
J	McIntosh, SE; Campbell, A; Weber, D; Dow, J; Joy, E; Grissom, CK				McIntosh, Scott E.; Campbell, Aaron; Weber, David; Dow, Jennifer; Joy, Elizabeth; Grissom, Colin K.			Mountaineering Medical Events and Trauma on Denali, 1992-2011	HIGH ALTITUDE MEDICINE & BIOLOGY			English	Article						Denali; Mt. McKinley; injury; illness; rescue	SEVERE FROSTBITE; PREVENTION; GUIDELINES	Scott E. McIntosh, Aaron Campbell, David Weber, Jennifer Dow, Elizabeth Joy, and Colin K. Grissom. Mountaineering Medical Events and Trauma on Denali, 1992-2011. High Alt Med Biol 13:275-280, 2012.-Denali (Mt. McKinley) is the tallest mountain in North America and a popular climbing destination for high altitude mountaineering expeditions. National Park Service (NPS) personnel care for and manage medical incidences and traumatic injuries for mountaineers each year. We retrospectively examined NPS medical reports from the climbing seasons of 1992-2011. Medical complaints, diagnoses, treatment, provider training, and overall numbers of injuries and illness were analyzed. Fatalities were included only if they were cared for by NPS medical personnel prior to death. Of the 24,079 climbers on Denali during this period, 831 (3.5%) required medical assistance from the NPS. There were 819 diagnoses; 502 were due to medical illness and 317 were traumatic injuries. Patient encounters occurred most frequently (71%) at the 4328m camp. Frostbite was the most common individual diagnosis (18.1%), while altitude-related syndromes were the most common illness category (29%). Most patients (84%) were treated and released to descend without additional intervention, whereas 11% needed air evacuation, and 4% needed another type of NPS assistance to descend. The only fatality in this series was caused by traumatic brain injury due to a climbing fall. A broad variety of medical complaints were evaluated and treated by NPS personnel, most commonly altitude related problems and frostbite. The results of the study will enhance the awareness of potential illness and injuries encountered by medical providers participating in high altitude mountaineering expeditions. Additionally, providers responsible for evaluating mountaineers prior to their expeditions can educate them on the spectrum of physical and environmental conditions that increase the chances of illness or injury. This ideally will decrease the incidence of morbidity on both Denali and other high altitude mountaineering destinations.	[McIntosh, Scott E.] Univ Utah, Div Emergency Med, Salt Lake City, UT 84132 USA; [Campbell, Aaron] Adventist Hlth Med Grp, Sandy, OR USA; [Weber, David] Talkeetna Ranger Stn, Denali Natl Pk, Talkeetna, AK USA; [Weber, David] Univ Utah, Remote Rescue Training, Salt Lake City, UT 84132 USA; [Dow, Jennifer] Alaska Reg Hosp, Natl Pk Serv Alaska Reg, Girdwood, AK USA; [Joy, Elizabeth] Intermt Healthcare, Clin Outcomes Res, Salt Lake City, UT USA; [Grissom, Colin K.] Intermt Med Ctr, Shock Trauma ICU, Murray, UT USA	McIntosh, SE (corresponding author), Univ Utah, Div Emergency Med, 30 N Med Dr, Salt Lake City, UT 84132 USA.	Scott.mcintosh@hsc.utah.edu					Bruen KJ, 2007, ARCH SURG-CHICAGO, V142, P546, DOI 10.1001/archsurg.142.6.546; Cauchy E, 2011, NEW ENGL J MED, V364, P189, DOI 10.1056/NEJMc1000538; Harirchi I, 2005, BRIT J SPORT MED, V39, P898, DOI 10.1136/bjsm.2004.016097; Jenabzadeh K, 2006, J BURN CARE RES, V30, pS103; Leigh-Smith S, 2004, WILD ENVIRON MED, V15, P157, DOI 10.1580/1080-6032(2004)15[157:CMPITR]2.0.CO;2; Lischke V, 2001, WILD ENVIRON MED, V12, P74, DOI 10.1580/1080-6032(2001)012[0074:MAITEA]2.0.CO;2; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; Mcintosh SE, 2008, HIGH ALT MED BIOL, V9, P89, DOI 10.1089/ham.2008.1047; McIntosh SE, 2011, WILD ENVIRON MED, V22, P156, DOI 10.1016/j.wem.2011.03.003; McIntosh SE, 2010, WILD ENVIRON MED, V21, P103, DOI 10.1016/j.wem.2009.12.024; McLaughlin JB, 2005, WILD ENVIRON MED, V16, P92, DOI 10.1580/1080-6032(2005)16[92:GOAMCT]2.0.CO;2; Mort A, 2011, CLIN J SPORT MED, V21, P530, DOI 10.1097/JSM.0b013e318234be97; National Park Service, 2005, MOUNT DEN NAT PARK R; Roscoe C, 2006, WILD ENVIRON MED, V17, P75, DOI 10.1580/PR03-05.1; Schoffl V, 2011, WILD ENVIRON MED, V22, P46, DOI 10.1016/j.wem.2010.11.008; Smith Larry O, 2006, Phys Med Rehabil Clin N Am, V17, P633, DOI 10.1016/j.pmr.2006.05.003; Twomey JA, 2005, J TRAUMA, V59, P1350, DOI 10.1097/01.ta.0000195517.50778.2e	17	16	17	1	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1527-0297			HIGH ALT MED BIOL	High Alt. Med. Biol.	DEC	2012	13	4					275	280		10.1089/ham.2012.1027			6	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	063LZ	WOS:000313001900008	23270445				2021-06-18	
J	Rogachev, B; Ohayon, S; Saad, A; Vorobiovsky, V; Gruenbaum, BF; Leibowitz, A; Boyko, M; Shapira, Y; Shnaider, A; Zlotnik, M; Azab, AN; Zlotnik, A				Rogachev, Boris; Ohayon, Sharon; Saad, Amit; Vorobiovsky, Victoria; Gruenbaum, Benjamin F.; Leibowitz, Akiva; Boyko, Matthew; Shapira, Yoram; Shnaider, Alla; Zlotnik, Moshe; Azab, Abed N.; Zlotnik, Alexander			The effects of hemodialysis on blood glutamate levels in chronic renal failure: Implementation for neuroprotection	JOURNAL OF CRITICAL CARE			English	Article						Brain injury; Glutamate; Glutamate oxaloacetate transaminase (GOT); Glutamate pyruvate transaminase (GPT); Hemodialysis	AMINO-ACID LOSSES; CLOSED-HEAD INJURY; SCAVENGING ACTIVITY; CLINICAL-TRIALS; ISCHEMIC-STROKE; RAT MODEL; BRAIN; DIALYSIS; PLASMA; COMPARTMENTS	Purpose: The purpose of the present study is to investigate whether hemodialysis (HD) is effective in lowering blood glutamate levels. In addition, we examined the effect of HD on glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT) levels in the blood and described the rate and pattern of blood glutamate clearance during HD. Materials and Methods: Blood samples were taken from 45 patients with stage V chronic kidney disease immediately after initiation of HD and hourly, for a total of 5 blood samples. Samples were sent for determination of glutamate, glucose, GOT, GPT, hemoglobin, hematocrit, urea, and creatinine levels. A blood sample from 25 healthy volunteers without chronic renal failure was used as a control for the determination of baseline blood levels of glutamate, GOT, and GPT. Results: Glutamate and GPT levels in patients on HD were higher at baseline compared with healthy controls (P < .001). In the first 3 hours after HD, there was a decrease in blood glutamate levels compared with baseline levels (P < .00001). At the fourth hour, there was an increase in blood glutamate levels compared with the third hour (P < .05). Conclusions: Hemodialysis may be a promising method of reducing blood glutamate levels. (C) 2012 Elsevier Inc. All rights reserved.	[Zlotnik, Alexander] Soroka Med Ctr, Div Anesthesiol, Dept Anesthesiol & Crit Care, IL-84101 Beer Sheva, Israel; [Rogachev, Boris; Shnaider, Alla; Zlotnik, Moshe] Soroka Med Ctr, Dept Nephrol, IL-84101 Beer Sheva, Israel; [Rogachev, Boris; Ohayon, Sharon; Vorobiovsky, Victoria; Gruenbaum, Benjamin F.; Leibowitz, Akiva; Boyko, Matthew; Shapira, Yoram; Shnaider, Alla; Zlotnik, Moshe; Zlotnik, Alexander] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Saad, Amit] Univ Haifa, Dept Philosophy, IL-31999 Haifa, Israel; [Azab, Abed N.] Ben Gurion Univ Negev, Fac Hlth Sci Ben Gur, Sch Community Hlth Profess, IL-84105 Beer Sheva, Israel	Zlotnik, A (corresponding author), Soroka Med Ctr, Div Anesthesiol, Dept Anesthesiol & Crit Care, IL-84101 Beer Sheva, Israel.	zlotnika@bgu.ac.il		Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915			BERGSTROM J, 1989, ADV EXP MED BIOL, V260, P1; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BERL S, 1962, J BIOL CHEM, V237, P2562; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; Boyko M, 2010, J NEUROSCI METH, V193, P246, DOI 10.1016/j.jneumeth.2010.08.026; Campos F, 2011, J CEREB BLOOD FLOW M; Campos F, 2011, CLIN SCI LOND; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castro MCM, 2001, NEPHROL DIAL TRANSPL, V16, P1814, DOI 10.1093/ndt/16.9.1814; Choi JY, NEPHROL DIAL TRANSPL; COHEN GA, 1976, ANN INTERN MED, V84, P275, DOI 10.7326/0003-4819-84-3-275; CRAWFORD DR, 1978, NEPHRON, V22, P418, DOI 10.1159/000181484; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Divino JC, 1998, J ENDOCRINOL, V156, P519, DOI 10.1677/joe.0.1560519; Divino JC, 1997, NEPHROL DIAL TRANSPL, V12, P2339; Garred LJ, 1997, NEPHROL DIAL TRANSPL, V12, P535, DOI 10.1093/ndt/12.3.535; Gil HW, 2007, J KOREAN MED SCI, V22, P598, DOI 10.3346/jkms.2007.22.4.598; GIORDANO C, 1980, CLIN NEPHROL, V14, P230; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; IKIZLER TA, 1994, KIDNEY INT, V46, P830; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KOPPLE JD, 1982, AM J CLIN NUTR, V36, P395; Mate M, 2009, EUR J PHARMACOL, V604, P51, DOI 10.1016/j.ejphar.2008.12.022; McIntyre CW, 2010, SEMIN DIALYSIS, V23, P449, DOI 10.1111/j.1525-139X.2010.00782.x; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; Nagy D, 2010, CELL MOL NEUROBIOL, V30, P1101, DOI 10.1007/s10571-010-9542-8; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Pakfetrat M, 2010, SAUDI J KIDNEY DIS T, V21, P707; Soupart A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017903.77985.CD; Sulowicz Wladyslaw, 2007, Med Pregl, V60 Suppl 2, P14; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2008, NEUROSCIENCE; WOLFSON M, 1982, KIDNEY INT, V21, P500, DOI 10.1038/ki.1982.52; Zauner A, 1996, ACT NEUR S, V67, P40; Zlotnik A, 2010, EXP NEUROL; Zlotnik A, 2010, BIOL REPROD; Zlotnik A, 2011, ANESTHESIOL IN PRESS; Zlotnik A, J NEUROSURG ANESTHES, V23, P45; Zlotnik A, 2009, AM SOC AN ANN M LA U; Zlotnik A, NEUROCHEM RES; Zlotnik A, 2008, AM SOC AN ANN M FL U; Zlotnik A, 2007, NEUROCHEM RES; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120; Zlotnik A, 2011, NEUROCHEM RES, V36, P732, DOI 10.1007/s11064-010-0388-8; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	55	16	16	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2012	27	6							743.e1	10.1016/j.jcrc.2012.07.002			7	Critical Care Medicine	General & Internal Medicine	057YF	WOS:000312599800041	23084134				2021-06-18	
J	Zhu, ZD; Ma, GJ; Wu, CW; Chen, Z				Zhu, Zhao Dan; Ma, Guo Jun; Wu, Cheng Wei; Chen, Zhen			Numerical study of the impact response of woodpecker's head	AIP ADVANCES			English	Article							BRAIN-INJURY; VISCOSITY	Woodpecker can beat trees 20-25 times per second and lasts for several seconds, with a 1200 g deceleration, but it appears that they never get brain concussion. How does the stress wave propagate from the beak tip to brain and how does a woodpecker protect itself from brain damage? In this paper, we establish a finite element model of typical woodpecker head based on its X-ray tomography images and conduct the numerical analysis of the impact response of the woodpecker's head by using a viscoelasticity material model. Especially, the woodpecker head response to an impact speed of 7 m/s is investigated to explore the stress concentration zone and how the stress wave propagates in its head. The numerical results show that the stress wave in the head propagates from the upper beak to back skull and is reduced by the specific structure of hyoid and viscoelasticity of biomaterials. The maximum stresses in skull and brain are both below the safe level. The stress in skull almost disappears before the next impact. The stress in brain lasts for a little longer but shows smaller value with little variation. The stress is impossible to accumulate in the limited pecking time, so the brain damage can be avoided. Copyright 2012 Author(s). This article is distributed under a Creative Commons Attribution 3.0 Unported License. [http://dx.doi.org/10.1063/1.4770305]	[Zhu, Zhao Dan; Ma, Guo Jun; Wu, Cheng Wei] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian, Peoples R China; [Chen, Zhen] Univ Missouri, Dept Civil & Environm Engn, Columbia, MO 65211 USA	Zhu, ZD (corresponding author), Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian, Peoples R China.	cwwu@dlut.edu.cn; chenzh@missouri.edu	WU, ChengWei/B-2590-2019	WU, ChengWei/0000-0003-1284-9442; Chen, Zhen/0000-0002-9231-8395	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [10972050, 90816025]; doctoral education foundation of China Education Ministry [20110041110021]	This work was supported by the National Natural Science Foundation of China (10972050, 90816025) and the doctoral education foundation of China Education Ministry (20110041110021)	GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Gindl W, 2002, COMPOS PART A-APPL S, V33, P1141, DOI 10.1016/S1359-835X(02)00080-5; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Lunde KB, 2008, J MECH BEHAV BIOMED, V1, P199, DOI 10.1016/j.jmbbm.2007.10.001; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Neubauer S, 2004, CAN ASSOC RADIOL J, V55, P271; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; Ono K., 1980, STAPP CAR CRASH C 24, V101, P60; Pithioux M, 2004, MED ENG PHYS, V26, P647, DOI 10.1016/j.medengphy.2004.05.002; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schwab IR, 2002, BRIT J OPHTHALMOL, V86, P843, DOI 10.1136/bjo.86.8.843; Stark RD, 1998, CONDOR, V100, P350, DOI 10.2307/1370276; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Vincent IFV, 2007, P I MECH ENG C-J MEC, V221, P1141, DOI 10.1243/09544062JMES574; Wang L.Z., 2011, PLOS ONE, V6; Wang LZ, 2011, SCI CHINA LIFE SCI, V54, P1036, DOI 10.1007/s11427-011-4242-2; Yoon SH, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016003; Zhou P, 2009, J BIONIC ENG, V6, P214, DOI 10.1016/S1672-6529(08)60126-2	20	16	16	0	54	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	DEC	2012	2	4							042173	10.1063/1.4770305			8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	061DX	WOS:000312828700086		DOAJ Gold			2021-06-18	
J	Ma, M; Shofer, FS; Neumar, RW				Ma, Marek; Shofer, Frances S.; Neumar, Robert W.			Calpastatin Overexpression Protects Axonal Transport in an In Vivo Model of Traumatic Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; axonal transport; head trauma; traumatic brain injury; viral mediated transfection	CALPAIN INHIBITOR MDL-28170; BRAIN-INJURY; STRETCH-INJURY; OPTIC-NERVE; HEAD-INJURY; CASPASE ACTIVATION; CORPUS-CALLOSUM; GENE-THERAPY; MICROTUBULES; MICE	Traumatic brain injury (TBI) causes substantial morbidity and mortality worldwide. A key component of both mild and severe TBI is diffuse axonal injury. Except in cases of extreme mechanical strain, when axons are torn at the moment of trauma, axonal stretch injury is characterized by early cytoskeletal proteolysis, transport disruption, and secondary axotomy. Calpains, a family of Ca2+-dependent proteases, have been implicated in this pathologic cascade, but direct in vivo evidence is lacking. To test the hypothesis that calpains play a causal role in axonal stretch injury in vivo, we used our rat optic nerve stretch model following adeno-associated viral (AAV) vector-mediated overexpression of the endogenous calpain inhibitor calpastatin in optic nerve axons. AAV vectors were designed for optimal expression of human calpastatin (hCAST) in retinal ganglion cells (RGCs). Calpain inhibition by the expressed protein was then confirmed in primary cortical cultures. Finally, we performed bilateral intravitreal injections of AAV vectors expressing hCAST or the reporter protein ZsGreen 3 weeks prior to unilateral optic nerve stretch. Immediately after stretch injury, Fluoro-Gold was injected into the superior colliculi for assessment of retrograde axonal transport. Rats were euthanized 4 days after stretch injury. Both hCAST and ZsGreen were detected in axons throughout the optic nerve to the chiasm. Calpastatin overexpression partially preserved axonal transport after stretch injury (58.3 +/- 15.6% reduction in Fluoro-Gold labeling relative to uninjured contralateral controls in ZsGreen-expressing RGCs, versus 33.8 +/- 23.9% in hCAST-expressing RGCs; p = 0.038). These results provide direct evidence that axonal calpains play a causal role in transport disruption after in vivo stretch injury.	[Ma, Marek; Neumar, Robert W.] Univ Penn, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA; [Ma, Marek; Shofer, Frances S.; Neumar, Robert W.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA	Ma, M (corresponding author), Univ Penn, Ctr Resuscitat Sci, 125 S 31st St,Suite 1200, Philadelphia, PA 19104 USA.	marekma@mail.med.upenn.edu			Penn Vector Core NIDDK P30 Molecular Therapy Center Grant; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS055880]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS055880] Funding Source: NIH RePORTER	We thank Xinran Wang for helpful technical assistance, Margaret Maronski for preparing cultured cortical neurons, and David Meaney for the use of his optic nerve stretch device. We would like to acknowledge the University of Pennsylvania Preclinical Vector Core facility for providing vector production services, and partial funding through the Penn Vector Core NIDDK P30 Molecular Therapy Center Grant. Additional support was provided by the National Institutes of Health grant NS055880 (M.M.).	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; BILLGER M, 1988, CELL CALCIUM, V9, P33, DOI 10.1016/0143-4160(88)90036-X; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Czeiter E, 2009, MOLECULES, V14, P5115, DOI 10.3390/molecules14125115; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; GASKIN F, 1975, ANN NY ACAD SCI, V253, P133, DOI 10.1111/j.1749-6632.1975.tb19197.x; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Hirano Asao, 1995, P49; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; JOHNSON GVW, 1989, BIOCHEM BIOPH RES CO, V163, P1505, DOI 10.1016/0006-291X(89)91150-9; KEITH C, 1983, J CELL BIOL, V97, P1918, DOI 10.1083/jcb.97.6.1918; Ma MR, 2012, J NEUROTRAUM, V29, P445, DOI 10.1089/neu.2011.2060; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; OBrien ET, 1997, CELL MOTIL CYTOSKEL, V36, P125, DOI 10.1002/(SICI)1097-0169(1997)36:2<125::AID-CM3>3.0.CO;2-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SAHENK Z, 1988, BRAIN RES, V460, P199, DOI 10.1016/0006-8993(88)91224-3; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200	53	16	17	1	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	16					2555	2563		10.1089/neu.2012.2473			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	035CS	WOS:000310920900004	22776025	Green Published			2021-06-18	
J	Nelson, DW; Rudehill, A; MacCallum, RM; Holst, A; Wanecek, M; Weitzberg, E; Bellander, BM				Nelson, David W.; Rudehill, Anders; MacCallum, Robert M.; Holst, Anders; Wanecek, Michael; Weitzberg, Eddie; Bellander, Bo-Michael			Multivariate Outcome Prediction in Traumatic Brain Injury with Focus on Laboratory Values	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Coma Score; Glasgow Outcome Scale; hematologic tests; outcome; traumatic brain injury (TBI)	GLASGOW COMA SCALE; PROGNOSTIC VALUE; CLINICAL-TRIALS; HEAD-INJURY; IMPACT; MODELS; HYPERGLYCEMIA; COAGULOPATHY; ENROLLMENT; ALBUMIN	Traumatic brain injury (TBI) is a major cause of morbidity and mortality. Identifying factors relevant to outcome can provide a better understanding of TBI pathophysiology, in addition to aiding prognostication. Many common laboratory variables have been related to outcome but may not be independent predictors in a multivariate setting. In this study, 757 patients were identified in the Karolinska TBI database who had retrievable early laboratory variables. These were analyzed towards a dichotomized Glasgow Outcome Scale (GOS) with logistic regression and relevance vector machines, a non-linear machine learning method, univariately and controlled for the known important predictors in TBI outcome: age, Glasgow Coma Score (GCS), pupil response, and computed tomography (CT) score. Accuracy was assessed with Nagelkerke's pseudo R-2. Of the 18 investigated laboratory variables, 15 were found significant (p < 0.05) towards outcome in univariate analyses. In contrast, when adjusting for other predictors, few remained significant. Creatinine was found an independent predictor of TBI outcome. Glucose, albumin, and osmolarity levels were also identified as predictors, depending on analysis method. A worse outcome related to increasing osmolarity may warrant further study. Importantly, hemoglobin was not found significant when adjusted for post-resuscitation GCS as opposed to an admission GCS, and timing of GCS can thus have a major impact on conclusions. In total, laboratory variables added an additional 1.3-4.4% to pseudo R-2.	[Nelson, David W.; Rudehill, Anders; Wanecek, Michael; Weitzberg, Eddie] Karolinska Inst, Sect Anesthesiol & Intens Care, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Inst, Neurosurg Sect, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [MacCallum, Robert M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Immunogen Grp, London SW7 2AZ, England; [Holst, Anders] SICS, Kista, Sweden	Nelson, DW (corresponding author), Karolinska Inst, Sect Anesthesiol & Intens Care, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	david.nelson@karolinska.se	Wanecek, Michael/AAE-7998-2021		Regional Agreement on Medical Training and Clinical Research (ALF); Stockholm County CouncilStockholm County Council; Karolinska InstitutetKarolinska Institutet; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Cancer and Traffic Injury Fund (CTRF)	Funding for this study was provided in part by the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and the Karolinska Institutet, funds from the Karolinska Institutet, The Swedish Research Council, and The Swedish Cancer and Traffic Injury Fund (CTRF).	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Bishop CM., 2006, PATTERN RECOGNITION; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Farin A, 2004, ACT NEUR S, V89, P101; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Helmy A, 2010, ACTA NEUROCHIR, V152, P953, DOI 10.1007/s00701-009-0584-y; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; R Development Core Team, 2008, R LANGUAGE ENV STAT; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Salehpour F, 2011, J CRIT CARE, V26, P352, DOI 10.1016/j.jcrc.2010.12.005; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Young B, 1989, ANN SURG, V210, P472	47	16	17	0	11	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2613	2624		10.1089/neu.2012.2468			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400003	22994879				2021-06-18	
J	Neyens, DM; Boyle, LN				Neyens, David M.; Boyle, Linda Ng			Crash risk factors related to individuals sustaining and drivers following traumatic brain injuries	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Traumatic brain injuries (TBI); Cognitive impairments; Crash data; Case-control study	ACCIDENT RATE; SEVERITY; DAMAGE; YOUNG; COMA	Objective: Some crashes result in drivers experiencing (or sustaining) a traumatic brain injury (TBI) while other crashes involve drivers that have already experienced a TBI. The objective of this study is to examine the factors that influence these two TBI crash groups. Methods: Data from the Iowa Department of Public Health's Brain Injury Registry and Department of Transportation's crash records were linked together and used in logistic regression models to predict the likelihood of a driver sustaining a TBI in a crash and those who drive after a TBI. Results: Between 2001 and 2006, there were 2382 crashes in which an individual sustained a TBI. As expected, a higher likelihood of sustaining a TBI was observed for motorcycle drivers who did not wear a helmet and in crashes that resulted in total or disabling vehicle damage. Focusing specifically on the post-TBI drivers (and not occupants), 1583 were involved in crashes. These post-TBI drivers were less likely to wear seatbelts or have passengers in the vehicle at the time of the crash, and were more likely to crash at night. Post-TBI drivers were also involved in significantly more multiple crashes (about 14%) when compared to drivers who have not experienced a TBI (about 10%) during the study period. When controlling for gender, date of injury, and severity of TBI (using Glasgow Coma Scale), individuals that sustained a TBI when they were younger were more likely to be involved in multiple crashes. Conclusions: Different factors influence the crash likelihood for those that sustain a TB! in a crash and those that crash following a TBI. In general, post-TBI drivers have a higher occurrence of multiple crashes and this should be further explored to guide driver rehabilitation, evaluation, and training. (C) 2012 Elsevier Ltd. All rights reserved.	[Neyens, David M.] Clemson Univ, Dept Ind Engn, Clemson, SC USA; [Boyle, Linda Ng] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	Boyle, LN (corresponding author), Univ Washington, Dept Ind & Syst Engn, Box 352650, Seattle, WA 98195 USA.	linda@uw.edu					Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Brenner LA, 2008, REHABIL PSYCHOL, V53, P18, DOI 10.1037/0090-5550.53.1.18; Bunn TL, 2005, ACCIDENT ANAL PREV, V37, P862, DOI 10.1016/j.aap.2005.04.004; Dimarco F, 2001, EURA MEDICOPHYS, V37, P215; Donmez B, 2010, J TRANSP ENG, V136, P403, DOI 10.1061/(ASCE)TE.1943-5436.0000068; Farmer Charles M, 2003, Traffic Inj Prev, V4, P38, DOI 10.1080/15389580309855; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; FORMISANO R, 2001, EUROPA MEDICOPHYSICA, V37, P257; Grossman DC, 1997, ACCIDENT ANAL PREV, V29, P313, DOI 10.1016/S0001-4575(96)00085-1; HANDLER BS, 1995, J REHABIL, V61, P43; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Hill JD, 2007, TRANSPORT RES F-TRAF, V10, P177, DOI 10.1016/j.trf.2006.09.002; IDPH, 2007, IOW PLAN BRAIN INJ 2; IDPH, 2007, IOW COD FACT SHEET T; IIHS, 2009, CURR US MOT BIC HELM; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Kegler SR, 2003, J HEAD TRAUMA REHAB, V18, P469, DOI 10.1097/00001199-200311000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lowenstein SR, 2001, J TRAUMA, V50, P313, DOI 10.1097/00005373-200102000-00019; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; MacLennan PA, 2004, INJURY PREV, V10, P363, DOI 10.1136/ip.2003.005025; MASSIE DL, 1995, ACCIDENT ANAL PREV, V27, P73, DOI 10.1016/0001-4575(94)00050-V; McCrea MA, 2007, MILD TRAUMATIC BRAIN; McGwin G, 1999, ACCIDENT ANAL PREV, V31, P181; Neyens DM, 2008, ACCIDENT ANAL PREV, V40, P254, DOI 10.1016/j.aap.2007.06.005; Neyens DM, 2007, ACCIDENT ANAL PREV, V39, P206, DOI 10.1016/j.aap.2006.07.004; NINDS, 2007, TRAUM BRAIN INJ HOP; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Peden M., 2004, WORLD REPORT ROAD TR; PeekAsa C, 1996, J TRAUMA, V41, P989, DOI 10.1097/00005373-199612000-00008; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Segui-Gomez M, 2000, AM J PUBLIC HEALTH, V90, P1575, DOI 10.2105/AJPH.90.10.1575; Stutts J. C., 2003, DISTRACTIONS EVERYDA, pHS; Tagliaferri F., 2006, ACTA NEUROCHIRURGICA, P148; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Woodward M, 2005, EPIDEMIOLOGY STUDY D	44	16	16	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2012	49				SI		266	273		10.1016/j.aap.2012.01.008			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	074WI	WOS:000313845300034	23036405				2021-06-18	
J	Yanuck, D; Mihos, CG; Santana, O				Yanuck, Danielle; Mihos, Christos G.; Santana, Orlando			Mechanisms and Clinical Evidence of the Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Central Nervous System Disorders: A Comprehensive Review	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						brain; CNS; neurology; non-lipid lowering; statins	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; RANDOMIZED CONTROLLED-TRIAL; TRANSIENT ISCHEMIC ATTACK; GUILLAIN-BARRE-SYNDROME; MULTIPLE-SCLEROSIS; STATIN USE; ALZHEIMERS-DISEASE; INTRACEREBRAL HEMORRHAGE	The hydroxy-methyl-glutaryl-CoA reductase inhibitors, better known as statins, are principally used in the treatment of hyperlipidemia and play a pivotal role in the primary and secondary prevention of atherosclerotic heart disease and stroke. Evidence also exists for the potential benefits from statin use in a variety of other disease processes, conferred via their non-lipid lowering properties, which are known as pleiotropic effects. Our paper serves as a focused and updated discussion on the pleiotropic effects of statins in neurological disorders. Emphasis is placed on the discussion of randomized, placebo-controlled trials, and their importance in further elucidating this interesting phenomenon.	[Santana, Orlando] Columbia Univ, Div Cardiol, Mt Sinai Heart Inst, Echocardiog Lab, Miami Beach, FL 33140 USA; [Yanuck, Danielle] Mt Sinai Med Ctr, Dept Internal Med, Miami Beach, FL 33140 USA	Santana, O (corresponding author), Columbia Univ, Div Cardiol, Mt Sinai Heart Inst, Echocardiog Lab, 4300 Alton Rd, Miami Beach, FL 33140 USA.	osantana@msmc.com					Abellan-Miralles I, 2006, REV NEUROLOGIA, V43, P659, DOI 10.33588/rn.4311.2006100; Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bar EE, 2008, EXPERT OPIN INV DRUG, V17, P185, DOI 10.1517/13543784.17.2.185; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Beltowski J, 2010, MED SCI MONITOR, V16, pRA73; Bessler H, 1999, BIOMED PHARMACOTHER, V53, P141, DOI 10.1016/S0753-3322(99)80079-1; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Biffi A, 2011, NEUROLOGY, V76, P1581, DOI 10.1212/WNL.0b013e3182194be9; Birnbaum G, 2008, NEUROLOGY, V71, P1390, DOI 10.1212/01.wnl.0000319698.40024.1c; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Carlsson CM, EVALUATE SAFETY EFFE; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Cemeus C, 2008, J NEURO-ONCOL, V90, P9, DOI 10.1007/s11060-008-9627-0; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chroinin DN, 2011, STROKE, V42, P1021, DOI 10.1161/STROKEAHA.110.596734; Collins R, 2004, LANCET, V363, P757; Correale J, 2007, AUTOIMMUNITY, V40, P148, DOI 10.1080/08916930601183522; Damier P, SAFETY EFFICACY PRAV; Diringer M, STATINS CEREBRAL BLO; Edwards IR, 2007, DRUG SAFETY, V30, P515, DOI 10.2165/00002018-200730060-00005; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Everett BM, 2010, CIRCULATION, V121, P143, DOI 10.1161/CIRCULATIONAHA.109.874834; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Figueiredo E, ROLE STATINS PREVENT; Flint AC, 2012, STROKE, V43, P147, DOI 10.1161/STROKEAHA.111.627729; Frederiksen JL, SIMVASTATIN TREATMEN; Frederiksen JL, SIMVASTATIN ADD ON T; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gao X, 2012, ARCH NEUROL-CHICAGO, V69, P380, DOI 10.1001/archneurol.2011.1060; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Goldstein LB, 2008, NEUROLOGY, V70, P2364, DOI 10.1212/01.wnl.0000296277.63350.77; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Golomb BA, 2009, DRUG SAFETY, V32, P649, DOI 10.2165/00002018-200932080-00004; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hackam DG, 2011, CIRCULATION, V124, P2233, DOI 10.1161/CIRCULATIONAHA.111.055269; Harris JR, 2010, SUBCELL BIOCHEM, V51, P47, DOI 10.1007/978-90-481-8622-8_2; Hoe Heo J, EFFECTS VERY EARLY U; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kazui H, CLIN STUDY PITAVASTA; Koob AO, 2010, EXP NEUROL, V221, P267, DOI 10.1016/j.expneurol.2009.11.015; Kramer AH, 2010, NEUROCRIT CARE, V12, P285, DOI 10.1007/s12028-009-9306-9; Kurinami H, 2008, INT J MOL MED, V21, P531; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Lapchak PA, 2009, BRAIN RES, V1303, P144, DOI 10.1016/j.brainres.2009.09.064; Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Li XL, 2011, CELL IMMUNOL, V271, P455, DOI 10.1016/j.cellimm.2011.08.015; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Markovic-Plese S, 2008, FUTUR NEUROL, V3, P153, DOI 10.2217/14796708.3.2.153; Matsumoto M, JAPAN STATIN TREATME; Miesbach W, 2005, J NEUROL SCI, V238, P93, DOI 10.1016/j.jns.2005.06.008; Migrino R, CAROTID PLAQUE REGRE; Mihos CG, 2012, RHEUMATOL INT, V32, P287, DOI 10.1007/s00296-011-2008-6; Mihos CG, 2011, INT J GEN MED, V4, P261, DOI 10.2147/IJGM.S16779; Mihos CG, 2010, CARDIOL REV, V18, P298, DOI 10.1097/CRD.0b013e3181f52a7f; Miron VE, 2007, GLIA, V55, P130, DOI 10.1002/glia.20441; Miron VE, 2009, AM J PATHOL, V174, P1880, DOI 10.2353/ajpath.2009.080947; Mutez E, 2009, PHARMACOL RES, V60, P41, DOI 10.1016/j.phrs.2009.03.010; Paintlia AS, 2009, GLIA, V57, P182, DOI 10.1002/glia.20745; Patassini S, 2008, NEUROSCI LETT, V448, P166, DOI 10.1016/j.neulet.2008.10.023; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pugh MJV, 2009, J AM GERIATR SOC, V57, P237, DOI 10.1111/j.1532-5415.2008.02124.x; Putaala J, 2011, NEUROLOGY, V77, P426, DOI 10.1212/WNL.0b013e318227b1c2; Rajabally YA, 2004, MUSCLE NERVE, V30, P663, DOI 10.1002/mus.20112; Rockwood K, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-26; Rojas-Fernandez CH, 2012, ANN PHARMACOTHER, V46, P549, DOI 10.1345/aph.1Q620; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Rudick RA, 2009, NEUROLOGY, V72, P1989, DOI 10.1212/WNL.0b013e3181a92b96; Sarkey JP, 2007, J NEUROCHEM, V100, P1265, DOI 10.1111/j.1471-4159.2006.04309.x; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Scola RH, 2004, ARQ NEURO-PSIQUIAT, V62, P540, DOI 10.1590/S0004-282X2004000300031; Serbanescu I, 2004, J LIPID RES, V45, P2038, DOI 10.1194/jlr.M400097-JLR200; Sillberg VAH, 2008, STROKE, V39, P2622, DOI 10.1161/STROKEAHA.107.508341; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sorensen HT, 2010, CIRC-CARDIOVASC QUAL, V3, P413, DOI 10.1161/CIRCOUTCOMES.110.936278; Sorensen PS, 2011, LANCET NEUROL, V10, P691, DOI 10.1016/S1474-4422(11)70144-2; Sparks DL, 2006, ACTA NEUROL SCAND, V114, P3, DOI 10.1111/j.1600-0404.2006.00690.x; Squizzato A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007551, 10.1002/14651858.CD007551.pub2]; Sterzer P, 2001, STROKE, V32, P2817, DOI 10.1161/hs1201.099663; Sugawara T, 2008, ACTA NEUROCHIR SUPPL, V104, P287; Tandon V., 2005, Indian Journal of Pharmacology, V37, P77; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Togha M, 2010, MULT SCLER J, V16, P848, DOI 10.1177/1352458510369147; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Tsakiri A, 2010, EXP NEUROL, V221, P320, DOI 10.1016/j.expneurol.2009.11.014; Valone F, IMMUNOTHERAPY BHT 30; Vergouwen MDI, 2008, STROKE, V39, P497, DOI 10.1161/STROKEAHA.107.488791; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2011, EXP NEUROL, V230, P27, DOI 10.1016/j.expneurol.2010.04.006; Weber MS, 2008, CURR TOP MICROBIOL, V318, P313; Westover MB, 2011, ARCH NEUROL-CHICAGO, V68, P573, DOI 10.1001/archneurol.2010.356; Whitfield JF, 2006, EXPERT OPIN INV DRUG, V15, P1479, DOI 10.1517/13543784.15.12.1479; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020945; Zinman L, 2008, AMYOTROPH LATERAL SC, V9, P223, DOI 10.1080/17482960802031092	105	16	16	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	NOV	2012	122	11					619	629		10.3109/00207454.2012.704455			11	Neurosciences	Neurosciences & Neurology	019PK	WOS:000309751600001	22720798				2021-06-18	
J	Schneider, EB; Hirani, SA; Hambridge, HL; Haut, ER; Carlini, AR; Castillo, RC; Efron, DT; Haider, AH				Schneider, Eric B.; Hirani, Salman A.; Hambridge, Hali L.; Haut, Elliott R.; Carlini, Anthony R.; Castillo, Renan C.; Efron, David T.; Haider, Adil H.			Beating the weekend trend: Increased mortality in older adult traumatic brain injury (TBI) patients admitted on weekends	JOURNAL OF SURGICAL RESEARCH			English	Article						Weekend admission; Weekday admission; Head trauma; Traumatic brain injury; Older adults; Nationwide Inpatient Sample	HOSPITAL ADMISSION; WEEKDAY ADMISSION; STROKE; CARE	Background: Weekend admission is associated with mortality in cardiovascular emergencies and stroke but the effect of weekend admission for trauma is not well defined. We sought to determine whether differences in mortality outcomes existed for older adults with substantial head trauma admitted on a weekday versus over the weekend. Methods: Data from the 2006, 2007, and 2008 Nationwide Inpatient Sample were combined and head trauma admissions were isolated. Abbreviated injury scale (AIS) scores were calculated using ICDMAP-90 Software. Individuals aged 65 to 89 y with head AIS equal to 3 or 4 and no other region score <3 were included. Individual Charlson comorbidity scores were calculated and individuals with missing mortality, sex, or insurance data were excluded. Wilcoxon rank sum andStudent t-tests compared demographics, length of stay, and total charges for week day versus weekend admissions. The chi(2) tests compared sex and head injury severity. Logistic regression modeled mortality adjusting for age, sex, injury severity, comorbidity, and insurance status. Results: Of the 38,675 patients meeting criteria, 9937 (25.6%) were admitted on weekends. Mean age was similar (78.4 versus 78.4, P = 0.796) but more weekend admissions were female (51.6% versus 50.2%, P = 0.022). Weekend patients demonstrated slightly lower comorbidity (mean Charlson = 1.07 versus 1.14, P < 0.001) and head injury severity (58.3% versus 60.8% AIS = 4, P < 0.001). Median weekend length of stay was shorter (4 versus 5 d, P < 0.001). Weekend and weekday median total charges did not differ ($27,128 versus $27,703, respectively, P = 0.667). Proportional mortality was higher among weekend patients (9.3% versus 8.4%, P = 0.008). After adjustment, weekend patients demonstrated 14% increased odds of mortality (OR 1.14, 95% CI 1.05-1.23). Conclusion: Older adults with substantial head trauma admitted on weekends are less severely injured, carry less comorbidity, and generate similar total charges compared with those admitted on weekdays. However, after accounting for known risk confounders, weekend patients demonstrated 14% greater odds of mortality. Mechanisms behind this disparity must be determined and eliminated. (C) 2012 Elsevier Inc. All rights reserved.	[Schneider, Eric B.] Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, Baltimore, MD 21287 USA; [Hambridge, Hali L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Carlini, Anthony R.; Castillo, Renan C.; Haider, Adil H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Schneider, EB (corresponding author), Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, 600 N Wolfe St,Harvey 616, Baltimore, MD 21287 USA.	eschnei1@jhmi.edu	Haut, Elliott R./J-3948-2019; Carlini, Anthony/AAN-1153-2020	Carlini, Anthony/0000-0003-1419-4515; Haut, Elliott/0000-0001-7075-771X			Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Carr BG, 2011, ARCH SURG-CHICAGO, V146, P810, DOI 10.1001/archsurg.2011.60; Carr BG, 2010, J TRAUMA, V69, P1042, DOI 10.1097/TA.0b013e3181f6f958; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Crowley RW, 2009, J NEUROSURG, V111, P60, DOI 10.3171/2008.11.JNS081038; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Haut ER, 2006, J TRAUMA, V61, P272, DOI 10.1097/01.ta.0000222939.51147.1c; HCUP Nationwide Inpatient Sample (NIS), 2008, HCUP NAT INP SAMPL N; Heros RC, 2009, J NEUROSURG, V111, P57, DOI 10.3171/2008.11.JNS081550; Horwich TB, 2009, AM HEART J, V158, P451, DOI 10.1016/j.ahj.2009.06.025; James MT, 2010, J AM SOC NEPHROL, V21, P845, DOI 10.1681/ASN.2009070682; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Meretoja A, 2010, STROKE, V41, P1102, DOI 10.1161/STROKEAHA.109.577718; O'Brien EC, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/383012; Zhan C, 2003, QUAL SAF HEALTH CARE, V12, pII58, DOI 10.1136/qhc.12.suppl_2.ii58	19	16	16	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2012	177	2					295	300		10.1016/j.jss.2012.06.022			6	Surgery	Surgery	004VD	WOS:000308708400025	22795343				2021-06-18	
J	Frankenfield, DC; Ashcraft, CM				Frankenfield, David C.; Ashcraft, Christine M.			Description and prediction of resting metabolic rate after stroke and traumatic brain injury	NUTRITION			English	Article						Brain injury; Stroke; Critical illness; Energy metabolism	CRITICALLY-ILL PATIENTS; ENERGY-EXPENDITURE; MECHANICAL VENTILATION; BODY-TEMPERATURE; VALIDATION; MODERATE; OBESE; HYPERMETABOLISM; HEMORRHAGE; SEVERITY	Objective: To compare the effect of stroke on the metabolic rate compared with the effect of traumatic brain injury and to determine whether the metabolic rate is predictable in both types of brain injury. Methods: Indirect calorimetry was conducted prospectively in mechanically ventilated patients within the first 6 d of admission to a critical care unit owing to ischemic stroke, hemorrhagic stroke, isolated traumatic brain injury, or traumatic brain injury with collateral injuries. Clinical data were collected simultaneously and a predicted value of the resting metabolic rate was calculated using the Penn State equation (using body size, body temperature, and minute ventilation). Results: One hundred thirty patients were measured. Ischemic stroke showed a lower incidence of fever, a lower body temperature, and a lower resting metabolic rate than the other groups; whereas in hemorrhagic stroke, these variables were similar to the trauma groups. Sedation decreased the resting metabolic rate, but this effect seemed particular to the trauma patients. The Penn State equation predicted the resting metabolic rate accurately 72% of the time, and when its component variables of body temperature and minute ventilation were controlled in an analysis of variance, all the differences among the brain injury and sedation groups were eliminated. Conclusion: Stroke is a hypermetabolic event most of the time. Body size, temperature, and minute ventilation explain most of the variation in the resting metabolic rate after traumatic and nontraumatic brain injuries. The Penn State equation therefore predicts the resting metabolic rate in brain-injured patients no matter the mechanism of injury. (C) 2012 Elsevier Inc. All rights reserved.	[Frankenfield, David C.] Penn State Milton S Hershey Med Ctr, Dept Clin Nutr, Hershey, PA USA; Penn State Milton S Hershey Med Ctr, Dept Nursing, Hershey, PA USA	Frankenfield, DC (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Clin Nutr, Hershey, PA USA.	Dfrankenfield@hmc.psu.edu					Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Bardutzky J, 2004, INTENS CARE MED, V30, P151, DOI 10.1007/s00134-003-1988-4; Bardutzky J, 2004, J NEUROSURG, V100, P266, DOI 10.3171/jns.2004.100.2.0266; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; CHIOLERO RL, 1993, METABOLIC SUPPORT CR, P95; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Esper DH, 2006, JPEN-PARENTER ENTER, V30, P71, DOI 10.1177/014860710603000271; Finestone HM, 2003, STROKE, V34, P502, DOI 10.1161/01.STR.0000053031.12332.FB; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Frankenfield D, 2011, JPEN-PARENTER ENTER, V35, P264, DOI 10.1177/0148607110377903; Frankenfield DC, 2009, JPEN-PARENTER ENTER, V33, P27, DOI 10.1177/0148607108322399; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Frankenfield DC, 1997, INJURY, V28, P617, DOI 10.1016/S0020-1383(97)00117-4; GARREL DR, 1994, AM J CLIN NUTR, V59, P971; HEYMSFIELD SB, 1987, AM J CLIN NUTR, V45, P526; Kasuya H, 1998, NEUROSURGERY, V42, P1268, DOI 10.1097/00006123-199806000-00038; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241; PHANG PT, 1990, JPEN-PARENTER ENTER, V14, P259, DOI 10.1177/0148607190014003259; RAUBENHEIMER D, 1995, FUNCT ECOL, V9, P21, DOI 10.2307/2390086; Raurich JM, 2007, JPEN-PARENTER ENTER, V31, P58, DOI 10.1177/014860710703100158; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; WEEKES E, 1992, CLIN NUTR, V11, P18, DOI 10.1016/0261-5614(92)90058-X; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	28	16	17	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007			NUTRITION	Nutrition	SEP	2012	28	9					906	911		10.1016/j.nut.2011.12.008			6	Nutrition & Dietetics	Nutrition & Dietetics	994DQ	WOS:000307911500015	22464552				2021-06-18	
J	Goecks, CSB; Horst, A; Moraes, MS; Scheid, T; Kolberg, C; Bello-Klein, A; Partata, WA				Goecks, Cristina S. B.; Horst, Andrea; Moraes, Maira S.; Scheid, Taina; Kolberg, Carolina; Bello-Klein, Adriane; Partata, Wania A.			Assessment of Oxidative Parameters in Rat Spinal Cord After Chronic Constriction of the Sciatic Nerve	NEUROCHEMICAL RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; SUPEROXIDE-DISMUTASE; NEUROPATHIC PAIN; XYLENOL ORANGE; FREE-RADICALS; NITRIC-OXIDE; STRESS; ACTIVATION; ASSAY	Although reactive oxygen species (ROS) are involved in neuropathic pain, the direct relationship between these species and chronic constriction of sciatic nerve (CCI) has not been studied in spinal cord. Thus, this study induced CCI in rats and these animals were sacrificed 3 and 10 days after the surgical procedure to determine the superoxide dismutase (SOD) and catalase activities, as well as ascorbic acid, hydrogen peroxide (H2O2) and lipid hydroperoxide levels in lumbosacral spinal cord. Von Frey Hair and hot plate tests were performed to assess the degree of mechanical and thermal hyperalgesia at days 0, 3 and 10. The results showed that CCI significantly induced mechanical and thermal hyperalgesia at days 3 and 10. Parallel there was increase in spinal cord lipid hydroperoxide at days 3 and 10 in rats submitted to CCI. In Sham rats a significant increase in this parameter occurred at day 10. H2O2 decreased at day 10 only in CCI group. SOD activity was decreased in Sham and CCI groups at day 3, while catalase activity was increased in CCI rats at days 3 and 10. Ascorbic acid levels were reduced only in CCI rats at day 3. Although the role of such changes is unclear, many were not specific to neuropathic pain and the differences could be related to different degrees of central sensitization in Sham and CCI rats.	[Goecks, Cristina S. B.; Horst, Andrea; Moraes, Maira S.; Scheid, Taina; Kolberg, Carolina; Bello-Klein, Adriane; Partata, Wania A.] Univ Fed Rio Grande do Sul, Dept Fisiol, Inst Ciencias Basicas Saude, BR-90050170 Porto Alegre, RS, Brazil	Partata, WA (corresponding author), Univ Fed Rio Grande do Sul, Dept Fisiol, Inst Ciencias Basicas Saude, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.	partataw@gmail.com			Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Byers MR, 2001, BONICAS MANAGEMENT P, P26; Clemens JA, 2000, FREE RADICAL BIO MED, V28, P1526, DOI 10.1016/S0891-5849(00)00258-6; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Guedes RP, 2006, NEUROCHEM RES, V31, P603, DOI 10.1007/s11064-006-9058-2; Guedes R, 2008, CELL MOL NEUROBIOL, V28, P1049, DOI 10.1007/s10571-008-9279-9; Guedes RP, 2009, BRAIN RES BULL, V80, P422, DOI 10.1016/j.brainresbull.2009.08.007; IASP-InternationaL Association for the Study of Pain, 2008, PAIN S, V3, pS1; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Joe B, 1997, MOL CELL BIOCHEM, V168, P87, DOI 10.1023/A:1006834924854; Khalil Z, 2001, FREE RADICAL BIO MED, V31, P430, DOI 10.1016/S0891-5849(01)00597-4; Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007; Latremoliere A, 2008, J NEUROSCI, V28, P8489, DOI 10.1523/JNEUROSCI.2552-08.2008; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mruk DD, 2002, CONTRACEPTION, V65, P305, DOI 10.1016/S0010-7824(01)00320-1; Muthuraman A, 2008, EUR J PHARMACOL, V587, P104, DOI 10.1016/j.ejphar.2008.03.042; Nalk AK, 2006, EUR J PAIN, V10, P573, DOI 10.1016/j.ejpain.2005.08.006; Nishikawa M, 2009, ADV DRUG DELIVER REV, V61, P319, DOI 10.1016/j.addr.2009.01.001; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Rhee S G, 2000, Sci STKE, V2000, ppe1; Roe JH, 1943, J BIOL CHEM, V147, P399; Rossato MF, 2010, J PAIN, V11, P545, DOI 10.1016/j.jpain.2009.09.016; Sodergren E, 1998, J BIOCHEM BIOPH METH, V37, P137, DOI 10.1016/S0165-022X(98)00025-6; SPECTOR R, 1977, BIOCHEM PHARMACOL, V26, P1507, DOI 10.1016/0006-2952(77)90423-3; Tsai CC, 2005, J PERIODONTAL RES, V40, P378, DOI 10.1111/j.1600-0765.2005.00818.x; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vaculin S, 2010, NEUROSCI LETT, V477, P82, DOI 10.1016/j.neulet.2010.04.037; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vanderah TW, 2007, MED CLIN N AM, V91, P1, DOI 10.1016/j.mcna.2006.10.006; Varija D, 2009, INDIAN J MED RES, V129, P587; Viggiano A, 2005, BRAIN RES, V1050, P72, DOI 10.1016/j.brainres.2005.05.021; Yowtak J, 2011, PAIN, V152, P844, DOI 10.1016/j.pain.2010.12.034	38	16	18	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2012	37	9					1952	1958		10.1007/s11064-012-0815-0			7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	985PP	WOS:000307280100014	22674084				2021-06-18	
J	Leonardo, CC; Musso, J; Das, M; Rowe, DD; Collier, LA; Mohapatra, S; Pennypacker, KR				Leonardo, Christopher C.; Musso, James; Das, Mahasweta; Rowe, Derrick D.; Collier, Lisa A.; Mohapatra, Shyam; Pennypacker, Keith R.			CCL20 Is Associated with Neurodegeneration Following Experimental Traumatic Brain Injury and Promotes Cellular Toxicity In Vitro	TRANSLATIONAL STROKE RESEARCH			English	Article						Chemokine; Hypoxia; Inflammation; Ischemia; MIP-3 alpha; Rodent	ISCHEMIA-REPERFUSION; LIVER; ISCHEMIA/REPERFUSION; MECHANISMS; EXPRESSION; STROKE; DEATH; RATS	Traumatic brain injury (TBI) is complex and involves multiple processes that contribute to functional decline. Progressive neuropathies result from delayed cellular death following the initial impact. Although the precise mechanisms responsible for delayed injury are unknown, numerous data implicate a role for the peripheral immune system in perpetuating neuroinflammation after TBI. A previous report demonstrated that splenic CCL20 chemokine expression was upregulated 24 h after lateral fluid percussive impact (LFPI), prior to neuronal expression but consistent with neurodegeneration. Here, we expand on those data to report increased CCL20 protein expression in white matter 48 h after LFPI and demonstrate that CCL20 is directly toxic to primary neurons and oligodendrocytes subjected to oxygen glucose deprivation. The temporal expression profile of CCL20, coupled with in vitro toxicity to primary cells, suggests that this chemokine exerts deleterious effects on cell viability following TBI. These findings warrant further investigations into the use of CCL20 as a potential biomarker and/or therapeutic target.	[Pennypacker, Keith R.] Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Biomed Sci, Morsani Coll Med, Tampa, FL 32612 USA; [Mohapatra, Shyam] Univ S Florida, Coll Med, Dept Internal Med, Sch Biomed Sci, Tampa, FL 32612 USA; [Leonardo, Christopher C.; Musso, James; Rowe, Derrick D.; Collier, Lisa A.; Pennypacker, Keith R.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 32612 USA; [Das, Mahasweta; Mohapatra, Shyam] Univ S Florida, Morsani Coll Med, Dept Internal Med, Tampa, FL 32612 USA	Pennypacker, KR (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Biomed Sci, Morsani Coll Med, Tampa, FL 32612 USA.	smohapat@health.usf.edu; kpennypa@health.usf.edu	Pennypacker, Keith/I-5092-2012; Mohapatra, Shyam/C-2500-2012		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS052839]	This work was supported by NIH RO1 NS052839. We want to thank Dr. Christopher Katnik and Jesus Recio for their effort with the primary neuronal cultures. There are no conflicts of interest.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Duckworth EAM, 2005, BRAIN RES, V1042, P29, DOI 10.1016/j.brainres.2005.02.021; Fan CG, 1999, J MOL MED, V77, P577, DOI 10.1007/s001099900029; Freyaldenhoven TE, 1997, BRAIN RES, V759, P9, DOI 10.1016/S0006-8993(97)00045-0; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hall AA, 2009, J NEUROSCI RES, V87, P333, DOI 10.1002/jnr.21857; Jaeschke H, 2000, J GASTROEN HEPATOL, V15, P718, DOI 10.1046/j.1440-1746.2000.02207.x; Jiang HC, 2007, SURGERY, V141, P32, DOI 10.1016/j.surg.2006.03.024; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Okuaki Y, 1996, LIVER, V16, P188; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rowe DD, 2010, BRAIN RES, V1366, P172, DOI 10.1016/j.brainres.2010.09.078; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Savas MC, 2003, J PEDIATR SURG, V38, P1465, DOI 10.1016/S0022-3468(03)00497-4; Shimizu Y, 2001, HEPATOLOGY, V34, P311, DOI 10.1053/jhep.2001.26631; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005	19	16	16	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483			TRANSL STROKE RES	Transl. Stroke Res.	SEP	2012	3	3			SI		357	363		10.1007/s12975-012-0203-8			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	992FK	WOS:000307760800009	24323811				2021-06-18	
J	Olson-Madden, JH; Forster, JE; Huggins, J; Schneider, A				Olson-Madden, Jennifer H.; Forster, Jeri E.; Huggins, Joseph; Schneider, Alexandra			Psychiatric Diagnoses, Mental Health Utilization, High-Risk Behaviors, and Self-Directed Violence Among Veterans With Comorbid History of Traumatic Brain Injury and Substance Use Disorders	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						risky behaviors; substance use disorder; suicide; traumatic brain injury; utilization; veterans	TBI IDENTIFICATION METHOD; ABUSE; ALCOHOL; RELIABILITY; SUICIDALITY; PREVALENCE; VALIDITY; OUTCOMES	Objectives: To describe various characteristics of veterans with co-occurring histories of traumatic brain injury (TBI) and substance use disorder (SUD) for purposes of hypothesis generation. Study Design: Archival data collected over a period of 4 years. Participants: Sixty-five veterans across eras of service with confirmed histories of TBI and SUD. Methods: Demographic and TBI information were obtained from an archival clinical database. Electronic medical records were reviewed for mental health utilization, psychiatric diagnoses, self-directed violence, and risk-taking behaviors. Results: In addition to a SUD, veterans were reported to have an average of 3 additional psychiatric diagnoses and a median of 3 TBIs per person. All utilized various mental health services in addition to substance use treatment. Individuals were found to have engaged in a variety of risky behaviors. There were significant associations between suicidal ideation and assaultive behaviors, as well as between suicide attempt and impulsivity. Conclusions: This study describes a sample of veterans with co-occurring histories of TBI, SUD, risk-taking behaviors, and self-directed violence. More research is needed to examine these complex interrelationships and to identify specific risk factors for intervention/prevention strategies.	[Olson-Madden, Jennifer H.; Huggins, Joseph; Schneider, Alexandra] Mental Illness Res Educ & Clin Ctr, VISN 19, Denver, CO 80220 USA; [Olson-Madden, Jennifer H.] Univ Colorado, Dept Psychiat, Denver, CO 80202 USA; [Forster, Jeri E.] Univ Colorado, Dept Pediat, Denver, CO 80202 USA; [Forster, Jeri E.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Forster, Jeri E.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Denver, CO 80202 USA	Olson-Madden, JH (corresponding author), Mental Illness Res Educ & Clin Ctr, VISN 19, 1055 Clermont St, Denver, CO 80220 USA.	jennifer.olson-madden@va.gov		Huggins, Joe/0000-0001-8151-5062	Eastern Colorado Health Care System Veterans Affairs Medical Center in Denver, Colorado; VISN 19 MIRECC	This material is the result of work supported with resources and the use of facilities at the Eastern Colorado Health Care System Veterans Affairs Medical Center in Denver, Colorado, and the VISN 19 MIRECC.	Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Defense Task Force on Prevention of Suicide by Members of the Armed Forces, 2010, EX SUMM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hufford MR, 2001, CLIN PSYCHOL REV, V21, P797, DOI 10.1016/S0272-7358(00)00070-2; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Miller N. S., 2005, TXB TRAUMATIC BRAIN, P509; Office of Applied Studies, 2007, DAWN SER D; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Ruff R. M., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI DOI 10.1097/00001199-199009000-00006; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Tate PS, 1999, BRAIN INJURY, V13, P767; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Zuckerman M., 1994, BEHAV EXPRESSION BIO; Zuckerman M., 2007, SENSATION SEEKING RI	30	16	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2012	27	5					370	378		10.1097/HTR.0b013e318268d496			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	004OQ	WOS:000308691400091	22955102				2021-06-18	
J	Orringer, DA; Vago, DR; Golby, AJ				Orringer, Daniel A.; Vago, David R.; Golby, Alexandra J.			Clinical Applications and Future Directions of Functional MRI	SEMINARS IN NEUROLOGY			English	Article						functional magnetic resonance imaging (fMRI); blood oxygenation level dependent (BOLD); tractography; tumor mapping; language lateralization; traumatic brain injury (TBI); epilepsy surgery	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; SUBGENUAL PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; MAJOR DEPRESSION; WORKING-MEMORY; PREOPERATIVE ASSESSMENT; EEG-FMRI; CHOLINERGIC ENHANCEMENT	First described for use in mapping the human visual cortex in 1991, functional magnetic resonance imaging (fMRI) is based on blood-oxygen level dependent (BOLD) changes in cortical regions that occur during specific tasks. Typically, an overabundance of oxygenated (arterial) blood is supplied during activation of brain areas. Consequently, the venous outflow from the activated areas contains a higher concentration of oxyhemoglobin, which changes the paramagnetic properties of the tissue that can be detected during a T2-star acquisition. fMRI data can be acquired in response to specific tasks or in the resting state. fMRI has been widely applied to studying physiologic and pathophysiologic diseases of the brain. This review will discuss the most common current clinical applications of fMRI as well as emerging directions.	[Orringer, Daniel A.; Vago, David R.; Golby, Alexandra J.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Orringer, Daniel A.; Vago, David R.; Golby, Alexandra J.] Harvard Univ, Sch Med, Boston, MA USA	Golby, AJ (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	agolby@partners.org	Vago, David/P-5264-2014; Vago, David/I-4341-2019	Vago, David/0000-0002-6269-9027; Vago, David/0000-0002-6269-9027; Orringer, Daniel/0000-0001-6427-8376	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R25 CA089017] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U41 RR019703] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB015898] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R25CA089017] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR019703, U41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015898] Funding Source: NIH RePORTER		Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Atlas SW, 1996, NEUROSURGERY, V38, P329, DOI 10.1097/00006123-199602000-00019; Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Binder JR, 2008, EPILEPSIA, V49, P1377, DOI 10.1111/j.1528-1167.2008.01625.x; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Bizzi A, 2008, RADIOLOGY, V248, P579, DOI 10.1148/radiol.2482071214; Blomstedt P, 2011, ACTA PSYCHIAT SCAND, V123, P4, DOI 10.1111/j.1600-0447.2010.01625.x; Bremner J Douglas, 2002, CNS Spectr, V7, P129; Bremner JD, 2002, CNS SPECTRUMS, V7, P135; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chen CM, 2008, RADIOLOGY, V248, P971, DOI 10.1148/radiol.2483071280; Cheung MC, 2009, J NEUROL NEUROSUR PS, V80, P1099, DOI 10.1136/jnnp.2009.173161; Chhatwal JP, 2012, J ALZHEIMERS DIS, V31, pS155, DOI 10.3233/JAD-2012-120730; Damasio A., 1994, DESCARTESERROR EMOTI; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; DREVETS WC, 2004, NEUROBIOLOGY MENTAL, P461; Dupont S, 2010, RADIOLOGY, V255, P128, DOI 10.1148/radiol.09091079; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Frings L, 2008, EPILEPSY RES, V78, P161, DOI 10.1016/j.eplepsyres.2007.11.006; Fu CHY, 2008, BIOL PSYCHIAT, V64, P505, DOI 10.1016/j.biopsych.2008.04.033; Gasco J, 2009, STEREOT FUNCT NEUROS, V87, P395, DOI 10.1159/000258080; Gasser T, 2005, NEUROIMAGE, V26, P685, DOI 10.1016/j.neuroimage.2005.02.022; Gasser T, 2011, ACTA NEUROCHIR SUPPL, V109, P61, DOI 10.1007/978-3-211-99651-5_10; George MS, 1997, J NEUROPSYCH CLIN N, V9, P55; GEORGE MS, 1994, BIOL PSYCHIAT, V35, P647, DOI 10.1016/0006-3223(94)90776-5; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; Golby A, 2005, BRAIN, V128, P773, DOI 10.1093/brain/awh400; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gron G, 2002, ANN NEUROL, V51, P491, DOI 10.1002/ana.10157; Hall WA, 2005, SURG NEUROL, V64, P20, DOI 10.1016/j.surneu.2004.08.099; Hall Walter A, 2009, Top Magn Reson Imaging, V19, P205, DOI 10.1097/RMR.0b013e3181934a09; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Holodny AI, 1999, AM J NEURORADIOL, V20, P609; Hou BL, 2006, NEUROIMAGE, V32, P489, DOI 10.1016/j.neuroimage.2006.04.188; Janszky J, 2006, EPILEPSIA, V47, P921, DOI 10.1111/j.1528-1167.2006.00514.x; Jimenez De La Pena M, 2012, RADIOLOGIA; Johnson SC, 2006, NEUROBIOL AGING, V27, P1604, DOI 10.1016/j.neurobiolaging.2005.09.017; Kapsalakis IZ, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/727810; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.987.899; Kim MJJ, 2005, AM J NEURORADIOL, V26, P1980; Koylu B, 2008, BRAIN RES, V1223, P73, DOI 10.1016/j.brainres.2008.05.075; Krings T, 2001, J NEUROL NEUROSUR PS, V70, P749, DOI 10.1136/jnnp.70.6.749; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Ludemann L, 2006, J MAGN RESON IMAGING, V23, P435, DOI 10.1002/jmri.20530; Machulda MM, 2003, NEUROLOGY, V61, P500, DOI 10.1212/01.WNL.0000079052.01016.78; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Moeller F, 2009, NEUROLOGY, V73, P2023, DOI 10.1212/WNL.0b013e3181c55d17; Nimsky C, 2006, NEUROL RES, V28, P482, DOI 10.1179/016164106X115125; Nimsky C, 2011, NEUROSURG CLIN N AM, V22, P269, DOI 10.1016/j.nec.2010.11.005; Ota T, 2009, BRIT J NEUROSURG, V23, P406, DOI 10.1080/02688690902838815; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Petrella JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001104; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Powell HWR, 2008, J NEUROL NEUROSUR PS, V79, P686, DOI 10.1136/jnnp.2007.115139; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Ries ML, 2008, J AM GERIATR SOC, V56, P920, DOI 10.1111/j.1532-5415.2008.01684.x; Roessler K, 2005, J NEUROL NEUROSUR PS, V76, P1152, DOI 10.1136/jnnp.2004.050286; Roux FE, 2003, NEUROSURGERY, V53, P1342, DOI 10.1227/01.NEU.0000093424.71086.8F; Roux FE, 2003, NEUROSURGERY, V52, P1335, DOI 10.1227/01.NEU.0000064803.05077.40; Sabsevitz DS, 2003, NEUROLOGY, V60, P1788, DOI 10.1212/01.WNL.0000068022.05644.01; Sakatani K, 2003, ACT NEUR S, V87, P59; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; Saykin AJ, 2004, BRAIN, V127, P1574, DOI 10.1093/brain/awh177; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schwindt GC, 2009, NEUROIMAGE, V45, P181, DOI 10.1016/j.neuroimage.2008.11.024; Shanks MF, 2007, MAGN RESON IMAGING, V25, P848, DOI 10.1016/j.mri.2007.02.005; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shinoura N, 2007, STEREOT FUNCT NEUROS, V85, P99, DOI 10.1159/000098524; Signorelli F, 2003, MINIM INVAS NEUROSUR, V46, P265; Signorelli F, 2001, NEUROL SCI, V22, P3, DOI 10.1007/s100720170029; Small SA, 1999, ANN NEUROL, V45, P466, DOI 10.1002/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Suarez RO, 2009, EPILEPSY BEHAV, V16, P288, DOI 10.1016/j.yebeh.2009.07.034; Swanson SJ, 2007, NEUROPSYCHOL REV, V17, P491, DOI 10.1007/s11065-007-9050-x; Ulmer JL, 2003, AM J NEURORADIOL, V24, P213; Vago DR, 2011, NEUROSURG CLIN N AM, V22, P279, DOI 10.1016/j.nec.2011.01.003; Wagner K, 2012, J NEUROL NEUROSUR PS, V83, P503, DOI 10.1136/jnnp-2011-300417; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wierenga CE, 2011, NEUROPSYCHOLOGIA, V49, P392, DOI 10.1016/j.neuropsychologia.2010.12.011; Wilke M, 2011, HUM BRAIN MAPP, V32, P1882, DOI 10.1002/hbm.21156; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	109	16	16	0	30	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	SEP	2012	32	4					466	475		10.1055/s-0032-1331816			10	Clinical Neurology	Neurosciences & Neurology	077AD	WOS:000313999400014	23361489	Green Accepted			2021-06-18	
J	Schuur, JD; Brown, MD; Cheung, DS; Graff, L; Griffey, RT; Hamedani, AG; Kelly, JJ; Klauer, K; Phelan, M; Sierzenski, PR; Raja, AS				Schuur, Jeremiah D.; Brown, Michael D.; Cheung, Dickson S.; Graff, Louis; Griffey, Richard T.; Hamedani, Azita G.; Kelly, John J.; Klauer, Kevin; Phelan, Michael; Sierzenski, Paul R.; Raja, Ali S.			Assessment of Medicare's Imaging Efficiency Measure for Emergency Department Patients With Atraumatic Headache	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-CARE; RADIATION-EXPOSURE; UNITED-STATES; FREQUENCY; VISITS; CT	Study objective: Computed tomography (CT) use has increased rapidly, raising concerns about radiation exposure and cost. The Centers for Medicare & Medicaid Services (CMS) developed an imaging efficiency measure (Outpatient Measure 15 [OP-15]) to evaluate the use of brain CT in the emergency department (ED) for atraumatic headache. We aim to determine the reliability, validity, and accuracy of OP-15. Methods: This was a retrospective record review at 21 US EDs. We identified 769 patient visits that CMS labeled as including an inappropriate brain CT to identify clinical indications for CT and reviewed the 748 visits with available records. The primary outcome was the reliability of OP-15 as determined by CMS from administrative data compared with medical record review. Secondary outcomes were the measure's validity and accuracy. Outcome measures were defined according to the testing protocol of the American Medical Association's Physician Consortium for Performance Improvement. Results: On record review, 489 of 748 ED brain CTs identified as inappropriate by CMS had a measure exclusion documented that was not identified by administrative data; the measure was 34.6% reliable (95% confidence interval [CI] 31.2% to 38.0%). Among the 259 patient visits without measure exclusions documented in the record, the measure's validity was 47.5% (95% CI 41.4% to 53.6%), according to a consensus list of indications for brain CT. Overall, 623 of the 748 ED visits had either a measure exclusion or a consensus indication for CT; the measure's accuracy was 16.7% (95% CI 14% to 19.4%). Hospital performance as reported by CMS did not correlate with the proportion of CTs with a documented clinical indication (r=-0.11; P=.63). Conclusion: The CMS imaging efficiency measure for brain CTs (OP-15) is not reliable, valid, or accurate and may produce misleading information about hospital ED performance. [Ann Emerg Med. 2012;60:280-290.]	[Schuur, Jeremiah D.; Raja, Ali S.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Raja, Ali S.] Brigham & Womens Hosp, Ctr Evidence Based Imaging, Boston, MA 02115 USA; [Schuur, Jeremiah D.; Raja, Ali S.] Harvard Univ, Sch Med, Boston, MA USA; [Brown, Michael D.] Spectrum Hlth, Dept Emergency Med, Grand Rapids, MI USA; [Brown, Michael D.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Cheung, Dickson S.] Carepoint PC, Denver, CO USA; [Graff, Louis] Hosp Cent Connecticut, Dept Emergency Med, New Britain, CT USA; [Graff, Louis] Univ Connecticut, Sch Med, Farmington, CT USA; [Griffey, Richard T.] Washington Univ, Sch Med, Inst Publ Hlth, St Louis, MO USA; [Griffey, Richard T.] Barnes Jewish Hosp, St Louis, MO 63110 USA; [Hamedani, Azita G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Kelly, John J.] Albert Einstein Med Ctr, Dept Emergency Med, Philadelphia, PA 19141 USA; [Kelly, John J.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Klauer, Kevin] Emergency Med Phys Ltd, Canton, OH USA; [Klauer, Kevin] Michigan State Univ, Coll Osteopath Med, Barberton, OH USA; [Klauer, Kevin] Michigan State Univ, Coll Osteopath Med, Wadsworth, OH USA; [Klauer, Kevin] Summa Hlth Syst, Barberton, OH USA; [Klauer, Kevin] Summa Hlth Syst, Wadsworth, OH USA; [Phelan, Michael] Cleveland Clin, Emergency Serv Inst, Qual & Patients Safety Inst, Cleveland, OH 44106 USA; [Sierzenski, Paul R.] Christiana Care Hlth Syst, Dept Emergency Med, Newark, DE USA	Schuur, JD (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	jschuur@partners.org	Raja, Ali S./AAE-5103-2019	Griffey, Richard/0000-0002-6279-7380	Brigham and Women's Physician Organization (BWPO); HealthONE, LLC; Hospital Corporation of America	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Dr. Schuur received a performance improvement grant from the Brigham and Women's Physician Organization (BWPO), which supported this project. The BWPO had no role in the study design, analysis of the data, or publication. Dr. Schuur developed a performance measure of appropriate head CT imaging in adults with acute atraumatic headache that was reviewed by the same National Quality Forum (NQF) panel that reviewed Outpatient Measure 15 (OP-15). This measure was rejected by the NQF committee and Dr. Schuur receives no financial benefit from this measure. Dr. Schuur serves as a member of the American College of Emergency Physicians (ACEP) Quality and Performance Committee. As a member of this committee, Dr. Schuur has drafted comments to the NQF and Centers for Medicare & Medicaid Services (CMS) during public comment periods on OP-15. Dr. Cheung receives consulting fees from HealthONE, LLC and the Hospital Corporation of America and serves as a member of the ACEP Quality and Performance Committee. As a member of this committee, he has drafted comments to the NQF and CMS during public comment periods on OP-15.	[Anonymous], CONTR REP; Baumann BM, 2011, ANN EMERG MED, V58, P1, DOI 10.1016/j.annemergmed.2010.10.018; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P74122; Department of Health and Human Services Centers for Medicare & Medicaid Services, 2011, FED REGISTER, V76, P42170; Drescher FS, 2011, ANN EMERG MED, V57, P613, DOI 10.1016/j.annemergmed.2010.09.018; Friedman BW, 2007, ANN EMERG MED, V49, P409, DOI 10.1016/j.annemergmed.2006.11.004; Frishberg B, EVIDENCE BASED GUIDE; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Gilbert JW, 2011, EMERG MED J; Goldstein JN, 2006, CEPHALALGIA, V26, P684, DOI 10.1111/j.1468-2982.2006.01093.x; *HOSP COMP, HOSP COMP QUAL TOOL; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jain S, 2010, PEDIATR EMERG CARE, V26, P902, DOI 10.1097/PEC.0b013e3181fe9108; Jordan JE, ACR APPROPRIATENESS; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Krumholz HM, 2008, CIRCULATION, V118, P1885, DOI 10.1161/CIRCULATIONAHA.108.190500; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Measures Implementation and Evaluation (MIE) Advisory Committee, 2010, MEAS TEST PROT PHYS; *MEDPAC, 2010, HLTH CAR SPEND MED P; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; *NAT QUAL FOR, EFF IM EFF; National Quality Forum, MEAS EV CRIT; Prevedello LM, AM J MED IN PRESS; QualityNet, IM EFF MEAS; Raja AS, 2011, ARCH INTERN MED, V171, P260, DOI 10.1001/archinternmed.2010.520; Raja AS, 2010, ANN EMERG MED, V56, P597, DOI 10.1016/j.annemergmed.2010.09.013; Raja AS, RADIOLOGY IN PRESS; Raosoft, SAMPL SIZ CALC; Scottish Intercollegiate Guidelines Network, 2008, SIGN PUBL; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Sun ZH, 2011, J MED IMAG HEALTH IN, V1, P21, DOI 10.1166/jmihi.2011.1003; Thijs RD, 2004, CLIN AUTON RES, V14, P4, DOI 10.1007/s10286-004-1002-4	37	16	16	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	SEP	2012	60	3					280	290		10.1016/j.annemergmed.2011.12.025			11	Emergency Medicine	Emergency Medicine	003OF	WOS:000308620500008	22364867				2021-06-18	
J	Stuart, B; Mandleco, B; Wilshaw, R; Beckstrand, RL; Heaston, S				Stuart, Barbara; Mandleco, Barbara; Wilshaw, Russell; Beckstrand, Renea L.; Heaston, Sondra			MILD TRAUMATIC BRAIN INJURY: ARE ED PROVIDERS IDENTIFYING WHICH PATIENTS ARE AT RISK?	JOURNAL OF EMERGENCY NURSING			English	Article						MTBI; Head injury; Concussion; Post-concussive syndrome	POST-CONCUSSION SYNDROME; GENDER-DIFFERENCES; HEAD-INJURIES; COMPLAINTS; SYMPTOMS; IMPACT	Objective: To identify patients with specific ED discharge diagnoses reporting symptoms associated with a mild traumatic brain injury (MTBI), compare frequency/severity of MTBI symptoms by discharge diagnosis, investigate head injury education provided at ED discharge, and learn about changes made by MTBI patients after injury. Methods: The Post Concussion Symptom Scale, a demographic questionnaire, and open-ended questions about the impact the injury had on patients' lives were completed by 52 ED patients, at least 2 weeks after injury, discharged with concussion/closed head injury, head laceration, motor vehicle crash (MVC), or whiplash/cervical strain diagnoses. Results: Between 1 and 23 MTBI symptoms were reported by 84.6% of the participants. Headache and fatigue were the most common; female patients had almost twice as many symptoms on average as male patients. Of MVC patients, 83.3% reported moderate severity scores for all 4 Post Concussion Symptom Scale categories, and these represented the highest overall severity scores. Concussion/closed head injury diagnosis patients received the most head injury education. The majority of patients were more cautious after injury. Conclusion: Most participants reported having MTBI symptoms. Although MVC participants reported the most severe MTBI symptoms, they had the least head injury education. Emergency nurses need to be aware patients may have an MTBI regardless of their presenting symptoms or injury severity.	[Mandleco, Barbara; Heaston, Sondra] Brigham Young Univ, Coll Nursing, Provo, UT 84602 USA; [Stuart, Barbara] Utah Valley Reg Med Ctr, Emergency Dept, Provo, UT USA; [Wilshaw, Russell] Univ Utah Hlth Care, Salt Lake City, UT USA	Mandleco, B (corresponding author), Brigham Young Univ, Coll Nursing, 474 SWKT, Provo, UT 84602 USA.	barbara_mandleco@byu.edu	Beckstrand, Renea/AAL-9507-2020	Beckstrand, Renea/0000-0002-9456-6536	Brigham Young University Graduate Studies research grant	This project was funded by a Brigham Young University Graduate Studies research grant.	Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bergman K, 2010, J EMERG NURS, V36, P221, DOI 10.1016/j.jen.2009.07.001; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; *CDCP, HEADS BRAIN INJ YOUR; Centers for Disease Control and Prevention, TBI PUBL; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Jennett B, 1981, MANAGEMENT HEAD INJU; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kozak G S, 1989, J Emerg Nurs, V15, P18; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Polit D. F., 2010, ESSENTIALS NURSING R; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Wei HG, 2000, ACAD EMERG MED, V7, P710, DOI 10.1111/j.1553-2712.2000.tb02052.x; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	35	16	16	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	SEP	2012	38	5					435	442		10.1016/j.jen.2011.04.006			8	Emergency Medicine; Nursing	Emergency Medicine; Nursing	007SG	WOS:000308907800014	21774974	Green Published			2021-06-18	
J	Yellowlees, PM; Holloway, KM; Parish, MB				Yellowlees, Peter M.; Holloway, Kevin M.; Parish, Michelle Burke			Therapy in Virtual Environments-Clinical and Ethical Issues	TELEMEDICINE AND E-HEALTH			English	Article						virtual environment; virtual reality; post-traumatic stress disorder treatment; traumatic brain injury treatment; ethical and legal guidelines for virtual reality	REALITY EXPOSURE THERAPY; ANXIETY DISORDERS; BRAIN-INJURY; VIETNAM VETERANS; MENTAL-HEALTH; REHABILITATION; PSYCHOTHERAPY; SIMULATION; AVATARS; PHOBIA	Background: As virtual reality and computer-assisted therapy strategies are increasingly implemented for the treatment of psychological disorders, ethical standards and guidelines must be considered. This study determined a set of ethical and legal guidelines for treatment of post-traumatic stress disorder (PTSD)/traumatic brain injury (TBI) in a virtual environment incorporating the rights of an individual who is represented by an avatar. Materials and Methods: A comprehensive literature review was undertaken. An example of a case study of therapy in Second Life (a popular online virtual world developed by Linden Labs) was described. Results: Ethical and legal considerations regarding psychiatric treatment of PTSD/TBI in a virtual environment were examined. The following issues were described and discussed: authentication of providers and patients, informed consent, patient confidentiality, patient well-being, clinician competence (licensing and credentialing), training of providers, insurance for providers, the therapeutic environment, and emergencies. Ethical and legal guidelines relevant to these issues in a virtual environment were proposed. Conclusions: Ethical and legal issues in virtual environments are similar to those that occur in the in-person world. Individuals represented by an avatar have the rights equivalent to the individual and should be treated as such.	[Yellowlees, Peter M.] Univ Calif Davis, Dept Psychiat, Sacramento, CA 95817 USA; [Holloway, Kevin M.] Natl Ctr Telehlth & Technol, Tacoma, WA USA; [Parish, Michelle Burke] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA	Yellowlees, PM (corresponding author), Univ Calif Davis, Dept Psychiat, 2450 48th St,Suite 2856, Sacramento, CA 95817 USA.	pmyellowlees@ucdavis.edu					Anderson P, 2003, COGN BEHAV PRACT, V10, P240, DOI 10.1016/S1077-7229(03)80036-6; [Anonymous], 2010, PRACTICING MED TELEM; Bart O, 2011, DISABIL REHABIL, V33, P1579, DOI 10.3109/09638288.2010.540291; Bell MD, 2011, SCHIZOPHRENIA BULL, V37, pS91, DOI 10.1093/schbul/sbr061; Botella C, 2000, BEHAV THER, V31, P583, DOI 10.1016/S0005-7894(00)80032-5; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Cobb SVG, 1999, PRESENCE-TELEOP VIRT, V8, P169, DOI 10.1162/105474699566152; Coodin S, 2001, PSYCHIATR REHABIL J, V24, P299, DOI 10.1037/h0095082; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Ferrer-Garcia M, 2010, STUD HEALTH TECHNOL, V154, P44, DOI 10.3233/978-1-60750-561-7-44; Ferrer-Garcia M, 2009, BEHAV MODIF, V33, P830, DOI 10.1177/0145445509348056; Flaherty JH, 2002, ACAD MED, V77, P336, DOI 10.1097/00001888-200204000-00017; Garcia-Palacios A, 2002, BEHAV RES THER, V40, P983, DOI 10.1016/S0005-7967(01)00068-7; Gorini A, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1029; Gorrindo T, 2009, ACAD PSYCHIATR, V33, P413, DOI 10.1176/appi.ap.33.5.413; Gourlay D, 2000, INT J MED INFORM, V60, P255, DOI 10.1016/S1386-5056(00)00100-3; Graber MA, 2011, MED HUMANIT, V37, P9, DOI 10.1136/jmh.2010.005637; Graber MA, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1299; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Gregg L, 2007, SOC PSYCH PSYCH EPID, V42, P343, DOI 10.1007/s00127-007-0173-4; Hodges LF, 2001, IEEE COMPUT GRAPH, V21, P25, DOI 10.1109/38.963458; Hoffman HG, 2004, SCI AM, V291, P58, DOI 10.1038/scientificamerican0804-58; Hoffman HG, 2011, ANN BEHAV MED, V41, P183, DOI 10.1007/s12160-010-9248-7; Hsiung RC, 2001, TELEMED J E-HEALTH, V7, P39, DOI 10.1089/153056201300093895; Hsiung RC, 2002, E THERAPY CASE STUDI; Klinger E, 2005, CYBERPSYCHOL BEHAV, V8, P76, DOI 10.1089/cpb.2005.8.76; Kramer TL, 2010, PSYCHIAT SERV, V61, P1153, DOI 10.1176/ps.2010.61.11.1153; Krijn M, 2004, CLIN PSYCHOL REV, V24, P259, DOI 10.1016/j.cpr.2004.04.001; Meyerbroker K, 2011, STUD COMPUT INTELL, V337, P47; Meyerbroker K, 2010, DEPRESS ANXIETY, V27, P933, DOI 10.1002/da.20734; Nagel DM, 2009, TELEHEALTH WORLD, P1; Nichols S, 2002, APPL ERGON, V33, P251, DOI 10.1016/S0003-6870(02)00020-0; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Perpina C, 2003, EUR EAT DISORD REV, V11, P261, DOI 10.1002/erv.520; Reger GM, 2011, J TRAUMA STRESS, V24, P93, DOI 10.1002/jts.20574; Repetto C, 2011, NEUROPSYCHIATRY-LOND, V1, P31, DOI 10.2217/NPY.11.5; Riva G, 2005, CYBERPSYCHOL BEHAV, V8, P220, DOI 10.1089/cpb.2005.8.220; Riva Giuseppe, 2011, J Diabetes Sci Technol, V5, P283; Riva G, 2009, BRIT J GUID COUNS, V37, P337, DOI 10.1080/03069880902957056; Rizzo A, 2011, J CLIN PSYCHOL MED S, V18, P176, DOI 10.1007/s10880-011-9247-2; Rizzo AS, 2002, STUD NEUROPSYCHOL DE, P243; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Rothbaum BO, 1999, J TRAUMA STRESS, V12, P263, DOI 10.1023/A:1024772308758; Rothbaum BO, 2010, CORSINI ENCY PSYCHOL; Salo R, 2002, PSYCHIAT RES, V111, P65, DOI 10.1016/S0165-1781(02)00111-7; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Schmitt YS, 2011, BURNS, V37, P61, DOI 10.1016/j.burns.2010.07.007; Schneider S M, 1999, Cyberpsychol Behav, V2, P125, DOI 10.1089/cpb.1999.2.125; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Taylor CB, 2003, CURR DIR PSYCHOL SCI, V12, P18, DOI 10.1111/1467-8721.01214; Wilson J, 2010, USE TECHNOLOGY MENTA, P104; Wood DP, 2010, CYBERPSYCH BEH SOC N, V13, P3, DOI 10.1089/cyber.2009.0396; Wootton R, 2003, TELEPSYCHIATRY E MEN; Wright J H, 1997, J Psychother Pract Res, V6, P315; Yellowlees P, 2010, TELEMED J E-HEALTH, V16, P1074, DOI 10.1089/tmj.2010.0148; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	56	16	17	1	54	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	SEP	2012	18	7					558	564		10.1089/tmj.2011.0195			7	Health Care Sciences & Services	Health Care Sciences & Services	004TF	WOS:000308703300013	22823138				2021-06-18	
J	Colak, T; Cine, N; Bamac, B; Kurtas, O; Ozbek, A; Bicer, U; Sunnetci, D; Savli, H				Colak, T.; Cine, N.; Bamac, B.; Kurtas, O.; Ozbek, A.; Bicer, U.; Sunnetci, D.; Savli, H.			Microarray-based gene expression analysis of an animal model for closed head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Rats; Craniocerebral trauma; Microarray	TRAUMATIC BRAIN-INJURY; C1Q FAMILY PROTEINS; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; GROWTH-FACTOR; ANGIOGENESIS; ISCHEMIA; DEATH; PATHOPHYSIOLOGY; MECHANISMS	Objective: Traumatic brain injury (TBI) is a major cause of death and disability in both children and the elderly. Mortality from TBI is said account for 1-2% of all deaths. One-third to one-half of all traumatic deaths is due to head injury. Of those who survive, the majority is left with significant disabilities, including 3% who remain in a vegetative state and only approximately 30% who make a good recovery. Microarray studies and other genomic techniques facilitate the discovery of new targets for the treatment of diseases, which aids in drug development, immunotherapeutics and gene therapy. Gene expression profiling or microarray analysis enables the measurement of thousands of genes in a single RNA sample. Methods: In this study, adult Wistar-albino rats underwent TBI using a trauma device. Brain tissues and blood samples were taken for gene expression at 1, 12 and 48 h post-trauma and were then analysed via microarray. Total RNA was isolated using an RNeasy Mini Kit (QIAGEN-Sample & Assay Technologies, Hilden, Germany) and tested using a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Overall changes in gene expression were evaluated using Agilent Whole Rat Genome 4 x 44 K oligonucleotide arrays and analysed with GeneSpring (GeneSpring 6.1, Silicon Genetics, Redwood City, CA) software. Only genes with a signal-to-noise ratio of above 2 in the experiments were included in the statistical analysis. Results: ANOVA (p < 0.05) was performed to identify differentially expressed probe sets. Additional filtering (minimum 2-fold change) was applied to extract the most differentially expressed genes based on the study groups (Control vs. 1st hour, Control vs. 12th hour, Control vs. 48th hour). Differentially expressed genes were detected via microarray analysis. A gene interaction-based network investigation of the genes that were identified via traditional microarray data analysis describes a significantly relevant gene network that includes the C1ql2, Cbnl, Sdc1, Bdnf, MMP9, and Cd47 genes, which were differentially expressed compared with the controls. Conclusions: In this study, we will review the current understanding of the genetic susceptibility of TBI with microarrays. Our results highlight the importance of genes that control the response of the brain to injury as well as the suitability of microarrays for identifying specific targets for further study. (C) 2012 Elsevier Ltd. All rights reserved.	[Colak, T.; Bamac, B.; Ozbek, A.] Kocaeli Univ, Sch Med, Dept Anat, TR-41380 Kocaeli, Turkey	Colak, T (corresponding author), Kocaeli Univ, Sch Med, Dept Anat, TR-41380 Kocaeli, Turkey.	tuncaycolak@live.com	Colak, Tuncay/F-5749-2018; Cine, Naci/M-5957-2019; Ozbek, Aydin/AAV-6294-2020; Ozbek, Aydin/J-4519-2018; Bamac, Belgin/F-7373-2018; Cine, Naci/F-7299-2018	Colak, Tuncay/0000-0002-9483-3243; Ozbek, Aydin/0000-0001-5864-8166; Cine, Naci/0000-0001-9063-1073; Bicer, Umit/0000-0002-2242-3894			Akdemir G, 2008, TURKIYE KLIN J NEURO, V1, P6; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bekman ZM, 2007, TURKIYE KLIN J INT M, V3, P35; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Colak T, 2010, TURK KLIN TIP BILIM, V30, P1171, DOI 10.5336/medsci.2009-11356; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Del Bigio MR, 1999, NEUROPATH APPL NEURO, V25, P54; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Jaakkola P, 2000, PROG NUCLEIC ACID RE, V63, P109; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; Koshimizu H, 2002, J NEUROCHEM, V82, P249, DOI 10.1046/j.1471-4159.2002.00965.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Oh JH, 2009, GYNECOL ONCOL, V114, P509, DOI 10.1016/j.ygyno.2009.05.027; Oh LYS, 1999, J NEUROSCI, V19, P8464; REINHOLD MI, 1995, J CELL SCI, V108, P3419; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; SLEMMON JR, 1985, P NATL ACAD SCI USA, V82, P7145, DOI 10.1073/pnas.82.20.7145; Son BC, 2000, ACT NEUR S, V76, P13; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun CY, 2006, CHINESE MED J-PEKING, V119, P589, DOI 10.1097/00029330-200604010-00013; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; URADE Y, 1991, P NATL ACAD SCI USA, V88, P1069, DOI 10.1073/pnas.88.3.1069; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Xing CH, 2009, J NEUROSCI RES, V87, P2571, DOI 10.1002/jnr.22076; Xing CH, 2009, J NEUROCHEM, V108, P430, DOI 10.1111/j.1471-4159.2008.05777.x; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Yong VW, 1998, TRENDS NEUROSCI, V21, P75; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Yuzaki M, 2010, EUR J NEUROSCI, V32, P191, DOI 10.1111/j.1460-9568.2010.07346.x; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.3.CO;2-N	46	16	17	0	22	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	AUG	2012	43	8					1264	1270		10.1016/j.injury.2012.01.021			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	970FG	WOS:000306112900006	22341557				2021-06-18	
